<SEC-DOCUMENT>0001628280-23-035989.txt : 20231101
<SEC-HEADER>0001628280-23-035989.hdr.sgml : 20231101
<ACCEPTANCE-DATETIME>20231101161710
ACCESSION NUMBER:		0001628280-23-035989
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		84
CONFORMED PERIOD OF REPORT:	20230930
FILED AS OF DATE:		20231101
DATE AS OF CHANGE:		20231101

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO THERAPEUTICS, INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		231368484

	BUSINESS ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANGAMO BIOSCIENCES INC
		DATE OF NAME CHANGE:	20000208
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sgmo-20230930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:66e428df-1cd2-4a45-95e8-7711e67a648c,g:c0e019b1-92dd-475a-ba81-4eb41606269d,d:dd6e71910c45410381852f4f4adeb648--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2023" xmlns:sgmo="http://www.sangamo.com/20230930" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sgmo-20230930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-25">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-26">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-27">Q3</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-28">0001001233</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" id="f-29">--12-31</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sgmo-20230930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">sgmo:ChangeInAgreementEstimateMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">sgmo:ChangeInAgreementEstimateSeptember2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">sgmo:ChangeInAgreementEstimateSeptember2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:OtherLicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:OtherLicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:OtherLicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:OtherLicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sgmo:USGovernmentSponsoredAgencyBondMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sgmo:USGovernmentSponsoredAgencyBondMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sgmo:USGovernmentSponsoredAgencyBondMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sgmo:USGovernmentSponsoredAgencyBondMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sgmo:USGovernmentSponsoredAgencyBondMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="milestone"><xbrli:measure>sgmo:milestone</xbrli:measure></xbrli:unit><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfCommercialMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>sgmo:product</xbrli:measure></xbrli:unit><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="option"><xbrli:measure>sgmo:option</xbrli:measure></xbrli:unit><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="performance_obligation"><xbrli:measure>sgmo:performance_obligation</xbrli:measure></xbrli:unit><xbrli:unit id="material_right"><xbrli:measure>sgmo:material_right</xbrli:measure></xbrli:unit><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-27</xbrli:startDate><xbrli:endDate>2020-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product_target"><xbrli:measure>sgmo:product_target</xbrli:measure></xbrli:unit><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-15</xbrli:startDate><xbrli:endDate>2023-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sgmo:LeaseholdImprovementsAndConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sgmo:FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-26</xbrli:startDate><xbrli:endDate>2023-04-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>sgmo:employee</xbrli:measure></xbrli:unit><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">sgmo:FullTimeEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-26</xbrli:startDate><xbrli:endDate>2023-04-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">sgmo:ContractedEmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-26</xbrli:startDate><xbrli:endDate>2023-04-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:November2023RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-11</xbrli:startDate><xbrli:endDate>2023-10-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:November2023RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:November2023RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sgmo:ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-28</xbrli:startDate><xbrli:endDate>2023-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sgmo:ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-28</xbrli:startDate><xbrli:endDate>2023-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sgmo:ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-28</xbrli:startDate><xbrli:endDate>2023-10-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="idd6e71910c45410381852f4f4adeb648_1"></div><div style="min-height:36pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.527%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Washington, D.C. 20549</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________________________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________________________________</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Mark One)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">September 30, 2023</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-30171</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________________________________</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">SANGAMO THERAPEUTICS, INC.</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:30.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.165%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.958%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">68-0359556</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">7000 Marina Blvd.</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Brisbane</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">California</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">94005</ix:nonNumeric></span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices) (Zip Code)</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">510</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">970-6000</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________________________</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.722%"><tr><td style="width:1.0%"></td><td style="width:38.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">SGMO</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:2pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.722%"><tr><td style="width:1.0%"></td><td style="width:21.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#9744;</span></div><div style="margin-top:2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;&#9744;&#160;&#160;&#160;&#160;&#160;No&#160;&#160; <ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9746;</ix:nonNumeric></span></div><div style="margin-top:2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of October&#160;30, 2023, <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">177,346,980</ix:nonFraction> shares of the issuer&#8217;s common stock, par value $0.01 per share, were outstanding.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.527%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.988%"><tr><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#idd6e71910c45410381852f4f4adeb648_16">PART I. FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_19">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_19">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_19">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_22">Condensed Consolidated Balance Sheets at </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_22">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_22"> 30, 2023 and December 31, 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_25">Condensed Consolidated Statements of Operations for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_25">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_25">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_25"> 30, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_28">Condensed Consolidated Statements of Comprehensive Loss for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_28">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_28"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_28">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_28"> 30, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_31">Condensed Consolidated Statements of Stockholders&#8217; Equity for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_31">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_31"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_31">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_31"> 30, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_34">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_34">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_34"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_34">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_34"> 30, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_34">11</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_37">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_37">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_79">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_79">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_79">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_100">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_100">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_100">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_103">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_103">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_103">41</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#idd6e71910c45410381852f4f4adeb648_106">PART II. OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_109">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_109">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_109">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_112">Item&#160;1A</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_112">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_112">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_115">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_115">Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_115">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_118">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_118">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_118">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_121">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_121">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_121">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_124">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_124">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_124">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_127">Item&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_127">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_127">53</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#idd6e71910c45410381852f4f4adeb648_130">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_130">54</a></span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated or the context suggests otherwise, references in this Quarterly Report on Form 10-Q, or Quarterly Report, to &#8220;Sangamo,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Sangamo Therapeutics, Inc. and our subsidiaries, including Sangamo Therapeutics France S.A.S. and Sangamo Therapeutics UK Ltd.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any third-party trade names, trademarks and service marks appearing in this Quarterly Report are the property of their respective holders.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE&#160;REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some statements contained in this report are &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These statements relate to our future events, including our anticipated operations, research, development, manufacturing and commercialization activities, clinical trials, operating results and financial condition. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements about:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our strategy;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated research and development of product candidates and potential commercialization of any resulting approved products;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, scope, rate of progress, enrollment, dosing, anticipated results and timing of our preclinical studies and clinical trials and those of our collaborators or strategic partners;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the therapeutic and commercial potential of our product candidates, including the durability of therapeutic effects;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the therapeutic and commercial potential of technologies used by us in our product candidates, including our gene therapy and cell therapy technologies, zinc finger, or ZF, technology platform, zinc finger nucleases, or ZF&#160;nucleases, and zinc finger transcriptional regulators, or ZF-TRs, which include zinc finger repressors, or ZF-Rs, and zinc finger activators, or ZF-As;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to establish and maintain collaborations and strategic partnerships and realize the expected benefits of such arrangements, including our ability to find potential new collaboration partners for programs that were previously the subject of collaboration agreements as well as for our Fabry disease gene therapy and CAR-Treg cell therapy programs;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated revenues from existing and new collaborations and the timing thereof;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates regarding the impact of the macroeconomic environment on our business and operations and the business and operations of our collaborators, including clinical trials and manufacturing, and our ability to manage such impacts;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our research and development and other expenses;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain adequate preclinical and clinical supplies of our product candidates from current and potential new suppliers and manufacturers or from our own in-house manufacturing facilities;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of Sangamo and our collaborators and strategic partners to obtain and maintain regulatory approvals for product candidates and the timing and costs associated with obtaining regulatory approvals;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with, and the impact of, regulatory requirements, obligations and restrictions on our business and operations;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others, including our ability to obtain and maintain rights to the technologies required to develop and commercialize our product candidates;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competitive developments, including the impact on our competitive position of rival products and product candidates and our ability to meet such competition;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our strategic pipeline prioritization, including plans for advancing our preclinical programs, and the expected charges and cost savings associated with our restructurings and any future cost reduction measures;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates regarding the sufficiency of our cash resources and our expenses, capital requirements and need for substantial additional financing, and our ability to obtain additional financing;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to continue to operate as a going concern, including our estimate that our available cash, cash equivalents and marketable securities as of September 30, 2023, in combination with the cost savings expected from the restructuring, workforce reduction and other potential cost reductions, will be sufficient to fund our planned operations into the third quarter of 2024;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our projected operating and financial performance;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our operational and legal risks; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our plans, objectives, expectations and intentions and any other statements that are not historical facts.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by use of future dates or by terms such as: &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;continues,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;seeks,&#8221; &#8220;should,&#8221; &#8220;will&#8221; and similar expressions intended to identify forward-looking statements. These statements reflect our current views with respect to future events, are based on assumptions and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, without limitation:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">There is substantial doubt about our ability to continue to operate as a going concern. We need substantial additional funding to execute our operating plan and to continue to operate as a going concern. We estimate that our available cash, cash equivalents and marketable securities as of September 30, 2023, in combination with the cost savings expected from the restructuring, workforce reduction and other potential cost reductions, will be sufficient to fund our planned operations only into the third quarter of 2024. If adequate funds are not available to us on a timely basis, or at all, we will be required to take additional actions to address our liquidity needs, including additional cost reduction measures such as further reducing operating expenses and delaying, reducing the scope of, discontinuing or altering our research and development activities, which would have a material adverse effect on our business and prospects, or we may be required to cease operations entirely, liquidate all or a portion of our assets, and/or or seek protection under applicable bankruptcy laws, and you may lose all or part of your investment. Future sales and issuances of equity securities would also result in substantial dilution to our stockholders.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are a clinical-stage biotechnology company with no approved products or product revenues. Our success depends substantially on clinical trial results demonstrating safety, efficacy and durability of our product candidates to the satisfaction of regulatory authorities. Obtaining positive clinical trial results and regulatory approvals is expensive, lengthy, challenging and unpredictable and may never occur for any product candidates.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are early in our research and development efforts for our core preclinical neurology programs that are the current focus, all of which are still in preclinical development. We may encounter difficulties in advancing product candidates from research programs to preclinical and clinical development.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Success in research and preclinical studies or early clinical trial results may not be indicative of results obtained in later trials. Likewise, preliminary, initial or interim data from clinical trials may be materially different from final data.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Many of our product candidates are based on novel ZF technologies that have yet to yield any approved commercially viable therapeutic products.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have historically incurred significant operating losses since inception and anticipate continued losses for the foreseeable future. We may never become profitable.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely heavily on collaborations with biopharmaceutical companies to generate revenues and develop, obtain regulatory approvals for and commercialize some of our product candidates. If conflicts arise with our collaborators or if the collaborations terminate for any reason, our revenues and product development efforts would be negatively impacted.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Biotechnology and genomic medicine are highly competitive businesses. Our competitors may develop rival technologies and products that are superior to or are commercialized more quickly than our technologies and product candidates.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Manufacturing genomic medicines is complex, expensive, highly regulated and risky. We are currently substantially reliant on third</span><span style="color:#2b2e2f;font-family:'Lucida Sans Unicode',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8209;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">party manufacturers. Manufacturing challenges may result in unexpected costs, supply interruptions and harm and delay to our product development efforts.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Even if we obtain regulatory approvals for our product candidates, our approved products may not gain market acceptance among physicians and patients and adequate coverage and reimbursement from third-party payors and may not demonstrate commercial viability.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to obtain, maintain and enforce necessary and desirable intellectual property protections for our technologies and product candidates in all desired jurisdictions, which could adversely affect the value of our technologies and our product development efforts and could increase the risks of costly, lengthy and distracting litigation with unpredictable results.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Third parties, who may or may not be competitors, may allege that we are infringing, misappropriating, or otherwise practicing in an unauthorized manner their patents or other proprietary rights. Such allegations may result in infringement actions, other misappropriation actions or threats of such actions, all of which could increase the risks of costly, lengthy and distracting litigation with unpredictable results.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our success depends on hiring, integrating and retaining additional highly qualified skilled employees and retaining current key executives and employees, which may be challenging given the uncertainty regarding our ability to obtain sufficient additional funding and to continue to operate as a going concern as well as the competition among numerous biopharmaceutical companies and academic institutions for individuals with these skills.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unfavorable global economic conditions could have a negative impact on our operations, which could materially and adversely affect our ability to continue to operate as a going concern and otherwise have a material adverse effect on our business, financial condition, results of operations, prospects and market price of our common stock.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The market price of our common stock has been and will likely continue to be volatile, and you could lose all or part of any investment in our common stock.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have fully impaired our goodwill and indefinite-lived intangible assets, have recorded significant impairment of our right-of-use and other long-lived assets, and may be required to record in the future significant additional charges if our long-lived assets become further impaired.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We currently do not meet, and may not regain compliance with, the listing standards of the Nasdaq Stock Market LLC, and as a result our common stock may be delisted. Delisting could adversely affect the liquidity of our common stock and the market price of our common stock could decrease, and our ability to obtain sufficient additional capital to fund our operations and to continue to operate as a going concern would be substantially impaired. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our recent restructurings may not result in anticipated savings or operational efficiencies, could result in total costs and expenses that are greater than expected and could disrupt our business.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional discussion of the risks, uncertainties and other factors described above, as well as other risks and uncertainties material to our business, can be found under &#8220;Risk Factors&#8221; in Part&#160;I, Item&#160;1A of our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022 as filed with the Securities and Exchange Commission on February&#160;23, 2023, as supplemented by the risks described under &#8220;Risk Factors&#8221; in Part II, Item 1A of this Quarterly Report on Form 10-Q, and we encourage you to refer to that additional discussion. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our plans, objectives, estimates, expectations and intentions only as of the date of this filing. You should read this report completely and with the understanding that our actual future results and the timing of events may be materially different from what we expect, and we cannot otherwise guarantee that any forward-looking statement will be realized. We hereby qualify all of our forward-looking statements by these cautionary statements.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by law, we undertake no obligation to update or supplement any forward-looking statements publicly, or to update or supplement the reasons that actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. You are advised, however, to consult any further disclosures we make on related subjects. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report includes discussion of certain clinical studies and trials relating to various product candidates. These studies typically are part of a larger body of clinical data relating to such product candidates, and the discussion herein should be considered in the context of the larger body of data. In addition, clinical data are subject to differing interpretations, and even if we view data as sufficient to support the safety and/or effectiveness of a product candidate, regulatory authorities may not share our views and may require additional data or may deny approval altogether.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="idd6e71910c45410381852f4f4adeb648_19"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 1.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS</span></div><div id="idd6e71910c45410381852f4f4adeb648_22"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited; in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:74.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-30">56,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">100,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="f-32">75,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="f-33">177,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InterestReceivableCurrent" scale="3" id="f-34">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InterestReceivableCurrent" scale="3" id="f-35">794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">1,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">3,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-38">13,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-39">18,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-40">147,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-41">300,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent" format="ixt:fixed-zero" scale="3" id="f-42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-43">29,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-44">28,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-45">63,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="f-46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-47">50,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="3" id="f-48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-49">37,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-50">27,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-51">62,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">14,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-53">17,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-54">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-55">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-56">219,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-57">562,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">15,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-59">22,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-60">17,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">21,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-62">14,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-63">16,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-64">1,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-65">51,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-66">48,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">111,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">109,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">34,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">38,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="f-72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-73">6,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-75">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-76">84,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-77">267,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-78"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-79"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-82">1,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-83">1,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-84">1,485,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-85">1,450,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-86">1,346,081</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-87">1,148,545</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-88">6,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-89">8,404</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-90">134,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-91">294,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-92">219,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-93">562,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited; in thousands, except per share amounts)</span></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-94">9,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-95">26,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-96">174,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-97">84,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-98">57,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-99">65,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-100">183,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-101">183,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-102">13,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-103">16,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-104">48,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-105">46,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of goodwill and indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="f-106">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="f-107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="f-108">89,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="f-109">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="f-110">44,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="f-111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="f-112">65,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="f-113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-114">115,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-115">81,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-116">386,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-117">229,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-118">106,408</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-119">54,894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-120">211,946</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-121">145,889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestAndOtherIncome" format="ixt:num-dot-decimal" scale="3" id="f-122">3,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestAndOtherIncome" format="ixt:num-dot-decimal" scale="3" id="f-123">1,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestAndOtherIncome" format="ixt:num-dot-decimal" scale="3" id="f-124">9,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestAndOtherIncome" format="ixt:num-dot-decimal" scale="3" id="f-125">5,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-126">102,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-127">53,125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-128">202,336</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-129">140,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-130">1,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-131">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-132">4,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-133">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-134">104,163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-135">53,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-136">197,536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-137">140,305</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net loss per share</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-138"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-139">0.59</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-140"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-141">0.34</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-142"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-143">1.14</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-144"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-145">0.93</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing basic and diluted net loss per share </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-146"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-147">177,171</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-148"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-149">158,042</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-150"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-151">173,375</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-152"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-153">150,850</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited; in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-154">104,163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-155">53,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-156">197,536</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-157">140,305</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-158">1,144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-159">6,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-160">981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-161">14,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-162">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-163">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-164">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-165">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on marketable securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-166">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-167">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-168">840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-169">1,101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-170">104,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-171">58,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-172">195,713</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-173">155,316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited; in thousands, except share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.563%"><tr><td style="width:1.0%"></td><td style="width:30.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.480%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.421%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>(Loss) Income</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-174">177,074,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-175">1,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-176">1,479,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-177">1,241,918</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-178">5,936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-179">233,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-180">205,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-181">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-182">103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-183">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-184">6,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-185">6,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="f-186">1,144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="f-187">1,144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net pension gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="f-188">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="f-189">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net unrealized gain on marketable securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-190">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-191">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-192">104,163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-193">104,163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-194">177,279,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-195">1,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-196">1,485,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-197">1,346,081</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-198">6,581</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-199">134,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.563%"><tr><td style="width:1.0%"></td><td style="width:30.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.480%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.421%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2023</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>(Loss) Income</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-200">166,793,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-201">1,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-202">1,450,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-203">1,148,545</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-204">8,404</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-205">294,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in at-the-market offering, net of offering expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-206">8,249,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-207">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-208">15,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-209">15,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-210">1,481,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-211">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-212">1,419</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-213">1,404</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-214">755,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-215">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-216">712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-217">719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-218">21,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-219">21,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="f-220">981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="f-221">981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net pension gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="f-222">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="f-223">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net unrealized gain on marketable securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-224">840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-225">840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-226">197,536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-227">197,536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-228">177,279,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-229">1,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-230">1,485,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-231">1,346,081</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-232">6,581</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-233">134,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited; in thousands, except share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.706%"><tr><td style="width:1.0%"></td><td style="width:30.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.405%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>(Loss) Income</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-234">153,352,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-235">1,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-236">1,373,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-237">1,043,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-238">13,160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-239">318,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in at-the-market offering, net of offering expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-240">8,483,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-241">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-242">42,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-243">42,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-244">82,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="f-245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-246">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-247">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-248">7,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-249">7,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="f-250">6,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="f-251">6,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net pension gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="f-252">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="f-253">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net unrealized gain on marketable securities, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-254">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-255">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-256">53,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-257">53,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-258">161,918,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-259">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-260">1,423,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-261">1,096,572</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-262">18,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-263">309,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.270%"><tr><td style="width:1.0%"></td><td style="width:29.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.580%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>(Loss) Income</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-43" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-264">145,921,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-265">1,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-266">1,334,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-267">956,267</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-268">3,987</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-269">375,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in at-the-market offering, net of offering expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-270">14,711,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-271">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-272">66,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-273">66,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-274">925,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-275">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-276">1,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-277">1,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-278">359,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-279">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="f-280">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="f-281">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-282">23,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-283">23,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="f-284">14,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="f-285">14,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net pension gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="f-286">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="f-287">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net unrealized loss on marketable securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-288">1,101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-289">1,101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-290">140,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-291">140,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-292">161,918,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-293">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-294">1,423,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-295">1,096,572</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-296">18,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-297">309,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited; in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:74.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-298">197,536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-299">140,305</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of goodwill and indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="f-300">89,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="f-301">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="f-302">65,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="f-303">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-304">13,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-305">8,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of discounts and impairment on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-306">2,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="f-307">324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization in operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-308">5,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-309">6,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-310">6,195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-312">21,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-313">23,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-314">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-315">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="3" id="f-316">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="3" id="f-317">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-318">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-319">1,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-320">5,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-321">5,848</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-322">5,220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-323">9,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and employee benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-324">4,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-325">1,225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-326">159,671</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-327">64,956</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-328">3,737</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-329">3,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="f-330">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="f-331">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-332">174,304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-333">166,578</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-334">59,551</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-335">225,621</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="f-336">193,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="f-337">254,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-338">18,484</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-339">12,697</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-340">115,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-341">16,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from at-the-market offering, net of offering expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-342">15,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-343">65,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-344">1,404</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-345">1,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:fixed-zero" scale="3" id="f-346">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="f-347">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="f-348">719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-349">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-350">14,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-351">65,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-352">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-353">479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-354">43,930</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-355">84,302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-356">101,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-357">180,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents, and restricted cash, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-358">58,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-359">96,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment included in unpaid liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-360">2,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-361">3,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenant improvement allowance included in contra-lease liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="sgmo:TenantImprovementAllowanceWithinContraLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-362">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="sgmo:TenantImprovementAllowanceWithinContraLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-363">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="idd6e71910c45410381852f4f4adeb648_40"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="f-364" continuedAt="f-364-1" escape="true">ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="f-364-1" continuedAt="f-364-2"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization and Description of Business</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo Therapeutics, Inc. (&#8220;Sangamo&#8221; or &#8220;the Company&#8221;) was incorporated in the State of Delaware in June 1995 and changed its name from Sangamo Biosciences, Inc. in January 2017. Sangamo is a clinical-stage genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients with serious diseases.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-365" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of these financial statements for the periods presented have been included. Operating results for the three and nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. The Condensed Consolidated Balance Sheet data at December&#160;31, 2022 was derived from the audited Consolidated Financial Statements included in Sangamo&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (the &#8220;2022 Annual Report&#8221;) as filed with the SEC on February&#160;23,&#160;2023.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-366" escape="true">The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in the Condensed Consolidated Financial Statements.</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements and related financial information should be read together with the audited Consolidated Financial Statements and footnotes for the year ended December&#160;31, 2022, included in the 2022 Annual Report.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity, Going Concern, and Capital Resources</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo is currently working on a number of long-term development projects that involve experimental technologies. The projects will require several years and substantial expenditures to complete and ultimately may be unsuccessful. In recent years, the Company&#8217;s operations have been funded primarily through collaborations and strategic partnerships, research grants and from the issuance of equity securities. As of September&#160;30, 2023, the Company had capital resources of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="f-367">132.1</ix:nonFraction>&#160;million consisting of cash, cash equivalents, and marketable securities. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Accounting Standard Codification Topic 205-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Presentation of Financial Statements&#8212;Going Concern</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC Topic 205-40&#8221;), the Company has the responsibility to evaluate whether conditions and/or events raise substantial doubt about its ability to meet its future financial obligations as they become due within one year after the date that the Condensed Consolidated Financial Statements are issued. As required under ASC Topic 205-40, management&#8217;s evaluation should initially not take into consideration the potential mitigating effects of management&#8217;s plans that have not been fully implemented as of the date the Condensed Consolidated Financial Statements are issued. When substantial doubt exists, management evaluates whether the mitigating effects of its plans sufficiently alleviates the substantial doubt about the Company&#8217;s ability to continue as a going concern. The mitigating effects of management&#8217;s plans, however, are only considered if both (i) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (ii) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued. Generally, to be considered probable of being effectively implemented, the plans must have been approved by the Company&#8217;s board of directors before the date that the financial statements are issued.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s history of significant losses, its negative cash flows from operations, its limited liquidity resources currently on hand, and its dependence on additional financing to fund its operations after the current resources are exhausted raise substantial doubt about its ability to continue to operate as a going concern within one year after the date that the Condensed Consolidated Financial Statements are issued. The Company&#8217;s current operating plan, its cash, cash equivalents, and marketable </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-364-2" continuedAt="f-364-3"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities as of September 30, 2023 are expected to allow the Company to meet its liquidity requirements only into the third quarter of 2024, which is less than one year following the date these Condensed Consolidated Financial Statements are issued. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Successful completion of the Company&#8217;s development programs and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to support the Company&#8217;s cost structure and operating plan. Management&#8217;s plans include, among other things, pursuing one or more of the following steps to raise additional capital and reduce costs, none of which can be guaranteed or are entirely within the Company&#8217;s control:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">raise funding through the sale of the Company&#8217;s common stock;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">raise funding through debt or royalty financing; and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish collaborations with potential partners to advance the Company&#8217;s product pipeline.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company is unable to raise capital on acceptable terms, or at all, or if it is unable to procure collaboration arrangements or external direct investments to advance its programs, the Company would be required to discontinue some or all of its operations or develop and implement a plan to further extend payables, reduce overhead or scale back its current operating plan until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan would be successful. Additional capital may not be available to the Company on a timely basis, on terms that are acceptable or at all. In particular, the perception of the Company&#8217;s ability to continue to operate as a going concern may make it more difficult to obtain financing for the continuation of its operations, particularly in light of currently challenging macroeconomic and market conditions. Further, the Company may be unable to attract new investments as a result of the speculative nature of its newly reprioritized core neurology preclinical programs. If adequate funds are not available to the Company on a timely basis, or at all, the Company will be required to take additional actions to address its liquidity needs, including additional cost reduction measures such as further reducing operating expenses and delaying, reducing the scope of, discontinuing or altering its research and development activities, which would have a material adverse effect on its business and prospects, or the Company may be required to cease operations entirely, liquidate all or a portion of its assets, and/or or seek protection under applicable bankruptcy laws.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Condensed Consolidated Financial Statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts of liabilities that may result from uncertainty related to the Company&#8217;s ability to continue as a going concern.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Significant Accounting Policies</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-368" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. On an ongoing basis, management evaluates its estimates including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, income taxes, fair value of assets and liabilities, including from acquisitions, useful lives and impairment of long-lived assets, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company recorded additional revenue related to a change in estimate in connection with the collaboration agreement with Kite Pharma, Inc., a Gilead Sciences, Inc. subsidiary (&#8220;Kite&#8221;). This adjustment was driven by a reduction in the estimated future level of the Company&#8217;s research and development services and as a result, future project costs. This resulted in an increase in proportional cumulative performance on this collaboration and an increase in revenue of $<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-369">8.9</ix:nonFraction>&#160;million, a decrease in net loss of $<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" sign="-" name="sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="f-370">8.9</ix:nonFraction>&#160;million, and a decrease in the Company&#8217;s basic and diluted net loss per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-56" decimals="2" sign="-" name="sgmo:IncreaseDecreaseInEarningsPerShareDiluted" scale="0" id="f-371"><ix:nonFraction unitRef="usdPerShare" contextRef="c-56" decimals="2" sign="-" name="sgmo:IncreaseDecreaseInEarningsPerShareBasic" scale="0" id="f-372">0.05</ix:nonFraction></ix:nonFraction> for the nine months ended September 30, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2023, the Company recorded additional revenue related to a change in estimate in connection with the collaboration agreement with Kite. This adjustment was driven by a further reduction in the estimated future level of the Company&#8217;s research and development services and as a result, future project costs. This resulted in an increase in proportional cumulative performance on this collaboration and increased revenue by $<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-373"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-374">4.9</ix:nonFraction></ix:nonFraction> million, decreased net loss by $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" sign="-" name="sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="f-375"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" sign="-" name="sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="f-376">4.9</ix:nonFraction></ix:nonFraction> million, and decreased the Company's basic and diluted net loss per share by $<ix:nonFraction unitRef="usdPerShare" contextRef="c-57" decimals="2" sign="-" name="sgmo:IncreaseDecreaseInEarningsPerShareBasic" scale="0" id="f-377"><ix:nonFraction unitRef="usdPerShare" contextRef="c-58" decimals="2" sign="-" name="sgmo:IncreaseDecreaseInEarningsPerShareDiluted" scale="0" id="f-378"><ix:nonFraction unitRef="usdPerShare" contextRef="c-57" decimals="2" sign="-" name="sgmo:IncreaseDecreaseInEarningsPerShareDiluted" scale="0" id="f-379"><ix:nonFraction unitRef="usdPerShare" contextRef="c-58" decimals="2" sign="-" name="sgmo:IncreaseDecreaseInEarningsPerShareBasic" scale="0" id="f-380">0.03</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> for the three and nine months ended September 30, 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-364-3" continuedAt="f-364-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-381" continuedAt="f-381-1" escape="true"><div style="margin-top:9pt;padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its revenues pursuant to the provisions of Accounting Standards Codification Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC Topic 606&#8221;). The Company&#8217;s contract revenues are derived from collaboration agreements including licensing arrangements and research services. Research and licensing agreements typically include nonrefundable upfront signing or license fees, payments at negotiated rates for time incurred by Company researchers, third-party cost reimbursements, additional target selection fees, sublicense fees, milestone payments tied to ongoing development and product commercialization, and royalties on future licensees&#8217; product sales. All funds received from the Company&#8217;s collaboration partners are generally not refundable. Non-refundable upfront fees are fixed at the commencement of the contract. All other fees represent variable consideration in contracts. One of the Company&#8217;s contracts also contains a provision where the Company reimburses its customer for certain costs they incur which is accounted for as a reduction to the contract transaction price as the Company does not acquire any distinct goods or services in exchange for such payments. Deferred revenue primarily represents the portion of nonrefundable upfront fees or milestone payments received but not earned.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under its agreements, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations based on estimated selling prices; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company&#8217;s performance obligations in its collaboration agreements represent distinct bundles of licenses of intellectual property and research and development services, with these components being individually non-distinct. Options to license the Company&#8217;s intellectual property and/or acquire research and development services also represent performance obligations when they grant customers a material right, e.g., a right to a discount the customer would not have received if they did not purchase the Company&#8217;s services under the existing contract. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from bundles of licenses of intellectual property and research and development services are recognized over time using a proportional performance method. Under this method, revenue is recognized by measuring progress towards satisfaction of the relevant performance obligation using a measure that best depicts the progress towards satisfaction of the relevant performance obligation. For most of the Company&#8217;s agreements the measure of progress is an input measure based on a level of effort incurred, which includes the value of actual time by Company researchers plus third-party cost reimbursements. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration allocated to options that include material rights is deferred until the options are exercised or expire. The exercise of such options is accounted for as contract continuation, with target selection fees and estimated variable consideration included in the transaction price at that time and allocated specifically to the respective target&#8217;s performance obligation. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant management judgment is required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations under the arrangement. Changes in these estimates can have a material effect on revenue recognized. If the Company cannot reasonably estimate when its performance obligations either are completed or become inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. For variable consideration, the amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint and, if necessary, adjusts its estimate of the overall transaction price. A cumulative catch-up is then recorded in the current period to reflect the updated transaction price and the updated measure of progress. The estimated period of performance and level of effort, including the value of Company researchers&#8217; time and third-party costs, are reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current expectations.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price of each performance obligation identified in the contract. The Company uses key assumptions to determine the stand-alone selling price, which may include forecasted revenues, development timelines, discount rates and probabilities of exercise of technical and regulatory success, and the expected level of effort for research and development services. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract modifications occur when the price and/or scope of an arrangement changes. If the modification consists of adding new distinct goods or services in exchange for consideration that reflects standalone selling prices of these goods and services, the modification is accounted for as a separate contract with the customer. Otherwise, if the remaining goods and services are distinct from those previously provided, the existing contract is considered terminated, and the remaining consideration is allocated to the remaining goods and services as if this was a newly signed contract. If the remaining goods and services are not distinct from those previously provided, the effects of the modification are accounted for in a manner similar to the effect of a change in the estimated measure of progress, with cumulative catch-up in revenue recorded at the time of the </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-364-4" continuedAt="f-364-5"><ix:continuation id="f-381-1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">modification. If some of the remaining goods and services are distinct from those previously provided and others are not, to account for the effects of the modification the Company applies principles consistent with the objectives of the modification accounting.</span></div><ix:nonNumeric contextRef="c-1" name="sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" id="f-382" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from collaboration and licensing agreements as a percentage of total revenues were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kite Pharma, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-59" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-383">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-60" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-384">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-61" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-385">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-62" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-386">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen MA, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-63" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-387">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-64" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-388">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-65" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-389">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-66" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-390">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis Institutes for BioMedical Research, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-67" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:fixed-zero" scale="-2" id="f-391">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-68" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-392">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-69" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-393">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-70" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-394">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other licensing agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-71" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-395">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-72" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-396">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-73" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-397">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-74" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-398">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="f-399" continuedAt="f-399-1" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Goodwill, Indefinite-lived Intangible Assets and Long-lived Assets</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of consideration transferred over the fair values of assets acquired and liabilities assumed in a business combination. Intangible assets with indefinite useful lives are related to acquired in-process research and development (&#8220;IPR&amp;D&#8221;) projects and are initially measured at their respective fair values as of the acquisition date. Goodwill and indefinite-lived intangible assets are not amortized. Intangible assets related to IPR&amp;D projects are considered to be indefinite-lived until the completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs if and when regulatory approval to market a product is obtained, the associated assets would be deemed finite-lived and would then be amortized based on their respective estimated useful lives at that point in time.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite-lived intangible assets are assessed for impairment on an annual basis and whenever events and circumstances indicate that these assets may be impaired. The Company evaluates the carrying value of long-lived assets, which include property and equipment, leasehold improvements and right-of-use assets, for impairment whenever events or changes in circumstances indicate that the carrying amounts of the asset may not be fully recoverable.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In testing for goodwill impairment, the Company has the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If the Company elects to bypass the qualitative assessment, or if a qualitative assessment indicates it is more likely than not that the carrying value exceeds its fair value, the Company performs a quantitative goodwill impairment test to compare the fair value of its reporting unit to its carrying value, including goodwill. If the carrying value, including goodwill, exceeds the reporting unit&#8217;s fair value, the Company will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value (but not in excess of the carrying value of goodwill).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing each annual impairment assessment and any interim impairment assessment for its indefinite-lived intangible assets, the Company determines if it should qualitatively assess whether it is more likely than not the fair value of its IPR&amp;D asset is less than its carrying amount (the qualitative impairment test). If the Company concludes that is the case, or elects not to use the qualitative impairment test, the Company will proceed with quantitatively determining the fair value of the IPR&amp;D asset and comparing its fair value to its carrying value to determine the amount of impairment, if any (the quantitative impairment test).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the qualitative impairment test, the Company considers the results of the most recent quantitative impairment test and identifies the most relevant drivers of the fair value for the IPR&amp;D asset. The most relevant drivers of fair value identified are consistent with the assumptions used in the quantitative estimate of the IPR&amp;D asset. Using these drivers of fair value, the Company identifies events and circumstances which may have an effect on the fair value of the IPR&amp;D asset since the last time the IPR&amp;D&#8217;s fair value was quantitatively determined. The Company then weighs these factors to determine and conclude if it is not more likely than not the IPR&amp;D asset is impaired. If it is more likely than not the IPR&amp;D asset is impaired, the Company proceeds with quantitatively determining the fair value of the IPR&amp;D asset.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing the quantitative impairment test, the Company uses the income approach to determine the fair value of its IPR&amp;D asset. This approach calculates fair value by estimating the after-tax cash flows attributable to an in-process project over its useful life and then discounting these after-tax cash flows back to a present value. This estimate includes judgmental assumptions regarding the estimates that market participants would make in evaluating the IPR&amp;D asset, including the probability of successfully completing clinical trials and obtaining regulatory approval to market the IPR&amp;D asset, the timing of and the expected costs to complete IPR&amp;D projects, future net cash flows from potential drug sales, which are based on estimates of the sales price of the drug, the size of the patient population and cure rate, its competitive position in the marketplace, and appropriate discount and tax rates. Any impairment to be recorded is calculated as the difference between the estimated fair value and the carrying value of the IPR&amp;D asset on the Company&#8217;s Condensed Consolidated Balance Sheet.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-364-5" continuedAt="f-364-6"><ix:continuation id="f-399-1"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a change in circumstance occurs that indicates long-lived assets may be impaired, the Company performs a test of recoverability by comparing the carrying value of the asset or asset group to its undiscounted expected future cash flows. The long-lived asset evaluation is performed at the asset group level, i.e., the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. If this review indicates that the carrying amount of the asset group is not recoverable, an impairment loss is measured as the amount by which the carrying amount of an asset group exceeds its fair value. Any impairment loss is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets, except that the carrying amount of an individual asset shall not be reduced below its fair value.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that may indicate potential impairment and trigger an impairment test include, but are not limited to, general macroeconomic conditions, conditions specific to the industry and market, an adverse change in legal factors, impairment of goodwill or indefinite-lived intangible assets, business climate or operational performance of the business, and sustained decline in the stock price and market capitalization compared to the net book value.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Calculating the fair value of a reporting unit, an asset group and an individual asset involves significant estimates and assumptions. These estimates and assumptions include, among others, projected future cash flows, risk-adjusted discount rates, future economic and market conditions, and the determination of appropriate market comparables. Changes in these factors and assumptions used can materially affect the amount of impairment loss recognized in the period the asset was considered impaired.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-400" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo considers all highly liquid investments purchased with original maturities of three months or less at the purchase date to be cash equivalents. Cash and cash equivalents consist of cash, deposits in demand money market accounts and U.S. government-sponsored entity debt securities. Restricted cash consists of a letter of credit for $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="f-401">1.5</ix:nonFraction>&#160;million, representing a deposit for the lease of the corporate headquarters in Brisbane, California.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:36pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="f-402" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-403" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-404">56,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-405">100,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-406">94,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-407">178,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-408">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-409">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-410">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-411">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-412">58,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-413">101,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-414">96,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-415">180,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesPolicy" id="f-416" continuedAt="f-416-1" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo classifies its marketable securities as available-for-sale and records its investments at estimated fair value based on quoted market prices or observable market inputs of almost identical assets, with the unrealized holding gains and losses included in accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;). The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as non-current marketable securities in the accompanying Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments are subject to a periodic impairment review. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time and extent to which the fair value has been less than the cost basis, the Company's financial condition and its intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value. Realized gains and losses on marketable securities are included in interest and other income, net, which are determined using the specific identification method. Credit losses related to the marketable securities are recorded in interest and other income, net in the Condensed Consolidated Statements of Operations through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. </span></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-416-1">If the Company intends to sell, or if it is more likely than not that the Company will be required to sell, a security before recovery of its amortized cost basis, the allowance for credit losses is written off, and the amortized cost of the security is written down to its fair value, with an impairment charge recognized. This also results in a reversal of any unrealized gains and losses for this security that were previously included in AOCI. Impairment charges are included in interest and other income, net in the Condensed Consolidated Statements of Operations.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-417" continuedAt="f-417-1" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether it has the right to control the identified asset. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-364-6"><ix:continuation id="f-417-1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arising from the lease. Lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. Right-of-use assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the implicit rate in the Company&#8217;s leases is generally unknown, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of remaining lease payments. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease in a similar economic environment. The Company considers its credit risk, term of the lease, and total lease payments and adjusts for the impacts of collateral, as necessary, when calculating its incremental borrowing rates. The lease terms may include options to extend or terminate the lease when it is reasonably certain the Company will exercise any such options. Rent expense for the Company&#8217;s operating leases is recognized on a straight-line basis over the lease term. The Company will evaluate the lease arrangement for impairment whenever events or changes in circumstances indicate that the carrying amounts of the right-of-use asset may not be fully recoverable. To the extent an impairment of the right-of-use asset is recognized, the Company will recognize lease impairment and subsequently amortize the remaining lease asset on a straight-line basis (unless another systematic basis is more representative of the pattern in which the Company expects to consume the future economic benefits from the asset) from the date of impairment to the earlier of the end of the right-of-use asset&#8217;s useful life or the end of the lease term.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected not to separate lease and non-lease components for its real estate and copier leases and, as a result, accounts for any lease and non-lease components as a single lease component. The Company has also elected not to apply the recognition requirement to any leases with a term of 12 months or less and does not include an option to purchase the underlying asset that the Company is reasonably certain to exercise.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-418" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div></ix:nonNumeric></ix:continuation><div id="idd6e71910c45410381852f4f4adeb648_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-419" continuedAt="f-419-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-420" continuedAt="f-420-1" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="f-419-1"><ix:continuation id="f-420-1" continuedAt="f-420-2"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents and marketable securities. Fair value is determined based on a three-tier hierarchy under the authoritative guidance for fair value measurements and disclosures that prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurements and unobservable (i.e., supported by little or no market activity).</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-420-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="f-421" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurements of the Company&#8217;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-422">3,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-423">3,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-424">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-425">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-426">3,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-427">3,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-429">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-430">28,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-431">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-432">28,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-433">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-434">18,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-435">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-436">18,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-438">1,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-440">1,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-442">8,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-443">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-444">8,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-445">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-446">5,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-447">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-448">5,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-449">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-450">12,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-451">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-452">12,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-453">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-454">75,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-455">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-456">75,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-457">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-458">79,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-459">3,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-460">75,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-461">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-462">50,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-463">50,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-464">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-465">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-466">50,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-467">50,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-469">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-470">18,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-472">18,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-474">101,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-476">101,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-477">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-478">11,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-479">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-480">11,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-482">24,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-483">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-484">24,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-485">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-486">7,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-487">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-488">7,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-489">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-490">37,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-491">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-492">37,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-493">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-494">5,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-495">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-496">5,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-497">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-498">207,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-499">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-500">207,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-501">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-502">257,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-503">50,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-504">207,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-505">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents and Marketable Securities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally classifies its marketable securities as Level&#160;2. Instruments are classified as Level&#160;2 when observable market prices for identical securities that are traded in less active markets are used. When observable market prices for identical securities are not available, such instruments are priced using benchmark curves, benchmarking of like securities, sector groupings, matrix pricing and valuation models. These valuation models are proprietary to the pricing providers or brokers and incorporate a number of inputs, including in approximate order of priority: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications. For certain security types, additional inputs may be used, or some of the standard inputs may not be applicable. Evaluators may prioritize inputs differently on any given day for any security based on market conditions, and not all inputs listed are available for use in the evaluation process for each security evaluation on any given day.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="f-506" continuedAt="f-506-1" escape="true">CASH EQUIVALENTS AND MARKETABLE SECURITIES</ix:nonNumeric></span></div><ix:continuation id="f-506-1" continuedAt="f-506-2"><div style="margin-top:6pt;text-indent:36pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesTextBlock" id="f-507" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the Company&#8217;s cash equivalents and marketable securities (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-508">3,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-509">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-510">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-511">3,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-512">3,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-513">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-515">3,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-516">28,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-517">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-518">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-519">28,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-520">18,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-521">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-522">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-523">18,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-524">1,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-526">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-527">1,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-528">8,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-529">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-530">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-531">8,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-532">5,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-534">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-535">5,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-536">12,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-537">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-538">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-539">12,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-540">75,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-541">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-542">51</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-543">75,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="f-544">79,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" scale="3" id="f-545">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" scale="3" id="f-546">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-547">79,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-548">50,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-549">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-550">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-551">50,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-552">50,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-553">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-554">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-555">50,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-556">18,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-558">293</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-559">18,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-560">101,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-561">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-562">193</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-563">101,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-564">11,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-565">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-566">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-567">11,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-568">24,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-569">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-570">180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-571">24,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-572">7,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-573">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-574">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-575">7,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-576">37,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-577">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-578">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-579">37,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-580">5,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-581">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-582">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-583">5,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-584">207,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-585">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-586">918</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-587">207,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="f-588">258,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" scale="3" id="f-589">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" scale="3" id="f-590">918</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-591">257,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt;text-indent:36pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="f-592" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of marketable securities by contractual maturity were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:74.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="f-593">41,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="f-594">177,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="f-595">34,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="f-596">29,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-597">75,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-598">207,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:RealizedInvestmentGainsLosses" format="ixt:fixed-zero" scale="0" id="f-599"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="us-gaap:RealizedInvestmentGainsLosses" format="ixt:fixed-zero" scale="0" id="f-600"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="us-gaap:RealizedInvestmentGainsLosses" format="ixt:fixed-zero" scale="0" id="f-601"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:RealizedInvestmentGainsLosses" format="ixt:fixed-zero" scale="0" id="f-602">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> realized gains and losses on the sales of investments during the three and nine months ended September&#160;30, 2023 and 2022. Total unrealized gains for securities with net gains in accumulated other comprehensive income were not material for the three and nine months ended September&#160;30, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages credit risk associated with its investment portfolio through its investment policy, which limits purchases to high-quality issuers and also limits the amount of its portfolio that can be invested in a single issuer. The Company did <ix:nonFraction unitRef="usd" contextRef="c-7" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded" format="ixt:fixed-zero" scale="0" id="f-603"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded" format="ixt:fixed-zero" scale="0" id="f-604"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded" format="ixt:fixed-zero" scale="0" id="f-605"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded" format="ixt:fixed-zero" scale="0" id="f-606">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t record an allowance for credit losses related to its marketable securities for the three and nine months ended September&#160;30, 2023 and 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-506-2"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had unrealized losses related to its marketable securities for the three and nine months ended September&#160;30, 2023 and 2022. The Company had no material unrealized losses, individually and in the aggregate, for marketable securities that are in a continuous unrealized loss position for greater than 12 months as of September&#160;30, 2023 and December&#160;31, 2022. These unrealized losses were not attributed to credit risk and were associated with changes in market conditions. The Company periodically reviews its marketable securities for indications of credit losses. The Company considers factors such as the duration, the magnitude and the reason for the decline in value, the potential recovery period, creditworthiness of the issuers of the securities and its intent to sell. No significant facts or circumstances have arisen to indicate that there has been any significant deterioration in the creditworthiness of the issuers of the securities held by the Company. Based on the Company&#8217;s review of these securities, the Company determined that <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="0" id="f-607"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="0" id="f-608">no</ix:nonFraction></ix:nonFraction> allowance for credit losses related to its marketable securities was required at either September 30, 2023 or December 31, 2022.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also considers whether it is more likely than not that the Company will be required to sell the debt securities before recovery of their amortized cost basis. Based on the scheduled maturities of its investments and projection of its cash flows in accordance with the current operating plan as of September 30, 2023, the Company determined that it was more likely than not that it will be required to sell various securities before recovery of their amortized cost basis. As a result, the Company reclassified its non-current marketable securities investments of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="sgmo:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-609"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="sgmo:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-610">34.4</ix:nonFraction></ix:nonFraction>&#160;million as current as of September&#160;30, 2023 and recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="f-611"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="f-612">0.4</ix:nonFraction></ix:nonFraction>&#160;million related to those securities during the three and nine ended September&#160;30, 2023. <ix:nonFraction unitRef="usd" contextRef="c-6" decimals="INF" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:fixed-zero" scale="0" id="f-613"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="INF" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:fixed-zero" scale="0" id="f-614">No</ix:nonFraction></ix:nonFraction> impairment charges were recorded during the three and nine ended September&#160;30, 2022, as the Company concluded at that time it had the ability and intent to hold the long-term investments until maturity.</span></div></ix:continuation><div id="idd6e71910c45410381852f4f4adeb648_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-615" continuedAt="f-615-1" escape="true">BASIC AND DILUTED NET LOSS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="f-615-1"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share has been computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding during the period, without consideration of any potential dilutive securities, as their effect would be anti-dilutive.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The total number of shares subject to stock options and restricted stock units (&#8220;RSUs&#8221;) outstanding and the employee stock purchase plan (&#8220;ESPP&#8221;) shares reserved for issuance, which are all anti-dilutive, were excluded from consideration in the calculation of diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders. Stock options and RSUs outstanding and ESPP shares reserved for issuance as of September&#160;30, 2023 and 2022 totaled <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-616">22,131,291</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-617">18,524,016</ix:nonFraction>, respectively.</span></div></ix:continuation><div id="idd6e71910c45410381852f4f4adeb648_52"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-618" continuedAt="f-618-1" escape="true">MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES</ix:nonNumeric></span></div><ix:continuation id="f-618-1" continuedAt="f-618-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pfizer Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Giroctocogene Fitelparvovec Global Collaboration and License Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company entered into an exclusive global collaboration and license agreement with Pfizer Inc. (&#8220;Pfizer&#8221;), pursuant to which it established a collaboration for the research, development and commercialization of giroctocogene fitelparvovec, its gene therapy product candidate for hemophilia A, and closely related products.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under this agreement, the Company is responsible for conducting the Phase 1/2 clinical trial and for certain manufacturing activities for giroctocogene fitelparvovec, while Pfizer is responsible for subsequent worldwide development, manufacturing, marketing and commercialization of giroctocogene fitelparvovec. Sangamo may also collaborate in the research and development of additional adeno-associated viruses (&#8220;AAV&#8221;) -based gene therapy products for hemophilia A.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of the agreement, the Company granted Pfizer an exclusive worldwide royalty-bearing license, with the right to grant sublicenses, to use certain technology controlled by the Company for the purpose of developing, manufacturing and commercializing giroctocogene fitelparvovec and related products. Pfizer granted the Company a non-exclusive, worldwide, royalty-free, fully paid license, with the right to grant sublicenses, to use certain manufacturing technology developed under the agreement and controlled by Pfizer to manufacture the Company&#8217;s products that utilize the AAV delivery system. During a specified period, neither the Company nor Pfizer is permitted to clinically develop or commercialize, outside of the collaboration, certain AAV-based gene therapy products for hemophilia A.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement has a term that continues on a per product and per country basis until the later of (i) the expiration of patent claims that cover the product in a country, (ii) the expiration of regulatory exclusivity for a product in a country, and (iii) <ix:nonNumeric contextRef="c-160" name="sgmo:AgreementTerminationTerm" format="ixt-sec:durwordsen" id="f-619">fifteen years</ix:nonNumeric> after the first commercial sale of a product in a country. Pfizer has the right to terminate the agreement without cause in its entirety or on a per product or per country basis. The agreement may also be terminated by either party based on an uncured material breach by the other party or the bankruptcy of the other party. Upon termination for any reason, the license granted by the Company to Pfizer to develop, manufacture and commercialize giroctocogene fitelparvovec and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-618-2" continuedAt="f-618-3"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related products will automatically terminate. Upon termination by the Company for cause or by Pfizer in any country or countries, Pfizer will automatically grant the Company an exclusive, royalty-bearing license under certain technology controlled by Pfizer to develop, manufacture and commercialize giroctocogene fitelparvovec in the terminated country or countries.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon execution of the agreement, the Company received an upfront fee of $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="f-620">70.0</ix:nonFraction>&#160;million and was eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="f-621">208.5</ix:nonFraction>&#160;million in payments upon the achievement of specified clinical development, intellectual property and regulatory milestones and up to $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="sgmo:AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="f-622">266.5</ix:nonFraction>&#160;million in payments upon first commercial sale milestones for giroctocogene fitelparvovec and potentially other products. To date, <ix:nonFraction unitRef="milestone" contextRef="c-163" decimals="INF" name="sgmo:CollaborativeArrangementNumberOfMilestonesAchieved" format="ixt-sec:numwordsen" scale="0" id="f-623">two</ix:nonFraction> milestones of $<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="sgmo:MilestonePaymentsReceived" format="ixt:num-dot-decimal" scale="6" id="f-624">55.0</ix:nonFraction>&#160;million in aggregate have been achieved and paid. The Company is eligible to earn from Pfizer up to $<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="sgmo:MilestoneRevenueReceivable" format="ixt:num-dot-decimal" scale="6" id="f-625">220.0</ix:nonFraction>&#160;million in remaining milestone payments for giroctocogene fitelparvovec and up to $<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="sgmo:MilestoneRevenueReceivable" format="ixt:num-dot-decimal" scale="6" id="f-626">175.0</ix:nonFraction>&#160;million for other products that may be developed under the agreement, subject to reduction on account of payments made under certain licenses for third-party intellectual property. In addition, Pfizer agreed to pay the Company royalties for each potential licensed product developed under the agreement that are <ix:nonFraction unitRef="number" contextRef="c-166" decimals="2" name="sgmo:ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty" scale="-2" id="f-627">14</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-167" decimals="2" name="sgmo:ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty" scale="-2" id="f-628">20</ix:nonFraction>% of the annual worldwide net sales of such product and are subject to reduction due to patent expiration, entry of biosimilar products to the market and payment made under certain licenses for third-party intellectual property. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Pfizer in accordance with ASC Topic 606 and concluded that Pfizer was a customer. The total transaction price under this agreement was $<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="sgmo:CollaborativeArrangementTransactionPrice" format="ixt:num-dot-decimal" scale="6" id="f-629">134.0</ix:nonFraction>&#160;million, which represented the upfront fee and research services fees of $<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="sgmo:CollaborativeArrangementResearchServiceFees" format="ixt:num-dot-decimal" scale="6" id="f-630">79.0</ix:nonFraction>&#160;million and fees related to <ix:nonFraction unitRef="milestone" contextRef="c-169" decimals="0" name="sgmo:CollaborativeArrangementNumberOfMilestonesAchieved" format="ixt-sec:numwordsen" scale="0" id="f-631">two</ix:nonFraction> achieved milestones in an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="f-632">55.0</ix:nonFraction>&#160;million. Sangamo was responsible for internal and external research costs as part of the upfront fee and had the ability to request additional reimbursement from Pfizer if certain conditions were met. None of the constrained clinical or regulatory milestones were included in the transaction price. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at the time was uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified the performance obligations within the agreement as a license to the technology and ongoing research services. The Company concluded that the license was not discrete as it did not have stand-alone value to Pfizer apart from the research services to be performed by the Company pursuant to the agreement. As a result, the Company recognized revenue from the upfront payment based on proportional performance of the ongoing research services through 2020, the period during which the Company performed research services. The estimation of progress towards the satisfaction of its performance obligation and project cost was reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s assumptions regarding the timing of its deliverables.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company satisfied the deliverables and research services responsibilities within the arrangement. As a result, the Company recognized the remaining deferred revenue from the upfront payment in December 2020.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">C9ORF72 Research Collaboration and License Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Company entered into a separate exclusive, global collaboration and license agreement with Pfizer for the development and commercialization of potential gene therapy products that use zinc finger (&#8220;ZF&#8221;) transcriptional regulators (&#8220;ZF-TRs&#8221;) to treat amyotrophic lateral sclerosis and frontotemporal lobar degeneration linked to mutations of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene. Pursuant to this agreement, the Company agreed to work with Pfizer on a research program to identify, characterize and preclinically develop ZF-TRs that bind to and specifically reduce expression of the mutant form of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of this agreement, the Company granted Pfizer an exclusive, royalty-bearing, worldwide license under the Company&#8217;s relevant patents and know-how to develop, manufacture and commercialize gene therapy products that use resulting ZF-TRs that satisfy pre-agreed criteria. During a specified period, neither the Company nor Pfizer will be permitted to research, develop, manufacture or commercialize outside of the collaboration any zinc finger proteins (&#8220;ZFPs&#8221;) that specifically bind to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement has a term that continues on a per licensed product and per country basis until the later of (i) the expiration of patent claims that cover the licensed product in a country, (ii) the expiration of regulatory exclusivity for a licensed product in a country, and (iii) <ix:nonNumeric contextRef="c-170" name="sgmo:AgreementTerminationTerm" format="ixt-sec:duryear" id="f-633">15</ix:nonNumeric> years after the first commercial sale of a licensed product in a major market country. Pfizer also has the right to terminate the agreement without cause in its entirety or on a per product or per country basis. The agreement may also be terminated by either party based on an uncured material breach by the other party or the bankruptcy of the other party. The agreement will also terminate if the Company is unable to identify any lead candidates for development within a specified period of time or if Pfizer elects not to advance a lead candidate beyond a certain development milestone within a specified period of time. Upon termination for any reason, the license granted by the Company to Pfizer to develop, manufacture and commercialize licensed products under the agreement will automatically terminate. Upon termination by the Company for cause or by Pfizer without cause for any licensed product or licensed products in any country or countries, the Company will have the right to negotiate with Pfizer to obtain a non-exclusive, royalty-bearing license under certain technology </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-618-3" continuedAt="f-618-4"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">controlled by Pfizer to develop, manufacture and commercialize the licensed product or licensed products in the terminated country or countries.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following termination by the Company for Pfizer&#8217;s material breach, Pfizer will not be permitted to research, develop, manufacture or commercialize ZFPs that specifically bind to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene for a period of time. Following termination by Pfizer for the Company&#8217;s material breach, the Company will not be permitted to research, develop, manufacture or commercialize ZFPs that specifically bind to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene for a period of time.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="sgmo:MilestonePaymentsReceived" format="ixt:num-dot-decimal" scale="6" id="f-634">12.0</ix:nonFraction>&#160;million upfront payment from Pfizer and is eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="f-635">60.0</ix:nonFraction>&#160;million in development milestone payments from Pfizer contingent on the achievement of specified preclinical development, clinical development and first commercial sale milestones, and up to $<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="f-636">90.0</ix:nonFraction>&#160;million in commercial milestone payments if annual worldwide net sales of the licensed products reach specified levels. In addition, Pfizer will pay the Company royalties of <ix:nonFraction unitRef="number" contextRef="c-174" decimals="2" name="sgmo:ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty" scale="-2" id="f-637">14</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-175" decimals="2" name="sgmo:ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty" scale="-2" id="f-638">20</ix:nonFraction>% of the annual worldwide net sales of the licensed products. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property. Each party will be responsible for the cost of its performance of the research program. Pfizer will be operationally and financially responsible for subsequent development, manufacturing and commercialization of the licensed products. To date, a milestone of $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="sgmo:MilestonePaymentsReceived" format="ixt:num-dot-decimal" scale="6" id="f-639">5.0</ix:nonFraction>&#160;million has been achieved and paid, however <ix:nonFraction unitRef="product" contextRef="c-176" decimals="INF" name="sgmo:CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" format="ixt:fixed-zero" scale="0" id="f-640">no</ix:nonFraction> products have been approved and therefore <ix:nonFraction unitRef="milestone" contextRef="c-176" decimals="INF" name="sgmo:NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" format="ixt:fixed-zero" scale="0" id="f-641">no</ix:nonFraction> royalty fees have been earned under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pfizer agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Pfizer in accordance with ASC Topic 606 and concluded that Pfizer was a customer. The Company concluded the total transaction price under this agreement was $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="sgmo:CollaborativeArrangementTransactionPrice" format="ixt:num-dot-decimal" scale="6" id="f-642">17.0</ix:nonFraction>&#160;million, which represented the upfront fees of $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="f-643">12.0</ix:nonFraction>&#160;million and fees related to achievement of one milestone in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="f-644">5.0</ix:nonFraction>&#160;million. None of the constrained clinical or regulatory milestones were included in the transaction price. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at the time was uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had identified the performance obligations within this agreement as a license to the technology and ongoing research services. The Company concluded that the license is not discrete as it does not have stand-alone value to Pfizer apart from the services to be performed by the Company pursuant to the agreement. As a result, the Company recognized revenue from the upfront payment based on proportional performance of the ongoing research services through 2020, the period the Company performed research services.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company satisfied the deliverables and research services responsibilities within the arrangement in September 2020, and as a result, earned a $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="f-645"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="f-646">5.0</ix:nonFraction></ix:nonFraction>&#160;million milestone, which the Company recognized on a cumulative basis during the year ended December 31, 2020. In addition, the Company recognized the remaining deferred revenue from the upfront payment in September 2020.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2023, Pfizer notified the Company of Pfizer&#8217;s assignment of the collaboration and license agreement to Alexion, AstraZeneca Rare Disease, pursuant to a definitive purchase and license agreement for preclinical gene therapy assets and enabling technologies that closed on September 20, 2023.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kite Pharma, Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2018, the Company entered into a global collaboration and license agreement with Kite which became effective on April 5, 2018 (&#8220;Effective Date&#8221;), and was amended and restated in September 2019, for the research, development, and commercialization of potential engineered cell therapies for cancer. The collaboration and license agreement relates to the design of zinc finger nucleases (&#8220;ZFNs&#8221;) and viral vectors to disrupt and insert certain genes in T-cells and natural killer cells (&#8220;NK-cells&#8221;) including the insertion of genes that encode chimeric antigen receptors (&#8220;CARs&#8221;), T-cell receptors (&#8220;TCRs&#8221;), and NK-cell receptors (&#8220;NKRs&#8221;) directed to mutually agreed targets. Under the agreement, Kite is responsible for all clinical development, manufacturing and commercialization of any resulting products.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of this agreement, the Company granted Kite an exclusive, royalty-bearing, worldwide sublicensable license under the Company&#8217;s relevant patents and know-how to develop, manufacture and commercialize, for the purpose of treating cancer, specific cell therapy products that may result from the research program and that are engineered </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex&#160;vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using selected ZFNs and viral vectors developed under the research program to express CARs, TCRs or NKRs directed to candidate targets.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Effective Date, the Company received a $<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="sgmo:MilestonePaymentsReceived" format="ixt:num-dot-decimal" scale="6" id="f-647">150.0</ix:nonFraction>&#160;million upfront payment from Kite. In addition, Kite reimburses the Company&#8217;s direct costs to conduct the joint research program. Under the terms of the agreement, Sangamo is also eligible to receive contingent development- and sales-based milestone payments that could total up to $<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-8" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="9" id="f-648">3.0</ix:nonFraction>&#160;billion if all of the specified milestones set forth in this agreement are achieved. Of this amount, approximately $<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-8" name="sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="9" id="f-649">1.3</ix:nonFraction>&#160;billion relates to the achievement of specified research, clinical development, regulatory and first commercial sale milestones, and approximately $<ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-8" name="sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="9" id="f-650">1.8</ix:nonFraction>&#160;billion relates to the achievement of specified sales-based milestones if annual worldwide net sales of licensed products reach </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-618-4" continuedAt="f-618-5"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specified levels. Each development- and sales-based milestone payment is payable (i)&#160;only once for each licensed product, regardless of the number of times that the associated milestone event is achieved by such licensed product, and (ii)&#160;only for the first <ix:nonFraction unitRef="milestone" contextRef="c-183" decimals="INF" name="sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment" scale="0" id="f-651">10</ix:nonFraction> times that the associated milestone event is achieved regardless of the number of licensed products that may achieve such milestone event. In addition, the Company is entitled to receive escalating, tiered royalty payments with a percentage in the single digits based on future annual worldwide net sales of licensed products. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial research term in the agreement is <ix:nonNumeric contextRef="c-180" name="sgmo:InitialResearchTermOfAgreement" format="ixt-sec:durwordsen" id="f-652">six years</ix:nonNumeric> from the Effective Date and will expire in April 2024. Kite has an option to extend the research term for up to <ix:nonFraction unitRef="option" contextRef="c-180" decimals="INF" name="sgmo:NumberOfOptionsToExtendInitialResearchTerm" format="ixt-sec:numwordsen" scale="0" id="f-653">two</ix:nonFraction> additional <ix:nonNumeric contextRef="c-180" name="sgmo:ExtendedResearchTermOfAgreement" format="ixt-sec:durwordsen" id="f-654">one-year</ix:nonNumeric> periods for a separate upfront fee of $<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="sgmo:SeparateUpfrontFee" format="ixt:num-dot-decimal" scale="6" id="f-655">10.0</ix:nonFraction>&#160;million per year. All contingent payments under the agreement, when earned, will be non-refundable and non-creditable. Through the amendment and restatement of the agreement in September 2019, the Company and Kite agreed to expand the scope of the collaboration program to incorporate the use of lentiviral or retroviral vectors provided by Kite. Kite has the right to terminate this agreement in its entirety or on a per licensed product or per candidate target basis for any reason after a specified notice period. Each party has the right to terminate this agreement on account of the other party&#8217;s bankruptcy or material, uncured breach.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Kite in accordance with ASC Topic 606 and concluded that Kite is a customer. The transaction price includes the upfront license fee of $<ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-656">150.0</ix:nonFraction>&#160;million and estimated reimbursable service costs for the research projects over the estimated performance period. None of the clinical or regulatory milestones have been included in the transaction price, as none of the milestones have yet been achieved, and all amounts are fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at this time is uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price also includes actual and estimated payments by Kite for the work by Company researchers and reimbursement of the Company&#8217;s costs incurred with third parties. The Company uses the expected value method to estimate payments related to the Company&#8217;s researchers&#8217; work, taking into account the impact of constraint. Variable consideration is included in the transaction price only to the extent it is probable a significant reversal of cumulative revenues recognized would not occur. The Company will re-evaluate the transaction price including the estimated variable consideration included in the transaction price and all constrained amounts in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified <ix:nonFraction unitRef="performance_obligation" contextRef="c-185" decimals="0" name="sgmo:RevenueNumberOfRemainingPerformanceObligations" format="ixt-sec:numwordsen" scale="0" id="f-657">four</ix:nonFraction> performance obligations within the Kite agreement as follows: (1) a license to the technology combined with the obligation to perform research and development services to apply the Company&#8217;s technology to Kite-selected targets; (2) production of research materials; and (3-4) <ix:nonFraction unitRef="material_right" contextRef="c-185" decimals="0" name="sgmo:RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod" format="ixt-sec:numwordsen" scale="0" id="f-658">two</ix:nonFraction> material rights, each for an extension of the research period for an additional <ix:nonNumeric contextRef="c-186" name="sgmo:RevenueRemainingPerformanceObligationRenewalPeriod" format="ixt-sec:durwordsen" id="f-659">one-year</ix:nonNumeric> term. Such extensions contain material rights because their exercise does not require payment of a fee that is commensurate with the value of the incremental research term. The license to the Company&#8217;s intellectual property is not distinct from the related research and development activities as the licensed technology is not shared with and cannot be utilized by Kite without the research services performed by the Company. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated variable consideration (payments by Kite for the work performed by the Company&#8217;s researchers and third-party costs, as well as any future milestones and royalties) to the specific performance obligations to which they relate, as such allocation would meet the allocation objective in ASC Topic 606. The Company allocated the fixed consideration of $<ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="sgmo:RevenueRemainingPerformanceObligationFixedConsiderationAmount" format="ixt:num-dot-decimal" scale="6" id="f-660">150.0</ix:nonFraction>&#160;million to the performance obligations based on their relative standalone selling prices. Standalone selling prices of optional research years are similar to those of the initial year, but additionally take into account the intrinsic value of the discount upon exercise and the likelihood of exercise. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fees allocated to options with material rights are deferred until the options are exercised or expire. The exercise of options is accounted for as contract continuation, with target selection fees and estimated variable consideration included in the transaction price at that time and allocated specifically to the respective target&#8217;s performance obligation. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for the combined license and research services performance obligations is recognized over time, as Kite consumes the benefit of such services as they are being performed by the Company. For the license combined with research and development services performance obligation, the Company recognizes revenue based on proportional performance of the ongoing research services over the period during which the Company performs the services. The estimation of progress towards the satisfaction of this performance obligation and project costs are reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s assumptions regarding the estimated volume of required activities. The production of research materials performance obligation is accounted for under the right to invoice practical expedient, as the Company has the right to invoice Kite for these services in an amount that corresponds directly with the value of the services. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023 and December&#160;31, 2022, the Company had a receivable of $<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-661">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-662">0.7</ix:nonFraction>&#160;million, respectively, and deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-663">1.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-664">19.4</ix:nonFraction>&#160;million, respectively, related to this agreement. Changes in deferred revenue balances during the three and nine months ended September 30, 2023 relate to a reduction in the estimated future level of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-618-5" continuedAt="f-618-6"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company's research and development services under the collaboration agreement with Kite, as well as ongoing normal progress in the delivery of the performance obligations. The amounts of transaction price (excluding the amounts recognized as invoiced for the production of research materials performance obligation) remaining to be recognized were $<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-665">1.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-666">21.2</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="sgmo:RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount" format="ixt:num-dot-decimal" scale="6" id="f-667"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="sgmo:RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount" format="ixt:num-dot-decimal" scale="6" id="f-668">1.5</ix:nonFraction></ix:nonFraction>&#160;million relates to fees allocated to options with material rights, as of September&#160;30, 2023 and December&#160;31, 2022, respectively. These amounts are expected to be recognized within the next <ix:nonNumeric contextRef="c-190" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="f-669"><ix:nonNumeric contextRef="c-189" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="f-670">12</ix:nonNumeric></ix:nonNumeric> months. The timing of recognition will be affected by whether and when Kite exercises options for additional years of services and could be subject to significant changes.</span></div><div style="margin-top:6pt;text-indent:36pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-671" continuedAt="f-671-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Kite agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of license fee fixed consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-672">5,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-673">6,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-674">17,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-675">18,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services variable consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-676">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-677">619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-678">1,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-679">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-680">5,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-681">6,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-682">19,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-683">19,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company recorded additional revenue related to a change in estimate in connection with the collaboration agreement with Kite Pharma, Inc. This adjustment was driven by a reduction in the estimated future level of the Company&#8217;s research and development services and as a result, future project costs. This resulted in an increase in proportional cumulative performance on this collaboration and an increase in revenue of $<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-684">8.9</ix:nonFraction>&#160;million, a decrease in net loss of $<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" sign="-" name="sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="f-685">8.9</ix:nonFraction>&#160;million, and a decrease in the Company&#8217;s basic and diluted net loss per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-56" decimals="2" sign="-" name="sgmo:IncreaseDecreaseInEarningsPerShareDiluted" scale="0" id="f-686"><ix:nonFraction unitRef="usdPerShare" contextRef="c-56" decimals="2" sign="-" name="sgmo:IncreaseDecreaseInEarningsPerShareBasic" scale="0" id="f-687">0.05</ix:nonFraction></ix:nonFraction> for the nine months ended September 30, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2023, the Company recorded additional revenue related to a change in estimate in connection with the collaboration agreement with Kite. This adjustment was driven by a further reduction in the estimated future level of the Company&#8217;s research and development services and as a result, future project costs. This resulted in an increase in proportional cumulative performance on this collaboration and increased revenue by $<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-688"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-689">4.9</ix:nonFraction></ix:nonFraction> million, decreased net loss by $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" sign="-" name="sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="f-690"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" sign="-" name="sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="f-691">4.9</ix:nonFraction></ix:nonFraction> million, and decreased the Company's basic and diluted net loss per share by $<ix:nonFraction unitRef="usdPerShare" contextRef="c-57" decimals="2" sign="-" name="sgmo:IncreaseDecreaseInEarningsPerShareBasic" scale="0" id="f-692"><ix:nonFraction unitRef="usdPerShare" contextRef="c-58" decimals="2" sign="-" name="sgmo:IncreaseDecreaseInEarningsPerShareDiluted" scale="0" id="f-693"><ix:nonFraction unitRef="usdPerShare" contextRef="c-57" decimals="2" sign="-" name="sgmo:IncreaseDecreaseInEarningsPerShareDiluted" scale="0" id="f-694"><ix:nonFraction unitRef="usdPerShare" contextRef="c-58" decimals="2" sign="-" name="sgmo:IncreaseDecreaseInEarningsPerShareBasic" scale="0" id="f-695">0.03</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> for the three and nine months ended September 30, 2023. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Novartis Institutes for BioMedical Research, Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2020, the Company entered into a collaboration and license agreement with Novartis Institutes for BioMedical Research, Inc. (&#8220;Novartis&#8221;) for the research, development and commercialization of gene regulation therapies to treat three neurodevelopmental disorders. Under the agreement, which was effective upon execution, the Company granted Novartis an exclusive, royalty bearing and worldwide license, under its relevant patents and know-how, to develop, manufacture and commercialize certain of its ZF-TRs targeted to three undisclosed genes that are associated with certain neurodevelopmental disorders, including autism spectrum disorder and intellectual disability. The Company was performing early research activities over the collaboration period for each gene target and manufacture the ZF-TRs required for such research, costs of which are funded by Novartis. Novartis was responsible for additional research activities, studies enabling INDs, clinical development, regulatory approvals, manufacturing of preclinical, clinical and approved products, and global commercialization. Subject to certain exceptions set forth in the agreement, the Company was prohibited from developing, manufacturing or commercializing any therapeutic product targeting any of the three genes that are the subject of the collaboration. Novartis also had the option to license certain of the Company&#8217;s proprietary AAVs for the sole purpose of developing, manufacturing and commercializing licensed products arising from the collaboration.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, Novartis notified the Company of its termination for convenience, effective June 11, 2023 (the &#8220;Novartis Termination Date&#8221;), of the collaboration agreement. Novartis had indicated to the Company that the termination relates to a recent strategic review. As of the Novartis Termination Date, the collaboration agreement was terminated in its entirety and following the Novartis Termination Date the Company is not entitled to receive any further milestone payments or royalties from Novartis. As of the Novartis Termination Date, the parties have no further obligations to develop or to fund the development of any collaboration research programs under the collaboration agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon entering the agreement, Novartis paid the Company a $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="f-696">75.0</ix:nonFraction>&#160;million upfront license fee. Novartis was also obligated to pay the Company for the use of its resources and reimburse third-party costs incurred in the Company&#8217;s conduct of early research activities. The Company was also eligible to earn from Novartis development and commercial milestones and royalties on potential commercial sales of licensed products arising from the collaboration, none of which were triggered or earned. The agreement was going to continue, on a product-by-product and country-by-country basis, until the expiration of the applicable royalty term. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-618-6" continuedAt="f-618-7"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All payments received under the agreement were non-refundable and non-creditable. The transaction price of $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="sgmo:CollaborativeArrangementTransactionPrice" format="ixt:num-dot-decimal" scale="6" id="f-697">95.1</ix:nonFraction>&#160;million included the upfront license fee of $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="sgmo:CollaborativeArrangementLicenseFee" format="ixt:num-dot-decimal" scale="6" id="f-698">75.0</ix:nonFraction>&#160;million and research costs of $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="sgmo:CollaborativeArrangementEstimatedReimbursableServiceCosts" format="ixt:num-dot-decimal" scale="6" id="f-699">20.1</ix:nonFraction>&#160;million. All clinical or regulatory milestone amounts were considered fully constrained throughout the term of the agreement. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Novartis in accordance with ASC Topic 606 and concluded that Novartis was a customer. The Company had identified a single performance obligation within this arrangement as a license to the technology and ongoing research services. The Company concluded that the license was not discrete as it did not have stand-alone value to Novartis apart from the research services to be performed pursuant to the agreement. As a result, the Company recognized revenue from the upfront payment based on proportional performance of the ongoing research services through the estimated research period. The estimation of progress towards the satisfaction of performance obligation and project cost was reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current assumptions regarding the timing of its performance obligation. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notice of termination was accounted for as a modification of the contract, as it changed both the scope of the Company&#8217;s remaining services and the consideration to which the Company was entitled. The effect of the modification was not material, as the Company was nearing the completion of its assigned early research activities, and consequently, of its sole performance obligation.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023 and December&#160;31, 2022, the Company had a receivable of <ix:nonFraction unitRef="usd" contextRef="c-206" decimals="INF" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:fixed-zero" scale="0" id="f-700">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-701">2.2</ix:nonFraction>&#160;million, respectively, and deferred revenue of <ix:nonFraction unitRef="usd" contextRef="c-206" decimals="INF" name="us-gaap:ContractWithCustomerLiability" format="ixt:fixed-zero" scale="0" id="f-702">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-703">9.6</ix:nonFraction>&#160;million, respectively, related to this agreement. </span></div><ix:continuation id="f-671-1" continuedAt="f-671-2"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands):</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Novartis agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of upfront license fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-704">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-705">7,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-706">9,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-707">23,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-708">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-709">2,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-710">2,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-711">6,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-712">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-713">9,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-714">12,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-715">29,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:continuation><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biogen MA, Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company entered into a collaboration and license agreement with Biogen MA, Inc. (&#8220;BIMA&#8221;) and Biogen International GmbH (together with BIMA, &#8220;Biogen&#8221;) for the research, development and commercialization of gene regulation therapies for the treatment of neurological diseases. The companies planned to leverage the Company&#8217;s proprietary ZF technology delivered via AAV to modulate expression of key genes involved in neurological diseases. Concurrently with the execution of the collaboration agreement, the Company entered into a stock purchase agreement with BIMA, pursuant to which BIMA agreed to purchase <ix:nonFraction unitRef="shares" contextRef="c-220" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-716">24,420,157</ix:nonFraction> shares of the Company&#8217;s common stock (the &#8220;Biogen Shares&#8221;), at a price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-221" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-717">9.2137</ix:nonFraction>, for an aggregate purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-718">225.0</ix:nonFraction>&#160;million. The collaboration agreement became effective in April 2020.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, Biogen notified the Company of its termination for convenience, effective June 15, 2023 (the &#8220;Biogen Termination Date&#8221;), of the collaboration agreement. Biogen had indicated to the Company that the termination relates to a recent strategic review. As of the Biogen Termination Date, the collaboration agreement was terminated in its entirety and following the Biogen Termination Date the Company is not entitled to receive any further milestone payments or royalties from Biogen. As of the Biogen Termination Date, the parties have no further obligations to develop or to fund the development of any collaboration research programs under the collaboration agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the collaboration agreement, Biogen paid the Company an upfront license fee of $<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="f-719">125.0</ix:nonFraction>&#160;million in May 2020. The Company was also eligible to receive target selection, research, development, regulatory and commercial milestone payments and royalties on potential net commercial sales of licensed products arising from the collaboration, none of which were triggered or earned. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the collaboration agreement, the Company granted to Biogen an exclusive, royalty bearing and worldwide license, under its relevant patents and know-how, to develop, manufacture and commercialize ZF and/or AAV-based products directed to certain neurological disease gene targets selected by Biogen. Biogen had selected <ix:nonFraction unitRef="product_target" contextRef="c-223" decimals="0" name="sgmo:CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty" format="ixt-sec:numwordsen" scale="0" id="f-720">four</ix:nonFraction> targets over the course of the collaboration and had exclusive rights to nominate up to <ix:nonFraction unitRef="product_target" contextRef="c-224" decimals="0" name="sgmo:CollaborationAgreementNumberOfAdditionalProductTargets" format="ixt-sec:numwordsen" scale="0" id="f-721">seven</ix:nonFraction> additional targets. These rights expired upon the Biogen Termination Date. For each gene target selected by Biogen, the Company performed early research activities, costs of which were shared by the companies, aimed at the development of the combination of proprietary central nervous system delivery vectors and ZF-TRs (or potential other ZF products) targeting therapeutically relevant genes. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-618-7" continuedAt="f-618-8"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the collaboration agreement with Biogen in accordance with ASC Topic&#160;606 and concluded that Biogen is a customer. The transaction price included the upfront license fee of $<ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="f-722">125.0</ix:nonFraction>&#160;million and the excess consideration from the stock purchase of $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="sgmo:SaleOfStockExcessConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-723">79.6</ix:nonFraction>&#160;million, which represented the difference between the $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-724">225.0</ix:nonFraction>&#160;million received for the purchase of the Biogen Shares and the $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="sgmo:CollaborationAgreementEquityIssued" format="ixt:num-dot-decimal" scale="6" id="f-725">145.4</ix:nonFraction>&#160;million estimated fair value of the equity issued. The equity issued to Biogen was valued using an option pricing model to reflect certain holding period restrictions. None of the clinical or regulatory milestones were included in the transaction price, as all such amounts were fully constrained throughout the term of the collaboration agreement. The transaction price also included actual and estimated cost-sharing payments by Biogen for the work by Company researchers and reimbursement of the Company&#8217;s costs incurred with third parties. The amounts paid and expected to be paid to Biogen for the use of Biogen&#8217;s resources and its expenses were consideration paid to a customer. Since the Company did not acquire distinct goods or services in exchange for these payments, they reduced the transaction price and were recorded as a reduction in revenue. The Company used the expected value method to estimate cost sharing payments, taking into account the impact of the constraint. Variable consideration was included in the transaction price only to the extent it was probable a significant reversal of cumulative revenues recognized would not occur. The Company re-evaluated the transaction price as uncertain events were resolved or other changes in circumstances occurred.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company concluded that the licenses to its intellectual property for each target were not distinct from the related research and development activities, as the licensed technology was not shared with and could not be utilized by Biogen without the research services to be performed by the Company pursuant to the agreement. On the other hand, each combination of a license to the Company's intellectual property as applied to a specific target and the related research and development activities are a discrete research project that is distinct from any other target&#8217;s project. The targets Biogen could select were options that provided Biogen with material rights, as the exercise of the options did not require payment of a fee commensurate with the value of the incremental license rights. As a result, such options also represented performance obligations. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, the Company allocated fixed consideration of $<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="sgmo:RevenueRemainingPerformanceObligationFixedConsiderationAmount" format="ixt:num-dot-decimal" scale="6" id="f-726">204.6</ix:nonFraction>&#160;million included in the initial transaction price to the existing targets&#8217; license and research services performance obligations and those performance obligations for options that include material rights, based on their relative standalone selling prices. Through June 30, 2023, all such material rights have expired.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notice of termination was accounted for as a modification of the contract, as it changed both the scope of the Company&#8217;s remaining services and the consideration to which the Company was entitled. The remaining research and development activities to be undertaken by the Company after the notice of termination were not distinct from the related activities performed prior to the modification on the same targets but were distinct from the activities on other targets. The remaining material rights were also distinct from the prior research and development activities. To account for the effects of the modification, the Company updated its estimate of the transaction price and allocated the remaining transaction consideration based on the relative standalone selling prices of the remaining distinct goods and services. Progress for each ongoing performance obligation was then remeasured using an updated estimate of the total level of effort required for each performance obligation and the total revised transaction price and a cumulative catch-up in revenue was recorded. The modification resulted in an increase in revenue of $<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" format="ixt:num-dot-decimal" scale="6" id="f-727">127.1</ix:nonFraction>&#160;million. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023 and December&#160;31, 2022, the Company had a receivable of <ix:nonFraction unitRef="usd" contextRef="c-227" decimals="INF" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:fixed-zero" scale="6" id="f-728">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-729">0.5</ix:nonFraction>&#160;million, respectively, and deferred revenue of <ix:nonFraction unitRef="usd" contextRef="c-227" decimals="INF" name="us-gaap:ContractWithCustomerLiability" format="ixt:fixed-zero" scale="0" id="f-730">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-731">132.2</ix:nonFraction>&#160;million, respectively, related to this agreement. Changes in deferred revenue balances during the nine months ended September 30, 2023 relate primarily to the impact of the contract modification. The amounts of transaction price remaining to be recognized were <ix:nonFraction unitRef="usd" contextRef="c-229" decimals="INF" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:fixed-zero" scale="0" id="f-732">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-733">151.3</ix:nonFraction>&#160;million as of September&#160;30, 2023 and December&#160;31, 2022, respectively. </span></div><ix:continuation id="f-671-2"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Biogen agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of license and other fixed consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-735">7,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-736">132,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-737">21,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost-sharing payments for research services, net variable consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-738">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-739">2,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-740">2,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-741">8,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-742">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-743">9,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-744">134,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-745">30,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:continuation><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid $<ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="sgmo:CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" format="ixt:num-dot-decimal" scale="6" id="f-746">7.0</ix:nonFraction>&#160;million for financial advisory fees during the year ended December&#160;31, 2020, equal to <ix:nonFraction unitRef="number" contextRef="c-223" decimals="INF" name="sgmo:CollaborativeAgreementPercentOfInitialRecognition" scale="-2" id="f-747">2</ix:nonFraction>% of $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-748">225.0</ix:nonFraction>&#160;million received for the sale of shares and <ix:nonFraction unitRef="number" contextRef="c-223" decimals="INF" name="sgmo:CollaborativeAgreementPercentOfInitialRecognition" scale="-2" id="f-749">2</ix:nonFraction>% of $<ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="f-750">125.0</ix:nonFraction>&#160;million received for the upfront fee. The fees incurred related to both the collaboration agreement with Biogen and the stock purchase agreement for the sale of shares. The Company believes that the allocation of fees on a relative fair value basis between the two agreements is reasonable. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-751">4.1</ix:nonFraction>&#160;million, which represents <ix:nonFraction unitRef="number" contextRef="c-223" decimals="INF" name="sgmo:CollaborativeAgreementPercentOfInitialRecognition" scale="-2" id="f-752">2</ix:nonFraction>% of the initial transaction price of $<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="sgmo:RevenueRemainingPerformanceObligationFixedConsiderationAmount" format="ixt:num-dot-decimal" scale="6" id="f-753">204.6</ix:nonFraction>&#160;million, as a contract cost asset. This balance was </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><ix:continuation id="f-618-8"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">released into general and administrative expenses on a systematic basis consistent with the transfer of the services to Biogen in accordance with Accounting Standard Codification Topic 340, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In March, as a result of the notice of termination and resulting modification of the contract, the progress for each performance obligation was remeasured and the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-5" name="us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" format="ixt:num-dot-decimal" scale="6" id="f-754">2.5</ix:nonFraction>&#160;million as a cumulative catch-up to expense. The Company recognized as expense <ix:nonFraction unitRef="usd" contextRef="c-246" decimals="INF" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="6" id="f-755">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-756">2.6</ix:nonFraction> million during the three and nine months ended September&#160;30, 2023, respectively, and $<ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-757">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-758">0.4</ix:nonFraction> million during the three and nine months ended September&#160;30, 2022, respectively.</span></ix:continuation></div><div id="idd6e71910c45410381852f4f4adeb648_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:AssetImpairmentChargesTextBlock" id="f-759" continuedAt="f-759-1" escape="true">IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS</ix:nonNumeric></span></div><ix:continuation id="f-759-1" continuedAt="f-759-2"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three months ended March 31, 2023</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023, as a result of the sustained decline in the Company&#8217;s stock price and related market capitalization, termination of the collaboration agreements with Biogen and Novartis, and a general decline in equity values in the biotechnology industry, the Company performed an impairment assessment of goodwill, indefinite-lived intangible assets, and long-lived assets. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as a single reporting unit based on its business and reporting structure. For goodwill, a quantitative impairment assessment was performed using a market approach, whereby the Company&#8217;s fair value of equity was compared to its carrying value. The fair value of equity was derived using both the market capitalization of the Company and an estimate of a reasonable range of values of a control premium applied to the Company&#8217;s implied business enterprise value. The control premium was estimated based upon control premiums observed in comparable market transactions. This represents a level&#160;2 nonrecurring fair value measurement. Based on this analysis, the Company recognized a pre-tax goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-760">38.1</ix:nonFraction> million during the three months ended March 31, 2023. As a result, the goodwill was fully impaired as of March&#160;31, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before completing the goodwill impairment assessment, the Company also tested its indefinite-lived intangible assets and then its long-lived assets for impairment. Based on the qualitative assessment, the Company determined it was more likely than not that its indefinite-lived intangible assets were not impaired. The Company determined all of its long-lived assets represent one asset group for purposes of long-lived asset impairment assessment. The Company concluded that the carrying value of the asset group was not recoverable as it exceeded the future undiscounted cash flows the assets are expected to generate from the use and eventual disposition. To allocate and recognize the impairment loss, the Company determined individual fair values of its long-lived assets. The Company applied a discounted cash flow method to estimate fair values of its leasehold improvements and right-of-use assets, including leasehold improvements in the process of construction and a cost replacement method to estimate the fair value of its furniture, fixtures and laboratory and manufacturing equipment. These represented level&#160;3 nonrecurring fair value measurements. Based on this analysis, the Company recognized pre-tax long-lived asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-761">11.2</ix:nonFraction>&#160;million on the right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-762">5.0</ix:nonFraction>&#160;million on the related leasehold improvements, and $<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-763">4.2</ix:nonFraction>&#160;million on construction-in-progress, during the three months ended March 31, 2023. No impairment was recognized on the remaining long-lived assets as their carrying values were not in excess of their fair values.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three months ended June 30, 2023</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2023, the Company&#8217;s stock price and the related market capitalization continued to decline. In April 2023, the Company announced a restructuring of operations and a corresponding reduction in force, see Note&#160;9 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company also initiated discussions around several actions aimed at reducing costs, preserving liquidity and improving operational performance metrics. These actions include but are not limited to deferral and reprioritization of certain research and development programs, further reduction in force, and closing or downsizing its facilities. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reassessed its indefinite-lived and long-lived assets for impairment as of June 30, 2023. Given the actions contemplated above, the Company determined that it was more likely than not that its indefinite-lived intangible assets were impaired. Accordingly, the Company developed an estimate of the fair value of its indefinite-lived intangible assets using the multi-period excess earnings model (income approach) and concluded the carrying value of its indefinite-lived intangible assets were fully impaired. This represents a level 3 nonrecurring fair value measurement. As a result, an indefinite-lived intangible assets impairment charge of $<ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-764">51.3</ix:nonFraction>&#160;million, as well as the related income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-5" name="sgmo:EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount" format="ixt:num-dot-decimal" scale="6" id="f-765">6.3</ix:nonFraction>&#160;million due to the reversal of a deferred tax liability associated with the indefinite-lived intangible assets was recognized during the three months ended June 30, 2023. The impairment charge was primarily driven by a higher discount rate applied to future cash flows based on market participants&#8217; view of increased risk related to the asset. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that there were indicators of impairment in its long-lived asset group as of June 30, 2023, based on the same factors above as well as the impairment of its indefinite-lived intangible assets. As the estimated fair value of this asset group, based on a market approach, exceeded its carrying value, <ix:nonFraction unitRef="usd" contextRef="c-253" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-766">no</ix:nonFraction> impairment loss was recognized. This represented a level 3 nonrecurring fair value measurement.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-759-2"><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three months ended September 30, 2023</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2023, the Company&#8217;s stock price and the related market capitalization continued to decline, and as such, the Company reassessed its long-lived assets for impairment as of September 30, 2023. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined all of its long-lived assets continued to represent one asset group for purposes of long-lived asset impairment assessment. The Company concluded that the carrying value of the asset group was not recoverable and the estimated fair value of this asset group was below its carrying value. The lower fair value of the asset group was mainly driven by the sustained decline in the Company's stock price and the related market capitalization. To recognize the impairment loss, the Company determined individual fair values of its long-lived assets. The Company applied a discounted cash flow method to estimate fair values of its leasehold improvements and right-of-use assets, including leasehold improvements in the process of construction, and a market approach to estimate the fair value of its furniture, fixtures and laboratory and manufacturing equipment. These represented level&#160;3 nonrecurring fair value measurements. Based on this analysis, the Company concluded the fair values of the long-lived assets were lower than their net book values due to declines in the market prices for leases, furniture, fixtures, and equipment. The Company recognized pre-tax long-lived asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-767">17.6</ix:nonFraction> million on the right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-768">13.7</ix:nonFraction>&#160;million on the related leasehold improvements and construction-in-progress, and $<ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-769">13.5</ix:nonFraction> million on furniture, fixtures, and laboratory and manufacturing equipment during the three months ended September 30, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to assess whether its long-lived assets are impaired in future periods. As the Company finalizes and implements its plans related to cost reductions and liquidity preservation, it is reasonably possible that additional impairment charges will be recognized if the Company changes how it uses various long-lived assets or elects to dispose of them, and the cash flows associated with these assets become separately identifiable. In this case, such assets will be tested for impairment separately from the remaining long-lived assets of the Company.</span></div></ix:continuation><div id="idd6e71910c45410381852f4f4adeb648_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-770" continuedAt="f-770-1" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:36pt"><ix:continuation id="f-770-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-771" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows total stock-based compensation expense recognized in the accompanying Condensed Consolidated Statements of Operations (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-772">3,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-773">4,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-774">11,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-775">13,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-776">2,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-777">3,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-778">9,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-779">9,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-780">6,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-781">7,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-782">21,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-783">23,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="idd6e71910c45410381852f4f4adeb648_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-784" continuedAt="f-784-1" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="f-784-1" continuedAt="f-784-2">At-the-Market Offering Agreement</ix:continuation></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-784-2">In August 2020, the Company entered into an Open Market Sale Agreement&#8480; with Jefferies LLC (&#8220;Jefferies&#8221;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of the Company&#8217;s common stock having an aggregate offering price of up to $<ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-5" name="sgmo:StockOfferingProgramMaximumValue" format="ixt:num-dot-decimal" scale="6" id="f-785">150.0</ix:nonFraction>&#160;million through Jefferies as the Company&#8217;s sales agent or principal. In December 2022, the Company entered into Amendment No. 2 to the Open Market Sale Agreement&#8480; which increased the aggregate offering price under the at-the-market offering program by an additional $<ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-5" name="sgmo:SaleOfStockIncreaseToAggregateOfferingPrice" format="ixt:num-dot-decimal" scale="6" id="f-786">175.0</ix:nonFraction> million. The Company is not obligated to sell any shares under the sales agreement. <ix:nonFraction unitRef="shares" contextRef="c-266" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="0" id="f-787">No</ix:nonFraction> shares were sold under the sales agreement during the three months ended September&#160;30, 2023. During the nine months ended September&#160;30, 2023, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-267" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-788">8,249,261</ix:nonFraction> shares of its common stock for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-789">15.1</ix:nonFraction> million. During the three and nine months ended September&#160;30, 2022, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-268" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-790">8,483,104</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-269" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-791">14,711,770</ix:nonFraction> shares of its common stock for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-792">42.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-793">66.4</ix:nonFraction> million, respectively</ix:continuation>. </span></div><div id="idd6e71910c45410381852f4f4adeb648_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="f-794" continuedAt="f-794-1" escape="true">RESTRUCTURING CHARGES</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-794-1" continuedAt="f-794-2">On April 26, 2023, the Company executed a restructuring of operations and a corresponding reduction in workforce (the &#8220;April Restructuring&#8221;), designed to reduce costs and increase focus on certain strategic priorities. The April Restructuring resulted in the elimination of approximately <ix:nonFraction unitRef="employee" contextRef="c-270" decimals="-1" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="f-795">110</ix:nonFraction> roles, including <ix:nonFraction unitRef="employee" contextRef="c-271" decimals="0" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="f-796">55</ix:nonFraction> full-time employees and <ix:nonFraction unitRef="employee" contextRef="c-272" decimals="0" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="f-797">55</ix:nonFraction> contracted employees and eliminated open positions, in the United States, or approximately <ix:nonFraction unitRef="number" contextRef="c-270" decimals="2" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" scale="-2" id="f-798">23</ix:nonFraction>% of the total United States workforce as of April 26, 2023, and included one-time severance payments and other employee-related costs, including additional vesting of service-based stock compensation awards. <ix:nonFraction unitRef="usd" contextRef="c-273" decimals="INF" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="0" id="f-799">No</ix:nonFraction> expenses related to the April Restructuring were incurred during the three months ended September&#160;30, 2023. The Company incurred approximately $<ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="f-800">5.3</ix:nonFraction> million of expenses related to the April Restructuring in the nine months ended September&#160;30, 2023, of which $<ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="f-801">4.1</ix:nonFraction>&#160;million is included in research and development expense and $<ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="f-802">1.2</ix:nonFraction> million is included in general and administrative expense in the accompanying Condensed Consolidated Statements of Operations. The Company </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-794-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expects the April Restructuring and the cash payments related to the April Restructuring to be complete by the third quarter of 2024.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="f-803" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of accrued April Restructuring costs included within other accrued liabilities on the Company&#8217;s Condensed Consolidated Balance Sheet as of September 30, 2023 (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="3" id="f-804">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="f-805">5,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="f-806">3,033</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="3" id="f-807">305</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="f-808">1,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="idd6e71910c45410381852f4f4adeb648_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-809" continuedAt="f-809-1" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="f-809-1"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period. During the three months ended September 30, 2023 and 2022 the Company recorded an income tax expense of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-810">1.3</ix:nonFraction> million and $0.1&#160;million, respectively. During the nine months ended September&#160;30, 2023 and 2022, the Company recorded income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-811">4.8</ix:nonFraction> million and income tax expense of $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-812">0.2</ix:nonFraction> million, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to maintain a full valuation allowance on its U.S. federal and state, Sangamo France, and Sangamo United Kingdom net deferred tax assets, as the Company believes it is not more likely than not that these benefits will be realized. The net tax benefit for the nine months ended September&#160;30, 2023 was primarily related to the impairment of the IPR&amp;D asset, which was offset by the reduction of its United Kingdom&#8217;s deferred tax asset. The tax expense for the nine months ended September&#160;30, 2022 was primarily due to foreign income tax expense.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the Inflation Reduction Act of 2022 was signed into law, and became effective in 2023, with tax provisions primarily focused on implementing a 15% minimum tax on global adjusted financial statement income and a 1% excise tax on share repurchases. The Company has evaluated the provisions of the tax law and noted that the law change would not have a material impact on the Condensed Consolidated Financial Statements.</span></div></ix:continuation><div id="idd6e71910c45410381852f4f4adeb648_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-813" continuedAt="f-813-1" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><ix:continuation id="f-813-1" continuedAt="f-813-2"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">November Restructuring</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 11, 2023, the Board of Directors of the Company approved a restructuring of operations and a corresponding reduction in workforce (the &#8220;November Restructuring&#8221;), designed to reduce costs and advance its strategic transformation into a neurology-focused genomic medicine company. The Company notified employees affected by the November Restructuring on November 1, 2023.  The Company expects the November Restructuring to result in the elimination of approximately <ix:nonFraction unitRef="employee" contextRef="c-277" decimals="0" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="f-814">162</ix:nonFraction> roles in the United States, or approximately <ix:nonFraction unitRef="number" contextRef="c-277" decimals="2" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" scale="-2" id="f-815">40</ix:nonFraction>% of its United States workforce. The Company estimates that it will incur approximately $<ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="f-816">8</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="f-817">10</ix:nonFraction> million in cash-based expenses related to employee severance and notice period payments, benefits and related restructuring costs. The Company expects that the majority of the restructuring charges will be incurred in the fourth quarter of 2023 and that the execution of the November Restructuring will be substantially complete by the second quarter of 2024. The Company may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the November Restructuring.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Departure of Certain Officers</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the November Restructuring, the employment of each of D. Mark McClung, Executive Vice President, Chief Operating Officer, and Jason Fontenot, Ph.D., Senior Vice President, Chief Scientific Officer, will terminate, effective as of January 2, 2024. In connection with the termination of their employment, pursuant to the Amended Severance Plan (as defined below), Mr. McClung and Dr. Fontenot are entitled to certain severance benefits in exchange for the execution of a general settlement and release agreement. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><ix:continuation id="f-813-2" continuedAt="f-813-3"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Approval of Amended and Restated Executive Severance Plan</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2023, the Compensation Committee of the Board of Directors of the Company approved an amendment and restatement of the Company&#8217;s Amended and Restated Executive Severance Plan (as so amended and restated, the &#8220;Amended Severance Plan&#8221;).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of such amendment and restatement is to provide for the payment of certain severance benefits in the form of a lump sum (instead of in installments or monthly reimbursements) following termination. Specifically, if an Eligible Employee (as defined in the Amended Severance Plan and which includes all of the Company&#8217;s executive officers) becomes entitled to severance benefits under the Amended Severance Plan, (i) cash severance payments will be made in the form of a lump sum within <ix:nonNumeric contextRef="c-280" name="sgmo:ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod" format="ixt-sec:durday" id="f-818">60</ix:nonNumeric> days following the Eligible Employee&#8217;s termination (instead of in the form of installments over the applicable severance period, which may range from <ix:nonNumeric contextRef="c-281" name="sgmo:ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod" format="ixt-sec:durmonth" id="f-819">9</ix:nonNumeric> to <ix:nonNumeric contextRef="c-282" name="sgmo:ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod" format="ixt-sec:durmonth" id="f-820">18</ix:nonNumeric> months following such termination depending on the Eligible Employee&#8217;s position) and (ii) cash payments intended to replace COBRA premium reimbursements may be made in the form of a lump sum within <ix:nonNumeric contextRef="c-280" name="sgmo:ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod" format="ixt-sec:durday" id="f-821">60</ix:nonNumeric> days following the Eligible Employee&#8217;s termination (instead of in the form of monthly reimbursements over the applicable severance period), in the Company&#8217;s discretion, in each case to the extent that such payments (a) are exempt from Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), as determined by the Company in its discretion at the time of the Eligible Employee&#8217;s termination, or (ii) may otherwise be made in a lump sum upon such termination without causing adverse tax consequences under Section 409A of the Code.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes regarding the timing and form of payment of certain severance benefits under the Amended Severance Plan, as described above, were the only material changes made under the Amended Severance Plan. No other material changes (including changes regarding eligibility for, or the amount or type of, severance benefits) were made under the Amended Severance Plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change of Company Headquarters</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, the Company announced that it expects to close its Brisbane, California facility in early 2024 to conserve cash resources, and intends to transition Company headquarters to its Richmond, California facility as of January&#160;1,&#160;2024. The Company may incur charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the closure of its Brisbane, California facility and the transition of company headquarters to its Richmond, California facility.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nasdaq Deficiency Notice</span></div></ix:continuation><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-813-3">On October 27, 2023, the Company received a deficiency notice (the &#8220;Notice&#8221;) from the Listing Qualifications Staff (the &#8220;Staff&#8221;) of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notifying the Company that, for the last 30 consecutive business days, the bid price of the Company&#8217;s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). The Notice has no immediate effect on the listing of the Company&#8217;s common stock on the Nasdaq Global Select Market.</ix:continuation> </span></div><div style="margin-top:6pt;text-indent:31.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 2.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; contains trend analysis, estimates and other forward-looking statements within the meaning of Section&#160;27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements include, without limitation, statements containing the words &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;continues,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;seeks,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; and other words of similar import or the negative of those terms or expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties, estimates and other factors that may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Actual results could differ materially from those set forth in such forward-looking statements as a result of, but not limited to, the &#8220;Risk Factors&#8221; described in Part I, Item 1A our Annual Report on Form 10-K for the year ended December&#160;31,&#160;2022 as filed with the Securities and Exchange Commission on February&#160;23,&#160;2023, or the 2022 Annual Report, as supplemented by the risks described under &#8220;Risk Factors&#8221; in Part II, Item 1A of this Quarterly Report on Form 10-Q. You should also read the following discussion and analysis in conjunction with our Condensed Consolidated Financial Statements and accompanying notes included in this Quarterly Report and the Consolidated Financial Statements and accompanying notes thereto included in our 2022 Annual Report.</span></div><div id="idd6e71910c45410381852f4f4adeb648_82"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious diseases. We plan to deliver on this mission through development of our clinical and preclinical product candidates leveraging our novel science and process development capabilities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Updates</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In November 2023, we announced that we have made additional progress towards our strategic transformation into a genomic medicine company focused on treating neurological diseases. This progress includes a restructuring of our operations and corresponding reduction in workforce, or the November Restructuring, designed to reduce costs and focus resources on our proprietary neurology-focused epigenetic regulation programs and adeno-associated virus, or AAV, capsid delivery technologies. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We expect the November Restructuring to result in the elimination of approximately 162 roles in the United States, or approximately 40% of the United States workforce. We estimate that we will incur approximately $8&#160;million to $10&#160;million in cash-based expenses related to employee severance and notice period payments, benefits and related costs in connection with the November Restructuring. We expect that the majority of the restructuring charges will be incurred in the fourth quarter of 2023 and that the execution of the November Restructuring will be substantially complete by the second quarter of 2024. We may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the November Restructuring.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As part of the November Restructuring, we expect to close our Brisbane, California facility in early 2024 to conserve cash resources, and we intend to transition our company headquarters to our Richmond, California facility as of January&#160;1,&#160;2024.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Core Preclinical Neurology Programs</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our preclinical development is focused on two innovative areas aligned with our strategic transformation: (i) development of epigenetic regulation therapies treating serious neurological diseases and (ii) discovery and development of novel engineered AAV capsids to deliver our therapies to the intended neurological targets. Indications for our preclinical programs include chronic neuropathic pain and prion disease.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cornerstones of our portfolio of epigenetic regulation therapies treating neurological diseases are Nav1.7 and prion disease. The Nav1.7 pathway to potentially treat chronic neuropathic pain has been identified as our flagship program in our wholly owned neurology pipeline, with an investigational new drug application, or IND, submission expected in 2024. The first data from this program was presented in a platform presentation at the American Society for Cell and Gene Therapy (ASGCT) 26th Annual Meeting in May 2023. The data demonstrated potent and specific repression of Nav1.7 expression without impacting other sodium channels and that the zinc finger repressors, or ZF-Rs, were well tolerated in nonhuman primates. We have identified the human-specific lead candidate ZF-R and have found no off-target activity. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We presented updated animal model data from our wholly owned prion disease program at the Prion 2023 conference in October 2023, showing that our ZF-Rs significantly reduce expression of the prion protein in the brain, extend lifespan and limit formation of toxic prion aggregates.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to make progress in developing novel engineered AAV capsids enhanced for delivery to neurological targets. We have made significant progress in identifying new, potentially transformative AAV delivery capsids that we believe may be capable of crossing the blood-brain-barrier.  We presented data at ASGCT describing the identification of multiple novel AAV capsids exhibiting characteristics consistent with enhanced blood brain barrier transit. We expect to share nonhuman primate data from our capsid development efforts in early 2024. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We presented preclinical data at the 30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Annual European Society for Gene and Cell Therapy (ESGCT) Congress in October 2023 showcasing updates from our neurology epigenetic regulation programs. Data presented included an oral presentation demonstrating how zinc finger activators (ZF-As) can be designed to potentially address neurodevelopmental disorders such as autism spectrum disorder and intellectual disability. This presentation showed how ZF-As can be designed to restore normal gene and protein expression of SCN2A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This was accompanied by a poster presentation demonstrating Shank3 gene activation, mediated by ZF-As, as a potential therapeutic approach for Phelan-McDermid syndrome. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical Programs</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fabry Disease</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Since our last update in August 2023, an additional three patients have been dosed in the Phase 1/2 STAAR study of isaralgagene civaparvovec, our investigational gene therapy for the treatment of Fabry disease, resulting in a total of 25 patients dosed to date, which includes 14 at the planned Phase 3 dose of 5x10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vg/kg. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">All subjects dosed to date continue to demonstrate sustained, elevated &#945;-Gal A levels, with 12 patients having achieved at least one year of follow-up and the longest treated patient having now achieved three years of follow-up. Additionally, all 11 patients who were withdrawn from enzyme replacement therapy, or ERT, remain off ERT, for up to 24 months for the longest withdrawn patient. Treated patients continue to report improvements in their quality of life, some even over and above the benefits they were experiencing on ERT.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are no longer enrolling additional patients in this study at this time, as we believe we have already successfully enrolled sufficient patients to provide a preliminary assessment of efficacy and safety. We expect to complete the dosing of remaining enrolled patients in the Phase 1/2 study in the first half of 2024. We expect to present updated clinical data from the Phase 1/2 STAAR study at a medical meeting in early 2024.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October 2023, we received U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for isaralgagene civaparvovec. U.S. RMAT Designation aims to facilitate the development and expedite the review of new potential therapeutics that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. Companies granted this designation are given the opportunity for more frequent interactions with the FDA. These clinical programs may also be eligible to apply for Accelerated Approval and Priority Review if relevant criteria are met. The FDA has previously granted Fast Track Designation and Orphan Drug Designation to isaralgagene civaparvovec.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are actively seeking a potential collaboration partner for our Fabry disease program. While productive discussions with the FDA continue regarding a potential Phase 3 trial design, we have decided to defer new investments in Phase 3 planning activities until we are able to successfully secure a collaboration partner or financing to fund a potential Phase 3 trial. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Renal Transplant Rejection</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Since our last update in August 2023, we dosed the first patient at the second dose level in the Phase 1/2 STEADFAST study evaluating TX200, our wholly-owned autologous CAR-Treg cell therapy candidate for renal transplant rejection. The product candidate continues to be generally well tolerated in all four patients dosed to date. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have received all necessary regulatory and ethics approvals for an accelerated dose escalation protocol from European regulatory authorities that allows dosing to potentially advance more quickly through the cohorts, and which also allows for a new and highest fourth dose cohort, compared to the three cohorts in the previously approved study protocol. The new, fourth cohort dose will be 18-fold higher than the first cohort starting dose.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have completed manufacturing of the dose for the patient in the third cohort, who recently received a kidney transplant. Dosing of this fifth patient is expected in the fourth quarter of 2023, pending approval to move to the third cohort from the Safety Monitoring Committee.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have also completed manufacturing of the dose for the first patient in the fourth and highest dose cohort, who recently received a kidney transplant. Dosing of this sixth patient is expected in January 2024, pending approval to move to the fourth cohort from the Safety Monitoring Committee. Dosing of this patient on the expected timeline would represent an acceleration of 18 months compared to the dosing timeline under the previously approved study protocol.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are actively seeking a potential collaboration partner or direct external investment in our CAR-Treg cell therapy programs. We plan to provide an update on these efforts in the first quarter of 2024. We have decided to defer new investments in these programs until we are able to successfully secure a collaboration partner or external investment. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Partnered Programs</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hemophilia A</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Phase 3 AFFINE trial of giroctocogene fitelparvovec, an investigational gene therapy we are developing with Pfizer Inc., or Pfizer, for patients with moderately severe to severe hemophilia A, continues to progress. Dosing of all patients in the trial is now complete. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A pivotal readout is expected in the middle of 2024, with Pfizer anticipating submitting a biologics license application and a marketing authorization application in the second half of 2024 if the pivotal readout is supportive.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and Pfizer plan to present updated data from the Phase 1/2 ALTA study of giroctocogene fitelparvovec via an oral presentation at the 65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> American Society for Hematology Annual Meeting and Exposition on December 11, 2023.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are eligible to earn from Pfizer up to $220.0 million in milestone payments upon the achievement of certain regulatory and commercial milestones for giroctocogene fitelparvovec and product royalties of 14% - 20% if giroctocogene fitelparvovec is approved and commercialized.    </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October 2023, Pfizer notified us that it had assigned to Alexion, AstraZeneca Rare Disease, the collaboration and license agreement between Sangamo and Pfizer for the development and commercialization of potential gene therapy products that use zinc finger transcriptional regulators, or ZF-TRs, to treat amyotrophic lateral sclerosis and frontotemporal lobar degeneration linked to mutations of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prevail Therapeutics</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2023, we entered into a research evaluation and option agreement with Prevail Therapeutics, or Prevail, a wholly owned subsidiary of Eli Lilly and Company, which granted Prevail rights to evaluate certain proprietary engineered cerebrospinal fluid, or CSF, -administered AAV capsids developed by us. Under the agreement, Prevail has an option to obtain an exclusive license to use the capsids for certain neurological targets. If Prevail exercises its option for a target, Prevail would lead and fund all further research, development, manufacturing and commercialization of Prevail products incorporating the licensed capsids for that target.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chroma Medicine</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2023, we entered into a research evaluation, option and license agreement with Chroma Medicine, or Chroma, to develop epigenetic medicines leveraging our zinc finger proteins, or ZFPs, for sequence-specific DNA recognition of targets outside of the central nervous system. If Chroma exercises its option for a target, Chroma would lead and fund all further research, development, manufacturing, and commercialization of Chroma products incorporating the licensed Sangamo ZFPs for that target.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaborations</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our multiple collaborations with biopharmaceutical companies bring us important financial and strategic benefits and reinforce the potential of our research and development efforts and our zinc finger, or ZF, technology platform. They leverage our collaborators&#8217; therapeutic and clinical expertise and commercial resources with the goal of bringing our medicines more rapidly to patients. We believe these collaborations reflect the value of our ZF technology and AAV capsid engineering platforms and will potentially expand the addressable markets of our product candidates. To date, we have received approximately $817.0 million in upfront licensing fees, milestone payments and proceeds from sale of our common stock to collaborators and have the opportunity to earn up to $1.9 billion in potential future milestone payments and exercise fees from our active collaborations and research evaluation and option agreements, assuming all options are exercised and targets are selected, in addition to potential product royalties.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current operating plan, our cash, cash equivalents and marketable securities as of September 30, 2023, in combination with the cost savings expected from the restructuring, workforce reduction and other potential cost reductions, are expected to allow us to meet our liquidity requirements only into the third quarter of 2024. Our history of significant losses, negative cash flows from operations, limited liquidity resources currently on hand and dependence on our ability to obtain </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional financing to fund our operations after the current resources are exhausted, about which there can be no certainty, have resulted in management&#8217;s assessment that there is substantial doubt about our ability to continue to operate as a going concern for at least the next 12 months from the date the Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q are issued. Our ability to continue to operate as a going concern is dependent upon our ability to raise substantial additional capital to fund our operations and support our research and development endeavors. In this regard, we are actively seeking substantial additional capital, including through public or private equity or debt financing, royalty financing or other sources, such as strategic collaborations and other direct investments in our programs. However, additional capital may not be available to us on a timely basis, on terms that are acceptable or at all. In particular, the perception of our ability to continue to operate as a going concern may make it more difficult to obtain financing for the continuation of our operations, particularly in light of currently challenging macroeconomic and market conditions. Further, we may be unable to attract new investments as a result of the speculative nature of our newly reprioritized core neurology preclinical programs. If adequate funds are not available to us on a timely basis, or at all, we will be required to take additional actions to address our liquidity needs, including additional cost reduction measures such as further reducing operating expenses and delaying, reducing the scope of, discontinuing or altering our research and development activities, which would have a material adverse effect on our business and prospects, or we may be required to cease operations entirely, liquidate all or a portion of our assets, and/or or seek protection under applicable bankruptcy laws, and you may lose all or part of your investment.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing &amp; Process Development</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the November Restructuring and the anticipated closure of our Brisbane, California facility in early 2024, we now expect to be substantially reliant on external partners to manufacture clinical supply for our neurology portfolio. We are retaining our analytical and process development capabilities at our Richmond, California facility. We continue to operate a cell therapy manufacturing facility in Valbonne, France.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Macroeconomic Conditions</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and operations and those of our collaborators may continue to be affected by financial instability and a general decline in economic conditions in the United States and other countries caused by political instability and conflict, including the ongoing conflict between Russia and Ukraine and conflicts in the Middle East, and economic or financial challenges caused by current and potential future bank failures or by general health crises such as the COVID-19 pandemic, which have led to market disruptions, including significant volatility in commodity prices, credit and capital markets instability, including disruptions in access to bank deposits and lending commitments, supply chain interruptions, rising interest rates and global inflationary pressures. These macroeconomic factors could materially and adversely affect our ability to continue to operate as a going concern and could otherwise have a material adverse effect on our business, operations, operating results and financial condition as well as the price of our common stock. In particular, our ability to raise the substantial additional capital we need in order to fund our business and to continue to operate as a going concern may be adversely impacted by these macroeconomic factors, and we cannot be certain that we will be able to obtain financing on terms acceptable to us, or at all. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Components of Results of Operations</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues have consisted primarily of revenues from upfront licensing fees, reimbursements for research services, milestone achievements and research grant funding. We expect revenues to continue to fluctuate from period to period and there can be no assurance that new collaborations or partner reimbursements will continue beyond their initial terms or that we are able to meet the milestones specified in these agreements.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred net losses since inception and expect to incur losses for at least the next several years as we continue our research and development activities. To date, we have funded our operations primarily through the issuance of equity securities and revenues from collaborations and research grants.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we expect research and development expenses to decrease in the near-term in connection with the April and November Restructurings, we expect to continue to devote substantial resources to research and development in the future and expect research and development expenses to increase in the next several years if we are successful in advancing our product candidates from research stage through clinical trials. Pursuant to the terms of our termination and transition agreement with Sanofi S.A., or Sanofi, certain expenses related to research and development activities may be reimbursed to us. Any reimbursement funds to be received from Sanofi will decrease our research and development expense.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries and personnel related expenses for executive, finance and administrative personnel, stock-based compensation expense, professional fees, allocated facilities expenses, patent prosecution expenses and other general corporate expenses. Although we expect general and administrative expenses to decrease in the near-term in connection with the April and November Restructurings, we expect the growth of our business to require increased general and administrative expenses as we continue to advance our product candidates into and through the clinic.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Condensed Consolidated Financial Statements and the related disclosures have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these Condensed Consolidated Financial Statements requires us to make estimates, assumptions and judgments that affect the reported amounts in our Condensed Consolidated Financial Statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe the following policies to be the most critical to an understanding of our financial condition and results of operations because they require us to make estimates, assumptions and judgments about matters that are inherently uncertain. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our critical accounting policies and estimates relating to revenue recognition and valuation of long-lived assets including goodwill and indefinite-lived intangible assets are the most significant estimates and assumptions used in the preparation of our Condensed Consolidated Financial Statements. See Note 1 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the accompanying notes to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in our critical accounting policies and estimates during the three and nine months ended September&#160;30, 2023, as compared to the critical accounting policies and estimates disclosed in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in Part II, Item 7 of the 2022 Annual Report.</span></div><div id="idd6e71910c45410381852f4f4adeb648_85"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations for the Three and Nine Months Ended September&#160;30, 2023 and 2022</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.652%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentage values)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentage values)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,062)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107%</span></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues primarily consisted of amounts earned from our collaboration agreements. We anticipate revenues in the future will be derived primarily from our collaboration agreements. The terminations of our collaboration agreements with Biogen MA, Inc. and Biogen International GmbH, which we refer to together as Biogen, and Novartis Institutes for BioMedical Research, Inc., or Novartis, became effective in June 2023, following which we are not entitled to any further milestone payments or royalties from either Biogen or Novartis, nor does either Biogen or Novartis have any further obligations to develop or to reimburse the costs of any of the programs previously subject to the Biogen and Novartis collaborations.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease of $17.1&#160;million in revenues for the three months ended September&#160;30, 2023, compared to the same period in 2022, was primarily attributed to decreases of $9.6&#160;million and $9.1&#160;million in revenue relating to our collaboration agreements with Novartis and Biogen, respectively, due to the termination of collaboration agreements in June 2023, and a decrease of $1.4&#160;million in revenue relating to our collaboration agreement with Kite Pharma, Inc., a Gilead Sciences, Inc. subsidiary, or Kite. These decreases were partially offset by an increase of $3.0 million in revenues from other licensing agreements. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase of $90.1 million in revenues for the nine months ended September&#160;30, 2023, compared to the same period in 2022, was primarily attributed to: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase of $104.2&#160;million in revenue relating to our collaboration agreement with Biogen, primarily due to the impact of termination of the collaboration agreement, which resulted in an increase in the measure of proportional cumulative performance; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase of $3.1&#160;million in revenue relating to our license agreement with Sigma-Aldrich Corporation; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase of $3.2 million in revenues from other licensing agreements.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These increases were partially offset by a decrease of $17.3&#160;million in revenue relating to our collaboration agreement with Novartis and a decrease of $3.3&#160;million in revenue relating to our collaboration agreement with Sanofi, due to the terminations of such collaboration agreements in June 2023 and June 2022, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating expenses</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.652%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentage values)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentage values)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,027)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(368)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,238&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,239&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of goodwill and indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,806&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,452&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,136&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,958&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,178&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consisted primarily of compensation related expenses, including restructuring, stock-based compensation, laboratory supplies, preclinical and clinical studies, manufacturing clinical supply, contracted research, and allocated facilities and information technology expenses.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease of $8.0 million in research and development expenses for the three months ended September&#160;30, 2023, compared to the same period in 2022, was primarily attributable to lower compensation and other personnel costs mainly due to lower headcount as a result of restructuring of operations and corresponding reduction in workforce announced in April 2023, or the April Restructuring, and lower manufacturing and lab supply expenses primarily related to termination of collaboration agreements with Biogen and Novartis, and deferral and reprioritization of certain programs. These decreases were partially offset by higher depreciation expense. Stock-based compensation expense included in research and development expenses was $3.2 million and $4.4 million for the three months ended September&#160;30, 2023 and 2022, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease of $0.4 million in research and development expenses for the nine months ended September&#160;30, 2023, compared to the same period in 2022, was primarily attributable to lower manufacturing and lab supply expenses due to deferral and reprioritization of certain programs, termination of collaboration agreements with Biogen and Novartis, and lower compensation and other personnel costs mainly due to lower headcount as a result of the April Restructuring. These decreases were partially offset by higher facilities and infrastructure-related costs including depreciation expense, restructuring charges related to the April Restructuring, and higher external expenses as we advance our clinical and preclinical pipeline. Stock-based compensation expense included in research and development expenses was $12.0 million and $13.7 million for the nine months ended September&#160;30, 2023 and 2022, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to devote substantial resources to research and development in the future. While we anticipate that our research and development expenses will decrease in the near-term in connection with the April and November Restructurings and the related reprioritization of certain programs and deferral of certain new investments, we ultimately expect research and development expenses to increase in the next several years if we are successful in advancing our clinical programs and if we are able to progress our preclinical product candidates into clinical trials and/or if we are successful in securing new collaborations or other capital necessary to advance our clinical programs. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The length of time required to complete our development programs and our development costs for those programs may be impacted by the results of preclinical testing, scope and timing of enrollment in clinical trials for our product candidates, our decisions to pursue development programs in other therapeutic areas, whether we pursue development of our product candidates with a partner or collaborator or independently and our ability to secure the necessary funding to progress the development of our programs. For example, our current focus is on our core neurology preclinical program, and we do not yet know whether and to what extent we will progress any resulting product candidates from our preclinical program into the clinic and in what therapeutic areas. In this regard, in connection with the April and November Restructurings, we have paused further development of certain preclinical programs following conclusion of collaborations with Biogen and Novartis and are deferring new investments in Phase&#160;3 planning activities for our Fabry disease gene therapy program and in our CAR-Treg cell therapy programs until we secure a collaboration partner or external investment. We are actively seeking collaboration partners or a direct external investment, as applicable, to progress our Fabry and CAR-Treg programs. Furthermore, the scope and number of clinical trials required to obtain regulatory approval for each pursued therapeutic area is subject to the input of the applicable regulatory authorities, and we have not yet sought such input for all potential therapeutic areas that we may elect to pursue, and even after having given such input, applicable regulatory authorities may subsequently require additional clinical studies prior to granting regulatory approval based on new data generated by us or other companies, or for other reasons outside of our control. As a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condition to any regulatory approval, we may also be subject to post-marketing development commitments, including additional clinical trial requirements. As a result of the uncertainties discussed above, we are unable to determine the duration of or complete costs associated with our development programs.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our potential therapeutic products are subject to a lengthy and uncertain regulatory process that may not result in our receipt of any necessary regulatory approvals. Failure to receive the necessary regulatory approvals would prevent us from commercializing the product candidates affected. In addition, clinical trials of our product candidates may fail to demonstrate safety and efficacy, which could prevent or significantly delay regulatory approval. A discussion of the risks and uncertainties with respect to our research and development activities, including completing the development of our product candidates, and the consequences to our business, financial position and growth prospects can be found in &#8220;Risk Factors&#8221; in Part&#160;I, Item&#160;1A of the 2022 Annual Report, as supplemented by the risks described under &#8220;Risk Factors&#8221; in Part II, Item 1A of this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of compensation-related expenses including restructuring, stock-based compensation for executive, legal, finance and administrative personnel, professional fees, facilities and information technology expenses, and other general corporate expenses.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease of $2.3&#160;million in general and administrative expenses for the three months ended September&#160;30, 2023, compared to the same period in 2022, was primarily attributable to lower compensation and other personnel costs mainly due to lower headcount as a result of the April Restructuring. Stock-based compensation expense included in general and administrative expenses was $3.0&#160;million and $3.4&#160;million for the three months ended September&#160;30, 2023 and 2022, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase of $1.8 million in general and administrative expenses for the nine months ended September&#160;30, 2023, compared to the same period in 2022, was primarily attributable to Biogen contract cost asset amortization primarily driven by a notification of termination of the collaboration agreement, higher external professional service costs, and restructuring charges related to the April Restructuring. These increases were partially offset by lower compensation and other personnel costs due to lower headcount as a result of the April Restructuring. Stock-based compensation expense included in general and administrative expenses was $9.3 million and $9.7 million for the nine months ended September&#160;30, 2023 and 2022, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we anticipate that our general and administrative expenses will decrease modestly in the near-term in connection with the April and November Restructurings, we expect higher general and administrative expenses to support the growth of the business as we continue to build out our product portfolio and advance our product candidates into the clinic.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Goodwill, Indefinite-lived Intangible Assets and Other Long-lived Assets</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2023, we recognized impairment charges of $44.8 million and $154.7 million, respectively. During the nine months ended September&#160;30, 2023, we experienced a sustained decline in our stock price and related market capitalization, our collaboration agreements with Biogen and Novartis were terminated, we initiated actions including seeking external financing and deferral and reprioritization of certain research and development programs, and equity values in the biotechnology industry continued to decline. As a result of these factors, we concluded our goodwill, indefinite-lived intangible asset, and long-lived assets, primarily comprising right-of-use assets, related leasehold improvements and construction-in-progress, and manufacturing and laboratory equipment, were impaired. Based on our analyses, we recognized a pre-tax goodwill impairment charge of $38.1&#160;million, a pre-tax indefinite-lived intangible asset impairment charge of $51.3 million along with the income tax benefit from the reduction of the associated deferred tax liability of $6.3 million, and a pre-tax long-lived assets impairment charge of $65.2&#160;million during the nine months ended September 30, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information see&#160;Note&#160;6&#160;&#8211;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Goodwill, Indefinite-lived Intangible Assets and Other Long-lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the accompanying notes to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest and other income, net</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income, net was $3.5 million and $1.8 million for the three months ended September&#160;30, 2023 and 2022, respectively. The increase of $1.7&#160;million compared to the same period in 2022 was primarily driven by an increase of $1.3 million in research tax credits and by $0.8 million related to fluctuations in foreign currency exchange rates. These increases were partially offset by $0.4 million of impairment charges related to marketable securities which we determined we will be required to sell before recovery of their amortized cost basis.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income, net was $9.6 million and $5.8 million for the nine months ended September&#160;30, 2023 and 2022, respectively. The increase of $3.9 million compared to the same period in 2022 was primarily driven by an increase of $3.7 million in interest income reflecting increase in market interest rates, $2.6 million related to fluctuations in foreign currency </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exchange rates, and $1.0 million in research tax credits. These increases were partially offset by a $3.0 million benefit received in 2022 from Employee Retention Credit under the Coronavirus Aid, Relief, and Economic Security Act and by $0.4 million of impairment charges related to marketable securities which we determined we will be required to sell before recovery of their amortized cost basis.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax expense (benefit)</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense was $1.3&#160;million and income tax benefit was $4.8&#160;million during the three and nine months ended September 30, 2023, respectively, and the income tax expense was $0.1&#160;million and $0.2&#160;million for the three and nine months ended September&#160;30, 2022, respectively. The increase for the three months ended September&#160;30, 2023 compared to the same period in 2022 was primarily driven by the valuation allowance recorded for Sangamo United Kingdom deferred tax assets during the three months ended September 30, 2023 as we determined that it is not more likely that the deferred tax asset will be realized. The income tax benefit for the nine months ended September&#160;30, 2023, compared to the same period in 2022, was primarily driven by the reduction of the deferred tax liability due to the impairment of the associated indefinite-lived intangible asset.</span></div><div id="idd6e71910c45410381852f4f4adeb648_88"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have incurred significant net losses, and we have funded our operations primarily through the issuance of equity securities, payments from corporate collaborators and strategic partners and research grants.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, we had cash, cash equivalents, and marketable securities totaling $132.1&#160;million, compared to $307.5&#160;million as of December&#160;31, 2022. Our most significant use of capital during the quarter was for employee compensation and external research and development expenses, such as manufacturing, clinical trials and preclinical activity related to our therapeutic programs. Our cash and investment balances are held in a variety of interest-bearing instruments, including U.S. government-sponsored entity debt securities, commercial paper securities, money market funds, corporate debt securities, asset-backed securities and certificates of deposit. Cash in excess of immediate requirements is invested in accordance with our investment policy with a view toward capital preservation and liquidity.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, we entered into an Open Market Sale Agreement&#8480;, or the sales agreement, with Jefferies LLC, providing for the sale of up to $150.0&#160;million of our common stock from time to time in &#8220;at-the-market&#8221; offerings under an existing shelf registration statement. In December 2022, we entered into Amendment No. 2 to the Open Market Sale Agreement&#8480;, which increased the aggregate offering price under the sales agreement by an additional $175.0 million. Approximately $194.5&#160;million remained available under the sales agreement as of September&#160;30, 2023. No shares were sold during the three months ended September&#160;30, 2023, and we sold 8,249,261 shares of our common stock for net proceeds of approximately $15.1 million during the nine months ended September&#160;30, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Accounting Standard Codification Topic 205-40, Presentation of Financial Statements&#8212;Going Concern, or ASC Topic 205-40, we have the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet our future financial obligations as they become due within one year after the date that the Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q are issued. As required under ASC Topic 205-40, management&#8217;s evaluation should initially not take into consideration the potential mitigating effects of management&#8217;s plans that have not been fully implemented as of the date the Condensed Consolidated Financial Statements are issued. When substantial doubt exists, management evaluates whether the mitigating effects of its plans sufficiently alleviate the substantial doubt about the company&#8217;s ability to continue as a going concern. The mitigating effects of management&#8217;s plans, however, are only considered if both (i) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (ii) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued. Generally, to be considered probable of being effectively implemented, the plans must have been approved by the company&#8217;s board of directors before the date that the financial statements are issued.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our current operating plan, our cash, cash equivalents and marketable securities as of September 30, 2023, in combination with the cost savings expected from the restructuring, workforce reduction and other potential cost reductions, are expected to allow us to meet our liquidity requirements only into the third quarter of 2024. Our history of significant losses, negative cash flows from operations, limited liquidity resources currently on hand and dependence on our ability to obtain additional financing to fund our operations after the current resources are exhausted, about which there can be no certainty, have resulted in management&#8217;s assessment that there is substantial doubt about our ability to continue as a going concern for at least the next 12 months from the date the Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q are issued. Our ability to continue to operate as a going concern is dependent upon our ability to raise substantial additional capital to fund our operations and support our research and development endeavors. In this regard, we are actively seeking </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">substantial additional capital, including through public or private equity or debt financing, royalty financing or other sources, such as strategic collaborations and other direct investments in our programs. However, additional capital may not be available to us on a timely basis, on terms that are acceptable or at all. In particular, the perception of our ability to continue to operate as a going concern may make it more difficult to obtain financing for the continuation of our operations, particularly in light of currently challenging macroeconomic and market conditions. Further, we may be unable to attract new investments as a result of the speculative nature of our newly reprioritized core neurology preclinical programs. If adequate funds are not available to us on a timely basis, or at all, we will be required to take additional actions to address our liquidity needs, including additional cost reduction measures such as further reducing operating expenses and delaying, reducing the scope of, discontinuing or altering our research and development activities, which would have a material adverse effect on our business and prospects, or we may be required to cease operations entirely, liquidate all or a portion of our assets, and/or or seek protection under applicable bankruptcy laws, and you may lose all or part of your investment.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> While we expect both the April and November Restructurings to be complete by the third quarter of 2024 and the second quarter of 2024, respectively, we may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, each of the restructurings. In addition, we may not achieve the expected benefits of these cost reduction measures and other cost reduction plans on the anticipated timeline, or at all, or we may use our available capital more quickly than we  expect, which could otherwise accelerate our liquidity needs and could force us to further curtail or suspend, or entirely cease, our operations. Moreover, we rely in part on our collaboration partners to provide funding for and otherwise advance our preclinical and clinical programs. However, in June 2022, our collaboration agreement with Sanofi terminated, and in June 2023 our collaboration agreements with Biogen and Novartis terminated. While we may identify new collaboration partners who can progress some of the programs that were the subject of these collaborations as well as our Fabry disease gene therapy program and our CAR-Treg cell therapy programs, we have not yet been, and may never be, successful in doing so in a timely manner, on acceptable terms or at all, and we may otherwise fail to raise sufficient additional capital in order to progress these programs ourselves, in which case, we will not receive any return on our investments in these programs. In any event, we need substantial additional funding in order to progress the programs that were the subject of these collaborations as well as our Fabry disease and CAR-Treg programs, and to otherwise execute on our current operating plan. If we raise additional capital through public or private equity offerings, including sales pursuant to our at-the-market offering program with Jefferies LLC, the ownership interest of our existing stockholders will be diluted, and such dilution may be substantial given our current stock price decline, and the terms of any new equity securities may have a preference over, and include rights superior to, our common stock. If we raise additional capital through royalty financings or other collaborations, strategic alliances or licensing arrangements with third parties, we may need to relinquish certain valuable rights to our product candidates, technologies, future revenue streams or research programs or grant licenses on terms that may not be favorable. If we raise additional capital through debt financing, we may be subject to specified financial covenants or covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or pursuing certain transactions, any of which could restrict our ability to commercialize our product candidates or operate as a business.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as we focus our efforts on proprietary human therapeutics, we will need to seek regulatory approvals of our product candidates from the FDA or other comparable foreign regulatory authorities, a process that could cost in excess of hundreds of millions of dollars per product. We may experience difficulties in accessing the capital markets due to external factors beyond our control, such as volatility in the equity markets for emerging biotechnology companies and general economic and market conditions both in the United States and abroad. In particular, our ability to raise the substantial additional capital we need in order to fund our business may be adversely impacted by global economic conditions and disruptions to and volatility in the credit and financial markets in the United States and worldwide, such as has been experienced recently due in part to, among other things, the impacts of the COVID-19 pandemic, the ongoing conflict between Russia and Ukraine and conflicts in the Middle East, and disruptions in access to bank deposits and lending commitments due to bank failure. We cannot be certain that we will be able to obtain financing on terms acceptable to us, or at all. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating activities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $174.3&#160;million for the nine months ended September&#160;30, 2023, primarily due to:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net loss of $197.5&#160;million, adjusted for non-cash goodwill, indefinite-lived intangible assets, and long-lived asset impairment charges of $154.7&#160;million, other non-cash expenses related to stock-based compensation of $21.3&#160;million, depreciation and amortization of $13.2&#160;million, and amortization of operating lease right-of-use assets of $5.9&#160;million, offset by income tax benefit of $6.2&#160;million related to reversal of the deferred tax liability as a result of impairment on the associated indefinite-lived intangible assets, accretion of discounts and impairment of marketable securities of $2.0&#160;million, and other non-cash adjustments of $1.1 million; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease in deferred revenues of $159.7&#160;million, mainly attributed to the impact of the termination and related contract modification of our collaboration agreement with Biogen and a change in estimate for our collaboration agreement with Kite, a decrease in accounts payable and other accrued liabilities by $5.2&#160;million, a decrease in accrued compensation and employee benefits by $4.2&#160;million, and a decrease in lease liabilities by $3.7&#160;million. These were partially offset by decrease in prepaid expenses and other assets by $5.2&#160;million, and a decrease in accounts receivable by $2.5&#160;million.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $166.6 million for the nine months ended September 30, 2022, primarily reflecting our net loss of $140.3 million, a decrease in deferred revenues of $65.0 million, an increase in prepaid expenses and other assets by $5.8 million, and a decrease in lease liabilities by $3.3 million. These decreases were partially offset by $38.2 million of non-cash expenses related to stock-based compensation, depreciation and amortization, amortization of premium on marketable securities, and amortization of operating lease right-of-use assets and a $9.4 million increase in accounts payable and other accrued liabilities.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing activities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities was $115.8&#160;million for the nine months ended September&#160;30, 2023, related to maturities of marketable securities of $193.9&#160;million, partially offset by purchases of marketable securities of $59.6&#160;million, and purchases of property and equipment of $18.5&#160;million.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities was $16.7 million for the nine months ended September 30, 2022, related to maturities of marketable securities of $255.0 million, partially offset by purchases of marketable securities of $225.6 million, and $12.7 million from purchases of property and equipment.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing activities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $14.4&#160;million for the nine months ended September&#160;30, 2023, related to $15.1&#160;million of proceeds from the at-the-market offering, net of offering expenses of $0.4&#160;million, and proceeds from purchases of common stock under the employee stock purchase plan of $0.7&#160;million, partially offset by taxes paid related to net share settlement of equity awards of $1.4&#160;million.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $65.1 million for the nine months ended September 30, 2022, mostly related to $67.5 million of proceeds from the at-the-market offering, net of offering expenses of $1.7 million, and proceeds from purchases of common stock under the employee stock purchase plan of $1.1 million, partially offset by taxes paid related to net share settlement of equity awards of $2.0 million.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Capital and Capital Expenditure Requirements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate continuing to incur operating losses for at least the next several years and need to raise substantial additional capital. The effects of the current macroeconomic environment, including the effects of war in Ukraine and conflicts in the Middle East, financial and liquidity challenges associated with current and potential future bank failures, inflation, climate change, rising interest rates and other economic uncertainty and volatility, has resulted and may continue to result in significant disruption of global financial markets, which could impair our ability to access capital on terms that are acceptable or at all, and in turn could negatively affect our liquidity and our ability to continue to operate as a going concern. Future capital requirements beyond the third quarter of 2024, the period until which we expect our existing cash and cash equivalents, in combination with the cost savings expected from the restructuring, workforce reduction and other potential cost reductions, will be sufficient to fund our planned operations, will be substantial, and we need to raise substantial additional capital to continue to operate as a going concern and to fund the development, manufacturing and potential commercialization of our product candidates. In this regard, we are actively seeking substantial additional capital, including through public or private equity or debt financings, royalty financings or other sources, such as strategic collaborations. However, additional capital may not be available to us, on terms that are acceptable or at all. If adequate funds are not available to us on a timely basis, or at all, we will be required to take additional actions to address our liquidity needs, including additional cost reduction measures such as further reducing operating expenses and delaying, reducing the scope of, discontinuing or altering our research and development activities, which would have a material adverse effect on our business and prospects, or we may be required to cease operations entirely, liquidate all or a portion of our assets, and/or or seek protection under applicable bankruptcy laws, and you may lose all or part of your investment.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we focus our efforts on proprietary human therapeutics, we will need to seek FDA approvals of our product candidates, a process that could cost in excess of hundreds of millions of dollars per product. Our future capital requirements will depend on many forward-looking factors, including the following:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the results of preclinical testing of our early-stage core neurology program product candidates;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, progress, timing and completion of clinical trials for our product candidates and potential product candidates;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outcome, timing and cost of regulatory approvals;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of our collaboration agreements;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays that may be caused by changing regulatory requirements;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of product candidates that we pursue;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs involved in filing and prosecuting patent applications and enforcing and defending patent claims;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and terms of future in-licensing and out-licensing transactions;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of establishing sales, marketing, manufacturing and distribution capabilities;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of procuring clinical and commercial supplies of our product candidates;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we acquire or invest in businesses, products or technologies, including the costs associated with such acquisitions and investments; and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of potential disputes and litigation.</span></div><div id="idd6e71910c45410381852f4f4adeb648_94"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future minimum contractual obligations as of December&#160;31, 2022 were reported in the 2022 Annual Report. During the nine months ended September&#160;30, 2023, there have been no other material changes outside the ordinary course of our business from the contractual obligations previously disclosed in our 2022 Annual Report.</span></div><div id="idd6e71910c45410381852f4f4adeb648_100"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our exposure to market risk relates to our cash, cash equivalents, and marketable securities. The goals of our investment policy are preservation of capital, fulfillment of liquidity needs and capturing a market rate of return based on our investment policy parameters and market conditions. We select investments that maximize interest income to the extent possible within these guidelines. To achieve our goals, we maintain a portfolio of cash equivalents and investments in securities of high credit quality and with varying maturities to match projected cash needs.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The securities in our investment portfolio are not leveraged and are classified as available-for-sale. The majority of these available-for-sale securities are short-term in nature and subject to minimal interest rate risk. Our investments currently consist of U.S. government-sponsored entity debt securities, commercial paper securities, corporate debt securities, asset-backed securities and certificates of deposit. Our investment policy, approved by our Board of Directors, limits the amount we may invest in any one type of investment issuer, thereby reducing credit risk concentrations. All investments are carried at market value, which approximates cost. We do not use derivative financial instruments in our investment portfolio. Our market risks at September&#160;30, 2023 have not changed materially from those discussed in Item&#160;7A of our 2022 Annual Report.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operations in the United States as well as in Europe. The functional currency of each foreign subsidiary is the local currency. We are exposed to foreign currency risk, primarily through operations of our subsidiaries in Europe which conduct business primarily in Euros. We record gains and losses within our stockholders&#8217; equity due to the translation of our subsidiaries&#8217; financial statements into U.S. dollars. Our foreign currency exchange risk at September&#160;30, 2023 has not changed materially from that discussed in Item&#160;7A of our 2022 Annual Report.</span></div><div id="idd6e71910c45410381852f4f4adeb648_103"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision of our principal executive officer and principal financial officer, we evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of September&#160;30, 2023. Based on that evaluation, as of September&#160;30, 2023, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inherent Limitations on Controls and Procedures</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including the principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures and our internal control over financial reporting will prevent all error and all fraud. A control system, no matter how well designed and operated, can only provide reasonable assurances that the objectives of the control system are met. The design of a control system reflects resource constraints; the benefits of controls must be considered relative to their costs. Because there are inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, for our company have been or will be detected. As these inherent limitations are known features of the disclosure and financial reporting processes, it is possible to design into the processes safeguards to reduce, though not eliminate, these risks. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events. While our disclosure controls and procedures and our internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives, there can be no assurance that any design will succeed in achieving its stated goals under all future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with the policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting that occurred during the quarter ended September&#160;30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="idd6e71910c45410381852f4f4adeb648_109"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not party to any material pending legal proceedings. From time to time, we may be involved in legal proceedings arising in the ordinary course of business.</span></div><div id="idd6e71910c45410381852f4f4adeb648_112"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below we are providing, in supplemental form, changes to our risk factors from those previously disclosed in Part I, Item 1A of the 2022 Annual Report. Our risk factors disclosed in Part I, Item 1A of the 2022 Annual Report provide additional discussion about these supplemental risks and we encourage you to read and carefully consider the risk factors disclosed in Part I, Item 1A of the 2022 Annual Report for a more complete understanding of the risks and uncertainties material to our business.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have historically incurred significant operating losses since inception and anticipate that we will incur continued losses for the foreseeable future.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a history of recurring net losses, including $197.5 million, $192.3 million and $178.3 million for the nine months ended September 30, 2023, and years ended December 31, 2022 and 2021, respectively, and we have otherwise generated operating losses since we began operations in 1995. The extent of our future losses and the timing of profitability are uncertain, and we expect to incur losses for the foreseeable future. We have been engaged in developing our ZF technology since inception, which has and will continue to require significant research and development expenditures. To date, we have generated our funding from issuance of equity securities, revenues derived from collaboration agreements, other strategic partnerships in non-therapeutic applications of our technology, federal government research grants and grants awarded by research foundations. We expect to continue to incur additional operating losses for the next several years as we continue to develop our preclinical core neurology. If the time required to generate significant product revenues and achieve profitability is longer than we currently anticipate or if we are unable to generate liquidity through equity financing or other sources of funding, we may be forced to further curtail or suspend, or entirely cease, our operations.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There is substantial doubt about our ability to continue to operate as a going concern. We need substantial additional funding to execute our operating plan and to continue to operate as a going concern. If adequate funds are not available to us on a timely basis, or at all, we will be required to take additional actions to address our liquidity needs, including additional cost reduction measures such as further reducing operating expenses and delaying, reducing the scope of, discontinuing or altering our research and development activities, which would have a material adverse effect on our business and prospects, or we may be required to cease operations entirely, liquidate all or a portion of our assets, and/or or seek protection under applicable bankruptcy laws, and you may lose all or part of your investment. Future sales and issuances of equity securities would also result in substantial dilution to our stockholders.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant operating losses and negative operating cash flows since inception and have not achieved profitability. We estimate that our available cash, cash equivalents and marketable securities as of September 30, 2023, in combination with the cost savings expected from the restructuring, workforce reduction and other potential cost reductions, will be sufficient to fund our planned operations only into the third quarter of 2024. Our financial position raises substantial doubt about our ability to continue to operate as a going concern. Our ability to continue to operate as a going concern is dependent upon our ability to raise substantial additional capital to fund our operations and support our research and development endeavors. In this regard, we are actively seeking substantial additional capital, including through public or private equity or debt financing, royalty financing or other sources, such as strategic collaborations and other direct investments in our programs. However, additional capital may not be available to us on a timely basis, on terms that are acceptable or at all. In particular, the perception of our ability to continue to operate as a going concern may make it more difficult to obtain financing for the continuation of our operations, particularly in light of currently challenging macroeconomic and market conditions. Further, we may be unable to attract new investments as a result of the speculative nature of our newly reprioritized core neurology preclinical programs. If adequate funds are not available to us on a timely basis, or at all, we will be required to take additional actions to address our liquidity needs, including additional cost reduction measures such as further reducing operating expenses and delaying, reducing the scope of, discontinuing or altering our research and development activities, which would have a material adverse effect on our business and prospects, or we may be required to cease operations entirely, liquidate all or a portion of our assets, and/or or seek protection under applicable bankruptcy laws, and you may lose all or part of your investment. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this regard, in April 2023, we announced a restructuring of operations and a reduction in force, or the April Restructuring, and a significant reduction in our internal manufacturing and allogeneic research footprints in California, and in November 2023, we announced a further restructuring of operations and reduction in force, or the November Restructuring, including a strategic transformation to focus resources on our proprietary neurology-focused epigenetic regulation programs and AAV capsid delivery technology and move all U.S. operations, including our headquarters, to our Richmond, California facility. While we expect both the April and November Restructurings to be complete by the third quarter of 2024 and the second quarter </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of 2024, respectively, we may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, each of the restructurings. In addition, we may not achieve the expected benefits of these cost reduction measures and other cost reduction plans on the anticipated timeline, or at all, or we may use our available capital more quickly than we expect, which could otherwise accelerate our liquidity needs and could force us to further curtail or suspend, or entirely cease, our operations. Moreover, we rely in part on our collaboration partners to provide funding for and otherwise advance our preclinical and clinical programs. However, in June 2022, our collaboration agreement with Sanofi terminated, and in June 2023 our collaboration agreements with Biogen and Novartis terminated. While we may identify new collaboration partners who can progress some of the programs that were the subject of these collaborations as well as our Fabry disease gene therapy program and our CAR-Treg cell therapy programs, we have not yet been, and may never be, successful in doing so in a timely manner, on acceptable terms or at all, and we may otherwise fail to raise sufficient additional capital in order to progress these programs ourselves, in which case, we will not receive any return on our investments in these programs. In any event, we need substantial additional funding in order to progress the programs that were the subject of these collaborations as well as our Fabry disease and CAR-Treg programs, and to otherwise execute on our current operating plan.  </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise additional capital through public or private equity offerings, including sales pursuant to our at-the-market offering program with Jefferies LLC, the ownership interest of our existing stockholders will be diluted, and such dilution may be substantial given our current stock price decline, and the terms of any new equity securities may have a preference over, and include rights superior to, our common stock. If we raise additional capital through royalty financings or other collaborations, strategic alliances or licensing arrangements with third parties, we may need to relinquish certain valuable rights to our product candidates, technologies, future revenue streams or research programs or grant licenses on terms that may not be favorable. If we raise additional capital through debt financing, we may be subject to specified financial covenants or covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or pursuing certain transactions, any of which could restrict our ability to commercialize our product candidates or operate as a business.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as we focus our efforts on proprietary human therapeutics, we will need to seek regulatory approvals of our product candidates from the FDA or other comparable foreign regulatory authorities, a process that could cost in excess of hundreds of millions of dollars per product. We may experience difficulties in accessing the capital markets due to external factors beyond our control, such as volatility in the equity markets for emerging biotechnology companies and general economic and market conditions both in the United States and abroad. In particular, our ability to raise the substantial additional capital we need in order to fund our business may be adversely impacted by global economic conditions and disruptions to and volatility in the credit and financial markets in the United States and worldwide, such as has been experienced recently due in part to, among other things, the impacts of the COVID-19 pandemic, the ongoing conflict between Russia and Ukraine and conflicts in the Middle East, and disruptions in access to bank deposits and lending commitments due to bank failure. We cannot be certain that we will be able to obtain financing on terms acceptable to us, or at all. Our failure to obtain adequate and timely funding will adversely affect our ability to continue to operate as a going concern and our ability to develop our technology and products candidates.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unfavorable global economic conditions could have a negative impact on our operations, which could materially and adversely affect our ability to continue to operate as a going concern and otherwise have a material adverse effect on our business, financial condition, results of operations, prospects and market price of our common stock.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instability and a general decline in economic conditions in the United States and other countries caused by political instability and conflict, including the ongoing conflict between Russia and Ukraine and conflicts in the Middle East, and economic or financial challenges caused by current and potential future bank failures or by general health crises such as the COVID-19 pandemic, have led to market disruptions, including significant volatility in commodity prices, credit and capital markets instability, including disruptions in access to bank deposits and lending commitments, supply chain interruptions, rising interest rates and global inflationary pressures. These macroeconomic factors could materially and adversely affect our ability to continue to operate as a going concern and other could otherwise have a material adverse effect on our business, operations, operating results and financial condition as well as the price of our common stock. For example, the recent closures of Silicon Valley Bank, or SVB, Signature Bank and First Republic Bank have resulted in broader financial institution liquidity risk and concerns. Although we were able to access all of the funds we had in deposit with SVB, future adverse developments with respect to specific financial institutions or the broader financial services industry may lead to market-wide liquidity shortages. The failure of any bank in which we deposit our funds could reduce the amount of cash we have available for our operations or delay our ability to access such funds. Any such failure may increase the possibility of a sustained deterioration of financial market liquidity, or illiquidity at clearing, cash management and/or custodial financial institutions. In the event we have a commercial relationship with a bank that has failed or is otherwise distressed, we may experience delays or other issues in meeting our financial obligations. If other banks and financial institutions fail or become insolvent in the future in response to financial conditions affecting the banking system and financial markets, our ability to access our cash and cash equivalents and investments may be threatened and our ability to raise additional capital when needed could be substantially impaired, which could have a material adverse effect on our business, operations, operating results and financial condition as well as the price of our common </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock. In particular, failure to secure any necessary financing in a timely manner and on favorable terms could require us to delay or abandon clinical development plans or we may be forced to further curtail or suspend, or entirely cease, our operations. In addition, any or all of these factors could disrupt our and our collaborators&#8217; supply chains and adversely affect our and our collaborators&#8217; ability to conduct ongoing and future clinical trials of our product candidates. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a biotechnology company with a reprioritized preclinical focus and with no approved products or product revenues. Our success depends substantially on clinical trial results demonstrating safety, efficacy and durability of our product candidates to the satisfaction of regulatory authorities. Obtaining positive clinical trial results and regulatory approvals is expensive, lengthy, challenging and unpredictable and may never occur for any product candidates.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biotechnology company with a reprioritized preclinical focus and with no approved products or product revenues. While we and Pfizer have ongoing clinical trials evaluating product candidates that use our platform technologies in hemophilia A, Fabry disease and CAR-Treg cell therapy, we have decided to defer new investments in our Fabry disease gene therapy program and our CAR-Treg cell therapy programs until we are able to successfully secure a collaboration partner or external investment. Going forward, we expect to focus substantially all of our efforts on our core preclinical neurology programs and should we be successful in raising additional funds necessary to execute our operating plan and to continue to operate as a going concern, we anticipate initiating clinical trials in the future on our preclinical product candidates. We are and will be substantially dependent on the results of these clinical trials, and there is no guarantee that final results of clinical trials conducted on our product candidates now or in the future will demonstrate the safety and efficacy of any of our product candidates. In addition, none of our product candidates has obtained regulatory approval. Obtaining positive clinical trial results and regulatory approvals is expensive, lengthy, challenging and unpredictable and may never occur for any of our product candidates. If we fail to obtain positive clinical trial results and regulatory approvals for our product candidates, our anticipated revenues from our product candidates and our prospects for profitability would be adversely affected, which would likely cause the market price of our common stock to significantly decline.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are early in our research and development efforts for our core preclinical neurology programs that are the current focus of our research and development efforts, all of which are still in preclinical development. We may encounter difficulties in advancing product candidates from research programs to preclinical and clinical development.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are early in our research and development efforts for our core preclinical neurology programs that are the current focus of our research and development efforts, all of which are still in preclinical development. We have not yet demonstrated our ability to successfully commence any clinical trials of any product candidates from our core preclinical neurology programs. We intend to advance our core neurology program product candidates from research programs through preclinical development and to submit new INDs, applications for clinical trial approval and equivalent filings in other jurisdictions necessary to conduct human clinical trials evaluating our product candidates. The preparation and submission of applications to conduct clinical trials require us to conduct rigorous and time-consuming preclinical testing and studies and prepare documentation relating to, among other things, the toxicity, safety, manufacturing, chemistry and clinical protocols of our product candidates. We may experience unforeseen difficulties that could delay or otherwise prevent us from executing this strategy successfully. For example, we may encounter problems in the manufacturing of a product candidate and may fail to demonstrate consistency in the formulation of a product candidate. Our preclinical tests may produce negative or inconclusive results, which may lead us to decide, or which may lead regulators to require us, to conduct additional preclinical testing. If we cannot obtain positive results in preclinical testing, we may decide to abandon a product candidate altogether. In addition, our ability to complete and submit such applications to conduct clinical trials may depend on the support of collaborators and the timely performance of their obligations under relevant collaboration agreements. If our collaborators are not able to perform such obligations or if they choose to slow down or delay the development of a product candidate, we may not be able to submit the clinical trial applications on a timely basis or at all. Furthermore, the submission of applications to conduct clinical trials involves significant cost and labor, and we may not have sufficient resources and personnel to complete the filing of all intended applications, which may force us to scale back the number of applications or forego potential applications that we believe are promising. Any delay, suspension or reduction of our efforts to pursue our preclinical and clinical development strategy could have an adverse effect on our business and cause the market price of our common stock to decline.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may use our financial and human resources to pursue a particular research program or product candidate and fail to capitalize on other programs or product candidates that may be more profitable or for which there is a greater likelihood of success.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have limited resources and may forego or delay pursuit of certain research programs or product candidates that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities or pursue collaborations rather than retain sole responsibility for development. Our current and future research and development programs for core neurology program product candidates may not yield any commercially viable products. The evaluation of the commercial potential or target market for a particular product candidate is forward-looking and based upon assumptions involving, for example and not limited to, market evolution, advances </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in disease standard of care, competition and reimbursement. This reliance on assumptions means that, if our assumptions prove to be inaccurate or incomplete, we may pursue opportunities that end up having a number of competitors that are more advanced than our product candidates, or we may relinquish valuable rights to a product candidate through strategic collaboration, licensing or other royalty arrangements in cases where it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate.  </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented several strategic decisions to reallocate resources among our various clinical and preclinical development programs, including most recently our announcement in connection with the November Restructuring that we have decided to defer new investments in our Fabry disease gene therapy program and our CAR-Treg cell therapy programs until we are able to successfully secure a collaboration partner or external investment. Although we are actively seeking collaboration partners or a direct external investment, as applicable, to progress our Fabry disease and CAR-Treg programs, there can be no assurance that such efforts will be successful in a timely manner, or at all, in which case, we will not receive any return on our investments in these programs. As part of the November Restructuring and the related strategic reprioritization, we have determined to focus substantially all of our efforts on our core preclinical neurology programs. Investment in preclinical programs is highly speculative, as it entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate effect and/or an acceptable safety profile. Previously, as part of the April Restructuring and the related strategic reprioritization, we had intended to increase our focus on preparations for a potential Phase 3 clinical trial of isaralgagene civaparvovec, our gene therapy to treat Fabry disease, the Phase 1/2 STEADFAST study evaluating TX200, our CAR-Treg cell therapy to treat patients receiving an HLA-A2 mismatched kidney from a living donor, but with the November Restructuring and the related strategic reprioritization, substantially all of our efforts are now expected to be focused solely on our core preclinical neurology programs. In 2022, we also made the strategic decision to halt further material investments in our BIVV003 SCD program beyond completion of the Phase 1/2 PRECIZN-1 study. In March 2023, Biogen and Novartis notified us of their respective terminations for convenience of our collaboration agreements with them, and in April 2023, we made the strategic decision to pause further development of the programs that were the subject of these collaborations. While we may potentially identify new collaboration partners who can progress some of the programs that were the subject of these collaborations as well as our Fabry disease and CAR-Treg programs, we may not be successful in doing so in a timely manner, on acceptable terms or at all, and we may otherwise fail to raise sufficient additional capital in order to progress these programs ourselves. As a result of these strategic decisions, we could miss valuable opportunities to capitalize on the potential of our discontinued and halted programs. We may also allocate internal resources to a product candidate in a therapeutic area in which it would have been more advantageous to enter into a collaboration or that does not prove to have viable commercial opportunities. Any failure to use our financial and human resources efficiently could harm our business and operations.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our collaborators control certain aspects of our product development efforts, including certain of our clinical trials, which could result in unanticipated delays and other obstacles in the commercialization of our product candidates.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on collaborators to design and conduct clinical trials for the product candidates that are the subject of the related collaboration agreement. As a result, these clinical trials may not be conducted in the manner or on the timeline we desire, which may negatively impact our product development efforts. For example, Pfizer is the trial sponsor of the Phase 3 AFFINE trial of giroctocogene fitelparvovec and we depended on the efforts of Pfizer to diligently seek to lift the clinical hold on the Phase 3 AFFINE trial and resume the trial. Although dosing in the AFFINE trial has now resumed, we cannot guarantee that we will not experience future delays in this trial or that the trial will be completed on the anticipated timeframe or at all.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lack of control over aspects of product development in our collaborations could cause delays or other difficulties in the development and commercialization of our product candidates, which may prevent us from receiving any milestone, royalty payments and other benefits under the agreement. In addition, under their respective agreements, our third-party collaborators have certain rights to terminate the agreements by providing us with advance notices, therefore, the actual milestone payments that we may receive under these agreements may be substantially lower than the full amounts provided for under these agreements. For example, in June 2022, our collaboration agreement with Sanofi terminated, and in June 2023, our collaborations with Biogen and Novartis terminated. As a result, we will not be entitled to any further milestone payments or royalties from any of Sanofi, Biogen or Novartis. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our collaborators licensing our ZF technologies may decide to adopt alternative technologies or products or may be unable or unwilling to develop commercially viable products with our ZF technologies, which would negatively impact our revenues and our strategy to develop product candidates using ZF technologies.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our ongoing collaborations leverage our ZF technology platform. These collaborators may elect to adopt alternative technologies in the future, which could decrease the value of our ZF technology platform and impede the development of product candidates using the platform. Additionally, because our collaborators are likely to be working on more than one development project, they could choose to shift their resources to projects other than those they are working on with us. If they do so, this would delay our ability to test and develop our ZF technology platform and would delay or terminate the development of our product candidates using the platform. Further, our collaborators may elect not to develop product candidates arising out of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our collaborations or not to devote sufficient resources to the development, manufacturing, marketing or sale of these product candidates. If they terminate the collaborations with us or allow them to expire, such as the terminations for convenience of our collaboration agreements with Biogen and Novartis, and we wish to continue developing the product candidates, we will be required to seek the support of other collaborators or develop the products ourselves. Particularly as a result of the November Restructuring, we do not expect to have sufficient resources and expertise internally to allow us to continue the development of these product candidates and we may not be able to identify a suitable partner or negotiate a favorable collaboration agreement to allow us to continue the development of these product candidates.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercialization of our technologies will depend, in part, on collaborations with other companies. If we are not able to find collaborators in the future or if our collaborators do not diligently pursue product development efforts, we may not be able to develop our technologies or product candidates, which could slow our growth and decrease the market value of our common stock.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have financial resources ourselves to fully develop, obtain regulatory approval for and commercialize our product candidates. We rely significantly on our collaborations with other biopharmaceutical companies to provide funding for our research and development efforts, including preclinical studies and clinical tests, and expect to rely significantly on such collaborations to provide funding for the lengthy regulatory approval processes required to commercialize our product candidates.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, we have collaborations with Pfizer to develop a product candidate to treat hemophilia A and with Alexion, AstraZeneca Rare Disease to develop product candidates to treat amyotrophic lateral sclerosis and frontotemporal lobar degeneration linked to mutations of the C9ORF72 gene. Any delays to or discontinuances of these collaborations could have a material adverse effect on our business, results of operations, financial condition and prospects.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were also party to collaboration agreements with Novartis to develop product candidates to treat certain neurodevelopment disorders, including autism and intellectual disability and with Biogen to develop product candidates to treat tauopathies including Alzheimer&#8217;s disease, alpha-synuclein related diseases including Parkinson&#8217;s disease and other neurological diseases. In June 2023, our collaboration agreements with Novartis and Biogen terminated. As a result of these terminations, we are no longer entitled to any milestone payments or royalties from Novartis or Biogen, and Novartis and Biogen have no further obligations to develop or to reimburse the costs of any of the programs under the applicable agreement. In April 2023, we made the strategic decision to pause further development of the programs that were the subject of these collaborations. In the future, we may identify alternative options to advance some of the programs that were subject to such agreements, including potential development internally or with a collaboration partner. However, we cannot guarantee that we will be able to successfully secure any such options, including identifying an alternative suitable collaboration partner or negotiate a favorable alternative collaboration agreement. In such case, we may be unable or unwilling to continue developing the programs subject to these collaboration agreements due to the lack of adequate capital resources or otherwise.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we completed the transition of the rights and obligations of Sanofi, under our prior collaboration agreement back to us. Although we expect to complete the Phase 1/2 PRECIZN-1 study of BIVV003, our product candidate to treat SCD, we cannot guarantee that we will be able to complete this study in a timely manner or at all. Also, we do not expect to make additional investments in our SCD program and, accordingly, do not plan to continue developing BIVV003 beyond completion of this study.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to secure additional collaborations or if our collaborators are unable or unwilling to diligently advance the development, regulatory approval and commercialization of our product candidates, our growth may slow and adversely affect our ability to generate funding for development of our technologies and product candidates as well as our ability to continue to operate as a going concern, and we may be required to cease operations. For example, although we have decided to defer new investments in our Fabry disease gene therapy program and our CAR-Treg cell therapy programs until we are able to successfully secure a collaboration partner or external investment, there can be no assurance that such efforts will be successful in a timely manner, or at all, in which case, we will not receive any return on our investments in these programs and our ability to continue to operate as a going concern may be materially and adversely affected. In addition, our ongoing collaborators may sublicense or abandon development programs with little advance notice, or we may have disagreements or disputes with our collaborators, which would cause associated product development to slow or cease. In addition, the business or operations of our collaborators may change significantly through restructurings, acquisitions, other strategic transactions that may negatively impact their ability to advance our programs. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under typical collaborations, we expect to receive revenue for the research and development of our product candidates based on achievement of specific milestones, as well as royalties based on a percentage of sales of any commercialized products. Achieving these milestones will depend, in part, on the efforts of our collaborators, which we have no control over, as well as our own efforts. In addition, business combinations, changes in a collaborator&#8217;s business strategy and financial difficulties or other factors could result in that collaborator abandoning or delaying development of any product candidates covered by our collaboration agreement with that collaborator. For example, the transition back to us of the rights and obligations of Sanofi related to BIVV003 and the related termination for convenience by Sanofi of our prior collaboration agreement followed a change </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Sanofi&#8217;s strategic direction to focus on allogeneic universal genomic medicine approaches rather than autologous personalized cell therapies. In addition, Novartis&#8217;s and Biogen&#8217;s decisions to terminate their respective collaboration agreements with us each related to a recent strategic review. Further, if we fail or any collaboration partner fails to meet specific milestones, then the collaboration agreement may be terminated, which would preclude our ability to earn any additional milestone payments under that collaboration agreement and would reduce our revenues. In addition, even if a collaboration product candidate is successfully developed and approved for marketing by relevant regulatory authorities, if sales of the commercialized product fails to meet expectations, we could receive lower royalties than expected. In any event, the milestone and royalty payment opportunities associated with our collaborations involve a substantial degree of risk to achieve and may never be received. Accordingly, investors should not assume that we will receive all of the potential milestone payments provided for under our ongoing collaborations, and it is possible that we may never receive any further significant milestone payments or any royalty payments under our collaborations.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are substantially reliant on third parties for the manufacture of our product candidates for clinical development. If one of our third-party manufacturers fails to perform adequately or fulfill our needs, we may be required to incur significant costs and devote significant efforts to find new suppliers or manufacturers.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the November Restructuring and the anticipated closure of our Brisbane, California facility in early 2024, we expect to rely solely on contract manufacturing organizations, or CMOs, to manufacture clinical supply. We intend to continue to rely on third parties for the manufacture of product candidates for later stage clinical trials, and for commercial-scale manufacturing for any approved product. The manufacture of biopharmaceutical products in compliance with the FDA&#8217;s cGMP, or comparable foreign GMP regulations, requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls. Manufacturers of biopharmaceutical products often encounter difficulties in production, including difficulties with production costs and yields, quality control, including stability of the product candidate and quality assurance testing, shortages of qualified personnel, as well as compliance with strictly enforced cGMP requirements, other federal and state regulatory requirements and foreign regulations. If our manufacturers were to encounter any of these difficulties or otherwise fail to comply with their obligations to us or under applicable regulations, our ability to conduct later-stage clinical trials could be jeopardized. Any delay or interruption in the supply of clinical trial materials could delay the completion of our clinical trials, increase the costs associated with developing our product candidates and, depending upon the period of delay, require us to commence new clinical trials at significant additional expense or terminate the clinical trials completely.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our CMOs must comply with cGMP requirements enforced by the FDA through its facilities inspection program and comparable foreign regulatory authorities. These requirements include, among other things, quality control, quality assurance and the maintenance of records and documentation. We and our CMOs may be unable to comply with these cGMP requirements and with other FDA, state and comparable foreign regulatory requirements. The FDA or similar foreign regulatory agencies may also implement new standards at any time or change their interpretation and enforcement of existing standards for manufacture, packaging or testing of products. We have limited control over our manufacturers&#8217; compliance with these regulations and standards. Failure to comply with these requirements may result in fines and civil penalties, suspension of production, suspension, variation or delay in product approval, product seizure or recall or withdrawal of product approval. If the safety of any product supplied is compromised due to our manufacturers&#8217; failure to adhere to applicable laws or for other reasons, we may not be able to obtain regulatory approval for or successfully commercialize our products and we may be held liable for any injuries sustained as a result. Any of these factors could cause a delay of clinical trials, regulatory submissions, approvals or commercialization of our product candidates, entail higher costs or impair our reputation.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current agreements with our CMOs do not provide for the entire supply of the drug product necessary for all anticipated clinical trials or for full scale commercialization. If we and our CMOs cannot agree to the terms and conditions for them to provide the drug product necessary for our clinical and commercial supply needs, we may not be able to manufacture the product candidate until a qualified alternative manufacturer is identified, which could also delay the development of, and impair our ability to commercialize our product candidates.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of third-party CMOs with the necessary manufacturing and regulatory expertise and facilities is limited, and it could be expensive and take a significant amount of time to arrange for alternative CMOs, which could have an adverse effect on our business. New manufacturers of any product candidate would be required to qualify under applicable regulatory requirements and would need to have sufficient rights under applicable intellectual property laws to the method of manufacturing the product candidate. Obtaining the necessary approvals or other qualifications under applicable regulatory requirements and ensuring non-infringement of third-party intellectual property rights could result in a significant interruption of supply and could require the new manufacturer to bear significant additional costs which may be passed on to us.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have limited experience manufacturing biopharmaceutical products, and there can be no assurance that we will be able to maintain compliant manufacturing facilities and manufacture our product candidates as intended.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the November Restructuring and the anticipated closure of our Brisbane, California facility in early 2024, we expect to rely solely on contract manufacturing organizations, or CMOs, to manufacture clinical supply. However, we continue to operate a cell therapy manufacturing facility in Valbonne, France to manufacture supplies for our cell therapy product candidates. Operationalizing the Valbonne facility requires us to transition manufacturing processes and know-how of our product candidates from our CMOs to our own facilities. Transferring manufacturing processes and know-how is complex and involves review and incorporation of both documented and undocumented processes that may have evolved over time. In addition, transferring production to different facilities may require utilization of new or different processes to meet the specific requirements of a given facility. Additional studies may also need to be conducted to support the transfer of certain manufacturing processes and process improvements. We cannot be certain that all relevant know-how and data has been adequately incorporated into the manufacturing process until the completion of studies and evaluations intended to demonstrate the comparability of material previously produced by CMOs with that generated by our facilities. Although some of our employees have experience in the manufacturing of biopharmaceutical products from prior employment at other companies, we, as a company, have no prior experience in biopharmaceutical product manufacturing, and continuing to operate the Valbonne facility will require us to comply with complex regulations and to continue to hire and retain experienced scientific, quality control, quality assurance and manufacturing personnel. In addition, government approvals are required for us to operate manufacturing facilities and are time-consuming to obtain and maintain. As a manufacturer of biopharmaceutical products, we also will be required to demonstrate and maintain cGMP compliance. These requirements include, among other things, quality control, quality assurance and the maintenance of records and documentation. Furthermore, establishing manufacturing operations will require a reallocation of other resources, particularly the time and attention of our senior management. Even if we are able to establish our own manufacturing capabilities, we could encounter challenges in operating the manufacturing facilities in compliance with cGMP, regulatory or other applicable requirements, resulting in potential negative consequences, including regulatory actions, which could undermine our ability to use these facilities for our own manufacturing needs. Any failure or delay in the development of our manufacturing capabilities could adversely impact the development of our product candidates.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Special regulatory designations, such as RMAT, orphan drug designations or fast track designation, may not be available for our product candidates or may not lead to a faster development or regulatory review or approval process. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received RMAT designation for our product candidates to treat severe hemophilia&#160;A and Fabry disease. Additionally, some of our product candidates, including our product candidate to treat Fabry disease, have also been granted Orphan Drug Designation by the FDA, and some have also been designated Orphan Medicinal Products by the EMA. Regulatory authorities in some jurisdictions, including the United States and the EU, may designate drugs for relatively small patient populations as orphan drugs. In addition, our product candidate to treat Fabry disease was granted FDA Fast Track Designation in May 2023. For additional information regarding these special regulatory designations, see &#8220;Business-Government Regulation&#8221; in our 2022 Annual Report.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we request such designations for our other current or future product candidates, there can be no assurances that the FDA, the European Commission or comparable foreign regulatory authorities will grant any of our product candidates such designations. Additionally, such designations do not guarantee that any regulatory agency will accelerate regulatory review of, or ultimately approve, those product candidates, nor does it limit the ability of any regulatory agency to grant such designations to product candidates of other companies that treat the same indications as our product candidates prior to our product candidates receiving marketing approval. Such designations can also be revoked. RMAT designation can be revoked if the criteria for eligibility cease to be met as clinical data emerges. Orphan drug exclusivity may be revoked if any regulatory authority determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the product to meet the needs of patients with the rare disease or condition. In addition, the FDA may withdraw Fast Track designation if it believes that the designation is no longer supported by data from our clinical development program. Fast Track designation alone does not guarantee qualification for the FDA&#8217;s priority review procedures.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our recent restructurings may not result in anticipated savings or operational efficiencies, could result in total costs and expenses that are greater than expected and could disrupt our business.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2023 and November 2023, we announced restructurings designed to reduce costs and increase focus on our key strategic priorities. We may incur additional expenses not currently contemplated due to events associated with the reduction in force, and our restructuring activities may subject us to reputational risks and litigation risks and expenses. We may not fully realize the anticipated benefits and savings from this restructuring due to unforeseen difficulties, disruptions, delays or unexpected costs, which could adversely affect our financial condition. In addition, we may need to undertake additional workforce reductions or restructuring activities in the future.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, our restructurings may be disruptive to our operations. For example, in connection with the November Restructuring, we expect to close our Brisbane, California facility in early 2024 and move all U.S. operations, including our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">headquarters, to our Richmond, California facility. We may experience delays or other difficulties in effectuating the transition of certain research and other operations, which could result in significant disruptions to our business and delays in our development efforts and clinical trial timelines. In addition, our workforce reductions could yield unanticipated consequences, such as attrition beyond planned staff reductions, increased difficulties in our day-to-day operations, loss of institutional knowledge and expertise and increased risk to our internal controls and disclosure controls. Our workforce reductions could also harm our ability to attract and retain qualified personnel who are critical to our operations.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently do not meet, and may not regain compliance with, the listing standards of the Nasdaq Stock Market LLC, or Nasdaq, and as a result our common stock may be delisted. Delisting could adversely affect the liquidity of our common stock and the market price of our common stock could decrease, and our ability to obtain sufficient additional capital to fund our operations and to continue to operate as a going concern would be substantially impaired.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is currently listed on the Nasdaq Global Select Market, which has  minimum requirements that a company must meet in order to remain listed. These requirements include maintaining a minimum closing bid price of $1.00 per share, which closing bid price cannot fall below $1.00 per share for a period of more than 30 consecutive trading days, or the Bid Price Requirement. On October 27, 2023, we received a deficiency notice, or the Notice, from the Listing Qualifications Staff, or the Staff of Nasdaq notifying us that, for the last 30 consecutive business days, the bid price of our common stock had closed below $1.00 per share, thereby failing to satisfy the Bid Price Requirement set forth in the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). The Notice has no immediate effect on the listing of our common stock on the Nasdaq Global Select Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have 180 calendar days, or until April 24, 2024, to regain compliance with the Bid Price Requirement by having shares of our common stock maintain a minimum closing bid price of at least $1.00 per share for a minimum of 10 consecutive trading days. In the event we do not regain compliance with the Bid Price Requirement prior to the expiration of the compliance period, unless Nasdaq exercises its discretion to extend this period, our common stock may be subject to a delisting action by Nasdaq.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reverse stock split may allow us to meet the Bid Price Requirement, but we cannot assure you that a reverse stock split will be approved by our stockholders or that any reverse stock split, if implemented, will be sufficient to enable us to maintain our Nasdaq listing. Additionally, if a reverse stock split is implemented, there can be no assurance that the market price per new share of our common stock following the reverse stock split will remain unchanged or will increase in proportion to the reduction in the number of old shares of our common stock outstanding before the reverse stock split. The liquidity of the shares of our common stock may be affected adversely by any reverse stock split given the reduced number of shares of our common stock that will be outstanding following such reverse stock split. Furthermore, following any reverse stock split, the resulting market price of our common stock may not attract new investors and may not satisfy the investing requirements of those investors.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that our common stock is delisted from Nasdaq as a result of our failure to regain compliance with the Bid Price Requirement, as a result of Nasdaq not granting us an extension or the panel not granting us a favorable decision or due to our failure to continue to comply with any other requirement for continued listing on Nasdaq, trading of our common stock could be conducted in the over-the-counter market or on an electronic bulletin board established for unlisted securities such as the Pink Sheets or the OTC Bulletin Board, but there can be no assurance that our common stock will be eligible for trading on such alternative exchange or market.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, if our common stock is delisted from Nasdaq, the liquidity of our common stock would be adversely affected, the market price of our common stock could decrease, our ability to obtain sufficient additional capital to fund our operations and to continue to operate as a going concern would be substantially impaired and transactions in our common stock could lose federal preemption of state securities laws. Furthermore, there could also be a further reduction in our coverage by securities analysts and the news media and broker-dealers may be deterred from making a market in or otherwise seeking or generating interest in our common stock, which could cause the price of our common stock to decline further. Moreover, delisting may also negatively affect our collaborators&#8217;, vendors&#8217;, suppliers&#8217; and employees&#8217; confidence in us and employee morale.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have experienced and may continue to experience difficulties in hiring, integrating and retaining qualified skilled employees.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stability and potential growth of our organization is critical to our ability to successfully achieve our strategic objectives. We may not be able to hire, integrate and retain a sufficient number of qualified employees with the appropriate levels of experience and skills to accomplish our growth objectives.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There currently is a shortage of skilled individuals with substantial experience discovering, developing and manufacturing genomic medicines, which is likely to continue. As a result, competition for these individuals is intense and the turnover rate can be high. We have experienced, and may continue to experience, difficulty hiring, integrating and retaining employees with these skills on acceptable terms given the uncertainty regarding our ability to obtain sufficient additional funding and to continue to operate as a going concern as well as the competition among numerous biopharmaceutical companies and academic institutions for individuals with these skills. In this regard, as a result of our April and November Restructurings, 272 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">roles at our company were eliminated. Accordingly, we have been and are operating with a shortage of resources and may not be able to effectively conduct our operations with our substantially reduced number of employees. In addition, our history of implementing significant workforce reductions, along with the potential for future workforce reductions, may negatively affect our ability to retain or attract talented employees.  Moreover, any negative or unexpected results in our preclinical or clinical trials or applications for marketing approval would make it more challenging to hire and retain qualified skilled employees. If we do not obtain sufficient additional funding in the near term so that we can continue to operate as a going concern and to potentially achieve our growth objectives, the progress of our research, development, manufacturing and regulatory efforts will slow down or halt altogether, which would materially and adversely affect our business, financial condition, results of operations and prospects, and we may be required to cease operations.  </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent on certain key members of our executive team and certain of our scientific, clinical development and manufacturing personnel, the loss of whose services may impede the progress of our research, development and regulatory efforts. For example, in 2022, our former Senior Vice President, Head of Development, resigned from Sangamo, and in connection with our April and November Restructurings, the employment of each of our former Executive Vice President, Technical Operations, Executive Vice President, Chief Operating Officer, and Senior Vice President, Chief Scientific Officer,  was terminated. We could experience resignations of other executives and employees in the future given the uncertainty regarding our ability to obtain sufficient additional funding and to continue to operate as a going concern as well as the intensity of the competition for talent in the biotechnology industry, particularly in the San Francisco Bay Area.  Additional resignations or workforce reductions could result in more significant disruptions and threats to our stability and potential growth. While we have entered into employment agreements with each of our executive officers, any of them could leave our employment at any time, as all of our employees are &#8220;at will&#8221; employees. We do not have &#8220;key person&#8221; insurance on any of our employees.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have fully impaired our goodwill and indefinite-lived intangible assets, have recorded significant impairment of our long-lived assets, and may be required to record in the future significant additional charges if our long-lived assets become further impaired.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test goodwill, indefinite-lived intangible assets and long-lived assets for impairment annually or more frequently if changes in circumstances or the occurrence of events suggest impairment exists. Any significant change in market conditions, including a sustained decline in our stock price, that indicate a reduction in carrying value may give rise to impairment in the period that the change becomes known. For example, during the three and nine months ended September 30, 2023, we recognized impairment charges of $44.8 million and $154.7 million, respectively. We have now fully impaired our goodwill and indefinite-lived intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and have significantly impaired our long-lived assets. For additional information regarding these impairment charges, see &#8220;Note&#160;6&#160;&#8211;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Goodwill, Indefinite-lived Intangible Assets and Other Long-lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Part I, Item 1 of this Quarterly Report on Form 10&#8209;Q.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that changes in circumstances, many of which are outside of our control, or in the numerous variables associated with the assumptions and estimates used in assessing the appropriate valuation of our long-lived assets, could in the future result in significant additional impairment charges to our long-lived assets, which could adversely affect our results of operations. </span></div><div id="idd6e71910c45410381852f4f4adeb648_115"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 2.&#160;&#160;&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="idd6e71910c45410381852f4f4adeb648_118"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 3.&#160;&#160;&#160;&#160;DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="idd6e71910c45410381852f4f4adeb648_121"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="idd6e71910c45410381852f4f4adeb648_124"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 5.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">November Restructuring</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 11, 2023, our board of directors approved a restructuring of operations and a corresponding reduction in workforce, or the November Restructuring, designed to reduce costs and advance our strategic transformation into a neurology-focused genomic medicine company. We notified employees affected by the November Restructuring on November 1, 2023. We expect the November Restructuring to result in the elimination of approximately 162 roles in the United States, or approximately 40% of our United States workforce. We estimate that we will incur approximately $8 million to $10 million in cash-based expenses related to employee severance and notice period payments, benefits and related restructuring costs. We expect that the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">majority of the restructuring charges will be incurred in the fourth quarter of 2023 and that the execution of the November Restructuring will be substantially complete by the second quarter of 2024. We may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the November Restructuring.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Departure of Certain Officers</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the November Restructuring, the employment of each of D. Mark McClung, Executive Vice President, Chief Operating Officer, and Jason Fontenot, Ph.D., Senior Vice President, Chief Scientific Officer, will terminate, effective as of January 2, 2024. In connection with the termination of their employment, pursuant to the Amended Severance Plan (as defined below), Mr. McClung and Dr. Fontenot are entitled to certain severance benefits in exchange for the execution of a general settlement and release agreement. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Approval of Amended and Restated Executive Severance Plan</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2023, the compensation committee of our board of directors approved an amendment and restatement of our Amended and Restated Executive Severance Plan, or as so amended and restated, the Amended Severance Plan.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of such amendment and restatement is to provide for the payment of certain severance benefits in the form of a lump sum (instead of in installments or monthly reimbursements) following termination. Specifically, if an Eligible Employee (as defined in the Amended Severance Plan and which includes all of our executive officers) becomes entitled to severance benefits under the Amended Severance Plan, (i) cash severance payments will be made in the form of a lump sum within 60 days following the Eligible Employee&#8217;s termination (instead of in the form of installments over the applicable severance period, which may range from 9 to 18 months following such termination depending on the Eligible Employee&#8217;s position) and (ii) cash payments intended to replace COBRA premium reimbursements may be made in the form of a lump sum within 60 days following the Eligible Employee&#8217;s termination (instead of in the form of monthly reimbursements over the applicable severance period), in our discretion, in each case to the extent that such payments (a) are exempt from Section 409A of the Internal Revenue Code of 1986, as amended, or the Code, as determined by us in our discretion at the time of the Eligible Employee&#8217;s termination, or (ii) may otherwise be made in a lump sum upon such termination without causing adverse tax consequences under Section 409A of the Code.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes regarding the timing and form of payment of certain severance benefits under the Amended Severance Plan, as described above, were the only material changes made under the Amended Severance Plan. No other material changes (including changes regarding eligibility for, or the amount or type of, severance benefits) were made under the Amended Severance Plan.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the changes made under the Amended Severance Plan does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the Amended Severance Plan is filed as an exhibit to this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nasdaq Deficiency Notice</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 27, 2023, we received a deficiency notice, or the Notice, from the Listing Qualifications Staff, or the Staff, of The Nasdaq Stock Market LLC, or Nasdaq, notifying us that, for the last 30 consecutive business days, the bid price of our common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). The Notice has no immediate effect on the listing of our common stock on the Nasdaq Global Select Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have 180 calendar days, or until April 24, 2024, or the Compliance Date, to regain compliance with the minimum bid price requirement by having shares of our common stock maintain a minimum closing bid price of at least $1.00 per share for a minimum of 10 consecutive trading days before the Compliance Date. If our common stock does not achieve compliance by the Compliance Date, we may be eligible for an additional 180-day period to regain compliance. To qualify, we would be required to transfer our listing to the Nasdaq Capital Market and meet the continued listing requirement for market value of publicly held shares and all other applicable initial listing standards for the Nasdaq Capital Market, with the exception of the bid price requirement, and must provide written notice to Nasdaq of our intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. However, if it appears to the Staff that we will not be able to cure the deficiency, or if we are otherwise not eligible for the additional compliance period, and we do not regain compliance by the Compliance Date, the Staff will provide written notification to us that our common stock is subject to delisting. At that time, we may appeal the delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq listing rules. However, there can be no assurance that, if we receive a delisting notice and appeals the delisting determination by Nasdaq to the panel, such appeal would be successful.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to actively monitor the closing bid price of our common stock between now and the Compliance Date and, as appropriate, will evaluate available options to resolve the deficiency and regain compliance with the minimum bid price requirement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 6.&#160;&#160;&#160;&#160;EXHIBITS</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description of Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1001233/000162828023020692/sgmo-20230602xex33.htm">Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.3 to the Company&#8217;s Current Report on Form 8-K filed June 2, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1001233/000162828022032209/sgmo-20221219xxex31fifth.htm">Fifth Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed December 19, 2022).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1#+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sangamoexecutiveseveranc.htm">Amended and Restated Severance Plan of Sangamo Therapeutics, Inc.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sgmo-20230930xex311.htm">Rule 13a &#8212; 14(a) Certification of Principal Executive Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sgmo-20230930xex312.htm">Rule 13a &#8212; 14(a) Certification of Principal Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sgmo-20230930xex321.htm">Certifications Pursuant to 18 U.S.C. Section 1350.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from Sangamo&#8217;s Quarterly Report on Form 10-Q for the three months ended September&#160;30, 2023 is formatted in Inline XBRL and it is contained in Exhibit 101</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________</span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* &#160;&#160;&#160;&#160;The certifications attached as Exhibit&#160;32.1 accompany this Quarterly Report on Form&#160;10-Q pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed &#8220;filed&#8221; by the Registrant for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended.</span></div><div style="padding-left:54pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">#&#160;&#160;&#160;&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Indicates management contract or compensatory plan or arrangement.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">+&#160;&#160;&#160;&#160;Filed herewith.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="idd6e71910c45410381852f4f4adeb648_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idd6e71910c45410381852f4f4adeb648_7">Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: November&#160;1, 2023 </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.089%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SANGAMO THERAPEUTICS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ ALEXANDER D. MACRAE</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Alexander D. Macrae</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ PRATHYUSHA DURAIBABU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prathyusha Duraibabu</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Senior Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Principal Financial and Accounting Officer)</span></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>sangamoexecutiveseveranc.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>sangamoexecutiveseveranc</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- sangamoexecutiveseveranc001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       SANGAMO THERAPEUTICS, INC.  AMENDED AND RESTATED EXECUTIVE SEVERANCE PLAN  INTRODUCTION  The Sangamo Therapeutics, Inc. Amended and Restated Executive Severance Plan (the  &#8220;Plan&#8221;) is amended and restated effective as of October 28, 2023 (the &#8220;Effective Date&#8221;). The  Plan was previously amended and restated effective as of February 6, 2019, which amended and  restated in its entirety the Company&#8217;s Executive Severance Plan that became effective as of  March 14, 2017.  The purpose of the Plan is to provide severance benefits to certain executive officers and  other key employees whose employment with Sangamo Therapeutics, Inc. (the &#8220;Company)  terminates under certain prescribed circumstances.  This Plan is designed to be an &#8220;employee welfare benefit plan,&#8221; as defined in Section 3(1)  of the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;) and to meet  the descriptive requirements of a plan constituting a &#8220;severance pay plan&#8221; within the meaning of  the Department of Labor regulations published at Title 29, Code of Federal Regulations, Section  2510.3-2(b). This Plan is intended to provide benefits to a select group of management or highly  compensated employees from the general assets of the Company within the meaning of  Department of Labor regulations published at Title 29, Code of Federal Regulations, Section  2520.104-24.  This Plan supersedes all severance pay plans, policies, programs, guidelines, practices,  arrangements, agreements, letters and/or other communication, whether formal or informal or  written or unwritten, of the Company under which the Eligible Employee is eligible to receive  benefits. This Plan represents exclusive severance benefits provided to Eligible Employees and  such individuals shall not be eligible for other benefits provided in other severance pay plans,  policies, programs, guidelines, practices, arrangements, agreements (including any employment  agreement with the Company), letters (including any offer letters from the Company) or other  communications of the Company.  Article 1  Definitions  1.1 &#8220;Base Salary&#8221; means 1/12 of the amount of annual base salary payable to the Participant  at the salary rate in effect on the last day of the Participant&#8217;s employment with the Company  (without giving effect to any reduction in the Participant&#8217;s base compensation that would  constitute Good Reason for a resignation by the Participant with Good Reason).  1.2 &#8220;Board of Directors&#8221; means the Board of Directors of the Company.  1.3 &#8220;Cause&#8221; means misconduct, including the following:  (a) commission of a felony or commission of any other crime against or involving the  Company;  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       (b) an act of fraud, dishonesty or misappropriation committed by the Participant with respect  to the Company;  (c) willful or reckless misconduct by the Participant that materially affects the Company or  any of its officers, directors, employees, clients, partners, insurers, subsidiaries, parents, or  affiliates; or  (d) a material breach by the Participant of any employment agreement or the Proprietary  Information, Inventions and Materials Agreement between the Participant and the Company.  1.4 &#8220;Change in Control&#8221; means a change in ownership or control of the Company effected  through the closing of any of the following transactions:   (a) a merger, consolidation or other reorganization approved by the Company&#8217;s stockholders,  unless securities representing more than fifty percent (50%) of the total combined voting power  of the voting securities of the successor corporation are immediately thereafter beneficially  owned, directly or indirectly and in substantially the same proportion, by the persons who  beneficially owned the Company&#8217;s outstanding voting securities immediately prior to such  transaction;  (b) a stockholder-approved sale, transfer or other disposition of all or substantially all of the  Company&#8217;s assets in complete liquidation or dissolution of the Company; or   (c) any transaction or series of related transactions pursuant to which any person or any  group of persons comprising a &#8220;group&#8221; within the meaning of Rule 13d-5(b)(1) of the Securities  Exchange Act of 1934, as amended (other than the Company or a person that, prior to such  transaction or series of related transactions, directly or indirectly controls, is controlled by or is  under common control with, the Company) becomes directly or indirectly the beneficial owner  (within the meaning of Rule 13d-3 of the Securities Exchange Act of 1934, as amended) of  securities possessing (or convertible into or exercisable for securities possessing) more than fifty  percent (50%) of the total combined voting power of the Company&#8217;s securities (as measured in  terms of the power to vote with respect to the election of the members of the Board of Directors)  outstanding immediately after the consummation of such transaction or series of related  transactions, whether such transaction involves a direct issuance from the Company or the  acquisition of outstanding securities held by one or more of the Company&#8217;s existing  stockholders.  1.5 &#8220;Change in Control Period&#8221; means the twelve (12)-month period beginning on the date of  a Change in Control.  1.6 &#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended.  1.7 &#8220;Eligible Employee&#8221; means an employee of the Company serving as (i) the Chief  Executive Officer, (ii) an Executive Vice President, (iii) a Senior Vice President or (iv) a Vice  President, unless the Plan Administrator determines otherwise.   1.8 &#8220;Employer Group&#8221; means the Company and any other corporation or business controlled  by, controlling or under common control with, the Company as determined in accordance with  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       Sections 414(b) and (c) of the Code and the Treasury Regulations thereunder, except that in  applying Sections 1563(a)(1), (2) and (3) for purposes of determining the controlled group of  corporations under Section 414(b) of the Code, the phrase &#8220;at least 50 percent&#8221; shall be used  instead of &#8220;at least 80 percent&#8221; each place the latter phrase appears in such sections and in  applying Section 1.414(c)-2 of the Treasury Regulations for purposes of determining trades or  businesses that are under common control for purposes of Section 414(c) of the Code, the phrase  &#8220;at least 50 percent&#8221; shall be used instead of &#8220;at least 80 percent&#8221; each place the latter phrase  appears in Section 1.414(c)-2 of the Treasury Regulations.   1.9 &#8220;Good Reason&#8221; means a Participant&#8217;s resignation following any one or more of the  following without the Participant&#8217;s written consent:  (a) a material diminution in the Participant&#8217;s base compensation or target amount of annual  cash bonus;   (b) a material relocation of the Participant&#8217;s principal place of business, with a relocation of  more than fifty (50) miles to be deemed material for such purposes;  (c) a material diminution in the Participant&#8217;s duties, responsibilities or authority, which in the  case of the Chief Executive Officer shall include a material change to his or her direct reporting  relationship with the Board; or   (d) a material breach by the Company of any employment agreement between the Participant  and the Company.  In order for a termination of employment to be for Good Reason, the Participant must  provide written notice to the Plan Administrator of the existence of one or more conditions  described above and the Participant&#8217;s intent to resign for Good Reason hereunder within a period  not to exceed thirty (30) days of the Participant&#8217;s knowledge of the initial existence of the  condition (and in no event later than ninety (90) days of the initial existence of the condition).  Following the Participant providing this notice, the Company shall be provided a period of at  least thirty (30) days during which to remedy the condition. The Participant shall continue to  receive the Participant&#8217;s compensation and benefits during the cure period and if the condition is  not cured during such period, then at the end of such period the Participant&#8217;s employment shall  cease and the Participant may become entitled to the severance benefits described in this Plan;  provided, however, that the Participant may only become entitled to such severance benefits if  the Participant&#8217;s employment terminates within two (2) years of the initial existence of the  condition that gave rise to the resignation for Good Reason. If the condition is cured, the  Participant shall not be deemed to have &#8220;Good Reason&#8221; to terminate the Participant&#8217;s  employment.  1.10 &#8220;Participant&#8221; means any Eligible Employee who has commenced participation in the Plan  pursuant to Article 2. An individual shall continue as a Participant in the Plan until such time as  set forth in Article 2.  1.11 &#8220;Separation from Service&#8221; shall mean the Participant&#8217;s cessation of Employee Status and  shall be deemed to occur at such time as the level of the bona fide services the Participant is to  perform in Employee Status (or as a consultant or other independent contractor) permanently  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       decreases to a level that is not more than twenty percent (20%) of the average level of services  the Participant rendered in Employee Status during the immediately preceding thirty-six (36)  months (or such shorter period for which the Participant may have rendered such service). Any  such determination as to Separation from Service, however, shall be made in accordance with the  applicable standards of the Treasury Regulations issued under Section 409A of the Code. For  purposes of determining whether the Participant has incurred a Separation from Service, the  Participant will be deemed to continue in &#8220;Employee Status&#8221; for so long as the Participant  remains in the employ of one or more members of the Employer Group, subject to the control  and direction of the employer entity as to both the work to be performed and the manner and  method of performance. In addition to the foregoing, a Separation from Service will not be  deemed to have occurred while the Participant is on a sick leave or other bona fide leave of  absence if the period of such leave does not exceed six (6) months or any longer period for which  the Participant is provided with a right to reemployment with one or more members of the  Employer Group by either statute or contract; provided, however, that in the event the  Participant&#8217;s leave of absence is due to any medically determinable physical or mental  impairment that can be expected to result in death or to last for a continuous period of not less  than six (6) months and that causes the Participant to be unable to perform the Participant&#8217;s  duties as an employee, no Separation from Service shall be deemed to occur during the first  twenty-nine (29) months of such leave. If the period of leave exceeds six (6) months (or twenty- nine (29) months in the event of disability as indicated above) and the Participant is not provided  with a right to reemployment either by statute or contract, then the Participant will be deemed to  have a Separation from Service on the first day immediately following the expiration of such six  (6)-month or twenty-nine (29)-month period.   1.12 &#8220;Target Bonus&#8221; means 1/12 of the amount of the Participant&#8217;s target bonus for the year in  which the Separation from Service occurs (without giving effect to any reduction in the  Participant&#8217;s target amount of annual cash bonus that would constitute Good Reason for a  resignation by the Participant with Good Reason).  Article 2  Eligibility  An Eligible Employee shall, upon execution of the General Release (as defined below)  and the General Release becoming effective and enforceable in accordance with Section 4.4  below, become eligible to receive the severance benefits upon the Eligible Employee&#8217;s  Separation from Service without Cause or for Good Reason as set forth in Section 4.1 or 4.2.  Participants shall cease participation in the Plan upon the earliest of (i) the Participant&#8217;s  Separation from Service for Cause or without Good Reason, (ii) the Participant&#8217;s failure to  comply with the General Release requirement or (iii) for a Participant eligible to receive  severance benefits under Section 4.1 or 4.2, the date the Participant has received all such  severance benefits, as applicable.  Article 3  Plan Administration  The Compensation Committee of the Board of Directors shall serve as the Plan  Administrator. The Plan Administrator is responsible for the general administration and  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       management of this Plan and shall have all powers and duties necessary to fulfill its  responsibilities, including, but not limited to, the discretion to interpret and apply this Plan and to  determine all questions relating to eligibility for benefits. This Plan shall be interpreted in  accordance with its terms and their intended meanings. However, the Plan Administrator shall  have the discretion to interpret or construe ambiguous, unclear, or implied (but omitted) terms in  any fashion it deems to be appropriate in its sole discretion, and to make any findings of fact  needed in the administration of this Plan. The validity of any such interpretation, construction,  decision, or finding of fact shall not be given de novo review if challenged in court, by  arbitration, or in any other forum, and shall be upheld unless clearly arbitrary or capricious.  Article 4  Severance Benefits   4.1 Severance Benefits Upon Involuntary Termination. If a Participant has a Separation from  Service due to a termination by the Company without Cause or a resignation by the Participant  with Good Reason, in either case other than during the Change in Control Period, the Participant  shall be entitled to receive the following benefits, provided that the General Release has been  delivered by the Participant pursuant to Section 4.4 below and is effective and enforceable  following the expiration of the revocation period applicable to that General Release under law,  and subject to Section 4.6 pursuant to which the following benefits may instead be paid in a lump  sum.  (a) Cash Severance. The Company shall pay in cash an amount equal to the Applicable  Multiple (as set forth in subsection (c) below) of the Participant&#8217;s Base Salary. Such severance  payment shall be paid in a series of successive equal installments over a period of months equal  to the Applicable Multiple. The first such payment shall be made within the sixty (60)-day period  measured from the date of the Participant&#8217;s Separation from Service; provided, however, that  should such sixty (60)-day period span two (2) taxable years, then the first such payment shall be  made during the portion of that sixty (60)-day period that occurs in the second taxable year. The  remaining installments shall be made in accordance with the Company&#8217;s regular payroll schedule  for its salaried employees.   (b) Reimbursement for Health Coverage. If the Participant is eligible for and timely elects to  receive continued health coverage under the Company&#8217;s health plan under COBRA at a level of  coverage at or below the Participant&#8217;s level of coverage in effect on the date of the Participant&#8217;s  Separation from Service, then for a number of months equal to the Applicable Multiple (the  &#8220;Coverage Period&#8221;), the Company shall reimburse the Participant monthly an amount equal to  the monthly COBRA premium paid by the Participant, less the premium charge that is paid by  the Company&#8217;s active employees for such coverage as in effect on the date of the Participant&#8217;s  Separation from Service; provided, however, that the Coverage Period will end earlier on the  date, if any, on which the Participant first becomes covered by any other &#8220;group health plan&#8221; as  described in Section 4980B(g)(2) of the Code. The payments shall commence within the sixty  (60)-day period measured from the date of the Participant&#8217;s Separation from Service. However,  should such sixty (60)-day period span two (2) taxable years, then the first such payment shall be  made during the portion of that sixty (60)-day period that occurs in the second taxable year. The  remaining payments shall be made in accordance with the Company&#8217;s regular payroll schedule  for its salaried employees. In order to receive reimbursements hereunder, the Participant must  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       provide proof of payment of the applicable premiums prior to the applicable reimbursement  payment date.  The first payment shall include any payments for the period from the date of the  Participant&#8217;s Separation from Service to the commencement date. The Company shall reimburse  the Participant under this Section 4.1(b) only for the portion of the Coverage Period during  which the Participant continues coverage under the Company&#8217;s health plan. The Participant  agrees to promptly notify the Company of the Participant&#8217;s coverage under an alternative health  plan upon becoming covered by such alternative plan. The COBRA health care continuation  coverage period under Section 4980B of the Code shall run concurrently with the Coverage  Period. Notwithstanding the foregoing, the Company reserves the right to restructure the  foregoing COBRA premium reimbursement arrangement in any manner necessary or appropriate  to avoid fines, penalties or negative tax consequences to the Company or the Participant  (including, without limitation, to avoid any penalty imposed for violation of the  nondiscrimination requirements under the Patient Protection and Affordable Care Act (or any  other applicable laws and regulations) or the guidance issued thereunder), as determined by the  Company in its sole and absolute discretion, including treating such reimbursements as taxable  benefits subject to withholding.   (c) Applicable Multiple. The Applicable Multiple under this Section 4.1 shall be as follows:  (i) Chief Executive Officer: 18  (ii) Executive Vice President: 15  (iii) Senior Vice President: 12  (iv) Vice President: 9  4.2 Severance Benefits Upon Change in Control. If a Participant has a Separation from  Service due to a termination by the Company without Cause or a resignation by the Participant  with Good Reason, in either case during the Change in Control Period, the Participant shall be  entitled to receive the following benefits, provided that the General Release has been delivered  by the Participant pursuant to Section 4.4 below and is effective and enforceable following the  expiration of the revocation period applicable to that General Release under law, and subject to  Section 4.6 pursuant to which the benefits under Section 4.2(a) or 4.2(b) may instead be paid in a  lump sum.  (a) Cash Severance. The Company shall pay in cash an amount equal to the sum of (i) the  CIC Applicable Multiple (as set forth in subsection (d) below) of the Participant&#8217;s Base Salary  plus (ii) the CIC Applicable Multiple (as set forth in subsection (d) below) of the Participant&#8217;s  Target Bonus, subject to any reduction provided for in the Incentive Compensation Plan (for  purpose of which &#8220;Employment Agreement&#8221; shall include this Plan) or any successor bonus plan  for any bonus paid to the Participant under such plan in connection with such Change in Control  and based in whole or in part on the target bonus amount. Such cash severance payments shall be  made in the form and at the times set forth in Section 4.1(a) over a period of months equal to (i)  twelve (12) for the Chief Executive Officer and (ii) the CIC Applicable Multiple set forth in  Section 4.2(d) below for the other Participants.   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       (b) Reimbursement for Health Coverage. If the Participant is eligible for and timely elects to  receive continued health coverage under the Company&#8217;s health plan under COBRA at a level of  coverage at or below the Participant&#8217;s level of coverage in effect on the date of the Participant&#8217;s  Separation from Service, then for a number of months equal to the CIC Applicable Multiple, the  Company shall reimburse the Participant monthly an amount equal to the monthly COBRA  premium paid by the Participant, less the premium charge that is paid by the Company&#8217;s active  employees for such coverage as in effect on the date of the Participant&#8217;s Separation from Service.  Such reimbursement shall be made in accordance with and subject to the conditions set forth in  Section 4.1(b) (but for the number of months equal to the CIC Applicable Multiple determined  under this Section 4.2 rather than the Applicable Multiple determined under Section 4.1).  (c) Accelerated Vesting. The Participant shall vest on an accelerated basis with respect to  100% of the unvested shares subject to any option to purchase shares of the Company&#8217;s common  stock or any other equity award granted to the Participant to the extent outstanding and unvested  at the time of the Participant&#8217;s Separation from Service. To the extent necessary to comply with  Section 409A of the Code, such acceleration shall occur within the sixty (60)-day period  measured from the date of the Participant&#8217;s Separation from Service and should such sixty (60)- day period span two (2) taxable years, then such acceleration shall occur during the portion of  that sixty (60)-day period that occurs in the second taxable year. In order to give effect to the  intent of the foregoing provision, with respect to any such equity award other than a stock option,  in the event of such Separation from Service, notwithstanding anything to the contrary in any  applicable equity incentive plan of the Company or any agreement evidencing such equity  award, in no event will any portion of such equity award be forfeited or terminate any earlier  than the sixtieth (60th) day following the date of such Separation from Service. Each of the  Participant&#8217;s stock options to the extent outstanding as of, and as so vested in connection with,  the Participant&#8217;s Separation from Service under this Section 4.2(c) shall remain exercisable for a  period of twelve (12) months measured from the date of Separation from Service, but in no event  beyond the expiration of the maximum option term.   (d) CIC Applicable Multiple. The CIC Applicable Multiple under this Section 4.2 shall be as  follows:  (i) Chief Executive Officer: 18  (ii) Executive Vice President: 15  (iii) Senior Vice President: 12  (iv) Vice President: 9  4.3 No Duplication of Benefits. Notwithstanding anything to the contrary, under no  circumstances shall a Participant be eligible to receive payments under both Sections 4.1 and 4.2.  4.4 Release Requirement. Notwithstanding anything to the contrary in this Plan, in order to  receive any severance payments or benefits under this Plan, the Participant must first execute and  deliver to the Company, within twenty-one (21) days (or forty-five (45) days if such longer  period is required under applicable law) after the later of (i) the effective date of the Participant&#8217;s  Separation from Service or (ii) the date the Participant receives the General Release (as defined  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       herein), a general settlement and release agreement in substantially the form attached hereto as  Exhibit A (the &#8220;General Release&#8221;) and such General Release must become effective and  enforceable in accordance with its terms following the expiration of any applicable revocation  period under federal or state law; provided, however, that in no event may the applicable twenty- one (21) (or forty-five (45))-day period or revocation period hereunder extend beyond sixty (60)  days following the date of the Participant&#8217;s Separation from Service. If such General Release is  not executed and delivered to the Company within the applicable twenty-one (21) (or forty-five  (45))-day period hereunder or does not otherwise become effective and enforceable in  accordance with its terms, then no severance payments or benefits will provided to the  Participant under this Plan. The Company, in its sole and absolute discretion, may modify the  form of the General Release to comply with applicable law and shall determine the form of the  General Release.   4.5 Section 280G.  (a) If any payment or benefit a Participant would receive from the Company pursuant to this  Plan or otherwise (&#8220;Payment&#8221;) would (i) constitute a &#8220;parachute payment&#8221; within the meaning of  Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by  Section 4999 of the Code (the &#8220;Excise Tax&#8221;), then such Payment shall be equal to the Reduced  Amount.  The &#8220;Reduced Amount&#8221; shall be either (x) the largest portion of the Payment that  would result in no portion of the Payment being subject to the Excise Tax or (y) the largest  portion, up to and including the total, of the Payment, whichever amount, after taking into  account all applicable federal, state and local employment taxes, income taxes, and the Excise  Tax (all computed at the highest applicable marginal rate), results in the Participant&#8217;s receipt, on  an after-tax basis, of the greater economic benefit notwithstanding that all or some portion of the  Payment may be subject to the Excise Tax. If a reduction in a Payment is required pursuant to  the preceding sentence and the Reduced Amount is determined pursuant to clause (x) of the  preceding sentence, the reduction shall occur in the manner (the &#8220;Reduction Method&#8221;) that  results in the greatest economic benefit for the Participant. If more than one method of reduction  will result in the same economic benefit, the items so reduced will be reduced pro rata (the &#8220;Pro  Rata Reduction Method&#8221;).  (b) Notwithstanding any provision of Section 4.5(a) to the contrary, if the Reduction Method  or the Pro Rata Reduction Method would result in any portion of the Payment being subject to  taxes pursuant to Section 409A of the Code that would not otherwise be subject to taxes pursuant  to Section 409A of the Code, then the Reduction Method and/or the Pro Rata Reduction Method,  as the case may be, shall be modified so as to avoid the imposition of taxes pursuant to Section  409A of the Code as follows: (A) as a first priority, the modification shall preserve to the greatest  extent possible, the greatest economic benefit for the Participant as determined on an after-tax  basis; (B) as a second priority, Payments that are contingent on future events (e.g., being  terminated without cause), shall be reduced (or eliminated) before Payments that are not  contingent on future events; and (C) as a third priority, Payments that are &quot;deferred  compensation&quot; within the meaning of Section 409A of the Code shall be reduced (or eliminated)  before Payments that are not deferred compensation within the meaning of Section 409A of the  Code.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       (c) In the event it is subsequently determined by the Internal Revenue Service that some  portion of the Reduced Amount as determined pursuant to clause (x) in the preceding paragraph  is subject to the Excise Tax, the Participant agrees to promptly return to the Company a  sufficient amount of the Payment so that no portion of the Reduced Amount is subject to the  Excise Tax.  For the avoidance of doubt, if the Reduced Amount is determined pursuant to clause  (y) in Section 4.5(b), the Participant will have no obligation to return any portion of the Payment  pursuant to the preceding sentence.  (d) The accounting firm engaged by the Company for general tax compliance purposes as of  the day prior to the effective date of the Change in Control shall perform the foregoing  calculations unless otherwise determined by the Company.  If the accounting firm so engaged by  the Company is serving as accountant or auditor for the individual, entity or group effecting the  Change in Control, the Company shall appoint a nationally recognized accounting firm to make  the determinations required hereunder.  The Company shall bear all expenses with respect to the  determinations by such accounting firm required to be made hereunder.  4.6 Lump Sum Payments. Notwithstanding anything in this Plan to the contrary, if any  amounts under Section 4.1(a), 4.1(b), 4.2(a) or 4.2(b) are exempt from Section 409A of the Code  (as determined by the Company in its sole and absolute discretion at the time of a Participant&#8217;s  Separation from Service) or such amounts may otherwise be paid in a lump sum upon such  Separation from Service without causing adverse tax consequences under Section 409A of the  Code, then:  (a) the Company shall pay any such amounts under Section 4.1(a) or 4.2(a) in  a lump sum (instead of in the form of installments) within the sixty (60)-day period measured  from the date of the Participant&#8217;s Separation from Service;  (b) the Company, in its sole and absolute discretion, may pay any such  amounts under Section 4.1(b) or 4.2(b) in a lump sum (instead of in the form of monthly  reimbursements) within the sixty (60)-day period measured from the date of the Participant&#8217;s  Separation from Service; provided, however, that such lump sum, if any, (i) shall be paid without  regard to whether the Participant is eligible for and timely elects to receive continued health  coverage under the Company&#8217;s health plan under COBRA, or pays any COBRA premiums, and  (ii) shall be calculated without regard to any provision in the Plan under which the Coverage  Period may end earlier due to the Participant becoming covered by any other &#8220;group health plan&#8221;  as described in Section 4980B(g)(2) of the Code; and  (c) for clarity, any amounts under Section 4.1(a), 4.1(b), 4.2(a) or 4.2(b) that  are not paid pursuant to this Section 4.6 shall be paid in accordance with the applicable form of  payment and schedule set forth in Section 4.1(a), 4.1(b), 4.2(a) or 4.2(b), in each case subject to  Section 7.1, as applicable.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       Article 5  Claims and Review Procedures  5.1 Claims Procedure. Any individual (&#8220;claimant&#8221;) who has not received benefits under the  Plan that the claimant believes should be paid shall make a claim for such benefits as follows:  (a) Initiation - Written Claim. The claimant initiates a claim by submitting to the Plan  Administrator a written claim for the benefits.  (b) Timing of Plan Administrator Response. The Plan Administrator shall respond to such  claimant within ninety (90) days after receiving the claim. If the Plan Administrator determines  that special circumstances require additional time for processing the claim, the Plan  Administrator can extend the response period by an additional ninety (90) days by notifying the  claimant in writing, prior to the end of the initial ninety (90)-day period, that an additional period  is required. The notice of extension must set forth the date by which the Plan Administrator  expects to render its decision.  (c) Notice of Decision. If the Plan Administrator denies part or all of the claim, the Plan  Administrator shall notify the claimant in writing of such denial. The Plan Administrator shall  write the notification in a manner calculated to be understood by the claimant. The notification  shall set forth:  (i) The specific reason for the denial;  (ii) A reference to the specific provisions of the Plan on which the denial is based;  (iii) A description of any additional information or material necessary for the claimant to  perfect the claim and an explanation of why it is needed;  (iv) An explanation of the Plan&#8217;s review procedures and the time limits applicable to such  procedures; and  (v) A statement of the claimant&#8217;s right to bring a civil action under the Employee Retirement  Income Security Act of 1974 (&#8220;ERISA&#8221;) Section 502(a) following an adverse benefit  determination on review.  5.2 Review Procedure. If the Plan Administrator denies part or all of the claim, the claimant  shall have the opportunity for a full and fair review by the Plan Administrator of the denial, as  follows:  (a) Initiation - Written Request. To initiate the review, the claimant, within sixty (60) days  after receiving the Plan Administrator&#8217;s notice of denial, must file with the Plan Administrator a  written request for review.  (b) Additional Submissions - Information Access. The claimant shall then have the  opportunity to submit written comments, documents, records and other information relating to  the claim. The Plan Administrator shall also provide the claimant, upon request and free of  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       charge, reasonable access to, and copies of, all documents, records and other information  relevant (as defined in applicable ERISA regulations) to the claimant&#8217;s claim for benefits.  (c) Timing of Plan Administrator Response. The Plan Administrator shall respond to the  claimant&#8217;s request for review within sixty (60) days after receiving the request. If the Plan  Administrator determines that special circumstances require additional time for processing the  request, the Plan Administrator can extend the response period by an additional sixty (60) days  by notifying the claimant in writing, prior to the end of the initial sixty (60)-day period, that an  additional period is required. The notice of extension must set forth the date by which the Plan  Administrator expects to render its decision.  (d) Notice of Decision. If the Plan Administrator affirms the denial of part or the entire  claim, the Plan Administrator shall notify the claimant in writing of such denial. The Plan  Administrator shall write the notification in a manner calculated to be understood by the  claimant. The notification shall set forth the specific reason for the denial and a reference to the  specific provisions of the Plan on which the denial is based.  5.3 Authority. In determining whether to approve or deny any claim or any appeal from a  denied claim, the Plan Administrator shall exercise its discretionary authority to interpret the  Plan and the facts presented with respect to the claim, and its discretionary authority to determine  eligibility for benefits under the Plan. Any approval or denial shall be final and conclusive upon  all persons.  5.4 Exhaustion of Remedies. Except as required by applicable law, no action at law or equity  shall be brought to recover a benefit under the Plan unless and until the claimant has: (a)  submitted a claim for benefits, (b) been notified by the Plan Administrator that the benefits (or a  portion thereof) are denied, (c) filed a written request for a review of denial with the Plan  Administrator, and (d) been notified in writing that the denial has been affirmed.  Article 6  Amendment and Termination  It is intended that the Plan shall continue from year to year, subject to periodic review by  the Plan Administrator. However, the Plan Administrator reserves the right to modify, amend or  terminate the Plan at any time; provided, that no amendment or termination shall adversely affect  the rights of any then Eligible Employee under the Plan without the consent of such Eligible  Employee.  Article 7  Miscellaneous  7.1 Section 409A.  (a) The severance payments and other benefits under this Plan are intended, where possible,  to comply with the &#8220;short term deferral exception&#8221; and the &#8220;involuntary separation pay  exception&#8221; to Section 409A of the Code. Accordingly, the provisions of this Plan applicable to  the severance payments described in Article 4 and the determination of the Participant&#8217;s  Separation from Service due to termination of the Participant&#8217;s employment without Cause or the  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       Participant&#8217;s resignation for Good Reason shall be applied, construed and administered so that  those payments and benefits qualify for one or both of those exceptions, to the maximum extent  allowable. However, to the extent any payment or benefit to which the Participant becomes  entitled under this Plan is deemed to constitute an item of deferred compensation subject to the  requirements of Section 409A of the Code, the provisions of this Plan applicable to that payment  or benefit shall be applied, construed and administered so that such payment or benefit is made  or provided in compliance with the applicable requirements of Section 409A of the Code. In  addition, should there arise any ambiguity as to whether any other provisions of this Plan would  contravene one or more applicable requirements or limitations of Section 409A of the Code and  the Treasury Regulations thereunder, such provisions shall be interpreted, administered and  applied in a manner that complies with the applicable requirements of Section 409A of the Code  and the Treasury Regulations thereunder. The severance payments under Article 4 shall be  treated as a right to a series of separate payments for purposes of Section 409A of the Code.  (b) Notwithstanding any provision in this Plan to the contrary, no payment or distribution  under this Plan which constitutes an item of deferred compensation under Section 409A of the  Code and becomes payable by reason of the Participant&#8217;s termination of employment with the  Company will be made to the Participant until the Participant incurs a Separation from Service in  connection with such termination of employment. For purposes of this Plan, each amount to be  paid or benefit to be provided to the Participant shall be treated as a separate identified payment  or benefit for purposes of Section 409A of the Code. In addition, no payment or benefit which  constitutes an item of deferred compensation under Section 409A of the Code and becomes  payable by reason of the Participant&#8217;s Separation from Service will be made to the Participant  prior to the earlier of (i) the first day of the seven (7)-month period measured from the date of  such Separation from Service or (ii) the date of the Participant&#8217;s death, if the Participant is  deemed at the time of such Separation from Service to be a specified employee (as determined  pursuant to Section 409A of the Code and the Treasury Regulations thereunder) and such  delayed commencement is otherwise required in order to avoid a prohibited distribution under  Section 409A(a)(2) of the Code. Upon the expiration of the applicable deferral period, all  payments and benefits deferred pursuant to this Section 7.1(b) (whether they would have  otherwise been payable in a single sum or in installments in the absence of such deferral) shall be  paid or provided to the Participant in a lump sum on the first day of the seventh (7th) month after  the date of the Participant&#8217;s Separation from Service or, if earlier, the first day of the month  immediately following the date the Company receives proof of the Participant&#8217;s death. Any  remaining payments or benefits due under this Plan will be paid in accordance with the normal  payment dates specified herein.  (c) During the period the COBRA premium reimbursement arrangement remains in effect,  the following provisions shall govern the arrangement: (i) the amount of the COBRA premiums  eligible for reimbursement in any one calendar year during the Coverage Period shall not affect  the amount of such costs eligible for reimbursement in any other calendar year for which such  reimbursement is to be provided hereunder; (ii) no costs shall be reimbursed after the close of the  calendar year following the calendar year in which those costs were incurred; and (iii) the  Participant&#8217;s right to the reimbursement of such costs cannot be liquidated or exchanged for any  other benefit.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       7.2 Not an Employment Contract. The adoption and maintenance of this Plan shall not be  deemed to confer on any Participant any right to continue in the employ of the Employer Group,  and shall not be deemed to interfere with the right of the Employer Group to discharge any  person, with or without cause, or treat any person without regard to the effect that such treatment  might have on the person as a Plan participant.  7.3 Benefits Non&#8209;Assignable. No right or interest of a participant in this Plan shall be  assignable or transferable, in whole or in part, either directly or by operation of law or otherwise,  including but not by way of limitation, execution, levy, garnishment, attachment, pledge,  bankruptcy, assignments for the benefit of creditors, receiverships, or in any other manner,  excluding transfer by operation of law as a result solely of mental incompetency.  7.4 Tax Withholding. The Company shall withhold any applicable income or employment  taxes that are required to be withheld from the severance benefits payable under this Plan.  7.5 Applicable Law. This Plan is a welfare plan subject to ERISA and it shall be interpreted,  administered, and enforced in accordance with that law.  7.6 Gender and Number. Any masculine pronouns used herein shall refer to both men and  women, and the use of any term herein in the singular may also include the plural unless  otherwise indicated by context.  7.7 Severability. If any provision of this Plan is held invalid or unenforceable by a court of  competent jurisdiction, all remaining provisions shall continue to be fully effective.  7.8 Binding Agreement. This Plan shall be binding upon and inure to the benefit of the  Company, its successors and assigns, and the Participants and their heirs, executors,  administrators and legal representatives.  IN WITNESS WHEREOF, Sangamo Therapeutics, Inc. has caused this Plan to be  executed by its duly authorized officer effective as of the Effective Date.  SANGAMO THERAPEUTICS, INC.  By: /s/ Alexander D. Macrae  Its: President and Chief Executive Officer          </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       Exhibit A    GENERAL SETTLEMENT AND RELEASE AGREEMENT    This General Settlement and Release Agreement (the &#8220;Agreement&#8221;) is by and between  Sangamo Therapeutics, Inc., for itself and for all of its affiliated, related, parent and direct and  indirect subsidiary companies, joint venturers and partnerships, successors and permitted assigns  and each of them (collectively, the &quot;Company&quot;), on the one hand, and [Participant] (&#8220;the  Executive&#8221;) for [himself/herself], and the Executive&#8217;s agents, representatives, heirs and assigns,  on the other hand.  1. Payments. In full and complete consideration for the Executive&#8217;s promises and  undertaking set forth in this Agreement, following the eighth (8th) day following receipt by the  Company of this fully executed Agreement from the Executive, the Company will provide the  Executive the consideration, if any, to which the Executive is entitled pursuant to, and in  accordance with the terms of, the Sangamo Therapeutics, Inc. Amended and Restated Executive  Severance Plan, as amended and restated by the Compensation Committee of the Board of  Directors of the Company on October 28, 2023, unless the signature on this Agreement is  revoked pursuant to Section 8 below or any other conditions for receipt of the consideration have  not been met.    2. Release of Known and Unknown Claims.    (a) It is understood and agreed by the parties to this Agreement that in consideration  of the mutual promises and covenants contained in this Agreement, and after the opportunity to  consult with counsel, the Executive irrevocably and unconditionally releases and forever  discharges the Company, its parent, subsidiary and affiliated companies, and all of their past and  present officers, directors, employees, agents and assigns (collectively, the &#8220;Released Parties&#8221;),  from any and all causes of action, claims, actions, rights, judgments, obligations, damages,  demands, accountings or liabilities of whatever kind or character, which the Executive may have  against the Company or any of the Released Parties by reason of or arising out of, touching upon  or concerning the Executive's employment, separation of the Executive&#8217;s employment and  reapplication for employment with the Company, or any statutory claims, or any and all other  matters of whatever kind, nature or description, whether known or unknown, occurring prior to  the date of the execution of this Agreement. The Executive acknowledges that this release of  claims specifically includes, but is not limited to, any and all claims for fraud; breach of contract;  breach of the implied covenant of good faith and fair dealing; inducement of breach; interference  with contractual rights; wrongful or unlawful discharge or demotion; violation of public policy;  sexual assault and battery; invasion of privacy; intentional or negligent infliction of emotional  distress; intentional or negligent misrepresentation; conspiracy; defamation; unlawful effort to  prevent employment; discrimination or harassment on the basis of age, race, color, sex, gender,  national origin, ancestry, religious creed, physical or mental disability, medical condition, marital  status, sexual orientation, genetic information or characteristics, or any other basis protected by  applicable law; any claim under: Title VII of the Civil Rights Act of 1964 (&#8220;Title VII&#8221;); the  Americans With Disabilities Act of 1990 (&#8220;ADA&#8221;); the Age Discrimination in Employment Act  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc015.jpg" title="slide15" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       of 1967 (&#8220;ADEA&#8221;); the Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;); the  Equal Pay Act of 1963 (&#8220;EPA&#8221;); the Fair Labor Standards Act (&#8220;FLSA&#8221;); the Consolidated  Omnibus Budget Reconciliation Act (&#8220;COBRA&#8221;); the Worker Adjustment and Retraining  Notification Act (&#8220;WARN&#8221;); the Occupational Safety and Health Act (&#8220;OSHA&#8221;); the Lilly  Ledbetter Fair Pay Act of 2009 (&#8220;Fair Pay Act&#8221;); the California Fair Employment and Housing  Act (&#8220;FEHA&#8221;); the California Labor Code; and CalOSHA, or any other wrongful conduct, based  upon events occurring prior to the date that this Agreement is executed by the Executive.  Notwithstanding anything to the contrary herein, this Agreement shall not release the Executive's  right, if any, to claims the Executive may have for: (i) indemnification pursuant to the bylaws of  the Company or insurance policies of the Company, for any claims arising out of the Executive's  conduct as an employee or officer of the Company during the Executive&#8217;s employment, (ii)  unemployment, workers' compensation, state disability and/or paid family leave insurance  benefits pursuant to the terms of applicable state law, (iii) continuation of existing participation  in Company-sponsored group health benefit plans under COBRA and/or an applicable state  counterpart law, (iv) any benefit entitlements that are vested as of the Executive's termination  date pursuant to the terms of a Company-sponsored benefit plan governed by ERISA, (v) stock  and/or vested option shares pursuant to the written terms and conditions of the Executive's  existing stock option grants and agreements, existing as of the Executive&#8217;s termination date, (vi)  violation of any federal, state or local statutory and/or public policy right or entitlement that, by  applicable law, is not waivable, and (vii) any wrongful act or omission occurring after the date  the Executive signs this Agreement. In addition, nothing in this Agreement prevents the  Executive from filing a charge or complaint with the Equal Employment Opportunity  Commission (the &#8220;EEOC&#8221;), the National Labor Relations Board (the &#8220;NLRB&#8221;), the Occupational  Safety and Health Administration, the Securities and Exchange Commission (the &#8220;SEC&#8221;) or any  other federal, state or local governmental or regulatory agency, entity, commission or official(s)  (collectively, &#8220;Governmental Authorities&#8221;).  This Agreement does not limit the Executive&#8217;s  ability to communicate with any Governmental Authorities or otherwise participate in any  investigation or proceeding that may be conducted by any Governmental Authorities, including  providing documents or other information, without notice to the Company.  While this  Agreement does not limit the Executive&#8217;s right to receive an award for information provided to  any Governmental Authorities (including, without limitation, the right to receive an award from  the SEC&#8217;s whistleblower program), the Executive understands and agrees that, to the maximum  extent permitted by law, the Executive is otherwise waiving any and all rights the Executive may  have to individual relief, including monetary recovery, from Governmental Authorities or  otherwise based on any claims that the Executive has released and the rights the Executive has  waived by signing this Agreement.      (b) The Executive represents and warrants that the Executive has not assigned or  subrogated any of the Executive&#8217;s rights, claims or causes of action, including any claims  referenced in this Agreement, or authorized any other person or entity to assert such claims on  the Executive&#8217;s behalf, and the Executive agrees to indemnify and hold harmless the Company  and each of the Released Parties against any assignment of said rights, claims and/or causes of  action.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc016.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc016.jpg" title="slide16" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">         3. Waiver of Unknown Claims.      (a) Releases of Unknown Claims/Waiver of Civil Code Section 1542. The parties  agree that this Agreement is a full and final release of any and all claims and the Executive  expressly waives the benefit of Section 1542 of the California Civil Code, which provides:    &#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE  CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO  EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE  RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE  MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE  DEBTOR OR RELEASED PARTY.&#8221;    (b) The Executive hereby expressly waives and relinquishes all rights and benefits  under Section 1542 of the California Civil Code and any law or legal principle of similar effect  in any jurisdiction with respect to the Executive&#8217;s release of claims herein, including but not  limited to the release of unknown and unsuspected claims.    (c) The Executive acknowledges that the Executive has had the right to, and has been  provided an opportunity to, consult with legal counsel, and the Executive expressly  acknowledges and agrees that this Agreement is intended to include in its effect, without  limitation, all claims which the Executive does not know or suspect to exist at the time of the  execution of this Agreement, and that this Agreement contemplates the extinguishment of those  claims.    (d) The Executive acknowledges and agrees that the Executive may later discover  facts different from or in addition to those the Executive now knows or believes to be true in  entering into this Agreement. The Executive agrees to assume the risk of the possible discovery  of additional or different facts, including facts which may have been concealed or hidden, and  agrees that this Agreement shall remain effective regardless of such additional or different facts.  The Executive further acknowledges and agrees that neither the Company nor any of the other  Released Parties had any duty to disclose any fact to the Executive prior to the execution of this  Agreement.    4. Permitted Disclosures and Actions. Nothing in this Agreement shall prohibit or restrict  the Executive from lawfully (A) initiating communications directly with, cooperating with,  providing information to, causing information to be provided to, or otherwise assisting in an  investigation by Governmental Authorities regarding actual or possible violations of any law or  regulation; (B) responding to any inquiry or legal process directed to the Executive individually  (and not directed to the Company and/or its subsidiaries) from any such Governmental  Authorities; (C) testifying, participating or otherwise assisting in an action or proceeding by any  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc017.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc017.jpg" title="slide17" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       such Governmental Authorities relating to actual or possible violations of any law or regulation;  or (D) making any other disclosures that are protected under the whistleblower provisions of any  applicable law. The Executive agrees that (i) no one has interfered with the Executive&#8217;s ability to  report within the Company or to any Governmental Authorities possible violations of any law,  and (ii) it is the Company&#8217;s policy to encourage such reporting. Additionally, pursuant to the  federal Defend Trade Secrets Act of 2016, the Executive shall not be held criminally or civilly  liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is  made (i) in confidence to a federal, state, or local government official, either directly or  indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a  suspected violation of law; or (b) is made to the Executive's attorney in relation to a lawsuit for  retaliation against the Executive for reporting a suspected violation of law; or (c) is made in a  complaint or other document filed in a lawsuit or other proceeding, if such filing is made under  seal. Furthermore, nothing in this Agreement prohibits or restricts the Executive from engaging  in communications or other activity protected under the National Labor Relations Act. Moreover,  nothing in this Agreement waives the Executive&#8217;s right to testify in an administrative, legislative  or judicial proceeding concerning alleged criminal conduct or alleged unlawful acts in the  workplace (including, but not limited to, sexual harassment) on the part of any of the Released  Parties in the event that the Executive is required or requested to attend such a proceeding  pursuant to a court order, subpoena or written request from an administrative agency or the  legislature.  In addition, nothing in this Agreement prevents the Executive from discussing or  disclosing information about unlawful acts in the workplace, such as harassment or  discrimination or any other conduct that the Executive has reason to believe is unlawful.  Furthermore, this Agreement shall not in any way limit the Executive&#8217;s right to disclose factual  information related to a claim filed in a civil action or a complaint filed in an administrative  action regarding any act described in California Code of Civil Procedure Section 1001(a),  including (without limitation) an act of workplace harassment or discrimination, failure to  prevent an act of workplace harassment or discrimination, or an act of retaliation against a person  for reporting harassment or discrimination, as described in subdivisions (a), (h), (i), (j) and (k) of  Section 12940 of the California Government Code.  Nor does this Agreement require the  Executive to obtain prior authorization from the Company before engaging in any conduct  described in this paragraph, or to notify the Company that the Executive has engaged in any such  conduct.    5. Non-Admission of Liability. The Executive expressly recognizes that this Agreement  shall not in any way be construed as an admission by the Company or any of the other Released  Parties of any unlawful or wrongful acts whatsoever against the Executive or any other person or  entity. The Company and each of the Released Parties expressly denies any violation of any  policy or procedure, or of any state or federal law or regulation. The Company and each of the  Released Parties also specifically denies any liability to or wrongful acts against the Executive,  or any other person, on the part of themselves or any other employees or agents of the Company.  This Agreement shall not be admissible in any proceeding as evidence of or any admission by the  Company of any violation of any law or regulation or wrongful act. This Agreement may,  however, be introduced in any proceeding to enforce this Agreement.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc018.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc018.jpg" title="slide18" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">         6. No Filing of Claims. The Executive specifically represents that the Executive has no  pending complaints or actions against the Company, other than any claims or charges with  Governmental Authorities described in Section 2(a), above, or any of the other Released Parties  with any state or federal court or any local, state or federal agency, division or department based  on any events occurring prior to the date of execution of this Agreement.    7. ADEA Waiver and Advice of Counsel. The Executive acknowledges that by entering  into this Agreement, the Executive is knowingly and voluntarily waiving and releasing any rights  the Executive may have under the Age Discrimination in Employment Act (&#8220;ADEA&#8221;), and that  this Agreement satisfies the requirements of the Older Workers&#8217; Benefit Protection Act, 29 USC  Section 626 (f). The Executive also acknowledges that the consideration provided for the waiver  and release provided in Sections 2 and 3 above is in addition to anything of value to which the  Executive was already entitled. The Executive further acknowledges that the Executive has been  advised by this writing that (i) the Executive&#8217;s waiver and release do not apply to any rights or  claims that may arise after the execution date of this Agreement; (ii) the Executive has the right  to consult an attorney prior to executing this Agreement; and (iii) the Executive has up to twenty- one (21) calendar days after the Separation Date (or after the date the Executive receives this  Agreement, if later than the Separation Date) to seek the advice of counsel and to consider the  effects of this Agreement upon the Executive&#8217;s legal rights (the &#8220;Consideration Period&#8221;)  (although the Executive may choose to voluntarily execute this Agreement earlier). To the extent  that the Executive has signed the Agreement without obtaining the advice of counsel or before  expiration of the Consideration Period, the Executive is expressly waiving the Executive&#8217;s right  to consider the Agreement for any remaining portion of that 21-day period, and the Executive  acknowledges and agrees that the Executive&#8217;s decision to shorten the Consideration Period is  knowing and voluntary and is not induced by the Company through fraud, misrepresentation, or  a threat to withdraw or alter the severance offer prior to the expiration of the Consideration  Period, or by offering more favorable terms for signing the Agreement prior to the expiration of  the Consideration Period. The Executive acknowledges and agrees that any discussion between  the Executive and the Company or any of the Released Parties concerning the terms and  conditions of this Agreement does not extend the Consideration Period.    8. Revocation Period.  The Executive acknowledges that the Executive has been informed  that, after the Executive signs this Agreement, the Executive has the right to revoke the  Executive&#8217;s signature for a period of seven (7) calendar days from the date that the Executive  signs the Agreement. To be effective, the revocation must be in writing, signed by the Executive,  and delivered to Whitney Jones via e-mail at wjones@sangamo.com on or before 5:00 p.m.  Pacific time on the seventh (7th) calendar day following the date the Executive signs this  Agreement. The Executive acknowledges and agrees that the Company has no obligation to  comply with the terms of this Agreement until the Revocation Period has expired without  revocation, at which time this Agreement will become effective and enforceable.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc019.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc019.jpg" title="slide19" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       9. Nondisparagement. Subject to the protected communications and other activity  described in Section 4, above (&#8220;Permitted Disclosures and Actions&#8221;), the Executive agrees not to  disparage any of the Released Parties in any manner likely to be harmful to any of them or their  business, research and development programs, business reputation or personal reputation.  Likewise, the Company agrees to instruct the Company&#8217;s current members of its Executive  Leadership Team to not disparage the Executive in any manner likely to be harmful to the  Executive&#8217;s business reputation or personal reputation. Notwithstanding the foregoing, the  parties may respond accurately and fully to any question, inquiry or request for information  when required by legal process. For purposes of this Agreement, &#8220;disparage&#8221; shall mean to  make, publish or communicate any negative, belittling or derogatory statement, whether oral or  written.   The parties agree that the obligations under this section include (without limitation)  refraining from publishing any disparaging remark on any blog, online social network or any  other website (including, but not limited to, www.glassdoor.com), whether or not such comments  are made anonymously..    10. Confidentiality. Subject to the protected communications and other activity described in  Section 4, above (&#8220;Permitted Disclosures and Actions&#8221;), the Executive agrees to comply with the  Employee Confidential Information and Invention Assignment Agreement (&#8220;CIIAA&#8221;) that the  Executive entered into with the Company on [insert date]. The Executive consents and agrees  that the Executive will not, at any time, disclose the existence of this Agreement and/or the terms  of the Executive&#8217;s severance benefits to any person, firm, company, association, or entity or the  press or media for any reason or purpose whatsoever, other than to the Executive&#8217;s attorney, the  Executive&#8217;s immediate family and to the Executive&#8217;s accountant or financial advisor for tax  purposes, except to the extent such disclosure is necessary to enforce the terms of this Agreement  or is otherwise required by law. If the Executive is served with any subpoena, court order, or  other legal process seeking disclosure of any such information, the Executive shall promptly  send to the Company, within forty-eight (48) hours, via email to Scott Willoughby at  swilloughby@sangamo.com, such subpoena, court order, or other legal process so that the  Company may exercise any applicable legal remedies. The Executive agrees and acknowledges  that a violation of this paragraph by the Executive shall be a material breach of this Agreement.    11. Company Property.  By entering into this Agreement, the Executive represents that the  Executive has returned to the Company all Company property, including all papers, records,  data, notes, drawings, files, documents, samples, devices, products, equipment, and other  materials, including copies and in whatever form, relating to the business of the Company that  the Executive possesses or created as a result of the Executive's employment with the Company,  whether or not confidential, and all keys, equipment (including, but not limited to, computer  hardware, software and printers, wireless handheld devices, cellular phones and pagers), access  or credit cards, company identification, company vehicles and any other property owned by the  Company in the Executive's possession or control and has left intact all electronic documents of  the Company, including, but not limited to, those that the Executive developed or helped to  develop during the Executive's employment. Company property includes all originals plus hard  copies and electronic versions of all documents, such as e-mails, facsimiles, files, handbooks,  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc020.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc020.jpg" title="slide20" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       letters, manuals, memoranda, power points, records and reports.  The Executive further confirms  that the Executive has cancelled all accounts for the Executive&#8217;s benefit, if any, in the Company's  name, including, but not limited to, credit cards, telephone charge cards, cellular phone and/or  pager accounts and computer accounts. In addition, if the Executive has used any non-Company  computer, server, or e-mail system to receive, store, review, prepare or transmit any Company  confidential or proprietary data, materials or information, the Executive represents that the  Executive has provided the Company with a computer-useable copy of such information and has  permanently deleted and expunged such Company confidential or proprietary information from  those systems. The Executive further acknowledges and agrees that the Executive no longer has  access to and does not claim ownership of any Company cloud storage, social medial accounts,  or similar accounts.      12. Remedies for Breach of this Agreement.    (a) Injunctive Relief. In the event of a breach of the provisions of this Agreement, the  Executive agrees that any remedy at law for any breach or threatened breach of the provisions of  such paragraphs and the covenants set forth therein, will be inadequate and, accordingly, each  party hereby stipulates that the other is entitled to obtain injunctive relief for any such breaches  or threatened breaches (without the necessity of posting a bond). The injunctive relief provided  for in this paragraph is in addition to, and is not in limitation of, any and all other remedies at law  or in equity otherwise available to the applicable party.    (b) Remedies Cumulative. The remedies in this paragraph are not exclusive, and the  parties shall have the right to pursue any other legal or equitable remedies to enforce the terms of  this Agreement.    (c) Governing Law; Consent to Jurisdiction. This Agreement shall be deemed to be a  contract made under, and shall be construed in accordance with, the laws of the State of  California, without giving effect to conflict of laws principles thereof. All questions concerning  the construction, validity, and interpretation of this Agreement shall be governed by and  construed in accordance with the domestic laws of the State of California, without giving effect  to any choice of law or conflict of law provision that would cause the application of the laws of  any jurisdiction other than the State of California. Each of the parties hereby irrevocably and  unconditionally consents to submit to the exclusive jurisdiction of the courts of the State of  California or the United States District Court for the Northern District of California for any  litigation, proceeding or action arising out of or relating to this Agreement (and agrees not to  commence any litigation, proceeding or action relating thereto except in such courts). Each of the  parties hereby irrevocably and unconditionally waives any objection to the laying of venue of  any litigation, proceeding or action arising out of this Agreement or thereby in the courts of the  State of California or the United States District Court for the Northern District of California and  hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any  such court that any such litigation, proceeding or action brought in any such court has been  brought in an inconvenient forum.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc021.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc021.jpg" title="slide21" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">         13. Counsel. The parties hereby acknowledge that they have had the reasonable opportunity  to consult with attorneys of their own choice concerning the terms and conditions of this  Agreement, that they have read and understand this Agreement, that they are fully aware of the  contents of this Agreement and that they enter into this Agreement and accept its terms and  conditions freely and knowingly and with a full understanding of its legal effect.    14. No Other Amounts Due. The Executive acknowledges that the Company has paid the  Executive all wages, salaries, bonuses, benefits and other amounts earned and accrued, less  applicable deductions, and that the Company has no obligation to pay any additional amounts  other than the payment(s) described in Section 1 (&#8220;Payments&#8221;) of this Agreement. The Executive  acknowledges that the Executive has been reimbursed by the Company for all business expenses  incurred in conjunction with the performance of the Executive employment and that no other  reimbursements are owed to the Executive.    15. Entire Agreement. This is the entire agreement between the Executive and the Company  with respect to the subject matter hereof and the Agreement supersedes any previous  negotiations, agreements and understandings. The Executive acknowledges that the Executive  has not relied on any oral or written representations by the Company (or its counsel) or any of  the other Released Parties to induce the Executive to sign this Agreement, other than the terms of  this Agreement. No modifications of this Agreement can be made except in writing signed by the  Executive and the Company&#8217;s Chief Executive Officer.    16. Section 409A. It is the intention of the parties that the provisions of this Agreement  comply with the requirements of Section 409A of the Internal Revenue Code (&quot;Section 409A&quot;)  and the Treasury Regulations thereunder. Accordingly, to the extent there is any ambiguity as to  whether one or more provisions of this Agreement would otherwise contravene the applicable  requirements or limitations of Section 409A, then those provisions shall be interpreted and  applied in a manner that does not result in a violation of the applicable requirements or  limitations of Section 409A and the Treasury Regulations thereunder. In no event may the  Executive, directly or indirectly, designate the calendar year of a payment.    17. Severability.  If any provision of this Agreement is held to be illegal, invalid or  unenforceable under existing or future laws effective during the term of this Agreement, such  provisions shall be fully severable, the Agreement shall be construed and enforced as if such  illegal, invalid or unenforceable provision had never comprised a part of this Agreement, and the  remaining provisions of this Agreement shall remain in full force and effect and shall not be  affected by the illegal, invalid or unenforceable provision or by its severance from this  Agreement. Furthermore, in lieu of such illegal, invalid or unenforceable provision, there shall  be added automatically as part of this Agreement a provision as similar in terms to such illegal,  invalid or unenforceable provision as may be possible and be legal, valid and enforceable.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc022.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc022.jpg" title="slide22" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">       18. Ambiguities. Both parties have the right and have had a reasonable opportunity to  consult with an attorney regarding the terms of this Agreement and, thus, it is understood and  agreed that the general rule that ambiguities are to be construed against the drafter shall not apply  to this Agreement. In the event that any language of this Agreement is found to be ambiguous,  each party shall have an opportunity to present evidence as to the actual intent of the parties with  respect to any such ambiguous language.    19. Waiver. No waiver by any party of any breach of any term or provision of this  Agreement shall be a waiver of any preceding, concurrent or succeeding breach of this  Agreement or of any other term or provision of this Agreement. No waiver shall be binding on  the part of, or on behalf of, any other party entering into this Agreement.    20. Attorneys&#8217; Fees. In the event that any party to this Agreement asserts a claim for breach  of this Agreement or seeks to enforce its terms, the prevailing party in any such proceeding shall  be entitled to recover costs and reasonable attorneys' fees.    THE SIGNATORIES HAVE CAREFULLY READ THIS ENTIRE AGREEMENT. THEY  HAVE THE RIGHT AND HAVE HAD A REASONABLE OPPORTUNITY TO CONSULT  WITH AN ATTORNEY REGARDING THE TERMS OF THIS AGREEMENT. THE  SIGNATORIES FULLY UNDERSTAND THE FINAL AND BINDING EFFECT OF THIS  AGREEMENT. THE ONLY PROMISES MADE TO ANY SIGNATORY ABOUT THIS  AGREEMENT, AND TO SIGN THIS AGREEMENT, ARE CONTAINED IN THIS  AGREEMENT. THE SIGNATORIES ARE SIGNING THIS AGREEMENT VOLUNTARILY.    PLEASE READ CAREFULLY. THIS SETTLEMENT AGREEMENT AND GENERAL  RELEASE INCLUDES A RELEASE OF KNOWN AND UNKNOWN CLAIMS AND OF  ANY RIGHTS OR CLAIMS ARISING UNDER THE AGE DISCRIMINATION IN  EMPLOYMENT ACT OF 1967.    [signature page to follow]    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sangamoexecutiveseveranc023.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sangamoexecutiveseveranc023.jpg" title="slide23" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">         IN WITNESS WHEREOF, the parties have executed this General Settlement and Release  Agreement on the dates set forth below.           SANGAMO THERAPEUTICS, INC.:                 ____________________________________      DATE:______________________________             EXECUTIVE:             ____________________________________      DATE:______________________________                                         </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>sgmo-20230930xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia08617af3e904de580c889778132321f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Alexander D. Macrae, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed this quarterly report on Form 10-Q of Sangamo Therapeutics, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:144pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;1, 2023</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; ALEXANDER D. MACRAE</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Alexander D. Macrae</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>sgmo-20230930xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i723f7fd5dc264e3c97684753b38fe382_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><font><br></font></div></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Prathyusha Duraibabu, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed this quarterly report on Form 10-Q of Sangamo Therapeutics, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:144pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;1, 2023</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PRATHYUSHA DURAIBABU</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prathyusha Duraibabu</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>sgmo-20230930xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1b52080df94c405eb9503c161609e9d3_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><font><br></font></div></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certifications Pursuant to 18 U.S.C. &#167;1350, as Adopted</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350), each of the undersigned hereby certifies in his or her capacity as an officer of Sangamo Therapeutics, Inc. (the &#8220;Company&#8221;), that, to the best of his or her knowledge&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;the Company&#8217;s Quarterly Report on Form 10-Q for the period ended September&#160;30, 2023, to which this Certification is attached as Exhibit 32.1 (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or Section 15(d) of the Exchange Act&#59; and</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:79.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; ALEXANDER D. MACRAE</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Alexander D. Macrae</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;1, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PRATHYUSHA DURAIBABU</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prathyusha Duraibabu</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;1, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Sangamo Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form&#160;10-Q), irrespective of any general incorporation language contained in such filing. A signed original of this written statement required by Section&#160;906 of the Sarbanes-Oxley Act of 2002 has been provided to Sangamo Therapeutics, Inc. and will be retained by Sangamo Therapeutics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>sgmo-20230930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:66e428df-1cd2-4a45-95e8-7711e67a648c,g:c0e019b1-92dd-475a-ba81-4eb41606269d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sgmo="http://www.sangamo.com/20230930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.sangamo.com/20230930">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.sangamo.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000007 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>0000008 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHEQUIVALENTSANDMARKETABLESECURITIES" roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES">
        <link:definition>0000009 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASICANDDILUTEDNETLOSSPERSHARE" roleURI="http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE">
        <link:definition>0000010 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES">
        <link:definition>0000011 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETS" roleURI="http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETS">
        <link:definition>0000012 - Disclosure - IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>0000013 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.sangamo.com/role/STOCKHOLDERSEQUITY">
        <link:definition>0000014 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGCHARGES" roleURI="http://www.sangamo.com/role/RESTRUCTURINGCHARGES">
        <link:definition>0000015 - Disclosure - RESTRUCTURING CHARGES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.sangamo.com/role/INCOMETAXES">
        <link:definition>0000016 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://www.sangamo.com/role/SUBSEQUENTEVENTS">
        <link:definition>0000017 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>9954471 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>9954472 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>9954473 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHEQUIVALENTSANDMARKETABLESECURITIESTables" roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables">
        <link:definition>9954474 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables">
        <link:definition>9954475 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>9954476 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGCHARGESTables" roleURI="http://www.sangamo.com/role/RESTRUCTURINGCHARGESTables">
        <link:definition>9954477 - Disclosure - RESTRUCTURING CHARGES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>9954478 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails" roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails">
        <link:definition>9954479 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration And Licensing Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails" roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails">
        <link:definition>9954480 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSDetails" roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails">
        <link:definition>9954481 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails" roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails">
        <link:definition>9954482 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails" roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails">
        <link:definition>9954483 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Available-for-Sale Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHEQUIVALENTSANDMARKETABLESECURITIESNarrativeDetails" roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESNarrativeDetails">
        <link:definition>9954484 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASICANDDILUTEDNETLOSSPERSHAREDetails" roleURI="http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails">
        <link:definition>9954485 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails">
        <link:definition>9954486 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails">
        <link:definition>9954487 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails_1" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails_1">
        <link:definition>9954487 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails">
        <link:definition>9954488 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails">
        <link:definition>9954489 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails">
        <link:definition>9954490 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails" roleURI="http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails">
        <link:definition>9954491 - Disclosure - IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails">
        <link:definition>9954492 - Disclosure - STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDetails" roleURI="http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails">
        <link:definition>9954493 - Disclosure - STOCKHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGCHARGESNarrativeDetails" roleURI="http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails">
        <link:definition>9954494 - Disclosure - RESTRUCTURING CHARGES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGCHARGESAccruedRestructuringCostsDetails" roleURI="http://www.sangamo.com/role/RESTRUCTURINGCHARGESAccruedRestructuringCostsDetails">
        <link:definition>9954495 - Disclosure - RESTRUCTURING CHARGES - Accrued Restructuring Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.sangamo.com/role/INCOMETAXESDetails">
        <link:definition>9954496 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetails" roleURI="http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails">
        <link:definition>9954497 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" abstract="false" name="CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_AchievementOfCommercialMilestonesMember" abstract="true" name="AchievementOfCommercialMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" abstract="false" name="CollaborationAgreementNumberOfAdditionalProductTargets" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" abstract="false" name="IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" abstract="false" name="ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" abstract="false" name="CollaborativeArrangementEstimatedReimbursableServiceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_AgreementTerminationTerm" abstract="false" name="AgreementTerminationTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_IncreaseDecreaseInEarningsPerShareBasic" abstract="false" name="IncreaseDecreaseInEarningsPerShareBasic" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease" abstract="false" name="DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty" abstract="false" name="CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_BiogenMAIncMember" abstract="true" name="BiogenMAIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_CashEquivalentsAndAvailableForSaleSecurities" abstract="false" name="CashEquivalentsAndAvailableForSaleSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_PfizerMember" abstract="true" name="PfizerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_MilestonePaymentsReceived" abstract="false" name="MilestonePaymentsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CNineORFSevenTwoMember" abstract="true" name="CNineORFSevenTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" abstract="true" name="AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod" abstract="false" name="ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" abstract="false" name="CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborativeAgreementPercentOfInitialRecognition" abstract="false" name="CollaborativeAgreementPercentOfInitialRecognition" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" abstract="true" name="AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementLicenseFee" abstract="false" name="CollaborativeArrangementLicenseFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_November2023RestructuringPlanMember" abstract="true" name="November2023RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_StockPurchaseAgreementMember" abstract="true" name="StockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" abstract="true" name="AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty" abstract="false" name="ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="sgmo_PfizerC9ORF72Member" abstract="true" name="PfizerC9ORF72Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_OtherLicensingAgreementsMember" abstract="true" name="OtherLicensingAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_ChangeInAgreementEstimateSeptember2023Member" abstract="true" name="ChangeInAgreementEstimateSeptember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" abstract="false" name="AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent" abstract="false" name="IncreaseDecreaseInNetIncomeLossAttributableToParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_TenantImprovementAllowanceWithinContraLeaseLiability" abstract="false" name="TenantImprovementAllowanceWithinContraLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementTransactionPrice" abstract="false" name="CollaborativeArrangementTransactionPrice" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_AtTheMarketOfferingAgreementMember" abstract="true" name="AtTheMarketOfferingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_RevenueRemainingPerformanceObligationRenewalPeriod" abstract="false" name="RevenueRemainingPerformanceObligationRenewalPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" abstract="false" name="CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_JefferiesLLCMember" abstract="true" name="JefferiesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" abstract="false" name="CollaborativeArrangementNumberOfMilestonesAchieved" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_CollaborationAndLicenseAgreementMember" abstract="true" name="CollaborationAndLicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember" abstract="true" name="FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_NovartisInstitutesForBioMedicalResearchIncMember" abstract="true" name="NovartisInstitutesForBioMedicalResearchIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount" abstract="false" name="RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_MilestoneRevenueReceivable" abstract="false" name="MilestoneRevenueReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment" abstract="false" name="ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" abstract="false" name="CustomerContractLiabilityMilestonePaymentEligibleToReceive" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_InitialResearchTermOfAgreement" abstract="false" name="InitialResearchTermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_USGovernmentSponsoredAgencyBondMember" abstract="true" name="USGovernmentSponsoredAgencyBondMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_NumberOfOptionsToExtendInitialResearchTerm" abstract="false" name="NumberOfOptionsToExtendInitialResearchTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_StockOfferingProgramMaximumValue" abstract="false" name="StockOfferingProgramMaximumValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" abstract="false" name="NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" abstract="false" name="ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" abstract="true" name="AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_ExtendedResearchTermOfAgreement" abstract="false" name="ExtendedResearchTermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_ContractedEmployeesMember" abstract="true" name="ContractedEmployeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" abstract="true" name="RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" abstract="false" name="CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount" abstract="false" name="RevenueRemainingPerformanceObligationFixedConsiderationAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" abstract="false" name="SaleOfStockExcessConsiderationReceivedOnTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_SBFiveTwoFiveMember" abstract="true" name="SBFiveTwoFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_KitePharmaIncMember" abstract="true" name="KitePharmaIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod" abstract="false" name="ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_ChangeInAgreementEstimateMarch2023Member" abstract="true" name="ChangeInAgreementEstimateMarch2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_PfizerSB525Member" abstract="true" name="PfizerSB525Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_April2023RestructuringPlanMember" abstract="true" name="April2023RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_FullTimeEmployeesMember" abstract="true" name="FullTimeEmployeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" abstract="false" name="CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_SBFiveTwoFiveAndOtherProductsMember" abstract="true" name="SBFiveTwoFiveAndOtherProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementResearchServiceFees" abstract="false" name="CollaborativeArrangementResearchServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_SaleOfStockIncreaseToAggregateOfferingPrice" abstract="false" name="SaleOfStockIncreaseToAggregateOfferingPrice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_RevenueNumberOfRemainingPerformanceObligations" abstract="false" name="RevenueNumberOfRemainingPerformanceObligations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_LeaseholdImprovementsAndConstructionInProgressMember" abstract="true" name="LeaseholdImprovementsAndConstructionInProgressMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_CollaborationAgreementEquityIssued" abstract="false" name="CollaborationAgreementEquityIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod" abstract="false" name="RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_IncreaseDecreaseInEarningsPerShareDiluted" abstract="false" name="IncreaseDecreaseInEarningsPerShareDiluted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember" abstract="true" name="ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_SeparateUpfrontFee" abstract="false" name="SeparateUpfrontFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>sgmo-20230930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:66e428df-1cd2-4a45-95e8-7711e67a648c,g:c0e019b1-92dd-475a-ba81-4eb41606269d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_529b748b-c55a-49cc-a8ae-30d8d35195b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8f89a693-6c48-4035-90e9-5c6ed454909d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_529b748b-c55a-49cc-a8ae-30d8d35195b7" xlink:to="loc_us-gaap_AssetsCurrent_8f89a693-6c48-4035-90e9-5c6ed454909d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_f5f73ef3-1ca0-4fe4-9bca-6303a2796194" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_529b748b-c55a-49cc-a8ae-30d8d35195b7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_f5f73ef3-1ca0-4fe4-9bca-6303a2796194" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_902cc96a-9071-4327-97e6-6c61516c9c87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_529b748b-c55a-49cc-a8ae-30d8d35195b7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_902cc96a-9071-4327-97e6-6c61516c9c87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d8fbb357-f911-467a-b2f2-819a80484d45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_529b748b-c55a-49cc-a8ae-30d8d35195b7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d8fbb357-f911-467a-b2f2-819a80484d45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5cbe2a33-5c67-4900-ae99-43bf7156929c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_529b748b-c55a-49cc-a8ae-30d8d35195b7" xlink:to="loc_us-gaap_Goodwill_5cbe2a33-5c67-4900-ae99-43bf7156929c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_696d05fc-eb20-434c-aa65-5327ad1d7fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_529b748b-c55a-49cc-a8ae-30d8d35195b7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_696d05fc-eb20-434c-aa65-5327ad1d7fcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7903dcb4-16e7-4a5b-a419-021d0adef78e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_529b748b-c55a-49cc-a8ae-30d8d35195b7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7903dcb4-16e7-4a5b-a419-021d0adef78e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_b9636a2c-e552-498b-9a96-9c762320af1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_529b748b-c55a-49cc-a8ae-30d8d35195b7" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_b9636a2c-e552-498b-9a96-9c762320af1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6b3b18f0-b978-47c8-8c37-ce4a4b3dc775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9a2b7dfa-1a1e-42fc-b832-a60163038417" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6b3b18f0-b978-47c8-8c37-ce4a4b3dc775" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9a2b7dfa-1a1e-42fc-b832-a60163038417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_034097cc-f64d-4a3c-8c36-57845c8cb8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6b3b18f0-b978-47c8-8c37-ce4a4b3dc775" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_034097cc-f64d-4a3c-8c36-57845c8cb8e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent_29559334-ce89-4c12-ace9-f20440c6b967" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6b3b18f0-b978-47c8-8c37-ce4a4b3dc775" xlink:to="loc_us-gaap_InterestReceivableCurrent_29559334-ce89-4c12-ace9-f20440c6b967" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c1bd698f-f9ca-4aa3-b97f-5149673bdd02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6b3b18f0-b978-47c8-8c37-ce4a4b3dc775" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c1bd698f-f9ca-4aa3-b97f-5149673bdd02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fc2fa7e8-c6b0-4beb-a950-c0d4c40a2ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6b3b18f0-b978-47c8-8c37-ce4a4b3dc775" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fc2fa7e8-c6b0-4beb-a950-c0d4c40a2ab7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8314483d-2a69-4aca-88fe-139b0def57bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_5e187de2-8a9b-4d0f-827d-443c7d4f88f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8314483d-2a69-4aca-88fe-139b0def57bf" xlink:to="loc_us-gaap_PreferredStockValue_5e187de2-8a9b-4d0f-827d-443c7d4f88f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f65edcec-558a-4df0-927c-66e26796eab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8314483d-2a69-4aca-88fe-139b0def57bf" xlink:to="loc_us-gaap_CommonStockValue_f65edcec-558a-4df0-927c-66e26796eab1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fb82ad62-5789-431f-b8c2-d09c18cbcb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8314483d-2a69-4aca-88fe-139b0def57bf" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fb82ad62-5789-431f-b8c2-d09c18cbcb5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8c8db4b3-40c1-4a21-a8b1-9dbf93117f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8314483d-2a69-4aca-88fe-139b0def57bf" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8c8db4b3-40c1-4a21-a8b1-9dbf93117f2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b31f29fd-3c44-4750-9b66-ae6cb7d3782c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8314483d-2a69-4aca-88fe-139b0def57bf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b31f29fd-3c44-4750-9b66-ae6cb7d3782c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0667a441-293a-4446-932c-71009ac62c88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_650733b6-a99c-47ec-a611-7d32c0f29e91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0667a441-293a-4446-932c-71009ac62c88" xlink:to="loc_us-gaap_LiabilitiesCurrent_650733b6-a99c-47ec-a611-7d32c0f29e91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a145d44c-a379-4880-8fbe-8033b32a819a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0667a441-293a-4446-932c-71009ac62c88" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a145d44c-a379-4880-8fbe-8033b32a819a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1c02b594-6739-4da4-94d9-f4a560a3fe4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0667a441-293a-4446-932c-71009ac62c88" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1c02b594-6739-4da4-94d9-f4a560a3fe4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_32a359c9-981e-4a07-b4e4-52c088525b70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0667a441-293a-4446-932c-71009ac62c88" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_32a359c9-981e-4a07-b4e4-52c088525b70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9aa4265c-313c-4006-846c-b98b92aafc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0667a441-293a-4446-932c-71009ac62c88" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9aa4265c-313c-4006-846c-b98b92aafc0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5018525e-4a58-48ee-bbbd-d98755a156ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c2145dff-754c-403d-813b-9ceeb58c8f86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5018525e-4a58-48ee-bbbd-d98755a156ce" xlink:to="loc_us-gaap_AccountsPayableCurrent_c2145dff-754c-403d-813b-9ceeb58c8f86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_99b6e919-a397-4748-bae7-044adbc9077b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5018525e-4a58-48ee-bbbd-d98755a156ce" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_99b6e919-a397-4748-bae7-044adbc9077b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b137b06c-2c19-4107-8e0d-d2cfcfb71b40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5018525e-4a58-48ee-bbbd-d98755a156ce" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b137b06c-2c19-4107-8e0d-d2cfcfb71b40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4d95c817-a1bb-4276-869a-4e6feb17e01d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5018525e-4a58-48ee-bbbd-d98755a156ce" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4d95c817-a1bb-4276-869a-4e6feb17e01d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3a93fa59-7747-4584-8c86-8696b1341dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c21d0dae-3c3d-409b-a25f-f94c071f812e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3a93fa59-7747-4584-8c86-8696b1341dcb" xlink:to="loc_us-gaap_Liabilities_c21d0dae-3c3d-409b-a25f-f94c071f812e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_ae728379-306b-448d-a256-783f1f2451ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3a93fa59-7747-4584-8c86-8696b1341dcb" xlink:to="loc_us-gaap_CommitmentsAndContingencies_ae728379-306b-448d-a256-783f1f2451ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b7930396-0283-4f4d-98aa-2b9ce65911cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3a93fa59-7747-4584-8c86-8696b1341dcb" xlink:to="loc_us-gaap_StockholdersEquity_b7930396-0283-4f4d-98aa-2b9ce65911cd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8c85e4f8-466d-45f9-8882-d5049004262c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4a0c8f1f-d044-4b71-b04a-ba33a1715035" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8c85e4f8-466d-45f9-8882-d5049004262c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4a0c8f1f-d044-4b71-b04a-ba33a1715035" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e4de5c0e-820b-4d4d-a103-79cd75f14bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8c85e4f8-466d-45f9-8882-d5049004262c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e4de5c0e-820b-4d4d-a103-79cd75f14bf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b26e0975-57eb-48ee-8674-3ccce324b9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ae761683-8b41-4ca5-a8be-d8584430e051" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b26e0975-57eb-48ee-8674-3ccce324b9f6" xlink:to="loc_us-gaap_OperatingIncomeLoss_ae761683-8b41-4ca5-a8be-d8584430e051" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_636786ff-13b0-45d2-98be-2f0f9bd0787a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b26e0975-57eb-48ee-8674-3ccce324b9f6" xlink:to="loc_us-gaap_InterestAndOtherIncome_636786ff-13b0-45d2-98be-2f0f9bd0787a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_276b20dd-ce8c-45c2-abad-e920651dbcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e465289c-a91f-493c-ad75-3e7037737768" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_276b20dd-ce8c-45c2-abad-e920651dbcfe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e465289c-a91f-493c-ad75-3e7037737768" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6f9de705-94a5-48ea-8536-b8fd133fde5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_276b20dd-ce8c-45c2-abad-e920651dbcfe" xlink:to="loc_us-gaap_OperatingExpenses_6f9de705-94a5-48ea-8536-b8fd133fde5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9726a168-bda1-4c26-b137-5685288351d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_8fd8466d-2396-4041-b850-ed4388bfa603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9726a168-bda1-4c26-b137-5685288351d4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_8fd8466d-2396-4041-b850-ed4388bfa603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6d699e02-81eb-4182-bf55-e9a673e21399" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9726a168-bda1-4c26-b137-5685288351d4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6d699e02-81eb-4182-bf55-e9a673e21399" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_e1897e00-bab9-4dc2-92d9-82ade6e166a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9726a168-bda1-4c26-b137-5685288351d4" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_e1897e00-bab9-4dc2-92d9-82ade6e166a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_ae7e24d5-4588-46b4-888e-ef052c0819a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9726a168-bda1-4c26-b137-5685288351d4" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_ae7e24d5-4588-46b4-888e-ef052c0819a1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_73ec8a94-baaa-4d25-a721-3dc9e3e950d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_7f6303c2-3f94-42c5-baa5-e8a083b4ae75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_73ec8a94-baaa-4d25-a721-3dc9e3e950d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_7f6303c2-3f94-42c5-baa5-e8a083b4ae75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_38c8b9ad-344a-4c5f-b000-87120523b060" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_73ec8a94-baaa-4d25-a721-3dc9e3e950d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_38c8b9ad-344a-4c5f-b000-87120523b060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_2a30eb86-699b-40d1-bf4a-058b139c4c16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_73ec8a94-baaa-4d25-a721-3dc9e3e950d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_2a30eb86-699b-40d1-bf4a-058b139c4c16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8f8793bd-7021-47e2-89dc-10992639c0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_73ec8a94-baaa-4d25-a721-3dc9e3e950d2" xlink:to="loc_us-gaap_NetIncomeLoss_8f8793bd-7021-47e2-89dc-10992639c0dc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ea065f01-719f-4b0f-9cb2-01f5dbf0e975" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_11caf99a-8ea7-468a-aa90-d1a5773bf096" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ea065f01-719f-4b0f-9cb2-01f5dbf0e975" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_11caf99a-8ea7-468a-aa90-d1a5773bf096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aa0b1468-1af5-4d1c-84d3-379837223400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ea065f01-719f-4b0f-9cb2-01f5dbf0e975" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aa0b1468-1af5-4d1c-84d3-379837223400" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b201b8dd-26c2-49f4-82e5-e9dc652a14ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ea065f01-719f-4b0f-9cb2-01f5dbf0e975" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b201b8dd-26c2-49f4-82e5-e9dc652a14ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4aff73a5-1fdb-40b8-8087-f1aef95e1797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ea065f01-719f-4b0f-9cb2-01f5dbf0e975" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4aff73a5-1fdb-40b8-8087-f1aef95e1797" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ee80c42-0084-48b9-a40e-d2999b0fdbd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_a3f85821-27d0-4030-b9f3-eb39b8d25e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ee80c42-0084-48b9-a40e-d2999b0fdbd5" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_a3f85821-27d0-4030-b9f3-eb39b8d25e0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_8d766cb0-be5b-4052-b3f7-f1475cfb7d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ee80c42-0084-48b9-a40e-d2999b0fdbd5" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_8d766cb0-be5b-4052-b3f7-f1475cfb7d1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c2834d80-0fa7-4bb4-a2ba-1069a4866ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ee80c42-0084-48b9-a40e-d2999b0fdbd5" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c2834d80-0fa7-4bb4-a2ba-1069a4866ec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e855bb66-4f1b-4c66-a196-a320caf13525" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e855bb66-4f1b-4c66-a196-a320caf13525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5ade69bb-1e93-46de-9e8e-87d0a93992bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5ade69bb-1e93-46de-9e8e-87d0a93992bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_cccc8f19-fed2-4a25-b0df-bf40aeca67d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_cccc8f19-fed2-4a25-b0df-bf40aeca67d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_123ab7c1-d15c-4673-a5cd-4de0103cdcf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_123ab7c1-d15c-4673-a5cd-4de0103cdcf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_5b7b09b2-811f-4e4b-8c7b-7cc8ed2aec58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_5b7b09b2-811f-4e4b-8c7b-7cc8ed2aec58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_092fa363-b686-4fe5-b8c7-f3e2202cdeec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_092fa363-b686-4fe5-b8c7-f3e2202cdeec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_5c4047be-2a3b-498c-a059-5dd4a3d61da2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_5c4047be-2a3b-498c-a059-5dd4a3d61da2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_727de2c4-a291-4e4f-ae75-6c45ee0828fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_727de2c4-a291-4e4f-ae75-6c45ee0828fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dbcd465c-25ca-499e-b0d7-7defbc69cd2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_NetIncomeLoss_dbcd465c-25ca-499e-b0d7-7defbc69cd2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cb119f1e-a2a6-4663-a2dd-84965aea7d57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_ShareBasedCompensation_cb119f1e-a2a6-4663-a2dd-84965aea7d57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3a96f8dc-6bf6-46a2-9546-e7f167d7df5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3a96f8dc-6bf6-46a2-9546-e7f167d7df5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_28d07335-a2d2-4ef3-93b4-ceaabd1dcad6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_28d07335-a2d2-4ef3-93b4-ceaabd1dcad6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_5c5c60d0-297a-4dbe-b7a7-edbcc103ad11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_5c5c60d0-297a-4dbe-b7a7-edbcc103ad11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_2881cdae-e27e-4703-a3b4-bf954c85d2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_2881cdae-e27e-4703-a3b4-bf954c85d2d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_d9ee2d12-87fa-4687-a2c1-57a2ad9a5eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_d9ee2d12-87fa-4687-a2c1-57a2ad9a5eb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_55ce2dac-3d81-4edd-9956-e1e587bb5a21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_55ce2dac-3d81-4edd-9956-e1e587bb5a21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_063ec5e0-da2a-4691-afb3-cbdc8e34664e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ceaec60-d31b-44f0-999d-0738e4f67f1f" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_063ec5e0-da2a-4691-afb3-cbdc8e34664e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_87208dce-5ebf-43db-9f00-a012dd10b168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_71903c3a-815c-43b7-acee-4dcb49ccbedf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_87208dce-5ebf-43db-9f00-a012dd10b168" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_71903c3a-815c-43b7-acee-4dcb49ccbedf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_56a94a43-0635-401b-8e69-a16c1b592374" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_87208dce-5ebf-43db-9f00-a012dd10b168" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_56a94a43-0635-401b-8e69-a16c1b592374" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_4216148d-9133-4d0c-a4d2-8b71c979fecc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_87208dce-5ebf-43db-9f00-a012dd10b168" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_4216148d-9133-4d0c-a4d2-8b71c979fecc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ac8dbfa-5381-4f73-92b7-b691f78c5f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6bd0c040-e3f5-4557-9235-c208dcba8ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ac8dbfa-5381-4f73-92b7-b691f78c5f3a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6bd0c040-e3f5-4557-9235-c208dcba8ed9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_1a39579f-3276-4c36-9727-14143b49cf23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ac8dbfa-5381-4f73-92b7-b691f78c5f3a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_1a39579f-3276-4c36-9727-14143b49cf23" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#FAIRVALUEMEASUREMENTSDetails"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b167f95e-3cd1-4312-810d-58e09f1d44d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_702e5c88-3505-4f0c-a1a6-4a8994bb555c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b167f95e-3cd1-4312-810d-58e09f1d44d9" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_702e5c88-3505-4f0c-a1a6-4a8994bb555c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_b326bf98-7fb1-4eb4-963b-9115fda5a376" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b167f95e-3cd1-4312-810d-58e09f1d44d9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_b326bf98-7fb1-4eb4-963b-9115fda5a376" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_419f1083-b29a-414d-8da4-df577cda1539" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_b2c5a2a2-8717-42e7-9b12-ea069f7390ba" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_419f1083-b29a-414d-8da4-df577cda1539" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_b2c5a2a2-8717-42e7-9b12-ea069f7390ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_526d64d1-29a2-40df-8011-06a72bb1fd20" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_419f1083-b29a-414d-8da4-df577cda1539" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_526d64d1-29a2-40df-8011-06a72bb1fd20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_7ff61672-9890-4586-b130-b0ee2ea810be" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_419f1083-b29a-414d-8da4-df577cda1539" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_7ff61672-9890-4586-b130-b0ee2ea810be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a7d4cdeb-858f-4e10-9302-eee9a3b36897" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_1046f5f1-21b8-44d3-b7e6-fae826bc2e85" xlink:href="sgmo-20230930.xsd#sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a7d4cdeb-858f-4e10-9302-eee9a3b36897" xlink:to="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_1046f5f1-21b8-44d3-b7e6-fae826bc2e85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_cb9755fd-dc09-49fc-bf39-622e85737a75" xlink:href="sgmo-20230930.xsd#sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a7d4cdeb-858f-4e10-9302-eee9a3b36897" xlink:to="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_cb9755fd-dc09-49fc-bf39-622e85737a75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_30ab5e9a-c347-4bce-8002-8cee02e4a69f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a7d4cdeb-858f-4e10-9302-eee9a3b36897" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_30ab5e9a-c347-4bce-8002-8cee02e4a69f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2e144167-5815-4cfd-86fc-fd318ddc6f00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b7531d38-f089-4232-a6d9-8da18f847e33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2e144167-5815-4cfd-86fc-fd318ddc6f00" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b7531d38-f089-4232-a6d9-8da18f847e33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4f7cd3e6-b572-492f-a736-79f1733ea26d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2e144167-5815-4cfd-86fc-fd318ddc6f00" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4f7cd3e6-b572-492f-a736-79f1733ea26d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_9a5c5970-79a2-44d2-800c-12d68ef75403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2e144167-5815-4cfd-86fc-fd318ddc6f00" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_9a5c5970-79a2-44d2-800c-12d68ef75403" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_d4b94b57-728e-4f43-924b-f22bcee216b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_eea47f8a-0032-4dfe-849a-3e5e0e1de994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_d4b94b57-728e-4f43-924b-f22bcee216b3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_eea47f8a-0032-4dfe-849a-3e5e0e1de994" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_138494c7-a07b-4fd2-9808-46f750fb90f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_d4b94b57-728e-4f43-924b-f22bcee216b3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_138494c7-a07b-4fd2-9808-46f750fb90f3" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>sgmo-20230930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:66e428df-1cd2-4a45-95e8-7711e67a648c,g:c0e019b1-92dd-475a-ba81-4eb41606269d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b39d3b97-5b34-4b2c-99d3-3c789132898d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b39d3b97-5b34-4b2c-99d3-3c789132898d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5576e49f-65cb-42cb-a719-2d6bda090d13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_CommonStockSharesIssued_5576e49f-65cb-42cb-a719-2d6bda090d13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_59052909-d91a-4284-ae9e-3bc09480e40d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockholdersEquity_59052909-d91a-4284-ae9e-3bc09480e40d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_df86c2f9-d83a-4c08-8ac1-1e786247a2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_df86c2f9-d83a-4c08-8ac1-1e786247a2d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7dfff7b7-1013-443d-a72d-930386c60369" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7dfff7b7-1013-443d-a72d-930386c60369" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_56d68673-069a-407b-b0ce-2eb8461a371b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_56d68673-069a-407b-b0ce-2eb8461a371b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_005ba924-77ad-47de-a737-74c503c3c95f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_005ba924-77ad-47de-a737-74c503c3c95f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b2a0ef5c-ea21-4c06-936e-61070e995cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b2a0ef5c-ea21-4c06-936e-61070e995cbc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a796dd97-ab1f-437c-b5d0-213ac4624005" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a796dd97-ab1f-437c-b5d0-213ac4624005" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0ac3a67f-c40b-4946-aec6-eac2c372aaba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0ac3a67f-c40b-4946-aec6-eac2c372aaba" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_6a0ad952-6a9a-4753-80f4-cc528a9e489d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_6a0ad952-6a9a-4753-80f4-cc528a9e489d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_138c920f-9728-4cf6-97db-a83aeef06759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_138c920f-9728-4cf6-97db-a83aeef06759" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9de7f209-0948-4d14-80d1-c7201ccc8a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9de7f209-0948-4d14-80d1-c7201ccc8a92" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c5276bee-8b29-4a0b-9358-89f50d120384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_NetIncomeLoss_c5276bee-8b29-4a0b-9358-89f50d120384" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a9f30b7e-477c-4388-86be-799af18993db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9b5a702a-8314-411a-9bd5-2180c2a5a39a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4ce05336-3bb6-4617-aca6-53badd38941c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b39d3b97-5b34-4b2c-99d3-3c789132898d" xlink:to="loc_us-gaap_StatementTable_4ce05336-3bb6-4617-aca6-53badd38941c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5fe2d2d7-b7c3-426e-a42a-0b877b9a2e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4ce05336-3bb6-4617-aca6-53badd38941c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5fe2d2d7-b7c3-426e-a42a-0b877b9a2e0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5fe2d2d7-b7c3-426e-a42a-0b877b9a2e0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5fe2d2d7-b7c3-426e-a42a-0b877b9a2e0a" xlink:to="loc_us-gaap_EquityComponentDomain_5fe2d2d7-b7c3-426e-a42a-0b877b9a2e0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_206e6dd3-0bc1-4856-9dd6-2c2966681c53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5fe2d2d7-b7c3-426e-a42a-0b877b9a2e0a" xlink:to="loc_us-gaap_EquityComponentDomain_206e6dd3-0bc1-4856-9dd6-2c2966681c53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_41012d0f-6e9e-41f0-8079-28332e44f5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_206e6dd3-0bc1-4856-9dd6-2c2966681c53" xlink:to="loc_us-gaap_CommonStockMember_41012d0f-6e9e-41f0-8079-28332e44f5e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_264f6831-be1f-4278-b7cf-d04a40a0acfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_206e6dd3-0bc1-4856-9dd6-2c2966681c53" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_264f6831-be1f-4278-b7cf-d04a40a0acfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f4d5d31c-3a15-4cde-ab9d-5722f6dc585e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_206e6dd3-0bc1-4856-9dd6-2c2966681c53" xlink:to="loc_us-gaap_RetainedEarningsMember_f4d5d31c-3a15-4cde-ab9d-5722f6dc585e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4fbc8012-b5c6-4d2d-8557-f0db21053131" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_206e6dd3-0bc1-4856-9dd6-2c2966681c53" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4fbc8012-b5c6-4d2d-8557-f0db21053131" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_afffaae2-b1a4-45e2-9656-1f2e35fff2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_afffaae2-b1a4-45e2-9656-1f2e35fff2d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dc35a279-f4b5-484c-a98e-5017b3d4a79c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_afffaae2-b1a4-45e2-9656-1f2e35fff2d6" xlink:to="loc_us-gaap_NetIncomeLoss_dc35a279-f4b5-484c-a98e-5017b3d4a79c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_afffaae2-b1a4-45e2-9656-1f2e35fff2d6" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_65901e9b-3ef2-4ae0-80c1-e6508fb4a527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_65901e9b-3ef2-4ae0-80c1-e6508fb4a527" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6949d0e3-9fc1-4e50-bb3b-8d1dee4c567b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6949d0e3-9fc1-4e50-bb3b-8d1dee4c567b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1a4fa180-07d6-45f3-b665-9abd40c38932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1a4fa180-07d6-45f3-b665-9abd40c38932" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_3522d7a9-86f1-4c17-8f0d-09b326c7a114" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_3522d7a9-86f1-4c17-8f0d-09b326c7a114" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_7258ccf3-c084-4b14-bd55-8a184f5a3d14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_7258ccf3-c084-4b14-bd55-8a184f5a3d14" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bc8e70c0-b598-44e0-8125-769bf3035314" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bc8e70c0-b598-44e0-8125-769bf3035314" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_94b29c98-79f9-4ebf-a406-8e75b0b90655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_ShareBasedCompensation_94b29c98-79f9-4ebf-a406-8e75b0b90655" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_d257e291-416d-403f-a28c-271377508563" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_d257e291-416d-403f-a28c-271377508563" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_afffaae2-b1a4-45e2-9656-1f2e35fff2d6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_158ef3cb-0c53-4c56-9076-16fcea5a50d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_158ef3cb-0c53-4c56-9076-16fcea5a50d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dbf1ab2b-4f92-4ab7-9aac-4b13ed635ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dbf1ab2b-4f92-4ab7-9aac-4b13ed635ec7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_bf0ecf52-aacd-4384-a501-c905d460893c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_bf0ecf52-aacd-4384-a501-c905d460893c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9c7cff04-f5bb-43f2-8770-e80d0e096476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9c7cff04-f5bb-43f2-8770-e80d0e096476" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_bea79c3e-53e3-4566-9884-b78aee85a482" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_bea79c3e-53e3-4566-9884-b78aee85a482" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_024027ce-bea8-4fb4-b1f0-eafa1225d02a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_024027ce-bea8-4fb4-b1f0-eafa1225d02a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_07a72633-d451-440d-908e-67650f128e42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_07a72633-d451-440d-908e-67650f128e42" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_4fe24ea3-516b-4e14-8dbe-b8e6200fd72b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_4fe24ea3-516b-4e14-8dbe-b8e6200fd72b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_14aadeb0-1325-4f90-a532-1cab6877700a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_afffaae2-b1a4-45e2-9656-1f2e35fff2d6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_14aadeb0-1325-4f90-a532-1cab6877700a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80dfc936-4fe3-4836-b198-74f420ac9d39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80dfc936-4fe3-4836-b198-74f420ac9d39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a91abe3a-180a-4324-b375-da6c26fc1bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80dfc936-4fe3-4836-b198-74f420ac9d39" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a91abe3a-180a-4324-b375-da6c26fc1bb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_7f8b18ec-7ba3-4e2b-a499-56e054ffa265" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80dfc936-4fe3-4836-b198-74f420ac9d39" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_7f8b18ec-7ba3-4e2b-a499-56e054ffa265" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dcc8d2b5-1a38-46c9-ab15-19bb3a26f401" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80dfc936-4fe3-4836-b198-74f420ac9d39" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dcc8d2b5-1a38-46c9-ab15-19bb3a26f401" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_669d2bb4-a885-41c9-9c72-27741b89dc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80dfc936-4fe3-4836-b198-74f420ac9d39" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_669d2bb4-a885-41c9-9c72-27741b89dc9a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f59e1c12-7de9-43c6-86fd-d156371a1056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f59e1c12-7de9-43c6-86fd-d156371a1056" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_448d87c3-398c-44c1-9726-7e6816ba1a70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f59e1c12-7de9-43c6-86fd-d156371a1056" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_448d87c3-398c-44c1-9726-7e6816ba1a70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8023dcef-ecfa-49f1-b448-ef74c69442eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f59e1c12-7de9-43c6-86fd-d156371a1056" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8023dcef-ecfa-49f1-b448-ef74c69442eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_fd15ef9e-10ed-4fd0-a853-da4abf5731fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f59e1c12-7de9-43c6-86fd-d156371a1056" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_fd15ef9e-10ed-4fd0-a853-da4abf5731fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72465fb5-762c-4963-b934-b38fe5c42087" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f59e1c12-7de9-43c6-86fd-d156371a1056" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72465fb5-762c-4963-b934-b38fe5c42087" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ff29bd8f-779a-46fa-833f-dcb4e57cd1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ff29bd8f-779a-46fa-833f-dcb4e57cd1b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a49b963-577b-43cb-8bab-c9a62e08828a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a49b963-577b-43cb-8bab-c9a62e08828a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2bd58bdf-10af-4d03-a024-707237b1a94a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2bd58bdf-10af-4d03-a024-707237b1a94a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_398fbc1d-e535-48f0-b11b-13e8d2899568" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d952b609-17d2-40e9-8f90-c984ec08fcac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d952b609-17d2-40e9-8f90-c984ec08fcac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_6fea400a-3510-472e-b29e-8b76bc857315" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d952b609-17d2-40e9-8f90-c984ec08fcac" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_6fea400a-3510-472e-b29e-8b76bc857315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability_09aa9332-0993-40d4-a4a0-ce976eae399a" xlink:href="sgmo-20230930.xsd#sgmo_TenantImprovementAllowanceWithinContraLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d952b609-17d2-40e9-8f90-c984ec08fcac" xlink:to="loc_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability_09aa9332-0993-40d4-a4a0-ce976eae399a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ef49dbc7-b0ed-4aee-8252-b78cd9f1657b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_StatementTable_ef49dbc7-b0ed-4aee-8252-b78cd9f1657b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_64836ca8-1917-40c6-b321-1266aa4f5a63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ef49dbc7-b0ed-4aee-8252-b78cd9f1657b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_64836ca8-1917-40c6-b321-1266aa4f5a63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_64836ca8-1917-40c6-b321-1266aa4f5a63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_64836ca8-1917-40c6-b321-1266aa4f5a63" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_64836ca8-1917-40c6-b321-1266aa4f5a63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_091b9fe2-7cbd-4c35-b97b-cf51987a5850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_64836ca8-1917-40c6-b321-1266aa4f5a63" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_091b9fe2-7cbd-4c35-b97b-cf51987a5850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AtTheMarketOfferingMember_98371f13-ca13-49ba-b108-fff831a8f010" xlink:href="sgmo-20230930.xsd#sgmo_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_091b9fe2-7cbd-4c35-b97b-cf51987a5850" xlink:to="loc_sgmo_AtTheMarketOfferingMember_98371f13-ca13-49ba-b108-fff831a8f010" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_72919a25-8cf0-4dcb-a70d-94e52c4e5565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_091b9fe2-7cbd-4c35-b97b-cf51987a5850" xlink:to="loc_us-gaap_EmployeeStockMember_72919a25-8cf0-4dcb-a70d-94e52c4e5565" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_9e73e984-f180-4277-b21d-4931bb86856f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_9e73e984-f180-4277-b21d-4931bb86856f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_250123ae-6ad1-4fb6-ac73-ed405d6c91ad" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_250123ae-6ad1-4fb6-ac73-ed405d6c91ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_f4674f99-d3fd-430e-9fca-2bf0597716ff" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_f4674f99-d3fd-430e-9fca-2bf0597716ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInEarningsPerShareBasic_bed42041-5019-4795-9d19-6453eedc588c" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_sgmo_IncreaseDecreaseInEarningsPerShareBasic_bed42041-5019-4795-9d19-6453eedc588c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_59ab7cbc-e101-4ab1-950c-a4e0ba4b805a" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_59ab7cbc-e101-4ab1-950c-a4e0ba4b805a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_3e35a35f-042b-43f7-aade-25d8ba40adeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_3e35a35f-042b-43f7-aade-25d8ba40adeb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_6bfbfd98-62c4-4264-a7e8-0a4deb059cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfChangeInAccountingEstimateTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_6bfbfd98-62c4-4264-a7e8-0a4deb059cbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_11a23a59-fa9a-49d0-8212-2a4b4759fe42" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_6bfbfd98-62c4-4264-a7e8-0a4deb059cbb" xlink:to="loc_srt_CounterpartyNameAxis_11a23a59-fa9a-49d0-8212-2a4b4759fe42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_11a23a59-fa9a-49d0-8212-2a4b4759fe42_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_11a23a59-fa9a-49d0-8212-2a4b4759fe42" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_11a23a59-fa9a-49d0-8212-2a4b4759fe42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f715c184-6b47-46bf-8eb5-4415881679a9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_11a23a59-fa9a-49d0-8212-2a4b4759fe42" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f715c184-6b47-46bf-8eb5-4415881679a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_0c9d1749-b1a6-42c6-8e7f-efb98ced9c19" xlink:href="sgmo-20230930.xsd#sgmo_KitePharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f715c184-6b47-46bf-8eb5-4415881679a9" xlink:to="loc_sgmo_KitePharmaIncMember_0c9d1749-b1a6-42c6-8e7f-efb98ced9c19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e02d3983-eef4-4607-90ea-a037586c4780" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_6bfbfd98-62c4-4264-a7e8-0a4deb059cbb" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e02d3983-eef4-4607-90ea-a037586c4780" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_e02d3983-eef4-4607-90ea-a037586c4780_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e02d3983-eef4-4607-90ea-a037586c4780" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_e02d3983-eef4-4607-90ea-a037586c4780_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_67f5703c-c2f8-4572-97db-19c5ec934d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e02d3983-eef4-4607-90ea-a037586c4780" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_67f5703c-c2f8-4572-97db-19c5ec934d1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInAgreementEstimateMarch2023Member_d43aeec4-3fc3-426b-b0d3-ea496a704e31" xlink:href="sgmo-20230930.xsd#sgmo_ChangeInAgreementEstimateMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_67f5703c-c2f8-4572-97db-19c5ec934d1b" xlink:to="loc_sgmo_ChangeInAgreementEstimateMarch2023Member_d43aeec4-3fc3-426b-b0d3-ea496a704e31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInAgreementEstimateSeptember2023Member_c3758bd1-0e98-43ee-b924-42c277d3198d" xlink:href="sgmo-20230930.xsd#sgmo_ChangeInAgreementEstimateSeptember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_67f5703c-c2f8-4572-97db-19c5ec934d1b" xlink:to="loc_sgmo_ChangeInAgreementEstimateSeptember2023Member_c3758bd1-0e98-43ee-b924-42c277d3198d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_76c22c79-279c-4cd6-bd9c-014d08f59bca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e8373e11-426c-4fa9-b07b-33d321cee5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_76c22c79-279c-4cd6-bd9c-014d08f59bca" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e8373e11-426c-4fa9-b07b-33d321cee5dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_2c94af65-9016-4989-a047-784fcd98b36f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_76c22c79-279c-4cd6-bd9c-014d08f59bca" xlink:to="loc_us-gaap_ConcentrationRiskTable_2c94af65-9016-4989-a047-784fcd98b36f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_601524fc-3d3f-4ca4-88fa-e8f6613c3767" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_2c94af65-9016-4989-a047-784fcd98b36f" xlink:to="loc_srt_CounterpartyNameAxis_601524fc-3d3f-4ca4-88fa-e8f6613c3767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_601524fc-3d3f-4ca4-88fa-e8f6613c3767_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_601524fc-3d3f-4ca4-88fa-e8f6613c3767" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_601524fc-3d3f-4ca4-88fa-e8f6613c3767_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f65f462-94c2-4707-b53f-fc8ca5937a9b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_601524fc-3d3f-4ca4-88fa-e8f6613c3767" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f65f462-94c2-4707-b53f-fc8ca5937a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_c20f2a74-0586-4953-b75a-8edd04f64f3a" xlink:href="sgmo-20230930.xsd#sgmo_KitePharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f65f462-94c2-4707-b53f-fc8ca5937a9b" xlink:to="loc_sgmo_KitePharmaIncMember_c20f2a74-0586-4953-b75a-8edd04f64f3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_7809cc20-6a4a-494e-80d3-672e15ce6c06" xlink:href="sgmo-20230930.xsd#sgmo_BiogenMAIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f65f462-94c2-4707-b53f-fc8ca5937a9b" xlink:to="loc_sgmo_BiogenMAIncMember_7809cc20-6a4a-494e-80d3-672e15ce6c06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_4d05789c-071e-4368-8286-36e530146940" xlink:href="sgmo-20230930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f65f462-94c2-4707-b53f-fc8ca5937a9b" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_4d05789c-071e-4368-8286-36e530146940" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_OtherLicensingAgreementsMember_c7146890-7f16-4621-9cc2-ed62b2f163eb" xlink:href="sgmo-20230930.xsd#sgmo_OtherLicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f65f462-94c2-4707-b53f-fc8ca5937a9b" xlink:to="loc_sgmo_OtherLicensingAgreementsMember_c7146890-7f16-4621-9cc2-ed62b2f163eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_de4da23e-204f-4d7e-8c71-4d2681d16e25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_2c94af65-9016-4989-a047-784fcd98b36f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_de4da23e-204f-4d7e-8c71-4d2681d16e25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_de4da23e-204f-4d7e-8c71-4d2681d16e25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_de4da23e-204f-4d7e-8c71-4d2681d16e25" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_de4da23e-204f-4d7e-8c71-4d2681d16e25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_76b08b11-19d2-4c45-8675-71cd2a765e40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_de4da23e-204f-4d7e-8c71-4d2681d16e25" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_76b08b11-19d2-4c45-8675-71cd2a765e40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_979019e9-a31e-42bb-a2a6-2981071679c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_76b08b11-19d2-4c45-8675-71cd2a765e40" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_979019e9-a31e-42bb-a2a6-2981071679c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_5213914a-6e94-46f5-8c22-9e63a27a6e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_2c94af65-9016-4989-a047-784fcd98b36f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_5213914a-6e94-46f5-8c22-9e63a27a6e8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5213914a-6e94-46f5-8c22-9e63a27a6e8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5213914a-6e94-46f5-8c22-9e63a27a6e8a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5213914a-6e94-46f5-8c22-9e63a27a6e8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b2fa07fa-41af-44ed-bd26-15282fa9d6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5213914a-6e94-46f5-8c22-9e63a27a6e8a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b2fa07fa-41af-44ed-bd26-15282fa9d6ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_cc423642-9f02-4d9c-9ace-95fff732ad2d" xlink:href="sgmo-20230930.xsd#sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b2fa07fa-41af-44ed-bd26-15282fa9d6ea" xlink:to="loc_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_cc423642-9f02-4d9c-9ace-95fff732ad2d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#FAIRVALUEMEASUREMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f2cd5c93-a83d-42f3-9aad-eb6fedd6e711" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6f371ffb-ec3e-4b2a-9f33-6d15b4784ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f2cd5c93-a83d-42f3-9aad-eb6fedd6e711" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6f371ffb-ec3e-4b2a-9f33-6d15b4784ecc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_83c2f968-afe6-4842-8799-4144f13ed5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f2cd5c93-a83d-42f3-9aad-eb6fedd6e711" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_83c2f968-afe6-4842-8799-4144f13ed5fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_813b53cf-2a3b-4006-b701-b1ae9b6a6e92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f2cd5c93-a83d-42f3-9aad-eb6fedd6e711" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_813b53cf-2a3b-4006-b701-b1ae9b6a6e92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13464ffa-b917-4e3f-9cae-ad803d36b90c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f2cd5c93-a83d-42f3-9aad-eb6fedd6e711" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13464ffa-b917-4e3f-9cae-ad803d36b90c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0eefe90f-92c1-4a91-81f3-3b13a6f2b3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13464ffa-b917-4e3f-9cae-ad803d36b90c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0eefe90f-92c1-4a91-81f3-3b13a6f2b3d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0eefe90f-92c1-4a91-81f3-3b13a6f2b3d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0eefe90f-92c1-4a91-81f3-3b13a6f2b3d8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0eefe90f-92c1-4a91-81f3-3b13a6f2b3d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ed2c295-8265-4e35-b8cc-8ecf373017ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0eefe90f-92c1-4a91-81f3-3b13a6f2b3d8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ed2c295-8265-4e35-b8cc-8ecf373017ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ed5ac443-6f73-450d-94b6-955003421b14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ed2c295-8265-4e35-b8cc-8ecf373017ef" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ed5ac443-6f73-450d-94b6-955003421b14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c990e1f1-fb8d-4b17-820a-d2a4df464baf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13464ffa-b917-4e3f-9cae-ad803d36b90c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c990e1f1-fb8d-4b17-820a-d2a4df464baf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c990e1f1-fb8d-4b17-820a-d2a4df464baf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c990e1f1-fb8d-4b17-820a-d2a4df464baf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c990e1f1-fb8d-4b17-820a-d2a4df464baf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0a4f327a-3f96-448d-bcc6-0e22851cc9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c990e1f1-fb8d-4b17-820a-d2a4df464baf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0a4f327a-3f96-448d-bcc6-0e22851cc9d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_234ba549-1f59-4474-9ea6-8f41771200b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0a4f327a-3f96-448d-bcc6-0e22851cc9d5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_234ba549-1f59-4474-9ea6-8f41771200b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3a472d4e-aa58-4330-9db1-88d16f561620" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0a4f327a-3f96-448d-bcc6-0e22851cc9d5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3a472d4e-aa58-4330-9db1-88d16f561620" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8ef38931-847b-4c10-994e-f4aec1065a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0a4f327a-3f96-448d-bcc6-0e22851cc9d5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8ef38931-847b-4c10-994e-f4aec1065a1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_48063000-c12c-45df-a572-c3c7d07af3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13464ffa-b917-4e3f-9cae-ad803d36b90c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_48063000-c12c-45df-a572-c3c7d07af3a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_48063000-c12c-45df-a572-c3c7d07af3a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_48063000-c12c-45df-a572-c3c7d07af3a0" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_48063000-c12c-45df-a572-c3c7d07af3a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_48063000-c12c-45df-a572-c3c7d07af3a0" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1b322808-7e99-4eb0-8b95-c9c8efc83c97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1b322808-7e99-4eb0-8b95-c9c8efc83c97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a6a27ef7-a3b4-40cb-851d-d6ab47a01f87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a6a27ef7-a3b4-40cb-851d-d6ab47a01f87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_1cbd3739-5345-4c35-84d1-47830de4010a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_CommercialPaperMember_1cbd3739-5345-4c35-84d1-47830de4010a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_de5ef2bc-ad8a-4f77-9b1c-bc46141cdb02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_de5ef2bc-ad8a-4f77-9b1c-bc46141cdb02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_fc0dc9bc-e66c-43e4-9cd5-94fb7ffc8e91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_fc0dc9bc-e66c-43e4-9cd5-94fb7ffc8e91" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_27c6e43a-7169-4e97-991b-70e4df481dba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_27c6e43a-7169-4e97-991b-70e4df481dba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_4bf2e92b-82ad-4fbf-9638-97e232701205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_CertificatesOfDepositMember_4bf2e92b-82ad-4fbf-9638-97e232701205" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_USGovernmentSponsoredAgencyBondMember_0459ac61-7beb-4b9c-a09e-92cc911b8c67" xlink:href="sgmo-20230930.xsd#sgmo_USGovernmentSponsoredAgencyBondMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_sgmo_USGovernmentSponsoredAgencyBondMember_0459ac61-7beb-4b9c-a09e-92cc911b8c67" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:to="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d78ee9ee-d510-4987-81aa-7ff0c2347cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d78ee9ee-d510-4987-81aa-7ff0c2347cb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_2d85b8c4-86f9-4ce2-bbc6-c537522e9b27" xlink:href="sgmo-20230930.xsd#sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_2d85b8c4-86f9-4ce2-bbc6-c537522e9b27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_ed4dec4c-e0f1-4ae3-a68d-5f81ccc7c030" xlink:href="sgmo-20230930.xsd#sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_ed4dec4c-e0f1-4ae3-a68d-5f81ccc7c030" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_12f6139e-d0b1-4665-a54e-6f37c9008365" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_12f6139e-d0b1-4665-a54e-6f37c9008365" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_5d8b4098-3777-4779-b338-312afef21e78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_5d8b4098-3777-4779-b338-312afef21e78" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d5e058ff-1f03-4299-9719-2ecbb6b4e95e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d5e058ff-1f03-4299-9719-2ecbb6b4e95e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_85890670-2887-4676-8436-5edebee91e57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_85890670-2887-4676-8436-5edebee91e57" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_3400f25d-4f3c-42ce-a1bb-3c9a00a9e109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_3400f25d-4f3c-42ce-a1bb-3c9a00a9e109" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_1ae66f38-6c94-4335-9d3c-c962dcc9f77f" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_1ae66f38-6c94-4335-9d3c-c962dcc9f77f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_2c5045a9-4dc4-4573-82cb-ccf99128ee02" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_2c5045a9-4dc4-4573-82cb-ccf99128ee02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_8c9a0c52-f443-4ff2-b079-00f1032c1231" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_8c9a0c52-f443-4ff2-b079-00f1032c1231" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_40b3a339-0c96-4aba-9ec2-fb7790584a01" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_40b3a339-0c96-4aba-9ec2-fb7790584a01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_56888822-76ba-44fa-8029-28f7f4dd09e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_56888822-76ba-44fa-8029-28f7f4dd09e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5f135116-2a7c-48da-b08e-573e74d1dd12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_56888822-76ba-44fa-8029-28f7f4dd09e9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5f135116-2a7c-48da-b08e-573e74d1dd12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5f135116-2a7c-48da-b08e-573e74d1dd12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5f135116-2a7c-48da-b08e-573e74d1dd12" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5f135116-2a7c-48da-b08e-573e74d1dd12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5f135116-2a7c-48da-b08e-573e74d1dd12" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_8be84086-0ce7-42e4-b7af-569b2ed2f63f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_MoneyMarketFundsMember_8be84086-0ce7-42e4-b7af-569b2ed2f63f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_e3ebe3b2-9d65-449a-aee9-c11e60c9dc20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_CashEquivalentsMember_e3ebe3b2-9d65-449a-aee9-c11e60c9dc20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_b0ed3819-0248-48e4-a47f-d71dcc7ac60d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_b0ed3819-0248-48e4-a47f-d71dcc7ac60d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_163e719c-3df3-4a75-9e6d-30eebc782c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_CommercialPaperMember_163e719c-3df3-4a75-9e6d-30eebc782c2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_66815925-7a23-43ac-946f-fcc94d03935f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_66815925-7a23-43ac-946f-fcc94d03935f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_12330b50-3786-4156-9855-2fe8cc408323" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_12330b50-3786-4156-9855-2fe8cc408323" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_ea91e2a1-4690-4bbf-b4ff-67638b76b632" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_ea91e2a1-4690-4bbf-b4ff-67638b76b632" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_ca2b6c44-1e55-4831-af4b-01ed7d2db08b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_CertificatesOfDepositMember_ca2b6c44-1e55-4831-af4b-01ed7d2db08b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_USGovernmentSponsoredAgencyBondMember_c598677b-b968-471b-a1e3-a69502463f61" xlink:href="sgmo-20230930.xsd#sgmo_USGovernmentSponsoredAgencyBondMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_sgmo_USGovernmentSponsoredAgencyBondMember_c598677b-b968-471b-a1e3-a69502463f61" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AgreementTerminationTerm_cd6a3c79-6d37-4e47-ae75-c405f11254a0" xlink:href="sgmo-20230930.xsd#sgmo_AgreementTerminationTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_AgreementTerminationTerm_cd6a3c79-6d37-4e47-ae75-c405f11254a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_f37bec0b-dff7-498b-bd7a-1a1f25af25d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_f37bec0b-dff7-498b-bd7a-1a1f25af25d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_ad6f52df-eac1-4409-9f4c-b803111f4abe" xlink:href="sgmo-20230930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_ad6f52df-eac1-4409-9f4c-b803111f4abe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_f036edd5-7ccc-4a76-ac24-58f49dcfed34" xlink:href="sgmo-20230930.xsd#sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_f036edd5-7ccc-4a76-ac24-58f49dcfed34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_ba90c8da-5611-40eb-86b9-1e571453d837" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementNumberOfMilestonesAchieved"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_ba90c8da-5611-40eb-86b9-1e571453d837" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestonePaymentsReceived_f4c7157b-ed47-46aa-abfc-4b6e0d99c08a" xlink:href="sgmo-20230930.xsd#sgmo_MilestonePaymentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_MilestonePaymentsReceived_f4c7157b-ed47-46aa-abfc-4b6e0d99c08a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneRevenueReceivable_1ca805ff-a145-47ac-b7e6-667d3e192fd9" xlink:href="sgmo-20230930.xsd#sgmo_MilestoneRevenueReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_MilestoneRevenueReceivable_1ca805ff-a145-47ac-b7e6-667d3e192fd9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty_0803240b-88a7-46a7-82b8-5dda4ccc8d44" xlink:href="sgmo-20230930.xsd#sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty_0803240b-88a7-46a7-82b8-5dda4ccc8d44" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_c8ddbcb5-7f33-4745-bea5-d600ec9082bd" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_c8ddbcb5-7f33-4745-bea5-d600ec9082bd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementResearchServiceFees_093025b4-3f36-4856-a196-f4a1713c0a52" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementResearchServiceFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_CollaborativeArrangementResearchServiceFees_093025b4-3f36-4856-a196-f4a1713c0a52" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_a88cf3fb-ee61-44c1-858c-82019715a142" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_a88cf3fb-ee61-44c1-858c-82019715a142" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_da3a9100-ec30-4971-8edc-eeb86b871227" xlink:href="sgmo-20230930.xsd#sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_da3a9100-ec30-4971-8edc-eeb86b871227" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_3675ada3-4443-47eb-86c4-aaa132c36e38" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:to="loc_srt_CounterpartyNameAxis_3675ada3-4443-47eb-86c4-aaa132c36e38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3675ada3-4443-47eb-86c4-aaa132c36e38_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_3675ada3-4443-47eb-86c4-aaa132c36e38" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3675ada3-4443-47eb-86c4-aaa132c36e38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_426b5f06-1fee-491a-a83f-31f7b6032ded" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_3675ada3-4443-47eb-86c4-aaa132c36e38" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_426b5f06-1fee-491a-a83f-31f7b6032ded" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerMember_796aa5cb-7301-4d42-9942-ee998c4335d1" xlink:href="sgmo-20230930.xsd#sgmo_PfizerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_426b5f06-1fee-491a-a83f-31f7b6032ded" xlink:to="loc_sgmo_PfizerMember_796aa5cb-7301-4d42-9942-ee998c4335d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerSB525Member_d1545f8e-9426-45ed-8669-c42af8101fdf" xlink:href="sgmo-20230930.xsd#sgmo_PfizerSB525Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_426b5f06-1fee-491a-a83f-31f7b6032ded" xlink:to="loc_sgmo_PfizerSB525Member_d1545f8e-9426-45ed-8669-c42af8101fdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerC9ORF72Member_7f5bad9b-8fb7-4b48-b86b-5db3f57f4b66" xlink:href="sgmo-20230930.xsd#sgmo_PfizerC9ORF72Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_426b5f06-1fee-491a-a83f-31f7b6032ded" xlink:to="loc_sgmo_PfizerC9ORF72Member_7f5bad9b-8fb7-4b48-b86b-5db3f57f4b66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c9981315-7dbf-42b1-95d9-e35e38f2dc44" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:to="loc_srt_ProductOrServiceAxis_c9981315-7dbf-42b1-95d9-e35e38f2dc44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c9981315-7dbf-42b1-95d9-e35e38f2dc44_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c9981315-7dbf-42b1-95d9-e35e38f2dc44" xlink:to="loc_srt_ProductsAndServicesDomain_c9981315-7dbf-42b1-95d9-e35e38f2dc44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_33896858-9cfa-4529-89ba-044a49495750" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c9981315-7dbf-42b1-95d9-e35e38f2dc44" xlink:to="loc_srt_ProductsAndServicesDomain_33896858-9cfa-4529-89ba-044a49495750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember_ae154ac5-eb87-4cec-a543-27dbcf0ee234" xlink:href="sgmo-20230930.xsd#sgmo_SBFiveTwoFiveAndOtherProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_33896858-9cfa-4529-89ba-044a49495750" xlink:to="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember_ae154ac5-eb87-4cec-a543-27dbcf0ee234" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SBFiveTwoFiveMember_bd6404a5-bfe5-438e-879a-d9e10141e327" xlink:href="sgmo-20230930.xsd#sgmo_SBFiveTwoFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember_ae154ac5-eb87-4cec-a543-27dbcf0ee234" xlink:to="loc_sgmo_SBFiveTwoFiveMember_bd6404a5-bfe5-438e-879a-d9e10141e327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturedProductOtherMember_ac40599c-4580-416e-b2a0-95a5cdbec641" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManufacturedProductOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember_ae154ac5-eb87-4cec-a543-27dbcf0ee234" xlink:to="loc_us-gaap_ManufacturedProductOtherMember_ac40599c-4580-416e-b2a0-95a5cdbec641" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_219e9c4a-91d3-4b7b-8e21-f3f90e9afd74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_33896858-9cfa-4529-89ba-044a49495750" xlink:to="loc_us-gaap_LicenseMember_219e9c4a-91d3-4b7b-8e21-f3f90e9afd74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CNineORFSevenTwoMember_1f299038-8d78-4c7a-a53f-528c90ac38f3" xlink:href="sgmo-20230930.xsd#sgmo_CNineORFSevenTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_33896858-9cfa-4529-89ba-044a49495750" xlink:to="loc_sgmo_CNineORFSevenTwoMember_1f299038-8d78-4c7a-a53f-528c90ac38f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22731599-4f4c-4083-93da-32bb056a69c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22731599-4f4c-4083-93da-32bb056a69c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_22731599-4f4c-4083-93da-32bb056a69c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22731599-4f4c-4083-93da-32bb056a69c0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_22731599-4f4c-4083-93da-32bb056a69c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b46b554e-bf23-45f2-bf98-a910f230c570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22731599-4f4c-4083-93da-32bb056a69c0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b46b554e-bf23-45f2-bf98-a910f230c570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_1326172e-ac7c-4c2b-beba-c858ed322180" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b46b554e-bf23-45f2-bf98-a910f230c570" xlink:to="loc_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_1326172e-ac7c-4c2b-beba-c858ed322180" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_644514e4-d0c2-4137-8f74-e52333d19058" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b46b554e-bf23-45f2-bf98-a910f230c570" xlink:to="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_644514e4-d0c2-4137-8f74-e52333d19058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfCommercialMilestonesMember_bd9a7c42-bfb7-4ed4-9492-c24d1e6a6f5e" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfCommercialMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b46b554e-bf23-45f2-bf98-a910f230c570" xlink:to="loc_sgmo_AchievementOfCommercialMilestonesMember_bd9a7c42-bfb7-4ed4-9492-c24d1e6a6f5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_031ce2e3-9a74-4dc5-b785-6985520ec45d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:to="loc_srt_RangeAxis_031ce2e3-9a74-4dc5-b785-6985520ec45d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_031ce2e3-9a74-4dc5-b785-6985520ec45d_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_031ce2e3-9a74-4dc5-b785-6985520ec45d" xlink:to="loc_srt_RangeMember_031ce2e3-9a74-4dc5-b785-6985520ec45d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5eaf7152-587b-45e8-932a-5382bdf3cb79" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_031ce2e3-9a74-4dc5-b785-6985520ec45d" xlink:to="loc_srt_RangeMember_5eaf7152-587b-45e8-932a-5382bdf3cb79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0adc14a6-e2f5-40cd-8f92-4e160d555995" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5eaf7152-587b-45e8-932a-5382bdf3cb79" xlink:to="loc_srt_MinimumMember_0adc14a6-e2f5-40cd-8f92-4e160d555995" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1066b86b-9701-4142-bbbf-8250e2256638" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5eaf7152-587b-45e8-932a-5382bdf3cb79" xlink:to="loc_srt_MaximumMember_1066b86b-9701-4142-bbbf-8250e2256638" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestonePaymentsReceived_cd477ed3-2a83-4e76-84a2-0e7bb4446c4e" xlink:href="sgmo-20230930.xsd#sgmo_MilestonePaymentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_MilestonePaymentsReceived_cd477ed3-2a83-4e76-84a2-0e7bb4446c4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_5aa58236-f2bb-4037-8513-96735cc81eb4" xlink:href="sgmo-20230930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_5aa58236-f2bb-4037-8513-96735cc81eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_a0e7b564-880d-4a8e-a35d-080f608bbeb0" xlink:href="sgmo-20230930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_a0e7b564-880d-4a8e-a35d-080f608bbeb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment_ca7b4a76-bc35-4dd6-afcc-4f0b9adfc86a" xlink:href="sgmo-20230930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment_ca7b4a76-bc35-4dd6-afcc-4f0b9adfc86a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_InitialResearchTermOfAgreement_d195e79f-2896-4de2-81a9-481f781af954" xlink:href="sgmo-20230930.xsd#sgmo_InitialResearchTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_InitialResearchTermOfAgreement_d195e79f-2896-4de2-81a9-481f781af954" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm_3e6c24e3-7fdb-4bbb-868e-b2284f5be0d5" xlink:href="sgmo-20230930.xsd#sgmo_NumberOfOptionsToExtendInitialResearchTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm_3e6c24e3-7fdb-4bbb-868e-b2284f5be0d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExtendedResearchTermOfAgreement_635f63e9-c415-4a05-95ca-d61bded3c161" xlink:href="sgmo-20230930.xsd#sgmo_ExtendedResearchTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_ExtendedResearchTermOfAgreement_635f63e9-c415-4a05-95ca-d61bded3c161" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SeparateUpfrontFee_445049cf-ec05-4fe5-8798-3b231a4b0a15" xlink:href="sgmo-20230930.xsd#sgmo_SeparateUpfrontFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_SeparateUpfrontFee_445049cf-ec05-4fe5-8798-3b231a4b0a15" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_9d40c92b-8f96-4f8e-9159-5dc6a7e4ad6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_ContractWithCustomerLiability_9d40c92b-8f96-4f8e-9159-5dc6a7e4ad6d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueNumberOfRemainingPerformanceObligations_fffe0c18-9e18-4185-bcd8-72eb38fe5a6c" xlink:href="sgmo-20230930.xsd#sgmo_RevenueNumberOfRemainingPerformanceObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueNumberOfRemainingPerformanceObligations_fffe0c18-9e18-4185-bcd8-72eb38fe5a6c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod_393539a0-10f3-4d72-81a8-4e4eb3dbe3b2" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod_393539a0-10f3-4d72-81a8-4e4eb3dbe3b2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod_4df58a41-7317-4f0a-a39c-23eecf61037d" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationRenewalPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod_4df58a41-7317-4f0a-a39c-23eecf61037d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_6bc6468e-db3b-4605-8d6f-5056d10fe5e1" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_6bc6468e-db3b-4605-8d6f-5056d10fe5e1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3facc2d0-e302-4369-bb14-9578df30e375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3facc2d0-e302-4369-bb14-9578df30e375" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7dfaf5eb-0a78-485d-bcae-f66da7bd7f95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7dfaf5eb-0a78-485d-bcae-f66da7bd7f95" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount_e525f8e5-46d1-4740-9645-b06f06b48f2b" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount_e525f8e5-46d1-4740-9645-b06f06b48f2b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5271fd13-c7af-402c-9200-9becac39ea3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5271fd13-c7af-402c-9200-9becac39ea3c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_aebcb38c-a0d3-4d46-ae49-f3a6b71b371b" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_aebcb38c-a0d3-4d46-ae49-f3a6b71b371b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_6da8a7fd-6a63-4335-a6a5-9cf18a080324" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_6da8a7fd-6a63-4335-a6a5-9cf18a080324" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInEarningsPerShareBasic_ab73661c-3f9a-48f7-b073-71ac7de4688d" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_IncreaseDecreaseInEarningsPerShareBasic_ab73661c-3f9a-48f7-b073-71ac7de4688d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_ab19a780-8d75-46aa-9b0d-3466d272ff0f" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_ab19a780-8d75-46aa-9b0d-3466d272ff0f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b6ab88bc-bd33-48d7-971d-b52d364cd3fa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_srt_CounterpartyNameAxis_b6ab88bc-bd33-48d7-971d-b52d364cd3fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b6ab88bc-bd33-48d7-971d-b52d364cd3fa_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_b6ab88bc-bd33-48d7-971d-b52d364cd3fa" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b6ab88bc-bd33-48d7-971d-b52d364cd3fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2467f42e-ab75-48bb-9de3-b5d055aff740" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_b6ab88bc-bd33-48d7-971d-b52d364cd3fa" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2467f42e-ab75-48bb-9de3-b5d055aff740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_f42195ee-c830-4e52-9d41-7f1b4b11e8eb" xlink:href="sgmo-20230930.xsd#sgmo_KitePharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2467f42e-ab75-48bb-9de3-b5d055aff740" xlink:to="loc_sgmo_KitePharmaIncMember_f42195ee-c830-4e52-9d41-7f1b4b11e8eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_935b580e-5b36-4a22-8720-de8b713c2a26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_us-gaap_TypeOfArrangementAxis_935b580e-5b36-4a22-8720-de8b713c2a26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_935b580e-5b36-4a22-8720-de8b713c2a26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_935b580e-5b36-4a22-8720-de8b713c2a26" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_935b580e-5b36-4a22-8720-de8b713c2a26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_310b344d-c365-4d14-a112-fbbf0ac28a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_935b580e-5b36-4a22-8720-de8b713c2a26" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_310b344d-c365-4d14-a112-fbbf0ac28a0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_c034f5fd-18e1-4c2d-89ec-91649515a8b2" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_310b344d-c365-4d14-a112-fbbf0ac28a0d" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_c034f5fd-18e1-4c2d-89ec-91649515a8b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c7203263-4d15-4106-aca7-cc63e3b8f613" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_srt_RangeAxis_c7203263-4d15-4106-aca7-cc63e3b8f613" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c7203263-4d15-4106-aca7-cc63e3b8f613_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c7203263-4d15-4106-aca7-cc63e3b8f613" xlink:to="loc_srt_RangeMember_c7203263-4d15-4106-aca7-cc63e3b8f613_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e3f8f2b8-8631-4dcc-be5d-a5681694d026" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c7203263-4d15-4106-aca7-cc63e3b8f613" xlink:to="loc_srt_RangeMember_e3f8f2b8-8631-4dcc-be5d-a5681694d026" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_72d9e8df-f9ba-4eee-8e0a-f37299981900" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e3f8f2b8-8631-4dcc-be5d-a5681694d026" xlink:to="loc_srt_MaximumMember_72d9e8df-f9ba-4eee-8e0a-f37299981900" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2ad30cb0-2bbc-424d-a1c3-731725f371b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2ad30cb0-2bbc-424d-a1c3-731725f371b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2ad30cb0-2bbc-424d-a1c3-731725f371b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2ad30cb0-2bbc-424d-a1c3-731725f371b1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2ad30cb0-2bbc-424d-a1c3-731725f371b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_90542d72-849a-4fd3-8804-c25b9f2fc1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2ad30cb0-2bbc-424d-a1c3-731725f371b1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_90542d72-849a-4fd3-8804-c25b9f2fc1c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_abe606f8-6ba1-429d-bfc4-595c05b8b71b" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_90542d72-849a-4fd3-8804-c25b9f2fc1c2" xlink:to="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_abe606f8-6ba1-429d-bfc4-595c05b8b71b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_706f4d9f-e7a5-452f-8810-b1a0e70e24cc" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_90542d72-849a-4fd3-8804-c25b9f2fc1c2" xlink:to="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_706f4d9f-e7a5-452f-8810-b1a0e70e24cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_srt_ProductOrServiceAxis_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283" xlink:to="loc_srt_ProductsAndServicesDomain_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7b5d702e-5c58-40f6-9687-a2bca8df648b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283" xlink:to="loc_srt_ProductsAndServicesDomain_7b5d702e-5c58-40f6-9687-a2bca8df648b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_ed98bdbb-3d33-4210-84a8-624b6324ca40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7b5d702e-5c58-40f6-9687-a2bca8df648b" xlink:to="loc_us-gaap_LicenseAndServiceMember_ed98bdbb-3d33-4210-84a8-624b6324ca40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_fe06fdd0-46a7-4f07-9905-beb663d8fcf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LicenseAndServiceMember_ed98bdbb-3d33-4210-84a8-624b6324ca40" xlink:to="loc_us-gaap_LicenseMember_fe06fdd0-46a7-4f07-9905-beb663d8fcf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b2672e91-bbe9-498d-962b-3a8a472b3739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b2672e91-bbe9-498d-962b-3a8a472b3739" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a2636f52-548c-4d9c-a585-8345ae5c625b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a2636f52-548c-4d9c-a585-8345ae5c625b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_a2636f52-548c-4d9c-a585-8345ae5c625b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a2636f52-548c-4d9c-a585-8345ae5c625b" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_a2636f52-548c-4d9c-a585-8345ae5c625b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_8713c103-0c3f-4ec2-901d-dc4d3341727b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a2636f52-548c-4d9c-a585-8345ae5c625b" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_8713c103-0c3f-4ec2-901d-dc4d3341727b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInAgreementEstimateMarch2023Member_ffdca726-c898-4210-a95c-500361f17fd9" xlink:href="sgmo-20230930.xsd#sgmo_ChangeInAgreementEstimateMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_8713c103-0c3f-4ec2-901d-dc4d3341727b" xlink:to="loc_sgmo_ChangeInAgreementEstimateMarch2023Member_ffdca726-c898-4210-a95c-500361f17fd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInAgreementEstimateSeptember2023Member_c1ac2ffb-f8a0-4c1f-b2c7-ff6f51c7ae28" xlink:href="sgmo-20230930.xsd#sgmo_ChangeInAgreementEstimateSeptember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_8713c103-0c3f-4ec2-901d-dc4d3341727b" xlink:to="loc_sgmo_ChangeInAgreementEstimateSeptember2023Member_c1ac2ffb-f8a0-4c1f-b2c7-ff6f51c7ae28" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails_1" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails_1"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestonePaymentsReceived_cd477ed3-2a83-4e76-84a2-0e7bb4446c4e" xlink:href="sgmo-20230930.xsd#sgmo_MilestonePaymentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_MilestonePaymentsReceived_cd477ed3-2a83-4e76-84a2-0e7bb4446c4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_5aa58236-f2bb-4037-8513-96735cc81eb4" xlink:href="sgmo-20230930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_5aa58236-f2bb-4037-8513-96735cc81eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_a0e7b564-880d-4a8e-a35d-080f608bbeb0" xlink:href="sgmo-20230930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_a0e7b564-880d-4a8e-a35d-080f608bbeb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment_ca7b4a76-bc35-4dd6-afcc-4f0b9adfc86a" xlink:href="sgmo-20230930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment_ca7b4a76-bc35-4dd6-afcc-4f0b9adfc86a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_InitialResearchTermOfAgreement_d195e79f-2896-4de2-81a9-481f781af954" xlink:href="sgmo-20230930.xsd#sgmo_InitialResearchTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_InitialResearchTermOfAgreement_d195e79f-2896-4de2-81a9-481f781af954" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm_3e6c24e3-7fdb-4bbb-868e-b2284f5be0d5" xlink:href="sgmo-20230930.xsd#sgmo_NumberOfOptionsToExtendInitialResearchTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm_3e6c24e3-7fdb-4bbb-868e-b2284f5be0d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExtendedResearchTermOfAgreement_635f63e9-c415-4a05-95ca-d61bded3c161" xlink:href="sgmo-20230930.xsd#sgmo_ExtendedResearchTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_ExtendedResearchTermOfAgreement_635f63e9-c415-4a05-95ca-d61bded3c161" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SeparateUpfrontFee_445049cf-ec05-4fe5-8798-3b231a4b0a15" xlink:href="sgmo-20230930.xsd#sgmo_SeparateUpfrontFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_SeparateUpfrontFee_445049cf-ec05-4fe5-8798-3b231a4b0a15" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_9d40c92b-8f96-4f8e-9159-5dc6a7e4ad6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_ContractWithCustomerLiability_9d40c92b-8f96-4f8e-9159-5dc6a7e4ad6d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueNumberOfRemainingPerformanceObligations_fffe0c18-9e18-4185-bcd8-72eb38fe5a6c" xlink:href="sgmo-20230930.xsd#sgmo_RevenueNumberOfRemainingPerformanceObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueNumberOfRemainingPerformanceObligations_fffe0c18-9e18-4185-bcd8-72eb38fe5a6c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod_393539a0-10f3-4d72-81a8-4e4eb3dbe3b2" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod_393539a0-10f3-4d72-81a8-4e4eb3dbe3b2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod_4df58a41-7317-4f0a-a39c-23eecf61037d" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationRenewalPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod_4df58a41-7317-4f0a-a39c-23eecf61037d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_6bc6468e-db3b-4605-8d6f-5056d10fe5e1" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_6bc6468e-db3b-4605-8d6f-5056d10fe5e1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3facc2d0-e302-4369-bb14-9578df30e375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3facc2d0-e302-4369-bb14-9578df30e375" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7dfaf5eb-0a78-485d-bcae-f66da7bd7f95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7dfaf5eb-0a78-485d-bcae-f66da7bd7f95" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount_e525f8e5-46d1-4740-9645-b06f06b48f2b" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount_e525f8e5-46d1-4740-9645-b06f06b48f2b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5271fd13-c7af-402c-9200-9becac39ea3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5271fd13-c7af-402c-9200-9becac39ea3c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_aebcb38c-a0d3-4d46-ae49-f3a6b71b371b" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_aebcb38c-a0d3-4d46-ae49-f3a6b71b371b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_6da8a7fd-6a63-4335-a6a5-9cf18a080324" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_6da8a7fd-6a63-4335-a6a5-9cf18a080324" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInEarningsPerShareBasic_ab73661c-3f9a-48f7-b073-71ac7de4688d" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_IncreaseDecreaseInEarningsPerShareBasic_ab73661c-3f9a-48f7-b073-71ac7de4688d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_ab19a780-8d75-46aa-9b0d-3466d272ff0f" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_ab19a780-8d75-46aa-9b0d-3466d272ff0f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b6ab88bc-bd33-48d7-971d-b52d364cd3fa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_srt_CounterpartyNameAxis_b6ab88bc-bd33-48d7-971d-b52d364cd3fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b6ab88bc-bd33-48d7-971d-b52d364cd3fa_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_b6ab88bc-bd33-48d7-971d-b52d364cd3fa" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b6ab88bc-bd33-48d7-971d-b52d364cd3fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2467f42e-ab75-48bb-9de3-b5d055aff740" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_b6ab88bc-bd33-48d7-971d-b52d364cd3fa" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2467f42e-ab75-48bb-9de3-b5d055aff740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_f42195ee-c830-4e52-9d41-7f1b4b11e8eb" xlink:href="sgmo-20230930.xsd#sgmo_KitePharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2467f42e-ab75-48bb-9de3-b5d055aff740" xlink:to="loc_sgmo_KitePharmaIncMember_f42195ee-c830-4e52-9d41-7f1b4b11e8eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_935b580e-5b36-4a22-8720-de8b713c2a26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_us-gaap_TypeOfArrangementAxis_935b580e-5b36-4a22-8720-de8b713c2a26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_935b580e-5b36-4a22-8720-de8b713c2a26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_935b580e-5b36-4a22-8720-de8b713c2a26" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_935b580e-5b36-4a22-8720-de8b713c2a26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_310b344d-c365-4d14-a112-fbbf0ac28a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_935b580e-5b36-4a22-8720-de8b713c2a26" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_310b344d-c365-4d14-a112-fbbf0ac28a0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_c034f5fd-18e1-4c2d-89ec-91649515a8b2" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_310b344d-c365-4d14-a112-fbbf0ac28a0d" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_c034f5fd-18e1-4c2d-89ec-91649515a8b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c7203263-4d15-4106-aca7-cc63e3b8f613" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_srt_RangeAxis_c7203263-4d15-4106-aca7-cc63e3b8f613" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c7203263-4d15-4106-aca7-cc63e3b8f613_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c7203263-4d15-4106-aca7-cc63e3b8f613" xlink:to="loc_srt_RangeMember_c7203263-4d15-4106-aca7-cc63e3b8f613_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e3f8f2b8-8631-4dcc-be5d-a5681694d026" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c7203263-4d15-4106-aca7-cc63e3b8f613" xlink:to="loc_srt_RangeMember_e3f8f2b8-8631-4dcc-be5d-a5681694d026" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_72d9e8df-f9ba-4eee-8e0a-f37299981900" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e3f8f2b8-8631-4dcc-be5d-a5681694d026" xlink:to="loc_srt_MaximumMember_72d9e8df-f9ba-4eee-8e0a-f37299981900" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2ad30cb0-2bbc-424d-a1c3-731725f371b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2ad30cb0-2bbc-424d-a1c3-731725f371b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2ad30cb0-2bbc-424d-a1c3-731725f371b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2ad30cb0-2bbc-424d-a1c3-731725f371b1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2ad30cb0-2bbc-424d-a1c3-731725f371b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_90542d72-849a-4fd3-8804-c25b9f2fc1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2ad30cb0-2bbc-424d-a1c3-731725f371b1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_90542d72-849a-4fd3-8804-c25b9f2fc1c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_abe606f8-6ba1-429d-bfc4-595c05b8b71b" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_90542d72-849a-4fd3-8804-c25b9f2fc1c2" xlink:to="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_abe606f8-6ba1-429d-bfc4-595c05b8b71b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_706f4d9f-e7a5-452f-8810-b1a0e70e24cc" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_90542d72-849a-4fd3-8804-c25b9f2fc1c2" xlink:to="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_706f4d9f-e7a5-452f-8810-b1a0e70e24cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_srt_ProductOrServiceAxis_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283" xlink:to="loc_srt_ProductsAndServicesDomain_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7b5d702e-5c58-40f6-9687-a2bca8df648b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283" xlink:to="loc_srt_ProductsAndServicesDomain_7b5d702e-5c58-40f6-9687-a2bca8df648b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_ed98bdbb-3d33-4210-84a8-624b6324ca40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7b5d702e-5c58-40f6-9687-a2bca8df648b" xlink:to="loc_us-gaap_LicenseAndServiceMember_ed98bdbb-3d33-4210-84a8-624b6324ca40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_fe06fdd0-46a7-4f07-9905-beb663d8fcf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LicenseAndServiceMember_ed98bdbb-3d33-4210-84a8-624b6324ca40" xlink:to="loc_us-gaap_LicenseMember_fe06fdd0-46a7-4f07-9905-beb663d8fcf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a2636f52-548c-4d9c-a585-8345ae5c625b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a2636f52-548c-4d9c-a585-8345ae5c625b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_a2636f52-548c-4d9c-a585-8345ae5c625b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a2636f52-548c-4d9c-a585-8345ae5c625b" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_a2636f52-548c-4d9c-a585-8345ae5c625b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_8713c103-0c3f-4ec2-901d-dc4d3341727b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a2636f52-548c-4d9c-a585-8345ae5c625b" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_8713c103-0c3f-4ec2-901d-dc4d3341727b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInAgreementEstimateMarch2023Member_ffdca726-c898-4210-a95c-500361f17fd9" xlink:href="sgmo-20230930.xsd#sgmo_ChangeInAgreementEstimateMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_8713c103-0c3f-4ec2-901d-dc4d3341727b" xlink:to="loc_sgmo_ChangeInAgreementEstimateMarch2023Member_ffdca726-c898-4210-a95c-500361f17fd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInAgreementEstimateSeptember2023Member_c1ac2ffb-f8a0-4c1f-b2c7-ff6f51c7ae28" xlink:href="sgmo-20230930.xsd#sgmo_ChangeInAgreementEstimateSeptember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_8713c103-0c3f-4ec2-901d-dc4d3341727b" xlink:to="loc_sgmo_ChangeInAgreementEstimateSeptember2023Member_c1ac2ffb-f8a0-4c1f-b2c7-ff6f51c7ae28" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_eafb897c-21c2-4ce8-b9c6-fc7995f87142" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_fbd75a12-60d9-4907-9010-51f94408e495" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_eafb897c-21c2-4ce8-b9c6-fc7995f87142" xlink:to="loc_us-gaap_RevenuesAbstract_fbd75a12-60d9-4907-9010-51f94408e495" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c7f7503-8341-4111-aacd-485ea5b4a7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_fbd75a12-60d9-4907-9010-51f94408e495" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c7f7503-8341-4111-aacd-485ea5b4a7e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_72d110a0-da2b-4033-9863-610c7623998f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_eafb897c-21c2-4ce8-b9c6-fc7995f87142" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_72d110a0-da2b-4033-9863-610c7623998f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_fb0a4087-bcd8-40ca-bae0-9ef2af6520e1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_72d110a0-da2b-4033-9863-610c7623998f" xlink:to="loc_srt_CounterpartyNameAxis_fb0a4087-bcd8-40ca-bae0-9ef2af6520e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fb0a4087-bcd8-40ca-bae0-9ef2af6520e1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_fb0a4087-bcd8-40ca-bae0-9ef2af6520e1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fb0a4087-bcd8-40ca-bae0-9ef2af6520e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_391edf36-243c-4245-89ff-94031b0fc5d7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_fb0a4087-bcd8-40ca-bae0-9ef2af6520e1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_391edf36-243c-4245-89ff-94031b0fc5d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_cd91c30f-4e2b-47ab-961c-c5300ae9acbf" xlink:href="sgmo-20230930.xsd#sgmo_KitePharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_391edf36-243c-4245-89ff-94031b0fc5d7" xlink:to="loc_sgmo_KitePharmaIncMember_cd91c30f-4e2b-47ab-961c-c5300ae9acbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_9059f7fb-940a-49d0-a945-b5af2d31c98f" xlink:href="sgmo-20230930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_391edf36-243c-4245-89ff-94031b0fc5d7" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_9059f7fb-940a-49d0-a945-b5af2d31c98f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_43593823-d15c-48e8-9061-40aff1c7d26d" xlink:href="sgmo-20230930.xsd#sgmo_BiogenMAIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_391edf36-243c-4245-89ff-94031b0fc5d7" xlink:to="loc_sgmo_BiogenMAIncMember_43593823-d15c-48e8-9061-40aff1c7d26d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bee0ae7e-5ce2-4271-a00d-243a9468387b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_72d110a0-da2b-4033-9863-610c7623998f" xlink:to="loc_srt_ProductOrServiceAxis_bee0ae7e-5ce2-4271-a00d-243a9468387b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bee0ae7e-5ce2-4271-a00d-243a9468387b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_bee0ae7e-5ce2-4271-a00d-243a9468387b" xlink:to="loc_srt_ProductsAndServicesDomain_bee0ae7e-5ce2-4271-a00d-243a9468387b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bdaf85e1-774e-4466-b613-ae1c030e9bae" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_bee0ae7e-5ce2-4271-a00d-243a9468387b" xlink:to="loc_srt_ProductsAndServicesDomain_bdaf85e1-774e-4466-b613-ae1c030e9bae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_6847bc9b-4d63-4c6c-88b6-b2d950949014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bdaf85e1-774e-4466-b613-ae1c030e9bae" xlink:to="loc_us-gaap_LicenseMember_6847bc9b-4d63-4c6c-88b6-b2d950949014" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_718bbdbe-bc3e-4b94-9a63-f8366aa47084" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bdaf85e1-774e-4466-b613-ae1c030e9bae" xlink:to="loc_us-gaap_ServiceMember_718bbdbe-bc3e-4b94-9a63-f8366aa47084" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_5ef03b15-8eaa-4306-aeae-adfa3f5695bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_us-gaap_ProceedsFromCollaborators_5ef03b15-8eaa-4306-aeae-adfa3f5695bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_93f971aa-ab77-4905-a516-eac257f5334e" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_93f971aa-ab77-4905-a516-eac257f5334e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementLicenseFee_8a135d56-f3f1-4b7c-8e52-e7bd87604cd8" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementLicenseFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_sgmo_CollaborativeArrangementLicenseFee_8a135d56-f3f1-4b7c-8e52-e7bd87604cd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_99e469d7-6487-4c39-9523-6757ad462ce5" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_99e469d7-6487-4c39-9523-6757ad462ce5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_812af4b0-9458-467c-9386-3f91e4364ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_812af4b0-9458-467c-9386-3f91e4364ea2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_4b252bb2-1ccd-4c06-9e64-861cfe3ebab5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_us-gaap_ContractWithCustomerLiability_4b252bb2-1ccd-4c06-9e64-861cfe3ebab5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1f2044df-2291-46cc-91f1-9f4a4fa3d894" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1f2044df-2291-46cc-91f1-9f4a4fa3d894" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_49972b3f-cefa-4851-a414-d98a0d412585" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1f2044df-2291-46cc-91f1-9f4a4fa3d894" xlink:to="loc_srt_CounterpartyNameAxis_49972b3f-cefa-4851-a414-d98a0d412585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_49972b3f-cefa-4851-a414-d98a0d412585_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_49972b3f-cefa-4851-a414-d98a0d412585" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_49972b3f-cefa-4851-a414-d98a0d412585_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0602388e-64ee-4b26-8052-c65a7b452a52" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_49972b3f-cefa-4851-a414-d98a0d412585" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0602388e-64ee-4b26-8052-c65a7b452a52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_2c8e5423-eb6a-4cce-987f-8ef10921b833" xlink:href="sgmo-20230930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0602388e-64ee-4b26-8052-c65a7b452a52" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_2c8e5423-eb6a-4cce-987f-8ef10921b833" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_6f05a37b-8f75-49f6-9ede-81c86c3d692a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1f2044df-2291-46cc-91f1-9f4a4fa3d894" xlink:to="loc_us-gaap_TypeOfArrangementAxis_6f05a37b-8f75-49f6-9ede-81c86c3d692a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6f05a37b-8f75-49f6-9ede-81c86c3d692a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_6f05a37b-8f75-49f6-9ede-81c86c3d692a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6f05a37b-8f75-49f6-9ede-81c86c3d692a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_719dbc77-0920-4320-9082-f0b6af0358ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_6f05a37b-8f75-49f6-9ede-81c86c3d692a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_719dbc77-0920-4320-9082-f0b6af0358ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_8fadd970-33ae-441c-946a-643379d43b4a" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_719dbc77-0920-4320-9082-f0b6af0358ab" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_8fadd970-33ae-441c-946a-643379d43b4a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_62ffbd77-f671-464c-8473-484b48b3b496" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_62ffbd77-f671-464c-8473-484b48b3b496" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_bd105985-461c-4e55-940f-7dda9434f407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_bd105985-461c-4e55-940f-7dda9434f407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_922a697b-9510-443d-9e26-8bc37fb1e6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_922a697b-9510-443d-9e26-8bc37fb1e6c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_b5e99c10-2628-4857-aa54-729f44059732" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_ProceedsFromCollaborators_b5e99c10-2628-4857-aa54-729f44059732" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty_13cf2db3-0c9a-4a95-a12b-bb35a01de215" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty_13cf2db3-0c9a-4a95-a12b-bb35a01de215" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_8e73df6e-9715-4c0e-93df-ca1c0372308d" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAgreementNumberOfAdditionalProductTargets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_8e73df6e-9715-4c0e-93df-ca1c0372308d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_32f79930-6fd4-4ec5-8698-c793ee60301b" xlink:href="sgmo-20230930.xsd#sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_32f79930-6fd4-4ec5-8698-c793ee60301b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementEquityIssued_5432122d-1588-4a98-8403-670fda2333b2" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAgreementEquityIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_CollaborationAgreementEquityIssued_5432122d-1588-4a98-8403-670fda2333b2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_41f82ee2-7748-4123-bd41-83667f0291a6" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_41f82ee2-7748-4123-bd41-83667f0291a6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_2d022b18-e15d-4690-930b-fbd063436629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_2d022b18-e15d-4690-930b-fbd063436629" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ff376c15-cc14-4d07-bc89-d5825a1291b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ff376c15-cc14-4d07-bc89-d5825a1291b0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_2a43d6a9-4ee3-497b-978c-f21c8400c894" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_ContractWithCustomerLiability_2a43d6a9-4ee3-497b-978c-f21c8400c894" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_37c8705f-f3aa-42a5-8bb5-986d491f8a98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_37c8705f-f3aa-42a5-8bb5-986d491f8a98" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_6aad20fb-84ad-4bc1-831e-41844f4f561f" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_6aad20fb-84ad-4bc1-831e-41844f4f561f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition_dc1a3714-af76-493c-8e30-4679bcd4fc60" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeAgreementPercentOfInitialRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition_dc1a3714-af76-493c-8e30-4679bcd4fc60" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_366ff414-9dc0-4f90-b2af-8205b422ee98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_366ff414-9dc0-4f90-b2af-8205b422ee98" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_784f8b5a-31eb-43da-a2dc-805fab74ff0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_784f8b5a-31eb-43da-a2dc-805fab74ff0c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_5ce86106-451d-4919-bbe1-e7a43f42efc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_5ce86106-451d-4919-bbe1-e7a43f42efc6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4be3fe96-c523-46d6-9547-99eca0fb4422" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4be3fe96-c523-46d6-9547-99eca0fb4422" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_64a9d038-3c27-4ef2-ae7a-2ca8df941ac5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4be3fe96-c523-46d6-9547-99eca0fb4422" xlink:to="loc_srt_CounterpartyNameAxis_64a9d038-3c27-4ef2-ae7a-2ca8df941ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64a9d038-3c27-4ef2-ae7a-2ca8df941ac5_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_64a9d038-3c27-4ef2-ae7a-2ca8df941ac5" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_64a9d038-3c27-4ef2-ae7a-2ca8df941ac5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_df1ae68a-51f7-4da5-9a19-328a52ec12d1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_64a9d038-3c27-4ef2-ae7a-2ca8df941ac5" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_df1ae68a-51f7-4da5-9a19-328a52ec12d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_10bbead9-3868-4628-95ef-80e9e84a26cd" xlink:href="sgmo-20230930.xsd#sgmo_BiogenMAIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_df1ae68a-51f7-4da5-9a19-328a52ec12d1" xlink:to="loc_sgmo_BiogenMAIncMember_10bbead9-3868-4628-95ef-80e9e84a26cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_09737444-33b7-4ed7-95d0-4d519e0ff50f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4be3fe96-c523-46d6-9547-99eca0fb4422" xlink:to="loc_us-gaap_TypeOfArrangementAxis_09737444-33b7-4ed7-95d0-4d519e0ff50f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09737444-33b7-4ed7-95d0-4d519e0ff50f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_09737444-33b7-4ed7-95d0-4d519e0ff50f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09737444-33b7-4ed7-95d0-4d519e0ff50f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5af3602-6a70-4ac0-85ed-26424acca964" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_09737444-33b7-4ed7-95d0-4d519e0ff50f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5af3602-6a70-4ac0-85ed-26424acca964" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_StockPurchaseAgreementMember_42de198f-6beb-4b9a-b6ec-ff68858f27b5" xlink:href="sgmo-20230930.xsd#sgmo_StockPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5af3602-6a70-4ac0-85ed-26424acca964" xlink:to="loc_sgmo_StockPurchaseAgreementMember_42de198f-6beb-4b9a-b6ec-ff68858f27b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_d817e479-50d9-4192-988e-a073ab1234e5" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5af3602-6a70-4ac0-85ed-26424acca964" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_d817e479-50d9-4192-988e-a073ab1234e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_62508d5f-1201-4e3f-8a71-48ec7e5eb36e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4be3fe96-c523-46d6-9547-99eca0fb4422" xlink:to="loc_srt_ProductOrServiceAxis_62508d5f-1201-4e3f-8a71-48ec7e5eb36e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_62508d5f-1201-4e3f-8a71-48ec7e5eb36e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_62508d5f-1201-4e3f-8a71-48ec7e5eb36e" xlink:to="loc_srt_ProductsAndServicesDomain_62508d5f-1201-4e3f-8a71-48ec7e5eb36e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_df4a01c4-a16c-4d32-aca4-fd6ae229fca2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_62508d5f-1201-4e3f-8a71-48ec7e5eb36e" xlink:to="loc_srt_ProductsAndServicesDomain_df4a01c4-a16c-4d32-aca4-fd6ae229fca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_7f1f4470-f87c-45c3-8a68-0f3452a06ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_df4a01c4-a16c-4d32-aca4-fd6ae229fca2" xlink:to="loc_us-gaap_LicenseAndServiceMember_7f1f4470-f87c-45c3-8a68-0f3452a06ca7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_5933f904-1d86-49ae-bdcb-6ef4a3b4e8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_5933f904-1d86-49ae-bdcb-6ef4a3b4e8fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_fbe7bae8-2473-4851-b920-a8cb790b7fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_fbe7bae8-2473-4851-b920-a8cb790b7fb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_ea549ec0-a37a-4519-837a-a2344fc51ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_ea549ec0-a37a-4519-837a-a2344fc51ea1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4d86fcbb-6371-4490-9b5f-e1d84f327007" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4d86fcbb-6371-4490-9b5f-e1d84f327007" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount_23e284fe-d46e-4109-8c6d-bc780e5ca8bf" xlink:href="sgmo-20230930.xsd#sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:to="loc_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount_23e284fe-d46e-4109-8c6d-bc780e5ca8bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_8bd4b0e7-5cb4-43b8-8fd4-dfd16c99d9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:to="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_8bd4b0e7-5cb4-43b8-8fd4-dfd16c99d9a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_18ba7cf5-55cb-42b2-b46f-258483c051da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_8bd4b0e7-5cb4-43b8-8fd4-dfd16c99d9a4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_18ba7cf5-55cb-42b2-b46f-258483c051da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_18ba7cf5-55cb-42b2-b46f-258483c051da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_18ba7cf5-55cb-42b2-b46f-258483c051da" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_18ba7cf5-55cb-42b2-b46f-258483c051da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce0ddec7-37e5-4eaf-ab48-0e6015a03b25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_18ba7cf5-55cb-42b2-b46f-258483c051da" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce0ddec7-37e5-4eaf-ab48-0e6015a03b25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_23a3d12e-6683-449f-a5fa-ae38a42bf9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce0ddec7-37e5-4eaf-ab48-0e6015a03b25" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_23a3d12e-6683-449f-a5fa-ae38a42bf9a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_1107510f-bb31-4d45-9362-6f148a43b892" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce0ddec7-37e5-4eaf-ab48-0e6015a03b25" xlink:to="loc_us-gaap_ConstructionInProgressMember_1107510f-bb31-4d45-9362-6f148a43b892" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_LeaseholdImprovementsAndConstructionInProgressMember_147fe502-01d0-4000-ab2f-58a8ba2bc2c4" xlink:href="sgmo-20230930.xsd#sgmo_LeaseholdImprovementsAndConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce0ddec7-37e5-4eaf-ab48-0e6015a03b25" xlink:to="loc_sgmo_LeaseholdImprovementsAndConstructionInProgressMember_147fe502-01d0-4000-ab2f-58a8ba2bc2c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember_c638e827-de7b-4279-9ad6-6de5c24dd497" xlink:href="sgmo-20230930.xsd#sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce0ddec7-37e5-4eaf-ab48-0e6015a03b25" xlink:to="loc_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember_c638e827-de7b-4279-9ad6-6de5c24dd497" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7ec7cde3-cfb0-4e2a-a3c4-7a7d3aa412c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0e9b68de-295e-4fb4-8c0e-9aa24df109df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7ec7cde3-cfb0-4e2a-a3c4-7a7d3aa412c8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0e9b68de-295e-4fb4-8c0e-9aa24df109df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d3e0591-9900-49eb-a7a4-0b5bde565be1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7ec7cde3-cfb0-4e2a-a3c4-7a7d3aa412c8" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d3e0591-9900-49eb-a7a4-0b5bde565be1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2e375ec8-5c2a-452a-b8da-9c0dd439633e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d3e0591-9900-49eb-a7a4-0b5bde565be1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2e375ec8-5c2a-452a-b8da-9c0dd439633e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2e375ec8-5c2a-452a-b8da-9c0dd439633e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2e375ec8-5c2a-452a-b8da-9c0dd439633e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2e375ec8-5c2a-452a-b8da-9c0dd439633e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_139c6703-bd20-4f7b-95e3-e147d305a445" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2e375ec8-5c2a-452a-b8da-9c0dd439633e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_139c6703-bd20-4f7b-95e3-e147d305a445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_61dbac46-36d4-4dbf-bc2a-c6b89c1570b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_139c6703-bd20-4f7b-95e3-e147d305a445" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_61dbac46-36d4-4dbf-bc2a-c6b89c1570b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_278ebb49-11de-46df-9bdc-f5236d9137f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_139c6703-bd20-4f7b-95e3-e147d305a445" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_278ebb49-11de-46df-9bdc-f5236d9137f6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#STOCKHOLDERSEQUITYDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14fdf9f8-4ec2-4260-8d49-2a1d1a824f28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_StockOfferingProgramMaximumValue_177bed66-a1f2-46ac-95f6-f0de1a00a49b" xlink:href="sgmo-20230930.xsd#sgmo_StockOfferingProgramMaximumValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14fdf9f8-4ec2-4260-8d49-2a1d1a824f28" xlink:to="loc_sgmo_StockOfferingProgramMaximumValue_177bed66-a1f2-46ac-95f6-f0de1a00a49b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice_cb9c8895-893b-4064-b743-a766fbd6fd84" xlink:href="sgmo-20230930.xsd#sgmo_SaleOfStockIncreaseToAggregateOfferingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14fdf9f8-4ec2-4260-8d49-2a1d1a824f28" xlink:to="loc_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice_cb9c8895-893b-4064-b743-a766fbd6fd84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cec6f962-8474-4946-80eb-dd1126aea2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14fdf9f8-4ec2-4260-8d49-2a1d1a824f28" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cec6f962-8474-4946-80eb-dd1126aea2e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_25c22c8f-b6fd-4787-a9d7-6e827b040f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14fdf9f8-4ec2-4260-8d49-2a1d1a824f28" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_25c22c8f-b6fd-4787-a9d7-6e827b040f8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061fb694-3ef7-4145-8084-8c8c6a88b66a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14fdf9f8-4ec2-4260-8d49-2a1d1a824f28" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061fb694-3ef7-4145-8084-8c8c6a88b66a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5fe0108f-0934-457b-8a90-646550c34ec2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061fb694-3ef7-4145-8084-8c8c6a88b66a" xlink:to="loc_srt_CounterpartyNameAxis_5fe0108f-0934-457b-8a90-646550c34ec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5fe0108f-0934-457b-8a90-646550c34ec2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_5fe0108f-0934-457b-8a90-646550c34ec2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5fe0108f-0934-457b-8a90-646550c34ec2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6f7223f6-8ee0-445c-941d-314e2b5cec1a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_5fe0108f-0934-457b-8a90-646550c34ec2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6f7223f6-8ee0-445c-941d-314e2b5cec1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_JefferiesLLCMember_94a51da9-9314-4b32-86b1-0ec27ec30437" xlink:href="sgmo-20230930.xsd#sgmo_JefferiesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6f7223f6-8ee0-445c-941d-314e2b5cec1a" xlink:to="loc_sgmo_JefferiesLLCMember_94a51da9-9314-4b32-86b1-0ec27ec30437" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4ea4e460-1a14-4177-824c-29696185a09e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061fb694-3ef7-4145-8084-8c8c6a88b66a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4ea4e460-1a14-4177-824c-29696185a09e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4ea4e460-1a14-4177-824c-29696185a09e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4ea4e460-1a14-4177-824c-29696185a09e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4ea4e460-1a14-4177-824c-29696185a09e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f587f18-7cf7-47e3-afa9-5eb4475164ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4ea4e460-1a14-4177-824c-29696185a09e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f587f18-7cf7-47e3-afa9-5eb4475164ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AtTheMarketOfferingAgreementMember_1de86c8b-c407-41a3-b545-6cbf41ae93da" xlink:href="sgmo-20230930.xsd#sgmo_AtTheMarketOfferingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f587f18-7cf7-47e3-afa9-5eb4475164ee" xlink:to="loc_sgmo_AtTheMarketOfferingAgreementMember_1de86c8b-c407-41a3-b545-6cbf41ae93da" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#RESTRUCTURINGCHARGESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_abaebbe3-03a9-4ec6-8b7e-2e4242fd6e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_7556c64a-331f-4a4d-bd0e-9ad53f30b2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_abaebbe3-03a9-4ec6-8b7e-2e4242fd6e4e" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_7556c64a-331f-4a4d-bd0e-9ad53f30b2fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_19987266-4eeb-46da-b002-beb71dc85914" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_abaebbe3-03a9-4ec6-8b7e-2e4242fd6e4e" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_19987266-4eeb-46da-b002-beb71dc85914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_056a0a5d-b386-47e8-ac56-8238e9acb277" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_abaebbe3-03a9-4ec6-8b7e-2e4242fd6e4e" xlink:to="loc_us-gaap_RestructuringCharges_056a0a5d-b386-47e8-ac56-8238e9acb277" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60e49eba-4284-4253-8653-34cfdfef2bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_abaebbe3-03a9-4ec6-8b7e-2e4242fd6e4e" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60e49eba-4284-4253-8653-34cfdfef2bfa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_bc422eb8-c8ed-4956-b5ed-dc05ba73b05d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60e49eba-4284-4253-8653-34cfdfef2bfa" xlink:to="loc_srt_TitleOfIndividualAxis_bc422eb8-c8ed-4956-b5ed-dc05ba73b05d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bc422eb8-c8ed-4956-b5ed-dc05ba73b05d_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_bc422eb8-c8ed-4956-b5ed-dc05ba73b05d" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bc422eb8-c8ed-4956-b5ed-dc05ba73b05d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3f64ffeb-9056-4acd-9d82-0a30d47abb4f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_bc422eb8-c8ed-4956-b5ed-dc05ba73b05d" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3f64ffeb-9056-4acd-9d82-0a30d47abb4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_FullTimeEmployeesMember_c9c4e072-304b-4e47-92cc-f32bd2430340" xlink:href="sgmo-20230930.xsd#sgmo_FullTimeEmployeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3f64ffeb-9056-4acd-9d82-0a30d47abb4f" xlink:to="loc_sgmo_FullTimeEmployeesMember_c9c4e072-304b-4e47-92cc-f32bd2430340" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContractedEmployeesMember_8e8f7f54-fdd3-441f-b186-d8f53ac97ab7" xlink:href="sgmo-20230930.xsd#sgmo_ContractedEmployeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3f64ffeb-9056-4acd-9d82-0a30d47abb4f" xlink:to="loc_sgmo_ContractedEmployeesMember_8e8f7f54-fdd3-441f-b186-d8f53ac97ab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9e9a6624-f2e6-4867-b673-bcfbc7d09e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60e49eba-4284-4253-8653-34cfdfef2bfa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9e9a6624-f2e6-4867-b673-bcfbc7d09e5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9e9a6624-f2e6-4867-b673-bcfbc7d09e5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9e9a6624-f2e6-4867-b673-bcfbc7d09e5a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9e9a6624-f2e6-4867-b673-bcfbc7d09e5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a5be9e62-2230-4875-b8ec-5cb883bc9a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9e9a6624-f2e6-4867-b673-bcfbc7d09e5a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a5be9e62-2230-4875-b8ec-5cb883bc9a2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0f6ae204-8d4f-488b-afad-b2dd4dc14fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a5be9e62-2230-4875-b8ec-5cb883bc9a2d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0f6ae204-8d4f-488b-afad-b2dd4dc14fa8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_6610b832-edd8-4a86-b833-48c01a4efdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a5be9e62-2230-4875-b8ec-5cb883bc9a2d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_6610b832-edd8-4a86-b833-48c01a4efdf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_347b1662-b9f0-4c0b-92fb-0a85b9e3307f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60e49eba-4284-4253-8653-34cfdfef2bfa" xlink:to="loc_us-gaap_RestructuringPlanAxis_347b1662-b9f0-4c0b-92fb-0a85b9e3307f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_347b1662-b9f0-4c0b-92fb-0a85b9e3307f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_347b1662-b9f0-4c0b-92fb-0a85b9e3307f" xlink:to="loc_us-gaap_RestructuringPlanDomain_347b1662-b9f0-4c0b-92fb-0a85b9e3307f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_5e6ac2ad-42d3-4ada-8848-c08999cf6c23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_347b1662-b9f0-4c0b-92fb-0a85b9e3307f" xlink:to="loc_us-gaap_RestructuringPlanDomain_5e6ac2ad-42d3-4ada-8848-c08999cf6c23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_April2023RestructuringPlanMember_4cf1c02b-49ee-4268-a73e-931348992ef8" xlink:href="sgmo-20230930.xsd#sgmo_April2023RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_5e6ac2ad-42d3-4ada-8848-c08999cf6c23" xlink:to="loc_sgmo_April2023RestructuringPlanMember_4cf1c02b-49ee-4268-a73e-931348992ef8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_5ad1f67c-9edd-4d20-9eed-c805619bc8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_5ad1f67c-9edd-4d20-9eed-c805619bc8cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_8ffdd13e-30bd-4b75-bfc2-3763fb798316" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_8ffdd13e-30bd-4b75-bfc2-3763fb798316" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_cf73d301-c247-46a1-86d2-1e31c6492f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_cf73d301-c247-46a1-86d2-1e31c6492f1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod_a7ffe7d8-c751-426c-a9ed-9286afa36971" xlink:href="sgmo-20230930.xsd#sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:to="loc_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod_a7ffe7d8-c751-426c-a9ed-9286afa36971" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod_ed1a27f5-bb12-453c-b24d-0f04888b6a7a" xlink:href="sgmo-20230930.xsd#sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:to="loc_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod_ed1a27f5-bb12-453c-b24d-0f04888b6a7a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:to="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2fb1fb4e-a93e-46a3-bd62-d07660e16991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2fb1fb4e-a93e-46a3-bd62-d07660e16991" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2fb1fb4e-a93e-46a3-bd62-d07660e16991_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2fb1fb4e-a93e-46a3-bd62-d07660e16991" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2fb1fb4e-a93e-46a3-bd62-d07660e16991_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0e2e3a62-3f62-4ab7-94b0-a71b35b8feb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2fb1fb4e-a93e-46a3-bd62-d07660e16991" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0e2e3a62-3f62-4ab7-94b0-a71b35b8feb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_719276e2-e388-4fbe-a814-c78ed8ee7d43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0e2e3a62-3f62-4ab7-94b0-a71b35b8feb2" xlink:to="loc_us-gaap_SubsequentEventMember_719276e2-e388-4fbe-a814-c78ed8ee7d43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_b721c84b-f2bf-4c1a-a6b7-87573ffc44dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:to="loc_us-gaap_RestructuringPlanAxis_b721c84b-f2bf-4c1a-a6b7-87573ffc44dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_b721c84b-f2bf-4c1a-a6b7-87573ffc44dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_b721c84b-f2bf-4c1a-a6b7-87573ffc44dd" xlink:to="loc_us-gaap_RestructuringPlanDomain_b721c84b-f2bf-4c1a-a6b7-87573ffc44dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_e0341ee8-f9bc-45a0-a1e9-f5c95152a8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_b721c84b-f2bf-4c1a-a6b7-87573ffc44dd" xlink:to="loc_us-gaap_RestructuringPlanDomain_e0341ee8-f9bc-45a0-a1e9-f5c95152a8dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_November2023RestructuringPlanMember_66d5cf82-fb7a-458b-9b12-71d9c757f2dc" xlink:href="sgmo-20230930.xsd#sgmo_November2023RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_e0341ee8-f9bc-45a0-a1e9-f5c95152a8dc" xlink:to="loc_sgmo_November2023RestructuringPlanMember_66d5cf82-fb7a-458b-9b12-71d9c757f2dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9d511d71-41be-4273-bd58-a060b6d16970" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:to="loc_srt_RangeAxis_9d511d71-41be-4273-bd58-a060b6d16970" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9d511d71-41be-4273-bd58-a060b6d16970_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9d511d71-41be-4273-bd58-a060b6d16970" xlink:to="loc_srt_RangeMember_9d511d71-41be-4273-bd58-a060b6d16970_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_13947b44-6245-4e0d-86e6-fd7f2266c740" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9d511d71-41be-4273-bd58-a060b6d16970" xlink:to="loc_srt_RangeMember_13947b44-6245-4e0d-86e6-fd7f2266c740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0570574c-95c5-4890-921c-4583bb0fc3c7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_13947b44-6245-4e0d-86e6-fd7f2266c740" xlink:to="loc_srt_MinimumMember_0570574c-95c5-4890-921c-4583bb0fc3c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_364161a3-8c7e-4d4b-b108-a23711a37027" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_13947b44-6245-4e0d-86e6-fd7f2266c740" xlink:to="loc_srt_MaximumMember_364161a3-8c7e-4d4b-b108-a23711a37027" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7089eeae-d5f2-4632-969f-cfdb6231a1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:to="loc_us-gaap_PlanNameAxis_7089eeae-d5f2-4632-969f-cfdb6231a1fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7089eeae-d5f2-4632-969f-cfdb6231a1fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_7089eeae-d5f2-4632-969f-cfdb6231a1fa" xlink:to="loc_us-gaap_PlanNameDomain_7089eeae-d5f2-4632-969f-cfdb6231a1fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f57915d5-e702-4ef0-a366-def0ec9d9ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_7089eeae-d5f2-4632-969f-cfdb6231a1fa" xlink:to="loc_us-gaap_PlanNameDomain_f57915d5-e702-4ef0-a366-def0ec9d9ab8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember_55b157fc-2a68-4db7-90a2-7d00a1666f9c" xlink:href="sgmo-20230930.xsd#sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f57915d5-e702-4ef0-a366-def0ec9d9ab8" xlink:to="loc_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember_55b157fc-2a68-4db7-90a2-7d00a1666f9c" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>sgmo-20230930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:66e428df-1cd2-4a45-95e8-7711e67a648c,g:c0e019b1-92dd-475a-ba81-4eb41606269d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ProceedsFromCollaborators_5c747b3a-23da-4620-a116-bcfa9a047241_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollaborators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from collaborators</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollaborators_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollaborators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collaborators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollaborators" xlink:to="lab_us-gaap_ProceedsFromCollaborators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_85962d1c-a0e1-472b-ab32-4307fa53c34d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization in operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_96949d18-c3d3-46db-8225-0d14dfdb8509_terseLabel_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified sales-based milestones if annual worldwide net sales of licensed products reach specified levels</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_label_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Specified Sales Based Milestones If Annual Worldwide Net Sales Of Licensed Products Reach Specified Levels [Member]</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_documentation_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified sales based milestones if annual worldwide net sales of licensed products reach specified levels.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" xlink:to="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f74512f3-25e9-45cc-a0c9-c334b4d60a3a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_96a1ac88-359c-4a45-a329-7eb4a9ff20ab_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_d28148d7-61ac-4622-9489-66975a2f5d05_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_5ebd8f0c-1aac-46ff-a98b-0c262c2976df_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aa44d8a8-b290-43ea-b431-9ab751836071_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_236915fe-399e-4696-beb2-0dd94981687c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation, expected timing of satisfaction period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty_705f37cc-04fb-426a-ae43-4c07f29f484c_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of neurological disease gene targets selected by counterparty (in product targets)</link:label>
    <link:label id="lab_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty_label_en-US" xlink:label="lab_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Number Of Selected Product Targets By Counterparty</link:label>
    <link:label id="lab_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty_documentation_en-US" xlink:label="lab_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Number Of Selected Product Targets By Counterparty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty" xlink:to="lab_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b297db44-7d76-4d34-893a-b169bda4b8a6_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_d18e48f2-103b-4d57-8fcc-6269a152fdcd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_StockPurchaseAgreementMember_7efd27a9-ec4b-4ccb-988f-baf1a30f98f3_terseLabel_en-US" xlink:label="lab_sgmo_StockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Purchase Agreement</link:label>
    <link:label id="lab_sgmo_StockPurchaseAgreementMember_label_en-US" xlink:label="lab_sgmo_StockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Purchase Agreement [Member]</link:label>
    <link:label id="lab_sgmo_StockPurchaseAgreementMember_documentation_en-US" xlink:label="lab_sgmo_StockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_StockPurchaseAgreementMember" xlink:href="sgmo-20230930.xsd#sgmo_StockPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_StockPurchaseAgreementMember" xlink:to="lab_sgmo_StockPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_a8e076c3-10f4-42b6-9b4a-48a7d909f8f0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_31db49f9-2fa7-45ed-a180-3672d85d155e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_95ce1468-143b-421b-8a2f-f783d711cdc3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_JefferiesLLCMember_05ef6155-bdd1-4be0-a14b-68f9d9ac64a6_terseLabel_en-US" xlink:label="lab_sgmo_JefferiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jefferies LLC</link:label>
    <link:label id="lab_sgmo_JefferiesLLCMember_label_en-US" xlink:label="lab_sgmo_JefferiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jefferies LLC [Member]</link:label>
    <link:label id="lab_sgmo_JefferiesLLCMember_documentation_en-US" xlink:label="lab_sgmo_JefferiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jefferies LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_JefferiesLLCMember" xlink:href="sgmo-20230930.xsd#sgmo_JefferiesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_JefferiesLLCMember" xlink:to="lab_sgmo_JefferiesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_507fa54d-b6fc-49a6-b9e3-fda73313d27a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_9c007478-e2db-4c41-a460-565782820d8a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_1069f2de-653e-4b0d-ad7f-22b7c76c8839_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of employees eliminated in restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_724884e1-41e9-42ec-b7d4-fb2cf7822801_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_decea078-e0b4-4358-95c0-95272c0018c2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenues</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_8ecd993f-9cfb-44c8-a292-d8fdb1d87b89_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_d176f03e-2fb7-40d1-907e-9b92b5c43959_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_a74dfb38-fd8c-4873-aae0-96f9e6c5a88d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_3b6675c8-1160-4dfc-8b53-6c7fffbb26a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impaired Long-Lived Assets Held and Used [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impaired Long-Lived Assets Held and Used [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:to="lab_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_3460097e-0ea1-4c5a-be6d-b670fa65f53c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1c2cac54-d374-4fb5-92f3-fd7ce7cc2c49_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember_ea45bc41-866d-44f3-9c85-2f36b7f309f2_terseLabel_en-US" xlink:label="lab_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, Fixtures and Laboratory and Manufacturing Equipment</link:label>
    <link:label id="lab_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember_label_en-US" xlink:label="lab_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, Fixtures And Laboratory And Manufacturing Equipment [Member]</link:label>
    <link:label id="lab_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember_documentation_en-US" xlink:label="lab_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, Fixtures And Laboratory And Manufacturing Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember" xlink:href="sgmo-20230930.xsd#sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember" xlink:to="lab_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_9494738e-f0e1-49ad-a27e-6782d9d4d906_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount_8c5200f7-9e53-4661-bb4a-ae76307e0faa_terseLabel_en-US" xlink:label="lab_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation amount, related to material rights</link:label>
    <link:label id="lab_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount_label_en-US" xlink:label="lab_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Related To Material Rights, Amount</link:label>
    <link:label id="lab_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount_documentation_en-US" xlink:label="lab_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Related To Material Rights, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount" xlink:to="lab_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_0c8381b7-3be6-4613-9088-a1907eb89295_terseLabel_en-US" xlink:label="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer concentration risk</link:label>
    <link:label id="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_label_en-US" xlink:label="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Collaboration Agreements, Grants And Licensing Concentration Risk [Member]</link:label>
    <link:label id="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_documentation_en-US" xlink:label="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Collaboration Agreements, Grants And Licensing Concentration Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" xlink:href="sgmo-20230930.xsd#sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" xlink:to="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_766758c0-907d-476b-9dcd-74863c777503_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_da18fddc-d2f0-4e27-9d86-e1805e27c190_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_f3cb543c-dd71-4be6-8b9a-0f22f40d7426_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from at-the-market offering/ issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_10d44a85-376c-4d85-aecd-431237392095_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_ecb65dfc-f643-4693-9118-efa16ffdcbb7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d13b6922-7a13-490e-b66f-b9d08e944e71_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenues</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_RevenueNumberOfRemainingPerformanceObligations_5179d160-2095-41eb-8dfd-6d98f6a89b32_terseLabel_en-US" xlink:label="lab_sgmo_RevenueNumberOfRemainingPerformanceObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of remaining performance obligations</link:label>
    <link:label id="lab_sgmo_RevenueNumberOfRemainingPerformanceObligations_label_en-US" xlink:label="lab_sgmo_RevenueNumberOfRemainingPerformanceObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Number Of Remaining Performance Obligations</link:label>
    <link:label id="lab_sgmo_RevenueNumberOfRemainingPerformanceObligations_documentation_en-US" xlink:label="lab_sgmo_RevenueNumberOfRemainingPerformanceObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Number Of Remaining Performance Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueNumberOfRemainingPerformanceObligations" xlink:href="sgmo-20230930.xsd#sgmo_RevenueNumberOfRemainingPerformanceObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_RevenueNumberOfRemainingPerformanceObligations" xlink:to="lab_sgmo_RevenueNumberOfRemainingPerformanceObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_2acaa018-13f1-4efb-80b5-2fa24b5ca425_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_b99c85d7-65ba-4c4a-b23b-4b82673f1980_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_5e07d2c6-b54d-429a-9c14-70d63f9b3d3f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_b9bcc7a3-8971-47c2-abaa-7cdb1cca82a6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_977859e4-5402-453a-9ae8-4191da45c3c6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember_e4bbde2b-c956-450a-a394-6cda470de363_terseLabel_en-US" xlink:label="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">S B Five Two Five And Other Products</link:label>
    <link:label id="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember_label_en-US" xlink:label="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">S B Five Two Five And Other Products [Member]</link:label>
    <link:label id="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember_documentation_en-US" xlink:label="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">S B Five Two Five And Other Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember" xlink:href="sgmo-20230930.xsd#sgmo_SBFiveTwoFiveAndOtherProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember" xlink:to="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a2b5e035-9504-4b8e-97a9-7a1a71ef3589_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and employee benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_c950b41b-8650-4139-91c8-2a3880660ddb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_3bc4d35a-307f-464a-8a60-82870d332b1a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_b673c2cb-2e3a-46e7-b045-b3a67914f45a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d0fef6ea-7780-468f-972d-4f8752b2d5dc_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_887db85e-4479-468e-92e8-6ff95b982a4b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_81317237-bbc2-4421-a5c5-d1f657b2f6e9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_76d85f5a-9549-48cf-9719-4fadffa3be3d_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper securities</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_796d2ce2-e727-4103-9b51-91ed75c7970d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_a56d5333-bf44-4fe8-9adc-e93b836ecdf4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseAndServiceMember_69a5ad73-e896-4598-945f-8287ce336829_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Service</link:label>
    <link:label id="lab_us-gaap_LicenseAndServiceMember_e6b7b90e-0d7d-47e0-a359-d030d725c5aa_verboseLabel_en-US" xlink:label="lab_us-gaap_LicenseAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Service</link:label>
    <link:label id="lab_us-gaap_LicenseAndServiceMember_label_en-US" xlink:label="lab_us-gaap_LicenseAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseAndServiceMember" xlink:to="lab_us-gaap_LicenseAndServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_119b4219-48dc-4dbe-a9fe-6157b2d77e57_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net loss per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_4485774b-6fcc-423e-9169-d4c44670dfca_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_45f146f7-6b64-490f-b24e-b8a58bbf973e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_USGovernmentSponsoredAgencyBondMember_90303df8-2385-413f-902c-0459e226fe66_terseLabel_en-US" xlink:label="lab_sgmo_USGovernmentSponsoredAgencyBondMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency bonds</link:label>
    <link:label id="lab_sgmo_USGovernmentSponsoredAgencyBondMember_label_en-US" xlink:label="lab_sgmo_USGovernmentSponsoredAgencyBondMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government-Sponsored Agency Bond [Member]</link:label>
    <link:label id="lab_sgmo_USGovernmentSponsoredAgencyBondMember_documentation_en-US" xlink:label="lab_sgmo_USGovernmentSponsoredAgencyBondMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government-Sponsored Agency Bond</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_USGovernmentSponsoredAgencyBondMember" xlink:href="sgmo-20230930.xsd#sgmo_USGovernmentSponsoredAgencyBondMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_USGovernmentSponsoredAgencyBondMember" xlink:to="lab_sgmo_USGovernmentSponsoredAgencyBondMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_67522c10-a489-4f90-b68b-86d08e5ed2a1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementTransactionPrice_63703583-b314-481a-877b-1370c6ee3c10_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement transaction price</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementTransactionPrice_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Transaction Price</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementTransactionPrice_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement transaction price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementTransactionPrice" xlink:to="lab_sgmo_CollaborativeArrangementTransactionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_2953a05b-1f15-41dd-95a2-cda1f690f804_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_KitePharmaIncMember_e8ce7e67-7a64-41eb-b364-3cc0562a9108_terseLabel_en-US" xlink:label="lab_sgmo_KitePharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kite Pharma, Inc.</link:label>
    <link:label id="lab_sgmo_KitePharmaIncMember_label_en-US" xlink:label="lab_sgmo_KitePharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kite Pharma Inc [Member]</link:label>
    <link:label id="lab_sgmo_KitePharmaIncMember_documentation_en-US" xlink:label="lab_sgmo_KitePharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kite Pharma Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember" xlink:href="sgmo-20230930.xsd#sgmo_KitePharmaIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_KitePharmaIncMember" xlink:to="lab_sgmo_KitePharmaIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_570ff78f-0d14-40d3-a769-b11666cca899_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_d2b0425e-dca8-4670-bb7e-46f3c0a1f8d2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0aa5e7b2-8cb2-494f-96b5-db2532b5f337_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_def1e823-e172-4937-b778-111588749331_terseLabel_en-US" xlink:label="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential amount to be funded for achievement of specified commercialized and sales milestones</link:label>
    <link:label id="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_label_en-US" xlink:label="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Additional Revenue Recognition Milestone Method Revenue Eligible To Receive</link:label>
    <link:label id="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_documentation_en-US" xlink:label="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate additional revenue recognition milestone method revenue eligible to receive.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" xlink:href="sgmo-20230930.xsd#sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" xlink:to="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_951f1f4f-3bc6-4665-a5c6-fdb93db33d83_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-than-temporary Impairment Loss, Debt Securities, Available-for-Sale, Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_66119e04-7517-428e-b235-0bad4273dee4_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and employee benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_86f9902f-67aa-42ee-845b-15c58cad2a49_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Interest Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_755495e9-3525-4bd3-8805-56d1b5da66f6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_2b9a4906-15ab-425c-98b1-021dbc0879ae_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, estimated fair value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_49fbd397-7dda-4dba-a3fd-e83335d04488_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1328c029-2d3c-4b71-8206-a11194bd7f25_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_73ce691a-5d83-4a17-af7b-28549c6cfac0_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_29d3e610-7cd0-4a3f-bb8d-b6a98dfa3414_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit established as a deposit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_b7bd26e4-6d57-48a4-90fa-28c0789d0510_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5dec39a1-3f43-48e2-a489-3fb96e21a4a5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RESTRUCTURING CHARGES</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice_74761b5d-c55d-4a6f-82ec-5d13f9a27ad2_terseLabel_en-US" xlink:label="lab_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock offering program, increase to aggregate offering price</link:label>
    <link:label id="lab_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice_label_en-US" xlink:label="lab_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Increase To Aggregate Offering Price</link:label>
    <link:label id="lab_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice_documentation_en-US" xlink:label="lab_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Increase To Aggregate Offering Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice" xlink:href="sgmo-20230930.xsd#sgmo_SaleOfStockIncreaseToAggregateOfferingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice" xlink:to="lab_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ea33d111-3a4f-4142-82af-4ea3f8c4f126_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_c9f8c9d5-bcd9-41c0-9f86-6512425a728f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_69d5a123-14f7-4b6e-9295-ecb7f7fcf135_terseLabel_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in revenue</link:label>
    <link:label id="lab_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_documentation_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_03d82774-128c-4e8f-913e-72c2b26ae30b_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2de2f263-47f1-4e4b-abb7-2ac757155a56_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_November2023RestructuringPlanMember_6ba1e092-8045-4dbe-9a84-bb081b5f477a_terseLabel_en-US" xlink:label="lab_sgmo_November2023RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2023 Restructuring Plan</link:label>
    <link:label id="lab_sgmo_November2023RestructuringPlanMember_label_en-US" xlink:label="lab_sgmo_November2023RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2023 Restructuring Plan [Member]</link:label>
    <link:label id="lab_sgmo_November2023RestructuringPlanMember_documentation_en-US" xlink:label="lab_sgmo_November2023RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2023 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_November2023RestructuringPlanMember" xlink:href="sgmo-20230930.xsd#sgmo_November2023RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_November2023RestructuringPlanMember" xlink:to="lab_sgmo_November2023RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_40f4ecf3-2cd6-4695-ad3d-f29f20101605_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Goodwill, Indefinite-lived Intangible Assets and Long-lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_f77b1145-f4ca-42df-b695-e6a772203ded_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_4ff567c4-0cde-40dc-89b9-51057c3cbcb2_negatedTerseLabel_en-US" xlink:label="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, gross unrealized losses</link:label>
    <link:label id="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax</link:label>
    <link:label id="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents accumulated gross unrealized loss before tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="sgmo-20230930.xsd#sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_9659e74a-26a9-4993-89fa-ad5f065f5895_terseLabel_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Specified Preclinical Development Clinical Development And First Commercial Sale Milestones</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_label_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Specified Preclinical Development Clinical Development And First Commercial Sale Milestones [Member]</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_documentation_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified preclinical development clinical development and first commercial sale milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" xlink:to="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_0bf0d2c2-cde0-42ff-b68e-d78309578b98_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c1afb7c2-3a7d-4ccb-97f4-c8e82d78d794_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_be73ddb5-1721-4a36-ad6d-74229a149ddf_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimate of transaction price, increase in revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:to="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_edcff641-d2b1-4273-a0fa-58956585ca3b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_0c926c4f-bb17-4042-8746-aafb408376d7_terseLabel_en-US" xlink:label="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of milestones included in transaction price</link:label>
    <link:label id="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_label_en-US" xlink:label="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Clinical Or Regulatory Milestones Included In Transaction Price</link:label>
    <link:label id="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_documentation_en-US" xlink:label="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of clinical or regulatory milestones included in transaction price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" xlink:href="sgmo-20230930.xsd#sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" xlink:to="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_3f80c8e3-bc2b-4d00-b820-18323bc160af_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_April2023RestructuringPlanMember_64093ec0-14de-456e-b9d0-753be542317b_terseLabel_en-US" xlink:label="lab_sgmo_April2023RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2023 Restructuring Plan</link:label>
    <link:label id="lab_sgmo_April2023RestructuringPlanMember_label_en-US" xlink:label="lab_sgmo_April2023RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2023 Restructuring Plan [Member]</link:label>
    <link:label id="lab_sgmo_April2023RestructuringPlanMember_documentation_en-US" xlink:label="lab_sgmo_April2023RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2023 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_April2023RestructuringPlanMember" xlink:href="sgmo-20230930.xsd#sgmo_April2023RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_April2023RestructuringPlanMember" xlink:to="lab_sgmo_April2023RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc010e49-8c08-4f5c-97c8-da13514dc107_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_393873a9-7e68-47a2-ae38-dfd7a586d3d2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e8c7513-1891-447c-b9e2-d7a8b1bedb09_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_4c4d4781-b30d-43b7-8180-cc9a5111a44b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH EQUIVALENTS AND MARKETABLE SECURITIES</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_82ab3f75-a2e1-4005-a3bb-b5f4e1069c26_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_385ef1f4-727f-4822-8b51-cca3c1283995_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_79d3de43-8d58-4df8-8e49-bb5e475207ef_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_53ab6447-264c-4fae-b4bb-550502afd0cd_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_bb567b73-5c85-4085-8f2a-7ee57ada2799_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_fa63d7e6-5061-4cda-9b97-1c69e5c74a2f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_42b24d46-29ed-43a8-9006-84609f391b8e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_670d1d76-3f6a-4040-82fe-11b8a7de3428_negatedLabel_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash equivalents and marketable securities, gross unrealized losses</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents And Available For Sale Securities Gross Unrealized Loss Before Tax</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents and available for sale securities, gross unrealized loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" xlink:to="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_4d007ba3-1a88-4a6b-89f0-0cacc399c865_totalLabel_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash equivalents and marketable securities, amortized cost</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_label_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents And Available For Sale Securities Amortized Cost</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_documentation_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents and available for Sale Securities Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" xlink:to="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_9a7ce0bc-6a46-48d8-8221-289664501e73_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_dab093a1-5b1a-4c92-b85f-72b480afcc15_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash adjustments</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_1d8d71d3-1c65-4e3b-8b17-d42543c3422a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5e0fd9b2-4490-4ce3-b316-9afebd865850_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net pension gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_5967b247-0066-4504-a5c9-98303a1f7793_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net pension gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_87c70daf-e623-40ad-952d-ea6d9d494969_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9f8f6c5e-4327-47fb-9146-a89d60cf3ee6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_250a035f-93ba-4007-a65d-1e39b0a19ab1_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9c77f286-f758-4f1c-8341-31db7be92f20_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC AND DILUTED NET LOSS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_c9380c38-6ec5-42f1-9502-e51a6181e48a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_b714cc72-c423-40e6-a597-af6f20038bb1_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_636f5252-8150-44f9-9372-545282ad10e0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6f692cc6-edef-497d-91ca-4989f7ca8654_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_79a65759-d9d5-4211-bfbe-dd4940d47728_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_09555523-5975-4c19-ba61-67ddcb97e9fc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Fair Value Measurements of Cash Equivalents and Marketable Securities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities_eed4be42-31c8-475e-920e-47e9d07b8e66_terseLabel_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash equivalents and marketable securities, estimated fair value</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities_label_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents And Available For Sale Securities</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities_documentation_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents and available for sale securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities" xlink:to="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_29c1baca-468a-4051-996c-343387dcbf3f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_c92aaecd-d27b-43f2-bcdc-ea4df0eb6dc9_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_b491674d-7aa0-4238-85ae-26806235f742_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8380e75a-9a78-486b-80f7-b0b0ea7b0644_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_befe0b9f-6668-4afd-b176-2de286deb1f2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_d195d18d-3df1-4336-a8c0-10f2a9d69370_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_InitialResearchTermOfAgreement_accb9d9e-6abb-41e8-ad21-60c6c0759405_terseLabel_en-US" xlink:label="lab_sgmo_InitialResearchTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial research term of agreement</link:label>
    <link:label id="lab_sgmo_InitialResearchTermOfAgreement_label_en-US" xlink:label="lab_sgmo_InitialResearchTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Research Term Of Agreement</link:label>
    <link:label id="lab_sgmo_InitialResearchTermOfAgreement_documentation_en-US" xlink:label="lab_sgmo_InitialResearchTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial research term of agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_InitialResearchTermOfAgreement" xlink:href="sgmo-20230930.xsd#sgmo_InitialResearchTermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_InitialResearchTermOfAgreement" xlink:to="lab_sgmo_InitialResearchTermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_f47bdff7-6997-42f4-b583-f458f42c3041_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_b900afa2-9d1f-469c-99b7-f97b4f0f540b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized (loss) gain on marketable securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManufacturedProductOtherMember_aa31db89-6bca-4503-a1a5-cf9e58874b57_terseLabel_en-US" xlink:label="lab_us-gaap_ManufacturedProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other products</link:label>
    <link:label id="lab_us-gaap_ManufacturedProductOtherMember_label_en-US" xlink:label="lab_us-gaap_ManufacturedProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufactured Product, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturedProductOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManufacturedProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManufacturedProductOtherMember" xlink:to="lab_us-gaap_ManufacturedProductOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_1efc3f2d-2657-4f07-bbcb-44ea3ebb80c5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ChangeInAgreementEstimateMarch2023Member_86970551-7f6e-4da0-be66-87868e229790_terseLabel_en-US" xlink:label="lab_sgmo_ChangeInAgreementEstimateMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Agreement Estimate, March 2023</link:label>
    <link:label id="lab_sgmo_ChangeInAgreementEstimateMarch2023Member_label_en-US" xlink:label="lab_sgmo_ChangeInAgreementEstimateMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Agreement Estimate, March 2023 [Member]</link:label>
    <link:label id="lab_sgmo_ChangeInAgreementEstimateMarch2023Member_documentation_en-US" xlink:label="lab_sgmo_ChangeInAgreementEstimateMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Agreement Estimate, March 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInAgreementEstimateMarch2023Member" xlink:href="sgmo-20230930.xsd#sgmo_ChangeInAgreementEstimateMarch2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ChangeInAgreementEstimateMarch2023Member" xlink:to="lab_sgmo_ChangeInAgreementEstimateMarch2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_38e960cb-4e7b-49c1-b42f-e208ab3fb9cb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_d5a462f2-96cc-4622-ad2a-42db7951a374_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_d5ceba95-fcb7-4165-912b-496ba617a9bc_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_cddae295-7500-49b5-87a1-6cbb34e63dc7_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_854f8ba6-53fb-4d50-bee1-9839f39f5c7d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of investments available-for-sale</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_1ddefcd3-aab1-458e-980f-b3ecdcd5c595_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_98d0f80b-db35-4eb4-ac9c-2536e53b0b6a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_23a262af-40a7-4a34-be66-f4ec7e1af93a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_107c83bf-c9ee-4fdc-a5bc-e6e27138917d_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, number of milestones achieved</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Number Of Milestones Achieved</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Number Of Milestones Achieved</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementNumberOfMilestonesAchieved"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" xlink:to="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_PfizerSB525Member_ff817780-1810-44e2-94fb-aae6e38e9df8_terseLabel_en-US" xlink:label="lab_sgmo_PfizerSB525Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer SB-525</link:label>
    <link:label id="lab_sgmo_PfizerSB525Member_label_en-US" xlink:label="lab_sgmo_PfizerSB525Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer SB-525 [Member]</link:label>
    <link:label id="lab_sgmo_PfizerSB525Member_documentation_en-US" xlink:label="lab_sgmo_PfizerSB525Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer SB-525 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerSB525Member" xlink:href="sgmo-20230930.xsd#sgmo_PfizerSB525Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_PfizerSB525Member" xlink:to="lab_sgmo_PfizerSB525Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_3939b3f2-222b-4cf9-adce-096116a5679e_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_0a8cf59f-32ae-463a-9f76-8d17c2c9d70e_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasury bills</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_83268b6b-930d-4f66-babe-d677583c3100_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_3728a0a8-da80-4699-9ece-569649982f8f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, non-current</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_dcac1ab2-6182-40b7-a049-63e5df9c41cc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4760f6a6-399d-43c2-8d68-0d95e3785a23_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_fc53314f-30f2-430b-9521-63a81bd22a19_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_58214789-c954-44ab-9f85-8f5491add51b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ChangeInAgreementEstimateSeptember2023Member_71f8e151-fad7-485a-ba4f-b67eb7cef8c7_terseLabel_en-US" xlink:label="lab_sgmo_ChangeInAgreementEstimateSeptember2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Estimate, September 2023</link:label>
    <link:label id="lab_sgmo_ChangeInAgreementEstimateSeptember2023Member_label_en-US" xlink:label="lab_sgmo_ChangeInAgreementEstimateSeptember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Agreement Estimate, September 2023 [Member]</link:label>
    <link:label id="lab_sgmo_ChangeInAgreementEstimateSeptember2023Member_documentation_en-US" xlink:label="lab_sgmo_ChangeInAgreementEstimateSeptember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Agreement Estimate, September 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInAgreementEstimateSeptember2023Member" xlink:href="sgmo-20230930.xsd#sgmo_ChangeInAgreementEstimateSeptember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ChangeInAgreementEstimateSeptember2023Member" xlink:to="lab_sgmo_ChangeInAgreementEstimateSeptember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_a67cad39-a961-438e-8bf1-1351caac28fd_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of discounts and impairment on marketable securities</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_006510cf-a006-407f-a7ca-6c2169262fda_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_da2e6845-04bb-4794-9be2-576daa0b6254_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_590a2cfa-c3ab-494d-ad5a-b5c32d9a1795_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c11780bb-671c-4060-bee1-064775b2e0ce_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net loss per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_3b3bf4fd-259f-4a34-bd8d-d272e2d89ded_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_PfizerC9ORF72Member_7a895396-e30d-4f73-b9d2-4f226c1e16f5_terseLabel_en-US" xlink:label="lab_sgmo_PfizerC9ORF72Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer C9ORF72</link:label>
    <link:label id="lab_sgmo_PfizerC9ORF72Member_label_en-US" xlink:label="lab_sgmo_PfizerC9ORF72Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer C9ORF72 [Member]</link:label>
    <link:label id="lab_sgmo_PfizerC9ORF72Member_documentation_en-US" xlink:label="lab_sgmo_PfizerC9ORF72Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer C9ORF72</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerC9ORF72Member" xlink:href="sgmo-20230930.xsd#sgmo_PfizerC9ORF72Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_PfizerC9ORF72Member" xlink:to="lab_sgmo_PfizerC9ORF72Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_b0f4c170-3c31-4fd8-8c5e-b7553c608aae_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_eb035ed3-11b7-4a4d-8af1-7b2d6ae5f00d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of positions eliminated in restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated, Period Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AchievementOfCommercialMilestonesMember_d2a0d429-0b8a-457c-8d4c-49eb62a121f4_terseLabel_en-US" xlink:label="lab_sgmo_AchievementOfCommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Commercial Milestones</link:label>
    <link:label id="lab_sgmo_AchievementOfCommercialMilestonesMember_label_en-US" xlink:label="lab_sgmo_AchievementOfCommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Commercial Milestones [Member]</link:label>
    <link:label id="lab_sgmo_AchievementOfCommercialMilestonesMember_documentation_en-US" xlink:label="lab_sgmo_AchievementOfCommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of Commercial Milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfCommercialMilestonesMember" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfCommercialMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AchievementOfCommercialMilestonesMember" xlink:to="lab_sgmo_AchievementOfCommercialMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d3f7b54e-37f0-4c93-a19e-e76c835f9436_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_e864953e-a313-4ac2-b288-800d86e4307b_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e750f8c6-be4f-4e33-bc41-15d73755a2b6_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod_b61a2d12-ca64-4ac5-80ff-e33bd7be715d_terseLabel_en-US" xlink:label="lab_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of material rights for renewal of research period</link:label>
    <link:label id="lab_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod_label_en-US" xlink:label="lab_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Number Of Material Rights For Renewal Of Research Period</link:label>
    <link:label id="lab_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod_documentation_en-US" xlink:label="lab_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Number Of Material Rights For Renewal Of Research Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod" xlink:to="lab_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_72178eb5-32fc-4fd4-a460-daa4517885d3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring expected cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_6d985f40-8670-4347-a7dc-53b99016ba49_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3b90354a-1f28-4fd7-92f0-ad576f7e6372_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_df78454b-119a-4dd9-9824-116231cc43ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ContractedEmployeesMember_bc89da40-03ea-48d4-b77e-98c5ebdd2c1a_terseLabel_en-US" xlink:label="lab_sgmo_ContractedEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracted Employees</link:label>
    <link:label id="lab_sgmo_ContractedEmployeesMember_label_en-US" xlink:label="lab_sgmo_ContractedEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracted Employees [Member]</link:label>
    <link:label id="lab_sgmo_ContractedEmployeesMember_documentation_en-US" xlink:label="lab_sgmo_ContractedEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracted Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContractedEmployeesMember" xlink:href="sgmo-20230930.xsd#sgmo_ContractedEmployeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ContractedEmployeesMember" xlink:to="lab_sgmo_ContractedEmployeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_95a9f134-89ae-4ad3-b6f1-a107a98b754f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dadfc4f9-20b3-4fdf-9d5e-a1a2c85884d2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_f6fa760e-d8f8-44ca-b79c-8abbd99b886a_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31, 2022</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_574393dc-6362-4231-b682-faad0a20a778_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at September 30, 2023</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_PfizerMember_23a8d343-a992-4dc7-a2ff-012b702f41a6_terseLabel_en-US" xlink:label="lab_sgmo_PfizerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer Inc.</link:label>
    <link:label id="lab_sgmo_PfizerMember_label_en-US" xlink:label="lab_sgmo_PfizerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer [Member]</link:label>
    <link:label id="lab_sgmo_PfizerMember_documentation_en-US" xlink:label="lab_sgmo_PfizerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerMember" xlink:href="sgmo-20230930.xsd#sgmo_PfizerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_PfizerMember" xlink:to="lab_sgmo_PfizerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_c10a597c-d921-4bab-9123-a56d732a2573_terseLabel_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified research, clinical development, regulatory and first commercial sale milestones</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_label_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Specified Research Clinical Development Regulatory And First Commercial Sale Milestones [Member]</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_documentation_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified research, clinical development, regulatory and first commercial sale milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" xlink:to="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_OtherLicensingAgreementsMember_3aa1dcb5-8c5b-4042-bda6-2e208413c680_terseLabel_en-US" xlink:label="lab_sgmo_OtherLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other licensing agreements</link:label>
    <link:label id="lab_sgmo_OtherLicensingAgreementsMember_label_en-US" xlink:label="lab_sgmo_OtherLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Licensing Agreements [Member]</link:label>
    <link:label id="lab_sgmo_OtherLicensingAgreementsMember_documentation_en-US" xlink:label="lab_sgmo_OtherLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Licensing Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_OtherLicensingAgreementsMember" xlink:href="sgmo-20230930.xsd#sgmo_OtherLicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_OtherLicensingAgreementsMember" xlink:to="lab_sgmo_OtherLicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c19db977-15db-4fd4-92d3-3e4bc4db1ce3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_542000c3-e38f-45fa-828b-1dd4046b3c32_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_a906817d-7bcc-4584-b6db-f124a2714af5_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_9e592023-dbd7-407b-a1f4-92d7c3a18663_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_40df8702-6ba9-4d08-9eaa-3bd6197f18b7_negatedLabel_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in net loss</link:label>
    <link:label id="lab_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_label_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Net Income (Loss) Attributable To Parent</link:label>
    <link:label id="lab_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_documentation_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Net Income (Loss) Attributable To Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent" xlink:to="lab_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_94d23761-b10c-4d86-a4d7-7e67ad2f6a32_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement estimated reimbursable service costs</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Estimated Reimbursable Service Costs</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement estimated reimbursable service costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" xlink:to="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_6d778334-7c0f-4c6c-a8f1-df554dd7da09_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow disclosures:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_85e8e7f6-2a68-4e58-817f-378df24737fc_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_3f4277a2-3fce-4526-9716-460681e0c581_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AtTheMarketOfferingMember_f4245fa0-bd95-4901-9787-3e41ebe39c3e_terseLabel_en-US" xlink:label="lab_sgmo_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At the Market Offering</link:label>
    <link:label id="lab_sgmo_AtTheMarketOfferingMember_label_en-US" xlink:label="lab_sgmo_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At The Market Offering [Member]</link:label>
    <link:label id="lab_sgmo_AtTheMarketOfferingMember_documentation_en-US" xlink:label="lab_sgmo_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At The Market Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AtTheMarketOfferingMember" xlink:href="sgmo-20230930.xsd#sgmo_AtTheMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AtTheMarketOfferingMember" xlink:to="lab_sgmo_AtTheMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_03dd5d16-806a-40cc-be86-35622ab2af4f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment included in unpaid liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e220c9a0-4d16-42d3-a353-0c351a360b35_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_d99d9e5f-2128-4f0d-a44b-e3e5413e650a_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f6be8dd9-cf88-489f-9092-d550b9852002_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_5c8f2af6-cd5b-4890-801d-0ed6a2aa6b03_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease_9c6ec8c5-2d39-486a-a259-f5fe6dc92664_terseLabel_en-US" xlink:label="lab_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current marketable securities investments reclassified to current</link:label>
    <link:label id="lab_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease_label_en-US" xlink:label="lab_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Excluding Accrued Interest, Current, Increase (Decrease)</link:label>
    <link:label id="lab_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease_documentation_en-US" xlink:label="lab_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Excluding Accrued Interest, Current, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease" xlink:href="sgmo-20230930.xsd#sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease" xlink:to="lab_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentChargesTextBlock_63f1c4d4-c9da-40ee-8273-a55c81e84ce3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentChargesTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentChargesTextBlock" xlink:to="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CNineORFSevenTwoMember_e0a607de-19f2-4cb8-ab6a-4d82166ff7e6_terseLabel_en-US" xlink:label="lab_sgmo_CNineORFSevenTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C9ORF72</link:label>
    <link:label id="lab_sgmo_CNineORFSevenTwoMember_label_en-US" xlink:label="lab_sgmo_CNineORFSevenTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C Nine O R F Seven Two [Member]</link:label>
    <link:label id="lab_sgmo_CNineORFSevenTwoMember_documentation_en-US" xlink:label="lab_sgmo_CNineORFSevenTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C nine ORF seven two.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CNineORFSevenTwoMember" xlink:href="sgmo-20230930.xsd#sgmo_CNineORFSevenTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CNineORFSevenTwoMember" xlink:to="lab_sgmo_CNineORFSevenTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_421aa516-e043-4456-ac11-bbb292dba471_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_31b75b1a-6273-4b42-be61-7c659d937436_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseMember_5fde1587-4f11-4959-83ae-4fbad563ac48_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License</link:label>
    <link:label id="lab_us-gaap_LicenseMember_label_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember" xlink:to="lab_us-gaap_LicenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_27f40297-572e-43a5-94f8-1361b14c3096_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c5050c08-b1b8-41a2-8317-271bed70c32a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3dda4f60-cf5b-438a-97e8-441791ae8e27_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_db1ae5da-71df-42b1-98ec-a60248d7f4f6_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of products approved</link:label>
    <link:label id="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_label_en-US" xlink:label="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration And License Agreements Number Of Products Approved Under Agreement</link:label>
    <link:label id="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_documentation_en-US" xlink:label="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and license agreements number of products approved under agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" xlink:to="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_55d0040d-a466-448a-9833-253f9c888181_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0674051e-3cf3-4803-841a-7aab8735ede1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d58e610c-9989-4cd9-845f-55aab77c99cc_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_3ad9abf8-99e9-4dd1-a8e8-22156d040a9f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used [Line Items]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_af27fe74-aabf-4444-bb5b-6479e14def0c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_937bafe8-cecf-406e-b5d8-db055baa2f2a_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_c3d38285-54de-44e0-a591-f312efb9a1b9_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f6f3f38b-cabb-4d23-ac66-2febb4f5a6d2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a51d91f7-7eb5-4fb7-bcd8-dfb33ab25f5e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_74605ca5-011c-470b-8165-66afd366fb1d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bb47e69f-4232-4850-a223-c16b71818ff9_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_b803f110-f400-4f42-9092-ce79be0f601a_terseLabel_en-US" xlink:label="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent development and sales-based milestone payments to be received</link:label>
    <link:label id="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_label_en-US" xlink:label="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Development And Sales Based Milestone Payments To Be Received</link:label>
    <link:label id="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_documentation_en-US" xlink:label="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent development and sales based milestone payments to be received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" xlink:href="sgmo-20230930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" xlink:to="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_e6b87b80-e2be-4240-8b89-5ed39b9c7bcd_terseLabel_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified clinical development intellectual property and regulatory milestones</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_label_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Specified Clinical Development Intellectual Property And Regulatory Milestones [Member]</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_documentation_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified clinical development intellectual property and regulatory milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" xlink:to="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_LeaseholdImprovementsAndConstructionInProgressMember_25e8200f-1df5-4355-b005-656d15f1e417_terseLabel_en-US" xlink:label="lab_sgmo_LeaseholdImprovementsAndConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements and Construction-in-Progress</link:label>
    <link:label id="lab_sgmo_LeaseholdImprovementsAndConstructionInProgressMember_label_en-US" xlink:label="lab_sgmo_LeaseholdImprovementsAndConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements And Construction In Progress [Member]</link:label>
    <link:label id="lab_sgmo_LeaseholdImprovementsAndConstructionInProgressMember_documentation_en-US" xlink:label="lab_sgmo_LeaseholdImprovementsAndConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements And Construction In Progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_LeaseholdImprovementsAndConstructionInProgressMember" xlink:href="sgmo-20230930.xsd#sgmo_LeaseholdImprovementsAndConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_LeaseholdImprovementsAndConstructionInProgressMember" xlink:to="lab_sgmo_LeaseholdImprovementsAndConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_b627af49-a531-4baa-a3e4-8c453a6ee798_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government-sponsored entity debt securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government-sponsored Enterprises Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndOtherIncome_47aa8c39-da1c-4923-b153-1f305432d8af_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndOtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income, net</link:label>
    <link:label id="lab_us-gaap_InterestAndOtherIncome_label_en-US" xlink:label="lab_us-gaap_InterestAndOtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndOtherIncome" xlink:to="lab_us-gaap_InterestAndOtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_921e5862-22f5-4227-9293-11c3b0d41992_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded_2b16e777-d673-4212-adf1-bb23aaff7fee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss related to marketable securities, not previously recorded</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Not Previously Recorded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_e269585e-1fc8-47de-8f21-750c63272e56_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_f480c8e3-80d2-45e5-821e-cff7de184820_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e3fbc7bd-b572-48a7-b98b-0848e82d8183_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_7fbb15ff-9ad1-40d4-912d-e196a5dd5b35_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenues</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_bef096e7-2566-4d38-833b-92af4ce69e57_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_66596c39-c060-495e-9870-b8caf8c0120b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_b67c0704-71fc-473c-8bc3-dca9f030470e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_d2023454-366f-43ea-9c3c-f5c24c1f0450_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_18b35381-9b37-4779-8c55-dd2a45396d75_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_4ba49fd7-b9a8-401c-a05d-a44f350e7df2_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash equivalents and marketable securities</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6945c700-8403-4673-a913-cbf288cdbb61_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_bc6cb5ba-0275-4291-9316-0086a48afc8b_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration received on transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_18bc36a6-b952-4ac7-b18f-e7f8fa0fe53b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_1548f5fe-1639-4f1d-8ffe-49d992e15701_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivableCurrent_cd33278c-805a-4e4a-a461-f360b94b5322_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable</link:label>
    <link:label id="lab_us-gaap_InterestReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivableCurrent" xlink:to="lab_us-gaap_InterestReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dee00222-47e9-4904-a3e9-938cc975c5da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_608990ac-482b-47c5-a74c-74cf30e54573_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_3332ebeb-0d45-486a-9270-8eaa26047d78_terseLabel_en-US" xlink:label="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novartis Institutes for BioMedical Research, Inc.</link:label>
    <link:label id="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_label_en-US" xlink:label="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novartis Institutes For BioMedical Research Inc. [Member]</link:label>
    <link:label id="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_documentation_en-US" xlink:label="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novartis Institutes For BioMedical Research Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember" xlink:href="sgmo-20230930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember" xlink:to="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_315b4c72-30e0-4291-8c0f-883f0895a454_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4a08a8ac-a2cb-4fb9-8f70-eec223d15baf_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod_0b3c65c1-549e-4646-b131-9b7622b1bf64_terseLabel_en-US" xlink:label="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive severance plan, severance benefits, termination period</link:label>
    <link:label id="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod_label_en-US" xlink:label="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Severance Plan, Severance Benefits, Termination Period</link:label>
    <link:label id="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod_documentation_en-US" xlink:label="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Severance Plan, Severance Benefits, Termination Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod" xlink:href="sgmo-20230930.xsd#sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod" xlink:to="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6bd1e573-4012-4f27-b663-8edde1817471_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_30577cd4-dd28-48b2-bfda-184ef651af2d_verboseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_e6a1bb89-3f72-4944-b58a-cd36ac20d481_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional neurological disease gene targets (in product targets)</link:label>
    <link:label id="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_label_en-US" xlink:label="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Number Of Additional Product Targets</link:label>
    <link:label id="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_documentation_en-US" xlink:label="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Number Of Additional Product Targets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAgreementNumberOfAdditionalProductTargets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" xlink:to="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember_33688d39-c0c4-4b6b-939c-b907f4ebb719_terseLabel_en-US" xlink:label="lab_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approval Of Amended And Restated Executive Severance Plan</link:label>
    <link:label id="lab_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember_label_en-US" xlink:label="lab_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approval Of Amended And Restated Executive Severance Plan [Member]</link:label>
    <link:label id="lab_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember_documentation_en-US" xlink:label="lab_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approval Of Amended And Restated Executive Severance Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember" xlink:href="sgmo-20230930.xsd#sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember" xlink:to="lab_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_294f5662-f620-4a34-982c-59bde0e74cf4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable_ee31c530-044f-4d93-9073-3f2a86d8b902_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Accounting Estimate [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Accounting Estimate [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfChangeInAccountingEstimateTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:to="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_34b833fa-ace1-406c-a3d9-e47ffcb8e9b1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8fb003db-efea-41af-a341-cd444749f321_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_3522a5fb-eaed-4f2e-839c-571225971f9b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_960e73b1-b15f-4007-8188-ebeec01df524_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_2c3f70d7-7c40-4e55-a0e9-9f5d9a4c88bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0a9b5ed1-54db-4b86-8c82-40b77a6ebd70_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_849a5030-6fd5-4014-8745-b88875e5e59e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash adjustments</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_59f0880a-d8b5-43e9-b866-e0dc634a293b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_01c4f775-7273-4d83-b801-221764c56f75_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from contract with customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_e535c81d-03bb-4a65-ae45-57f2c7a36e97_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_ac4f4074-2c91-4cba-84ef-35168f7fbd8b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_f871850a-cc1e-4899-b6c7-a5ec175014d4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_f50fc0bd-9af6-4f98-983c-e64e34457283_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_FullTimeEmployeesMember_2e28ac6b-e8e5-4e52-bf5b-5b21a9359cf3_terseLabel_en-US" xlink:label="lab_sgmo_FullTimeEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Full-Time Employees</link:label>
    <link:label id="lab_sgmo_FullTimeEmployeesMember_label_en-US" xlink:label="lab_sgmo_FullTimeEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Full-Time Employees [Member]</link:label>
    <link:label id="lab_sgmo_FullTimeEmployeesMember_documentation_en-US" xlink:label="lab_sgmo_FullTimeEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Full-Time Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_FullTimeEmployeesMember" xlink:href="sgmo-20230930.xsd#sgmo_FullTimeEmployeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_FullTimeEmployeesMember" xlink:to="lab_sgmo_FullTimeEmployeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_277c0734-4697-4185-9d49-bbae7f8c5da8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1161b472-5c59-4c18-af36-56909e5f5f52_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a57de60d-9a2c-4d1a-9ed8-50573573ef9a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_65d8b238-9afd-4fba-92b6-1d296313ccbf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod_46c95bb4-59bb-45e8-b66b-fee8c0db054f_terseLabel_en-US" xlink:label="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive severance plan, severance benefits, lump sum, payment period</link:label>
    <link:label id="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod_label_en-US" xlink:label="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Severance Plan, Severance Benefits, Lump Sum, Payment Period</link:label>
    <link:label id="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod_documentation_en-US" xlink:label="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Severance Plan, Severance Benefits, Lump Sum, Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod" xlink:href="sgmo-20230930.xsd#sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod" xlink:to="lab_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_MilestoneRevenueReceivable_3c4d510a-1c22-423b-a746-b200d3c494fd_terseLabel_en-US" xlink:label="lab_sgmo_MilestoneRevenueReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone revenue receivable</link:label>
    <link:label id="lab_sgmo_MilestoneRevenueReceivable_label_en-US" xlink:label="lab_sgmo_MilestoneRevenueReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Revenue Receivable</link:label>
    <link:label id="lab_sgmo_MilestoneRevenueReceivable_documentation_en-US" xlink:label="lab_sgmo_MilestoneRevenueReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone&#8203; revenue receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneRevenueReceivable" xlink:href="sgmo-20230930.xsd#sgmo_MilestoneRevenueReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_MilestoneRevenueReceivable" xlink:to="lab_sgmo_MilestoneRevenueReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_cd0b5c8a-c751-4748-b91b-0b38e9e82d39_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial advisory fees</link:label>
    <link:label id="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_label_en-US" xlink:label="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement, Commission Fee, Portion Of Gross Proceeds, Value</link:label>
    <link:label id="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_documentation_en-US" xlink:label="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement, Commission Fee, Portion Of Gross Proceeds, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" xlink:to="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fc162bc5-6263-49ad-bd01-914bc60fe546_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in at-the-market offering, net of offering expenses (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AgreementTerminationTerm_17960238-e45d-44a3-8d89-71839cd9c33d_terseLabel_en-US" xlink:label="lab_sgmo_AgreementTerminationTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement termination, term</link:label>
    <link:label id="lab_sgmo_AgreementTerminationTerm_label_en-US" xlink:label="lab_sgmo_AgreementTerminationTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement Termination, Term</link:label>
    <link:label id="lab_sgmo_AgreementTerminationTerm_documentation_en-US" xlink:label="lab_sgmo_AgreementTerminationTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement Termination, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AgreementTerminationTerm" xlink:href="sgmo-20230930.xsd#sgmo_AgreementTerminationTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AgreementTerminationTerm" xlink:to="lab_sgmo_AgreementTerminationTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_dffbd818-9bc3-4b14-a046-bbf79f52461b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_2085ba7a-9e3c-4c3c-ac4d-3561b1f7df27_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_5bc0a253-ca69-4560-a4e6-8e33c60edece_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_c52c0df9-cb66-4355-9f47-5ab7c7516259_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, amortized cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_266cdcd5-f1eb-4001-9cd4-460374a840b2_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_499f1d8c-9c40-48fd-a11e-e11a74c0d3a8_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, estimated fair value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_a02b2e98-a0e3-475a-8c93-277be4342d7b_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_807eeddd-82eb-4377-a835-07f043e31ee7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_95912bc4-3ab6-4db0-8546-2d77eb4224e7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in at-the-market offering, net of offering expenses</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_1e18bc0f-9177-4885-8f41-53a1503ae3ea_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementLicenseFee_3e4277aa-dac3-499a-8eaf-75184933dc33_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementLicenseFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, license fee</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementLicenseFee_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementLicenseFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, License Fee</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementLicenseFee_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementLicenseFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, License Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementLicenseFee" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementLicenseFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementLicenseFee" xlink:to="lab_sgmo_CollaborativeArrangementLicenseFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_73093e9d-b0ac-40b5-ab6e-55b5447b71ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3723692b-6dad-4444-8135-e14f44efbe7d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fb3f0016-1fbf-4cec-b58a-861bfe76f3cd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_cd3ab22b-f8fd-4db5-ad1d-bde2ecc914f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount_93bd77fb-f084-47ce-a927-cd9ef5758f6c_verboseLabel_en-US" xlink:label="lab_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in deferred tax liabilities</link:label>
    <link:label id="lab_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount_label_en-US" xlink:label="lab_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Reduction In Deferred Tax Liabilities, Amount</link:label>
    <link:label id="lab_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount_documentation_en-US" xlink:label="lab_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Reduction In Deferred Tax Liabilities, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount" xlink:href="sgmo-20230930.xsd#sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount" xlink:to="lab_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AtTheMarketOfferingAgreementMember_93a28f4d-d900-4549-9bda-add41dbea7e1_terseLabel_en-US" xlink:label="lab_sgmo_AtTheMarketOfferingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Offering Agreement</link:label>
    <link:label id="lab_sgmo_AtTheMarketOfferingAgreementMember_label_en-US" xlink:label="lab_sgmo_AtTheMarketOfferingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At The Market Offering Agreement [Member]</link:label>
    <link:label id="lab_sgmo_AtTheMarketOfferingAgreementMember_documentation_en-US" xlink:label="lab_sgmo_AtTheMarketOfferingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At the market offering agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AtTheMarketOfferingAgreementMember" xlink:href="sgmo-20230930.xsd#sgmo_AtTheMarketOfferingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AtTheMarketOfferingAgreementMember" xlink:to="lab_sgmo_AtTheMarketOfferingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e373750c-1284-4081-8c47-9c5380a5770b_verboseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_3d47ea54-684f-4466-969f-44ca63c875cc_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues under agreement</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Compensation Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_6c624256-9fc1-4f96-92ad-00e4855accec_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationAndLicenseAgreementMember_bd1ebd99-bdc7-4ffb-ac16-04364c4e6126_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationAndLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration And License Agreement</link:label>
    <link:label id="lab_sgmo_CollaborationAndLicenseAgreementMember_label_en-US" xlink:label="lab_sgmo_CollaborationAndLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration And License Agreement [Member]</link:label>
    <link:label id="lab_sgmo_CollaborationAndLicenseAgreementMember_documentation_en-US" xlink:label="lab_sgmo_CollaborationAndLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and license agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationAndLicenseAgreementMember" xlink:to="lab_sgmo_CollaborationAndLicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_681d9359-4f39-4062-96e5-353a7b4f4542_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ad226a66-5ec1-4f2c-95a9-6a54059b5d0b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_IncreaseDecreaseInEarningsPerShareBasic_5e4da015-61bf-4045-8e7a-fd4705c5e579_negatedLabel_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decreased net loss per share, basic (in dollars per share)</link:label>
    <link:label id="lab_sgmo_IncreaseDecreaseInEarningsPerShareBasic_293d93fd-9185-4d51-b0f9-102aa29a8590_verboseLabel_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased earnings per share, basic (in dollars per share)</link:label>
    <link:label id="lab_sgmo_IncreaseDecreaseInEarningsPerShareBasic_label_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Earnings Per Share, Basic</link:label>
    <link:label id="lab_sgmo_IncreaseDecreaseInEarningsPerShareBasic_documentation_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInEarningsPerShareBasic" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_IncreaseDecreaseInEarningsPerShareBasic" xlink:to="lab_sgmo_IncreaseDecreaseInEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3ccc886e-88c5-401a-a73f-360cb555ecde_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2fdad536-b814-486e-aa81-dc1599f8ee52_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, amortized cost</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_f61ded1a-7478-44ef-b5b9-f0ee2f5b1def_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_06974657-946a-4124-9749-9f47f1afd4bf_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_cb5c6347-bde5-4fd3-87f7-731e36be707d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturing in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_ddb4659f-186a-4845-9f22-adbeb726e611_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_8d237f67-4cc9-462b-a504-8627ff4ab4fb_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_2734a5f3-e6d4-445b-acba-bf30adf5e3f2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_eba5af82-23a6-4a02-b992-b0c0c9339f68_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_78d24876-080d-4eb8-b03c-1940821aa9c5_verboseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e02640ed-2c85-4023-b831-a630a78d3c46_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing diluted net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateLineItems_8b0763ed-da37-4541-a0b5-dd7efe66231d_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate [Line Items]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateLineItems_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="lab_us-gaap_ChangeInAccountingEstimateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementResearchServiceFees_68d1d8ed-2f3e-4886-b636-474be8a75a44_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementResearchServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research service fees</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementResearchServiceFees_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementResearchServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Research Service Fees</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementResearchServiceFees_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementResearchServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Research Service Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementResearchServiceFees" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementResearchServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementResearchServiceFees" xlink:to="lab_sgmo_CollaborativeArrangementResearchServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_589e2825-20bb-408d-90ae-7e7561408214_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_34921323-0687-409c-8040-dafef0a89b65_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_StockOfferingProgramMaximumValue_58eebf36-fb2c-4197-b43a-cc39e8b28cba_terseLabel_en-US" xlink:label="lab_sgmo_StockOfferingProgramMaximumValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock offering program, maximum value</link:label>
    <link:label id="lab_sgmo_StockOfferingProgramMaximumValue_label_en-US" xlink:label="lab_sgmo_StockOfferingProgramMaximumValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Offering Program, Maximum Value</link:label>
    <link:label id="lab_sgmo_StockOfferingProgramMaximumValue_documentation_en-US" xlink:label="lab_sgmo_StockOfferingProgramMaximumValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Offering Program, Maximum Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_StockOfferingProgramMaximumValue" xlink:href="sgmo-20230930.xsd#sgmo_StockOfferingProgramMaximumValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_StockOfferingProgramMaximumValue" xlink:to="lab_sgmo_StockOfferingProgramMaximumValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_a418433e-b4ab-4d5e-b39a-c304ea613d7f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_56a085cc-7dbd-4387-a1fe-1d130450cc56_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_MilestonePaymentsReceived_dfc86405-16ae-4051-98ec-c7b78e7c717e_terseLabel_en-US" xlink:label="lab_sgmo_MilestonePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments received</link:label>
    <link:label id="lab_sgmo_MilestonePaymentsReceived_label_en-US" xlink:label="lab_sgmo_MilestonePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments Received</link:label>
    <link:label id="lab_sgmo_MilestonePaymentsReceived_documentation_en-US" xlink:label="lab_sgmo_MilestonePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestonePaymentsReceived" xlink:href="sgmo-20230930.xsd#sgmo_MilestonePaymentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_MilestonePaymentsReceived" xlink:to="lab_sgmo_MilestonePaymentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_95decd73-1ccd-466a-baf2-5e43e9346844_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_f2813fb0-7c4a-4772-bd29-1c4d454f16cd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1b96e146-6d25-402d-b477-b49501077dc7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_03fa1087-bdeb-4515-b3fe-32525cc0b566_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_626d9d3c-75f4-4c73-8132-1cb0134727ad_terseLabel_en-US" xlink:label="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and sales-based milestone payments to be received</link:label>
    <link:label id="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_label_en-US" xlink:label="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contract Liability Milestone Payment Eligible To Receive</link:label>
    <link:label id="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_documentation_en-US" xlink:label="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contract liability milestone payment eligible to receive.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" xlink:href="sgmo-20230930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" xlink:to="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ba3af84a-910b-4de7-90ef-0cb454a85290_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_5ba2cc09-5423-4c4d-917d-0f0eb3acad81_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_91ca99aa-d1e8-4b47-84dc-180d58c9d1a8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty_34d2df49-6705-499b-8736-06fdcb70ce1c_terseLabel_en-US" xlink:label="lab_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net sales per developed licensed product which will trigger royalties by counterparty</link:label>
    <link:label id="lab_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty_label_en-US" xlink:label="lab_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Eligible Royalties, Triggered By Percentage Of Net Sales Per Developed Licensed Product By Counterparty</link:label>
    <link:label id="lab_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty_documentation_en-US" xlink:label="lab_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Eligible Royalties, Triggered By Percentage Of Net Sales Per Developed Licensed Product By Counterparty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty" xlink:href="sgmo-20230930.xsd#sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty" xlink:to="lab_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationAgreementEquityIssued_2e9572a5-2fda-4193-8e2d-65986b411bfa_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationAgreementEquityIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, equity issued</link:label>
    <link:label id="lab_sgmo_CollaborationAgreementEquityIssued_label_en-US" xlink:label="lab_sgmo_CollaborationAgreementEquityIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Equity Issued</link:label>
    <link:label id="lab_sgmo_CollaborationAgreementEquityIssued_documentation_en-US" xlink:label="lab_sgmo_CollaborationAgreementEquityIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Equity Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementEquityIssued" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAgreementEquityIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationAgreementEquityIssued" xlink:to="lab_sgmo_CollaborationAgreementEquityIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_ca289025-cc2d-4525-b5f0-5e69dc2fbff6_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6cd4dc90-8890-497e-b692-8731ae9c0e30_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_53854cbd-bf64-4dd5-aa25-2b752843463e_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_fe175929-91cc-4ce3-8e36-c950b12471b1_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_52974ff7-2654-4bb9-b0ea-a806c5b5278a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_0c835546-e038-4962-a8d5-e39898889288_terseLabel_en-US" xlink:label="lab_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed consideration</link:label>
    <link:label id="lab_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_label_en-US" xlink:label="lab_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Fixed Consideration Amount</link:label>
    <link:label id="lab_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_documentation_en-US" xlink:label="lab_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Fixed Consideration Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount" xlink:to="lab_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_d9397bf4-a5d4-4f04-b2d1-ee72ee634e01_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fdf90f34-48ee-4629-9447-aad972041c4b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_8b460544-4c3b-4ee3-aaca-fd8aeca875a2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value on recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_e86c31f3-e26a-4be2-8953-79f83422379d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment on right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_eaf62820-79cc-4872-8fb8-0f99d3a73e3b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_5e96d78d-62dc-4997-aeec-895a9fb8af4d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_f4e05a67-624e-4fd3-8532-5781458162ad_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_5b0d28ba-2509-4f53-902a-143485a54263_terseLabel_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash equivalents and marketable securities, gross unrealized gains</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents And Available For Sale Securities Gross Unrealized Gain Before Tax</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents and available for sale securities, gross unrealized gain, before tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" xlink:to="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsMember_bededf4a-c211-4d4c-ac3f-999a00e34511_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsMember" xlink:to="lab_us-gaap_CashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_a78f7b36-9842-4a32-b9b2-7bd2862e7062_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_1effd3a2-3bda-4204-8ca2-df7e9785d833_negatedTerseLabel_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decreased net loss per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_de925261-2427-4fd3-b3b6-4a6e3f3057cf_terseLabel_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased earnings per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_label_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Earnings Per Share, Diluted</link:label>
    <link:label id="lab_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_documentation_en-US" xlink:label="lab_sgmo_IncreaseDecreaseInEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInEarningsPerShareDiluted" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_IncreaseDecreaseInEarningsPerShareDiluted" xlink:to="lab_sgmo_IncreaseDecreaseInEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_f4e2fe82-6feb-4f53-9212-dc8f31588ccd_terseLabel_en-US" xlink:label="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, excess consideration received on transaction</link:label>
    <link:label id="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Excess Consideration Received on Transaction</link:label>
    <link:label id="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_documentation_en-US" xlink:label="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Excess Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" xlink:href="sgmo-20230930.xsd#sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" xlink:to="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_SBFiveTwoFiveMember_adb4a791-033f-4f63-99a0-7f6828aff3af_terseLabel_en-US" xlink:label="lab_sgmo_SBFiveTwoFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">S B Five Two Five</link:label>
    <link:label id="lab_sgmo_SBFiveTwoFiveMember_label_en-US" xlink:label="lab_sgmo_SBFiveTwoFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">S B Five Two Five [Member]</link:label>
    <link:label id="lab_sgmo_SBFiveTwoFiveMember_documentation_en-US" xlink:label="lab_sgmo_SBFiveTwoFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">S B Five Two Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SBFiveTwoFiveMember" xlink:href="sgmo-20230930.xsd#sgmo_SBFiveTwoFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_SBFiveTwoFiveMember" xlink:to="lab_sgmo_SBFiveTwoFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0c7c2fee-ccb7-4383-ba05-72303d328aa8_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_99ab6c77-9d5c-4edc-a4d1-8a116b53aaf4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_b3de321f-e2a6-4e16-ac6a-1536967fe96d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_20bb44c7-812f-42d8-bf43-6102245963be_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_8047fbcb-34e1-4a47-9c6c-e348bdb0600b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_9651500c-b8aa-4656-aa0d-e46da38c8305_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of goodwill and indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_65bcbe34-37fe-4d58-a306-93f0cb681dd6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_33038c67-3cf3-4c2c-871d-ee1973e2daff_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative catch-up to expense</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" xlink:to="lab_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_BiogenMAIncMember_242b3ae5-7b59-41bb-88bd-54ad82612075_terseLabel_en-US" xlink:label="lab_sgmo_BiogenMAIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biogen MA, Inc.</link:label>
    <link:label id="lab_sgmo_BiogenMAIncMember_label_en-US" xlink:label="lab_sgmo_BiogenMAIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biogen MA, Inc. [Member]</link:label>
    <link:label id="lab_sgmo_BiogenMAIncMember_documentation_en-US" xlink:label="lab_sgmo_BiogenMAIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biogen MA, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember" xlink:href="sgmo-20230930.xsd#sgmo_BiogenMAIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_BiogenMAIncMember" xlink:to="lab_sgmo_BiogenMAIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_c71dd956-d1b0-417c-8b48-a7912219af86_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, asset, after allowance for credit Loss</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f07c4b0c-6c2f-4ce4-b374-d42c201215c8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing basic net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_SeparateUpfrontFee_3f50255c-33b5-4fb6-aeb1-09afbeb5fc61_terseLabel_en-US" xlink:label="lab_sgmo_SeparateUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate fee for additional term</link:label>
    <link:label id="lab_sgmo_SeparateUpfrontFee_label_en-US" xlink:label="lab_sgmo_SeparateUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Upfront Fee</link:label>
    <link:label id="lab_sgmo_SeparateUpfrontFee_documentation_en-US" xlink:label="lab_sgmo_SeparateUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate upfront fee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SeparateUpfrontFee" xlink:href="sgmo-20230930.xsd#sgmo_SeparateUpfrontFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_SeparateUpfrontFee" xlink:to="lab_sgmo_SeparateUpfrontFee" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_271c620c-3338-44e0-a6f7-0de45c3ded7e_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_dde1e931-a7b3-4208-bc01-b04d551b3546_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c724e0ef-e8e0-4962-bfaf-4044ef9241a6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_2ee0d4be-356a-4971-a940-9266c8bec9c3_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod_ac743a52-9dd1-42d6-9591-5fa8dd54eda8_terseLabel_en-US" xlink:label="lab_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal period</link:label>
    <link:label id="lab_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod_label_en-US" xlink:label="lab_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Renewal Period</link:label>
    <link:label id="lab_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod_documentation_en-US" xlink:label="lab_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Renewal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationRenewalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod" xlink:to="lab_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock_2c426cc1-a530-4693-adc6-8367fe34905f_terseLabel_en-US" xlink:label="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from Strategic Partnering Collaboration Agreements and Research Activity Grants as a Percentage of Total Revenues</link:label>
    <link:label id="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock_label_en-US" xlink:label="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Revenue From Strategic Partnering Collaboration Agreements And Research Activity Grants As A Percentage Of Total Revenues [Table Text Block]</link:label>
    <link:label id="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock_documentation_en-US" xlink:label="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Revenue From Strategic Partnering Collaboration Agreements And Research Activity Grants As A Percentage Of Total Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" xlink:href="sgmo-20230930.xsd#sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" xlink:to="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_66631f9a-5b7f-43e3-8ce4-f12c4488dfa3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_ceb58585-7a2e-4369-8605-a61bb9c538a5_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_51f4743b-6b8a-40e2-a67c-c7cb4683d692_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4daa1165-627d-459b-9efe-a55c4050e97f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_afecd363-15ee-4dd5-ba2d-e588206b4bf1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_97693acc-e1d3-4c6f-a39e-b769f543e7ff_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue related to Sanofi agreement:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d96e450f-a578-4ca1-a33e-489dbe37ad95_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0b701023-0ef1-4ad6-b2b1-16296bdd5bc3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_f8af2ad2-53c7-456b-80e1-95a81831ede7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_2a372a14-232a-41b3-9f50-811c53413e0c_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital resources</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_69c090d1-3b15-47ac-85dd-3b4f397682aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_55901b08-99b3-4ff9-9d2a-a29d92a0b289_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenues, non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability_cfe2960f-db6f-4168-9e56-d69e29a29bce_terseLabel_en-US" xlink:label="lab_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant improvement allowance included in contra-lease liability</link:label>
    <link:label id="lab_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability_label_en-US" xlink:label="lab_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant Improvement, Allowance Within Contra Lease Liability</link:label>
    <link:label id="lab_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability_documentation_en-US" xlink:label="lab_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant Improvement, Allowance Within Contra Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability" xlink:href="sgmo-20230930.xsd#sgmo_TenantImprovementAllowanceWithinContraLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability" xlink:to="lab_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_4e4e2f8c-a0ce-454c-88f5-09c083fc645d_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_8ff87ab3-c130-4bee-acec-4cb9f4bd89cb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_a1c7b53b-daa2-4f70-81ba-342f165d5df3_terseLabel_en-US" xlink:label="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, gross unrealized gains</link:label>
    <link:label id="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax</link:label>
    <link:label id="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents accumulated gross unrealized gain before tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="sgmo-20230930.xsd#sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment_e42d2d3d-c742-4dc8-ad12-7468c461f092_terseLabel_en-US" xlink:label="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum amount of achieved milestones to receive payment</link:label>
    <link:label id="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment_label_en-US" xlink:label="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Development And Sales Based Milestone Payments, Maximum Amount Of Achieved Milestones To Be Eligible For Payment</link:label>
    <link:label id="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment_documentation_en-US" xlink:label="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Development And Sales Based Milestone Payments, Maximum Amount Of Achieved Milestones To Be Eligible For Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment" xlink:href="sgmo-20230930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment" xlink:to="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_cbd87413-a4a9-49d7-b05f-ec3150576db1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_aaa2af35-d198-405e-a713-c41f7c15f619_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_93c8d4bc-338a-4920-af34-9da58f61c9e4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ExtendedResearchTermOfAgreement_0922dd60-da2c-4a7e-a33d-bccdd162d054_terseLabel_en-US" xlink:label="lab_sgmo_ExtendedResearchTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended research term of agreement</link:label>
    <link:label id="lab_sgmo_ExtendedResearchTermOfAgreement_label_en-US" xlink:label="lab_sgmo_ExtendedResearchTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Research Term Of Agreement</link:label>
    <link:label id="lab_sgmo_ExtendedResearchTermOfAgreement_documentation_en-US" xlink:label="lab_sgmo_ExtendedResearchTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Research Term Of Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExtendedResearchTermOfAgreement" xlink:href="sgmo-20230930.xsd#sgmo_ExtendedResearchTermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ExtendedResearchTermOfAgreement" xlink:to="lab_sgmo_ExtendedResearchTermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6b0d068-b236-4879-87a3-e6067d8b2d96_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_d9ad417a-68c2-4377-a2f1-a4f958f0b900_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_cb99cde1-5719-4b78-abe4-bb2d11540f1e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm_9bd08ef7-53cd-4839-b083-8552867a239f_terseLabel_en-US" xlink:label="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options to extend initial research term</link:label>
    <link:label id="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm_label_en-US" xlink:label="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Options To Extend Initial Research Term</link:label>
    <link:label id="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm_documentation_en-US" xlink:label="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Options To Extend Initial Research Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm" xlink:href="sgmo-20230930.xsd#sgmo_NumberOfOptionsToExtendInitialResearchTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm" xlink:to="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_d3ec3a36-95d9-467e-9f0c-19cb12d3a5f0_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_e74d0ecb-738f-44de-886a-bd5f12c06425_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_bd8c58a7-4af6-41f4-9fc3-82276c98246b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition_1ff48597-7a32-4a36-bebe-f0a168d54c05_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of initial recognition</link:label>
    <link:label id="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition_label_en-US" xlink:label="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement, Percent Of Initial Recognition</link:label>
    <link:label id="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition_documentation_en-US" xlink:label="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement, Percent Of Initial Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeAgreementPercentOfInitialRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition" xlink:to="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_896693c5-6c4c-4786-8bf1-5c6e0110513b_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_bed5bccc-bd97-4947-9db4-b40426541870_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_902da0f3-293d-46f0-aea5-8a5ba3c41bcd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss related to marketable securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0827faf9-5915-4b42-a01f-f1593f912e67_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturing after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d439bec-2b3a-46d6-a4d6-1257c52e2361_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>sgmo-20230930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:66e428df-1cd2-4a45-95e8-7711e67a648c,g:c0e019b1-92dd-475a-ba81-4eb41606269d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sangamo.com/role/Cover" xlink:type="simple" xlink:href="sgmo-20230930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_86b7574a-7fff-4351-9a19-9eb6dc7b18fb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_DocumentType_86b7574a-7fff-4351-9a19-9eb6dc7b18fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_2ab16f4e-4468-4822-a957-6f8dd2c060ac" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_DocumentQuarterlyReport_2ab16f4e-4468-4822-a957-6f8dd2c060ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a9549ca6-b1fa-4650-85c5-b5df623a02af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_DocumentPeriodEndDate_a9549ca6-b1fa-4650-85c5-b5df623a02af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_085e8c83-7cc0-4141-a471-963b7ec1c164" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_DocumentTransitionReport_085e8c83-7cc0-4141-a471-963b7ec1c164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ebc2ac99-10bb-40b9-974f-376d4448ad48" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityFileNumber_ebc2ac99-10bb-40b9-974f-376d4448ad48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_37e3d79e-5c41-4c64-95b9-094590950c72" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityRegistrantName_37e3d79e-5c41-4c64-95b9-094590950c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c6382f08-f0a1-4dec-a0fe-a91f34fd53cd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c6382f08-f0a1-4dec-a0fe-a91f34fd53cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e7548695-9f1c-45c8-adc3-90b37cbdeba5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityTaxIdentificationNumber_e7548695-9f1c-45c8-adc3-90b37cbdeba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_423385f1-7b85-4620-ac9b-f27142cd8ee8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityAddressAddressLine1_423385f1-7b85-4620-ac9b-f27142cd8ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6c9f4819-b1d5-4bcb-bec0-93a05b9ed6ff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityAddressCityOrTown_6c9f4819-b1d5-4bcb-bec0-93a05b9ed6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2f3ff0ec-e9fa-4487-9d5f-5f2de7c908bf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityAddressStateOrProvince_2f3ff0ec-e9fa-4487-9d5f-5f2de7c908bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_dcde192d-3902-48cb-8eca-c03d218b7061" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityAddressPostalZipCode_dcde192d-3902-48cb-8eca-c03d218b7061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3562e4a1-b7bd-4278-a2d8-44ede9417600" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_CityAreaCode_3562e4a1-b7bd-4278-a2d8-44ede9417600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4378b21a-d38c-45c4-9f4a-2120d127d489" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_LocalPhoneNumber_4378b21a-d38c-45c4-9f4a-2120d127d489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_28f15113-9cfc-4ce9-a5c0-68e1dab6af1e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_Security12bTitle_28f15113-9cfc-4ce9-a5c0-68e1dab6af1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_655104a9-adaf-46e3-b790-2af9bc83d4c2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_TradingSymbol_655104a9-adaf-46e3-b790-2af9bc83d4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_41f2ac39-a325-4119-9b14-fcce3221fc6b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_SecurityExchangeName_41f2ac39-a325-4119-9b14-fcce3221fc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c818b410-c272-4a70-90c9-ca9027b28cfb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityCurrentReportingStatus_c818b410-c272-4a70-90c9-ca9027b28cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b66259b6-8be8-4616-a4bd-6b4a7981ddfb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityInteractiveDataCurrent_b66259b6-8be8-4616-a4bd-6b4a7981ddfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_414d5822-8a88-4cfe-af10-4c794853df55" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityFilerCategory_414d5822-8a88-4cfe-af10-4c794853df55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_72cac73b-7019-41f9-b1b6-a4f1aac7d48e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntitySmallBusiness_72cac73b-7019-41f9-b1b6-a4f1aac7d48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_086b17a6-7ada-4e4a-b4e4-08c3c36a7c49" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityEmergingGrowthCompany_086b17a6-7ada-4e4a-b4e4-08c3c36a7c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e2cd0fc6-2233-4926-bf3f-e054382102a9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityShellCompany_e2cd0fc6-2233-4926-bf3f-e054382102a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9e511bb9-1e13-4c58-8182-6bfacad68369" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9e511bb9-1e13-4c58-8182-6bfacad68369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_992d9572-b02c-4a57-b900-f6f3d90da4c9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_AmendmentFlag_992d9572-b02c-4a57-b900-f6f3d90da4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_34e84dc9-d5b0-4788-8a30-b886c441e4d0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_DocumentFiscalYearFocus_34e84dc9-d5b0-4788-8a30-b886c441e4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_5de09cc4-930f-46fa-8300-a011a7452743" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_DocumentFiscalPeriodFocus_5de09cc4-930f-46fa-8300-a011a7452743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_79db4361-8fc0-4c4e-9570-eabafe74497b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_EntityCentralIndexKey_79db4361-8fc0-4c4e-9570-eabafe74497b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_088a6d17-c8b9-4ff6-a2be-6cc32af9dcd6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6b613534-afc6-4bd8-ab15-af9f57e66467" xlink:to="loc_dei_CurrentFiscalYearEndDate_088a6d17-c8b9-4ff6-a2be-6cc32af9dcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ae0b5a69-77bb-4c6d-bdbd-ec933e4580b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ffb6eca5-b9e9-4657-8c37-90aa613d9b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ae0b5a69-77bb-4c6d-bdbd-ec933e4580b5" xlink:to="loc_us-gaap_AssetsAbstract_ffb6eca5-b9e9-4657-8c37-90aa613d9b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_b10d178b-752d-4a89-afc2-bb1c40ba83d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffb6eca5-b9e9-4657-8c37-90aa613d9b93" xlink:to="loc_us-gaap_AssetsCurrentAbstract_b10d178b-752d-4a89-afc2-bb1c40ba83d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2662a3a3-d2e1-4709-9260-1c9cb67ab0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b10d178b-752d-4a89-afc2-bb1c40ba83d0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2662a3a3-d2e1-4709-9260-1c9cb67ab0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_eceac758-fda1-4d79-9e72-64720cfb64f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b10d178b-752d-4a89-afc2-bb1c40ba83d0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_eceac758-fda1-4d79-9e72-64720cfb64f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent_540d918f-667c-4a69-9ca6-14d52251c395" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b10d178b-752d-4a89-afc2-bb1c40ba83d0" xlink:to="loc_us-gaap_InterestReceivableCurrent_540d918f-667c-4a69-9ca6-14d52251c395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_eaf1f26e-8342-4a67-aef3-aacaff0b0dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b10d178b-752d-4a89-afc2-bb1c40ba83d0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_eaf1f26e-8342-4a67-aef3-aacaff0b0dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b854d1b2-3db1-4729-9664-6723b00f3dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b10d178b-752d-4a89-afc2-bb1c40ba83d0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b854d1b2-3db1-4729-9664-6723b00f3dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b0a85b8b-3419-4b12-8538-cc43401a1286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b10d178b-752d-4a89-afc2-bb1c40ba83d0" xlink:to="loc_us-gaap_AssetsCurrent_b0a85b8b-3419-4b12-8538-cc43401a1286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_8b62ec8d-7ec4-4c11-8212-0f929512d046" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffb6eca5-b9e9-4657-8c37-90aa613d9b93" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_8b62ec8d-7ec4-4c11-8212-0f929512d046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_dfd4e6d6-7e63-4f3a-af0a-c18df7d6b468" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffb6eca5-b9e9-4657-8c37-90aa613d9b93" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_dfd4e6d6-7e63-4f3a-af0a-c18df7d6b468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c9d6071b-e67d-4e06-8d6a-20eab5e73ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffb6eca5-b9e9-4657-8c37-90aa613d9b93" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c9d6071b-e67d-4e06-8d6a-20eab5e73ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3659040d-5ef9-4c47-a219-4494b3d456aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffb6eca5-b9e9-4657-8c37-90aa613d9b93" xlink:to="loc_us-gaap_Goodwill_3659040d-5ef9-4c47-a219-4494b3d456aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_cdb7c6ec-54dd-4a53-b44f-01d1db68e941" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffb6eca5-b9e9-4657-8c37-90aa613d9b93" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_cdb7c6ec-54dd-4a53-b44f-01d1db68e941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c11fdae7-500b-40ee-9113-b787b5fed9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffb6eca5-b9e9-4657-8c37-90aa613d9b93" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c11fdae7-500b-40ee-9113-b787b5fed9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_6c2f0421-a2d4-4784-b4a4-7817f1c8cac7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffb6eca5-b9e9-4657-8c37-90aa613d9b93" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_6c2f0421-a2d4-4784-b4a4-7817f1c8cac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f8e52e71-99f3-474c-a043-062c650bf093" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ffb6eca5-b9e9-4657-8c37-90aa613d9b93" xlink:to="loc_us-gaap_Assets_f8e52e71-99f3-474c-a043-062c650bf093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7248f4e8-3b83-4e45-94c1-efd909280f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ae0b5a69-77bb-4c6d-bdbd-ec933e4580b5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7248f4e8-3b83-4e45-94c1-efd909280f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_6f1740cf-cb39-4a7e-bc22-aa2de4ac5760" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7248f4e8-3b83-4e45-94c1-efd909280f3c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_6f1740cf-cb39-4a7e-bc22-aa2de4ac5760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_881b41be-863a-4476-9ec3-e9456fe59d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6f1740cf-cb39-4a7e-bc22-aa2de4ac5760" xlink:to="loc_us-gaap_AccountsPayableCurrent_881b41be-863a-4476-9ec3-e9456fe59d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_227c1d04-e09d-42ac-afdc-043e2cce6c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6f1740cf-cb39-4a7e-bc22-aa2de4ac5760" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_227c1d04-e09d-42ac-afdc-043e2cce6c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_eef8847f-6c6d-469f-bf88-8eb9fcf9874d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6f1740cf-cb39-4a7e-bc22-aa2de4ac5760" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_eef8847f-6c6d-469f-bf88-8eb9fcf9874d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_649cca40-b1bd-458e-93f3-8aafcc9bb41c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6f1740cf-cb39-4a7e-bc22-aa2de4ac5760" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_649cca40-b1bd-458e-93f3-8aafcc9bb41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8fe22303-9780-43aa-9d6e-7de5d479f6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6f1740cf-cb39-4a7e-bc22-aa2de4ac5760" xlink:to="loc_us-gaap_LiabilitiesCurrent_8fe22303-9780-43aa-9d6e-7de5d479f6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_2ada53bc-d823-48ae-a251-9e697fcf35a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7248f4e8-3b83-4e45-94c1-efd909280f3c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_2ada53bc-d823-48ae-a251-9e697fcf35a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_67948ade-dd6d-4ab9-baa5-2c355eb40e81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7248f4e8-3b83-4e45-94c1-efd909280f3c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_67948ade-dd6d-4ab9-baa5-2c355eb40e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f61314ea-4fe8-4f56-9d7b-4aad04fda664" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7248f4e8-3b83-4e45-94c1-efd909280f3c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f61314ea-4fe8-4f56-9d7b-4aad04fda664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_17e5be3a-3bef-42b4-a88f-573e0e8b610d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7248f4e8-3b83-4e45-94c1-efd909280f3c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_17e5be3a-3bef-42b4-a88f-573e0e8b610d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9171baa6-757d-476f-82c3-0e590ea89fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7248f4e8-3b83-4e45-94c1-efd909280f3c" xlink:to="loc_us-gaap_Liabilities_9171baa6-757d-476f-82c3-0e590ea89fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b21582ca-637a-4c1b-a34d-5fb75a12c038" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7248f4e8-3b83-4e45-94c1-efd909280f3c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b21582ca-637a-4c1b-a34d-5fb75a12c038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_54e16308-9e78-40ae-9c26-3c2b1bc30c06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7248f4e8-3b83-4e45-94c1-efd909280f3c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_54e16308-9e78-40ae-9c26-3c2b1bc30c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f7b9cbf6-e423-4759-917a-72a67de831ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_54e16308-9e78-40ae-9c26-3c2b1bc30c06" xlink:to="loc_us-gaap_PreferredStockValue_f7b9cbf6-e423-4759-917a-72a67de831ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4ca72984-360b-48d6-affa-de920a27782c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_54e16308-9e78-40ae-9c26-3c2b1bc30c06" xlink:to="loc_us-gaap_CommonStockValue_4ca72984-360b-48d6-affa-de920a27782c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a75fbeaf-0870-4bd7-acc8-dd5fa524445e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_54e16308-9e78-40ae-9c26-3c2b1bc30c06" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a75fbeaf-0870-4bd7-acc8-dd5fa524445e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3c0531eb-f35b-4d92-aa33-696806bbed67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_54e16308-9e78-40ae-9c26-3c2b1bc30c06" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3c0531eb-f35b-4d92-aa33-696806bbed67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b2b56925-c434-49e1-a369-2d521a01902e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_54e16308-9e78-40ae-9c26-3c2b1bc30c06" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b2b56925-c434-49e1-a369-2d521a01902e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_886fda55-2360-411e-887e-b54a7ffd1177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_54e16308-9e78-40ae-9c26-3c2b1bc30c06" xlink:to="loc_us-gaap_StockholdersEquity_886fda55-2360-411e-887e-b54a7ffd1177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_995a2d5d-b533-483d-83ab-8f3a5f7ff5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7248f4e8-3b83-4e45-94c1-efd909280f3c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_995a2d5d-b533-483d-83ab-8f3a5f7ff5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_915a10e2-c44a-4c5e-8cae-27c4a852acff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_d047c3ca-d7df-45de-9c0c-9a80b66f0e98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_915a10e2-c44a-4c5e-8cae-27c4a852acff" xlink:to="loc_us-gaap_RevenuesAbstract_d047c3ca-d7df-45de-9c0c-9a80b66f0e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e0bc6a9e-2ee3-4543-b5c1-2190698dab6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d047c3ca-d7df-45de-9c0c-9a80b66f0e98" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e0bc6a9e-2ee3-4543-b5c1-2190698dab6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_632390ba-b167-4590-bb9c-45bfe2590832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_915a10e2-c44a-4c5e-8cae-27c4a852acff" xlink:to="loc_us-gaap_OperatingExpensesAbstract_632390ba-b167-4590-bb9c-45bfe2590832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e9c359e1-80c6-4ef4-8f8d-2bbe01834e66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_632390ba-b167-4590-bb9c-45bfe2590832" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e9c359e1-80c6-4ef4-8f8d-2bbe01834e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ff761ac1-4967-4be4-b51d-971104199798" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_632390ba-b167-4590-bb9c-45bfe2590832" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ff761ac1-4967-4be4-b51d-971104199798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ce5a2900-d16c-47de-8b99-02f8568eaa13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_632390ba-b167-4590-bb9c-45bfe2590832" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ce5a2900-d16c-47de-8b99-02f8568eaa13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_9a7e0ae4-53f0-4924-af81-c61f4db0c366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_632390ba-b167-4590-bb9c-45bfe2590832" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_9a7e0ae4-53f0-4924-af81-c61f4db0c366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d457ceee-d771-4f6d-ae8d-d0277932cf88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_632390ba-b167-4590-bb9c-45bfe2590832" xlink:to="loc_us-gaap_OperatingExpenses_d457ceee-d771-4f6d-ae8d-d0277932cf88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c998eea6-4e62-4bcf-b0d6-3021e3c3083e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_915a10e2-c44a-4c5e-8cae-27c4a852acff" xlink:to="loc_us-gaap_OperatingIncomeLoss_c998eea6-4e62-4bcf-b0d6-3021e3c3083e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_247d83a7-f056-4999-8bf5-79d573e2ee0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_915a10e2-c44a-4c5e-8cae-27c4a852acff" xlink:to="loc_us-gaap_InterestAndOtherIncome_247d83a7-f056-4999-8bf5-79d573e2ee0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5d9339f0-d0a4-4748-9a35-f3ed7b04ceb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_915a10e2-c44a-4c5e-8cae-27c4a852acff" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5d9339f0-d0a4-4748-9a35-f3ed7b04ceb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9eeb0179-1133-41b2-acb0-953d3334d172" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_915a10e2-c44a-4c5e-8cae-27c4a852acff" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9eeb0179-1133-41b2-acb0-953d3334d172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_579f9a97-a453-4e63-8613-9e4e36938e88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_915a10e2-c44a-4c5e-8cae-27c4a852acff" xlink:to="loc_us-gaap_NetIncomeLoss_579f9a97-a453-4e63-8613-9e4e36938e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_83a87b54-f9e8-476d-a667-3d9c5da34526" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_915a10e2-c44a-4c5e-8cae-27c4a852acff" xlink:to="loc_us-gaap_EarningsPerShareBasic_83a87b54-f9e8-476d-a667-3d9c5da34526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6174f5ac-9450-48f2-8902-f8afb2b0fe9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_915a10e2-c44a-4c5e-8cae-27c4a852acff" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6174f5ac-9450-48f2-8902-f8afb2b0fe9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_72ae8a70-2fdd-42c7-a775-e202eabb23cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_915a10e2-c44a-4c5e-8cae-27c4a852acff" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_72ae8a70-2fdd-42c7-a775-e202eabb23cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_062f9638-9946-41cd-b8aa-0d93b918e520" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_915a10e2-c44a-4c5e-8cae-27c4a852acff" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_062f9638-9946-41cd-b8aa-0d93b918e520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dcb1a6fd-59da-4c98-a030-e0f7e49a0791" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4b914214-47d5-401a-a5b9-4b93abd7338c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dcb1a6fd-59da-4c98-a030-e0f7e49a0791" xlink:to="loc_us-gaap_NetIncomeLoss_4b914214-47d5-401a-a5b9-4b93abd7338c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_286b3fa3-f05b-4d1d-94ff-b8c2db350787" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dcb1a6fd-59da-4c98-a030-e0f7e49a0791" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_286b3fa3-f05b-4d1d-94ff-b8c2db350787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_4dfe3fc4-7927-41ef-87b4-a175fc3b9b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dcb1a6fd-59da-4c98-a030-e0f7e49a0791" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_4dfe3fc4-7927-41ef-87b4-a175fc3b9b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_74ca5cd7-925d-46c4-beb5-8c3fc533c325" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dcb1a6fd-59da-4c98-a030-e0f7e49a0791" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_74ca5cd7-925d-46c4-beb5-8c3fc533c325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_39a49a52-6941-468f-a750-f510769b573e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dcb1a6fd-59da-4c98-a030-e0f7e49a0791" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_39a49a52-6941-468f-a750-f510769b573e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0f346afd-2a39-4777-a95e-3c328ebfa437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4ce05336-3bb6-4617-aca6-53badd38941c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0f346afd-2a39-4777-a95e-3c328ebfa437" xlink:to="loc_us-gaap_StatementTable_4ce05336-3bb6-4617-aca6-53badd38941c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5fe2d2d7-b7c3-426e-a42a-0b877b9a2e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4ce05336-3bb6-4617-aca6-53badd38941c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5fe2d2d7-b7c3-426e-a42a-0b877b9a2e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_206e6dd3-0bc1-4856-9dd6-2c2966681c53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5fe2d2d7-b7c3-426e-a42a-0b877b9a2e0a" xlink:to="loc_us-gaap_EquityComponentDomain_206e6dd3-0bc1-4856-9dd6-2c2966681c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_41012d0f-6e9e-41f0-8079-28332e44f5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_206e6dd3-0bc1-4856-9dd6-2c2966681c53" xlink:to="loc_us-gaap_CommonStockMember_41012d0f-6e9e-41f0-8079-28332e44f5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_264f6831-be1f-4278-b7cf-d04a40a0acfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_206e6dd3-0bc1-4856-9dd6-2c2966681c53" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_264f6831-be1f-4278-b7cf-d04a40a0acfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f4d5d31c-3a15-4cde-ab9d-5722f6dc585e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_206e6dd3-0bc1-4856-9dd6-2c2966681c53" xlink:to="loc_us-gaap_RetainedEarningsMember_f4d5d31c-3a15-4cde-ab9d-5722f6dc585e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4fbc8012-b5c6-4d2d-8557-f0db21053131" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_206e6dd3-0bc1-4856-9dd6-2c2966681c53" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4fbc8012-b5c6-4d2d-8557-f0db21053131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b39d3b97-5b34-4b2c-99d3-3c789132898d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4ce05336-3bb6-4617-aca6-53badd38941c" xlink:to="loc_us-gaap_StatementLineItems_b39d3b97-5b34-4b2c-99d3-3c789132898d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b39d3b97-5b34-4b2c-99d3-3c789132898d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5576e49f-65cb-42cb-a719-2d6bda090d13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_CommonStockSharesIssued_5576e49f-65cb-42cb-a719-2d6bda090d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_59052909-d91a-4284-ae9e-3bc09480e40d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockholdersEquity_59052909-d91a-4284-ae9e-3bc09480e40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_df86c2f9-d83a-4c08-8ac1-1e786247a2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_df86c2f9-d83a-4c08-8ac1-1e786247a2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7dfff7b7-1013-443d-a72d-930386c60369" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7dfff7b7-1013-443d-a72d-930386c60369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_56d68673-069a-407b-b0ce-2eb8461a371b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_56d68673-069a-407b-b0ce-2eb8461a371b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_005ba924-77ad-47de-a737-74c503c3c95f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_005ba924-77ad-47de-a737-74c503c3c95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b2a0ef5c-ea21-4c06-936e-61070e995cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b2a0ef5c-ea21-4c06-936e-61070e995cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a796dd97-ab1f-437c-b5d0-213ac4624005" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a796dd97-ab1f-437c-b5d0-213ac4624005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0ac3a67f-c40b-4946-aec6-eac2c372aaba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0ac3a67f-c40b-4946-aec6-eac2c372aaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_6a0ad952-6a9a-4753-80f4-cc528a9e489d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_6a0ad952-6a9a-4753-80f4-cc528a9e489d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_138c920f-9728-4cf6-97db-a83aeef06759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_138c920f-9728-4cf6-97db-a83aeef06759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9de7f209-0948-4d14-80d1-c7201ccc8a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9de7f209-0948-4d14-80d1-c7201ccc8a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c5276bee-8b29-4a0b-9358-89f50d120384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_NetIncomeLoss_c5276bee-8b29-4a0b-9358-89f50d120384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a9f30b7e-477c-4388-86be-799af18993db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_CommonStockSharesIssued_a9f30b7e-477c-4388-86be-799af18993db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9b5a702a-8314-411a-9bd5-2180c2a5a39a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_52423e8b-d8af-49ca-8b7a-a2665854daa3" xlink:to="loc_us-gaap_StockholdersEquity_9b5a702a-8314-411a-9bd5-2180c2a5a39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a789e796-2ed3-4fdb-b60a-6a9d3623b4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ef49dbc7-b0ed-4aee-8252-b78cd9f1657b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a789e796-2ed3-4fdb-b60a-6a9d3623b4c0" xlink:to="loc_us-gaap_StatementTable_ef49dbc7-b0ed-4aee-8252-b78cd9f1657b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_64836ca8-1917-40c6-b321-1266aa4f5a63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ef49dbc7-b0ed-4aee-8252-b78cd9f1657b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_64836ca8-1917-40c6-b321-1266aa4f5a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_091b9fe2-7cbd-4c35-b97b-cf51987a5850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_64836ca8-1917-40c6-b321-1266aa4f5a63" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_091b9fe2-7cbd-4c35-b97b-cf51987a5850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AtTheMarketOfferingMember_98371f13-ca13-49ba-b108-fff831a8f010" xlink:href="sgmo-20230930.xsd#sgmo_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_091b9fe2-7cbd-4c35-b97b-cf51987a5850" xlink:to="loc_sgmo_AtTheMarketOfferingMember_98371f13-ca13-49ba-b108-fff831a8f010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_72919a25-8cf0-4dcb-a70d-94e52c4e5565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_091b9fe2-7cbd-4c35-b97b-cf51987a5850" xlink:to="loc_us-gaap_EmployeeStockMember_72919a25-8cf0-4dcb-a70d-94e52c4e5565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ef49dbc7-b0ed-4aee-8252-b78cd9f1657b" xlink:to="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_afffaae2-b1a4-45e2-9656-1f2e35fff2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_afffaae2-b1a4-45e2-9656-1f2e35fff2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dc35a279-f4b5-484c-a98e-5017b3d4a79c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_afffaae2-b1a4-45e2-9656-1f2e35fff2d6" xlink:to="loc_us-gaap_NetIncomeLoss_dc35a279-f4b5-484c-a98e-5017b3d4a79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_afffaae2-b1a4-45e2-9656-1f2e35fff2d6" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_65901e9b-3ef2-4ae0-80c1-e6508fb4a527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_65901e9b-3ef2-4ae0-80c1-e6508fb4a527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6949d0e3-9fc1-4e50-bb3b-8d1dee4c567b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6949d0e3-9fc1-4e50-bb3b-8d1dee4c567b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1a4fa180-07d6-45f3-b665-9abd40c38932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1a4fa180-07d6-45f3-b665-9abd40c38932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_3522d7a9-86f1-4c17-8f0d-09b326c7a114" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_3522d7a9-86f1-4c17-8f0d-09b326c7a114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_7258ccf3-c084-4b14-bd55-8a184f5a3d14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_7258ccf3-c084-4b14-bd55-8a184f5a3d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bc8e70c0-b598-44e0-8125-769bf3035314" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bc8e70c0-b598-44e0-8125-769bf3035314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_94b29c98-79f9-4ebf-a406-8e75b0b90655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_ShareBasedCompensation_94b29c98-79f9-4ebf-a406-8e75b0b90655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_d257e291-416d-403f-a28c-271377508563" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_55155bb0-1497-4ef6-ad0c-21f1d2c5169e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_d257e291-416d-403f-a28c-271377508563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_afffaae2-b1a4-45e2-9656-1f2e35fff2d6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_158ef3cb-0c53-4c56-9076-16fcea5a50d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_158ef3cb-0c53-4c56-9076-16fcea5a50d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dbf1ab2b-4f92-4ab7-9aac-4b13ed635ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dbf1ab2b-4f92-4ab7-9aac-4b13ed635ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_bf0ecf52-aacd-4384-a501-c905d460893c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_bf0ecf52-aacd-4384-a501-c905d460893c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9c7cff04-f5bb-43f2-8770-e80d0e096476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9c7cff04-f5bb-43f2-8770-e80d0e096476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_bea79c3e-53e3-4566-9884-b78aee85a482" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_bea79c3e-53e3-4566-9884-b78aee85a482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_024027ce-bea8-4fb4-b1f0-eafa1225d02a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_024027ce-bea8-4fb4-b1f0-eafa1225d02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_07a72633-d451-440d-908e-67650f128e42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_07a72633-d451-440d-908e-67650f128e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_4fe24ea3-516b-4e14-8dbe-b8e6200fd72b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0612b1c9-fa0d-44f2-971f-b040f08fbec9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_4fe24ea3-516b-4e14-8dbe-b8e6200fd72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_14aadeb0-1325-4f90-a532-1cab6877700a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_afffaae2-b1a4-45e2-9656-1f2e35fff2d6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_14aadeb0-1325-4f90-a532-1cab6877700a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80dfc936-4fe3-4836-b198-74f420ac9d39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80dfc936-4fe3-4836-b198-74f420ac9d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a91abe3a-180a-4324-b375-da6c26fc1bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80dfc936-4fe3-4836-b198-74f420ac9d39" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a91abe3a-180a-4324-b375-da6c26fc1bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_7f8b18ec-7ba3-4e2b-a499-56e054ffa265" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80dfc936-4fe3-4836-b198-74f420ac9d39" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_7f8b18ec-7ba3-4e2b-a499-56e054ffa265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dcc8d2b5-1a38-46c9-ab15-19bb3a26f401" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80dfc936-4fe3-4836-b198-74f420ac9d39" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dcc8d2b5-1a38-46c9-ab15-19bb3a26f401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_669d2bb4-a885-41c9-9c72-27741b89dc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80dfc936-4fe3-4836-b198-74f420ac9d39" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_669d2bb4-a885-41c9-9c72-27741b89dc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f59e1c12-7de9-43c6-86fd-d156371a1056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f59e1c12-7de9-43c6-86fd-d156371a1056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_448d87c3-398c-44c1-9726-7e6816ba1a70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f59e1c12-7de9-43c6-86fd-d156371a1056" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_448d87c3-398c-44c1-9726-7e6816ba1a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8023dcef-ecfa-49f1-b448-ef74c69442eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f59e1c12-7de9-43c6-86fd-d156371a1056" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8023dcef-ecfa-49f1-b448-ef74c69442eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_fd15ef9e-10ed-4fd0-a853-da4abf5731fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f59e1c12-7de9-43c6-86fd-d156371a1056" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_fd15ef9e-10ed-4fd0-a853-da4abf5731fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72465fb5-762c-4963-b934-b38fe5c42087" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f59e1c12-7de9-43c6-86fd-d156371a1056" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72465fb5-762c-4963-b934-b38fe5c42087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ff29bd8f-779a-46fa-833f-dcb4e57cd1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ff29bd8f-779a-46fa-833f-dcb4e57cd1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a49b963-577b-43cb-8bab-c9a62e08828a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a49b963-577b-43cb-8bab-c9a62e08828a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2bd58bdf-10af-4d03-a024-707237b1a94a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2bd58bdf-10af-4d03-a024-707237b1a94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_398fbc1d-e535-48f0-b11b-13e8d2899568" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_398fbc1d-e535-48f0-b11b-13e8d2899568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d952b609-17d2-40e9-8f90-c984ec08fcac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_db2ea7a5-cfdc-45c5-912a-afa076ddb1c6" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d952b609-17d2-40e9-8f90-c984ec08fcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_6fea400a-3510-472e-b29e-8b76bc857315" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d952b609-17d2-40e9-8f90-c984ec08fcac" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_6fea400a-3510-472e-b29e-8b76bc857315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability_09aa9332-0993-40d4-a4a0-ce976eae399a" xlink:href="sgmo-20230930.xsd#sgmo_TenantImprovementAllowanceWithinContraLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d952b609-17d2-40e9-8f90-c984ec08fcac" xlink:to="loc_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability_09aa9332-0993-40d4-a4a0-ce976eae399a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="sgmo-20230930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7732bc6c-1252-412d-96cf-4ee3a97cfb15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_a23ac556-c54b-4c70-967a-c968ad0df60c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7732bc6c-1252-412d-96cf-4ee3a97cfb15" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_a23ac556-c54b-4c70-967a-c968ad0df60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="sgmo-20230930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_956d7765-9e59-4e53-b97b-bab426b78504" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_2ebf74f8-ae34-481b-a9b9-537f605bde58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_956d7765-9e59-4e53-b97b-bab426b78504" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_2ebf74f8-ae34-481b-a9b9-537f605bde58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIES"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_15475481-8fec-431f-bed4-ccfcedebfe22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_bc478a76-12ec-4677-bcf5-84cdc563a474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_15475481-8fec-431f-bed4-ccfcedebfe22" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_bc478a76-12ec-4677-bcf5-84cdc563a474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE" xlink:type="simple" xlink:href="sgmo-20230930.xsd#BASICANDDILUTEDNETLOSSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ea32314c-a93b-419d-a5a9-a4cf1729b65a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_dcc1ecf3-05f9-41c8-ab94-31c4b865b1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ea32314c-a93b-419d-a5a9-a4cf1729b65a" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_dcc1ecf3-05f9-41c8-ab94-31c4b865b1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2509577d-7d04-4950-b2f1-435df4ab12e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_e1bd5ea1-b269-423e-91bd-6fb71cb75fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2509577d-7d04-4950-b2f1-435df4ab12e0" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_e1bd5ea1-b269-423e-91bd-6fb71cb75fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETS" xlink:type="simple" xlink:href="sgmo-20230930.xsd#IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETS"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b2cf64ec-6bb0-435c-a327-b5a8e002e00e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesTextBlock_6b39688b-35ed-4739-b1a9-cb9d6400e1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b2cf64ec-6bb0-435c-a327-b5a8e002e00e" xlink:to="loc_us-gaap_AssetImpairmentChargesTextBlock_6b39688b-35ed-4739-b1a9-cb9d6400e1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="sgmo-20230930.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_54d5f443-74d6-4db8-bf67-d3f970a57d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_71e3d217-0fe3-450d-9e53-5aa78393bbee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_54d5f443-74d6-4db8-bf67-d3f970a57d3b" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_71e3d217-0fe3-450d-9e53-5aa78393bbee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sgmo-20230930.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fa1352f9-98bd-4851-b67b-4ee32d1cf46e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4e82afdc-e0f3-4410-9864-243e68e9c961" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fa1352f9-98bd-4851-b67b-4ee32d1cf46e" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4e82afdc-e0f3-4410-9864-243e68e9c961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/RESTRUCTURINGCHARGES" xlink:type="simple" xlink:href="sgmo-20230930.xsd#RESTRUCTURINGCHARGES"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/RESTRUCTURINGCHARGES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f95fcf4a-086c-4fc8-99f6-d506c8229559" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_c76fcb39-6083-423f-baa0-3159b4e768b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f95fcf4a-086c-4fc8-99f6-d506c8229559" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_c76fcb39-6083-423f-baa0-3159b4e768b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/INCOMETAXES" xlink:type="simple" xlink:href="sgmo-20230930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_76dbb676-e74b-423d-b5ec-44346dffd8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_e0d98752-95e3-4519-967b-1bbf836c6478" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_76dbb676-e74b-423d-b5ec-44346dffd8c1" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_e0d98752-95e3-4519-967b-1bbf836c6478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="sgmo-20230930.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_19d53075-07d5-4cf7-bb95-2d9c06ec2ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_5e21ba71-a3d7-4ba6-ac8f-8c97ba560abf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_19d53075-07d5-4cf7-bb95-2d9c06ec2ea2" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_5e21ba71-a3d7-4ba6-ac8f-8c97ba560abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="sgmo-20230930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf09a187-79b9-4dc1-b1c7-f98875b674ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1cd16b22-428b-4677-91aa-98af259dc61b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf09a187-79b9-4dc1-b1c7-f98875b674ef" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1cd16b22-428b-4677-91aa-98af259dc61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_9d645fb4-f01b-448a-94e9-9d8bf451d4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf09a187-79b9-4dc1-b1c7-f98875b674ef" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_9d645fb4-f01b-448a-94e9-9d8bf451d4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_28591a38-7010-409b-99a5-5814b7c83268" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf09a187-79b9-4dc1-b1c7-f98875b674ef" xlink:to="loc_us-gaap_UseOfEstimates_28591a38-7010-409b-99a5-5814b7c83268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_08000aac-cf7a-4d6d-bfb9-15756ebfaa0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf09a187-79b9-4dc1-b1c7-f98875b674ef" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_08000aac-cf7a-4d6d-bfb9-15756ebfaa0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_ff0a1519-3105-4114-82f0-af33152f9207" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf09a187-79b9-4dc1-b1c7-f98875b674ef" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_ff0a1519-3105-4114-82f0-af33152f9207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c87b64b5-17bf-48f2-8391-c76217d47e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf09a187-79b9-4dc1-b1c7-f98875b674ef" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c87b64b5-17bf-48f2-8391-c76217d47e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_38a17381-3e5a-42c6-9c08-c08ba94ce54f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf09a187-79b9-4dc1-b1c7-f98875b674ef" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_38a17381-3e5a-42c6-9c08-c08ba94ce54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_6a66a7aa-3aeb-404a-aa8d-a5c65f4d72e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf09a187-79b9-4dc1-b1c7-f98875b674ef" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_6a66a7aa-3aeb-404a-aa8d-a5c65f4d72e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_40c509f8-c3d3-44ed-8b1d-5fc30f7c125f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf09a187-79b9-4dc1-b1c7-f98875b674ef" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_40c509f8-c3d3-44ed-8b1d-5fc30f7c125f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_10dd8178-df93-4dcc-802b-dc40d720bab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf09a187-79b9-4dc1-b1c7-f98875b674ef" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_10dd8178-df93-4dcc-802b-dc40d720bab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="sgmo-20230930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d98735a6-7826-467d-bf57-c1a74e7c5ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock_250b2430-36fe-4511-a95e-fae13e933d05" xlink:href="sgmo-20230930.xsd#sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d98735a6-7826-467d-bf57-c1a74e7c5ad7" xlink:to="loc_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock_250b2430-36fe-4511-a95e-fae13e933d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_779a886a-39de-4724-bcc9-99789e5d7769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d98735a6-7826-467d-bf57-c1a74e7c5ad7" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_779a886a-39de-4724-bcc9-99789e5d7769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_ca0818f8-0bdc-4d8d-a9da-5fec29ff40e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d98735a6-7826-467d-bf57-c1a74e7c5ad7" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_ca0818f8-0bdc-4d8d-a9da-5fec29ff40e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="sgmo-20230930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6cd27c75-e743-47b5-ae29-aaa45e9f1e26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_51d327f3-1874-4633-b536-af5128514927" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6cd27c75-e743-47b5-ae29-aaa45e9f1e26" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_51d327f3-1874-4633-b536-af5128514927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESTables"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6c4fd06e-ae1a-4791-83e3-cb4e7db94dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_775aff6d-9953-4fee-b385-8d37a5e70a85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6c4fd06e-ae1a-4791-83e3-cb4e7db94dfa" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_775aff6d-9953-4fee-b385-8d37a5e70a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_23eaa311-8935-461b-8ca2-f228ce2c1948" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6c4fd06e-ae1a-4791-83e3-cb4e7db94dfa" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_23eaa311-8935-461b-8ca2-f228ce2c1948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5038827f-fcee-4881-89fe-f4e27ce847cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_0d472e13-d92f-4def-89bf-8279620e9632" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5038827f-fcee-4881-89fe-f4e27ce847cd" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_0d472e13-d92f-4def-89bf-8279620e9632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="sgmo-20230930.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d702a58b-e6e9-4b48-bd6e-95d6012293b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_909fe3fa-b2c7-4fb8-b8c2-8b552c35c26f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d702a58b-e6e9-4b48-bd6e-95d6012293b0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_909fe3fa-b2c7-4fb8-b8c2-8b552c35c26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/RESTRUCTURINGCHARGESTables" xlink:type="simple" xlink:href="sgmo-20230930.xsd#RESTRUCTURINGCHARGESTables"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/RESTRUCTURINGCHARGESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_580bd1f8-78a1-4f28-878c-e173dc21936f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_ccb571ad-df5d-40d7-9326-a3294bc94a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_580bd1f8-78a1-4f28-878c-e173dc21936f" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_ccb571ad-df5d-40d7-9326-a3294bc94a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1bcf717-73f1-485c-a72a-f93e5caca9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_6bfbfd98-62c4-4264-a7e8-0a4deb059cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfChangeInAccountingEstimateTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1bcf717-73f1-485c-a72a-f93e5caca9b9" xlink:to="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_6bfbfd98-62c4-4264-a7e8-0a4deb059cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_11a23a59-fa9a-49d0-8212-2a4b4759fe42" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_6bfbfd98-62c4-4264-a7e8-0a4deb059cbb" xlink:to="loc_srt_CounterpartyNameAxis_11a23a59-fa9a-49d0-8212-2a4b4759fe42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f715c184-6b47-46bf-8eb5-4415881679a9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_11a23a59-fa9a-49d0-8212-2a4b4759fe42" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f715c184-6b47-46bf-8eb5-4415881679a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_0c9d1749-b1a6-42c6-8e7f-efb98ced9c19" xlink:href="sgmo-20230930.xsd#sgmo_KitePharmaIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f715c184-6b47-46bf-8eb5-4415881679a9" xlink:to="loc_sgmo_KitePharmaIncMember_0c9d1749-b1a6-42c6-8e7f-efb98ced9c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e02d3983-eef4-4607-90ea-a037586c4780" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_6bfbfd98-62c4-4264-a7e8-0a4deb059cbb" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e02d3983-eef4-4607-90ea-a037586c4780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_67f5703c-c2f8-4572-97db-19c5ec934d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e02d3983-eef4-4607-90ea-a037586c4780" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_67f5703c-c2f8-4572-97db-19c5ec934d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInAgreementEstimateMarch2023Member_d43aeec4-3fc3-426b-b0d3-ea496a704e31" xlink:href="sgmo-20230930.xsd#sgmo_ChangeInAgreementEstimateMarch2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_67f5703c-c2f8-4572-97db-19c5ec934d1b" xlink:to="loc_sgmo_ChangeInAgreementEstimateMarch2023Member_d43aeec4-3fc3-426b-b0d3-ea496a704e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInAgreementEstimateSeptember2023Member_c3758bd1-0e98-43ee-b924-42c277d3198d" xlink:href="sgmo-20230930.xsd#sgmo_ChangeInAgreementEstimateSeptember2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_67f5703c-c2f8-4572-97db-19c5ec934d1b" xlink:to="loc_sgmo_ChangeInAgreementEstimateSeptember2023Member_c3758bd1-0e98-43ee-b924-42c277d3198d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_6bfbfd98-62c4-4264-a7e8-0a4deb059cbb" xlink:to="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_9e73e984-f180-4277-b21d-4931bb86856f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_9e73e984-f180-4277-b21d-4931bb86856f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_250123ae-6ad1-4fb6-ac73-ed405d6c91ad" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_250123ae-6ad1-4fb6-ac73-ed405d6c91ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_f4674f99-d3fd-430e-9fca-2bf0597716ff" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_f4674f99-d3fd-430e-9fca-2bf0597716ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInEarningsPerShareBasic_bed42041-5019-4795-9d19-6453eedc588c" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInEarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_sgmo_IncreaseDecreaseInEarningsPerShareBasic_bed42041-5019-4795-9d19-6453eedc588c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_59ab7cbc-e101-4ab1-950c-a4e0ba4b805a" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInEarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_59ab7cbc-e101-4ab1-950c-a4e0ba4b805a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_3e35a35f-042b-43f7-aade-25d8ba40adeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_7fa295b9-a2c8-410e-927d-4b7b22f612ba" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_3e35a35f-042b-43f7-aade-25d8ba40adeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c5c697e-2940-44c5-9096-e29855a71a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_2c94af65-9016-4989-a047-784fcd98b36f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8c5c697e-2940-44c5-9096-e29855a71a6c" xlink:to="loc_us-gaap_ConcentrationRiskTable_2c94af65-9016-4989-a047-784fcd98b36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_601524fc-3d3f-4ca4-88fa-e8f6613c3767" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_2c94af65-9016-4989-a047-784fcd98b36f" xlink:to="loc_srt_CounterpartyNameAxis_601524fc-3d3f-4ca4-88fa-e8f6613c3767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f65f462-94c2-4707-b53f-fc8ca5937a9b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_601524fc-3d3f-4ca4-88fa-e8f6613c3767" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f65f462-94c2-4707-b53f-fc8ca5937a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_c20f2a74-0586-4953-b75a-8edd04f64f3a" xlink:href="sgmo-20230930.xsd#sgmo_KitePharmaIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f65f462-94c2-4707-b53f-fc8ca5937a9b" xlink:to="loc_sgmo_KitePharmaIncMember_c20f2a74-0586-4953-b75a-8edd04f64f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_7809cc20-6a4a-494e-80d3-672e15ce6c06" xlink:href="sgmo-20230930.xsd#sgmo_BiogenMAIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f65f462-94c2-4707-b53f-fc8ca5937a9b" xlink:to="loc_sgmo_BiogenMAIncMember_7809cc20-6a4a-494e-80d3-672e15ce6c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_4d05789c-071e-4368-8286-36e530146940" xlink:href="sgmo-20230930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f65f462-94c2-4707-b53f-fc8ca5937a9b" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_4d05789c-071e-4368-8286-36e530146940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_OtherLicensingAgreementsMember_c7146890-7f16-4621-9cc2-ed62b2f163eb" xlink:href="sgmo-20230930.xsd#sgmo_OtherLicensingAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7f65f462-94c2-4707-b53f-fc8ca5937a9b" xlink:to="loc_sgmo_OtherLicensingAgreementsMember_c7146890-7f16-4621-9cc2-ed62b2f163eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_de4da23e-204f-4d7e-8c71-4d2681d16e25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_2c94af65-9016-4989-a047-784fcd98b36f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_de4da23e-204f-4d7e-8c71-4d2681d16e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_76b08b11-19d2-4c45-8675-71cd2a765e40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_de4da23e-204f-4d7e-8c71-4d2681d16e25" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_76b08b11-19d2-4c45-8675-71cd2a765e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_979019e9-a31e-42bb-a2a6-2981071679c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_76b08b11-19d2-4c45-8675-71cd2a765e40" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_979019e9-a31e-42bb-a2a6-2981071679c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_5213914a-6e94-46f5-8c22-9e63a27a6e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_2c94af65-9016-4989-a047-784fcd98b36f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_5213914a-6e94-46f5-8c22-9e63a27a6e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b2fa07fa-41af-44ed-bd26-15282fa9d6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5213914a-6e94-46f5-8c22-9e63a27a6e8a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b2fa07fa-41af-44ed-bd26-15282fa9d6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_cc423642-9f02-4d9c-9ace-95fff732ad2d" xlink:href="sgmo-20230930.xsd#sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b2fa07fa-41af-44ed-bd26-15282fa9d6ea" xlink:to="loc_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_cc423642-9f02-4d9c-9ace-95fff732ad2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_76c22c79-279c-4cd6-bd9c-014d08f59bca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_2c94af65-9016-4989-a047-784fcd98b36f" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_76c22c79-279c-4cd6-bd9c-014d08f59bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e8373e11-426c-4fa9-b07b-33d321cee5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_76c22c79-279c-4cd6-bd9c-014d08f59bca" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e8373e11-426c-4fa9-b07b-33d321cee5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a5f803af-eabc-4d2f-b592-a31a11def51d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4b138846-8ad1-41fb-b110-a8789498a632" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a5f803af-eabc-4d2f-b592-a31a11def51d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4b138846-8ad1-41fb-b110-a8789498a632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_34839aae-5c6a-4234-9bff-6a4bd9db4353" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a5f803af-eabc-4d2f-b592-a31a11def51d" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_34839aae-5c6a-4234-9bff-6a4bd9db4353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e54ab75d-5bde-45aa-950d-047e48ce6487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a5f803af-eabc-4d2f-b592-a31a11def51d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e54ab75d-5bde-45aa-950d-047e48ce6487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#FAIRVALUEMEASUREMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_69f35c61-71fc-49ff-b4e0-da0509bf1087" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13464ffa-b917-4e3f-9cae-ad803d36b90c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_69f35c61-71fc-49ff-b4e0-da0509bf1087" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13464ffa-b917-4e3f-9cae-ad803d36b90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0eefe90f-92c1-4a91-81f3-3b13a6f2b3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13464ffa-b917-4e3f-9cae-ad803d36b90c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0eefe90f-92c1-4a91-81f3-3b13a6f2b3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ed2c295-8265-4e35-b8cc-8ecf373017ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0eefe90f-92c1-4a91-81f3-3b13a6f2b3d8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ed2c295-8265-4e35-b8cc-8ecf373017ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ed5ac443-6f73-450d-94b6-955003421b14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6ed2c295-8265-4e35-b8cc-8ecf373017ef" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ed5ac443-6f73-450d-94b6-955003421b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c990e1f1-fb8d-4b17-820a-d2a4df464baf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13464ffa-b917-4e3f-9cae-ad803d36b90c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c990e1f1-fb8d-4b17-820a-d2a4df464baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0a4f327a-3f96-448d-bcc6-0e22851cc9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c990e1f1-fb8d-4b17-820a-d2a4df464baf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0a4f327a-3f96-448d-bcc6-0e22851cc9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_234ba549-1f59-4474-9ea6-8f41771200b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0a4f327a-3f96-448d-bcc6-0e22851cc9d5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_234ba549-1f59-4474-9ea6-8f41771200b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3a472d4e-aa58-4330-9db1-88d16f561620" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0a4f327a-3f96-448d-bcc6-0e22851cc9d5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3a472d4e-aa58-4330-9db1-88d16f561620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8ef38931-847b-4c10-994e-f4aec1065a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0a4f327a-3f96-448d-bcc6-0e22851cc9d5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8ef38931-847b-4c10-994e-f4aec1065a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_48063000-c12c-45df-a572-c3c7d07af3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13464ffa-b917-4e3f-9cae-ad803d36b90c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_48063000-c12c-45df-a572-c3c7d07af3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_48063000-c12c-45df-a572-c3c7d07af3a0" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1b322808-7e99-4eb0-8b95-c9c8efc83c97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1b322808-7e99-4eb0-8b95-c9c8efc83c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a6a27ef7-a3b4-40cb-851d-d6ab47a01f87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a6a27ef7-a3b4-40cb-851d-d6ab47a01f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_1cbd3739-5345-4c35-84d1-47830de4010a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_CommercialPaperMember_1cbd3739-5345-4c35-84d1-47830de4010a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_de5ef2bc-ad8a-4f77-9b1c-bc46141cdb02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_de5ef2bc-ad8a-4f77-9b1c-bc46141cdb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_fc0dc9bc-e66c-43e4-9cd5-94fb7ffc8e91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_fc0dc9bc-e66c-43e4-9cd5-94fb7ffc8e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_27c6e43a-7169-4e97-991b-70e4df481dba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_27c6e43a-7169-4e97-991b-70e4df481dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_4bf2e92b-82ad-4fbf-9638-97e232701205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_us-gaap_CertificatesOfDepositMember_4bf2e92b-82ad-4fbf-9638-97e232701205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_USGovernmentSponsoredAgencyBondMember_0459ac61-7beb-4b9c-a09e-92cc911b8c67" xlink:href="sgmo-20230930.xsd#sgmo_USGovernmentSponsoredAgencyBondMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6f430ce-8a6c-4181-8120-e993ddbc9ac1" xlink:to="loc_sgmo_USGovernmentSponsoredAgencyBondMember_0459ac61-7beb-4b9c-a09e-92cc911b8c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f2cd5c93-a83d-42f3-9aad-eb6fedd6e711" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13464ffa-b917-4e3f-9cae-ad803d36b90c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f2cd5c93-a83d-42f3-9aad-eb6fedd6e711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6f371ffb-ec3e-4b2a-9f33-6d15b4784ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f2cd5c93-a83d-42f3-9aad-eb6fedd6e711" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6f371ffb-ec3e-4b2a-9f33-6d15b4784ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_83c2f968-afe6-4842-8799-4144f13ed5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f2cd5c93-a83d-42f3-9aad-eb6fedd6e711" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_83c2f968-afe6-4842-8799-4144f13ed5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_813b53cf-2a3b-4006-b701-b1ae9b6a6e92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f2cd5c93-a83d-42f3-9aad-eb6fedd6e711" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_813b53cf-2a3b-4006-b701-b1ae9b6a6e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_05ad773e-35d1-4ca8-8f09-51311d691ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_56888822-76ba-44fa-8029-28f7f4dd09e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_05ad773e-35d1-4ca8-8f09-51311d691ed8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_56888822-76ba-44fa-8029-28f7f4dd09e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5f135116-2a7c-48da-b08e-573e74d1dd12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_56888822-76ba-44fa-8029-28f7f4dd09e9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5f135116-2a7c-48da-b08e-573e74d1dd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5f135116-2a7c-48da-b08e-573e74d1dd12" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_8be84086-0ce7-42e4-b7af-569b2ed2f63f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_MoneyMarketFundsMember_8be84086-0ce7-42e4-b7af-569b2ed2f63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_e3ebe3b2-9d65-449a-aee9-c11e60c9dc20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_CashEquivalentsMember_e3ebe3b2-9d65-449a-aee9-c11e60c9dc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_b0ed3819-0248-48e4-a47f-d71dcc7ac60d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_b0ed3819-0248-48e4-a47f-d71dcc7ac60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_163e719c-3df3-4a75-9e6d-30eebc782c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_CommercialPaperMember_163e719c-3df3-4a75-9e6d-30eebc782c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_66815925-7a23-43ac-946f-fcc94d03935f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_66815925-7a23-43ac-946f-fcc94d03935f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_12330b50-3786-4156-9855-2fe8cc408323" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_12330b50-3786-4156-9855-2fe8cc408323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_ea91e2a1-4690-4bbf-b4ff-67638b76b632" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_ea91e2a1-4690-4bbf-b4ff-67638b76b632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_ca2b6c44-1e55-4831-af4b-01ed7d2db08b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_us-gaap_CertificatesOfDepositMember_ca2b6c44-1e55-4831-af4b-01ed7d2db08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_USGovernmentSponsoredAgencyBondMember_c598677b-b968-471b-a1e3-a69502463f61" xlink:href="sgmo-20230930.xsd#sgmo_USGovernmentSponsoredAgencyBondMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_103b8d30-8abd-4822-8fa0-043bb5ab56d9" xlink:to="loc_sgmo_USGovernmentSponsoredAgencyBondMember_c598677b-b968-471b-a1e3-a69502463f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_56888822-76ba-44fa-8029-28f7f4dd09e9" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:to="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d78ee9ee-d510-4987-81aa-7ff0c2347cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d78ee9ee-d510-4987-81aa-7ff0c2347cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_2d85b8c4-86f9-4ce2-bbc6-c537522e9b27" xlink:href="sgmo-20230930.xsd#sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_2d85b8c4-86f9-4ce2-bbc6-c537522e9b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_ed4dec4c-e0f1-4ae3-a68d-5f81ccc7c030" xlink:href="sgmo-20230930.xsd#sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_ed4dec4c-e0f1-4ae3-a68d-5f81ccc7c030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_12f6139e-d0b1-4665-a54e-6f37c9008365" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_12f6139e-d0b1-4665-a54e-6f37c9008365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_5d8b4098-3777-4779-b338-312afef21e78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_5d8b4098-3777-4779-b338-312afef21e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d5e058ff-1f03-4299-9719-2ecbb6b4e95e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d5e058ff-1f03-4299-9719-2ecbb6b4e95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_85890670-2887-4676-8436-5edebee91e57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_85890670-2887-4676-8436-5edebee91e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_3400f25d-4f3c-42ce-a1bb-3c9a00a9e109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2cf48aed-f9fa-4a02-b708-d33eaf9392b6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_3400f25d-4f3c-42ce-a1bb-3c9a00a9e109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_1ae66f38-6c94-4335-9d3c-c962dcc9f77f" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_1ae66f38-6c94-4335-9d3c-c962dcc9f77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_2c5045a9-4dc4-4573-82cb-ccf99128ee02" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_2c5045a9-4dc4-4573-82cb-ccf99128ee02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_8c9a0c52-f443-4ff2-b079-00f1032c1231" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_8c9a0c52-f443-4ff2-b079-00f1032c1231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_40b3a339-0c96-4aba-9ec2-fb7790584a01" xlink:href="sgmo-20230930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d9b5f736-dd6b-459d-a9a8-9e83e2623a70" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_40b3a339-0c96-4aba-9ec2-fb7790584a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c313cf92-a4fe-4379-b505-d5ef823120a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d01b5971-be24-4bad-9e00-d013c145ba9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c313cf92-a4fe-4379-b505-d5ef823120a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d01b5971-be24-4bad-9e00-d013c145ba9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_308dc0c4-3bec-4ed4-b20b-1e36dfc2bab6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c313cf92-a4fe-4379-b505-d5ef823120a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_308dc0c4-3bec-4ed4-b20b-1e36dfc2bab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_8bed2f6e-1cc5-4526-9017-f3796d3bd3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c313cf92-a4fe-4379-b505-d5ef823120a3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_8bed2f6e-1cc5-4526-9017-f3796d3bd3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESNarrativeDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a6b4b8a5-ac89-454d-8643-091361b80177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_666e7438-ab03-475b-876d-1ebb05077535" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a6b4b8a5-ac89-454d-8643-091361b80177" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_666e7438-ab03-475b-876d-1ebb05077535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded_b9f6278f-8452-4986-b36f-f7be797eaf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a6b4b8a5-ac89-454d-8643-091361b80177" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded_b9f6278f-8452-4986-b36f-f7be797eaf8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_ceb9fab2-58c8-4e3d-99f5-0d6e90758dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a6b4b8a5-ac89-454d-8643-091361b80177" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_ceb9fab2-58c8-4e3d-99f5-0d6e90758dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease_07bfc746-a301-4cb7-8d2d-8739fc519750" xlink:href="sgmo-20230930.xsd#sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a6b4b8a5-ac89-454d-8643-091361b80177" xlink:to="loc_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease_07bfc746-a301-4cb7-8d2d-8739fc519750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_c6f41533-42a4-4302-9cd2-961b628b8d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a6b4b8a5-ac89-454d-8643-091361b80177" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_c6f41533-42a4-4302-9cd2-961b628b8d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#BASICANDDILUTEDNETLOSSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6428a647-5aca-42cf-beec-a60f468bb1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9b00f28c-6eb1-478b-9c9a-68a745f673b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6428a647-5aca-42cf-beec-a60f468bb1a5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9b00f28c-6eb1-478b-9c9a-68a745f673b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_319ef040-de16-4f8d-a62a-2f43b9d7cd01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_319ef040-de16-4f8d-a62a-2f43b9d7cd01" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_3675ada3-4443-47eb-86c4-aaa132c36e38" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:to="loc_srt_CounterpartyNameAxis_3675ada3-4443-47eb-86c4-aaa132c36e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_426b5f06-1fee-491a-a83f-31f7b6032ded" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_3675ada3-4443-47eb-86c4-aaa132c36e38" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_426b5f06-1fee-491a-a83f-31f7b6032ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerMember_796aa5cb-7301-4d42-9942-ee998c4335d1" xlink:href="sgmo-20230930.xsd#sgmo_PfizerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_426b5f06-1fee-491a-a83f-31f7b6032ded" xlink:to="loc_sgmo_PfizerMember_796aa5cb-7301-4d42-9942-ee998c4335d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerSB525Member_d1545f8e-9426-45ed-8669-c42af8101fdf" xlink:href="sgmo-20230930.xsd#sgmo_PfizerSB525Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_426b5f06-1fee-491a-a83f-31f7b6032ded" xlink:to="loc_sgmo_PfizerSB525Member_d1545f8e-9426-45ed-8669-c42af8101fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerC9ORF72Member_7f5bad9b-8fb7-4b48-b86b-5db3f57f4b66" xlink:href="sgmo-20230930.xsd#sgmo_PfizerC9ORF72Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_426b5f06-1fee-491a-a83f-31f7b6032ded" xlink:to="loc_sgmo_PfizerC9ORF72Member_7f5bad9b-8fb7-4b48-b86b-5db3f57f4b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c9981315-7dbf-42b1-95d9-e35e38f2dc44" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:to="loc_srt_ProductOrServiceAxis_c9981315-7dbf-42b1-95d9-e35e38f2dc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_33896858-9cfa-4529-89ba-044a49495750" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c9981315-7dbf-42b1-95d9-e35e38f2dc44" xlink:to="loc_srt_ProductsAndServicesDomain_33896858-9cfa-4529-89ba-044a49495750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember_ae154ac5-eb87-4cec-a543-27dbcf0ee234" xlink:href="sgmo-20230930.xsd#sgmo_SBFiveTwoFiveAndOtherProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_33896858-9cfa-4529-89ba-044a49495750" xlink:to="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember_ae154ac5-eb87-4cec-a543-27dbcf0ee234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SBFiveTwoFiveMember_bd6404a5-bfe5-438e-879a-d9e10141e327" xlink:href="sgmo-20230930.xsd#sgmo_SBFiveTwoFiveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember_ae154ac5-eb87-4cec-a543-27dbcf0ee234" xlink:to="loc_sgmo_SBFiveTwoFiveMember_bd6404a5-bfe5-438e-879a-d9e10141e327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturedProductOtherMember_ac40599c-4580-416e-b2a0-95a5cdbec641" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManufacturedProductOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember_ae154ac5-eb87-4cec-a543-27dbcf0ee234" xlink:to="loc_us-gaap_ManufacturedProductOtherMember_ac40599c-4580-416e-b2a0-95a5cdbec641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_219e9c4a-91d3-4b7b-8e21-f3f90e9afd74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_33896858-9cfa-4529-89ba-044a49495750" xlink:to="loc_us-gaap_LicenseMember_219e9c4a-91d3-4b7b-8e21-f3f90e9afd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CNineORFSevenTwoMember_1f299038-8d78-4c7a-a53f-528c90ac38f3" xlink:href="sgmo-20230930.xsd#sgmo_CNineORFSevenTwoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_33896858-9cfa-4529-89ba-044a49495750" xlink:to="loc_sgmo_CNineORFSevenTwoMember_1f299038-8d78-4c7a-a53f-528c90ac38f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22731599-4f4c-4083-93da-32bb056a69c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22731599-4f4c-4083-93da-32bb056a69c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b46b554e-bf23-45f2-bf98-a910f230c570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_22731599-4f4c-4083-93da-32bb056a69c0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b46b554e-bf23-45f2-bf98-a910f230c570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_1326172e-ac7c-4c2b-beba-c858ed322180" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b46b554e-bf23-45f2-bf98-a910f230c570" xlink:to="loc_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_1326172e-ac7c-4c2b-beba-c858ed322180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_644514e4-d0c2-4137-8f74-e52333d19058" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b46b554e-bf23-45f2-bf98-a910f230c570" xlink:to="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_644514e4-d0c2-4137-8f74-e52333d19058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfCommercialMilestonesMember_bd9a7c42-bfb7-4ed4-9492-c24d1e6a6f5e" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfCommercialMilestonesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b46b554e-bf23-45f2-bf98-a910f230c570" xlink:to="loc_sgmo_AchievementOfCommercialMilestonesMember_bd9a7c42-bfb7-4ed4-9492-c24d1e6a6f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_031ce2e3-9a74-4dc5-b785-6985520ec45d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:to="loc_srt_RangeAxis_031ce2e3-9a74-4dc5-b785-6985520ec45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5eaf7152-587b-45e8-932a-5382bdf3cb79" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_031ce2e3-9a74-4dc5-b785-6985520ec45d" xlink:to="loc_srt_RangeMember_5eaf7152-587b-45e8-932a-5382bdf3cb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0adc14a6-e2f5-40cd-8f92-4e160d555995" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5eaf7152-587b-45e8-932a-5382bdf3cb79" xlink:to="loc_srt_MinimumMember_0adc14a6-e2f5-40cd-8f92-4e160d555995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1066b86b-9701-4142-bbbf-8250e2256638" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5eaf7152-587b-45e8-932a-5382bdf3cb79" xlink:to="loc_srt_MaximumMember_1066b86b-9701-4142-bbbf-8250e2256638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4617373f-29a9-4663-91ca-81b2c5f8a3bb" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AgreementTerminationTerm_cd6a3c79-6d37-4e47-ae75-c405f11254a0" xlink:href="sgmo-20230930.xsd#sgmo_AgreementTerminationTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_AgreementTerminationTerm_cd6a3c79-6d37-4e47-ae75-c405f11254a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_f37bec0b-dff7-498b-bd7a-1a1f25af25d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_f37bec0b-dff7-498b-bd7a-1a1f25af25d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_ad6f52df-eac1-4409-9f4c-b803111f4abe" xlink:href="sgmo-20230930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_ad6f52df-eac1-4409-9f4c-b803111f4abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_f036edd5-7ccc-4a76-ac24-58f49dcfed34" xlink:href="sgmo-20230930.xsd#sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_f036edd5-7ccc-4a76-ac24-58f49dcfed34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_ba90c8da-5611-40eb-86b9-1e571453d837" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementNumberOfMilestonesAchieved"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_ba90c8da-5611-40eb-86b9-1e571453d837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestonePaymentsReceived_f4c7157b-ed47-46aa-abfc-4b6e0d99c08a" xlink:href="sgmo-20230930.xsd#sgmo_MilestonePaymentsReceived"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_MilestonePaymentsReceived_f4c7157b-ed47-46aa-abfc-4b6e0d99c08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneRevenueReceivable_1ca805ff-a145-47ac-b7e6-667d3e192fd9" xlink:href="sgmo-20230930.xsd#sgmo_MilestoneRevenueReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_MilestoneRevenueReceivable_1ca805ff-a145-47ac-b7e6-667d3e192fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty_0803240b-88a7-46a7-82b8-5dda4ccc8d44" xlink:href="sgmo-20230930.xsd#sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty_0803240b-88a7-46a7-82b8-5dda4ccc8d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_c8ddbcb5-7f33-4745-bea5-d600ec9082bd" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_c8ddbcb5-7f33-4745-bea5-d600ec9082bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementResearchServiceFees_093025b4-3f36-4856-a196-f4a1713c0a52" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementResearchServiceFees"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_CollaborativeArrangementResearchServiceFees_093025b4-3f36-4856-a196-f4a1713c0a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_a88cf3fb-ee61-44c1-858c-82019715a142" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_a88cf3fb-ee61-44c1-858c-82019715a142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_da3a9100-ec30-4971-8edc-eeb86b871227" xlink:href="sgmo-20230930.xsd#sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a5e6e290-9b31-4348-9479-180d561977c1" xlink:to="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_da3a9100-ec30-4971-8edc-eeb86b871227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7c0c4886-6e3c-4182-a145-a033dffad2ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7c0c4886-6e3c-4182-a145-a033dffad2ae" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b6ab88bc-bd33-48d7-971d-b52d364cd3fa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_srt_CounterpartyNameAxis_b6ab88bc-bd33-48d7-971d-b52d364cd3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2467f42e-ab75-48bb-9de3-b5d055aff740" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_b6ab88bc-bd33-48d7-971d-b52d364cd3fa" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2467f42e-ab75-48bb-9de3-b5d055aff740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_f42195ee-c830-4e52-9d41-7f1b4b11e8eb" xlink:href="sgmo-20230930.xsd#sgmo_KitePharmaIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2467f42e-ab75-48bb-9de3-b5d055aff740" xlink:to="loc_sgmo_KitePharmaIncMember_f42195ee-c830-4e52-9d41-7f1b4b11e8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_935b580e-5b36-4a22-8720-de8b713c2a26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_us-gaap_TypeOfArrangementAxis_935b580e-5b36-4a22-8720-de8b713c2a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_310b344d-c365-4d14-a112-fbbf0ac28a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_935b580e-5b36-4a22-8720-de8b713c2a26" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_310b344d-c365-4d14-a112-fbbf0ac28a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_c034f5fd-18e1-4c2d-89ec-91649515a8b2" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_310b344d-c365-4d14-a112-fbbf0ac28a0d" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_c034f5fd-18e1-4c2d-89ec-91649515a8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c7203263-4d15-4106-aca7-cc63e3b8f613" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_srt_RangeAxis_c7203263-4d15-4106-aca7-cc63e3b8f613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e3f8f2b8-8631-4dcc-be5d-a5681694d026" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c7203263-4d15-4106-aca7-cc63e3b8f613" xlink:to="loc_srt_RangeMember_e3f8f2b8-8631-4dcc-be5d-a5681694d026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_72d9e8df-f9ba-4eee-8e0a-f37299981900" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e3f8f2b8-8631-4dcc-be5d-a5681694d026" xlink:to="loc_srt_MaximumMember_72d9e8df-f9ba-4eee-8e0a-f37299981900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2ad30cb0-2bbc-424d-a1c3-731725f371b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2ad30cb0-2bbc-424d-a1c3-731725f371b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_90542d72-849a-4fd3-8804-c25b9f2fc1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2ad30cb0-2bbc-424d-a1c3-731725f371b1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_90542d72-849a-4fd3-8804-c25b9f2fc1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_abe606f8-6ba1-429d-bfc4-595c05b8b71b" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_90542d72-849a-4fd3-8804-c25b9f2fc1c2" xlink:to="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_abe606f8-6ba1-429d-bfc4-595c05b8b71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_706f4d9f-e7a5-452f-8810-b1a0e70e24cc" xlink:href="sgmo-20230930.xsd#sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_90542d72-849a-4fd3-8804-c25b9f2fc1c2" xlink:to="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_706f4d9f-e7a5-452f-8810-b1a0e70e24cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_srt_ProductOrServiceAxis_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7b5d702e-5c58-40f6-9687-a2bca8df648b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_bf0a3c9e-e109-4aa4-a346-5ebbb3cf5283" xlink:to="loc_srt_ProductsAndServicesDomain_7b5d702e-5c58-40f6-9687-a2bca8df648b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_ed98bdbb-3d33-4210-84a8-624b6324ca40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7b5d702e-5c58-40f6-9687-a2bca8df648b" xlink:to="loc_us-gaap_LicenseAndServiceMember_ed98bdbb-3d33-4210-84a8-624b6324ca40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_fe06fdd0-46a7-4f07-9905-beb663d8fcf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LicenseAndServiceMember_ed98bdbb-3d33-4210-84a8-624b6324ca40" xlink:to="loc_us-gaap_LicenseMember_fe06fdd0-46a7-4f07-9905-beb663d8fcf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b2672e91-bbe9-498d-962b-3a8a472b3739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b2672e91-bbe9-498d-962b-3a8a472b3739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a2636f52-548c-4d9c-a585-8345ae5c625b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a2636f52-548c-4d9c-a585-8345ae5c625b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_8713c103-0c3f-4ec2-901d-dc4d3341727b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_a2636f52-548c-4d9c-a585-8345ae5c625b" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_8713c103-0c3f-4ec2-901d-dc4d3341727b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInAgreementEstimateMarch2023Member_ffdca726-c898-4210-a95c-500361f17fd9" xlink:href="sgmo-20230930.xsd#sgmo_ChangeInAgreementEstimateMarch2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_8713c103-0c3f-4ec2-901d-dc4d3341727b" xlink:to="loc_sgmo_ChangeInAgreementEstimateMarch2023Member_ffdca726-c898-4210-a95c-500361f17fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInAgreementEstimateSeptember2023Member_c1ac2ffb-f8a0-4c1f-b2c7-ff6f51c7ae28" xlink:href="sgmo-20230930.xsd#sgmo_ChangeInAgreementEstimateSeptember2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_8713c103-0c3f-4ec2-901d-dc4d3341727b" xlink:to="loc_sgmo_ChangeInAgreementEstimateSeptember2023Member_c1ac2ffb-f8a0-4c1f-b2c7-ff6f51c7ae28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1216e498-612d-4cfd-b9a8-2518b4d3b13e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestonePaymentsReceived_cd477ed3-2a83-4e76-84a2-0e7bb4446c4e" xlink:href="sgmo-20230930.xsd#sgmo_MilestonePaymentsReceived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_MilestonePaymentsReceived_cd477ed3-2a83-4e76-84a2-0e7bb4446c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_5aa58236-f2bb-4037-8513-96735cc81eb4" xlink:href="sgmo-20230930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_5aa58236-f2bb-4037-8513-96735cc81eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_a0e7b564-880d-4a8e-a35d-080f608bbeb0" xlink:href="sgmo-20230930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_a0e7b564-880d-4a8e-a35d-080f608bbeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment_ca7b4a76-bc35-4dd6-afcc-4f0b9adfc86a" xlink:href="sgmo-20230930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment_ca7b4a76-bc35-4dd6-afcc-4f0b9adfc86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_InitialResearchTermOfAgreement_d195e79f-2896-4de2-81a9-481f781af954" xlink:href="sgmo-20230930.xsd#sgmo_InitialResearchTermOfAgreement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_InitialResearchTermOfAgreement_d195e79f-2896-4de2-81a9-481f781af954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm_3e6c24e3-7fdb-4bbb-868e-b2284f5be0d5" xlink:href="sgmo-20230930.xsd#sgmo_NumberOfOptionsToExtendInitialResearchTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm_3e6c24e3-7fdb-4bbb-868e-b2284f5be0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExtendedResearchTermOfAgreement_635f63e9-c415-4a05-95ca-d61bded3c161" xlink:href="sgmo-20230930.xsd#sgmo_ExtendedResearchTermOfAgreement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_ExtendedResearchTermOfAgreement_635f63e9-c415-4a05-95ca-d61bded3c161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SeparateUpfrontFee_445049cf-ec05-4fe5-8798-3b231a4b0a15" xlink:href="sgmo-20230930.xsd#sgmo_SeparateUpfrontFee"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_SeparateUpfrontFee_445049cf-ec05-4fe5-8798-3b231a4b0a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_9d40c92b-8f96-4f8e-9159-5dc6a7e4ad6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_ContractWithCustomerLiability_9d40c92b-8f96-4f8e-9159-5dc6a7e4ad6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueNumberOfRemainingPerformanceObligations_fffe0c18-9e18-4185-bcd8-72eb38fe5a6c" xlink:href="sgmo-20230930.xsd#sgmo_RevenueNumberOfRemainingPerformanceObligations"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueNumberOfRemainingPerformanceObligations_fffe0c18-9e18-4185-bcd8-72eb38fe5a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod_393539a0-10f3-4d72-81a8-4e4eb3dbe3b2" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod_393539a0-10f3-4d72-81a8-4e4eb3dbe3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod_4df58a41-7317-4f0a-a39c-23eecf61037d" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationRenewalPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod_4df58a41-7317-4f0a-a39c-23eecf61037d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_6bc6468e-db3b-4605-8d6f-5056d10fe5e1" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_6bc6468e-db3b-4605-8d6f-5056d10fe5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3facc2d0-e302-4369-bb14-9578df30e375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3facc2d0-e302-4369-bb14-9578df30e375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7dfaf5eb-0a78-485d-bcae-f66da7bd7f95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7dfaf5eb-0a78-485d-bcae-f66da7bd7f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount_e525f8e5-46d1-4740-9645-b06f06b48f2b" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount_e525f8e5-46d1-4740-9645-b06f06b48f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5271fd13-c7af-402c-9200-9becac39ea3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5271fd13-c7af-402c-9200-9becac39ea3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_aebcb38c-a0d3-4d46-ae49-f3a6b71b371b" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_aebcb38c-a0d3-4d46-ae49-f3a6b71b371b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_6da8a7fd-6a63-4335-a6a5-9cf18a080324" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent_6da8a7fd-6a63-4335-a6a5-9cf18a080324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInEarningsPerShareBasic_ab73661c-3f9a-48f7-b073-71ac7de4688d" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInEarningsPerShareBasic"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_IncreaseDecreaseInEarningsPerShareBasic_ab73661c-3f9a-48f7-b073-71ac7de4688d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_ab19a780-8d75-46aa-9b0d-3466d272ff0f" xlink:href="sgmo-20230930.xsd#sgmo_IncreaseDecreaseInEarningsPerShareDiluted"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e17e7cc5-6d2c-49f1-b11d-ad27010411ad" xlink:to="loc_sgmo_IncreaseDecreaseInEarningsPerShareDiluted_ab19a780-8d75-46aa-9b0d-3466d272ff0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails_1" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails_1"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b000d478-ef5b-4a79-bf36-6e41c81fbf4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_72d110a0-da2b-4033-9863-610c7623998f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b000d478-ef5b-4a79-bf36-6e41c81fbf4e" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_72d110a0-da2b-4033-9863-610c7623998f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_fb0a4087-bcd8-40ca-bae0-9ef2af6520e1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_72d110a0-da2b-4033-9863-610c7623998f" xlink:to="loc_srt_CounterpartyNameAxis_fb0a4087-bcd8-40ca-bae0-9ef2af6520e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_391edf36-243c-4245-89ff-94031b0fc5d7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_fb0a4087-bcd8-40ca-bae0-9ef2af6520e1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_391edf36-243c-4245-89ff-94031b0fc5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_cd91c30f-4e2b-47ab-961c-c5300ae9acbf" xlink:href="sgmo-20230930.xsd#sgmo_KitePharmaIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_391edf36-243c-4245-89ff-94031b0fc5d7" xlink:to="loc_sgmo_KitePharmaIncMember_cd91c30f-4e2b-47ab-961c-c5300ae9acbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_9059f7fb-940a-49d0-a945-b5af2d31c98f" xlink:href="sgmo-20230930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_391edf36-243c-4245-89ff-94031b0fc5d7" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_9059f7fb-940a-49d0-a945-b5af2d31c98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_43593823-d15c-48e8-9061-40aff1c7d26d" xlink:href="sgmo-20230930.xsd#sgmo_BiogenMAIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_391edf36-243c-4245-89ff-94031b0fc5d7" xlink:to="loc_sgmo_BiogenMAIncMember_43593823-d15c-48e8-9061-40aff1c7d26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bee0ae7e-5ce2-4271-a00d-243a9468387b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_72d110a0-da2b-4033-9863-610c7623998f" xlink:to="loc_srt_ProductOrServiceAxis_bee0ae7e-5ce2-4271-a00d-243a9468387b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bdaf85e1-774e-4466-b613-ae1c030e9bae" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_bee0ae7e-5ce2-4271-a00d-243a9468387b" xlink:to="loc_srt_ProductsAndServicesDomain_bdaf85e1-774e-4466-b613-ae1c030e9bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_6847bc9b-4d63-4c6c-88b6-b2d950949014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bdaf85e1-774e-4466-b613-ae1c030e9bae" xlink:to="loc_us-gaap_LicenseMember_6847bc9b-4d63-4c6c-88b6-b2d950949014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_718bbdbe-bc3e-4b94-9a63-f8366aa47084" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bdaf85e1-774e-4466-b613-ae1c030e9bae" xlink:to="loc_us-gaap_ServiceMember_718bbdbe-bc3e-4b94-9a63-f8366aa47084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_eafb897c-21c2-4ce8-b9c6-fc7995f87142" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_72d110a0-da2b-4033-9863-610c7623998f" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_eafb897c-21c2-4ce8-b9c6-fc7995f87142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_fbd75a12-60d9-4907-9010-51f94408e495" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_eafb897c-21c2-4ce8-b9c6-fc7995f87142" xlink:to="loc_us-gaap_RevenuesAbstract_fbd75a12-60d9-4907-9010-51f94408e495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c7f7503-8341-4111-aacd-485ea5b4a7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_fbd75a12-60d9-4907-9010-51f94408e495" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c7f7503-8341-4111-aacd-485ea5b4a7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fe851f2d-0aa5-4e35-8605-39d66f5d4869" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1f2044df-2291-46cc-91f1-9f4a4fa3d894" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fe851f2d-0aa5-4e35-8605-39d66f5d4869" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1f2044df-2291-46cc-91f1-9f4a4fa3d894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_49972b3f-cefa-4851-a414-d98a0d412585" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1f2044df-2291-46cc-91f1-9f4a4fa3d894" xlink:to="loc_srt_CounterpartyNameAxis_49972b3f-cefa-4851-a414-d98a0d412585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0602388e-64ee-4b26-8052-c65a7b452a52" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_49972b3f-cefa-4851-a414-d98a0d412585" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0602388e-64ee-4b26-8052-c65a7b452a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_2c8e5423-eb6a-4cce-987f-8ef10921b833" xlink:href="sgmo-20230930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0602388e-64ee-4b26-8052-c65a7b452a52" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_2c8e5423-eb6a-4cce-987f-8ef10921b833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_6f05a37b-8f75-49f6-9ede-81c86c3d692a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1f2044df-2291-46cc-91f1-9f4a4fa3d894" xlink:to="loc_us-gaap_TypeOfArrangementAxis_6f05a37b-8f75-49f6-9ede-81c86c3d692a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_719dbc77-0920-4320-9082-f0b6af0358ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_6f05a37b-8f75-49f6-9ede-81c86c3d692a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_719dbc77-0920-4320-9082-f0b6af0358ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_8fadd970-33ae-441c-946a-643379d43b4a" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_719dbc77-0920-4320-9082-f0b6af0358ab" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_8fadd970-33ae-441c-946a-643379d43b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1f2044df-2291-46cc-91f1-9f4a4fa3d894" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_5ef03b15-8eaa-4306-aeae-adfa3f5695bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_us-gaap_ProceedsFromCollaborators_5ef03b15-8eaa-4306-aeae-adfa3f5695bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_93f971aa-ab77-4905-a516-eac257f5334e" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_93f971aa-ab77-4905-a516-eac257f5334e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementLicenseFee_8a135d56-f3f1-4b7c-8e52-e7bd87604cd8" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementLicenseFee"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_sgmo_CollaborativeArrangementLicenseFee_8a135d56-f3f1-4b7c-8e52-e7bd87604cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_99e469d7-6487-4c39-9523-6757ad462ce5" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_99e469d7-6487-4c39-9523-6757ad462ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_812af4b0-9458-467c-9386-3f91e4364ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_812af4b0-9458-467c-9386-3f91e4364ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_4b252bb2-1ccd-4c06-9e64-861cfe3ebab5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_95a6d6ae-5400-4a29-a3a1-f5a9a64321be" xlink:to="loc_us-gaap_ContractWithCustomerLiability_4b252bb2-1ccd-4c06-9e64-861cfe3ebab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4847b7b1-52c2-46c2-bfb3-f70f81de1777" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4be3fe96-c523-46d6-9547-99eca0fb4422" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4847b7b1-52c2-46c2-bfb3-f70f81de1777" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4be3fe96-c523-46d6-9547-99eca0fb4422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_64a9d038-3c27-4ef2-ae7a-2ca8df941ac5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4be3fe96-c523-46d6-9547-99eca0fb4422" xlink:to="loc_srt_CounterpartyNameAxis_64a9d038-3c27-4ef2-ae7a-2ca8df941ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_df1ae68a-51f7-4da5-9a19-328a52ec12d1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_64a9d038-3c27-4ef2-ae7a-2ca8df941ac5" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_df1ae68a-51f7-4da5-9a19-328a52ec12d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_10bbead9-3868-4628-95ef-80e9e84a26cd" xlink:href="sgmo-20230930.xsd#sgmo_BiogenMAIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_df1ae68a-51f7-4da5-9a19-328a52ec12d1" xlink:to="loc_sgmo_BiogenMAIncMember_10bbead9-3868-4628-95ef-80e9e84a26cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_09737444-33b7-4ed7-95d0-4d519e0ff50f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4be3fe96-c523-46d6-9547-99eca0fb4422" xlink:to="loc_us-gaap_TypeOfArrangementAxis_09737444-33b7-4ed7-95d0-4d519e0ff50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5af3602-6a70-4ac0-85ed-26424acca964" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_09737444-33b7-4ed7-95d0-4d519e0ff50f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5af3602-6a70-4ac0-85ed-26424acca964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_StockPurchaseAgreementMember_42de198f-6beb-4b9a-b6ec-ff68858f27b5" xlink:href="sgmo-20230930.xsd#sgmo_StockPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5af3602-6a70-4ac0-85ed-26424acca964" xlink:to="loc_sgmo_StockPurchaseAgreementMember_42de198f-6beb-4b9a-b6ec-ff68858f27b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_d817e479-50d9-4192-988e-a073ab1234e5" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e5af3602-6a70-4ac0-85ed-26424acca964" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_d817e479-50d9-4192-988e-a073ab1234e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_62508d5f-1201-4e3f-8a71-48ec7e5eb36e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4be3fe96-c523-46d6-9547-99eca0fb4422" xlink:to="loc_srt_ProductOrServiceAxis_62508d5f-1201-4e3f-8a71-48ec7e5eb36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_df4a01c4-a16c-4d32-aca4-fd6ae229fca2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_62508d5f-1201-4e3f-8a71-48ec7e5eb36e" xlink:to="loc_srt_ProductsAndServicesDomain_df4a01c4-a16c-4d32-aca4-fd6ae229fca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_7f1f4470-f87c-45c3-8a68-0f3452a06ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_df4a01c4-a16c-4d32-aca4-fd6ae229fca2" xlink:to="loc_us-gaap_LicenseAndServiceMember_7f1f4470-f87c-45c3-8a68-0f3452a06ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_4be3fe96-c523-46d6-9547-99eca0fb4422" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_62ffbd77-f671-464c-8473-484b48b3b496" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_62ffbd77-f671-464c-8473-484b48b3b496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_bd105985-461c-4e55-940f-7dda9434f407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_bd105985-461c-4e55-940f-7dda9434f407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_922a697b-9510-443d-9e26-8bc37fb1e6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_922a697b-9510-443d-9e26-8bc37fb1e6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_b5e99c10-2628-4857-aa54-729f44059732" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_ProceedsFromCollaborators_b5e99c10-2628-4857-aa54-729f44059732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty_13cf2db3-0c9a-4a95-a12b-bb35a01de215" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty_13cf2db3-0c9a-4a95-a12b-bb35a01de215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_8e73df6e-9715-4c0e-93df-ca1c0372308d" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAgreementNumberOfAdditionalProductTargets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_8e73df6e-9715-4c0e-93df-ca1c0372308d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_32f79930-6fd4-4ec5-8698-c793ee60301b" xlink:href="sgmo-20230930.xsd#sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_32f79930-6fd4-4ec5-8698-c793ee60301b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementEquityIssued_5432122d-1588-4a98-8403-670fda2333b2" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationAgreementEquityIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_CollaborationAgreementEquityIssued_5432122d-1588-4a98-8403-670fda2333b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_41f82ee2-7748-4123-bd41-83667f0291a6" xlink:href="sgmo-20230930.xsd#sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount_41f82ee2-7748-4123-bd41-83667f0291a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_2d022b18-e15d-4690-930b-fbd063436629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_2d022b18-e15d-4690-930b-fbd063436629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ff376c15-cc14-4d07-bc89-d5825a1291b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ff376c15-cc14-4d07-bc89-d5825a1291b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_2a43d6a9-4ee3-497b-978c-f21c8400c894" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_ContractWithCustomerLiability_2a43d6a9-4ee3-497b-978c-f21c8400c894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_37c8705f-f3aa-42a5-8bb5-986d491f8a98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_37c8705f-f3aa-42a5-8bb5-986d491f8a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_6aad20fb-84ad-4bc1-831e-41844f4f561f" xlink:href="sgmo-20230930.xsd#sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_6aad20fb-84ad-4bc1-831e-41844f4f561f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition_dc1a3714-af76-493c-8e30-4679bcd4fc60" xlink:href="sgmo-20230930.xsd#sgmo_CollaborativeAgreementPercentOfInitialRecognition"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition_dc1a3714-af76-493c-8e30-4679bcd4fc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_366ff414-9dc0-4f90-b2af-8205b422ee98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_366ff414-9dc0-4f90-b2af-8205b422ee98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_784f8b5a-31eb-43da-a2dc-805fab74ff0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_784f8b5a-31eb-43da-a2dc-805fab74ff0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_5ce86106-451d-4919-bbe1-e7a43f42efc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1787106c-b991-42fe-93a2-be761926caab" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_5ce86106-451d-4919-bbe1-e7a43f42efc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5291485a-1302-49a8-8d26-9bde298e75cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_8bd4b0e7-5cb4-43b8-8fd4-dfd16c99d9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5291485a-1302-49a8-8d26-9bde298e75cf" xlink:to="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_8bd4b0e7-5cb4-43b8-8fd4-dfd16c99d9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_18ba7cf5-55cb-42b2-b46f-258483c051da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_8bd4b0e7-5cb4-43b8-8fd4-dfd16c99d9a4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_18ba7cf5-55cb-42b2-b46f-258483c051da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce0ddec7-37e5-4eaf-ab48-0e6015a03b25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_18ba7cf5-55cb-42b2-b46f-258483c051da" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce0ddec7-37e5-4eaf-ab48-0e6015a03b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_23a3d12e-6683-449f-a5fa-ae38a42bf9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce0ddec7-37e5-4eaf-ab48-0e6015a03b25" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_23a3d12e-6683-449f-a5fa-ae38a42bf9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_1107510f-bb31-4d45-9362-6f148a43b892" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce0ddec7-37e5-4eaf-ab48-0e6015a03b25" xlink:to="loc_us-gaap_ConstructionInProgressMember_1107510f-bb31-4d45-9362-6f148a43b892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_LeaseholdImprovementsAndConstructionInProgressMember_147fe502-01d0-4000-ab2f-58a8ba2bc2c4" xlink:href="sgmo-20230930.xsd#sgmo_LeaseholdImprovementsAndConstructionInProgressMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce0ddec7-37e5-4eaf-ab48-0e6015a03b25" xlink:to="loc_sgmo_LeaseholdImprovementsAndConstructionInProgressMember_147fe502-01d0-4000-ab2f-58a8ba2bc2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember_c638e827-de7b-4279-9ad6-6de5c24dd497" xlink:href="sgmo-20230930.xsd#sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ce0ddec7-37e5-4eaf-ab48-0e6015a03b25" xlink:to="loc_sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember_c638e827-de7b-4279-9ad6-6de5c24dd497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_8bd4b0e7-5cb4-43b8-8fd4-dfd16c99d9a4" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_5933f904-1d86-49ae-bdcb-6ef4a3b4e8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_5933f904-1d86-49ae-bdcb-6ef4a3b4e8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_fbe7bae8-2473-4851-b920-a8cb790b7fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_fbe7bae8-2473-4851-b920-a8cb790b7fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_ea549ec0-a37a-4519-837a-a2344fc51ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_ea549ec0-a37a-4519-837a-a2344fc51ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4d86fcbb-6371-4490-9b5f-e1d84f327007" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4d86fcbb-6371-4490-9b5f-e1d84f327007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount_23e284fe-d46e-4109-8c6d-bc780e5ca8bf" xlink:href="sgmo-20230930.xsd#sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_0b4add0c-a91a-4d9a-8e33-438646fcd6bd" xlink:to="loc_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount_23e284fe-d46e-4109-8c6d-bc780e5ca8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8f1e56b-125b-45b8-b5d0-e8ce8b81c8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d3e0591-9900-49eb-a7a4-0b5bde565be1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8f1e56b-125b-45b8-b5d0-e8ce8b81c8d7" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d3e0591-9900-49eb-a7a4-0b5bde565be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2e375ec8-5c2a-452a-b8da-9c0dd439633e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d3e0591-9900-49eb-a7a4-0b5bde565be1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2e375ec8-5c2a-452a-b8da-9c0dd439633e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_139c6703-bd20-4f7b-95e3-e147d305a445" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2e375ec8-5c2a-452a-b8da-9c0dd439633e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_139c6703-bd20-4f7b-95e3-e147d305a445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_61dbac46-36d4-4dbf-bc2a-c6b89c1570b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_139c6703-bd20-4f7b-95e3-e147d305a445" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_61dbac46-36d4-4dbf-bc2a-c6b89c1570b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_278ebb49-11de-46df-9bdc-f5236d9137f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_139c6703-bd20-4f7b-95e3-e147d305a445" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_278ebb49-11de-46df-9bdc-f5236d9137f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7ec7cde3-cfb0-4e2a-a3c4-7a7d3aa412c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6d3e0591-9900-49eb-a7a4-0b5bde565be1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7ec7cde3-cfb0-4e2a-a3c4-7a7d3aa412c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0e9b68de-295e-4fb4-8c0e-9aa24df109df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7ec7cde3-cfb0-4e2a-a3c4-7a7d3aa412c8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0e9b68de-295e-4fb4-8c0e-9aa24df109df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#STOCKHOLDERSEQUITYDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_acebfa25-6627-4d20-8f12-d65a5e65a055" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061fb694-3ef7-4145-8084-8c8c6a88b66a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_acebfa25-6627-4d20-8f12-d65a5e65a055" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061fb694-3ef7-4145-8084-8c8c6a88b66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5fe0108f-0934-457b-8a90-646550c34ec2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061fb694-3ef7-4145-8084-8c8c6a88b66a" xlink:to="loc_srt_CounterpartyNameAxis_5fe0108f-0934-457b-8a90-646550c34ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6f7223f6-8ee0-445c-941d-314e2b5cec1a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_5fe0108f-0934-457b-8a90-646550c34ec2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6f7223f6-8ee0-445c-941d-314e2b5cec1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_JefferiesLLCMember_94a51da9-9314-4b32-86b1-0ec27ec30437" xlink:href="sgmo-20230930.xsd#sgmo_JefferiesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6f7223f6-8ee0-445c-941d-314e2b5cec1a" xlink:to="loc_sgmo_JefferiesLLCMember_94a51da9-9314-4b32-86b1-0ec27ec30437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4ea4e460-1a14-4177-824c-29696185a09e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061fb694-3ef7-4145-8084-8c8c6a88b66a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4ea4e460-1a14-4177-824c-29696185a09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f587f18-7cf7-47e3-afa9-5eb4475164ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4ea4e460-1a14-4177-824c-29696185a09e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f587f18-7cf7-47e3-afa9-5eb4475164ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AtTheMarketOfferingAgreementMember_1de86c8b-c407-41a3-b545-6cbf41ae93da" xlink:href="sgmo-20230930.xsd#sgmo_AtTheMarketOfferingAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f587f18-7cf7-47e3-afa9-5eb4475164ee" xlink:to="loc_sgmo_AtTheMarketOfferingAgreementMember_1de86c8b-c407-41a3-b545-6cbf41ae93da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14fdf9f8-4ec2-4260-8d49-2a1d1a824f28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_061fb694-3ef7-4145-8084-8c8c6a88b66a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14fdf9f8-4ec2-4260-8d49-2a1d1a824f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_StockOfferingProgramMaximumValue_177bed66-a1f2-46ac-95f6-f0de1a00a49b" xlink:href="sgmo-20230930.xsd#sgmo_StockOfferingProgramMaximumValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14fdf9f8-4ec2-4260-8d49-2a1d1a824f28" xlink:to="loc_sgmo_StockOfferingProgramMaximumValue_177bed66-a1f2-46ac-95f6-f0de1a00a49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice_cb9c8895-893b-4064-b743-a766fbd6fd84" xlink:href="sgmo-20230930.xsd#sgmo_SaleOfStockIncreaseToAggregateOfferingPrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14fdf9f8-4ec2-4260-8d49-2a1d1a824f28" xlink:to="loc_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice_cb9c8895-893b-4064-b743-a766fbd6fd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cec6f962-8474-4946-80eb-dd1126aea2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14fdf9f8-4ec2-4260-8d49-2a1d1a824f28" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cec6f962-8474-4946-80eb-dd1126aea2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_25c22c8f-b6fd-4787-a9d7-6e827b040f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_14fdf9f8-4ec2-4260-8d49-2a1d1a824f28" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_25c22c8f-b6fd-4787-a9d7-6e827b040f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#RESTRUCTURINGCHARGESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_773cf7ac-d78f-49dd-b7e3-6f77fc7de5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60e49eba-4284-4253-8653-34cfdfef2bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_773cf7ac-d78f-49dd-b7e3-6f77fc7de5d3" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60e49eba-4284-4253-8653-34cfdfef2bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_bc422eb8-c8ed-4956-b5ed-dc05ba73b05d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60e49eba-4284-4253-8653-34cfdfef2bfa" xlink:to="loc_srt_TitleOfIndividualAxis_bc422eb8-c8ed-4956-b5ed-dc05ba73b05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3f64ffeb-9056-4acd-9d82-0a30d47abb4f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_bc422eb8-c8ed-4956-b5ed-dc05ba73b05d" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3f64ffeb-9056-4acd-9d82-0a30d47abb4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_FullTimeEmployeesMember_c9c4e072-304b-4e47-92cc-f32bd2430340" xlink:href="sgmo-20230930.xsd#sgmo_FullTimeEmployeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3f64ffeb-9056-4acd-9d82-0a30d47abb4f" xlink:to="loc_sgmo_FullTimeEmployeesMember_c9c4e072-304b-4e47-92cc-f32bd2430340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContractedEmployeesMember_8e8f7f54-fdd3-441f-b186-d8f53ac97ab7" xlink:href="sgmo-20230930.xsd#sgmo_ContractedEmployeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3f64ffeb-9056-4acd-9d82-0a30d47abb4f" xlink:to="loc_sgmo_ContractedEmployeesMember_8e8f7f54-fdd3-441f-b186-d8f53ac97ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9e9a6624-f2e6-4867-b673-bcfbc7d09e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60e49eba-4284-4253-8653-34cfdfef2bfa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9e9a6624-f2e6-4867-b673-bcfbc7d09e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a5be9e62-2230-4875-b8ec-5cb883bc9a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9e9a6624-f2e6-4867-b673-bcfbc7d09e5a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a5be9e62-2230-4875-b8ec-5cb883bc9a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0f6ae204-8d4f-488b-afad-b2dd4dc14fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a5be9e62-2230-4875-b8ec-5cb883bc9a2d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_0f6ae204-8d4f-488b-afad-b2dd4dc14fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_6610b832-edd8-4a86-b833-48c01a4efdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a5be9e62-2230-4875-b8ec-5cb883bc9a2d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_6610b832-edd8-4a86-b833-48c01a4efdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_347b1662-b9f0-4c0b-92fb-0a85b9e3307f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60e49eba-4284-4253-8653-34cfdfef2bfa" xlink:to="loc_us-gaap_RestructuringPlanAxis_347b1662-b9f0-4c0b-92fb-0a85b9e3307f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_5e6ac2ad-42d3-4ada-8848-c08999cf6c23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_347b1662-b9f0-4c0b-92fb-0a85b9e3307f" xlink:to="loc_us-gaap_RestructuringPlanDomain_5e6ac2ad-42d3-4ada-8848-c08999cf6c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_April2023RestructuringPlanMember_4cf1c02b-49ee-4268-a73e-931348992ef8" xlink:href="sgmo-20230930.xsd#sgmo_April2023RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_5e6ac2ad-42d3-4ada-8848-c08999cf6c23" xlink:to="loc_sgmo_April2023RestructuringPlanMember_4cf1c02b-49ee-4268-a73e-931348992ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_abaebbe3-03a9-4ec6-8b7e-2e4242fd6e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60e49eba-4284-4253-8653-34cfdfef2bfa" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_abaebbe3-03a9-4ec6-8b7e-2e4242fd6e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_7556c64a-331f-4a4d-bd0e-9ad53f30b2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_abaebbe3-03a9-4ec6-8b7e-2e4242fd6e4e" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_7556c64a-331f-4a4d-bd0e-9ad53f30b2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_19987266-4eeb-46da-b002-beb71dc85914" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_abaebbe3-03a9-4ec6-8b7e-2e4242fd6e4e" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_19987266-4eeb-46da-b002-beb71dc85914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_056a0a5d-b386-47e8-ac56-8238e9acb277" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_abaebbe3-03a9-4ec6-8b7e-2e4242fd6e4e" xlink:to="loc_us-gaap_RestructuringCharges_056a0a5d-b386-47e8-ac56-8238e9acb277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/RESTRUCTURINGCHARGESAccruedRestructuringCostsDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#RESTRUCTURINGCHARGESAccruedRestructuringCostsDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/RESTRUCTURINGCHARGESAccruedRestructuringCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9a59df8d-cdb6-4df9-88ff-9ef6e9f4768d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_6f4ad2d0-0956-4455-98bb-a1c0b5da155b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9a59df8d-cdb6-4df9-88ff-9ef6e9f4768d" xlink:to="loc_us-gaap_RestructuringReserveRollForward_6f4ad2d0-0956-4455-98bb-a1c0b5da155b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c06b2731-f1d1-457a-b41c-0285d9d529ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6f4ad2d0-0956-4455-98bb-a1c0b5da155b" xlink:to="loc_us-gaap_RestructuringReserve_c06b2731-f1d1-457a-b41c-0285d9d529ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_73db0c43-6223-40b6-9f80-2f1d563fcfce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6f4ad2d0-0956-4455-98bb-a1c0b5da155b" xlink:to="loc_us-gaap_RestructuringCharges_73db0c43-6223-40b6-9f80-2f1d563fcfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_25a17767-4f8b-49a7-b53d-2eedaf8f7554" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6f4ad2d0-0956-4455-98bb-a1c0b5da155b" xlink:to="loc_us-gaap_PaymentsForRestructuring_25a17767-4f8b-49a7-b53d-2eedaf8f7554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_88cd2536-ce11-4839-b230-030a1b98f023" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6f4ad2d0-0956-4455-98bb-a1c0b5da155b" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_88cd2536-ce11-4839-b230-030a1b98f023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_be50bc34-8fb3-4d7c-9837-1c2d5946f994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6f4ad2d0-0956-4455-98bb-a1c0b5da155b" xlink:to="loc_us-gaap_RestructuringReserve_be50bc34-8fb3-4d7c-9837-1c2d5946f994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6f40496d-d830-4185-ad89-50565af42489" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f747a03e-029f-47e6-8f59-03f42a6258d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6f40496d-d830-4185-ad89-50565af42489" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f747a03e-029f-47e6-8f59-03f42a6258d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="sgmo-20230930.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_05b44a42-2e81-476c-812e-c05286711e12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_05b44a42-2e81-476c-812e-c05286711e12" xlink:to="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2fb1fb4e-a93e-46a3-bd62-d07660e16991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2fb1fb4e-a93e-46a3-bd62-d07660e16991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0e2e3a62-3f62-4ab7-94b0-a71b35b8feb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2fb1fb4e-a93e-46a3-bd62-d07660e16991" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0e2e3a62-3f62-4ab7-94b0-a71b35b8feb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_719276e2-e388-4fbe-a814-c78ed8ee7d43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0e2e3a62-3f62-4ab7-94b0-a71b35b8feb2" xlink:to="loc_us-gaap_SubsequentEventMember_719276e2-e388-4fbe-a814-c78ed8ee7d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_b721c84b-f2bf-4c1a-a6b7-87573ffc44dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:to="loc_us-gaap_RestructuringPlanAxis_b721c84b-f2bf-4c1a-a6b7-87573ffc44dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_e0341ee8-f9bc-45a0-a1e9-f5c95152a8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_b721c84b-f2bf-4c1a-a6b7-87573ffc44dd" xlink:to="loc_us-gaap_RestructuringPlanDomain_e0341ee8-f9bc-45a0-a1e9-f5c95152a8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_November2023RestructuringPlanMember_66d5cf82-fb7a-458b-9b12-71d9c757f2dc" xlink:href="sgmo-20230930.xsd#sgmo_November2023RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_e0341ee8-f9bc-45a0-a1e9-f5c95152a8dc" xlink:to="loc_sgmo_November2023RestructuringPlanMember_66d5cf82-fb7a-458b-9b12-71d9c757f2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9d511d71-41be-4273-bd58-a060b6d16970" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:to="loc_srt_RangeAxis_9d511d71-41be-4273-bd58-a060b6d16970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_13947b44-6245-4e0d-86e6-fd7f2266c740" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9d511d71-41be-4273-bd58-a060b6d16970" xlink:to="loc_srt_RangeMember_13947b44-6245-4e0d-86e6-fd7f2266c740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0570574c-95c5-4890-921c-4583bb0fc3c7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_13947b44-6245-4e0d-86e6-fd7f2266c740" xlink:to="loc_srt_MinimumMember_0570574c-95c5-4890-921c-4583bb0fc3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_364161a3-8c7e-4d4b-b108-a23711a37027" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_13947b44-6245-4e0d-86e6-fd7f2266c740" xlink:to="loc_srt_MaximumMember_364161a3-8c7e-4d4b-b108-a23711a37027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7089eeae-d5f2-4632-969f-cfdb6231a1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:to="loc_us-gaap_PlanNameAxis_7089eeae-d5f2-4632-969f-cfdb6231a1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f57915d5-e702-4ef0-a366-def0ec9d9ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_7089eeae-d5f2-4632-969f-cfdb6231a1fa" xlink:to="loc_us-gaap_PlanNameDomain_f57915d5-e702-4ef0-a366-def0ec9d9ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember_55b157fc-2a68-4db7-90a2-7d00a1666f9c" xlink:href="sgmo-20230930.xsd#sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f57915d5-e702-4ef0-a366-def0ec9d9ab8" xlink:to="loc_sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember_55b157fc-2a68-4db7-90a2-7d00a1666f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_124aedba-d3ef-4ec2-9c20-1b0bb03a541a" xlink:to="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_5ad1f67c-9edd-4d20-9eed-c805619bc8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_5ad1f67c-9edd-4d20-9eed-c805619bc8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_8ffdd13e-30bd-4b75-bfc2-3763fb798316" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_8ffdd13e-30bd-4b75-bfc2-3763fb798316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_cf73d301-c247-46a1-86d2-1e31c6492f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_cf73d301-c247-46a1-86d2-1e31c6492f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod_a7ffe7d8-c751-426c-a9ed-9286afa36971" xlink:href="sgmo-20230930.xsd#sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:to="loc_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod_a7ffe7d8-c751-426c-a9ed-9286afa36971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod_ed1a27f5-bb12-453c-b24d-0f04888b6a7a" xlink:href="sgmo-20230930.xsd#sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d3973520-804c-4b55-8a4a-fc9602c3130f" xlink:to="loc_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod_ed1a27f5-bb12-453c-b24d-0f04888b6a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>sangamoexecutiveseveranc001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]X)UKQG\$=)MRC_V]:.UR\,WRM(^YPZG/ 8YS]1[UO7_ (N6Y^&4PAFN]/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>(=2,=G?Q6MDHO61LO(Z #!^8\+USTH [+_A7OB7_HI&M_\ ?I*/^%>^)?\
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M"-;M@R-F+G=U/WVZU'\6[[Q!X-\&Z&UKKU\+[[4UO+<K,<S)ABI8=-V .0*
M.G_X5[XE_P"BD:W_ -^DH_X5[XE_Z*1K?_?I*T;2S6\UZ*71M>U"5--N1'?0
M/>&:*4-&3MYS\P+(>M<?<ZAJDW[0'_"-?VQJ,>DR6OF^1'<L,-Y6[(.<]><4
M ;__  KWQ+_T4C6_^_24?\*]\2_]%(UO_OTE9^B>+]6T/XMS^!=8O&U"SN$\
MW3[J55$J?)OV.5 ##AAG&<@>M=5\1KBXLO &LWUG<SVUU;6[2Q2PR%2K#Z=?
MH: ,7_A7OB7_ **1K?\ WZ2C_A7OB7_HI&M_]^DK!\'3W/BCP%I<;>)]3C\2
MW]K<S)(EX?E,<A4%DY&WE1T&>:V/BS8>)XO#(UKPUJU[;75BFZZMX9#MECQR
MP']Y>O'49]!0!-_PKWQ+_P!%(UO_ +])1_PKWQ+_ -%(UO\ [])4?A?7?^%D
M:=I%[I]U?6-O9@'4?*N'!>7&/(R3DCHQ;KC: <DXQ?'^K:CIOQ:\+:3;:O?6
MNFWX7[5$ERP5OG()R3\O'I0!O?\ "O?$O_12-;_[])1_PKWQ+_T4C6_^_25K
M>'H/-U+^V[#6[VZT9X;B!H;BY\U!)',%$B$\X(23N>U<GX+UW4OBEKNKZC+J
M%Y8^'K"40VEI9RF%IB<G=(ZX;I@X! Y]N0#6_P"%>^)?^BD:W_WZ2C_A7OB7
M_HI&M_\ ?I*Z"#0M1M=;D_XFU[/HTEFZ+!+,2\,NY2")/OMD ]22,'GFN'^!
M6LZKXCT35;S6-2N[V:*Z\F,RS$A5V@\#IG)Z]: -C_A7OB7_ **1K?\ WZ2C
M_A7OB7_HI&M_]^DJ_::1>ZE!>P1:UJ,*IJ[AY!<L7$"CB-2<X!) SUQGGI7&
MZ3=ZG>?'36_"TNMZK_9-M9B2&(7;AE;;$<[LY/+MUH Z/_A7OB7_ **1K?\
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M%=Z[>VVA1VGGF,WC(J'RE8G=G(&23UH Z3_A7OB7_HI&M_\ ?I*/^%>^)?\
MHI&M_P#?I*UM$TFYN].O9X];U*33]5M()K-I9R9;5F5B=K=<<H><]P>*Y/X/
M>(]3N;[Q!X=\27L]QK6FW!R\TI.Z(?*<#I@,,Y[AQ0!K?\*]\2_]%(UO_OTE
M'_"O?$O_ $4C6_\ OTE27D=U#\/_ !)KL>I:B'EMKB\L,W3_ +B-48Q;>>^
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M<:E\7-(\0Z<7CTV^MW35"%(WJ@ VL#V<;5Q_LFM+_A6^M_\ 11O$?_?:T?\
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M3SZ[6(ZU9^(UM)J/Q<\)7RZ5?7FF6RI]JD2PEDC4%R<-A3GCJ*ZG_A6^M_\
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M[1M/8V=G#:VRC>8[:#:/^^5'7\*XK_A6^M_]%&\1_P#?:T?\*WUO_HHWB/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(Y(XQ!YF0G13\PX/?N?6CQ=X3T_QGX=FTC4E&&&Z.95^:*0='7_#N"16]10
M#@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5SVN0ZT'OKVVU=K2T@M-T4,<$;EI &+%BP/'W1
M@>AKH:S/$4\-MX;U*6>5(HQ:R99V  ^4]S0!S'@^?Q)KWAC0];EUQF-W'ONH
M/LT0&TAA\A"Y!!P><YQBF>!_&EM+X?L8_$&N6[:K=7=Q#&)65'DQ,Z(-HP!]
MW ]<59^%5U;O\+="99XRL5J!(0P^0@G.?2O/?M>GK\![ETN+82G6=^0ZY+?;
M@0?KLY^GM0![-J6NZ7HXSJ%[%;X7>=Y^ZO3<<=%]SQ5V*6.>))8I%DC=0R.A
MR&!Z$'N*\NO=9TG3?'GB*T\3:E/8V>IQ026,_F%8;B$1!60,!C(;<<?[1]:[
M[PS9V>G^&[&TT^">"RCCQ!'.27"9.W.[D<<X/(Z4 8.O>)'B\>V'AJ353I$%
MQ9&XCN0B%KB7?M$2M(K*, 9(QDY&,=]C2I-2TY=4;7K^*6VMY=T%TZ+$/)V*
M27[9#;LG@<=!TK*\5?\ "*Z]J3^%_$T-M@VR7-O).VPY9G4['XPPV X!R0>X
M!KBK6YDT/P=XVL;N27Q+X9TXPQV,D[EMX;'F(77[RQDKDCI@].@ /4[;Q%H]
MV9Q%J$&;=!+*';840]'(;'RGUZ57A\8^'+BYL[>'6[&2:\_X]T68$R\D<?4@
MX]<<5Q&E:S8-\7$NI-;@O8I_#VU;A%586(GR50CJH&3R6(YR>*YRPN=/A^"7
M@YA/;1NNL6SD[E!#"X.XGW"]?:@#V6_US3-,=DO+V*%DC\UP3GRTSC>V/NKG
M^(X%,_X2/13:QW4>J6DT,LABC:"42>8X&2J[<[B!S@=J\\UK6M-T7QQXIAEU
M;38_[6T^W5EU&9H@C!'4;"%(=-IR>F">^3B0W^B:#;^!;"+4;*6)8)8K?7I'
M#1Q[8PK!.=N]^@W$@8Z$\4 =XWB?0DTV+46U:S6SF?RXY3* '?.-H]6SQCK4
M:^+_  XSWB#6[$M9@-<#SA\@)P#[\\<=^*\?N+^Q_P"%8>);66Z5I%\3DD3@
M*Q!ND.2,#!*@DC [\"NYN[C33\:](/FVNX:',$^9<C]XA7'X;L>V: .QM=<T
MJ]TC^UK;4+:33]I8W(D&P <')[8]Z6PUK3M3FF@L[N.6:$ R1='0'H2IY /8
M]#7COVH_\(YJMU9NL]C8>.&N[^.$[_\ 15D#$X'5<X;\,]J[6[\K5_BIX<U+
M1KB*>*WL;G[?- X93$X7RE8CCE]S >Q- '9:FEY)IERFGRI#>,A6&1UW!&/1
MB.^.N*XBZN_$%O\ $/3?#@\0S-;W5A+=/+]EAWAE8  ?+C'->@UYSJE_9I\=
MM$C:ZA#C29T*F09#%P0/J<'B@"?4M3UO0?$GA6VU+6U:UN+B\6[8Q1QI)&D;
MO&S''RD#&<$#BNNT[7M)U>PEOM/U&WN+6)F625)!M0KR0WI@<\UR?C2>S7XA
M>!(KF6 $75R^V1AQ^Y(4X/\ M8Q[URFJSO-_PLI-+/VEXK^RN7@MF!>2-5B,
MN /96!_$4 >IP>)=$N&N%CU2V#6R"68.X38AZ.<X^7_:Z5#!XQ\-W+NL.N6#
ME+?[4^)U^6+.-Y]!R.?<>M<MIFI>#M=U)==TW4I[^[@L9$DGDE8+;0L,E9,X
M )/0'GJ>QK!TB\TBQ_9\L+V73[6_CC@CBE4_=0F89+E?F 5L,1WQ0!Z?#XBT
M>=+IUU&W46BAKCS6\LQ*>A8-C /8G@U6M_&7ANZU"VL(-<L9+NY020PK,"SJ
M1D8^HY'J*X.UU*TN/B+K1&JIJ'VOPXOES(@$<I#R9\O:,%1ZY;T))K,BMK#5
M_@UX2L-,-N^L>?:-:B''F1RJX,CG'(PH8D__ %J /6=1\0:1I#[=0U""W( +
M;VP$!. 6/\()[G J5=8TY]0;3UO83>+#YY@#?/Y><;\=UR1S7F<FIZ+9^)/%
MNA>+[^YLOM]R980SLL=W;/$B!5P.2-I7 Y].]7([C3?#7Q%T%[I_[-T]O#;6
MEM]MDP0RRH1&6/5PN..M '4:SXZT32="&JI>17,3W MH_);<#(6"D$CIC/.>
MGUJ>74K.Z\0Z2EOXABC+QRM_9R%&-T".&.?F 7!.1UKRQ[R"3X8:U*'PMOXI
M,TVX$&)/MBG+ \CCUKL-;U33[GXH>!98+N!UD@ORC!Q\P9$"D>H.#@]^U '7
M7/B'2+*[%K<ZC;Q3%UB(9L!7;[JD] QXP#R<TZ[U[2[&=H;J]BB=2JMN/"EO
MN@GH"<C /)SQ7F_AS6M"&AZEX3\4Q+-K*:E.TMA*A,EXS3&2-T'\0.5P>V,G
M I_B2ZN-(U77=5T/4K>\7[3$NJ^'[L F5RD:AH2/F#%=F!@@D>V* /5JANTD
MDM)5BG>"0J=LB $J?H01^E4;;Q%I5WK]WH4-XC:I9QK+/;8(9%8 @],'J.AX
MR*NWD\-K9S3W$J11(A+.[!5 ]R: .+\">+C=_#_2M=\2ZO EQJ#,J^9LB4L)
M&0*@ !).!ZUU.F^(='UBYN;;3=2M;J:V($R0R!BF>GX>]>+6%Y8-^SMH$,MS
M;DK?PJ\;.O'^EDD$?[N3]*Z[6IA-\4;ZWTNYA6^F\)2QV^R0 ^9YN4Q[\Y'M
M0!W4?B'2)M02QCU&W:YD++&@;_6%?O!3T8CN!R.]:=>:^#=?\,:WH/AK3&MT
MEUK3%CC^PM&1+:2QKL=R/X0.3D]>!U(%=YINLZ?J[7BV%RLYL[AK6X !&R5<
M;EY';(Z<4 7JXBS\:7$OQ,ET.>()I=S Z:?/_P ]9X6/G@'VSC_MF?6MSQ5K
MT/A_1);AKB"*YE(@M1,X4-,Y"KU[ D$^@!-<)XW\/WNA>";'5;?5X99?#LD=
MY:EX1&9<??!?=SO!8G^\: /2+[6M+TRX@@OM0MK::<GRHY90K/@9) /8 'FL
M[_A-_#'V":^_MVQ^S0R>5(_FCY7QG&.O3GZ#-<EXHU_1M<NO &H07=M);W&J
M+*NYU^4&%^".Q!(!]#5C1[G3%^*?CAY)K0,+2S#,S+T".'S_ ..Y_#- '<-J
MM@FGQZ@;R'[)*%:.8."L@;[NW'7/;'6J9\5^'UTU]1;6+-+1)#"TCRA=L@ZH
M0>0W^SUKR31]4CT[P)\/-6N;B==&M&GAO9[9B3;.X98V;&2 /F!] WO5_P 8
M'PR?AWXKU+1[EKB/4);3SKN24M'<2K*O"9X)"XR1Q^(. #U*Q\0Z/J>HW&GV
M.I6MQ=VPS-#'(&9!G&<?7CV-<K\1/%JZ9X=G;2=96#4(KF&'"*K!B9%5X\D$
M;@I)P/F&,U5U>YMQ\5M'CTZXM5G?0[J.$*ZXR60QCZ<$@>QKC[G7M*?X$1Z7
M/<QQZQ9S0)=V<IQ.DJW*EV93SSDG=[^M 'LVI:[I>CC.H7L5OA=YW'[J]-QQ
MT7W/%/N=7T^UMH)Y;N(1W&/(*G=YN1D; ,EN.>,\<UYQ>:WI&G>._$%MXEU*
M>QLM4A@EL)_,*PW$(B"L@8#&0VXX_P!H^M-L[C3O"GCKP_\ :!)8>'7T62UT
MV6]8A8Y3-N(9F^Z6C"XW8.,#VH Z3X?ZW=:V?$;3ZC]OAMM6D@MI=JC$0CC(
M'R@#J3[UU5[?6NG6QN+RXC@B!"[G.,L3@ >I)X ZFN)^&UY9W.I^,A:S1N'U
MR29=A^\K1QX8>H)!Y[U>^(6J6>E6.CRWD$!5]4A6.ZN<^59OAB)FP1G&"!D@
M9/)H VQXFT3^S[B_;5+6.UMG,<\DD@3RG'\+ X*GV/-%IXFT._U,Z;::K:S7
MHC\SR$D!;;ZX_$?2O)KO4K(6/Q6B;41<--;1R1R2 *90;8 ,, #!. "!SQC/
M6MZ>[TZ/Q+\+O*N+55\FX V.H&#:X'X%L#ZT ;OQ"\4Q:1X3UAK#5TM-3M82
MR%55]KXRJ-N!4$CH#R>,5U6GR/-IMK)(VYWA1F/J2!7C']M6<7P>\5:'J]S%
M%XBB>\-U;3$"661I&=753RPVE<$<87VKV'1)XKG0K":%U>-K="K*<@_** .7
M\0ZGK$/Q$\/Z+9ZI);6>I0W#RA88V9#$H(VEE/7/.<T_PMXCU.Y\9>(?#.HR
M17?]EB*2*]BCV%ED7.QP.-P]L9P>!6+XS?3[OXN>$;*YO?*_T6]5_*N3$Z%D
M7;\RD$$X./6I_ ]W!X/U.[\&:PT$%X)#<6=\X"'4HF/#,W\4J]#GD^_6@#M)
MO$6CV]_'8S:C;I<22>2JLV 9/[F>F[_9SGVIUQKVEVMW]FGO8DE\Q(B">!(V
M-J$] QR,#J<BO*-#NO#^H>'F\+>)KF_.NV]VXETSS'5YIO-+J\>!R&)#;LX&
M23QS6EJ]U/H^K:CJ>AZE;ZC:/JD:ZCH%T 91/O10\)'()PK '(XS[4 =M8>,
M-+U'Q/J6APS+Y]B(PQ/&YV#EE'KM"@Y]_:KEIXCT:^N5MK;48))70R1@-_K$
M'5D/1@/49%<3'J=IIGC[X@1W<9FEFL[::*S'W[E$MWW!1WZ8SV)K"TS6M.N/
M$?PXNX=1MS;B&XB6VMES%:$VX"P@\L7Z ACDD X&: /1M \8Z5XB;4OLDZA+
M*X>(ESMW*@7<^#T&21^&:T+'7]*U.[DM+._AEN(T$C1 X;8>C 'JON.*\J:>
M63P;\0--L=TNIQ:[<73VD?\ K&@\Z-FX]&0,!Z\XS6L+SP_XI275?"]_>:CX
M@BTRX2W?S6S;;XS@.. "7V@ \YY' )H U/&WBU;4:2FCZRL<\FKV]K*D:JPF
M0R!9$#$'D=]IR.<UWE>)W?B+0KKX9>#K6*Z@2ZL=0T]+FV8@2V[QN%D++U7G
M/)ZY]Z]K5@ZAE(*D9!'<4 <-;7^LWWQ)UK0?[9GALK2TAN(O+AA+9?.024.1
MQQ6Y!J T2RO;O6]<AELEGVQ74P2/RP %*N5 &0X;GCKBN&2Y\.S_ !H\1?VK
M=V'EKI]LJ&>=5&X9R 2>O(XKHK?5O"&G>&]2T^WFMKG1[<LDH617CDDG9F\A
M3G!;YNF>-P]\ '3P:SIMS=0VT-[#)/-")XXU;)>,]''^S[U$_B+1X]1CL'U&
MW6YDD,2(6QN<=4!Z%O\ 9SGVKA/ LW_"*ZY=>#]7GB&I/ DVG3O-O\RWP0L&
M3WC.X <9!+8ZUC^&;KP[JGAO3_#FO7%^?$%A<*LFEF1UD-RC$AUP.A/S;LX
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M"!1!:0PWP@ANWS(JF-?+R&Y!/8'D=.HJ/Q3J>FQW_C71X?(TJX3253:B9FU
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M1-"0T4+'Y/-*C QTWMC.*U[S6M.L8XGFN0?.0O&L2F5G48)8*H)*C(YQCD4
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MPUXKTN_M=*TV35(I=7EL8Y7C)^9VV OST)&<D#D4 =*(T"; B[/[N.*7 SG
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MAJ.Z6*U\Z2<)JLJ;OLIV ;$SP'?. 6R.#P:[6B@#P>YO+3_A6WBFSDE=I?\
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MELD]LYIEOY.H?%?^W=.N8I-.@T8P7=S$X,3N9-R+N'!( 8GT!'J*[ND  &
M!Z"@#A?A1=6\_A>[2*9'8:G=L55LD!IF(./0@@UL>/?#\OBGP-JVC6[ 3W$/
M[K<< NK!E!/8$J!^-='10!R/A_Q?I4?A>S_M2[BL+ZV@2*ZL[A@DT<BC!78?
MF.2., YXQ7 R:3JNB^'I?%=U8W CNO%":S=V80F2.S!;;N7^\"5<CM@9Q@U[
M654L&*C(Z'%+0!Y_JNI:'XG\+^*+_P /0+>33:/-%)?10D>8?+;9&"0"QY/
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MWC#2P)[G1'^T8C.?/MF&)D!]U^8>ZB@#K+74K6\NKNV@D9IK1Q'.#&RA&(#
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MH8K=IUVLB>6AV[<#;@D\8!]>:ZC4-8L=,D@BNIF$UP6$,,<;222;1EL(H+$
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_.IZRM%\1Z7X@-TNGSN\EI((YXI87B>,D9&5< X(Y!QS6H[*B,['"J,D^@H
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MO-%9RR1RQ$!E94)&,CU% &Q17$>$O'6BW&E^'M+NM49]5NK&'YI4?$TOEJ6
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *KWEG%?0B&XW-#D%XP<!P.S>H]N_0Y'%6** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIXH=^<8,C(%'/')K5E\0V$7B2VT%C-]MN(7GC_='847&?FZ'J.F: -6BBB@
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ME>5',.Q@78L0>2#R3Z5)>^'9;OQCIVOB^5/L4$D"V_DYWJ^-Q+;NORC''YT
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M;5;74&B4W$*,&5'QR 03QGWKG=0\%7I\3W&N:#XBN-'EO51;Z%;=)DF*C"L
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M\._]>25UE8_A703X9\-66C?;'NUM(Q&LKH%) [8'_P!?ZUL4 %%%% !1110
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M2?NXP,8YZU_$'BO4]*OA!K5U<:!'<V,7V2]BA26U2Z(.]97*MC#;0.@(R<T
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M5R"&7H"#TXP:Z*B@#DKKP);RZ5IUA;7LD(M-1&IO*T8=Y[@.7+/T&"Q)( ]
M, 5>3PY,GB^?Q$+\>?+9+9>28/D"*Q8'[V<[B>_3CWK?HH \E\5:%'X6\.>'
M-)&KYSXE@N4F=%5X]TC.S8Z$ MGI@=Z[2Y\(0:N=1N-5NS<W%_8-IXD@3REB
M@;).P9;DD@DDG.!VKIJ* .,MO EQ#?:%?3>(KR>XT>*2&(F&-5>-E5=I '^R
M,G.3ZBF2?#T2^$=6\.OJSFWU.Z>YEE$ WJ7?>P7G&,@8R.!G\.VHH X3Q9)I
MGB=3X(E:>XU426\LC1P21B%0P8RA\;1A00,'J0.]=+K4DEGH<MKIL(:[DB,%
MG"HP V,*3Z*O!)[ ?2M:B@#*\-:)#X;\-:=HT#;DLX%CWXQO/\3?B<G\:U:*
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *X;XKI,?!R-%=W%OB_M581$ .&F08;(.1SG'3/7-=S6
M1XE\/P>)]#ETNXGE@5W219H<;D=&#J1D$=5'6@#!O-1U&X\3S^'+:XOW6SL(
MYY)X7A2:1I&< DL ,*$'W1R3S[Y%U?>-+./PC9ZCJD=M?W=^]I=M!'&XD38[
M*_3AL <#C/;'%;VK^!1J-_9:K;:[J-AK-K"8&OX=A:>,G<5=2NTC)) P /3I
M4UUX+CN6T=QJEXLFEW!NED;:[3RD$%I"1SD$C P!VQ@8 ,0+XBM/&^E^')?%
M%U/!-I<\TLYMH5D++(H##Y< X;'((]LGC(;5/$Q\$>*+_P#X22X%SX=O;J&!
MU@BS<+%AAYV5YX./EV^IS7?7/AL7'BZV\0B^F2:WMFMDA"*4*,06SQG.0._:
MLT> XAH6O:2=5NC#K5Q+<7#[$W*T@ <+Q@#@=<XH @O=:U+_ (3/P7%'=M'9
M:K;W+W%L$7:62$,ISC=U;U["N>GU+Q+-H/CB]7Q)<12:%>S_ &79;P_,L<2.
M$?*\KSVP>3DGH.Q?PB)-4T"_?4[@R:+&\<*[$Q('4(Q?CK@#IBJZ^!HQIGB&
MQ.J7)CUV226Y.Q,H74(VSC@;0!SF@"O=:IJ%_<:7C47ACN]+\\6=@H-RTS;?
MG)8%5C4$C)(&3@YKE)-3U/Q'X8^'&IW6I7$5S=ZFB3F (JNP63YRI4C/R#VY
M/%=G'X&6#5++4(-9OX9H+!=.F\L1_P"D0J<J#E3M;GJN#Z8JO!\.+6V\-Z5H
M\.KZ@ITJ\%W:7/[LO&1N^7!7:1AVZ@G^5 %>ZU'6]:U+7],TN>\CDTOR[>"6
M%H5S*8E?S) XY&6 P !@'UXJZOXDUO1%TR3Q/]KLK%[$+=7VEQB6."[W$%I/
ME)"8P1QC)(.>VQJ'@-9]>.LZ9KNIZ5>31)#>-;E&%TJC"E@RD;P.-V*T)/#3
MQRYL=2F@A:T6TD@D19E< L=YW<[SO;))(/<&@#1TF0W&A64AO4NVDMD)NHL;
M925'SKVP>M>=7/B77H_ACXKU-=5E%_I>I74-O<>5%G9'(%4$;=IX]LUZ-H^E
M6NAZ-9Z59*PMK2)8HPQR< 8Y/K7*WOPW@O+/6]/&M7\6F:M.]S):($PDKD%R
M&V[L$C.W./K0 R^NM:NOB3!HL&M3VMA<:*]TRQPQED<2HN5)4\X/<$<GCH1D
MV'C#5T\-V-A->^9J5SX@DT5;YHUW!$=LR%<;=^U<#C&2"0>:ZZ/PJ8_$UOKO
M]J7+W$%B;$+(B$,A8,2<*/FR!TP/:LQ_AO8RZ%<:9+J-XS/J+:G!=+M66VN"
MQ;<A QU)X([F@#(N7D\/?%74+Z:ZN+V.V\*RW*K-MW +,"5! &0<9Y]?3%7=
M/G\6WW_"/ZM:32/;W0C?4$G>'R6BD4'=$%^8%21@$\CKDUJVW@LCQ -:U'6;
MR_N38&PE22*)(Y8RVX@JJ^N.G/OCBH-!\ KH$L<,6O:I/I-N_F6NFS.ICB.<
MK\V-S!3R 3@8'7% %'P@_B#6M1U.XNO$4YM],UNYM1 +>(">)0 %8A1C&0>,
M=^N>-OQ/K,]GJF@:/;3?9Y-6NGB:X !,:)&SMMSD;C@*,@]35CPYX;7PZVI%
M+Z:Y%_>27L@E51MD?&[;@#C@<'-)XI\+6GBK3X;>>>>UN+:9;BUN[9MLD$J]
M&4_S% &)K%]KGA.POWFU%;V&ZOK:WTTR*OFP"5E1]YP%;!)*Y_$TC)XLL[W4
MI/M4\>E-I[O&]TT+S0W*Y.5VC!0CJ#T/3%:,O@BUU#P]>Z5K>H7FJ/>JJS74
MQ5'&TY38% 5=IY''4G.:33O!]Q:6-Q#>^(]2U*9X&MXIKG83"C<'  P6/]YL
MG]<@' ZXNOZA\$[CQ!?>);N3[5I$3/:QQ1QH6)7)W!=W()!&><GMQ7<ZF]]:
M:CI=C_;5P\$D,K-#$JF\N'^7:1A JHH)RQVC.W)YJ<>"K1O +>$)[NXFLOL_
MV99CM$BH,;>@QD8':F/X+=M6T_5EU_4DU"VMFM9IP(LW$3,&VD%-J\@8*@?G
MS0!RG_"5:_-\)M+UO^T7BU#^T$MIW$4>94^U&(Y&" =H_AQS6Y>SZU>?$ZXT
M&+7+BTT]]'6[ AAC+QN9BAVLRGLHZ@]3C'4/7X;VR>%AX>35[\6:WGVM"VQF
M0B3S0H)7IN.23DGUQQ6N/#1'BQO$7]HS?:FL18^7Y:^7L#%\],YW$GK[4 5?
MA[JU]K'A"&?4I_M%W%//;O-M"^9Y<K(&(' ) %9-P_B#5OB!K>A0>(I[&SAL
M8+B(PV\9>-G+@@$KT^49SD^A%=+X8\.IX8TM["*[FN8VFDG#3*H8,[%F^Z!Q
MDFN4@$MS\8];-GJ0MG_LVWB'R*ZNP9RPP?XER#P>,\@T 8\7BKQ1<>'=%$FI
MK#J4?B4:)>RI A2X 9@7P1QT'0CO70&ZUBU\01^%6U._U"1+)[Z2ZC$,4SJT
MI5%Y 7"X.2!DDKT'!T;GP'9RZ;I5C;WUS;II]\-1$@",\UP&+%W)'.2S$@8Z
M]@*F\2>#8]>O['5+?4[O2]6LU*1WEIMRR'JC*P(9<\X/>@#G[G5/%^A^'[&7
M7(+FYBAO)$O9]-5'N/L^TF-V4#&<D;MH[9'4U-:^*3>1>&=/T[7?MJ:U=71_
MM((HD$489PFW: 'P40Y7L3C.*Z"/PU-;+9R6VL78NX"[2SS!9#=%PH/F# X^
M5<!=N, #@8K-O/AQIEUI"6L=U<VU['?/J,=_;D))'<.<LP&,;3TVXZ =^: ,
MSQA-XG\,^"?$5['KV]H)(Y+"3RD,J1LRJR297!Y)P0,^]2^*&\0^'-/MKI?$
M<]PUUK%K&R-;Q*$B=U5HQ\N<=<'KCN>M:=_X&&J^&+S1]0UJ_N);W9]IO7">
M8P4Y55 7:J@]@.Y[G-7_ !!X:_X2+3;.SN=1GC^S7$=SYL2)N=XSN7((( R.
M<4 <M<:??:E\6-=M[+5IM,)TFU+301(S_?DP!O! 'KQGW%5=(\9ZY<VFG:+>
M.9=5;5;O3KBZMPB&9;=2Q9 WR@M\OY-@9QCL+CPPY\1/KEEJ<UI>36RVUP!&
MCI(JDE2 1\K L>^/4&JFI?#[2K[0+73(IKJTFM+@W=O?0R8G6<DEI"V.2Q)S
MVY[8& #$OM;\4>&-.OUOG5TN[^VM=(GN&1Y8O..UO,"8!"<E?7O4MU8S67Q?
M\->9J%S=H^G7F!/M)5AY>2"H'7CCH,<8K6G\"6VI>';K2]9U.^U&>YV%KV1E
M25"ARA0* J[22>G.3G.:6V\&3KKNEZQ?>(;^\N].BDB0M'$BNK[<A@%_V>3U
M]Q0!9\8:W/HUGIL5LXBGU+48+!)B ?*WDY8 \$X4XSQDC.>E12V6NZ<=9D&N
M&2R:T\RT\Q%::"50=QSMPRGC@@]>U:'B;PY9>*M%DTR^,J(S+)'+"VV2*13E
M74]B#5.P\+W%OI]U%>Z[?:A=SPF 7=PJ Q(>H15 4$]R<DD#/0"@#D3K_B"?
MPC\/[R'5WBN=6N8(+QS"C>8'C9BW3@Y7M@5LV,VIGQ1_PB5QKMU-]DL/MLUX
M(XTFG+RLJ+PN % Y(&22/<&P/ ,2Z1X?TU-6NEBT.=)[9MB;F9 54/QR,,1Q
MBK/B#P:FLZO9ZU9ZI=Z5J]M&8!=6H4^9$3DHZL"&&>1Z&@#'O+SQ+H<_A"TO
M]92XN+G4FM+QH8D"3Q['9205RK8"YVX%,N=:UE-2^(-K'JDJKI=G!<6),49,
M+-#(Y'W?F!*CKFMO4_!D-_I5A;1ZE>07EA="\AOR5>4RX(+,",-D,1C '0#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+Y'7Y<'/I6[KFLVI\<O9$?93-I0,-[;P>9+>@NW[E& (VCJ0!D[L@C'/H5%
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MQ+T?7-+F62QL-/N%N[I#\C;RNR/=T)&&8CM@9QD4OPUGC>/Q(@;#R:[>3(K
M@M&S#:X!ZJ?7I0!L^+?%,/A73K>YD@GF>XN8K>,1Q,X!=P,L5'& 3@=2>!6!
M>>(OL'Q/MC<:A>+I<VB23BT:)_\ 6"9%&V(+O+8SQ@GK5OXGH_\ PB]K.L4D
MB6VIVD\OEH6*QK*I9L#G %5#?6\_QAL+P%E@.A2H'D0H QF5@#D<$J"<'G%
M'4VGB71[_1(]9MKU9+&1MJR!&R6W;=NW&[=NXVXSGM4FEZ_INL3W5O9SL;BT
M8+<02Q/%)'D9&5< X(Z'&#7DL?VF+PN^H06MW<V^G>++B\NK>V++*;9C( Z;
M2&(^<,,=<'TKOO"<OA_5-2N=8T.TNW\V%8IK^Z\X&3!X0>;RV.<D<#@<\X (
M_BGJ-_HOP]U/5=,O);2\M1&T<D>#UD53D$$'@FKTEC+%-IXC\27HN))T*Q2M
M&RS*OS.I 3/*!N01@XK'^,9\SX7ZO:QAGN)UC6*) 6=R)4)P!R< 9J87?A"S
MDLKS3;&U;4D8);I:6NQW9QLVL0O"_-R3P,9[4 :EUXZ\.6<E_%)?EI-/(%TD
M4$DC1Y!.<*I)&!DD<#C/6G1^-O#LMY8VL>I*[7VT6TBQN8I&(W!?,QMW$?PD
MY]JYO3+B"/QK\0Y9'58Y([78[# DVP%6VG^+!X.._%<]&Z1_"_X>PL");;5;
M%YH]IW1!')<L.H !Y)]?>@#O[_X@^%],DO([G5%$EFP6X2.&20ID9SA5/ '4
M]!D9ZBLWQ;K$DC>#K_2-4D^QWVL01-Y#C9/$RNW/<CY1QG\*H:1JFEV'Q)\>
M_;YHHUD^Q$;QGS5^SC*K_>//W1R<]*PH=,N- \%?#ZPO8WBFAUU+IX6!)@B9
MI6&[T"AU!ST- 'I^H>(]+TN6:.YFD+P1B6<0P22^2ASAGV*=HX/7' )[4R?Q
M5HL$^FPM>[FU,9LFCB>19^,_*R@CISUZ<URVAWJ^'?&'BRWUUS"E_<K>V=Q(
MI*7$1C"[%/=EV@;>O/ K/TWP;J0^#MI8A6M]8LI7U'3U?AH)!(TD:'T^4[2.
MVXB@#T*36=/AOKBSEG\N:V@%S,71E2.,YPQ<C;CY6[_PGTJ"S\2Z5?:I_9L4
M\B7IB\Y89X)(6>/.-R[U&X?3-<9?VNJ^)/A;JVKV]HZZKK$<=W':AOF$2%2D
M0(YY12<>LAIVE7>@>+9H[G2++4_[8@MID\^^-P#8%T*E29"5+$X&%SW/:@#K
M1XLT4W]M9F[97NG,=O(T+K%,XZJDA&QCP> >>U;$B>9&R;F7(QE3@CZ5Y-X2
MN=$U#3-%T#4]'U5O$&EO"K65PUP8X9(L+YP8GRPH&2/K@ Y&?69)$BC:21U1
M%&69C@ 4 >1V&KZXWP^\2:_-XINX;O3+R[C@:5(3&PB/R(RE.=W3@YR>*]"T
M37FN/!VFZUJ\8LY;BVBDECP>'8#"@=222,+R>0.M>5:#X6_MWPSJ-]IL<<?B
M'3]<N;ZS$\>!.N[(5U;JC X!['OUKI/$GB"3Q'X/TG6K*POB^G:A#=:EIJ!X
M[E$4,K@ 88D%L@CKMS0!U-WXXT:UTS5KQ6N9)-*C\RYM?LTBS*,$@E&4$*0/
MO?=]^*IS>(M-U/1?#UU>ZG>Z5+=W5N8TBCDB,\I /E'<N6C);!/0@=:PYQH?
MB'PWXFU#PW87UQ<SZ+<6S7DXGWR,4.V%1+RQSZ=.!WJMJ^H07G@GP*T0EQ#J
MFGF0/"RE1&!O;!&=J]"W2@#LM1\=^&M*O+JTO-35)[79YT:Q.Q3><+T4]Q^'
M>K.H^*]%TIW%[=M&D<BQ2S>2[11.V,!Y "J'D=2.H]:Y_2)H6^,.ON"#YFG6
MT<;XX9E+EE!Z$C(R*YJRGTJTGUKPOXKT[5I[R?4+B6WAC^T/%?Q22%T*A#L!
MYP<X QR>N #T.\\7Z%8ZC/I\UZ3>P1"9X(H7D?:3@8"J2Q]AD\'TJJ/B#X7:
MVL[E=55K>[8+',L,A123M =MN(SGC#XK&LGAMOB_*6"0Q1^'HH,[LHK+*S%-
MYZD+@^N.:Y&8J?@5KEJB-]I?492D(0[VS=[U(7J?EY^@H ]:U/7]/T@N+J24
MLD?FNL$$DS(G]Y@BD@<'D^A]#52;QIX=@:P5]5A)OXC+:[ S"50,D@@'\NI)
M ZFN-U+4['1/'^IW.NKJ/]DZO;V[6-[9M.8\HI5HV$1ZDG(X[FG-;V&G^+/A
M]!9:>VGV5N+]E@?),"R)\F_/W2Q/0]SCM0!T6I?$#1[;P=J7B*R::\BLB\3Q
M+!(KK*!]UU(!3J,E@, UT>GWJ:A917,:RJ''26%XSG_=8 UY+J44E]X>^*4%
MI&\LD]QYL*(I)E41("R_WAE3T]*]4T:^@U+2;:ZMO,,+H-I>-D)XZX8 T <K
MXCO=0M_B;X3TVWU*YAL=22[:Y@0KAC%&&7!(R.3S@UIW7Q \,6@O#+J6?L4G
MEW(C@D<Q'&23M4_* 1EN@]:PO%5Q$OQ<\%2%_P!W;1WHG?'RQ%XE";CT7)'&
M:H0S0[?BADC_ $C=Y61_K1]F"?+_ 'OFR.,\T >A7.MZ?:Q6SO.9/M0W6Z0(
MTKRC&<JJ@DC!!SC'(J"#Q1HMSI":I#?*]I))Y*D(V\R9QLV8W;\\;<9]J\XT
M[53X9O?!^NZA#<-H[^'(]-FFCB:3[).-C'>J@D9V[>G4>U:>NN%N?#'B33]*
MD@T2TU26:YC2V*,RRQE/M+1X###,Q)(S@Y[T =G#XHT>>&^D%WY?V  W<<T3
MQR0@C(+(P#8(Z'&#VJE'X_\ #$C60&J*J7R[K>9XG6)^-V-Y7:&QSM)!]JYZ
M\CCO_&VK>([*56TN/P\UG)<)RDTS.64*>C%1W&>6 ]JQ"\:_#?X<0L/WEOJ=
M@TT94[H@@.\L/X0,\D],T >E:3XGTC6Y[R"QNF,UGCSXY87B9 <D-AP#M.#@
M]*;;^*M&NM2M[".Z=;BZ1GMO,@=%N%'),;,H5^.?E)XYZ5P^NVT^K>-?%UGI
M[_Z1>>&Q;0.#A7ES)\H;IG##Z9J;POJ/A_Q%-I$9TG53KM@09(+PW&VQ<##M
MN<[.V !R<C@<X /0M1FGMM,NY[6'S[B.%WBB_ON%)"_B>*\\\-:G/XL\*Q7^
MC^*;I]=14:^M7* *^1YD?E%?D'W@K#';D\UZ#JEU)8Z1>W<,8DE@@>5$(^\5
M4D#CZ5Y7XTL=!UFUCU_PV)[#QJ&1K>*W1HKEW)&5FBP.,9RS#&!R2.H!Z;J6
MNZ?I)9;J24NL9E9(('F94_O$("0.#R?0^E-_X2/238V=Y%=K/#>C-M]G5I6F
M&,G:J@DX'7CCOBN$U2_B\.?$"^N/$L>HII^IVEN+>\LFG\M)(PP:)A$<\ELC
M([GUJ!Y+;P5K_AW64TBZLO#)L;BS"+$\ALV>42*[KRR[]HXZC.#TH [B/QEH
M$MK:7*7^8KNZ%G$WDR?Z_./+;Y?D;/9L59?Q'I,5]>V4EULN+*$3SH\;KMC)
M(#9(P1D'IFN)\6S6L_AK3=8L-+DMM.@\06U_,Z6I1I(PXWSM'@-R3U(R0,]Z
M(=5MKKXD:W?(EP+.70(ECN'MW5&P\AZD<9SQG&>V>* -RX\=^%=4TR\ABUZ2
M!'L&N3<P1NK1Q'Y?,5BN-P)'')'I1<^,;+1I_#&FI]NO4U./*71MY)&:)82P
M<[5RSDA<@#(!)(%<_H[(G[/#V^TK,NC30-$5(<2E&&W;UW$GIWS39YQ:M\,=
M2DCF:TM8WBG>.%G,;M:[ I"@D'=QC'6@#O=/\1:9JFH7UA9SR/=6) N8V@D0
MQD\C.Y1U'(]15G3M2M=6LUN[-V>!F*AFC9,D'!X8 ]17$^+K74])\56&MZ'&
M?-UB/^R;I?[CD%H9R.^P[L^U=S8V<.G6%O96R[8+>-8HQZ*HP/Y4 1:OJ*:3
MI-S?NA?R4)6->LC=%0>[$@#W-<W\/->U'5=,O]/UPI_;FE7CVUV%Z,"=R./]
MDJ<#_=J779H]:\36&@1WTMK]G_TZ:2)5)+H1Y:#>K*3DER,$C8I[USEZK^"_
MBKI^HO?75[;:W;FVU!I(TS$R8\J1O+10!U7)'3//H =QJGB;2=',XO+AQ]GC
M$LYB@>40H>C.4!VC@]<< GM6?-XULD\6V&APQ7$RW5FUV+B*WD="N4";2H((
M.XDMT'&3S7-6NMVWAOQ;XHTOQ%:7,D&KW(N;*5+1[A+N-HE0Q?*IR1MQ@^M6
MKE_[-^)7ARYET^6UMI-&EM8XH82ZQR;XR(OD&!@#V''I0!Z%6+'XMT22YMH5
MO"!=R&*VF:%UBF?^ZDA&QB<'&#SCC-6/$-G<ZAX:U2RLG\NZN+26*%\XVNR$
M*<]N2*\VNC_PD?PHTCPU:Q20Z_";.W:V9"LEI)"Z!Y&'\*A58ANAR .30!T&
ML:X-1\?KX8>;4[>T&FO,SVD4\;F8RJBG>JYVJ-QS]W)YSBNPTNTGL=+MK6YO
M9+V:) CW,J@-(1W('&:Y!KF$?&T,7 3^P?(WG[OF_: =F>F['..M=U0!R&A:
MAJ4GQ&\3:;=WS3VEM;VDEO&451%O$FX# YZ#KFJEG?:AXJG\4FVU*>QETN\>
MRLTB( 5D16\QP1\^YF(P>,#CG)I="GB/Q9\4D.-LMI9I&W9V02;@IZ$C(SCI
M4'BG1[,W>HMX=6Y/B'4T$$J6MR\<0.,"6?:<+M!SV+8QSF@";2KK6?'_ (0T
M/5['69-$6:$O<FVB5VDD!VD#>" H*L>Y.1Z<V?!G]I07&OOJ6O7&I65M<BWA
MFN4C3;L3,K?* ,;F*\_W#5^SM+;P)X!2WA#31:59$@ ?-*R@DX'JS=O>J@\*
M7TG@2ST2/4EL[L[9;N8P"599"WF2@J2,AG)SSR..0: *.D:_JFH_%!K>61HM
M)ET8W5K;%<$CS@HD;OEAD@=@1GG-=W7F-EHWB:#XPP2W>NBY5='S).-.$:O'
MY_,/#$ ]]W7VKM]#\2:=XA-ZMBTNZRG:WF66)HR&'< ]0<'!]J +6HZM9:4L
M'VN8JUQ)Y4,:(SO(^"<*J@D\ GIP!56W\3Z1<Z;)J$5V6@CG-LX,3B19MP7R
MRA&[?D@;<9YK%\;ZG_9VI>'1);[+>6ZD$FI+;><]F?+.-@P=K/G;D@@#/%<=
MI<.G3Z1XGT[5!JUK%+XC,T=V(Y(Y8,JACFW$>JY/H.3@4 >JZ?JMIJGV@6K2
M;K>3RIDEA>-D;:&P0P!Z,#^-&HZM9:4L'VN8JUQ)Y4,:(SO(^"<*J@D\ GIP
M!7-^!+C5W?5[34[N'4X;:9%MM6BB"?:U*9.['!*\*2./Q!H\;ZF-.U/PZ)+?
M9;RW4@DU);;SGLSY9QL&#M9\[<D$ 9XH TI?&GA^#1)]8FU 1V4$Q@F9XG#1
MR X*,F-P;)'!'<4A\;^'A?S6+:@5N8H_-V&"0>:N<9C.W$G)Q\F:\LOFQ\.?
MB#8""^\^;6FEA2>"3?*K&$J>1R2%8XZ@#D"NWU>YMYOBKX4GBD1XEL[M3(O*
MJ7$>P$] 3@X]: .EL/$^C:GI$VJVMZILX7:.5G1D:-U."K*P#!LD<$9Y'K42
M>+]#9KY)+MH)+&(37$=Q!)$Z1GH^UE!*^X!KS2XCNY])\73Z?;SW36_B>/43
M;0%E>Y@3RBQC(P3]TD$=UXK>COO#.LV.JZSI%I?23II4UO+>WGG@H",B >;]
MXEB3A<X(]QD ZBR\<>'=0O+"UMM0WR7Z;[4F&0)+\N[ <KMW8YVYR/2JWC'Q
M':66@:U#!?7,-[;6CLTMK"S^0Q0E-S!2J9X/..#G@<UQIEB3PA\+TZ26UY:&
M=<<PA8'5BX_A 8@'/K2VNIC1])\>:!K$=Q'J=S<7MU;_ +AW%U%(GR,A (.
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M ZHX$ !() '^(.>E &[XL\4P^%K.SEDMYYGN[R&U01PLX&]P"25'& 3@=2>
M#5VX\0:?;>2LC7!EFB,R01VTCR[!U8QA2RCG'('/'6N>^)JN- TVY$<CQ6NL
M6=Q,8T+E(UE!9L#G JE!?_V3\3K_ %/4B\.E:OIT L[N9"B1M&6S&Q/W"=VX
M XS]>* .VTW4[+6-/BOM/N4N+64921#P<'!'L0>"#R*J:EXET?2-0M;"_O5A
MNKH.T,95B7"@D]!Z#IWX Y-8GP^TV>QMM>NGC>*VU'6+B[M8W4J1$V &P>1N
M(+ >A'K4'BN2-?B1X(9C\L4EX9&QQ&&AVJ6/;)X&>IH T/\ A8?AC[!/>?VA
M)Y=O(T<Z?99O-B*X+%X]NY0 1R0![ULS:UI\-G;77G^9%= -;^2C2M,"-P*J
MH);CG@=*X*RG@75OB6Y90DVPQDCB4"V"';_>^;CCO6+!<G2-%\ ZS?07\FD6
MVE-8WK6AD5[21EB(9@A#8S'M/_ZJ /3[7Q/H][I;ZC!>!K>.4P/E&#K*#CRR
MA&X/D@;<9Y'%9VH^/-'LM$U?48S<3R:4N;BU%O(DR$C*[D9054_WB,8YS7':
MW#91Z19^(O#^CZB^EPZNE[>E&F6>Z0QNC3*&(?Y=X],X)Z<FQJ4>C:_X.\5:
MAX:T^]N)KG2WA>\F$^^=@IQ&HE^9L>H]0!GG !Z'H^HKJVE6]XJ2(9$4LKPO
M'@D G 8 XYZU>K)\,WT.H>'+"> 2>7Y"+F2-D)(49X8 ]>/PK6H **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHKG_ !CXG3PIH@OC;33O)-' @2-F"L[!06QT'/U/04 =!17G^IZ]
M]A^)FE2O>7ZV%QI4\ALS')\SJZ 8AQN+8)[9KI['Q3H^H:)_:]O=$VGF&([H
MV5Q(&V^64(W;]W&W&22,4 ;-%96F>(=.U:]N[&WDD2\M-IGMYXFCD4-]UL,!
MD'U'%6=1U2TTJ*.2[D*F6011(BEWD<]%51DD\$_0$]!0!<HK@?"^N>?XZ\:M
M<7]V+"SBM'$=Z606V4D+X5L;1QG/0C!R1BNDMO%6E7.J+IIEF@NI(3/$ES \
M/FQCJRE@,X[CJ/2@#:HK)L?$>GZA<V\$!N,W,1GMW>W=4EC&,LK$8Q\P]^<]
M*@'C#1/M=I ;EPMY,8+:<PN(9I!GY5DQM)X..<''&: -VBN9C\?>'9KXV<5U
M.\XNC9LJVDIV2A<X;Y?E]B>N#CH:JZ;XI\.:3X;FU,ZS>W%@U])&;B[61V60
MO@H,KE5#':,C ]: +^C^'+G3/$^N:S)?Q3#56B9H5MRGE^6FQ<-O.>.O'6NA
MKG=/\<:#J>IW.FVMU*UY!$9O):VD5I8Q_%&"O[P?[N<]JQH?&NF>(/ &H:IJ
M$NHZ39DS1O/!#*DD2"1T5E<*1NPHSC."<&@#NZP]>T/4-9N+=(=<GL=/V/'>
M6L4*,;E6QQO/*<9&1SSV/-.'B/2K34-,T=[BX-W?1;K4/!(WG*JY)W[=N0.3
MD]ZL/KVG1/?+),Z?82HG9HG"@L 5 .,,3D<+D\CU% &@B+&BHBA44 *H& !Z
M4ZLG3_$>G:EJ=QID3RQW\""5[>XA:)_+)P' 8#*YXR.AX-.UOQ%I?AV*WEU2
MY,"7$RP1MY;,"[' !(&!]3B@#4HK"M?%^DWMJ)[9KJ0M+)$L'V602LR8W?(5
MW8&1SC'([FGVWBO1;O1_[4AO,VWG?9R#&PD$N<>7Y>-V_/&W&: -JBL&+QAI
M$MU>6I:ZCN;*#[1<026D@=(\\-C;\P/MGH:?_P );HOV/2;O[4YM]6D2.RD$
M$FV1GY4?=^4G!^]CI0!MT5S=OJND)XGUQEU.^DN;6WB-W:N)#% OS;61=O5N
M<E<YP*33?'OAS5>;2^8Q?96O/.>!TC\H'!.\@#(R.,YH Z6BL2'Q9I,M_+8M
M)<07:0?:1#/;21N\70L@*Y;GL.1Z50C^(WAB6"PN%OI!:WS^7#=-;2"'<20%
M:0KM4G!X)!H ZJBL;2_%.E:OJ5SIUK+,MW;H)6BGMY(2T9. Z[P-RY&,CBF)
MXOT9[ZSM?/D0WI*VDSP.L5P0,X1R-IXY'//;- &Y17*S_$;PS!#=S-=W#1V4
MY@NF2SF;R&&,E\+\J\CYCQUQG%/U#QC;V7BW2]#6WN)1>027!GC@=UVC& NT
M'/+ D] .O6@#IZ*R/^$ETW[2L(:=@UR;595@<QF4'!7>!C@@@GID$9SQ6K)(
MD4;22.J1H"S,QP% ZDF@!U%8EOXMTBXN[.V$TL;7P)M'F@>-+C S\C, "<<@
M=QR,BN:O=5_X2'QYJ/AR2XU:UM8+&/RGLTGA99G=P9"R@< *N"WRGGK0!Z!1
M6;/>VWAW04GU2_=HK:-(Y+F5<O(W"@X4<LQQP!U/%)INO6&JWEW90-*EW9[#
M/!-$T;H&&5.".0<'D>E &G165K7B/2O#WV4ZI="W%U*(8F*,07/8D# Z$\XZ
M&JND^*M&\427VGZ?>3I=6X FB>%X)4!Z, X!P?6@#?HK@O 7B-(/AGH-]K-]
M-/=7;M"C/NEEGD,CX4=23@?@!V K<E\;:#!HM]JLUU)';6$I@N@UO)OAD&/E
M9<9[CGIR.: .AHK#L?%VC:AK(TFWN)?M31&:+S('1)D&,F-V 5P,C[I-:]U=
M065K+=74R0P0H7DD<X55'))- $M%8]GXGTN]U7^S%DFBO3!]H2&X@>(O%G&Y
M=P&1GKW'<5$GC#17FM$^TR+%>2>5:W#PNL,S]E60C:2<''/S=LT ;M%<W=^.
M] L[K4;5[BX>YTX*;F&&TED= P)!P%R5P,EAP,CGD5?_ .$CTQ[6QN+>9KE;
M^/SK58(V=I$ !+  9  89SZ@=3B@#5HKDM5\>65D^A"VM[N=-5N3"L@M9/D5
M=V[*XW;LJ1MQGJ2.*LQZGI;>,+L)?ZB]_#IRO)8;)/*6/<2'5-O+DG'&3QC%
M $UGH%ZNO3:EJ6M37\*2O)8VK0)&EKN&#RO+D*2H)[,?7-;U<;HWQ%TN^\*K
MKVH)=65LT[Q[GM)2JCSFCCRP4@DX7."0"<5OR^(-.AUEM(>27[>+9KH1"!SN
MC4@$J0,,<D# .?:@#3HKA(/&NF>(/ .H:IJ$NHZ39DSQO/##*DD2"1T5E<*1
MNPH)QG!ZUMW'BS1-)FT_3[F\F^T74!DMU:&1WE55!)R%.YN1P.22.* .@HK$
MLO%VB7VB7>L)>>59V;O'<M/&T30NOWE96 (/(XQW%$7BS29-7CTEGN(=0E02
MQP2VTBLR$X#?=P!GCGH>#B@#;HJIJ>IV>CZ=+?W\XAMH@-[D$]2   .222
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M&6U9[>18Y@%W$*Y&UF Z@'C\* .AHJAK>JQ:'HMYJD\4TL5K$TK)"A9B ,\
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MXW9WDEW=>!-1:PU)7M[J1;JWBT^2*"S9H741)&% P"<;N>.I%=#XATB_M/'
MBTU?]!\40_9M0VM@Q-%RTH]VBWIQWVFO1:PM&\/7&GW\U]J.LW6JW!WI TZ(
M@MXV8,54*!G)"Y)_NCI0!N*JHBHBA548  P *\NT/4;& ?$.SN8WEEFU6X"P
M+$6,^Z%!L7 ^8^PZ9!/!KU(].*P/#GAV;0;O5YGODN1J5XUXZB#9L=@JD [C
MQA1_C0!Q-MI5WH5Q\,=/NTE>73TF%TZ(SK"6@*@,P& -QV@^U9GB^YNM3\/^
M+[)M,OX+N'45,5G:63K'+$LD>+AW5<2,R@GDGH,#C->T44 <';7*R_%Z:_\
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MN..U;/\ :.E:GI6J:WH'A>\OKZ'398F.I02Y;//V?$F2X/)(7(XQG)%>ET4
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M67S@R@9(X'\1)[]0 =OJOBS3-'6YDN/M#P69 NYH86D2WR ?G(]B"0,D @G
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MQ2$Q2 X*$@;21QT..0<\U9A\::7+',_E7T826.&'S;5D^U/(,H(L_?S@\C@
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MZQIZ7MO'*D+E@OFK@M@XR.>F1P>_7I5V@ HHHH **** "BBB@ HHHH ****
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M6EI>V\.F/-<W$EU;/ R;H]HC&\#))/.,C"]>1GN** .-^*__ "2WQ!_U[?\
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MY[+XJ FWO'M8] ALA=M;OY;2I*21OQC."#UQ77:RQ71+["2.3 X"1H79B5(
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M:-$F9V8\=-I!XZY^M '=W?C:QMM:OM(BL-3N[^TA69H;>VR75B1\I) /0\G
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M\/:<KQ2Q21VT:.DL91E8* 00:TJ "BBB@ HHHH **** "BBB@ HHHH ****
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M$8D_TJ/=M)0[\+@]=^W'>@#J:*YW3_&>G:AH;:D(;F%DNC8O:2H!,+@-M\K
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M2:.%D.Z)9'4J"KAL@+R3CGH:ZC^W;*SBTNRM+:>>XN[?S+:TC*[Q$JC+,68
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ML_V85-Z/*/[G]P8^?7YCVSQS6KX0M-0TOQ%XHMKK3ITAN]3>]ANB5\IT:-
M.<[LJ>,<>M=E10!E^)=*?7?"^J:3'+Y3WEK) KGHI92 3[<UQ-QIVJ>)?!&C
M>&KK2[JSOK>:U6\DD7$<2PL"SH_1MVW "Y/S<XP:]*HH XR*"['Q<N=1-C="
MP;2([1;GRSL,HF9B/7&&ZXQ[UV=%% 'G6CO?Z7\1_%VJ2Z'J<ECJ(M!;2QP@
M[O*C*MD$@CD\9%7=?U7Q+>Z2;C3M&OX(%OX8YH0$%T]L.97C&[ ))51SG 8\
M<8[BB@#RI= U:>?X@6UMH5S;1:SIL:V;32)AG$#H0S;C\Q9AUSWR:U6TZ\\1
MZ=X2T\Z?=V@TJZMKN[DNH]FQH5X1?[Y9L<KD8SST!] HH \VTBPU7P_X?\1>
M&9]+NKN2>:Y?3YXUW1W"39(#MT0@L=V['MFG6WA^]T3Q!X!M4MKBYM]'L+BV
MNKJ-"45WCC5?<@E3TZ<9KT>B@ KCI+:['Q>AU$65P;$:,UF;D)\@E,RN!Z]!
MUZ5V-% 'F,5E?>'_ !/K5M=^#7URTU*\:\L[V&.)]I<#='*7(V@$=>>#4VOO
M=Z3XPTF\LM'O)KNWTDP7#:3''*H5F&V,QLR[4!5BIZ\8Z UZ17/:CX0M;[6'
MU:WU'4].O946.9[*XVB95SMW*P93C)P<9YH XJZL4OOAS+IVA:3JJ7FGZA!>
MSV=_$([F8^<)7;KM);YB,''&/:MJS.IW?Q137'T._M].?1#;^9*%#*WG;_F4
M-G. >!D],@9KL-.TV#3862)I9'<[I)II"\DC8QDL?ITZ#L!5R@#RK38/$ND^
M X;>VTN^27^VI)+V&)0)S:/*[DQ$G&X@J.#D9/0\TZ'0=5EE^(5M!H5S:Q:Q
MIR+9M+(A#/\ 9V3:QW$[BQYZ]\GU]3HH \UU.WU2^\(^#HET6_CGL=2L99X6
M0%DCA WN<$\9Z#J?2M'3K>_\,^-_$-S-975UINL&*YMY[>,R&.14V-&ZCD9P
M"#T]2*[FB@#RA/"^IZ3I'A6 V,\LT?B!M4O$A7>MM&_F<9'7&]1@9[XK4EL[
MM?%GC.ZDT.>^LKZRM88HGC^6ZV!Q(@STX?@G ->AT4 <)X,T6[T37[J#3I=2
M'AAK53%;:B&W6\^[[D>_YM@7KU&2,$\UV.I_\@F\_P"N#_\ H)JU4%[;?;+*
M:V,LD0E0H7CQN /7&01^E 'E.D64_BOX.>'?#T%E<I)*MJ99Y(R(XHDD5RX?
MHQ(7  ).6Y YQM36^JZ;XP\8%-&O+J+6K>!K6>';Y8*0F-@Y)^4YYZ$D= :[
M'0-$@\.Z):Z3:S3RV]LFR(SE2P4=!D 9K2H \LT[2M8L-+^'5Y<:/> :*DD5
M["@5Y$#0&,,%5B2,GH.0.U:MQH]Y=77B[7_L<Z&_TT6-G;;/WLNU7^=E_ARS
M@ '! &3BN^HH \RNM.U)O!G@"T73+QKC3+VQDO(Q$<PK%&5<GUP3VSGM1XGT
M.[NM9O\ 5=!M-2TSQ-'+&EO<P _9[^,!?]=_#@98'=@_+QG@5Z;10!Q6GPW=
MK\1_$NHS6-T+.XL[:.&81$B1H]^X#'/\0QZUQ]AX?US2_"7@R^?P\]_+HJW%
MO?Z7(BF1DE(.] WRL1M4\=<X]<>RT4 >9Z]I>J:MH%EJNC>&AI\FGZI;ZA'I
MKK'%/<K%NW!MI*@G=P"<_+ZD 7[:34=3^)VG:TNA:E;V']DRVSR7*(A1VD5N
M1NS_  D>OMCFN]HH 1L[3MQNQQFO(&M/$FH6OAN]U'P]J4NL6.M)-?NSQ[0@
M\P8A&_ 3E>F!P,DG)KV"B@#C?#UIJ.G^/O%!GTV<6NH307$-V"OE[5A"D=<[
MMPQC'O79444 <+X@M;V;XI^%]1AL+J2QL(;I+FX2,E4,B +[GIV!Q5GQY:7=
MY/X8-I9SW M-:ANYS$F?+B57#,?^^AP.?:NQHH XS3[;4--^)OB"[DTVXDLM
M2MK0Q72;2B^4KA@W.[/S#  .:Y2/PYKDG@")8M(9]0TW79-3%A=*%%U$9)#L
MR>.5D/T(KUZB@#F/"TWVV5[R/PJVA1"/8?M$,<<TC9!P A/R#'?J2...=^^N
M6L[&>Y2VFN7C0LL$(!>0]@,D#/UJQ10!P6BZYK$NIK-=>#M7CO[MUCEN9S$L
M-O%G[H(<G:,D],L?3@"7Q=X;@\127%KI^CPI?W:?9[K59K?:(8NA(SS(^,A<
M9 /.1CGN** .;>^B\)R:!H-II%U)ITBBU6YCP4M\ *@;N2?7ZFNDJ&2UAEN(
MIY$#219\LDYVDC!('3.,C/7!([U-0!Y_IVGZAX'\6ZW/'IUS?Z'K-Q]L$EHN
M^2UG/WPR=2K=05SC&,5N:O;W?BOP[JNFQ02V4%W9RP)+<J4=G9< [>H4=\@$
M^GKTE% 'FMQIVJ>)?!&C>&;K2[FSOK>:U6\DD7$<2PL"SH_1MVW@+D_-SC!I
M;*WUGP[>^+M+ET:]O8-6NI[ZRN[8*R'S$ ,;Y(VE2!C/7MVSZ310!X_;:+K>
MD:5X/U:;PQ+J*V&FG3M0TUUC>5 =A$D:DD$Y7IP<'MSCT?PX"UC)/_8J:1',
M^Z.U*(LFW ^:0(2 QYXR<#&>>!LT4 <E\0=&U'5='T^XTJ/SKS2]2@U%+?<%
M\_RR<ID\ D$XSW%0RV4WB'QQH6NK:75K::1;W)8W$1C>22554(%/)"@,2>F<
M8SSCLZ* .-\!6]W9S^)5O+&YMOM>LW%Y 98\"2)@@#9[=#P<'VKKYI1#$TC*
M[!1G"*6)^@%/HH X7X7:7=6'@:'3-7T^:VN8;F64Q3IZRF1"".#V/7@BJ.K6
M=[HGC[4M2F\+2:_I>K1PE6MXHY);:6-=A4JY'RL,'.>*](HH \YN;'5]#\8Z
M-XEBT-I+)M/DT^ZLM/56:TW2^:K!1@-V#%>X)]*R;GP]K^JV/BUH-&EAN)=7
M@U.RCO"@2Y\L1GRSACUVGKQ[]:]<HH X2PGDU'3+V>+P5+HSK:21MYMO&)9)
M&& D>PY*^K' Z<=2*]M'XCTWX-Z?:Z987":Q:6\$$L!51*%4J)-F[Y2VW)!_
MKQ7H=% 'G>A6=Y9_$6\U1=!U&WTZZTF)!-,P=]ZNY._YF8L<CCD],X[:OPQL
MKS3/ .GZ?J%I-:W<!E$D4JX(S*S#GH>".E=?10!R_P 1+:ZO_ 6L6%E:S7-W
M=6[1111+DECZGH!]:Y^YT34]-CT3Q7H-A,=4MK:*TU/3B-C7<( !'/&]#R#W
MZ9(XKTBB@#S?Q!#>P^,+3Q.OAB?6=-N; 6=S:>2AN+9U=F5PCG!!W$'!]\T>
M)HI5T?0KB'P[-;7BZH+FWM+ 1?:+=51B6*9".2!AAG #=21SZ16+KOAFTUZ:
MTN9+B\M+RSW>1=6<YCD0-C<.X(.!P0>E '(Z=Y6KP^*+,:7K-EKNMV4C,^IV
MRQ+*%C\I50JQ4!=Z\$Y^;/-4H(M;N[/P#&/#>I1G1YXTO/-\M2"L#1DKEN5S
MSDXSD8SSCT+2]%BTUC*UU=WMR5V?:+N7>X7K@8 51P,X S@9S@5IT ><M;^(
M+76_B#?:5I\HNKR&W.FO-'\DKQP[&QGC(/3=@'Z5#I5EJ1\=Z!JZZ!JD<)TZ
M:WN9[R1#*)"R'<_S$@<' _)0*],HH \KM=+UF#X4^(O#LFC78O2;R.$@*5G,
MLCLA3!Z889)P!6C_ &?J6F>*/#OB5+&YGM!I']F7T"(3+;G(<.$ZL-PP<9.,
M$9KT.B@#RKQ%X:U*^T7Q[J-M87#7&OBWAM+0+^\*Q(%WL/X<G<<'D #/)Q6_
MJ$%W=?$#PEJ$5A=FTM;6Z2XE,1 B:14"@]^JGITKMJ* /,M"T.\LO$6EZAH5
MIJ.DI<R,VM:7,#]D3*$EX\\;B^,;#T/(&"*[/P[K\FNQWOGZ7=:=/:7)@>&X
MQDC 96&.Q!!_SFMJHK>UAM49(4"AF+L<Y+,>I)/)/N: *6OW&HVFCR3Z5:M=
MWB21%8%*@R+YB[ERW ^7=R>E<3XAT./Q)XDT'4M*T:\L-8M+Z.:YOI8/)V0+
M]]&;I(2,* N[KU S7I%% 'F$5E?>'_$^M6MYX-;7+74;Q[RRO88XFVEP-T<I
M<C8 1UYX-6O+UOPAXTNM130I]3TW5;.VCD73%7-M/"I4*$8KB,@]<\5Z+10!
MPNO6^M2:]X.UMM)EG-G-<_:;>U96:(2QE4!)(!QP"<XZFJUSH=]JWBWQA"]O
M/;6VJZ1'90W10[/,"R!N>N!O'/?M7H=% 'F,VEZKXA^'>F>$;O2[FTU"%K:"
MZF9?W4:0NI,BOT;<$X YRW( R:T[*VO(/&'C>\DL+L6][!;+:R"(D3&.)E8#
M\2.N,]>E=W10!S/P]M+K3_ .C6-[;RV]U;6RQ2Q2+@JP_G]173444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5GZQI2:U9K93SS1VS.#.D+E&E3!^3<I! )QG!Y QWK0K'\2ZCJF
MFZ49-'TJ;4;QV"+'&R (#U<[F7('IGDX''4 ',^%-&_X1_X@:UIVD23_ -@)
M9PR/;R2M(L%TS-\J%B2,H Q&?XA[5@VS6LOCR!_&FB:MINIW=WG3[DWS/:2E
M3^[CQ&VP-M ^4@[CGUQ77>&K_5E9[5O"E[81!'GEN;RYA9[B4XX^1C\S'N<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[#) _,T /HKBS\1(1\/H/%PTJY,$LOEF 2)NC_?&(%CGUQTSU_&NTH ****
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MDNMQ=,Y!((QD$\#&.^,U$O@#3$\/:;H:7E^MEIUPMQ;@.FY75MRY.WD Y/\
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M&3@G*Y.!GH* //O#AU.X^%\7BB]\8W]K=O931F6<B2&,F4@/Y>,L_&!SG+8
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M^6)/S'!"XQUS$8]6E\;>&],O]=N9//TF?[9]BG,<<LD912RXQM)R>1@CG&*
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M*[<<YP/?BMNB@#FU\$Z:NFZQ8?:+PV^KR/+>J9!F1G&'(./ER !QCIQ46I^
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MM@]:OR^&+"?7[76Y'NC?P0"W,BS%!*@;< ZK@-AN:73-3UBYU.2WO]&2VM3
MLT-W%<B56)/,; JI##KT(QWK2EO+>"YM[:255FN"PB3NVT9/Y#^8]: ,BU\)
M6-L;)7N+NX@L)?.M8+B0,L3X(# XW' 9L D@9X P,)X9T%]$?5&\^Z:&[NC/
M'%<SF5DS]XY[9/89P .Y-'AWQ')KE]K=K+8_97TR[^RG][O\SY%;=T&/O=.:
MWZ *6KZ9!K6DW6FW32+;W4;12B-L%D8889[9!Q6+J?@/1]6TK3;*Y:[5], %
ME=PSF.>   8#KCL .>N!WYKIZR->\16F@K:QR1RW%Y>R^3:6D(!DF?J<9(
M')8D "@"K/X+TFYT!-(E^UM&LZW(N#<N9S,I!$AD)R6X'/IQT J63PIIDFLV
M6JYNEN[2#[.KK<N/-CW!MLG/SC<,\]3US45WKVJ:8EM)J&B#RI[B&WWVER)?
M*,CJ@:0%5P!N_AW?UKH: .4A^'>A6^MS:E!]MA6>;SYK*.Z=;623.=[1 X)S
MSCI[5J:?X=M--US4=7AFN6NM1V?:=[@JVP;5P,<8'''XYK7HH P;3PE8VOV%
M&N+NY@T^3S;2"XD#+"^"H8'&XX#, "2!G@# K>HHH Y"7X;:!+;75L3?K;7%
MU]K$*7CA(9=X<LBYPI)'X9.,5IV_A:TM-8N]4M[F\2ZNH4@D8R!AL0':!D'D
M9//4YYS6Y10!RA^'FA_\(_8Z,/M:PZ?+YUE,DY6:V?).4<<]2>N?T&);?P+I
M4&HSZ@9K^:ZN# 9GFNF;S/*8,FX=#R/3V&!7344 9FMZ!8>(+:&&]1]T$JSP
M31.4DAD7HRL.A_3UJ >&;,P7ZRSW,MQ?Q"&YNG8>:\8! 4$ !1@MPH'4GJ<U
MM44 4=&TJ#0])MM,M7E:VMD$<0E;<50# 7/<#WI^J:79:UIEQINHVZW%I<)L
MEC;HP_H>^>U6ZP?%OB.3PQI,=^EE]J5KB*!AYNS9O<(#T.>6Z4 2Z?X;M;&Y
MMKF2XN[V>UC,5L]W(',*G&0, 9)  +'+8[U0D\!:-)9:M9AKQ+;59'DN85N&
MVY<Y?:#]W<>3C^7%=110!A/X5LY-1TF_DN;MKC2D9+5BXP P"MD8^;( '/IZ
M\U1A^'>A6VMS:E;_ &V%9YO/FLH[IUM9)<YWM$#@G/..GM75T4 9%EX=M+#7
M[_6HIKDW=^$6X#."C! 0@QCC )Z?CFM>D<L$8JNY@.!G&36'X3\1/XFTB6^>
MS^R-'=36QB\S?S&Y7.<#KB@"D?A]H?\ ;EQJD?VV'[5)YUS:173I;7$G]YXP
M<,?4=#W!K0N_#%G<ZT=8@FN;+4'B$$LUJX7SD'0.""#CL<9'8U=>XOUUF&W2
MP5M/:%GDN_. *2 C";,9.1DYSVJ[0!S]UX-TJXLM+LT$]O;Z9.MS;)#)C;*N
M<.202Q^9B<YR2<YJ>/PW;1:_=:W'=72WUS"()&WJ5V+G: NW P23G\\U#HWB
M.35/$NO:/)8_9SI30#S/-W^:)%+ XQQ@ >M;] '*Q?#_ $F'2=/TR.>^6TT^
M[^VVR><,I,&+!LXR?F9C@Y'-:*>&[:/Q#/KB7-T+Z>W%L[;EV^6"2 %VXX))
MS6E)>6\5Y%:-*HN)D=XX^[*N-Q_#<OYUD>&/$4GB'^UQ+9?9'T[49+$KYN_?
ML53NS@8SNZ>U %0> =&'AL:$'O!:)<?:H7$^)()=Y?>CXR#N)/?K4D/@?2X+
M^ZOTGOS>75J+6:=KIF9TYY.>">3R1QQC&*Z6B@#F?^$&TS^R=)TP3WHM=)F2
M>S42C,;I]PDXRV,G@YZ\U=A\,V,.MZAJQ>:6?4(EAN4E8-&Z*"%7;C& "?S.
M<U4\1>*9M!U;2+!=-^U-JDQ@@83A-KA=WS9' QW&:N6^IZF=12UN]'\E)(G=
M9H[@2+N7'RG@$$Y)'T- %#0? >C>';E9;)[YHHBQM[6>[>2&V+9SY:$X!P2,
M\GD^IJK'\,_#\5G;V:-J*VUK="[M8Q>R!;=P2<1\_*,D^_/6K.C^*+_7/#NJ
M7]GHZF^L[J>UCLS<@"5XFV_?(P,GVKI8F=H4:1 DA4%D!SM/<9[T 9$7A?3[
M?7KO6;=[F&[NT59=DQV$JNQ7V'@L%XR0:IQ>!-$B\,+X>*3R6$<OG0[Y3YD,
MFXON1Q@@AB3G/<]N*W=1FNK?3KF:QM1=W:1EH;<R",2-CA=QX&?6L:?Q+<6O
MBK1-#GTT(=2MY93*)P?+:-067&.>6 SD4 6[?P];P2SW+W5U/?30BW-W*RF1
M8P<[5P H&3G@<GKG K.7P'I*:#IVBK->K8Z=.MQ;()1E'4[E.[&3@Y.#Z_3&
MIXDU=] \.:AJR6OVK[' \[1>9LW*H)/.#V'I5K3+PZAI5G>E/+-Q DNS.=NY
M0<9[]: ,G3M >S\7:EJZW%WY5W$B/%-/O5W&,,J]$  Q[EFX  ST%%<[XK\4
M/X8_LP_V?]J74+V*QCVS!"LLF=N01]WCK^E %Q?#6E+/K$WV52^L +>D_P#+
M0!-@'TQG\S4=UX6TV[\*+X:(ECTP0+;E(VVDQJ,8)Q[<TZ+5-4&H6MO=Z-Y4
M-PS)Y\=R)!&0I8;A@'!VD9]<5L4 8;^%K.74M)U"2YNVN-*1DM6+C # *V1C
MYL@ <^GKS5"#X=Z%:ZU-J5O]MA2>;[1+8QW3K:R2YSO:('!.><=/:NKHH PV
M\*:>=;OM7BDNH;N]C5)_*G(1BJ[0VWIN"G&<?KS5-? >E+HFF:.LUZMEIDZW
M%J@E&4=3E3G&3@D\'U^E6K[Q')9>,M(T$V6Z/48II%N?-^[Y8!(VX_VASFMZ
M@#EM1^'^C:EKKZP9+^UNYE5+HV=V\ NE' $@4C/'':KZ^&+&/Q%#KD;SQW4-
MM]DC1& C6'(.S;C&,@'U]ZVJ* "L:Z\-VMWXBMM=>XNEO;:-HH=C@(J-C<-N
M,'.!UYK9HH YZ;P=IKWNH7$,MW:IJ7_']!;R[8[@XP21C*DC@E2I/>II_"VG
MSZOI>I*T\,NEQM%:)"P6.-& #+MQ@@@ <^G&*VF)"DJ,L!P,XS532I[VZTNW
MGU*R6QO'7,MLLPE$9STW  &@"FOARU3Q%<:ZEQ=+?3VXMF8."HC!) "D8X))
MS_.LX^ -(/AA_#IFO?[,>;SFC\[DMO\ ,^]C/W_FZUU-% ',W?@32+W4+Z]G
M>],FH6ZP7J)<LB7 "[0SJN 2!QZ>U.3P3ID2:*L<]Z/[&_X\R9]Q4[=I))!W
M?+Q@\ = *F\7^(Y/"VB#4DLOM:B>*)E\W9MWN$!Z'/+#BM&6XOUUBWMX[!7L
M'B=I;OS@#&X(VKLQDYR>>V* +M85QX3L9-6N]2MY[NRN+U%CO/LLNP7  P"P
MP<,!QN7#>];M4;BYU"/5;:"#3UELGCD::Y\\*8F&-J[,9;=SSVQ0!GW'A#3)
MI]'EC\ZV&CC_ $*.W8*D7R[3QCGY>.<UO5@^%?$3^)+.^GDL_LCVE_-9-'YN
M_)C."<X'4T7WB.2R\9:3H!LMT>HQ3R+<^;]WR@"1MQ_M#G- %C4/#UIJ6MZ=
MJTTMPMSIQ<VVQP%7>-K9&.<CCG\,527P7IRVNLVWVB\,6LLS7H,@_>%EVMCC
MY<KQQCBNCHH YV?P;87$.CQ/<WNW1V5K/$H&QE&U2>/FPO'.>/QJ>Z\+V<^L
M?VO#<75GJ#0B":>V<*9D'0.""IQV. 1V-:D%Y;W,US%#*KO;2"*8#^!BH;!_
MX"RG\:GH YZZ\&:3<V6EV:^?;V^F3K<VR0R8VRC.').2Q^9B<YSDYS5J[\.V
MM[KUAK4LUS]KL4=(-K@* ^ ^1CG.!^7&*UZ* .=3P;I\=MK-N+F\\O6&9KW,
M@^<LNUB./ERO'&*B'@325N=.N$EOXYK"U%E')%=-&SP Y$;E<;@/S]ZZ>B@#
ME$^'FB1:%#HT37J6,-R+J-!<$[7#;UP3G #$D <>N:ZI050 L6(&"QZGWXI:
MI27%^NLP6Z6"O8/"S27?G %'!&U-F,G(R<YXQ0!3U#PU9WVL0ZNDMQ9ZE%$8
M!<VSA6>,G.Q@0589Y&1P>F*KWO@O2;[0X]'87$5HL_VEA%*0\DN[?O9CDD[N
M<YZUT-% #44I&JEV<@ %FQD^YQQ3J** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y7XAV5]<>$+J
MZTR>YBOK#%W$()WC\T(0S1MM(R&4$8]2*ZJ@@$8(R#0!Y6WBRWM?&]CXB2XN
MW\-ZC8F#+7#M&ET(_.&U,[<E#MX_B!'!!S8US3KVRF\%6KZGJ,,UYJ#+>A+V
M0AMT;NR<GH#PIZ@ 8P:[&/PCH<6BV.D)8H+&QG2XMXNR2*^\'\R?S-2ZMX=L
M-:N[&ZO//\VPE\ZW,<S($?&-V >>"1S0!R<U@^@>/_!FEVNHZE+:26]^)$N;
MMY-^U5*ELGDC>0#UQCTK L='LQX,^)Q_TC]U>Z@JC[3)CY8489&[!.1U/)Z'
MBO3+SP]87VN6.LS^<;VQ#K;LLK!4#@!AM!P<@#.?2H(O".C176JSK;R'^U-W
MVN(SN8W++M8A,X!( !(&: .-@N9+*P\!Z';2,L&J6;2R^==2*)'2",K'OY(!
MW$[1@';CID&IXIT[6?#W@G70VNS#%Y:S6<4%S(7M8Y)E1D+$Y9#\V >!S797
M'P_\/7?AV#0Y[>>2UMW5X'>YD:6)E&%*N3N&    <8[4]_ NB2Z ^BRI=26D
MDBRS,]U(99G4@@N^=QP57'/84 9%I!)H_P 6HK&"]O9;:^TB2XGCN+EY094E
M0!P&)"G#$87 ]JW?&VKW.@>"=8U6R3=<VUJ[Q9&0&Z D>@SG\*G/ARQ;7X-;
M9KAK^" VZ2&9L>62"05Z') /2M2:&*Y@D@GC62*12CHXR&4C!!'<4 >=:V9]
M!T[PIK>DWMW-/<7MK;7(DG>1;R.888L"2-V<$$=/IQ2^'=)?5?&'B7[5JVK&
M/3-6B>VB6]<*/W2L5(S\RG.-IXQTQDUU.G>$-*TS[(D0N)(+)BUG!/.TD=N<
M$?*#Z D#.< \8JQI?AVPTC4;^^M//$]^XDN2\S.'8# ."<#@8XQ0!)X@4MX<
MU+#R(PM9&5HW*,I"D@@@@CFO/OM]Z?"/PRO?M]W]HNKRSBN'^T/^^5H6+!^?
MFR0#SFO4719(VC=0R,"&4C@@]JY2'X;^'8+>R@"7SQ6-P+BT5[V4^01G"I\V
M549Z#K@9S@4 <O)82:CJ7Q$AGU35?*L/+>U5+Z1/*8V^_((.<!CG:3M]JFN]
M0OH?"G@?QE/>W12%+7^U%6=UCEBF0*9'4'!*NRMT]:[)/".EQRZO*OVH/JP
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M72+".RLXRD*9/S.79B3DLS$DL2>22:AUK0M-\0V(L]3MA/$KB1#N*M&XZ,K
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M);-%</'Y;$8)&TCGZU)!X<LX=0BOC-?33PJRQ&>[DD5-PP2%8XSCC.,X)]:
M/-XWFA^$_CF>WN9[>>'5-1DCE@E:-@1(>X(-=+JMU=IJ_A%+EIVT6>WD%R(B
MQ+3>6I0N%^8K][VS@GM6NO@C14T34-'"7)L=0E>6YC-RY+LYRQSG(R>N#7.^
M+-%!UC2H[C2-:N=+LK-HX+O2KEA<1R,PRKX8,5VHO///6@#/DL]7LOAIXROK
MF]U:%E>ZDTUI;J59$MT!,1P3E>_7DC&:L:K:?VIXL^'\$US<QB73;OS'AE*2
M,/*BR-XY&?4$'WK7T;PJMWI>IV-[)K9T>^C2,6NIWA>;^+>=P)958%1MW9X/
M [[5SX3TRY33,FYCGTQ2EG<1SL)(U( (S_$"  0V>E ' 3+>:9H?Q.\.M>W5
MYIVGZ>9+1[J0R/'YMN[-&7/) P,9[&M2._N;K4?"_AX&,6\NA"Z\MYWA$[@(
MN,KR=JECMZ<Y/05UTGA?2Y=&O=*:.4V]]N^UMYK>9.6&&+/G)R..O0 # %5-
M4\"Z'K&E:?87<4Y&G8^QSI.RS0X&/ED!ST '/H/2@!_A#3=1TC3[NQU'4UOS
M'=.8/G9V@B8!EB9FY8C/4\X(KG_BPKO9^$UC?RY#XFL@KXSM.7P<=Z[32M)M
M-%L%L[)'$8)8M)(SN['JS,Q)8GU)JGKWAC3?$GV0:D+AA:3+<0"*=X]DJYVO
M\I'(S0 R&SU.UU=;G4-86>S: PK'Y0BVR,ZX/!Y)Z>WXUYI/!<R> /&NHMJ^
MK?:]*U6]^Q2"^D!B\MAM[_,,#'S9XZ8YKTY/#-D+VVNY)[^>2V8O$)[R1T5B
MI7=M)P3@G!(XJJ/!&C#2-2TO;=&SU.9Y[M#<OF1W^\<YR,]P,4 <[+'-IWCK
MP=-%?WSMK$-RM\LMR[)+MA#J0A.U"&Z;0*P8=)N]5\(^+[]O$&L17FE:G?\
MV&1;YP(O*.5!&?F& !\V<#ICG/H\WA;37N]+O9#=--I*L+1O/<E 5VG@?>RO
M'.:Y7P=X:6\@\21:K!J4$%[K-U<-;2[XX[B%WRA((Z$=0",CAA0!'#?7.J>+
M/AIJ%XNVYNM*NII1C&':&(GCMR:@L9[CQ/\ #_7?$,E]=VVKPS7;0/'.R?9#
M"6V)M!QC"C<"/FR<UW=UX<T^\UJPU>19A=V"LEL4E9516 ##:.#D =1VJK)X
M,T>2XOI%2>*'4&WWMM%,RPW#="64=R.N,;N^: .1GU2^M4\'>.+V>YBL[R"*
M#5;;SW$,9F0;)MF=H <@'CHP]*FU75;JST6VU2.YECC\0:U%$K27#JD-LV0F
MT\^6'" D@ CS3Z#&WXE^T:PTOA)-!N'L;N%%EOSL%O'&3\X'.=X4?* .I!X
MS6YJNA:9K>BR:/J%G'-82($,)X  Z8QR",#!'2@#AM:36_!>G^(]8@U");=]
M/,D%AYKS>3*I"F52_1<,"5QC.*U;#1M0A\0Z3J]MJL45A)&T<\'VN6X%\&7*
M,-_ 88)R.HSVK7T?P=H^C6-Q:11S7*7,?E3->SM.SQX(V9<G"X)X''-0^'_
MNA^&;CSM.CN?E!$*3W,DJ0 ]1&K$A<^HY]Z -V\B$]E/$7D3<A&Z-RK#CJ".
M0:\PT>YU^[^%WA._M$DU:50TU]9O=&.:[C^<'#D_,5)4X/7 ]J]2GA%Q!)"S
M.JNI4E&VD#V/:L*U\&:58:=I]C9-=V\6G,S6ACN6W1[N",DG<.3PV10 SP-J
M=CJGAYIK"2^*+<RI)#?[O.MWW$F)MQ)^7( YZ8JAXAO[FY\=:9X>5HQ;S6$U
MSY;SO$)Y%95"Y7DX4L=O3G)Z"NFTS2[72;>2&U0CS96FE=FW-)(QRS,>Y/\
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MYN#C;E=J%=V<Y!S]1FN(\4:'+9> =)LM3U1M6N;36;: 7.YE.PSK\K?,<D#
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M$]/UM[86S7:%_)#[MF&(QG ST]*B\#?\D]\._P#8+M__ $4M>7:':_V?\-/
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MX3JMI=)>^;<NXFV1*RG!.%(.<;0,9K.\-:/*/"'BZ/1)8[6_.MW5O TLS*A
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M\/V5O>:B-1N84\J2["[?-921DC)YXYYZT :=%>9^-9[S3=4U2^U&QGU#P_)
MD9N["8_:-*8+\S;,C@[@Q(YQUR,58DF;Q?XLU_2OM,!@MK:W-JCLZD))'N,R
M;6'.3C=U&!TR<@'HE%>8:Q:WOAO2?#/B&[U>74SH]R+;5)U9E2>%F,?F,F2"
MT;;3D^A-6O$.IR:?X<O/$$$[01ZGJ-O )S(P6&U,BQEQ@\;@&;<,'#CN!0!Z
M+17 7'AR[TV[U.\35UM[.ZTR1?L%J\B9E3YA,C;\J0" <=<C-8NF:?:6WPRT
MG6KK6-6BO=1LK.W=X[AW:8LZD1HI8*&;[FX8X))/4D ]9HKR^V^U1:[XXTXB
M2QMUTJ&YBM[>Z?$+E9/F4C&TG:,A>,CJ:H6,,EAHOPTUJ*]O6OKV:UMKEY+E
MV62*2!B5*$[<94=LYYY/- 'K]%>=Z= GC9?%D5[?7%M?6FIRVEO)%*5>RC0+
MY;(,\9Y8GODC. ,*TS^(O&-_H<MU#/!;:;;2VZ3LZ^<'W;Y@$(YR$&?X>V,F
M@#T.N?7Q%/\ \)__ ,(T]FBQ'36ODN1*26Q(J;2N!CJ3U/:I?"=E>:;X;M;&
M_P!6_M6YMB\3WA4@OAB,').2/NDYZBN7UC2K?6?C%%9W;W MV\.N76"9HBX^
MT+P64AL=^".GIQ0!Z'17C=OJNHZ)9SZ"VHS/IT?B==,BO+F5BRP-'YGELX(.
M VU<YZ$BM;Q!H-]H>@^+KA=9,,$VER7$%C:O)'Y$L:G,B-NR >,J.#0!Z=17
MF-O;-I?BCP!<V]W>-+J<$L5[YMP[K,HMMZY4G:,,,C %5["VU#QEX7GUF/68
M=.U*"]F=KS+E[3RY3^[*[@NS8 "I&"#DY)S0!W&JZ[/#K4>AZ9!#/J<EG)>8
MGD*1JBLJC) )R6;'X$^Q?H>J:O<Z?<7?B#28='$?S*GVM9<(%!8L0 !@Y_"N
M8DTNTE^-T3.C$G06G.)''SBX49Z]/;I6->0^?X9^*EM<2W$\5O)*8A-.[E,6
MRL "3G /..E 'JUK<Q7EI#=0-NBF19$;&,J1D?H:EKS:ZLM1L_#7AB?1]/34
M[:*U\Z\TI[@J]P#&@WIN."4/\)X^88YQ74>"=0L-2\+6]QIS7?D>9*NR\SYT
M3>8VZ-\DG*GCJ>E '0T5Y_XCLO[0^*.BV$EY?1V=UIUR9X(;J2-7VE,=#\O7
MDK@GUKC]96_TCPAX_P!&AU*_:TTB[MC83FY??&LNQFB+9RR@-C!SUH ]PHKS
MO6+2/0O%?AW1H;F]^PZ[>SRWSS73OO>.'*IDGY0[8) P#C'3BG0V+I\0=8\*
MQRW T6\TA+T(LK#[),9#'^[.<H"!NP.,CB@#T*J5M-J#ZI?17%I%%91^7]EG
M67<TV1\^Y<?+@\#DYK@?"%S+JVEZ?X8OG<ZCH]W(FI-YC;F$)^1LYR?,WQGG
MJ XJ&ZUB]\/ZK\3KVUEGF>QM;6:V2:5I%B8PN3@,3A<G.!Q0!V/B3Q%/H-[H
MD*6:3Q:E?I9-(92IB+ G(7!W<*>XKH*\KUS3+.*V^'NHPRRS3S:M:F2X:5F-
MQNC=B[<\G/0]@2!@<5+%:7WC>'Q&$U..SO[34YK:*<-();(1MA"H#  $#)_O
M9.<]@#TV0N(V,:JS@':K' )]S@X_*L/P=XAD\4>&XM5EM5M7>::,PK)O"[)&
M3[V!G[OI7.Z+<CQ-XTUO3=6G%U%I=G9K BDHDIEC+O.%!ZDX /\ "!QC)JQ\
M(XQ%\/+6,,S;+J[7<QR3BXDY)[F@#L+B^MK6XM;>:54ENY#'"IZNP5G('_ 5
M)JQ7 >,M.M;OXD^!S/&6,CWB,0[+P("0.#QSZ4FBQIXPU#Q=#J<DR36>H-8V
MRI*R&VB5%V2)@\,Q+-NZG@=!B@#T"N9U_P 4W>C>(]&T:'3(KE]6:58)&NC&
M%,:;FW#8<<=,9_"H_AOJVH:W\/M(O]48O>21LKR$8\S:[*'_ !"@_C6-X[BE
MF^(O@".&X:WD,][B5%#%?W([,"* .LMM0U=M0^RW>DP1*T#RQS0W9D0LI4;&
MS&I4G=G//0UEZ+XGU37_  =<:M8Z5!_:*3S0QV;W.$8QR%.9-OH">E:6G6EY
MIVK7+W^K->)=K'';+(BH590Y8 * #QSGK^0KS!S)'\ ]>GAGG@FBO;MT>"5H
MR#]I8=5(R,$\'B@#V=<E1N !QR <U5U26^@TRXETRUCNKU4S##))Y:NWH6P<
M5RNO23CQKH45ZDMQHDEG/O@B1I/WXVX=T7)*A20#@@%AT)%<OJ&FZIIGP=\3
M75Y=:K#<%YI;,RWLWF1VX<B($%OE^4\KW&,\B@#NY?$5S#XVL/#\MC&L=U92
M77VA9B2"A4%=NT=VZY_"K'BW7)O#?A;4-9@M$NFM(C*8GE\O('7G!_*N3UK3
MHM6^)/ANTN9)UADT:Y\P0S-&SC=%P64A@/H1^6:P;Y+G3O!7Q+T'[5<76FZ:
MH%G)<2&1D$D0=H]QY(4D=?6@#UZUF-Q9P3D;3)&KD>F1FIJ\]N;J;4/%VE^'
M9'@%L=$6Z2&<L%F<MM;[I&XJH! [;B>P(Z+P?IEWHVD2Z=>:M_:3P7#A'(.Z
M)#AEC)));:#U)Z$4 1>*?%%QX=N](@CTZ.Z&IW:V<;-<&/9(P)&1L/R\=1^5
M7H-0U@:C;V][I,$<$VX>?;W9E",!D!@8UZX/-<K\3T>2]\%I'*T+MK\(610"
M5.U^<'C\ZZ2WL+RRU:2>_P!9DNK:>%8(HY%6-DDW$G;L R2,>XVT ;M%>'W-
MM(OPH\0:S_:&HG4=-U.Y-G.;R0F+9<8'?YN./FR:Z^XLAI'Q.\.I:W-YMU:S
MO!>B2Y=Q*46-E;!.%(+'&W&.@P* /0:Y^X\13V_CJQ\/&S3R;JTEN5N?-.[*
M%05VXX^]US7F<>CR7OPTU_6VUC54U/2KN^ELYS?2?N_*D8A<9PV0N"6R>>M=
M3#<SWGQ%\'75TFRXFT&>25<8VN?*)'YDT >AT5Y+:3S:_P#"+4?%DMU/;Z]$
M+JZ6=)2&MGB=RL0&<!=JJ"O0Y).2<U?O;V;2-4\+>-+]I(;._MH[75(6D;RK
M>255*2[2<+ALH3Z,* /2Z*\TU*]N+#2M'N3,ULGB/609VED<".%U=HH^""F=
ML8(&.2WK46OPZEX(TK7M0AUB..VNA;[+.,/MLP94CDE0EB5!5B<#'(R.E 'J
M%%<(?#]]I^J/J5GKUK86]S82P^0F]HY)-I9)\LQ *]2<<CK57P??26OB:#2-
M;TJXTO7$L74%)C+;7ZADW2JV?OC&3D;L-R30!Z+16%XRN8;3P?JDT^I3:;&(
M=INX%W21EB%&T?WB2 /<URVD1SP_$V?2S!+86-SH(G-JETQ.\3;0Y*_=DP2"
M5)^IH ]&J*YDEBM99((UEE5251GVACZ$X./R->*Z;'-#\-/"'B+^T+]]4_M.
M",S/=.0T;W!1D*YVD$'G(R?6NRTQX_%?B3Q=!J32$:;,EI;0K(R^0GE[O,7!
MX9F).[KA0!0!T7A'7F\3^%-/UI[<6YO(S)Y0;=LY(QG ST]*VZXSX3_\DL\/
M_P#7N?\ T)J[.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "J.KZ/8:[I[V.HP>=;LRMMW%2&!R&#
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ME>ZA!;JEW>[/M$@ZR;!M7/T%5(/#.DV^I:E?I;NUQJ2A+SS)G=9E V@%&)7
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MNY6D*$YPS%LL0>A/3 QC KH5.Y0?49I: .<'@3P\NAVNC+:3C3[64300B\F
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M<YR4C+%4/)Z 8R<=: .:\):990_$[QO+';1K)%/:%& Y!>W!8_B2372>-/\
MD1/$/_8,N?\ T4U64\/:5'KTNN)9JNHRHJ23!F^8 8!*YQD D9QG!QFK]Q!#
M=6\MO<1I+#*A22-QE64C!!'<$4 >2RZ,NBZ+X$\0:3/=IJL\]A;39N'9;F*1
M '0J3C &2, 8 JS;6$_C?3-=FDU>UL-1M-3GC^U&%C/8"*0[ K>8-J[ #T .
M23DY-=[IWA?2-*>![6WD_P!&!6W$UQ)*L (P1&'8A../EQQQTJI>^ O#&H:[
M_;5SI,3WY(+R!V59".F] =K_ / @: -ZU+-:0LTGFL44F3;MW''7';/I7FRV
M4WC>\\664U_;6]Y9WS6\+/"S36:!%\N2,B1=N3EL@<G.21P/3JYW5O GAG7-
M775=1TJ.:]"A3*'=/,4= X4@./9@: .?^?\ X6-X,\R\%Z_]C7.ZZ"[?..(O
MGQVSUQ[U1T_^T(]&^)4>FWKQ7<5],+::XG)\K]PA^^YXQS@DX%=[-X?TR?6;
M;5Y('^W6J&.&19G4(IZ@*#MP<#(QSBL37?"L=OX<UR/0=.2>\U/FYAN+ER+C
M) ?ER0'*9 /3.,\"@#%T[1Y-0\1^%[W3[+4+"RM[)VU-7,MOYDF%\I6&1YC!
MMY)Y!&<DY%9=T&C\-_%B'S9I$C:4)YLK.5!ME.,L2<9)K2T3PE:C4+2XTSPU
MK.@303([SW.IED*JP+($69P^X KR ,'.>,5V4'A;1K<ZELL]PU//VQ997D6;
M(P=P8D=./I0!P5WHRZ#<>"-:TB>[74+V[M[2\5KAW%S"\9+[E)(^4+D8  Q[
M#$=]JEUHT?Q1U"R9DGAN;?;(HR4!AC!8>X!)_"O0].\-:5I4D,EK!*6@0QP&
M>XDF\E3U";V.P< <8X %%KX:TFTN-0GBM27U'_C\$DKR+-QCYE8D=..G3B@#
MGM-\/"V\1Z3KEGK-G%:SPO$]O:0,$OP4+*S$R-EEP6W8)(SDUVDL23PO#*H:
M-U*LIZ$'@BL+0?!/AWPQ<23Z/IJVTK@KN\QWV@G)"[B=H)[#'2M]U#HR'(##
M!VD@_@1R* /%;>?_ (1SX6^)M4TR/[/=#6+FV:XB^]%"UR%8CTPIX/;@UU>N
MV::!XL\)SZ$ODI?W+6=W!"QVW$1C+;V]67;G?UYZUU%AX6T73;"ZL;:S_P!$
MNR[3PRRO*DA?[Q(<D<]_6ET[PSI6E-$UK!+NAC,4)EN))?)0XRJ;V.P<#[N.
M@]* .-\ :#:7E[J^HW,MY-<:=X@O4M2]W(0BC"X(W?-P?XLG@>E=1X[U2]T7
MP+K6HZ<#]KM[5WC(&=IZ;OPZ_A5_2- TW0OM/]G0O%]JF:>;=,[[Y&ZM\Q/)
M[GO6A)&DL;1R(KHX*LK#((/4$4 >;:W;QZ-8^#]:T!F%U<7UK;RNK$F]AE'S
M>8?XS_%N.2,$U#H6F65O<_$>2*VC22.YE5& Y -LI/YDDUW&G>%-&TIX&M+5
MU6V)-O&\\DB0$Y!\M&8JG!(^4#@D=#22^$]$FOK^]:RQ<7Z;+ETE=?,&-O0$
M ''&1@D<9H \VTVQBTS0?AAJ]K).M[<S6MK-(9F(>%X&RFW.-O P,=L]>:T(
M;"?QQ!XD$FJVUG?V>IS0)<&%C/8K&W[LHPD7:"H!X !RV<UVQ\':$;/3K3[)
M+Y&FNLEFGVJ7$+#@$?-V' ]!4.H> _#&J:W_ &Q>:3%)?' >3>ZB3'3>H(5^
M@^\#0!R<^BV^O?$P:=J%Y=W5I/X:2641W$D2ROYV-X4-\N< X''3K7IL:+%&
MD:YVJ HR23@>YZUG?\(_IO\ ;_\ ;GDR?VEY7D>=Y\G^KSG9MW;=N><8Z\UI
MT >2V/AC3M?3QY)?37,3P:Q<-!+%<O&(&$,9\P!2!D<<G/ ^M)H6JZCXCN_#
M>E:U+;;KCP^EV(KZ$R)<RERK,5#*"P0*W.<;B<5Z!-X1T2>[NKEK-@UV=UU&
MD\B13GIF2,,$?C@Y!SWI=?\ "6A>)X+>+5]/2X%NVZ%@[1O&?]ED((Z#C/84
M >?ZMHD^CZ?X7TV37KJ],?B:.WWQ2/'Y<3H[^4?G.=O&&)R!@#&*2]N)_"-]
M\0XM%:6..VTRWNX8R[2"*5ED#.-Q/. "?I7?R>$-"DL]/M#8[8-/E$UJD<TB
M".09^?Y6&6Y/)R>3ZU/%X<TJ+5;O4UMF-W>1B*X=YG<2(.BE22N!D\8[F@#F
M-.\/)_:^B:[9:U:1VLL31O%;0/C4E=,C>3(=S#!;=@GKDU1\&:/8;O'!2#RF
M35[B)'B=D9%\J,X# @BNIT/P-X;\.7<EUI.F);32 C(D=@@/4(&)"9_V<58L
M_"VD:>+X6L$T?V]V>YQ=2GS&;JQRW4^HYH \N6U@U#X=?#&>\C$\K:K:QL\A
MR2K"3<,^^!^5;/C%)])O=3O+K2QJOAS[.D#R6D@%UI.U.653U7#!N"#Z\"NT
M;P;H#:#;Z(;#.GVTBRP1>=)F)U.05;=N7'/0]S3I?"6BS/.S6L@6X18YXDN)
M%CE55"A60,%(V@#!'(X- &O!-'<V\<\3;HY%#HWJ",@UYO;^';+Q%\0O&VG:
ME->RVB1V+)"+R0!6:-SD8;L<D#H,].E>EJH50J@!0, #M7!Z?X>ENOB+XHO[
M^QOH;2\BMH[:XCN&B$@1&#@['!QDC&10!Q^GF^U'P_X#34+^\D?^V9K(SK<.
MIGA3S0"<'DD*!NZ^AKJ+"PLH?B%_PB$D+-H]EI/VFTM+B1I5D=YCO<[B=VW@
M#.<9.*ZRZ\*Z+=KIR2695--(:S2&5XEA(& 5"D#..*GU+0--U:YMKF[@;[3:
MY\F>*5XI$SU ="#@]QG!H \Y@T74-=\->,O#\,\[G2]0==(G:0ET(59!%NSD
MJ"=O.>&QV%=)X7U&T\:FQUJ*$)!:V0B*KE=EPX&]..08P !_OGTKJ['3[73+
M46UG"(HMQ8C))9B<EB3R22<DGDTVQTNRTVUDMK*W6"&2225EC)&7=BS'/N2?
MIVH \DMM6N=,\ I +J=(;SQ6^GW%R96+Q6[3L&.\G(^5=N<Y&?6MV]L+71/B
MQ:3:9:)&QT"Z<0QC"LRNF/E'&3T)[X%=9'X.T"/1KO2/[/5]/O',D\$LKR*S
M$Y+?,20<\Y&.>:;8^"M TZ_MKZ"R=KNUC,4,TUS+,Z(>V78\>GIVH XO0-,E
M\0>'?#?BB+7[6VNTDBGN;N.W8RW#'Y9()&\S!!8[<8XP-H'2JLGD>*?AOXXU
M;4E\W486OXUW'YK58E;9&O\ =& "0/O;CG.:[JR\!>&-.UQ]8M-)BBO6<R%E
M=M@<]6"9V@^X&:+SP)X;O[R^NI]./F7Z%+L1SR1I.",9=%8*3S]XC(ZYS0!>
M\+_\BEHW_7C!_P"BUKG=?5H_BQX0*RS!9[>^$B>:VP[43:=N< _,>0*Z^PL+
M73+&&RLH5AMH5"1QKG"@=!S56ZT#3;W6+35KB%VOK0,()1,Z^6&^\  <<X&>
M.<4 >3W&E0S^"_B'>2SWCW&FZI=O9NUW(3"R(C*0=W7W.>.*]?TN9[C2+*>4
M[I)($=CZDJ":S!X-T(6.H67V27[-J,C2W<9NI2)F;[Q/S=^,^N*V+2TAL;.*
MUMPRPQ*$0,Y8@#H,DDF@#BX)(M?^)GB'1]7B6:UL+.V-G;2C*,) QDDQW;.U
M=W;'&,FN*NHY;[PQ:6FI[KM-,\:)I]G/.2SM;B8#!8]>ZY]J];U#P]IFIW\-
M_<02+>0H8TN()WAD"'DJ61@2N><'BFW7AC1KW1$T:>PC-@C!UB5F7:P;<&#
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M'ME:16'*L&QM!]N:Z&Y\*Z+=Z$^BS66[3Y&+R1"5QYC$[B78'<Q)Y)).3UH
MP];CM-2\8VNG%3?W*Z8\AL)V"VT2,X'G,<$[^"JX![].M<39R7.H^ ?AO/<7
MUX9I=62WDD6Y<%T_?#!YY/R+SU&.#7I]WX1T.^OK6^NK+S;JUB\F.5IG),><
M['^;YUSV;(JO#X#\-6]K:6T&G&*&SG^TVZ1W$J^7+S\PPW7DX],G% ')VVGR
M6>O^/-!TB^;3XGL;:2W:25BL$TBR*7!))&2%R1]:T?!M^J>);O3-2T(Z)K4=
MDKR0P,&M;B)7QYL9'?+8.>>1G...CF\):)<76H7,UH[RZA$(KHM<2?O4'0$;
ML8'.,=,T2^%]+-I>Q&U>Y:ZM3:R&YNI79HB#\F]B653GM]>M &T"& (((/((
M[TM9?AW1H_#^@6NEQ']W &"@$D*"Q;:"23M&<#/. *U* "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,&5AD$'((KS_ ,3Q6.J>)-7MEC%[=6VD?OH[MA]GM%8N0Z#!)D;';'"CD<4
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M\;A@MQS0!Z?6;JVKIIK6ENB"6]O9?)MH<XW$ LS$]E5023^'4@5F> [^QO\
MPNC6%G/8I%<3QRVD_P!ZWE\QBZ>F 20/;%95^[O\;M&BESY$>BW#PYZ>89%#
M8]]H% '5AM5&L1(5M&TW[,3)("PE\_<,87ILQGOG-7ZX66%?^%W1#=)B;P[*
M7'F-C/GQC(YXX],5P<NF6T/PDU36E\W^TM/U>5K2X:5BT.+P+\N3QD9SZ]^U
M 'NU<YKWB"\TGQ'X>T^*V@>VU2X>&25G.]-L;/P,8[=<_A6(@L_$?Q"\3Z'K
M:),MM:VXLH)0"!$Z$R2(#_%N(!;J,+574[>"SU+X=6MK>SWL$%]+$ES.^]Y
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MUSUP1D5+67X<M;6T\/V,=I#%"A@1BL2A1N*@DX'>M2@ HHHH **** "BBB@
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M<O.5.23QZGUK<#*PRI!'J#2T 8TOA319I9I&LL"=52:-)76.55 55= 0K
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M9^6S((!C'RA2 ../IQ0GAG1XY-1<62L=279>;W9A.,8^8$D'CCZ<5JDA022
M!U)HW*5W;AMZYSQ0!4TS2[+1K".RT^W6WMHQA47)_4\G\:N4@(/0@]N*6@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "N5\=RV(L-+MKT32-<ZG!';V\;A$N)02RI*2"/+^4EN#TXR
M>*ZJJ.K:-INNV7V/5+.&[M]X<)*N0&'0CT/O0!YI9I=0?\+/L;2^M-.DC6-X
MFA;RX;=VMLL1_=Z<MQR,X'2M#3?#G]JZ[X4U*#1S86MC8L+X. GF.57RT&T_
M,5;<V[ISUR<5NZ[X1MET75/^$>TG3(M2O(%@<R1A5EB! :,D XRF0#CK@]JP
MM(\#69U&UNH/!D'AZX@F24W45\&;"L"541G!# %3NQP3P>E &?X=T&R^R>,M
M5ALA-J>EZU?2:<2S'RI!$NT*,]R>G? ]!4_A[3-.UG2O"OB.'6K2&>%XB9;6
MWQ/<2, )(96+DMDD[LC.1FO0M-T33=(DN'T^T2W:Y<R3%"?WCGJS>I]^M5+#
MP=X<TS6)=7L=&L[>_DSNGCC ;GKCTSWQUH \ZTRSM_%WA.YOM0U>TL=4M+^6
M2YN4MO\ 3+25)6PH<OG&T!0,8VG %:MEX?TK5?B)XYM=0LH[FW,%BQBERR;F
MCDRVT\9]#U&3CK782>#O#DNO+KDFC6;:FI#"Y,8W;AT;TS[]:L+X?TI+V[O$
MM%6YO%"W$JLP:4#H&.>0.@]* /(K.QME^&/@?7_+W:NNHV48O68F4(9=FS<>
M=FWC;T]JZ.:"'Q3XM\7:'JEQ8)+%Y<<$=U;>8Z6[0J=\1+C'SEB2!P<9/ QV
M?_"):#_9L&G?V9#]BMY/,AM^=D;=<J,X!SS^?K2:OX/\.Z_<6]QJVCVEY-
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MIC9BA3<>=NWC;TKVRL8^$]!-A;6!TV'[):R"6"#G9$XZ,HSP1VQTY]:V ,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%("& (((/0BEH ***8LL
M;2/&KJ73&Y0>5STR.U #Z*"<#)I%=7&58-]#F@!:*** "BD5E<95@PSC(.:6
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MXKU6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDL9%I*P>*1D8$*2"&4@CI7F7]GK!X:^&VJPW5['?WL]G:7$ZW+[GAD@;<G7
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MSH JZ+HFG^'M.33]+A:"TCSLB,KN%R<G&XG')-:%5+O4K2QGLX+B4++>2^3
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M&F/ !9F)8D8&#GC QTJM;^"O#MI<PW4&F1QW,,)@28._F!#_ +6<D^YY'8T
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M6$6<_P 6WG&,]*M*3M7?C=CG'3-<7\7(4E^%VNEP<QP!U()&#N%4-;TNSO\
MXJ>'8KJ(R13Z5=>;&6.V0 QX!&<$<GCH>] 'HH((R#D&BN'^&426MEXCL(!L
MM+/7KJ"VB!^6*/Y6"KZ %CQ[UVY 92K $$8(/>@#FM=\5BV\*Z]JVC>1=2Z3
MYJN)&.PO&H9AD=<9QVY!K;TRZ:]TNSN9 HDF@25E7H"R@\>U>36=A86OPV^)
M#P6EM#*MWJD*M'&JL(QT48'W1QQTK3ATRTTGQ?\ #V[LH1%<7UM/%=R@DM.H
MM@P#G^+! (ST[4 >H9&<9&3VI:\?TVQB\7^%+G4+W6+.PU2SOY9+F[6U)O+2
M5)6PN_?TV@*!C&TXQ7L Z4 <UX[\277A'PG=Z[;6T-T+79OAD<KN#.J\$9Z;
MO2JLGB^]TGQ1I6B:[I\$2ZL'6TN[2<NOF* 2CJR@CJ,$9SFJ/QH_Y)+KGTA_
M]')6R?"$-WXBL-<U._N;Z?3U86<4@18XBPPSX51EL8Y)Q[4 ='N&[;D9ZXHR
M!U(KQF9K22T\+ZSI0_<7'BA E_<,#=W(>5U?) &$ZJ%.25"Y Q6UI?AG1]:^
M)/C*._M?M,,$UA/"C2-M5_*+;A@]<_S/J<@'=1:JFJ66HG1Y89KBV>2W5I"?
M+\Y5'!(YP"0#CT-6[)KK^S[=K_R!=^4IG\@GR]^/FVYYVYSC/:O+-!TK34\
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M\*E95.@V)6683L#'QO!SD>G/8<5H6>A:98:C<:A:VBQ7=R )I58YD X&[GG
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M2V?O$CCFLRV\$>%[-XFM]!T]#"YDC_<*=C>HST]O2@"3QC_R)&O_ /8-N/\
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M.ENH5)K3RRQW <$+@$'L3[UQ=WHFF#X8^.KT6<7VFQUF]-I+CYK?;*N/+/\
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MKBQ@ENK;(@F9,M%GKM/;/M0!RGP]MX;#5_&.G6D:0V=OJV88(QA(]T2$A1T
MSV%1?#.YCM=&UL7$\<5M_P )#>16AD<*"IDX5<^K;N*ZG^Q[?35NYM%L;6"^
MNS^\FVX!;^^^.6QZ=3TR.HBL_">D6NA6.D26D=U;V<BS1F=0Q,P);S#_ +18
MD_B: -NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:*-U4XSC))[<]LGVH VZ*Y&?QG>VOB&TTF;P].&U"&22P=;A"92F"RN/^6>
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MR<"?X?6%YHG@?2])U* 075G%Y;CS%=6Y/(()_7%6_P#A!_"/_0K:)_X+XO\
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MRI6!8%'*'...W;/UJ[JM[<V5J&L["2^N7;;'"C! 3URS'A1QU_  FN8^%?\
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M\ "@#VZBO,?%M]=:/K6IW6L6UW/H,S1B+4]/G8OIA"J"LD8(.TM\Q(ZAL'/
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MX_\ !)E\[,MS<HVR=TX%NY&,$8/N,$T ==HEYJ5[9.^JZ8-/NHY6C,:S"57
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MX9C=/%?%3=P&X<QSE551N7..BJ#C&<<YK8G@2XMG@8LJ.NT[&*D#V(Y%2T4
M<W_P@NA#0[+1A#<BPL9EFMXA=2#8ZG*G.[)P>0":N_\ "-:?_;S:W_I/]H-;
M?93+]H?_ %6<[=N<=><XSFM>B@#GK;P5HUEIEOI]JMW#!;W)NX2EW)NCE.[+
M!MV>=[9!X.3D5)<^#]$OM)O=-O;/[3#?2>;<M*Y+R2  !MW4$!0!C&,<5NT4
M 8>F>$='TO3;FP2"2XAND\NX-Y,T[RI@@*6<D[0"<#H,GUIVG>%=,TQ[5HA<
M2_8U*6@N+AY1;J1C";CQQQDY..,XK:HH YT>"-$&G:I8>7<FVU25IKQ#=2?O
M7;ACG=D9 &<8Z4MYX*T:]?3I72ZBN=/C\JWNH+J2.98_[A<'++['-=#10!SD
M7@7P_#I&J:6+21[/4Y&ENHY+B1][L<EAEN#P.1SP*=9>"M&LM3M-35;N6_M8
MFBCN)[R61RI(R&);YAP.#P/2NAHH YG3_ 'AW2M6?4;.TEB9I3,(!</Y"R'^
M-8L[0WOCCMBIKGPAI#SZO=K;3F;4XBERD=RZ+(2FS<%W;58KQN S^9KH** ,
MKPWI!T'P_::9YC.(%(7+E]H+$A0QY(4$*">P%0?\(GI0O=5O MR)]518[QA<
MR?O%48  S\N 2.,=:W** .=/@G1#I^EV'EW(MM*E66S074G[IE&%.=V3@$@9
MSUJ.]\ ^'K_7)-7FM95N9@!<+%</''<XZ>8BD!_Q'/?-=-10!E2>'=/E\0Q:
MZRS?VA%"8$<3.%$9.2NW.W!(!Z5DW7PY\-WB:A%/;7#6]_+Y\UO]JD$7F%@S
M,J;L*Q(Y(YZXQFNKHH P+[P;H]_J5KJ++=0WUO%Y*W-O=R1R/'UV.RMEA]3F
MJX^'_AX:%+HHM[@6$L_VB2(7<HW2;MV<[N/FP<# R*Z>B@#(_P"$:T_^W5UK
M_2?[06V^RB7[0_\ JLYVXSCKSG&<URWB3PG;Z=H,-AINC7M_ILNHB[OHH+MO
MM"]6WQ%G'S%]N<'IG'/(] HH X3PMHC6^KPWFGIXCL[1583Q:M>-(LN1P%C9
MV((.#NXZ8YR<=3K>@Z?XALXK;48Y&2*9+B)HY6C>.1?NLK*001D]#WK2HH Q
M8?"VF6^L-JT*W"7C6PM"XN7QY0Z+@G'!.<]<U2?X?^')/#1\/R63R:=YIF2-
MYW9HY"2VY6)W*<DG@]SZUT]% &7H?A^P\/6C6]BLIWG=)+/,TLCGH-S,23CL
M.@IFI^&].U?4['4;L7!N;%F:V:.X=!&2,$X! .1QS6O10!BW7A;3;G59-37[
M1;7DT0AGEMIVB,R#H'VGDCL>H[&DO?">CWUGIMI);O';Z;*DUI'!*T2Q.GW3
M\I&<>];=% &4GAW3X_$3:\%F_M!X!;M(9W*F,'(7;G;C))Z=:J6W@O1;/]W#
M#*MF)_M*V7G,;=9-V[<(\X'S?-CH#SC-=!10!2O](L=4ELI;RW65[*X%S 6_
M@D (!_\ 'C^GI1;Z396FJ7NI00*EW>B,7$@ZOL!"Y^@-7:* ,'_A$-(\[5Y=
MESOU=0EZ?M,G[T!=H[_+\O'&.*:?!FC-;:3;E+GRM)96LE^U2?NBHVCOS@<<
MYXKH** /*7T(3ZWJ<NI^'O$T&H7-V\@ETB^*6\J?=1@1*H!VA<[@.<]N!VNG
M^&E-OHLVJS7-Q?Z69&AD>X8D;\C#D8$A"X&2.2,]ZZ&B@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&MO.]N6D"X=D.&VX)R 01]0:Y;Q[:WGV;2/$NBHO]K:?<HD,<P*>=',1&T3
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M;R=BXS@KR#E2<CIFC7+.^TWXC:7XFCMI[O3S8R:==+;QF1X,N'60(.6!(P<
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MML+#."@?.-X]/KZ5C:3=0ZC;SW<'@>XT>6*V=99+BQ1)2Q&/+BV_,PSU; &
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MUR68J'0.-CJ <')!W=..0#I+;QYI%]I>GW]HEW,FHS_9[./R=C3M@L=NX@8
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MR*,98$ ;CGOTP#755QFL6]];?$_1]5CTZYNK1M.GM&D@4$1NSHPW9(P, \T
M<_X=\46WA:'QA+=P:G=VUMKTYDDB5IO(BV1C<S,<X'/ R<=J[Z[UV&"6."UM
M[B_N7A^T"&UV;O+Z!B795 )X'.3SCH<>?_8-0;P;\1+0:;??:-2OKJ2SC-LX
M,RR1HJD<=RIZ].]+=VMYI&O:9K=SX8N=:TRYTB"RGACM1)/:31EB#Y;<[3N(
M./3/ID ]"T'7;#Q)H\.IZ=(S6\A*X==K(P.&5AV(((K2K+\/Q+%I2LFDQ:4D
MCF1;1$52@/3>%XW'J<=,XYQFM2@ HHHH **** "BBB@ HHHH **** "BBB@
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MUJ>_U&<_*T=E)<$VT3A=N]8^S8)ZYY.>M;=%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %5[^T^W:?<6GGSV_GQM'YUN
M^R2/(QN5NQ'8U8HH S-#T.#0K$V\5Q=74CMOFN;N4R33-@#+-] !Z<5IT44
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
? "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>sangamoexecutiveseveranc002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&NXFDMY?L[JLB #+(Y7:>H(]<@C(KCO OC6RM/"UC%K>IW,UW/?3V_VB9))
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MB.[TUQH6J#6;++3+?+.%L6VX?#.=IST ')SR  < '76_B?2[J6!(7N'%PK/
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M6PO;W<99R(74C#$$9Q][Y^ : .MG\4Z5!]G'G2RR7%M]LCB@@>1_)X^<JH)
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M'="SDF$+F))SC",X&T') Z\$X.#6)XK<?\+!\$2!7:.&:Z:5U0E8PT)52Q'
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M>/#%03@, 2.>#R#ZUI5A^#[R.\\):6\:3(([6*,B:)HSN5 #PP!ZY&?:MR@
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M)%YSQ6T+2ND?(W$#H#@X[G!QG!JQI>IV6LZ9;ZCIUPEQ:7";XI5Z,/Z>F.U
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M%FL:XU_'*-36%7@$!78(E*KAMQ_O'/'Y5T%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *;)(D4;22.J(H+,S'  '4DTZN)^)MVZ:1
MH^F*2(M7UFUL)R.\3-EQ^(7'T)H Z^SNX[ZV2YA#^4_*,RXW+V8#K@^],OM0
MM].C26Z8QPLX0RD?*A/ W'L">,]/6L76=7N%\4:1X=M)OLSWD,UQ+<*JEE2/
M:-J!@1DEAR0< 'CG(FT_3=5N-(U/3?$5Q;WL<TDL4$J+AGMF&%\P !=_)!VC
M'2@#>HKD/A?JUSK7PWT:\O'+W B:%W/)8QNT>3ZDA0:Z^@ HHHH ***Y+7M3
MU+2?&F@JUZRZ+J326DB>6G[NXVEH_F(SAL,,>H';B@#K:HMJD:ZU_9AMKO?]
MF-SYXA)AP&V[=_3?WV]<5PNB>*=4OK3Q#ISZE(^JPWZ0:?*8(P&AE/[F4+MP
MPP'9O93C%;<.J:I%\4!H4MXLNG_V*;L(8E5O,$JIN+#KQGI@<]* +*^.=';P
M]J>M@7?V/3II()_]';>&C^]\O4 >IQ[UIW&MV=MI=MJ$K,([DQK F/GD>3&Q
M /4DCV]3@9KS6/\ Y);\2?\ L(ZK5[Q;;SRZ5X ,=]/ K:G9($14(#>6YW\J
M3D>AX]J .ZT;7(-:%V([>ZMIK28P3PW,6QD; /8D,"""""13=?\ $-CX;LXK
MJ_$YCEF2!?*B+_,S!1D] ,D=2*Q;'4-3'Q"O_#\NHRS6D>DQ7*.T<8=9&=D)
MR% _AS@BN2U/6+[7?@U9:AJ,HENGU:)&<(%R$O=@X''110!ZY117$V>JZOXI
MC\1SZ7J)L3IE[+86L0B1UDDB4;FDW D@L2,*5P!ZT =M17F%OXRUWQ$? \VG
M74.GQ:[%=+<(;<2;'CC;)4D]-P) ]AG(R*]$TR"\MM,MX-0O!>W:(!+<B(1^
M8WKM' ^E %NBN L+WQ/JGB[Q#9#78;:STB]MR%6R5C+$T8=H^3D<'&[)/TZ&
M&RUSQ;K>DZ3K^CV]Q(EU,LLMG+]F6W-NQ.0K;O,#@8Y)P3GY<<  ]%K*A\0V
M,_B:?P^@G%]!;"Y?=$5386VC!/7G/3CBN=AU'Q!XGLM:N]"U&*SN+*_DL[2"
M6-3%(8F 8RDJ6^8[L;2,#%8FO:^GA_XL22W!5+BZT.WM8FR1$DKW$@!9R"%4
M'N1^!)Q0!WNO^(;'PW9Q75^)S'+,D"^5$7^9V"C)Z 9(ZD5JUY]\0;:[M? $
M$5[?O?7 U"RWS-&L8)\],X50,#\_K5[4-9U74_$&L:/I37D!TV&+]Y:K;L3+
M(I8;O./W0-O &3\W/2@#LZ*\YO\ Q7KFBV6B2^*X[C2(9K>1;Z\L8DG2&X#
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M-STK;KA$U2^TNS\+Z+!<7=S<:G TGFJL(DCCCB0E4#!4SEEY;)QGKQB!]?\
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MJ8]W(3"@#Y1@$]R#0!IT5RLNKW6J^-[SP[:7DEE%864=Q--$B-([R$A0-ZL
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MRK!KO['=W>'1?)M(O,D.Y@N0OH,Y/H :NT <B?!5Q_;7]I1:Y-"TU@EC=I'
MI$JIG:REL[#\QSUZ]JK6_P /'M="\/V$6N7 N-$G\VVN3 A^7:4*;>F-IZG)
MS^5=O10!QMUX&O(_$5QJ^A^);S2FO507T2P1S+.5&T. PPCX[@'Z5=7PHT/B
MJPUJ"_*I9V9LE@>+<71B"2SELELJ#G^==+10!S-QX1^U^(]3U6:_/EZAI_\
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M4K&036M_:@*\;XP>#D$$=1WJO<^!H-5\-W>E:WJ=YJ-Q=;2]\VV.1&0Y0H%
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MNK>.WDB>-<;8\[3D?Q<G)Z'/04 <S+XOU/1QX]GN[A;M='DA6S1HU15\R-2
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M44 %%%% !1110 445A>++JXM-,MVM]1BL ]W$DLC*6D>,M\R1  DR-T'![T
M;M<M_P )UIX$%TUG?#29XYI$U01AH-L8)8M@EE!"G!(&:R_#^HZEJ5[XPT>X
MN[V**PDA^S/*(_/C22(.5)P01G.,Y.#SSTY:"RF'[-;R_P!HW>TZ47\O]WM
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MO*W!L?=SG('?M6]10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%U(<1Q3+(6*,W1=P.03UQCM0!L:SXOL;7P3?^(=.F%VD-O*T1C1F'F(K':X
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M&KKG# $9!!_(\BJ5_K-CILJ0W$KF9T+K##"\TA4=6VH"<#(&<8Y%78W$L22
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M,==J@DX]^*YGPK%J7B;0+77M7U"[AEOT$\%K:2^7';QMR@XY<[<$ELC)Z 4
M=E16#8SW.@:?=OK^I&X4796WG9 'D1MH10B#ELDK@#)(R!S4]OXFTFY:]1;A
MHY;)0]Q#-"\<D:GHVQ@"0>Q (- &O17,1_$+PO*MBZZGB&^.V"=H)%B+<X4R
M%=JL<="0:MV7C#0[^6^BANW62Q02SI-!)$P0YPX#*"RG!Y&10!N45RT'Q&\*
M7-S801:LI:_(6W<PR!'8]%WE=H8^A(/(]15W4/%^B:7+=)=W;*+0HMU(L+ND
M!?&W>R@A<Y'4\ @G&: (=1\.W5[XSTG7DOH8X].BFB%N8"Q<2!=QW;AC&T8X
MKHJQ+_Q=HFFZHVF7-X1?" W @2%W=DR!\H4'<<D<#)Z\<&H#XY\.KHMKK!OV
M^P74OD1RBWE/[S.W8P"Y4YXP0* .BHJG+JEI#J-K8.\@N;I&DB00N057&XD@
M87&Y>I'4>M7* "BBB@ K L="U!-=FU'5=:;4(DE=[&V^S)$ML&XY(Y=@N5!/
M8GUK?HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *Y'XGG=\.-<@4,\TULT<4:*69V/0 #DU
MUU% 'F=W<12ZQ\-9%)9(!(9CM/[K-L5&_P#N_-QSCFKOAVYA@\7>/9Y&*0O-
M!(CE2!(! JL5/\7S#''>N_HH \9LH+X?";P7<V]O/*VBW\%U?V:QGS1&K.&^
M3J2,AL8[9KJY?(UGXCZ3KVGS!M/T_3KA;NZ7A&WE=D>>Y&&8CMQG&17=T4 >
M4>'QY?[/-Y:-$Z7(L+R(P-&1)O8R;1MQG)R,>N:L7DL97X9D D6\B--\I_=#
M[.4^;^[\W'..:]/HH \HU*\DM-9^)5U;Z6NIE[:S\JVEA+QW&V,J_'\87.2!
MZ8XJSHMU'+\5;"^BDU*\M[G0GA6[FM'1&?SD; &T!  /0#W)KTZB@#Q:)G'[
M/>I:,UK=+J%NDT#P-;N&\PSL0JY'S''/&<#K73RW+:5\2=/UV[+?V+>Z*+*.
MZP2D$PDWX<_PAAW/<8[5Z%10!XQXDTV8>$O'E_%#+]EU?4K9[* 1DM*$:+?(
MJXSAB&.<<A<],5UM[/%)\7=$GC;?#_95Q&95!*AF="JDCC) ) KNJ* ,GP[X
MCL/%&G/?:=YPC25HG2>(QNK  X*GGH0?H17)^))D'Q@\(R_,8K>"\6>0*2D1
M=!M#-T&<=Z[JSLHK*-UCW,\CF261SEI&.!D_@ /0  # %6* /*HW0Z;\41M;
M-R\WD#8<S VP0;/[WS9'&>:MZI97$GPP\.:WIT3/JF@P6]Y'& 0[!(PLT1'7
ME=P(ZY KTJB@#S[Q5INJ'P&E]#9SW%^+^#5;NTA8B615D5C&I'.54*HQS\@Q
MS5>*]\.:S8:KK&DV%^\Z:7-;R7MXLX9-PX@'F?>);G"Y /U&?2:* /)-ZIX0
M^&$>UA):W=H;A=AS"%@96+C^$!B 2:W_  Y<KIWCCQG!=QSQ&>YBN8W:%O+,
M7D*-V_&WJ".N<UWE% 'BNC0WUIX!\ ZD+:X>WT>_=]0MEB8R1*QD7S"F,_*&
MSTS@YKI[J./4O'=WXBLI VFV^@O:RW*#Y)I&?<J*?XL $G&<%@.M>AT4 >.1
M'R_AO\.861Q-:ZK9O/'L.Z$)NWEAC*@9&2?6KVIB>PUR[U/PQ?R_:I=25;W0
M+I-\=T=ZJ9HLC*\ /O&1\O/2O5:* ,/QE<36G@W5Y[?3$U.5+9R+-TWK+QT*
M_P 0[D=\5Q&E7L+_ !)T745DU"YMIM%FB^U2VCQ1A_,C;:%V@(H /MZDFO4Z
M* /$Y03\#]6M5BE^U/JCNL B;S&!O X(7&2-HSGT%=/::JN@?$_7Y]46;[%K
M,%J^FW4<32(PC0JT>5!PVXE@.^?<5Z+10!Q'PG++X%BA>">%TN[DE9H6CX:=
MV!&0,C!'2C5].L/$^N^)-"N7'EWFDVT ;' D62X;@]"R%D;';BNWHH \C\C6
MIOA9KM[XDA9=7.F2Z5;Q %F<(&4L!U+2.,G'4*IJ\VK"STCP%&UN\<#6WE3Z
MA':&::S=8%'EJ-I*,Y)4DCH".^1Z=10!XC+#.WPW\96L=EJ!DC\0FZV202%S
M%]HB?=R,L=JDG&3QS70:]JUOIWCBVU[4;?5#X?U#35MX[JV6=#!*DCM\Z)A@
MK!N"1VZ5Z=10!Y7JT&F6L?@\Z;IDUE9'7Q=^7(C[PA1P9G#<H"Q!^;U!.#D#
M<\3.O_"S?!+\E(OMOF.%)6/?$ NX]!D\#/6NXHH \3UW4'U#0[[?8WEK<VNO
MQR2:?;63K'&@N%/FL57]XSCYLY.<\#C-=:UQ')\7+FY,4C0-X<6/#H5#/YS.
M8R2.&VG.WK7?T4 >8>$4N=,U_2+/1=1FU+P[<0R,UG>1YGTG"94;\9 )(0*W
M/IG!-=EXLU8Z9HK)#(T=W=LMM ZJ6\MG(4R''14!W$GCCWK=HH \P\=>&)]*
M\(66HZ9JM[<W.@RPSZ=;R1PD-M(&P>7&&.4R,9Y[U/XMURQD;P?XGC:ZA>&Y
MD92UK)(J*\)WI(J@LK8P!QP<GI7I%8&N>'[W4-5M-4TW6I=.O+:)X0&A6:)T
M<J2"AQSE5Y!!XH X*2^T2^\$^.Y-.U/[;J>IPRS2VZV\D14M'L1$1P&;IC..
M3Z=*U?$RW+?#[PSJ%A:W-U#IL]K<W5M:EEE:%8V1PH&#N4L#CC[M=GINE3VT
MQN]0OC?7I3RQ+Y0C5%SDA5'3) )R2>!Z5J4 >5:M;Z?XH\,:W?\ A'3;Z>^>
MUC5KJY\]'FV2*_D+YG+<*PR. 2 "<G&MX=U7PUKVIVFJ6FFZD+VRC<S3:AYX
M^P@KADW2':6)P,+GC)[5W]% 'B<*E?@3HEFT,@N8]0B+P&)O,4"[WDE<9'R\
M].AKJ-75K[XHNEI)M,_AJ>VCN!G8)6D!4;AQG'..N*]$HH \G\)W6C:E8:)H
MNHZ)JIU_2WA#VMS]H\NWDBP/.#$^6% !(]<X'6H=RMX&^)L01C+=:A>-;IL.
MZ8-$BH4&/F!(."/2O7J* /-1/]E\9>#-0>&X>V?1Y;8/%"SXE/ED(<#Y3P>N
M.A]*Z7X@VEQ??#W7K6T@DGN);*18XHU+,QQT '4UTM% 'G=ZL'BF?P6FDYED
MTV[CN[F<(0+>-(R&C8D<,S%1MZ\$XP*P=%;3$TVY\'^)M'U6ZU>.YE"6Q-PT
M%Z#*720$'8J\@DG&"":]BHH X;1I#8_%?Q1%/!<+]O@LGMF$+%'5$<.=^,#!
MP.37.3>$]6NK/Q!X2MDD@L].N'U+2KA> 7?]Y#&OLLGF9_X#7KE% 'F^H6FL
M^(OA7J6I)9.FLZG'%="TR0P1"A$0[\JK''K(:9:3:)XR@DDT;3M3&L)93Q>?
M?^>IL6>,KMW2'!8L0,+G@$]J]+HH \J\*7FBZM:Z+IE]HNJ_V_ICQ&2VNOM'
MEVLD> 90S'RP, D>N0,<U2D(?X<_$>%8W,UUJEZ\$>P[I@^W85&,L#@X(]*]
MBHH IZ1(LNC63HVY3 G/X"O(YW=/A%XOT9K:Z%^MY=CRC;N-Q><LH4XPV0<\
M9XYKVBB@#S_4IHYOB)X*E@;,26=VCR*I*H72,(&/0$D' /I7.^&&TQM&MO"7
MB#1M5GUZRD\O[+(;AH)F5LK,&SY83HV3CO@'C/L5% %+5YH[?1[R25@JB%^?
M4X/ ]3[5PWPKT'2I/ >A376EP'4K1&W>?#^\A?>W.&&5..]>C44 >3^,+V2\
ME\<Z6UE=6TWV#_1TM+1MVH?N3^\DD"\A3\H7('&#G.!9CNHI_%?PYG\N8)#I
M]RDC20LOELT4:KNR/ER58#.,]NM>GT4 <,)38?&2ZDGAG$=YI$$<,BPLR,RR
MN6!8# P""<D<5R1@OY_!_B2?3K66YFM?%;ZE]D5"&N8%F1_E!^\"%R,==O%>
MS44 <OH_B71M?N)-4L+*0+%;%)[^XM&A9!D$19906YR2!D#'N*\YMG6S^%7P
M\%W&Z&VUVV$\;1G<A#2$Y7&>F#TKVZN?\4>'9_$+:48K^.U&GW\5\ UN9-[I
MG"GYA@<F@#E-:1KOQAJWB32;!-3MK3P[+:R*J[H[R5GW+%Q]_ !SC/W@.M9^
MFW\<WC3P;J*F_FA-A<Q22&R>*&%RL>(U7: BK@C/H.6.*]:&<#)!/?%+0!XI
M<@O\%?$]JD4AN9=4F>.$1MYCAKD,I"XR05&<^@]J["2Y6#XQ07ACG>VO=#6"
M":.%G1G$Y8C(&!A2"<XXKNZ* .4^(%^^G:%:SK8K<1F_@664V_G_ &1-V3.$
MP<E<#'H2#STKD+29(M9^(9VZB\=YIL#03W-NX,V(9%)Y4 98@!<#.>!BO6J*
M /)F=5\-?"]-K![6XMC<+L.80MNRL7_N@,0#G%1VVHMI&@>._#VKPW*:I<37
MUQ;D6[N+N.5#L92 0<#@^F/;CUVB@#"\%,3X'T)6CEC=+""-TEC9&5EC4$$,
M >HK@XY3;>%_B7I<UO<I=S7=_-$A@?#K)&!'M;&"6/0 YKUFB@#S"65/M?PQ
M90<6ZGSB%/[H&V*?/_=^;CG'-9NE/ID-K?\ A#Q/I&K76I?;)S%;C[0T%^KR
MM(C@J=@&6&2< 8R><U[#10!E>(-&&N^%M1T8L(OM=J\ ;J$)7 /O@XKE_!/B
M2#2?#5AH/B!7TW5M.A6U>*=&"RA!M5XVQAP0!T[UWM% ' ^-9+Z<>'==BLKE
MK#3=56>XA$9,AA*E/-*8S\I8G'7'/'(!*L6I_$0>(K*4-IMIHLEO/=+]R5F?
M<J _Q8 )..F0.IKOJ* /&(1L^#W@NV>*03P:E:-+"8SOC"39<LN,@ <DGU'K
M7432H_Q>NY4):)O#@A$@!V%Q,S;=W3.TYQZ5W]0W<4L]G-%#(D<CH55W3>%S
MWQD9_.@#QJPCM_$?P+T/P]88DU64VXCC5</"5F#-*?[JA0QW=#G SFI_&EY+
MJ.F>.].-C=VUTG^IMK2S;_2T"+^_DD"_-T(QD !0,$UZ5X3T%_#'AFRT5[M;
MI;1/+241>62O;(W'FMJ@#SRVO(9_BKI5X%D2#_A'GC\R6)D"N948*<@8)4$X
M/.*@\*Z+;^(O!?BG1;H-&EWJMZREE*E0TFZ.10>V<,#[5Z565KNFZEJ=O!'I
MFMS:2Z2AY)(H$E,B8(*X<$#KG/M0!@> 9-5U.T?5]=B\N^A3^S0 <AO)8K+(
M/]^0'\$6NET75[;7M)AU*S6=8)MVT3Q&-^&*G*GD<@U/864.FV$%E;@B&% B
M[CDG'<GN3U)[FK% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWUM$DXDLI1%*9(F122H;Y21AA@]15VO/F\3Z\NG>/9/M%F;C0V9K4_9SLVK
M),$;LY[9S^':BT\0>(;?5?!\E]>6L]IKL126W2WVF)_)\P,'SDDD$'@#G@4
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M>ZA$NF),@MSH%VQD$H ;+;1C[HQQ^==H^IQIK46EF"Y,LD#3B40DQ  @8+]
MW/2KM 'E'DV1T#Q-I3:M?%=>N9KAY!X<O,P^8H5@!CGA1C^M=9IOBO2['3+6
MTE?4IG@B6,R+HMV@; QG&PX_.NKHH \ZURYT?4-<M-?TN\U73M9MHS#Y_P#8
MEU)'-$3DQR)Y8W#/(P00:T+3Q1"\L<NJWM[-Y9RL5IH-Y"A;U;<K%L=AD#V)
M ([6JVH7]KI=A-?7LPBMH5W.Y&<#Z#DGL .M 'F5O;Z99:-J'AZTU/4H_#]Z
M\A^SG0;LRPQR',D:2;<!3DXRI(R>M:"7>EV_C&'7;6[OHH8--_LV.T_X1^\(
M5-P8'=M'.5 Z=/SKL-+U^WU/4+W3Q;7=M=V81I(KF+;E6SM96!*L#@]#QCG%
M:U 'DGV'33X6N]';5]1\V34O[3AN%\.W8$<GF^9@J0=PSQU%:B7UK_PF-GXA
MEU2_D:"Q:S>+_A';L;PS!V(8+QRHQP<#KD\UZ/10!YM'=V6FZ_J>IZ)J%_:I
MJFU[FWGT"[E42@8\Q,*N"1U!R">:K7-OH8T?P]IFFWFI6MOHMZEZIET&[E::
M1=V=Q"KC<78G'<]J]2HH 9#(LT$<JYVNH8;E*G!'<'D?0T^D)"@DD #DDUA6
M7B[3K_4K2SACN@M[$TUG<M"?)N%7J58=..?FQD<C.: (QX<NE\<3^)%U"+]Y
M8"Q%N;8G:H<N&W;^3ECVZ?G6*_P\NI/ =]X6;6HMEW<M.;@61RNZ7S2 OF?W
MN^>E=Q),D2NS$G8NXJJEFQ[ <G\*HZ!KMEXDT:'5=/,AM9F=4,B%&^5RIX/3
ME30!S^I^#=4D\1_V_HGB$:7?SP)!?+]D$T-R%^ZVPM\K#) .3Q^.9&\&WL7B
M*RUBRUZ6.:.R:SN?/MUE,RM)YA=>0$<L3V*]!C Q7744 <!:?#F\L]!T+2EU
MY7CT?4A?Q,]EDMAG(0X<?\]&R?ITK4E\)7[:]K>K0ZTD$NI6L=NFRU.8"F[:
MP._DY8Y&!GVJ[K'BW3M%:Y\Z.ZG6S"->-;1>9]F5_NEP.??@$@<D $5N@AE!
M'0C(H Y[3_#+0^*7\17DUO)?M9_8R;:W,2NNX,6;+,2<@ <\#/6K/BO0!XH\
M,WNC&Z>U^TJN)D7<4*L&''<949'<9IUOXDT^YUK4=)C%P;K3HDEG!@8##9QM
MXRWW3T!]JDT#7;+Q+HT.JZ>9#:RLZH9$*-\CE#P>1RIH Q[+PIJ4/B^#Q%>:
MZ+B<6'V*>*.T6-'&_>"OS$J,]<Y/N.@W]6TNUUK2+O3+U2UM=Q-#( <'##'!
M[&KE% ')^'?"VMZ1'!;ZAXF?4;6S7;9QM:",C VJ96#9DP#[>IYQC.;X=W3^
M!;KPP=;BV7%V;DW LCE<S>:1M\S^\,9]/SKN+F=;:UFN&1W6)"Y6-2S$ 9P
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M)U"&*$0M:G$?E[MISOY^\<\#\*QD^'EU'X$T_P +KK46RSN4G6X-D<MME\P
MKYGKWSTKO** /.-%^WS?%/QJMAJ-G')Y-BKB2 R MY3?, '!&/3GJ*TO^$ :
MQ?P_+HVJM:S:0)U+3P"87'G<R,PRN&)R<CUQC%=@EK;QR&2.")9#U94 /YU+
M0!Y^_P -[MM"U'21X@S%>:I_:0>2S!93Y@DV\,,DL!D\#'0"MFYT62T\6GQ=
M=ZI D%KICVLT7V8@"/<)&?=O..5]#QZ]:Z>@@$8/(H X?P_:Z/X@\;W?C#29
M&FM&M(X!*N1'-,-V7 (&65"$W?[3#L:[BFHBQH$10J@8  P!3J .*;P3JEEX
M@O[[0?$LNFV.I2^?>69M5F_>D89XV8_(3CG(//KP*OWOA:XN/$^B:O;ZC'#%
MI,,L,5N]N9"XD55.Y]XY^48X^N:Z:B@#G(/#=U%XWN_$3:C"\=S:I:&U^RD8
M16+ []_7YCV_"LK1/ FI:%(;"U\33?\ "-B4R1Z<;9?,12<F,39SLS[9QQD=
M:[BB@#B_^$)U*Q\0ZA?:'XCDTZQU.7S[RT^RK*?-(PSQL3\A/?(//X8T)?"L
MB^+[/7;+43;K#8BPEMVB\SS(@^\88GY3G@G!R/0\UTE% '#Z3X#U'1)Y;*Q\
M2S1^''E:4::;92\88Y:-9<Y"$D]LX/!!YJ1O!%]::EK<FCZTEKI^LEI+JTEM
M?-*2LNUGC;<-I/&00PKM** ,GPQHS^'O#=AI#W?VK['"L*R^6$R%&!QD_P Z
MUJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *XCXJFZ3P>CVU[-;?Z=:HXBV_O%:9%(.0>.<\=>^
M1D5V]8OBKP\OB?0)=,:Y>U9I(Y8YD4,4='#J<'J,KTH Y;5[:^/Q4T.WM]0*
M7!T>Z!NI(E9@/,CY"C"Y_#'L:SKGQ?XDM_A[JMZM[;OJ6E:RVG/<-;@>>HG5
M V!PIP_H>G2NO_X1B[;Q18:[+JPEFM+1[4HUL/W@<AF.0PQR!CC@>O6LF?X=
MS3^']6T@ZRJIJ6I'4I)!:?,CEU?:OSXQN4=>V: ))]1US3?$.E^';K6([BXU
M>>>=;F.T6,VUO&@)C4$D,Q8\,V>,Y!JAJ/B?6M*F\6Z/+>&2YTS2SJEA>>4@
M9TVM\DB@;20RXR ,CTKIM=\,'6IM*OTO/LNKZ7(9+>Z2+<OS#:ZLA/*,.HW
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M5?!$'A@:P/)ANA<B?[+\Q(E\W&-^/O?I^= #M0UK7-6U'7K+0Q=Q2:6RP0M
MENRR3&,2?O/-.=OS*,*!T)SZ=3HLVHW&BV<NK6J6NHM$IN(48,J/WP03QGW-
M<[?^";\^))M<T3Q'-I%S>1HE_&ELDT=P4& P5S\K <9Y_GGJK.U2RLXK9&=U
MC7&^1LLQ[LQ[DGD_6@#S;2+N;P_KWQ#UBYO[FYBTZ2.:6,I&//VVJD D+QV
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M@X95/1B#S@X.#WQ0!>HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA?B>DGV3PS<<_9[;Q%92W
M![!-Q7)]MS+7=55U+3K75]-N-/O8_,MYT*.N<'Z@]B#R#V(H Y/QAJ]AI_B[
MPY#=-;V<TBW)AU.Y.%@&U0R*"0I=N,;N!CH<XJK\*[RV.@:W%]H+M;ZO>-+O
M&UE!D)!88&"1SC ^E=M:V\J6L45Y(MS)$>)2@!;'1B.@;UQ^G01:IIQU*PEL
M1)Y,%QE;AD&'9#]X ]B1QNZCMSR #EO@_!-!\+-$692I9))$![(TKLO_ (Z1
M7<5'!#%;01P01K'%&H1$48"J!@ #TQ4E !1110 5PFO:QI]K\1K:RFDATZ[?
M2V(U"3EY4,O^HB4_*6R-QX8] !SQW=-:-&969%++]TD<CZ4 </\ !^YAG^&.
MD1Q2!VA62.0#^!O,;@^^,<>XJOH\^G?\+6\;&66VR+.S#%V7@;'W@^WW<_A7
MH*JJ+M50H] ,4WRH\D^6F3U.WK0!X?9W%C#\#O"#B6W1UU6U8G<H(87')^H7
MK[5N3:KHUIXK\5Z/XLU.>QCU&19K<L^V*ZMFA1-JG!R1M88'KQWKU3R8L8\M
M,?[HI'@AD*%XD8QG*%E!VGV]* /,K>WTBV^)7A73UC5(8M!FBA@NV#2*"R!5
M8-SG;G@\XR*BU?5-,T#QMXHM'U/2X!J>GV\9BU"8P+$P1T4)\I#)M.3C&"<<
MY./5#&A;<44MZXYKDIM \0PZS?W%K>Z3>6E[*)=FHVK-)!\H78I5@"HQD# Z
MGGG- ')7D]AX7MO DYU=Y_#MK;36<NJ6C!D64J@1R1G .UU]LD57\6IX93P%
MJ][I5R9[:_U2TEFNII=T=Q()DWE,\'"CDCCKZ&O4M)T:#3-.>U*PR>=(TLVR
M((C.W7"= .G'/N2<DWQ#$$5!&FQ1A5VC ^E &5=:WH.AW-A;3W-M:R:K-LME
M5<"=\ =0,9Y49/L*H?$6WO[KX>:Y!IBN]V]JVU(_O.O&Y1[E=P_&MF_TR'43
M;+/CRH)5E"!1RRD,O/8 @' ZX';(-Z@#A+/7_#?BZ.SNO#_DW&M0V4JVQ08>
MQW1XP_9?F"K@_AQDURCRP:K\"+?18"%UZ'RK9+0G%Q'>)*,G'4-G+$^A)Z5[
M''#%"6,<2(7.YMJ@;CZFD$$(G,XB02D8,FT;B/3- ' Z7+9#XPZ]]HFMFGCT
MBU5V8KD$%]_TXQG\*YGPLD%]\/?!Z6/B!-)UB%[LV,S;7B8AV#1.I/.5(P.N
M!D5[*8HR23&N3U.*:]M!)&8W@C9#U5D!!_"@#R4ZU?R'PAK&K6D%KI]EK-Y#
MJ$EN2;9IF#(EP">B%V<[CT)KH8%C?XIZQJ]G/'_9:Z(D5[,KCRVN!(2N3T++
M'U] P]:[SRT,7E[%\O&W;CC'IBD2&**(11Q(D8X"*H 'X4 >)I=V@^ 7A<M<
M0@K>6@Y<<$7 )_(9S75VFMVND?%GQ NN7<-K'>6=JVESW#A8WB16\Q58\9WM
MG'?K7H/DQ8QY:8]-HI'@BDV>9$C;#E-R@[3ZCTH \5\/:YI-AX.\.Q2BT0C7
MKI8[RX)$5@V^4AF (Y*G"@D#G/:H[NYAG\$_%&UANFNIC=F?)4!F0QQ?.0 !
M@X.#CD#/->WF&(QB,Q)L!R%VC'Y4NQ 6.U?F^]QU^M 'G7BG5],O=5\!75M>
MV\L3:IE)5<;6'DN,@]QD@?7BE\.7UI8ZKXYTWQ++#%-+?R77^DL )K-XU5,9
M^\H"E3CH>*]#\F/ 'EIA1@?*.!2200RNCR1([(<HS*"5/MZ4 >-:-;2:>OPH
MLM<9%NXVNV\NX(W(AB8Q@@]"!L'L0!77>"[BW?QWX[B@FB;_ $V!]J,#_P L
M%#' ]P<^]=RT:,<LBDCN10L:*<JB@GN!0!PVM7;:9\6]$O-1<1Z5/ILUI;RR
M'"1W1=6()Z LB@#UQBN/\41+%X?^*-]%(@TB\>W%J0PV23A%\YD[$EL D=U/
MI7M$L4<T9CEC61#U5QD'\*/*CV!-B[%Z+C@4 5=+BLEL89;%(!%)&F'A PX"
M@#D=<#@5QNCW\>F?$GQ=;ZW-' ;M+>>SDG8*DMNL95@I/'RL3D?[1/>N^"A1
MA0 !V%,E@AGV^=$DFTY7>H.#ZC- 'B\$+Z)X,\(37S_9].C\5>= TQVK#:L9
MO++$_=4@@C/9A756%YIUQ\9M3F\ZW;&AP%68C('F.3UY'!!/M7H+*KKM90P]
M",TTQ1DDF-<GJ<4 >&Z+JD6F^!_ ^ISW$R:+9WU['>36QW&V+O(L3G . ,D9
M]&]ZT?&/_"--\._&&IZ-=O="_-MY]X\NZ.:57 PG8L%QG'J.X./8?*C*,GEI
ML;AEVC!I%@B6-8UB01K]U0HP/H* ([.*S2$264<"Q2 $-"!AP!@'(Z\ #Z5P
MVC#3;OXP>+HI1:S2FSL@$;:QX#EN/8A,_A7H  48   ["D$:!MP10WKCF@#Q
MK3+OP_?Z'J'A7Q5>WJZM'?3>=IH<J]RYF,D;18&6W94Y!_2NE\/7\&F^,O&5
MEX@FB@EN)H[F%KI@%FM?+"C!/!"X(/H2?6N^,$1F$QB0R@8#E1N ],T200S%
M#+$CE#E2R@[3ZCTH \5L+<:9H7PWM=69(\:Q+)#%<D!DA(E,60>1P4^F0*ZC
MQ+J&F>%?B)I&H->6-HKZ9/;FWNG\B(*9$;<C $;RW48Y&3GIGT1HT<Y9%8^X
MS7,:OH>NR>('U/3;W3IH98$@:SU&W9UCVDG=&RD8)SR"#G YX& #C5N-$T'X
M=6TBW>FZM%-K:2/<12EK6REDF+AF*D'9'D<'&3C. :K?VG8_VC\30^J1W7VG
M2(7CF;:HE @E!*X !4$@ \]0,DFO3-'T-; 74URMH]U=[?/%O;B*+"YP N3G
MJ>223GL, :IBC)),:\@ \=0.E 'D_P!HT^"P^%#1S6T9#Q\JRC&ZV(;\VX/O
M6CI>KZ/I_C#XC7FH7-N+.W>TEERP/"P#/'<[AC'KQ7H_DQ<?NTXZ?**/)CY_
M=ISU^4<T >;>&M2LKZ^D\7ZU<P2ZK?(8=-TR.97DM;?!8(%!_P!8P!9C^'&,
M5SEGKFE3GX>W=O>6UO:17KJ+"W^9;(-$X$;L<L9">.2,]EKVP11J<K&@([A1
M0(8EZ1H/FW<*.OK]: ///#-_96VL>/;&ZN(H[@ZC).8G;#>48(_G([+[]*YK
M1;PVGA'X7ZG+(#HUI*Z7S@Y2*1D9(F?T"LQY/3(KVDQH2Q*+EA@G'6D\J/84
MV+L;JN.#0!YKJJ12>-O$^JVDT1TL>&S!>RJP\M[C<Q0$]"P3\@P]:R8[C3X/
M!?PI9)K:-A?6F2K*",P.'S_P(C/OUKU]((HXA$D2+&.B*H 'X4ODQ8QY:<?[
M(H P/'=Y;6'@76;F\L#J%LELWF6H8KYBGC!(Y YR2.@!KCM(U2RG^+.F2C5[
M:^6XT&2*-[=0(2WG(=D>,DX )()8CG.*]3(!!!&0>U0O%Y<6;>&+S$4B,-\H
M'MD X'X4 >'V5KINI_L]V^GVBV\FKRS;+:.+'G?:?M!VD8Y!V]^R^U=C:MI\
M/QCUA=1>U$IT:VPTVT;OF<.1GVQGVK?\#^&IO#'AFSTR\^RS7-J'47$(.75G
M9NXR/O8QD]*9!X;NO^$[U#7+I;.6SNK6*W6(DLZ>66(;E<<[NG;U- 'FHM+;
M3?"?A^*X,46FS^,Q/8Q3$ "T,C[3@_PD<^F&'K7::A+'HOQ;TFYNA%;Z1=:7
M-;VTN L:W32AVR>@9E4<]\5WK1H^-R*V.F1FDDABFC,<L:/&>JLH(/X4 >>:
M+X?AUR^^(%N<-H.K3I' 4Y5I?* FD3L?GQS_ 'E/I5KP+<:IK-BDFJ1-'>Z-
M%)IA9QQ)<*=KR#U&U8\'_:<5W:JJ*%4!5 P !@"@*%S@ 9.3B@#QOPQ=^'=7
M\-:7H&N7E^=>T^X57THR%91=(QPZ@#."<L6S@ DDU9L]:L[31?B'I&N7,,&K
MR75Y((;A@&GA>/$)0'[PV@  9Q@5ZP((A,9A$GFD;2^T;L>F:'MX)7#R0QNX
M4J&903@]1]* ,'P#/%<?#[P\\,BNHTZW0E3G#"-01]0>*XO3&T2.Q^(MKJPM
MC+-JMP6@D \V5&B3R]J_>.6SMQWZ<UZL    , 5&T$+3+,T2&51A7*C</H:
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M;3:3;Q3>0<B>=7)=1CJPAX..?F KUXPQF(Q&-#&1@IM&,?2ECC2*,1QHJ(O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<PD$4ABD&TJ4< $J00"#@CCWJOJ7B/1M'N8K;4=3MK:>56=(Y) &954LQQZ
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M02.,#<.>G/6N@# KN!&W&<]J\:6YL'^'7Q.Q-;EI=3ORN&&7RJ[,>N3G'Z4
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M16@L2<7$=TDJ_-MZCH7W=,9.: /1H?%^GS^,+GPXA;[1;PH[L4;!9B0%''.
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M613$5W!P?E(ZYSZ5XAH^J>'I?#^C^&KOQ+IUK!IFK?:$EN)&CN66.9V561E
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MK2\O42]A9?+C*F%G.2RAB 0.0<&NOTOQ)H^LP74UC?1R):,5N-P,9B(&?F#
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M*QO&WBI=(M-(CM9G']IW]O 9X8V?$+G+,I (W%00._.0* .O(# @@$'J#0%
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M[42%U1=RC  "CKU.,GFM.V\3:1=7,ULEYY<\,(N'CGC>%A%TW@.!E<_Q#(H
MUJ3 QC P*YS1-9TJS\*6=V=>EU*UEE:*&]F&Z2X<R, JA5!8Y!  '1:CUW7H
M;_P1X@O=%U&2*YL;:?+HFV2&5$+;65UR#TZC.#Q0!TY 8$, 0>H-*  , 8 K
MSN^U75(]*^'=S'J5PIO[FUBNT&,3AH&<ECC.<KZXKLK'7],U'4;VPM+DR75D
M0+F+RW!B)Z Y'?J/4<B@#2HJKI^HVNJ6HNK.0R0EF0,49<D'!Z@=""/PJU0
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MN#Y-O$L29.20!C)]35FBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "J]]?6NFVCW5Y,L,*8!9O4G
M  '4DD@ #DDXJQ7%_$B"]_L_1=1M89;B#3-7M[R[AB4L[0KD,0HY)7(;'M[4
M ;MOXFTJYENX$FE6XM(Q+-;R6\B2A#T8(5#,/< \\57_ .$UT Z;I^HB]=K3
M4)1#:RK;2D2N3@*,+U)!QGKCBL4I'K_Q-T;6M)E$MG8Z?.EU<Q\H^\KLCSW(
M(9B.V!G&17.3^%-5N[?Q#X/MDDM[*QN&U/3+A>!OD^>&)?99?,)^B^M 'HVH
M>)=)TI[I+ZY:'[+ +F9FA?:D9) .X#'8\=>#Z57LO&>@:CJ5MI]K?[[BZB,M
MN#$ZK* ,D*Q&TD \@'([BN:GGN=1^%&O:UJ%LUO?ZOIDI%N1\R#R2L<8'7DY
M8#U<U1FGA$WPP*L,0#][@?ZH?9BGS?W?F^7GOQ0!V]]XLT739MEW=M&@F$#S
M>2YA20]%:0#8IR0.2.M.U?7-/LQ/9RW<\=PL/FN;6%I7A0Y =MJL%'!P3Z'T
M->:Z9+I4-MJ/A'Q3I>JW.I&\G:.V!N&AOU>5I$==IV 989)P!C)[UM:-J2^&
M_''B>RUN.>)M1EBN+"81/(L\8C">6I .64C&.O- &Y\,[^[U/X=:+>WUS)<W
M,T3-)+(V68[VZFNLKS3X?^);#P_\.?"EIJ27<$MVQM8]UJX <N<;CCA3D<].
M?8X]+H I:AJMGIAA6YD823L4ABCC:1Y"!D[54$G Y/''>N!T'7XKG3_',NI:
M]?Q:?!>M#'=ME);9/*7.U=N5*DGC;P1TJYXCO7T#XH:1K6HI+_8LFFRV(G5"
MZ6\[2*^6QG:&"@9]JP!=1SZ!\4MD5P!=M,;<O;NHEW6RJH7(Y);MUH [Q_%>
M@Z/;:7;W>JL7NK;?;M*C-).JIN+'"_>(YQP23@#)Q4O_  F.B-IL.H17,LUO
M+!]I4PVTLC"+GYV55+*.#U Z'TKC);B!M;^&+D@I!;S>:V,B(FV"C=_=^;CG
M'(IVKW]KX=^(FJR^(H]233-4@@-G=VK3E R*5:)A$<Y).1QW/K0!W1\1:5]B
ML[N.[$\5ZNZV^SHTK3#&255020!UXX[UBZK\0M)M-+TZ^LC->QWU_'9*8H)#
MY;%PKAQC*L!G"D;B<8%<PTMMX)\2:!JXTBZLO#+Z=/9*BQ/(;-GF$BLZ\LN\
M <=CP>E6_%<MM-X=TC5+#2Y+73X_$5K>2,EJR,\>[YYF0+N&23U&2,'O0!JS
MZE=#XIZ9$EY=_P!GW&CSW!M64JH970 [,!MV">#S6[8^*=&U'2;O5+6Z>2RM
M"XGD\B1=A3[PP5!..^!Q7-W-W%/\7M$G7>L;:/.F70KAF="JG/1B 3@\U4O-
M(O;+QY=:):Q;M%\28OK@@\0M$5$XQZ2@QJ?=C0!Z%;W$=U;1W$6[RY%#+N0J
M<'U! (_&H[_4+73+;[1>3".,L$'!)9B<!5 Y8D] !DU9KB?B!'=V][X9UF.*
M6>PTW4A+>QQ*6*HR,GF;1R0N[)QZYH WX/$^D7"WQ%V8WL0&NHIHGCDB!&02
MC -@]CC![5#H_C'0=?O%M=+OQ<3/;BZ4")P#'D#.2 .I''7GI7,W2Q:CX]NO
M$5E,K:9;Z"]K-=(<QRR,^Y4!Z,0 2<9QD#O6K\,-J_#;0HMNR2&V6.5"NTHX
MZ@CL?\: .M) !). .IKE+'Q+X?TO1M7U>37[BYL(K^43S7.YO(DXS$@"@[5R
M,  ]3S76$@#). *\6O763X9_$6% S2W&L7301A3NE5F3:5'5@<'!'H?2@#U"
MQ\5Z+J.L-I5K>[[P1F54,3J)$!P61B K@$_PDUROQ-\5Q6O@C5VTO4[NWO+=
MEB%Q:Q/L$FX H9=I4'DC@@YXZ\4[5;B&;XB^"Y+:52BV5XAD495"Z1A 3T&2
M#@'TKBYM0,/P-U+PI>V]TGB"S#13VI@=FD8S[O,! PRMG.[U/TH ]6GOM._X
M3.UMGUBYCOTLY'_L]6/E.F5S(PQC<.,<]S3+/QUX;U#4(+&UU(2W$\LD,:B)
M\%T!+ G;@8 /7K@XS6)>7<,GQ:T&X!98O[)N%9I$9-K,R%5;(&TD G!P:I>$
MK>34/"'C6QLF\N\N]2U$PDC:3YA/EOSV/&#[4 =A#XKT6?4+6Q6[82W88VK/
M"Z1W&.3Y;D!7XYX)R.11=>+-$L[@0SWA0&X%KYWE.8A*?X#(!L#9XP3UXZUP
MWA2^T'6X=$T^YTC53K^FM$9+6Z-QLM)$ #2;F.P#@X]<@8YI/!^L6UCH(\&:
M[I,]SKEI=2!;:6T9X[DF5G28/M*A?F!+$\8)]* .NT_Q;;ZMXIUCP_%#>0O8
MK&GG&V<?.ZNQ.2NU0 %P6QN.<9&*Q/!GBR#3_ %E?^(M2N)'FO;BW%Q+&\I9
MA.ZJI*@XX  Z>@J?1KA=/^*?BY+J.:,7D=G+ YB;8R)$P=M^-H /')ZUG^"]
M&M_$?PEN=#N]R>?-=JP92'B+3N\;X/.1\K"@#OI=4M(=0M;!WD%S=(TD2>4Y
MRJXW$G&!C<.I'4>M7*XOP#)JNK6S:OKL/EWT"?V:!G(8Q,1+(/\ ?D'_ )#6
MNTH Q+_Q=H>F2W,=W>%!:LB7,BPNT<!?&T.X!5<Y'4C&1GK1?>+M#TW5'TRY
MOMM\D'V@P)$[N4R!P%!W')' R>O'!KS3QK>MJ.D>.].^QW-K=(_[JTM;1O\
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MUB_9?*%Q) D(2,$G:JKQR3R>^!Z"II?$^D17VEV9NBTNJ*6LFCB=TF &XX<
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M8VT@9/WO<>U 'H%%<?8^*/#NDZ%K&L'5[^XL(=0E%Q+<I(Y@EXS&J[<J@)
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MNRH SC!'/09'K5>V\6:+=:+)JT=Y_HL4I@DW1L'24$+Y90C=OR0-N,G(QUH
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M\5M):?$/PAJ+6UU+:Q1WL+O! TFUW2/8#M!QG:>3QQ7<44 >7Q$Y^)N8)_\
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M#R/2NJU*43?$KP=<11RM!'9W:R2B)MJ%UCV!CC )VG@UWE(R[E*DD9&,@X-
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M?+(+L68?>.>2<5O4 >8W>GWFK>)OB-96:RQ3:AIEO!:RLC*DCB.16 8C!P6
M..F:BO=_BGP'X>T.VM;BWUB"XLQ-"\+(UF82/,=B1@ !6P?XLC'6O4Z* .'\
M*G'Q&\:R&*54N)+0PR-$RK*$AVMM8C!P>.*[BBB@#A]<:2R^*F@W\EM=26SZ
M=<6PDA@:0"0O&0I*@[<@'DX''6L71VETCPGXH\,ZO:W#ZB\]X8$$+-]N2;<4
M9"!ALEL'^[CG%>I44 8_A/3+C1O"&CZ9=OON;6SBBE.<C<% (!]!T_"J_C2W
ML+OPQ/;ZG#=26DLL2NUIN\V(^8N)%V@GY3ANG:N@HH \COK/Q#?>!O&FCM=/
MKEO':H-/U#R<37 P6:,D?ZPK@<CJ6/?@:4FKQ:QX]\$7]E::@]I';7B/,UG(
MJJS)& #E<@9&"<8R>O!QZ510!Y=X0U1M*T8^#=8T2\N-7M;F41(]HSP7(:5G
M6;S,% OS9))R,<9/%7K&01^-_'\TD4RQ36UJ(G,+;92D3JP4X^;!(''K7H=%
M '*_#59(OASH4$T<D4T-JL<D<J%&1AU!!Y%=5110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7.^,
M_$Y\*Z&+Y;66XDDFC@0(A*J78+N;VYZ=2<"NBKC_ (FVMS=>"I?LMM-<O%=6
MTS1P(7<HDR,Q"CDX )X]* +>H>.M&TR[2SNEOUNWMFN5MQ92EV1<9P-O)YZ#
M. "3@"DN/'FB6UO<7#-<M;VL<4EW*MNV+82 ,N\=0<$$@ D=\5DS3O=_%70[
M]+#4%M?[+GB,KV<BJC.Z%0QVX4D*3@X([X/%<_XR?4=4M?&VFR:3J:S^5_H,
M5G:N([E/+'[UY%&)&ZC:3T  4F@#OK_QAI&GZNNE2O<O?/;FYCBAM9',B @?
M)@?,>>@SC!SC%+9^+])O]&BU.WDE:.6<VJ0F(K+YP)!C*'D,"#G/0#/3FN9M
M)9IOB-H-\=/U".W70I(7DDLY J.70A6., D*3@\^N#Q618:?;7?A_6+/6-.U
MB*&X\3W$\4\%M-'+;ABS1W"?+G&1C.,#=S0!W\GBO3(+&:YN//@\JZ6R,4D)
M$C3MMVHJ_P 1.]<$<=\XYIUIXHTNZ34R\K6KZ6?]-2Y788 5W GM@KR""17!
MM>^)]-\/2QW*3ZM:PZS#''J8L-US]EV@M,(]IW.APH?:<]<'%9U]HVIZHWQ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5!:V<-FD@B!W2.9)'8Y9VP!DGZ #V  ' J>B@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT^QGO)A(8H4+L(T+M@>@')J'1M5M]=T:SU6T#BWNXEEC$@PVTC(R* +U%%%
M!130ZLS*K E3A@#T/7G\Z=0 4444 %%%8FL>)[32))XOLUW>36T N;B*T0.\
M41) 8@D9SM;@9/!XH VZ*BMKB.[M8;F$DQ3(LB%E*G!&1D'D?0U+0 4444 %
M%%% !1163XA\1V'AK0[G5[WSGMK;_6"WC,C _0=/QP* -:BD5@RAAT(S2T %
M%%% !163J7B&RTO5]+TRX6<W&I2-' 4B)3(4L<MT' /'6K-IJ2W=_?6@M;N(
MV;JIEEB*QR[EW9C;^(#H?0T 7:*** "BBB@ HJE>:DME>V-LUK=RF\D:,20Q
M%TBPI;,A_A'&,^M6]ZEV0,"R@$J#R >G'X'\J '452TG4EU?3(;Y+6ZM5ESB
M&[B,<JX)'S*>G3/T(J[0 4444 %%%9NIZU!ILL%OY4US>3J[PVL 4R.J %B-
MQ P,CJ1R0.] &E15'1]5M];TFWU&U29(9@2$GC,;J02"&4\@@@BKQX&: "BN
M<B\;:5-HVL:JJ7@MM(GD@N0;=MX:-0S87K@ ]3CH:V]/O8M2TVUOH PBN84F
M0,,':P!&??!H L4444 %%%% !1163>>(;*Q\0Z;HDRS_ &O41(8"(CL^1=S9
M;IT[#/44 :U%%'2@ HI%97171@RL,@@Y!%+0 4451U/5(],TJ?4/(N;M(>L5
MG'YLC'=M(51U(/7TP: +U%(#D ^OK65K7B&RT*73HKQ9RVH7:6D)CC+#S'.!
MN/0#K^5 &M163#XALI_$\_A]5G%[#;"Z8M&50H6VC!/7G/3CBM:@ HHHH **
MQ[7Q+8WFLZKI44=U]ITM(WG!@(!#[MNSNWW3T'IC-2^']=L_$NAV^KV E%K.
M7">:NUOE<J<CMRIH TZ**9-+'!#)-,ZI%&I9W8X"@<DF@!]%8>G>*;34M2AL
MDM+Z+[1;?:[:>6'$4\7'*L"<'D?*VT\CBMII$0X+#=M+!1R2!UP.IZC\Z '4
M5E:#X@L_$=I<7-BLRQP7,EJXFCV-O0X;CKU]:U: "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3E  NPJ -HP, ?C8TKPK<6/BBXU^ZUF:[N;BU2VDC$"1QD*20<#)'WNF?Q-
M$GC/5;_1M&BO+*WNI8EN4%V;2,231P<[G12""0=N>#P2:QX?$,U]X1FU/2?$
MUI<VSWT:K>W"JCPPDH'3:$ \T9;:"O.5X[5U6K6%U?+:-9WYLYK:<3!O+WK(
M-K*49<C(.[U!X%<W>?#R"ZM)VCU![749M4CU7[3!" BSH JXC)(VX'()))).
M: *VD:Y?WUYXSTJZFGGM["")[9[F%8Y=LL3$A@ .,KQD X/-9WAO6[JS\&^
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MS&R=VPDX "\@9SB@!+;6=9\2Z/K^J:7J1LVL+N>WLX!$C(_D]Y-P+'<<]"N
M1WY.?-\099=+T#6;XWNEZ)J%CYDM[:P+*L%QD#;)N5MJ=<''/>NA3P:]E<ZN
M-+U1[.RU>1IKJW\D.4D88=XFR-A;OD,,\XJT/#4EF(8-)O(K:QCLELOL<UOY
MT11<X.-P.<$CK@]P: ,>[UO5K;4O L4>JP7-OJ1,=Y)#&I6X(@+[U;L"1GC%
M0^%8+^3QMXU!UBZ<PW4,:"58V4 PJPX"@X7<< $>^3FM!/ <%K'X:ALKYXH-
M ):%7C#F5BI4ECD=F/3')_"KUIX8DL/$NK:Q::G*@U+8\ELT:L@D5-@;/WB,
M <9'/>@#E-&\:ZK=^#?"/VBY4ZKKUX]N]UY:@1HK.695QC=M4*,C&3DYQSJ2
M:QK&E^,KGPY)?&YBNM,>^LKN:%/,A=&VLC!0H8<@@X!['-/@^'5O#X1T[0CJ
M,WFZ7<?:K&^2,+)%(&+ D<AA\Q!'0C\ZU8_#DKWUQJ=W>I-JDMI]CCF6#9'#
M&3D[4W$Y)P22W8=,4 <5I_B3Q,/#G@KQ!<ZPLRZI>V]I<V@MD5&64D;MP&X,
M" >"!VQZ^G7MU'8V%Q>2@F.")I6QUPH)/\JY)? +)X:T'1%U4B+1KJ*ZAD-N
M-SF,Y0-\V,<G.,9XZ=^R>-98FCE575EVL"."#UXH \VO/$^NVWPXMO':7N\[
M8[N?3?+3R3 [ %%;;O#!2/F+'D'C!P+&HV\]U\8-&DBU.[B272+B1 J1?(-\
M?RC*'@]\Y/H16C:^ 4M]$_X1UM2>;P\)0ZV;Q R! ^\1&3/,>>VW..,UI77A
MN6X\8VGB%;\(UM;/;);^3E2C$%LG.<Y Q].E &Q?O/%IUU):F$7"Q.T1G.(P
MP!QN/9<]?:N$T?Q'J@\6^'M/EU*2_MM2L)GGD:!4B,T80[H&"J63YB,G((Q@
MGFNUUG2X=;T2^TJX9TAO('@=HSA@&!!(]^:YNT\"W,.HZ#?W'B*[GGTB)X$_
M<1HLD;!1M( X^Z,GDGVH YZR_P"1)^*7_7_J7_HA:[OPG_R)NA_]@^#_ -%K
M65!X*DAT?Q'IW]J;DUV:::9_( ,1E4*X7YNF!QGI[UOZ/8-I6C6>G--YWV6%
M(5DV;2RJ  2,GG H YZWU2_\2>(_$.G6>HRZ=#I+1VZ-#'&[/*R;RS;U/RC(
M  QT//(QS2>-/$6I:'X9N(;BWL[RXUHZ3?J( Z,R[P67/0?(#CW(S78R>%I+
M?Q+>:YI&H?8I[^-([R*2'S8Y2@PK@9!5P.,Y(/<54G\!P?8-$L[*^>WCTF\%
M\K-&'::;YB6<Y'4NQ.,=>,4 ;^CVE_9:;'!J6I'4;I68M<F!8BP+$@;5XX&!
M[XS7&3>*[F+Q?+H^I:E<:/=-?QBQCF@3[+>6VY<A9"I.\C<,;A@D 5Z$.G/6
MN6U#PA)JT$MC?ZD+C39+T7@B:W'FQD2>8$63=PN>/NYP2 1V ,ZWUK5I+WQU
M9MJ#D:2(VLY/*CW)N@\P@_+@\^HZ5A37FI:[??"Z]^UI#J-Y9W,KW!B#!6:V
M4L0O SR<=O8]*ZJ\\%2S:WK%]:ZS/:0:Q"J7ENL*MN94V!E8\K\N,@=?44R+
MP(;6Q\.):ZO.+S0$9+6>:%'5E9 A5T&,C:.,$'W- &)'X@\6:8WBG1)9#K.H
M:9';W-I<0P*DLL,A^8;!\I=0K8XY(Z=J@U3Q -=^'?BR\TKQ+=3)!9$B-XDB
MN;:0*^]'&P8!XYQG@X/>NO/A5A!J$R:E)'JU_-#+-?+&./*8%$5.@0 $8)/W
MCDG-03^";>_&NRZA<![K6;,6<\EM%Y2J@# $*2V6^8\DGH!VH IF;4-/TWPW
M -99+6>(^<WEH]U(?+!1(D$9! .2QQD =>M<^_B_Q&WP_CU&.]2.^@UO^SY)
M)+=294^T>7\P'R@X/.!],5TI\#W0N-$O$\172W^F1/!Y_D1D2Q,%!781A3\@
M(///7-5?^%;[=%N-+77+DP2ZG_:(,D*,4;S/,"\8S\W4GKVQ0!):7FMP^/;[
MPY=ZS)<07&D_;H9E@CC>V?S#&0G!!'0C=N/'>N5TW5=:T?\ 9^77K+5Y3>B+
MS0T\22;29B&QQR3NSEMW->A+X<E_X3-?$;WP,GV'["8!#A2F_?G.[.=WZ?G6
M,/ASM\!W'A'^VKAK&4[8V:%-T4>\OM&,9.>I.>!T% %SQ#?:E%K MH=3-M U
M@TD4-I&LMS)-N^\59& C QR<#)P37+7^L7/B#P/\/-6O-GVFYUNQ>78, MEP
M2!VZ5UMSX0GF\2?VU%K4]O+-9+9W<<42%9E4D@KNSL/S'IG^M9\'P\:W\.:%
MHRZU,\>CWD=Y#)) I+&,G8A (^7DY[GU% "%&D^-%ZB2M$[>&XP)$ )4_:'Y
M&01^8JKI/B+69M O](O-0/\ PE%OJ7V R") /F.Y)%3;C9Y67YY^5N:Z&31!
M9>*[GQ9/?_*NG_99(1 2!$C&3(P2=V2?7CC%96@1:1XG\8R>,M-25K<626T<
M[QO&L[Y8E@K $E5.W=C^)AVH [5%*HJERY  +-C)]SCBO-I?$VMV5YH+R:FM
MU)>:T;"\BMX5-HB,9-JI)M#%U"KGYCSN!["O2R,@CUK@8/AF\&DZ9IB^([W[
M-I5\MY9#R(\QX+':3CYC\YY/Y4 6-!_Y*SXP_P"O2P_]!EH^$G_),M)_WKC_
M -'R5K67AN:Q\3ZMKD>H!I-1BBB:)X<J@C!"$'=D_>.?7VJ7PEX>_P"$5\/0
M:.MVUU% SE)&C"M\S%SG!P>6/I0!1O-8N;[QY_PC%K=/9I#IWVZ>:)5,C%GV
M*J[@0 ,$DX/;IS7,ZAK&IZGX)\>Z/J%VXO-$AN(S<PQHOVF)H&=-P((!(.&V
MXZ<8KK]5\,_:_$5IX@L+PV6J6\+6S.8_,CFA)SL=<@G!Y!!&#ZU#-X/CD\/Z
MSIRWC+<:T9#?79C!9MZ[#M&< !< #G '<Y- %KP=!)!X1TH274MP6M(6!E"#
M8/+7Y1M4<#WR?>N?:*[?XVF/^U+M8%T,3K"!&4&9\,H!7H=HR?O>^,"NNT>P
MDTO2+2PDG$_V:)85DV;2RJ !D9//'_UJSKSPR9_%]OXBM]1FMIDM/L<L2HK+
M+'OW@9/(^;KCJ/3K0!YM#?ZUH?@KQ7KVF:F+<:?KUY+]F\A76<>> RNS9(&#
MQMP1ZGMVU_K6I:GXDU/1M-:^A%A;0N9;-;<N9)0Q&[SCC: HX Y).2,"HY/A
M\9?"FM: ^K,8=6NI+J:46X#(9&WL%^;&,@8STYZ]IM5\$W5WK4&N:9K]QI6K
M"W%M<S00*\=R@.1NC?(R.<'M0!L^&)=:F\.V;>(K>*#5MI6X2)@RD@D C!(Y
M&#CMFM>JNG6*Z=8QVPFEF*Y+RRG+R,3EF..,DDG@ >@ JU0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !4-W=V]C:2W=W-'!;PJ7DED;"JHZDFIJ\Y^,DC_P#"/:+;.2+&YUNUBO?0
MQ9)(/MD#\A0!TR^+;4V)U$Z?J:Z8$\S[8;;Y2G7=LSYF,<YV=.>E;-E=Q7]C
M;WD!)AN(EE0D8.UAD?H:FP,8P,>E<@;]Y_&J^$;"=["RL=+6Y8P!=[9;8B L
M#A5 R>Y)'/!R =A17DVJ^+?$5IX3\3PC4-NIZ#J4-LMX(4_TB&1TVEAC ;:Y
MSM Z#I6W=2:_;?$*VT0>(IVM=2L)9V)MXMUNZ,H_=?+P"&Q\^_\ $T =]17D
MUWXF\1V?P_\ $$Z:LSWVCZV=/2Z>%-TT7FQJ-XQC.)#R .E;;7OB'P]\0]&L
M+W6#J>G:VDZ^6\"1_9I8TWY3:,[2.,$D^YH [ZBO,K7Q%K,&J^%?,U5K\:A=
MRVU\\4:_8W.QV A8J&.W:!N&0><DFH9]2\37&F^.;A/$<T+:'<2M:^7;1?,$
MA60(^5.5^F#SU[4 >IU4U/4(M*TNYOYHYI(K>,R,D,9=V [!1U-<7J&OZM9S
M>$=?FOWCT345BBU"W6./;%)*@,;[BNX+O.#SW%=%HTEUJ<NK74E[,UC+<-!9
MQ@*NQ4&QF!"YY</C)/ !'6@#0TC5+;6])MM2LRYM[A-Z;U*L.Q!!Z$'(/TJ[
M7(^++ZY\,Z=IC6-I>G2(I2M\;!!)-%'M.U@#DD;L%B.?UK3\)ZC%JOAZ&\@U
M==6BDDD*704*67>=JL !AE7 / Y% &W17FOC37]9TJU\2WEIJS&;3UCEM;>T
MC5T@0*"WV@LN,L2?E#9VX('>K7BGQ1=:/JJ'4;B_TS1KBR0V^I6L"RQ0W!+;
MO.RK$#&S'&/O?@ >@45YYXB\3W6C7EJ=1OKRTT6>PC\G6+&%9H5N23N:7Y3\
MI&PKQ@Y/X6WUJ_U/6_[$M+FY=;?3(+F2YL'AW3/*6 8&3C:-F>!SNYXX(!VS
MR)'C>ZKN(49.,D]!3J\IU*/Q++<>!8M>U"6VU$ZG)%-]D,>Q\1R%9"NTC?C'
M'(&3@#-:.M>)KO2_$EUINK:C>Z1'))$NEWQA1K2<;5W+(VT[7+;P<XP,8QW
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M/+Y5F!Y^8XSD>U;G@'4]0U#3=5M]2NC=SZ;JMQ8K<,BJTJ(1M+!0!G!QP.U
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M7X>N+J^O[FP6"W_T9]NT?(LC.!M&S;N/(^[QR0*[6PLH=-TZVL;92L%O$L2
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M/1AV(/3@YJI=>!+2;2]/L8+V> 6FH#4VEVJSSW <ON<D8Y8DD #L!@"NLHH
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MBV .?E&,8QCO4$2:=\.[2^O+^^NYX=4U)IVVVK2%)I!R (P3M^7N/QYKKZ*
M.:\$:#!H6C3-%:-:M?W4MXT#=8@[$JF.V%QD=CFIO"=AJ>GV5Y'J.HW=^KW3
M/;2W8 E$9"\$#H-V[ /.,=.@WZ* ,#4/#"S^(XO$%A>/9:DL!MI6"!XYXLY"
MNI[@\@@@_451O_ =K>:$=+2^N(?-OAJ%Q<!5,DTX</N.1@<@< = !76T4 -0
M,$4.VY@.6 QD_2G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQG->.Z?_ &=JWP%?0;?R)M6N)I4AM4QYIF-RVUL=>!@EN@ /.!76PW]OX?\
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M,A52$XY^;''/2L7QMXJ&E:?I"V<LI&IW]M!Y]O$\@\EV^8HR@C<5!  YYR*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK%7#<],8].*]$KF]2\/:L_B"36-(UX6<DT"02P7-J+B(A2Q!4;E*GYCG!P:
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MBTFFQE;:1]I5V] =NW=T'>NOTW3;?2K);6V4[=S.[,<M([$LSL>Y)))^M6Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@'2M3EU*?2_.C?[6]F51RZ,4.UF!VKE6/'/3GKF+Q3I-FU[>SZ#!<-XEOHA
M_P!EN9(HQQA9+C80H" Y&>3T&:N6<.@>"/#>D>%[\M);M"8@TEJTD4C#EBQ
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MY[\]:XZ-+Z#P]!J,-G=36^F^+IK^ZMTA;S#;EWVR*N,L!N##'U[5T$MVNO\
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MHYL(=_F C!P!D G()![U9O\ Q;I6G?:WE:=X+)MMW/# TD=N< _,0.P()QG
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M++XA^'.LW.EZ-=HDDMO*BM;%)[C9*C._EXW8"KQD9.T\8QGT:B@#@M=N6O\
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M@DC(Y'<>'/$=KXFL);NUM[RW\J9H)(;R$Q2(P /*GL0RD>QK7JO:6<-E&RQ
MY=R\CL<L['J2?7@#V  ' % ')?$%97N_"?E6US-Y.N0SRF&!Y!'&%<%FV@X
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M9= _LZ&/[.XDN93O8L$QNP,JH..<GL*K3P7?_"-?#>$:=J)EL+JU>[064I,
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M/"MFVO ?VC\X=O+\LR+O;:[)_"S+@D=B>W2@"YJ&LVUE=PV.R:XO9T9X[:W
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MCD@=37GEA:WP^ FI:4VF:BNHM%=QK:M9R"1C)+(RX&WG(8'/;O5^ZN-0\/\
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M6"LH"D99F+')[ #I3?#E^OC3X9Z5JVOZC+:0&)_MCPW!MA(R,4W,ZD$#Y2<
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MA)YR>G3&>,Y!H ZJBL'5O%EGI$=[,UK>7-OI^#>S6R*RV_ ;YLL"<*0Q"@D
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MW(N7^S.!"7A55#<<98$>W?BN_HH \9<P&VUW0[G1O$3:'=ZM+.Z6FG&X5@)
M6"2JWW69,D;<C)&>]>OV5Y!J-A;WMJ^^WGC62-L$94C(X/(^AKG-/\$#2D%M
M9>(M;ATU2=MB)HRJ@G.T.4,@'T;/O730016UO'! @CBB4(B+T50, 4 <;K5K
M?:7\2].\2K:W%UILFG/IUP+>-I7MR9!(K[%!8@D8. <8JD-)NDC\?:V+2Y"Z
MU$L5I;"%O-?RX#&&*8RNYB>N#@ G%>AT4 8/@E9(?!&AVT\$T%Q;6$$$T4T;
M(RNL:AA@CGD=1Q5?X@Q37/@+6K.UMY[BYN;22&**&)G9F88'0<?4UTU% 'F!
MT74-&L=!\6:!ITYU"VLX;35=-$1C>[A"@'"G&9$/(/?D9-:6OSW'_"8>%?$<
M.EZE/8PQ74$ZQ6CF6%I%3:63&<94C/05WM% 'D_V+5G\'?$6VDT6_CGU*\N9
M+6,Q;C*'C15 VYSRIR>GO4^JVUWI^K>']?E\-W.LZ;_92V%U:I:^9/;."&#B
M-AD\Y!Q_A7J-% &-X:CB737E@T5-'AGE,J6PA6-R" -TBKP&./KC&><BM=W$
M<;.P8A1D[5+'\ .33J* .*^',=S8>%[R*ZL;N&9;ZZG$4L+(SJ\K,NW=@'((
M_KBH=6AB\<G1)+?2=0L[NRU"&[::^LV@>W1&W,N6'S;L;<*2.<GI7=T4 <!I
MS:CX9\?^(OM>EW]W9ZQ)%<VEU:PF50RH$,;X^YC P3@8[BJO@GPM>WWPYT.R
MO[G7="N;,2AH[:80,^YR1N&">F,9QU->DT4 <_)J,&BM;:)<V>LW\9MQ_IAM
M6N5DZC;(R _,<9Y '/6H? V@-X>T.>W,/V=)[V>ZBM<@_9XW<E8^..!C(' )
M/7K7344 <O\ $30[[Q#X&U'3M-(^VGRY8D8X$C(ZOM/UVXK-U&*?QCJGA::'
M3[ZS_L^\^W7;75N\1BVH1Y8+ ;R6('RY& 3GIGNJ* .*\,)<1_$#Q?<2V5Y%
M;WLEJ;::6W=4D"0[6P2.,$=\9[5VM%% 'C\^G:LOPH\4>'CHNH&^:[N?*"P%
MEFWSEU*$=1M.<]!BNFU*.XN_B#X3O(K.]^S06=U'--]F<")I%0*&)''*GZ=Z
M[JB@#R;PG92:?I]OX6U7P(;C4[-_*347LHWM)4#?+,93W YQ][(]3QZS110!
MRNIWL-U=ZKI/B#0KFZTHLGD2K9-<1R HI9=J!F!#9^;&.>#D5P\'@[6;+P'<
MQZ?82SV]IK@U'3M)O#\[VJD?NB&Z9^8A3STSR:]BHH \VN--C\8>&-9@TKPG
M)H4]QI[VXFO;-+:5W."(QCG9D<D\<C&><;?ACQ'JFL1V=K=^&]0T^Y@0+>RW
MD02)2%P1$V?GR<8(&,9R>@/744 >+W%GK$7PQU'PPF@:I)?V^IF0E8/W<B&\
M$@9&Z-E3VZ8.<5V42W+_ !?&H&PO$M'T-;;SF@;8LOG%]A8<9VGKG';.:[:B
M@#AM/M+IOB%XOE-G<I!>6=M%;S/"RQR,BR!@&(QP6'U[5S4UGJDOP*MM#_L3
M4EU&W%M"8#;DLS1S(S$ 9^4!2<G@]LUZ]10!YKK4<ND>/+C6+KPQ<Z[I&J6D
M**UO:":6UECW<&-N0K!LD^M2ZOH5A?V^E0SZ)J&B/''--9W6CPL'L6+#Y&$0
M(RPY(P1D$9Z$^BT4 8?@\ZP?"EC_ &^<ZEM82ML"%AN.UF4=&*[21V)-87Q:
MM;O4? 5SI]A97-W=S30E(H(6<X656.2!@< ]:[FB@#G+K7(IY[5K32-1GO?,
M$<3RV,L20AN&9F8 ;0.2.^*YGQ98ZCJ6HCQ7I=A,-0T"41VEM):L&OD./,!R
M,[3GY".A!/?CTFB@#SO5[S4[#QAI/C"VT34[S3KC3FL;NUAMR;FV8N'#>6>3
MSP<>F?3+_%;ZCJVG^';A=&O(MFO6UV8%@+R10(3N>0+D \YQG.".^:]!HH \
MYU%=8B\:>*-0TO3)YI9-$CBLS-;L(I9D+G;D@ _>'L>E4M.COW\9^%M7.C:X
MR"QN(;N>ZB^99&$?5<_(HPV   ?X0:]3HH \=GTW4I/@[KNEKI6H&_GU*62*
MW^RON96N1("..FWG].M;/B#49=,^( U/3M-U>2272DCGDM+$W(8&1B@>/<K(
MRX)!/7.,<5Z37-WGA$3:W<ZM8:WJNF7%T$^TK;/&T<NT;0=LB, < #(Q0!P\
MMA"OA;P_/X=T:^U"#P]>N+W2K^WV7$@D1M[;& !?]YO '!SQTKN/"IM;IKB_
ML_#+:)%*JK_I%HD$\Q&<[E7D*. ,\DYXQR=G3]/BTZ!HXWEE=VWRS3-N>1L
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M%6*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>=Q &!ZGCSZUT[7HOAYX>\/?\(YJ)O-(U2W>X.U0CJDQ;,9+?,".<\ =STR
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M%:6V\R1[MOR\C/.?R]2 :]IK.E#Q!XFGL=+OVU>UMK=[M7.SSEVN8P@9MHP
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MQ[NVC8W$MQ;Q*-VTC9"RG<V3WP!C/K0!NZ=XH@U(V3QV-VEI?0F>WNG">6Z
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M"V)1'"5?&!D<^N,]LU@6NEZHGP5UG1VTN\&I3F[2*V,1W-YLCLI],88<YXH
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M27('S$-@>QZ5)X=\06/BC0[?5M.9S;S9&V1=KHP)#*P[$$$4 6K>P@M;J>>
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MD8.?KC!K%CGDF^-MDTVGSV<IT28MYCJP<>;'@@J2,CD$?SX- 'HE%4=9U/\
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M$41ON_A&"3N'T[9'&"=#5=:M]*DLX&22:[O93%;6\6-TC!2S'D@ !0223^I
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M<V4NGW7V2XM9@ID$Q*A5&TD-N+J 0<'- '2T5S47C6R76+K2M0MI[&Z@LS?
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M"3_"22!GL *2UFO=3T;49$\&OH[?8I8O+=8O-FE88"IM/W1SEFQGCCK7=44
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M+$,9V&T@X/RL._M7M%8^M^'+?7I]/EN+FZB-A<+=0"%E $@! 8Y4YX)&.G-
M'+ZKIFN7NOZQXHT6U:"\BT4Z?IZW"A6FE+F0MM/0#@#=C)SVZTM-L-43QKH.
MM#P[J,4(TZ:"[FN9HWF\PE#N?YB2.#C\@ *]-[44 >1OH6N-\'[S1!HUW_:4
MFHM,L'R9*&[$N<[L?=]^M=+X]L+V2/1M=T5DAUFTNDA@$P_UB3D1NC#VR&]M
MAKMBRJ5!8 MP 3UK&C\,6*>))==>6\EN7P5BEN6:&)@NW<D><*VW(S[GU- &
MAIUC%I>FVUC!GRK>-8U+<DX&,GU)ZFN4\9:':ZYJ,,=[INH P0;[/5M-)$]M
M*205X.<$;3T(ZYQQ7:T4 9'A>/5X?"^G1Z]()-46$"X88Y;WQQG&,XXSFN-\
M7Z!<ZEJVH:AI>GZCI_B*WV+IVI6;8CNEV*=LW.-H;<#N X QGI7I-% 'F]_8
MZMH?C:^U.7PS_P )!8:M#!O-NL9DMIXTV$8D(^1A@YSQ3]0L]?T/Q/I7B>TT
M/[7"UB]C>Z=8LH>W4R>8A0$@,03@XQGKWX]%I@EC:1HU=2Z_>4'D?44 </XL
MMM<UCPWIVH#2I/M-GJ]MJ T]'4S>3&X)7.=I?&3@''.,G&3##'J\WCW5-9DT
M&]ALKG18[>,LT9<.'<[64-P3GH,XXR1V]!I%96SM8'!P<'H: //M*TO5(/@>
M^B2Z;<)J@TJ6S^S';N,C(RC!SC'(YS3)],U>&+X?7T>D7,[:2ABO+=&02(6M
M_+S\S $!NISTKT6B@#@+C0M0U3QEXI66TFM[/4]&2QCNC@KOQ(&[YXWCG SB
MH_" UA(K#2M1\%Q6=[9!$GU(B(PNJ8^="/F+-CIC@G)/&*]#HH \ST_P_>0>
M)=.U;1;"_P!&NI[HMK5F6_T.6/#;I ,D;B=N-O//('-=SXCTU]9\,:MID9"O
M>6<L"D]BR%1_.M.B@#SVVN=<E^#.F'089#J<-K!;RQ(0LJ^65CF5=W <;7 S
MT/O52UTW4[7Q9K&I6WA6X^QWFAB...YEC8RRJ9#LE^<DLV0.IX/)'0>B06,%
MM<SSP*8VG.Z55/RLW3=CUQU/?O5F@#@/"7A^XT3Q,3HZ:C9^'9;5C-I]\Q*P
M7&X;1%DD@8W9P2O3!/;5^)%A>ZK\/]6T[3K62ZN[F(1Q11X!)W ]20 ,"NI5
ME=0RL&4C((.012T <5JEM?W?CSPAJ,6G71M+.&Z6YD*@>49$0*",Y/*G.,XK
MGKWPQKFI6?B\6U@T5S-J\.I:>MUM\NX$0C^4\\9*$8..HKU8G R>E-CD25 \
M;JZ'HRG(- '$6%UK-_I=[<:=X030]0BM)!$;H19DN-ORJNT_<SU9L9XXZXQM
M/T[6I?$W@[5Y/#VH++;PW$6HSW4T;2&1T0;C\Q^0$-C'KPHXSZE10!YII/A^
M\M?$FF:IHMA?Z-+<3LVMV#M_H;J5;+J,D;BVW&WG!Y YK+U+1O$ \%^,O#,&
M@W<UQ>:A<7-O<!T$4D<D@=<'=G=ZC'&.2*]>1UD4,C!E/0@Y!I: .)BMM1?X
MHV6JOI5U%9C16M'E;81'*95?:<,<\ \C(K*CLM5\.^*-9@E\(_VY9:E=M>6E
MW%Y68F<#=')O(VJ",@\\'OT'I=% 'GT-EK7AGQ[<:I_9,FH6&JV-O!+]@"_Z
M--$",!6(_=G)P>W>M'X=66HZ?HVH0ZEITUG(^IW,Z"1D.]'D+ C:3^N*["B@
M#C_&-E?7>O\ A2:TL9[B*RU W%P\8&(T\MESR1GEAP,U0MK'4HM<\?7#:9="
M+4DB%FV%_?%8/+..>/F]<<<UW]&1G&>?2@#G_ UK<V'@;1;&]MY+>ZM;..&6
M)\95E4 ]"01Q70444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5RWC[Q!?^'/#@N]/MA++)<0P%RP
M'EAW5<X/4\X'YGISU-<M\0]*O]8\(RV^FV_VFZCN+>=80X4N(Y5<@$D#. >I
MH LWOB<6DZ60M VHF#[0]M)<1QB-"2!EB<98@XQGH<XK(B^)NG7.GZ)=V>FW
M]PNK3O;1J@3,<RALQMENN5Z_=[Y JGJMMX@T_P 7Q^);3PX=3M+^R2VN[#SH
MQ/;LC,48$G:>'((!Z]SUJ76;#7+R]\*78T0C[)J+75S#;R18MXRC(%R6&YOF
M!.!CKC/&0"]#XYG?4[32Y?#.J0:C<VDERD#M%_ X7&[?@=<Y.!C'4G%53\25
M&@WFJCP]J31Z;-)#J2;HP;5D.&Y+?/@<_+GCTJW?6&HM\4M-U2/3IGT^#39K
M:2X#QX#NZ,."V[&%/:N?&A:ZW@GQUIW]C7 NM6OKN:S0RQ?.DJ@*2=^!TYS0
M!V5SXEC&I#3["V-[=?8UOC&)%0F)B0NW/WB2#QP!W(R*UK*Y^V6-O=>6T?G1
M+)L?JN1G!]^:\_UOPXVM6ME%>Z!J$5W::=']BU*QF1+BWN!N#1DA^G"$=5Y/
M(KM]!BU&#P_I\6KRK-J26Z+<R+T:0*-Q_.@#&N_&L4%A?ZI;Z=<7>EZ?*\5S
M<Q,N?D.)&12<LJG.3QT.,UD>,-9FNM6\'P65L;S3-0N_.^61=ERHA=U7!/3H
MW/' J#2M&UO0O#&N^%1IDEVL\ES_ &?=JZ>4\<V2/,R<J5+'/!R.F:EO/#FH
MZ9-X#L["QGO;;0VQ<SH\:\>28\X9@2<G.!VH ZO3=(M/#VE7*Z3IWE>:[W)M
M%DP/,8<A<G"C(Z#@<\5YGKFMW/BCX-6^MZG8B.8WUO+$XPW!NP,*!SPOR\C)
MKV+[R],9'0UY(GA[Q(OPBMO#+:#,;ZTNHA\MQ#B14N/,+J=_W=H&,X.>W>@#
MN;'Q:EQXBN=%OM-N=.GBM/ML;7#H5EAW;2WRL=I!['GFJ7_"P]/6[TD2V[)9
M:M,L%I<B5&.]AE-Z [E#=NO;(%5=3T74-5^(+736%Q%IMQH,NGO<[X_DDD<-
M]W=G@ \XZU7\()XFL[6PT'4O"]O#)8A(GU82QM%+$F &51\^]@,<@8)R?2@#
MKO$6MQ^'- O-7FMI[B&UC,DB0;=VT=3\Q K#M_'\1US3+"]T;4+&WU48L;R<
M)Y<SXSM(!+*3VW $^E6/B1_R37Q'_P!@^7_T$UE-IUYXH@\((^GS6D&F3PW\
M\TQ7EDC(5$P3NR6!STP/7B@#4N_&T,&G7VJP:?<76DV$KQ7%U$RY^0XD9$SE
ME4YR>.AP#4Z^+8)/$=GI$-K)(M]9->VEV'7RIT&,A><Y^8'IT.:YC2]$US1/
M".M^$?[,DNA*URMA>+(GE/'-N(,F3N4J6.1@Y[9J]K/A"_M/#'AF+071]6T!
MX$@DDX#IM$4N?8J2Q'^S0!I6'C6/4-"OM2CTVX5[.\-B]JSIYAF#A-O7&=S#
M&3SFC6/&MOI:Z@8[4W)TU ]XJSHC)\H<J@8_.P4@XX'(YSQ69I7@NYT?QN[V
MS9T&6&*ZE5CEGO(U,>3_ +P(<GNR@U7:SU_PYXOUB2W\-KKFEZM,MU%(DT:/
M;R[%1E??_"=H.1T]Z -*;XAV[7=E;:9I&H:B]_IYU"T,.P"5!MXY;Y3SSNQT
MP,D@5TXNIVTE;M+*3[0T(D%J[*K!B,[">@(/!/\ .N3.FZPOQ%T749--+6L&
MF2VUQ/ R"-)'9&PJE@Q4;2,X]*[9AE2/44 </X9\<RW?@;3]<U>T=9KZ41V\
M<3*3/))(P5$&>,<#+8X!)[UN67B9)?$3Z!?VCV6H^1]IA4N'2>/."48=P>H(
M![\CFN"L?"GB1?A[X>L_[,,.J>&[^.Z2&2=-MX$9]P4@D*"K<%L<YX Y/6+I
MEUK?CG3/$$UE/8V^FVDT:)<%1)+)+M!X4G"J%/7J3QQS0!I>*O$B>%=(_M.>
MRFN;99%25HF4>4&(4,<D?+DC/I5JXU=;;4X;-X3L:V>YEGWC9"JX'S?7/'T;
MTJ?5=-M]8TF[TV[3=;W4+0R#V88_.N4\.>&=4D\$WNG>()Q_:-U:MIS3)R1"
MBM'&?<G+/]7H M/XZMH+#3]6N;"XAT6_D2.&^8K\N_[CNG54;C!YZC(%-TSQ
M-J-WX_U[2)K'R['3X;<K)YJ_+O$C%V^N ,#.,<]:P6T#6]8^&]IX(U#3)+>>
M+[/:SW@=##Y,3J?,0YW$E4  P#D\X'-:T>C:E'X^\1NUB[:;K-E;Q+>)*@$1
M175@P)W9^88P"/<4 2M\1-.CFTN22!AI^J3K;VUT)48[FSL+H#N56QP?<9 K
MH=<U,Z+HMWJ0M)KM;6,RO#"1O*@9.,D G':N*\(0^)]-L[+P[J'ABW5[$+#_
M &N)8S#)"F &"_?WE1C&.O)QTKT1E5U*L 5(P0>A% ',?\)K!]J\.1"QF,6O
M)NMIQ(FQ#LW[6YZ[>F,Y-5?%GB'3T\+^('U;0[B^TNQ<0SHC(1-PK$C+ X!9
M0>X.>#BN:;P!K,?A:^MD*M>:+<F3PY\W(19/-7)SU8$1\] @]:Z#Q;H&HS_"
MR_T6RMFO-3NH<.(V50\KMO=LL0 -Q8T 3ZCXDU&T\<Z)H=IIVZSN;26=F$B@
MMMVC !Z!=V?4_ASS.BZV/"=QXZN;;1;F[M;75GGG%L4188Q"A8_,1D]3@9Z<
MXXST&IV.K_\ "9^&=:MM*EGAALY[:XC\V-6@9]A4MEL%?E.=N3[&LQ=&UO\
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MD,.0&SC'?@4==\+ZKJ.G^-]2@T^4WFN6\5I:VA= X6-"-[DMM&23QDD #N2
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M507LL\%E-+:VXN)T0LD)?9O([9P<5E>%M7U+6-/N'U;34T^\M[EH'BCG$J'
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MP\6"792QQC / R* +^EZQJNK>/O$6C7=G9OI=I#;*%,Q;Y761MQ4IABW (R
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M!G SC.!G%6J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ***S-;U.XTNU@>TT^6^GGN([=43(5-QQO
M=@#M0#DG!H TZ*XZ#Q];);>(GU"W2-]#E2*7[+-YRS%P"@0D+\Q)"X/0]ZOK
MK^HVFJM;ZOI MK,6;71OH)C+%%M^\CDHN#CD8SGGTH Z*BN+O/&U_::9I.K?
MV+&=.U.Z@@A+79$R+,P".R;,#@YP&)''OC0M?$]Q<ZSXCTL:?$L^CI"ZM]I.
MV<2*S#^#*X"^AZT ;UQ>6UIY7VFXAA\Z011^8X7>YZ*,]2?2IJX2?QC!J'A_
MPCJT^@Q3Q:O?VZ1K+(K?9)')VN,KR0 >1BM.;Q9-+K&JZ;IMG;W-QICQK- ]
MR4F<,JL71-IRH#>O)!''&0#HA>6QO39"XA^U"/S3!O&\)G&[;UQGC-+<W5O9
M6TES=3Q001KN>65PJH/4D\ 5S@U=6^(-YI,>C6XOX]*%Q'?/( TJ&0J(R0I*
MKN!/?Z5S.G>+-2F^$5]X@US2+/4X@;EW@\_*R()Y 5*LF J@ #EL@=J /359
M74,I#*1D$'((I:Y^7Q#C4K#1M.M8I+^>S^V&-Y/+C@A!"@DA2>6.  .QZ8K#
MO_B.UAX:UR_?2"=1T2=8+VR^T  ;B-KJ^WYE(8$?*#UXH [RBN8M?%%[_P )
MA%H.HZ2MHMU;/<VDRW(D+!" RNH4!6^8'@L/>NGH 9%%'!$L4,:1QJ,*B# '
MT I]4-;UBT\/Z)>:M?N5M;2(R2%1DG'8>Y. /<UBS^*KO2]2TBWUK3([6WU6
M06\,T5P9/*G(RL<@*C&<$ @GD8]Z -Z^U73M+5&U"_M;02'"&XF6/<?09(SU
M%6P01D'(->=Z<M[K'Q)\76&IV%E<67V2S@DC>X9@D3"4X4&/YLDDD<8XY->@
M0016UO'!"@2*)0B(O15 P * )**S=?UNU\.Z)=:K>;C# H.U!\SL2%51[DD#
M\:RIO%%WINNZ;INL:=#;C4]R6L\-R9%$RC/EOE%P2.A&<XH Z>BN(E\?S1>#
MM<U\Z2A?1[R:UFM_M1P_EL%+*VSOGH1^-/N-=UMOB=8:3!#:G3WTI[HJT[*S
M'S(U+'Y",KR O?))(Z4 =I17+:3XLFUR97T^SMYK07DMI.5NCYUOL+C<\>SC
M)4<9Z,#SVR?#_BK77M/%M_J&G+=)IVH3PQ6]E*TDA,:1@1HI09!Y.[.<D_+0
M!W]%<M8^*[J;Q1/X>N=/MUODT\7R""Z\Q<;@I1LJI5@2.QR#6-9_$F^N=!T?
M7I/#PATN^NUM97-X#)$S2F-6"A?F7(&<D'G@$<D ]!9E12S,%4#)). !53^U
MM.^QQ7G]H6OV65Q''-YR['8G:%#9P23QCUK(NM<FU#4=4TK3-.M[[[ BB[^T
M3>6A=EW"-?E;)VX))P!D=><</X7U:'2/@[X1DN=(AU&&:ZB@VRLH$+M.0KX(
M.2"<C'YB@#UNBN3N_%>J#Q9>^';#0TGN8+-+N.66[$:.K,5^;"DKRIZ Y]NM
M0VOC^&Z\*:)JZV+)<ZO=BQAM7DX2;>RL&?'W1L8YQS@<<T =E17-:1XFN[_Q
M5J>@7&F)#+IRQO).EQO1UD!*$ J#V(/H1WKI: "BL?Q+X@@\-Z;%=S^7B6XC
MMU:63RXT9SC<[8.U1ZXJG<^*)-,TR>ZU2T@@;[7':VI2YW1W&]5*N'*C:N6;
M/!QL/6@#I**XF/XBVMM=:O#JD$21Z?:?;1<V4_VB*:/.TJ&VKB3<0-O?(-:L
M6M:X-7MK*YT )'=6[RI<17!>.)UQ^[E.P;2<\$9YR/>@#H:*X=/B#))X&TSQ
M.-)7R[RZ6VD@-SS'F8Q @[/FY&<<5/>^,-87Q/J6A:9X<%Y<6<,,X9KU8ED1
MV(/53@C' [\].X!U<5Y;3W$]O#<0R36Y FC1P6C)&0& Y&1SS1<WEM91J]U<
M0P([K&K2N%#,QP%&>Y/ %<8WB26,^-WT_1+.VU+251Y)))/^/D^3O5G*KGA<
M8'/ID55/B*Z@\ ^&+[6]'M=1:\EL4W-/OVM)LVS$,G#Y).!G']Z@#T.BN4UK
MQFEA>ZA9626,US81J\T=U>" NS+N")\K9;;@Y.!\PZ\XAM?'D6IRZ5;V-M%'
M=:C9&[CAOYC 3AMIC'RMELYSZ 9YH [&BJVGW$UWIMK<W%NUM/+"DDD#')B8
M@$J3WP>/PJS0!!'>6LMU+:QW,+W$(#21*X+H#T)'49P?RJ>O-HIK[3_BCXM;
M1M*AN[AK&SD*/,($)_>9)8*3N/;CZD5M6_CZRN_#NA:E&D4,VL*3#%<SB-(]
MH)?<^#P,8X&22.!G@ ZJYNK>RMWN+J>*"!!EY)7"JH]R>!4BLKJ&5@RL,@@Y
M!%>7^*/$D?B;X<>,[6YLHX[G382I:.3SH9 1E)(WP,]^V0>*ZT:ZT-SI>AV-
MNEQJ$UD+EEDD*)%"NU=S$ GEB  !SSTQ0!NV]Y:W9E%M<PS&%_+E$;AMC8!V
MG'0X(X/K4]<#\,1(LWB\2VL=K(->E#0Q-N53Y<?0X&1WZ#KTKOJ ()KRUMYX
M89KF&.6=ML2.X#2'&<*#U./2IZX'Q_F#Q5X+NH+,7%TM_*J*I56;]P_&X]!G
MG_&I[7QOJLCZUIUSX<$6NZ9 +I;);S<EU"<X:.39UX(P5ZX_  [>BN9L_%CZ
MCH6@:C96D,SZPR!8OM) C!5F8[MG.T*<C YXKIJ "BHYYXK:WDGF<)%$A=W/
M15 R37'W'CR6ST&Q\27.EA- NWCS.)\S0QR$!)73;C:<KD!B1D=>P!VE%<?-
MXNU:3Q%K6B:=H$=Q<:=#%,KRWHC257#'G"D@_+P,'/<BBW\?V5YH6A7\210S
MZQ&TD45U.(TC"#Y]SX/ . ,#))'09( .PHKG?"OBC_A(QJ$4EJ+>YL)_)D\N
M3S8I!C*O&^!N4CVXQ714 %%8VJZ]]BU>PT>U@6XU&]621$>38B1H!N=B 3U(
M  ')/;DC%D\=R6^G^)//TK&J:!'YUS:+<?))&4+JZ.5&00#_  Y!&* .SHK!
M\.:SJFM1FYO-&%C9RP136TOVD2-+O7)!4 %<<?7/;D5O4 %%<WKWB>YT?Q'H
MND0:6;HZH9E27SPFQHXR^"".G3GL,\'H<F/QOKDL.N01^&X#J.BO_I41U#$3
M)L$BE'\O)8J>A4#U(Z4 =U17+P^,H;^'05TVV\V\UFU^UQ12R;!%$%!9G(!Z
M%@H ')/IDU1NOB!)9:9XC:?2?^)IH"B2YM%N/DDC9=RR(Y7D$ _PY!XH [:B
MN._X32\MK>.?4](AL8[QX8].:6]7$Y=&=M_'[L*%)/7/;)XJYX;\6?VWJVIZ
M7-;1QSV.QA-;3>=!.C#(*OM'(Z$8X]Z .EHHK(UW78]&^PPK%Y]Y?W MK6'?
MM#-@DDG!PH4$DX/T.: ->J;ZMIL6H)I\FH6J7LGW+9IE$C=^%SDUC6GB>Y?Q
M%=^';RPA@U6.U%W; 7!:&YBSMR&V94AN"-I]1FN?^'EJ^NZ)+<:S86<_EZQ<
MW44QE,CK.LS $ H,8Q@'/0#@4 >BT45R'CS6=7TA-"72TMR+W5K:UE:25D."
MV=HPIP&VD$]@>ASP =0+RU:\:S%S";I4\PP!QO"]-VWKCWJ>O-YGO[7XP7$E
MAIEO-?R^'8V>/S_+B#^>V2TFW)'& =N3QP.VM9?$"UN_#.EZG);QVUUJ$\EL
MEM/<!4CDC+A]TF/NCRVYQSD#&30!V5%<WX9\5_V]J&J:?+;)%<:>Z9E@F\Z"
M='&59'P,]P1C@^M=)0 5435-/DGD@CO[5YH@3)&LRED ZY&>*XSXE:C<_:O#
M?AR":2"/6]0$-U)&Q5O(7!= 1R-V0,^F:Z/5/">BZKX>ET22PMX[1HC'&L<8
M7RLC *XZ$4 ;=%<_)KUS+K-UHNE6T-W>6$$<MT\\QB12^=B\*Q)(4GI@#'7.
M*Q7^)"MH6G:E;:1+(\^J)I5U;-,JO:S%]K#T;';IG(Z=@#NJ*XV/Q;K;^(;W
MP^?#T U*.V2[M\7^87B9BN7;9E2",8"MU].:JGXCO_PB^D:PNB2N][J(TZ:W
M6=<PR^88S@X^?E3CIGCI0!WE%<;8^-KT>(;W0]:T*2QO8[-KZU6WG%P+F)3@
MA< ?.#QM_P E]EXSNI-=TC2[_2X[:;5;-[J&-;G=+"54-LE0JNTX/7U!';-
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M.1QSR< %C^&?%=MIGC*PTR2VMY-3O);VRO%N"'RX0%,!?E.%8;L]QCU'HM%
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M1D# YYX[E=VP;@ V.0#QF@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBF2LR1,R1F1@.$! R?J: 'T5@^#_$3^*-
M74Y+/[(YGFA,/F;]NR1DZX&?NU?UK5(M%TBXOY0&\L )&6"^8[$*B9/ RQ S
M[T 7Z*PO#VI>(=0:<ZWH-OI:*%,1BOQ<&0G.>BC&./SK=H **** "BBL2?Q/
M86_B@:#+-%'=?9?M01VP\B_/PB_Q8",3Z<=<\ &W17(#XAZ2?"MKK<+K=M>3
MK;6UK:N'>2=ONQ9X ;GGL.>O>SJ6K^)-*T:YU.72+*X\F(R-;6]TQ=0!G@E
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M358^'-7:+3HSX=T79II!LQ_;EU^X(&!M_<\8''TXZ5M?:?&/_0(T+_P:3?\
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M);S$SA2>I5<[5)'' % 'GEW)"UMX?UK2BTD4_BB-!JD[C[3<J\S(Z<#B+&5
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MWJF5)HH@PA1_F7<"V0.<$J!R.*V]9\/ZAX?\+^+XM)UN)9;B.*XCLH4-O':
MG#B,EVV^8%8 9'/3K7=7_AO1=3T0:+>:;;RZ: %6WV85<=-N.A'J*Y_7/"$%
MCX+ET;PYHEI-;2SQM<V<DFTW$88%P';/SD  $GCL1@4 5K'0?M7CZVU2QL+G
M3])BT[;-$0]N'N-PV_("-Q5<@M@CD#)[<C?Q;?A3\1%$L_\ H^M7?EMYS[@
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MOV,2B=_+^REMOE9^3=N_BQU[5=R"2,\CK7A][:Q?\*5\3J-P\C79A&0QRO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBB@ HI'=8T9W8*JC)8G  H!# $$$'D$4 +1110 4444 %%%% !1110 4444
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M%<6A>%-0UVUM_P"T([(LKQQR!.5;:PR?0@@X!K>B?S(D?&-R@X],T /HHHH
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M$%W?:O!+IZ0R))&L'E?.2FUB=QST88]ZH>-=)DUVWBT^31[S4+,,LK?9[U(
M'4Y7.2"<=?2L\V>KR3V\EQH&LW @E69(Y=8B*%U.5)7=S@X//< T -T6,R^.
M_B)&))(RQL@'C;:R_P"C#D'M618:KK#_  I\'7QNKN5)[N :I.LC-,T#.P."
M/F.6V XYQFMFWLM3M=1U6_A\,ZDMSJ@473?VE =VU=JX&?EPO'%8&M:9J-CX
M:TK2(?!VLMI-A<>:OV/44:YB(5@OEE&W8RQSUX_0 Z+P_87UQXI\1R"]U,:'
MMB2PW3OMWE#YNS=R0#MP>@)('3CD8[B[U;X8?#N:ZO;A[JXURWWW+/NDR6E&
M[+9Y^N:TO#2>(XYFNK32/%@LY(GBD@U?5(W;)QM9!(=RD<\^_0]K\>@31>'+
M/0D\(Z@+.RF$]H1JL0D@D!)#*P;/!)ZYZT 6-'@O/#WQ0?1(=2O[W2[W3&O3
M%>W#3M!*L@7*LV2%8-T]:YSPMJUS9_#OP)IL#B--3O)H)7,S0Y ,S! Z@E2S
M!1QSU'?-=99KJ]G)<3KX8OY;VX01R7<NH0-*5&=H!SA0,DX  R2>IK+/AG?X
M33PS+X,O9=,B?S(5?4XB\+9)W(^[(.2>_<CIQ0!T7AK2M5TG5]46[U!)+&XV
M2VMD;AYWMCC#X=P"58\@=NU=/7$:%!JGA^W>.V\+ZE<22$>9<7FK1S2OCH"S
M-G R< <#)]36M_;7B#_H4Y__  .@_P#BJ .7LH;Z;XT>*!97D=LPL+3<7@\S
M/#?[0Q4OC=M5TOX4:QYVL2_VM;!YOM%JYB;:T[;. <@;3C&>WM2_V/J UR[U
ME/#NKQW]VBI-+'JT2[E7[HP#@ ?2DN]$N[[2]0T^[\+ZK/%J#*;EI-7B9W"_
M=7<6R%'7 QU/J: $U2PGL_B)X?LX=8U40:Q:W0O4-XY#F,(RE1TC/S$93;QT
MQ7/:M>ZEI_P^\?6]MJVHJ=(U'99S&Y=I40B([/,)W$#<W4YYKJYK35+C5]-U
M2;PUJ3W>G(R6[G4H, , &R,X.0!G/I7,^,-)U9/!_B.VL?"VJM<ZRRO,1=)<
M;I,K\VU,D<+CC H W=1M-0\,_$'PW/::OJ-W#J\TMM?6US.9$8B,N)$7HF,'
M[H QQ6(=<N?#_A3QS>VDABF;Q/) )\ ^2',*E^>. 3CWQ72V U07-MJ3>%]3
MN9H8C';->7\.Z!&QD '!R< $MEN.M06^CW$%CJUE)X.O+FUU:5YKR*?486$C
MMC<W7@\#IC&!C% $NM+<>'/&'AE=/NKR2TU2:2RO+:6YDE##RRRR*6)*L-IR
M1U%9EO>WNBW7B+PA/?WLVHW4JR:1<3W4CR-#,=H().?W1#$XQP,UJ:?::II\
M]M.WAG4KN6TC,5LUUJ<,AA4@ A>1R0 -QRV.,U6M[[6=<\0V7B!_ UY ;"&:
M" 7,\4<NYRNYL$YP N!Z[C0!+(USJ?BW4_#222M!IUC;^4KZE-!(^_=NEW*"
MSD849)X/UJI;7&N0ZGH'A34]2AU"X^Q7,LTZ73V_VETD554NH+$JI;(XR1D]
M*F\0:)<^(M0MM1N/"FI6VH6ZF-+NRU:."78>2A96Y'^)I-6T!]8TRQL9O!E[
M"+!MUI/;ZI&DT+'J0X;.3U).<GD\\T ;_A?1KZRL[FRUF^CU#R;TS6BM*TKV
M\9Y1&9N7*]B>>GH*Z&.WABFEE2-1)*07?NV.!D^U8WA2UEL-/>UDTJYL@K;B
M]S=BYDG8]69P22>!U]@.!6]0 5Y9]CN=1N/B##/K.K!-/E#6GEWKH8F^SAP0
M5(. 3]W[OM7J=8,?A'3XGUATFNPVK_\ 'X?-^_\ +MXX^7Y>.,<4 <.EQ?PZ
M9\/?$)U74)+[5+FUM[Q7N&\J5)86+#RON#D @@9]2:O8U?QDWB:&TNS:W=E?
MR6EM*E_+$;78%VMY:+A@3ECD\@D=!72MX*TM].TBP,MV+?2)$ELE$W,;(,*<
MX^; )'.>M0ZE\/\ 0]2UU]8;[;;74RA;G[)=O"MRHX D"D;N.* .?UB6ZNAJ
M"'5KC4+ZWT2-WCL9FMX;60JS>>75ADN1E1@D!>P-5$O-2U6X^&+RZM?1'5+*
M0W@AF*"4BUW9('&<D\]1G(P0".QN_!&B7>JSZ@T=Q$]Q;K;7$4%P\<4T:@A0
MZJ0#@$@>U,M? ND61T8P/>@Z.&%F6N&;9N7:V<YSE?EP> .F* .6L?[;CL?&
MVBZ1?3SS6&H0BQ%Y=L7V.L;O$)6)8;@64'.06ZUN>!]9M=3O=4A6+4["_@$0
MN=+U"1G-N?FPR,204;V],]ZT3X+TPMJ;>=>A]2FBN+AUG*DR1LI1E(^Z1L7I
MV%:.GZ-;V%Y<WN^6>]N51);B8@NRIG:O   &3T'<YH T:\E\7:C=VVC^(=6T
M[5+ZZN++5(@MVLS0PVH#Q(;=4#$28R=Q*@'<<G*XKUJN2N_ASX?O8]4BE6\$
M&I3?:)X$NW6,2D@F15!P&) .: ,VZM)M1^+%[I4VJ:DFGOHD=PUO#=O&-YF9
M3@J05X4?=()QZ9%:/PSO;N^\"VCWMS+<S137$'G2MN=U29T4L>YP!S6G!X6L
M;;6SK$4UV+TVHL][3%_W0)('S9R<DG)YSU-3Z#H%GX;TXV%@9OL_F-(%EDWD
M,Q+-@GGDDF@#2D;9&SA2VT$X'>O,-&77?$_AC1O$UIJD5G<M(+JXN&OY6C9,
MGS(6AV[ HZ>HVYSG)/J-<K9_#S0+#69-1M4NXEDF^T-9+=.+4RYSO\K.W.>1
MV!Z"@#E_L=SJ5]\0;>?6-6$=A(C6HCO7C,3?9P^05(. Q^[]WVJ&.XU"+1_A
M[XB.JZA)?ZG=6EO=A[AO*ECEB8L/*'R9R <XSGG)KNH_"5A%+K$J378?5_\
MC\/F_?\ EV\<?+\O'&.*B;P3I;:;I.G^9=BVTF5)K)1-S&R#"'..< D<YZT
M<I::+>>)->\::?-XBUF".TNXUM#!>,GE,T*MGCJ 3]WI[9P10M-7OM=\/_#'
M4=2;=>2ZIB1\8WE8Y5#?B #^-;.@Z)+>^+_&,MQ_:UG;WUQ%L8(\27$0B53@
MLO!R",J0WOBNHO/"FF7@TE=LL$>DL'LHX'V+$P&T''?CC!XH Y[1VE\97?BQ
M;N]O+66QU&2PM%M[AXO(5$7;( I&2S%CDYX&.G%<_'K6L77@+POX[NKF\#64
MF-5MX9W2.XMP[1M(44@$C ?IR,]L5Z!<>$]/FU6ZU*&6ZL[B]01W?V68H+@
M8&X>H'&X8;'>J6NRR6-E%X8TKP[<3P75HUO%)'&OV6W&-H$A)!"@'. "2!@9
M- &+KVNSV6@Z]XIL[R4023PV5JQG8Q)&)%CDF"\J#N9_FP>$4]SF34+?6_#,
MM_X@@O(ULH],G8Z?)>RW7G3(C.CJ7 P<+SCJ*ZR/P]IB^&8_#TEJDNFK;"V,
M+CAD QS[^_KS5#0/!.D>'0XMFO+D&,PHM[<O.L49ZH@8X53@9QUP,T 86E:?
MK%T?#NOVVK1Q0.J->-)?RS+>I(!QL*A5;<<C;C!..E>@5RVA_#_0_#U\+BP%
MX(T9G@M9+MW@@8YR4C)P#R>?>NIH X[5M1EO/B3IWAJ666&Q;39;YA%(T9GD
M#JBH64@X W-@'GC/2L2)[IU\?^&[JYN[BQTR%9K.9[A_,5986<QEP=S!2.,D
M\'!S7;ZOX>L=9N+.ZF\V&]LG+VUU ^R2(D88 ]""."""#Z4T>&[%=,OK$-.!
M?EC=S^9^]F++M)+?[H XQ@  8H S?AS:1VWP]T!HVF)FTZW=O,F>0 ^6OW0Q
M.T>PP*Z>6-98GC8L%=2I*L5.#Z$<@^XJGH^DV^AZ5;Z;:/*;6W01PK*VXH@&
M N>I ]ZO4 >)6]E%;_L\Z]+&TVY_M:D/.[J +EP,*20#ZD#GOFNL\NXT3XC>
M&XH=0OYHM5L;K[5%/<,Z,T:QLK*A^5#\Q'R@"MEO &AG2-0TH"[6QOY&>:$7
M+[1N;<RH"?D!;DXQFKTGABREU;3-3DGNGNM-1H[9C)P%8 ,",8.0!G/I0!P^
MC_V[XJ\+:7XEM-3BLKLR_:9KA[^4QA QWPM#MV!0!M]1C.<Y->I5REM\/- L
M]:EU*V2[B$LWVA[-+IQ;-+G.\Q9VDYY],]JZN@#SCXF%HO$W@.XG.-.CU@"8
MG[JR$#RB?QW5Z+)L\I_-V^7M.[=TQWS[55U72;#7--FT[4[6.YM)AAXG'!]#
MZ@CJ".16=9^%K>UC2&34-3N[9,;;>ZN2Z8'0'NP]F)% &):77_"2>//$6CW4
M]Q'9Z7;VJVT5O</"'\U"[290@G^%1S@8XY-<HVKZW<>&]-AGU6]2XL?%R:2;
MJ.3:US"LNW+]F]#G@[><Y->E7WAJRO-835XY+BTU%8O(:XMI-K21YSM8$$,,
M\C(R.Q%0W7@W2+K3;#3]DT-M8W"W4*Q2D'S@Q8.QZL=Q)Y/)))S0!S$.E/\
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MBM4DDD2)0BF0Y; & ,]ZL4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)<W7DR7"@_>1-AX/;<5S[#FF_$6UN[SX=:_;V09KA[*3:J]6&,D#ZC(_&I_
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M[<C&?0FL3P?X@_X3O^R=09=HTZWWW2$8VWK9C*X[;5$AQZ2J: .N6XU(ZO'
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MO4-5AM1I]I<""&^D3RY"SY(P>.G0<>W P >DUFVNK#4+N\BLHA+%:,89)2^
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MOG6\L$SQ21MC&0R$$9'%:U% &/I'A?2="O;V[TZW>*6\8/-F9W!; &<$D G
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M:8ZR6:"[F'DLHPI'S=AD#/:K-OX<TNUU6_U**W?[5J"JMTSS.ZRA1@ J25P
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MEMNW;G>=V/KUS[]:YX^ O#AT:/2?L,@LXKC[5$HNI=T4N2=Z/NW*<D]".IH
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M)KB1C"P.048MN0C)Z$=33H/!.A6]W-=K;W#74]O]FEGDO)GD>/G@L6SWZ]:
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MO"UY,4A<9P44OA>23@5+J/@#PSJNM?VO=Z8&O"H61DE=%F Z"15(#C_>!]*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/C6QU#PD?$4%E??9Q(8A;LJ"8N'\O;MWX!W<8)!KHP_[H2.I3Y=Q#8ROUQ0
MZBN7T_QU8:A<:0JV=Y%;ZQO^PW,BILEV MR Q9<@$C('X'BJMS\1K*&/6'CT
M;6+@:1*4O/+A0>6H4,7^9QD8/3K[8YH [*BL:;Q+9AM.BM$EO;C4(3<6\,&
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M"%8FR W!8,P4D9V@XYZD'$EUXNM83??9+2ZU!+&%)KAK4QG:KKN7 9@3\O/
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MK%=(>T:Y"?()6E5P/7H.O2M'_A"=!_Y][G_P.G_^+H_X0G0?^?>Y_P# Z?\
M^+H QM%@U#PGXB\2QSZ?=WEEJ=X=0LY[9-^790&B;^X05&"<+CN*P[?PKJGA
M31O T@L9KYM(NIY+V"SP[IYZO]T$C(4N!Q]:[7_A"M SC[/<9ZX^W3__ !='
M_"$Z#_S[W/\ X'3_ /Q= '!:W;ZG'I'Q0O;W2KBTM[^UCD@DD9""%MU4C@YR
M.^,C.1DXK?FLI_%,?@Z..RN;>/3;B&_N9IXR@39&0(U)^^69ARN1@'GIG2U7
MX<>']5TZ6R<7T"2C:[17LA)'<?.6'Z58L? FB6$$$:K>2M" !))>2Y..F0&
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MKBR8PQZF"GV1X=Q(D)W;MV#]P#).,XYQ/H=OJ7A6]\3V%QIEU>PW]_-J%C-
MF]9?- S$Q_@((QEL#!ZUW]% 'E^E^%]0\.WGP[LC;S7*:1%=?;9XD+)&TL9
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MY/\ 98;,J!,T^XJ8\9QD%6).<8!-4XK;43\4VUE]*NH[$Z(MKYA,9Q*)2Y7
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M(DN$B.]2J>6^T*,')(P<DC!R:[/2_%B-K&GZ'<Z9>VC7=J9;.XF";+@(%W@
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MYK,WKV1N49,)(K%6++G(7<I /4\<8.:Z"O-/^$=O?^$GM=8T?3KW1M4?4?\
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MVTQBD&"",,.1R*DTW3;;2;".RM$988\_><NS$G)9F/+$DDDGDDU;HH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>sangamoexecutiveseveranc003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV )/ JMX8N+ZZ\+Z9/J5FMG>O;(9K=5VB-L= .WT[=*HZ]X>U;4]7M=0T[Q
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M8LI[FRB#)*XBV^8@'!##KZ\<4 =Q!XLT::2_B>Z:VEL(O/N8[J)X62+&=^'
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M7+K':E5N94A=T@+8P'900O4'GH"">#4^H>(-/TT'S7EE81>>4MH'F98_[Y"
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MNV-M+9PB1IY[U2]M#"-S2* "6'8* 1R2!R!U(H TJ*R=$\2:9XBCF?3999!
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M#D$%[,9KQX[&<P792RE/D$ $EQMRJC/4]<'&<&MJ[URQM9[2W#M/<WBL]O#
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MRT"R?,&/3@X/I70T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/+(R0H;/ /!KK_#]W]M^*>M7T5I?+9W.FVRQ7$MI)&C%2Y(RRC'4=<9KO:*
M,+QII\^J^"-<L+4%KBXL9DC4?Q,4.!^)XJEH>NVEC\.-$U26.XDM_L-N&6W@
M:9ERJ@_*H)P#UXXQ7552L--ATUIEM24MY7,GD?PH['+%?0$DDCIDG&,T <II
M6BV4_P 0AXBT:S:TLSISP73_ &=H%N9&=2F%(!)4!LMCN!D\X(+=[KXWW=[&
M#Y-EH$=K*PZ>9),74?\ ?*Y_$5V[9*G:0#C@D9JK8:=!IZ3>7N>6>0RSS/\
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M+#$LLELZIO$CL4W8QD!AQFJ&AO-X?M/%FB:O9W4L]Q?7-U:LEN\BWD<PR I
M(W9X([<=J])HH \J@T>^T%/AGI]U#<32Z<TANWBA>18=T+* 64$ !F"_A4UY
MIE[JWB#XDV-M#<12:EIUO!:2R0ND<KK%(K .1@\L >>]>GT4 >;>&[O3]>.G
MPMX7U"UUNS'[V2\MW"6;A<,RNW!R>@7DYYP,US$TUY#\$[WPA<Z3J0UVRQ"\
M*6<CK+^_#"17"[6!'/7.:]PHH 9#*LT*2JKJKC(#H58?4'D?C7G/B+4T\/\
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MI CLH7* 94G:6P>F><'->O44 5[&=+BQAEC#A60<.A4CCN" 15BBB@ HHHH
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MG:'RGGB#G9(R?PLPYQ^=9OQ!BN(Y?#6IQ6ES<P:?JR37*VT32NL91UW!5!)
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M[(1_!'''@D^Q9U'XT =Q7/7?C32;.&6ZE^T'3H9_L\M^L>8(Y VT@GK@-P6
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M3LYW@\;3W()'1=#\6:_9ZYX5O=6M-4N?M5G=6MG]H5@R*K1/V7!7C/&">@H
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M=V8_W,\G.%4]><'!( ..":-2\9:5I223W/VC[##.+>>]6+,,,F=N&/7AC@D
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M5K7CB2SCT)K/2KQ_[3U#[(V]45HRI8,N"WWCL8#MCG/0$ [*BFQL7C5RC(6
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M5RM]X^TRRU'4=.2RU6[O-/5'F@M;-G8JP)RN<9  Z].1C.:Y_P 3^(;#5H/
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MZU2WN+BWT>QGMKJYCC)16:)$4_0E3].^* .FTKQ;::K%J[I:7=NVDRM%<QW
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M#)P2"01SCU%9OQ&N-4M?"AN-,@N9UCN8FO8K1B)GM@V9 A'()'ISC--\!S6
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M>U5"(!MW8.YAN(7YB%R0"/45G_\ "93S^-]-TFRTZ>>PNM--\+A3&-ZEHPK
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M": -^BN'D^)ME'I=UJ9T75OL-E=M:WDQCC MRK!"Q&_+#)_AS@=<5W .1D4
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ML99#P90O*2'W*E<^^: .FHK*O]<BM-3ATN""6[U"6)IQ!$5&V-2 78L0 ,D
M=R>W!QA:EXS6Y\#:_J>E6]RM]IT5Q%- X19+69$)RX+8('!RI.0>,T =ED9Q
MGI17&^"M$L&L=+U_^S9K/4CI\<,DK2+FY!56+N$8AB3DY;YN34EIXBO=1\>Z
MQX>FTR46-K;0_.'3G?OR[?-D @  #)X).,T ==G-%>4> ?%</A[P%HT=SIU^
M]G)>S6SWRA?+B=[EPN[+!B,D9(! SUSQ7;ZMXJATPWXALKB^.GQB2[$#(/+!
M7=@;F&YMOS8'8CU&0#H**IZ5J=IK6E6NIV,GF6MU$LL38QE2.X['VKB/"$J^
M/;[6M:U4?:+"WOY+*PLI.842/&9&3HSL3U.<8P* /0Z*YT:;8^%[S4-;-VUO
MI8LQYL#R,8X-A+;D7D*""<@>@XYI!XO@BOM,M[_3[RP35#MLYI]A5WQD(VUB
M48CD ]>G7B@#HZ.HR*X/QQKT.H>#/%,%I875Y!9VT\$US$RJL<HC).,L"VPD
M%L#CW((&CHVMQV7AS0;&&WDN[U]+AF$,;JNU BC<S,0!DG [GGL"0 =4Z*Z,
MC#*L,$>U<OI_@:VTR)+6VUK6UTY!M2Q-W^[1?[H;;Y@7VW5I>&_$5EXHT@:A
M8B1%$C1212@!XI%.&5@"1D>Q-7M0N9+/3[BYBMVN'BC+K$K!2Y Z9/ H GCC
MCAB2.-52- %55& H'  IU>1:WK<_B+X;>&]<U"TEAF;5+*8,""&#3#.U5))&
M.,$9]J[O3_%]M=:OJ&F7EC=Z9<65N+LB[V8> DCS 59@ "IR#@B@#HJ*Y=?&
M]FNI:5;7-G=6T.K';97,FPJ[8R%8!BR%AR,CV.#Q6CXF\06_A;0+K6+NWN)[
M>V7<ZVZ@MC.,\D"@#7HS7*0>.+.?Q';:'=Z9J-BU^C-97%S&%CN=HRP4ALJ<
M<X8 _3BN2\+>*(/"6@Z[--IM_-I]OK]VL]Q"%*6Z&4*I.Y@6QQ]T' ZT >L4
M5RVK^-HM+UZ318]'U.^OELC>HEM&C"5 P7Y<L.>3UQTXR2 8K[Q_96-KJ%X^
MGWQLM-ECAO9MJ#R7<*<;2V6V[USCUXS0!UU%86H^)X[.\O[6WL;F^FL+=;BY
M2 H&56W;0 S#<3M/']>*??>(TMIY+6TLI[ZZB@6XEAB9%**V=H)9@-QVM@#T
MYQQ0!M45F^']=L?$VA6NL::[/:W*[DW## @D$$=B""/PK2H **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ KE?B#I=]JOAN*/3[9KF>"^MKDPHRAF6.168+N(&< \9KJJ* .1_L^XU_Q
MMI6NM:3VEII=K.B?:%VR322[01MZA5"GD]2>/6N*@TCQ'%\/='\.#PY>M=Z5
MJD,DK[XPDJ).7S&=W.5]< >M>QT4 >9^)]!O-0U6]U31]/U'2O$T4D:VE[;L
M!#>)A>)\$J0OS [N<*,9Z5M"UOH_BQ/JS6%P;#^Q5M?M"J"K2B5G( SGH>N*
M[*D9E1=S,%'J3B@#R1="UL?!ZWT0Z/=_VDFHB9H/DR$%WYN<[L?=]^M:5S9Z
MEHGC75;UO";Z]IFL&*>*2)8C+;2B-4*.)",*=H.<\5Z510!YYXB\/)JKVR7N
MCW=G>6UF'L]2T8X>VF+-F$$$9 ^7DC:<D_+FH-2T"[U?3]+C\1V-^-9MM.C:
M/6=*.)8KD[@Z94^RGIMY/(XKTJB@#RRXTSQ-IFHZ'X@U31$\02MI26.IV\0C
M:2.16+B10WRM]X@XK6U;2(=9TJRMM7\*O#9S2O,%LL"?3V 78Y*'[Q^;.W.,
M@<@$UWM% '.^";36++P\+?6;F>XE2>46\ER09F@W'R_,(_CV]?UYK/6TU+3_
M (HW^I#39Y["]TZ&);B-EVQM&SE@P)W9PPQ@'/YX[*B@#R,Z%KA^#\VB?V/=
M_P!I-J)F$'R9V?:_.SG=C[OOUK1\3VGB#6;GQ/83Z-=WEI<:?MT@K(BP1DQ'
M<9%+ ^9O/&0<8&,<FO2Z* /-X[#6X=0\":E_8=RPL;":TN81)'OA9HXU4M\V
M-N4/0D@=L\5V/B@ZPOA?4CH 4ZMY#?9@V/O_ (\9],\9QFM>B@#S33+#4HO'
M>DZVGAS48;4Z7+;W$MS*CS>871LR?.2>%('?V I-(\+ZK??!V_\ #=Q;26&H
MR-<&,3XP2TS2IR"1@Y /IS7IE% '%>%KC4+ZXMA=^"DT6XMP?M5PZQ;6;:1B
M$J<G)YR< #(YS5OXBZ7?:OX,N8-.MS<74<T%PD*D R".57(&>,X4XKJJ* ."
MMSJUW\2[;7WT"^@T_P#L9[8F4Q[T<RAQN4-Z*> 2>F0*P(M"UM/A!INBG1[K
M^TH=12:2#Y,A!=&4G.['W??K7KE% ' Z=%J_AOQSKTYT>\O].UIXKFWGM]F8
MI%0*T<@9AM' P>G].8T[PYXBTWPAX0OF\.F[N=%:YCNM+F:,M-%,V=R<D;EP
MIP<'K7LM(652H+ %C@ GK0!YOXGL=2USX<ZS!8>%WL)[T1);V06-9FVN&+2;
M3M48Z#.>/? ]%@D\V!)#&\989V.,,OL:DHH X"0:[X6\?:S?V^AW6KZ7K0AD
M5K1T#V\T:"/:P=A\I !SGBI+O3]:T_QWIGBJ2S:ZBETUM/OH+4[VMLR>8K*#
M@N ?E..>,X[#N?,CV%]Z[!G+9X&.M.H \K\0^%M5O= \=7UMI\S7GB"2!+:S
M!7<$B55#-SA2<,<9Z8[\5T&J6U]=_$#PGJ,6G71M+.WNEN)2H'E&54"@C.3R
MISC.*[/<N[;N&[&<9YQ2T >3ZGHFM7/AKX@VD6D79GU:\,EDIVCS5*(N>O'W
M3UQ70ZG:W]UXU\&W\6G71M;**Y%U(5 \HR1JJ@C.3R#TS7;T4 >4:EX4UO6;
M3QI%;VDEO<76I07^GM.0$G\H)\IP>,E#UQU!KH;VTN_%6N>&KU]-N["+2I7N
M[C[0H#!]A41+@G=R<DCC"]>:[:B@#R:XT+6IOAEXPTI=(NA?:CJ5S-;0G;ET
MDE#*<YP. <Y->IP$S6<99'C+(,JPPR\=#4U(2%!)( '))H \Z\%GQ/X=TN'P
MC<:#,[V;M%#JHD3[,T&XD.>=VX XV@<D<D=1:T.UU3PIJ?B:TDTRYOK;4;Z7
M4;*: *P=I -T3Y(V$$<$\$'K7> @@$'(/0TF]=X3<-Q&0N><4 >8:7X3U+P]
M/\/;);66ZCTA;HWL\6"D;2QL,#)!(W,1P.@HOO#^L:A8_$>WCTZ9'U;#6)D*
M@38A5,#G@Y7OCK7J%% 'GU[%JM]K'@>^_L.]BCL))6NE8H6B5H3&"<,?XCT&
M3C\JN/8ZAH7Q(OM;6SGO-+U6SBBE:W&][>6+(7*]2I!/(S@]?6NUHH \JU?P
MGJP^'_B6*#3Y9=1UO5OMZ6B,N8D\V,@,<[<[8\GGJ<<UZG&_F1J^UEW#.UA@
MCZTZB@#SNWT&_P!4U#Q_:W%I<V<&N*L=K<R 8(^S^63@$D<CH<9%03:3J_B'
MP%I7A2]TN>TO()+:*[G;'E(D+*3(C _-N"< <@MSC%>E*RMG:P.#@X/0TM '
M'^'K.^M_B%XLO9[">*TOOLOV:=@-LGEQE6Z'(Y/<<TWXL?\ )+?$'_7M_P"S
M+795D>(M&LO$NDW&B7MS+'#<*/-2%U#LN<]P<#('2@#"O;&Y\3:[X8G%C<6L
M&E2M=W$DZA3O\LJL:\_-R<DCY<+UYKDM2T7Q#_P@OB[PO!H%W-<W.H3W$%P'
M012QR3!UP=V=V.HQQCDBO7;>(P6\<1E>4HH7?)C<WUP /TJ2@#BX[?49/BK;
MZN^EW45D=%-HTK;"$E,P?:<,>PZC(JAI&H-8_$_QSBQN[@,+$K]G3=\P@.%/
M/&>Q/'J17H=8VG>'+?3=>U+6(KJZDN-2\O[0LA0H=B[4P HQ@<=>>^: .#TS
MP;K'A;_A$M5BMC=O8&Z74+2!@61;AB^8\X#;#@$#D@<5JW&B7%WJ_B+Q#-HK
MW=O>VMO8QZ=*%#W$2MF1B"0 <,=H)!^7G%=^S*@RS #IDFEH \H;P3JLVB^(
M=$T:XO8]$GM8GT^WU,DF&Y5]Y1-WS"/"J.>,GC/-;NAW6I7L)=_ T>DW5O"Y
MF:98BLLFP@)%M.2"3R3@8XYSQW5% 'G?ACP]<:1XHM)]#MM1TO1YX)&U+3+I
MLPPRG&SRN3SDG.TE<#MP*U_'VC:CJ=AI5[I4?GW>DZE#?K;;@OGJF0R G@'#
M'&?2NMHH XXV$^M^.=+\0FSN;2TTNSF0"=-LDLDNT;0N<X4*>>Y(QGFCP!:7
MUC'KR7]A<6C7.L75Y#YH&&B=@5.03@^QYKL:* ,;5[[4['5+!K33IKVP9)1=
MB$INC/R;& 8C=_$,#GG/.*XZT\&K>^,-9U+2]/ET;3+_ $F2RG5T\O[1.Y_U
M@C[;1W(&2>.YKTJB@#SCP?%J]O;V&BZCX+AMKVQV1RZH5B,#HF!O0CYB[ =,
M<$Y.,8H\*_\ "3>%[>;PJV@S7"QW,K66J+(GV?RG<N&DR=P8%C\H!)Z>]>CT
M4 <;I]IJ6F_$OQ!>/IL\MCJ5O:F.Z1EV(8E<,&&=V>1@ '/M7+0>%]>D\#V@
MBT^6+4]*\0-JT=I*RK]H3S78*&R0"5?N>HKUNB@#C9;*?7?&NC>(#8W5K:Z1
M:W'$Z;9)9)0J[ N<X4 DGH21C/-<K%H6MI\(-.T4Z/=?VE#J*S/!\F0@NC*3
MG=C[OOUKURB@"I?V46K:3<64S31Q74+1.8VV.JL,'!['FO.]=^'%RVL>'#9:
MOX@GMX;MC/(^H$FV3RV 9,]#G X[&O3Z* ./\>V5]>PZ!'8V4]V;76+6[F\O
M'RQ1L2Q))&3[=:T=:\+V^OWEM?/J.JV4T,31H;*Y,)VL02#@?[(_(5OT4 >1
M0_#S4D\*>.[1I]2>>^GN/L<=Q<^8LZ[49)"/[[%=NX\XK=UNUU'Q'\/?#NJ:
M%&LU]8RVFI16SMM\XHN&C)/0\L.>XKT"JUK8P63S&W4QK,YD:,'Y0YY9@.Q)
MY..IYZDD@&;H6K:GK),]UHMSI5NJ8$=XR&5W[D!2<*,'D\G/08YQ?A_:.;SQ
M3K!&(=2U>0VY[/'&!&''L2K?ABNPN8%N;=X7=U1QABC;3CN,CD?AS2V\4,-M
M%%;(B0(@6-8P H4#@#';% ''ZEI^H:5\2H/$L-K->:?<Z=]@N4@&Z2!E<NKA
M>K*<D$#)'6LZ?P]J T#QY>K8S&\\0K(EM9KMW*/(\I"W. 2<L>> 1WXKT6B@
M#)\,)-%X8TN"XMY()X+6**2.0#*LJ $<<'GN*PK>UU+3?B;K&H'3)Y['4+*W
M5+F-EVH8M^X,"=V?F&, Y]N<=D64$ L 6Z GK2T >1IH.MK\(+313H]U_:4>
MHK,T'R9""Z\W.=V/N^_6M*YL]2T/QIJUVWA-M>TS6&CGADB6(RV\HC5&1Q(1
MA3M!SG KTJB@"KIL4L.G0)-##!(%RT4 ^2,GG:/7'3/&>N!7$:!I^I> M6U>
MS73+F_T*_NVO;:>T =[=WQNC=,@XXX(S[UZ#10!R?BC2[_QGX/U?2XX6L5NK
M?9!]HP'9P0P+ $[5X YYY/ QSFWUGJ?B^S\-6MWI=S83V%_!>WS3!0J&('Y4
M()W[FQ@CC&2<'BN]#*6*A@6'49Z4M 'E,6G:_HWACQ?X6?0[R\-Y]MEL+RW*
M&.59E8@/E@0P)Z8Y[4LFE:UI%[H&MR>%WU2!=&BTR^L/W3S6[QDL)%!)5LEF
M'!Z8KU6D9E4 LP ) Y/<T <G)K=YH.EV-PWAAXH;R["206QC!LT;"AI,<,Q.
M.%]<9..>HNHFFM)HEQN>-E&?4BB:VAG>-I8PYB;>@;H&[''3(['M4M 'DJ:3
MKQ^&/AS1GT&\2\TZ]M#*A:,Y6*3<[##8Q@<=SZ=ZV=8T*_UKQQJY%K/#8W_A
MQM-6[8#:LK.YY&<]&ZX]J]!HH \]\(?VMY=CIFH>"HK&^LPB7&HE8C"X3C=&
M0=Q9L=,<9R3Q@Z'Q8_Y);X@_Z]O_ &85V59?B+0;;Q+HEQI-[+/':W "RB$@
M,PSG&2#CIVH YZ_LKGQ+K?AFX^P7-M!I4K7EP\Z!3O\ +*K&O/S9)R2,KA>O
M-<U<:%K4WPR\7Z4ND70OM0U*YFMH3MRZ22AE.=V!P#G)KU6WB,%O'$97E**%
MWR8W-]< #]*D#*V=K X.#@]#0!Q<-M?O\4K753IMTMA_8AM&F8* LIE#[2,Y
MZ#KC%<SXOTKQ-KVD^+=.N=$N[RZ:;.ERB5!;K;@J5VJ6SYG#9.,\XR!Q7K=%
M 'F_BK1IM=N9[^/2-5TW78+93INH63@.S$9\F4JQ7 ;KN^7!.#UJ*[L-<T3Q
M4=7O?#B^(K?4K&WCNQ;+&9+>YC4@E5<@;&R>_P#]?TVB@"CH\<L>EQ">SALY
M&RQMH<;8@22%XX) QDCC.<5>HHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K \566MWEM8G0WL3-
M#=K)-#?;O*ECPP(.WG()##ME16_10!R,USJOAG4/$6MZL+:XT58UFM_LZ.UU
MP /+Q]W;G.,=V)/4U<@\42R:S=Z++I<L>IPV2WL40E5EEC+%<;NQ##!R/IFI
MO&*ZV_A/4%\._P#(5*#R1N"DC<-P4G@-MW8)[XKF-%TC4H/B+%J\?AV6QT^X
MT?[,[S7$;2+()=Q,N&8LQ'?+9XR1S@ V_A_X@OO$WA*TU6_M?)>X#2*0P*L"
M[8  Y   '-9WQ5@BD\+6DKQJTD6J691B.5S,@./PJU\-=/U31O!=EH^JZ>]I
M-8AHMS2HXE^=CN7:3\N".N#UXXR7?$33M1U7P[!:Z98R7<XOK>8JCHN%2178
MY9@.@H NZMXJBT^ZNK2VM_M=S:0B:>/STCV@YPH+'EB 3CZ9(R,UK+QQ::Q!
MI3Z+:3WC:E;2740;$:HB$*P=CD!MQVX&><]N:QM0M-=T/QO?ZO:>'?[;TW5X
MH?,B62-9;6:-=O\ &<%2,9P>H_.Q?V_B-M<TD76C_;-':UD\^SM)D2.*X9\K
MYFXKO0)QT.3D[<X% &C9^.+'4='T:^M()/-U:9X+>"=A&0Z;]X9N0,;&'&<\
M8ZU1\2>+]4L-.TF6UTB6*:[UF*PE661,H/-P<<X.\ @'L#GCI6%HWAF['@73
M_#OB+PHUS:Q75P91%,A>',CNDL9# @?-CCYN3QCK)-X;\2Q^$-.A9+O4I--\
M017MM#/,AN39QOE59B0I?&3R>F![4 >FPN\D*/)&8G9060D$J?3(XKSCXC_:
M'U&&75O#6H:GX8M(=\DMC>F-XY"?F<QJP9@J@=P!EO:O1H'DD@C>6+RI&4%H
MRP;:?3(X_*L:YUC54U6ZL(_#5U-$%'V>[$\7DR9'._+!DP>.%8X&0.U '*:E
M=V$MQX#\-:*^=#U5I)VVNQ\V"*/S C$\D,6&X'K@@]36CH=S_9?Q-UCPW  F
MGR6$6HP0J,+ Q8QN%'8$@' XSD]S4,O@J;2+/PC<:<OVFY\/2,&C7"^=%*I6
M4)DX!YW $]L9K3T31KF3QGJWB>\@:W-Q!%9VD+D%UB3+,S8) W,>!G@ 9Y.
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MXBCD57VL&*A ?O'Y3Z#D<D\5PUQX<\03?"OQ'HJZ+<#4+W4)IH(C-#\R/.)
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MC$*6X*E512V5DX;)P,YY;&!0!W6H>)Q:W]_96=C)?7&GVRW-Q%'(JOM;=M"
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M3#%'CN41BI_/\#79ZMXCGL=0N+*TTQ[J2VLC>RN\GE1[,D!5;!RYVGC@>IH
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MW2B6UM2S%&=N1(RKM! ]>#Q7844 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9M@>1B.K=06^Z#U&1Z4 ;=%<1X)UB"]UC4[26TU/2]4BAA^T:7>RM(L8!?\
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M(2GEJ<JNWIP3GUJI;>"='M$,$*3C3_/^TC3S*3;K)NW9">F[YMN=N><5T5%
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M?AC_ -A#2O\ T&M[377Q5XO\6V&IM-Y>G20V]M DK1^4C1[O,&TCYF).&Z@
M8[UMOX+T232]-TUH;C[)IDJ2VB"[E'E,GW#G=DX[9SBI[OPQIMWJG]IXN(+U
MHA!)/;7#Q-+&.BOM(SCL>H[$4 >;1ZAJ\GP\TOQ->75U-/H.ILETZRLOVRT2
M4QNS*#AB!\V3W0^M7(M;?3/&>LB-I9K+7;8C1C+<.Z-.C")T4$_*K,P;CL,]
M*](&CZ>NBG1TM8UT\PF P*,+L(P1^1-1?\(_I>-* M$ TG_CR_Z9?(4X_P"
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MUMC''+<.VS,#L0I)R 3S@<?A7;1^'=.C\12:\J3?VC)$('D-Q(5,8.0NS.W
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M:=9D?A_3HM9@U5(Y!=06GV.,^:Q419W8*YP3D=3S6G0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M17/>,]=ET'0T>UV_;[VYBL;/<,@2RMM!([X&6QWQ0!T-%8=QJ=GX=DT[2DCN
M;N]O2_DQH5,DI1=SNS,0/3.3W&*K+J$7BWPS-?:0\]M>P/*D)D7:\-Q&2"C
M$@C(P1D@@T =+16/X5UZ+Q1X6T[6HDV"[A#LF<['Z,OX,"/PK8H **** "BB
ML?4?$4%CJL>E16MS>W[V[77D6X3(B4A2Q+LHZD #.: -BBL_1-9L_$&BVFK6
M#,UK=)OC++M/H01Z@@BJ&H^+;/3O$$6B-:7\]]+;M<1K##D.%(! )(&>1[#N
M10!OT5Q9^)>F#1KC4QIFKM#9RO%?H+8;K-D.&\SYL''7Y2QQSBMB]\4VEM?Q
MV-M;W-_=O:&^$5L$R(00 V791R3@ '- &Y17$ZGX]'V7PQ=Z/8SWEKK=RB+*
M-BE5VEBN&8?,=I'H.><XK8U+Q3!IT=VZZ??77V*(2WBVZH3;@KNPV7&6V\X7
M)QCU&0#>HKE+KX@Z/!+IL=O#?WS:G:O=6?V6W+><JJ&(&2/FP1QV[XING:QH
M^I>-H2+'4K;67T<3_P"E(T:I;F1?E*DXWACSQQ@C- '6T5S%EXZTR^FTOR[>
M\2UU61XK*[=%\N9ER<<,67(4XW*,XK/\**8_B/XYB$DK(KV14/(S[<PDG&2<
M#)/% ';T52U75;31M/DO;URL2%5 4;F=F("JH'5B2 ![UQ"WTDWQGLO,L[^T
M/]BSNT4[AE;]XF"H1F7/4$#G\Q0!Z)17"V7BWPYH7A'5-<M;34DL(=0F6X1D
M9Y/.+X<X9CM&XXY( ]*TY/'%E#K7]DRZ;JJ74D+36H-L,7:J0#Y?.01D?>"X
M')XH Z>BN-O?%FAZOX'UJ]OK/45LK4RVNH6NPK/$5'S*=K<<$'(;&#UJW-XN
MTO29M%TQ;74'?4+8O:)'"7RJ(&VDYY;!'KUR2!DT =/17)-\0M,C\-ZCK<ME
MJ$4>F3FWO;=XT$T##'4;L$?,IR">M:USXBMK7Q#::+);W)N;R"2:!E"['" %
MAG=D'YAU'>@#7HK@;'Q@FM^$/$-[K>DWL.GP274$JQ%6/E)E&4%&W;L DG@#
ML>E;UMKNG66DZ'#9P7$AOK938VBD&5HP@.26; VJ1DENI'))&0#H**Y>7QYI
M4&CZM?S0WD;Z0VV^M#$#-"<9!(!(((Y# X([U)9>-+&\UNRTLV=_;O?0M-9S
M7$(6.<* 6"G.<@'/(&1TS0!TE%,FD$,+R%78*"=J*68_0#K7$:3XN\-Z'X'T
M:^L;;44TF\N3;6RLC2.K-*RY<EB0-V3U)QT':@#NJ*PM(\56NK:S>:3]CO;.
M]M8UF,5W$$,D3$@.N">,@CG!'I1XQUV;PUX2U'5X+1KJ2VA9U0,  <?>;)'
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MP).%8X7/ ^E4M2\930^)O#NG6&G3W5IJD,MR)XS&/,14! 4,PQ]]22<>V><
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M/'3D9 -RBN)G\?"XUKPS!I%C/>V&L137"SQE 75$Y4!F!!!92<XZ8&><=M0
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ME>)$4CCCE3UQBM.6VO)/%'@&Y6PO/)L;6X2Z<P-B%GB1%#<?WE(]NO2O0:*
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MDA5+'\ .37D-II6JP_"SPOIKZ3?"^M-8BGG@\ABR1K<-(6],;2.GT]:]@HH
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M; )&3@'CO7644 </J%I?Z[XJLM?TZREC72=/NA!]KB:$W$\J@*FUL,%&WDG
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M #H!0!P&I6&H6GB/P7J4&@LMO:+>QS6MBJ8MS,J[ >0.Q!8<9R>]=^Y<1L4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *B@MH;;S#%&%,CEW;J6;U)/)X 'T ':I:* "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0^UL%B!QS^1H T:*** "BBB@ HHKG-3\5FTN+^'3]*NM4?3?+^V1VQ&]=XR
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M]M[L01/O63=UF"D#(.T$,>F#7H=EX,L[37X];;4-3N;Y;3[)(T]P")4W%@6
M &03T&![9YJF/AUI8\(R^&!?ZG_9LC#"F92R('WA%)7@!OQ]2: "749=8^(E
MWX=>>>WL[+3DN2L$K1/-([$9W*0VU0.@/5CG.!7(:CXA\01>%-<MO[6N%N]&
MUV&RCNU5=T\+R1X#\<L%?!*XSQ7H5]X6M[S5K35TO;NUU2VA,'VR H'EC)R4
M<%2K#//3@],56O? ^FWVAOI+7%W'%+="\GEC=?,GFW!]S$J1U X  X Z#% &
M=ITE_IGQ2DTA]5O+VSNM(-ZR73*VR59@F4P %!#=!Q6AX_U^X\.>$KB^M&"7
M#RQ6\<K#(B,CA=Y!XX!)YXSBKH\-0?\ "41>(6O;QKR.U^R;24V&,L&(("YR
M6 .<_IQ5W6-(LM>TFYTO48!-:7*;)$)QD>H/8@X(/J* .4U6>]\,>,/#<=K>
M7=S8ZK,]G=6]S*9<.$++*I/*G@Y ^7'856\%:<L/CWQFXN;M_)O(  \[,'S;
MK][UZ\9KI;'PS#:W5G=75_>ZC-8HR6K7;(3$&&"?E5<L0,;FR<9]3E=)\,P:
M/J^I:E%?7DLVI2+)<+,4*EE7:, *",# Z]J ,'XOQ>9\--3<2RQF-H3^[D*[
MLRH"#CJ,$\55\1Z>_P#PL7P7917MU%FWU$&??OEQMC)PS9Y[9[#I78Z_H=GX
MDT.ZTB_\S[-<J%<QMM88(((/J" :H'PC VKZ5J<FIZC+=:8DB1-)(C;_ #,;
MRV4YS@=, 8XQ0!QEMXEU72=#UBQ:_EN)8/$B:3;W=TX+QQ2&,Y9L'D!F 8@X
MXX.,5U6C:=X@T_Q3,]Q=QG19[;Y;66\>XE2<-RRLZ@["O49.#TI6\ :1-I^M
M6%Y)=7=MK$YN;E)F48EX^9"J@J1M7'TJWX>\*P^'R7.J:IJ4VSRTEU&X\UHT
MX.U<   X&3C)P,G@4 9?Q7_Y);XA_P"O;_V855;PMJ'B2[\+7NI36MO8:1LN
MHH;<L\DTH4;2S$ *!UP <^M=-XCT"W\3Z)<:3>7%Q%:W VR^05#,,@XR5..G
M:KMA:?8+"&T$\LRPH$5Y=NX@# SM 'Z4 >::SK.I6:+J-IJMW>2KK\=N]Q$Q
M6U6%I0GV?83AR <%@#\V?FR,5H_9M6UGXB>(M)/B34[2SMK>SGA6W**49BY(
M!V_=^7GC)XR>*OR?#/27L9[$:AJT=H]X+V*!+D!;>7?O)0;>A/9MV,G&#S6Q
M8>&+?3_$5WK45[>O<74,<,L<KJR%4SL_AW9&3SG)SSF@#CO"%E)#9^/)H-1O
MHYXM6NT20S;R,1QD-AL@GC&2.E.T;Q%?7NE_#_3+F]F#ZU:23W5R'Q))Y<8;
M8&Z@L6R2.<*<8S750>#[.UN=8FMKV_B757:2:)91L21E"LZ@J>2 .N?;%4[C
MX>:3<^&]-T5KF_0:6P:QO(Y52XMR.!M8+CIQR#0!D^+8M:\.> /$\T/B*X>2
M'-S9,,&:"(X'EL[9+#.[#=?>I-7?5;OQ_HNDPZY>VEE>:7-+,D&P$,I094E>
M"<]3G'.,'FMJX\%65YX9N]#N;_49H[W'VJZDF#3S#C@L5P!P. !C\36!JUC*
M?BAX<CBNM01+73IXFO(X0<.Q3:K'84Y /&/R.* ,^QU36+&U\2>'[[Q#*#I>
MI6T,&H2IOGFAFVOY(VC+2$':"!G+=NT\6JZLDWCZQCN]0M(]/L8KJS$\JRRP
M,T4C'YB7R"4!P2<9XQ737O@32[[2I+.6>\6>2]74&ODD"S_:%QMDSC;D   8
MP .E1_\ " V'VG5+G^T=5,VJ6JVMVS7 .\ ,N[!7&<,P]!G@"@#F;.\U>R'P
M^U-];OKEM7$4%W!*P,3AK<OD+C[P(SNSD\Y]*TO -D(_$WC*0W-U(8]6* 23
MLP(,49Y!ZD=!Z#BMEO!-FUMH5O\ VA?A-$96M,-'G*KL&[Y.?E)'_P!>KFG^
M&;33=>U#5K:XNP]^XEFMS+^Y\P*%WA<9R0!U)'M0!5\30ZAIOAEU\/6KRS+.
MDDD$<NV6:/>&E"N>=Y7=SG/ISBH/ ^M6.LP:C)9W=^QCG"R66H!A/9-L ,;;
MLG!()SD]3SQ6YJNEKJMO%$;JYM7BE69);=@'5EZ=001Z@CFH],T2WTR[OKT2
MRSWE\R-<3R[0S[%VJ,*   /;N: .<\:W&IQ^)O"EI8:M<645]=2P3K$J$$")
MFSR.HQQG(S@X-<]=7FO:!<>--#&NW]S%::,=5L;N8J\T)PX*%BN""5XXR!TK
M:\>PO<^*/!RQM=QB&^DEEGMHBWDKY3 ,3M*@%L#GBMV;PC9W%EJT,]W=R3ZM
M%Y-W=$H)6CVE0@^7:J@%N@[D]3F@#BM=76M+^$U[XCB\3ZHU]-IMM+@LFR-L
M+G9\N1D-SSGC.:V]:?4I_B7I6EQ:S>6UC=Z;/))%"5&&5D&5.W()SU.<=L=:
MV;_P?9ZCX-'A>XO+TV(B2$N&02,BXPI.W'8<XSQ4C^&(9?$-EK;ZA>M=V=NU
MNG,>UD;!;(V=20/3I0!P]EXGU2QT%].EU&:20^*VT..^F(:5(=V<DD8+8RH)
M'4@UU=QI>HZ7_;4D&OW(M)K,O;02'S);>10=S*[[B5/R\$'!/&*:_P /-'GT
M?5=+NIKRYM]2NVO93(ZAXYR0=Z%5&TY ]OS-6]/\)0V.G75M)JVJWLUQ%Y+7
MEY.))53^ZN5VCK_=R>^<"@#BEU77+GPS\.98];NH9M4DCBNW 5C)F%F+'(SN
MR..WJ#4XO-8\-^(?$F@2>(Y'M/['_M*TU#4L2-9L6*$,0!N&1D#';H><N\3:
M"FD)X'T:QGU%K>PU%6$Z1[W@B$;J"2$VX!('S#ZYKJKOP7IFHV6JP:C)<7<F
MJ1+#<7$C*)-B_<5=H 4 DD8'4Y.: ,'0M1OH?B):Z8)=1_L^YT5KDK?.6:25
M9$7S%#$LF0Q^4X_W15SX9?\ ($U?_L.7W_HXU>M? ]I;:Q9:L^J:M<7UK;M;
M"6:X!\Q"0<, H'!4'C&>^:O^'O#MOX;MKFWM;FYF2XN'N6^T%20[G+$;5'4]
MJ ,'QM<:G%XB\*VMAJUQ917UY)!.L2H05\IFSR.HQQG(Z9!K,L9=4TCQ'XG\
M,W>IW6IV(TK[?:S7;!I8MVY&0L ,C(R/3%7/'\+W/B/P>D;7<8AU!Y99[:(L
M85\M@&)VD ;B!SQ71Q^&;9$U)GNKF2[U%!%/=L4\S8 0JKA=H !.!CJ2>O-
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M]2V8C <2,#C Y)"#DY/)K&O=8U:W^%5IX[@U*=]36.*\FA,A,$J,X#0^7]T
M!L @;LKUZUW$7ABUB\3-KWVJ[>X:T%D8G96C,0)8 Y7<3DDY)SS5&U\":;:6
M0TU+F\;1UG$Z:8[(85(;>%!V[]N[G:6Q^'% &.B:EK/Q"UW2GUW4[:Q73[:>
M..!E1HF<OD*=O'3ZG YQP=CX<ZK>:U\/](O]0F,UW)&RR2D8+E79<GW(45>C
M\,PP^([[7([^\6[O(5@D&8RBJN=NT%.V3U)Z\YJ7PWX?MO"^B0Z19SW$MM 6
M\OSV4LH)+$9 &>2: ,5]1EUKXAW_ (>DN)[>SL+".?;!*T3S22,?FW*0V%
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MD\BQH75 S'^)F"J/Q) _&N3L-*UVT\3V%\E_$FERQ/'=6TNHRW1G;;E'CWH
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M3W"7%QK4MD)I)FD6%6NBIDPQ(W 9YQR<9S0![-6'XJ\1CPOI<=\]E+=(]Q%
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MTV_5S [*^8W*,K*P96!'0@@&M&B@#*LM @M;W[=<7%Q?WHB\A;BZ*EDCSDJ
MJJHR0,G&3@9)P*R-(^'>C:)J'VBRGU%;42F:/3FNV-K%)G.Y8^F0>1G(!Y'0
M5UE% %'6='L=?TBYTO4H!/9W"[9$)QGN"#V((!!]16):^ ["#4-*OIM2U>\N
M-+#K;/<79.%< $' &>!]3WSQCJ:* .2MOAUHMGK$U_;3:C#!/-]HETZ.[9;1
MY,YW&,=>><=/:G7_ ,/M(O=?FUB.YU*RGN0!=QV-VT,=UC@>8%Z\<<$5U=%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'-$]NXD1A X/R8W<?2@#N].\=Z!J-KJD_P!IEM?[+&Z]BO('ADA7&0Q1AG!
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M(D>9?GV ;B/G7H#UH Z+^W1I7Q0U4S2:G/;OH\$\=E&LDS!S(^[;$,[> ,\
M"NJA\5Z/<:'9:Q!<F2UOF"6P1"7E<Y^0+C.[@Y';!S@ US]C+)_PM?4K][*^
MCMI-&@C$KVDFW>KNS+N P2 PX!KD=#L-5L/#7@G56TZ_V:-J%W]NM#;.LJQS
M/(!($(RP4,#P"<'ZT >F1>+=*>/4O,:>&;35#W=O) QEB4C(;:H)92.ZY'7T
MK%O?'7AO5_#M\SSZI%8-8"X>[@M9EQ$W&4=5^\.^.ASGH<4;^SDU'Q9K7B2U
M@N38KX>;3U(MW#7$K.7^5,;F"C SCJV.QJ$PW+?L_?8!8WOVT:*+7[+]ED\W
MS?+V[=FW/7OC% &W>^+XM*UCPWH\%I>W$6HPO()_+9R8TCR!ZLV2I/H,YZUL
M:9XDL-7O]1LK47'VC3G"7*20LA5B,@#/7(Y!'%<AJ'VB#6_A]JG]GW\MM;6]
MQ#/Y5J[/$[PHJAEQE<E2,G '? J7Q=I>HVOBZQOM&^0Z[&=)O\-@H-K.DX]6
M11)^E ':Z7J=OK&FPW]J)/L\R[HS(A0LO8X/.#VJ#7]>L?#6E2:GJ1E6TC($
MCQQ,^S)P"0.<9QS[U6N=<L=#U72="^Q7:I=*8X)8H"8(MHPJLW\)/05H:MIE
MOK.CWFF72Y@NX7A?Z,,9'O0!4/B.P7Q#!H;"X6_G@-Q&IA.TH,9.[IP2 1G-
M<GXXUQ)+?0[RUNKRUCM_$5O:W#;GB1U#D.I'1URON.#[UA#3/%8T'1O$<MI)
M)KN@W"645KN/^D0 F&5OJ^0V?2,'O70>,=.EL=%\*64,%U=O;:U:3W#P6[R$
MA6+22MM!QDDD_6@#I--\6:9JL^H6\*WD=Q8!6G@FM)(Y=C [65"-Q!P<8&>*
MI^'M:T.U\&:=>65]>7.GS,8K62Y+R3SL78 <_,QR#CT [ 5GV;O%\6=8O7M;
MP6C:3!&L_P!DDV,ZNY90=N"<,.!7'Z3:ZQI7P_\ !.J)I%_*^AWDKWUA]G99
MO+?S%+*C %B ^1CU^M '2^.?$EOJ7P_\4KIUU>6>I:5&/.C5FAEA8X*YP>0P
M/8D&NBTOQ;IE[J<&CJURMV]OYT336[HDZK@,8W(P^,CIZY&17->,+]O$?PZ\
M12Z;HE^OVJW6*'=9.L]R^?[F-VT#&"1Z]AS9U R3_$#P5<Q6=ZT$-K=+-+]D
MD"Q%T0*'.W"Y*GK0!T'C*\TVQ\*7\VKW-Y;6.S;+-9A_-0'N"@)7Z]/6FWOB
MW2-)U"UTN>2Z-W/ 988UMY)&D50,X(!W-R.!D^M4?B=#/<_#C6[6VMY[FXG@
M\N.*")I'9B1T"@FL^[:27XC^$[I+.]-O%IURDLOV23;&SB/:&.W"D[3UH ZK
M0M?L/$=@]W8-)MCE>"6.:,QR12*<,C*>0167<^+!%X]A\,BRNBK6+7+S+$2,
M[T5<$=AELGH./>J/P^2:*X\5B:UNH//UV>XB,]N\8DC98P&7<!D$J>E)J(GL
M?BY8:@]E>2VD^CR6BRP0-(JR^<K88@87@$Y.!0!C^&?&%GX?M/$?]L76H3PV
M^OW,7G,DMP+>(%57>_.U1T&37>:AK=M82>3Y=Q=7'E>=Y-K$9'"=-Q Z#T[G
M!QG!KS*6WO)/AS\0;5=-U$W%[JEY);1&RE#3*Y78RC;D@X/-7;V9M$\71ZMJ
M6BZC?:1J6FV\*RV]M(\EK-%O^5XQ\P!W^G7\: /1=(U>QU[2K?4]-N%N+2==
MT<@!&><$$'D$$$$'TJ[63X;MK>UT6);32AI=N[,\=KL",H)SEE'1CU([9P>:
MUJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *BN+>&[MI;:YB26"5"DD;C*LI&""/2I:J:EJ=KI-I]
MHNW*JSK&BJ"S2.QPJJ!R23VH ?96OV*U2W$TDJ1C:C2G+!>P)[X]3SZY/-,U
M'3XM4MC:W)8VS_ZV(=)5_NM_LGN._3ID''/C?1X4U?[<TUC+I$:RWD-PGS(C
M#*L-I(8'IP3SQ5BU\4V,VH76GW$=Q8W=M:B\>.Z4#]R21O!4D8!!!YR/2@#;
M    & .@HK'L/$5O?W,,0M;N!9[9KN&69 $DB!49R"<??4X.#CM59?&6F?;=
M.@D2YAAU)MEC=21XBN&QD!3G()'(W 9[9H Z&BHYYXK6WEN)Y%BAB0O([G 5
M0,DD^F*Q(O%^G/=Z?#-%=6J:EQ8SW$6V.X.,@ YRI(Y 8*3VH WZ*\[N[L^)
M?B!JOA^^MM1%C!81"+R6\LQR.[YFR&XX5=IYQ@\<G/2Z_JI\'>"KF_$=UJ#:
M?:\%V#/(57&YVX],D_7 [4 ;]%>;:]K$C:OX$U.8WUL)KB19H<OB7]PQ'[M2
M0QSTXS75:=XPTK4+/4KAC/9_V8^R[BNXC')$<!AE><@@@C'6@#?HK$M/%%E<
M:X-&F@NK._>$W$,=S&%\Z,'!*D$CCN#@CTJE\0?$\OA+PC<:A:QK)>R.EO:H
M_P!TRN< GV')_"@#J**YZU\*JE@JW6J:G-J!3]Y>B\D4E^[*@.P#/1=N/4&N
M5U%[OP_XN\!QW][>7,HL[N*Y$;N_VEXXD"MY8)!8DD],\\]* /2Z*Y&Z\5Z'
MJ_@S6;VY_M""SMO-MKZ,1.EQ P'S A>0<$'/3GK6K'K%G::?IT5M'<W,EQ;"
M2VMTPTK1JJY8EB!QN7)8]2!R30!LT5Y_XM\=HWPUU36-!-QYZ%K9F\O:]K+O
M",'!^ZPW<=><5T>AZ+:V=Y<:G:C4+;[4BH]G<2DH&4GYPI)PQ[G//UH W:*\
MTU6[MX/C(=/U+6KJTTN30_M/E-J<L$?G^>5R,.,':#P...E=%IM[IMC9ZKJV
MG7U]JFGQX5D2X>[VL@)<QEF)(PP! [J: .IHK"TKQ9IVM?V>;!9YDOK<W,;J
M@VI&#C+\_*<\ 'DX/H<1:CXTTO2T:XN5N1IZ7'V:6_6,&"*3=MPQSG ;Y2P!
M /!.0: .BHK"U7Q98:3]N+QW-PFGQB6]:W0,+=2,Y;)&3CG"Y..<<C+[;Q3I
MMYJ\.F6YEDFN+'^T(&"_)+#D ,ISZL.#B@#:HKB=;^(5O:^%9]6TVSN;AH[[
M^SV5D"^5+Y@1MV3V)P,9R<=N:OW^IZ5+XH\-P7BZC!J4QG:SBPZ(<1G?YF#M
M.%' ))&1ZT =/16+IGB:SU:YU2V@AN4GTQ_+N4E0(58C( R><CD'I[T+XEMI
M;2SE@M;N::\A-Q#:H@$IC&/F() 4<CJ1UQUXH VJ*S="UVP\1:8M_ITC-$7:
M-E=2KQNIPRLIY!!KF;_5[K7/B4/"<%Q+;6%C9"\OG@<I),S$!(PPY5<'<2""
M>F?4 [BBN \77DO@&;2=9LKBY?39KU+._M)YWE78^<2)O)*LI'0<'//K2:MJ
M#:Q\2#X;O+2^?35THR;(SLS(\VSS<A@< +P>Q)XH ] HKRG2H1KFIZ_H.HR:
M^8-+6V@M+L2'[1;XBWER5ZR,3UVG(P*ZKPUK>@V?@JRO=/N+V33Y9GAMOM)>
M2>:0RLNT!OF)+ X'8=< &@#K**P;;Q?I<SZI%.9;.XTK8;N"X3YXPXRA&TD-
MN[;2>>.M-3QAIZZE-IUU!>VEY';&Z6&6#<TL0."R!"V[!ZCJ/2@#H**YWP_X
MTTSQ-+"NG07[136YN([B2U986 ;:5#]-P)Z?X&M/4-6AT^>VMC'+/=71;R8(
MMNYPHRQ^8@  $=3W% %^BO._&&LQS-X/U6&6^MHFUP02Q$NI8*)0RM&#\QW)
MQP3Z=:Z*S\:Z1<V^KS3?:;+^R 'O8[N$QO&A4LK8[@@'&.>* .BHK#L/$UEJ
M>IC2FAN[6[EM/M<23*%,D).W<I4G&"1P2",CBO.S+<_\*<\8R?;;WSK6_OA%
M-]ID\P!)"%!?.2,<8)H ]@K!U[PZ^MZEI%X+WR#IEQ]IC01;@[[2OS'(XP3P
M,?6M73B3IEH2<DPIDG_=%8-OJFC+XOUKRVU ZC;6D1ND*2F,)EMNQ.YZ\J.?
MSH Z>BN2L_B-H=ZFE31)?"UU.400736S"+S"2%0MZDCW]#@U?U7Q;I^DB^:2
M.YGCT] ][);QAA;*1GYLD9..<+D@8..10!O45PFH78F^)WA2XL[J:2TO-/NY
M=BS-Y<@"QE&"D[0<,><=ZUV\;Z4F@ZEK)2Z^RZ;<26UV/*^>)TP&XSR 2.F:
M .DHK*O-=M89[>SCCGNKNYA,R6]N!O\ +&,N22 HR0,DC)Z9KD?A[K4,'A[6
MKNZGNWC_ +>N88%N"[S'+*$CPV6W=!@]._>@#T.BL?2O$EGJFIWFF".>VU&S
M"M-:W"@.%;[K @E64^H)]\5/JVM6FC);&YWM+=3K;V\,8R\LA!(49P.@)R2!
MQUH T:*S-%UVTUQ+O[,LL<MG<-;7,,R[7BD !P<$@\$'()!S4.M>)].T&\L+
M6^-P);Z0Q0>7 S@M@G&0,9XZ=3V% &S17*)\0-,D^WQ)8ZLU[8L!/9"S8S*I
M&X/MZ;2.AS^M75\7Z5-9:1<VCR71U<$V,42C?+A2S?>( P <Y(QTZT :]Y:1
M7ULUO.&:%^'0' <?W3['N._3I4X&!@=*XK7/B#;VG@Z?6M-M+B=X[K[$\;)M
M-O-Y@C(D!/8D=,YX[<UOSZ_%#Y4:V5Y->21F;[)&B^:J X+'+!1STYY[9P:
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MO,7V"/;_ 'MP(Q[9Z<T ;]%85KXMTVYU>[TETNK:^M$$EQ'- =L:$;@QD7*
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MSUZ5?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY."/Y=:YW1-(BG^%VAZ1KFDZQ$Z7TQ:2""5)[)R\KI,,+GN!D CY^>]>LT4
M<MX%36HM*O(-8N)KM8KMTL[JXA\J:> !=K.N <YW#) ) !JCJD%YI'Q1M?$+
MVUS<Z5<Z6=/E:WB:5K>02>8K%5!.ULXR <'KBNWHH \@\1Z#J$OACQS?V^GW
MCOKEY;M9V:6[F1EB,8+E ,KNPQYQP!GKBO7(95GA250X5AD!T*-^((!'XT^B
M@#BI%G3XQ"^-G>&S70C;FX6VD,?F><'V[@,9VC/Z=:XV'2M6B\*VE\FA7=VV
MF>(+F\FTZ:W97GMY#(-R*P&XA7! KV>B@#S#6X[?5_ GB.;1O"-W82W=D;=
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M0C++QTXSS]*\XT#1[[4O 'B_1_L]S9W5]>:@8/M,#Q!EE+%&^8#@Y_"O2J*
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M'I/@RV>QN9);?69-0NT@B,BVR/YG!*Y'&]0<9[XKUJ@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH Q-?\-Q>(+C3)9KVZMSIUTMW
M"L&S!D4$ MN4Y&&/%;8Z444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !2.H=&4Y 88."0?S'2EHH BM[>&T@6"",)&N< >YR3[DG))[DU+110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !114<\\-K;R7%Q(D4,2EY)'.%50,DD]A0!)15>
MSNA>VJ7"Q21H_*"4;6*]CCJ,^AY]0#Q61;>*X+K4M;L8["]\[1S$)UVJ2X=2
MP* ,=PVC..O8#/% &_14-K=07MI%=6LJ303('CD0Y#*>014U !1110 4444
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M5M9D0H$N$5BR[AMR.2?ND9Z=." /\6W-Q:>'Y9+;4H=.D,D:FXD4L0I<!@@
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M3KB_OIH-<F,]QN,8*2$*,IA1C[J\'/2NDT^T>RLH[>2[GNY%'S3S[=[GU.T
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M^2VT^Q) /H!6]10!3TG3_P"RM*MK#[7=7?D($\^[DWRR>[-W-7*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1N W$*$;G XS@FJHBFU+X,#P8]G+'X@CC2Q-F\9!5UD&)<XQLP-^_I[YH ]
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M.YP< X-7M.U"TU;3K>_L)TGM;A!)%*G1E- %FBN<\6^*1X932P+6>=[^_AM
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MJ&G2,\+,R$.A1T=3AE93R"".AK1H **\]\1^+-0TKQUI<R-CP[%<C3+YL_\
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M^T,?,+;-F_ DY ZX&*QKO4M<USP!X8U>;2=1-_HVHV]SJ=D]LZ2R+'N5F16
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M1>?;O'YD;[=K#<!D'!IGBD3'XA>#;B.SO98+22[:XEAM9)$B#PE5R5!').*
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MH&@_V=>VFIP7%I]J$UNZ+;>207<.1M(PIV[2<[A[X .RO_%5A8/>CRKJY2P
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MR< \MB@#'\.>+;3PW#XK;4Y-2N8+;7IU,H22X^SP[8P"['.%'USUXKK=0O\
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M<OFJPC#[<8"CCM52[TJ]U7QCXVM8H+JW74=&CM+>[>W=8C(%D!P^,<;QW^E
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MP2REAR P7/UH Z*BBLS4-;CLKEK6&TNKZ[6+SW@M0I98\D!CN91R00!G)P<
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MUMH;.UCMH$V11J%49)X]R>2?<URGAWQ!<>,M+UN*>POK%%N+BS1HW170+\F
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MCD<^85!(WG^]G)[TGCCQ)/X6\-R:A;V<ES(98X5V[<1EW"AFR1GD]!WQT&2
M#I**\[U?4FM/B?H-V\.H#S],NB;($NS,&0#"!BH/)Y';DFNET_QAI>HZ(^J(
M+B)8[DVCV\L6)EG#;?**C/S9([]Z -^BL73/$MIJ6L7>CM!<V>I6L:RO;7*J
M&,;<!U*LRLN>.#P>N*V2< DYX]!0 M%<19>*_#FB^'=?UN"/4OLEMJ4PO \;
MN_G_ "[]JL?E7) P=H'M6O9^,-/N]?31_L]]!/- T]O)/ 42X1<;MAZG&1U
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M"!S^G6LJ33=3UKX3VW@BXTN[MM618+*1G@;R46)US,)<;"-J9 !SDXQ7JU%
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ML"/;M^/-1_$O3[S4_ &I6MA;27-SNAD6&,99PDR.0!W.%/%=910!PEZ]S?\
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MNW2RN;J/9/+;@+M,@P#NSN&2 2 #5WQ@DDW@S6H(899II[&:*..)"[,[(0
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M>PT4 <IX5EM-0NWO[/PC)H@$/EO+=V26\[DD'8H')48))/!.,9YKJR<#-%%
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MH)![\UQUWX=UC5-+\:PVMC(ES<:M%J%BEU'MCN5C\H[3GCDQD8..HKH- ?\
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MP0Q1C+RR,<*BCU/O@  DD $USG@;3=2TJZU6U:[O[G0E,7]FMJ((G3@^8OS
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M[#Y&?2@"VGC6U9]6MVTS45U#2T66XL0D;2F-AD.F'VN,#L<YXQFIM%\7V/B
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MO\%@S;<_-M!QSW!QB^-->D>?PM;V-M->:=J=]&SO"T>RYC\MW$8W,,YPK'.
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MH.Q^JY[''>N4A\1WU[\0=1\.R:9+]AM[.-_,#ISO9@7/S9"X7  R>I(% '7
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M<9SP5;[N<X]Q4L7C7SO[;M_[&OH-2TN!;@V<[1@RQL"5965BN/E.><CT)XH
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M)<)<+<&,9RNY2N&/RD<@G K2TC41J^DVNH+;3VR7,8E2*<*'"D9&0"0..>M
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M7?&1&VUB4<CD ]>F<\4[2_%MOJ<VM0FRNK671WV7*7!C!^[N!&&/RD<@G H
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MJ?AVPN[NWDAGE@C9O,*?.2H)8;20 2>G!]JU: "BBB@ HHHH **** "BBB@
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M0Q:*^G6\;IMDN'=MQ(4\A1@#YL<D]ADYTGAC6=0^#NCZ7#;-;ZSI:VTJVT[
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M6=6FT:\M;&\L;:.*6<Q@AD+Y!4,3_%[^^*Z#Q2=8'A?4CH 4ZMY#?9@V/O\
MMGC/7&>,XS6O10!YMI&G:DOQ TC6$\/7]O:OI<EM<37<R-*)"Z-ND.\DC ('
M4^P%>DGI2!E+%0PW  D9Y'^<4QQY\#+',R;@0)(\$J?;((_2@#Q[PY9W7B;X
M&V7AJWL9Q+>9B,[J/*2/[06,F[/. #A>N>V.:VY=/U+PYXQU:0^%&U[2]5>.
M>":'RC)!((U1D?S"/E.T'.<#WKM?#GA^U\,:+#I-E+.]K!GRQ.P8J"22,@#/
M)/6M6@#A6T_4U^(/AZ];2RMM;Z?/!<26P'E0O(4(4<@D#:1D#\NRW>CWM_\
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MM()Y4VW \QF"EE8@95B.<<_G737=WXA\0>%=827P]-8--82P0VDD\;RRRNI
M.0VU5'N<G/08Y *?A/Q6+/2O"&DW6EW<,%_810VUZY38\BPABNW.X @'!(YQ
MZ<UWU></H^M&P^'T8T>X+Z0\9O1YD7[O; 8S_'\W)SQGBO1Z .*T3QC=7&H>
M*)-6M!9Z?I-P4,ID5A$BQJQW8Y).2>,XZ<U>/C*.WGTK^T=.N+*TU9UBM+AV
M4@2,,HD@!^0L.G4=B17.S^$]6U#_ (3K19;1H;;6I3/;7_FKY?,2J%*@[L[E
MYXQC//3-FYTO6/%&B>']*U'2IK&:QN[>>^F=T,?[GG]V58EMY QP, G.",$
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MO6,T8,80@,P&3N(ST'&!UKH;KQ&BZ[;Z+80+<W\UHU[AY/+1(0P4$M@G)8X
M ['.* -RBL'PIXG3Q5ILE[%I]S9HDK0D3LA)=258#:QZ$=\9K.N]?U5?B;;:
M!'9Q-8'3)+EB9<%SYD:[B,?P\C'?=0!UB2QR%Q&ZL4;:VTYVGT/H>13Z\E\/
M>(3X0TKQ?=0:)+<:?:>(+M[AH72-88\H/E4_>(ZX';O7<:IXLMK*\%C:FVFN
M_LXN2MQ=+;H$8D+\Q!RS;6P,=CDCC(!T5%8_A?Q)9^+/#]OK%DLB13;E:.3&
MY&4D,IQQP15/4/%,D+:K_9FF2:B-)&;L))M);;O,<8P=[A2#C@<@9SD  Z2B
MN=M?%:W7B.VT<6,T;W6F_P!HPO*=I"[E78ZD95LM[UEW'Q&AMO#5UK+Z3=,M
MKJ+:=-'&ZG:XD$>[/4C)XP"?:@#MJ*Y5_&,EL4@U'2_[.O9YY$M8;R[C59(T
M"DREU)"CY@,<G)Z'K5KPKXKM?%$-\(HO)N;"X-M<1"02*&'(97'#*1T/'TH
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MKLJF[+(2G(SP%'&?7H*POAY8Q^(_#]IJNLZ;')=PZC<W4-X9?WGF^=(O;!P
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M8EC4DLV#A5!5> 221@=< '345QT_C^&TTO7YKC3+@7^A ->62.I.PKN616)
M9".<XSP>*GL_&;S:]I6G76CW%I%JT#RV5P\BMO**'92HY7Y3D9Z^@H ZEW6-
M&=V"JHR6)P /6A'61%=&#(PRK*<@CU%9GB2Z@L?#6IW-U8O?6L=M(T]NNW]Y
M&%.X?,0,8S639>);6*P\-V.G64,,NIV GM+62;RDCC5$.P,%.2 Z@ #H">,4
M =51533+N6^T^*YFM7M97R&@D(+(02,$CCM5N@ HHHH **** "BBB@ HHHH
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M-H+&Y>1"/,@4_> 8D MCMTS7I!(4$D@ <DGM3(9XKF%9H)4EB<95T8,I^A%
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M@:/:0HX.3DGIUP37IM% 'G6H:5X@O_"OA*V.B.ESINHV<]Q$+F(E8X0-QSN
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M ]<&N@T2;5+JV>YU2Q33WD(V6BR"1HU'=F7@L3V&0 !SUK266-CA74GT!IU
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M !1110 4444 %%%% !1110 5@^+?$I\*Z0FH&PEO$,\<++&X7;O8*#SR>2.
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M-QXLU?4KZ^A?3XI='DTNW1V5I,R'+2-M)  PH SSSG'% $T/Q B;6M,L9;2
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M."5;@GN/QK8U?PC<^+M3U"_O87TY9='DTRWCD97D#2'+2-L)7 PH R<\].*
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M&X5B)/+\S:R < C.#G/J!3;H^*]?\*ZQ!?Z)#I\UQ82VL-HEVDS22.I&]GP
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M%=)6'X-L;O2_!ND:;?0^3=6=I';R+N# E5 )!!Z'%;E !1110 4444 %%%%
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M?>:"2!(JF('9N"[CG/L#MKDVU75/$7P@\67>LP6C;8[\1LDA?:4+J %*C 7
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MPMY;NW^S7+Q*TL&\/Y;D<KN'!P>,]ZGH **** "BBB@ HHHH **** "BBB@
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M)R" <Y.<8K6M='US_A-]'U>XL84@M]*>RG\NX#;79E;*Y R!MP>G? ]>VHH
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MCE410<\<\&N5/@GQ3)\/Y?#$GV''VTO)*MRP:]C:X\QBYV?)\I((^8D^@&"
M;/A&[;0O#.B:<\)N-=U5)-0EAW;<&1O,D>1N=JJ7"YP23@ &K]IXWAGT]YY+
M-O/?4'L+.*"3S!>.O\4;$+\GWLL1@;&Z]Z&J>&-5;QK#K:V.FZK;2Z<MC/;7
M$IB6)E<MN4;6!4YY!YX%6-3T/76\4>']7M(]/F6R@G@D@9VB2'S-N'3"G=@+
MM[9]L\ $$$EWK?Q31;RVBB30+$O^ZE,BF:XP <E5.0B/V_B]Z[FN L=/\0^%
M+#Q3J;1VE_J=[>--:J9&W7'"K&IP/E^4'"C/7J *[U"Q12X"L0,@'.#0!Q7Q
M"NHY9_#VB.&9;[4%GFC49,D4'[PKC_:?RU_X%5FS\>0?V-K&I:I9-9)IM^UC
MY<<GG-.XVX"8 RQ9MN/4'FK3>'I[GQ__ ,)!=>2T%I8"VL$W$LLC,3(YXXX"
M*,9XS7.6?@G6%\)Z)!=FT?4;#5UU6>-)"5N'WNS9<CKE\CC'R@9[T =(?$MU
M;:WINE7^FQV\^IPS/:A;G?AXU#%)/E&W@]1N'!]LT3X_M[?PQ/JU[9-#-!?O
MI[VJ2;\2++Y9.[ ^7'S9QTJ[;Z#<WOB]/$>J%$-K;M;V%HC;O*#D%Y&/]]L
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M?:&VS0C8&A<A<KN"<XR.<5=L_"VN'Q#KEW/#IMK9ZKID=J(X)68P,BNH4#:
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M6O2&)"DJ,L!P,XS7GMIX3UV'X::WX>>*R^W7[W7EL+AO+"S,QR3LSQNZ8YH
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M/F1\DX+8]@,Y].HNV/CV1_#S7-]9QQZFFJOI!AB=FC:=6(+ XW;=H+=,\8H
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MMA(_A!'U) Z=_1UW;1NQNQSCIF@!:*XOQ-J>MV_C_P +:;8R6RVEV+J1DDW
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MV4SE9WB.S=,O^R Q(&#G;U&<5U] %34],LM9TZ;3]1MH[FTF&)(I!D,,Y_F
M:?8V-KIME#96-O';VT*[8XHE"JH]@*P]3\07NF^,=(TA[> 6.II*(KDL=RRH
MN[81TY&2#GL169IGC6]O],\0,UO9C4=+OS8QVZ2,5E<L%0D]@Y8 <<<]<4 =
M:=1LAJ@TPW47VXP^>+?<-_EYV[L>F>,TFI:KI^CV;7FI7L%I;+P99Y BY],G
MO[5@KK=W_P + .A2:?9B7^R#=I=AR68^8J["-N57.3U/:N"U+4M7UCX&>);S
M5I+>5FEG4-'D$%;G;C!Z*, #V% 'LP.1D=*JV6HV6H_:/L=U%/\ 9IFMYO+8
M'RY%QN4^A&1Q7.VWB/58/&%IH>I:?:Q0W]I)/:/#,6=3&5RLF0!G# Y&<=.>
MM9#^.;VS\'>*=;BT6R2XTC49K=X%G(639M!<MLRQ);T''>@#L5\/:0NO/KHT
MZW_M5T$9NMGS[0,8SVXX^G%:5<E!XFU6+Q?IVD:GI]K#;ZI;2S6CPS%W0QA2
MRR @#D,.A.#QSUKK: "BN&TS5/$-U\1/%-B'LFM[*"U$$;EP%#+*P/'<G&3Z
M 8Z53E^(U[#X-T[7YK2SA,FH?8+^"21LVC>848_[6W;DCCCGM0!Z+17,ZSXJ
M_L,:S>W4<;:9I=LCNZ9\QYFZ1 =,X*'/_31:AN_$VHZ)JFC0ZU:6RVNK3"U2
M6W=B;>=AE4;/WP<$;ACD=* .LJ.>>*VB,LTBQH"!N8X&2< ?7-25QT=^VK_%
M2XT]CFUT6Q24)V-Q,3\WX("!_OM0!T-UKND6-]%8W>J65O=S8\N"6X1)'STP
MI.35S[1#]I^S^8GG;-_EY^8KG&<>F:XSQSX:T23PCK*R:9#<ZA?AQ [(&FDN
M7XB ;KP=H'HJ^@-)XNBO-#^&L5^LWFZKH<$,ZW!/+M&%$F3W#KO!_P!Z@#N*
M*AL[J.]LK>[BSY<\:R+GT89'\ZP/%GB&]\.2Z7.MO;OIMS=QVMU/(Q!MMYPK
MD#@KG ZC!(H Z6BN:U7Q0=)N-8GFB1].TRU221T)\QIGSB(#IG&TY_VUJK:^
M*]3_ .$DM--N=,,]M=PR.MS:0R@6\B#.R0NH!!' ;C)&,"@#KZ*XBT\:WXUS
M0+#4;.U@DU@29M%D/GV15"ZB0=\@$=%P?6DTOQ;XBU2]U(1:+9"UTO4I+2Z(
MNF9RBH&S&-HW-D]#CJ!ZD '<45RGA7Q3/XFCL[VV>PGL+B!GE^SN3):R_+B)
MP>IY;G"_=Z<UU= !4<]Q#:P//<2I%$@RSNP  ]R:YD^)-2U,ZT^@VMM/'I,[
M6S+.[!KF9%#.BD?<QD+DYR<\ #)YKQ1XCF\1^&?!VK:1Y2V6H:Q9DI,2&WB0
MG8V.,!EY]Q0!Z%INKZ=J\<LFGWD-RL3F.3RVR4<=58=0?8U=JI964=N9)S;6
MT5Y<;6N7@3'F,!@$GJ<#@9KF/'6IZQ8:AX9@TV2!(KW5$@F\S=E_E9P,CHOR
M\]SQ[Y .F@U73[G4)]/@O8);RW4--"D@9HP>FX#IT[U<KS@/J\?Q5UT:7;6<
MEZVD6A8W$C)$IW2>@+'/;^?8Z-AX_34?#N@7J6PAO=8$FV)MSK%Y>?,8[1E@
M"  !C.X=.30!VU%<[X6\07NLRZE;7^GO;36,P19Q&ZQ7*,,JZ;P#Z@CG![\U
MT$ID$3F)5:0 [59MH)]S@X_(T 5]/U&RU:S2\T^ZBN;9RP66)@RD@D'GV((J
MU7G,'CR\A^'NE:_;:):(;N_^RR6L<VT1YN&CRORX8G&>=O)S6YIOB/5G\77O
MA[4K"SCN%L5O[5K>=F1D+E-KDJ"""!R!T/2@#H-/U&RU6T%U8745S;EF021,
M&7*D@C/L0:)M1LK>_MK":ZBCN[H.8(68!I HRVT=\ \UYMJ'BW5KOX7VVKZ;
M;6>FRSZD+6:*,DA5^T^6=I ')[G'<\9Z=5>:W=V?C/P[I%WI]F[7\5RPND<E
MHS&H+!05X!RO.><'B@#J:IQ:KI\^I2Z;%>P27L*>9+;I("Z+G&6 Z?C7):EX
MWO\ 2I[>2\L;>"&?5%L$M)9,7#1%]@G'."I/.,=.]/MP!\;+_ ZZ!#G_ +_O
M0!VU%%</JWCB\BBU2?1[%;Q=-G:!K?RY3)<LF-X0JI"D'(&<Y(/2@#N*JZAJ
M-EI5H;J_NHK:W#*ADE8*N6( &?<D5RFK>-KO1=3TI[S3_+T?4X28;@HYE2<I
MN2%X^S-T'/)XQ4OB;7M3T3P9#J6H:38SW#30)<6QE)2(O(JC'RG>02/3IQ0!
MV%%<EJWBR6#Q'=:%9&R34(;1;BW@O'*&]9MWR1GMC:,GGKTXS5:35-<?XL6V
MEJ]LMB-':Y\H[L\S(K$^K#&!V&3ZT =M17 W/Q N_L,6K:=IK7VGM<^4;>&&
M5IVBWE#*I"[3TSM].X/ FF\6>(9M7\3:;I^DZ?YFC+$XDFNFVR*\9?LN=Q
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M'%(8G>%PZAQC*Y'&1D5;KR+2]>U7PUHGC/5;'3[6XL[+Q#>2W(FF*.R[ER$
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MG0W,;WEHJ-/"#\T8<$J3]<&K= ')ZWX6N/$D5QIVK&.738[4):LLY$K7&/\
M6O\ +@,.-N,XRQP<C&;JGAWQ;K7P\AT34)-+DU9)8#)<B>0)((Y%?<?W>0QV
MX/&,\^U=]10!Q7BOPQ>^*+>]LKW3=,NH)(A]BF>9EELYMN"P(3.,X(P<G&",
M'B1/#.L6?C#2=7M[JVNHX=)&F7;W+,)&PZOYB@ AB<'@D=>IKJKR\M]/LI[R
M[E6&V@C:261NBJ!DD_A3[>XAN[:*YMY%DAF021NO1E(R"/PH X30O#GB_P .
M^9H5G>:8_A_SG:WN9-_VJWC9BQ0+C:Q&3@D\=<'I5ZV\/:S;^(?%NH[+%HM8
MBA2W7[0X*F.,I\_R<9SGC.*[&B@#S.#P/XDTK3/"UYID^G#6M$MFLY8I)',%
MU"V,C=M#*<@$<=:UM<\->(M;T>TN_M]G;>(;*\6]M0@9K9"%*F(D_,5()RV,
MY/0#BNVHH Q=!7Q#(KW'B V,4Q4*EM8LS(OJQ9@"2>.,8 '?-:UQ!'=6TMO*
M-T<J%''J",&I** //+?P7K0\#MX(N9;2330?)6_$K>:;;?NVF/;C?CY<[L=_
M8[%YH&IMX]TG6+6.R&GV-G+:E&G82'>5.0-A'&T=^]=)>7EKI]I+=WEQ%;V\
M2[I)96"JH]2319W=OJ%E!>6DJRVT\:RQ2+T96&01]0: )ZY;4-"U7_A8%EXA
ML&LV@%@]C<).S*R@R*X90 0QXQ@D5U-'09- 'G+^"]>D\'>+='/]G"?6[ZXN
M87%PY6-92.&_=YR,=NOM5J\\.^*=/U^WU[0)--:XFLH[/4+*[D<1/LSL='5<
MY&XCD=*Z_3=8T[6$G?3;R&Z2WF,$K0MN"R  E<CC(!%7: *FFQ7D5B@U">.:
M[;+2M$I" D_=4'G Z#/)QGO5NBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q#KG]BPV21QK+=
MW]VEG;(QPN]LDLQ] JL??&.];%<WXT\-W/B32[4:?>+9ZG87:7MG,Z[D$B9&
M&'=2"0?Z]* *FH>*-4\-66N7FO6$4EE81QO:W5M\@NF?Y?+V%F*L&(&<D<YI
M][XCU30=9T:VUB*TDM=6E^S)+;!E-O<$95&R3O5L$;AMZ=*AO_"^L^+/"^HZ
M9XHN[.&6ZB$<2:<',<+*P82$O@L=P7CC &.Y-2G0-8UJ;0V\0&Q TF<76;61
MG^TSJI56(95V ;BV,MS@9XY ,.?QUXE&A>(]5BTS2Q'H5]-!,C3.3+'&%)"G
M PV"3D\=!CO72/XCFO\ 7H=%TGR4G-BM]//<(76)&.$7:",L3D]1@#OFL,^#
M-;;POXNTIGT\2Z[=SW$3B9\1"4 8/R<D;>W7/:I_^$6U[3O$5CX@TJ33VN3I
MZ6&H6EQ*XCD5#E71PI(8>A7&* .;TK7-0\._#WQKJ_V&SN+JWUV\::&1SY1.
MY0<<9(R>AQ]:Z;5M0UK_ (69H6GVUU;)92V,\YB:-CEEV DD,,\,<>G.<]L^
M7P)KTW@OQ1HCW6FM/K5_-=(Z[U6-9&!.>"2?EZ>_6MS4?#^KW/BC0M<M9;*.
M6SMI;:YBE+L-LFT[D( R05Z'&: *J^-OL%UXSEU2S@A@T'RFW6[%FF#1;QDD
M#GE0../6I;WQ1JNARZ'<:O;VAL-5GCM6^SA@]I+(,H"22)%SP3A<=<=JKR>!
M[G4[SQDFIO;K8^(%B5/(D9I(3'&$!(*@'H&Z^W/6IE\,ZSJECH>GZ\]BT&E7
M$5P\UO([-=-$#LRI4!,G#'ENF.] &?<>,_$SVWBJ6UT[2U_L"9MWFS.WFHL8
MD(& /F()Y. ..#U'<:5?KJFD66H(A1+J!)U4G)4,H;'ZUR*>%-96T\9PDV&=
M>9VA(F?]UNB$?S?)S@#/'T]ZZ?P]8W&F>'--T^Z\HSVEM' QB8LK;%"Y&0#S
MC- &#\4-0U+2_ .H7>F7"02J8T=V4EMCNJ';@C!^;K_7D9GB(ZFGQ'\&[%M9
MK\VNH#/S)$.(^3U. .W<^G4=)XUT"?Q/X0O]'MIHX9YPAC>0$J&5U<9QS@[<
M?C5"XT+7;SQ;X>UNX.G8TZ&XCG2.1QN,H4?+E3]W:.I&?:@"#3/%FMWN@:LP
MTNWGUC3=2.G2) Y$)Y3][\W(4*^XC.>#S5=/&.H7:>++&UGT^6ZTBT2YM[V%
M"8I Z.<%-QY!0CAB#^E5;CP/K\NF:[!'<Z?')?ZRNJ)&TCM'(HV9AE^4':0@
MSC.>F*OV_A+6I-?UZ^O;K3T@UC3H[5T@1RT3*KJ ,\$?/G/?'04 :O@.:^N?
M VB7&H31S2S6,$@=5()!C4_,23ENN3Q6OJVHQZ1HU]J4J,\=I;O.ZIU8*I8@
M>_%9WA#3-2T7PQ8:7J<EJ\MG ENAMMVTJBA026[G&>E3^)]2BTCPQJ=]/,D*
M16[D2.F]0Q&%RO?DC@T <W_PF&M)/X5_T33YH_$*;D4.Z?9SY?F8+8;?\N1G
M"\CT/#==\:ZGH?FW5U;6<,*:BEK'92,3<3P,ZIYZL&P!EL@%>@ZY-9.C66O^
M&HM)N9K'PU=VT(2WA:VO9VE"N0&\E7!0$]<+@''85-?^!/$MUI&M::M]I;K=
MZFM_#<RB0RR 2JXCDP,#:%P",\ # H Z9?$%_!\0?^$?O8[9+2>S:ZLYE5MT
MI5@'0Y.,KD'W![56?Q;=0VNFK(D37.JS2_9&CMY'5;= 2)6126;*[3@8^^.1
M@FIO%?A2?Q+::4RWBVVH65PKFXB!7]VPV3*O4C<A./<"D\6^&;_4QI-_H%W!
M9:KI$I>U\Y"871EVO&X'(4C'(Z8H G\+:YJ>JSZG:ZGITMN]E*JQ77V>2&*Z
M1AD,BR#((P01DXXYYKH9#((F,2JTF#M#-M!/N<''Y5EZ'#K:PR3Z]/:-=R8
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MZ&@#A_!OB'5_#OPX\-W:6EF^DO>FUF#.WG8DN77>N/E&"1P<Y]JZ[5O%U_\
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MG#4Y'N 76"$[0OR@@LQ9L=1T)]CG)X4UD67C. FPW:^TC0D3/B+=$(_F^3G
M&>/I[U#'X.U[3;_0-9TN;3SJ-CIBZ5>6\\CB&XA7!!5PI*L&&?NGKCMR 9&C
M:KJ&A^'?B+J;VEG<75KJL\DD3,RQ.%ACR1P3R.<'UQGO6QJVKZY+XM\%06EQ
M:PVU_!/.\31,076$'G##*X<X'J,G/&&#P7K[:!XPL9;C33+K\TDD>TN%BWHJ
M')P<X"],<^HK0O?#&L2WGA/4+6:Q2[T:.6&9)2[(RR1JA92 "2-H.#C.<9%
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M/4]:N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ*A2$/YL4C0^8&R3@J<'Y<<>IH [ZBN(\%7>LWGB/Q7]OOH)XK;4O(5%MRI
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MUM=QJVUF@E5PI]#@\'VJY7G.G:9K4/CWQ-XNMM(EAMI=.$-O92.J/?3I@AR
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M4 0W5I;7T!@N[>&XA/6.5 ZG\#2V]M!:0+!;0QPPH,+'&H55^@%2T4 %%%%
M$-O9VUH)!;6T,(D<N_E(%W,>I..I]ZFHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBF2F01,8E5I,?*'. 3[G!H ?17-^!M>O?$GAI=0U".".Y^TSPLD&=@"2,@
MQGGHM;]R9Q;2&V6-I\?()6*KGW(!- $M%<KX5\5OJ?PZM_%&K+%!FWEN)Q"#
MM149LXR2>BU0B\7ZE:Z5H.NZE';+IVL311&"-"'M1,,Q,7+8;^$-P/O9'3D
M[FBBB@ HHKGKKQ1%:^,XO#\B2+)+9FYAQ"S>>1NW*&'RKM"CKUWCIW .AHKS
M;4_B'?/X#M/$6C-:&22]CM)HKJTE C9F"E1\RD[<XST.#TZ#77Q1JFE>/-.\
M,ZREG<+JD$DEI=VD;18:,$LKHS-V'!#?A0!V5%58]3T^:\>SBOK9[I,[H%E4
MNN.N5SD4V75=.@<I-?VL;!_+*O,H(;&=O)ZXYQ0!<HKG+?Q+:>(_#=]=Z#JM
MI"Z>;''<RD.D95BH=AD?*2I(SU%;#7L%EIT=Q?WMNB!%WSLP2-B1U!)P ?K0
M!;HK*U2YEFTR"?3=5LK8/-&1<3 21NA894<@98< YJY<ZC8V8<W5Y;P"-0[^
M;*J[5)P"<G@9XS0!9HJ![ZTBLQ>274"6I 83-( F#T.[I3%U*Q>Q-\E[;M:
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M8@L)HW#(0.IR.* )Z*Y"T\3S7OQ*71[6^LKK26TI[I3;@,RRB5$P7#$'@GC
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M[02_:;ZVA\D*9?,E5=@;[N[)XS@XSUQ0!:HI$=9$5T8,K#(8'((I: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ***;)&DL;1R(KHPPRL,@CW% '%_"L@^"B01_P A"\_]*'KK;+4+
M/4[);RPNH;JV?.V:%PZ-@X."..H(I++3;#349+&RMK5'.66")4!/O@40Z986
M]A]@@L;:*SY'V=(E$?)R?E QR3F@#SGPKITVL_L\+I]K\T]SIMS'$!_$Q:3
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MFFN4*0V&!;W<D)/[HYSL89[=>GXU7\?VNF6WPKUC2H9OM;:=-$QEE;>T;R7
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M0O964@RBLI+I)EO3)'?W]Z[AO#^BN;@MI%@QN7#SDVR'S6!R"W'S$'G)I_\
M8NE>?-/_ &99^=.,2R>0NZ0>C''/XT <Y\*I&E^%WAYF8L1:A<DYX#$ ?D,5
MV-06=C::? (+*U@MH0<^7#&$7/K@<5/0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4-S=VUG&)+JX
MB@1F"!I7"@L> .>YJ:N"^+<5LWA*UEN5CVQZG:9=N-BF5=QSVXH ZZ#6])N?
MM/V?4[*7[*<7'ESJWDG_ &\'Y?QIQUC3!#;S'4;3RKEML#^>NV4YQA3GYCGT
MKBY]%M++XO:++HEK#;C^S+@:BEN@13%E1#N XR6SCV7VKB[;4["+X->$[5[N
M!;B#5K?S8BXW1;;H[BP_A ]3ZCUH ]FN-;TFSD>.YU.RA>,JKK).JE2V=H()
MX)P<>N*<=8TP7OV,ZC:"ZSM\CSUWYQG&W.<XKAM,TO1]1^+/BI;BRLKE#964
M@62-74D[R6P>">%.?I5.TFOM#U333'+:ZWX:OM8=;=B-MU87$CONY'#J&+Y[
M@$]J /1/[:THVCW?]IV?V:-_+>;SUV*W]TMG /M3KS5]-T^*.6]U"TMHY!E&
MFF5 PZY!)YKR:ZOK.U\%_%&RGN(8[I]1O62!F =@T2%2%ZD'!.?8^E;$>LZ3
M)KVGPQ7%I;W9\.H7OKB7<CP,V/+C3(4MN4DMSC &#V /1'U&QB6W:2\MT%S@
M0%I5'FY&1MYYX]*IR^)M#BTBZU;^UK-["USYT\4RNJ$?PY!//MUYKR'1QI^H
M>"OA@LGV>X9=2$$@;#$#9+\C>WW>#ZBM^XAAAUGXJVUM&B*=*@?RHP -QMY<
MG []* /0]#UJS\0:/;:E92QO'-&KE4<,8V*AMK8Z,,C(JH?%NCCQ3_PCOVV#
M[<L/FNAD VDL J>[')..N![BHO UW;7?@C1#;3Q2B.PMT<QL&VL(ER#CO[5A
MRW,-K\:KD231123>'X4A$C ;W^T28 ]3DCI0!V#ZQID=^MB^HVBWC':MN9E$
MA.,XVYSTJ[7C=J\6H? '4(+S/]LP-,LZ'_7+?^<2OOO+%<=^17K6FBY72K-;
MT@W8@03D=WVC=^N: ,#Q]XHN?"OAUKVQM?M=YNW)#_TS3YY6/L$5N?4BN@L[
M^VO]-@U"WE5K6>)9DD)P"A&0?RKF$BO/$>OZAJ%E=V'V*U5M,C6XMFG#G@S$
M;9%QEMJ$'/\ J_>L?X;2KI]OK7@/4Y8IY]$F*QAAQ+:R#>AP2>F<$9..!0!U
M>H^,O#NF6$UY<:S8^7%"9]J7",S(#C*@')YXX[\4Q]8CU6PTB\T[7+*TCFN8
MC(&*2^>I'S0*<C#DD<C)&.E><Z)I>G_\,YS7\5E;F].C72FX$8,F,MD;NN/E
M''L/2M?Q%/87>C?#ZYMY;>8IK5C&)4(./W;$KD?AQ0!Z'>ZOINFLBW^H6EJS
M_<$\RH6[<9/-8.JZQJ5I\0_#NEQ3Q?V=J$%T\D?E?-NC52/FST^;L!T[USEG
MJVB)XD\<:+XMN;>W>ZE4J+N41B:S,0550DC(!W].06/>K=X+:'X@_#Z&UC>&
M!;"]6&*4G>J"*/:#GG.!WYH [676-,M[^.QFU&TCO)" EN\ZB1B>@"DY-7"<
M G!./2O'-.GT/6_#6IZ%XGUVYM=2BU&9KFQ5HDF>7SB\;193>Q(V 8)]!Q7L
M2_+&,D\#DMU_&@#@-:USQGX=-GK5[_9DVES744$^G11,)K=9&"J1)NP[ D9X
M ]/6O0:X*\\7^%-9U**2[\0Z6FGZ;/YJ1-=)ON)UR VW.=JGH,99L$< %NR3
M5+&34SIJW47VX0BX-MN_>",G&XKUQGB@"W7'+XU/_"RQX;>#;8RP.MO<G_EI
M<QX>1![!'7\0170:[JT6AZ+=:A+@F)?W:%L>9(>$0'U+$#\:\[\7^&->TWP1
M!J*7]A->Z#-_:JLEHZ/)("7ERYD(PV7)&WG@<4 >G7%Y:VC1+<W,,+3.$C$C
MA2['L,]3[5'8ZGI^J)(^GWUM=I&Y1VMY5D"MZ'!X/M7G_C&\TOQ+I_@+5(EA
MFM[W6[8J6 )*-')E#^. 1ZBM'P[%!:_%CQ;!;I'$C6=BYCC  W8D&<#OC'Z4
M =-X@DFBT>5K?5K;2I=R;;NX161?F&1AB <C(Z]ZL7.JZ=92/'=7]K \<1F=
M99E4K&" 6()X7) STY%<E\7DA;X;W\DJH6CFMBC,!E3]HCZ'MQFH;NRL9_CC
M:^=;02,= D<AD!RPG4 ^YQF@#MXM0LI[ 7\5W!)9E-XN$D!C*^N[.,>]<K8^
M*);_ .)DNE6VI6=UI(TDW0%OM8I+YH7YG!.>/IUZ5P$=XNF^%+/>0FAP>,YD
MO0/]7'")F*AAT"!]I/;I771W6EW'QP/E7%I+]H\.[&VNK>8?/!P?4[>WI[4
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M5B:EXGFA\;>'H+;4K-]$O[>[DE==I&8E!SYF2,9)Z8QBF?%O_DE^LGL!"3[
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MWTRVM(/@WX)O4AA2X&LVK><% ;/V@@_-UZ<?2@#W"66."%YII%CB12SNYP%
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M32?V;9[YW$DK>0N9&!R&8XY(/<T^[TS3]0>)KVQMKEH3NC,T2N4/J,CBK5%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !39"XC8QJK/CY0S8!/N<''Y4ZB@#FO ^A:AX=T%]/U VK/\
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MU6]6/5?$?AJYO/+*16>CW?F;^A9SN.2<#@ < G)/;K9_LMM \T_E1Q(-S.^
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MCM:;8\;XV(4'#D9("XX Z5WEOK.FW6JW.EV]Y%+?6R!YH4.3&"<#/ITZ5>H
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M*** "BBB@ HHHH **** "L#Q?XB'AC2H+U]L<,EU'!+<21LZ6ZMG]XX4@D<
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MV37'-X5U==4\,ZE;W5E'/IEF]E<*ZLZLK!!N3IS\G0^O6NQ<L$8H SX.T,<
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ME>&M!MO#/ARQT:U9GBM(]F]NKG.68_4DG\:U: "BBB@ HHHH **** "BBB@
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MRONPN.."&]<]JZ33=<UJ+QY+X=U8V,L<NG_;X)+6-T,8$@0HVYCNZ@[N._%
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M&U""UEU>VUK^Q81"&2*>9BH1L$DJ,/DC)^Z: .P?7--37(]%:Z7^T9(FF6
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M#+G&"2V?3'7(Y^\^(.KQ>#]1OH[.S75=*U1=.O(GW&-B9$0/'SD AP1D\>]
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MEQ.OF[(XRFQ6Y4$%B=V,9YZYK3H **** "BBB@ HHHH **** "BBB@ HHHH
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MI4MC82QX^;ODG':J(\":N/ NF:(VJ6;7ND7%O/8RBW81GR6RHD&XDY'7&/\
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MY^T%6Q($E\P#;VR3CKV]^/0J* .:MO#M_:>.+[78;RW%KJ%O!'<P-$6<-%N
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
G **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>sangamoexecutiveseveranc004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<</(!M7J,Y/&><5AZJ[V/Q=TJ]EM[EK>;2)K5)(H6<>:948*2 0O )R<#WK
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M,<]Q7,7&H2ZAI6@W,NG7]K<V?B2*6ZTZWL)$ALD$KYX5?G8Y#$_,26. ,XH
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M5PTA.W8<*2K9!&&QR#65XFU(VOC72+:>UGAM);67_B86UHTLQ?<O[A6524#
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MQ55) Z]0,X..E>437NB)INN>%M1O[NRTN?6)9F\S39WD51,'90ZJ4P74X;J
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MO'//0<].:UHY$EC62-@R,,@CN*\]\/W0\.:CXNTS7HI<W>HS7ULWE,XNX9%
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MF\L4DCS*(]V2P'+D <?>)(XYJUIWB[1]2TZ_ODG>WBTYF2\6ZB:%X"HW'<K
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M[FO0Z* .9L]3TI-;QIFF7*27$6;J?[#+"B1QABN2R ,V7P .<$^E>>^1=?\
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M=2>&?'VHVUC=M'K5Y;?8[:.W=I)!'Y8>38!D!B'/(Y SW%>C7?AV6Z\8V/B
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M0+%(HR=Y(^4=1SZ'MS63JGF>,K_PI+:V5[:M87RW]VUS;/$8%5&!CRP&YBQ
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MBV)TB6!IY[*2((YE1L'> 1PI_IF@#N-1U"VTJPFO;N3RX(AEFQD]<  =R20
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MX]#V]:NU';V\5I;16T"".&)!'&B]%4#  _"I* "BBB@ HHHH **** "BBB@
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M19,?)  )=LXPN#U/)P< @&M1O%VFR-I\=@)M1FU"V:[MX[8+EH1C+DN5 'S
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M$$<@@D&M9U#HR'.&&#@D'\QTH 6BO+/!OB^T\/>&I_[1749H%UBY@DO-C2I
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M'4[Z..*RD6" -.R+Y;ER-QPH[XR/84 >DT5@GQ?IDEOH\EH)KR36(S+90PJ
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MI5DSPI!!SG&?QJSJ5A=66L>"=2M?#LD%I9S7?FV=A"I-N)8R$RJG:#DC<0<
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MN?UB>[T7QR;JPTG49)1I,5O<R:5;I.A.YMH,;.I0K@[3SD-R..:]Q9PR>!M
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MFV&JRWE]-:3:=<6KQQ)*'=D9)%8L!M*D\C;SG'4=:T'=8T9W8*BC+,3@ >M
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M C1EM5DN9M9C,UG&N%W1A Y=B>@ (]\D<4>'O%$'B*6^BALKRW>QG:VN//5
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MI_>OC<PPHQG XZ4 <?I7AG4?!7B32;V.";4=/&BQ:7=& ;GBDC.1(%ZE#DC
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MFJ^><H@PO7)Y '-;T]K?#XLVNI+I]RVGQZ2]FUR -HD:56 QG.,+UQBNRHH
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MY0SSS\WIGCFF1Z;J@M_B&ITNZ#:HSFR&%_?9@$8QSQ\P[XXKT>D9E4 LP )
MY/>@#S@:9JH3X<C^R[K.E*!?<+^Y_P!',?///S>F>*EAT[4UN/B"[:7= :F
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M(S&\>>5SAC@].*]"HH \UUK1]2\8^"=6MK#PVN@S21(88[E8UDFD219,'82
MGR8Y/).< #F6ZN-;U[Q-X.U,^&-1MA833M>+*T0$9>$I\IW_ # $]>,CID\5
MZ+10 5Y5XNTWQ)KEGXNTZYT6ZO7D7&DR+*@MUBVCHI;/FYW<D$\@ @5ZK10!
M4TQY9-+MFGMWMY3&NZ%R"R<=#@D9^A-4-7O]3L=7L#;Z;/>Z<\4PNS 4W1-F
M/8V&(+#[XP.?;BMAY8X]OF.J;C@;CC)]*=0!YE;>"1>^(O$MWI=C)HVEZKI#
MV+QNGEB:X<G]Z(Q]T*IQR!DD\=2;7A :L([#3-0\%16-]9!$N-2*Q&%PG\<9
M!W%FQTQQG)/&#Z'2,"RD!BI(QN'4?G0!Y/H#W5]X,\8Z-:Z=//<WFJ:C;PMM
M'E'>[+N9NBA<Y.>>. :U9=*UFQU"RT*33KG4M#M]'BMK8Q2(L7GJ-K-."P)&
M N.&'H":ZSP_X=MO#D%U#:W-S*ES</<OY[*?WCG+$84=3V_*MB@#R72=(UVW
MT+X?6\^AWB2:1<EKL90[$\MTW<-ZMT'.!TKI]=769O&,=O+I=S?Z"]EB)(9$
M6,7.XY,P+ E=N,=1UX)Z=G10!Y)IFAZ_9^"? Z2:'=&YT740US;*\9D*;9%W
MK\V,98=2#713Z5?W_P 2;FZEL;B&QN?#_P!@:Y!4A)3(S$#G/ ;KC&:[A65U
M#*P93R"#D&EH \MCT/6[OX6_\()=:9+'?HJV7VK -N8@X(F#9_NC[OWL\8[U
MNZ?8WEC\2=4OC877]GMI<%M%/@$.\;.2,9ST8<XYKM:* .2^&EA?:3X$L=/U
M&SEM;N!YM\<F#]Z5V'()!X85=\<6US>^!]:L;*VDN;JZLY8(HH\9+,I Y)
MYKH** //=5LM3N+7P-Y6E7;-IMW%+>+A<Q*L+(>_/+=L]*O7UAJ&D?$H>(XK
M2:\TV]T\65PL W26[HY96V]2I!(XR0:[2B@#RG7/"NK3>%/%,UOITSWVN:I!
M<Q6BE=T<4<D9RQS@,0C-C/<#K727EM>S?$_1]433[DV,.G3023;0 CNR,H(S
MGHISQ794C,J*69@JCJ2<4 <CX#LKZQ?Q)]MLIK;[7K4]W 9,?/$X7:>"<?=/
M!YK?UR2_AT2\ETJ'SK](R8(B0-[]AD\#/K6A10!YOXOT4^,&TQ[70+RQUZWN
MH9!?RHJ?945@7S(I(<8R JD\D=.:2YL=2T#QKK$[^%#K^FZM(EQ!-"(C)!*$
M5&1]Y&%.T$'.![]O2:* .%NM/U(>.O"EY_99%O9VMS'<O; >5"TH3:HY!(&T
MC('OQ5GQKH>J75_HVLZ 574[28V[L>GV>8;7)]=AVN!_LFNQHH XKQOH]P_A
MS1M.TBPFN%M-0M)-D>/DBB<$DDD=A]351O[=\,>.]8U"WT*[U;2];6"13:L@
MDMYD0(5<.P^4@ YSQ7H%(752H9@"QPH)ZGVH \Z\06&MV7BG3_$LGA^/6X);
M#['?64&QGMR'+JR;\!L;BIZ9QGBMB36[S0-)L[IO##Q0W=V%DM[8QAK2-L /
M)CAFSV7U R<<]=4,T-O/+$)E5WC/F(K'H1_%CV]>U $U<;>6>I6OQ5@U>+39
MKFQGTC[$TT3+B)Q,7)8$@XVGL#D\5V5% 'DMSH6MS_#+QAI2Z1="^U'4KF:V
MA.W+I)*&4YW8' .<FM/6+/4M,\9?V^GAE];TW4;**">!5C,]K+&6VD*YP00Y
M!P>OX9]'HH S]%29-,C,]C#8NY+_ &6+&(@3P"1P6QUQQG.,]:T*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *XKXLQHWPRUN4J/-A@#QO_ !(VX<@]J[6N5^(^G:AK'@/5=+TR
MRDN[N[B$<:(Z* =P.268#% '&NUO;^*_!B>#I]UQ(0-6ALY"\/V?:-S2@$J&
MZX)Y)KL)_'4%N5G?3KD:<=3&EFY) (EW;-VP\[-W&>OMBM_2/-&CV:SV\EO*
MD**\4A4E2  >5)'ZUYAJNB^*M4TV07V@37>K6VLQW*W1N8MCVZS!E6 %OE^0
M#((7IDDGB@#K[OQP\6O:CHUIX>U.\N[ 0O((C& R2$C>"6Z#'0\^V 2*>B>*
MK[5K;Q4^IZ-*UK87DUOY,4D;'8D:93DC).6;TYQFK&BV6J1?$?7=2NM+EAL[
MVTMHXYO-C9=\8?<,!MV/FX..W:J>CZ;K.F?\)E:2:3+)'?7MQ>6LZ31[91)&
MJJH!;(;(.=V![F@#1T;Q#I=OX7\.KI5@\:ZE"HT^P4C*H$W'))P HZGGMU)
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M /0D#(':LO7O"NK:CIGCC4;?3I3>Z]##;6MF9(PX2--NYR6VC)).,D@ =\@
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MY''-7*H:--<SZ3;O=V4EE-L ,$CJS+@8Y*DC\B?Z"_0 4444 %%%% !1110
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MVDDBY6X5MI7?G;CON] 30!UE%<SH/C&VUG7K[1'CCCOK2-9\P3B>*6-N-RN
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M4F4!3@$GCAARV/;)IFH>/XK*UNI!91F>PA66]MIKR..2-B@<QH.=[A2,]!R
M"3P #LJ*IZ3J=MK6D6FIV;%K:ZB6:,L,'!&>1V-8=UXNN$\3WGA^ST.YN;R"
MT6Z4F6-$D5F*CDG@9!Z\^W>@#J**X-?B6K>';;7_ .P;Q=,,P@O)7D0&V?S/
M+.%SEP&ZD8Z_4#7UKQA!IEW=V=NEO<7-G"LT\<UVL'!!(5<YW.0,XX'(R1F@
M#I:*XN#XC6E\_AX:?I=Y=)KD,LMLX*+@QKED.6X(/!S@>A-1K\0+Q[#5Y$\,
MW37FCR,M];_:(PJ*JA]RO_'E3D #MSCC(!VS2QHZ(SJKOG:I."V.3CUIU>9Z
M]J4%QXY\!Z]INGR7<E[97DD21A5DE5HHR@9B0 !N/4\<UMV'Q"LY;#5GU2QG
MTR_TF6.&ZLI75FW2$"+:P.TAB0 <@>O'- '8T5QT/C^W.L76DRV:O>1V9O81
M9W23I,@.&4,=H5QZ'MT)JO:?$8SZ)#K<^A7-KI4\$3PW<TT81I))%C"'G*C+
M EB,8!/ID [FLA_#MJ_B>/Q 9KD7L<!MEPXV>42&*[<=R <]?>I].O[NZGN8
M+NQ%LT.PJZ2^8DH8$Y4X'3&.0/\ %NMZU;Z'9Q33J\DD\Z6UO"F-TLKG"J,\
M>I)/0 F@#2J)[JWCG2!YXEFDY2-G 9OH.IK#M_$[_P#"02:!?6/V;4FMC=6P
M6;?%<(#@A7P"&!QD$=\\BN7\(62^*9=>?7=+BF\C7YGCG:;+Q/"RB-5(P<*!
MUS@\\<F@#M==T"S\16<5K?/<K'%,LRFWN'A;<,CJI!QR>*N01VMA!;V4 CAC
M1!'#$"!\JCH!["N>^(FNZAX<\$ZAJ6FQ(]Q&JJ'=L>7N8+N QR02.*P?$4DL
M'Q*\&WQTO-_);WZ-#"REGPB;07.!@9)YZ9- 'H]%<G9>.[270]0O[^TDL9["
M]^P3VK2*Q\XE0H5L@$'>O)P!SG &:DT?QI;:EXFG\/S10QWJ6PNHVM[D3Q2Q
M[MIPP PP/52/?F@#J**R/%4$-QX3U=)HDD3[',<.H(R$.#7G/A6'PE<?#?0K
M;4-#$MS>P06KS_V6X)>0A-WG%,9&[.[=VXH ]=HKF;WQ7+:>*AX<M]'NKJ[-
MB;N.3S$5) '"8R3QR>2<=. <UD-\2W7PY<:U_P ([>_9["=X-2!FC!MF1]KA
M>?WF.O&!COG(H [VFR2QPQM)*ZI&HRS,< #W-<OJ/C.2U\2_V#9:'>7UV]@;
MV$I)&B2+O"XR3\HY.2V.F #D5R7C3Q%9^,/@]K]RUB]M=V,RP7%K< %[:99$
MR,_0\$=C0!ZO16->:Z8M931;"W6ZU$VYNG1Y?+2./.T%FP3DG(  /0]*P[GX
MBP0>&;S64TNX<Z==&TU&V+J)+5P0"3U#+R#D=CGUP =K165<:U]GU2SL_)1U
MGMY+B682_+"B;<D\<@EACUY]*Y[_ (63IXNM(+Q1_8=6F6"VFCN5>17?[GF1
M=4#>N3C(R!0!VU%<CI?C6ZUC5+BTM/#E]Y=IJ+6%U,\L8$.%#;R-W(YZ#../
M7%:_BK6O^$<\*ZIK'EB1K.W>54/1F ^4'VSB@#5:1$(#.JD\#)QFG9KB_!^@
M65QX3LM6UJWBU/4]0MENKJYN(A*S%UW;%!!PH!P%7CCIS5&'Q1H/A7PIKNJ:
M,MSJ5E:7;-+#&I3[.Q"*8\R8X![#)4$#&!0!Z%17,'Q=/#*L%WHES;7%U="W
MT^*25,W64+E^"=BJ 2V>1CN>*;_PF7E7.KZ?=:>8=4TVU^V&W\[*3P<_/&^!
MGD$<@<_G0!U-%<L?&D7V#PQ??89/L^OO%'$=XW0M(A<;AW& >AJA<_$&Z#ZT
MEAX6U&[?2)O+NE$L:X7:&W#D[C@\*,GCG'&0#N**H:)K%IK^BV>K6+%K6[B$
MD988(![$>H/!^E7R<#- !7,Q>!=)MKF22TN-4M()9&D>UMM0ECA+,<L0H;Y<
MGTQ3M'\4RZY;V-Y9:>LFGWZN8+A;@'9A20)%"_(3C'!.._/!H/\ $&)?!,GB
M?^S9?(AN3;30^:-ZD3>5D=C\WTXH ZV!;:V5+. 1QB-!LA7 VJ.!@>E/EEC@
M3?+(D:9 W.P R3@#\Z\XN;B?2?B_J\NE:*]_=3:+ YAA=(MQ\V3+,S$#H .Y
M/'OBUJ/C71M8\#+JMYH4]U;K?):W-E.$#6TXE5</D]F*] >HZ4 >@45SFL^+
M8--OKBQMDMY[NVA6>6.:[6 8;.U5)SECM/'3IDC(J#3/'-EKUEI4FC0/<W&I
MP/<1PRMY?E(C;7,AP<88A> <GIQD@ ZJBO/];\;ZJNC:9<66CS6L\^MQ:;<1
MW3;"A\T [#CYE8 @-TP<]:[V%I'A1I8Q'(5!9 V[:?3/>@!]%<=IWB74[CQ]
MX@TRYM8HM.TZ"W82></E#"1C(>.^ ,=MM.F\>16VDV6NW&GR1Z!=R(B7GF#=
M&KG"2/'CA"2.<DC(R!0!U]!.!D]**\^BUG4?$$OC73=2TZ#[#9 P*ID#A1Y.
M\9&.22<^W YQF@#OXY$EC62-U=&&593D$>QIU>:>"_%4FE>%/!=C=:3<)8W\
M$-G%?&1<><8R0-F=VT[2,^W3&#6SK?Q#LM(BU"XCABN;;3I?*NL72)+D8W>7
M&?O[<\Y*\@XSB@#LJ*BM;F&]M(;JW??#/&LD;?WE(R#^1KG]0\6/ NJR:;I<
MNHQZ2=MWY;X8OM#%(UP=[!2"1P.0,DY  .EIKJ61E#%"1@,N,CW&>*PF\2_:
M+^/3],LVN+TVBWDD<[^2(8VX4.<$AR0<+CL<XXSDS_$BSB\.KJR:;>.R7XTZ
MZM_E#VLV\*5;GGDC&W.<CI0!T&@>'[3PY926EE).T,DKS%9G#8=B2Q!QGDG-
M:M<Q9^++FYUV^T2;19;74(;07MM'+.A6>,L5Y9<A3N&".?QKG])^(=]!\.;+
MQ-JVE2S"YF"YMY%./,E*C@\@#(  !)H ]'H) &2< 5S">*[D3P65UHD]IJ=W
M<R16EK+.A\V-%#&4LI(50#@]3G P:JWFNVVO:/XGT2^LO(O["U?[1:RD2(RL
MA*2(V/F4X] 01R!0!U\<B2QK)&ZNC#*LIR"/4&G5S?P^_P"2<^&_^P;;_P#H
ML5TE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %<G\1-,U'6/# LM+LGNK@W=O+M$B( L<JN<EB.RF
MNLHH XOQ;IVNC6=%\3:%8)>W%E'+!<Z=+*L;2Q2;2=K$[0RE >N#53Q/8^)/
M$/A$1_V((;J2]MY5LDN(R8HXY%<EW) +'!X&0./>N_HH Y"6PU-_B?:ZT-,F
M^P)I+VC2>9%D2-(KXQOSC"D9]?;FN<AT7Q;9Z%?QVNF3*T_B22^GMENHT>XL
MY'+%%</A6^[D$CC(SS7I\LT<$32S2)'&@RSNP 4>I)IRLKH'1@RL,@@Y!% '
MG.G:#K5EJ/C.1- BM[75;6+[)'!<1\,(2FS' !R<D].N":9'H&NQZ)\/[8Z1
M*9=%EB:] FB^4+"T9Q\_/)SQVKTJJQU"R6W>X:\MQ C;'E,J[5;.,$YP#GC%
M '%?V7K,/B7QC?#0A=6VI1VB0132Q;;A8U*R*PW<9#'&1]?2I_!WAF?P_K]^
M]A;W>GZ!- A33KF99!'<;B6:,!FVKC'&>2?0"NWHH PO&=E=ZEX+UG3[&W:X
MNKNSE@B0,J_,RE026(&.:Y]](UA]<\"W7]E3"+2K>9+PF6+,;/"(QCY_FY&>
M.WY5WM% ')>$]-U*Q\0^*+F]L)+>"_O5N+=VDC;<HC5.0K$@Y7/TJ7X@Z1?Z
MUX3DMM,A$]W'<07"0EPGF>7*KD G@' /6ND6X@:X>W6:,SHH=HPPW*IZ$CJ
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M6J3WD%N)DS&DCHP#L3MR IS@GM7J]5O[0LOMWV'[7;_:]N[R/,'F8]=N<XH
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M@C Q[UECPWKVI?#>'P-J&G&)XQ%:2:@LL9A:"-U(=1NW[BJ@8*CGOCFO3**
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MS,TD?$GF[_NALXQQG'7\ZY5/#7B9/A-:>&6T0F]L[F'!2ZBQ(J3^86&6& 5
MQGG/4#J?6:* ..\2:1J<GB;P]XHTVU:XDT\2PW-B717>*50"5).W<I .,X/K
M4#Z#?W.I>)=?:QD2XOM.6PM+,R)YA #99CNV@EFX^;@+ZG [BD9E12S$*H&2
M2< "@##\%V5WIG@O1]/O[=K>ZM+2."5"RM\RJ 2"I(QQ6[3(9HKB%)H9$DB<
M!D=&!5AZ@CK3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *S-;U632;6!X;&:\FN+B.VCCC!PK.<;
MG8 [4'4G!K3KF?&UGK5[IMDNC1B<1WL<EY:^=Y1N+<9W(&/3)VY'&0".^" 4
MY/'A@T[Q--+I9>Z\/G-Q#!<!T=3'O#*Y"]LY&,@CO4EGXUN)M;T6RO-%DM+?
M686>TN#<*Y+*F\JR ?*-N<'/;D"N=E\+>(/*\=0Q:-:PPZY:1QVB07*X1A!Y
M6TC   /)/Y9K5GT;5Y-3\#7"Z<^S2%<7F98\J6@,7R_-SSS]/?B@#/\ 'NMM
MKWPZ\32V6EQ76FVZ30?:))@&+I\K21IM((5L\[@?E..V>^T?_D"6'_7M'_Z"
M*\V'AGQ3IO@CQ!X-M]+CO+:<7'V"^%TB I*2VUU/S!@6/L?4=:])TB*X@T:R
MANXTCN(X421$?> 0,<' S^5 %"]UQI-:DT/3[.*\NX[<3W(FF\N.-&)"@D*Q
M+-AN,= 2>V?.M!U.TT?X2ZC=7^@)>V:ZQ.LEBY39'FYPH.<CY6*] >E=5<:5
MKFB?$.\U[3+!=2L-5MHH;J(3K')!)'D*PW8!4@G('/\ 7!E\)^)9/AIK&AOI
ML(OKO5'N8E2Z4KL-P)<DG&.!@=3SR!0!U.L>,+VP\3MH%AX?FO[MK!KV$BX2
M-9-KJNW)^[U/)[X&.<BKJGQ"BT^VOYH[6VD?3@/M=O)?I'-OVAG2-<'S"H..
MH!((&:L/IVIR?$ZTUP:>XL%TI[-W:5-RNTBOG ;D#;@^_K6?#9>+?#'B75UT
MK2K75=)U6Y-XCR7@@:UE8 .&R"67(!^49H V8_%@U.18=!M%O9OL4=\XFE,*
MHD@)C4G:QWM@\8XQR1QG%O?&&M7.I^#5LM*-I%JTDQFM[YVAE#)$Y\MAM.!D
M!L]\#@4MUI?BG0/&,FNZ59P:S%J-G#!?PF=;=EECR%D4G(VD$\=:LZWI'B"X
MU'PKJZ6]O=W>G7,TES LWEJJRQL@"L1R%R!G&3C..U %JVUS3T\:ZW;SZ5'9
MW-E813W&H,5)EBRV!P,[1ACR?PJ*;QT;32].UR\TPPZ'?O&J7/G9DB63_5O)
M'MPJG(Z,2,CCTK3>&K_4O%_B*2\MFBTW5=(33Q.DBD@@.&.W.<?/Q].U4?\
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M-R5!SC+#\ >E;'AN\\97306^OZ3:6(MQB>ZBNA+]J(&!L0#Y 3R23GC&.<@
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MN/)..!@=>PU(O&$W_"2Z7IEUI$EO:ZM'(UC=&=69RB[R'0#Y,KR.3[XKG_\
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M%,4B]DSEN.I/<G@ ]25E<95@PR1D'/(X-+7':?JV@^%_!^G'2;BVGL+RZ=+
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MVTBY+1R;>CQL0-R,#D'%6/$.O1Z#:VK&+SKF\NH[.UAW;0\KGC)P<  $DX/
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M@OG_ +S>)&DSC;C'..M<\?!7B _"&X\*>59?VA).SA_M!\O:;CSNNW.<<=*
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M+:OI*V+B.<LRN)#)D J,KSCL>,X'2@"KX;UKQ%?^+/%%M=06;1V,L,4<2W#
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MQGDDC@8YYV7P7XAE^&FK^'/)LA>WE\]Q&_V@^6%:<2\G9G( QTH ].KF=?\
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M->M_#6@W.J7"-(L6U4B4X,CLP55'IEB!GM0!JUG:EKVDZ.RKJ.HVUJ6Q_KI
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M:*X(BG3:K!U.#SAONY[=:T8?%&KQ^*-*TO4-.M(8-7MI9;1XIF=T>-58B08
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MX6W*'&,C/3C(J[0!B^$=+N]$\):5I5]Y)N+.V2!FA<LK;0!D$@'G'I6U110
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MT!#F-F8,0<A<XP.O!.*AN/&'B63_ (2H6>G:6IT%\DRS.PE01"3 P!\Q!Z\
M<=>U.U\"^*(M)T"SDO=(,FD:F+PS;92UT,."[_[?S\CG)_B%:T7A;64_X3(D
MV!.NY\G$S_NSY0B^;Y/09X^GO0!3O_$&L:EXD\"OITT%O9:M;37?DRHS'<(
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ME#I[VT]O)9FZED*L.#@1X.3@.=V.#PAZU#H/AM=.BU:6]\J:YU>Y>XNU4$H
M5"B,9Z@* ,D#)R<#.!#X+\+R^%-$>RDNOM<H=EB=S]V!21#'G'0+C\2W6@#)
MT_QU+_PBC:A/I]O'?3:N^EVUK"Y"23&4HN6(Z<%B<= >*K2R7UK\8K&759;5
MHX]"N'$T$;(-HD0L"I9NF.N><]!3/^%>ZK-X1DTY[RTM]2@UAM7L9XRSHLOF
M%PK@J#CYB./K[5HKX;\0ZEXMLM9U?^RHH4TZ6QN+>V>20L'922I*KUQ^'O0!
M%#XVU:X&BZA;:3+=:=J4L:O#%93B6VB<964R$;& XW  8SP3UJKXGUV_\0^
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MA>3S]X<5U5<9JGAC7+CQ5J=_:W=@UGJ&GBT'VH.TEIC=GRP."&SD\CD#KC%
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MDK6L3!D!&047KDG)]361\3]0U+2_ =]=:9<1P2AHXW=E);8\BH=N",'YNO\
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ME\"Z'>^&O!]AHU^]O)-:*4\R!F*N"Q(/(&.OO0!OS&40N851Y0#L5V*J3[D
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M*?.M90048$@]><'&1[$5K4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^#]5U*/_ %T-NPA [RM\J#\6*UN54O\ 2]/U6)8M1L;:[C4[E2XB60 ^N"*
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M-'O8[>XE#[+?R7P?/PS X"$L5W=O?%,U1=0B^*GAE(3:FZ32+D.KE@CC=&"
M>2OKG!Z8]ZLZEX"N[VPO)XM1ACUB[U.'4I7:(M _E8"0LN<E %'N3SQT !'!
MXSU.1?&$,+V=S)HMM'=6MP871)E:-GPR[N>4(# X((--LO%?B%)O!]U?C3FL
M=?1(WAAC<212-#Y@8.6P02#\NWCU/6IW\&:U)?\ B2[DU6R=M<L4MI%%LRB-
MU1T!'S'Y0')QU)[BI6\'ZDUEX1MQ=VF?#[1LS;&_?[(S'Q_=R#GOS0 SP3<:
MO=>(_%GVZ_AN(H-2\D*+<J0!$A4*=Y 4 ],$DY.>:N:S/'X%\+3WEI#E6ND>
MZF6#<(E=@'E,:8R%7L.P&<\FK&B>';W1_$FM7JWT+Z?J5P+KR?)/F+)L5"-V
M<;?ESTS[^NIJ]OJ%Q;Q?V;<Q0SQS*Y\Y2R2(,[D('J#U[=><4 5/#6IR:O:3
MW8U"QU"S:0?9;FS& R;5R&&XX8-N!Z=N!6W7.>&?"\>@W^KWR1P6YU.9)6M;
M4$11%5VY' R6.23@=N.,GHZ .)O^/C-HY_Z@MS_Z-CJFOC37-0TZQUK1[!KR
MUN)QFR%C*'-N6(WB8G;N PV,8YQVR=^Z\/WD_CRR\0)/ +>VLY+0P%3N8.RL
M6ST&-HXQ6/H?@WQ#H#/I-GK\'_"->:SQ1-;G[5"C$DQ))NP!R?F()&>,4 0^
M*O&6L^';?5;YUL8ULKF,06)4RR7%N2BF5F5OW>2S 9&,KSG-;%SKVIV'Q#L-
M&NS:#2M1MI7M9!$PD,Z8)C+;L?=)8''.".V:P]4^'NLWVF^)M,CUJU6SUB[-
MXCR6S-,C94A"V[&P; !QG%=!XG\+2>)M$L[6:]\B_M;F*X2[@3;L93\^T9)
M*E@!D]1G- %2X\57EII]G-)Y+R:I?M;V!CMW;$0#L)&4,2^40L,8SN7IR:M>
M'-6UN[UC4K+4[-C:0A'M+\6SVXF!'S(R.20RGN."/2E\5>%/[=T>SM].NSIM
M[ITZ7%A<(FX1.@( *]U()!%6]!LM<A5Y]?U&VNKHJ$5+.%HH47N<$DECW)],
M #G(!M5S=UKEU=^+W\.:;)##)!9B[N+B6,R8W-M1%4$<\$DD],#'.1TE<SJ'
MANZ7QA#XGTB>%+HVOV.ZM[@'RYX]VY2&'*L#WP<CB@#E]:\1ZEK7PX\9VLWV
M>UU/24N+6\*1LR2IY9(:/Y@5W CJ6QSUKM?#,$R>'].>[>WEF%M&$>*$Q[4*
MK\O+,>W7(SQQ6/=>"YI?"_B#3XKJ'^T->>1[JY9#L3>NW"KG.%4 #)]3WQ72
M:1;3V6DVMI<M&TL$2Q%X\X;: ,X/3..E %VO/O$?C+6= COKR9;&,6U_%%'8
M;3))+;,Z)YK.K?NR2Q(W #C')->@UYSJ'P]UJ[TG7]*CUJT%KJ.H?VA$\ELS
M2AO,1]CMNP5&P 8&<8Z 8H 2X36I/BQKJ:'+8PW)TFU)EO$9U7YY.-JD9SZY
MX]#38?B1<KX=M+O588M.ECU.73-4N5B:6&UDC!^8 '.UCM )X&><UOGP]J]K
MXKEU^SO+*:6ZLH[6XBGB9 "A8AT()X^8_*?;YJ+3PO>:18PP:?<V]P9)Y[C4
M5NT(6\>4Y8\9V\].&P!CGK0!!+XJNK:RTF)I[2ZN]4N94M[FSA:6(PH&<2!%
M8ECM"C ;J<YP*R-6\8^*M(\,^);V2P@W:88WL[R>UDBCNHVP"/++;@RG@\X-
M2M\-)+?1(4TG44T[5+74I=2LY(H]T,!?AH0I_P"6>WCMZX'2KNK^%?$'B#P?
MJ6EZIJ]FU]?HD1>&!E@@13GY4+$LQ[DD=O3D E37]:L/&]CI6JFP>RU&SFN(
MOL\;*]NT6TD,Q8AP0W7"\]J;IVN^)-;TG2M>TNWLI;*]N%+V;@K(EJ21YGF%
ML%P &V[>Y';)MWGAV_O?%FB:S)-:B/3[>:"2$*Q\SS0H8@]L;1Q@UG>'?!VO
M^'D&C0Z[ WAN*4O#&;<_:E0MN\KS-V-O)&<9QTQQ@ CO_%^M75OJESX?M1</
M87;VT=HUC+)]I,;;7_>@A4.=V.N, GK@=Q;2M<6D,SQ/"TB*YC?[R$C.#[CI
M7&1>$?$6D:[J,F@:[;6^DZG<-=3P7-J9)()6^^T1R!R><-D ]C7:PQB&&.)2
MS!%"@LV2<#N>YH 63?Y;>65#X.TL.,]LUYY;>/KY?A]9>(-0C@A:74)+6ZGA
M@=X[6-973S"N<D?(HZ]6S[5Z&^[8VP OCY0QP,^]<=H?A?6] \-VFF6]_9RR
M07LMQ)OC8)/'(9"T9&21RXP>?NCB@#<\.W\VI6$EU)>V5[ TI^S7-G]R2+:N
M"1N;# [@>>W05KUSWA3PQ'X;74VB6&$7]V;HVUN,0P955VI]=N2<#D]!BNAH
M YA-;U#6?$.L:9I$MK;II0CCDEGB,GF3.N[: &&% QD]23VQSQ?@G7;_ $7P
M!X$C@6V:'4;][*=71BRAGF;<K!@!]W'(/6NL'A?5M,\8:AK6AZA:1V^JA#>V
MUW"SA9$&T21E6')'4'\_3*MOA]JMGX,T+2XM5M'U#1;\7MO*]NPC8Y<E'&[)
M&)#R,=!Q0!=NO&USI.J>,$OXX);31+6"Y@\I"COY@<[6))'50,@#KTJ>SUOQ
M"/$NGVLMF;O3;J-Q<3)82V_V.0#*\N?G5N1TR#S[56/@.[O]0\1RZQJ4$UOK
MEG%;31P0%#&45@&0ECC!;H<YQU[5>\-Z+XIL6@AUW7[:^M+08A,%N8Y9^, R
ML6(.!V Y."3QR =77%?$:YU.VA\.KI]ZENEQK=I!*&B+[P7W#)W#Y<J,@=?4
M=^UKG_%WA^X\0V%BEG=16]U8W\-]"TL9=&:,YVL 0<')Z&@"LFM:EJ?B/4-!
ML+BUAFTNVA>[N9+=G#RR@E55-XPH"Y.23\P';-3^#?$DOB32;E[NW2WO[&\E
ML;R.,DH)8S@E2>=I!!'UJJ/#.HV'BJ7Q#IMW;/<7MLD&H03(R1S,GW)%(R5(
M!(P<Y'?/-:GAS08] L)XO-\ZXN[J6\NI@NT22R-EB!DX'0 9/ % &Q7 >+O&
M&M>';;6;W;8Q)8F-K6T=3+)=Q?+O=BK9C&2R@D8!7G.:[^O/-6\ :O?VOBJP
MBUFU6RUR7SPTELS31MM4!-V[&P;1CC(&: -&^UW7W\>KX>T\Z=%!-I37J3SQ
M.[1L)%3D!ANZ],KUZ\8.2WC3Q&?A]/KT4%@UWIE[+;ZB@A=E>.*0H\D8W@@A
M?FP2>AK=M_#FJQ^,K;7Y[RTE,6F&P>-8V3<2X<N.3@9 &.>.]5M*M['P/HMY
M;>)-6TY+?4+Z>96E;RU;S26:/#'G'/UH V8M5N+WQ!;6UC-;2Z>+(75Q)Y9+
M'><1;&W8 8!SR#]T>M;=<I\/- 70/"T<8:=C<.94\_[Z1=(D.>FV,(,=CFNK
MH Y?QEKVJ:%+H0TZ.TD6_P!3BLI1.&R X8Y!!X^[Z'K6;:ZQXLG\3ZOX;-QI
M N+>"*ZAO?LLFT(^X;3%YG)RO7<..QZ5L>*M O->DT9K:X@A&G:C%?MYJD^8
M4##9QTSN///TIEOH&H6_C;4?$ FMFCNK..V6## KL+$,6[Y+'C% &+I?CZYU
M'PSX<G>!(M2U>2:)O+A>9(_)+B1@B_,<E!@9XW9)XY&\::SI=CJ0U33=TRWD
M%II=P8'MTO&F.%RK$E=ISN]0.*@A^'.I6WA32+*UUB*WUC1KJ6YLKU(24/F,
MS.CH3]TAR#SV'TK1U3P=JWB/PW-;:WK$0U4RQ3VT]G"5BMI(SE"J,Q+<DY)/
M.>V!0!1NHM3B^+_AT7US;7 .FW9C:*$QX;,>X$%FXZ8_'ZU+9^.K]-!U:YO8
M+5[V#76T>U2(,D;MO5$+9).,L6/L*MQ>&_$5SXIT?7=3U'3/,L+>:"2*WMGQ
M('VY();@_+^'H:J'X>3W?AS7=*O-01)=0U1]4MKFW0AK:4L&7@GG!7KQD$]*
M -HW'BNSO=01[2SU&U2Q,UI+%^X9[@9_<D,S<'@AN,=\UEZ/XLU"7Q=IVC7<
MUE=)>6$D[O:Q,HAF0J&0/N97'S8X.01SUJ=O#?B35_#^H6.O:[;_ &BXM'M8
MGT^!HU3<.9&!8EFXZ#: "<=:@LO"&NQZ[H&JW.J:?NTRTDM'A@M&5&0[<;<M
MP?EY/0=A0!ST/_)-/B;_ -A'5?\ T&MZ37M3T&#P:<V@T2^2&TN9'B8R0R-'
M^[P0P&&;Y<D<<=<TZ+P5J2>%O%&CM>VI?7+FYG$H1L0^<,$8S\V.QXS2>)SI
M47@@^$]6O;9]3FL%BM[:*0++-(,+&T:GG.\ ^V#V!H Z/3+Z\OM6U0%H#I]M
M*((2L9#LX4%R6W$$ G;P!R#Z5KUGZ'IG]CZ+:6!E,TD2?O9FZRR'EW/NS$D_
M6M"@#FY];N[[Q;/X?TR2"%K.U2XNKB6,R8+DA$50P[*23GI@=\CC?".O3Z'X
M:N(Y%C?4+_Q+=VH,<3NBOO9G8(/F( 1L#.>G(ZUU.H>%]3A\9_\ "2Z%?6T,
MMQ;K;7MM=QLR2JIRK@J00PZ>A'I6./AQJ#>'[BT;6XHM175Y-7L;N"W(\B5F
M)PP+'<I#$8XZ]Z (M=\0>*8_#?BQ"AMTL[(W%EJGV)X?,&T[DV.V0X/1NG?'
M%:D6OWNG6F@:.98Y+V\LS/YT5E)((XD5!_JU8DL2X&<@<'CL;+^&]<UGPUJN
MG^(=6MI+F^M'M4-G 4BA# C=M+$LQ.">1TP,<DTK[P9KD]GH=[:ZU;6_B#2%
M,<<RVY\B6)E56C=2Q)!V@YSUS@#C !1O_&7BO3?#4]W/IENES!JD5HDDT+Q)
M=0NZJLBJ3E#SR#G&/PJ[J&M^+]'U?1+"Z;19CJ=]+"K11RKLC$9=<Y8\Y!SZ
M\=.M3ZSX4UW7/#J6=YJUHU^]W#<R2K"RPH(V#*B)NSC(Y).3D^P&AKV@7^KZ
MSX?U"*>VB&ESM.\;!CYA9"A /88)YY^E &):ZYXONM0\2:*L^CB\T@QR+>&V
MDV2I)&75?+W\'@@MN/;@T-XXU*?PUX,UBWM[5%UJ]MK:ZC=68IYF=Q0Y_P!D
M]<]:U;3PYJ-IXB\2:J+BU8:Q'"B1E6'E&-"@)/\ %G.>U9<7@34XO"OA?1EO
M[0MH=[%=&4QMB81YPN,_+G=UR>E $SZYXGOO%GB'0[!]*@6P@@F@GFA=S^\#
MG#*&&3\HYR,>ASP:=XNU35_"OAS6(X[.R@U!"U_=3,"MN0I "(6!8LXP.3CT
M-:-IX?U&T\6ZYK:SVK+J4$,*0D,#'Y88 D]\[CQ@5A:=X!UG2K#PM':ZM9F?
M0O.3]] S13+(,;MH8$.HR!SW/3- &/X@\17GB'X;7,US%%]JL_$$5GE$:)93
M'<H VULE,C&0<XY^E=1:Z_XATWQS9Z%KZ:?-;:I#+)93V2.AC>, M&X8G/RG
M(;CZ>E+_ (5YJ+Z!K.F2ZS S7FK'5+>3[*?E?S%DPXW<@E<<8Q[]N@AT.[N]
M>M=<U9[9KJR@DAM((-WEH7QO<L>22%  QP,]<T <CX6UT:!X(NYUCWSW'B&X
MM(%VEAODN"H)"\D 9.!R<8[UTVB:OKLWB:YT^^LVFTW[,)H-0%F]L ^[#1,K
MDY./F!';CK65'\/+F7P=>Z)<ZDD=R^H/J-I>6R$&"8R>8IVD\X/'7D'M6_X?
ML/$4+^=XBU6TNI43RXTLX#$G;+ODG+' Z8 YXYH WZY'Q)KVN6/B[0]%TN.P
M*:I%<GS+@.3&T2J<G!&1\W3OC&1G(ZZN"\7&Y_X6=X'^QF'SA'J!"S9VL/+C
MR,CD?7!^AH Y_P 1^(M6U#P+X]T'7HK4:EI,"$S6JLL<\4@W(P#$D'@Y&:ZB
MWUO7;#Q9HVD7QL&M-5LYGMQ#$^^W>)5.&8MAP0W8+3-5\#76JZ/XD1[NWCU+
M7PB32["8X8T&U%4=6P,\G&2Q.!TJ]=>'=0N/$OAW6)+FU1-(AFCDCPW[SS%5
M20?X<;0>] &?I_B[5SI7B2'419#7-*N?L\4,4+!)=^/(;!<DB0L!U&.?2C6/
M%][INNMH<]_IUA?-9))9RW=NP@O9CN#*K;P% (48R3\W?I3+>VT7Q3\0[37]
M'OX[N"SM"MV]M('BEDW?N5;'!9<R-ZCY?45I^)/#=]X@AU*PG.GW.FWL02-+
MF-BUJ^W!D7U[$#Y<$=>: '7.NZE;>/\ 2-$9+;['>V4T[$*?,#Q[>,YQCYO2
MJ=GK_B+7=&MM>T."RFM)KLJEG*"KO;B0H7\S=@-P6 QTXY-6%\*7</B;0-1B
MO(WMM)L6LMDH)DE#!06+= ?D';GFJ.B^#-=T"2;2K'7+=?#4D[RI"UN3<PJS
M;FB1]V I)/S$$C/&#S0!#XN\8:UX<MM9OBMC&EB\;6UFRF62ZA^7?(Q5LQC)
M8 D<%><YJUJI#?%[PRP[Z9>?SCJEJWP_UB_L_%6GQ:S:K9:Y-]H#26S--&V%
M 0MNQL&P8XR!FMI_#FIR^+=&UN:\M7^P6LMO*BQ,OF&3:2R\G:!M& <_6@#J
M:PO%/B Z#:6(A1'N]0O8K&V$F=@DD/WFQS@ ,<#KC'&<UNU@^+?#2^)]*A@2
MY-K>6ES'>6=P%W>5,ARI([CD@CWH SVU_5=-\96WAV_:UG&I6LDUA=1Q,F)(
M^71UW'(P0001Z>]5_ FN>)_$VFV&LWW]EQ:?,LZRQ0H_F[UE95*DD@#"D8//
M&<\X&G'H5]=Z]:Z[JC6C7EC;20VD,&[RU:3&]RQYY"@ 8X&>3GAW@GP_=>%_
M#%OH]U<0W)@>0K+$A7<'=GY!)Z%L=: .AKDM=US6K3QKHVB6 L1!J,%P_F3H
M[-&T87G@C(^;IQG'45UM<YJ>@7E[XTT77(YX%@TV*>,PLIW2>:%!.>@QM'8Y
MH YE?%/BZ30O$LJOHZW7AZ>99)#;R%;I402 !=_[LE3@G+<]N];$GC"2[DTB
MULT,$]_IHU%W^S/<^4AV@*%3&22QY/ V^]1Q>$-233_%ML;NT)U^21U8*W[C
M?&(\'^]@#/;FH+GP1K$,'A^]T?5K>TUO2+,6+/)"7@NH< ;77.1RH/!X/YT
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M ]JWDRHJLHWKNR6PV00< CIWJPO@G5EMO%T#ZK:2#7U;G[,R^4S1"-C]XY
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MN&=Z2J""#]T]%Z]/76N_$&HV_B[PKIZF VFKP7#3J8SN5HXU8;3GH2W0@]*
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M(;O5I]8TS4XXAJ.D7?V>5X5*I,I&Y' ).W(/(R<$50^)7_'EX;_[&*P_]&4
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MM=*U1()/]&?=-"45B!\_RMSUYR3T&.>NU6:\MM(O)M/@CGO8X7:"*1]BNX'
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MU[D=Z ,2]^'8GT-8K;5)+76DU%M5744B'_'RV<_)G[FT[=N>@&2>\]YX,O\
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M(]KODB81^6-K;L;.^"">N".M7!X8U;^S(].N+^PO[-M/CLYK>YM#L++N_>*
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MYE.X[CM)&!@<Y.3C%&V\!W4?AC_A$[C4XY] 60;<PD3F$/O$);=CMC=C[O&
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MN[659;>>-98I%Z,K#((^H- &7X5\/1>%]!CTN&0.BR22_*NU5+N7*JN3A1G
M&3P*VJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *XGXIR7L/A!7L[U[;-[;1R;%!WJTJJ02>@Y[
M=>G3-=M6)XL\/?\ "3^'Y=,%T;21I(Y8YPF_8Z.'&5R,C*],B@#E]7@U$_%3
M0X+>]C6Z.CW0-S)#G \R/D(" 3^.._/0OTSQ+KMUX5O7EN;%;S3]8?3KJ^E
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M9-LAW?/R3R-OOFMJU\*WMIK>OZFNJPNVKQ11E7M#^Z\M"JG(<;LAB3P.>F*
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MEK>3B))-^<-&RHQ!]0<#N#73UAZ!I&KV):;7-<_M6ZV>6C);+ B+U/R@G+'
MR2>W '.=F42&)A"Z))CY6=2P!]P",_G0!XKX>T[5/$7P<O/#VG:8)&O;VXC-
MW/*BPQ#SR2V,ER1C@!>O>NSU.ZU70+=--BU)(8++2%-L\<0FGN9D!!+I@D1@
M*N2,<M]X5K>"O"\_A'1&TR34$O8_.DF5Q;^4078L0?F;/)JO?^#[NY\3:AJM
MKK1MH=2LUM+J VPD;"[L&-R?E^\<@@C^@!BMXL\07\7@5[*6RM_[?A8W > O
ML<0%\@[N@/.WOCKS26,?B!/BK966I:X+AXM":9_*M@D;$SH&PN3@D*N3GMQB
MKUCX!O[*+PJG]NQ2'P_N$>ZR_P!:#'Y>.'X&WZG//3BMB]\-3S^,[3Q%:ZE]
MG:.T-G/"8 _FQEP_!)^4Y'7!X].M '.IXWU+3])\6W=_]GN)M,U-;&T5(S&A
MWB,)NY)QNDR>>F:Z2WM_$MOK>Q[VVNM,DM26DEB"O%< \;57&8R.Q.>/O5DG
MX?)=Z=XFT_4[\7%MKMQ]I;RH/+:!\*%*DLV<;%/3J*T="T'7;$*VL>(_[4D@
MC*6W^B")0<8WN Q+MCCJ!R>YS0!R2^-/$;?#G2];26R:_GU;[',&A(5E-RT0
M"\_+P!R0WYUJ)K?BC1?&R:'J<]EJ4>I64UQ821P&W\N6/DQM\S?+@CDG-87B
MG0)?"GPXT_29-5BE8:W!)%.8/+VE[C><J6.<%B>HX%=C?>$6UNXN;K5KY7FD
MT^6PMS:Q&,0+*/G<99B6.%[X &/4T 8VF>*=5_X2;P[ITU]%>#5;2=KDI!^Y
MAGC16(AD& ZY)4\MT'-95QXL\6Q^$/$&OB_L =%U.> P+:'%PD<@4@DME!C/
M3)SWK>M/ NJ0W?ANZG\1K)+H<<D$8CL%19(V0)C&XX;"C)R1Z 4DGP^NI?"6
MO:"^LP[=8O);IYA9G,?F-N90/,YYZ'/YT -F?49_C+:Q)J3I:_V&\ZP>6I5<
MSQAA]3@<]L<5WE<S+X7NW\4Z=KT>JK%/!9&QN46VR)HRX?Y<M\ARO^UQ734
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MRY8X'88ZUKT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT76O(3)KWPSTN:QO;$>(/ Y#A;BWQ]HM87R2'7HZ\GG]1P* /7$<21JZ_=8
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MG>/8?E/4@AL<Y_#I0!VE8>L>*]/T4W(ECN;C[)&DMW]EB\PV\;$@,PZX^4G
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M_BW5K>_-M9QQWD$%LL2,LD4896+DC=N;#8P1CY>O.>\\.?\ (KZ3_P!>4/\
MZ * +Z)% JQHJ1J3A54  GKP/SJ2N$\7+>R?$7P7!!J=S;0S/=DQQJA4,L#8
M;#*<G#$<YQGC%3V>JZMXHD\1-I>H_8?[+O9+"V01(XDEC52S2;@3M+-@!2O
MZ\\ ':45@^"O$1\5^#]-UMX1#)<QGS(QT5U8JV/;*G'M4'B'7)[;Q%H/A^TD
M\F?5GF9KC:&,<<2;FV@\;B2H&00.3@T =+17G&I^.+_PE?>)-/U(B_-AIZ:C
M8SLH1G1W\O9)M '#XY '':NAD'B#1[Q+^YU**]TF.SEDOD>-4=)%&X&':OW3
MR,,21QR: .FHKC=)N/$VL:9H&NVM_;^5?;)[RRD11'' ZYQ&P7<77*]3@G/
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MH(&T<?* *TZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHDNJZE'>MH[F2WE%MY<S'84 =]QR,')  R0">G/54V1_+B>3:S;5)VJ,DX[
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M(V],8':I+WP7J&K>%]0TK5?$4EY=W\8AENS:J@2,'.U(U( .>I))/X#'8T4
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N'^*PN!X/1H+VXMO\
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M&>@%/U+P;%=1:!;V5U]BM=$FCFMH5BW@E%*@,2>F"??WH Z2-&C@1&D:5U4
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M&"[@9;W. !^0KD;?P#%:Z1<Z!%J,@\/7$K.;(QC>BLVYHEDSQ&3GC!."<$4
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M;#79K51%&@F-M'(@8(N I?9NQQU]: /2*J:GJ$>E:7<W\T<LD5O&TKK$NYB
M,G ^E<1:^)AJ7A;6+[1O$RH8Y8DSJ<6R6PY =&7;DL?FVY#98@<XJ!=8OYKW
MQEI$TUW)8PZ0MS;B\15E7>D@;H <':#AN1STH [S2-3AUK1;'5+='2&\@2XC
M60 ,%=0P!QGGFF+JC-J%_:_V?? 6D:.)C$/+GW G$9S\Q&,'IC(KS&SN?$'A
MKP/X.U^#6GN+)HK&VN-,:!!'Y4BJ@*$#=O&0<DG)[ <5V.A:EJ,WQ"\4Z9=7
MC3V=I%:/;1LBCRO,5RPR ">0.N>E %NQ\7V^I^$8/$=AIVHW-O.VU+>*(&8C
MS/+)VYQ@8)//2N@,B"58BZB1E+*N>2!C)Q[9'YBO']+U+4='^ &EZAIEXUK/
M%.%)5%;<KW90CY@<<,>G-=)<6US+\;8T&IWD<8T)I1&A0JO[] 5 *G . 2>O
M'7M0!WU%>=6FO:OII\4:'J6HS7.L6\B-IDCI&IEBFPD) 50#B0[6.#TKO[2&
M6"TABFN'N)40!YG !<]R0  /P% $U%>8GQ%K-I=^')CJK7K7NL&QO'@C7[$R
MMYF$C)4,2H5?F&1D,"3TJS-XGNK;Q<^E:S?7ND7$FHH+!WB4V=Y;[E_=A]IP
MY7=G)!R1@XXH ]$)P"<$X["JFDZ@=4TN"]:RNK(R@G[/=ILE3DCYADXZ9_&I
M[A'>VD6*5H7*D+(H!*GUP<C\Z\L@\2^(KGX=>"]535BE]J&JV]M=.T"%95>9
ME.1@8Z#[I'&: /6*Q]<\16N@S:9%<P7#_P!H7D=G$T2 JLCGC<21@<'UZ5R4
MGB/4?"FN^*;>_P!0GU6TL=)34X?/1%=6)<% 451M)4=N*H^(X+^;3_ >I7FJ
MS7$MSK5C)-%M01;G!8; !D!>0.3D'G)YH ]&AU!IM7NK V5W&+=$<7+Q@12[
ML\(V>2,<\<9%7:X&;Q/J&D>)/&[7-P]W9:3IL-Y;VY15VDK(Q7(&3G:.3FM/
M3+;7I_["U9-<66WGA$FH02QKLD#H"OE8&5PQXR>1UR: .KIHD0RM$'4R*H9E
MSR <X./?!_(UYG?>(M9L;C2[A=5:[DFU]+&Y^SQJ;,0O(RB,%E!+J,9*DX8$
M$]JDLKB?2O'/Q!U.6_O)XM.MK>?R&*%7402/L^[D '.,8Z\YH ]*K+\1:[;^
M&M"NM7NX;B6WMEWNL"AFQ]"0/UKEM.G\6WDGA_5;:622VN0CZA'</"(6B=0=
MT07Y@5)X&>1UR:Y_7]1O?%OP;U[Q'_:,T$4Z7'D6J*FQ84D*;6R,EF"DDYX)
M&, <@'K4,HG@CE4$*ZA@#UY&:?5;3_\ D&VO_7%/Y"O.G\1:S9W7AZ;^U6O7
MO-:-C>-!&OV(HQDPD9*AB5"K\PR,A@2>E ';:-XBM=;OM4M((+B*739Q!-YR
M!<L5# KR>,$=<5L5Y=8:7K&I^)_'2Z3KLNE2I?Q,C10(^]_LZ8W[@?E]A@^_
M:IO#?C;4/%;^&-/DD-E-?:=->WLL( 9S&_E!4R" "V6/? &* /2Z*\[BO_$E
MW/XO\,6NJ2?VGI:13Z=?>5'ND61"RQR KM."I7.!D<]JT?#VO3^)[#PY-:7L
MZ%K<W.H?*F25^0QM\O!,F[ICB-J .SJI;ZE!<7UQ9?-'=0 ,T3C!*$D!QZJ<
M'GVP<&N @U;Q7XCT&/7=!:5;AKIVBAEDA%JT*2E"C#E\[5.6Z[NF!Q6EXQN9
M--\:^"KV'AYKR6QE _CCD3.#[!D4_A0!W%%8_BFYN[3PS?3V5]:V%PB#;=77
M^KBY )/!R<9P,')QQ7+Z=K.J/XMUK1TO;Y;4:3'>VTEY$@EC<LZD@8SM.T'#
MC(.> * /0*KWUVEA83W<D<DB0H79(EW,0/05Y=IVN^(U\->"/$-QKDT[ZG?6
MUI=6IAC6)TE+ MPN[>#@Y!Q[5N#4;WQ5#XN:'49K*#3)Y=/@CA5.72,%W?<#
MNR6P!P,#UYH ZW0]7@U_0[+5K5)$@O(5FC60 ,%(R,X)&:FO;^&QM;F=@TIM
MX_->*(;GV\]OP/Y5@?#;_DFGAS_KPB_]!KG]"M[@>)?B"TFI7DRPRJHCD*%6
M!MP1GY<C&> "!]: .YT/5X-?T.RU:U21(+N)98UE # 'IG!(S^-:%>0>'KO5
M]$\(_#V^AU:5K:]GMK"6Q,2"+RY$;G.-^X$ YW8]A6]<ZGXA\1'Q NARW-O<
M:?=O9VAC:$1"1%4YE#Y8@L3G'\.,<\T >@,2%)"EB!T'4UR0^(NC[-1E>VU-
M8-,F:"]F^R,RP,OWMVW)P.N1D8YKI=.>[DTRU>_2..\:%#.D3919,#<%/<9S
MBO,/#L&L7W_"P[#2H+%FNM8N(?-NIV41[D4$[0AW8!SU&: /4K2[M[^SAO+2
M9)K>9!)'(ARK*>00:FK@+72KCPGI_ASPW!J[_98;659(K9,W5U+D$%000L8+
M,220!E036*GBGQ'=> /#6H)J9AO[C7$T^X=H8R)4^T-'\P X.%&=I'>@#U=I
M$1D5W56=MJ G&XX)P/7@$_A52#4&FU:[L#97<8MT1Q<O&!%+NSPC9Y(QSQQD
M5Y_JNDZI:>/O!UK<^)M1NC-)?N)"D2; (LK\H3:3AB,D=.F*TAXCO],\3^-O
MM=R]U8Z3IT-Y! 45=N4D9E! R<[1US0!W=4K'4&O;B]B-E=V_P!EF\H//&%6
M;@'<ASRO.,^H-<]I,.OWMMX?UJ/6T>*YB6;4+>2-?*=9$! BP,J5) &3R.N:
MYZY\0:]#X9^(%PNK2&YT>[D6TE,,>418D8+C;@\D\XS0!Z?17F]SJ'B30-7\
M*ZC<:TU_8:S<1V5U9O BK$\B$JT9 W<8.<DY_E#J7B+6;">PN4U5KN23Q EE
M.+>-3:+ \I019902X&,E2<,"">U 'IU->1(]N]U7<P4;CC)/05Y_YVOZIXN\
M7Z4GB*YM;:QAMI;8PP1;XRZ.V,E2"N1SD9.!R.<XLFHZCXCL?AGJ5QJ-S!/>
MS_OA!L"EQ"_S[2I&>.^0,G H ]<JEI.H-JFG1W;65W9%V8>1=QA)%PQ&2 3U
MQD>Q%66C<VYC69U?;M$N 6!]>F,_ABO-=,\2^(IOA?I.LN+S49C?2KJ+V<2>
M?]G665<QKC&1M08 SC..>0 >G45SW@[5K;6M(EO;/6&U2V:X81R2(%DB&%_=
MN !A@<]1G!![UCWL^M7GQ.N-!AURXM-/;1UNP(88R\;F8H=K,I[*.H/4XQU
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M4 , ?7!(S^-:-<G\,?\ DF7AW_KR2NLH **** "BBB@ HHHH **** "BBB@
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M7R,#!&6/!'0XK9M/#R)J4VIW]PUY?RVPM?-*!%2+.2JJ.F3R3DDX'8 5M44
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ME '8,<(QR!@=3T%>866NZK!J_A%O[4N+Y=1N98+VY  M;CY'8>4IP0%*C#
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M9H(<)&%G6.;;^]&WYB5XX('3C.2?1$\*VT/B9-=@N[F*:.Q%@D"[/*6(-N
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M=HVX).!EF!/% %/X>1ZM?:!I6O:EKMU=M>:?'OM71!&KG!WC SNQP<GG)Z<
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M.0ZY^4G  #;<9P*SM7\!V^J7ECJ,>L:I9:M:1&'^T+>11)-&3DJX*[2,DD#
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MJ56ZFGBM87<96-I'"[R.^ 2<>U5_#O@2#P]+$J:SJUY9VV?LEG=3AHH.PQ@
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M]M 0;>X6)_,E#-O)(.0   .G7.>,3-\/+%_"E_X<;4]1-G?3M/*V8M^YGWL
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M/NJ<G[V3G(' LV]MJVM^/_$VFOXDU*VM+,6,T*6[(NTL&8KG;]TXP>YXR>*
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M0RJ6PNWIP,MSGBJD%_XBLK[PSX2UK4HWO+V:Y:XN[60[WAB0.J;MJX<[ER0
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MJ=Y-I[WO]DW$:A0R02,HF=>_R@D XZ G/8XH 2\\/Z??:_IVMSQ$WNGI(D#
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MXVNVTZ-GFAA90PPF_') SM(/XU+HVHC6-#T_4UC,2WEM'<",G)7>H;&>^,T
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M6]N\D*NSD_*[1,A7IR7 ^@X'J>E+>)I-FFHR+)>B%!.Z@ ,^!N/''7/2K=%
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MOK^2":UF58W*B-SEEY_N@C)(Z'%=-X5T)M"TN99V5[V]N9;V\9/NF61LD#V
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M+;YGPA5+@+M=1]\$<8/ [ <Y]/LO#4%K<V]S/>WM]<6L30VTMVRLT*M@'&%
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M:6(9;KRM3(2UN&M76%W()";R,;B >,]L=:?H_BT:MXNUG1197,2:>8HQ(\)
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M&QT/I0!T=%<_:>,M*O6U*.-;Q)M.02SP36KQR>6<X=58 D'!_*G_ /"7Z/\
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M,Z]_X,I/\:/^$1@_Z#.O?^#*3_&@#&O$'B3QQX9UFQCN5M-)BNI;F:2W>/\
MUB!%C 8 ELY) '&WGJ*Y*2VO&^"5]IXTW4?MK:FSK;_8I?,*F\$F=NW.-G.:
M]&_X1&#_ *#.O?\ @RD_QH_X1&#_ *#.O?\ @RD_QH PY;IM*^*TVH365_+:
MZCI$,-M)!:O(&D61R4; ^0X8'+8'J17-Z%ID%U\/-!T[6+36M.N8;NYDBO;>
M&1);.0R.ROD*?E96QD_+R/P] _X1&#_H,Z]_X,I/\:/^$1@_Z#.O?^#*3_&@
M"+P-)K+Z#*FMR>?-%=2QPW1A\EKF$'Y9&3L3S]< ]\UTU4-+TI-+21$N[VYW
MD'-W<-*1]"W2K] '%:RLI^*WAN=;:Z>"&SNHY9DMW:-&?9M!8# SM/>L"&.X
M/A?XEP_8+\27MU=M:H;.4&8/ J*4&WG+ CBO5** /))#-HNH^'M9U#1=1O=)
MET.&PG$%N[2VDR'=EHQAL')'3J*TKR?^S1H36'ARZTW2+N]FDGEMK$O=0YCP
MK%%5FC,AR"0-P7'0GCTFB@#Q*[M+X?#[QMIJ:/J_VB?7?/@C>VDD>2,R0L"#
MR6X5B3D].3R,]GJ+/)\5-*O$L[N2V72+B-I/LTFP,S(RJ6VX!(!X-=U10!YA
MX3LKO2]?TB/09M1.@7,<CW6EZC ^=,.S*['< K\QV[><@DC(Y'IKN(XV=L[5
M&3@$G\A3J* .!\!W$^E>!]3DEL+Q;B&\O+A;>6W>-Y TCLFT,!G<,?G77Z39
M'2M%MK:1]\D4>9I ,[Y#R[8]2Q)_&K]% '$?#PR6]EXB-Q:W<&_6[RY036TB
M%XG?*LH(YR/2J(\9Q7>K"^N_#?B61K9F6QMQI,H"D_*9"2 -S#@9^ZI/J:]%
MHH JZA;RWNDW5M')Y,TT#QJX/W&*D _@37EIM+S5?@['X)DTZZAUQ$BL6A>!
MMBE)%_>[\;=FU=VX'V'/%>N44 <-=B2+XMZ1+]GO)+>'29K=[D6TC1AV=" 7
M QDA3WK:\;V=Q?\ @37K2TB::XFL)DCC09+L4. !ZFM^B@#S*\N)+YOA]-%I
MVI!+6Y#3[[&4&," H2PVY4;CCG&>HXYJEK.DZGJU_P#$>#3[.Y$UT+&2T,L+
MQI<&%0756( .2NWKWKUJB@#A?#%[I6NZG:7EMX5OK*]MD;SI[^V:,VQ*X*(S
M?>)/]WC&2<< WO'-]=V2:.T-G/+:O?*+JYM[4W$MJFUOG10K$$GY=P!P">Y%
M=910!XQ=6UV/#GQ(LHM)UC?>R![02V\LC2AHD P3DL20>.HQSCI73ZD9)?&/
M@&XCM+UH;>.Y\^06DF(=\ 5=YV_+EN.:] HH \?UC1M5UF#XA0:=9W0GGO;6
MZM5E@>-;I8EC+*K, #DH1]<5TFIY\8:[X3N;"WNX18737ET\]N\1@7RR/+.X
M#YBQ P.P)Z5WE% 'B^IK>0>!O'?AT:5J4FHSZC=7$*1VCLDD4DBLKJ^-ISZ
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MNK209D\U&.5('E\ \!5![ Y&=KX5136WP^L+6YM;FVN(7F$D5Q T3#,SL.&
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M S6XGB&VD\0W>ABWN/MUO;"ZVD+MDC+%05.[N01SB@#7HKFK?QQI5UHNGZE
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MS0[8KC8HWA#G.1G/(&1R,T^/QUI<DEHRPW?V.\OCI\%[L7RGG!*[?O;@"RL
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M[]Q Q[CMS0!OT5Y[:WLMQ\;(T>VO[0_V#(S07,@92?.C 90K,H]#CGCFO0J
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MJ/*B-TD8@D C(!!X/3MKGPU%<^*[3Q";ZZ6XM86@2%=GEE&(+ Y7=R0.];=
M'E,=C?0ZEXZ:+0M52WU32HEM7E4R-(PBD7!.XMN+,.#R.^*LO9WW]E_#B/\
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M3?#YLYHY[S5]1U26(DQ&\:/$9((R%C103@D9()Y/K0!POA"VFMK&P\.ZGX"
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M!9\@Q+G#Y7DM@G.<D#%>Q44 >7^(]*O9]6O]8\/VNK:5XF62-4"1LUKJ"X7
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MZ;=W:[K:*)5N8%",1.1&>&#8& 20#WS@ %SQ5K^D-X+U>;7](U$V%O*(+JV
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M22 ,CU% &[17.>#?&VD>.=)>_P!):4"-_+EAF4+)&V,\@$CD=P:Z.@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%VK'PQ?^'KV.UTN\MKF&]F#-%,B#<2&(P3_ 1DD[R>QQWM%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+/1+6*>\=AYTR6\*(N6EE<X5%'J3^'K0!?HKG6\:Z3%I^K7=P+J Z0VV]A:
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M$,%VYQSC)R>G'0:.D6D6^I:C)K3W>C.%N+>>>Y\X11A?F <DDC()R23SU.*
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M,*#S)H&,B\+_ 'MK@@'GBMO51::QX*\27.C>$[RREN=.>V5I-/,=Q<.P.$"
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MR-'(FW>J_P 14@''O^-0SBTN_!?B:[TKPS<V'VZQ>% ;$I<W4GEN!E "V!N
M!;U/;!/?T4 >9>)(;NY^!<&G0:=J$E^;.TA^RK:2>8'0QE@5VY&,'GIQ4_BI
MI++QCIWB.70[S5M&FL6LYHX+5GFMGW[UD\L@-@\@\=OIGT:B@#R_5;:YT]M
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M^TV*V=+&W^T-931LY"[1SM(?&1W%=OX<MX(-(4VVD)I,$CM(EJ(PC*">KJ.
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MT6*]$.I<6=ZT!6"9MN[:&/.2,D<8/8T_5?&6G:1#<W4T%W)86DHBNKR&,-'
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M;3[KP[J.FW<47EWD]U$$B0A<'RFS\^3C&. ,DGH" 7IO&VF6TED\T5TEA>W
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M@C=NQN^7=MQGVYH ZBBL*Z\4V]O/?1PV5Y=I82)%=20!"(F95;!!8,<*ZDD
M@9]CA]YXCB@O;NSM+&\U&XLXUDN4M F8@P)4'<RY8@$[1DXQZC(!M45RTWQ
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M1$MF;[98&=QP4907B)^\&(^;OSR>* .RT[3H].A95EFGED;=+/.VYY&QC)/
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M4]E+,@9K:?&^,^AQWJY110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMX8BFM_"NDV]Q"\$\-G%%)&^,JRH 1QQU%6]4MWN])O;:+'F30/&N3QDJ0*
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M3_B3XEGDTZ9K'4Q:R0W:LGEKY<11@1G=G.,#% '8UDWVNQVVJKI5M;2WFH&
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M$FAK9K<, %\T2L^,9ST8<XH AT:YG^(?PU#ZG83(;^/?A;@1!_G) 5D)8*,
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M$%S_ &6MAJELLB+(&#%UD0M@,<D@^O\ +OM%^UM8>;>6,5C)*Q<6J$,8EP
MS+P6XR<<#..<9.C10!S/C[P_=^)?"-S8Z?(B7R21W%OO.%9XW#!3['&*HW=C
M?^*-;\.7UQI5SI\>E2O=SK.R%FDV%5C3:QR,DDG@8 ]>.THH Y'P!8:CIMIK
M,>HZ?+:-<:M=7<6]T;='(^Y3\K'!]0:ZZBB@#B=3\*75SX\:ZC5#HNJ6JC58
MV_CDA8>6,=]P;!_V4([U)X"\.ZCX>L+F#4F\W[*[6=@0<DVB,S1D_P"T=V#[
M*OI794R*6.>,212)(AZ,AR#^- 'ELGA?7KKX8^*-)_LN2*_NM3EO+>&26/\
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M)T0RQE4R4?)7(9,\GD5HZVOB[4=)L;B/2_*!OD:[TJ"[196M@IRIER%)+8)
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M<R$AM^#D$ >] '6'QE)#Y5M?:8NG:E,TIBM[R\C1#$A \PR+D $L   3G/&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^#[/%Y,>I:D4CV#:I$*D$#M@]* /68Y$EC22-U>-P&5E.0P/0@^E.K(\*_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "L3Q1:/?Z=%:G2(=5M)9@MW:R%03%M;E=Q W!MA'(^HZ
MUMT4 >7#P)KMIX>>/1YFA?3]634='L;Z;S/+C5-K0LX)P&W/@ G (YR3CM=
MN_$&H;KC6M+ATI57:MJMR)V=N[%@  .P SU.>U;E% ''^#O"EUX=U#4DFD5M
M.BGD&DQC_EC#*1(X_P"^_E'LGO6;H5AXS\,O<^'[73K.[TIKB62SU-[H*;>.
M1RY#QX)<J6.,8!]1V]"HH Y+1],U*U^(?B#4Y[-EL;Z"VBAF,B$DQ!P25!R
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M12>:I;,08$LO8'=Q].U<I<>$O%MQIJQ3V6GW&H6^M1WS7SW9WW<:3;U7[OR
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MO2IN)&GD;S"HPN0S$<#@<<"M.B@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]:\DTV5OAW\<0C6$NFZ)XD78D,I3"2$\8V,1P_'7@24 >[R%EC8H%+X^4,<
MGMDUR7P^\;OXXTR_NY-.6Q:SO&M2BS>:&P <YVKZ^E<C.$\0?M#W6DZW$MQI
M]CI7F65O,,IO.PEP.F[YGYZ_*/2N4\&1Q_\ "D/'X'S!+N=D).2"$3!SZ^]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,H"/$LMK,B!"K!R!M(4'(/%=WIR3QZ?"MS%#%-C+Q0_<0DYV@]\=,X&<9P*
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MB0W,\3;76")=SJK#E2W3(Y'-=S7'^-_#=_J5YHNO:,L;ZMHMPTL4$C;%N(W
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M(CLB#RMD'?@\..!SUKJK2TU&'XFZMJSZ;<?8)M.A@CF#)\[HSL1C=G^(8R*
M*VJ^*]!UCP5I6LWFDW5YI][=PHD1"@PS"7:-_P PZ.".,]/2KC^)M2_X61+H
M":9(]I#IPN=R2)ERTFW<<D8 VL,=>?I7)1>'M?3X4:9HIT6Y_M"#5!<20^9%
MQ&+HS9SOQ]TCOUKJI;'4X/BG'K$6FRS6%UI"6;3+(@\AUF9SO!.<;6XP#SQ[
M@ A\-^-Y[O0M4U;6;-[6&WOI;=-KHPRL@C6-<')8M@9. 2>N*O0>.;!=:N=*
MU*(V,\-FU\':5)(WA7[QW*3@KCD'ZC-<H/"OB&?P?KNBQV @O(M7DU&RFFD0
MPW)\\2HN 2<$ @[@,''7G&NMKJOB[P_J6G7/AE?#QN+*6W>25HW9I&7: FS^
M 9R2<9X '7 !IQ>.;3^V=,T^ZM)K9=5#?8YFD1@S 9VN%)*,1TS].#Q755PO
MA2;7Y19V.J>$HM.N+4!;F_+Q-')M&,Q!?F);'? &3R3@'NJ ,[6-:M]&BMS,
MKRS74ZV]O!'C=+(V< 9( X!)).  :HV?BA+C5[W19K&:#5K: 7*VS.I$\1.
MT;9P1G@YQ@_G5#QOHVHWL^A:QI47VFYT>^%PUKN"F:)E*N%)P-V#D9(%$&FW
M.H^.U\3R6<]M;VFFM:0Q2A1)*[/N8X!.   !G&23V&2 8?@BRA\5V\FJ:SI;
MF]M]7N+B&],BAU9)2JQ@JV[:% 7!^4@=Z]*KD/AU8ZCIF@W-KJ6GS6<S7US.
MHD9&RDDA9>58]C77T <C/XCU _$I?#JZ<S67]FFY9Q(F6W2JFX@GA5PPQU.>
MG2N4\,>)8O"&A^(IVTF\FTZV\078GF@V!+>,R!0<,P+8XX4' KJ+VQU.V^*5
MMK,&G275C-I)LGECD0>2XFWY8,0<8] >:YF?P_KLWPX\9:4-&N1>ZEJ5S/:Q
M&2+YTDD#*<[\#@<Y- '=ZGXDBL[R2RM;<WEW% +B2-94C"HQ(498CYFVM@>W
M..,V/#FOV/BC0;76-.9S;7*DJ'&&4@D%2/4$$5QE_9ZWH_B]M<M_#;:QI^IV
M<,5Q;AHQ/:RQY (#'!4AN<'K^O=:2MPNFQ&ZMH;69LL8(2"L0)R%R."0,9(X
MSF@"Z0""",@]J\CT,^'+;QGXXAUE8!#!=Q>2LB$B)3'EMF/N\G/&*]<)P"<9
MKS[PY%K&C^*_%E_<>'=0>WU*ZCEMFC> [E5-IR#(,9- $'P_\0&T\':WK.HW
MTTF@6][,^G3W#F27[*,;0<Y8\\ 'YOTKIQXK6WUC3].U/3KBP;4@?LDDC*RL
MX&3&VTG:^.<<@\X.:X5?AWK.I>'?&PD2/3)]>N8[FSL1(&6%HVW N5RH9R!G
M&0/>NDOK+4O%]SX9-WI5QIQTV]2_NS,R8#HC 1H58[@6;.>F!Z\4 6W\=6T;
M03-I]T-/FU+^RUN3M'[[<4SL)SLW C/7VQ23^."NO:CH]KX?U2[NK!H/.\H1
MXV2YPX.[H !QUYZ<$CC]0TCQ3J6GP/J'A^YNM7L]<BNGN3<1;'@2;<JP O\
M*-FW(.WIDDFNLT&RU.'XB>)-0NM-F@M+Z"T6&8NC*6C5@PX;/5N"1SB@#&^(
MNN1:Q\._$GV33I;NQMTD@-T&4 2J<%E!.656X)]CC.*[_2_^019?]<$_]!%>
M6KHWB33?AUK_ ()_L*YNY"+@6-[%)'Y4T<C%QNRP8-EB,8/Y<UZCI(F72+-;
MB!H)EA17B9E)4@8(RI(/X&@"VS!5+,0 !DD]JY2;Q[9P:7;ZU+97*Z%/*(UU
M#*[5#-M61ESD1DXP>O(R *Z2_M5OM/N;-F*+/$T19>H# C(_.O-X] UR\^&
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MNK^WDGC^TF/&$.&7AB=W0XQT(-96K6&LW.J>$;P:(5%I>R7-S%;/'MMT:-D
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
' %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>sangamoexecutiveseveranc005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^+H;O4)FL;:UM)D2:3]W &$A8@= ..3[5+X#T72!X5T"]73+9=1@T^&)Y6@
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M!/!KDO#/A_4-'\67GA^02S:+!*FKQ7,G.^1U*F,]O]8K2>Q ]:SDN+'2=?\
M$6B>*-,U:==0OI+BS:W2>2&\BD _=X0[=PQM.[ QC- ':ZGX\\.:3=2VUW?G
MSH[8712."23,1(&Y=JG<.>V> 3T!JT?%.E"15$LSJ9X[?S4MI&C$CE0JE@N
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M:DCSHFC7!O[*3/59@?+BQZ(3,?P2O1J ,_7-7AT'1+S59XII8K6)I62%"[$
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M6\U29X8&D6,.(F8!F.!D@87D]3@4 :E%8-MXNTN\A=X!=EQ<-;+ UK(DDCJ
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M@B2:3]VVT*Q(7YL8R2K<9SP: (-#TAM(M'6>]EOKR9_,N;N555I7P%SM4 *
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M U/0UD71-3TVSO=01TO;>*2*YCE6-R+DC!91D;<L.^3Q@UZ110!XWKDVL1>
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M,P$2*"C,,$AU]^G0U=T76+*^\6:5>:R=734(+<V5JUSH\MI$7?&XLQ+#<VT
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MI>&.)71C(-N5()&<COZ5IV4TFA_$3Q5=WME?&WU".T>TDAM9)5E\N,JRY4$
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MN(MBW&!G"GL<<[6P?:N$30]2USP;\0-(@M;RUN]0U2XN+3[1;O")D/EE<,P
MPVTC\:U=3$_C.V\*0PV%[:75GJ5O?7@N+9XA;")6W+N8 $DD*-N<@YZ4 ;EO
MX]T>[U-M/MH]0EF2\^Q2[;*3$4F 07R/E7GJ<=#V&:Z>N*\#)-%KGBXS6=W
MMSJIGA>>V>-9(_+1<J6 !Y4UVM 'FL/B*/P]\0O&(NO[5O(5BLI(K>!)+DQ@
MHY<A>=BYY/0<UV%OXJTJ]TFQU&QF:\BO\_94A7+RD D@ XQC!SG &.:Y^UED
MT/XD>)KR]LK[[-?V]H;66"UDF60QJX9<H#@Y(X.,URW_  CFI^&-.\.:K<Z)
M+J-M;W%Z]]IUL@ED@2Y<,I51]XIM ./4XXYH [F7XA:!;Z3<ZA/)<Q+:W(M+
MF)K=M\$I( 5P.%!R,-G!SP:O:;XKT[4];GTB-+N&\BA%PJ7-NT7FQ9V[TW#D
M9XKB/$UM%?\ @/4)=%\+7=F;R[M&6-;!EN)]DR,SNB@D *#C=@\'U&=B_@GO
M/BG;SQ6UZEM)H,UK]J^RR!$D>164%L8!P": -I_&>E17%DLOVA+:^F^SVMZT
M?[B60YPH;KS@X) ![$US=U>_\)-XYUS0KZ+5([*ULH%A-MNC:*1S(6ERIZ_*
MNT\].G)SF^$8XET[3O#>K>![@ZSIY2(W$MF&M3LX$XE/!X&>.2>!ZUT&CF:/
MXI^);F2RO4MI[2UCBG:TD$;LF_< VW!QN'U[4 9X\4Z=X8^'&IZKHIU74Q;7
M4D+27Q9I//+!2S[\$*&(XP/I782>(8$EB@6TO)+IXFG-LL8\Q(U;:6()'?H.
MI[ \UYM-I>IW?PI\8V4.F7WVN;5I[F&![9T>6,W"N"H8#=E0>!6]XEMK7Q!?
MVEZBZ]HNH16A>RU2WM9=PRQS%*@4Y!PK;&P3GMW .ZL+V+4=.MKZ#=Y-S$DT
M>]=IVL 1D=C@]*L5S&@ZSJ<6F^';+6],NAJ=];L9Y+>#]S;LBY_>$'"%AC ]
M<BNGH X_QAI4L.A^(]:&J:DD\5C)+:I!>21)"4B)!VJP!.X$G.>U0>%]%DO_
M  OX?U:35M6,T]A')=J]_,RS%X>3@M\I#$$%<8Q6SXV$C^!]<@A@GGFGL9H8
MHH(FD9G:-@  H)ZFH?![/:_#W1X[BWNH9;73H8IH9+=UD5UC 8;2,GD=AS0!
MR_P]\:6EMX*\,VVIR7TL]Z?(^V21.\9F9VVHTA_B/X^^*ZB#4='_ .$VU*,7
M%XNHV]BC7"2EU@2(,Q#*&^4GK\P].O6N M;'4(OA+X0L'TK4A>6FJ6TD\'V*
M7?&J3EF8C;T .<]ZZ5UG'Q,UR\_LR[FM7T-(4+6T@CF=6=C'N*XR0P_.@#I]
M/\16VHW5M#';7<8NK<W-O+)'A)8QMY!!./OKP<'GI6O7F_A/3KS1_$EC!HDV
MJ/X<FMY&GL=3@<'3V&-BQNX!Y)(V9/ )]#7I% 'G5U%+>?&2XTF74]3BT\Z&
M+SR8K^6-5E\[;N&&XX[=/:N7N->U?4OA#XR>?4KF==+O9;>PU.*0QO<1*Z@$
ME,!N"03T.?:NGN-.CU#XUR7-[H\]SIO]B"U$T]@[P^<)MV-Q7'W3UZ>]:?Q+
ML'D^&.K:;IEC++))"L4%M:0%CG<#@*HX'!]J -J^\1VFG7B:?Y5Q=7OV8W1M
M[= S+$#@N<D#KP!G)[ U4F\=Z##9Z1=_:)G@U<@6CQV[L')!.#QP>#\O7T%8
M^JWU[-XNM[>33-3_ ++FTT&&:SMG5Y9BQS'+)PT8 P0"5!).3VKEM&MM0B\*
M?#NVFT?5(Y=.U'==*UE(3&H60%C@' RPZ_RH ]-T/Q+8Z_-?06R7,-S8R*EQ
M;W4)BD3<,J<'L1R*V*XOP]'.GQ,\77$EI=QV]S'9B&:2W=8Y"B,'PQ&#@D5V
ME &+%XFLY[B%(H;IX)[A[6*Z6,&)I%W!AG.0 489( )'!-<7HGBFV\-WWC)M
M0?4[JWM=5)RJR7)MXO*0Y8G.U1SW[' X-,LM/O++Q'97WAL:I:+=ZB1JFCW<
M#FV526WSQLPPAXW J?FR![4BP79T/XF1?V=J&^_DN#:*;*7,X:W"+M^7G+#'
MZ]* .YNO$UC;W5O:0+->W5Q;&[CAM5#,81C+\D#&6 '.3G@&N6\8ZU!J_ACP
MUK6D7MP+>XUBS"/%(\8=&E 977(STQ@CM5>UNM0BO/#EC=:5JJ:=_8D:&2UM
M765KD8!AD? :-0!GDJ">IP*PK*SU*/X4>%].DT;5$NK+6(7FB^R.S*B7#.S8
M )P%(Y[]LT =D'EC^-0A%Q<&"3P^\IA:9C&'^T(NX*3@'''%=K7%%)S\9(;P
M6EY]D_L)K?[1]F?RQ(9E<*6Q@':"?_KUVM 'G!U]- ^)?B;[1_:EY%]BM9([
M6W22Y923)O*ISM7IGH.GJ*ZRT\6:1J&C66J6,[74-\VRV2)"9)'&<J%/0C:V
M<X P<UA(\FC?$[6K^\L[W[)>V%LEO-#:R3*S1E]R_(#@_,.#C-<K)X<U30-/
MTC6Y=%EOX(]4O;N\TJ%1))%#<'Y=JCAF0!<@>I^M 'INB^(;'73=QVWFQW-E
M+Y-U;3IMDA;&0"/0CD$$@^M:C,$0L<X R< D_D.M<[X4%C.+O4-/\/OI4-QL
M!:>V\B:<KGEEZX&0!GGKQC!/1,0JECG &>!DT <78>+/#>B^%+S68[C4GTY;
M^5)'GCED=93)@CYN47<<#=@"M:T\7Z;>ZQ<:5'%>I=Q6YN426V9//C!P6CS]
M[G _$5YS<V6H2?"7Q%8+I6IF\N-9DFB@^Q2[W0W2R!@-O3:"<UU]V)IOBSH]
M['9WIM5TN>)Y_LL@17=T95+;< X4]>G>@"SX8\;1:UX:DUF]MI[.(7$D:ATS
MNQ,T:*,9W.<*,#N<"K?_  FNE13:C;W:7=I=6%O]JFMY8"TGD_\ /10F[<N1
M@XZ=\5Y_;Z7K)^&JZ=#HMW)?Z-K#7LEK-$46Z07+OL0G[^5;((R./7%;L<VG
MZMHVKW^F>$;VPF.F36YFN-/,=P[,.(D4 LPSDG'&<=>< &FWQ-\/)IYU"1=1
M2R\B&=;AK&3RV$A 4!\;<Y.#S@'O5[3_ !QH^HZY)HZ"\@O%B,\2W%J\?VB,
M=6BR/G'TZ]JXSQ()(/V>K2&:VN(I[:UT^*6&6)HW5TDB!&U@#U%=#J%N?$'C
MSPWJEK;W*6^CQW,UQ-+;O'_K$"+& P!8]20!QM]2* +NG_$'0]4G1+;[;Y1:
M9'N'M'2*(Q EA(Y&$. 3@X/TR*M)XPTXZG:V$L5Y;RWL3RV9FA*BY"C)"=]V
M.=K8/M7(:'HU_JGPP\3Z*MM<VE[=W%]Y*W,#P[A([%#\P'!!'TS5OPM=VFL7
M&GK-X(N;#5K3FXGN[()';L!AC'(?O$G@;>QR>!0!K>&O&\6L:)>:K>VL]E!#
M<RQ#S$SPLA15XSN<G P,\G S6E:>*=/N=5N=+G$UE?6\'VIH;M0A,.<>8""0
M5!X//'?%>=1Z3K,G@#4=,@T>Z?4-.UI[_P"SSQ%([I%N?,"JQX?<O/&>GN*T
MKFSM_&/AS5TT/PK<Z5?RZ=+;_:;^T%O)N8<0J3R0><G[H_'@ E\5^(4O]1\&
MS6/]I0PW6LPB.;+1PW,)#$Y /.3M(W $CD<9KTFO*+_5+K6-(\%Q)H.L17>G
M:M:M>PM82 0A(W5B&(PR]\@GCKC->KCD4 <[K][I4.N:!;7\M['=2W1-FL&]
M8W?8V0Y'RD8R<$_A5>Z^(&C6LVJ0B+49YM+(^U1PV4A9 5W;L8'R@<YZ'MFJ
MOC6.>3Q%X0>&TNYTMM2,TSPV[R+&GENN6*@@<L*SK6.X37OB),UA?B.[CA^S
M-]CEQ-MM]AV?+\WS<<?RH [ZRO+?4;"WOK202VUQ&LL3CHRL,@_D:GKG/ ,4
MUOX T*VN()H)X+***6*:)HV5E4 @A@#UKHZ "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***SM8UJT
MT.UAFNMY,\Z6T$<8RTLKG"J,X&3[D#WH T:*PK;Q=IDL&K27)EL6TEMM['<J
M T65# _*2""",8)S]:+;Q792ZTNDW-O=6%V]L;N);I5421 X+ JQQCN&P1Z4
M ;M%<Y%XTTV2\TR%H;N*#56*V%U)&!%<$#/'.X9'(W*,]J+SQKIME;W-ZT-W
M)IMK,8+B_BC#11,#M;/.XA3P2JD#GG@X .CHKF=5\<Z7I6J?V:;?4+N[:T-Y
M&EI;-)YJ @?(>C'G/''!YI-4\26ES87UM!:ZE.\5H);D6P\M[8.NY0WS*P?'
M.U<L/3D9 .GHK@? _B&&P^'WA*&X^T76H:C;[8(4(,DI52S'+$#@#))-:LWQ
M T6W\/2:U,MVD$-T;.:/R"7AF#["KXX&"1SG'/!H ZFBL'3O%ECJ.NSZ/]GO
M;6[B@^TH+J QB:+=MWKGG . <@'GI4*^-M,-QIH:*Z6TU.;R+*]*#R9WYP!S
MN&<'!*@'L<8H Z2BN=U7QGIVD0SW<\-V^GVTP@N;V) T4+Y .[G<0"0"54@'
M@\@XZ%65U#*0RD9!!X(H 6BN='C&R,FN1"SOC+HH#7<?EKNVE2P*C=\P*@GC
M^?%6+;Q-:W>GZ/>P6UR\6K%1;X"Y *EPS?-P-JD^V,=>* -JL[7=*_MS0KW2
MFG:".\A>"215!8*P(.,\9P:Y4^*-+TG0O%VM:/97]S-974C7<4Q9<S+&I) <
M_*@&,X [X!XK.U[5I9-1\!:K<)>V[2W3"6$,2)<P,>(T8@Y/3C- 'H&DV)TS
M2;2P,QF%M$L*R%0"P48&0.^!5RL;0?$MIK[WT,,%U;75C*(KBVNH]DB$@,IP
M"1@@Y!S1XKNM/L_"VI3:J+DV MW$_P!F#%]F.<%>1QWXQ0!LT5QEYXL;3-5\
M*Z5I^F7<]KJ4+R*^Y2QC2$L%&YLEN5))/0=236P_B>U%PZ16EW/#'>)927$2
MJ429F5<$;MV 7&3C H VZ**Y#0O&AU*[\1-?6,UC9:5<O$9I2FU%2-68L0Q.
M>2> >,=Z .OHKGT\7V2ZQ;Z9=VE]9W%U"\UH)XA_I"H,L$"DG< 0=I ;VK-M
M?B7HUY9?;H++5WLQ%/(]PMBY1/*)#*Q'0\9 ].N* .RHKDD^(>CEM+,EMJ45
MOJD8>UN'M3Y<C%-XC&,DOCH ""> 35NQ\::7=QZPT\=U8/I""6\BO(MC)&5+
M!\ G((4].>* .BHK+L=:6]OA:/87EK(T'GH9U3:Z9 X*L1GD<=:LZIJ=IHNE
M7.I7\OE6EM&9)7P3A1[#K0!;HK"M/%5I<ZG+ILMI>VMZEH+U898PS20D[=R[
M"V>>,=>>E9=K\2M$N[73;R.WU$6.H3BWCNGMB(DD+E%5SGC)';.,C.* .QHK
M#U/7+43WFFQVU[>2P0B2Z6R.&@1LXRVY3N(!("DM@=.1G)^%,TMQ\,-#FFE>
M61XF+.[%F8^8W))ZT ;^O:)!X@TMK&>>XMQYB2I-;2;'C=&#*P/(X(!Y!%5;
M#P_=12QOJFO7VJB)@\<<T<4:!AT8B-%W$=1DD9YQD U3\1>*;C1_$^@:1!IM
MQ<+J+REY(]G*I&S;5RP^;.T\X& >I-<[8Z\GA[QQXZ>6'4[V*$VD@A@#3M&G
MDEG/S'"C))QGZ#B@#TNBL<>)+&6RT^XLQ+>MJ,/GVL, &^2/ );YB H 9<EB
M.2!U(%<_K7BWPUJO@Z\N;]=1%G#=K:W4,2NDT$ZR+A&*GY?FV\[L'/4T =Q1
M7-:OXWTW1]8DTF2TU*YODM#=B&UM6<R(& (7^\>>W'!YSQ70P2B>WCF"N@D4
M,%==K#(S@@]#[4 245R5IKFA6NK^*[R%-0^TV0A;4=\<C#B,[?+0]/E&20 #
MD'FGV/C_ $F^N-(C2WU"*'5D!M+F6WVQ.Y3?LW9^]C/MP1F@#JJYC_A$;BWU
M.\N],\2:G817LQGGMU6&5-YP"5,B,5S@<9Q[5#HWC%]0UOQ#;W=A-9V>E2B-
MIY2FU0(P[,Y#<9SD=>!S@Y%7%\86(U2SL+JUO;22^C>2R>>(;;@*-Q"A26#8
MYVL ?;- &Q8V46GVH@B+L,EF=VW,[$Y+$]R3_G%6:XU?B9HC6$=^+;4_L)N3
M:RW)M2$@??L&\D\ MZ9(R,@9%;>H:W;Q7KZ7%;W5[=^1YTL-H0&CC.0&+%E
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M4D\,-9EE@U.)U:TFW#;'&S@,5V[N.0,#GFNC\8RZK!X0U.31+5;K41#^YA9
MV[D9PIX) R0.Y %;E% 'FFE)<Q?$BTUA-'US[#+HKP/<W<9:3S/-5CN!)*\
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MD1^'[V.>ZUPW-K$JJP>,S1/P03T5#D].P)H [UO'%K'K;Z1)I.K)>- 9[9#
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MA^%7# XR2>V ">1M-%UBW^%?A"W.DW;7FD:I;7%U:A/W@1)&+;03AN&!X/\
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M'RCG<">VX#-:6K>.[#2;6XOY+6YETRUG^SW%Y$4*QL&V,=I;<P5N"0.QQG%
M'544B,KHKHP96&01T(KEM5\=66E#59FL;R:TTF1([Z>,+B,L%/ )!; 92<>O
M&: .JHKF-2\:P6'B!]#ATG4KV_\ L?VR-+>-")4W!>"6 '.>3@<=R0#13XFZ
M.WAZ'6/L>H!&OAI\\!A'FVTY8+MD7/N.F: .UHKE=/\ '-O>ZY<Z+/I&IV.H
MQ0&YA@N8T!N8LXRA#$9SV)!_7%;3/B1IVHZ4-7;3=2M=(-J]R;^>)1&-K;=G
M#$ECV '/09Q0!V=%<\/%<4.KV.G:CI]W82Z@K&T:;85D91DQDJQVOCG!Z]B3
M6-/\4+*&QOKY-"UJ6UT^ZDMKV1(4Q;E" S'Y^1G/3. ,G'&0#NJ,\X[UR=_X
M]L[74;>QM--U#49KJQ-_:FU12L\8Q]TEASAL\X_$D IIVKZ1<>-+QFTJ\L]7
M32HIIYK@8_<%B0N QY!W9X[=Z .MHKEM/\<6E_=Z-$;"[ABUJ.22PFDV8D"+
MO((#94E>1G]#Q57P[XTFOH_$EWJUE)8V>EWTT7FLR,L:1HF5.TDEB2S< CG
M)H [.BN<A\86Y\0V6BWMC<V5Q?QO)9M*499=@RR_*QVL <X/YUT,C%(V<*SE
M03M7J?84 .SGI17 Z;XOT#0_ L6KZ?I%_!IDE])#Y*J&=)&F*%F!8\%R>A/7
MI6]IGBJ+4/$=QH<VG7MC>1VXNXA<A,30[MNY=K''..#@\CB@#H*,YZ4R5S'$
M[A&D*@D(F,M[#->;KXLM=(^'&DW_ (5T:>*RN]0%M'%(R[H=UP4<D,QR6.[
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MK.3^P 661PP?]^/F4@D8Q@=ON_2NYU.[DL-+NKN*V:Y>&)G$*L%+X&<9/ H
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MCGZU;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5=(^)-KXFMM.N-2T^XT[^S[B.VVF6!A(75PI(RIS@XZ=:[8RQA"Y==H."V>
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MP%PA#;P"FXY(W#/&>,BL^Y\+^(O^$(\8:-!X=*27^K?:K2.&>((8RT38&6&
M AZX[8SS@ [ZR\5BX\4'0KK2[NQFDMFNK:28H1/&K!6X4DJ>0<'G'ITKHJXZ
M[LM2N/B9HVK)IEP+"'3YH)9B\?R.[(0"-^3]TYP#70Z/>WU_8F;4-,?3IQ*Z
M"!Y5D)4,0&RO'(YQ0!%J?AW3=9OK:YU&W6X%O&Z1Q2<I\Q4DD="?E'YFO/\
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M6S+=V#]UGC.Y/SQM^C&@"34O%,6EQ:K--8W,D.G&-"T.&,LC[=J*,]?G7.<
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MUP69CP. !W/3\-VR\;1:GH&C:C8Z=<22ZK,8(X&X$3KNW^8P!V@;&YP<\<4
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MA. 3\S'D[0/RR,]6OCO2[JQTR?3Y(9'U*W:YA6YG$"JBD [V.<'<0N "<Y[
MD '545A>%/%-KXLTR:ZMXVADMKE[6XA9@VR5.H##AAR"".H-;O2@ IGFQ^=Y
M/F)YNW=LS\V.F<>E<;+\1(DT>PUN+2I[C2K^[^R6TD4J"1F+E%8JV JLRG!W
M9Y&0.UN/5+23X@S60T-H]872!.+N5D!>+S,"+*D\;\Y^G>@#JJ*Y73?&?]I>
M&;S5UTUXYK6Y>T:R>4>9YJN$V9 P&)(P.^1R,T:QXUATR2]@BAMYKFPA66ZB
M>\6(@E=VQ,CYVQST Y'/.* .JHKC(_B';WESHL.FZ5>78UBTDN;5PR(#L W*
M<G@@G!)P/3-:_A?Q&/$=E=R/9R6=U97<EG<V[N'V2)@G##@C!!S[T ;E-=TC
M1GD9511EF8X %.KS/XA:V-=^''B22STQ;O3K=9(?M+2 $R(=I>-2.55LC=D'
M@X![@'I8(90RD$$9!'>EKE9/%$&FPVFFP"VEOEL8[ADN+I8%"$84;B#EB5;
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MFQ Q_N3'C[_/)SQV_*N[HH *Y+Q9INI7WB+PO<V5A)<06%ZT]PZR1KM4QLG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$VUKK-E;P6UR74[9(@W+*#G&6'X ]*V/#U[XSN?)AU[1[6R%LI\Z>&Z64WC
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MVEELVE6-F1XV0X8G;D9!QGGUK#F\/>))QX^:738 ==MDCM0ERIPWV?R^<@<
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M;BQ:=0+B*;J4?. 1P1G'?\0#7\&B4?$[QOY]C%9RF.Q+I"^]6.R3Y@<#.?<
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M8]86Y'S0+]T>3C._:,<G Z\XY@O?!^I:S=^/+>XA-K;:[% MI.75L-''M^8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ9+#;6TJ[ TX!)D\O^!>0,8!Z\8Q6YX4GO[R:TBO/!":1>6P_P!+NY(XO+)
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M1N8;FV\X'8CU&?-]!LKCQ5\#M'\,P65PLETL2/.Z8CCB68.9-W0\+@*.<D9
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MFF3):V$=N%EWQD N)&+M\V<, H  )&.<9JC\6T3_ (0.6=MP:&[M64J3QF=
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M.HHL13;*Q?;,S<KM)/."3V'3(!TMYX[M(-8GTJTTK4]0O(K5+I$M8E(EC8D
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M0\H-TWLP1<^V6% "_P#"$>'_ /GTF_\  N;_ .+H_P"$(\/_ //I-_X%S?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS679Z#XAMO W@B-]$G-WHFH1R7%HLT7F-&$=2RDL%ZL.,]/2O5!)&93$'7S
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M *H& !Z5R$]CJEI\4VU>+39;FPN=)CM3-'(@$3I*SG<"0?NMQ@')XXZCL:*
M/);CP[K\OPHU_15T6X&HW>HRS0PF2+YD:X$@.=^!\H]>M:NH6FM:-XVO=8@\
M,MK>FZO##OB5HA-:31KMQAS@J1C)!ZC\_0UD1V95=69#A@#DJ>O-.H IZ6DZ
M:;"+F"&WF(+-##]V/))"@]\ X)[G)KD[_3]4D^+FFZO'I=P^FP:=+:R7 >/
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M4T<@#DI_K#&A^^%YSDCH<9JT_BFUNKBPM-)1;^XOK7[9&-^Q%@XP[-@D D@
M8))SZ$CFM*T;7/#VC:_X=CTQ[V&ZFN)-/NUEC$>V;)VRY8,"I)R0#D=.>*@L
M_"VK^"O$&C7^F64FL64>CQZ5=Q12(DJ%&W"50[ $$D@C/% %SX5@"V\5 6GV
M/'B&YS;\?NSLCR..,?2J?Q'M]-'C7P3+J$-N8)+N=;@RH"KJ(L@-GJ <=:V_
M FG:KITOB-M3T_[(+W5YKV#,ROE'5 /NG@_*:A\7:9JU]XQ\*7MCI<MQ:Z9<
MRRW,BRQ+@,FT8#,">OIVH S/!(-QX_U:^\/>8O@Z2T54(R()+H-@M"#_  @
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0$>>V:19 Z/Q&R.,!MQX[8)YJ?3?'$%WXIAT&XBMEFN8&GMYK2[%PC;?O(Q
M&U@.>X([T =915>^O;?3=/N;Z[D$=M;1-+*Y_A51DG\A7)P_$*W;6M,L)K:$
MIJ:M]F>VO$F='"[@DJ@ (2.!@L,\9[T =I17G[?$R5="FUQO#MRNG6EXUK>2
M-<)NBQ)Y995_CP3R!@>A/.-!]>UD_%'^PDM8#81Z8+K/GD,VZ4*7(V]1M("^
MY.><  ZR*>&<R"*6.0QML<(P.UO0^AY'%$D\4)02RI'O8(FY@-S'H!ZFO/;G
MQ4;/P=XSU;0]#AL;W3KV:.<2NH\R540M,=H()^8<9YQU%-\4"6Y'@&]O;:%+
MS^VH%WJ_F':8I"?FP#R0"1[4 >D45QVN>/K;2O[3:WBMKD:6<7*/>K%*Q"AF
M$2$'>0".I7)X!)S5R/Q7#JT]M9Z-:I>RW-BM\XGD\I(X7^YO.UCN;GY<=CG'
M&0#H8IXIPQAE20*Q1BC X8=0<=ZDK@_A, /#6I@6PM@-9O/W Q^Z_>?=XXXZ
M<>E:'CO7-4T2UTC^S(87-YJEM:R/)(5(5I!P.#]X @GL#T- '65'!!%;1+%!
M&D<:]%08'/)K$D\07$FJ2:18V,5QJ5O;)<72/<E(H=^0J[]A)8[6Q\HX&3CC
M,_AKQ%;>)M+:\MXY()(9GMKFWEQO@F0X9#CCC^1% &Q17/\ BGQ0?#/]F$Z;
M/>"_O8[-3$ZC:SYQU.3T/MZD52;QG-!Y-I?:=;:=JTB22_9KS4$2-8U;:&,@
M!^]V 4]#G&* .MHKC]+^(-EJ^D6=Q;6K_;[J\>Q2S+CB9 6?YQD; HW;AGC'
M&3BK!\9?8K;5'UC39K&2PGC@!W9BN6DP$,<C!01D@'(&WO0!U%1P3PW,*S02
MI+$XRKQL&4_0BN4L/'$5]KMWH<EI#+>1VGVN'[%=K<13IG:5W$+M8'L>W.:S
M[3QG::3\-])U_3M!2WTB5E1K=)0@M5:3:&.%QMR<G'3/>@#OZ*R;S6Q8ZB\,
MT48M8+-KRZN?-_U*C.,KCG.&QS_"WH,X,'Q#M7U?2;26" 0:L=EO)!>+*\;X
MRJRH!\F>G!89X- ':4R::*WA>:>5(HD&6=V"JH]23TI9"ZQL8U#. 2JDX!/8
M9[5X[KNK:AXG^"GB.^UBSMLI--Y3+)OV%)]H !48P!C.<GVS0![)UHKF+/Q5
M-_PD]MH5]I,MF+JU>>SG:96\T)M#!E'W#A@>I_ \5F3_ !-TZ$6-VJ6\NF7=
MR+=98KM6G3<2%D:''"$CKNR 02.U '=5!=7UI8A#=W4%N';:AED";CZ#/4U/
M7F\!FUKXA^++#6=.M9].CL;6&1);C*Q0MYK$CY>K'D],;1R<"@#TBH_/B\_R
M/-3SMN_R]PW;<XSCKC/>N-'C6#2_#5CK0TMH_#+%(DN1-F2*(D(DC1D?</'\
M1;!!(Z@1QV\"_'"=DBC'G>' TA"CYS]H(R?7@ 4 =M%/%.&,4J2!&*-L8':P
MZ@^]25YKX,U6R\,^%->N)(B(D\0W=O!;P@ N[3;4C4<#DD#T'X5TP\3SVWB*
M#0M2T^.VO;R!Y;%TN#)%.4&60MM!5@,'[I&._:@#I**X67XC&'P=)XBDTG9'
M;WK65W ]R ]LPD$>6.W'4@G'8@\]NCGU6<:E+8QZ>+E8[,7$A289RQ(5 & !
MSM;G(X!]L@&G!/#<PK-!*DL3C*O&P96'L14E>?Z?XVL=-\$^&M0TWP])%8ZI
M<I:PVMNR 0%W8#CC)."< =>I'6MG3O&!FU36-/U;3FTV?3;=;MLS"57@8-\V
M5'!&TY'Y$T =/17%MX]E2WT&[.B2O:ZZP6R,=PN\%EWH'#8"Y7)X8\C%=I0!
M''/%,TBQ2H[1ML<*P)5L9P?0X(_.I*\GT'6+SPR_C1]*\-RW]M;ZW-+,()4B
M$:>5&3M4\LW4[0/QYKK7\=Z;/!I[:?+:O)?VGVV(7ER+=%C. -S88[B<C !^
MZ>F* .KHK@XOB=;W&DZ5?0:1=2F]U+^S)(TD0^3-SQG/S @9!& 01DBM*P\:
M*USKUOK-@VF2Z-"MS-F82JT+*S!P0!S\IR/YT =55>>^M+6:*&XNH(I9CB-)
M) K.?0 ]:Y6W^(%O)KNF:;-;VX75%;[-);WBS,C@;MDJ@?(2/0L,\9K"T>";
MQ+JOC2WUS1(+^W%\D;1?:,LFR)"B)D+QDDYRO+'\0#TN">&YA6:"5)8G&5>-
M@RGZ$5E:UX7TO7KBWN;I)X[NV!6&ZM;AX)4!ZC<A!P<=#Q7%-XLE@\!^%+WP
MSI%M8V>I:E!;"W,FSRD:8Y4 +CYL$$]MQZUU-UXHGCU.XTJUL(9]2M;)+N:V
M-UL9@V[Y8OE.\_(<D[1ROKP :NF:-::2CBW\^21\!YKF=YI'QT!=R3@9/'09
M-:%,AD,L$<A4H74,5/49'2B9VBA=TB:5E!(C0@%CZ#) _,T /HKSI/BH_P#P
MC]AXCF\-WD6@W#A)[TSH3!ER@;9U9<XR>.3QGOJW7C2^'B+4=$T[PW<WUS9)
M#*2+F.,.DA(W DX&,9 /)]!B@#L**Y.Z\9NNFZEJUAIC7NEZ;+)'<2K,%D?R
M_P#6-&F,,%YZLN=IQVS*?&4;:]H5E#:K)8ZU"TUI?>=A6P@<J5VYW8.0,\\^
ME '1S3Q6T+S3RI%$@RSNP55'J2>E2 @@$'(-<=XH\10P>%_$-SJ&AKJ&FV+&
M)XA*I%P  6)# 8 )P>IR#QQ6I<:\L5_8Z/I]HD]]/:FY\EI/+CAA&!N9@IQD
MD*  <\] * -F.>*8R"*5',;;'"L#M; .#Z'!''O4E>7>"=9M?#VE>+;J[M4L
M_P#BI)84ME=0HD98E"AN!C)SGCCFM^U^(FGC4M3L=2^SP-867V\SVMR+B%X0
M<'#!00P/&TC/(QF@#HM9L-,U;3GTW5DBEM;HA/*D;;O;.1@Y!SD9&.>*IZ;X
M3T[3)DE6;4+IHSF(7M]+<+&?55=B ??&?>N-\3W5WJ'B/P)>W6CQVJRZF&BF
M,H>55,3G8XVC:3P< L.#STSZ<>E #7=8T9W8*BC)9C@ 41R)+&LD;J\;@,K*
M<A@>A!KS&;5]3\1^#OB#'J]C:_9[-[R","7?Y9C@7: "HSSEMV1R>E:?AKQ5
M/96OA'2;O298;74;&.*VO#,IW2)"&PR#E00#@Y^H% '>T5Q][XY>Q*W,^DR1
MZ<=4&F>;))LE+EMGF",K@IN[[LXYQ2Z?KVL77Q)UC1Y+6 6%G;6[*1.=V'+G
M?C;R3@#&>,=3F@#KZCFGBMX_,GE2),@;G8*,GIR:2Y>:.UE>VB26<*2B.^Q6
M/8$X.![X->/ZMJUYXD^#>G:YJUI"9WO[::*1#O;YKD @#'RX'R@9.10![+17
M,67BYV\1WFC:KIC:;)!9?;XY&G60/ &VL6V_=(/49/UK/C^)%D;[1T>& V>K
M2K#;R0W:R2QLPRGFQ ?(#[$X/!Q0!V],EFC@0O+(D:#JSL *?7G7P^:+QJNH
M^*]5B2Z>2]E@L8IE#):P)P JG@,>2S=3Q0!Z&KHX!1E8$9!!SD4ZN.LKKPMI
M7B_5!9S?9+Q+,/?6RVTB1HB$L)3\H4<$\C[W'I44?Q&M#J.D0O;PFVU9Q';O
M!=K++&Y&5$L8'R;NG#-@\'% ';45P$WQ*N(]'U755\-W)M-)O9+6]9KE R!&
M 9E'.XC.<=,=^U;NK>++:POUT^W:S>\-N+DB[NQ;H$)(7YB"220< #L<D<9
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M282921RPZ#C^?L*D\=Z1J&K:5IS:9 MQ<6.IVU[Y!D">8L;Y*@G@''K74T4
M<3%I>LZ/XYO/$,.GF[M=7M(H[NW@F3S+>:($*07*AEVD@\YSVK4\'Z!-H=IJ
M4MUM6ZU/49M0FC0Y$9<C"9[X4+D^N:WY)HH0#+*B9Z;F S1'+',"8I$<#NK
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M(8'D$'N*?0!Y9_PB'B>YTK7G2WMK+4&U\:SIV^<.KLH0!&P. 0I_.MG4-/\
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M53)##(I'ENI()VYP",Y&.E=[10!Q'A1O&MO;6>BZOI-I#'9!8WU1+I7%Q&G
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M%&8[B\@N?,-V-I'RIM^3/4DGV YXI>$=.\9:#86WAFYM;)M/LFV1:LMQ\SP
MY"^3M^_CY<DX'7G'(!8\/:]KNH:WXJBN[.UEAL+KR(HHK@Y $:L% 9 #G=DD
MD>F#BC0_%]A_PAWAVXT[28K5]7<PV.G1,%1#EB<D+PH"EB0OX$FIM&TG6='\
M2^)IS9PS6.HW NH95G <GRE39M(X.5ZDXQ7/Z?X)URR\(^$3'%"NM>')V?R&
ME'EW$;9#J&'0E3P2.H_&@#I1XPF@U/5-(O=,$>J65G]NBBBGW)<PYQN5RJX(
M(P01],U0LOB#=W$'AN^N-!-OINN21P1S?:@SQRNI91LV\J<$;L@^WK/<:%?Z
MEKU]XBELF@F_LEM.M+1I$+DLQ9F<@E1SM P3P">^*RAX8UQ?"/@G3/L*FXT6
M]MI[K]\FTI$K*=ASR3NXSC\* /2*QM8GEO;A-$LY&CEF3?=3(<&"#..#V=L%
M5],,W\.#LUSNJ>!O#NM:C)J%_8R274@4.Z74L>0!@<*P'2@#+^$8Q\+=# _N
M2?\ HUZT/%$TNHVUYH]I(R(MLTM],AP4CVG$8/9GQ^"@G@E36-X0\,ZIX'^'
MJ6^G:=;W.ND@S1/=L(W/F'D,<@80]@,D5J:W\/\ P_K$E]>RV#M?W*$LXNY4
M#/L"J2%8#H .G:@!WPV_Y)KX<_Z\(O\ T&K'CN&*;X?^(EEC1U&FW# ,,X(C
M8@_45%X!\,CPIX/L=.>(1W8C5KK;*S@R[0"1D\#@<# ]JU/$.G2ZOX:U73(7
M1);RSFMT9\[0SH5!..W- '&:)XQO=&T[PK:ZGH4D&E7\-M9P7XN%<B5HQL#Q
M@?*&QP<GW Z5<U?XCV^GV]Y>VUO;7=I9W)MYHUO MR^UMCM'%M.X YZD9P3T
MQE(O#^JZOI'AO2-2L190:1+;S7$AF63SV@7Y!'MYP6 )+8( Q@YR(=*TWQEX
M9U#4-*TZRL+W2+J[EN;6\FN2C6GF,6973!+X8DC!&>Y&> !\+6P^-37<01$E
M\-"5GQMW#[1U/X>M6;CQ\UOX=B\3G2]WAYY!F=9SYRQ%MHE,>W&W.#C=G!SC
MJ ^;0+^X^(DFHS0%],DT0Z:\WF*'9S)O+;1VQQ]>V*Q[?PIKW_"O9/ ES!&8
M@/LR:FLB[#;[\YV?>$@7C&,9_BH Z1/$]S)XKO-!73H?-CL1>VDINCMN4+;?
M[GRX/7KU'7-5M%\:R:[X6TW5[33X?/OKK[,MJ;KE"&8-E@G50K,1CH.#2>*/
M"=QJ5UH5QI4PMI+)VMIGSR;21-LB@_WN%*^A&:30?"$FB^,-5O(W1=(E87%G
M;*.(YY%"RG';A!C_ 'VH ["N>UKQ%>Z=>7,%KI8ECM;(WDES<S&&$\D"-7VL
M"WRD\XQQZUT-<3K6C:_=^+YYUM;6^TR6Q$-KY\^P64WS;GV;3N)!'(YXQD"@
M!S^/R\'A>:ST>:XC\0*3%^^53$WEE]I!Z],9X'?VI]KX\CALO$,FN6/V"XT)
MU6XBBF\X.'4-'L;"Y+9 P0.:P]+\,>(K6Q\"0W.GPAM"=OM/EW"ME3$8QC.,
MG)SCICN33M8\$:KKTGCB%T6T366M9;&9I VUX%4#>!R 64=,\'UXH =K4E_-
M\3/ DU_I=M:N\EWMDBG\QA_H[?(WRKC&<\$CK^/I->?S67BW6=?\*:G>:+:6
MC:7+,UT#>A@V^(IE<*>.<@'GL<=:] H YE]5M_\ A9,.DOI$7VHZ8]Q'J)*E
M_+$B@QCC(&3GKVZ4F@>+)?$*65Y964$FG74CHTL=SNDMRH8@2)M^4G;C&>"1
MUID^E:B_Q/M-:6V!T^+3)+-I/,7=O:17R%STPN/7/:L;3?"5[_PD^DZZFF+H
MVI)N_M>2WF7R+T%",!%/)+D-D@8YY)Q0!Z'7(:WXYCTZ75(K*.RN)=, \^*>
M]$#R-L#[(UVMN.TCK@9('KCKZX-].\5^'?%NJW>B6%GJFEZO(D[Q377D-:S!
M C-G:=RD*#P,_P!0"GXAUZ]U;4_ ESIUM&;*^NC<)'<3M$S.('(5P$.-N<YY
MY'3O4:6=Q9?%N"PM=)TZ.VETNXNY(!<L$9Y)8EDD(\O[Q  QC!'<9Q6UKND:
MU=ZWX4NU@6[_ +,G>>\E5UC#%HRF$4GL6SSV Y)J673-3/Q/M]<6RSIZ:6]D
MS>:N_>TBOG;G[H"X]?:@#';QSI/AO15;2;"S;1;.X-MY$%V/M 42%&=(=IRH
M;)QN!(YKH+WQ/=--JL6BZ8NHOI<8:X!G,9=RF\1Q@*VYMN.N!E@/7&%H>F>,
M_#3W.@6=I8W.D/<226>I27&U[:.1BQ5H\$NP+'&" ?4=IO[+\4^'/&&K7NBV
M-IJFFZPT<SI/=>0UK,JA"Q^4[E( / S_ % 'S>)=;N/&_AZRMK&."SO=.DO'
M@N96BE##9D.-AP5W'Y><GJ1BK-CKS2:IXM33_#L*ZCISQ>:!*JO>DQ[ERP4\
M[< 9SZ<4W4-$UP>+_#^LP+;7AM[2:UNV>3R@I<H=ZC!R,J>.O3GO5CP[I.HV
M7C'Q1J-U;".UU*6![=A(K'$<80[@#QDC(Z\>E $FF^+7U;PYHFJV=G$[ZJZJ
ML!N"/+X8MEMG)4*V1@<@C-9NK_$>WT^WO;RU@M;NULK@V\T8O MRY5MKF.+:
M=V#GJ1G:>V,V?#'A.XT+Q!JTKRJVF&=Y=-A'_+'SMK3#Z;U^7T!;UK.TO3?&
M/AG4M1TS3K*POM(N[N6ZMKR:Y,;6GF,6973!+@,21@C/J,\ '>PRI/!'-&<I
M(H93C&01D5EZMJ]W9:A965GIYN'N5D=IY',<$"H ?G<*V"20 ,<\^E:L:LD:
MJSEV  +$ %CZ\5RGB;3=;NO$ND7-K:6^H:5"DBW%E-/Y2B4XV2G@A@N#Q@XS
MD#- %$_$C/A.PUR+2'E^T:@-/EA2X4B-_-\O*MCYQD9' S[5I67B^4:]J6E:
MUIR::]G9#4%E6X$JM;Y8$M\HVD%3D<_6N3C\(>)8_"<>DO8VS2Q:^-05H[D8
M:(3F4]0,$@@ ?7.*V]7\,7^M^,-4N);=H=-U#0&THR^8I='9F8MM!Z8;'U'I
MS0!C>,=3NM;TWPAJ;:3#%97&N6,EO*TVZ9$:0%2R[<+N'8,<<?AZG7ETNA^,
MKOPOH&BW&E67GZ-?VDAN?MH$=Q'"W# ;21D 9R/H#V]07.T;@ V.0#D4 8.M
M>)X-,U.+3(WL_MLD!N/],NA!&J [1EL$DDYP .QZ<9P(_B69M)TJ]BT.=WO=
M3_LR6(3K^ZEY^Z2,."!D'@'(Y%6O$FE^(;/Q=:>)_#MO;W[?9#8WEA/-Y/F1
M[RZLCX(!!)Z]C4>O:5XBUB#P]--:0&XM=7BU">&*8;88D5AY:L<%VYSG &<]
M!B@#1T?Q/J&HZKK.CW.DPVNIZ>L4BI]K+Q2I(#M.\)D'Y2"-I_&N.\*:C!'\
M/K#6]?TZWNIDU*:2R=92\TMU)<R(  5 7DXSD\#) Q75V&FZG:_$#7-:>Q8V
M=W:00P[94W%H]V<C/ .[CGMSBN=M? ^M3_#&UT.5(K36-.O3?VLAD#Q-()FD
M4$CG&&P>/?F@#JAXHN+3Q+:Z%JVGQV]Q?0R2V4D%QYL<S(,O&254JP!STP1W
M[5EZ;X_O+ZVN-1GT VND64MU%?7;7:DP>3GD)C+Y(QQT)[U<DTJ_UWQ+HFLZ
MAIYL4TB.9U@,J2/+-(H3@J<;0,\D@DD<#%9^C>$;^?P1XA\/ZK$+5M2N+N2.
M1) X"S,64\=QGD?K0!M6WB'5'U'2XKG09([/48W=;B*4R?9L+N F&T!,CC(8
MC/'O6/+\2[5$L+V*"VN-,O+A8 T-X&N8U8D+(T(7[O<_-D @XSD"WX97Q@UK
M:Z9KUC96T-I&(YKR&Y\PW8 P-J;1LSP22?8#GC/\*Z=XT\/6D/AA[6QETRU;
MR[?5_M'SB#.0##MY<#@<@?7'(!>U[QS/H5MJ6H3:01IVGW26SO-,8I)MVW+Q
M(5PZC?\ WAG#=,5DWTMYI_QBOWT?24O;N708F,?G+ I/GOEF8@^@'0GIVY%3
MQ%X3\4ZOIWBNQ>RLKJ:^N/,L;^6YP4@#(5@5=ORXVG/(!))Y-=#)IVMVOCM?
M$8TV.YBN-*2RE@M[A=\,BR,^?GVAE^;&<YXZ4 <WXN\0V_BWX57=\]@UI>6>
MI06UQ;389[:9;B,,H;OP>HZ@UV.L>+8[#4KC3;3[ ]Y;P+-(MY>BV7YL[54[
M6RQVGM@<<\USNK>"M5;P/JEA;10S:IJVJKJ5P!(%CC/FH^T,>2 L87..3SQ5
MW4=/\3Z1XQG\0:!86^H6VIV\45[8W%R(7CDCR%=7P1C#$$<T ='X8U^'Q/X=
ML]8@@E@2X4DPS##(P)!!_$'GO6O573EO5L8_[1:)KMLM((ON*2<[0>"0!@9/
M7&>,XJU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !117*_$BYO;3X>:Y-8A XLY0[M(4**5()7 .6
M]N/K0!NV>LZ7J-Q+;V6HVES/" 9(X9E=D!Z$@'BK,T\5M"\T\J11(,L[L%51
MZDGI7&6E['83^'HCI-B?$%[:&"W=)20ELBJ[%GV @9V_* >2.>I#[CQ#_:MC
MXIT#4K-(-1T^S9W17\R.:)XR5D4D ]L$$<'UH Z<ZQIBP6DYU"U$5X5%LYF7
M$Q;&T(<_-G(QBKM>23QH?AQ\,'**774-+ ;'(^6NYD\0WE[JNJ:=HEG;W,NF
M!!.UQ.8U:1EW"-<*><8R3TR.#S@ Z*BN&3XB"YTSP_JEKIP-CJ=Z+&X::<H]
MG,25PRA3D;@1G(ZCUJ[:>,7D\0>(]*O+6UMFT:!+CS!<E_-1E+!B-@V@8P>N
M* .EFOK2WNK>UFN88[BY+"")W :7:,MM'4X')Q4]<?-K]POB/PE::EH-LEUJ
M:3LLOG>8UFZQ%V5<H#DC )&.]4+CQYK0M/$EQ;>'K=UT&=UN/,OMOF(B!R4P
MARV#T( ]STH [^BN:D\6+-?Z)8:? 'N-6M6O$:9MJQ1*JG)QG))8# ]SGCEW
MA/Q+<^)$U+S].2S:PO)+*3;/YFZ5#AL?*..00>^: .CK&UBRT'Q)'+X?U0V]
MV2%F>S\[#@*1AL*0P&<<UD^/M7U;28-#&EB "[U>UMI6DD920T@.T8!P#C!/
M8$\'/&/<OJ,'QA9['3[674)?#:%D:<I$&^T')9]I8CL,+D\=.P!Z#:6EO8VD
M5I:0I#;PJ$CCC&%51T %35QEC\0(;OPUINH2VT=M>WUU)9BWEGPB2QE]Y+X^
MZ!&QSCG('>KWAKQ1+K6I:IIUQ:+%-8LA6X@<R07".,@HQ Y'0CL>YH Z6BLC
M7]?@T*&U\SRS/>3BW@6238I;:6)9L' "JQZ'L.]8EEXQU.^;6K.VT>&YO].5
M9(?*N6$%XC#.$D*<..A4CKWH [*BN3\+>,)_%<5O<66GQBV^S[KMVG8-!<9(
M,&"G+#')XQD<<BL23XC:Y_8>HZS;^%DEL]+NIH+T?;AO"Q-AFC&SYL $G./;
M/. #T"2^M(KV&SDN84NIE9HH6<!W"_>(7J0,C-3UR)\2V]UXN\/P1:9!-'J5
MA+=6E^S#S$0*A*@;<C.Y>_;I5?2?&6MZO<WOD^'$^RZ?J$]E=NEYN<>6N<HN
MT;R3QCCJ.O. #MJ9++'!"\TTBQQ1J6=W. H'))/85R%EXTNWUW1-+O\ 38;:
M;6+:2>.$3DRVS*@?9*I48R">>Q!&#UK/T#Q'K=UHGBV^U.QL[M+&]NXA MPP
M!$2J#& 4(VX!.>Y)X&: .]M[B"[MHKFVFCF@E4/')&P974\@@CJ*EKD;'Q7&
MVD>%K>QL(8[S6;19K>T#[(K>-8P[$D#[JY"@ <DCIR1!/XZN+*#Q'!<Z6G]J
MZ';_ &IX%N,1W$)4L'1RN>Q!!'![GK0!VM9D_A_3;G78-:EAE.H6Z&.*47$@
M"J>HVAMN#@9XYKG[/QGJ+ZMX>@OM'BM[+7(B;>5+K?(CB/S,.NW !&<88^^.
ME=?//%:V\MQ,X2*)"[L>BJ!DG\J )*K7VHV6F6YN+^\@M81QYD\@1?7J?I7)
M7'CN>S\/67B>YTQ%T"Y:,M()B9H8I" DK+MP0<KD Y&>]5M0N=5D^,.GVR6]
MI+;IH\[QI)<, 5:6,,Q&P_-QC'(([B@#N[>XAN[>.XMYHYH9%#))&P96!Z$$
M<$5'>W]GIML;F^NX+6!>#)-($4?B:CM;"#2M,%GI5I!!%$I\F!?DC!.3C@'
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MY?:P'&&]N1U'3G&QHWB2^N_%&H:!JNG0VEU;V\=W$T%P9EDB=F7DE5PP*^E
M'2T5B^+-<E\->%[_ %F*T%V;2(RM$9?+R!UYP?Y5AKXVU*U\0:19ZOH0M-/U
M@^79W27(D99-NX+(N!M+=L$_SP =M17!WOQ'6"S74[2TAO-.%SY+1Q3DW10/
ML,JQA2",C.,YV\\=*LCQ;K=UXGU;1=/\/PSMILEMYDCWNP-'*"2P^7[P'\/L
M>>@(!UEO?6EW)/';7,,SV\GE3+&X8QO@':V.AP1P:GKB+/QG96.G^*]2O-*B
ML1I5\89A;L&:ZDVIM;.%RS%E49]N:OS^)[S2M<TJPUJP@@BU5C%!/;SF01S
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MNO'%_)HOC$6<%E_:.@0[_-6<R0R Q%PPXSN&""I[CK0!WM([JB%W8*JC)).
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M9DO+B0AE15(&.<;.>1UH\/Z#KFGZ7XJMW,-I=:G?75W93QR[_*,J@)N&!RI
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M;G3[@3_8;Q[DHR)(Q;8Z;3E@2><XYKTC2XKB#2K2&[6);B.)4D$3EER!C@D
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M+UP #S0!YRW@OQ*?!]YI+0V#W$VN'44=9RJF/SQ+R-IP3C@9/7DUN:GX9O\
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M)\IVAMO^UGH:M'PKXD.I>*+KR])1-:TV*V2))GQ"Z(Z!<[.5^?.[ Z8VC.0
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M@D3(*KT8#/KBM.30]9U]]!&OQ6<(TJY6\D>WF+_:)D4JA4%1M7+%CGG@#WH
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MATY;M?WLSR:-V%GEQ, #V_>]<?PJM &KXC\2W=CX<\2:A_9=G>V6G$HL<LI
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M 4444 %%%% !6?J>B:=K/D?VA;"<6\@EB#,P"..C#!^\.QZBM"B@!  J@#.
M,<G-+110 4444 %%%% !1110 4444 %%%% !6?8Z'IVFWMU>6EMY5S=$&>3>
MQ,I'0MD\D= >U:%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<YVXS[UH444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNYC@C'% 'KRNKYVL&P<'!S@T@E60/Y3H[+P0&Z'T->5R)I/AO7OB#;@2Z=I
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M;;XDNI>K@.1CW ^Z#Z 5NT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMQ=VPQ#++&&9!UQGTSS59/!WAV*""&/1K2.*WF,\*I'M"2'^,8Z-[]:N7)U
M:Q8^3<6B6!603Q2*?-=L#;L.<8'.<BK3W5O&P5YXE9GV ,X!+>GU]J *L&BZ
M;:ZG/J4%I&E[. )9Q]^0#H">X';TJ_UJ*>ZM[50UQ/%"K' ,CA03Z<T]I$3;
MN=1N.%R>I]!0!A1^"/"\48CCT#3U03BX"B!<"09P?PR>.G)JTOAK1D^V[=/A
M'V[_ (^L9_?_ .__ 'OQJS<ZK86FG3ZA/>0I9VZLTLV\%5 ZY-8>O>(-27PA
M!K7AR&RN)7$<ODWCD;T9<[%V_P#+0Y4 >IH T6\+:&]O9V[:; 8;)@UJF#B
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MP=.+7,@EG)MD/F,#D%N.>>?KS5Q-%TN/41J*:=:+?!/+^T+"HDV_W=V,X]J
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MJ'Q7\36&KPQRB*QM?[/BF4,I@8-YI4'U<@$^P':NXBBC@A2&)%2.-0J*HP%
MX %4[_1=,U26*6^L8+B6'/ER2("R ]0#U /<=Z /']1MF7X'^)X;A1+:6.IS
M0:9)*-Q6W6X55VL>V=P'L*]JM[:"TA$-M#'#$.0D:!5'X"JMUHFE7VGI87>F
MVD]D@ 2WDA5HU Z84C'%6X((K:%88(TCB085$& /H* .%FMK$?'$2306X)T
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M$96V0;8R<E1QT))R/<U8M=&TNRTY].M=.M(+)PRM;1PJL; ]05 QSWH \_\
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M58'((]:JS:98W&EG3)K2&2Q,0A-NZ@H4 P%QZ58BBC@B2*)%2-%"HBC 4#@
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MJLGLPQR/:IET'2$TE])32[-=.<$-:+ HB/\ P'&* .!M8HC\3==LKP:>5N-
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M,NW(>0*1N.%ZGN>GK5:P:\.HZDMQ?6L\(D7R(84P\"[1D.<G))R1TXKAM/\
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M5RFFR))\8]89'5E;1;4@J<@CS).:M_$V"&?X:>(1-&CA+*1UWJ#A@IP1[@T
M=''=1Q06ZW-U 97CSN#!1(0,L5!/3OWP*=%?6D]I]KBNH)+8 GSDD!3 ZG=T
MKSC4M.L;SQM\/!<6L,OFV%T) R@^8%AC(#?W@"3P>*J6&FQ36/C/2K2^BTH+
MXCC:T;RP8DFQ"ZJ4Z;6< $>] 'H.I^*-&TK0KK6)]0MVL[9"S/'*K9/91@\D
M] *N'5M/2R2\DOK:.W?@2O,H7/IG.,UY/XBO;N\\"^.[+6M(M;76K2"%[F:T
M.Z&XW#Y)%SR#M4@@\X KIK_4-(/B[0[6S>T6^CL)Y8[B60?9X8SL#_(" [G
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M4' 9-B@*Y')[]">O/J.DZ-IFE)(^G64%NUQM:9XD ,I P"Q[GW- %B[U"RL
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M/3)( '?GTJU:SR)JVK-<:O:36L?EF.V555K0;3NWMGG<1D9 QB@"0>']& N
M-(L +G_7C[,G[W_>X^;\:MVMI;65NEO:6\5O @PL<2!%4>P' J"'6=+N+M+2
M'4K.2YDC$J0I.I=D(R& !R01SFL/0=8U*\\<>*=*O)HGMM/%J;81Q;"!(C,<
M\G)X'Y=!0!KS>']%N)[F>;2+"2:Z39<2/;(6F7T8D?,.!P?2M".-(8UCC14C
M0!551@*!T %5;?5M-N[N2TMM0M9KF(9DACF5G3G'(!R.:N4 4(-#TBUNOM5O
MI=E%<;B_FQP*K;CU.0.I]:270='GU6/5)M*LI-0CQLNGMU,JXZ8;&:Y[Q9J?
MB?1-(U[6;:XTQ+2QB,EM!+:/(\H"*26<2J!\VX?=Z 4L%YXL?1K?4VO-*DAG
ML#.0MDZF%R@=>LIW+U'8]/>@#I(])TV&_>_BT^T2]D^_<+"HD;ZMC)HMM*TZ
MRN)I[73[6":?_6R10JK2?[Q R?QK$\&^)8M8\-:))?W]J=7O;-+AH ZJ[9&2
M0F<XK;NM6TVQN(K>[U"UMYY2!''+,J,^>F 3DT 16/A_1M,-P;#2;&U-Q_KC
M!;HGF?[V!S^-/LM%TO39#)8Z;:6K[=NZ&%4.,YQP.F>:N.ZQHSNP5%!+,QP
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M@=/:K-S;6][;26UU!'/!(-KQ2H&5AZ$'@U5BUO29Y8XH=4LI))?]6B7"$O\
M0 \]#^568[RUFN);>*YA>>+'F1JX+)GID=10!#::5IUA;O;V=A;6\,GWXXHE
M56XQR .>.*+'2=-TL,-/T^UM YRPMX5CW'WP!5+4]8:+6;'0[,K]NNT>9F(R
M(($P&<CN2650/4YYP0:M_P"()Y/$:>'-'6)[Y(A/=W$P)CM8R<+D C<[=ER.
M,D^A -B\TK3M1>)[VPM;EXCF-IX5<H?49'%,_L321<S7/]F67VB8%99?LZ[I
M >H8XR?QK(US7+G3+[0]"MI4EU/59759I4^6..-=\C[1C) P ,]2,].6:;K=
M_>:KK?AZ26%-4TWRY8I_+^2>*094E<Y&""K8/N,9P #870M(737TY=*L5L7.
M7MA;H(V/NN,4^/1M,BL9+&/3K1;23_60"%=C_5<8/3O4'A_6XM?TI;R-#%(L
MCPW$).3#*C%70GV(//<8/>K]S<V]G T]U/%!"OWI)7"J/J30!2/A[13'!&='
MT\I;G,*FV3$1_P!D8X_"I)=%TJ>XN+B;3+.2:X01SR/ I:5!T5B1DC@<&N>\
M,>)+C5?%7BBUEOK2YT_3S;&UEMP H5XV9LMDYP1C.>W:NA@UK2KJ*:6WU.RF
MC@&97CG5A&/5B#Q^- $9\/:(8H(CH^GF. [H4^S)B,^JC''X4Y-"TB.]-XFE
MV2W1<R&98%#ES_%G&<\GGK4@U;3FLC>KJ%J;4'!G$R[ ?3=G%63+&(O-,BB/
M;NWYXQZY]* 'UGVV@Z/9ZE+J-MI5E#?39\RYCMU61\]<L!DTZ+6=+GNHK6'4
MK.2XEC$L<23J7=",A@ <D8[TZZU;3;*XBM[O4+6WGE($<<LRHSYZ8!.30!SW
MC+PC;ZOH6L#3-*L/[9O[9K?[6T:H^",?,^-V*U4T.RU#3-.36=+L[B>T1=@G
MC67RG  )4D>W6KEUJVG6+.MYJ%K;LD?F,)IE3:F0-QR>!D@9]Q5>UFFDUZ\'
M]JVL]KY,1CLXU'F0DYR[,#DAN,<=J 'R:!HTUK/:RZ38O;W$AEFB>W0K(Y.2
MS C!.><FG#0M('G8TJQ_?1K#+_HZ?O$7[JMQRH[ \"GQZMITU\UC%J%J]VN=
MT"S*9!CKE<YJOKFK6^FV,H.HV5I=M&Q@^TL,,1_L[@6YXX- %VTLK6PMUM[.
MVAMH%^['#&$4?0#BIZP/!&JW6N>"='U2^96NKJV624JNT%CZ#M6_0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7$?%<HO@@R2;0B7]FS,W11YZ9)/85V]1W%O!=P/!<PQS0N,/'(H
M96'H0>#0!PT.H(_QC19Y(VM)]&(TQP049Q+^^"GINP%SCLHJ;X>6TEK=^*8X
M.-)&KR?8E'W1P/,"?[._(XXR#767.E:=>VT=M=V%K/;QXV12PJRKCI@$8&*L
M10Q6\*0PQI'$@VJB* %'H .E '#S3VUM\;P;B2*+S?#Z+'O(&]_M)X&>IY%<
M1?V=F_PE\>7I@A:Y36;LI.5!=2+@%<-U'7MZ^]>US6-I<7$<\UK#)-$"(Y'C
M!9 >N">1FJPT+1Q"\(TJQ$3L&9/LZ;6(Z$C')H X6]U6T@^)6J6>N:P=-AN]
M.@^PO)Y0BFC&_P U=TBD9W$9 QD8ZX%=9X,T_3]+\*65EI-Q<W.GQ!Q;S7#!
MF=-QP00 "O\ =/\ =Q6A=:+I5[;PV]WIEG<0PG,4<L"NJ?[H(P/PJZ%"J%
M & !VH Y.07NN^*KBYTZZLEM])5K/]_ TP:9PK2$;77&%V+WZN*P_AT?[$U'
M7? .H/#*;&3[3:*%PKVTOS%0I)X5B0<D_>KT"TTZQL"YL[*WMR_+F&)4W?7
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M 8EQ$?5>/E/TK-UK0HI]&U6+3+"RCO[VVDA\TJ(\EU(RS!2>^: /-Y=%T]_
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ML0T?3!+#(--LQ)" (F$"YCQTVG''X4@T72AOQIEF/,E$SX@7YI!T<\<M[]:
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MTS4(9IK/4;2XB@)$SQ3*PC(&?F(/''/-%CK&F:F\B6&H6MT\8!=89E<J#T)
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M&T64WL2-F,$] .F* /5-6U6RT^%HY]3M+*=T)B-PZC\<$C(&167\/M7O=?\
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M$-KI5Q9W,=N40)&+QF4L3CC>R# )Y/- '9?VUI7]F'4_[2L_L &3=>>OE?\
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MC,F%4LRCKM!;&>AQ0!NR1I+&T<B*Z,,,K#((]"*ABL;."U-K#:P1VY_Y9)&
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MA:VZW#7"P1"=A@R!!N(],]:5H(7E25XD:1,['*@E<]<'M0!XEI]]:?\ "GO
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M>8MP)1O/'(P@8D]@*V&U/1H=>\7Z!XNU6:P-[=-(D;L%2ZMGC5%"':22 I7
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MCMK#P[=3NL=O!X@LY)97.%C4,<LQ[#WJ#Q5<2:/XGT+Q;I<#7:7D3:7,D?\
MRU$GSP'Z>8,9]'KO7C25"DB*ZGJK#(-*RJP 90<'(R.] 'F7A#3K[3=<N/!=
MT&ELM-N5U2.XV;4>-_F1 .V)M[#_ *YU-X=O;.VNO'>F>))8HIWU":X<7! \
MVS=%6,C/WE"J5XZ=*]'VJ&+;1N( )QR0/_UFHY;6WFDCDE@BD>,Y1F0$J?8]
MJ .:^&UIJ%C\.=#MM4$@NTMAN63[RJ22BGT(4J,>U9OPWS:IXPCNF"2Q^(KN
M20N<?*P1E8^VTBN\K,&D)!K<VIVS*AND5+R)AE9=H(5O9@#CW& >@P <9+X^
M\':OJL5S=:_9?9+"4M:VX?<\\PRHDVCD@9(4=R=W]VK?Q+1YX_"<,(/VAO$5
MHR =0%WLQ_!0<UVHM;<$$01 COL%4WTE;G6X=3NF#M:JRVD8'$9889SZL1Q[
M GU- %3QLC2> O$:(I9FTNY  &23Y35Q*^)=%6R\!8N+))&MV2+5)I/W5HRP
M*'7J%+L&V@,< @]2,5ZG41MH#&D9ACV(<JNT84^H':@#RKPM?:')X3\6Z=J<
MJWL=QKEU#]G<JLDYD<!!C "LQY!P,8)X .-+P'?G0+G4_"VN2";7K.-9EF#[
MWO;8+B/;G!RH&TCCGGJQ->B&WA.<PQG+;C\HY/K]:7R8C)YGEIO_ +VT9_.@
M#Q*UUS29HOA_=VUY:6UG%J#!;"!MPLE:.0!)'.6+D\<D9YP#C-;FE_V&J?$6
M#6%M2\FI3%XI0OF/&8DV8!Y.6SMQWZ<UZ>MM H^6&,?/OX4?>]?K[T/;6\DZ
M3O!$TR#"R% 67Z'M0!Y5:PW&D3_"BQU:41WL*S+(DC#<O^C$!3],A?K4%O?:
M#/\ \)/X9\7ZG<VUS)J4[M9L<?:XG?=$T?R[F.-H !S\HKUYX8I&#/$C,.A9
M0337MH))TF>&-I4X1RH++]#VH ;9QB.QMX]KJ%B5=LC;F&!T)[FO.=*T^ZT[
MQ+=>!!;O_8YN1JUO(!\BVI8LT/X3 #'=6->D72SM:3+:ND=P481/(NY5;'!(
MXR,]JR?#^EZE:^;>ZY>6]WJLZ)&[VT1CB1%SA5!)/5F)/<GT H X6XU72;+Q
MAXLT?Q7JLNG1W[)) 9&"17-L850JK%3R"&&,]2<=ZD6\T;3/$%GH]OG2F30D
M2&ZO"6GF@+G9!&K<;AC)R&;D#'IZ9+;03LC30QR-&=R%U!*GU&>E.:*-Y$D:
M-2Z9VL1RN>N#VH \/T^\TZY^'?PQCEGMW\O6($D#L.,++D'/H2N?J*['Q/:2
M6?B,W7AG5K'3M6MM/\R73[M%%M=P&1V[8*D,&)8?WAGK7>_9;?:%\B+:O0;!
M@4DUI;7&WS[>*7:05WH&QCTS0!SOA[Q7I4NG^'K&?9INH:C8I-;:<^=P0+T'
M'0 <9Y(%5?BNC/\ "WQ %4L?LV< =@P)_2NDNM+AO-1M+N;!-H2\2[1G<01D
MGKC!/'KSSQBZ0&4JP!!X(/>@#SK7-1TK5/B!\/Y8;JUN8&:]9&#AE8B$8(/0
M_,.#ZCU%<YJ-PZ6/C]K#=-';:[;75Q#;$%VA7RFE('_ 3GZ'->R?9H/E_<Q_
M* %^4< =,4Y(8HR2D2*3U*J!0!YW!=^$M;NKK7--U:74[Q-*EBEG,@V0PD9"
MR   $MT!YX/I7/6\EC!\.?A@Z/;QL-6LB2" <E7#Y_K7L4=I;0QM'%;Q(C'<
MRJ@ )]2*7[+;X \B+ Z#8* */B-6D\+:NB*69K*8*!R2=AKRZYU'2[[X=?#>
M$75M.B:EIL4RE@R@K&0RMVR.X[9YKV2HOLUOM"^1%M&<#8,"@#RO7A/<>*OB
M!::0X-]/H$(2.)AO=P)!@ ?Q8('XBM#P_J/A+Q3J'A^^L]2NKS5+-6,%J' >
MS!3;()%51A0!MYX)QCK7HJP1*^]8D#_W@HS21VT$,DDD4,:/(<NRJ 6/N>]
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M^_9#D_Z+N/="3C^\"?I0!TVF_$'0-0M]3NGO([:UL;EH&EFRH(7:"QR.!N)
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MN;6:.:"50\<D;!E=3T((ZBI:Q/"-CINF^&+2UT>WF@TY=YMTF9BVPL2&^;D
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MT.KQ:A%)83L$BE3)\QR=H55QDMGC;C.>U2V.N:;J-O<SV]VA2U<I<>8#&T+
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MVOB;1[R_ALH+U6GG1G@!1E6=5ZF-B ) /]DF@#49%9"C*"IZ@C@TJJ%4*H
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M@#N>U=%>ZK9Z?)''<2/YDBLRQQQ-(Q48RVU03@9&3TY'K0!;$:*[.J*&;[Q
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M)V4[#(5CB:1@@ZL54$A1ZGB@#0HJ"SO+;4+.&[LYXY[:90\<L;;E93T(-3T
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M7?VJ:S\1P]W/,LUI!(D]Q'L\U?LY7=]U5P3P, 9XQFJ\=S:'PW\*4DEBS#/
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M-Z6(:1V6; ]N%)X^;//0U=3-U>67Q'M=,-Y>W$DUE<X>$J]Q $C,G10.5#8
M R.F:]SHH \PU#Q/HNN^._ 5]IETMS"KW@<QH28BT& K #Y3G P>:Q]&N/#\
M^CS^#_%-OJ4NNQ74@;3_ #K@"[8RETD3:=NTY!W< <D\<U[/BCO0 R62."%Y
M)75(T7+,QP /4FO$;*>U_P"%/^"(99(\IKEN9(W(RJK<,6W#L IR<]C7N-%
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MB2?K5R@#@?!=WJD?B6YTJXU6VU^PCLEEM]7C4>8HWX$,I7ACC+ ]>"3UIWQ
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MMI%E+9Z>N]H(92Y8*6)!.\[AG.[!Y&>W2MJBB@ HHHH **** "BBB@ HHHH
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MT- 'H&D>*-&UZYN+?3+U;B6W1))%",,*X)4Y( /0].F,&J\M]I__  FB6_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJC  '  I]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(2
M%!)( '))H 6BL9O%.D+J&FV7GR&;4BXM"(7VRA5+$AL8Q@9Z\\$9!K3N[N&Q
MMGN;ABL*#+L%)VCU..P[GMUH FHI$=9$5T8,C#*LIR"/44M !1110 445D:K
MXFTG1+JVM=0N)(IKHE8$%O(_FD=0NU3D^U &O16;IFOZ7K$MQ#87B2SVY FA
M(*219Z;D8!A^(K2H **I'5;4:VND'S?M;6YN1^Z;9L#;?OXVYR>F<U=H **:
M[B.-G;.%!)P"3^0ZU0T37+#Q#IPO]-E:6V,CQAFC9#N5BIX8 ]0: -&BBB@
MHHHH **** "BBB@ HHHR#G!Z=: "BJ]]?6VFV;W=W*(H4QEB">2<  #DDD@
M#DDXJGI/B"PUFXO;:U:5;FR<)<030M&\9894X8<@CD$<4 :E%%% !163_P )
M+I7]O_V']HD_M/9YGV?[/)G9G&_.W&W/&[./>B3Q+I46NIHCW$@U*1/,2#[/
M(2R9QN!VXVY[YQ0!K4444 %%9MSKVGV>N6.C32NM]?!VMT\IL.$7<WS8V\#M
MG/(JU?7UOIUC/>73LL$"%Y&5&<JHZG"@D_E0!8HJKIFHVVKZ7:ZE9N7MKJ)9
MHF*D$JPR#@].*M4 %%9$GB?2DNYK:.::XE@;;,+2UEG$3?W6,:D*?8G-6]-U
M6PUBV:XTZZCN85<QEXSD;AU'U% %RBBB@ HHHH **** "BBB@ HHK)A\2Z5<
M:Y+HL5Q(=1B4/)!]GD!53T8DKC'OG% &M16'JWB[1]%>07L\BI"Z)<21PNZ0
M%_N^8R@A<Y'7U!/!%;A('4XH **S8M>T^;Q#+H22O_:$4 N7C,3 ",MM!#$8
M//'!/0UI4 %%%9.L>)=)T![=-3N7@:Y<1PX@D<2.>B@JIRWMUH UJ*S=+U_2
MM9EGBL+Q)9K<@30D%)(\]-R, P_$5I4 %%%4M5U6UT;2Y]1NS)]GA +F*-I&
MY('"J"3R: +M% .0#5+4=5M=+^R?:?-_TJX2VB\N)G^=LXS@' XZG@4 7:**
M* "BBB@ HH!!Z'-4KO5;6RU&QL9O-\^^9UAVQ,RY5=QW,!A>/7&: +M%%% !
M12$@ D]!6+;>*])O-'U'5+>6:2UTZ22*X(@<.K1C+@(1N)'TH VZ*CMYTN;:
M*XCW>7*@==RE3@C(R#R/H:COKR'3M/N+VXW^3;QM+)L0LVU1DX Y)XZ"@"Q1
M6./$^E_VCI>GF65;K5(FFM4:!UWJ%WG)(P"!C(//(XJ[J>I6NCZ;<:A>NT=K
M;H9)76-G*J.2<*": +=%5[&\AU'3[:^MF+07,2S1DC!*L 1Q]#5B@ HJI?ZG
M:Z:D1N';?,_EPQHI9Y6P3M51R3@$^P!)XJ+1=;L=?L/MNGR,\0D:)P\;(R.I
MPRLK $$&@#0HHHH **** "BBLW3]>T_5-2U#3[25VN=/9$N4:)DV%@2OW@,\
M#.1QR* -*B@D#J<52&JVK:V^D#S?M:VXN3^Z;9L+%?OXQG(Z9S0!=HHHH **
M*S;#7M/U/5=1TVUE=KK3C&+E&B9-A<$K]X#.0"<CCI0!I4444 %%!.!FLW1]
M>T_7H[M]/E>1;2Y:UFWQ-&5E4 LN& /&X4 :5%%% !11D'.#TZT4 %%!(&,G
MK10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5Q?Q*O9(=%TO3(V*KK.K6VG2L#@B)VRX_%5*
M_0UVE<SXYT.?6M"A:S3??:=>0ZA:IG&^2)L[?Q&X#W(H R/'*7/_  E_@=+
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MWEBMBAMW60(5P6.\?,#DXZ5GR_#B_DT#5](_M]#'J&J?VCYCV0+(?,60@X<
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M8?D:>B)&BI&JHBC 51@ 5R?AW5-77QGK>@:I>17JVT$%U!,D B*B3<"A )R
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M(H+,?H#5:+Q-ILFH6M@[7%O=W1800W%M)$9-JECC< #@ YQTX]17(Z=*U_\
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M'?+9CSXYC(8?,.4<. !N'=16]10!S'B?PE/K[Z9?V>K/IFM::S&"\BA#KA@
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M]ZZ1D+PF-VY9<,5X_+TI]8NL^*M+T&\L[2_:Y6:\<I;K%:R2^8P&2!L4\XH
MYBU^&]];Z7HFG_\ "3.8M%O!<6A%D@.T!AM;DY;#'YN!ZJ:Z#2_#4NE>)]6U
M6+4F:UU*1)I+0PC(D5 F=^>A !Q@<]^U7-(\1Z5KDUS!8W):YM6"W%O+$\4L
M1/3<C@, >QQ@UJT 8'BKPY+XBM]/^S:@;&ZL+U+R"4Q>:A901ADR,C#'N*BT
M+PM<Z/XBUC5I=7>[_M/RFDB,"H%=$"9R.V!P.W<GK7251U+58M-LH[HP7-RD
MDB1@6L1E;YV #8'\(SDGTH SO%?AV7Q+8VEM'>K:?9[R*[W-#YFYHVW*/O#
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MMV;=5&5RKP^62PY[$GC'?FNTH H:SK-CX?TF?5-2F$-I  7<]LD ?J15X$,
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MFI2Z)9OK$446I&(?:4B;<@?O@^G>@">]O;?3[5[FZD"1+@9P222<  #DDD@
M#DDXIZ3J53>#'(Z%Q$Q&_ QG@$YQD=/6N-\2W3S_ !+\':0Q/V;_ $J]=>SN
MD>U/R+$_7%0W,-U)\;;9!J=XD(T-YA$NPH/WZ J 5/#8&3][CJ!Q0!T^@>(;
M3Q%#>RV<=Q&+.[DLY1.FP^8F-V!GISWQ6M7C27&LZ7X6\=:UI>K-:-I^O7LZ
MPK CK,0RY#E@3@CCY=I'J>W8W6NW^K>(KG2+'[="EM8P7#O9>1YA>7?C/FG&
MU0@Z#DGGW .THK&\+/KC>'K8>)(X5U5=RS&$@J^"<-QP"1@D#OFMF@ HHHH
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M.[*"<YZ<8YSL:SX7DU;5-(U6/59[+4-.$B"6&-&$B2 !P58$#[HP>WO7144
M<2?AQ;'0-8TAM7OFBU"^-\KL$+02^8),CCYOF49SV]*T[CPM)=:YH>JS:K-)
M/I(E";XE_?&4;7+8QC@< 8Q[UT=% '*+X)6U;5H-/U.:TT[5I'ENK58U8H[C
M#F)C]S=WR&QVQ5@^$88]?TC4[2Y-O'I5JUI;VJQ@IY;!003G.<*,?3O71T4
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MG0CHKHV5///U)]L=E10!RUWX,^T_V.QU6X,NFW7VSS945VN)L%27Z<8)&!C
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ME&2>I.2<FK]W;1WMG/:S9\J>-HWP<'##!_G3Y98X8GEE=4C0%F9C@ #N33Z
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M44X4G>RDI*A4#;@J<CICL.M<YK>H7GBWX2>)/$!U">"-TNE@MHPNQ88V9-K
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MCRI'X4 <UJ&IW&L^'OAEJ=V5-S=:G:RRE1@%C!(2<=N:V]._Y+)KO_8(M?\
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MXKS5;F2;3-?^P"==J-/&MRBCS,#!.&[8!P,YKV"VA:"W2)YY)V4<R2XW-]<
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M>YC/FJO3>K%21[$J2/K7154TS3;31],MM.L8A%:VT8CB0=E'\S[U;H ****
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M-<GQ4=!BOI54R)$7^^W&"P7(!(QG'% 'JM%<1=76H:%\0-(T:.^NIM.UNVN
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M#0!WU%9VA6MY::):1:C</<7OEAIW=L_.>2![ \#V%:- !1110 4444 %%%%
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M9 0[,S@Y9LG)ZU0'@*$^'8O#\NNZQ)I,<*V_V?="F^(#&PLL8;&.#SS76T4
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M<L.T@H^-RLK*00<#T/O5:=]/\$:9+>-;ZA>/=W0:XEA@,\TLC<;F"CH  .
M   *Z.B@#G?!VB1:1IUW<+9_9)M2NY;V6$]8]Y^53Z$+C(' ).*W;JVBO+2:
MUF7=%-&T;C.,J1@_SJ6B@#D%^'UHNCZ1IAUC56ATJYBN+9F>(L#&,1J?DQM
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M<V#Y? )]OI3]7\!VNJ:I:ZK#JVJ:?JD,(MWO+*54>>/.=KC:5///0?RKK**
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M75[=B PP37 0&)&P3M554 G R2,\ =.* /.=-URXT3P7,MK(89=0\636'V@
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M49'9EVG@*,#  QTH PK.S\2)>Z/K,&HPFP:+-^DNH23"Z5E!5HT,85&SR N
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MY*C#'A<5Z'H?ABST*PO+*&>YN(+N:2:1;AE/S2$E\;5'4GI^59O_  KW3/\
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M$5D!VMG&6W YW'VQ7M-4U3Q'K_@R2;4;ZSBU;1IKBZM[>78I8"/E>XSN//4
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M PP,X!H ZNBBN*GDU+5?B;/86FIW$&F6&G*UXD;#F:5CL XX.U"2?]KC!P0
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M.: .ZHK'\+0:K:^'+2VUJ_@O]1A#1S7,/1R&(&>!SC /N#6Q0 4444 %%%%
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M5FM+>6"9E^QK$P"_(" <@9.>NXCH!BUYT[?%FTMUU&YDM+C0))2@E/EE_-C
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M6EU"DUO,ACDC<95E(P0161IWA/3M-:SV/=3I8@BSCN9C(MN"-ORY[[20"<D
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M&T@J,G.<[C[ ,\2W-Q<6GB::#5+F]O+/2$E'V69K>'3W$3/O#*WSL_# 8/
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M52<(A=C] .30!XFHU>#X/:5XWAU[5I-9M1'+LDNF:*93-L,;)T;.>IR<]\8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 445R'C_5I]/MM$LXIGMX]4U:"QGG1BK)&V2P##[I;;MSU&3CF@#0'B
M*;_A/?\ A&GLE6,Z<U\MR)<EL2*FW;CCJ3G)[5OUYE>P1>'OBG>7>GQ-NC\+
M3SK 79E+K,IX!/&<#./KU)I^BZ=J&JZ=X8\2VVMPP,3#+=3B61S>*^ \3J3M
MR6.!Q\I& !0!Z517F%G?W.E>*+&V\1VMRK7.HNUAK5K.7@N]Y?9#*,_+@,
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M+-"LH\ODNX($A,F"N"<@_P!VM?Q9--9_%#P5+:@F2>'4(9%'\:")7 /T90:
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MCY<#&*V)],M9?C?$6$N3H33'$[CYA<*.QZ>W3VH [72KJZO=+MKF^L6L;J1
M9;9I YB;N-PX/UK&\3^+4T3PGJ>N6$$>H"P9DDC\WRQN5MK#.#R#V]C71N@D
MC9&SM8$'!(/YCI7B26%O:_ ;Q3)"K*?/NX\>8Q 5;@@8!.!0![;&V^-'QC<
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M,D2D*@ .!D#+?WMQSQ@5;L+N?4M4T'PZS0_9AX<@NTAED=%F<G:Q^4C<5"C
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M3&WWY!#9X8Y )Q[4 >JU7EO;>&[M[2251/<;C%'W8*,L?H,C\Q67X,O+C4?
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MO7B5OM#DE/)<_>W9R2!SG)]:74KQ/ OCMK^[GNGT;5K1E17F>18+F(%MB@G
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MPG2]AC,44\$[Q,BDY(^4C()QP<C@58U:74(=+GDTJWAN;Y0/*BGD,:,<C.6
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MF<[E0G Y.0.@/( -67\-Z:_B)=>*3_VBL/D"47$@'EYW;=N=N,\]*UJ0YP<
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MDE\]HEG<0F7.=_E9V[L\].O/6NGK*FU2:]T&>^\/I;WL^72!99"D<C*Y1OF
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M 1@CS P8@]P2<T >83ZWJ6D6VH:$;NX&F#Q1;Z8EVTAWPVTH#N@?J-OW0<Y
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MW]^GD%P\RCCD@,,DD9[=*L6US-I'B:RA\0Z>98KO4G-AKUI)O6<R%MD,XZC
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M@V5/T(JS;>#?#]I<WMQ#IJ"6]A$%R6=F\U,%?F!)!)!(+=3DY- '&+(MI;^
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M&UFMTDD:01L89&) 8G !YP..*[)O!7AYK;3+<Z</+TS/V3$K@Q@@ @G=E@0
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M1@JZ?W2S%CN'/ YX% '4^$-;E\2>$M,UF>)(9+R$2M&A)"Y)X&:VZY#X6?\
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MNMPMUNG@+G"-)'MP 3C(!./KQ73/JXM=>ATN[14^UJS6<H/$A499#Z,!R/4
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M<@@?,W0C&XXQUH ]DHKS]_"\5C?W>H0ZM;0P7NF2(UAIT#01S[1N$V1(<$9
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M88$8QP!Q[5662;1?$MK_ &YIL=Y9WFKDV&O6; R*[R-LAG!YP,[!_",+QQP
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MS7,BRSIY\GERLN "T>[:WW1U'852\:^(+SPWHT5[90V\K&Z@AD$S'A9)%3(
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MD7/EJ9O))V;\?-MSSC.<9[5/G(R* ,V]T'3=1O[.]NK=GN;(DVSB5U\HD8)
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MEZ3=:79:8D-I=KLN$61\R+C&TL3N*X)&,XY/K3/!^OWFOP:N;Z""&2QU2>Q
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M1KS2K>?3X,>3 X)$>.!M.<KQQQVH J^#=%C\/VVHZ?#J0NXEO'D$21[([3<
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M1I'=G<J.B[F).!DX&<#)J*/0-*BO_MJ648G\QI0>=JR,,,X7[H8\Y8#)R>:
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MYE3JSDC!.0  ,GM7'6-O;:IX4^%C78$[M<B"1F;)*>5)\A/IP./2@#VM'61
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^_&K@LOU'44 9FJ^$_#^N2V\NJ:/9WDEN (GGB#%1Z9/4>QXK850BA5 "@8
M X J%KVT1E5KF%2S^6H,@&6_NCW]J<MS \[P)-&TT8!>,,"R@],CJ* *VJ:-
MINM6ZV^IV,%W$K;E69 VUO4'L?<4:?H^GZ4&^Q6L<3, &<<LP'0%CR1^-6#=
MVRW0M3<1"X(W"(N-Y'KCK22WEK ',US#&$QOWR ;<],YZ9H I#PWHPOWOAIM
MN+AY!*[!.&D'1R.A;_:QGWJ5M$TQM3;4S8P_;FC\IKC;^\*?W=W7'M4>HZ_I
MVEZAIUC=7*)<:A(R0(6 )VHSEC[ +C/J1ZU<>]M8YU@DN84F896-I &(]0*
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MY)J_@C2]:U)X8I+FU6:9A\B*3UZG@?C0!/9>%/#^FZM+JMEHUE;W\N=]Q'"
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MZ%822W1S.S0@^8<YR1T)]^]6+OPQH5_+9R76D6<K68Q;EH1^Z'H!Z>W2KO\
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MIUWIATVYL+:6Q*A?LSQ*8\#H-N,5!'X=T2+2?[)32;%=.SG[+Y"^43ZE<8-
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M8BQU'3[:[M1C$,T0=1CI@'IBD;0])?1_[';3;0Z;MV?9/)7RL9SC;C'7GZT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>sangamoexecutiveseveranc006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K-UG7],\/6\5QJET+>*658D8JQ!9C@#@''
M7J>*TJX;XL.L?A"W=U+(NIV9954L2!,O  Z_2@#8TWQOX?U:]N[*TO6:YM8_
M-DB>"1&,?]]0RC>ONN>WJ*CT[Q]X:U5T%IJ.]'@DN1*T+I&(T.&)=@ ,=<$Y
MP0>XK*ND@U?XE:/K=BZM9Z787 O+M1\C;]H2/=W(P[$=N^,BN:T[2-0U;]G:
M71]/AD34A')FW="CDB<N5(.#\RC'OF@#T:V\4:3=7\%BLTT5Q<QF6W6>WDB\
M]1R2A91NP.<#G'.,4[3O$^DZK#?RV<\KKI\C176ZVE0QNHR5PR@D@=AFN4UB
M>/QI=^$)-*259[34H[ZZWQLC6L:HV]'R/E8DJNWOUZ#-&JZ/?VOQ F@LH&;2
MO$UN!?.O2%XL!R?3?$2GUP>U &Y+K&CWWB+P^5U6_AN;B*:6TM%62..Y0IDF
M12O\(&0#@@GWJCX\\2VUMX3\0)9WMW%>6EL^9[2)R(9=F45G"D*<E<\\9&<9
MJ/Q*0/B;X*8(YC@%Z)'5"5CWQ*%W$<#)&!FN4COI-+\">-?#&J6UX-88W\D>
M+9W%VLH9ED5@"".<'TQS0!Z'I^N06?A[2#=R7$]U-8QR^7%$\TK@(NYB%!.,
MD<GN1W-:>DZO8:YIL6HZ;<K<6LN=KJ".AP00>001@@\BO,'O/[#UC0]7U:RU
M;^QKK0X+-I8(YU>UGC))$B)A@"&].HKT'PK;6%OHY;3=-DT^TFE::..4,KOG
MJ[*W*ECS@\XQG!.  6=:U[3?#UFMWJER+>!G6,,49OF)P!P#W(JCIWC;P_JN
MI7.GVE\6NK>/SFC>%T+1_P!]-RC>ONN:Q_BVRI\/YV=2RK=VA*A=Q(^T1\8[
MTV_2#6OB-X>UBP</;:3:W37ETHPF)%"I&3W;.YBO;'.,B@#6T[Q]X:U66)+/
M4=XECEE61H71 L9(?+%0%QC."0<8/0BK=MXJTBZOK6S6>6.:[0O:^?!)$+A0
M,G86 #<<X'..>E>>:3I-_J_P#U#1K".2+4G^T_N70QNV9W<+@X^\O ^M:VK3
MKXS@\()IL4T=Y:ZG;WMTC1,C6:1JWF*^1\I)^4#OGC(&: .KO_%FCZ:;DW-Q
M(([5PES-' [QP,<'#NH(7J"<GC()Q6-XU\3?V?<Z!80/=>5J5ZB32VT,K;H=
MKL0CH#\Q*CA3NQD^]8>BRMH_A[Q7X=UF"9K^6ZO)(4\IF-]'-DJ4P/F)S@@=
M,<XJ.ZL+C0],^&VF7I>2YL+J(W112XB40NI+$<!02!D^E '?Z!IC:99RH-0O
MKR&:4S0B]8M)"C 8CRWS$#G[W(S@]*GO]8L].FA@F>1KB8,T<$,;22,%QDA5
M!.!D9/3D>HJZ"&4,I!!&01WKAM3>;1/BO;ZS?*_]D7>E&R6X"DI;S++OPY'W
M0P[GN,4 ;-YXNT__ (1.^US3Y'NDMXY1M2"0LLJ Y1T W)@CG<!COBLSP5#+
MJMEI/B$ZKJQFEL4^VV]QY@AGD=5;>JN,#!)P8\*161#8R6^C_$/5=DD=GJQD
M-E$4(:0B#875<9^=\XXYP#T(KK/!#AO VA)R)(K""*1&!#(ZQJ"I!Y!!H O:
MWKNF^'=.:_U2Y^SVRD*7V,W).!PH)ZD"J.F^-- U;6I=(L[[=?(GF"-XG02)
MTW(6 #CW4FL?XO$#X7ZP2"P!@R ,Y_?QU%JT<>O^.O#&H:2GGC2DN9KB5!M"
MJ\>Q8B3T8L?NGD '(% &_;>,=$N[JT@ANG/VUWCM93"XBG9,[@CD;3T/?G'&
M:GTSQ)I>L37\-C-+))8/Y=RC6TB&-L9QAE&3CTS7E45^][;>#+YK#4(9;75Q
M]ILH-/DC@L<K(/+5 O/)'/S'GJ <5U'BC3=1L/&<,^D*1#XFB_LZ^VM@Q.@+
M+./]H1"0?4+0!T/_  G/A[=IZ_;9 VH1--:J;:4&5%&20"N3QC ZG(P#D57/
MQ%\-#3YKW[7<&.WD:.X064QDMROWC(FS<@&>K "L_7XXK?XD>"$AB*V]K%>(
MQ1#LA#1HJ GHN<8&?2LJUD41_$S*.!<N[0?NS^^!MPGR<?-\W'&>: .^N-<L
M+>"VE\UIA=)YD"6\;2M*N =RJH)(P1STY'J*SF\=>&TTNVU)]25;6YN!:H[1
MN")=VW8XQE"#UW8Q7G\-PVAQ>#=8U*TU&71QH$>G7+6@E#V<X"'+JF&P=I4^
MX'M5WQ!#IP\,:?-I.E7%K;7/B&VO,/%)YDRAU,D[*WS*.#RW8 ]Z .WM?&.C
MWK:BEM)<O/81B2: VDJR%#G#*K*"P.#@C(H\(>)8_%?AZWU1()8?.7?L>)U
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M?Q)<JX2XV&$F,XE M@AV<?-\W'&>:SK2RMKKPMX04ZI>Z#K-GI*K!J"H0B,
M@>&96&TY(!VMC..* /4["^M]3L(;VT<O;S+OC8J5)'T(!'XU5UGQ#I7A]+9]
M4NUMEN9E@B9E)!=C@ D#CZG JMX.N=2O/">GW&KVR6U^Z'S8T0H#\Q ;:>1N
M&&QVS6#\4I4ATG09959HTU^Q9@JEB0).< <GZ4 ;.F^./#^JRWT-K>OYUBGF
M3Q26\D;A/[P5E!9?< ]1ZBJ$GCWPMJVF720ZO<QPO827!N8()5,<7W2ZMMX8
M9!QU'7%4;F*'4OB,GB"S8-8V.D2P7%V@RDCNP*Q@_P 1&&)QG&0.IJAX=!B_
M9^:U>*1+A-)G@:!HV#B0JX"[<9R21]<T =G:ZQIMCH6DO]MN+F.YAC6U9U:2
M>Y&S(8@#<6*C<3CCDG%,/C'0ETF]U-[TI;V+%+L/"XD@8<D,F-P]>G3FN(MO
MM.FW7P_UV:*9M+M]*-C=$1L3:2-&F&=<9 RNTGMWJ+7[&2YC^(>MVJ2&SU'3
M([2VVH?]*F6-@648RP^95!'7GTH ]"T;Q-I6OSW,.FW#RO;+&TF8708<$J02
M &'!Z9Z4>)]>B\,^'+[6)H)ITM8B_EQ(6+$#C..@]2>!4GAUTD\-:88^%%K&
MN"N"I"@$$'H1TQ6?X_M9[WX?:_;6T3S3R6,JI&@RS':> .YH LV_B6R;2;&\
MN#-')=@+'#]FD$DC[=Q"(5W$8R<XQ@9SBK6E:WI^M+.;*8L]O(8IXG1HY(G]
M&5@"/RY[5P4UY(FM^"_$H@NFT:"UEL[AV@=3;NZ+B0J1D*2NTMC ^E;7AVR>
MX^(/B+Q!;AAIUU!;6\;X(%Q(@.YQZ@ A0>AYQTH ZZYG6UMI9W21UC4L5B0N
MQQV"CDGV%>9:[XREUWX:6OB"PGO=-8WT&=JO$#&UP%P7(PPV]=IQFO43RI%>
M)PO(/@;I6DO9WBWMI=VT<T+VL@8%;D,P QSA1DD<<B@#U73/%&DZOJ=SIUI<
M2&[MT$CQRP/$60G ==P&Y<C[PR*9'XMT:2_M+3[2ZM>DK:RO ZQ3D<X20C:W
M'(P>>V:Y36(I-1^)MU'9NR_:?"\UK%<!3L$K2@J-W3..<>E4?"=WI.J6FBZ1
M?Z!JO]OZ8\7F6]TL_E6SQX!F#DE , E<<G( ZT >J5A:CXPT32Y;M+JZ<"S*
M"ZD2%W2W+XV[V4$+G(/L""<"MVO'?&EU/J.G>.M-;3[RWNE'[BVM+-@+M B_
MOY)%7Y^A&,@ *!@F@#T34O&>@Z3J+Z?=WK"\2#[1Y$<,DC,F0/E"J=QR>@R>
M">@-0IX]\,OH=MK*ZHGV"XF%NDGEOQ(3C:PQE3D]\5S$>K64/Q7TN[N6:WAD
M\-,%>>,IM/GK][(^7..^.H'4US^M:>UAX7UG5'MY(K+4?%5O=V\)C.YH_,C!
M?9C/S$,0,9(QZT >F:5XOT/Q#?W6EZ??/]MA3>T;PO$^P\!UWJ-R^XR.GK7(
MZ)J\(^%-]<^(==U*WB%Y<POJ$4C&= L[!=K $CH!TQVK4GAAUGXFZ1K6GLK6
MFFV%PMW=K]QB^T)'N[D8=B.W?&17(.LC_ CQ!9K!.;J2[N=D'DMYC;K@LN%Q
MDY7GZ4 >KWFL66G-#!*\LD\B%XX88FED95QEMJ@G R.3QD@=352+Q?H=Q86%
M[;7OVB+4&9;188V=Y64$L @&1C!SD#&.<5RNHZQ_PC?Q#AUV^@NI=#U'2H[5
M+N"!Y1!*CLVUE4$@,&].OTI^K:HEI>>&S%HLFF:;<RW#"[BT_=/;9'R@*%)C
M:4DYXSC@X). !WC?Q)%=^"X-8T;59X(XM3@AE9"82/WRI(D@(##'.0<5T6E^
M+]#U[4;G2["^?[;#'O:*2%XG*'C>F]1N7/<9'3UKS(6UR_@3Q#;1Z=J)>#Q1
M]K9)+>1G\G[0C;N02_R@DXR?7K7:3QQ:_P#$/0M:TX[K+2[2Y^TW>TA'\P*$
MC!/4C#,1V[X)H / 6KO'X2O;O5K^:;R=3NH1-.Q=R!,411W)Z  #J0 *Z33?
M$.FZK?75C;RR+>6H4S6\\+Q2*K=&VL 2#ZCBO+((+\_#][FTLKNX?3_$LM_/
M:1!XYI;?S7/R#@DX8,,>E=OX4N-!UC59-7T?3KW?]G\F6^O$F5OO B(>9RV.
M2<<#CUH ZV65(8GED)"("20">/H*Y[3?'OAO5Y(DLM1WB2&2=9&A=$"1G#DL
MP &.N"<XP>A%=%)(D4;22,%11EB>PKRK0=,OM2^ 5UI%E#)'J1BN0()$,;%C
M,[A2#C[RX'XT =[;^*M(N=233Q--%=2Q&>%)[>2+SD'4H64;L=P.>]95AXH\
M.Z1X;O=7;6[VYTY;V59+BZ61VCD+8,:C;D*"=H&,#UK-\.:IH/B+4M.NXM%U
M--4L@[3-J"SC[ 2I#C=(=I)X&%Y(Y.,5RMXKR?"#Q?;)!.UQ/K,[Q0B%M\BM
M<JRE5QD@J"<^QH ])/CCP^NHRV#7<JW*1^:J&UE'GKG&8OE_>\_W,Y[5SOCC
MQ/#J?PQU+6- U.ZMWM9XXF:,-!)&XE171PP#*<,>..M6M6GBF^*OA:XBR\*6
M5VK2JA*J7\O8"V, G!P#7)ZA:W%]X*^(MO:VMQ-+/K0N(8TA8M+&&@RZ#'S#
MY&Z9Z4 >C6'C;0-3U:;2[6]9KR.,RB)H)%,J#JT>5'F#_=S2GQIH"Z -<-Z_
M]FF4PF?[-+\KA]F&&W*_-QR!S6+?+#XH\;^%]0TK,L&EFXGN+H(555>/8L>2
M!EB3DKV"\XR,\/>3O#\*=;\.FROWU2#5&:2!+60X4W@=6!Q@@@C&"2?3K0!Z
M=JOCKP]HM[<6=]>NES;Q":6-+>1R$)QD;5.><],XP<U;;Q/I8G6,23,#<+;>
M:EO(T8E8@!"X7 .2!R< \=>*YRVGCE^,\MRJ2B)]!CA61X64;_.9BF2.&P0<
M=:QKF.XT_P 0RW_AF\N/-GU?9?Z!=QETF/F[6GBR,IP/,W#Y>/;% '=:GXLT
M?1S,;VXD6*!E2XF2!WC@+8P'=00O4=3QD$X!J.Z\9:'::E+ISW4DE[% +@P0
M6\DKLA. 5"J=W_ <]#Z5P=O/8:9J_B#P_P"*-*U:X>]U":XM! D\D-[%*=RH
M AV@CH=V ,<FMK3Q':?%@$P?9X(O#<5OP"8XW65F,8?&"0N#]* -@?$3PNUG
M:7BZBS6MRP19UMY"D;%MH$C;<1G=QAL5JZGK]AI+.MPTSND7G.EO \S)'S\S
M! <#@XSUP<9P:\GN$=_@=X@LTMYS=2:C,T< A;S&#76]2%QD@KSGT%;FIZC;
M:'X_U&\UFWU.31]7M[=K.\LA,R*R*5:-UBYR<Y''<T =?+XW\.1-IP.I(W]I
M1M+:&.-W$JJ,G! Z]L=<D#&:I:C\0=)M_!^J>(+(7%TM@7BD@^SR)(DH'W75
M@"@Y&2<<&N?DMK2P\5> ([+2Y-/LK<WS>1L;%NLD9V;_ .X6)Z'N2.U9NI6\
M]]HGQ2M[6WFDDN9?,@18VS,HB0$IQ\W*D<9H ]5TV^34;"*Z195#J"1+"\1S
MW^5P#BK59^B7T6HZ/:W,"RB-HU"^;$T9/ _A8 _I6A0 4444 %%%% !1110
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M =N!G-3V?BS3+V\%H@N4N'M?MD,<ENRF:'CYDXYZCCKR.* -RBL*S\7Z/?\
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MB5 '?KT&:P-5N;[4M(1[C2-5AO;/Q#%--96UC(L$,2W&=XVKB4L,,6^8Y)(
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M[F=HM<M+B000/)LC1B68[0< 5"DDVA_$_4=3O8IVTK5[&!8+I8F=87BW9C;
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MC"."S8'RCYAUKMZ* . T2:7PSXN\4PZM#<F#4;I;ZSN4@>19E*!3'\H/S+M
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M]LQ",'\LC<?F3!]A]*M^*QJ&H:?I'B&U\.W$UM8:B;B736B GG@:-HVD,?\
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M,[=I^;=C=\N[;C/>@"UK?AS^W;NV>75;^"TC5DGLH) L5RIQP_&<=N".":W
M !@# K$O_$]G97EY:1P7-W/8P"XNDME4F%#G;G)&20K$*,G Z<C++3Q=INH:
M99WUBMS<+?,1:1"$H\^%W$J'P-N.=Q('OF@#>HK)T+Q%9:^MVMLLT-Q93&"Z
MMIU"R0N.<'!(((Y!!(/K5G6(A+H]XI>1/W+D-%(R,#@\AE((H NT5X2-5O\
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MX8 X/4'O5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N1^)5C>7_ (,E2QM9;J:*ZMI_)A7<[*DR
M,VT=S@$XKKJ* .%F:YNOB?HNI_V;?QVBZ7/$\CVS81W="H8@$ D*3[=#@\5R
M[Z+K$OA_5+BWT:>XFM/%<NK)8W$)3[9;DD87<,$D,2!UXZ=*]BHH Y7PK+::
MA=27]GX3ET5?*\MY;NS2WGD.0=H YVC')/!)&.AKJ'<1QL[!B%&3M4L?P Y-
M.HH \]^&FDB&UU=M2T>2"[?5[FYA>ZM"K>6[ JP8C],YJ[KT^IMXUCM)=,U"
M?1Y+#]T]BN/,GWG*2N""JA<$ D*<G.>@[6B@#QS2++5(/"7P^M)]%U.*;3-2
M#W2FV8E$"R*6XSQEQ[GKC%=?KD-[;_$O0=5CT^ZNK3[#<6KO F[RW9D*[N?E
M!P>3Q7:44 >5ZAX?U+76^)%E;VUQ ^IF!K*2:)D28QQ*" Q&.67'XYZ5U7A[
MQ-J&N?9UN?#>HZ=+"A-X]Y!L56QRL1SE\MCD#&!ZX%=510!XMJL-U9?"#Q*M
MS974$C:X;A(YH60NCWB,I&[&<C_Z]=EJ=K<>(/&F@:K86=PB:/#=2M)=0/!O
MDDC")&-P!/<DC@8'/-;WBCP[#XIT5]+N+NXMX'='=H-NXE&##E@>ZBM>-62-
M59R[ 8+$ $^_% 'D$*:U>MX/U&ZT'6FO[34";\-%L2(F-UQ&F0H3)'S 8QC+
M$UI):WO]C?$F+^SKX2:C+.;-3:OF8-;B-=O']X?UZ5Z?10!YJEMJ%KJ?P_U
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MG\CR*=10!QOC>WO!K/A34K>QN;N&QU!FG6V3>ZJT3J&QZ9(R>U5M,%S#X_\
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M=V!W&: .BO/&^F6VI:=8Q07EY)J5NUQ:/:Q;TE4 '@Y'9A[#/)%9&M?$3RO
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MBJHB'@<#);&3GDT >@45S2QVG@JWU.]GNKB2RN)XV@A>1I75V"QB*/<>A8#
MS@9/0"IH?%,0UQ=&O;&YL[^6!KBVCD*,+A5^\$96(W#C*G'7/(YH WZ*X?\
MX6=8C0TULZ-JHTQ;DV]Q<%(P+<B3R\L-^2-W]T'&?7BM6V\71S>(3HT^E:A:
M3R6[W-JTZIBY12 VT!B5/(X8 \\XH Z.BN";XJZ<FDIJYT76!I0G:&XNS NV
MV(<IEANR1D?P@XR._%;&I^,K:PFU&."RNKT:;:+>7;0; $C8,1MW,-QPK' ]
M.N>* .EHKF+OQQ8V][HUK#8W]TVL6[7%FT$:D.JH'QRPP<,O7 &>2,&JQ^(5
MI'X:U369=(U,'2KAK>^M%6-I82H!+??VLN"#D$\?2@#L*BNK:&\M)K6X3?#,
MC1R+DC<I&"./8UGR:[$DNDQI:SS-J63'Y90B-0NXLWS?=QCE<\D>HJWJ6HVF
MD:9<ZC?3"&UMHS)+(>RC^?TH PK'P3;V,2VO]M:S<:>B[%LI[D-&$Z!<A0Y7
M'&"Q&.#Q73<* . .@KGU\610ZKI]AJ.GW>GMJ((M))]A5W SY9VL=KXY /7U
MSQ7+)&GB_P =^)]'UO1KB>R@AM(H0[Q_Z)N5V+@A\JS'!RN3\HSC% 'I5&:Y
M?QOK=SX1\"7VH:?;O<2VL(2,NX.S^$.Q8Y;&1ZD_F:P?$ETT?Q"\$:@^GW:W
M#K?*;8%6D;$0VCY6*]SSD 9Y(YH ]&HKFM/\:V%YI.H7MQ;7-E+I]U]CN+68
M*9!,2H51M)#;BZ@$'!S4NG^++>[\1R:!<VD]GJ M_M4:2,C++%G:2K(Q&0>"
M#^HH Z"BN,^*Z[?AIK4ZDK-# 'BD4X9&W#D$<BN7EN8[/Q5X,B\)W[S7%R0-
M4M8+EIHC;[1NDD7)"D'.#P2?6@#UNBN4E\>6,3"4V5V;#^TO[,-WA=HFW;/N
MYW;=WRYQU[8YI-0\=166N7VCP:'JU[>VD4<S);1(=Z.Q&Y<L,@8]CZ#K@ ZR
M@'(R*XO0_%E[JUSXFCO='N5MM/NFMU1&C8[5C0E3\V2QW$\< '&:FT#7]$M/
M!^@MI%E/';7R^7IU@"#*1@L1DM@  $DD\?7% '7$X&317%:SXJTF\\*^(AK&
MCW[0:=F#4+/:-S*5SE6# %2#G(.:MW?C&RTB\TO28M+U">:]M#-:1V\:L&5%
M'R9+#GD<G@=2: .JHKC[3XBZ7<Z)J%_+:7UM<:?<K:7-A+&//25V"HN <$,6
M&#G%7$\8P++K5O<:?>17>D0I<3P#8Y>-@2&0AL'[IX..E '245R%E\0;2\DT
M-FTK4;>SUH*+6[F1!&9&3>$(W;@< C.,$C@D<T_P[XEO]9\3^(-.N--F@M["
M=($;?&0OR!LMALY;<.@( QWS0!UE%<CI5I;?#_PW.)I)VMY+T?9X'G,K(9&5
M%0.Y'5OF.3@%CS@9K>T[4I+V>Z@FL9[26W*@B4J0X(R"I4G([<XY!XH JZ+X
M;AT34-3O8KV[GDU*;SYUF*;=^ N1M4$< "MJLW4]9ATVXM+3RI+B]O&86]O%
MC<VT99B20 H&,DGN!R2!69#XVL'TZYN9[:[MY[>^_LYK21!YCW!("HG.ULY!
M!SC')Q@T =+574K%=3TRYLFN+BW$\90S6TGER)GNK=C65!XIC?69]&N+"ZM]
M32W^TQ6[E#]HCS@F-@VTD'@@D8^G-0Z=XTM-4\*C7[>PO?*,WD"V<1B;?YGE
M[<;\ [N,$T :NC:/;Z'8"UMY+B8EM\L]S*9)9GP!N=CU. !]  .!6A7.:KXN
M@TR._DCL+F[73D#WODM&#%\H<KAF&Y@I#8'8CG)Q52Z^(-A'<Z=!9:?J&H-J
M5FUY9FVC4B9% ) RPP>1UQ^?% '745R-UX^M[:TO[DZ3J)33;>*XOU*HKVXD
M3?MP6&YE7D@=/4GBM6Y\26L>H6.GVL<EW>7L#7,4:$*!$N,NQ.,#+ #N2?J0
M ;-%<OIWCK3M1TN>_%I>P+#<BS\J94#O<;MIC7#$9#<') [YQS5K2O%5MJ6O
M7FARVTUIJ5M$LYBE96$D3' =64D$9X/0@T ;U%9&N>(;?0'TT7-M<2)?WD=D
MCQ!2$D<X7=E@<>X!JO)XKMHM9U/2C8WAN=/M%NVVJA$L;$@;/FZ_*>#B@#?H
MKC;+XBV5XFAW!TK4H;#6'6&WO)40()6!*H1NW<X(SC&>YJ7Q)KL-UI>O6%K8
M75^MG;LEV\#*HC8INVC+ LP!#$#L1WXH ZW.>E9?B'0X/$FAW.D74\\-O<KL
ME,!4,5[C+ XKF_!NLQ:=\/O"=L(WGO+G3HS% C*"P5%W,2Q  &1D^XZYJ27X
ME:7!H-YJDEE? V-X+&\MPJ%X)2P49PV"I+#!4G.: .NM+?[)9PV_G23>4@3S
M),;FQZX 'Z5-6;H^JRZK'<O+I=[8&&8Q*MVBJ9  "'7!/RG/Z&LW5O&%OIEQ
MJD,=A=W9TJU6[O3#M CC8,1C<1N;",<#TZYXH Z2BN8N_&]E;7^CVD5C?W3:
MO;O<6;01J1(JJ&QRPP<,O7 &>2*N^&_$</B.VNW2UN+2XL[EK6YMKC;OCD4
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M=I>VES9QZK?S2P3.!\T;Q*FX8/!RI.#CM796-H+&Q@M%EDE6% BO)C<0.!G
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MT+7-'TKP?JO_  CK:DVG:<=.U'3'V&10=I#QY.TD%?7D'ZX]=HH X'5'U_\
ML&TN-+T"6Q@FU",W=C:&-+K[+@[CE2 ')QPK9"]P<XS[#2-4M)_'BIX>N+>#
M4[=&LU#QG<WD;-O#?>W')/3KR>_IU('4N4##< "1GD"@#S5])UB#P_\ #Z9-
M(N9IM&>)+RU0H)%_<&,D98*0&([]*U--MM1M_'OBC4I],N5MKNSM4A=0&#O&
MK[@.<]6&"0,UV]% '*_#>PO=*^'^D:=J-K);7=M$8Y8GP2#N)Z@D$8-=5110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !6'XH\30>%=/AO;FTN;B*6XCM\P '878*"03DC)[ FMRN
M'^*S.GA&W>.,R.NJ695 0"Q\Y>,GB@"]IOC&+4?$DOAS4M'O--NY(#/;I=[&
M6YBS@X*L1GU4\US_ ($U6#P_X!WBVEE\S6;BT@AA7DN]RRJ,]%7U)Z 5N2:;
M=:SXYTS79+&>UMM)M)T02[1)-++M!  )X4*>3C);CUKF['3/%FF>!TM+;2[J
M.?\ MIY[NWBN(EEFM'E9V$;A\!L%>X/7!H ZA_&\5O:^(7N=-NA<Z"H>[@B9
M'RA3S R,2 1MSUP>.E-LO'*7.J:-:SZ1>VL&L1%[.YE*;78)O*E0=R\9P2!G
M%<N?#^MQMX]CMO#;00:UI\<=FB3PCY_(:,JWS8#;FR>W7D\9TIM)UEI? #+I
M%P1I7-[^\B_=?N#'_?\ FY.>,\4 >A5SD7BV.67Q# +"<3Z'M,R;U_>!D\P;
M#G^[ZXKHZ\\N-/UNP\3>,?L^C37<&MP1-;7*2QK&C+!Y;*^3N!R!C .<]J -
M-_B#;!/#K1:3J,YUZW:>U6,(3Q'OV'YN&Y R?EYR3@&ET_XAZ=-9:U+J=I=:
M5=:,5^VVEP%9U#?<*E20P;H,=3^%<E%%J&BWGPKM;S39A>6<-S!+;HZ,WRVP
M4D$-@^N,YX]:OZ_X'U'Q1'XJU"-/L5UJ$=K'8QS$9/D-O#/@D#<W '4  GTH
M ZO_ (2H6VM6.EZIIT]C+J"L;-V=761E&3&Q!^5\<XZ'L36/-\2XH]+U+4AX
M?U-K33+Q[6^<F(&'80&;&[YN3T7/ Y(J2]L=1\5ZCX;GN]*N-.72[G[;<^<Z
M$F14*B--K'<-S9SP,#U.*PI?#^O2> ?&VF#1;@7FJZC=3VD9EA^=)2"I)WX'
M3D&@#U)'61%=3E6&0?45Y[XND&G_ !1\)7MO82W5T]K?KY< 4/+A8]HRQ  &
M3R2 ,FNZT[S/[-MA+"\,@B4-&Y!*D#H<$C\C7->);#4!XT\-:Y;6,MY:V"74
M5PL#+YB^:J!6 8C(RISCGVH 73OB!I]UIVI37MI=:?>:9,EO=6,^WS%D<@1A
M2#M(<D './PYIT'CS3EUB\TS4D%E-;69O_,\U98W@4X8AEZ%<<J1],US^L>#
M-7U>'Q%K-M'';:I>W-G<65K.P(Q:X*B0@D9<[N,D ;<GK5Z2RUCQEX;U/3;O
MPZGA[[19R0%I9(Y&:5A@;=G\ /4G!/&!UH V[;Q4TFJ:9:7&D7MO%JD;R6LY
M 8#:H;$@'^K)!R,Y].#Q52X\>6MOI']N_8;A]!$WE-?(5.!OV>;LSDQ[N_7'
M.,<U%X;O?%%_96VEZSH+:<T$7E7=V;A'2;"X_=!23\QP><8&>IK!LO#VO0?#
M2Z\!S:<[3A'LX;\,GD/"S$B4_-N!"GE<9R..N: .IN?&'E^))M!M-'O;N\6R
M%[&8WC"2H6VC#%L 9SUQTX!S69_PLVW_ .$>CUW^P]1&GQR^3?2MY8^RN)/+
M((W9?#8R5!&#ZY ?9:/?Z?\ $=+R/3KA]+@T*/3TN-\?S.DA;&-V[ICG'6N>
MF\.>()?A+KNAC1;@:C=WTTL,)FA^9'G\P'=OP..O/6@#L;O4--7XAV-E+I,K
M:I]@FDM[WY=OE@KN0?-G.2.H'UYK+D^)L,>DWFJ_V!J?V&PO'M;V4F,>1M8(
M3C=\W)Z+GCO5F[L]3G^).CZNNE7'V&#3IH)92\7R.[(0,;\G[ISC-<W/X=\0
M3?#;Q=I(T6X%]J6HW,]M$9H?F220,I)WX' YR: .\O/$*1:XFB6=N;K4&M3>
M,F\(JQ!MH)8YY+< 8[')%)X6\30>*]*_M&VLKNVAWM&/M.P$LI*L,*S8P01S
MBN2UZ34H_&=E?Z7HE_-=0:7Y5RUE/ )D#OE8Y%D)4@;688R<Y[=>A\#26D6B
M-IMMI5]ICV;D2P7NTR%G^<ON4D-N))R#USP* -G5]6MM$T]KRZWE=ZQHB#+R
M.S!511W)) K+3Q9';W]_::M8SZ>;*S^W/._SPM#R"0X_B&.5_+-0^/M$U'6_
M#B#2#'_:5E=PWULDAPLCQ-N"D]L\_CBJ-]!KGCKPKJFF7VDOH27-H\*K<3)(
M[3'&#\A.$&._)ST&.0"^?&4=O-I1U#3KBSM-6=8K2XD92!(PRB2 '*%ATZ^A
MQ5C3/$ZZCK^L:.UC+;7.F*C.977;(K@E67!/R\'D].E<[<Z7K'BC0_#^DZCI
M4UC-97=O/?3.Z&/]SS^[*L2V\@8XX!.<$8-WQ5X8O[_Q3I>IZ8RHL\3Z=JO.
M"UJWSY'N"" >OST :(\70M:Z>PM&2[OX6N(;>69$Q$,?.S9P!\R\<GYNG!QE
M?\+.TXZ1%?KIUZY_M,:5<1)L8P3[@,'#?,.<@KG/M2>+=-U>R\3Z7XCT?24U
M:&&VDLKNPWJC^6S*RO'NXR"O3T_2MXCL==U?0]*>+P^8IDUBVO#9Q2Q;H88V
M!.]BP4N<'@$]0/>@#;3Q>V([>XTF>SU*5I2EI=31I^[0@&0N&("DL ,9))Z8
M!-0V'Q!TS4-(%W%#/]K-^=-^PY4R&Y'5 <[2,?-NSC;S[52\5V&LVOBG3/$^
ME:0NK1):O9WE@719 C,'5T+?*2".1G_$5==TOQ#>Q:'XAM-&CBO-,OS<?V2L
MJ!V@9-C L/E,G4]<<XR<<@"Z"SM\9M;,MA]CE.D0%P&#"0^8WS@CJ,8'(!R#
M7H$L4<\3Q2HLD;C:R,,AAZ$5Q>D0:O<_$RZUN?1+JST^XTJ*W5YY(MRNLCMA
ME5CV/;/;-=O0!Y!X'\9)X5^&VC/=Z-J#:1')+'/J*!#'"6G< E=V\J,C+ 8^
MIXKT&U\3I<>+[GPZ]E-#/#;"Z29V79-$3MW)@Y//!X&*XRP\.:W)\,6\#SZ7
M+!<NTD,MXSQF!8GF9S(I#9)VG@8!SUP.:V/'6C7070M0T.=;?5[2X6S@9QG?
M%*-C@COM&)/;8: .HT;5/[7M)+D6SP1K-)$A=@?,",5+#'\)(./4<TW6M:@T
M6&U,J[I;NY2U@0L%#2,"0"QZ#"G\N 3@5;L;.'3K"WLK9=L%O&L48]%48'\J
MQ_%]A'JFE0V5SHG]KV4TX6ZA4J'CCVL?,7++R&V]#G!.* (-1\8'2-/:[OM)
MN8Q'?1V3JKH<%]@5P<\J2X]_;M5QO$MO%XKET">"2*2.P-_]H9E\LQAPA[Y!
MS[=*X>Y\)^(%\!ZGIT!N[V.#4H;K2[:]F4S^1&\;%"Q..H?:"<XQG'07Y]*U
MC7_&TU]/HUS8Z=>^'Y=.,DLL9DB9Y,_,JL><9X4GMG'0 &[#XQ2>329/[*O/
M[.U9_+M;H -U!*LZCE%8#()_$"N.\.^(%\(6/C*XCT:ZN;&U\07,D[6VQ5@C
MVQ\@,1NQR<+T YQQG>\'3^+;/3=/\/ZEH/V=M/1()-2^T(T,L28 **#N+,H
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M<GD]SQ0!S=N?"MCX]\>1Z^UK#;1O:"VC8X92T.6$0'S!B<?=YS79?#&/78_
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M1W!4D$?C724 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\IE=GP.79B26QCJ>F.V*S[CQ'')?VFFZ= +R\NK7[6$>3RTC@X 9VP2,DX
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M.W.6^;&<<#/!.#7>T %%9%_K9@U:+2+*W%UJ,D#7!C:3RTCB!"[F;!(R3@
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M,*;99498XU)RA"K@@[0>3DFNH%AJS?$^WUJ33'6R&C&S>19HR%E,JOC&X$@
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M=P!.6S@9X'7/%=Y'(DL:R1NKHX#*RG((/0@TDLT4$32S2)'&@RSNP 4>I)H
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MJ[1QW+?4X%:\'BV8ZSJNCW.FJ+^PM$O EM<B1948D8W,%VL".A'3!KG%\/\
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MECO="DV75I'<*X(*AE8.0,@@^F?:EO=)U:X\0^"[Y-.?R=*6;[7F6/*EX?+
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MS<I/.SA5+C^(*#D ]ZZS4/#FGW][I]Z8(XKNQF66&9$ 8#!!4XZ@@GCUP>U
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M"G(# \9!(&>*MMXMU2Y\0ZQHNF:%'/<6$,,T<DUX(TE63<1G"DJ?EX&#[XH
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MPM,T0D"951D\X/8>E8#^-]3AU+1;>;P\/)UF)C9NEX"_F"/?M=2H"J1GD$G
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MEL$_+[=<G% '>T5Q,OQ!:>3PW_9&D->QZ_#+);LTXCV,D>\JPP<<\$]L'&>
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M9AAHV!((/X@\]Q6M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(?+.[GC)Y[\>_%=O10!YC;^%_%.B:?X6U+2K>UEU32; Z=>6,T^U+F([3E'
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MF^']-CT_2K..UM4R5CC'?U)/)/N:FDU&RAOH;&6[@2[G!,4#2 .X ))"]3@
MT <2?#FMZSX6TGPUK%K#$EE-!]JO$F#)/'"01L'W@S;5SN QD]:U/#^E:E9>
M-O$^I75JJ6FIO;M;L)0S#RX]AW#MG&1C/X5U=% '.^-M/UC4M $.BLAG6YBD
ME@>4Q"XA5@7BWC[NX<9],CO7)7FAZQIW_"9ZG/I]A:Z??:&$6.";)A,<4HV
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M_:#Q-=G+2>5]Q23G:N>2 .,GDXSQ5JBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N1^(^K:IHWA
M<7&E&%9'NH()'=B&"O(JG;@=3G&>P]3775S?CK0[SQ#X6ELM/,/VM9X9XQ,Q
M5&,<BOM) .,A2,XH =)K]X^MQZ#;6UJ=36T^UW):9C%"A;:H!VY8L0>PP 3Z
M R>%_$@\0P7T<ML;2_T^Y:TN[??O"N.<JV!E2""#@5E2:'K5IXR@\4VT-M++
M<67V/4+)9B ,-N1XW(^8C.#D+D<\=*T_#.@2:3+JU_=&/[;JMV;F58R2L8VA
M40$@9P!R<#DF@#H*XFZ\<7EC<Z:U[I<=M!?ZG_9\<$LI6Y"ERBS;",%20#@=
MF!R:[:O+#X-\6OI5I;S1:7/>6FM1ZB]Z]R^^]59"PW?)\F%('\6 , 4 ==8^
M)KF7QCJGA^^LX+4VELEW!-YY;[1$Q(+8*C;M(P>3R:BC\5W,O]C6@LH5U/5E
MDFAB,QV1P*,^8YV@YP5^7'5L9X)IGBKPG<:[J>BW]O<)!-;L]O>D<":TD7$B
M?B0N/3)-.\1^'KZ;Q)HGB/2/*>[TT20RVTK[%G@D&" V#A@0".Q[T 0CQ?,\
M7B33[S2X3JFCP>=);>=^ZN864L&5BO0@$$$<'CWIUCXK5]%\+0V-A#'?:U:I
M+!:AML5O&(P[DD#[J@@  <D@<<D1R>&;^XF\2ZN\4*ZCJMDME;V_F_+$BJP&
MYL=2S$G .  !FLL>$/$%A9>#=0L5LWU;P_:_8Y[5YB([F(HJ-M?;P?ER,CZ]
M.0"QX*^T_P#"QO'7VN"&&;=8[A"VY6_=-AAD \C'';WZUW]<CX;T?6[3QCXA
MUC4;>SAM]46VV)%<-(R&-"I!^0 ]>O'3H>M==0!Y_-+J<WQF-J]O:26RZ&<1
MR3-CRWN &;&S[QV@;>G YJ.P\21Z'X8\53Z;X:L;-= N7B:UMY@BS!(U8ON"
M=<'T[=:V?['U4?$YM?\ (M_[/.F"P_UQ\S=YN_=MVXQ@XZYK&D\)Z])H7C>R
M\BS$FO3RR6Q^T'"!XU3Y_EX(VYXSUH T[3Q?J1\0:'8ZAI,-O:ZU [VLL=R7
MD1T0.0Z[0 ",XP3TJG??$8PV?]J65E'>:>MR86BBD8W+('V&14"D$9!.W.2O
M.1TJ>?0-9FUCP9>"WM@FC)(+H&X.27B\OY/EYQUYQ570M"\9>'#-H-DVFRZ&
M9I'M;Z21A/;1NQ8KLQAV!)P<@>OI0!J_\);-=ZUJ6FZ=#:2SZ?<1PRVLLY2=
MD8(3*JX^Z YQZ[3R*ZNN \3>$+[Q'<2-)8VL&HPW2OIVLPS;98(@P)#@ $D#
M< O(.1D@\UT-GJ6KOXPU#3;JUM/[-2!9;:>&0F0= 1(#P,DMC'9#0!O5QEUX
MLUV3Q+J^@Z3H-M<7-A#%,DDU[L1U?=U^3(/RX Y'7)'?LZ\^M)[V#XO>)C:6
M:7(.GV893*$(/[S;U&,=<]QQP: +.G?$>UU+0],N5MEM;^^FEMVMKF3"V[Q9
M\S<P'('&,#G<.G)%2[^(][9>'=:OWT5))])N(HGVS,L,Z2,%62-BG/)Y7MCK
M4,O@/6M,T[2M0T6ZM&U^QO;F]E2;<()_M!S+'G&0,;0#C^'/':]XCT7Q5XG\
M$7]C<PZ?!?WC0[+=)V,4"I(KDE]N68XQP,#CW) -.S\2ZC_PF8T#4],AMA<6
M;7=K+%<&0E58*RN-H ;Y@>"1[FJ*^.+R&_T./4-+CM$U>Z>V2VDE(N8/O;'=
M".C;.<=,CDU9N]&U>Z\?Z;K:0P1VL&GRVKDS9=7D*G(7;@@;?49KFK;P?XM7
M3M CG@TIKS3-5%W<7)N7+7O#@R,=F0<,.#G/L!B@"[933V'C?XC7-A% ;B*V
ML9$67(0L(7.3@9_Q]NM10^)]1MOA5HVLZMIEGJ7VC[+O\R8G)D90)""F-P9@
M<#IZULV7AW5%\4^+;VX2W2TUB""*!TE+.ICC9"67'?=G@GI6/-X3\2S_  OL
M/#3P:<MY:/;(&6Y8HR0NK;B=F06V],<>O8 '0ZQXL-KJ=YIE@+1KJTA263[5
M*R*6;)5!A2<X&2>V1UR<4;7X@)?IH<:VR:==:K;RS)'J3F(!XV"F(<<L221[
M#.#G%-U'1_%&E^+[C7_#T5C=0ZE!%'?6-W,T>R2,$*Z.%/8X(Q_]:SK&A7VK
MVL-CK>F6&M64D+&X3=Y;13%B08B1D* =N=P; !YYH Z739[FYTVWGO+86URZ
M RP!MWEMW&<#/UQ3=5U.VT;2;O4[QREM:Q--(0,G:HR<>]4O">DW>A>%=/TR
M^NC=7-O'L:4L6[D@9/) !"Y[XJ;Q%HT7B+P[J&CSN8X[R!HBZC)4D<'\#@T
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M#:WTIAEN-X8A$&#R-N#UP3C'>JD6C>+O#WB/56T)-,O-)U6Y-V1>2O&]I,P
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M3RA>&3=AHQE9$X!)#!2!CKQ73^%=.NM,\.VL>H2>;J,J^?>2?WIGY;\ >![
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M3O'*Y1)XU8%XBP!(# 8_3O7/Q>&O$2:YKE\+/2XH-2TJ.U2"*X;]RZAP%SL
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M$0DVL-IXY&2,]#@'C.7K/C;6CX%\631VEM9ZSHLC6\I69I(P"H82(=H).&&
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M#S&)'+8)  XSGMS6)X_O=4O?A/XKCU?31:36S>5&ZME+A Z%9%[@'/0]".M
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M76HW)A> NQ$.W=OR>N5"'L <@=Z@D\3:@3XXCM;"QM;[1D1DEW%Q-F'S S<
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MF3S"I4Y48 (8XR:S[GQU>VGA6U\7R6$)T*9D>2,,?/B@=MJR^A/()3L#U.*
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MQPP1($CCC4*J*!@  =!0!4TG1-/T*W>WTVW,$+N9&3S&8;B<D\DX)/7UJ^2
M"2< =2:6N+N=3UH_%JVTJ*2V_L\:2]QY;;@3F:-68^K#' Z<GUH ZG3]4L-5
MBDET^\@NXXI#$[P2!U#C&5R.,C(JW7D6EZ]JOAG1/&>JV.GVMQ9V7B&\EN1+
M,4=EW+D( ",@<Y./QKM=2\5L-3DTS3?)^T16J7,DD\<CJ/,+;%P@)R=C$GL,
M<'/ !U%%8WA;6YO$/AZVU&YTZ?3KB3<LMK.I#(P)!Z@9!QD''0ULT %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5R7Q"TF?4=#L[RTC:6YTC4+?4DB09:01-EE [G:6P.YP*ZVB@#E
M/%.E7OB6+P]<:0]G)!::E!J+/+,RB1%!X7:K9R&ZTEEH>L6GC+Q%K/EV+0:C
M;P10)]H<,#$&'S?)@ [NV<8[UU$4$4"E88UC4L6(48&3R3^)J2@#S"T\!^(]
M*T#PM+I]QIPUWP^LL.QY'-O=0R?>4G:&4\#''!K:\2>'_$?B7P'J>EW,NGIJ
M6H!4"+(X@MU!!P&VEF/!R<#K[<]K10!R&KZ+KC^*M'\0Z=%823P6LMI<VT]P
MZ*%<JP97"$G!7H0,U@/\/==FT/4(6O;&/4E\0-KFGS+OV>9NR%D7&0",]"<9
M[XY[Z'7-+N;F^MH+^WDFL &NU1P?)!R1N]/NGCVJ>PO[75+""^L9TGM9T#Q2
MIT93WH Y.WT?Q-=>.+#Q%?6^EVZ0Z?):2017+R'+.K9!*#^[T[>]9,_@;Q!-
MX UO0,Z8+K4-2>\23[1)L56F$N#^[SD8QT[YKTNB@#D[W2=2/CG3_$DPL8K"
MRL)H)P;AMXW%6+#Y,$#;W(S[5QNDVNN1Z4FN1:3X?O\ 3&N'U.)SJ,T"\L65
M_**F-& (^AY/.37J6HZG8Z7%$]_<QP1S3);QF0\,['"K]36=;>"O#%G?_;;;
M0=/BN0V\.D"C#?W@,8!]Q0!!8ZOK5QXL6VEM;1=(FL%N$ +?:89/ERLH^Z =
MQ '7Y3Z''24@4 D@ $\GWJJVJ6*ZLFE&YC%^\)N%@S\QC!VEOIDXH MUR_BK
MPF^OZKHU[!<"!K622*Z_Z;6LBXDC_$A?IR:ZBB@#EM"\)'1O%FM:FLX-G=R>
M=;6X_P"6,D@7SS_P(QH?S]:JV_A;4VU7QG+<M:1V^O1HD!CE9VCVP^5\P*@>
M_!]J[.JD.J6-QJ5UIT-S&]Y:JC3P@_-&'R5)^N#0!PY\*>)9O#?A+3I5TH2Z
M'>6TSE;B3:Z0H4X/E_>;.>@ Z<U9U#P5>:SKWB:2_-LFFZSI\=FIBE9I8RF[
M#%2H'5LXSVKNJ* .('AK6]6TG1-)UT60ATVXAFFN()68W7D_<PI4;<G!;D]"
M!G.17O/"WB&.\\70:?\ V<UCKT9=9II7$D+F'RRNP+@@X'.X8ST/2N_HH X(
M>$]>@'@NX@?3FN]"MWMIT>1PCJ\2Q[E(7)(VYP0,YQD=:[WMS110 5S'B_0]
M2UN?0'L!:[=.U..^E\^5D+*BLNU<*W)W=_2NGHH Y-=#U>/Q[J6O*EDUM<:<
MEI&AN'#[D9FR?DP =V.IZ5A1^"-?B^'6@^'0=--UIUY#/))]H<(RQR;^/W><
MGITX]Z[ZSU2QU">[AM+F.:2SE\FX5#S&^ =I]\$5;H Y7^Q-6_X6*?$6RR^R
M?V5]A\OSV\S?YGF9QLQCMU]_:L%? NMGX:W'A]Y+!=0%_P#;(665VB;_ $CS
MMK'8"/3@&O2** .*N=#\33>+(M6+:7+#)8?9FCEDD(LI"Q)>(;?GR" <["=O
M8<5E67@CQ%9>%O"=H)-,>_T&\$NPRN(I8]K*?FVD[OFS]W%>E44 <@_AG4;O
MQU=:K>"S;3KG1QIDBI*PD)WLQ8+MP =Q&-U9D'@S6G\#CP3>R6CZ:A6'[>LK
M>8ULKA@OE[<!\#;G=COSTKT*B@#E+/0M4L_'>JZVL=D;.YLH;:&,3L'!C+$$
MC9@ [NQ.,=ZQ])L_%'@GP;H.EPQZ1<3179BN5,LC&6-Y"?W7RCYQN[C  )Z=
M/0Z3:"P; R.AH 6BBB@#F?%^AZCJTNAW>EFV-QIFH+=&.Y=D21=C*1N520?F
MSTJI::!K.A>*M5U73EL[NWU=8Y+B"65H3%<(NW<IVME6'4'D>]=C5*#6-.NM
M3N--M[V&6]ME#3PH^6C!Z;L=.G2@"CX4\/KX:T)+$RB69I9+B>11@/)(Q9L#
ML,G ]@*VZ** ,WQ#8WFI^'=1L=/NS:7EQ;O'#< D>6Q& <CD?4<UR.F^%O$4
M.O\ AO498=&M8=-M);2>"W>1L!MGS*2HR25/!QC/5J] JEJ.L:=I @_M"]AM
MC<2K#")'P9') "J.I/(H PF\),/B"?$$=P$LYH%-S;#_ ):7$>5C<_1';\56
MF'0-3TGQOJ'B#25MKF#58(X[RVGE,162,81U8*P(VG!&!Z\]*ZVB@#SW4/ >
MHMX-N-,LI+-M0OM5_M2[DED9(Q(9A(57"DD84*,XZ9]JO2Z!KVE^.;KQ#HZV
M-Q#JEO%%?VES.T922,85T<(V1@D$$#_#M*QF\7^&4G:!_$6DK,IVM&;V,,#Z
M$;LT 4? NA:EX=T.:RU-[5Y&NYYT:W9B,2.7YR!@\^]=/2*RNH92&4C((.01
M2T 5M1@GNM,N[>VN#;W$L+I%,!S&Q4@-^!YKS_3O!_B>";PC-*NC1-HAE681
MRR-Y^^/8TI)498GD@]3_ !<\=]<:I8VFH6=A<7,<=W>[Q;1,?FEV#<V/H.:M
MT >=MX-UY_"/B_2#_9PGUN]N+B%Q</MC67 PW[O.1CMU]JM>,;-+OP?:Z:UW
M;V_B"U>VDL1#('9+D,%0@$ E3R"2/N[O2NZJ@=#THZT-9.GVQU,1^6+HQCS
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M(KV#RI691YEPC!6RHQ@^F:]?JAJVCZ;K-NL6IVR7$,;"0)(3M##D'&>H]>U
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MH#Z:UQ-91V>H65W(XC?9G8Z.%SD;B.1TKO** *FFQ7L5B@U">.:[8EI6B4A
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M>XLM0:U9GNYKA&MW9AB1R^#E1TSCW]J -O4WN8M+NI+-HEN$B9HVE4LH('<
M@G\Z\FN[W4[_ .$?AC4-0ECNKB?4K"92H*LQ,P)W$G&2?3 KU^>(3V\L).!(
MA7/ID8KSM/!'B)? VC>'WGTMWTR[@E60/(H=(7W#/RGYFX&,8&.ISP :T/BZ
M^T[7]8TWQ!!:1QV6F_VHDMFS-^Y!8,K;L98%>HQGT%1VWBW69-2T8G2I)[#4
MCME$-E.K61(RI9V&UU[$@+CKS4M]X3O-5\7W^H7GV8:;?:,=*DC25C( 69BP
M^7'\1'7W]J;X8T;QEID=KI>K:IID^EV058[BW1Q<SHOW5<'Y5Z#)&<@8[YH
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MG##:)#G!S]/_ *YK0\2VFI:AH5Q9:6T"37"^4TDTC)M0\-@JI.[&0/3.>V*
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M*DMSB**5S,TYE$<:@8(VDD#N>^.U7K3PYXBA\80Z_(='11I7V!K2'S J8?>
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M444 %%%% !1110 4444 %%%8?B;7_P"PK:Q6*-9+S4+R*RME<X4.Y^\V.<
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M^>1G(/MUK#'Q \3V_A/1_%]WI^E_V)<&(7D43/Y\:NVWS%).W )'R\GIR,\
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M048$@]><'&1[$5K4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M FKS^!_$7A]KBQ$NKWLUT)@S[8A(^\C&WDC&/?/;'-W4/#/B2W\2#Q#X>O\
M3X+JYMH[?4+2\1W@EV9VNI7#;ADBNGUG7--\/:>U_JMT+>V4A2Y4MR3@# !/
M6M"@"KIUO<6MC'%=W)N;GEI9=NT,Q.3@9.%&< 9. !R>M6J** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *\]^+]W-'X<TO34D:.#5M6M[&Z=3@^2Q)89[9VX^F:]"K'\3^&[+Q7H
M,^E7Q=$D(9)8SAXG4Y5U/J#0!I?9+?[']C\B/[-Y?E>3M&S9C&W'3&.,5S2Z
MC)!X@M_!VC/%#]BTU)Y9YT,I5,^7&@ (R3@DDGH!QSQ:L+;Q9%;K:7NH:9+M
M&TWL<+B1AZ^63M#>^2,]NU5[SPM<P^*;3Q%I%T@NX[3[#<PW18K<19W*2PY#
M@]\'.<4 <[J'Q UFT\*Z[.+>R&L:'?QVER&5O*E5W4+(@SE<A\X).,=ZU)]:
M\46WC6+0&?266_LY+FWE$,G^C%&4$,-W[WAA_<R?2F:KX"N-0\-:Q8QWL":A
MK%XEW=7+1DJI1D*HJYS@! .3ZGOBM6YT#4+GQMIOB S6RQVEI);-!AB6WE22
M&[8*CC% ',W/CO7[3P/K&HM#I\NHZ1JQTZ8A'$<P\Q%#JN[*G$@X)/2M1/$7
MB+2O'6G:-KD6GRV>L1RFSDLU=6ADC7<4<L3N&W^+ R>PKG/&>@7N@_#GQ4;B
MZMW.I:O%?(40CRB\\(VG)YQM'/&:[6;P]=ZKK=GJ>JS0QO8031VJ6I/$DJA6
ME)/0[1@+VR>3V ,2#QCK,&L^'[7418^;J5S);7=G I8V;!69!YJL5+849!Y.
M<@"J\_BOQ9)8>+KFV.D1_P!@3R8WPR-YR)$LFW&\;203\W/T[TZS\ :];Z?X
M<M7UJP_XD5UYD3)9M^]0JRDO\_+_ #=L#.2<UH+X.U(6'BZV-W:9\0/(ZML;
M]QOC$>#_ 'L 9[<T +=>*]2M]3\*W++:1Z'K:JCLT3&2&9TW1KNW 88\ [>H
M]ZWM(O[S4+[5'=H#80W!M[8I&0S%0!(2=Q!P^Y> /NFN5\1Q::G@6/P9?:A;
M/K?V**.SABDVRO*I"Q2(IY'SJ"3V ;G -=KI.GII6E6MA&Q<01A2[=7;^)C[
MDY)]S0!B^.==U#P[H45_8+;,3=P0R"=2?EDD5,C!'/S=ZIWNM^(9/'\_ANP;
M38H3I8O8[B:)W9"9"G*AANZ=,KUZG&#H^,_#]UXFT-=.M;B&W/VB*=I)5+?Z
MMPX&!CJ5J,:!J \>-XD\ZVV'3!8?9\-G(<R;MWU.,8Z4 /\ !&O77B/PO#?7
MT<4=XLLL$PASL+QR,A*YYP=N?QJ/Q5KNH:+J'AV.U6V:WU'4X[*?S%)<!E9L
MK@@#[O?/6I?!N@77AK19-/NKB&X)N9IU>)2O^L<N1@YZ$TWQ3H%YKMSHDEM<
M00KINH)?$2*29"JLNWCIPQYY^E &#8:AKD?CWQJQN([R+3[:V:&T6 AG!CE=
M40[N#N/)(.<]N*TO!_BB3Q,\<\&IV%W;?9R;F&.$Q3VT^5PC*6)Q]_J.J]3F
MG2>%]4B\3:[JFGZK#;QZM:QQLK0%I(I8T9$96W8Q\P)X)X[=:?8^%I?^$N@\
M1WJV4-[%:/;2M9*5^U%BIW/GIC;PO/7KP* -7Q-JD^B^&[_4K:V:YFMXMZQJ
MI8GGDX') &3@=<5S7_">16OA?5_$@U&QU?2K6"-K=K53&YE8LICD!8[>3'U
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M#):-^\CC1E&\%_O8('! ')YXQK'P7-+K7B5Y[V)])UZ-5N+<1$2JPB\HX?.
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M,,,G/7 [_I5?PSX9\3Z.EMIE]XA@N]&LL"WV6Q2YD5?N([[L;1@=!DXP3C-
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M5BTC_A(89O#MN^8%-N1=",'(B+[L;>V<9QP,=@#/G\6>+'T[Q==6_P#9$?\
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M.[NS=7)):68KM#,3DX7^%1T YX Y)YJW0 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP2S-A&G+*9<$\;RH7\/K7.?VC;6?A[Q)-:3@6$'C+S[W[+M<I;9C)<+@@KN
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M^^(%)<=&*D8!]N:CU'2S<Z0VE692SMI4,+F(;3'&1@A !@$C(![9SSTK2HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS22ZA"<R9B51MY4'&& SG\*</%6K7VF#6=&TE+[3OM9MUB63$\L:R&-I5[
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MH **** (X8(K="D,:QJ6+%5&!D\DX]SS1%!%"9#'&JF1M[D#ECZGU[?E4E%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\DCG"JHY))IMG=Q7UC;WD.?*GC65-PP<,,C^= $]%%<]I_B.XN_&NIZ!+8K
MEG;17"3>;N,H<L.F/E^[ZF@#H:*YGQ!XBU.TU2+2M!TZUU&_\KSYHI[P0>7&
M20I'!))(;MQM]Q6]8/=RV$$E]#'!=L@,L4;[U1NX#8&<>N* +%%%% !1110
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M!1-:2 X*3H=R$'MR,9]":R/ ^N/XW%IKTL31K96OV=D9<8NVQYW!_NA5 /\
MML*[JJ]G8VNGPM#9P)#&TCRLJ# +NQ9C^))- '!W32V'Q5UZ>R1GN!X:6=(R
M2P:02OCCWVJ,"F^%K#0M9\*^%?$;7CIJ*-%))>0N!+<7##;)'(<$L"Q.5[8'
M0"NV71-.36FUA;?&H/'Y33[VR4Z[>N,9YQTSS5*P\&>&]+UF35['1[6"_D)9
MID7H3U('12>Y % '!6EA'XTTC7I+[5;*QU&SU*<2W36Y-U8B.4^7MD\P;5"
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M.5 VEL\$C/&:J>&]?N/#</C758H+^]\*64R/IPW9XVGS?++D9C#8QC(],\T
M>LT5RJ>-=L7F7FD75DDTD4=B;B2-1=EU+9'S?(%"DG=@@=L\56B^(^FA-72[
MB\BZTMX4EC6971_.8+&RR=-I+ $G&WO0!V3,%4LQ 4#))/ %"L&4,I!4C((Z
M&N;U76MFA:Y_:^ARR6]I:EYXHI%=;B)E8MM)*Y  (.<'VZ92T\0V5MI'AZVT
MZQ/G:E:HUE9*P41Q",,2S=E4%1GGD@ '- '2!U+L@8%EQD \BG5YEX6U2VT7
MQ#\0=0OK3[!%#=6Q>%2#\QA ^7'!W,<CIG<,XKH(/'<#:ZVC363?;'M6NK9;
M>XCE$RK]Y,Y 5QUP>/0F@#K:*X>R^)$5Y9Z'J)T2^ATS5YTMH[IV3"2N2$!7
M.X@D8W8Q]:MZ-XBU34/'WB#2)K$)9Z>MLJ,)5.-ZR-O/^]\HP.F* .MHK/T;
M4+C5-.%S<Z;<:=*7=?L]P1O #$ \'&"!G\:Y;XJ1!O"]K,'E5X]2M -DK*"#
M,@((!PW![YH [FBLW6=&M]=M4L[QI#9[]TT*.5$PP<*Q!!VYP2.^!VR#RG@S
M1$T'QKXCL=(,D>@1QP;;<N62*Y()=4SG'RE"1_M"@#O:*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI=% 'EEYX6\0:X_C?_B7G3WU.6SNK"2>5&!>!8R%8*3CYD /4=>N.>ET6_\
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MEF+'O]:ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5B^*=!'B+0WLUD$5S'(EQ:S$9$<T;!D8^V1@^Q-;
M5% &#?:+#XGM].EU%+JUFL;A;I(D<#9.O1LX^8#)QV.>E7=5T.PUH60OX!-]
MCN4NX<_PR)G!_6M&B@##\56%QK>C3:);[D%^ODSSXXBA/#GW8KD >IR>!6Q;
MV\5I;16T"!(8D$:(.BJ!@#\JDHH **** "BBB@#.TC0]/T**ZCT^ 0K=7,EU
M*!_%(YRQ_E^50GP]:'Q0/$/FW'VX6_V4?.-GE;MVW;C^]SGK[XK7HH Y73/A
M]H>D:FUW9F]CA,WGK8?:G^RI+G.\19QG/([ ],8%)=?#S0KG7;C5@;VWDNB&
MN[>VNGCANB.\B X;W['OG)KJZ* &2(6B*([1Y& R8ROTR"*R?#GAFR\+VDMK
MITEP8)96F9)I-_SL<L0<9Y^N*V:* ,B;P[:3^)H-?::Y%[!"8$VN @C)!*[<
M<Y(!]:SM5\ Z-JNNMK)DO[.\E0)<-8W;P"Y4=!)M(SQQV-=110!AW'A>TFFE
M>&YN[1)K9;22&W<"-HER NT@[>&(RN#[T-X3TW^T])OHC-"^DQ&"SCC<"..,
MJ%*XQSD #GTXQ6Y10!R5S\.M$N&U54DO[>VU3<UW:6]TR0R.PP7V]F/?'![B
MI-3^'^B:G'IV6O[6YTZ/RK:\M;MTG5/[I?))'U_#%=310!STW@W3)5TI5>ZC
M&ERF>V*RY/FG.78MDNQR<[LYR:D7PEIWV[6;N1KB5M8B$-ZCO\LB!2H   QA
M21QZ\YK=HH Y^'P=I\&DZ?IJ7.HB&PN([B)OM;[R4&%5CGE,8&WIQ6^P+(0&
M*DC 88R/?FEHH SK/1;2SOI;\^9/?RJ$>YG;<^P'.T= JYYPH SSUK1HHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC8HR0,Y..F:\ZT4-K7P3N?#MK9W$U]=S7,$0-N_EY:Y<AR^-H5>I.>JXZX%
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MU>6:5]3C:2T:"!Y%E55W<,!@G&, 9/(XK/'Q%T<V5[.MMJC2V+LEW;+9.98
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M)!/:IM2\;Z7I<-Q=31W3Z?:W MKF]C0&*&0L%(/.XX) )4$ \=C@ Z2L>_\
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M%&C?VM]DU0VD<ABNW%J?]#8-M(EYX(/4+D@<]Q0!I?\ "'67_02U[_P<7/\
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MG!K:&J1G6SI0AF,RP"X:0 ;%4D@9.<Y)!QQV/I0!F?\ "'67_02U[_P<7/\
M\71_PAUE_P!!+7O_  <7/_Q=6_$7B&U\,Z:-0OH;A[;S%C9X5#;"Q"@MDC R
M0,^]-7Q';'Q2/#S6UREZ;;[4&95V&/.W(.[GYCC&,_AS0!6_X0ZR_P"@EKW_
M (.+G_XNC_A#K+_H):]_X.+G_P"+JAK6OZ+=V6F/J5MJ4<<FL1V]MY8*YG63
M8I+(V-FX'J><< \5,?$]Q-X_G\-?V;<BWCLEF:=64;M[[0P^;(48(]<]N 2
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ML&XJ<!=P]<$=,UL7OB&VM-2?38H+B\O8[?[3)!;*I9(\X!.X@9)!P <G!XH
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M1@]AD@]#6[X6N8-5OK27_A!)-'O;8,;BXNK)(A$2I!$+CELGN!C;G/8'NJ*
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MD';SR.G/0YXJGXOT74+?Q=HGC'2K1[V2P1[:\LXR/,D@?/*9P"RDDX[UW-%
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MC36["*6=&D;9D@ _>'7@],UW6GZ?%IT#1QO)([MOEEE;<\C8 W,?7  ]
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M'(XZ\]JY.VM;NW\2^*+F/1-86TU#1XD@EF1I&=@)!ALDMN)91MZCN *]2HH
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M+4EE>W\H[@@NS*3GI]WGK[4 >OUP'AZZ;QWXAUZ[O9)&T?2[UM/M+-7*I(Z
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M?V]A<Z9!$DUPBI\RNY((W9'7IC/KBNA\5+))X3U:""&6>>>TEBBCB0LS,R$
M>W)ZGB@#R=M0D3P'X5N/#6K7=QXNF%LS6\5[)-YN0/,\Z,L0$]20,>HKV#4-
M6BL)X+989;F\N S16\.W<RKC<V6(  RO)/4@=37G5KX9U:S\(>&M=TBQDA\3
M:)9QV\]I(NS[7$ /,A)Z'U4\X/Z7O$Z7UQK&B>*H?#5QJ=K#!+:7VF30*9X@
MY1@Z*W#$%<'!_'K@ WH/'VDSZ>+A8KH7/]H?V6;)D43+<_W#\VWH"<[L8[U-
M%XTTUK'4[B>*YMI-,N%M;BWE"[Q(VT( 0Q4AMZX.<<\XK U&35X](L;G2?#,
M^G6-QJ"&\M;2*-+P6^TY8A3A6+8!VG<%[@GC.L=)N(6\96]]X2O)]-U"ZMI%
MMV*L9(BL:O@ALEQ\S<'JO7- '</XFM;6#49M3MKG3H]/C665K@*0RMG!78S;
MN5(QUSQ3$\5VZZQ::7?6-YI]Q>HSVOVA4*S;1EE!1FPP'.TX/IFN"NO!VO7O
MACQ%HFF7M]/I8%M-I2ZIE9!*C[WBRX#;/E4 MW/L371:A!<^+]4\,7 TZ\L5
MTVZ^W79N8BAC8(0(ES]\ECU7(PIYZ"@"27XFZ7%I][?_ -F:NUI87;VMY*+=
M<6Y4@%FRW(R>@R1C) XSVBL&4,I!!&01WKRB72M4D^'GCK3UTN]^UZEJ=W-:
M1&$YE21@4;T'0]<8[]J[6W\0O;ZQI.C2Z3?)'=VH*WC)B-9 K$QL#R&PC'\O
M6@#?FD$,#R%'<*I.U!EC[ 5Q&D^+O#FA^"-#O-/LM1CTF]N?LUJFPR.C-*RY
M?+$XW9/4GT':NXED$43R$,0HSA5+$_0#K7D=GH^K0_##PGIKZ3>B]LM8AGN(
M!$28XTG9V;/0_*1T/.?8T >A:/XIMM6UF]TEK*]L;VUC28Q7:*IDC8D!UVL>
M,@CG!'I6IJ%_;:9837MW)L@B7+'!)]  !R23@ #J37+6UO='XM7>H_8[E;&3
M1X[9;AHB$,BRLY7GV8<].U7O'NC7NO\ @R_L-.$;7A,<T*2?=D:.19 ISQ@[
M<<^M $D/BVV;73HMW8WME?M;FY@CF5&\]!P=A1F&X=U.#7+)XML]'\"Z1>>%
M])O#97NJ"U59G&Z,M<%7SO<DECNVC.!D9QBM7PQ="^N$N?\ A"'T.2WC8W$L
M]M&K%L8V0[/F8?[6!P,8)/'+6^B:Q'\+=+MCI-V;W3];6]EM=@$C1BZ:3*Y.
M"=K XS0!KW=^]C\7XKH6-_++-X>=OL49#OO\]>,;MB\#KN XZUTNG^,=-U+0
M+?58([D?:)S:QVKH!,9@Q4QXS@$;6SS@ $YQ62B7DGQ5M]7DTV\BL_[#:V:1
MHMP24S*X0[<\[1VR,\9KE%\/ZV/"\=U%HCW-SIWB&XU$Z=<H%^U6\A<?+NXW
M;7R!VQTSC(!VL_Q!TRSM]::\L[^"YT=%DNK0QJTGEL,JZE6*E2.^>.^*U=#\
M0)KKS^5IVH6T4:QO'-=0[$G5QD&,YYQCGIU'K7':K#+K/@77_P"S?!\VE275
MDUM#"]JD=Q/(1W"$[4'JQYSVQSW>BECHECOBDB<0(K1R*592  01]: &:EK$
M&FSVML8Y;B\NRP@MH<;WVC+'YB  !C))'4#J0*R(_'>F2:>UQY%XDZZC_99M
M&C42_:<_<SNVXQSNW8QWJAXP@U;3?%>A^*-.TZ?4[>TBFM;RUM\&41R;2'0$
MC)!49'_ZPFO:GXDNM'L;RTT:^@MI;^,7-M%M^V+:X.YL!L*Q;'"G<%[@] #5
MC\::=]CU::XBN+632IE@N8)0N\.^W9@ABI#;EP<]^<5:_P"$C@A2_:_M+JP6
MRC260SA6#J^X#9L9MQRI&.N<"N%LM*N(+KQI%>>$KR?3-1EM76W<JQECVHCX
M(?)<?,W7J.N:AF\(ZY/X>\1:+I-U>W&DF.WFTR/5@0ZS))O:$;P&,>$4?-QS
M[$T =W:^*K:7Q"FA7=E=V%]+ ;B!;@(1,@.&VE&89'<'!K6O[ZVTRPN+Z]F6
M&VMXS)+(W15 R37)^%;C^T;N&8>"#H4L"G[1-<V\2'<1C;$5.6&?XB ,#'?B
M]\0M#O/$G@35=*T]E%W-&K1!C@,RNK[<^^W'XT <YKVIR7OQ \#2G3M1M!)/
M.R>>RA9%\ASC:KG#<C[P!Y]CCHCXXT\:#K.KFSOO)T>XDM[N/:F]6C +$?/@
M@ CO7/7M[JVOZ_X-OU\,ZK;FRN97O%EC51$6A9."6&1D]>X]^*SKZPUFVT'X
M@:#'H5]//J=U<W=K/&H\EXY8U &[/W@5(VXSG';) !V&H^.K'3]0MK :?J=U
M=75FUW!';0!C(H )4<C+<_3WJ.PUC1[OQG*ZZ;J4.L_V1',_G(R_N"^0FS=C
M>&)!X[$9K,@MM0/CCPM>2:7>10V^DRVUP[1@B*1MFT$J2/X3R,@=\5=$%S'\
M6[K4VL[K[!_8B6HN!"Q4RK,SE1CD_*1ST[=: $M_B9I5SI^GZBNG:JNGWES]
MF^UO H2&0R&,!_FS@D=0"!D9P>*V;[Q-;6NH7EA!:W5[<V5N+FYCM@N8T;.T
M'<PRQVL0!Z>XSYW'H^K+\'+'1SI-[_:,>HK*]OY1W!!=F7.>GW.>OM6EK=W<
M6'CO4[O3M)UJ1;FPAAN9M.MTGW-\Q!9693&ZJ1C.>&Y'3(!W6@:[:>)-(BU2
MQ686LW,;2IM+CU ]/\#61KOBB]TSQEH6BV^F3SQ7RSR/(C1Y81I]U0S#&"RD
MDXZ<9YQ:\%/IJ^&+:RTJUO+2WL1]F-O>QE)HV !^<'N0P;(X.ZLWQ3:WZ>.?
M"FKVNG7%Y;VBW<,WD;<H9$0(3DCC*G)[4 8.EZ]'X8\1^.YFL=2OH;>\BE=;
M<>88H_(5F8EV''). 2?05W#^([5XK$V,4U]+?6_VJ"&#:&:+ .\ERH ^91R>
MI^M<A#97XE^(C-IUX!J0_P!#_<M^^_T<1\>GS>N/7I67_96IZ3%X3UB;PU+J
M]M;Z+'IFH6'DJTT#J%(=$;AN00<'I0!Z+X>\0V7B73GN[(2IY4SV\\,R[9(9
M4.&1@"1D>Q(YKG?%^L7=QXP\/^#[*XDM1J/F7%[<0MMD6",$[%;JI8C&1R!T
MKH?#B8TYY5T:/2(YI#(EJ(T1PN ,R!,C<<'H3@8'7-8'C'0=1_X270_%VC6W
MVN[TLR17%F&"M/ XPVTGC<N20"1F@#3O_"-JUK&-+DFL+F*6.4/%.X$NQPQ6
M3GYP0,'.3S7+66L+X>\>^/)18ZC?K&+.4Q6P\QD7R69CEV  Y)QG)[ UV5MK
MLNHJJ66F7\4K$;VO;9H5B'<G.-WT7.3W YKF[2VO(?%?CNZ>PNQ!?0VZVK^2
MQ$Q2$HP'_ B!SC/7I0!O'Q?I\D6C&RCGO)=8A:>SBB"@M&JAF8EB ,!E[YR:
MIS?$'2(?#$6O-!?&V>Y^RO&(07BD\SRR'&<##<<$^V:YC2(]?T[1/!NFW&D:
MDVG0V30W\5J DJS@*$5CN!$?7D'!XR<<5GC1M9C^'%YH_P#8-Y'<KKOGQQ*J
ML&C^TB0E<'H%'4XSVS0!Z)IGBRUU'7[G17LKZRO(K<72"[C"B:$MMWK@GC/!
M#8(STJC+\0=,CL;'4!9W\FGW]Q]FM+J.-6660DA0%W;@&*G!(&<>XS \$[_%
MF+4S9W']G?V&]JUPT1""0S*^TYZ?*#ST[=:XO1KF*VT+2;75/#WB9=(TZZ^W
MVZQ6B311X9F3,JL6>-=V00H)P.HXH ])U/Q9;Z=%>RI87MXEA&)+PVZI^X&W
M?@AF!+!2&(7)P1ZC.MI]_;:IIUM?V<HEMKF-98I!_$K#(-><R6UQHOC#6);K
MPA)X@TW5Y4NK2ZMH(I6C8QJK1OO(VK\H(.<<_7'HNFPM!IMO$]O!;NJ#,, P
MD9_NK[#I_A0!A#4-'_X6%<0"SO/[:BTK>TV&\MK?S.%49P3NSSCMUJC#\3-*
MGTVSU)=.U5=.N+G[*UT\"A('\PQC?\V<%AU4'&1G!XIQ@ND^+DNIFSN?L T0
M6OV@1$J91,7VC')^7OT[=:Y,:1JW_"FET;^R;W^TAJ/F_9_*.=GVSS<YZ?<]
M_:@#U^O/]!NF\<^*/$,U[)(VD:3=G3[6S5RJ/(G^LDD ^_R0 #P!VSS7?(P=
M%< @,,C<"#^(/2N TNPO_ OBK7'&G75]H6L7/VU);-/,>VF;[ZN@^8J>H*@X
MQ@T ='%HT.BZP^JQ7DD&FQV<BRVTDS&*([E;>H)PO"MG''3WJ!?&MBK:8]S:
M7MK9ZHZQV=Y,BB.1F&4!PQ9"PZ;@/P/%&M6]WXM\-:MIL$,MG#=V<D,<MRA1
MV=A@';U"COD G/ ]>;N;#4O$_@W0_#MSI=U9W]M/:_;7DCQ'$L)!9T?[K[MN
M%"DGYN<8- &W=?$&R@N-9@BTG5[J;2"OVI(8%X4KOW#<P&-O..I[ \U%J7C:
M5-6\*0Z7I\]Y9ZV'G$R-&"\8A9PJAF&#]TDG' QR3@4;:UO8];^($[Z?>"+4
M$B^R-Y+?OML'EG'_  +UQZ]*SK33-6L=/^&]U_9%Y,VCQO!>P1J!)&S6_E@X
M8@8W=\XH Z=O'EG_ &U>:3!I.L7-U930Q3B&V#!!+R'//W0,$G\@<'$MWXXT
MZTLIM2-K>2Z3!,89M0B16B0AMC-C=O*AL@L%(X/89JEX<M[N+X@^+;J>RN8;
M:^^R&WF>,A7\N(J^#['UQGM6!IFDZOIOPUU3P+/IES-?;+FUM+@(3#.DK,5E
M,G1<;^0<'Y> 30!LZEL/Q>\-S12LR3Z;=L<2$HP'EX(&<=SR/6NW=%DC9'&5
M88(]:X-='NM-\;^$8X[>YGL],TJ6SENA&2H8K&%R??8?IWKO'<1QL[!B%&3M
M4L?P Y- 'AEM<V\'P^\4ZA)KM[;:Q9:G=1V#C4)/,RK 11A"V&!/&"#P37I^
MF>(;U=%TJ*^L+BYUV6PCN;FTMPBLA( );>RJN6R ,YR#Z'&3\--,GLK'5EU+
M3)K:XDU:YNH3/#@F-V!4@_TSFH/%-E=Z9X[CU]O#CZ_I5U8K:3Q0Q)+-;NCL
MRLJMU4AR#C_#(!ICXDZ(^GZ5>0PW\J:G<-:Q*D&6289RCC/#94C S^7-,77M
M)U3Q+X::]T?5K359UNC9"ZC,7E;5Q)O ;!R ,<-U!XK-UBRNY7\)S6WAY[.*
M#5Q>36UM"/\ 1XMCKE]GRELL"0N?3G&3J>(;:ZF^(OA&\AL[B2ULQ=BXF2,E
M8_,C54S]2#TZ=\4 7;WQG96=O?W:6=[=6&GR-%=W=NBLD3+]_@L&8+GYBH..
M?0XMW'B.R$UE;6:R:A<7L!N(8[4KDP\?O"S$ +\R@'/)/&>:X_1['5- \/>(
MO#-QIEU=2SS73V$T4>Z.Y2;) 9^B$%B&W8]LU7T[0M5\"^(]$N_L5SJNGC0X
M]*N'M%WO!*C;MVWJ4.2..G>@#4^%LOG6WBAMEQ&!X@N0([ABSIA(_E)R>G3J
M:[VO-]!O]5\,:5XKU*X\-:G)YVM2W<,*^7O>)P@W?>[;23V]Z]#MITNK6&XC
M#!)45U##!P1D9% ')VWB*ZUCQ=XB\/3:9<QV=E!"OFK*@Y=9&+DA]P# * !D
M\<XS6!\/?&%OIO@;PG:7MIJ!2]VVJWQC!A\YV;:I).XDGC(!&>,]:V+:"_TO
MXB^)KN33+N6SU&UM6AN(E#(/+1U8'G.[)&  <Y].:YNVTC58?ACX,TU]+O?M
MNGZI:S7,(A.8TCE+,V>AX(Z'G\Z .\U?Q;:Z3#?SBRO+RWT[F]EME0B#Y0QR
M&8%B%(8A0< _A6U9W<%_907EK*);>XC66*1>C*PR#^1KS86EUH/BK6HKWP;+
MKMEJET;NSO(((I"A=5#1R;R-@!'!/K7H]A$T&GV\3Q0PND:JT< Q&AQT4>@[
M4 >=:E'9O\:9+&_O9H-/?0/M)B^W20IYWG[=PVL,';FD\#>+)[+P_JD^IW-W
MJ&G)K+6.CW#_ #RW:,X5 &)&[D_>)QUYXK1>QN)OC.VI2Z9</IAT3[#]H> E
M/.\_?CZ8_BQCWK7\;2ZO;:+:G1K6>9?MD(NTM0/.6VS\_EY_BZ#CD G&#R !
M3XVL8K77)+BSOH9M$ :\MS&K.%*;PR[6*D%<GKVYQ6'K?Q)EA\-RZCIF@ZH5
M9;8Q75Q$B1$3,%!4EOF()QC'4@_=.:R/[+U**;X@K#X?U"*'5].C6S+8<N_D
M.F&.XG<689SG'<BM77]+U*_^#EG8VUA</?V\5D7M2NV3,3QEP >"<*?KVH V
MK[4M*D\8>&X+_3;Z+5I5N&LF8C9%A/W@;:Y4DJ!_>QD=*?J7CC3M,MKJ]>VO
M)M.M+@6US>PHK1Q/N"GC<&8*Q )53@Y]#C-U=;V_\<^#=272[U+>V%V;DM'G
MR1)&%3=C/)(Z#..^*H>&IO$/A5[_ ,-R>'KR\W7LTUA?QE?L[1R.7S*Q(*D%
MCD8)/8'C(!T U'1_^%@W4(L[S^V8M+#M+AMCV_F<*JYP3NSSM[=:RU^*VBG3
M;/5&L-632KB4Q/?/; 10-O*#S#NR.1U .,C//%68[6\'Q>?4&M+C[&=$6T^T
M^60AE$Q<K_WR>O3MG-<9X?@G\0_ ]/#=K97#75X\L*R/$?)53<L3(7^[A1GC
M.[(QB@#T#5?&ECI<VJ(+2\NETF%)[Y[=4Q"K L/O,"QV@M\H/'OQ2WOC73[/
M5;'3DM;^ZGO[9KFV^SPY610 < DCGYAUX'<BN2\2V6NWX\4Z/+I%_=VYT\1:
M0T+*(&_<D,S_ ##=)OZ @]!@#DFW8VVHMXH\%W<NDWL$-GI4UO<EX\^4[+&%
M!QGKL/TXSB@"UK7Q$\OP%J>NZ7IUU]ILYVLYH+@(K6TVX+EQN((!93\I.<CW
M([>VF>>W662VEMG;.8I2I9>>^TD>_!KRF]T+5[WP1X\LH=,NOM-[K#7EK&Z;
M3-%NB.5SW.QN#S7J=C<O>6<=P]M-;%QGRI@ ZCMD D ^V: ,K4?%$%A/J$45
ME=WK:="LUT+8(3&&!(&&8$G )X!_I7,7=Z=*^,=S)%:WMXTF@*ZVUN=[,WGD
M$C<P5>%'4@<>IJ/QCHLE_JNH7^FVNJZ?XBMHE73[^Q5C'>?*"(Y>JX#9!WX&
M,<\$5H6D&HQ_% :G>6<_D_V"EK+<1PL8S.)2[*O?&#P>G;K0!I0>.=+NM!TS
M58(KIQJ5Q]EM[;8!*9@6#(P)PI&QLDG''?BLSQ'KEKX@^'GB\11W5K<Z;;7,
M4T4C;'CE2(L.48@CD$8)!KG]*B\1Z3X3TRU72=16'^V+A]0CMTVW @=Y&0H<
MC )9<E3N STI]OI.J0:#\1+%=!O8/[2$K62_*WF%[=45<ACDYSD]!ZT 6M37
M$7PRF#R!FN8$(#G:1]G8\C.#R!S7I; ,I4YP1C@XKSO4;.^DL_ &S3KQCI]Q
M%)=@0G,*K"R'/_ CVSZUZ+0!Y-X8\76WA32=>-UI^K7-G!KMXLUS!"94MXQ)
M@%V8Y( ';) Z]L^@7'B*W5DCL+:?4YFMUNO+M"G$39VMEV4?-@X&<G!]#7&V
M-EJEEH'B[07TBZ>]U*_O7M28\P/'.3M<R#Y0 #D@_-QP":JRZ!=>#M=LII/#
MLGB327TJVL)#!"DLT$L (#!&/W6#'.#_ "&0#T/0-=L/$NBV^K:;(SVTX.-Z
M[64@D%6'8@@BM*LW0HFBTJ/.FPZ;O)<6D2J/*!/ ;;QNQR<<9]>ITJ "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH ***HZIJMOI-LDLX9FEE6&&),;I)&Z*,D#U.20  2>E %ZBN0F^
M(-C:)K27=A>1W>CP"YN+9?+=FA(SYB$-@CCGD$>E36?C>WNM7TNPDTO4+9=4
MA:6RN)E0),53>RX#;E./[P&<'% '4T Y&1TKAM&\6W.L6'BF35-%N1:6%W/;
MF.-HV/EHB!DX8$L<LWISC/%5G\5#2M \%Q^'M'F&G:I)#%$A=-T<6PL(QN;E
MB%QDG YYS0!Z%GG'>BN$MU2/XV32;&B,GAQ9)%9LX;[00<\D= !QZ5H2>/-/
MADTN66UN$T[4YUM[6^)0HSMG82H;<JMC@D>F<4 =70#D9'2N"\<Z[#J/@OQ3
M!:6%S=P6=O-!-<Q,H5)0ASC+ ML)&['3!ZD$#I_"_P#R*6B_]>$'_HM: -:B
MN3MO$]_/\1+_ $%M-E6SM;2*02AX^2[-\[?-D+\N !D]212S>/+"WTV+6'M+
MK^PY)A$-1&WRQEMHD*[MPC+<;L>AQCF@#JZ* <C(Z5R=MXZBO=7N-.MM#U:1
M[6]6SN9!&FV#(!#L=WW>>V2,<@<9 .LHKE)?'NGP-ILTMM<+INI3K;VU]E"C
M.V=A*AMP5L<$CTSBI-2\;6FGVMY?+8WEUI]C<?9[JZ@56"/N"MA<[F"DX8@<
M<XS@T =/1D?G6#JGB>*PDNXK:RGOI;.(37"0LBE%() ^=AEB 3@=L9QD9R9?
M$GAW6=4\(78LKBZ;4&DDTR[ PD+>6V\,-P.< C&#S0!VE%8.E^*8-3U36-.^
MPW5M<:25$XG,8#!E+*5PQX('4XI$\4Q36UB8;"Y-W>P&YBM':-76(8^9R6VJ
M/F7C.>>G!P ;]0FUA-V+HIF94V*Q).T'K@=L\9QUP/2LWPWXCL_$^FO>6:RQ
MF&=[:>&8 /#*APR-@D9Z="1R*R]?\37^F>,]!T:VTV6>&^6>1W1XP7\M/N@,
MPQ@LI)..F!GF@#K,C..]%>7:9K*^&/$OCZ>'2KZ^B@NH9I5MMI\M!;JS,2[
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M\>/O$*O?DD"MO3/'FF:CI-S>-!=6MQ:W(LY[&= LZSL0%3&<'<2,'..Y(P<
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MJ,A2=Q4%U!('TS2)XFU!_B1-X>&FR_9(;%)_-5X_FWN5WG+9"C:1@9/)XZ4
M=902!UJEJ]])INCWE]%;-<O;Q-((58*7P,XR>!_GK7F6MZO/K?@GP/KFH6DT
M5P^KZ?*6&#Y@8[B55"3@]@1GCI0!ZU17.:?XQM;F^U6SO[.ZTN?3(5N9EN]F
M#"02) 49ACY3GTID?C2U&L:9I]W975I_:@;[%-*4*R,!NVL%8E&(Y (]NO%
M'345F^(=7CT#P[J.KRIO6SMWFV XW%1D#\3Q7-^$-&@U;PM9:[XB1-2U'48%
MO)'G7>L*N-RI&IR$ 4@<<D\G- ';45Q^B:MH.CZ?J\MIK)U"V2\!""8S/$[!
M$6').<[^ ">-P':I_P#A.+6+4[S3+O3[N"^M[,WR0@QN9X0<$H5;&0>H)'MF
M@#J:*XZR^(=G>?V'*=*U&"QUDK';7DJH$\UE+*A&[=S@C.,9Z$CFKFL>,[72
M8=0N%LKF[MM-.+R6 I^[P S8#,"Q52"<?3D@B@#I:*Y"[^(-I%J*V%CI6IZE
M-)IPU&#[+&I$\1( *Y8>N><=.,D@%VH^/K/3X-2NGTZ^>UTLQK?2A5!A+A6P
M%+9;:&4G'KQF@#K<BBN&U>.,?&#PO,GWI;"\W')P0!'C^9_.NWDC26-HY$5T
M8896&010 ZBO!M-N-)7P!KJMJ$X\1B_NX]-CMKIS=EU8^4J*IW%<XSQC&<UZ
MQI^JW>E>$-)G\0!CJLL4,4L4>-TEPP'RCD#.<D\@#!/04 ;=S:PWD!AN$WQ-
M]Y"3AAZ$=Q['@U,,$<=*XO4/$EGK>G>)="GMIK6_L[!Y7AD93O1D)5T9"01D
M>Q!H\)ZQ#IOP_P#"5OY;SW=UIL(A@0J"P6)2S$L0 !D9/N!R30!VE%<E!\0-
M-FLII/LUTMY#J"::]D0ID$[G"C(.W:>N[.,9^E6$\:V"6VNR7L$]I+HA47D3
M[6.&4,A4@X(8$8SCWQ0!TM%8G_"1QVZWSZE9SV,-G;+<O-(5=&0[ONE2<D;>
M1CN,9S5>#Q?;GQ%9Z+>V5S97-]$\MH961EEV#++\K':P!S@]N] '1T Y&1TK
M \;Q)-X$U]7!(&GSL,$C!$;$'CWK#\*>+(K;3O">CW.FWT*WUA%':WCJHBED
M2$,5QNW#@'!*@''&1S0!W=%<I/X[LH&>4V5V;!-2_LQ[L!=JS;MF=I.[:&.W
M..O;'-7+OQ3'!<ZC#;6-S>?V:R+=F%DS&64./E+ D!6!)_+)!  -^C/Z4$9&
M*\G\.^)$\)Q^,'71M3O;6#7[F2:2T0,((PD?)W,"<8/"YP!S@8H ]5E1I(F1
M9&C8C =<97W&01^8K*\,^';?PMHL6DVES<SVT3,R?:"I9=S%B,JH[D]:B;Q3
M9S1VG]F1OJ$EW:B[B2)E3]T<88ER ,DX ZYSZ'%;3_'.EZIH]I?6:3O+=3O;
M1VC!5E$J9+JV3M&T*23G&,8SD @'345Q5S\2M-LM)UF\N+"^6?1Y4BO;50C/
M'OQL8$-@JV>H.?:M2R\617/B;^PY]-OK*>2W:YMI+A5"W$:D!B &)4C(X8 X
M["@#H:"0.M0W=U!8V<UW=2K%;P(TDDC' 50,DG\*\X\5:F=4UKP+=_V7=V\<
MVK1O#/*5PR&-SAE#$J3\I (Z#G!&* /3:,C..]<OK'CBRTBVO+UK.YN+"QE\
MF[N82F(R" V%+!F"D\X''.,X.,M# _QJ@NK<[TG\-O(&4Y#CSTP1^&* .\R#
MTHKA;#Q3HVD>&_$.M:?H>H)!9ZG/_:$*!#*9AM\V3!?&/H>V<5TO]N1L^E+'
M:SR_VBN]"C(1&@7<6;YNG(&5SR1ZT :M%<I=>/M.LTM+N6VN/[*NKD6T=^"A
M3<255BN[<$)&-V/?H0:0^.HWUV^TBVT/5KFYL9X8;@Q1H0@E&1)][[N,'UZ\
M<&@#K**Y2]\?:=8107LMM<'2IKD6HOU*% Q;:&*[MVS<,;L>_0@TSQ+KL-WI
M.OV-K87-^EE;NEW) RJ(W*;MHRP+, 0Q ]1WXH ZX$$9'2BN:^'?_)./#?\
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M-T]*S+?QQ:MX@T[2+JU:W?4D=K1_.20$J,E'"D[&QSW!]<U1B\,ZMK/PUO\
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ML[DL;>(@B($\+D<$@8R1QG..*O4 %%%% !1110 4444 %%%% !1110 4444
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M[V!<EGVQH23C=AD7)/7J>IJQI_C"RU;Q')X:O;>V\Z6U-Q&8;A;F&:/.&4G
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *Y;QUHVJ:IIMA=:)Y3ZGI=ZE[##,VU)]H96C)[95SS74
MT$X&30!R]IJ?B>?3;F]E\,K9W"1[8+#[7'(\LA_B9P0JJ/J2>>.E9>D:#J_A
M;Q>TFGV\UYH^JIYVHEI(U,-WWE52W1OXE'3 QGI7;Q7,$Z[H9XY%SMRC@C/I
MQ4A&5(R1D=10!Y;X<;4;G1_'6F66ER3R76M7\,4QD18E+X7Y\MN &<G .1TY
MK6'AB_TSQ!X&CL[22XL-#M)[:>XWHOWXD12%+9/*DGCOWKJ-%\/6.@?;/L/G
M@7EPUS,))2^Z5OO-STS[<5JT <5X8TS6[ >+=]D;2>_U":[L997C=?FC55W!
M6)'*Y(]*Y^QT#Q,;_P (:C<>'PM]I\L@U*XFO8VDG9HF0R;AG*9.0,Y&<!<"
MO4([B":66**:-Y(2%D16!*$C(!';CGFI: .$TC2=;TL^,;5],\R'4+R>\M9D
MG3][YB*H0*2"""#DG ],UF6GA77;#2/ VHQ6);4O#T;6]S8F9,S1N@1RC;MN
M1@$9(SWQ7IU% '!:EX>U'4]0\1:]_9\D5Q=Z*=*L[1I(][9WL7<AMH^9@!\Q
MX4_2H'T/6SIO@&$:5*7T9XFO!YT7R!83&<?/SR<\=ORKT)Y$B7=(ZHN0,L<#
MG@4Z@"KJ5DFI:7=V$C%4N87A9EZ@,I!(_.O/1X;U[4/AO%X%U#3S&T8BM'U%
M98S"T$;J0ZC=OW%%Q@J.>^.:])DECAC,DKJB#JS' 'XT\$$ @Y!Z&@#C[C3M
M2'Q0LM6CTV5M-ATN2S:82Q\.TBL#M+9P OI77D9!'K2T4 >31^&?$R?"BQ\-
M/HI^V65U#REU$1(J3^87&6& 5 P#SG.0.IZ#4]!U#5O'L]W)8S1:9=:!+IKS
M^9'E)'<-]T-G &>?7VYKN:* .$\)'QE9VMCH6J:';1)8A(FU9;I&2:), %8Q
M\VY@,<X R3[5VEX7%E-Y<32OL.V-2 6..@R0/S-3T4 >;V?A'6I_@U9^'6C6
MQUJR6-X?,=70RQ2"1>5)^4X ]L]*Z/P[?^)-1D1M8\/Q:,L2_O!]I28S/T^7
M;]U>IY.>@]:Z6B@#C-#\*WFE^,]5G+)_8;S&_LXL\K<RKME^@ !([?O3Z5'I
M&FZQX4UWQ$(-,EU'3]4NVU"WDAEC4QRNH#HX=@0,J"",\5V]% 'EEKX+U[P9
M!X8O]$MXM5N=.MIK6_LQ*(O-69_,8QLV -K^O4 5N:ZGB[4-+T^=-.PIOE>\
MTN"Z19#;!2-AE)"D[L,0" 1\N2,Y[>B@#RW_ (1'79M,\>:>FD6UG%J\8>R"
M3KLW>2JA, #'(.2<#/3(YK5US3]=U;1_"@719$GL=4MKJXA%Q$3''&"&YW $
MY/ !/'<=*[VB@#B=.TW5O#/B[7[J#3I=1TW5W2Z0P2QJ\$P7:RL'9<@X!!&<
M=*QXO!NJZ3I_A*V@LS=266JOJ-\T4J!4WB3*KN()QO Z<@9]J]*AN(+CS/)F
MCD\MRC[&!VMUP<=#R./>D>X@CGB@>:-9I03'&S ,^.N!U.* .7T/3=1MOB#X
MGU*XL7BLK]+5;>4R(=QB1@V0&)&2W''Y54^*S.GA2T:./S)!JMF53.-Q\Y<#
M/:NXK&UK1]*\2JNGWLS.;:1+@PPSE&5@<HQ"G/4<=N* ,/5/#ESXL\117MY:
MRZ?:6NG7-HGFLAD=YP%8X1F 55'<\D^@R8?"9\96=I9:'JFA6T2V(2)M52Z1
MDGC3 &V/[VY@ .< 9)]J[I%VHJY+8&,GJ:4D $DX [T <AX*T_4]*;Q&;_3I
M8/M>K3WUO^\C;?&X7 X8X;Y>_'/6N9MO!NOGP/IT0LQ!J^DZVVJP02S(4G'F
MNVS<I(&5<C)[CTYKU&">&YA6:WECEB;[KQL&4]N"*DH X?4_#EUXNUV#4+RT
MGTR"VTVYM465T:1I)U"D_(S#:J@]^2?;GGY='\7S> =,\,R^'MUUI=S:J+E;
MN(0SQ0R*0R_-N!VJ,A@._P!*]8J."XAN4+P31RH&*EHV# $'!''<4 /0L44L
MNUB.0#G!KR6X\/>+;VPL7OM#2ZU>RUR*\FO6O(_](A28L!$"?D4+@;3MZ9P2
M37K=% 'G6B7M[:_$GQR8M*FNV;["2()8P%?[/T)=EX/J/3I60VBW/A&Z^'-A
MY/VN[CO+R26.!@,O)$[N%+$# W'&<9Q7HVG^';'3=9O]5MS/]KU H;EGE+!]
MHVKP>!@<<4:EX=L=5U2PU&Y,_P!IT]F>V,<I4(S#!.!P<CCF@#G)M U"[O\
MQ1KK6+QW%_IRV%I:&1-Y55;+,=VT99N.> OJ<"A<:!KC>#/ ^GKI4K76D7EE
M+=IYT7RK"N&(._!SV_7%=Y/JNG6MP;>XU"UAF"&0QR3*K;0,EL$YP!WJTCI)
M&LD;*R, 593D$'N#0!P45GXH\,>+]9GTS14U;2]8E2Y4_:TA:UFV!6#[NJG:
M#E02,=#4NI:=XDN/$T0N["+5=,;3PBCSUCA@NLG<[HW+#&-I 8C'3))KNJ*
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M >76'ASQ)9^'O K-I"M=Z',5N+5;J/<4,3)OW9V]3G )X_(>GIN**7 #8^8
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M62:(.\K)]W>[%V ]@6('L*Z"BB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/V\^5]VW\$ )_P!]:L>,M!O]1N=$U?2@DE_H]WYZP2/M$\;+MD0'H&(Z$\4
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MA0&C8L.",\@@\#BE7PQXEL['P7.Y75+[1IYC<":X"L8Y$=5RY')4,H)[XXH
MU-:\?0Z8NIM;0VES_9AVW,;WJQ2LP4,RQ(5.\@$==N3P.:GN?&<CVYN=,TM[
MBV73%U)I[F0P(4;)5%;:V7P#D'&..:R[>R\7^&?$>J_V7I5IJNEZK<?:U9[P
M0-:3,H#[L@ED)4$8&:75-%\2W7B"X^T6MMJEE+IJPV\LDPCCM9\,)',>#DMD
M8(!( QD9)H V(O&4%[::$VG6QFN]:@^T6\$C[!'&%#,SL < 9 X!R2/<C%\
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MTBWTE(DPT<=T)VG?U&!A5'/&23D=,<XOQ&DEBU#P;)!"9I%UQ"(PP4M^ZDR
M3QG'K^E %BQ\>RFZUK3]6T*ZLM3TRU^V"UBD%P;F'G#1E0,G(QCU/UQ<L/%D
M\WB2+0[[35M[J?3_ +?$(KCS/E# %&!52K?,/4=>:R=6\/:]JFHZYK^GC^S=
M3DTD:;IRR.I<?.79V*DA220!@G&,FJ^E:#K=OXQT;6%T"VLK:/3I;6YC%X'D
M5V9&+,<?.QVGG)SU)% %[1_%NEVGAK4]331_[/$>J2VAM(=I>XN3($[8&YF/
M]<U0D-VWQHT1[W3;>UF;2[D^9!-Y@D&Y."2JG*_3'(P:I-X*U^Z\):C;I#':
MZG%X@?6K%9959)/WF]58J3@XR#[XK9CM/$>I^.]"URYT2.QM[:SG@N$DO$=E
M9RAXV@Y'R\>O?% &OX\U.UT?P9J-]?:2NJVD: S6K%0KKD==W;..QJ+4O%<^
MG^)+'0;719+B6[M'GA<3*B?)MROL/F&3^0-.^(.E7VN^!M4TK38!-=W<8C0%
MPH'(.22>G%5+C3=4G\>Z#JXTYUM+2QF@F)ECW*\FPC W<@;>?KWH U/"OB(^
M)-/NI9;)K.ZL[N6SN8#() DB$9PP W#!!S@=:9K/B*[T^^N+6TTLSBVLC>2S
MSRF&+&2 BOM8%_E)P<8&.>:J>"=+U'2Y/$'V^T, O=6FO8#YBMF-PH ."<'Y
M>1^M5-<TG7KSQ=/)]AM]0TJ6Q$5KYUP$2TFR=SE,'<2",, 2,8XR: .FT+5X
M=?T&PU>W1TAO(%F5'^\H89P?I6A7-^ M.U'1_!.EZ9JEO'!=6D"PE$E$F0HQ
MG(&.?09^M=)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !4%W>6MA;/<WES#;P)]Z69PBK]2>*GKA_
MB_%')\+=:+HK%$C92PSM/F+R* .XHK!D\12Q>-H?#ILD(FL7O([@3?W652I7
M;QRW7)K"N?B)-;>%=2UHZ*&;3]3;3I85NL@D2+'O#%1D98<8H [NBN/D\6ZQ
M#XH.@R>'XQ<W%JUU9,+X%656"L)3L^0C(/R[^O&:I2_$::W\(7NLS:(?M-AJ
M)TZ[MDN05202*F5;;EA\ZGH* .]HKD;/QC?+XQM_#^M:&=.:^B>6PG6Y$PFV
M<LC  ;6 YP"1[UJ>)/$4'AV"R>;RE-Y=K:QO/+Y<2,59LNV#@84@<<D@<=0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9K+?F.,@-MEA9>,'GICI[G/1ZBY7Q[X"V2.IN;6[$VUR/, @4KNQUP2<>F:
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M^"TOB*.2X@UFPENIK.ZCG<-&ZW+X55SC#'@C')->K6?@GPW87%E<6VDPK/9
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MEU(R6F5W.#^0KTT#  ]*P]*T9M%U345MT#Z=J,[797(S#,P&_CNK$9]B3V/
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MO]5TF"YNHEVK*2RDKZ-@C</8Y%7+CP_IEUJ5EJ,ML3=62E;9UD9?*!&"% (
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M ]/\6ZQ=:%X2U+5[&*":6TMVG"RL0I"C)Z=?T^M:.GW+76EVMU+M5I84D;'
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MB._(!VU%8/@J]L=0\':9<:;#-!9F(I'#/]^/:Q4J?H01^%;U !1110 4444
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M.78L4_NDD\COCUYJEI?@SPWHNJ2ZEINC6EK>2YW2QI@C/7'9<^V*W"ZJ0&8
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M,$\\"MVJ%RVH'5-/-K+9BP/F"Z64,96^7Y/+(..N<Y[5<::))%C:1%=_NJ6
M)^@H Q[313IFNW]S;(KV6J,);F$_P3!=I<#H0RA01ZJ#SDXA@\"^%K9(4BT*
MR589O/C'EYVOSR/;D\=.>E;[.JD!F )Z9/6A'25 \;*Z'D,IR#0!F0>&M(M[
MD3Q6:JPF:X"[V*"4DDR!"=H;)/S8SS6J0""#T-(S!5+,0 !DD]J198V=D5U+
MI]Y0>1]: ,S3_#>D:6\+6=F(_(4K I=F6$'KL4DA,]]H%5XO!GAN#7VUV+1;
M1-39BQN!'SN/5L= Q]<9K:\V/>$\Q-Q) 7<,Y')H$T32M$LB&11ED##(^HH
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M6TUY:Y\B>2,,\>?0]JO4 >.6X.C^#OB1>Z+;0PZG!JEY' \,862./;&3MQR
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MDG\:MR1I-$T<B[D888'N* /$='TVUTSX&+XDLK7&K0V\T1NTR94@-R1( <]
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M\N8+?3KFPGVO<1AXFN1MV!@2!G!?&>Y]:]4OO#&AZGJ$>H7VE6EQ=HNP321
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MAE+=2" !CIP!3?&5W8S^%/&-UI[10K%K,:S2W3[YY+E'B!\OD>6J@<=21NX
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M 1>V<L3)% (UG,Q&)(WXWD$EBV>HRQ/>@#TS4]3L]'TVXU&_G2"UMT+R2.<
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MN:@LNH6LUL$B,-K&F)8.#N+G/(8CC@=#0!HU1U'1=*UA474]-M+T(<J+F!9
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M@#)$D@+H#T)'45RWQ$\52>'/"VH7.F:A8)JENBNL$V'<J6 .%W ]#G."..E
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M=/M)XH/]4DL*LL?^Z"./PKEX?"DEQX_U75=2TS3Y]-N;6&" 28D9#'NR=I7
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MV/I_V<MO,7V9-A;UQC&: ///%]]I\TWC^W@>WM[F+2TCO9+M]S3'R7:-(D)
M4?-][G+'IWJ."WT[5/$_PWDECMKHRZ1<"9B _F%8HB WK@YX/0UZ6^B:3)<B
MY?3+)IQ%Y(E-NA81XQLSC.W'&.E(FAZ1');R)I5BKVZA8&%N@,0'0*<<#Z4
M>536L:^!?B38V]U#I\$>LR;-QVQJ,0DIQT#G*_\  JZ*SL[;Q#X]@\1PQZ<K
MVFEFW2'SH9I&E+[@PV%@%7D!L@_-T K<\0^&3/HTT&@6NEVMQ+,DDZ2VX6.Z
M16RT<A49PW0G![C'-9VD^$0=4M+^Y\,>']%EM9/,6333OED.",;A&FU>>1\V
M>G% '*>&_P"PO$7@_14U/Q#=1:M8W:R26:&%+E;U7.X8V;R68G//(/)X->O3
MPPW$#PSQI)"X(='4%6'H0:J)HFE1ZHVJ)IEFNH,,-="!1*1T^_C/ZU<EBCGB
M:*6-9(W&&1QD$>A% 'B%E:VMS\(/AV9HHW/]M6J!B.0#.X8 ]1FNVT>TM=.^
M,.L6UE!%;0R:-;2/%"@12PDD4' [XP*ZK_A'M%^SQV_]CZ?Y,;%TC^S)M5O4
M#& ?>IX]*TZ*]-['86J79&#.L*AR/3=C- '#_%BUGCM/#VO)$\MMHNK0WEVB
M#)$(/S/COCC\R:[==5L'TU=22\A>R90ZSHX*L#TP1US5P@$$$9!K+M?#6A6-
MW]KM-%TZWN<[O.BM45\^N0,YH YBSO&D^,-[!J*%5DTB)M-248^7<?. _P!K
M.W(ZX4=A7$7VGI'X.U.%XU.FP>+D33"?^6<1G0.(SV7=O''H:]GOM+T_5%C7
M4+&VNUC;<@GB5]I]1D<4D^D:9=6T5M<:=:36\./+BDA5E3'H",#\* .,MK"R
ML/C+-:V=K!;PR^' TD44856(N" 2!P3@XKB433KG]G[15(MVN(;FVWD$;X\W
M6T\CE3C</SKVE-)TV.\%XFGVBW2KM$XA4.!TQNQG%0MX>T5X&A;1]/:)Y#*R
M&V0J7/5B,=??K0!QNLVEEH/Q"\)6\-C;V6D7,UR["*,)&UX8P(RV.-VT,%]Z
MA-O):^+?'XM/ETQ],26=5^X+HQODCL&*!2WU!->@W.G6-Y9?8KJSMY[3 'D2
MQ*R8'3Y2,<4U-+T^.P:Q2PM5LVSNMQ"HC.>N5QB@#&^'IS\.?#?_ &#;?_T6
M*Z2H;6SMK&W6"TMX;>%>D<*!%'X#BIJ "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BN+F"SMWGN9X
MX(4Y:25PJK]2>!4M<EX_O["QLM'^W0H[2ZM;K;/+*8XH9@2RR2$=5&"<=S@<
M=0 =!%K&F3V4E[#J-I):Q$B2=9E*(1U!;.!BB#6-,NKTV5OJ-I+=",2F".=6
M?8>C;0<XY'/O7D5U<6=Q;?%B&6]M+QVM4F0H%"LPM>65<GHV!G)[<YK::UL[
M/Q!\,)+:&&%Y(YPS(H!<&UR<GODX/UH Z7QYXF70?#&J2V.J6-OJMO;M-%%,
M59FP"0 A(.3CCK]#706$LMSI%K,S#SI8$<L5XW%0<X&.]>/C4[.Y^#GC*UU6
M:!=;6:\-]#,P#F;>3&<'D_*$"_[N!TKUK09HKCP]ITL,B21M;1X=&!!^4=Z
M.<\'>+A=Z=,NOZK8I?'4[FT@5F6$RB.0J JDY/ZFNHOM6TW3-OV_4+6TW E?
M/F5,@=2,GWKR.VTO1+SX9>-&O+2VEO/[1OUC;8#,)O,;R54]=VXC [Y]ZT)[
MV&*>^TZ^F@M-9A\-P1:A<W<FYKC*-\D2$X^\3EN>6 P>M 'IUUJ5C90I-=WM
MO!%)]QY954-QG@D\\4DFJ:?%8K?27ULEHW2=I5$9^C9Q7E^AK>:AX9\&77AO
M6K./7;/1]@M+H;X;F/$7F(Q!RK JG(Y'>HXO$L(N_!NI7_F>'])GMKN!2I1H
MK>Z$@'+.I4*55]IXX;KC- 'JT6HV,]A]OAO+>2SVE_M"2J8]HZG=G&*Y?3O$
MTVH?$NXTFVU&TN]*72A=(+<*=LGF["&8$Y.![=>E<?JXT?1+;3KG3;^:[\/W
M'B5+C5+EG1H-Y&<@H NP/L)P,;ACJ"*Z"UO-.D^.<S6]S;,\WA] 3'(I+L)R
M<<=3MQ^&* .MUZ2:+3E,&K6VER&:,?:+A%92-PRF&(&6&0/K4]UJ^F63RI=Z
MC:0-%'YL@EF52B9 W')X&2!GWKDOBPD)\'122*F^/4;0HS 97]^F<'MQFHGL
M;&?XY2"6VMY&_P"$>63#(#\WVAANQZXXSZ4 =U;W,%Y;QW%M-'-!(NY)(V#*
MP]01P15<ZQI8FGA.I68EMP6F0SKNB'JPSP/K7*_"C8O@CRH\>7%?WB(J]%43
MO@#VJMXJ>7PUXYT_7;:U,\>KV[:5/$%X><9>W)^IW(3V!H [(:UI1LUO!J=F
M;5G\M9A.NPM_=#9QGVKF=#\5M'J_B6#Q!JMC##9:@EM;/(5@7#1JVWYCR>?4
MUB^";.[L[Y_!%VK2P:#=F[6;9A)86&^!?J'9S[>2*J-9V-U'\5I9X()70R ,
MZABH^RJ>,].1^8]J /4KJ^M+&#S[RZAMX<X\R60(N?3)K#\5:U+;>!-4UK0[
MRV=[>TDN(9@!,C;5)XP<'IUY^E<?H5]+'XL\#/J#YL;GPTJ6<CGY3=D(7Y_O
M&,<?C5:_MWMM*^+)MR%TAXB8 /N>>;?]_M_X$5S[YH ](M-6@A\/6.H:G>00
M"6WC=Y9G6-2Q4$]<#UJ_;75O>VT=S:SQ3P2#*2Q.&5AZ@C@UYE<ZM%I?B/PC
M)J>IOIVF3Z)Y5M=CR_+6X.PD,SJ57* 8/'IGDUUO@JPT?3],O5T.\FN[.:]D
MF\YW5HV=L%_+*@+LSGIQG=0!LWVJZ=I@4W]_:V@?.WSYE3/TR:DFU"RMEA:>
M[@B$Y"Q%Y OF$] N>OX5Q>A7 /Q,\8V6K;/-EBMGM5EQA[0(00N>JARV[W-<
M5;Z>B^$O!D5[&CVI\5>79&7DFT)EV+D\E2,8'0@CM0![59WUIJ-LMS8W4-S;
ML2%EAD#J<'!P1QUK.LKSR;C5IKO7+.XMHI@510J?8UVC*.V>3G)R<=:T;.QM
M-.MQ;V5K#;0ABWEPQA%R3DG XR22:\IE@M!HOQ:B$4/EH\K!-HPK?91R!V.<
M_C0!ZA!K.EW-X+.WU*SENC&)1!'.K/L/(;:#G'(Y]ZL7%S!9V[W%S/'!"@R\
MDKA54>Y/ KS$6MG9ZA\+9;:&&&217!=% +AK4DY/?)Q^-='\5(HY?ACK_F1J
M^RU9EW#.".A'O0!T<&KZ9=7TEC;ZC:37<2[I((YE:1!ZE0<@<B@:SI9O_L U
M*S-YDK]G\]?,R!DC;G.<5Y_JFC:>FN^ +O0K>".^,^]Y+=0#):^43(S$?>&2
MO)[MZFN<NM9TNYT3PU=65S:V5DOBF.46;R[IX_W[^9)*S'*YR3C  ##DT >P
MSZYI%K*\=QJEE#(CK&RR7"*59L[5()X)P<#O@U3T#Q9I'B62\33+R&;[-.T1
MV2 EPH&7 Z[<G&>AQ7*>']+T?4/B?XU\ZRL[@)_9\D8>)6"DQ%MP!Z'(!S["
MK?PVN;?_ (J6T\Z/[2NOWSF'<-X7S!R1UQR* .TN[VUL(/.O+F&WBSC?,X1<
M^F347]K:=_9W]H_VA:_8<;OM/G+Y>/7=G%<EK-T]K\7O#XOCMTZ;3[B*T9ON
MB[+*3_P(Q@@?4@=ZX[Q19"/1_BHT:(=))@> 8!1;K8/.*^^2N<=Z /7X-5TZ
MZO9;*WO[66[A4-)!',K.@/<J#D"JGB3Q'I_A;0[C5=2F6.*(?*I;!D?LB^I/
M_P!>N2O+6SL?B3X%^QPPP&6ROE?RE"[U"1L,XZ\Y/YU>^+8_XM=K9QT2,GV
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *ANK2VO8&@N[>*XA;&8Y4#J?P/%356O=1LM-B66^NX+:-F"*TT@0%CT
M SU/M0 U]+T^3S-]A:MY@57W0J=P7[H/'..WI3?[(TS,1_LZTS%Q&?(7Y.<\
M<<<U7'B?0&^V8UK3S]B_X^O])3]SSCY^?EYXY[U/'K6ES:4-4CU&T?3R,BZ$
MRF,\X^]G'7CZT +/HVEW-R]S/IMG+<.GEO+) K,R]-I)&2/:KBJJ*%10J@8
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MU!?6<%W;2"2">-98W'1E89!_(U6OM;TK3)!'?ZE:6SD [9IE0X)P#R>!GC-
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M7N_B9IVEZ?JUM<Z9-8332PPA6*NI3:2W)Y#$CH/K7:NZQHSNP55&2Q. !ZT
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M!G.<=NM $[:?9/)-(]G;L\X"RL8P3(!T#''./>BST^RT]&2RL[>V5CEEAB5
M3[X%0WVN:3IDHBOM2M+:0@';-,J'!. >3TSQFEBUG2YY[:"+4;1YKJ/SH(UF
M4M*F,[E&<D8YR* );S3;'4 @O;*WN0F=OG1*^WZ9''04V32M.F$0EL+5Q" L
M>Z%3L [#C@?2FQZSI<UM<W$6I6;P6Q*SR+.I6(CDACG"D>]-M]4L]6AN$TO4
M;:66+Y6,;"0Q$C(W+G\1GK0!(-*TX/*XL+4/,"LK"%<N#U#<<@^]$>EZ?"(Q
M%8VJ")#''MA4;$/51QP#Z5A_#O5[[7O >EZIJ4PFO+A7,CA H.)& X' X JS
M<^+]'M?%</AV6\A2]D@:8AI H7YE55Y_B;<2!UP/<4 :(T;2Q T TVS$+,&:
M,0+M)'0D8ZU:BBC@B6*&-(XU&%1%P /8"J=QKFDVEXMI<:E:17#,$$3S*&W'
MH,$]3V'>K] %1M*TYK\7[6%J;P=+@PKY@_X%C-.O=.L=2B6*_LK>ZC5MRK/$
MK@'U (ZUF:=K)U?6-16WD5-/TR4VTLF!^]F"@N,GHJ!@/4MGH!S7M;C4&\.S
M7=AK5OK5S%-+(CQHBQRJ&/[G*9P0/EW#G(!(/((!T:J$4*H 4#  ' %+5'1M
M6M==T:SU6Q<M;742RQD]0#V/N.A]Q5Z@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N%^+8@_X05C/
MY?\ Q_6F"^/^>Z9_3-=U44UM!<@">&.4#D!U#8_.@#A;FWL!\;-+416X*Z%+
MM7:O&)DVX'L-V/QKE[/4],T[P[J(N(8)(AXUDCMWDD*PVK^9N25]I'R+@G&0
M"<#CK7K_ -@L]X?[)!O  #>6,C P/TI/[.LO*>+[';^7)C>GE+AL=,C'- 'B
MVK7\\D?Q0CTK4!>WTUO92*T& 98Q&!*R!?X0N1D9[<DUT6M:]X=O_$?P\N]-
MOK)K=;F01[)%'E(T# *1_#S@8/<8[5Z8D$,<C.D2*[ *6"@$@=!^%10Z=8V[
M!H+.WB8,7!2)5.X]3P.IH \CL+K0M3T35_#7BO6+J#44U&<SZ=F-)+AC,9(V
MB^3>V?DQ@]O3%>Q(O[E58$_+@[CD_C4;6=J]TETUM"UP@PLQC!=1Z ]:F(!!
M! (/4&@#P_4&M3\'?'@!A*+KUULP1@?Z0F,?A79WJV=K\7/#"6H@B#Z5=IMC
MP,J#&5'';J1^-=K_ &;8A2OV*WVDY(\I<$_E[FE%A9JZN+2 .F-K",9&.F*
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M!1MQZ8]* //+G5]'O/C#X=GM+^SF\W2[F,212JVXED*KD'KU('UK3^*GVL>
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MX#U+4-/NXS>V=NTOFW$._=CDX ( /IU'L:TIY-3N= @.G/"M]/&G[Z9=R19
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MAK1K.1+G7=;4,)IT&R%%0/)(57&<#HO&3WXJ+XEZI:W7PJ\02I(%A> I#(Q
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M&U\,F:6-,>(;)AO8#@.<G\!5;2YM-;XJ>-7EDM2186:EF9>!MDWC/I]W/X4
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MY+>&:+RI(8WCX^1E!'Y4XHI4*5!4=!CBG44 1R00RQ>5)$CQG^!E!'Y5(
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M'3('TS[^\_L;XOPWNJR+#IMYI'V6TN9#MC299=S(2> 6&#SUV@=J[Q5"J%4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
)BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>sangamoexecutiveseveranc007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!MP7.W!);/)Z 5J64UQX?T^[?7]3:Y7[65MYW0;Y$;:$0(@Y;)*X R2,XYK
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M*.9!"2C;3P2#G@\C(R!Q0!T/_"*R_P#0RZ]_X$)_\11_PBLO_0RZ]_X$)_\
M$5:\5>8/"6KO%--!*EG*Z20N4=6"$@@CD<BN?\'>,=.DT7PQIEU<737UYI\6
MR>6&3RYI1$&=1*1M9NI//7/?B@#6_P"$5E_Z&77O_ A/_B*/^$5E_P"AEU[_
M ,"$_P#B*DU/Q?I&D"62[DF%M!*(;BZ2%FB@<X #L!@=1GTSSBC4O%NE:7+=
MQRO-*;*!;F[-O$T@@B.<,V/4*3@9.!G&* (_^$5E_P"AEU[_ ,"$_P#B*/\
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MJ5_<RWT\MJZ0/)!>QR2&126SL4@MSNP!BO6((_*MXX]JIL0+M7H,#H/:I**
M/$M2^UQ?#?Q?X;&EZE)J9U*>58X[1RKQO<!U=6QM8$'@ D^U=E'.9/B^E_\
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MPN7 #&7:QX8#C>2!S@\D5KVGC'1KO2[B_6:2,6UQ]DF@DC(E2?( CV=2Q)&
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M(9IR!]]EZ@<X&>>#VQ7/_$&U>^\3>$%_LVZO+:VOVDNO+LWFC1"FW+84CJ:
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MQOYOW"K$C*YXST''J,]!/JT=OJ45BUM<M)) ]P6C0,%52 <X.<Y(  !SVZ'
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M$<4A<HH?YL\D=0"!GG!XJU9>*+V[^(&IZ"=+G6VL[>%Q-NC.2Y?YS\V=N%
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M XR.@QF@#T6BJ.D7TNHZ5;W5Q9S6<[H#+;S+AHWQR/?GN*O4 %%%% !1110
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M3@]@30!OT5R$_P 1-*A\._VR+6^>-+P6-Q"L:^;;3;PA60;N,$CIGKQFI/\
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M>3P2PQGFL'2_"VL7GP0/AN2U:RU:-6*1W&TJ76<RJ,@D8. /QKTY%*HJEBQ
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M^21U &><;EE8ZE%K'CVX?3+H1ZCY9LSA?WVV 1G'/'S#OCCFN]#*Q(# E>"
M>E+0!Y>VD:N/!/@*P_LFZ-UI=]9RWD8"_NDB4ACG.#U&,9S7ID\0N+:2(DJ)
M$*DCJ,C%244 >>>"I?$^BZ3:>%+S0)A+8GR%U02)]F> 'AQSNW;> N.O4CG$
M<>FZH(_B&#I=T#JI8V7"_OLP",8YX^8=\<5Z/10!YM9P>(+=?"]A=Z->W&D1
M:0D%Q;0R(I6[4*O[W+#='M!QR02>0>*R-/T/7[;P1X4TR30;I;C3-?6ZG5&C
M(\I9I&++\W3#K@=3SQCD^O++&[LBNK,GW@#DCZTZ@#@O&SW$7BCP_>Z?I=[=
MWEM'/(S6)C,J1L%7:R.0"K$]>H*\=ZQ9=,?6/"FH6&C:1J%MK=MJ$6LR6^LQ
MHGVR0R;CDJ2FUMA7 P!@9QUKN-5\*V&LZE%JJ7=]9WR1>1]IL;DQEXP2=C#E
M6 ))Y%:.FZ5!I<;B-YYI9,>9/<2F21\=,L>PR< 8 R>.30!A^%[BXOY_M#^$
MO[!1(RKF=8Q([G'";/X!SDG&>,#K1\1]+O=9\!ZC9:= ;B[8Q2)$" 7V2HY
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MT_PWHL]Q;:;(SW44,HPDC#S&CB#'E@"#M&%&0 <\4ZX^(.GA-!DL+&\U"'7
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0$DBJB^+&35?#]A<Z9+!)K*2E-T@)@:--[*X_3(S0!T4DB11M)(ZHBC+,QP
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MM0P@O(5F0.,, PS@^XZ5?H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD[\# Z_IFO4"0H))  Y)/:A65U#*P96&00<@B@#B6T_5[/QMIOB!=)GN+?\
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MH_$\5)')'-$LL3J\;C<K*<@CU!H \GU#P]XLU#3F%YH:W>JVVLQW7VUKN/\
M?0+,&58@3\@"@ J=O3/)-;-K:>*_#'BG6)+'1(]4T[6)ENP5O$B-K/L"N&W#
M+*=H(*@G Z5Z#10!P%]I_BC0O&2>(-.T]-:COK&.UO[>.9(&25"2LB;R 5^8
MC&<U-JVCZ^^N>'?%*6T<]Y8F:.[T^&51^YE'1&; +)@=<;N>G KN:* .!OO#
MNHWT_BO6OL$B76I:6-.M+0R1[\!6RSG=M&68=S@+ZG BU3PUK=]\.?#=O:VR
MQ:UH4EI=+:S2KMED@7:4W*2,')P?IG%>AU&+B$W!MQ-'YX7>8]PW!>F<=<>]
M '"-;>)=2\<V6N)H;:?&FDSVI-U<1,8Y696!(1FR,KV_'%8]IH'BAYO"=_=>
M'P=2T^[9M1N9KV-I)RT;+YFX9^3)SCJ.@7 KU>B@#S=="UP^'O']F=(F$VLS
MW#V8\Z+#"2%8QD[^.1DY[42:3XFT;5=!\0Z;I'VZ2/2$TO4-.-Q''(H4[@Z,
M3M.&SWZ?IZ110!P?B+3?%-VNB^(K.RMI-5TZXDD.EM. KP2(%:/S#QO& <],
MD]0!GI=!N-6O(9+G5-,33-^T1VGFK*ZXSEF9>.<C@9QCKS@:]% &!XTT.3Q#
MX3OK"W.V\VB:T?."DZ$/&<]OF _ FN:F\$ZG+K>C:IOB$]W&\/B#;TD0D2A1
MZ@,OECJ=K5Z)49N(5N%MS-&)V4NL98;BHZD#KCD4 <MX@TW4KKQYX5U&VL))
MK/3S<FYE$B#;YD>Q< L">>O'3UK+BT77;(^.+1=*,\.JRRSVLZ7$8WEX50+M
M)!!!').!CIGI7H-% 'G#:%KG]B^ +8:3,9=&E@:\'G1?*$A,9Q\_/)SQV_*N
M^U%;M]+NUL'1+TPN+=G&563:=I/MG%6:* /++#0?$G]J^#]4G\/;+O3S,NI3
M37L;RS.\6SS"P)RN>0,Y&<;0!4C^'=>D\$>-],_LB476KZA=3VBF:+#)+MVD
MG?QC'(_G7I<EQ#%+%%)-&DDI(C1F +D#) '?@$U)0!Y['IFOZ)XQM]?M=(EO
MK6]TV*SO+5)XEFMY(S\K#<P5EY(P&]ZU/ 6F:KI=OK:ZI8K:FZU>YNX@)EDW
M)(V1TZ?C^5==10!R/C#0H?$%Q!::AH$NH62Q%X[JVE2.>UFSP5+,I&1Z=P,@
M]L1M"\46-OX)U*X@DUB_T=IUO(UG02LDJ%%.YR%8J-H///->B-<VZ3K T\:S
M-]V,N Q^@I_F(/XU_.@#S&Y\*^(M3TOQ]:RV$-O)K3+):$W 96(C1<''(^[C
M)QS[<UO3:9J'B34/#LEYILVG6VDS_:Y!/)&SR2A"BJNQF^7+$DG'0#')QV)9
M0I8L H&<YXQ6=J%II_B'2WLY9R]O(P^:VN"C!E(889"""",]: //8M!N_$6F
M?$'3[*58;M]<$EM(_P!WS(TAD4'VRH!^M;T">)/%>B7VEZWH46AI/9RV\T@N
M4F,K.A3*!>BC.[DYX ]376:?IUKIEN8+6,JK.9'9F+,[GJS,>23ZFK)8 @$@
M$G SWH XOPC+XPALK'1M6T:&U%BBQ2ZBMTDB7"(,#8@^8%L#.[&.3UP*G\%Z
M9JNC7>OVM[8A+:?5+B]@N1,K"19&!4!1R".<YQVQGMUU% '*^.]*U'4['2)=
M,M?M4VGZM;WK0"14,B(3N +$#//<U2MM-UC1/'6I:['IKWEGK5M!]HA@F3S+
M:>)2H^^5#*5/4'.>V*[>HVN(4GC@>:-99 2D98!FQUP.] &!X-T";0M/U![H
M*MUJ6HSZA-&IR(C(V0F>^%"@GUS537M,U4^/- UJPL1=V]O;W%M./.6,Q^9L
M*L<]1\ISC)]C751W$$TDL<4T;O$VV158$H<9P1V."#4E 'G"Z'K?]D^/[<Z1
M,)-9DF:R'G1?.'A$8S\_'(SSV_*H_P"R/%&AWF@ZYIVC+J#II$6F:AIKW$<;
MKL.5=')*GDMWZ'\O2ZCAN(;C?Y,T<FQBC[&!VL.H..A]J *FD-?R6(FU*WCM
MIY&+?9HW#B%>REAPQXR2.,G R!FN5UJP\0Z/X\'B31=,&K6MY9+9W=HLZ12(
MR,6212Y (^8@BNU>XACFCA>:-99,^6A8!GQR<#O4E '#:YHVOW6H>&_$J6T4
MNHZ7/,TVGQR@ PS+M95=L NH .3@$YY'%1ZCX?U'4]2\0:__ &?+%<7.BG2K
M.T:2/S&R68NQ#;1\S*!\W0'Z5WM(K*WW6!^AH \Z?0];_LCP!;C29C)HTD+7
MH\Z+Y D)C./GYY.>.WY56BT3Q+HVB^+/#<.CM?VVHM=S6%['<1JH\Y3\D@9@
MP()Z@$'/;K7IQ(49) 'O0"",@Y% 'GHT37!+\/V;2G/]CH1>[)XR$S!Y7&6&
M[GGCM6CHNGZOI'B[Q1.^FF:RU"=+J"=)T!;$2H4VDYW97O@8[]JZZ:>*VA>:
M>5(HD&6>1@JJ/4D]*>"" 0<@]"* /*M-\'^(+/P9X1=;+;K'AVZ:5[-IDQ/&
MQ8.%8$J#M;C)'(-=#/H]]J7B:Y\22:=- 8M)>PMK5WC\V5W;<S'#%0!@ 9;N
M>G&>Q2X@EFEACFC>6+'F(K LF1D9';(J2@#S!/#NO1^"/!&F?V1*;K2-0M9[
MM1-#A4BSN(._!SG@?RJ?6_"]]J>LG5;#29]+\017JB+5+>>-8I[<.,^<H;+?
M)D8*DY YQG'HB7$,DTD*31M+$ 9$5@63/3([9P?RJ2@!K[MC;/O8./K7G&D>
M$;N/Q%8ZE9Z5<:"+B*0:W;).AMIV9" 416/S;SD' X!SSP?2:CEN(8#&)IHX
MS(P1-[ ;F/0#/4^U ' ^$K?QCHMC:^&+O1;9K>RQ#%K(N4V- IX/E?>W[>,=
M,\D^NIX<TS5=*\7^)6FL1]@U"Z2ZANQ,N"/*52NW[V<KW &._:NNHH Y_P <
M65YJ?@K5].T^U:YNKNU>"-%=5Y92,DL0,"L&^T/6!=^$O$%I8.]UI$36UW8-
M+&'DCDC56*-NV[E(R 2,^HKOJ* //M5\-ZEJ<GBO65T^1+K4M)_LRSM&DC#X
MVMEW.[:,LP[GA?4XJ77-!U?4OA/::3!8E=4MXK3-L\J#<T+QE@&!*\[#@Y].
ME=Y10!Q<UEK-U\0=$UI]'ECM8+">&8B>)MC2,I4?>R<!><#J>,]:G\#:;J.F
M?\) -0L7MOMFL7%[!ND1MT;[<?=8X/'(KJ8;B"X,@AFCD\MS&^Q@=C#JIQT/
M/2I* .2\::;J6HW_ (:>PL)+E+'54O+AED1=J*CJ<;F&3\P_*JMGIFK6_BSQ
MG?OI<QM]2AMTM&$L69#'&R'C?QDD8SV]*[>D9E12S$*H&22< "@#G? 6G7ND
M>!M(TW4;8V]W:6ZPR(75N1W!4D8KHZ9#-%<0I-#(DD3@,CHP*L/4$=:?0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7*_$.QU74/",L>D0"ZGCFBFDLRVW[5$KAGBS_M 8]QQWKJJ
MRM>_M=;:VDT:**6XCN4:2*67RU>+!W#.#SCIQUQ0!Q_A75_"7BG7K.[TZV72
M=>T\.MSI\L(AF"E"I4KP& )!!YQ[9JYJWQ+L=-MI[^.*WN=/MKDV\VR\47/#
M[&=(<?,H;/\ $"0"0,8RM]H%SXA\::#K3:.^EMI;O)+=321&6=2I41+Y;-E<
MG)+$8[#DU5T2P\9>&)KO0;/3;.\TJ2YEFL]2>Z"&V21RY5X\$N5+'&,9]1V
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M(-<:)[28NK8,<:J-P!R/F4'Z>]7[C2=9\3V_AZUUC3OL3:9>PWMW-YR.DSQ
M[1%M).&8@_,%P,CDT 1S_$.]6RU^ZM_#4TD>AW#QW6^[1/D1 [,O!RV#G;[=
M><5VMG=17UC;W<))BGC65,C!VL,C^=<$OA_6_P"Q/'EJ=-82ZW-.]G^^CP0\
M(C&[YN.1D^U=EX>@GM/#FFVMU$8IX+6.*1"P;#*H!Y!P1Q0!SGCZ>;4?#NNZ
M=:2-'!:Z?-+>S(<'/EEDB!]3PS>BX'\8(W/"'_(E:#_V#K?_ -%K6%XF^'&C
M:II^LS6UM<?VG>0S,A%_,B-,RG!*[]N,XXQBK6AZ5?\ A3PQH6FZ9IHN)"\*
M:@);P_N05 DD4MG.".%&!Z4 4?B#;Q'6O!=S@^:-=BC!W'&TQR$C'3J!^57?
M%>I/+XB\.^&8V*IJDLLMT0>L$*;BGT9BH/MN'>E\9Z9J.IWOAQ["R:=+#5([
MV=O,1?D574@9(RWS ^GO5?Q39O;^-_"7B$@BVMY9K*Y/]P3)B,GVW@+_ ,"%
M &7J3SZ9\9&ETG2%O+J3P[CRD=80Q%P.68]!@ =">G'IM:=JT?CSPO?H+:;3
M=3M)GMY(G8&2TND&058<'!((/0C\:-0TW4[3XBP>(K:P:^LVTLV$D<,J+*C>
M;O#8<J"O;KGVI^D6)\*Z5KVM:D46XO+B74)XT.X1C: L8/\ $0JCGN2<=J +
MG@GQ ?%/@S2]9=0LMS#^]4=!(I*OCVW*:H76H-JOQ)AT \V>GV/V^=>TDS/M
MC!]0H#-CUVGM4OPYT.X\._#_ $C3;M=MTD1DF4]5=V+E?PW8_"JALGTSXO?V
MBXQ;:MI?V='[>?$^[;^*$D?[C4 85A>W^B>.O'G]A^'CJ+":TD:&*9(%'^C@
MG&>K$DG '/.2._0V'C^UU-O#$EI9NUKKQE2.1GP\+QJS,K+CL5(X/6F6UAK.
MB^,_$FHPZ7]MM]6^SO;O'.BB-HX@A$@8@@9&<J&X[5E-X+U3P_IOA%],@34[
MG1KJ::YB601>;YROO*%N.&?@'M0!HZQXUOH-*\8?8M/A6^\/Q@DR3DHX:+S
MP^7/ Q\O<\9'6NC\.W%Y=>'[&>^1%G>!&)24ONRH.XDJ.3Z?K7&'POX@OO\
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M#.IE8@)Q][@')'7'&?6H;71[K4?&\7B6\M'LDMK VD$$KHTC,[AF9MA*@
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M[7JVHW$]MY=P""LC Y.<8''UYZ"MW4]*UF3Q3X8UJSL$D6TMI[:YBEG5#$9
MF&R,A@"ISCF@ A\2VEKJGC*:+P^8[O2DADNI$:,278\HLI)]E'&23S5>+XC3
MJ=!NK_P]<6FD:R8HX;XW"MLED4%59 ,A2> WXX%07FEZC:7'Q$U*YM#'::E8
MJ;=_,4D^7;LC9 .1D\CVZXJ#2M*O_%'@/P;ITM@UM:6Z65U/</(A5TB0,H0
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MN)+>&YADFB_UD:2 LGU Y%.N83<6LT(D>(R(4\R,X9<C&0?45Y_K'@_2M/\
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M#:01CZ&H8?'C-K6F6,EE;R1:DK>4]I>"9H7"[@LJA0%STR"1GCWH [.BN/\
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MPAPOR[MV,GC@9K8@UVV3QUJ5C=:5;VL]KIB7,FH;PS/%N8;2=H.T$,>3^ H
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MOC.K^6$.2(2/F);&/F"COU %=S10!P?]F>+?#GBG59]$LK'4M*U>87)2XN3
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M\7_"S1M4\/:JFDZ<B:K<JS1.]S(%\QFR21N(]>U>AT4 85K8W6@QZ/IFBZ?
M=,5G%TTEPVZ%<%@5SDMEB>_'\J/B#2M2O?&GAG4[6T$EKICW#3L9%5CYD>P;
M0>N#R<XKJZ* ./\ B7:2:OX0?0;;FZU:>*UC'H-X9V/LJ*Q_"MZW?4DUF6U:
MS@72([=/)N!+F1I,X*E<< #'/^1=^S0_:OM/E@S;=@<\D+UP/0=,XZX'I4M
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBTQ$O9)/.8B1_+,G]_R\[-V><XSGGK2:IX"\,ZSK(U:^TM)+W:%>19'02@=
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MTB/=H%E'-=C4 ;9%:Y9,?:/E WD<_>Z_C7D5TP3X&:VY;$EOJLRPL6^:/%X
M IZCY>/I7M:J%4*H  & !VKG9_ 7A>Z>^:?2(G^W2>;<*7?:[Y!+!<X4D@9(
M SWS0!S][I%IJ?QDN+.\$LUI+H"RR0-,^QF\\KR,], <=..E85CHUQK7P<<6
MVZ;4-(O+E[ N2Q(AG;$1/4J57;@\=/2O2T\-Z3%JG]I16K1WGD?9A*DSJ1%_
M< !P!GG'KSUJ72-$T_0K5K;38#!"SF0IYC,-Q.2?F)ZGDT <<^M)K7A[5/&F
MD0JS6ND.M@=H)$GEF1_K@E4]BKCN:BT70X+L>&O$UGKEI",*&>VMF#WX=<&.
M5C(=[9R<D$@@GC!KO+#3K/3+%+&RMXX+5-VV)!\HR23^9)_.LC2/ WAG0=3D
MU+2]'@MKI\_.F["YZ[5)PN?]D"@#C-%>72/$.CVGB#3(I_M5Q(=/U^S8,MX9
M$<A)Q]X$JQ/<9 QP#679/#X<^'OBO4-/BBM)4UZ>V>>*/#16YN45L;<' 4GH
M1CMBO4;'POH^G/;M;6K*+8EH$>>1TA)!!**S$*<$C( ZGU-$'A?0[>;4)8]-
M@#:B6-V&&Y9=WWL@\<]\=>] '':CIDGAG[9XHTG4K)6.DSF.PL;0I%=LB%UD
M(WL"1Q\V.0<9Y%9&J:?ILOA#P#K$(66\GU;39);S.9)F=@7WMU;YNQZ8XQBO
M0M!\&^'O#)F.CZ7%;&8;7.YG)7KM!8G ]AQ55/AWX3C0(NCQ^4LXN$B,CF-)
M <Y5-VU?H !0!M:RK/H>H*EW]C<VT@6Y_P">)VGY_P .OX5P/AB>33]?_L?6
MM"CTS65TV58[FS8-;7\:E-S^H<$#@\_,>>E>BW-I;WEC-93Q*]M-&T4D?0,A
M&"./:L^#PUI5N&\N&4L83;AWN9'9(SC*JS,2H.!PN.@]!0!Y+I&GP6/@#X=Z
MU!YBZBVI6D!G\QL^4[LK1XS@*1V_'KFM+QP;>ZTSQO?V.ZYN++8'O+A]ILI$
M12$M\#<.N2<@9;OS7H/_  AN@C3;/3A8L+.RE$UM")Y L3@Y#+\W!!Z>G:F7
M?@CPU?75[<W6DPRRWJ;+DL6Q(,8R1G&['\77WH Y/4])M=>^)FF6FH-/+;7?
MA^5IXA.ZJY\R,= >.N>,<@5#;:4GBJ[\4Z'-=VL$VGSBUMA/ TL]I (D\N2-
MO,!7)RV[J3U)&!7<V_A31;6_M;ZWLO+N;6+R8'65QL3NH&<8)Y/J>3S4&L>!
M_#6OZG'J6J:1!<7D:A1*2REE]&P0&'LV: .+UR'4;2.+4G@A\6Z5'I44-V 1
M'<Q8#$W,0.1EP<G!R=HP>*]&T6YMKS0M/NK-V>UFMHY(6<88H5!!(]<57N_#
M6E7MU)<S6\@EEA$$ABGDC#QC.%8*P!')X/J:TXHHX(4AB18XHU"HBC 4#@ #
ML* /+M%:32?$.CV?B'3(I_M4\AL-?M&#+>^8CD).#R"58GG(R!C@&L?4"J?!
M3QB2VUK75KM8#GF+%P H4]L#CCM7JMCX7T?3GMVMK5E%L2T"//(Z0D@@E%9B
M%."1D =3ZFJ=SX#\,7<U]+/I,3F_;?<@N^UVXRVW. QQR0 3WZT <]JNCV.N
M_&)[/4(VFM3X<4M$)&0/_I#?>VD9'MT_*N5U"">U^%/BZQ^TW4EII6M?9]/D
M:9MPB$L0*$Y^8*6=><]_2O5KGPOHUS/;7#6ABGMHO)BFMI7@=8^NS<A!*YYP
M3BL'Q-HMWJND3^$;#1#:Z;)Y!2^26,1*!*KR IG?NPIQP<D\D=: *VHM_;OQ
M&U'0+Z2Q,4>G0RVEM>VYE60,SB1U&]?F&%&>2,<8YSFP*=)U7P?X4U+6&U73
MI/MB-/,NU;B6/ 2)\D[@N6&"3DJ.XKMM?\(:!XH,#:SIL5T]N<Q2%F1T]@RD
M''MG%.U'PGH.K:+#H][I=O)I\&WR80"HBQP"I7!4^X- '!>.?#ND:9X-OK6W
MD:X1=9M9U@EPR69DECS''Q\BX).WL&]#7J$%M;V]JMM!#'' H*B-  H'IBLS
M_A%-"_X1Y]!_LV'^S'Y:#G#'(.XG.2V0#G.>.M:=K:P65K';6T8CAC&%4=O\
M?K0!XS%(OAKX;^--1TF!+6ZCUNYMA- @5X8#.JMMQTVJ3CTX/:NKUVRBT'Q1
MX0N_#T:0?;;PV=S%!]VY@,;,7<#[Q7;D,>>>O-=7!X8T2VN-0FBTV /J)8W>
M1N$N[[V0>.>^!SWHTWPUI.DO$]G;,K0H8X?,F>7R4/54WL=@X'"XZ#TH I^.
MKBTM_!U^;V[N[6&0)$9+,@2DLZ@*I/&6)V\]B>17*Z=;-;_$+7---M#86L^A
M13M:64I"*_F.N[("_-@8) 'X]:] U72K'6]-FT[4K9+FTG&)(GZ'!R/H<@'-
M9D/@KP[!=+=1:9&EP(#;^<'??L.<@MG)/)^;KSC- 'F.F6,5KX%^'>NQ--_:
M<FI6D+W!E8L8Y&963KC:1V_'KFNDU2>+P%X[NK[[/YECK]J5A0#.V]CR1$OH
M)0>G=A76?\(;H/\ 9MGIPLF%G92B:VA$\@6)QR&7YN".WIVJGY&JZ[K\46I:
M+'9Z9I=V9[>=[E9FNF52L;!0,H!N+')SD <\T :WA_25T30[6P&TR1H#*ZC
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M?#O1;[569[R6#YW;JX#$*Q]RH4Y]ZY"P\*Z;XAN/'4&HS73+;ZD_V=VNI/\
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MB  (YF9B,="&)W CUSFJJ^"_#R:"^AKIJ#39&WR0B1_WAXY=LY;H.I/0>@H
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M@>U7* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML]Q8RB6%)GAWKT+(Q5L'N,@U;!#="#VXKQ339;?0?A4UY:Q6]FLNMM!>W"1
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M='5[]UL\-J Q=D2/F<=/FYYXX^G'2I]1UBRTN:RANIE6:]G$$$>1EVP2>/0
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M&X;/KD<5?DECA0O*ZH@ZLQP!2^8FP/O78<8;/% %<Z;9%K-C:Q9LO^/8[?\
M5?*4^7T^4D55OO#>C:GJ<&I7NFV\]Y NR.:1,D+G.#ZC/.#T-:'GQ;9&\U,1
M_?.X?+WY]*P[G7Y-0\(3ZSX<:SF<JS0->2%(6"OM+,PZ# )'X=* '1^"O#D-
MO:P0Z3!%%:2&:W6,E1'(?XQ@\-[]:M:MX<T?79+>34K"*XEMF+0R'(>//7#
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M,?+CI5=_!7AJ2"[@.C6@AO'5[B-4VK*5QC('4# ..F1GK6XSHB%V950#)8G
M H1UD0.C!E(R"IR#0!GG0-,.I6^HM;%KVW3RX9VD<LB]P"3T/<=^].T[0]+T
MF>ZFT^P@MI+J0R3M&N"['DD_CD_C6A7!:OXI\4Z-'H)NK+2UDU>^CLQ$#(3
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M]*L-%L(['3+2*UM8_NQ1+@#W]S[U<HHH **** "BBB@ HHHH **** "BBB@
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M]LVH"/RA<F,>8$YXW=>Y_.JO_")^'_[/;3_['L_L32>:UOY0\LOUW%>F<]Z
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MC#%/8$]N.E '#:QINEV$7P^BTR22XM[;6EMX+B5][E LN1N[KD<=L 8I-/\
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MRHHRLK!2>02 &]\5SS^'[*U^'_@77]*A\O7_ #-/6.X1B9)MX56C8]UVYXZ
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M=9Z59I9V%M%;6R?<BB7:J_0=JLT %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@>+_ !&/"^AB]VQF
M26XBMHVF;;&C2,%WN>RC))^E;]8WB<Z/)I2V.NQ12Z??2K:NLIPNYONY/;Y@
M ".02* (([GQ%:ZQI]O=G3KRQNBX>XMX7B:,A"P&TNX(./O9[8QSFMI[NVCN
M4MGN(EG<92)G 9A[#J:\TL=+U7X=^,=$TG3M5GU#P[JLLD*V%T=\EH50MN1N
MNP8Y'0?4YK/L8M)\3^'-8M=>UP6.HV^IS/=J%C6XAD28F-D8C=]T(JX[?**
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M2=H/F#&?2N+M;:W3XVZGLAC7SM!A>4!0-Y\YQD^IP *Y[2;73]!\;0020_\
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ML&%W,H)P/2MFN8^'+*WPW\.;6!QIT(.#WV"NGH **** "BBB@ HHHH ****
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M,07'F*YCC#,0 P.,G;GID=ZW=#U>'4-/L5ENX&U"2TBGEA5QO&Y02=O4#)H
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MB3V4<$D3M&DFPE9#(PSWP5KT"+7],;3++4)KR"UAO84FA^TR+&2& (ZGKR*
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MMM86U)@D4036R,BS(5SN().#G(QD]*O6VI6%[)+':7MM.\)Q(L4JL4/N >*
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M];3K0W3+M:<PKO(Z8+8SB@#Q:;3;"'X'>(+J.U@$]KJ,ZV\NT;H0MW\H0]5
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MDL9()1U# D'(X/N : /+)]!N?ASX@T2;PMJ4TFC:KJ"6LNC3/YB*'R3)"3R
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MT"6\#A@D9\O9&S$_/GMP,^E8,NFZ=#\%-;OH[2W6YM]6D,,X0;XMMX H4]5
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M,Z=&=86T6^Y\P6;,8NIQ@L >F,^]7:** "BBB@ HHHH **** "BBB@ HHHH
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M6ULVW?B655PN<9.3P,\9Z50U+4H)QIK67B.SLP]Z@/,<GVM>AA7)X)R.1R*
M,G3/"DKZC:WNH:)X>TZ6UD\U'TQ"TCM@C[Y1"HYY'.>F:[*J4&KZ9=7TUC;Z
MC:37<'^M@CF5I(_]Y0<C\:0:UI9LFO!J5H;57,;3"92@<'&W.<9SQCK0 K:/
MI;1>4VFV9CWF388%QN/5L8ZGUIZ:;81W*W*65LLZC E$2A@,8QG&>E+8ZA9:
MI:BZL+N"Z@)($D,@=<CJ,CO4EQ<P6<#3W,T<,*?>DD8*H^I- $,.EZ?;7DMY
M!8VT5U-_K)TA57?ZL!DU8E,@B8Q*KR ?*K-M!/N<''Y5DW/BC1X="N]7CU&T
MFM;8,&=)UQO49V9SPW;'6N"NO'%_9>#H/%R>(]/N!-8AI=+<1D)<.%*A"N'^
M4M\RL2<#MUH Z?P%X1;PYX>M+74[+3FU*V:3%U;C>2&=F^\R@C ;%=)>Z7I^
MI>7]NL;:Z\LY3SX5?:?;(XK$T^^-A+/J%[XKM+[19U46[2^4K)(,[@'3"L..
MF"1@\\5MIJNGR::-22^MFL2NX7(E4QD=,[LXH =<:=8WFS[396\_E\)YL2MM
M^F1Q3Y;2VG:)IK>&0PMNB+H#L/JN>A^E8VJ^,]"TKP[>ZVVHV\UK:Y5O)D#$
MR <1\?Q'T_'I6M8WUMJ5G'=6D\4\+CAXG#KGN,B@ AT^RM[A[B&SMXYW^_(D
M0#-]2!DTVWTK3K2YDN;:PM8;B7/F2QPJK/\ 4@9-9FH>+]'TWQ)9Z%<WD,=Y
M<HTA#R!0BC&,Y[DD #OS5^[US2;"Y%O=ZG:03$@>7+,JGGIP3W[>M #O['TS
M][_Q+K3][_K/W"_/SGGCGFK%O;P6L(AMX8X8AT2-0H'X"I:P;GQ?I%OXKB\.
M/>P)?/;M,=\@ 0[E54YZLVXD#K@>XH U;W3K'4HUCOK.WNHU.Y5GB5P#Z@$=
M:66PLY[9+::T@D@3&V)XP57'3 (Q7'>%O&"!-6B\1ZU9QSQZW<6-J9F2'>J;
M0JJ.YY]^M=;J&JZ?I40DU"^M[5#G#32!,XZ]?2@"Q!;PVL0BMX8XHQT2-0H'
MX"I*C@GAN8(Y[>5)89%#))&P96!Z$$=14E !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<3\5V6/P,
MTKD+''?6;NQZ*HG3)/M7;4V2..:-HY45XV&&5AD$>XH X"]GT_4?C!X>E22W
MN(SI-R\3 A@3YB8*_D<$5S5GJ6F:=X?U(7$,$D0\:R1VSR2%(;5_,#)(^TCY
M%P3C@$X''6O7C8VC2"0VL!<8 8QC(QTYI/[.L?*>+[';^7)C>GE+AL=,C'-
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MB:(-Y.(QA">N .F>^* /.EL+G2O%.H>"8K=SI.MR_P!H0NH^2&$G_2HCZ D
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MGU"_I7MK6-H\K2M:P-(V06,8).1CK]*9_9MCMV_8K;;G./*7&?RH M9R,BN
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MF4-),$5F4X8!CP2#P0#QWKE-%N_"7BC7+/5=+U2[U'4([61/,$AS;1..1(,
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M(FB.X ?4 K_P*N+>_P!6&OZ=XLT^WECB\4P?V>D13FW;;NMY6]>DC'T4@=J
M.[N=8L+Z]T9K+Q+;0++,Q6"-HW-\H5@5&>< \Y7TJLOC"PU:_P!;T?3KY8[R
MP0*)."3)M+':I&"% '/3D^E8WBY+'2O$'P_LTDCBC@OS'&K, 0@@91^N!]:C
MTS4;.R\=_$"VNKF*&>7[/+&CM@L@M1EA_L@C!/3/'>@#2\#^,K/4O#F@PZIK
M%J^N7UJ)6A9U620\G[HQVYQBNNN[RUL+62ZO+B*WMXQEY9G"*H]R>!7C%I/8
MP?"_X:LLMO&RZS9%B&48.Y@Y/Y\UZEXPDB3P5KC2NBQ_8)QEB .8VH EM?%&
M@WIF%MK%E*8(5GEVS+^[C895CZ @@_B*EM-?TF^2Z>WU&W<6@S<?. 81C.7!
M^Z,<Y->:WIAM/A!X4U6RAWV]H-/EU![-09/)0 OT'.USNQZ@FKEQ_P (3K=O
MK.JP:O=W:3:;]EO=1BF)6",NI7/ &X$ENF0 <]0" =VOB313'<2'4[6-;9%>
M8RR!/+5L[2V[& <'![XIEKXJT"]U---M=9L9KUXQ*D"3*792-P('TY^G->?S
M7FKII?BW1]7N++5_+\/RS0ZQ;*%:2/;(%2502 WWB,=1FHI[/3]3\*?#E-'%
MNVI175G,AM\;T14S.6QR!P=V>^ >30!Z5>>(-(L+I;:[U*V@F9U3:\@&&;[H
M)Z GL#UI^HZYI>D_\A"^@MSM+D2-C"CJQ]%]SQ7E=I>Z!<0>(?"_B^_NX;U]
M2G9[$L0;M'E+Q-$ ,MD;0 #G@5IV>N:5H'C/Q1I?BN5;2+4(;=K5KQLK/;B$
M(T8;N0V[([EC0!U]]XTT>Q\0:=H[W<1FO8FF#[QL5 !@YZ$L2,#TY],W]?UR
MR\-Z)=:MJ$FRWMT+$ 9+'LH'J:X>\GT[2/'?@A_+&G:?_9MW!;1R@KMXBV)@
M\[B /EZ]NM=)\1$:3X<>(U12S'3YN ,G[IH T;7Q#IMQHUOJ;7D"0S!1GS 1
MO(SL'J?8<U;L-2LM5MS/8745Q$K%&:-@=K#JI]"/0\UYS+K-N/$/@/5_M4<F
MA"VEM3<JV8HKEHU"[FZ9."@/8DCUK9\-VY?XE^*=1LF#:9-#;1NZ'*27*@[B
M"."0NT'W/M0!U=_JUAIGEB]NHX6DR45C\S <D@#D@=_2H7\0Z-';6=R^JV8A
MO65+5_.7$Y8@ )S\W)'2N8\1:Q867Q"TVTGD@TZZ?3I634ICDLID4&&('Y2Y
M(#<@G   .:X"RO-/D^$_A&UFGA;RO$D22I+@;1]JD)# ]/E.2.P(]: /8;;Q
M3H%[;WEQ;:Q930V7_'S(DRE8O=CV'7GIQ4PU[23I::H-2M38.0%N1*/+8DX&
M&Z<GBN3LY;-_C5JD"R0-YNA0!XPP.\B5\@CO\I'X&J/AJQO;/79/!$T,ATS2
M+G^T8)FY5[9B6@BSZK+N/_;&@#TB6:*&!YY9$CB12[.YPJJ!DDD]!6</$FBF
M.XD.I6ZK;())R[[?+0YPS9Z X.">.*A\71V$OA+4XM4GD@L9("D\T9PT:GC<
M/IG/X5Q$-QKCQ>)-"U">TUI_["DDMM6M$VO*A#JL<JC(W$DD8ZC- 'H1UO2P
M]DAU"V#7P#6@\T?OP1D;/[W'/%,O/$&D:?<?9[S4;:"7*J5>0#:6^Z&/\.>V
M>O:O+4\0:1<Z5\+U@U"WD-M/ D^QP1"WV9EVN>BMGC!YJ[HNM:#';>)?"WBX
M(;^359Y'LYE)>]1W#1&,#E^ H '(VCI0!OOXG;2/B%K%KK&L10Z1!IT%Q$)@
MB+&[NX(SC)^[WS796MW;WUI%=6D\<]O,H>.6-@RNIZ$$=:X2PGLC\9M6,K6Z
MR1Z);KM9E)C^=RP_ $9JQ\()HI?AEI8BD1PCSKA3G;^^? _+% '4:CK^D:2^
MS4-1M[8X!/F.!M!. 6_N@GC)P*EO=5L-.2-KN[BB$F?+!/+XY.T#D\>E>8OJ
M>BV_B'Q=H/B_4KBQ-]<F6)';;'=VSQ*BA3@Y(VE<#GTYS5K2]5T[PMX^-MK$
MK:=92Z+:Q:2]\^ J)N\R,L>-^2N1G)P/:@#ND\3Z#):Q72:Q9-;S2^1'*)U*
M/)Q\H.<$\CBK7]KZ=]NFL?MUN+N&+SI83( Z1_WB.R^_2O'7DC'PTU&\ *VT
M'BYIY&*D>7&+L$DCJ !^5=5::WI=[\:?.MK^WFA?P]M25'!20BX).UNC8&>F
M>A]#0!IR>+M.\.>$?[4N]>364>Y>*&X0(!(S2$!!LXPN<%O;\*WH?$6C7-]'
M8PZI:27<J>8D"R@NR_W@.N/>O(EN(&^!=S)'+&T4&M[Y"I!"+]N!R<=!CGZ5
MVOC:1(K32_'6DD7)TAR\IAY^T6;_ "R@'O@8<'I\N1UH [*WU"SNKFXMK>YB
MEGMF"SQHP+1DC(##MQS5?4->TK27V7]_!;L$\U@[<JF<;SZ+GN>*A\-VLT.E
M?:;I"EY?2-=W"GJK/T0_[JA4_P" UQ'BC5]/_P"$C\4:;YD.G7G]D(&D8;IK
M\%9"J1*<C:N2#A23N[8S0!W[:WI27UO9-J-J+JY3S((?-&Z5<9W*.X]Q3+?Q
M#H]U!=SV^IVDL5F2+ETE!$)'4,>Q'O7G!D1?A;X-\5V#>?-X?AMI)3'R6A,:
MQW"#Z*23Z%/:I+:TU6T\77.ESP2"T\71"]E7;@6I1@)HSCN8BBY[MS0!Z!=>
M)=%LXTDN-3MD1XO/#%\CR_[Y]%_VCQ3[SQ#HVGO EWJME TZ&2(23J"Z!2Q8
M<\J "<]*X+Q1JVGCQ'XITWS(=-N_[(16D8;IK\%)"J1*<C:N2#A23N[8S65:
M7^F7-M\(_,N+=Q&FUM[# 9;7'?T< ?48ZB@#TX^)-&?3K>\CU2W,%VK&WD1@
MWF =2H'7'?T[UC_#K6;S7/#UU=7E\+UDU&YACG55 :-'(4C: ,8Q61%J5EX=
M^+>H1:M)!86ESID*:7)*1'$%5F,J*> &+$$CV'M5CX47-K-H&JQVTD;"/6+S
MY$/W5,I*\=AB@#K]0UG3=*(%]>PP$J7VNW.T=6Q_='<]!6;KOC+2-"M],FFN
MHG74;B*&W9'!5@Q&7W#C:%R<]^G>L'2[]=,^*?BF'69D@%Y!:RV$D[!5D@1"
M'52>/E<DD?[6:Y%(&T?P7X>N+I_(TM/&"W%LTIVK#:&238Q)^ZISD$\884 =
MD_BO^SOB'>PZAK,*:$-'BO8C)L5%9Y67AL9.0HQR>M=<FK:=)I::FE];M8NH
M9+@2#8P/ P?<\?6N*MKS3KGXV7$XGMWQX=B*,2,C]\Y.,]/E(/T-<;I>HII_
MP[\+:B9I?[(T_6[HWS6IW&!&>=4<@9^52ZGIW&.U 'K@\4Z#_9\]^=7LTM;=
M_+FD>8*(W_NMGH?8\U8T_6M+U6:ZAT^_M[J2U8).L,@8QD] V.G0_D?2O,/$
M[>&;CP3XSUC1KY[V2\L4CN;QI=T<CJ,(@Z N!Z<C(SUKTS0XK)=)M)K*. 1R
M01_/"!A@% '(ZX% &>GB[3+OQ1>>&X;M4O+>%69\C[[%OE4'J0%R?KCUK%\"
M^-+>Z\.::FOZW:G5[RXGC1962-Y=L[HN%&.RX'KBDL[ZUL/C'KL=W<1PR7.F
MVA@5VP9 IDW%1WQW].]</'<6"? B*59K99/[9#[@R@[A?=?KL_3VH ]CO_$&
MD:7*T5]J-O;NJAW#OC8I. S?W03QDX%%YXAT;3[C[/=ZK9P3>69O+DF4,$'5
MB,\#WKS3Q?K.G3OX^L8I8+"Z&G#>!\\^HGR&*E0<@1J#@[1GJ25JQ9WVFWOC
M3X>R+/;RXT>?:2P/S;(@,>^0V/H: /2=,U6PUFQ2]TV\AN[9R0LL+AE)'!'U
MJ/4-<TO26VW]]# VPRE7;D(.K$=E'J>*Y3X;3V\EQXPC@EC8#Q#<,%1@< K'
MSQV)S^M4?$NKZ>OC#6M.:2'3KPZ.H,[C=->J?,*QQ*<KA3G.%).['&,T >C1
M2QSPI-#(LD4BAD=#D,#R"#W%4GUW2H[T6;W\"SM((0A;K(?X >F[VZUA_#.Z
MANOAMX?,,JR".RBB8J<@,J@$?AT_2N5^U7.CZR)](U"WU?1+S73%<:5.!]HL
M[DS'>\3 Y(#@OM(^[ST)- ';Z-XPTK7-9U+3;.X1I+&41'YN9#M!8J.X&<9^
MM7;;Q!I%Y>):6^I6TEPX+1HL@S(!U*_WL=\9Q7FTTD\G_"S](TZ;&M7$IDM[
M=3^]=#;IRHZ\\@'U(]15C5;FS\1^$O!2:'+&=0COK1X8XR-]N$&)=P'*A5#!
ML\=!W% 'H5_K^D:7+Y=]J-O;N-I82.!L!. 6_N@G@$XS6$NJWZ?%:72GO2VF
M'1?MBPE% 23SMF=P&3P.Y[FN:TW7-#LM1\8^'?%[I'<7>I23+#.I)O+=U41!
M,<N0%"X7G@5G^*_MLGQ!$6B&*.X@\-QM)IS2!3-&MQE[?<#E25[CT]#0!ZSI
M^I6.JVPN=/NX;J ])87#*?H146H:WIFE'%]?0P'87(=N0@ZL1V4>IXJKX7U_
M2?$F@6M_HTD9M6C $2X!AP,;&4?=(Z8_+BN9T>_CTSXD^+K?6YHX&NUMY[.2
M=@J2VZQE6"D\85B<CU8GO0!U]QKND6HMC<:G9QBZ&;?=.H\T8SE>>1CG(JG'
MXR\.SZ/>ZM;:O:7%E9 F>2"0/LQVP.<GMZ]J\KALTT[PQX*74U1-/;Q-(]LM
MP,!+9O-,8.>@(P>>Q%=#J&GI-XW\77VDHK6K>'&@NS",K)=$L5''5@@&?0,/
M6@#HCXGL-<\,Z7J%OX@@TAKN2!AEHW8L=K&##=200..1FM_4-9T[2\"^O(H"
M5+A6;G:.K8ZX'<]!7E>HZKIMQ\'?"!BO+=_)N-+C<AQA74IN7/J.<CMWKI--
MU!--^*WB1-7FCA2^M+633996 1X8U82*I/'#L21[YH ZZ;7M(MXK26;4[-$O
M65;5C,N)RV,;.?FSD=*32]>TG7//_LO4K6\^SL$E\B4/L)Z9QZ_K7C[6L5EX
M2T2*[,2Z=/XT6:PBFP%^R&5MN ?X2,GTPP]:["VU+3['XN>(YY;J&.*/1;>6
M8AAP$:0L2!Z+C\* /0:*IZ5JUCKFEP:EIERES9SKNCE3.&&<'KR.01@U<H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ IK(KC#J&'H1FG5B^*[NVL_#UR]UK@T56P%O<KN0Y!^4-D$
MG&,8[T :_DQ9!\M,COM% AB"LHC0!A@C:.:S+WQ+HFF7;6=[JMK#=)%YS1/(
M-X3(&2.V21CUSQ5K2]5L-:T^._TVZCNK63(62,Y!(."/8@]J +$L$,\?ERQ)
M)'_==01^5*T4;XW(K8Z9&:Q?%/BBR\*V$%S=[F:XN([>)%4G+,P&3CH #G\,
M=36#=^)C8_$B%;C5RFAR:*]UY<BJJ+()D4$<!B2#T.>O% '<B.-6W!%#'N!S
M2JBHH5%"J.@ P*S[;7M*O-'35[>_@DT]QE;A6^4\[<?7/&.N>*=INM:=JYG6
MQNEEDMV"31D%7B)Y 92 1GW% %N2"&9T>6*-V0Y0LH)4^WI3FC1\;T5L>HS3
M9YXK:"2>>5(H8U+.[L J@=22>@K,C\4:+*+O%^BM9H)+A'5D>-#T<J0#M_VL
M8H U@ H    Z 4TPQG.8T.3D_*.3ZU077]*?2H=42\1K&9E6.=02KECA<<<Y
M) 'J2*;J'B31]*E,=]?Q0%2H=FSMC+?=WMC"9[;B,T :(AB!!$:9'0[1Q2""
M(3F81()2-I?:-Q'IFLJ\\6:!I]S/;76KVD<\$8DEC\P%D4G R!SD^G6J6K^.
M=&TS2=+U&.X6Z@U.YBM[9X<LK!W"ELCH%!)Y[C'6@#I656&& (/8BD6-%!"H
MH!Z@#K20S)<0I-$VZ-U#*<8R#5+4-;T[2VV7ER$?89"BJ78(.K$*"0H]3Q0!
M<CMX88O*BAC2/^XJ@#\J<J(@PBJH]ABN5\:>+X="\$SZQI]Q#-)*B_9)%^=&
M+,JA@1P0-V??%:&A6MPMU<WJ:Y/?Z;<*ODPSQC=$XR&(< $@\<$<8XH T+NP
M$NG7EK:2?8I;B-U$\*@,C,"-X]2.OX5RMOX4UFXTY=)U>309;$1>0TT-BPFD
M3&/XF*JQ'?GZ5U%]J]CIKJEU/L<J7VJK,0@ZL0H.%&>IXID.O:7/=VUK%>Q-
M/=0_:($YS+'@'<OJ,$=/6@"X]M!)Y?F0QOY9RA90=I]LT]HT?&]%;'J,U1M]
M=TJZM+J[AOX#;VDC1W$A;:(74 LK9Z$ C.:S-4\06M[H6M+I.I&'4+.T>; 3
M$D?RDJVR1?NG'7&#VH Z#R8LD^6F3U^45S_B'0]4O+S3[S1[RSB:T\S=:7D!
M>";> -QVD$, " >?O'UJIX/\7Z=?Z-H%E=ZM#+K5UI\,SQLWSR.8PS>V><XZ
MXYQ774 8.CZ%-;ZA_:>H+IXO1"T"BQMS&BHQ5FR226.57T QTZFJVN^'KW5/
M%N@ZK']D-KIGGB2*5CNE$J!#_"0,8SWS[5CZ1KUSXEU_7M/'B"32]1T^\D@@
MT]8HCF)<;96#J6<-U^4C P..IZBPOIK#PY8S:_.B7IC19R%^_+CD*HY.3G '
M- &H(8EB6)8T$:\! HP/PIP157:J@+Z <5C#Q;X?_L_[<=7M4M_.\@L[[2)<
MXV%3R&Y^[C-/TOQ3H6M7]S8Z;JMK=75MS+%%)DJ,XS[C/<<4 :<,$-NFR&)(
MDSG:BA1G\*?M&[=@;L8SCG%94'B;1KF]BLX=0B::9G2'J%E9/O!&QM8C!R 3
MC!J ^,_#7VQ+,:W9-</<BT5%E!)E./D&._(_,"@#:\J/=NV+N]<<TU+>")W>
M.&-&?[Y50"WU]:SK?Q-HUU>Q6D&H1/-,76'J%F*?>"-C:Y&#D G&*S]-\;:3
MJM[K-JER($TZ3RGGE&P'"@LV6& !G'/7&>E '2+&B9V(JYZX&*;%;P0(R10Q
MQJQR0B@ FL?1M2LK7PK9W<VN#4+?:%&H2X!G); P ,$D\  <\=:LP^(M'GM;
MNY74($BLSBY,K>68#U^<-@K^.* +_D0XQY28_P!T55_LN ZLFHL 98HC%$ H
M 4'&?<GC\!TZG-*U\8>';V^M+*VU>UEN;M/,@C5^9!C=Q[XYQUQS6W0 4T(@
M"@*N%^Z,=.W%<#?>(_[;\5:SH4&N2:2EC:1-#<1*/]<Q<EFW#!50J\' .3[8
MZ#2/%NA7WV.RBUZRO;V6!G#1$#SMGRNX'0#(/?\ ,4 ;S1HY!9%8CN1F@QHQ
M)**21@DCJ/2LVT\1Z1?7D=I;WT;SRH9(5.5\Y1U:,D8<>ZY%5+CQQX8M8II9
M=<LA'#+Y,C+)N"N "0<>F1D]!GF@#;\B'&/*3'^Z*>RJR[64$>A%94?BC0YM
M8CTF+5+9[Z12R0J^2P R<'H3CG'7%:U #5157:J@#T IL=O##'Y<44:1YSM5
M0!GZ5PFCZ]=>)M>U[3QX@DTO4M/O)((-/6*(_NEQME8.I9PW4[2, @<=3U%A
M?36'ARPFUZ9$O3$BSD+]^;'(51R23G  S0 :[I#7WAG4]+T^.WA>]MY(,L-J
MJ74J6.!SC/X^M.\.Z4VD:'8VD\=O]I@MXX))81_K-BA0<D \XZ=JB;Q=X?32
MI-4?5[5+..0Q/([[=L@ZH0>0W^SC-1+XV\-/<&!-9M6E%Q]EVJQ.9?[@QU/L
M* -MH(FF69HD,J#"N5&1]#2R0Q2LC21([(=R%E!VGU'I5.ZU:PMII;:>]2WE
M2$S,7.W8G3>2>,9]:I:-J-E:^%;.[FUS^T+<J%6_DP#<$M@8 '))X  Y]Z -
MLHK%2R@E3D9'0TM9UKKVE7EI<W4-]"8;5BEP7.PPL.H<-@J?KBET_7--U2XG
MM[.Z5[BWP9864I(@/0E6 .#V.,&@"ZT,30^2T:&(C&PJ-N/3%*D:1(J1HJ(H
MP%48 IU9M_XAT?2[R*TOM2M;>XE5G2*20!BJ@DG'H #S0!H-&CLK,BLRG*DC
M)'TI/)BQCRDQDG&T=^M4-.\0:1JVFRZC8ZA!-9PLRRS!L+&5^\&S]W YYHL_
M$&E7]TUK;WB&X6/S?*8%&,?]\!@"R_[0R* )K^WN'L+@:<T$%\T;""66/<J/
MC@D#&1530=+O+&*:XU6[BN]3N2IGFBC\M %&%1%))"CD\GJS'C.!EZ;\0="O
MX-4NI+H6UK8730-+,K*"%"@L<C@;F(Y]!ZUL'Q#I0O;2R-Z@N;Q/,MXB#NE7
M&<J,<C'7TH TB 1@@$>],A@AMU*PQ)&I.2$4 $^O%8'B+6],_L74HF\1+I#V
M[K%+=C :!SA@H##!)';GAL^E.O?%^GV/BNS\.R.WVF>!YF?8<* 5"C.,$DM^
M&.>HH W4MX(\;(8UPQ8;5 P3U/UI3#$TRS-$AE485RHW >QK@?#WC*WTZ7Q%
M'XEUY +?6I;6V>YVJ1&$CP,*   6ZXQSS797VLZ?IS!;JX",4,F%4MM0=7.
M<+[GB@"X88RQ8QID]3M%*J(@PBJH]ABN=N_&VE6WB#2])$I=[^!KA9 K;1&
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M'T;T/M0!-IVGP:79):VX.Q69R3C+,S%F)QQR23Q@<\5:JM8W]KJ=HMU93+-
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M5K(N P!7 ?>3Z=>?KS73>*(M2\/^,8=5T6(N/$,0TV?:,B.X )AG/J N\'V
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M6U[J5P?.<W"*&!D"OEBJDH<CJ1_LYK9T[6+#7/C%:WNFS&>V;P[*%FV,JO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUMJT-]'+971"P21@L96)P%50-Q;(/R@9X/'% &K16/%XIT:6VOY_MGEKI_\
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M86R",9Z@CJ*S?&?B2TLO#NN16]_<PWMK:.QEM86?R'V$H&8*53/'7'!SQUH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD''GR69C8KCS L 5L'OAL@XZ&L2PGC_X0_XFIN^:>^OWA7',JO JJ5'\0)!
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M, NXA'(VL0#R >/PKSYRRR?$Q$M=5==0TR+[+)<6TI:<_9G3@D=2Q "\'T
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M)'E48'RX!WMR.!D]<TRS\=^'[[09-8BNW%O'.+62-XF659B0HC*$9W$D<>]
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M:[D^QZG,L%M*('P7)(VL<?*00>#CH:M:3XJTO6+B_MX6G@GL-K7$5W T#*C
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M+<K#JA<6-R\8$=P4!) YR. 2-P&<<5IP6EK8V$TNDZ=!#(Z%UC2$0[VQP&&
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M"2"">QQCFN!M/!,LD?C6S\-07-AH>IV CMK>Y1XE:Z(;<41P&5,8!) !SQD
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M%S]G?RO-$Q?;OQC[ISZ?C0!JZEXPT_2[>YN9(;R6UL]IO)H8=RVV0&^<9!R
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MN6W?(6 /HQ QCKF@#IZ*YA/&]I*L21:7JC7C6;7LEDT*QS0Q!BN75V R2#@
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MVC2[HVUY<I=0W*!61E\E5VC!W%MRXQBN8TKP[KEEX,\$7BZ=<&^\/W+M=V!
M#O&^Y6*9.&8*P(&>>1UXH [R+QA9FYU*SN+2\MK_ $^ 7,EHZ*TCQ'HZ;6(8
M9!'7@]<50LOB)IU[_8LHT[4X;/6&6.VNY8E$?F,"50_-NR<'D C/>JEUIMQJ
MGBR]\2QVEU';PZ*]A"DD126>1W+'"'D 8 Y R2>PS6,NEZHG@;P#8G2[S[5I
MFH6DMY&(CF)(U8,?0]1TSF@#TR^OK;3+"XOKR98;:WC,DLC=%4#)-8R>+K9-
M0TZTOK&]L/[2XLY;A4V2MC.P[6)5B.0& STZ\4>.=!G\3^"-5T>UD$=Q=0XB
M+' W A@#Z D8_&L+4+?4/&,'AB"?3+NQN+#4(+^^,Z;5B,2ME4;H^YB "N1C
M)..E %1\>+?'WB'1-8T>ZFL;>UMHX0SQ?Z,7\PF4$/D,V%P5RPVC(%;WC'7+
MGPAX:M'L;2:[8SP6@D:124#,J;F+$%F.>/?DX%5]$@NX?B9XFO9;&ZCL[R"T
MCMYVC.QVC5]WT^\.3C-3_$;3KW4?"@73[62ZG@O+:X,,>-[JDJLVW) )P#Q0
M!BZC>M9_%O3KS[!?/--H<_\ H:$.Y82QX'WMB\=]P'O72:?XRT[4="74TANH
MV:Y-G]DD0"87 8J8\9QG(]<8Y) !K*=+Z?XGZ9JSZ7>16:Z3+!([1Y\N1I%9
M5.TGG"\XR >,UR[^'=<E\.WL\&CM-=6?BB;5H[&Z4*+N!BPP,\9*N3@\@CIT
MH ]$TGQ/;:IK%]H[VUQ9ZE9*LDEO<;<M&WW74JS CMUR#UIFK^*[31]<T_2)
M;.]FN=065H/(B#*Q1=Q&21ST]N>2!DU6\+2B]DDO(O"K:%%Y>PBX@CCFE;.3
M@(3A!COU)Z#'-7Q%:W<WQ#\)7D-G<2VMD+O[3,B96/S(PJ9]<D=NG>@!H^(M
MJUAJ-PFA:RT^F2,E]:B*/S+<* Q8G?M(P<C:Q)]*U9/%EDSZ7%90W%]-J=L;
MNVCA"KF(!26)<@#[RC&<Y/UKF;6SOTD^(+-IUX!J3%K/]T?WW[@1\>GS#OCC
MGI5;3DUZTL_".G7.CZC+I4.E+!=0VV$<72A%"R$L/W> W0X)ZY% '07'Q"TR
M#PA!XG%CJ,NG.Y24QQIOMR'*'S 6& &!!(R/PK8M-=BOIKY+>TNGBM"%,ZA&
M25MH.U"&))&0#P!GC-<3X5LM5L? 2^&[K0[B"6YN[FWD9XU>*.*25V+X!.5V
ML ,CDGIM!-:?@J'4/#!O_#5S9W4FE6#EM-OA%GS(C\QC;')922,X^;^8 S2/
M%WAS1/ NC7VG:?J$6D7ES]FMH]AD>-FE9<MEB<%LGJ3[=JT5\<PMJUUI/]AZ
MN-2AA6XBM3%'NN(B2-ZG?M R.=Y7L.O%<7:Z-J\7PK\-Z4^DW@O[35HIYX/+
MR4C6X,A;/0_*1T/]:ZOR;K_A;1U7[%=?8/[$^R_:/*.WS?.W[<=?N^V.W6@"
MPGC_ $R30M/U<6E]]GO+P6)4H@>"8OY>V0%N/F],UH-XFMD\176AM:7?VNWL
MQ>\(I62,L5&W#9SD'@@5YZ-#UG_A )XUTF[-W:^(O[3%J5 >6'[1YGR9."=O
M;.>*W[5M2G^)DVN/H>H0:?)H:P*\BKN#B9FP5#9R1V&3TSC/ !8B^)NERZ9I
M>J_V;JJ:9J$HA2\:!=D;LQ50P#;N2.J@CG&<\5KZ5XJ@U+7KG19=/OK&]A@%
MRB7:*/-A+;=Z[6/?C!P1GI7!0Z-J\?PA\.:0VDWG]H6E]!)/ (^45)]['/0C
M;Z'G\ZZH6]T_Q<34Q97/V Z(;7[08R%$IF#[>>?N]\8[=: .BU;6+;1XX#.'
MDEN9A!;P1 %Y9#D[1D@= 222  #DUF+XRLEEU.VN;2\MK[38!<S6CHK2/$>C
MIM8AEX(Z\'KBJ7C?2]1EU#P[KNFV[W;Z/>&6:U0C=)$Z%'*YX+ '('?FL_4]
M-FU/Q#JOB?R)K>T@T"6QC\^,QO*[$NQVGD*H '(&23CIF@"W;_$W2IGT=Y-/
MU6WL=6V);7\T 6#S'&50G=D'MG&,YYXS4^C^*[[4?%7B'3I=)N4M],:*-2K1
MMR4+Y.&SE@5P!G'&<<URVG64_BKX7>$=$@LKF-@ME+//+&52**/:Q96Z,6
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MJH!B229V$IR<%0",X]:[^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q="\
M,6F@R3RQW5_>3S$YFOKEIG1<D[%)^ZN2>!U[YQ6U110 4444 %%%% !1110
M4444 %%%% &-HGAN#0KO4KF"\NYFU&X-S.LY0CS" ,C:HQP ,>U;-%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2K._1"B7,"3*K=5#*#@_G6?HGB.+6]1U>R2TGMY-,G6"43%?F)4,"-I/&"*
M-JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:4+N0RW%O;_8FA=SU<)([;6/<KC/>MRRU>ZLHV"^%?$,LCG=)-*;4O(?4XF
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MF/QS\(I=?\>HL;HVV[H9\'=CWVXKL-!T!-#BDW:A?ZC<R8#W5]+OD*C.%&
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MW')))+$GW))/XU?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;NUM](1HX+:&<B*12NW$@_CQU&>_-;5% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVZDF\A%V@.<./8'!)P3P!FMJ]\9:-I[$W$\@MTN!:R70B8PQRDXVE\8Z\$]
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M[5+6*\M_&]M<1"]E:-E:7+C[0)CC!CV[BIZ8"A>H% 'K=%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M898(EP"1V+,6;'IM[Y%=/0 4444 %>>_$=IU\2>!C;1QR3#5CL21RBD^6>K
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/>%=2U^'Q5K'AO7+R/4OLD,-U!?I"(F9)"PV.J\ @J<8["@#LZ*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSZXH 4# P*\NUC3=0TGXC76GZ?$_]G>+X )W3@6\L>!*_MNB+8]6QZ5ZC2$
MD$@9'0^E '$?%GR+?X4:W$3'&GD*D:\ 9W+@#\JH7WB*R\/_ !-M]0UBY2'2
M+_1TALKYCF%9%D+.F[H"P*G/?:*]&*AA@@'ZTUXHY4V21HZYSM9010!Y9K=[
MI6A77A75;:"?3_"BRW:-/;JR+&\NTI*1C(5B) #Z-GH:Z[P=%H+-J>H:!)-<
M07LPDFNVD9DGE P2N>N!@$C@GCJ#73NBR(4=0RD8((R#0JJBA44*H&  , 4
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MH\,90Q&,&2(X))#8 S]2/KT>@:F-:\.Z;J@4)]LM8I]H_AW*&Q^M &C1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N6\?:-<:MH5
MM<6<9EO-*OH-2@B7K(8FR5'N5+ >^*ZFB@#EO$>ES^*H- NM+N+;R+/4(=1W
M2%OW@0'Y!@<9W=3TQTI_BOPDOB:;29Q<&WFLK@EV7K) ZE98OHRX'X5TB1I'
MNV(J[B6.T8R3U/UIU '.^-S-)X1O].LU#WNHPM96T?JT@*Y^B@EB>P4UJZ/I
MT>CZ+8Z9"2T=G;QP*3W"J%S^E6_+3S1)L7S -H;'./3-.H **** "D90RE6
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M!COZBLV7PQXETKQ/J.H>&M4T^.QU20375M?P._E2[0IDCVD9) &02!Q7;T4
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MZTM% '/_ /"/RZCK]MK&L21NUEN^Q6D1)CA8C!D8D N^. < *"<#/-=!110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6T<9,7V5&1RH8_O'W'"@KC(&1D=:OZ1XATS6M)_M2TNHS:9?]X6 &U6*[CZ
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MJED,[8.Y1\Q.023CO7/7BV\NG?%FUGELK@I&LRK"@""06H)95)."&')SG(H
M]@.HV08J;RWW#&1YJY&1D=_2I3/")%C,J!W&57<,D>PKS^Z^'^DZM\/U&G6%
MM!JTUG;W$5V$&]IXUW(S,>N22"3U#&KWA#58_%\T?B:>V^SBSM?LBK*NTQ3'
M#7'7L"J*#_LMZT =M14%G?6FHVB7=C=0W5M)]R:"0.C<XX(X/-3T 1?:8,R#
MSX\Q_?&\?+]?2C[3!Y:2>='L=@JMN&&).  ?7-<1;M;6WQCULSF*))-$MY&+
MD*& DD!)SZ<9-</I]K97?PR\ ;HXV(\2+&&'#*K7$V5!'(!&/TH ]OAN8+C?
MY$T<NQBK;&#;6'8XZ&N8\4^)KC2M2T*WT^YLI%N]5BL;N)AND17#'(PWR_<Q
MR#UKD=563PYX@\>#P[;):R+H,%Q'%;(% D'F#>%'&0/Y4NK+HKZ#\-;W3_LQ
M7^UK012J1N*F-R^3USN W9[]>: /4Y;RV@FCAFN88Y9>(T=P&?Z ]:)KNVM\
M^?<1187>=[A<+G&>>V2/SKRF)-*\2#QAI7B'6H[&X3491,DHB618 0871G&0
M H7!'0Y]>;A\/Z3J?Q5@M;^T6\BE\+JTHNHQNF83!0\@[MCUZ'Z"@#U '(R.
ME'2FQQI#$D4:A(T4*J@8  Z"J6MP0W.A7\-Q&DL3V[AD=00?E/4&@"PE[:R2
M1QI<PM)(N]%$@)9?4#N*6:\MK9XTGN88GD.$5W"ECZ#/6O&['3;&T\#?#/4X
M+:*._?4[)'N0O[QE97#*6ZD$<8Z<"NE\.1VFN7GCRR\011O<+J#Q2+,!E+/R
MQY)&>BXW,/<D]: /1:*Y/X92ZC/\-]"EU5I&NVM^6D^\R;CL)]RFVNLH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHIKNL:,[L%11EF8X 'J: (H[.UANI[J*VB2XN-HFE5 &DVC
M"[CU. 3C/2L^7PKX?FTV#3I-%L&LK=S)# ;==D;$DDJ,<')/3UJS]OM]0TVX
METS4;1RJ,JSJXD2-\<%L'MP2,BFV-V(=*L#?ZC:33RQ*#<1D(D[;<DH,]#R>
M.U %JUM+:QMUM[2WB@A7I'$@51^ J:J3ZOID5DE[)J-HEH_"3M.HC;Z-G!Z&
MI1?V9EBB%W 9)EW1IY@RX]0.XH L4572_LY$F=+N!EA_UI$@(3_>]/QIL>IV
M$MP+>.^MGG,8E$:RJ6V'HV,YQ[T 6JYO5]%U.]U=+RWBT%O)QY$EY8M)-'QS
MAPXQ^&*W+:_L[VW:>UNX)X5)#212!E!'4$@XXJI+XBT:'3[F_;5+,VMLF^:5
M)E8(/?!]N/6@#-FLO%=PBI-<^'Y%5U<![&4@,I!4_P"MZ@@$?2JM_P"']=U2
M6*6_3PS<R1 A'ETZ1F4'J 3)T/<5MV'B'3+_ $*WU<7<$5K-&CEI)5 C+*#M
M8YP#R.*MC4;(V0O1>6YM",B<2KL/;[V<4 8L=KXMAB2**[T!(T 546RE 4#H
M /-X%.\GQC_S_:%_X!S?_':V8;ZTN+B:W@NH)9H#B6-) S1G_: Y'XTT:E8M
M?&Q%[;&\ R;<2KYF/]W.: .4N_"FIW]W]KO+/PE<7.,>=-I3N_YF3-6[+2/$
M>F1&*P/AFUC8Y*0:=(@)]<"2N@GU*PMKJ*UN+VVBN)?]7%)*JN_T!.31<ZG8
M64JQ75];02.,JDLJJ2/4 F@#E+GPKJMY?RWUS;>%)KN:(PR3OIDA=D(VE2?,
MSC!Q].*Q-3\(>*+KQ1HLZV7A]K#3H98D5+9DC3S-O(C\S/&T<@C'O7J%4EU*
MTO3-;Z?J-G)=JI^4.)-A'&64,#@$CN* .=;0-=?33ISIX7:Q.2;=M-D,9).3
ME?,P>>:8_AG6)/LN^W\*-]D_X]LZ6Y\G_<_>?+^%3>!/%+:YX2TB[U6[M%U.
M^$C")6"%]LC+\JDY( 'O717&IZ?9W$=O<WUM!-)C9'+*JLW;@$Y- '+77AC5
M[[4X=3N[?PK/?0X\NXDTR1I%QTPQDSQV]*=<>&]9O-0&H7,'A6:\$9B$\FF.
MS[#P5W&3.,$\>]6=6UK4;+X@>'=)CD@_L_48KII5\H^8&C0$?-G&/F].W6CP
MSK6HZCXB\3Z??R0.FFW444!BB*?*T8?G).3SZ_E0!4/AC5VM+2U:V\)FWLVW
MVT1TMRL+>J#S,*?I4T.A:_;:A-?P+X8BO)O];<)IL@D?ZL),FNEN[ZTT^'SK
MVZ@MHLXWS2!!GTR:EBECGB26&1)(W&5=&!##U!'6@#D+7PUK-C=M=6D/A>"X
M+,WF1Z;(IR?O$8DX)[^M'_",ZP)+J06_A3?=C%RW]EOF8>CGS/F_&FZAKWB
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M3/#]QKDVH6[6$*EC+'(K!B/X5(/+$\8]:OV=Y!?VD=S;2QR1NN0R,& /ID4
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M7=]:6%O]HO+J"WA!QYDT@1?S/% %2/P]HL5Q!/'I%BDT"".&1;= T:#HJG'
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MWFD:8#\,V%E;AIW"2L$&95:U)8,?X@2!D'K7I1T326693I=D5G"K*#;KB0*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*S?#^N6GB70++6;$M]FNX]ZAA@KV*GW!!'X5I4 %%%% !1110 4444 %%%%
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MQ'>Q:7J6DS>&KYO/^S->JCV<Q/S^6.04;KC(P>GOV/\ 8&C?] BP_P# 9/\
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MGACQAH<<-B\>JW5W-:S?:&!/GG(W#;\NWGN<^U=N+O2=(>RTH3VEH\@\NTM
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MDLQQV!8GBMJH+.\MM0LXKNSGCGMI5W1RQMN5QZ@]Q4] !1110 4444 %%%%
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MID#6W]G'2'N0C,P+9EC4L>/O#L/<\\UL>,==N/#/A34-9MK2.Z>TC\PQ22E
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MS@@5K^'8_%[F$>(VTR-;==I-B[L;EL8W-N "CJ<#.3CH!@\C%X(\51>#M/\
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ML9% '?45S>K>)7T=M8NYDCDT[3;=&;8I\QYFY$8.<="AZ?\ +053MO$VM_\
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M&J3^%_&.DW,UG&^N7<]U!)'(SB/S%4!6RHZ;!R/7I7>R2)%&TDCJB("S,QP
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MZ<[L^J^'/"-FEF[VVG6L*K^[BB(CA5B0"VT80$YY; )S6XK!E#*05(R".AH
M6N9O-#U&?XA:=KT?V7[%:V<MJRM(PD)=E.0-N.-O3/>M>/6M-FUF32(KR)]0
MBB\Z2!3ED3.,GTY-7Z .7\.Z'JNF>)?$.HW@L_(U6>.9!#,S-'LC"8(* '.
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M,-]*-[I#&(V!$:?*Q(.WJ<<DG'8=5J&HV.C:=)>W]S#:6<(&^61@JJ"0!^I
MJQ#-'<0QS0R+)%(H='0Y#*1D$'N* '+N**7 #8Y .0#]:6BB@ HHHH ****
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MM#' )[9->?6OQ G3P#I^OW\-K9FYU![2>5(W>&U42R+YC $$CY ,Y'+9]J]
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M>E33^9_:$\\JR0VNWA< .N[><8YX[YJ#5_#7B!?%,/B;P_=Z?!?2VHM+ZTO
M[PRJ"65@RX;<"3VY'IW=J'AG7YM5T'4X=3M+BYL3,;B.ZC81,T@ WQJ"=I49
M !/0]<DD@'+Z_P"([GQ)\/K6\E@B^UVWB*"U81Y5)&CN H(W9*@\<'.*ZBP\
M1Z[:>-H?#WB&UL E_;R3V-Q8L^,IC?&X;J0"#D8'MSQF+\/]8_X1V_TZ34[)
MI7UG^U;9Q"P4GS?,VOSQD\<=/>NCAT2]N_$5OKVJ+;+<V=L\%I;02,Z(7QO<
MN5!).U0!MX&>N> #DO!^NKH/@&!EC+SWFMW-I NQG =IY#DJH)("JQP.N,<9
MS74>']<UB\UZ_P!-U&P<VT4:RVVH)9RV\<N>&0K)DA@?0G(]*P8_A]J9\&+I
M3:A!;:G::DVIV-W#EU24NS@,I XP[+^/X5U.@6WB,;I_$=W8/.%V)#IZ.L0'
M4L2YR6.!Z #/K0!B^/?^0QX*_P"PZG_HJ2H/%?C/5O#EMJU\\%C%!8R)]GM9
MLM+>Q?+O=2K?( 6(&5/*\]>-CQ3H5_K-_H,]FULJ:9?K>.)G8%\*R[1@''WC
MS[=*YW6/ >O:A9^+-/CU*P^S:W+Y\<TT;M,G"@1$@X"#;P><9/'- &_<:]J5
MOX[M]#E%I'97UC)/93F-BQE0C=&WS8. =W&,CCC&:S/#_C/4==\,M<I]@&K?
MVE]@\I(W,8(;[P^;)'EYDSQQ6EXC\*W/B+2]*26]6WU&RN4E-S;J5^4@K*J]
M2,HS >^*6Q\'0V'C>[UZ"0):S6T:"T4859E!3S .W[O:OXF@"GXHO7T/QIX5
MOHSA=0G?3+H#CS REHR?]UP<>S-ZUT>NWE_8:+<7.F60O+U0!%"SA026 ))/
M8 EC["L+Q!I[:]XT\/6Z#-OI,KZA=-V5]NV)/J2S-CT7W%7_ !GH=WXB\,W&
MFV-U';SN\;J903&X5PQ1P.2K8P?K0!GZ)XHN]3\2ZMH7VBPN6M[2.YM[VWB8
M1MO+*0R[SG!7J&YZ<&N(MIM:@^%WB_4%N[$R0:A?3*SVA9UE64_.I+X!X^7@
M[>.N*[;3O#NNVWC2;Q!<W.G,L^GI;26\,;KM9&8@*Q)X^;[Q'_ :J67@G4O^
M$(\0>'KRXM%;5)+J5)X2S!#,2V"I X!/7/- %D>(+S3XM&TAI(I-0NK1K@S1
MV4LJQQ($',:,68DN!G('4^@.7=^.?$ECX>-W/HD:74>K1V!,T<D*7$;N%66-
M6Y&<]">".]6]0\)^))DT35K'4M/@\0:7&T!#1N;:>)@H9&YW=5!R._YU+K?A
MKQ%KF@6]O=7M@^H"^ANY"H=((Q$P8(@Y)SCEB<\GV  .ET<ZR;:7^VQ8BX\Y
MO*^Q%RIBXVYW<[NN>U<9I5YK-YK/CJ*^O;>:WM&$*1K RD+Y&Y0IWG'WCG(.
M3GIT'H:%BBEP ^/F .0#]>]<A'X8U:SUOQ-=6MS9/::P%=8Y P=)!$(\$C(V
M\;NF>WO0!S7A3Q!K.A^$_ GF06+:3J @L-H+&=69"5?/W<97[N/Q]-O4_&6J
MR1:K/H5E]J.G7+6XM38SR-=,A <+(GRH<Y R&Z9.,\1#P7K"^&/"6DB6Q,FA
M7<%P\AD?$PB!  &W@G=[XQWJ6+PQXIT77]2D\/ZKIR:3JEP;J:*]A=Y+:5OO
MM'M(#9ZX; _7(!VEI.;JR@N&ADA,L:N8I1ADR,[6'8CH:\_\,W=_8:=XZN=+
MLA>WJ>(9_*@+A Q*Q#))[ $D_2O0H8O)MXXM[R;%"[W.6; ZD^M<!-X&UJ?P
M]XET\7MG#+JNIG48F4NR $H3%(,#*D)@D=<]* +EIXLU"]UC6]&ANM.GEM=/
M2\MKZ"%O+.2RD,N\[L%>H;^59_AGQ1J%GX!\-37LZ7=_K!5(66WD8J2K2.[A
M22^ I^Z!R1T'(U;/POK7_"7SZU>WFGB&ZTQ;*:&WB?*%68C82>GS=3Z8P.M9
M<?@#6U\&:1IBZM:0:KH<RRZ==11,4.T,N) 3R&5L$#I[T /O_&OB+3-%\2W,
MNDQNVEQ+/:WDMM-;0W*$<C8^6#*>,9P>N175:!<:[=+-/J\6GQV\JQO:+;,Y
M< KEA)GC(.,8K#U/P_XHU_PAJFGZK>Z;]NOH/LZK;"18(5/5N<LS'\ ,#'?/
M6:=%/!IMM#<B,31QJC^6Q*Y QD$@&@##.N7VJ>(M6T?1FM(7TN.+SYKJ-I T
MLBEE0!67 "@$G)^]C'%<9XM\2W?B;X/:C?1+'93PW*V=_;LI<K(LZ(RJP(XY
MSR#D''%=;_PCNHZ7XRU#7M&>UECU2*-;RUN7:/$D8VI(C*K?P\%<<]<UFZGX
M"NY? %WX>L;FV^UW]T;RZNI@RJ93,)6(4 \9 4#/ QUH [.SMGC_ ']T+:2]
M9=DD\,/E[E!) Y+' SZ^M<MX)OI-;U#Q/K,F&D74I-/MPQX2&$  #TRQ=C]?
M:NPA,IA4SHB2X^948L!]"0/Y5R7A*P?P]K/B+27 "W=])J=F2<"1)0N]1[JX
M(/H&4]Z )O"VIR>+=!U:+5;.V54OKFPDBAR494;:3SU)YYXIGPWUBYUCP9 ;
MV1I;NSEELII6ZN8G*AC[D $^^:7PWIUQX/T;6)=5E@9);Z>_!MRS']XV[9@@
M9.>!CKGI4O@#0[C0/"-M;WJA;V=Y+JY4'.V21BY7\,@?A0!GZ+>:S<?%'Q+:
MS7UNUE:06FR'R&!",)6 !W\-GJ2#GC@8KE/!^OZSX=^&_AR]C@L7TEKXVLR,
M6,Q$ERZ[U(^48)Z$'/J*[J+0-4L?'&J:Y9W%HUKJ-O"DL,H8.'B#!0". #NY
M."?:L&/P'K,?P[T[PSY]@9K2]6Y,^]]K!9C+C&W(.3C]?:@#2U7Q9J+W.LP:
M)"LDNED1['L9YQ<2[ Y0-'@)PRC)SR3Q@<]/I%]+J6CV=[/9S64T\2O);3##
MQ,1RI^AKE)_#7B?3?%-]JWAO4--CM]4V/>VE_&[K'*JA?,C*D$Y &0<9Q^79
M6D#VUI%#+.\\B* \K]7;N?;)[#@4 <+<^.=6FTW^U]%TU[ZU6Z,8LDL)VEFB
M60HSK*/D!X+;<'CC.:)O[4D^-<*)=6HC&A.ZJ]NQQ&;A,C[X^8X'S=..E/TK
MPGXIT&YN=,TS6+$>')YWEC\V)S=6JNQ9DC(.T\DX)SC.<'I6JVA:G_PL5/$2
MM:&T73C8>49&\S!D#[_NX[8Q^M '->'XY;+QIXY6]?3SIEJEJ+B!+,A3$+<M
MM5=Y"@9.00<\],UHVOB_6II-"N;?2GN-.U%T66"*PG1[-'&5<RGY'4<;L =>
M,BK^G>&;Y/$?B>\U#[(]EKBQ(T<4C;XU2(QXY7!R/ICWJKX8\.>+=%BMM'N]
M:L)]$LBH@E2)Q=O&I^6-CG:!P 2,D@8[YH EC\1Z_J^DMK6@6-I=V@O&ACM'
MRLL\22&-Y!(6"J<AB 0>!UR<"'2+S7+CXG>*+5[VVDM;2WM/*A,++A6$K  [
MN#GJV#GC &*CTCPEXET"XN]+TW5K%?#MQ</.GF1.;JV#G<R1D';U)PQZ9S@U
MJP>']2L?'6IZW;7%JUGJ-O DL4BMY@>(,%"D<8.[DG)]J ,)?&6O2?#K4/$5
MK8V!N["ZN%EM@KE6CCD*L5.X'( +>^.U=*VNM)<V<EM/;2:>;$WUU-Y;$B/
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M[E&&3A),D,IX/)K#^)<GE:OX(DV.^W7$.U!EC\C=!74Z%;ZZB23^(+JSDNG
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M*D AN.#T]^_<T4 8WA31[C0/"VFZ1=7,5Q)9P+#YD<90$*,#@D_G^@K9HHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
; "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>sangamoexecutiveseveranc008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKC4$F4VH(YC!DR&8GLN>A/IGEK17B^$O@:V>"9;BVU:T>:'RFWQ!)BSEEQD
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M65\DT?BCS?+E@D+%/M(?.2#NPHR3S[GF@#UC2_%&DZSJ-SI]G/(;JV02/%+
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M^LP-JQC(,8:3*EF.%PN>.3TK L+XW6H^ -1^R:@#!-*ES!%I\D4%FS0,HA1
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M13:K/(E_;I]CGN5=I+A=FX,S;?O$#/."2>F:O^*V"^$=9!!):RF55 R6)0@
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MXN;-@MQ;S1-%)$2,KE6 .".0>AJEXVUY_#?@_4]3A5VN(;=S#MA:0!]IVEL
MX7/<X'O5/PG+HFI7UUJ^C:?=J)8ECEOKM94>8CH@$GS,%]>G( SSAWQ*RWPY
MUV%%=Y9K1XHHT4LSL1P !R30!6T>:TL&M=8DU?6&%[ MO]@NEF?SI\!C)'&X
MW X!SM&W'/:M?_A,-#&EWVH/>&.#3V*W:O"XD@(&<,F-PXYZ<CD5RFI2RVOB
M#P7XBVRRZ1;VTMK=,B%C;-(B[791R!E=I/;O5'7;)[I_B!KEJLALK[1ELH-J
M'_2YA&_*#JV-RJ".O..E '5GXC^%ECDD;475(_*!<VTH4^;]S!VX.3QGH.]3
MCQUX?-[<6?VF<74""3R#:3!Y4)P&B7;F09[IG\JY;Q6PF^$6CQ0Q2.^ZP'E)
M$Q8;'C+Y4#(P%.>.,5I7$T;?&.PN1DP#0Y8S,%.P.TJ,%W=,E03B@#JM%UO3
M_$&FI?Z;/YUNS,F2A1E93AE96 (((Z$4NI:Q9:4ULEU(PENI#'!%&C.\K $D
M*J@DX ))Z#O7+_#8D6WB,,CH7UZ\F0.A7=&[Y5AGJ#V-3>--2>PUGPZK6LBV
MLLTPEU&&T,\MJ=GRJF%;:7R5W8/ ([Y  _7/'^FZ=X1N==LEFNUBF-KL$#@Q
MS;@A60$ IAB,YQ[=14EYXWM;?Q+I.D+:7Y^W12S&1K&8%53C 7;NSDC/& .O
M45YY-;W+_#CQQ9Q6&HF5=>-TJ2P2%VB\Z)MV2,L=JDG&3QS77:S?*WQ \):R
MMM>M8O:WD*NMK(3O;9L!7&5W;3C.* .BG\8Z';W+1273A4NA9O,(7,23G&(R
MX&T') ZX!.#S4^J>)-,TAIENI92T$7GSB&!Y3#'S\S[0=HX/7K@XZ&O*_$E[
M-J.@ZW&^G7UM=VVMHYL;6R=8Q&MPA\]F5?WK.!G.3[#C-;\&N)X;\<>(!K=A
M?M8:YY%Q8SI923"3$01H655)##'W2.YSB@"WJ_B&.W\?^&KN+59WTB^T^YF\
MJ%B\<N FPJBC+L=QP,$^E=18>*='U+1I-6M[O_1(I##(7C9'20':4*$!@V2!
MMQDDC'6N5N2J?$;P>PL39PPV%TC1+'\EOO";$)4;5. 1CVXKFI(+^31/$MS8
MV=U<M:^+?[2-M$&22YM@(\F,\$]"01W6@#U"Q\2Z5?W=W:).\-S9H))X;F)H
M71#T?#@97W'%<EXA\3)=^)?!PTR^OXX;N_PR^5)%%<Q>6QSDJ PSM[]"#C!S
M6;JUO8>,/"^NW'A33+]M1ETQK8WEVLR.1N#?9U\S[V0&SC@''/-.U+Q%:Z[+
MX&FL[*_#VVI(;J#[#+NMCY+J58;>Q/;L,]* /4G7>C*&*DC&Y>H]Q7G'@OQK
M9:?H'EZYJEU+.VJ7%L+B5))0G[YE022 %4SP!DC\J](9E1"S$!5&23V%>*SJ
M[?!/7;18)S=2:K(Z0"%O,8&[#@A<9(VC.?04 >KZGX@T_23(MRTS-%%YTJV]
MN\QCCY^9@@.!P>O7!QT-4;KQUX<M!9&34@POH6GMC%$\@E11DE=H.3TXZY(&
M*Y'4=0M=$\?:M<:Y;:G)I.L0P/97=D)W3*IL:)A%SD]1QW-226]I8>,/ ,=I
MICV%G;)?'R-C$6PD4;-YYV%N>">"2* .O/B_1_[/AO8Y;B:*6W%T!#:R2.L1
MZ.RA25'!Z@9P<=#6??>/M.@U3P_;6BSWEOJXDE2Y@MY)5\M8V;Y=H)+9VY !
MP,YQQ6!J]Y#X=^(FIW&NVNIMI>J00?9;NS$S*CH"K1.(CG)SD<=S27EM;Z+K
M'@*ZM=&N;'2K:2]7R(H'D:'S8SY895!(+'MV)QVH [74/%&E:8]RMQ-,WV50
M]RT-O)*(%(R"Y4';QSSVYZ<UJ6]Q#=VT5Q;RI+#*H>.1&RK*1D$'N*\_\/78
M\.:KXMT[7HIE-YJ,E_:N8F<74,B*!&F =S+MV[>O3BMSX=:/>Z!\/]'TS4 1
M=0PDNA.2FYBP7_@(('X4 :.I^)=,TFY>VN996GC@-S)'! \K)$#C>P4' R#]
M<'&<&GMXATSR+*:*=KA;V(S6PMXFD:2, $N H)P-R\^X'4BN1\1WSOXPU'39
MK*Z@232P+>>SM&:2^8E\QF55)55)'RY'WB2<5@:9:VM]X.\'I)?ZEH&K6>GL
MMMJ7E,B1L @>.0.-K*QQ@'&=AP?4 ]8T^_M]3L8KVT=G@E&49D*$\XY! (Z=
MQ5FL'P9=:G>>$[*?6+>."_;?Y@CC*!_G8!]IY&X8;'^U6]0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !117*?$JYN;'X?:Q?V5S/;75M!YD4L,A4JP(].OXT =717%6B:?<6>D+#X
MDNQJ-R8F11J#2>8RKYCJ4+$8(5@>.]:\WC'1K;5;[3)YIHKNRM6O)D>!P/)'
M5U)&&'TS0!O45P/C'5C#J/@W48KN]M;6XU$)+$2\>]#&[ -'U)R!@$9]JW;?
MQ7H^JZ;JSK+>0"P!2\C>VECGA!7(;9MW<CD$"@#H:*\QU;5+6QM/ %_8:MJ+
M:7+<JA>:9V:XB\EV&]>KL2!QC.>U=58>,]#UJTU/R9[N)[!<7<$EM+'<0@CA
MMA7=TY! H UK/3([26ZN=Y>\NB#-.0,G PJ@=E7G ]R3DDDS6=G#8P&*$'YF
M+NS'+.Q.2Q/J3_G%<8WC"PT'PSX7_LT:CJ-KJ<\-M!<SH\KE"22S'&2Q4-@=
M?; KN8Y!+$D@# ,H8!E*D9]0>0: '445Y[?>+-0L_B3IV]@/#=U))I ;/'VP
M .&_$YC'NK4 ='K?AZ\U#5;35--UJ;3KVVB>$?NEFB=&*D@HW?*KR"#Q5S3=
M*GM9C=7]^]]>E/+\TQK&J+G)"J.@) )R23@<\"M.B@ HKD]'\0_VK::KXC;S
MY-/M9I8+." %C(D9VM)@?>9F# 9X  Z9)KF-<\5RZUX$\/:_'+=Z<9=4LS*%
M9XD,;R#*D\!UQU/2@#U.BL72_%6EZM?WMC \\5S9JLDL=U;O ?+;.' <#*\'
MFF0^+M)EU&RLB\\37X)LY)8&2.XP,G8Q&"<<C.,CD9H W:**P-4N-:A\4Z0E
MKISW6E2*ZW,L=P(_(?C#,IY<8R !W.3R!0!OT5YOJ7B_Q#H7AR1;[2_L^N7N
MJKI]@99Q+',TA^60 ?=0#HOL,\DFNE?P_':Z=FX\0:FEZ5P;Z2\91O\ [WE$
M^5_P';B@#HZ*Q+/5(].T/3([VZ^V7K1)"3;_ +UIY53YR,?0DD\#O523Q_X>
MATJ349KJ6*&&Y^R3*]NX>&;(&QQCY>HY.![T =-16+IGBK2]5U>XTN!KA+R"
M(3&.XMWBWQ$XWIN W+GC(J,>,='-Y96[2S(E^Q2SN'A80W#8SA'Q@DCD?WNV
M: -ZBN9MO'V@7FH?8K>6Z>47;6;G[)*%CE5<D.2OR]^3C.#Z&I[+QEHVH7=A
M!#+-C40YLIGA98[C8,MM;Z GG&1R,T ;]%<9X1FN#XS\:6LMW<3PV]W;B%9I
M2_EAH58A<]!DG@5V= !17G^LM<R?%K3=*&I7\%A<:9+<2PQ7+(I=7 !Z\<'H
M.*D^'^LZE?ZWXGTZ6]?4M)T^Z2.QOW )?*DO'N  ?8<#/7F@#O**P9?&.CP7
M-M'++,D-U/\ 9H+HPMY#RY(V!\8R2" >AQP:Q_#UW+#\0O&\5S?3-9VR64B+
M/,62$-&[-C)PHSS0!VU%8=OXLTN?5;73BUQ#/>(TEH9X&C6X51D["1R0.<'!
MQSBH[;QIHMW<64<4TIBOY7AM+@Q,(IW3.55O^ MC. <<9H Z"BL=_$NGK<^4
M!<.GVD69G2%FC$Q8+L+#I@G!/3/&<\5%JGB[2='$\ET\_P!GMG6.YN(X&>.!
MCC =@..HSZ9&<4 ;M%<M/H^I7/B6^O;?6=133;O3FB\M)%*12$*$> =F W$D
M\9(Z]LVYEU7P9X,M-7O[ZYO'T]\7@G<.\MLTI +8X\Q$926'7:1R"#0!W=%(
MK*Z*ZD,K#((Z$55U/4K/1]-N-1U"=8+2W0O+(W11^')^@H MT5BV_BC3I[NZ
MLW%U!=VL"W,EO+;N',1) =0 =PR".,D'J*S[3XA^';[^S6@N+AH-2D$5O<&U
MD$1D)(5"Y& QP< G- '545@:[KUC!#?V.^[>:"W\R<V:,S6ZD'#$KT/!.!S@
M9QBJOPVNKB]^'.A7-U/)//+:AGEE8LS')Y)/)H =+X9U6#6KV_TKQ'+:QWTB
MRSV\]JDZA@H7*$D%1A1QR*W-.L%T^!U\V2>:5_,FGDQNE? &3@ #@ 8 Z 5:
M=UC1G=@JJ,DDX %8]KXFL;R6%(8[L_:(&N;=C;L%FC&WYE./]I>#@\]* -FB
MN>'C70VT&RUM;B4Z=>3""&86[_?+[ ",97YACD59U3Q-IVDM<K.9I#:0^?<B
M"%I/(CY.Y\=. 3CK@$XH V**\]U37X8?B)X=OH-0NIM,O=+N)EA@9Y$F(\O8
M5C7.6PQZ#-=AH>O6'B+3S>Z>[F-9&AD26,QO'(IPRLIY!'I0!I445PVFZG<^
M,_%>MVZ7<]MHFC3BSV6TAC>YN ,N6=<,%7@ *1GJ?2@#N:*YVWM!I_B6%H-<
MD>S,$D4EA<77FD2ED*NI8E\X##!)Z\8YJ2?QAH]M<6Z32S)!<7'V6*[,+>0T
MN2-F_&.H(STR,9H WJ*Y:Z^(6@6K:BIDO)'TU@MVD5E*S1#&XLP"\*!SNZ>A
M-:TVO6$=O:2Q.]R;R/S;:.W0NTJ8!W #^'!')P.0.I% &G17,MX_\.)IMK?O
M>2+!<W?V)2;>3*3YP4<8^0C_ &L=*D@\:Z3=);B!;QKBX>5(K5K5TF;R_OG:
MP! &1R<=0.O% '145Y]XYUZ+5/AL-;T34+F-/M4"I)"[Q-_Q\+&ZL.#_ '@0
M:]!H **S?$(;_A'=19)98I$MI'22)RC*P4D$$>]>4W.MZOI?PM\/>(K+7+V?
MQ!=&#;9S2^:M\S-AD\L].,G*XQB@#VBBJ5[JD&GI")PYFG.V*")2[NP&2 !Z
M#J>@KA_'?B2#5?AAK>H:-?W=O<64BQ2>6SP2PR"10R..".#]#F@#T6BLZ_UF
MVTZ1862>>X,9E\BVB,C[!P6('0?7KVS5*+QEHES9:;=6=RUT-2+BSCA0EY2@
M)?Y3TVX.<XQTZT ;U%8EOXKTF[TJ+4()I'CEN#:I'Y3"0S D&/:>0P(.<]@3
MTYJ:/Q#I[V5S=.TT*6TPMY4EA97$AVX4+C+$[U QG.1C- &K6%K?A^[UJ^AW
M:U<6^E^68[K3XXD*W()S@N1N4$<''4>E3Z9XCT_5-1NM.B,T-_:JKRVUQ$8W
M"-T89ZJ?49K6H **Y^[\9:1::I=Z63=RW]K$)9+>"SE=RI) *@+\W0\CCWJJ
MGQ%\-RVMC=QW4[V=XZQK<K:R&*-V.T+(^,(V>,'D=^M '545EQ^(+"76+S24
M:8WUI"L\D7DM]PD@%3C#9(/2J]KXMTF_TJQU&REEN(KZ1XK9$B822,A8, I
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MUE^=Q,6/!4;./X<+GL.1G'M(+J+X2>"K-]/OQ=6NJ6KSP_9)-\2I,69BNW(
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MP;N]+.E:FMW'K&?):UD9R/MGF$C )8!1DL,CW)KVE'62-77.UAD9&/T-.HH
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MP0<Y]#C-<CI-SJEI8^#=/O-'U6&Q32!#/);6K>>+A0@\IF W1(<$YRN2!D@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)!&Q5E+?WCC@=\^O%:MCXDM-2U9]&DMKRSO3:"[6.<*"\).W<K(QQ@\8R"*
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M2]@M[J&0I"&G:&/R%9F)8\*"2<9]<#BNXD\0VAALGLTFOI+V#[1;PVX7<\6
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MZ\=C0!>HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,CJ@5AQTRI^G>MZ^CN)_&?@:[CL;TV]I!=+<2?9G A+Q*JAN.,D$>W>N]HH
MY7XDVUQ??#S6K.SMIKFYN+<QQ10QEV9B1V'\ZS=1CN+GQQX*NXK*]-O;6UTE
MQ+]F<"$R1HJALCCE3].]=Y10!Y3ING:I9?"W4O MSIEW)JBQW%G;RB!C!.LC
M,4E\W&Q0-^2"01MZ9Q7I.EV!T[1++3S*7-M;I!YG=MJA<_I5VB@#R;PI9R:=
MI\'A75O K7.I6C^5'J+V4;VDJ!OEE:4]P.2.6R/4\;_BC0=3;QC8:CI"'RM3
M@;2]493CRXN767_> #J#ZLHKNJ* //O&%E<:7XKTG74\/R:UI,=F]C<6EO )
M9(,LK)(D9Z],'':JFO6CW&BZ-+IWAF;3XSX@M;UK:&SQ((D8%Y950$!N#QUQ
MCOD#TRB@#A3:W5Q\3M7N$L[H6UQHB6L<[P.L;2AW8KN(QT85=^&RW=OX$TNP
MO=/NK.XLH%@D6X3:2R\''/(]^ASQ76T4 <68YT^,#WYM+O[$-#%M]H%NY3S1
M,7VY Z[>?TZUR<^FZE+\'_$VF)I>H?;KK4+AX(#:N&=7GWJ1QTV\^U>P44 >
M<Z[+JNHZUJME+I&IRV$VEJ-/-M$8TED*MN$S$@@@D81CC&>"2*C.C75[\%M,
M1X)=.U;1K.&YMFN5"-%/ @.2,\ X9><<$UZ56)J_AF+6M3MKJYU'44MXDV26
M,4^VWN!G/[Q<?-^?(X/&: #PK;W*:*MY?Q"/4-08W=RG78S 83_@*!$_X#6/
MXN@O(_&/A'5H-/NKRVLYKE)Q;)O9/,BVJ2,],]^@[UV=% 'FT%O>"X^(SMIU
M\HU!1]ES:O\ OO\ 1Q'\O'/S<?KTYK*2QO\ 1X?".L77AJZU:R@T6/3+ZR6U
M\R>VD7:0ZQMRW((..WX5Z]10!C>&HXAITDT&B)H\4\IE2V\E8I"" -TBKP&)
M!]\8SSP.-\5KK.HW_BS3)M(U*:"33MFEFT3;#,QB;<9'!&6#' 5CT' )->ET
M4 >46]W)8^*/AXUW87L+QZ/<0R1& M(A"1#)1<G&1Z9YY JGXRTN>+PG\0?$
M#V\D$.JS67V>&1"CLL31KO*GE=S$\'!P!GK7I%[X;CO?%.GZ^U]<I/8QR110
MJ$\LJ^-V<KGG:.].\4>'8?%6A3Z1<W5Q;V\Y4R-!MW':P8#+ XY [4 8FHVK
M^)/&GAJ_M[2ZAM](,]Q/-<6[Q'+Q[%C7< 6))R<9&%Z\BL&WL[[_ (0/X@VA
MTV_%QJ%[J#VD1M7#3+*N(RHQW/Y=\5Z?$K)$JO(9& P7( +>_'%/H \QE&K:
M#JOACQ)%H^H7UFNCC3+VVMX";BW.58,(S@GYEP<=A]*U-=U36Y;72+J+1;^'
M3Y[\_:DMX0UY%#L.UMH)*EFSDK\P4]CG'=44 >-W.@ZQ=>%/B#I=MH=_'+>W
MBW-JLQ'[U<1<!BQW-\K9Y/3&<UV%] _BKQ/X;O;:TNX+72I9;J>6ZMG@;<R%
M%C4. 223DD<87KR*[2B@#R1]#U?4/"WB^"UTZ;[8WB$ZG:074+1I=1J\; ?,
M,8;81@^V:ZKPM<6NJWR7=OX+FT62*,K+/>V20R G^",CEAU);@<#UX[&B@#C
M_B':7=QIVBW-I9SW?V'6;6[FCMTWOY:,=Q"]3C/2H?%FG:M/J.@>(-#MF348
MV:TFCD RL$RX+/C.=CA&Q[&NVHH \_\ #7A6]T/Q=?:>J.?#L,BZC:.[$DSR
M(8V7)ZX(=S[NIK,M[>30_$&N:9J_@JXUJ*_OI;NRO8+2.9'64Y\N1FX3:<C)
MXQ^OJ=% '"6=M<6GQ1%T^GRQ6<?A^.T\R"V?R5E64L43 Z!2,?EUXKF8-+U5
M/AYIJ_V3?F>P\2+?RV_V=A(8?M+/N53][Y6!P*]AHH X?QW;WIT_2?$^E6^S
M5]-N$,5O,0IFCF(C>%L9Y.Y3WY K6?PKYN@66F?VOJ5F\'SR7%C-Y3S2')=F
M.#]YB6^IJ>3PS%-XD_MB?4=1F4;6CL'G_P!&C=1@.$QU[\G&>>N,;= %32[#
M^S-.AL_M=U=^7G]_=R;Y7R2?F; SUQ] *MT44 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 51U;5K7
M1K,7-TS8>1(8HT&7ED8X5%'<DG^IP*O5R/Q TG4=0L-)OM+A-Q<Z3J<-^;4,
M 9T3(95SQNPQ(SZ4 :-OXJMI-6GTFXL[RTU&*#[2MM*JLTT><;D*,P;!X(SD
M>F.:R+3XEZ5>66EWZ:?JBZ?J,XMDNW@41QR%RBAOFSR1U (&>2#D426DFM>.
M=+\1+:W=O9:593J3- R22R2;1L"$;B% )SC&2,9YQRD&D:M'\(=!TEM)O?[0
MMM1BEFM_).Y$6Y,A.>GW2#U]J /0=6\56^EK?NEC>7J:>F^\:U"'R1MW8.YA
MD[2&PN3@CU&=73[^VU33K:_LY1+;7,:RQ2#^)6&0:\ZEM;G0_&.LO>>#YM>T
M[5YENK6Y@MXY'B<QJC1R"0C:/E!!)P/SQZ)IL+0:;;Q/;P6[J@S# ,)&?[J^
MPZ=OPH Y[0M2D\2:WK=VK#[+IEVVGVB'[OFHH,DA'<[FVCT"G'WC7/\ B/PU
M-H%YHFJZ1JNIR:W/J<,$YFNG=+Q&),@:,G:H"AF^4  +]*TO $#Z,WBS3IT<
MRP:Q/=*JC+/%*JNA [YY'U!JK;^)=5FU1KZY\$:^]V-T5HKI$L4"$]2V\G+8
M!9L<#@#@D@%[XDM/#I^BSP7=S ?[9LXV6*4HKJTH!# =1[&MCQ8MQ!H%UJ=@
MVR_T^)[F ]GVC<8V]58#!_ CD UE_$2VN[W2]*AL[.XN98]5M;EUAC+;8XY
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MAY9N(Q,SA03QDJ?S'.*ZBXM9?$/C7P_KJ6=Y;6FC07+R&X@:-W>5%01A2,G
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MFVBB626$[]ZR(K=>I!J_)$]WX?\ [,C\._V?#K$K1O"MNN+>%E 9Y0N5WG&
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MH **** "BBB@ HHHH ***H:QK%KHEB+JZWMOD2&**,9>61SA44=R2?IW. *
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M* S!06!8J""<?09/% '1$9!&<>XJI;Z=!;6DL-NSH9F+R3*<N[GJQ/KP![
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MA@0R,,@]00: ,CP_X:MO#L,BQ7=_>SRX#W-_<&:4J,[5W'HHW' 'J:V&!*D
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M0Q 8$@$'UZFLJQ^)5C>Z:VJ#2-6BTR.*XDFNWA79$8205.&)R<<8R.<9R#@
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MIP73466-88I2K;_.&[ELE<?> QQSS7H9( ))P!WIOF)\GSK\_P!WG[W?CUH
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MX9)4V72@CY <Y&1NY( Z5ZY10!QMWJ.M>(?"FL ^'KRP$EA+!%;W!0S33,I
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ML5DD1-N&4$-U8$A2<=,P>$5\96=C8Z'JVFVD$-@JQ-J4=T'^T1IPNV/&02
M2V,<D<XQG:;X:UW1O!VK^#8K);BWG^T16-_YR"-(IBQ_>J3OW+O;[H(/'(H
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M&3(LI W%1RI!(XQSGM4>MV_BGQ/X'UFTNM'BL;F[MC;P62W:2D,>KO)P .@
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M;$2Q2!?G'0CA?PQ561-,T[3O!VIZKX5M+B]EEM-.MKA) WD!]I1SE0<@@D
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MEGW;<O$I7#*-_P#>YVMTQ65>RWUA\8=1?1M*CO+N70H6,;3"!"?/DRS-@G/
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M[97/15.<,3@\#TK"O]<EU*?6--TS3;>^33T"71GFV*TC+N\M1M;)"D$DX )
M]<<CX7U:'2_AGX!2YTB*_CN[NWMHWE9?]'D9FVR $'D8.,8^M 'IU[?V>FVY
MN+^[@M8 <&2>0(OYDXJ6&:*XA2:&1)8G 9'1@RL#T((ZBN#U*YU67XP6-F+2
MTFMTT>=XXY;I@"K2QJSD>6<-@8QR,9Y'2K7ASQ!!9Z7KUA_8]MI"^'693:I<
M%E*;?,#@[!A6R<<$]>* .UHJMI\US<Z=;SWEL+6XDC#20"3?Y9/\.[ SCZ5R
MTNLZR_Q4_L,06C::NE?:"K3L"P:4*6(V$%AM("],$_-S@ '66UY:WJ.]K<PS
MHCE&:)PP5AU!QW'I4U>0Z!XDNO"/AGQ%?P:,EQI=GK]Y]I<7 C9(S-M_=IM.
M[&<X)7VSV[G5_%J6>I7&FV?V![NW@6:07EX+=?FSM53M8DG:<\8&1ZT =+16
M3X9UZ+Q-X=L]7BMYK87"DF&88:-@2"#^(//<5K4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/Q
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M#-M*P1'YE9U^ZS@N.,X&.>IIUEH.NVWBZ;5TT:PM;*;1Q9BV@N1F)U=F ^Z
M<[N3P!SU[^@44 >9Q>$]=B\">$M&^Q1F[TC4+>XN/WZ[&2)B3M/<G/ ('?\
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M,GDXSQ5JBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU**..\L[R9HBKQ@A9$8 \;3@C'_UI;W0M=N?%'A74Y3:SC3/M+7;"0IDS)M
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M(.Q23]U<\D <9/)QGC.*MT %%%% !1110 4444 %%%% !1110 4444 %%%%
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M53AUZ9(Y'I7844 <''H/B[0O$6I3Z!+I4VF:K/\ :I8KUI UK,0 [+M'SJ<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%(&!S@@X.#CM1N 8*2,GH* %HH
MHH **** "BBB@ HIDTT5O$TLTB1QKU=V  _$TY65U#*0RD9!!R"* %HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BD)"@DD #DD]J%97171@RL,
M@@Y!% "T444 %%%% !14!O+42/&;F'>A"LN\94G@ CMFIZ "BBB@ HHHH **
M** "BD)"J68@ #))[4B.LB*Z,&1AE64Y!'J* '44V22.&,R2NJ(O5F. /QIU
M !1110 4444 %%%% !1110 444U)$?=L=6VG:V#G!]#0 ZBFF1%=49U#-G:I
M/)QZ4Z@ HHHH **** "BFK)&[.J.K,APP!R5.,X/IP:=0 4444 %%1O<0QS)
M"\T:RR?<1F 9OH.]24 %%%% !1110 44UI$5U1G4,^=H)Y/TIU !1110 44F
MY<D9&1U&:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***:TB(5#NJECA03C)]!0 ZBD)"J68@ #))[4B.LB*Z,&1AE64Y!'J*
M '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]S#F1!T60$JX'MN!K=KE/AKHMSH'P\T?3[Q"ER(FEE0]4:1V<J?<;L?A75T
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MNZ-JC:O9R7)MC#&)I(HR7#>8$8KO'L2#CU'-<SX^TR\NET35-)F%GK<%TMO
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M[*H*@G!.2, YK)TS2-<T_3O&>GOI32+?WEY=6DR3QXF$P 50"1@CG.['MFJ
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M+OA8]H+G P,DY/3)K<L/'-G/H6HZC?6LMC+IUX;&XMG=68394*JL#@[MZX/
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M*'<%VL"1[>]8UM\2Y+C0],UQO#]Q%I=W="UEF:X3="QE,0.WJPR!GIC/&<4
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M4QDE9$<DJ?O,,9Z?7BYK>G>(=4N?#%W+IZM+9ZE]LN8H9DVP1[&4("Q4NPW
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M$9, ;R,G/0$XZ<UW5% ''2:1?:EXI;Q)-ITUO]FTQ[.VM'DC,LCNV68E6*@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,CC(9'P,^A&.#ZURB>!O$&FZ#92Z1./MVE:I)>:;9WLQ<);,NPV[/SS@GG)
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M(P,RKO)'WL9[C'/?BL"Z\*ZU/_PD<2:]&MMJ962U5K4%H)!C.XY^=2%"X/\
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MC_QH S?$&A7/BHKI]W$MKI&\&Z^8&:Z53D1C'"H2 2<Y(XP,YKIE544*JA5
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M.N.Q35HGN"(9H#_RS4X/W"!L.!W)Y)KOZKWE]9Z=;FXOKJ"U@!"^9/($7).
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M[5N&'_+-(E(3/^\[ #_=;T-:F@ZGJ]YJFL6FJ6=K$EI.!;2VTA</&V<!\]'
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M$WSED9FR1C !W8ZUH6EMX<\%Z=!8VXLM*M990L498)YDC$# R<LQX'<]*VZ
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MFL].M[.]TO6II;N*26X,3V\LBX=6&T[AD C'XUZ#10!A>#=,OM&\':5I>HK
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M&_MQIYGTFRDL[J.29]N'1%WH0N6QLS@@9SC(ZT =S16?8-JQO=0&H1V:VHE
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M%W!26("DG@<M[5JWFAZQ=^,?#>L>59);Z;!/%.OVABQ,JH/E^3! V=R,Y[4
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M7G*R%6N=N8U"D<;AU([\=Z[6XT/5HOB+_P )!9_8Y+.;3ELYEFD970K(S@J
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M<:HRV[LZ#  ^\0"<XST&,XYQDZ5 !1110 4444 %%%% !1110 4444 %%%%
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M(-\[06R7<^#<20Q[?,8# )/4X' S0!:JEI^KZ=JWV@Z=>P70MY3#*T+A@C@
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M$@D$':#C:.&')K2L/$MW_P );K.B:JEK;"SMTN[:5=W[^$Y!<Y/&TC!'OUH
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M8\G>RT =:;;P]XHEAOHY;;46LI/W4L%QO$+X[%6P&P?K@UMUS$-[J-QX>O\
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M!&T8SDGFM*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "J]_90:GIUS872;[>YB:&1?56&"/R-6**
M/.O^%;7,GAC1;.?4]VJV5PK3WJY!DA*>2\8..,P@+]5![UN^(_#5U>:SHFNZ
M0\$>H:2SJL,Y*Q30R+M="0"5/ (.#@]JZBB@#CKCP=-JS>([S4)(8;W5]/\
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MRK$*&4_*",#K6EKOAWQ+KWAV&WNKC33?F]@N75'=88EB<,$3Y26)QRQ Z].
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M6!]CUQ]=3P?X?U+07UMM0NK2;^T=1DOE$$;+LWA1@DG_ &1Q^IH Z28RB%S
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MO;.9EW*LJ'@,.ZD$@_6F0Z'>WOB6TU[5EM4N+&VD@MK>WD9U#2$;W+%5/(4
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M!+VT1BDBESRKH78CCID \&@#J*I7NK6.GW=C:W4_ES7TABMUVD[V"EB,@8'
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MS<H8A7WJ 024QR<@GGMW5 !1574IKJVTN[GLK7[5=QPLT,&\)YK@':N3P,G
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MW T2SH,E"1U^GK[5S=IX3U^/Q!HNL3ZAIF^PLI+-[>"V9$*G:1M.XX)V]<8
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MW^\CKU /'0G&/?CT>B@#,T2UU6"W>76;V&YOI2-PMHS'#&!T5%))]223DY]
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MG)P.PYP!V&.M6J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML!ITT,]N9!Y2ON4IAAAADCG(K*B^'E]#X-AT4:S"US:ZF-2MIVMCM#"4R;7
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M,/B7P]=:Y?Z)<V]W# NF7@NRLD1<R$*R[<AA@88\\T 8EEJOBZ\U[7_#PO\
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M00<'GT^E:]YX;UG5?"NJZ=J6KV\E_J5N;=I8[<K#"A!'R)NR3\Q.2>>.P H
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M8I);8P?.KI'Y8P^[&W !QC.>_KJZO;7UU8&/3KQ+2Z$D;K*Z%UPKABI (R&
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M9_U;D\*,<]LYZC'/6Z8\\FE6<EU)%)<- AE>$Y1F*C)7VSTH M45A>,/$/\
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MEVIB+!@9S$Q3YOESC/(/6@#TJBN4EU74]9UW7=*TFZCLVTF.-0[1AS+/(A<
MYZ(!MSCDY/(QSOZ4^H2:3:OJL4,6H&)?M"0,60/CG:3VH @T?7]/UW[;]@DD
M?[%<FUG\R)HRL@ )&& /\0K3KRG2D\3>;XXG\/7MC;O;ZU-+Y=Q;F0SL(HSL
M)W#8,#K@GGMCG7T[QQ=>)4TJ'3X9K>6ZTM=0G:&-9&C+,4"J'(&-RODG/ '3
M.0 =_17F]SXE\9V.EZ!]NM;.TO;O6ETZ82QY$T9#%91M<[,A>5Y.<\BK47BW
M4]"O/%UOK<T-^FC6<=_#)##Y)=75R8R,GNF ??F@#OJYWQ!XFT#3HKB'509K
M>!D%T1;--'!O^[YF 0,\?F#W%9MKJ/BS^VM*/V5[G3KI6%\7BCC%LVW*O&0Y
M++G@@Y/?-9W@NWU,^(?&A&HQ,ZZEM/F6V59O(CP2 P.!QP#VH [/0KO3KW1;
M>[TR#[/9R@F-&@,)'./N$ CD>E:5>27FOZWK_P /?!6JO?K;7&H:Q:I<K#$-
MKYF.WKV!4''?O7J\:2K;JCRAY@N#(5P"?7 _E0!)17E%QXO\61>#=;\1&\T_
M_B3:E- T"VIQ<)'*$(R6^3C/J<]ZZYM:N]7\7W^@:?<BS33[6*:><1AW:27.
MQ0&XV@+D\9.1C&.0#J"0!DG ]Z6O(]:\3:QK/A,127*V=_I_B.'3+TP1_).1
M*F&&3D*00<9]LXZ]9<ZIJ^F>.=-TF\OHVT[4K.402B *PN4 )!.<8*98#U!H
M ["J4>JVTFLS:4HF^TPPK,Q,3!-K$@8;&">#Q7$>'/%NJ:UH%Q$UY%_;2ZH+
M)"MOM0QDAUD"$Y*F'+]><&M:#5M7G\>:QH#74"V\.G17%O(D'SHSLRDMDD,1
MM]A[4 ;>M^(-.\/62WFHRND+2K$&2)G^=CM .T'')QDX%:055+$* 6.20.M>
M*-+?W/P M;V\O#=2W%W;R#>NT[C>@DEAUR>>E=S:ZSKMEX[N=#OIK:_CETIM
M0MQ%!Y)1UD"&/[QR#D<GF@#LZ0$'H<UPGA+Q3/XFE6*/6(TO5MG%_I\]L(Y[
M2?Y<;5."4!W#G/;GM6;X-U#78OA9;:D-1MY9IKJ0RSWFU%@0W3B60G(#'!)
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M<Z;87DJ2W5E;3R)PKRQ*Q7Z$CBK5<WJ^N3CQ9IGAJRD6&:Z@ENIIRH8QQ)@
M*#QN+'J<@ 'CFL_3-<U6[U+Q)X;N[B-;_3%CE@O8XN)89%W E,X##!4XP.X%
M &O%XNTB?5+2P264O>&1;6;R6\J9DSO57Q@D8/UQQFMPL%ZGMG'>N)^$T4Z_
M#;1'FN!*C6RF-/+"^7R<\]Z9<MJ4GQGMK9-29+5=%>98/*!4?OXPP^IP.>V*
M .HT77M/U^&ZET^21TMKE[67?$T9$BXW## 'C/I6E7CMMJ.N:)X;\;ZUI5U:
MQ1Z?K]Y.T,L!D,^&7*DY&T8] 3]*[.\\0WVH:Y<:3I?GPFVLH;F2:*%)6W2[
MMBX8@8 0D]SD<C'(!U]%8_A:[UF^\/6TWB"P6QU3YEGB1@5R"0&&"< C!QGC
M-;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %<_XK\.S^(;;3_LFH"RNK"]CO87>+S49DR-K)D9'S
M'N.U=!6=K>N:?X=TR34=4F>&TBYDE6%Y HSC)" D#F@#EI_ .H3GQ27U]6_X
M2"W2*;-D/W9$?EDC##C'0=NY;O>D\(WLM[X7N3JD .A*PQ]D/[_='Y9_Y:?+
M\OUY_*M"Q\7:)?ZA#8174D5W/'YD,-U;2V[2KU)02*N[\,UN4 8OBWP__P )
M1X9O-'%VUHT^PK,J[MI5@PRO<97D=Q6;9^%=5B\7)XBNM<BFN#I_V*6)+((C
M8<N"OS$@9/())/J.@ZRB@#C++P+-%X3UW0+O5$FCU:2YE,L=L8S$TQ)/!<Y
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M(9KJ2ZGR6EGD !D8G).!P!Z =  *MT44 %%%% !1110 4444 %%%% !1110
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M""#(Q50%P>IP*WX_#EU'XSN/$0U"(O-8K9^0;8X558L&SOY.YCGV].M8=O\
M#FZM-,TJ"WU[R[K3+^6]MY_L@*DR%MZLA?G[YP<@B@""SUSQ-J_AWQ3'IET3
MJFDWKQV;SVH5IT"*X21,##'<1D!><<=:V-+\0OXA'AR32[U_)N;8WEV2B$E
M NP\?*QD...R/[8AM[2R^'SZQK>L>(':RU&Z21_-@ "2LJIDE!DYVC'  [YZ
MU/X&T.TTV#4]2M89(H]4O'N(HY 04AW$J #]T$EW [>90!T6I_\ (*O/^N#_
M /H)KR31]4\2^%_ACX:\117]K-I,,5O'<:=]FPQB=@FX29R7!8'& /RY]AGA
M6XMY(7)"R*4..N",5R6G^!I(-$T_0;[5%N]'L'1XH1;>7)*(VW(LC;B& (!X
M5<X'N" 4[W7?$6L?VZ?#L=P)M-N7M;9$6 Q32(JEA*9&# $G'RXP.<G.!VFG
MRW4^FVLM[;BVNWA1IH P;RW(&Y<C@X.1FN5N/!&H0>)+W5=!\2SZ5#J+![VU
M%LDRNX&-Z%ON,0.3@UUUM EK:Q6\>[9$@1=QR< 8Y)ZF@#A-0\6W$'BR[T:\
MU)]'N3<1C35G@7[->180M^\*GYR2ZXR,?+P>:T+#5]3N?%7B[27O#Y.GPVTE
MJXC7>AD1V;/&",J,9'3\ZEUKP?/KUK?:=?ZE%+I=W<+,(FM<RP@$$K')OP.1
MUVDC<?P=<^$KH^*+_6+#66M(M1MXX;R#[.'+^6&"LCD_*<,0>#^% '&2ZKJ?
MB'3_ (9ZF\T":E=W$KF5HLHK&"3G:",_3(K<L=;\26&L>(/#NHWUM=W=KIXU
M"QO_ +-LRA+ JZ*0,AEXP:L6GP^EL=!\.V4&M,;S0I3);7$EL"C94J59 0<8
M8_Q9]ZDU(:7X?EU&YUC58#K6KVCQ1,R^4K)$IQ'&I)QRY."226^@ !2T_P 7
M:G>Z%X/AQ))J.MV;7,TMND8<*B*6V!R$!)=>N<#/!H/B+Q1I%K]DU>V5)KS5
MHK#3;R?R\O')DEI$C8C<H5NF 3CCK3;+P-<ZCX#\)Q_;I]'UW2+:-H+E$#M"
MQ0!T9#PP/0CVK3U#P-)K7AY[+5];N;G4S-'<1:C'&L1@DCY0H@X &3QDD[CS
MTP 5_$<7B?3_  _XI=M7#646G//972JBW*2*C%U.%"[>!@@9&?7FMOP9%-%X
M-T?SKEYRUG"REE4;08U^7@#I[\U6@\+WUQH]_9Z]KLNISWEJ]H9DMU@6.-Q@
M[4&?F/!))/0=*TO#NE7&BZ':Z=<WYO6MXUB67RA'\JJ% VC/8>IY)^@ .7\1
MK?O\4_"\$.J3P6\MM=OY2HA4,@09Y')(8CGIVQDY?;ZWK/B/3-?U/2+Y;4Z=
M=3VUG 85=)C".3*2-WS-D#:5P,=36SK?AJ35=?TC6+;47L[C3A,G$0<21R!0
MPYZ'Y1@\_0U3B\'7&GW6L#2-5%I8ZO(T\]N]OYC12N,.\3;AM)ZX8,,\^U &
MIX5UU?$WA;3=:6+ROMD D:/.=K=",]QD&N<*W[_&MX?[4G%LFB+.L&Q"J@S[
M64<=]@)/7WQBNPTO3;71]*M=-LH_+M;6)8HESG"@8&?4UDW?AF67QG#XCM=2
M:VD%G]CFA\D.)4#[Q@D_+R2#ZCT/- 'G-KJ>MZ!X(\3:]IM]#%%8:[=R-:M
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M>#QU]0#O <@'UKA(K[Q3JOC?Q#I%KK%I:VVFM9R1G[%O)20,S(<MW QG/88
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M<1BE7!(^93TZ9^A%7:\JA\6^))_AMX6UE-0A6_OM4BMKEVMU(=7G9,8&,#
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MQ[]Z ,ZQ;Q6VKZ/=Q23S:=,A_M!+MH F"H*O#Y?S#![$G(]^:[6N2\.^")-
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MU_5KO6S=0&V9[E439$>H4(!@G )8Y)('/% $D.F:]%JMG*NOF>PDMW6[26-
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M^U66^MFM7N)@B&.-@1A%4  ]R3DD@9Z"HSX)=TT'S=;NII-&D\V)WB3YSLV
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MA<VL%X4C,DB1L,;_ )<9PV,@ \"NG?5+C5/&<7AT7<MM#%I2WTK0D+),S/L
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MM 98Y$56/';Y@1_6L:\NM9T>XTFU;6+F]EUZX5<,L<8MU2%G=8CCC<0H&[)
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M-<P:M=1VL$\)4QJ7!*DY.<$ G@&MZ@#B+SX:6=Y8:OIIUC4H],U*X:Y:TC9
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MJQX@T.T\2Z%=:1?&5;>Y4!FB;:ZD$,"#SR" : .0\16$A^(W@ZSBOKF,FUU
M&XW!I<8C)P2",]LX.*SK7Q-JNEZ%JMBU_+<S0^)5TBWN[EAO2)RARS8QD!F
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M$\LWGN)KUO(,.XAHC&$(& ,;L[LC.:Z^7PK!-K6D:K+J%\UQI<;QPC,85@X
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MF-EV[#C*$J2O!(/]* ,FVU-_$OC?6='%[/#8Z9:6SQ_992AF>8,WF;AR0 %
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M^9%D =@>_K@>E4=7UO4[+R+^VU2YO)?^$@CMI)X3MM!"TNSR-A.&(!P64'#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8!QC;AB,8_7FB[^'FCW<VK,UQJ,<.JQ!+NWCNB(W(38'QUW8QU.#CD&NMHH
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M ?'0@ 8QCCI5VZ\%Z9>>'CH\\UZZF9+@W33DW!F4@B0N>XV@=,   # KHJ*
M,)_"UJ^MZ;JS7EZ;G3XGBAW2!@5?&_=D9).!W[<8JL? ^F@ZC%#<7D%AJ4C2
MWEA%(HAE9OOGE=R[NX5@#7344 8LGAFT;Q';ZXEQ<Q7-O;&TBCC*"-8B02NW
M;Z@'\*?H/AZV\/)>I:W%S*+RZ>[E\]E/[USEB, 8R>W3TK7HH S3HZG7AJ_V
MRZ\T0^1Y64\O9G.,;<]1USFJR>%=-M]-U.QLU>TCU.:2:Z: @,S2##D$@XR/
MRK;HH Y67X?Z-<>$K?PU.]W+96I5K60R 2V[+]UD=0,$9/)S4T7@G3AH%_I%
MY<ZAJ"7\7E7%Q>W)DF9>< -V R2 !C))[FNDHH YS_A#;3[7H]TVH:C)/I.\
MV[R2JQ)9=K%LKSE>/0=L&@>"=*?^VUNC/=Q:T0;R*=EVL0 H(P 5( &,'L#U
MYKHZ* ,.P\,6]G<6<\][>ZA)8HR6C7;JWD@C!(VJ,MCC<V3C//)SD3_#31Y;
M;4[*.\U.WTW4F:2>P@N L(<G)91M)7)[ X]J[.B@"&UMDM+2*WC:1DB4*#(Y
M9B!ZD\FL?Q987&MZ+-H5N'3[>ODSSX^6*$G]X<]V*Y 'J0>@-;U% &7'H5O#
MJMG?0W%W$MI:FUCM4F(@*\8)3NPP #6I110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)N90Q"O"ZJ<D@#@=2.F,4 =)97,NAZ#8PZS=27-\3Y.]5W27$G)^55[D GT
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MB2"!I LA=& 8@87(!Y; XZUE:(T^A:3XJT#5K.ZENIKNZGMBD#R+>QS9*[6
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M5[R]FN[N>2 W<L4DB>:TSA%>7! 8\8!/ITXKLM5\3Z=HXN3<?:)%M4$ETUO
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MS,?4D\DUT]<G\,TEB^'.AP3V\]O-#;+&\<\31L"/9@#CWKK* "BBB@ HHHH
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MNGN!/"R9D=E<DI@X^88 S0!ZW15"_P!7AL)H[<137-U(C2);VZAG*KC+<D
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M[6'G:AY]J+Q1:J&(A/ <@D=3D #).#QQ1!XITZXU+3[!1.LVH6IN[;='@/&
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M>31--!%<Q;3.B_>*8)R1QE?O#TK*C^(VC7.\65KJEV4DFB;RK)\+)$"65B0
MI.#@-CWQ0!U]%>?OXMT[6OAO;:OKT>HV5M=&)BUJKJ0Q<% KKT&=HR< _C76
MWVN6]E>K8I%/=7IB,WV>W4,XC!QN.2 !G@9.3SC.#0!IT5S4WCWP_!H=MK#7
M,K6<]P+8,L#YCE+;2KC'R$'KNQ5K2O%.GZOJ]UI<4=W!>6\:S&*ZMVB+QL2
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M22RFTL WD-TFUXE895N,A@>VTG/3K0!OT5SW_"86(O;BPDM;V._BM#>):O$
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M3=7NJW<EM";*4/*LD@*,HV\@@=>W>O6;&02V%NX5US&ORR(58<=P>1^-3T4
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M:5D#PLJDJO.,GKT%5- DNO"_B3Q/#J=E?/!J-W_:%I/#;/,) R!6B.P'#+M
MP>HZ5W]% '+_  [T*Z\.>!=-TR\79<('D>,'/E[W9]F?;=C\*ZBBB@ HHHH
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M^^)L4-A=#^T[*..R9X619V6V*$*2,?>P/>@#NO#VHSZKH-E>W%O)!++"C,)
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M23M8;3CU!QU-4[W49='\&^%O%=GJ%S/<W$UH+PO.SK=)-@2 J3M!!.1@#;C
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MM?,GMI%"D.L;#YN00<=JTM>M7FT?0YM.\,3V$?\ PD%M?-:V]GB01(1ODE5
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MQCHI]JP] TJ\T_7]*N_#\.JZ?:7<KMJVCWD+BVM\HQ+Q,PPIWX "DYST !H
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M+:R-/8ZG$X%E)E=BQ,XSS\V5!(&W.>15KXGR^18^&YO+>39XALFV1KEFPQX
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M-C@A0#E>HYSU]*U: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;%="TEOHD4Q))NV'C=N(#?*2%(S]#0!TU%<GI_BJ\O/'&N:,^E7"VNG10$2
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M<GKVYQ3;'QU87NJ:59&PU&W758C)9W$\(6*4A-Y4?-D$#U&#C@F@#J**\_\
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M]MDF^UY)WJ\98C&.<X&/44 >[T5RMWX\L[?6K[28M*U>[O++R3*EM:[OED)
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M:P-/#<(HVJRLN=N0!D-CFF^+].UJ_CT+6[:R,D^E:BMT]@C R- 5*L <[3(
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MC;Z?J#6UT+ES)+-.%C7(^9LEB44<\FM:W\96?]NRZ/J%O+I]TMJ;Q#.Z,CQ
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M$@BNEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM5NO(\Y2DR,#@A^W*D'(^F:I^'_&4LO@S1M3U6 K>:BJ+"@= )G92Y(YPJ@
MGGL.YP" =G17'1?$73/+U5+J)H+S3)H89H?-1E8S,%B97!QM)(R3C'.12>*?
M%FIZ-X4UV^BTADO+"$,A>53&=P.) >X'I@$D8Z<T =E15/2[B>ZTZ":YMV@E
M902C,K'IUR..:N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5CZ]X<M/$*VOVFXOH&MG,D3V=T\#
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M9XJ[\0;#4=2T[2X=-T^6\DAU2VNI CHNU(W#-]YAS@<"NL$L;2M$LB&1 "R
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MZC:30.G#R ;XWW,-N"!@\C'OQ7927UG#*T4MW DB+O96D *KZD>GO5C.1D4
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M/(PISMW?CWS;WP?JNO6OC_3Y;62R76)HI;*>1T*N41 ,[6) +)W'0_A7IU%
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M"1U9EP,<E21^1/\ 07Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *S-<URUT&SCN+IAF:98(5+A
M=[MT&3P!@$D^@/TK3KEO'6CZKJFFV%UH@B?4]+O4O889FVI/M#*T9/;*N>:
M(+'QV+^[U?3K?3TN-4TZ)9_(MKI9$N(ST,;X&3GC# <XJQX<\9Q^*$LY-/LR
M\4MN9KAC+S:MN*B-QC[Y(/';![8)+35/$\^F7-]+X9%I<)'M@L#=QR/+(?XF
M<$*JCZY.3QTK+TC0=8\+>+VDT^WFO-'U5/.U$M)&IAN^\JJ6Z-_$HZ8&">E
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MX( /));(((_"O3JX*V\.ZC?:WXYCOK&:UL=>BCA@N/,C8@" Q,2 Q(YY']*
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MSF_9E(\GS #&"#G&XD\XZ=.:B\::=J>J6_AZ\T_3WFFT_58;V6U:5$<H%=6
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M\Y9XI!(LH\],'=M4DCIR.W<5)XCTKQ/XAT73]3BTZ"TU+3=2AO[?3'G5O,5
MP97D'RAFW'&,@8'/)J>RMM=O?B3:Z_/H4ME8_P!D/9N)[B(NCF57Z(S9'R]C
MWYQ0!V5Y>6^GV,][=2"*WMXVEED;HJJ,D_D*YM_&GV5-)N]0TV2UTW59$BM[
MDRAFC9QF,2ICY-WJ"V#UQ6OXDT<>(/#6I:09?*^V6SPB3^Z6& ?SKD9=$UOQ
M!X6T7P]JNF-:/9SV[7EUYT;1.D)!S'ABQ+[1U48R<]!D O7/CVX6YU^WM/#E
MY<2Z*5-P&FC0%2F_(.3_  ] ,GUQ74:5J4&L:19:G:[O(NX$GCW#!VLH(S[\
MUQT&D:Q'JGCNX;2IO+U98Q9XEB_>%8/+.?G^7GGGM^5=!X,LKO3/!>C:??6[
M075I9Q02H65OF50I(*DC'% #M3UVXM=6&F66G/=7 M&NW>1S%$$#;=N_:<N3
MT'H,DBL<_$2U?2?#FHVVEWL\.N2"*':4!1R&.T@MU^4^WJ13M;LM<N/&D#G3
M%U/0C9[$B:X5(X;G>27D4\L-N,$!L8.!SFN8TGPSXEM/"_@?3[C16$VC:@)K
MG9<Q-^[ D&1\PY.\' SP/PH [CP_XF?6=2U73+K3I;"_TUH_-B>19 R2*61@
MR\<@'CMBM#7-630]&N-1>WGN1"!B&W3<[DD* !]2/IUK"T33=1MOB'XFU*XL
M9([&_BM4MYC(AW&)7#9 8D9W#''Y5>\:0:W<>%KJ+P\3_:!*;5601LZ;AO57
M/W6*Y /;/;K0 VR\2S7&NZAH<^GK%J5I;)=*B3[XY4<D##%00<K@Y'YUYK]M
MNI?AUK7B.ZT:"YU"QU*ZN[>ZDGPT4J2E5(P,D(  %S@A0.E=9H>CZK8^/I]7
M3PZEEIMQI20[%N8RZR*[L0P!Y<Y'.2.Y;/%4;7POKD_PK\0^'YM/-M?W<EU)
M LDT95_,D+J,JQP><<T =/-XI^P0:?;7<=O'J5W$TB1S7:I&$7;EF<CCE@,
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M9!YL#.K[&[@,I((]#_*K5 !1110 4444 %%%% !1110 4444 %%%% !1110
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M8*2"/>@#J596^ZP/T-+7C'V*!QX!?PA9F'5T:W:_FM(#&GV;RQYHF8  Y.,
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M:QW<=H]S"MS*"T<)<!W ZD+U.*FH RO#4%S:>&M,M+RW,%Q;VL<,B%E;YE4
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M8WFDI91RM(A(=6<DE0<X^;]*N^ K#5-)\'Z?I>JVD=O-90K;C9,)-^WC=P.
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MV/8 I(&XC&3T]LT .MO'R1Z+K-WJVG_9;S2;L6<MM#-YHED;;Y>QB%SNWKU
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M?=G8 ?1O0T =G16%H.JZK?:EK%IJ=A!;BTG"P202^8)(VSMW>CX )'HZUNT
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M7R?W?](DXKN*Y;X>Z-J?A_PA!IFJQ01SQ2S./)E+@AY6?G@8/S8[UU)&1@T
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MCBV?O#))M *GC@D[NV:[_P 1>.+G0+75;^31\:?ILT<3O/,8GN-P4LT*E2&
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M:HGB%];T\R2;XVR>$?'(X+ _4<T :I^(;Q#78VTV&XFTNS-\KV=WYD$\0!+
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M*"A22,L.F03@_P NVWH4VNW:27.MV=O8,P"QV<$_G;<9RS/M&2>. . .ISP
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M,T1.<!@.F<'KZ4MU?VEDT"W5U# UQ*(81(X7S'.2%7/4\'BO.;>\U/3/'GQ
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MCG&XYQQU( .UHKS/6O&^L77P^GU"SMH+*_@U,:;>+YQ8(PF6-O+8+SG(Y.,
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MLI6D,[]-QR!L7KQR2>XQST=%0W5W;V-M)<W<\5O!&,O+*X55'J2>!0!A>-=
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M1T/6M7Q)X?OO$T+VNKZ'IU[;/:KY)2XVR6MSN?)5RH.W!C^88.5/R\XKMJ*
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M?*P1+GS!Y;$MM&&Z')XK2H \XGT/QGJ5AX8MKVSTI9M&U&&>6<7C8N%C1UW
M>7E<Y''//M5FRT7QAX<UK4[?1QI=UH^HW;WD<EU*ZR6;R'+C:!\ZYR0,CZBN
M^JK)J-E%J,.GR742WDZ-)% 6&]U7&2![9% '-ZKHFKW'C3PWJD"0S6NE17"3
M/+-MDD,B*N0 N."N3R.M4+;1O%_AW7]5315TR[TC4[M[Q6NY71[25^7X .]<
M\@ CZCK7>T4 <E;Z'JT/Q&&MR"&6Q_LA-/,C2XE9UD+[RH7&#GUJ30M&U.Q\
M:^)=4NHK<6>J&W,)28LZ^5'L.X;0.>O!-=310!Y_X;T/QEX;B_X1R%]-ET2*
M1OLVH-(PGAA+$[/+QAG&2 <XZ=>E$'AOQ'HE[XEL]-ALKS2]:FENXY)K@QO;
M2R+AP1M.X9 (P1[^M=^S!5+,0% R2>@JC9ZWI>H1K)9ZA;3QM*T*O'(&5G'5
M01P2/2@"EX-TR]T7P?I6EZB(!<V=LD#&"0NIV@#.2!6Y110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !61K^N+HL%FJ1":[OKI+2VC+;09&R<L><*%#$\'I6O7,^-O#EYXATNT;3+
MJ.VU33KN.]LY)03&9%R-KXYVD,0: (+WQ5J'AZUUNZU_3@+33XXY+>[MCA+H
MOP$"DDJP;"]2.0>*==>)=1T36='M-9M;86^K2?9XIK=V_<3XRL;9^\#@@,,<
MCI5;4O#>M^,/"FHZ;XDFL[.2YB5(8[!F=(G5@XD9F +'<J\8& #R<\2OH6LZ
M]/H3:_'91#2;@7;FVF9_M$ZH54@%1M7+%NYS@>] &7+XZ\0-HGB/4X-&T\+H
M5Y-#.CW;'S$B56.PA/O$$G) '08/.-%/%VIIK^@P7.FVT>FZXK_966<M-&RQ
M^8/,&-O(!Z$X/<U1C\(ZZ/#/C+3673_.UVZN9H&%P^V,2H$PW[OJ,9XZU:N/
M#>M377@V8)8 :)DW(-P_SYB,?R?N^>N><>GO0!0?QSXHGT[7;ZP\/6$B:+>S
M07"->MNE2,*3Y?R<M@D\X[ 9.:U!XYBU(64>D!!)<Z?'J!>XC=Q&CY"*509R
M2K9Y&-O?-87AB+5[NW\=6-A#:;+G7+R)9Y92#$S*@)*A3N !!'(R>..M79O!
MFM>'=0TK4/"$]G(;73H],N;34&94GC0DJX90<."3VQS0 H\?ZNUAH$Q\.F&X
MU*^:QEAN)6C,<@#$%<H,H0N=WOT-6$\<7UE#XJCU;3H/M>@QQSD6DC.DL<B%
MEY*Y&,'/'O4FK^'_ !#J<OAVXEEL);BPU 7UR/,=$'R,OEQC:20 W4XR03QG
M@70?$-MXE\3:M:?V<#J4=LMJ))G.#$""'&SHP8],XH N6OB.^GTN^U&UAM-8
MM8[03VCZ:Y_TB3YLQ8).",+W_BZ<8JOI_BN^G\5-X=F6PDNVTXWBO!(<0R!@
MIBD')R"P.>/H*R)OA_?_ /%0W&BFV\/RZG8" 06DS&,S[B3*<*-O'RY49P2>
MM7=,\-:_#XNTC698='M+>WTU[&6UM7=A&"ZME,J <[>^,9_BH R=)\4ZU'\(
M+[Q%J-K8ZDR&YD:*1V4.!/(&!!4C X 7T'6NME\12RZS8Z%I\<(OY['[=*TN
M=D$60HX&"Q+' &1P"<]CS<7@KQ!%\,]4\);]-8R^=':S>:XRDDC/N?Y/E(W8
MVC/UK4G\-:M;^)-)\2V M6O8;#^SKZT>9@DL6=P*/M^\&YY7D''% %#4?B+>
M:?X:\0W1TN ZKH,Z0W=N9R$97(V2(=N2&!!P<'@\^NQ;>)-4B\:P:%JFGVT,
M-[:R7-K)!,79=A4,L@( SA@>,CMSUK&USP)J>J>'O%"Q-9KJWB":)I-\K"*&
M./:$4,%)8X4\X'+>U;-WHNK77CO1M<\NR2UL[6:"9//8N3)M.5&S! V]R,Y[
M4 5=)\ 6^E7>@3(Z'^R)[Z1,9RPN&8C\@0/PKH/$=_?Z7X>O=0TVUCN[FVB:
M40.Q7S HR0",\XZ5J4$9&#TH XH^.)1J?A*,+9FQ\0Q%EGWL&1P@<*%[YS@'
ML>M-\3^*;[3?"6NZN=,L;VTL[CR8HY9"!*H<(S$;2#AR1CC.TG/(%9W_  K2
MXB\*ZEIL%Z@NX[KSM&E/2S1)3+$O3LS,"?0@=A6UXL\*W>J?#N;PUI3P>;)%
M'$);ERH^5E8L<*22<'\30!!J6J:VOQ3TO2[>2V%@^G37'EL6!8AT4DX[C/ ]
MSGVYK3M:U;P]9>/-3TW3[2XM[+7+BXN!/,4+*(XRRH #\V 3DX'3KSCK]1T/
M6)O&>CZ_:?81Y-G+:744LC_('96W(0OS8*]#M^M9(\(:Z?#GC/3B-.$NO7,\
MT#"X?;&)$5,-^[ZC;GCKF@#6O/$;#Q7X6LUT^"2WU:*>2.Z=_P!Y#MBWD!<<
M9R!G/KQ6//XY\0_V=XFO+?1=/VZ!<R),)+MOWD:(KG9A/O8)Z@ <=><7Y/#>
MM2:UX.O=E@(]%AECN5^T/ER\0C^3Y.<8SSBJJ^$]=_L;QK9%=/WZ]+-);D7#
MXC$D0C^;]WVQGC/I0!VUA=IJ&G6U[&"([B))5!Z@, 1_.N LM2UK4E\?1:B]
MJ]O:M+;HB;OD46X( ![<Y)]2:[?0K6XL- T^SNQ$)[>WCA?RG+*2J@9!(![>
ME<Q'X9URTO?%JVYT^2TUEFFA:25U=7:(1E6 4@ $9R"?3'.0 9/A7Q)JFC^'
M? EO<V%M_96I6\%DDBS$S+)Y.Y6*XV[3M/&<]#[5I:EX]NX[.[U#2=.^W6]I
M=-;FV2.5IK@(^QV0JI48(; .<@=1G%1'PCKHT#P7IX&G^9H-Q!+.QN'Q((XV
M3Y?W?4[L\^E.T[P]XP\/:E?V.D76ER:'>74ES%)<[_/LS(VYU50,.,DD9(]Z
M .Y$K26HEA3+,FY%DRG)' /!(_*O.O\ A8FN#P:OBEM%LA8PW;0740N6,A43
M^5F/Y<'''7&>>!W]'"M'!M3YV5<#>WWCCN:\W;P/K[?"Z[\+_P#$M%Y-=M,)
M?M#^6%-QYW_//.>W3WH Z"#Q-J=OXRCT35[&T@ANK.2[MI8)V<J(V 99,J!G
M# Y'';GK6:OCZ\FBTK4K33&NM-OYT0Q0PRF>&)_NS$[=I&,$KVSU-:-_H&J7
M_CC2]8>*S%E;V4UK/'Y[%R9-N=HV8(&WU&<]JSO#&@>,M @A\/M>Z9+H=LVV
M"]^?[4( <B/;C;NQ\N[/ [$T 2:YXWO]#6:\NK&W@MHM12T2VFDQ/<1%E0SI
MVQEN!@\#J*M7/B779?&&H>'=.TRQ,EO9QW44\]RP4AF9?F 7(/R]!GZ]JY_4
M_!'BF]TG7M/$NE2M>ZDM[#>322>;(BRJZQ. ORA0N 06'; SFNCL]$UJ#QW>
MZ_,E@T,^G16H1)W#;T9FS@IP"6QU/2@#+E\=2W?@/1/$']CVT@O;V*VFAFER
M(7\[RRR_*=V&!(Z=JTKOQ+KC>,[SPYI^F6+216"7D5Q/<L%(9ROS +D<J>!G
MZBL*+P/X@C^'FF>'O^):;JTU%;MI/M#[&43F; _=YSSCI[UT,6BZLGQ"N?$!
MCLC:RZ8EFJ>>V_>KL^3\F,'=CKVS[4 4;7X@-<^$-$U0V*QWNJWZZ:L)?*1S
M;W1B6QDJ/+8CN>!WS6AI'B/4KOQAJGA^ZLK4#3XXI6NXYF!D60$KB,J<<J0<
MO],UR%QH>IZ1X+TCPK<-H[ZI<ZH\T"23R!)%$CSG#A0T;#(&Y03Z=>.C\,MJ
MVFZ_)9:KHNGP37T9F:ZM+^2X=RF%'F>8H;;@X!R0.F.: -KQ!KPT9M/MHHEF
MOM1N1;6T;-M7."S,Q]%4$\=>!WS5&V\27R^*+GPS?06ZZA]C^V6<\9813IG:
M00<E6#8R,G(.:=XP\.76MC2[[39HHM3TJ[6ZM_.R(Y.,-&Q ) 8'J <46VB7
MMSXK/B6_AMXKB&Q-G;6T<Q<#<VYF9]HY)"@  X )YS@ &%\-[>;5-#NI-6M[
M*YC75[J=&92[K.L[889&!CL1R*N^/;/78[W0_$&B6*:F=)DE>;3F;:TRNH7<
MA_OJ,X_WC]*O>!M$U/P_H]Q9:D+0N]Y/<JUM*SC$CE\'<J],XJ]JT&M_VO87
MFE&UD@BBF2YM[B1D\S<4*E2%."-K=1WQWR #G?#/BSPMJ\VL^([026=]!:J-
M4M9XO+FB$6]LLO? +#//0#VJ:W\::C)J.C9TLS6.IL$;R(I3)9EAE2Y*[67L
M2,8]Q2_\(;+K'B/5=:U:&WM/MVE-I7D6TA=F1CEG=MH^;H ,' '7L#POI?C7
M38;32=5N]+DTZR"HEY!O^T3QK]U64C:IP &.3QD=3F@"6+Q3J^HZ9!K6CZ5'
M>Z;+=^2L*OB=X@Y0S GY0,@G;W'.1T$.AZIKUW\0?%5G*UI);6*VR11;F7:&
MC=UYP>26^8X[# XJMX=\->+/#:2:!:76G-X?$SO;W3%_M,$3,6,87&TD$G#9
MXSG!Z5JV.AZMIWCK7-6A-E)8:I' Q#NPE1XHRFW 7&#D'=GCT- &=I'C@/X-
MTW4/[,@M[S4=1>PMK.)\1^;YKKDMCIA68G'X<UI)XEO[7Q3_ ,(Y?VMLUW<6
MK75A/&[)'/M.&1@0Q1AP<C<"#VZ5SUM\/]77P5I^GO<64.KZ5J;:E9RI(SQ,
MQD=]CY4$ ARIP#Z^U=$NBZA?^)K;Q#J%O:PSV-I)!:6T<Y<%Y"-[,^P8&%
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MS1"&9F=-L83# H!SC/!H U/$.MQ>']*-[(AD9I8X(HP<;Y)&"*,@' R>3@\
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M&K'2;2*Z?2F\MX625FN9 @=D0JI"\, "<Y.1@#DYUIX,\16>B>#55],>_P!
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M?RY#N(;@D=%Y'2G_  _O]9U%_$$NJ75O,L.KW%N/+C92"FU1C)("X'3KGG-
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MIVTZYMQ.I,-LW_'NVW/'*[V]#(17LM !2,RHI9B%4#)). !7/W&NW-WXGN-
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M %%%% !1110 4444 %%%% !7/^,M N/$>A+:6D\4-Q%<PW49E!*,T;APIQR
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MIX=U.^%[?Z%IMU=#'[Z:U1V..F21S6NJJB!$4*JC  & !0!RC>'M2TOQK?\
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M[ ''. #DX.1C!PHO ^NQ?#74_"/VG3G67SH[:;+K\DDC.6?@\C=C _.O1:*
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M*Q$YV@= 3@G''';J=.CU9+B_.I3VLD+3DV8@0JR18'#YZMG/3_\ 4 :%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
,0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>sangamoexecutiveseveranc009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"LJJ>JD]5/N#D?A6E7%?"2RGL/A?HD5PA1WC>8*>RR2,Z_\ CK"NUH ****
M"N&\=W=]9Z_X3CL[^YMH[[4UMKE(I,"2/:3CVZ=1@\UW->??$.0?\)'X,VI(
MXM]66:8I&S")-I&YB!P,GJ: -ZZ\;^'["[O;&2[F>ZL%5IX8K:65U!S@X"DL
M, DD9 [GFMK3]0M=5TZWO[&99[6XC$D4B]&4]#7%Z7<0Q_$[Q9<R96"2QM%2
M4H=CE!)N"G&"1D9 JW\*5>+X::+!+&\4T,3))'(I5D.\\$'D<$4 :/B[Q3'X
M6L;29[>>9[J[BMD$<3.%WN 2=H]"<#J3@ 5@77B#[!\4HFGO;_\ LZ;0FG6S
M,4A)D\Y0-L(7<6QGC&<9]ZN_$R.4^'K"XCAEE2UU:SN)A%&798UE!9L#).!Z
M55%W'-\8;6]V2I;'0'C\R6)D <S*P4DCABHS@X..U '36GB?1[[0XM9MKO?9
M2ML1A&VYGW;=FS&[=NXVXS4FE>(-.UFXN[:TE<7-FP6XMYHFBDCR,J2K '!'
M(/0UY/#'>P>%HM1AL;VYATWQ/<WES:P!TF:W<R*'0#!. ^1CKSZ&N_\ "<NB
M:G?W6KZ-I]VHEB6.6^NTE1Y2.B 2?,P7N>G( SS@ ZJ21(8GEE=4C0%F9C@*
M!U)-8T/BW1YM0BL1-.EQ-$TUNDMM(GGHHRQCROSX'.!DXYQ3/&VFWFL>"-:T
MZP_X^[BTD2)<XW$C[N??I^-<UX:U/1/$E_IDJZ'JBZQ99:47RS@6#%</AG.T
MD] !R>X !P =19^+=%O]"N-:MKF5]/MBXEE^S2@J5X;Y2NXX[X%2:AXETW3(
MV>X:X.R$3RK%:R2-%&<_,ZJI*C@]<'@^AKE+71KZQ\>ZCHT5NQT'4I4UAI/X
M8Y%.)(_JT@B;'H6JEJ5Y;^'_ (@:W_PD-GJC:;JRP26=S:"=TRL8C>)EB[Y&
M1QW- '7S^-O#T$ME$VHJ[7T)GM?*C=_.0#.5*@Y/(X')R.*S]7^(>EV?@G4/
M$>GK/=K:LT!B^SNK),.-LBD H 2,YQP?<5BFVMK'QMX%BM-->PM+>VOAY&TD
M6XD"[ YZ*QP>">N1S6)J5M<7W@KXF6]K;3RRSZDT\*+$V98\199!CYA\K<CT
MH ]?M+J.\MEGB654;.!+"\3>G*L 1^58WB:\TVV;28K_ %2\L&FU"%;?[*6'
MGR9^6)R ?D;/(.,XZUJZ??0ZE8Q7=N)1#(,IYL31L1Z[6 (_$5R7Q(/[CPV%
M1W,>O6DSA$+;8U8EF..@'<T :=MXO@NO&U]X=6UNE-I#&YE-M)AF<MW P% 7
M[QP">G2NDKAK.1K/XO:L9;>XV7^G6HMY$A9D?8TF[+@;1C(ZD=:[F@#F=)UG
M18QKU]#K%W<Q079%T+G>5MGVJ/+C4J#CI@#.2>*U[#6+34;FXMH1.D]NJ-+'
M- \9 ?.T_,!D':>F>E>=VB6-Q:>/H=3MKN2QNM65L0HX=HR(E\V/ RVU@6R,
M_=K;\$-JUOK.I:?<:G_;>E10Q-:ZH\8$N26S"[CB0KUSU&[GK@ ':7%Q#:6T
MMS<2+%#$A>21S@*H&22?0"LI?%&F'S=WVN,Q6YN6#V<H)B! W ;<GKT'([BI
M_$(MSX;U07=M)=6QM)1+;Q@[I4V'*C'.2..*X7P];ZG;ZC=:/9:K)KFA/I<A
MMY[E/W]DY("PM)@9R.<'D;><8Y .R_X2S1?LFDW7VMOL^K.D=E(()-LK.,J,
M[?E)P?O8Z5Q]AXQM/#GBCQA%KFJ7DEO;W</DJR/.84,*LQVHIVH"W7 %<_;Z
M@)?!/@"PCLM1:YTS5K-;U!92YA**X8'Y>?7C/'X5U.EWMOHWC3QH=3AF1;V6
M"6V0V[-]J00*I"<?.<@C:.: .M;Q%IGE6DD,[7(O(C/;BVC:4R1C&7 4'@;E
MY]2!U- \1::UA:7D<LLD=V";=$A=I) .3A,;N.^1QWQ7FMEX8_LKPUX:TZ]U
M.[T'7;.UGDM]0B.Z*+?)N,$N?E8<KP3SM./<FO\ 5K-O"WB7Q'I=W]D-I<6E
M]_9Z2(;=FD5DF*)A@KA 2.V>F<"@#T6V\5Z+=Z2VI17N;=9C;L#&PD68''EF
M,C=OSQMQFHXO&&CRW%Y;>9<I<64/GW$+VDJND?9MNW)!]L]#7":I]ET^70_%
M&DZ+>KHD&JO<WO[J0S3;X2GVDQM\^ 6/)&3UQC!J]9WD>N_$C79;%)C'/X=B
M6(RQ-$7S)( 0K $#)[@?ES0!V'_"6:+]DTFZ^UM]GU9TCLI/(DVRLXRHSM^4
MD _>QTHU3Q7I&C^>;R>58[<J+B6."21(,XQO900O!!YZ @G@UY?;Z@)O!/P_
ML([+46N=,U:S6]064N82BN&!&WD]^,\=>U:,5Q8Z7KGB'0_%&EZM.-0OI;BS
M,"3R17D4H&(\(=NX?=.[ Z9H [J[\::#9ZB^GR7CO>+;BY$,,$DK/&3@% JG
M?G_9ST)[&L_5OB!IEIX>TS6+ 37MOJ-W%;0O% Y"[I K;AC((^;Y>I(P!UK,
MT]([+XK0?Z-]EMX?#26V!DQQ.LN[RP_0D+^@S7,11S+\-K5_LMR19^*!=S((
M'+I#]J+;]N,D;2#P* .SO-0N/^%H:"L5W>"QNM-N97M7#(N5*8)C(!W?,>HS
M6[I_BK1]4TV]U"TN97MK%WCN6:VE0QL@RPVLH)([@"N<O[E;GXJ^&KI(YA#_
M &=<J7>)E"ERA0-D?*3@X!P:JZGH][:>/9],LX]VC^)T$]Z >(7B*B4X])4*
MH?<YH ] M+J*]M(KJ N8I4#H71D)!Z95@"/Q%0:AJUGIC01W#L9KABL,,<;2
M22$#)PJ@G '4]!WJ[7 ^(;J70?BCI>N7T,[:-+IDEAYT<32+;3&0/N8*"0&"
M@9]J #P/KPED\775[J5S+9VNJ%(VN]P:)?+3Y-I *_,2-N.O;-;S^,M(7[?'
MF[^U6-O]IEM&M)%F:/LRHR@L,\9' /7%><7$5_?V'C&?3=/OIGCUZWU%(/(D
MB-S%'Y194) ^;Y2<#G@>U=-IL^A^)5O+_1=*U![P:?+ ]U>I,K1[AQ"#)]XD
M\G;D#'7D9 -[0?%]IJOA6PUFX26W-TD9$1@DRSL,A4!7,GU7(X)HE\=>'H-,
MO[^XO7ABT]Q'=I);R+)"QY 9-N[GL<8/K7GT<]S#X$\#ZDNG:G/;:&5BU*WB
MBEBF3,)C9E'#-L)YQQR??%KQ/_9&I_#WQ3?Z#I=YOO[>.+[3-%-YMXX/"A7^
M=@H[XQUQT- '9M\0O#"2F.3460_:H[0,]O(JF1_NX8K@@CG=G&.<TY/'GA]Y
M;N%9[K[3:[=]L;*83,#G#)'LW,#@\@$5C>.YHY]*\*/ KR1KK=E.0D9.V-&R
MS$ < #KGI4D$T:_&2^N3D0'0XHO.*G8765V*[NF0I!QZ4 7M8\1^']1\(VVI
M'6[NUTZ[EC\F[LMZ2%A( $X4D98;2"!W'%7[[QAHFG:K)I<]S(;^.#[0;>*W
MDD=DSCY0JG<<]AD\'T->8D/_ ,*5>T\B?[3_ &QO$'DMOV_;?,SMQG&SG/I7
M8^?%_P +F%UD_9_^$?\ +\_:=F_S]^W=TSMYQGI0!T=IXGTB^T.#6;:[\RRG
M;9$RQMN=L[=H3&[=D$8QGBDL_%.CWD6H.MWY)T[_ (_$N4:%H!C<"P8 @$<@
M]#7E=LEY;>$]/U..POKB#3/$5U<W=K KI-Y$AE42*!AC@/GCMGMFM+Q%:VOB
M#PCJ^I>$](O9I6-N\TTZ2K)>K'(&,2B3YFPH^AZ#/. #:O\ Q UW\3O"=M9W
M>HQ6]Q%=O-;2Q20QR*(LHV&4;N<_3C@<5Z!7FUYKUIKWC_P1J&GPWTEO&MZ)
M7-E*/*+Q* &^7CG@^G>O2: /,]$\:V/AZ]\4QZ_JUW*D&L/'&SI)-Y,7EQXS
ML4A$R3UP.OO7:'Q3HPU:PTP7;-=:A%YUH$AD9)DQDLKA=N,<]>XKC]*NH-*O
M/'%GJ5K.9KV_DFM[8P,3=QM"BC9QA\D$<=.^*AO/#&HZ'\*M#G4J=<\,Q+>)
M\W!V@F6+/]TH67\!0!Z%;ZI:76H7=C"\C7%IM$P,3JJEAD#<1@\<\$U%K^LP
M^']!O=6GBFEBM(6E9(4+,0!GMT^IX'4U!X:MIHM)^U7<9CO;]S=W"'JC/C"'
M_<0(G_ :;XQMYKSP1K]M;QM+/-IUQ''&@R68QL  /4F@#C]6\3RSW/@75OME
MW9V]W<$7<!1XHWS S_=8 N,XQU![9-=CIOBK1]5M+ZYM[HI'8,5NQ<Q/ T)
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MG:.5#C!4EP2W;!)QBM73+:32_B3HEO=.TAM/#/V2:YVG890Z'!;IDA2<=<4
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MNW1"N,?-@8]L9T)([ZS^*UC?SZ=</!<:&+,RVT1>*.83;B"W11CD$XSCUXH
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MNVLKE[<:!]G,XMG\EI?.W[-V,=/?]: -^P\2VFHS6:PP70BO8S+:W#1_NYD
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MC1HI-+U9%U0[1(]HRK;-P LV<%220!P<GVYH Z*N8U[Q6^D>*=#T9+"YF_M
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M16FH2"*SO)(L0SN?N@'J-V/E+ !NV:BN?'6DP7FJ6:0ZC<76F!#<PP6;LP#
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M+AM/@6YO3;Q[A;QMDAFY&>%8X&3@9Q3;SQIHUE>Z?:/)<22ZC"T]KY-L[B5
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M=_+!W#KM4GL1QGG%=-H&BVVBVDJ6GVI(;B4W MYY-X@+ 91!SM4$= 2 2<4
M:M%<I!XFGO\ QUJ?AQM-NDMK6VB8SJRC)<M\V0V0N% &.<YX'%<QX#\86FC>
M"],BU%=1E26_GMWO3&TD<;M<.$$CDYYX&><9&<4 >I45BZKXEMM,-V%M+N\-
MG&);H6J*WDJ02"=S#)P"=JY..W(SH:=J-KJVFVVH6,RS6MS&)(I%_B4C(^E
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M:')I,MW);0RNCN\: L=CAQC/ Y45LQAUC42.'<#E@,9/TK)\0>)M/\-)9OJ
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M\#_/I57[-=Z+JFC:Q>^%[O6--N-%M[&>*.S\V>TFBR<^6W.T[B"1Z?3/K5%
M&5X>ACBTI6BTB+28Y7:1+1(U1D![N%XW'J<=,X[5JT44 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5R'Q19XOAQK=S#++#/!;F2*6*0HR,".000:Z^N4^)-K=:A\/]7T^QM9KF[NH
M/+BBB0L2<C\!^- &78/X7O(-$M+?5G;5+DQM'Y%_([;T3S&W#?TPA!!XYQ6S
M>>-]/T_6[S2;NTO8;BVM&O%+J@6>,''[L[OF.>,<&J\>KS1:'81Q>']2FU"W
MCC6%)+<JJ2[-F68G  W')';.,UF>,](O_$<DEY9P2V]]X?(N--D>WS]IGX)
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MV5+#4;N232;:46D'[QPQ=]WWFVKC _BQZ9K8\>V=[.WAR]L[*>\%AK$5Q/'
M 7$>QU) )&<%A4&GI=Q_$W5M4GT^\BM)M+@B63R2P,B,[,HQG.-PYZ'MF@#9
ML_%VFZCHFF:G9+/.-2XM;=5 E=@"6!!( V[6R2<<=>1F70O$EIKTM_;Q13VU
MYI\PANK6X"AXV(RI^4D$$<@@FO,;#0-:L/!OA*];P_)?3:+/=+>Z5-&-[Q3.
MQW(&X8@;2 /7'K7I'A<I-%/>0^'?[$@FVA(I84BGDQG+.J$@#G !.>OJ* .6
M\;-;0_$OP?'=7DEM8W:7OVL?:WACDV1J4W88#@FIO UW>3>,_$4-A=W5[X51
M8S:3SRM*HFQ\ZQ2,263KW(!QBI?%-I<W7Q+\)7:Z=<W%A8)>+=RK 61/-C"J
M/]KD<XSBG>'K'4?!.O7&AQV=S=>&;@F>PFB7?]A8GYH6'79GE2.F?R -34?'
M&G:7;_;9[:[.E+<?9I-114,,;[MA)^;=M#?+N"D9JSJ>NVS3WVEPV=[?R6\(
M>[6S*J8E8$@9+*=Q )PN3CZC/#:!IUYHJ3^&M0\$+J%RD\GV353;Q/;RQLY9
M7E<G((SR,$G'%;&F+JGACQOXB6;2+V]L=7F2ZM;JU0.%8($:-\D;,8&">,=Z
M *OP[\1PZ;X!\'6MY'<R2:INABF&&7S-SMAB6ST!YP:ZM/%NF_;-<MKD2VG]
MBHDEW).%V!'4LK*03GA3[UY[IFD:UI_@'P++-HE\9]%O_,NK5%5I?+(D&Y5!
MYQO''!]JL:CX?UOQ'=>/HDTNYLAJUK9FSEG*A6>)2=K8/!)P.,@9.30!W-OX
MLMI-:MM*NK&]L9[N!KBV:Y10LBKC=]UCM(!!PV*@;QOI\4^E^=:WD5EJDHAL
MKYU3RI7890<-N&X#@E1FJNFZOK/BG37L+OP_?:/(UN\5Y-=A0@<H5Q%AB6^8
MYS@# ]36#X/@O+>UT_0M1\")#J=ALBDU)K>(VS(F!YJOG<7('  SD\XYP 7_
M !_X@@O/ _B>*SM;ZXCM()89+NV8*D<P7I]X,P4D;L @<^AQUWA_GPWI9/\
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M@E21R4/3..,XJ+Q=HMQ=ZSJ6I:-:ZIIWB2#RUL[NT5C#?KL4A9OX,!BRG=C
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M<2R;=DH>5F4I@Y(P?04:O:W]O\3='U:'3KBZM#I\]F[P[<1.SHP+9(PN >:
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MA-<MIUIJLWBOP=J[:#J^Z*WN8;^>[*[Q(Z(,D;OE0$-@  >@K-U'3-=7X?\
MBKPQ%H%_+>2ZC-/#*JKY4L;SAU*MGDX[8X[XH ]*U'Q-!87-];Q65W>R6,"W
M%RML$)C5MQ7AF!)(5C@9Z>XJ6]UY+:?[-;65S?W8@%P\%OL#(A) )+LHY((
MSDX/H:XWQ;I+ZM?W.HVEAK.E^(+>V7[!?6:D^<<9\F7:2A ;@[L#!Z\&H=2L
M]5T?Q7%K6I^&3K]KJ&G007:VD*2R6UQ'NR55L?(=YZ'M],@'>:!KMAXET6WU
M;39&>VG!V[EVLI!(*L.Q!!%:59NA1&+2H\Z;#IN\EQ:1*H\H$\!MO&[')QQG
MCG&3I4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(\JP 8\!,= ,YZ9J[!XJ5]8L]-N=*O[62]@>>U:15(<( 64[6.UL$'!_//%
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MFG6WD2/[1!<DX\B5/G1\]L$#/MFE\'07H\/Q7^J*JZGJ.+N[51@*S* J_P#
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MUTN@V5[!\1O%5]-93QV=[':+;SL!M<QHX?OD<L.HYKKF95&68 $@<GN:6@#
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M&WK@G:#GJ>F*?0!Y?I&GZMX?O;_0Y_!T>J)+>336.I@1&/9(Y?$Q;YAM+'.
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MBV4\%[/=S1M+YC;#N<[B=O#8Q^"@8K7'AF_@^(ES/ JC0=0$5]=+GI=1?*H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %9.O^'[3Q'9Q6M[).L,<R3A87"Y=2"I)QG@C-:U% "("J*I8L0,%CC)]^
M*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ K*U_P_:>([*.TO9)UA259@
ML+A<NI!4DXSP1FM6B@!$4JBJ6+D#!9L9/OQQ2T44 %%%% !1110 4444 8^N
M>&=.\0-:RW8N([FT+&WN;6=X98MV V&4C@X&0>.*FTO0[72BSQR75Q.PVF>[
MN'FDQZ L3@>PP*TJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)90./RQ2>'=8U+6;>:;4-!N=("E1&EQ*C-)Q\QPO3!R.>O6@#:HHHH ****
M"BBB@ HHHH **** "BBL/4/$?]G^+-&T)K*1O[368I<[P%3RTW$8ZD\CTZT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMZM]BU+39IKF-KHGYT= "A_Y9Y#$'9M]L5T5YX.T^^\*P^&YY[MM/A6-5 D
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MSEGD(ZL2>YKF+,#Q9XFL=5N=!O;!-&,ZPOJ$01WE?"Y0 G*;03GN2N.AKL*
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M^OHY-/N-DMI:-=R7$EN0,/\ .X#%2<$#G%9_CF2_7Q!X3M[/5+NRCO+YX)A
MP 9?*=L].3QQG('I70:#X>MM @D2*YO;N:3'F7-]<--*P&<#<>@&3@# Y/J:
MYOQ]:S7FO^$EBAU I;Z@9II[2!W\E?+8!B0I ^8C@_B,4 8%\^J^'KWQGH::
MSJ5U:0Z"VK64\]RS36T@#KM\S.2,KG!]/KG7FU"^%U\.)1?7(-\-MT/.;;,/
MLQ?YES@G=SGK760^'+!$U'[1YEW+J2>5=S3D;I4VE0GR@ * 3P .I/4DUDVW
MP[TBW_LHO=:I.VEONM&FO&)C&W:%&,84#CCKQG.!0!B^&=-OM;UOQ$;KQ'K*
MIINMLD"17(4;?*0[6&,%?FZ8P,9[FN7237E^#UKXUC\2ZJVJV1>81R3YAE03
MLI1T_BR.YYZ 8'%>JZ7H-GX>FU*]@FNY#?2FYN5?]YNDP 6"JN<X &!Z=*Y#
MX<^&//\  .FV>KKJ4:Q3/++IMU&8TWB5G4D,H8C[K8SMSVH T-,NY?%GBKQ+
M87EQ>6L.F"WA@AM[AX60O'O:0E2"22<#.0 O3DU@V&O>)[[PEIUW);7.J_V?
M?7-MJ$5G-Y-Q=1QDHLJ;2-V#C*@\FN\N_"]I/K;ZQ;W%U8W\L0AGEM74><@Z
M!PP()'8XR/6@>%K&&'3X["6YL/L"NL!MW&</C=NW!@^2,G=GGGKS0!QMOXF2
M^MO#&G:1?7%S;:G=7@D>\N)()@8]SB!GPSJ5W >I"#G!JS/IWB_2M+U:&WNX
M[[-U#<6E@+]VN!!G,L0F<!OF"G:>H&X9XK=O_ 6A:EHG]F7$4V!=->BY24I.
MMPQ+-*''1B2?;MC@5+!X.L8--6U6]U)YEF6<WLMT7N&=>%R[9R #C;C'7CDY
M *G@;6++5H=3-M)J4<T5P!/8:D7,UFVQ1L^8D[3@L.<<FG^(I#+XETRR6]NI
M-UO,YTRS=HGEY4"5Y R[47)')Y+# )%;.FZ-;Z9<7=TKR37=XRM<7$N-\FU=
MJCY0  !P  ._<U4U3PK8:MK5IJ\DMW!>VT;0B2UN&B,D;')1L=1D9['WH X;
M2=5\27GPXT6^C2YU62"]N%OK>*Y,=Q<0(\J#:_!8J0A/0MM]S78^"-4L=7T%
M[BPN[V>,7,BLE]N\^W;.3$^XDY7..O3%,L/ FF:5;00:==:A:BWN)+B)DN-V
MPOG<H# KM^8\$=\]>:V-*TBUT>&:.WWL]Q,UQ/*Y!:61NK'&!G@#@   4 <V
M]])K7Q'U#0+B>XALK#3XIEC@F>%I7D8Y<LA#84  #.,DGTQR6J75[J'PP\=:
M=J5S<7+:+<7%M;W)E96EC"AE$A4C>0&P<\'@GFO1]2\-6>H:O;ZNDUQ9ZE!&
M85NK9@&:,G)1@P*LN><$'!Z8J*Z\(Z9=>'+G0B9TM+MF:Y*2?O)V8Y8LQ!.2
M>OY=.* +NA6D=GHMI'&\S Q*V9IGD.2H[L2<>W2M&J]E:BRLXK999)5B4(K2
MD%L 8&2 ,U8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ J&[NX+&U>YNI5BA3[SMVYP/UXJ:N$^+5
MK'<>#HFD,F4U"TV[)&7K,@/0C/!/T[4 ;LWB-X?&]KX<:Q.VXLY+I;KS1CY&
M4%=N/]KKFMZO/-7TN*;XJ:'8>?=QP?V/=!F2X?S&'F1\>9G>/J"#[UC66OZA
MIOAMM.^VS21CQ7)HZ7%Q<-O6 ,2%,O+#. F[J >".#0!ZY17+:#H^J:5XDO9
M)]0C_LZ[A#1:>;F2=HY%(#.K/R%((R.F<>M=30!7O[E[.PN+F.$SO%&7$88+
MNP,XR>E4?#.M?\)'X9T[61!]G%Y"LWE;]VS/;.!G\JY.SF/BRX\9&\N;F/\
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M.<4S3/#^HVOB*[^T:CY>EWEKC^STOII'656&9$D.&48(! [D'O7*>%-+MV^
MMS*9+O<]E>,0+N4+E7EQ@;L >H'![YH [C1_$.I:K<6$O]B&/2K^T%U!>+<!
MB@(!59$*C:2".A89R/>NBKRZQN9-.\/^ -)M99%BU>W1IC->RJ&*VX81A^2@
M)(.%QG;CH33M5DUGP?9W,,^KA;+4=4LX8E$[RR:?#*Q64B1^<':=O]W)QTH
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MCU7H>X- '1>%_$;^(H]49[(VCV&HRV+(9 ^XH%RV0!C.[I[5O5XM/:2+X/\
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MLLRWR2 8!1@%5LG(QTS@<<5Z!0!EZYK<6B6]JSIYDUY=1VEO'NVAY'/&3@X
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M)%4@-_7OFNIK,O\ 68[>SU-[14NKG3X]\L'F;.=NX*6P<$CGIW% &DJJBA5
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M@LG)EV&/S'"[L8.[OQQ0!OUD7_AK3M2UJTU>=9EO+5&B1XIF0,A()5P#AER
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MQ;+=NO3 QB@#S*!+B'X46/B/^T]2?5+75=L4KWDA&TWIC*E<X8%2<[@2?7
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M44.3M7ID#K@9Z543X:^&4MTM5M[L6D=P+F*V%],(H7!R"B[L+SSQ0!TFH_\
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M &J0(6,C@]&X' X''?&:Y:&,:K\/?AY-J!:ZF7Q EMYLK$L8Q+,N"?HBC\*
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M\K1@$*3@'!Z]ZXS4C#XG^ ^K^)+[,FJS^=)))N.Z$K,5$0_NJ% &WH>IY.:
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M9)]N>3PH!YQDD=: .]N[^VLGMH[B54>YE$,*GJ[D$X'X G\*C6743K4D36T
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MU,1*['+$G=GD]?6N@KFY?$TUYXBNM"T2UCN;BR16O;B:0I%;EN53@$LY'..
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M)GG\L1":XG>9PF<[0SDD#..!UP,TJZF-0L-0?1WAN+FV:2!/,8B,S*/NDCG
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M_B"T74'LA^[EDE<O&?029#D#@9)YP">:Z"PL+32[&&RL;>.WMH5VQQ1C 44
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MX-9D^$]UJ4,=W/<6TBS23*&:0"U)^8GKSS]:])7PQI"W&HSK;.)=1 6[<3R
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M*RO>(9(Y9(\")'&Y<Y!; )Y*C@FN_P#"6A'P]<:K:+JB7,4DRSI9QPF..SW
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MASG@5=U+_D#_  O_ .OVU_\ 29ZZY/!?AV-;]8]*AC&H(([H1EE\U< ;3@\
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M!?A^2QO[*2PWVVH2^==QO-(PF?(.YLMUR!S["DU7P3X=URSM+74]-6YCM/\
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MW@.<]3B@#TH$'H0:7..M><>$6GTGQ7:Z/KFAVUEJHL)$MM0L"/L]]$K)N)&
M5<84\_WCZBKOQ8MTF\)VS,75EU*T"LCE2,S*#T]J .YW#!.1@=32@Y&1TKS3
M5M/TW0?&.B:%;)9V.EZD+JY*74;30SW?[L#(+@9V[L#.,GIG!JE?6L?A1;#1
M?[6$NE:AX@5+N-$\N*V5T+BW7D[49@N5ST..C4 >KA@>A!^E+7G*:7IMO\7K
MVRM;.VCMY?#FZ6WCC 0L9\9*CC) 7\A7-VK1-\)_AU,[(9QJ]DJ.3\W^N.X
M]>W/TH ]=0ZG_;4PD%I_9?D+Y14MYWFY.[(^[MQC'?.:N9!.,BN$M+2%OC%K
ML+*3'/HL#2+N/),C@]^. *X[0]/@TKX(#Q5912?VW%8SQ"[$C%TB,Y#X&<<
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M)#=?NP!YZDQQ,/7*;G/OM-8EU96Q\ ?%&%H4D2'4KEXQ(-^QA#&01GN.Q[4
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M1:)\.KEX8X1!;>,/W+J!MCC^U*!M/88P/I7;JEJ_QPN(U6$E_#F)E&,D^?\
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MM(K6V0LRQ1+M4$DD\?4F@"W1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN!(LJ-GHS!<$%3D$?G0!U%%<-9?$.6ZM_#U]-H4UOINM2)!'<-<*2DK@E1L
MR5."-W'TQ@G7TOQ/)?>(=9T:YL5LY]-5)-SSY$R."5=?E'R\$$]CQ0!T5%9^
MB:C+J^C6VH2VWV;[0@D2/?N.P\J2<#J,''O6A0 4444 %%%% !1110 4444
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M9(; &3[XKM+?PIX'NT#VV@>'IE)VAH[.%AGTX'6I_P#A!_"7_0K:)_X+XO\
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M70=;M7@=+:./(92\,J* '1E)Y!Z'\^M=.DL<N[RY%?8VUMISM/H?>G$A5))
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MB:P:!K4C,9@(*$>V.,5/0!Y?%X7UY/@G=>%SIA_M243QJGGQ[/WDS2!MV[H
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MCO+YVDGF+LY8L<G&XG:"<$@8' ]!0!KJH10J@!0, #H!2T44 %%%% !1110
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M] ;;&0&9/E.X\DX.!CN>UKPLOC>UM[31]7L;!(+)51M3AN=[7*)P L17Y6(
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M*L=/&J:#).\]IY4ZQS6P8Y,;*Y 90>A!SUR* -.[BTCP-#J^O)%Y<-R(MUM
MH&^7)5=HZ L74=AD9/4T\^)[BP\1:=I&LZ?%:G4E?[)/!<&5#(HRT;952IQR
M#R#5;Q5X=U/Q;X5O+.26*RNV>.:S3.]8GC;<N]@.<D8..!VSU*3:3J7B76-
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M)!*G<-V#T'Z5LZGXGU*U\8Q>';+2(KB2>Q>ZBGDNMB_*RKAAM) ^;J,GIQZ
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M9O$6EZ+J>GP02ZI9/<K$DY>2W*A28Y4*C!PW7U!&.]<?X:\1ZMX7\%W]_::
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 2C>=OWL#OCOZ5H4 <!-IOB_5]9\+:A?Z;IMO)I4TCW.V]9A+NB*%E 3@<Y
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M*R;E0,-JX4\G=WQTIEMHVKV_C_4]>,5F;2YL8K:-1<-OW(6;)&S !W8ZG&*
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M7,A&+>T8M'$H_P!I@"S')R< =!CC) (?%NMS^'/"VH:Q;VL=TUG$93$\IC!
MZ\@'\OUK!'C36++7M%@UC1H+?3-9816MQ#<EWCE*[E61=H W<XP3CU-7OB7_
M ,DS\1_]>,G\JK1:+J'B!?#,FI0V]O:Z6R7A\N4NTTJQE4Q\HVJ-Q8YYR />
M@"*\\;WVG76G&]T^"WBOM5&GI:2R[;D(SE%GQT*D@'&.A')J]'XC2'QKK5A>
M6-M;16&GQW;7JON=XB6^]\HP!M8XR:YAO!7BQM)@M)&TF:YM=;CU(WDD\GF7
MH64N _R?(0I"_P 7  &,<[LOA34+_P 6:W=WWV4:;J>DKIS&*5O,&-^6VE<
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M!HO,Y&>/3K[^U8MSXEUS5+[X?3V;VMM#K$;W$L+*S?/]F9L$@C*C=T]0#VH
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MZ5TZ^*M!9B%U>T*AMOF>:/+W=,;_ +N?;-:D,T=Q!'-"ZO%(H='4Y# C((H
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M?$?A74B+$1:1;30SJ)W)<R(JY7Y.@V9YQG/:L+5M+OM"\/\ BL7\^EQ'Q!J
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR-&<.$<$J?0XZ4 2T5%]I@\P1^='O+%0NX9) R1CUQS4C,J*69@JJ,DDX %
M"T5RGA?Q;/XB\2:]9&U6&RL%MFM7.=\RR*QWGT!"@@=<'GT&QK5QJL5O'%HU
MM!+>2M@/<LPAB4#)9MO)[  <DGL 30!IT5R7A;Q+JM[J^KZ'XAM+6WU+3!'(
M9K1F,$T4@)5ANY4C:00:UM"U<ZY9'5(PJ:=*3]E)'S2("1YA/8-C('I@D\X
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MV0V]LD>\>AP.15/3O#5M:Z++X>N[>"\T9<BWCF4/B,G(C93P=O\ "?0#N,D
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=_;M#\#_ !7%( UA;:G/'I;/SMMA<*%VD]L[@/:@#U/1_P"V&O[B2YU*PO\
M2WC4P/"FV1),_,IP2I7TYSV.>M6KMKP:SIPAOK6*U/FB>WD3,DYV_+L.>,')
M/!XJ[#%%#$$AC1$ZA4  _2N)\200#XL>"9O*C$LD=^C/M&YE$2X!/<#)_,T
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M4VM( =S?=&,]3@X'>O'HKZR/PZ^&"FY@,BZI8G&\94 ,&^F#P:Z'0= T:_\
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M F?1],DN9;E].M&GFB\B25H%+/'TV$XR5]NE-MM)L=+CD;2]-LX)2NT".,1
M@= 2!P/PKG;/4?$-UI6E:M9:EIFI6UW+!]H2&W8!(W=0QC8.?N@G.X=B>,8K
MI;W5=.TTH+^_M;4R'">?,J;OID\T 0:)HZ:1!<$OYMU=SM<W4V,>9(WH.P
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MB2+5--M+Z-&W(MS"L@4^HW XHGT72KIH&N-,LIFMP! 9(%8Q = N1Q^%7J*
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MD:;]H6X_L^T\]0%63R5W  8 !QG&* .3^&2QQV'B*"$*L,/B"]CC1>%1=X(
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MSV7BOQ_!H40ANGT"&2*.W7:3*%E"D ?Q=,?A4WA]_"WB#_A%=0M?$$]Q?68
MM+*)H%DBRF)$=%0,% !SGCCW&?0X],L(;MKN*QMDN6ZS+$H<_P# L9IMMI.F
MV5U-=6NGVD%Q/_K9HH55Y/\ >(&3^- '/?% A?ACXB)( ^QN.:30_"VFWEGH
M&KWCW%[/:6L;V@GE+1PDH/F51@9]SDUT]W96E_$(KRUAN(P<[)HPXS]#3K>V
MM[2$0VT$4,2]$B0*H_ 4 >+>(=5TVX\-ZC-8SVUG"GB5'>"63=</,MP@>0DG
MY!Z*!P,<C.*Z:STK1=7^+>O+<65E>02Z5:RA7C5T<EW._'0G[O/^-=T^C:7(
MUPSZ;9LUR09RT"DRD'(W<?-@^M/33-/BO#>1V-LET>LRPJ'/_ L9H X/PP;!
MKSQ[8W!MS(^J3-Y#XR4\B/G:>W'6N?TW4TTKP1\,;R_?;HB2XO';[B.8W$3/
MZ .<Y/ (![5ZZ^FV$DL\KV5LTEPH29S$I,BCH&..1]:0:5IRV+V(L+46;_?M
MQ"OEM]5Q@T <)XI@\-7/@WQS>:4(+F2XLFENIXY/,B:98F"XY*AP "<8/()Z
MU2O;+3KKQ=\-A=V]O(L^GW"L)%!$F(8RH/\ >P>0#7HZZ3IJ6"V"Z?:+9+TM
MQ"HC'_ <8KF=:\*37_BSP]=P6&FMI&F)<)+;R'&[S54#:FPKP5SUH XN^ATO
M0)_'H>R#^'I;VPC2WCD,,*W1VE_F'W5#&,MCZ8[5?AN;6X\?>*X;N^L+PW&A
MQ;A$ (W9?-X ).2H'J3]*]-_LVQ%@;#[%;?8R,&W\I?+(ZXVXQ3/['TS&/[.
ML\>5Y&/(7_5YSLZ?=SSCI0!Y+:6=G:^ _AA>0P0QW+ZI9!IE4!VW(X8%NIS@
M#'L*ZSPO/;0_$OQM;O)$D\EQ:&.,D!F'V8$D#J>AKK#H>D&*.(Z58F.,Y1#;
MIA3Z@8XJPME:K=F[6VA%R4\LS",;ROINZX]J ,;QI:Q7OAB>VEU$Z<9)H!%=
M;0PCE\U#'D'@C>%!![&LWP=J&J2Z[K6G:[86D>KVJ0&6\LB?*ND8/L;!Y5A@
M@@^W;%=;<VMO>0-!=013PM]Z.5 RGOR#Q3+2QM+"(Q6=K!;1D[BD,80$^N!0
M!S?BO3O#7BB^A\,:]%&;B2$W-H^_9("#AC&W4$<''?TXKB@WB?2-'\<>&(=4
MN-8BT[3Q)97C<SQ[U;,+,.KA1D=^GJ /5[O3;#4%*WME;7*D $31*X('3J/>
MG6=C9Z=;BWL;6"UA!R(X(PBY]<#B@#@-('A+Q)J'AW4[37I;ZZ@A=+:SC, *
M1LF'25$0$( ,8/ .,<D9Y"VT31[KX!W4R6D!U..XG6VEC4><LXNF$2J1R"<J
M !_>]Z]H@TJPTY[BXT[3;."XFY=HHEC,I_VF R?UKG? GA$^']#@@U2PTUM1
M@FF=;J ;V(>1W'S%01@/B@#D_$=_:O#XXLVEMK74(M'CCU"2Y?<]T_D.R+$A
M("@;OO#.2>G&:=%!I>K>)?AJTT=K=K-I-RLNX*XD*PQ<-_>P<\'H<UZA+IEA
M/=&ZEL;:2X,9B,KQ*7*'JN<9QSTJ,:+I0>%QIEF'@ 6)A N8P.@7CC'M0!YM
MXBGT>VG\9Z78)9Z:UMHT<$_G'_7+Y3F..&/("@!L$C/)QCO3+:_LO[1^%EW-
M=0>2-,N$DF=QM#?9HN"?7K7J$NFV$]V+N6RMI+D(8Q,\2E]AZKNQG')XI#I>
MGF&WA-C;>5;,&@3R5VQ$="HQ\I^E 'F]PEU!XF^* T1 FH'3+1X1",,9#%+R
M,?Q=/QQ4>J?9M1^&G@NYT(H+^.ZLA8F/[ROP)5/T7?N'L<UZ;%IMC!=O=Q65
MO'<R9WS)$H=L^K8R:;!I&FVMY)=V^GVD-S)DO-'"JNV>N6 R: /.+?2M,F\2
M_$X265JX2*' :-2%W6N6QZ9/)KK_ (>R&7X<^''9BQ_LZ $DYZ(!6M_8VE[I
MF_LVSW3C$I\A<R<Y^;CGGUJQ;6MO90B&UMXH(AR$B0*H_ 4 <7HL=O+\6/&$
M+I&X-E8AD8 YXDSD?B/SKCM)TM%^ M]J.C6,)UB-+U8[B*,&5$-PX<*W4?NQ
MT%>O#1M+$[SC3;/SI,AY/(7<V>N3CG-2VEA9Z>C)96D%LC'++#&$!/O@4 >?
M^(/LNH6OP_OO#QC\[^T;?[,8<9%J4/G+Q_"$'(]A67;Z9IKZ1\4MUG;$1SW(
M7,:_)_HRGCTY&>.X]J]0M-(TVPGDGL]/M+:63[\D,*HS=^2!S3!HFDJLJC2[
M(+-_K0+=,/WYXY_&@#S9K6TMM/\ A9=PPQ1W,MQ!OF50'??;-NR>IR<9]:])
MUO4+;2M$O;^\0/:V\+23*1D% .>._&:#HFDLL2G2[(K#_JP;=,)WXXXJ[)&D
MT;1RHKHW!5AD'\* /(]:\/Q^!GL_$W@74C';7EW"DFCI)YEO>"1@/W0[-@YX
MZ '& ,&[/>Z;+XR\7Z+XDULZ8+E8O)69H4CGM#"!A6D0]&\S(!ZDGUKT*#0]
M(M;TWMOI=C#='.9X[=%?GK\P&:?>Z3INHR127VGVET\)S$T\*N4/JI(X_"@#
MS6/1-%_X3KP=8B'[79_V-<HAO55GFC7RPF\8&[Y>@(X'8$5H^(HU\$>+]+UW
M3;$&SO[;^R)K:!,#S%&;; '3)!C] "*[N33+":\6[EL;9[E,;9FB4N,=,-C-
M3R11S!1+&CA6# ,,X8<@_44 >=^-]+@TW0?"<4@CDGAU^R+3E0"TC2[I&]MS
M$DTD&K:3'XZ\9Z3XHN;>W^U10B#[7((UELS%@JC$C@,7S@]2:[^[T^ROP@O+
M.WN0ARGG1*^T^V1Q3+K2=-OI()+S3[2X> YA::%7,9_V21Q^% 'G+W^FZ/XV
MTBTFU&?1]%DT-(M+FFV;<JYWH6E5L$IY1YP<  \\5LZ+9^#-&\/6-JU[!<Z=
M_:1?3Y;]XV5K@DD>20 ,!BV,#KG'%=??:;8:I (-0LK:[A!W".XB61<^N"#5
M35] LM8L8+&>"W^S1.K!#"&*@=D/\!QQD#."<8Z@ U:*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "HI[F"V56GFCB#'"EV R<9_D"?PJ6N/\ "]\V
MO^*O$U_+\T6GW?\ 95JAZ($4-*?JS,,^RKZ4 =/8ZA9ZG;"YL+J&Z@+%1+"X
M=20<$9''!&*E2>*222-)$9XR Z@Y*DC(R.W%>1>&O$6M>&/ =QJ5IH<%WI%G
M?WC73?:=DVSSWW-&FT@A1ZD$X/'>NK\7:NFEOX;\36;9BFO(;2<C@2VTX.,_
M[K;6'ISZF@#MJ*** "BBB@ JK?:G8Z9&DE_>06J.P1#-($W,>@&>I]JDNC.M
MK*;41F<*?+$I(7=VSCG%>/WVJ:GK7P3T[5=46*:>>^M9D:-B68FZ&1@@!?0#
M.,4 >S45R=MXLO+?Q/?:/KEE;6BPZ>=2BFMYS*/)#;6#Y488<'C(JG!X[NI+
MO19!IJS6.J2+'BW+O+:[QE&D&W;MZ!L'Y2>IZT =Q2,RHI9F"J!DDG  I:\\
M\:7#ZK\0O"GA.8G^S+GSKR\C[3B-241O5=PR1T/% '9VVO:/>.R6NK6$[+]X
M17*,1SCG!]>*T*S-8T&PUO3TM+J!,0NDL#!1F%T(*LOI@@?AQ68WB*_U&\UB
M#0K.VN/[*<0R&>4IYTVT,8UP#C *C<<\G&.,T =-17"+\1'OK7PO=Z5IBSV^
MN2O#^]GV/#(JL2I&TC@J03GMT/%.M_%GB6ZO-=TJ/1=/_M323&[L;QO(>-T+
M)@[-VXX(Q@#C.>Q .YHKA#\0KJ?3_"EW8:,LZZ^"JHUSM,3A&;;]W!&1][TS
MP>E.LO'&JK/KVF:GH!_MO2X%N8K6QE,JWD;9VE"5!Z\'(_PH [FBN2T_Q7>3
M^*[CP[-!8RWB:?\ ;5:"X.U3O"-$_!*D$CGN#T%8UG\1=6N/#NB^(9M#MHM,
MOKM;68"[+2QEI3&&4;<%00,Y()YX'6@#T:BN;M/$=VWCF\\.WUG!;JEJ+NUG
M64L;B/=M/&T %3C(R>HK0\/ZE<:OI$=_<01PK,S-"(W+!XLG8_(&-PPV.P(H
M U*K7NH6>FP+-?74-M$SK&'E<*"S' &3W)JS7->-M9.AZ5:W!TVWOXI+V"%U
MF?'EEY %<#:<D$Y[4 =+17)7GB;6?^$SNO#=AI-I)*E@MY%/-=LJ$%RGS (2
M.5/ SGCD5H^$/$!\4>&;;57MOLTLC21RP[MP1T=D8 ]QE3B@#<JM9:A9ZC$\
MME=0W$:2-$S1.&"NIPRG'<&K#%@C% "V. 3@$_6O+M6\7:DWPNU?5=+L+/3+
MB+4)+258W)V_OA&SJ0HRQ+9S@>O6@#U*BN6OO%%Q9:Y9Z%+_ &=;ZC<6S7">
M?,PCE(;:(T; );N>./0]NAL)I[C3K6>Z@^SW$D*/+#G/EN0"5SWP<B@"Q16;
MXAUA/#_AZ_U:2)I5M(3*47OCWP<#U.#@5C_\)<+/1M0UN^:SGTBVM5N8KRQE
MWK,26!0 ]",*.O.[M0!U55;34K&_EGCL[R"X>W;9,L4@;RV]&QT/M7.W7BJ_
MT>]T4:S8016>K3+;))!*6-O.PRB/D#<#@C<,8/;O6+H^JVOA[6?B)J=PI\BV
MO87*H.6)@3 'N20/QH ]&HKDK'Q;>R>*+32;FQCD@O(7=+JT+NL#J,E)"RCJ
M.C<9(QBNMH **YK7_$.H:7<W2064"6UM9_:6O+R0I%(Y) A4C^+Y<D]LC@YK
M,?QY=S1^$I;'1XY4\0QEE#W.UHF$1?:?EP1Q][K@'Y3P* .XJK+J5C!?V]A-
M>0)>7&?)@:0"23 ).U>IP 3^%<G!X]>RL/$CZ]91V]UH4J)*EK*9%F\Q5:/8
M6 .6W 8(ZUGZRVJ/\3? 3:C:VD>Y[U@8)"Q1OLS90Y SV^88SSP.X!Z-116+
MK.JWUE?6EM:VB>5+'))/?7#%8+<)C 8CNQ/'(Z$]L4 :%YJ=CI[P)>7D%N]Q
M((H5ED"F1R<!5!ZG)' JU7E&O^(SXG\'^$]92R47 \2VT?DI(&!=)70[7.."
M5X)QUKH8?&VI6&LZAI/B'1X[>YAL)-1M6LIS,EQ$GWD!*J0XX[<_S .VHKE=
M*\6F]T[^V)7L)-&%D]W)=VDQ?R67:3&P(Z@$G/!^4\"JESXVO-.TC2M?O].B
MCT;4'B5BDI,MJLN/+=QC!'(W =,\;J .KAU*QN+Z:QAO()+N!0TL*2 O&#TW
M <C\:M5P=H7A^+/B5[=(S*-(M6 <X#'=)U(I\7CZXE\(^&M?738@NKWD-K)"
M9SF'S'VA@=OS8QTXH [FBN'T_7]6'C_Q3#?/:KI6F6]L_#MF.,K*Y;&.6/?I
MP!UQ1#X[NI+O19!IJS6&J2+'B N\UKO&4:0;=NWH&P?ESU- '<445B:MKK6F
MLZ?HME$DNHWJO(/,8A(HDQN=L<GD@ =R>HQ0!=36M+D6\:/4;5UL03=,LJD0
M8!)WG/R\ GFK-O<0W=M%<VTJ303('CD1LJZD9!![@BO,]%O;O3M0^)5[<:=:
MS3VTD<DEJ)2(Y56V!/)4_>49P1WQ[UO+XSAM[#PM%LLM/?6;(3Q&=ML$9"1G
MREQCD[\ <<*?8$ [.BN;;Q%>K-I>F/8Q1ZS?K*[1-*3'#'&<,Y;&6'*@<#.[
MM67JGC36]&T"6^O/#P6>'4EL63[1A949U598^.0=W0D8/>@#N**Y&3Q5J=E<
MQ:=J=E8VFI7+S/"%N&EB%NFW]XQ"@Y)<#;@=SD5SVM>-]<N?"YEMK)+&[BUB
M&PG=R^R5&D4!X6*C*L#U(R!GKUH ]&EU"SAOH+&6ZA2[N%9H86<!Y OWB!U.
M,BK-<M<ZU/;^-]"TF\TNS,MY;7$BW:2EFB*!=RJ"H(!RO.><=*JS>-+V70-0
M\1:9I\-UI5C)*"IE*RSQQ$K(Z<8&"K8!^\!U&: .SHKC)/&E[=>(--TW1]-M
M[F#4M,.H6MS+<E!C*XWC:2H^;MN)XX')&IX1\0S>(M+N);JU2UO+.\FLKF.-
M]Z>9&V"5) )!X/(H WZ**Y_QMXAN/"GA.]UJWLX[LVH4M$\ICX+!<@@'."1Q
MQ]: .@HKCKKQ3KMGXKMM$ET6T)U&WEEL7%X?E,>W<)?DXX8'Y=WISUI-/\8Z
MG=:'J\AT3SM7TR_^P/:VLI=)&)3#ABN0F'!/&0 : .RHKC[+Q;?WNI:_I%M;
M6-WJ&F0QS1-#<$13[]WR$X)1@5([]1TIVF^,)]6\*:-JMI:0&\U*=8/LK2L!
M&V6\P$[<Y0(Y/'.TT ==117->*O$UYX>NM'AMM,2]&I78M!^_P!C*Q5F'!&"
M/E/.1CT- '2T5Q%CXVU2/4]:T?5]""ZO867V^W@L9C,MY%R $)4'=N^7D=:L
M6'BV]F\4+X?N;>R^V2Z<UXODSD^2X*@Q2#&0?F'S?7B@#KZ*XS3?&EY?>%-0
MU&73H(=5L[QK%M/\\G]^'"*A;;_$64@XQAA78Q[_ "D\T*),#<%.1GOCVH =
M16;KFH7FG64<ECI[WMQ+/'"J*<*@9@#(Y )"J.3QV_&N93QY<?8O%92TL[NX
M\/1B5F@N2(KA#&7X."58;6!'/(ZT =Q17$V?C+56U/PXE]I-M#9:[$?(DCN2
M\D<@B\SYUVXP1D#!)]?2K&F^,+B4^)H=4M+>RN=#)+(LS.)(RF]9,[1PPSQR
M>#0!UU%5=-ENY]-MIKZW2WNI(PTL*/N$;'^'.!G'3I57Q'K2>'?#U[JTD1D2
MV3<5!([@9) . ,Y)P< &@#4HKD;OQ3J%IX<U;68X-/OK2SLQ=V\]M<'R[D .
M77.#M(VCU^\.E32^*YXM6\*VOV*,PZZCDOYIW0LL)DZ8^8=NHH ZBJMOJ=C=
M7EQ9V]Y!-<VV//BCD#-%G.-P'3.#U]*YIO%>J7>FR:OHNCK?Z?'=FW$:2$3S
MJLGEO(@Q@ ,&P#U SD5BQ3:I:_$WQDVC6-M<7)L[%S]HF,2<+)W ))/;C'7)
M'&0#TFBLGPQKB>)?#&G:U'"85O(1(8R<[#W&>^#GFM:@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HIDTT5O"\T\B11(-SN[!54>
MI)Z5#8:A::I91WMA<1W-K+DQRQ-E6P2.#WY!H LUQOA2Q;0?%?B?3I1A+^\_
MM6V8_P#+19%"R >ZNO/LR^M=E4<L$4S1M)&K-$VY&(Y4],@]N,C\: .!L_"6
MNP>$]3\*.+-;6]GN,WZS$D0S.S-^[V_? 8@<X[Y[5<\8:.NHQ^&O#5FO[M+Z
M&XE'7R[: 9)/U.Q1[M[5VI(4$D@ <DFLBSUWP]<W<GV/5=.EN92H;RKA&=^<
M*.#D\G ^M &Q1110 445534K)]4DTQ+J(WT40F> -\ZH20&(],B@"R1D$>M>
M8Q^"?$R?#6R\+%=,,ME<PM'*+AP)$CF\S<?DX)  QSCKGL/3Z* .-O\ PSJ&
MI^.)=2N8[==,N-$DTN4+.?-!=]Q(&W&,<=:A\+:;XVTN"TT34IM+?3;':B7\
M+/Y\T2?=4H1@$@ $Y/&<9/-=Q10 5RWB[PM<:Q>:5K.DW$5MK>DRL]L\P)CD
M5AAXWQR P[CD5T0O+8WQLA<1?:Q'YI@WC>$SC=MZXSQFIZ ,6VG\07JK'<V%
MKIPX\R5+KSCCN$&P=?4XQZ&LBPT+6/#GB/7+G2X;:\L-7E%T(Y9S$T%QC#9^
M4[D; .1R,=#75VUY;7L;26MQ%.BN49HG# ,.HR.X]*AOM6T[3$=[Z^M[9(T\
MQVFD"A5SC)ST&: .)A\"ZAI5OX0M=/-M/'H]U)=74DLAC,KR!]VT!3W<D9/0
M 5IV.B:Q9^+/%.JM#:-!JD5NENHN&W Q(R_-\G&=V>,XQ75V\\5U;17$#B2&
M5 Z.O1E(R"/PH@N(;F/S()%D3)7*G."#@@^X/&* /)GTC5?#=I\-M)GBM9;^
MRO98\),?+D A?D,5R#@GMUKH-9\):UJ__"0ZI;W,6GZM?V4=C9A9"?*B1BQW
M.!P7)(XZ#')KK+_0].U.\M;N\MS)/:-N@?S&4Q-ZK@C![9K1H X/3O#WB"V\
M8V6N?8-(M;:/26L&LX)W(B/F!QM.P YQCH,9[XYSXO!/B&+X::3X<V:>;RSO
MDN'?[2_ELJSF7@[,Y.<=*],HH X;QSI<6NW.B1VE\+;6([LP9A<,ZPR1GSU/
MI^[Y!/<+ZBMGQ!>ZKHXTA-&M+&2V:YC@N(I697$9(4>4!P2.3SP /3D7[30-
M(L=6NM5M=.MXK^[_ -?<*@#O]3^ ^M68KJTN;J:**:&6XMB%E56!:(L 0#W&
M1@T 6*YCQUHFH^(-$M[+35MS*EY!<,9Y2@VQN'P,*>3C%;]]J%GIEH]W?W<%
MK;)]Z6>0(@^I/%)8ZA9:G:)=V%W!=6[_ '98) ZGZ$<4 <ZFC:LOQ%G\0&&U
M^QOI2V2IYY\S>LC/G&S&/FQU]ZE\!Z)J'A[PT-.U);?SEN)I0T$A=2))&?NH
MY&['X5K7VO:3I@8WVHVUOM94/F2 ?,W1?J?3K5YW6-&=CA5!)/M0 K$A25&3
MC@$XS7FY\#ZW/\.M=T&0V,=[>7\EY;LLS-'S.)0K':".F. :]&BECGB26&19
M(W 970Y# ]P>]/H X[7=#U#Q%!]EUO0]+O[*6V'[D7!#V\^YN4<H#C:5!88/
M' YK=\-Z;=:/X:T[3KV[-W<VUND<DY).\@=>>3^-6K74K*^N+J"UNHII;23R
MKA$;)C;&<'T.#5J@"EJZ7[Z7,NF" WG'EK<$B-N1D,0"0",CH>M<&_PSBOAX
MAAC@CT:PU>R6%K.WDWH+@,6\[:  ,848'7G.*])HH XM] UK7;?0+77HK2)=
M*NHKN>:"8O\ :9(@0FT%1M!)#'/3&.<YJG+X'U'4T\:6M\]O;P:[(DMM+#*7
M>)D154L"H[H#P?:O0*JZAJ-EI-D]YJ%W#:VT?WI9G"*/Q- &#X<7QF[PIXC_
M ++BCMAAI+)V=KIL8!(( 0<Y[DG'0=>HID4J31)+&P:-U#*P[@]#3Z .+U;0
M-?N?%]W?0?8+FPN; 6T)NI&#6+_-N9$"D-NR,\J> ,X'.7IGA#Q':VO@>.>/
M3B= +B?9</\ ,IB,8V_)R><]O3WKTBB@#SC5? 6J:XWC2*XDMK:/6GMIK.6.
M5G:)X%4+O&T<$H#P3P:M/I/B[5?$'A;5-0L]*@?27F-P([MV$N^(QEE'E\=<
M@'/U%=[10 5RGB#2-;N?%FD:G8I97=C;12)):7<K1JDC$;9EPK;F !'/J<$9
MS75T4 >96W@;Q##X5M+!WTY[K3]=&J0 2.JSJ)6DVL=IV$[L#AL8Z\\=#-HF
MK7VLW'B!UM[74(=.DM-.@\SS%1W^8O(V/4*, ' !/.<#K** //8_A^MWK-[=
MM8P:/;ZAILUGJ%O93;DN9'P X7  VC=\V 26Y [O7PIK>H^$-/\ "6L+:&TM
M'@2:\BE),\,+!E 0K\K':H.3@<D9KOZ* .6M-#U*/XA:KK,J6PT^\LHK5-LQ
M,@*%CDKMQ@[O7M7*P>#/%D?A+1/#_EZ4%T;489XYS</_ *2D<A<$C9\G&!_%
MD^E>CWFK:?86]U<7=Y###:*&N'9N(@>F[T__ %5:C=)8UDC8,C ,K Y!!Z&@
M#CSX7U)_%VOW,@M&TK7+*&"<^:PEB*(Z$*NW!SOZY&/0U#X6TSQMI=O::)J4
MVF/IMCM1+^)G\^:)/NH4(P"0 "<GC.,GFNXHH *Y#Q+H&K/XITGQ/H7V:6ZL
MHY+:XM+F0QK/"^#PX!VL",].?Y]?10!P$/AGQ$S>-I9H=.5M>B5;=%N7/EMY
M C^8[.GOUXZ<U8'AS4)/#.B:'J>D:;J=A;V MKRW>;GS$5%1XR4] _\ =(R,
M=*[>J;ZMIZ:K'I;7L OY$,BVV\>85'4[>N/>@#S^/P+XAT6P\.7ND7EO<:KH
MXGA:"[E8QS6\K9\K?C.4 4 D<X_"M3Q'H7B;Q!X8C@E&G"_>]@N3$)W$,*1N
MK; VPEB<')P.OM7<44 <?XIT/7;C5M)\1>'WM%U2Q22&6UNF(BGBDVEEW 9!
M!4$'%0Z_H/B/Q!X4V7#6":JMY!=QVRR-Y"")U;9OVY).#EMO4@8P,UV<LL=O
M"\TTB1Q(I9W<X50.I)/053T[6],U:2XCL+V&>2V8+-&I^:,GD;AU&>WK0!@W
MFBZU>^-?#NM/%8K#807$=PJSMG,H7[GR?,%V]3C/H.E9MAX3US1O#VL>%[,6
MDNFWCS_8[J24AK>.;.Y73;\Q4LQ&#\W?;7:ZCJ5EI%A+?:A<Q6UK%C?-*V%7
M) &3]2!^-6J .*M?"=[I?BW1+JQCMVTK2]);3AOF(E;)0AL;<?P>O>J,%IXH
M\(>&]?NK:WTJ2[N-6FOXTEG<H8I&R5X4'?Q@ 9R3^%>ATC*K$%E!VG(R.AH
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M_P &M;1I),-=C*H[;0W[J3C.#C\J[NL[4=#T[5I[::^MS+):OYD#>8R^6_\
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M:"*!?M#!P8@P^8;, '=V)QBNBO=6T_3IK:&\O8()KJ0101R. TKG@!1U-7*
M.<\!Z+?>'/!>FZ/J/D&YM(S&S0.71N2002 >_I71T44 %%%% !1110 4444
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M%HSP1D..3TY[UTFI>*9].UVRT.XN-.M+ZXMFGCEN-PBG8-M$2'(PV,$\D\C
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]:35?!]_KM]:S7\>GK/9ZE]IMM3A=A<I")2XBQM ^[\A^;'?!(KN** .0O\
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M;Q_)KADMWLVTV.PPTK&8['+[S\N"3NP1GWSVJH_@NXO]7\7OJ36_]G^(((H
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M( ZDL3A@0#D!1C/4UK3Z'XFU7PUJEGK&H:>U[>6DEI&MK&Z01!U(+G))9OR
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M]94_P_U]]'NM,75[!H_[6&I0S26[F60^:),2G=SCIQUP.F* -.+_ )+==?\
M8O1?^E#T?##_ ) .J_\ 8:OO_1S5?AT#4H_'DGB%YK62)M-6Q,8W*Q*N7W]"
M!DDC';U-2>#=!O/#NGWMK>2P2F>]FNU:'/'F,6*D$=L]>_M0!S^L_P!IGXPP
M+I'V1;MO#T@#W88H@^T+SM7!;TQD=<YXP5L/B!??V=-::I9PQ:[#JHTIU@1Y
M(F8KO$JJ,N5V G;U)&,C.1N:EH.H_P#"9VWB339;5W2Q:QEMKDL@92X?<'4'
M!!'0J:R]0^'LEYHT_DZGY&NR:D-66^2/Y4N%&U0%)^X$^7!/O[4 :GA_6=9N
M]<U#3]1LF:TB1);74%M)+=9,_>0I(20P/<'!'I4'B7Q!K6G>*M"T?3+>QD75
M%N!ON&;*-&F[/';D<=3C'&<C2T"T\0)NG\17UG-<;=B16$3)$H[L=Q)9C@>@
M';J:YWQB;D?$CP*;/R3.#?D+,2%8>2N1D9(X[X/T- #=/\7>)2OB32+K3+*X
M\0:1Y31?9W,<%Q'+]U_G.1M )(SVP*O:)XIO-0\4ZGH?G6-X(;*.[MKN"-HT
M;<S*5.6;< 5ZJ?;J*JZQX%O=7T_7IC?0V^K:L\!.U2\*1PD%8CT+*?FW'C.[
MI@8JW8^'-=@\92>(KB]T^0S:<MI);Q0N@#*S,H5B3@?-R2"?84 4-*\>7M[X
M,T&^DM[5=7UJ\>SAB4-Y2$2."Y&<D*B$XSR>.,\)IJ7Z?&R[6_EMY6_L!/+>
M"(Q@KY[=06;G.>_3%0P_#K48?!>CZ;'J5O%J^BWK7EG=JC&-F+LQ5U/.TAR#
M@]@?:MC3O#VN#QP/$FHWFG@-IJV3V]O$YY$A?(9C[]<>V.,D L>--=U'PY96
M6HVPM38B\BAOVFC9C%$[!?,4AAT)'!]<]N:</BZXA\<ZUH>H3V4=K9V0O()$
MA<,5QEPY+8RH*G '(8'BNDUK2K?7-$OM*NAF"[@>%_8,,9'N.OX5RC?#P36?
MAH7%^TE[IDI>\N.]VKK^]0_[+,$&#T48H FN?$6NV%WX1@O8+'?JTQCN@J.K
M1'RV?"@L>1C!))[\52T:YUBY\7^-H;R_@FMK0Q1+&+<J0A@+J%._C!<YR#GV
MZ#<\1Z#?:OK6@7MM);I'I=T;EUD+9DRA3:,#CAB<\U7B\-:I9^)?$.HVMW:-
M:ZNL;&&2-@Z2)%Y>-P.-O1NF>WO0!R/A'7M:T+P5X%D,=B^E7TD&GM%M<S@R
M;MLF[.W&1]W:>._IUL6O:OKDNN_V ;)$TJY:S4743.;B=%#.,AEV+E@N<'G)
M]CF)X'U6/PEX7T5;FR+Z)>P71E);$PB)(7&/ESGKSC'?/&E9^&]5T+6M9NM%
MGM#::O+]IDAN=P-O<$89UP/G!P"5.WD=: *&F>/Y]9N/!L]I!"ECKPN%FCD4
MF2%XD8D!LX(W*1RO2JFO>*-<?0/'L,,]K;7&B#;#<1PMEE:$2'@OPW. >G?%
M7I? 4^FZ?X73P_=0+<Z!([)]L4E)Q(I60MMY!)8L,=Z0>!=2N(/&,-[JELR^
M((PH,=N08G\H)G[W3C[O)QCYJ .H\.K=+X?L?M<T4LA@0AHHB@QM&!@LW/OG
M\*TZSM"M;^RT:VMM1FMY;F*-4+6Z%4P !QDD]L_C6C0 4444 %%%% !1110
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M< YZU(/%.M:KXLLM-TB2PBL;_11J4$T\#L\>70#*A@&X;IE>O7C! .[K&O\
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MW<7+K$A0H)@%9.2<\#KQ6)_P@7B-_#NFZ!)KUB]II=W!-:SM9L92D3917^<
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M7]RD*.X1 <EI&/154<L?8 FJD7B;29+RWLVGE@NKEBL$-S;20/*0"QVAU!.
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M'OA5XV^U74$XU"[>^!C0KY9DD3*\DYQCK7:MH%WJ>LZ9J.K7%NPTP.UNELI
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M0 SQ'<.3@<'(SZUH2^&KH>,=+UJ.\C^S6%D]GY4JEI) Q4EB^>ORCMZUT]%
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M33]06_-Q- 3'(P5E*[ PVKAL  ]ADDY-1>(?"%_XCL=1TO4+FRN;*[*&&66
M^;:$(JLR<X))4L.F"QZCBNRHH ;&@CC5 20H RQR3]:YZ\\.7DGCFU\1V=_%
M"JV1L;B&2$N6C\P/E#N&#D8Y!^E='10!PUKX&OM/T'4O#-GJ,*Z%>M+LW1DS
M6T<I/F1KS@CEL$],\AL5V=I:PV-G!:6Z!(((UBC0?PJHP!^0J:B@#G-2\/WM
MYXUTC7HKJW2'3X9H3 T9+2"3;D[LX&-HQP:SK[PGKEKXKO-;\-:U;V:ZBJ"^
MMKNV,R%D&T2)A@0VW QT/>NTJEJ6KV&D0I)?7*Q"1]D:X+/(W]U%&2Q]@":
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M1RV&/3/(.*T(O"L]IXRM=9LYK>.SM=+_ +-BM2C9";@P.[/;:!C'2NIHH X
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M]8O;'[,V%*[!&&R  <@Y)SD]^(4\$ZJL7BR-]7MI!K\9&?LI7RG:(1L?O<@
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MDELX7BDB7I.,ADW?[C L/?Z52\0>$M1N_$<'B'0-9&F:DL'V6<2P>=%<19+
M,N1@@DX(- &++XF\916WA:*[M++3[_4;U[.ZCEB+CA7*R+A^ 0H.WKVR.M7[
MW4/$NF*EKJ.J62.MC)(MQ;6^Z2YG#G"B')8(J;2Q'<]15N_\(ZA>SZ%.=:1I
M],NC=RR36VXW$A4J1@. BX;  SC Z]WW_A2^G\6W&LV>KK;Q7=DME<PR6WF,
M%4D@QMN 4_,>H8>U &9;>-;Z_P!&\%2>7';3>(&"SSA<I"1&7(4'^)B,+G..
M>M11^,]6TV'Q=<:B;:YM="E$$!C@*-.[!2FY]Q7(WA6 4>OM6/JVEGP[HWA?
MPE>>);*W,)>5+J_LE^R2+&NU8V5FP7RP8?-U4GLHK6TC3Y=?TS4_#5]?:-J6
MCW%LP:YT>#R1#(2.#AF4L<[N.1MY'(H UK'4/$Z>*+*WFM)+G2;F)_M,[VZP
MFUD RNWYB65N1CDCCFK/C[6;[P]X*U'6-.>);FT02*)4W*WS $$9'KZU'X<\
M/^(=.>%=:\2_VG!:C;;JEJ(F;C:&E;)W$ GCCGDY.,:?B?0H_$WAG4-%EF:%
M;R$Q^8HR4/4''?! XH S-0UO4;7QUH>DQ20FTU&TN9'#1Y9'C"8(.1P=W(]N
MM<E-XR\61>"]5\2-<Z;MTG498)+=;5O](1)@A&2_R<=/O<]ZZ2/PGKDWB'1-
M;U#7;:6YTV&:%HXK(K'() HXRY(/RY)R1TP!WIR_#R\F\$ZSX;?68,:G=R7+
M7 LS^[WR;V4+YG//0YH UVUF\U;Q?J&@Z=<+:IIEO%)<SF,.[22[BB@'@*%4
MDGJ<@#'6N.\&Z[=:1X1LK-5634-1UR]M]T<>X+M>1W95)YX4@ GN,YQSU5QX
M3U.'Q6?$6DZM;6UW=6Z6^H0S6K213[?NNH#@JPZ=2,5EK\-+@>&AI_\ ;S1Z
MA;ZD^I6-]%;A3!(S,2"N[#@[B".* "^\0>+M+T+Q3<S6T8CTZW^TZ?>W, 'G
M*%)9'17X8$<-P#Z5TGAEM=GMS>ZO=V<L-S!#+!#!"4,)*Y8,Q)W=1S@=^!6=
M<^%M:U3POJ>G:MK\4][?VYMC,EIMBAC((.V,-RQSR2>PXXKH]*M)K#2;2SGF
M2:2")8S(B% VT8S@DXZ>M '(^()-3/Q3\-VL&H^5:R6MU((3$&4,H09//)(8
MCV_$U@QW.MV$_P 1=1T>[M+<V-ZUR1- 93*4MT;9]X;00.O)Y[8Y[;6_#=SJ
M7B31]:LM16TFT])HG5X/,$D<@7./F&UAM&#R/4'I6>O@N]6U\5PG5;<_\) 7
M)/V0_N-T8C_YZ?-P/;F@!A\6W6IW.F6-E'+#+=:4FI3/#$)60/@*JAB!UW9)
MST [Y&QX3O=;O=&+>(+$6M]%,\7R@ 3(#\L@4$[<CMGJ#6#<^ ]2B70[W2->
M2RUG2[);!K@VNZ*Y@&/E>,MQR,\'K^&.MTFRN;&RV7EZU[=NV^:<H$#-@#Y5
M'"J   /;DDDF@#B(96U'X^W$%WS'I>C![.-N@:1U#R#WP=N?2N]NK&WO'MWG
MC#/;2B:)NZ. 1D?@2/H36%K_ (4;4=:LM?TR^_L_6K-#$LYB\R.:(G)CD3(R
MN>1@@@\UH6EIJTLD<FJ7MLRQG<(K.%HU9O5BS$D=\#'OF@#E!XIUK5/!>H>+
MM)EMQ;VS3R6]E)%D30PLRMN;.0[!&(QP,@$'K3T\4ZQK'B?1[32Y[2#3]5T8
MZA&TUN6DB.4Z_, W#=./QQ@V+?P-=6&F:KH=AJD<6B:B\K>4T!:6V67_ %B1
MMNQ@Y."1\N>]74\)/;>*]-U:SNX8;33]/.GQ6A@)/EDJ<[]_;:.U '*MXI\7
M?\(=K^J"\TU9_#UW<02_Z*Q%X(B#DC=^[RI[9Y]*V+W7_$-WXQL-&TN>PMK>
M^TEKU9)K=I'A8,@Y&X!_O<#Y>N3G&"\>!+T^&O$NCMJ\!_MRZGN&E%F1Y/FX
M# #S.<8X.169-;WUI\5?#]G!>6INH- E1V>(A90)$&,;LKTSU/0T 3:9XL\1
M3:3J]E>?V='JVD:C':W5XQ\N$6[$'S@&/WMA/RYZX^E">,-7^Q^-HX)H9I-"
M@2YM9[FT9#(K0M)M=,KW4@,, @@X-7;_ , 376GL\.J+%J[ZM'JTERUONB>1
M.%0Q[L[ H  W9R,YS39/ NIRW'B>9]>B9M?LTMYA]BXC81M'N7Y^F&.!G/3)
M/< @M/$?B*'4O"$E]<V4MGKT6R2"* JT+^3Y@8/N^;)!R, #/XU/9>*-1LKS
MQ3I^N31&[TU!<6?DP[?.@=?D8 D[FW@H1TSCUJT_@Z^?_A%?^)I;@Z!C_ET/
M[_\ =F/^_P#+\I]^:HRIH7C7QQI-_IEV+HZ2)?MDD!.PX93'$_J?,4.!_L$]
MQ0!U":9-?Z;IZ:S(DMS"8YIA$@5'E4AAC.2 & (P>PSGD5S&J^+Y[?Q5?:')
MJ$6E78\O^S5NH?W-\I4%L2'C=N)4 $8('WLXKO*Y+Q%X1N_$EKJ>FWM[:RZ;
M?2*\:R6Q:6TPJ@^6V[&<J2#@8+'KTH ZVO&K+5]<\.^#/$FNZ?<6BVUAKUW)
M);20EVN%-QAANW#9P>, ]*]C"E8PJ'D# +<_G7"2_#V\F\%ZWX=?68,:K>27
M33BS/[OS'WLH7S.>1P<T 7M2U_4+O7M2T?2C+$]A!$[RQVXF)DD#%002 %
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MT\F6$N\H?:68ON'S94?P^M=/0!YU\&96U#P?=:U<_-J.I:A/-=.?O;@VT+]
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MYS%N#EOE(XP,'IR3FNG37=0L/B%/H^K7%NNG7-F;K3I!%L)*']ZC,3R5!#<
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M[Q=JG]F:$RQS^3<WDBVL$G4HS]7_ . J&?\ X#7&_#VYL= \9:UX1LIMVFS
M:EIN<_*#A98^?1L$#T)-=DND:I+XALM2O-0M)8K6!XQ;QVC)\[D9D!,AP<+@
M<' )]:I^)O"EWK>OZ'K%CJ4-C<Z3([JS6QE,BN,,APZ_*10!T[AS&PC95?!V
MEAD ^XR,_G7E(\6^-I/ DWBV.;2FCL)Y_M%F+=@;B..5E8A]WR84<#!Z9)YQ
M7JXR%&XC..2.!7E?@?1[OQ%\.[G3&OX$TR[OKM)@D1,HC,[;D#;L?,.^. W0
M\&@#5N-?\3:KXN?1]%O-/MK>;1HM2MY9[5G9-\A7:PW<].O&,]#277B;Q)J-
MGJ=UH%N99[&[>VAM_LX,=PT;;7W.6!7)#8QT&,YK=@\,3V_C@^(([R!;?^SU
MT];,6Y!5%<N#OW]<DCITK-7P7K.G:]J%SH7B0V.F:E.;FYM'M5E9)6^^T3$_
M*6]P0#V- #?[:\27WC>;0H9K.QC;2([Y3);F22!F<J5/SX8C:>>![&L(^,_%
M2_#_ /X2F2?3@=/NC;W-LMNQ^U!9_*9@Q;Y..0 #R.O.!V$'ABYMO&<FO17\
M7EG3ET]+=H&)"JQ8,7W\G)YXZ5C/\/+V3P#?>%CK,&+JY:<W(LSE=TOFD;?,
M]>,YZ4 :MSK.IQ_$BUT(20#3[C3);D8B/F*ZNB\L3@CYCV'XUSMQXUUR+X9:
MSKZR6OV_3KZ:W7]R=DBI,(QD;L@X.>O6NHD\.7DWC6Q\1/J$&+:R>T:W6V/S
MAF#%@V_CE1@8-<_>_#G4KG0]<T&+7HH=+U&Z>ZC7['NEB9Y [*6W8900<8 /
M3G'! -&]U?7Y/B(WAVSNK*"UDTDWB2O;%WC;S0G(W8;VZ=><XYYR3QAXLC\!
MZCX@:YTX2Z+=RV]Q$+9B+SRY=A.=W[O([#//?G [!/#=^OC2/Q$^I0.RZ;]@
M,/V4C/SA]^=_'(Z8Z?G60_P_O)/!>N>'6UB#&JW4MPTXLS^[\Q][*%\SGGH<
M_G0 [Q'XP?3/$/\ 9MQ?QZ/'/:+)I]U<P;H+B<EMR.YX7&$XR#R>>@KMH"YM
MXC+CS"@W8Z9QS7-:KX:U+5;2]L;F^L9[&\MEA>&>S+")P"#(GS^X..Q .:2U
ML-7TKQ!HUA8ZB9=#MK$6\]K);@L-BD+*9?[Q(0;?3<: -CQ!<ZA9Z!>W&EQV
M\E[''F(7+[(P>Y8Y' &3U'2N8TSQ+J%SXJU+1(+V*[B32TOK6[EM2OS%V0C
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MEH4OAKPO8:--=K=FTC$8E6+R\@=.,FMJ@ HHHH **** "BBB@ HHHH ****
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M-QRI4\$G.?U=8ZQXNO1H&JVEG+/:7S1M?6[B!8H89%SOB8/O)7(X.=W/ Z4
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M7I0!U]%><7?BO7+;X?6WCI)XWB*I<S:;Y:[/L[L!M5\;O,"D'))!(/RBKO\
M:GB+5?&^K:)9:I:VEI'8074$WV3>Z;RPQ@M@GY1R>/;G( .ZJEJ6J0Z5';O/
M'<.)[A+=?)B:0AG. 3CHOJ>@K*\":Y=>)/!.F:K>J@NID82^6,*65V0D#MG;
MG\:@\;:SJ6BQZ))I\L*)=:O:VEP'BW,T<C@':<X''L>O:@#J:*X>34/$FH>/
M-9T"UU2UM+:"RAN(91:;W0NSC&"V"?EZGC';G(UO FN77B3P3IFJWJH+J9&$
MOEC"EE=D) [9VY_&@#H2P49) &<<UF6OB"PO-?O-$A:7[;9QI+,KQ,H"L2!@
MD#=T/(R*YKXA&^&I>$H[74);:*?6(XI$15(;Y'8$Y'."HXZ?D,4OLNJ7'Q5U
MR#3]1CM)_P"Q[0-<O )&SODZ+D#D_P#ZN<@ ]&JNMA9K<_:5M(!.3GS1&-V?
MKUK@M(\<:EJWASPJ#$?[2U@3^:]NJ940Y#E Y"Y)V]<@9/!QBNC\+3^(WEU*
MWUZU9889A]ANG\L//&1GYUC8@,IXSP#D<4 :>L:S8Z!ILNH:E*\-I$,R2+$\
M@0>I"@D#WK/MO%7A[5[FWT_SSYUTGFP07EK)#YZCG*"11O\ 7C-4OB?_ ,DR
M\1?]>3U@3Z!JOBL>"&%F+&RTAX+V6YEE4O(5081%4G@]R<?2@#M]-\06&JZG
MJ6GVK2FXTYT2X62)DVEAD8W 9XYSTY%:E>?:9+=V_C+XDS6"PM>1BT:%9VVQ
MEQ:\;CV&>M2:/XDU*7QA::/_ &B+VWN]*>Z\^2V"HLRLH)C*A=\9W>_3[U '
M>T5Y/%XM\5KX#M_%4VH6;"#4#!/:I:X$\?VKR3\V<J0",8].2<\>L4 %,6&)
M)'D2-%>3&]@H!;'3)[UR]AJNHW/CS7]#>Z_T6WM+>>W81KOC:0OD9Q@@;1C(
MKF;;QEXDN_!O@O5([BS6XU?4EL[G=;D@@F3!&&X&(QQU/J* /4:R]3\06&D7
MVG6=VTJS:A,(+?;$Q4O@G!;&!P#U.:Y#_A,-1\-W'C"+6[B/48]&M8;R"1(1
M"S>8&_=D#(^\H /OSFJWB2'5?[2\!W5_J*SF;5HVEA6)51)#$Y'ED<[1\P^8
ML3QR* /3**\^N?$'B?6+'4;_ ,-V\SRVE[);VUN5A\F<1/L;S&9@X)(8@C&!
MC@]:?>ZGXKOO&\^@6-_9Z<K:/'?H9+7S6A<RE2I^;#?=QG@<]#UH [ZBD0,$
M4.06QR0, GZ5YY<>(->M7\7Z9)J"_P!IZ>D=QI9-NN)XY 0BE<?,QD!0X[XQ
M[@'H3N(T9R"0H).U23^ ')K/T+7;'Q'IO]H:<TC6YD>(&2,H=R,5/!Y'(/6L
M+P]X@N/$=IX=N+2\8K/:&ZOLQKU&%V'CY3OW#CM&W?FN'TG5-;\/?#N?7+&]
M@2UM-8F$EHT&XSH]V4;+D_+][C [<YSP >M-JD*ZU'I1CN//> W <1-Y84,%
MP7Z!LGI5VN4FUS4+?XFQZ/)-#_9;:1)>;%BPX=9$7ELG/!/0#KWJII.I>)/$
M.B:1XBTRYMECO)UDEL)E C6U+$<, 6\T#!SG&<C% '0:=KNFZ[=:G8V_F.]C
M((+E)H60;F7.,,!D8]L5H6]G;6@86UO#"&Y(C0+G\J\P#ZS!K?Q'N](OX;-[
M2:.?+P"4R%;52%Y. #CD\GGMCGT/P_J3ZQX;TO4Y$5'O+2*X95Z*70,0/SH
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MD#(QR =C16/X6N=;NO#UM)XBLDL]5&Y9HXV5E."0&&"0,C!QGC-;% !1110
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M1@NTT]#):+#!L4R,FWS'.\[B%)P!@<D^F.DDBCE7$B*X'.&&:<J*BA44*HZ
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M%;;PVVK-92$M?W3W"AQD0AN=@&?NAF=L<?>-83?#RY?P-=^&#K4?EW-T;DW
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M66^ABA:V$& BQYV8;=U^8YXY]JIIX&@F;Q+'J5T+NUU\AIXA%L\LA0HVG)Z
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M-X?;SNW8SVQQ753>&-WC+_A(8=0EB\RT6UN+81JRRJK%EY/(^\0?4>E9EMX
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M\Z/9EMH;@9SC!'7%9NJ:Q<W'CFQ\+VMPUJ&L9-0N9D52Y0.$5%W @9)))QG
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M59;9)O(3F,7"Q 8Q@<'KC- 'J]4M5U6ST:Q:\O9"D8944*I9G=CA551R6)(
M KF+>]UG3?B5;Z1=ZJU]9W^G2W/EO"B""1'4?)M&=I#=&+'CK6EXS\/#Q-HB
M6,>H-87L=PEQ97*\E)TRRG'?@'CTY[4 6+;Q-:SZK!I<UK?6E[.K/%%<0$!E
M49)##*\9'&<\CBMJO.M#\4ZQ;^)]/\.>-]*BAU-]YT_4[4Y@NB%.X?[+;<\'
M\AQ3(]:\5^(=#76_#ZW'GF[?R;>0VXM7B24H48D^8"54G/'S=,"@#TBFF1%=
M49U#-G:">3]*XU;_ %;Q-?\ B6UTS4VTV32W%K;!41@TWEA]\FY6RN6 P,<
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MA5;31Z+J,KWUQ,IU6]7RW$>W(F;+<*#D_7'/04 =XTB*RJSJ&<X4$\L<9X_
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MXKL?$$E^?.M;9[81+$ CJY!8GG.<J,>E6]<T8ZS!;(M]<64EO<+<1S6^W<&
M( ^8$8YY!'(X[UJ44 <^OAN6ZUJQU35]0^V2:?O-I%' (D1F&TNPR2S8R!R
M,GC-95O\/?L.IW;6&OZA:Z/>S-/<Z4@0QLS<L%8C<BMW"D=>HKM:* .1OO [
MOXEN-;TC7;[1Y;U42^CMTC=9PHPI =3M;'&X?XYMW?A""76-(U*TOKFSDTZ!
M[8"/:WFQ-MRK%@3G*CYASU^M='10!R\?@JU>Y\1-?7#7=OKP474#(%"[4V#:
M1R/E _$9XI;+PBT<>E6^HZG+J%KI3K):))$JMN52J-(P^^5!., <\G)KIZ*
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M/7IZGFNAHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2^(-+ANQ:O=8D,RV^1&Q3S3C";P-N[D<9S7G4.H6UK?_  NOYY@+9=,G@:4
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M"W.6#$G'?)/?F;59K#2?%?@"Z6T.FZ9''?111F(KY>Z-?+7:!D,P'"]<\=:
M.PTR\M+GQ)K*6^N&\>)85EL05*69PW<#.6P203VJ6#Q-HUS>0VL5_&9;C=Y!
M((6?'7RV(VOC_9)K@;I9M1\4?$VQTJ=/[0N=,M8[<*X#,XBE! ]QD#V)%1W]
MU:^)_ 7A;3=)=1K$%U98MEXELWB($A=>J!0&&3CJ/44 =S=^-_#-E]J$^M6J
MFU<).%;<4;&<'&>G?T[XK<AFCN((YX9%DBD4.CH<AE(R"#W%>96MU8?\)%\3
MW>>WP\4(W%A\P%MM(]QNX^O%=3\.I4E^'/AW8X<II\*-@YVL$ (/N.F* +'B
MW6;G2M'G73@KZF\$KPAAE8U1<M(WLO'U)4=\U+X/OKG4_!6AW]Y*9;FYL()9
M9" -SL@).!QU-<WXFT/Q.J^(=1M-9TX6]Q:N/*FL&>18EC/[L,) .I8].K&G
M^"M5_P"$>^&_AM_$%]$!=1VMM:>5;N-N^-1'&V"V6X.6X'L* +_C;5=4TF;P
MZUA=1Q0W>L6UI<(8@S.CL<@,3QTQTS[UH>(];;2EL+2VVG4-2N5M;8,,A3@L
M[D=PJ@G'<X'&<U@?$NZMX!X666>-"/$%G(0S 80%LL?8=S1XM1A\1? -_G-H
ML]W"7'3?)!\GY[6H ZBZU:PT98K>\O'>8QLX78TDKJOWG*H"<#(R< #(Z50U
MO6_L_AO_ (2;2KA;NSMHOM,B1D,EQ .7*GLP7)'N,'KQC:_K%I:?$:UL9RNG
MRRZ8Q34%BWS7 ,G_ ![Q9!&>-Q&"3D8 ZUC^#KRW7]GV;>3BVTV[28,I&TCS
M,CGO0!Z=;7,-Y:0W5NXD@F19(W'1E(R#^1J6N*\':U8Z-H?A/PQJ5R8M9N-+
MC>.!D;)"IR,XP",'@GM72Z[9WNHZ)=V>GWBV=U,FQ)V0MLR>> 0>F1P01G-
M'+3^)]1N/B/H-A:.J:+<K>(3M!-P\2KE@>R@M@8ZD$\C%=S7DU_I7BJT^(7@
MV"35-*/EPW:P&#3G1(HPD>Y2/,/48 Y&,=Z]*LM:T_4-3U#3K6??=:>R+<IL
M8;"Z[EY(P<CTS0!A>%-5U2]\1^*K'4;I)TT^[BC@V1",*K1!\8Y/\7<FK5EJ
MDNOZYJMM:7#P66F2"V>6, M)<%0S#D$80,O;DDYX'.+X*O+:?QSXW$5Q$Y>]
M@9-K@[@(%!(]0""/K3OAI%);?\)9:3@BXC\0W3N#U*N$96_%2* *O@7Q[IS>
M&=)@\0:_ VL7<LR?OF"LY$\BJ#@87(  ''M72:AJ\FB>)-.M[F3?8:M(UO$S
M=8;@*65<]U<!NO0CT/'F=E'97_P1N/#"I%)KLDT\26' G6<W#%&*]5P"K%CT
M4=<5UOQ!MIY+?P78JYDN_P"WK1MPZD1JS.WX $T =_4%[>0:?92W=R^R&)=S
M$#)^@'<GH .I-4=*\2:3K5_J5CI]T);G39O)NH]C*8VY]1R.#R..#53Q-I&L
M:I+I[Z5J-I:BUD:5X[JU:99'P-AP'7[OS'G/)!Z@4 9O@O6M8U77O$]OJVU/
MLES"L%NH'[A'B#[21U//)YYSCBMW6[75KZ.*VTO4!IRL29KM8ED=0,85%;C)
MSU(. .G.1Q/@>'7+3QQXQFU2_LY88YXC<F*T9/,;R%(9?G. !P1SD]QTK=U7
MXBZ!8^'K'58KZ-H]1R+,NCJ&[%F&-P4=^/8<D4 5?#&O:II\GBBP\2WR7<>@
MLCC41$(S)$T?F895XW*,9QZBMC2=9_XIR+7]8G6UCNT298G.%A1_]6GJ7(89
MZDL<#L*XS5-0T?7?AKXIT[PW>2:C>?9)+F\N!"R>9(W)SD#DA2 HS@*!Z5J>
M(]8M++X<Z#?R6L$]K))8D3S(7CM =I$[ 8)"\'J.2* .LM]3LM<BN[>PO72>
M!@DH"%)8&(R,HXR..1D8(]:K^&=<;6;2[CN%1+_3[I[.[5.%WKT90>=K*58>
MF<=JY/P7>V[_ !+\5JE[-=FYM[*2*:2/'FJ$<%AA0-O( /0\<FKO@B)V\9^.
MKQ<_99=1BB0]B\<2A_U(H [&]O[73H!-=S+$C,$7/)=CT50.6)]!S5./Q-HL
MEA=7W]HP1V]HQ6Y:4^686'9U;!4^Q%<UXVFETWQAX0UFYR-&M9KB.[D_A@>2
M/;'(WH,[AN/ W>]8NL+%/K?C;7+.>(Z3+X>^RRS*X,<]SA\8/1BJE5X_O 4
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MC/*D<]^HS5JL_0]0M=4T:UNK*430-&NV0 X;@=,]:T* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M**JZAJ5GI5L+B]G$49=8UX)+NQPJJ!RS$] !F@"U16+_ ,);H0T^^OI-02*"
MQ?9=><C1M"V,X9& 8<'(XY[4RT\9>'[_ .U?9M3CD-J(S* K<>9]P#CYB3P
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MY& >N1@=3GC- &M")5A03.KR ?,RKM!/KC)Q^=4M5TI-8A2UN6S9;@TT./\
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MPDT?D2>:IQG_ %>W<1CG(&,5N6%]:ZG807UE.D]K.@DBE0Y#*>AH L450O\
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MT@N[7:9K>:%XI%#=&VN 2#ZCBK-]J5KIRQ&X=@TS^7$B(SO(V"<*J@D\ GV
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MUG4;FPLKEFNK90[QR0O&2A. Z[@-RDC[PR*T;R\M["U:YNI1'$N 203DDX
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MT"L=@&2.23P* .\HKG=(UC2;/PII$T%]=W=K<1HEI)/NDN+G(R.,;F; )/'
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MU*5O-NG3RD8C BCSG:H[9."3U) [  7J* *UK916KSR*6>6=]\DCG)8XP/H
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M1B[''89/ [ "M*BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME_#QANDNU@\\2-"1"XXR%?H2,C(K7JO]CB^W_;6W-,$,:%CPBG!( [9(&>_
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9%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>sangamoexecutiveseveranc010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "L[7=3.CZ)=7R0M/,BXAA7K+*QVH@^K$
M#\:T:Y+4[A]9\76VEVMVUK_9RFY,CVY9))6!55!. =J[B>>K+Z4 4?A+XRE\
M9>"XY[V0-J=I(;>[XP21RK8]U(_$&KNH_$SPKI-[J5E>Z@\5UIRAKB(V\FX
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M'7]$FOK6Z+)]H%B+B*#I]_J1G/8'H?2@#.^&)N[NPNM1G\;#Q-!*52(K"(A
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M%/%$S<G/!'4'Y2.G45+I/CG1=9\17&A6SW,=_#")PEQ;M$)(SCYDW#D<C\Z
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MY!XSRO QW[G:GU7Q-H%Y>:C>075UH$&GRW$QNS;K+%+&I8!/*/*L!CD$@]Z
M.ZHKE-,'B:[70=535+>:UNHA+J%K)&JHJNFY?)*KNR"0/F8Y%8<&O^+-=T6T
MU_0+>XD\VXW+9R?9EMY+<.5(W%O,#[1G.<9SQB@#NHM22;6+G31;W2O!$DAF
M>$B)PV>%?H2,<CM5VN/L]2U:\\>^(M$>_"6T%E;RVICA4-$SE\GG.X_*.O'L
M*H>'_$&KZIX;CL;F^9/$<>J-873K$F$*,68A=N-OE#(..I'- '?TC,%4L<X
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ML$8VNF[:Z\< ;N%_,FND@U'S]6O+#['=Q_9DC;[1)%B&7=GA&_B(QSZ9%7:
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M4(P3GIM QG-2R># ]UH-VFJW,-SI$#6HDB1!YT3!00P(.#\@Y'O^ !%\4?\
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M4/&RJNT@+QPHR>I]1QBQ9^#FL]-\068U-V&MS2SRN81F)I%"MMYZ8 QG/XT
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MQ79^$M2BU?0EO;?6%U:"25S%<A0K;-W"L !A@, \#I6;H_@F;0+"UM=.UVZ
MM;B:6,31JZE9&+%& P2,L3G.<XYQQ6QH&@V^@6UU'"V^2[NI+N=PH4-(^,X4
M=!P !STY)/- '*7MG<2?&NRVZI=Q@Z+-( BQ?*!-&"@RA^4]>>?<4V#7-:\0
M>#]8\2Z;J;6LMM+<FSM?*1HBD)("R97<2^TY((QD8Z<])-X;DE\90^)%U!EE
MBM6M%M_*!0QLP8Y.<[L@<^W2J2>"%MEU:TL-3FM=+U61Y;FT6-6*,XQ)Y3_P
M!NXP<=L4 8<FK#7O%?PSU<1&+[9:WDYCZ[2UNI(JN^O?\(QJWQ/UH1"5K1[1
MT0]&;[.@4'VR1FNNNO"<4NM:#?VUS]ECT2-X[:V2,%"KH$()SGA0,8QCWJ*/
MP7;/>>(I+ZX-W;Z\%%U T84*%38-I!R/E'YC/% &5K&J:SX8/AS49-3DU"VO
M[R&RO8)(XPH,HXDC*J",-V).0?7FJ5UK/B"T?Q?H[ZQ.=5M1%<:1)Y$.9(Y1
MMC3;LPW[WY"3ZCI7167A QPZ5;:AJ<NH6FDR+):1R1JK;E!5&D8??*@\8 YY
M.35Z\\,V-]XIT[Q!+N^UV,,D* 'APQ!&[UVX)'NV>U &+X;UZZ\2VN@W-I?3
M;38FYOE*1_,^=@C;Y>/G67[N/]6?6J'A+Q3<ZIK-KIVIZC=V6N1(YOM)O($0
M2''WX&"_,@(XPQXY/3)Z?0_"]CX?75!9;A_:%U)<OG^ M_"OHH.2!_M&JMGX
M29+S1KG4=1:^DT=7%I(T(20EDV$R,#\WR^@7U.30!JZ39W]G%<KJ&IF_:2Y>
M2)C"L?E1D_+'QUV^IY-:%9^DZ?<Z=%<I<ZE/?M+<O,C3!08E8\1C Z#M6A0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR^;'_?0L '7D<KD<UG:?K^C65CK&IS^)X[NQBO7$DLKKLMCM7]RI Y _$\T
M=-16&OC+PXUZ]G_;%J)TB,Q5FP-HZD$\''<#D5<TC7-,UZVDN-+O([F..0Q2
M%<@HXZJ0>0>1UH T***SM7M-0O([:+3]1>PQ.&GECC1W,>UOE7>I );;SCIF
M@#1HKSG1)?$6L>)?%FDGQ5>Q+I4L,5K(+:V).^/<2X\KGGTQQ4MOXEGT7QSJ
MEOX@UG%E#I=M,$=5VI*Q</L"J"WW<]SB@#T&BJ UO36TN#4DO(WL[@*894.[
MS<] H'+$^@YI=,UC3]9@DFT^Y2=8I#%( "&C<=593@J?8@4 7J**RE\2Z,U_
M%9"_C\Z9VCBR"$D=?O*KXVLPP<@'/!H U:*XWPYJ]TOB3QG%JFI-)9Z;<1>6
M\^Q%AC,(=N0 ,#)Y/IS6]9>(M)U"XDM[>\7SHX1.T<B-&WE'HX# 97_:'% &
MI17+Z;XBT73M!GU&Y\3QWMD;N11=S,N Q;_5KM W8Z#&:N#QEX<-U=6W]KVW
MG6J>9*A;HN=N1_>YP.,\G'6@#<HK)M_$VB7>BMK$&I0-IZL4:;. &SC:0>0V
M<#&,Y(HC\3:*]O>SMJ$426./M7G@Q-!D9&]7 (R.F1SVH UJ*Q+3QAX>O[^U
ML;75;>6YNHO-@C4G,B[=W';.TYQUQVJ'1/%]AKNM:IIUKY@:PF$.YHV&\[0S
M$9' &<>^,CC% '0T45SMIK&EP:CK]V_B1)X+<Q&>&1T$5CA2,!@/XL$D$GF@
M#HJ*P[3QAX>O[^TLK75K>6YNXA+!&I/[Q2N[CMG:<XZX[57CUO3+34/$-ZVO
M/>16:1-<6: .++"GA=HR2V"2.3D=J .DHKC#XKTW7/!UAJ3:T^B?:W@97& ^
MXE6\L;A\V1P<9ZUOZEXBTK29'CO;L1O'%YT@5&?RX\XWOM!VKP>3@<'TH U*
M*YO5?&FF:7K.C:<SM(VIAY$DC1F01K&6W @'.3M&!V.:OZCXET?29&2^ODAV
M%1(Y5BD6[[N]@,)GMN(H U:*S-0\0Z7I?F?;+H((H_.E949Q$ASAG*@A0<'!
M.,X-:8.1F@ HJK?ZE9Z9"DMY.(ED<1QC!+.YZ*JCECUX SQ3=-U6QU>W>:PN
M%F2.1HI, AHW7JK*<%6'H1F@"Y1164?$NC+?Q69OXQ-+*8(R0=CRCK&'QM+\
M'Y<YXZ4 :M%<=H&JW8\:^,[74-1>2QT\VK0^=M584:(NW( &,]SV')K<L?$>
MD:C<FVMKQ3-Y/V@(Z,A:+IYB[@-R_P"T,B@#5HKE[#Q%HNG:-J&J7/B>.\L5
MO9 ;F9UVQ$D?N5*@;@O;J:N?\)CX=%[<69U>U$]O'YDB%L87."0>C<\<9YXH
M W**H:1K6FZ]9&\TN[CN8 YC9DR-K#JI!Y!'H:NR*7C95=HR00'7&5]QD$?F
M* '45YUX(\>Z<OAZP@\0^((6U:XN;B-3.P5GQ.ZKG  7@ #ITXKM(==TR?69
MM(BNE;4(5WR0!3N1>Q/'3WH T:*JV6HVFH>=]EE\SR)#%)\I&UQU7D=14\TT
M5M!)//(D<4:EW=SA54#))/84 /HK)'B;22MPQN63[/%Y\HDAD0K'_?P5!V\'
MGIP?2GGQ#I(73F^W1[-2V_8WYVS[AD!3C&2.<4 :=%>=Z3XUM-%UGQ-!XEU]
M5C@U(0VIN-H*IY:-C"@< MUQW&377W7B;0[*XMH+C5;2.6ZC,L"F4?.@7<6'
MM@9STH U:*YP^/?"RZ<U^=:MQ;K(T3'G<K+C<"N-PQD9R.,CUJ75=1L&OM$4
M>(!9O/.)((8F4_;5*G"]"2O.<CTH WJ*YBW\<Z5<:]K&F9E7^RU3S'\ESN8J
MS,  .0 !CUSQFJ!\8Z5X@\"-JIUJ30HIR-MS@!X_G^4#<"&) P0,]30!VU%9
M%]XHT/3;U[*\U2VBNHX?.:$O\X3(&2!ZEA@=3GBI+;Q#I%WHG]M0:A ^FX)^
MT;L*,'!!ST.>,=<\4 :=%95OXET:ZU+^S4U"%=0_Y])<QS'C.=C8;&.<XK5H
M **YZP\7V&H>+=2T"+S/.L5BW.8V 9WWD@<8P HY[YXZ5;7Q-HSWD5J+^/S)
MI#%$Q!"2N.J*^-K,,'@$G@T :U%%<_X@\6V/A_4])T^X$AFU&8HNV-B$4*S%
MB0/;&.O/H#0!T%%<!:^+(])\;^*H]:UEAIMM#9R6RS*!Y>]9&8*%7)Z \Y.!
MR>*[%]9TY-/@OOM2/;7 4P/'E_.R,C8%R6R.< 'B@"]15+3-6L-9M3<Z==)<
M1*YC8KP4<=58'E2/0\U;D4O&RK(T9(P'7&1],@C]* '45Y#9^(_%/_"N]8\4
M'Q 9;G3+N=!;W%M"(98XWQM.U%8,1W#=>U="/$&H7OBWP/+'<36]EK%A<7,]
MB0NU6$2,O.-W&\]\<#B@#O:*R&\3Z*EZMHU^@E:?[*&VML,W_//?C;O_ -G.
M?:H;SQGX<L);R*YUBU62SVBX0-N:,MG (&>?E)QVQS0!NT5#:W5O?6D-W:S)
M-;S()(Y$.5=2,@@U-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7"_$^*3[%X:N^?L]GXALIK@]@F
M\KD_BRUW55M0L+;5-/GL;R(2VTZ%)$/<'^1]^U ')>,=7M=.\5^'8;H169F%
MP(]4DCW& [5S&F> [\<D'[N,$GBK\+KN!-!UR-I)<V^KWC2&:,H54R$@MD#!
MQR1V]!7<64$UO:I#/<&X=.!*RX9AV+=MWJ1C/H.E0ZKI_P#:EB]B\ICMI@4G
M"#YG0]5!_AST)ZXSC!Y !RWPAMIK7X6:(DZE2Z22JI[(\CLO_CI%=O38HHX8
MDBB14C10JJHP% Z "G4 %%%% !7G7Q(O+:'Q+X(66XB1H]761PS ;5VD;CZ#
M)'->BUCW^D:E=WCS6_B34+*)@,00PV[*O'8O&S<]>30!RNE7FGCXJ^+Y9+BV
MV_8+1=[.N, /O&?;Y<_A7)6-Y;)\)_AXLEQ&&BUNT+AF&4"RL6SZ8!&?3->G
M?\(_K'_0Y:M_X#VG_P 9H_X1_6/^ARU;_P ![3_XS0!AV=[;V/QBUE+F3RS>
M:9:FWR#^\"M)N(]AGD]JY:RUFRL? VL3O!;747_"52DR2J7CM5:XRL[*O)5<
M9'(SQS7HG_"/ZQ_T..K?^ UI_P#&:/\ A'M8/_,XZM_X#6G_ ,9H X6SN8[G
MQ)X_@@N[B^DO=&@:WD:+!G BF!*[5 *Y( (X.1R:BU#5K"Y^$/@X1W*$P7.F
M1OGC:T93>.?[N#GTKO\ _A'M8_Z''5O_  &M/_C-'_"/ZQ_T..K?^ UI_P#&
M: ,&PU&+1/BCXD;6;F.WMM3M[673KF9PL;I&A#H&/&0S%L=<'-<B]HNF>%]"
M2[VQ6=QXS6[LX9OEV6AE8J=IZ+CYOHP]:],/AW5SU\8ZJ?K;6G_QFE_X1_6/
M^ARU;_P'M/\ XS0!BZ7<VS?&;7%CFB)?2K885A\S*[Y'N0"/SKNZY[_A']8_
MZ'+5O_ >T_\ C-'_  C^L?\ 0Y:M_P" ]I_\9H =:Z9XDBUPW-SXC@GTWS';
M[$-.5&VG.U?,WYXR.<<X]ZWZY[_A']8_Z'+5O_ >T_\ C-'_  C^L?\ 0Y:M
M_P" ]I_\9H R_BCI\\_A'^U;%<ZAHD\>I6^._EG+#Z%-W%<UXAT?6=*/AGQ)
MIL.-:N)I+6]7^Z;O)&X_W8W*X]@*[C_A'M8/_,XZM_X#6G_QFC_A'M8/_,XZ
MM_X#6G_QF@#"^*%M;:9\'=3T^$A8X[:*"!">6VLH 'J<"F_$FXT]?".F202V
MXBDU.R>-D(PRK*N2,=@H_ "N@_X1_6/^ARU;_P ![3_XS1_PC^L?]#EJW_@/
M:?\ QF@#$-Y!:?&IFF?:M[H<4=L0I(E83N2%QUP""?0<]*Y**:8_#O7+.TBG
MGO=.UZ2[N[.$,)#"MV)",CH2HR.>0#CI7H__  C^L?\ 0XZM_P" UI_\9H_X
M1_6/^AQU;_P&M/\ XS0!S-IJ7@[7&N]=TB:XN[J'398IKR>:;;!&1GRVWG&X
MM_#UX)],X$5S90_#KX9*)H$:+5;,N P!3"N')],$\_7FO11X>U<=/&.JCZ6U
MI_\ &:7_ (1_6/\ H<M6_P# >T_^,T ="#D9%>=^,;:;1/B'H/C-H99=,AMY
M+&_:)"YMT;)60@<[<GD]A71_\(_K'_0Y:M_X#VG_ ,9I/^$?UC_H<M6_\![3
M_P",T 6H/$^D7_EKI=_;:C+(1MCM)ED(!_B;!.U1W)^G)P*XJ34;:W\;_$*0
MP+?[=)MS]C5N;C9'+NC'Y@'TS75+X<U9<[?&&JC//%M:?_&:=_PC^L?]#EJW
M_@/:?_&: //],UBRN?&'@"\BOQ/"UE=0A(("L%NQCCQ$F!G(Q@@DD8YQ4,UY
M:/X!^**+<1$R:G=&,!A\^Z- I'KD@@>N*]%_X1[6/^AQU7_P&M/_ (S2_P#"
M/ZQ_T.6K?^ ]I_\ &: .4U*YT]O%?PT(FMC&B7!!#+A0;?"_3Y@ /<5/X?UK
M3=,\6?$.^N+J-;6">"=V3YOD6!0S +DG!!!QWKI/^$?UC_H<M6_\![3_ .,U
M;TW2K^SN6DNM?OM0C*%?)N(8%4'CG*1J<_CCF@#1MKF*\M(;J!M\,R+)&V",
MJ1D'!YZ&I>@R:** /.O U[:S?$;QX([B)_-NK9H]K@[PL6"5]<$8.*GLKNR3
MXS:X\D\"E-(@3<S@8P[EAGV&"?PKOJ* /"M%OX],\#^!M6NC<'1["YO(K][5
MF#6Q=G$;L$Y  )_!O>O2_!Z^'KBXU/5?#RSRQ7K1F>]DDD9;AU!'R[S_  C
M)'!SCJ#CJNM   P!@4 5-4BN)])O(K1]ER\#K"V<;7*D*?SQ7GG@KQ!H&I>'
M?#^@75B9->TKRHGL);<^9;31C:TI)&% &6W9[XZG%>G4F!DG R>] 'DL^J6E
MM-\4IS9Q:HH:%C9[LB51 JMG'.T'.<=,&I]'U:RE^*FEWBZH;V&XT&6..=(-
MD);S8V*QX'W0 2<DD8.3Q7JE&* /#;N[M'^"GBB,31,7UJ4J@8$L#=JPP.^5
M&?H,UV6J7-@_Q>\,,DULP&G704AE.-Q38!]1NQ^->@44 >,QZU8V&B>+)7@M
MKJ(^+=V^0%X[96,6+AE4Y*J5)X/)&,U-'J5FNO?$ MJ$ERMUHL+Q7$L>T3 1
MR@D84+MR0 >AR.237L'6B@#R'[591>'/A5MG@0QW%OOPP&S_ $=E;/I\Q /O
M71^#KJ&W\<>,]/E8K=RZ@DZ1%3DQF% '^F01GUXKNZ* "O+EO;0:_P#%(FXA
M :V@Q\X^;%L5./7#<?7BO4:* /'Q=647A/X5!9X$:*ZM?, 8 I_H[!\^GS'!
M]S6O8RQ7'C?XD0P.DDLMI:JB(<ER('! ]<$@'TKTFB@#QB\U2QG^!&@Q)<*9
M('T^*0$$;722/>O/=0#GTK6\3ZQ9RZ_XHTX%;&=](0QR0Q;YM3!1R IP1L7.
M#@9Y)R *]1HH \@L=2M84^%&HRR,MI!9RV\DQ1L"0VJJ%Z<DL"!CJ1BG)J.@
MVNK>)O#OC%K^*:^OY9H(@\^R]MY -@0)]Y@ %QUX'IQZ[28!() R.E 'DWB"
M-=)EO;O0=4CT_4+33X8KO0]1(EBO8EC^5!D[B^"4RI.3C/7)]2L9I+G3[:>:
M!H)9(E=X6ZQD@$J?ITJ<@$@D XZ4M '&^/-6MM+N/#QNHH8HY;\@:C.FY+(^
M6WS>FYLE03P,Y.<8JA\-KF(ZOXPMA-/+(=6,VZ:(JS(T4>&/R@#.#C@9QP*]
M!HH ANDEDLYT@?9,T;!&]&QP?SKS+P1KVAW?AG1?#.IV)D\0:7*B-ITT!+Q3
MHV/.SC ');?GN>I.#ZG28&<X&?6@#RN;4[6WU[XHRFU34E%M;$V8;/GJMN5=
M>.<#H<=*BTG5[*?XB^%[R/4OM<,VD3Q(\4!2%&S&?+CP.@&<Y)(QR17K5&!0
M!X??7=K)\)/B"B3Q,TFM71C4,"6W2J5('?(!(]<5UVM76G2?$[P*T<ULR+;7
MNTJRD#<D>SZ9P<?CBO0J* .$\ 7-O+XA\:I#-&^[5S(H1@<@Q(-P]L@C/J*[
MNBB@#Q:S6QN_@WJGAMHXI=;FN;J--/P//\YIV,;%.HP"K;CP ,YP*Z?Q9;7_
M (9FT+Q79PO>WEG&FG7\4?WKF*3"K^(EVD?[QKT' SG SZU@RZ)JEYXB-S>Z
MNLNCQR)-;Z>ML%*R*."TF<L WS 8'('IR 7]$T]M+T>WM9'$DX!>>0?\M)6)
M9V_%BQ_&H/%*V+^%-534Q)]@>UD6X\K[X0C!(]\5KT4 >7Z5+K#S:OH3ZE;>
M([0Z-(]IJD2CSES\JPRE>&)Z@]3M)K&AU[3;GPK\,X(+CS9+*_M([I41CY+K
M ZE6XX;.>.N!GI7M  '0 ?2C '8>M 'FNDWFD:=X@\>V^M&%#=72N+>8?/<P
MF%1A%/+@G( &>3BLC2+*30[[X5Z;J[HEY;0WGFI(PS%NB^13Z$9"CW'%>PX!
M() R.E+0!Y;975@-1^*#>=;X?;SN7YA]F"GZC=D?6J*7MJ/#/PI#7,6Z*XM]
M^7&4Q;LISZ88@?6O8** .!T6YBM_BAXTLI25N+Q;22W0J<R*L!!8>P(QGUX[
MUQKZA:/^S7]B$H^TV\<,$L3 @K(+@$IS_$ "2.H'->X44 <!=7EC)\:-*D^T
M6[ :'-M?>" 6E0C!]2NX_3-<GYME+\._$TGVT1"V\427,3HID13]H4H7"\^6
M>I([<C)&#[76+XDT:]UBUM18:G]AN;6Y6X1FB$L<A4'"NF1D<YX(P0#VH Y?
MPOK.A^(/'UUK,&N:=+?R:>EFEC:S,QV*Y=G)95+'+8X' 'OQZ%6#8Z/J<MY;
M7FN7EC<36K%X$L[0PJK%2I8EG8GY688&!SWXQO4 >;>9*GQ \>:?!*8-2U'3
MK7^S\@@NRPRKN!]%8C)[5BW$T.N_!?3?#MB1'XBA^RVJ6?2>WN(I$#.5ZJ %
M9BW3!]Z]CI,#.<#/K0 M<+X]N(K'Q'X,O[EO+M(=2D$LI!VH6A<+GZGBNZHH
M \YTN]T\_$GQO-)/ JFQLP&D(4X"2;QSZ97([<9KD]'U*+2?"WP_U?47N1HM
MO:W%I>36SN#:RN5V,^SD#Y2OMGWKW*@@$8(R* .8\'1:"Z:AJ'A^.9K:]F$L
MEU))(PN9,8++O.<=!D<$Y]*Z621(8VDE=411EF8X 'N:=THH \H^&6C:'K_A
MN^2^C6\VZM<RFWDF9HR/,RK&+.T]B"16YXCN+>+XK^"HS+&A2"^!7<!MW)&%
M'MG!QZXKNZ* /#=6URRO-#21&%@;7Q+$\^F0PG_1P+GF69L$[F^]G(7G !(K
MK=(OM.;XG>,IY)X%5K"S :0A3@+)O'/3&5R.W&:]%P** .+^$TBR?"_0E#AF
MC@*.,\J0QX/H:[2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBL3Q7K:Z)HDDB3)'=SD06N_H)
M'(4,?]E<[B>P!H YZS\8WK?$TZ9<J%T6_ADATV7^_/ Q\W\\L/\ MF,=:[*_
MU*TTR%);N;RQ(XCC4*69W/154 ECP> #T->;^-_"TVD^![2_L-;NIY]!>*[L
M$F6'#LF/ERJ!F++GC)R>N:EUOQ'#)K_@OQ:PD.@*D\=RX0G[)+(BA3(!R.ZD
MGID^M %SP_XKB7Q1XUGU#6)CI.G_ &4Q_:D,?V?*.77;M!'([C/ ZUT">.?#
M3W4%N-6B5YX3-$75E1U"[CAB-I(')7.1W%<%<ZC:75[\4YH&=H;O3(1!)Y3!
M93]F=<*<8))*@>N1C-6;NXM/L7PO_>18AEB:3D?NP+<J2W]W#8'/>@#N;;Q3
MHFJZ;J$]KJ82*SRER[*T3P'&<E7 (XY!Q@^]5;#Q+H.E:!HWVCQ!]HBNT5+:
M[NS\]QQ]X\#'3J0*YZSN[:/QQ\0W>:-4>SM=K$\,5B<-@]R"0#Z9 K!@F@'@
M3X812.F^#4K9IE;K&%CD#%AV )7.>F10!Z5:>*=#U6SU"2UU)0EE\MRS*T;0
MY&02' /3D'&#VS46CZMIMIX9TN1=6N=2AG3;;W,B-)-<\$YVJN3P">G05SEE
M=VL7Q'\;2/-&L;V%J-Q/#%%D##/<C(!],UA:/;V-U\./!D,VKSZ+J-O$YM;]
M, 6\JC#)(&XPP;HV,X [\@';:QX[TS3;+3+F%;BX74+];*,I;R?*WF;)-PVY
M!&UOEQDD<#K4]_X\\,Z6\L=[JL<,D42S21M&^Y$8X&5QD'VZC!R.#7#:A?ZG
M<>$?#U]K$,7^@>*(FFN[6(B*:)7<?: HZ*Q.<]#G(ZUNVEU:7/QIFF4C$GA^
M*-"Z[3N\YV*<]&VD$KUQVH Z2;Q=H5O.T4E^ %F6W>41.8DE;&$:0#:K<C@D
M=1ZU7'B^T;QM)X:6&X\V*V$SR?9Y-N6;"@'&,<'+=.V>#7FOBS5([[PYXJMQ
M!-97%OJZ,VGV]JP#JLT>;B5@IW%@,@Y Z=2,UUGVM4^+DTO[^,:AH44=I(8'
M^9Q*Y/;@@$$@XP.M '43>*M%@G$4MZ%!F^S^<8W\GS<XV>;C8&SQC.<\=:AU
M7QOX;T6YN+;4-5AAFMXQ++'M9BJDX!PH/Y=>">@KSJU83?!6[\'7<1_X2.*.
M2T-@W^MDF,A*2*.K*20V_IU.>*Z#30D'Q?CAN9DFGC\-Q6S2GG?*)B67/]XC
M!QUQ0!WEQ?6MI827US<1Q6L<9E>9VPJKC.2?2JFG^(-,U.]DLK:=_M4<2S-#
M-"\3^63@. X!*YXR.*H>/+LV/@;5KC^S$U/9#S:2(75P2 2RCD@9W$>@KDM$
MOX)_BU:7<=Y=WT-UH+1QW36S(COYZL0H"@!0/R[DF@#OM3US3M'EM(K^<PO>
M2B& >6S>9(>B@@'D^GUI+;7]-N]5O-,@G=[VS :XB\EP8P>F<C'/;U[5G>.M
M&FUOPC>06G&H0;;NR8=5GC.],?4C'XUQ,C:]+J^C^++.WFAD\20'3I8.]HC)
MNAE(_P!G:['/]_% '<R^./#<"VK3:I'']J1Y(%>-PSJH)) QGMQZ\8SFJ]GK
M^BZMXAL[BQ\032M)IS3I81Y\N2(LI\TKMR&'  )!YZ5C^(DLK'XA> ;9/+2"
MT%V@!Z1 PA4SZ9(P,]34UY+"OQITP;U&W1IHCZ!C*A"_4@$@4 */B;IQ\+ZS
MKGV2]\JPEEC2/[+("^P[1D[<+ELYS]T=<5T<?B&Q.FVUW*TR^>,)$+>0R.V,
MD+'MWG'7@=*\R7S)?A=X[T>."=K^.[OY&A$+9VM(64],'(Y&.HJ_K>MVEKK'
MAKQ'="_?PZUA+9R75MYT?V>1C&P=@F&VG9M],CZ4 =L?&OAQ=/M[YM6@6WN+
MC[-&S9!\W.-A4C*D$\@@8[XJQI/B71]<NKJUTZ]6:>UV^;'L92 >A&X#*G'!
M&1[UYSXA30E\-65SH]K+#9WOB*UNFDG,A:YPZF2;$GS;<=2>N,]"">BMKB!_
MC7<M'*C*^@QQAE/#.)F;;GN=I!QZ4 =C?:A:Z;"LMW+Y:LX1  69V/1549+'
MV )KEO%7B**]^'_B&_T+4Y8;JP@EW,B;)(I$7.UE=<J?P!]*K>/;R71/$/A;
MQ#-#-+I%A-.EZT2%S#YL85)"HYP/F!/^U[U7\2ZAI.I_#GQ9?Z3:*D-Y:.!=
M" Q->2E". 0&;^$ ]^0.E '3P:]9V6EZ6M[<2/=W-JLBQQQ/-*X"@LVU 6P,
MC)QW'K536-=T6]\/V-ZOB)[*TN[B+[/<VK?-*=X^0<$X)^4C'UKG9-:MH=;\
M-6[C[+%-I'R:G#;F661LH#;H=IVGC<>"> !@URUO<1I\%-*LW65)[?6E#QRQ
MLK#%ZSGJ.<+R<=.] 'K%YXMT*POY["XU!!>01>=) B,[A<XX"@DGV'/7CBJH
M\?>%C;V=P-8A:"\(6*14<J"6V@.<83D$?-CD&L=+JU/QKFG\Z+R_^$>1!)N&
MW=Y[,1GIG:0<>G-<7/)"?@7XDMXRIF?4IRD2CYFS=!E('4Y49'L* /;G<1QL
M[9PH). 2?R'6O.]+U>7Q?>:Q*NL:AI<FFZHT<#)$ZPB")4W"0, A+98G=\PX
MZ <^A1S12P+/'(C1,NX.#E2/7->0I;W.M^!/B-IND2;[^YU:ZEAC4X:6/]WG
M;ZA@&4'H<T >EVGB?2+V]@LX;LB>X0R6ZRQ/&)U'),98 .,<_*3QSTJK'XY\
M,RWR646KPO</=?8U1%8YFP#MR!CH>O3MFN8UB\MO&2>#O[%8&\MM4@NYXU&'
MLXD5O,60=4[)@XR2.M7?A_+;R:YXRV,A>36&E4CJZ>6@##U&0PS]: -SQ7XI
MM_"UG:33PS2O=W<5M&L<3. 7< DD XP"2!U)&!6!<^)/[/\ B<@NM3N5TB70
MFN5MI(R,2><JC:@7>6QG@@GK5GXGY3P_IMR4<PVNL6<\S*I;9&LHW,0.PJHM
M_:3_ !FMKH2*(CX>=5>0;<,9U8#GH2N3@\XYH ZRU\1:1>Z)%K%M>QRV$O$<
MJ@_,=VW:%QG=NXVXSGC%/TO7=.UA[F.RN"\UJX2>&2-HY(B1D;D<!AD="1SV
MKR&WEEM_"=MJ4<-S<V6F^)[JYO(;1F658',JB1=I#8&\-QU'MFO0?",GAS4]
M2O-9\/PW,WGQ)'/J$[3_ +TC[J#S>3M'4CID#UP 4_$&O-H?Q(TG[9JLL.E2
MZ?<220-C9O5D"D #<Q.X\<^U='IWBC1-6T9]7L=2AEL$)5Y>5V,/X2#@@\C@
MC/(]:YSQ'-#I_P 4/#>HWS+!9+974)NI1B-)&*;5+GA20#C)YKEM7TN^6/Q+
MXCTVRN)=,EUJRO5MK?<DEQ%"!YTB8P>6RP(Z[,CM0!Z0GB[0F6^+WP@:Q027
M*7,3PO&AZ,5< X/J!BF6?C3P[J%]9V5KJ<<D]['YML-C 2#;NP&(QNQSMSD>
ME<@;WPIK.F:WK>BQW<\XT>>VEO[EY_E!&5A_>GYF+9.!G&/<9HFXMD\-_"Q1
M)&K07%L90#@Q@6[*V[T^8@'/>@#T/4/%.C:5*R7MYY2HZQR2^4YBB9L8#R %
M4)R/O$=1ZU@^)_$JP^+M&\/F2\BMKI)Y;I[:*4.0B+L5609QE\DKTV@$\D'E
M;2ZT2VN==\+^+K75'O;C4+B6"W1KAH[^*20NA0(=N>0#G&,<G@XW]5GMK7XG
M>#HF9(5M[&[CD4ON$19(]JECZ[3C/7% %S0+NTT,ZZ+GQ5J&NS:>B&YB>/>;
M=?G*A51>6('/4G;DXK2T/QC8:MX<L-7D6:#[8%V0^1(69F4MM0!<O\H)RN1@
M$]!7/:>RS^/OB!%$0[S6=JD0'\;+%(& ]2"0#Z9K'TQM,U+X;>$K2?4[S2+V
MT"1PZ@B%/LMRL3 A]PP01N4@\<@9YH ]1T_4K75+=I[.1GC5VC;<C(593@@A
M@""#5NN&\->)Y['P[)<>)&B9_P"TS8Q7MG;MLO<E0DH50<9.03TRO%=S0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !112$@ DG '4F@!:*QF\4Z0M_IUE]H<S
M:D6%IB%]LNU2Q(;&,8&<YYXQG-:=W=PV-L]S<,4A09=]I(4>IQT [GL.: )J
M*165T#HP96&00<@BEH **** "BBLC4?$VD:5>-:7=TRW"1"9D2%Y-J$D!CM4
MX'RMU]* ->BL&P\9Z!J<UI':7YD-X2+=C!(JRD GY6*@'@$]>U:.FZK::M'<
M/:-(5M[A[>3?&R8=#AL;@,CW'% %VBBJVH7T&F:=<W]T6$%O&TLA1"Q"@9.
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M*** "BBB@ HHHH ***I:GJ]CHUO'/?S^5')((DPC,6<Y( "@DG@T 7:*YO\
MX3WPWON4^WR;K4 W"_99LQ9&1N^7Y>.>:OV/B32M2U:33+2X,EU';I<LOELH
M\MONL"1@Y]J -6BBB@ HJGJFJV6BV$E]J$IAM8AF278S!!ZG .![U1L/%NA:
ME=PVMMJ,9N)T\R&*16C:5>N4# ;ACTS0!M45FV&O:=J>J:AIUI,SW6GE!<HT
M;+L+@E>2!G(&>/:M*@ HHHH **1F"*68@*!DD] *@L;ZUU.P@OK*99K6XC$D
M4B]&4C(- %BBJNI:C:Z3IT]_>R-';0(9)7",^U1R3A033K"]@U+3[:^M6+6]
MS$LT3$$95@"#@].#0!8HHJE>ZK::?=6-M<-()+V4PPA8V8%MI;D@87@'DT 7
M:**I7^JVFFSV4-RT@>]F\B';&S O@GD@<# /)XH NT449YQWH **** "BC.>
ME% !1110 451U?5[+0M+GU+496BM(%W2.L;/M'KA035JWGCNK:*XB),<J!T)
M&,@C(H DHHK+B\0Z;/K%[I,<SM>V40FGC\EQM4YP0<?-G!Z9H U**S]%UNP\
M0Z:NH:9,9K5G=%<HR9*L5/# 'J#6A0 4444 %%%% !1110 445FV&O:=J>J:
MAIMK,SW6GE!<HT;+L+@E>2!G(&>,T :5%% .1D=* "BBB@ HHHH ***S;+7M
M.U#6+_2K:9FO+ (;F,QLNS?G;R0 <[3TS0!I4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5QGQ
M*OI(=%TS3(V*C6=5MM-E8'!$4C9<?BJE?QKLZYGQUHD^M:% ]FGF7VFWD.H6
MR9QO>)L[?J5W >Y% &1XY2Y'B_P.EAY"7'VNY6(RJ2B?Z.W) P3@=LC.,9'6
MKGAG6]:/BC5O#'B!K6XN;6&.ZM[NVB,:S0N2/F0D[2",=?\ Z]K5]);Q++H>
MMZ7?1PSZ=,\\(FA+(^Y"C(XR"I )]P1R*LV6E1Z3?:EX@U.ZCDO;E$2214*I
M%$F=J*,D]6))ZDGH.!0!D?#J\<V^O:,Q)CT?5I[6W_V8<AD7_@(8J/8"NUKF
M/!&C3Z9I^H7MY&8KO5K^;4)(FZQ!S\B'W"!<^^:Z>@ HHHH *S=9AC31M4E5
M )'M'#-W("MC^9_.M*N;\2:_I\5M>Z4]ZUO=21&,LUE+,J[EZ_*,'@^M %#X
M90I-\+?#FY5+);*Z%AG:P)P:Q;OQMXA@^'7B36U>P^WZ5J4]JO[AO+9$D"<#
M?D'G/)-7_".M:/X9\+66BRZL]T;2/RTF73)X]PR<9&#_ #KG9K73I_!VO: W
MB,#^U[Z2[,XT>X_=;W#LNW//(X.: .HO=7\467C33M'-UIKPZO;3R0G[,W^B
M-%M)_B_>##?[///'2JD?BS7HO!WBZ>66RDU/P_//&LQ@81SJD8D!*!OE.&QU
M(X[TR\U73KWQ7HFN/K07^S(9HFA&E7'[WS0H8@_P_=&.#6:?[.;2O%EB?$ _
MXJ"620N-'N/W&] A&,_-P!Z<T ;U[XCU\:OX/L[.2Q5-:MI7F::%B4=(0^1A
MAD9.=O'3&1GBJOC;5]*\,>+[C4(H+^^\/W!B1X8S&LRE5969<G&-_.#T%5&N
M].;5/"UZ=='_ !(H9(B@TFX_?[XQ&3G^'@9[\UGZAJVGZ1IGBNX'B!U?7)E9
M9$TN:,6I8+'EF;(*A1DG@]<<X% '6?VSKEOXWTG15O+.[L[VR:[DF-L=R["H
M(4JX 5MPP2#@^M=D[JB,['"J,D^@KQKPWXPM=-U*$6.M^'=1MB4CGBT[1YH)
MEBSC<"NX87.<$8Z@<FO1#XW\/,"#<SD'@@V4_P#\10!STGC#6I_ +^.++[.;
M1-]P-/>/[]LKE3E\Y$FT%LXP.F#UJ/7)KS4?B+X*NK*^CC@NK6[FMP]ONV Q
M1DY^89)!]L>]9EK%I-GX<N_"L6NR?\(_.[A%.F7'GQ0NVYH@V,$<D!B,@'H:
MTM0U#2;GQ3H>KVNKBWM])BEBCM3I5PV\2*JGYN,8VC'% 'HZJ%&  ._ [UYO
M:7=Q:?&+Q8]OIMQ?.=/M/W<+QKV;J791_.NH_P"$X\/_ //U<?\ @%/_ /$5
MRVG:AIMEXZU3Q')K?F1W\,4+6RZ3<*4"="&YR>3VH P[OPS?>%?@[+9ZB8UN
M)]8@NC!$VY+</<QXC4]\8_,FNU\4ZYJ^F7&H>3<6UI!!8&>T'E^?+<RC<6!0
M'<(U 7) _BZC%9_C'5M'\4:%_9L&KO:9GBF:1],GD_U;AP, +U*BLV^GLKG7
MM7OH/$CPP:O9):W4;:1.[H45E!B8C"@[B2"#_4 &F_BW7;RZ\$"Q^P0Q^(+1
MYIEEB9C$X@$G!##(R>G!..HSQK^#]9U._NM=TS5I()[G2KWR!<0Q&,2HR*ZD
MKDX/S8ZUQ]A]AM)?",DGB/S?^$>A>(#^Q[@><&C$?_ <*/?)ST'%:V@:MI.C
MZWKNH3:PTZZK<+/Y::7<(8BJ!,9(.> .PH ]#)P,GI7BNO:W9VVL:=\0H;U7
MFAOC!- "3_Q+F_=CCOR/-_[:'TKM?$/BC3-6T.ZL+#5Y+*6X0QM.^FW$FU2,
M-@ +SCOGBFZKX@\/ZIX7NM&:[V"XM3;D_P!FSF-05QPNT'CL,T :WB/Q ^G2
MZ/86!B:]U>Y\B"1QN1$"EW? (W84<#/)(KE[==3M/BGX@+7<$URF@PO;RO!@
M8$CD!U!&3G/3'&*RG@L9/#&B6,GBB4ZMH<JR6&H#2)P,*-NV1#G<"O!P1T'X
MVX+V(^)+S7+KQ%"UQ=::MBT4>C7(12&9@PR<\;OQYZ4 /A\8>*O^$9\*>(6E
MTV2/5;FWM9K/R&7F4E0_F;CC!QQMZ=S6_IFKZ\GC+4_#E_=V5PZV$=]:W$=J
MT83<[(49-YW %<CD&N4$6G+X1\/:$OB$9T:[@N1,='N/WOE-N5=N>,]SDUK#
M5=.7QM<>(UUH?O=/6Q%N=*N/EVN7#;N_+'C'2@""+QOXAG^'_AC78_L'VO4M
M2BM;A&B8*5>9D^4[OEX&,D-UK=TK5]=7QGJGAW4+JRN'2QCO;6XBMFC";F9"
MK+O.X KGJ#7'06NG0>#M#T!?$8)TJ_2\$YT:X_>;)#(%VYXY."<UMQZMIT?C
M:Y\1C601-8+9"W_LJX^7:Q8-N[\L>,=* &VGCS41\.-&\1:BJQBZO)(;^YMK
M=G6UB#RKO"<G&41<G.-V>>E0^)]5U2\\.Z+<V6NVD]M<Z_:Q)<6L8*S1&12N
M[YN"&!W 8R1V'%1Z%>6WA[PSIFDVOB(2-97$DKL^D7 2XC<N3&R\XY?(.3]T
M<&J<ECX?&B3VMEJQL[J36$U>/R]*G,$4B%<($P/E^7GD9))XZ4 ='J.J^+&\
M;-X:T^]TQ"=(^VI<2VK?+()0G(#\@_AC/?'-3Q1XNUWP[8:K?3360FL)8O)L
MHHC*)X3L#22$$F+)9]N<?='WLTV'4[!/&\7B.;7?,VZ=]@>$:1<*6&_>6#=N
M> ,'CN3S6'J=E8W^G^)=,C\4/'8ZS=&\ ;1YVECD)4[2_0H-@P, X[\<@'52
M2ZHWQF^S#45%G'HOGK"8<A09PK '/4[!\WZ57/B[6KWP)<>-M-:V-I#YL\=A
M)&?WEO&[*V7SD.54L,# X&#UJ!M1T_\ X2^S\0)X@<2+8?8;N,Z1.?-7S/,R
MG'R<Y'.[CWYK/MDTJQT'4/#-KKKKH%XTFU&TRX,T$4A)DB5L8(.6P2,C/>@#
M9G\2>(=7\4V^F:%<Z?!:WNAC4[>6YMF9HR74 , WS<'VQGOC![V$2B",3,K2
MA1O*# +8YP/2O.HK[1;;QK;:Y;:KY=I;Z;_9J6?]EW&1'N# A_7@#ITKI_\
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M1VIO(6A:5XC)M5A@X 8<_C5G0["?2]#LM/N)XYWM84A\U(R@8*H ."3CIZT
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M5BU\%7]M>^$YVU:WD7P_;/;A?LA!G#1K'G._Y2 H]>: ,F/7_%TVG>*(5O\
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MVQ^6"/WGS?+].?RJ-O!-X=/\+6HU>$#0'C=&^QG]]LC,8S^\X^4G\?RKLJ*
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M4!"2+\PPP!(YR#@<<<T-7T6+2O !\(Z&A\VYMFLK=6.2 _#RN?0!F8GUX')
MKL*,#.>] %32]/ATG2;/3K?/DVD"01YZ[54*/Y5S1\&7UEK^JWVC:REI::O\
M]Y:36OFXDV[3)&VX;21UR&'M7844 <%I_P /+[2H?#9L_$ %SHL$EMODLPR2
MQ/C("[AM8;1@Y/OFI["'3/AQIEU%KNO+):ZC?RR0^? %^:0ERIVYW$\\X ]
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M=JG@W4=6T6VM;G7A)>I>Q7LUT]ID,T9!550. B\=,D]3G)KL$#!%#D%L<D#
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MYALBOE22XW<>9R!C@<?6M;PKHDWAOPW9:/)>)=K9Q"))5A\LE1TR-QYK9HH
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M>'/BCK6HZA>2WL-IX8^TAG1%?8LS$K\H )R#@X'457\2MJM_X=\&:O>:CO\
MMFL:?/):+$@BCWL&4(0-W&0,DG//2NE3P1-=:]/JNL:P;TW.F'3;BW2V6*-X
MRS$]R1][USG/..!07X=:A_8VFZ/)XHF>QTR[AN+/-FGFJL1RB,V<-C@ X'3D
M&@"_!J>K77C[7=#DOA':1:=#/;-#"H>)G9P3EL[C\O?CVKC],UC7-&^ *:_:
M:JSWHB\W=<1+)@M,0V.F2=V<MNKT"T\-RVWC&\U]K\2?:K6.U: PXPJ$D'=N
MZY8YX_*L0?#J1? %QX0_MR1K.3"1R-;KNBC#[]HP1EL\%CV'04 :5QK-UJ/C
M>3PW:73V:6U@MY//&B-(S.VU57>"H  ))P>HZ<URFH^-?$-MX6UY5GMUU71-
M4BLY)_(RMQ'(Z!6QG"L5?G@CCCK787OA::7Q!:>(++4$M=6BMC:3N;<O%<19
MW89-P((;D$-Q[U2U'P$E_P"'KW3%U QSZA>K>WET80QDD5E8 +D;5&Q0!SP/
M7F@!MGJ6N67Q$?0[V_BOK>YTM[V(>0(O)D614*@C)*D-WR>.M9=AXHUB/7O"
M]O<:BEY_:<D\-\L4*_9HW6-G'DR!06P5VGEOP-=#>^$Y=0\3+K$^H 9TZ33G
MAC@*Y1R"S!MQP<@8]/?K659_#R[MH?#T<GB6=_["D/V4K:QK^ZV%-IZ_-M.-
MWMTSS0!+X0_Y'OQW_P!?MM_Z3I7;5@Z+X=ETG7M:U-KY9_[5E25XA#M\LHH0
M8.XY& /QK>H P?&KW$7@?7)K2[EM9X;&:5)8L;@50GC(.,XQGKZ8-<J^I:OH
M/@;P7)::CO6[NM/MYO-A4MY4@4%5(  [\D$\]:[W5-/BU;2+W39F98KN!X'9
M>H5U*G'OS7,3>![NX\.:-I,NN&0Z7<P7"3-:CYO)QL7 88''/4GU% $4E]XA
MO_'^KZ#!JT5I:Q6$-Q#(EJK/&69A_$2"?EZGCV[CGH_%GBD_#O3_ !=+J5N&
MANDM[BT2U7;<K]I\AB6/*D]1MP![UV\/ARY@\77OB!=0C,EU:):^2;<[5"$E
M3G?D\L<_TZUC_P#"O)?^$#'A3^V!Y N//\_[+\_^N\[&-^/O_IQ[T /U'6M9
MU36==TS1OM<3Z6L<:/;I;L'F>,2#?YI^[AE&% /WN>F.ET&;4[C0K.76K5+7
M4FC'VF&-PRJ_0X()&#UZGK7/ZEX*OY/$;Z]HOB*;2+VZB2*_5+998[G8,*VU
MS\K < \\?CGJ;&T6QLHK99))-@YDD.6<GDL3ZDDD_6@"Q7 >.K:XE\9^"_+O
MYH%>^E"JB(0A$#_,,J<G''.17?US^N^')]9UK1M1COUM_P"RYFFCC,&_S&92
MIR=PXP3TH SK/4]2\1:QKUA8ZF]BFD.EJDBPQNTLQ3<S.&4C;D@87;T//(QS
MT?C?Q!JNC^%+FVDM;*YOM4?3;Z,P[UWJ'#,I)Z?)G'7G&:ZW_A%KBS\1WVLZ
M/J*6DFHH@O89;?S8W=!A9% 92K8X/)!]*J2^ XTL] M;"^^SQ:/=?;%,D/F-
M/*=VXN<CKO8G ZGC'2@#HM'MM0M-,B@U34%U"[4MON5@$6\;B1\H) P,#\*O
M444 </JFH>([GXBMX=L-4M[.TDT@W:R?91(\;>:$R,G#'ZX')X/%<])XS\50
M>%;Y9;FT_M?2M<CTV><0?+<HSH%8#.$)#\\'VQ6K?2R2?'&&.RU&V@N%T!E*
MRIY@;]_G;M#*<]^O:M*_\ K=Z#)IT>HF*>XU :E=71@W-+,'## W *HVJ,<\
M #KS0!$^HZW8^)-.\,7.LI<7.H-<79NX[58VAMT"[8U4[E+;C]X@\ \9YK.O
MO'.H^&Y?$VFWY2]N--2WEL;EU">:L[!%$H7 RKGDC&1V%=1KGA@ZO>Z5JD-Y
M]DU?3&8PW*Q;D8,,.C)D94CMN!'8U5NO UCJMEK<6KRFYN-81([B:-/+"*G^
MK$8).W:?FY)R3SQ@  6[EUWP]-=ZG=:@FH:+;Z=+/.DJ*DRRH-W[O8H&P@'A
MB2/6LVPU#QA<W.A:A!;SSV5YM;4(IOLZQ11NN0\)5M_RD]&W9'H:T](\*7T%
MLUOK^OSZW"(6@CCD@6)0C#:2VWEVVY&XGH3QSFJOAWP3J&A&"SD\3WE[HMJP
M:UL9(45D .55I1\S*O&!QT';B@"CH7BRXU'Q)%I=_J4NGZM'<R_:-)NH%198
M0'V&!]N6_@.=QSAN *-$\67%_P")H]*O]2ET_5H[J7SM*NH%1)H!OV&!]N6_
M@.=QSAN *UAX/FN9=(.J:DEXFE7/VFV<6VR;(!"JS[CE1GG &=HR>N0^#YKJ
M72O[4U)+R/2[K[5;-]FV3;AG:K/N.5&>P!.T9/7(!BOXEU]-*\?2?;;<W&BN
MYM&^S#:JK ),8SR<GJ2:=::YXAM=9\&R7FI17-KKL3)/;"W5!&P@\P,K#DG(
MP<\<\ 5I-X)G:V\40G55QX@+>:?LW^IRGEG;\_/RCOWY]JED\'W$DGAESJB
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MF-MR C?Z]?7VH [:BN?T^WUF/Q?J,T^I27&E20KY=N]N(U@D&!A&ZN"-Q)/
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M*O@G#<< D8)'KFMF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^&]?M?%&@V^L64<T=O.7"+,H#C:[(<@$]U-:M ')R>"GAU_4M2TK6;BPBU0
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M17,PMK:28QR2;%+;(QEF]@* (=-L%TVQ2V$\L[C+23S$%Y&)R6.,#D]@ !T
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M;HRD8(/X5Q*_#0+I%KH__"1ZH=-LKJ.XLX2L1:'8VY5WE"6 /3/0>O& #/\
M&NO:QI=IXFO;35G:?3UCDM8+.-62W4*I;[067&YB3\H).W! %:VJZKJ>D>,M
M N[C4)?[!U0&U>#8FV&Y(S&=VW=AL,,9ZXHOOAS;WJ:[!_;.HQ66M'S+FV3R
M]OF[0I<';N_A!QG''IQ5?Q(MAJM@? +B_O;Z1(2T[P, B;P3,9 H0%0"0!CG
M"B@#HO#<]U?6UUJ,]U)-;75P[V<;*H$< .U2" "0V-_.>&'I7/:C-KM_\2KK
MP_;:]-96+:.EV#%!&SQN960[2RG^Z.3GOC&<CN(((K:WC@A0)%$H1$7HJ@8
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M@7Y2HX!SG(Y)H ])HHKBK"]N_%FM^)K5=1N;"/3+A;.V%N0I5]@8RMD?-R<
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M[JMM>>%[A=5GOC?:JUI>7,8 LYE82$+$IY^7:N&48.#EC0!Z<LT;2O$KJ9$
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MX'TV]\.V.A0W%W965E*DT8MV3<SHVX%BZMGYN3ZGK721J4C56=G('+-C)_+
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M=0C;?W?&5 '.:+GP3#*NAO;ZMJ%K=Z/$T$%U'Y1=HF4*RL"A4\*.=O:NIHH
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MULA?F+ GYCC&!CJ_^$/T]=4T6^@FN8/[&@:WLX(V7RUC*A2#E23D*!U[5"?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBL/Q9KQ\/:&UU$BR7<TL=K:1MT>:1@J ^V3D^P- &Y166]W;:%:6T-Y=33
MW$S;$^4O+.^,G:J_0G & /051?5X_$.AW=YX>O&^VV,DB"-U9=LZ=8I4.#ST
M/UR.QH Z*BLSP]K=OXC\/6&L6H(ANX5D"D\J3U4^X.1^%:= !1110 445P7C
M^X\0Z3J.E:CX;EFGF#2/<::SYCN8T7+*H(.'QG&,<]B: .]HKC;O7[7Q+X0T
MW6M&OKB*.>]M(R8I"C*'N(XY(W [X8CVZBMV]UZPTR9K1C<33Q1"62*WA>=T
MCY 9MH)YP<9Y.#C.#0!JT5R>M>.]/L+#1+RQ$E]!J]W%!#-!$TB!6/S'@9W8
M# +UR.G!JU'J&EW/C>*!-0OUU'^SC(+!A(D)B+K^\*E0-^2!UR.1B@#HJ*PI
M/&&BPW-O%)<NJ7%S]DBN/)?R7FR1L$F-N<@CKC((SGBEU/Q;H^D><UY-*L,#
MK'<3I [Q0,<8#N 0O49],C.,T ;E%(K!E#*05(R"#P16??ZY9:?<BU<S2W1C
M,OD6\+2N$!QN(4' SP,]3TS0!HT5QGBWQK;V?PXOO$.B3FX+0-]FFCA9U5^F
M6X^7![-CD8-:>@:8D=W)J=OJ.KO!/"L;6E\TA4.#_K%$HW*2.., ^E '045P
MWQ-N[VPL=$EL+^YLY+C5[:TE:&3&Z)R0PP<C/OC--\8C7/".B2^(='U6YNH[
M'$EU87I61)HL_-M;&Y6 YSG''2@#NZ*Q%\4Z:^G6=Y']HF^UVJW<<,$#2R>4
M0#N*J#CK^)X&:?%XIT>YTNRU"UO!<P7Q(M1"C.\Q&<@*!G(P<Y'&#G% &Q17
M'ZWXH\.ZCX0OKJ;6+ZRLXI_LUQ/:+)'<6\JN,H<+E#G Y&,-[UNW^OV.FSR0
MS&=Y(H1/*L$#RF.,D@,P4' .UL=S@^AH TZ*YRYU/2;CQ3H49U*]BO)H99;:
MUCWK#<(4!)D&-I*C!&3D$U/?>+M&T[[0UQ/)Y%K((KFX2!WB@8XX=P,#&1GT
MSSB@#<HK#O\ Q?HFFZG%IUQ=.;N6$SQ110/(9$&/N[0=QY' R:MZ)KNG^(=.
M^W:=*TD(D:)P\;(Z.IPRLK %2#V- &C117"^-[J\M?%?A""UO[JWAO[YH;J.
M*4@2($W >W(ZC!YH [JBN#U?65U#X@Q^&)7U2&Q&F/*QM$GC=IC*J*V]!G:H
MW?-G;D\]!78Z79R:=I=M9S7D][)"@1KB?!DDQW;'>@"W17#KXN'B+2?%D%LE
M]92:<TT,4PA>-ODB5MQ8C"G<QP,@XP<4G@OQEITN@>&-.O+RXDU&]L(MLTL4
MA2:41AF7S2-K/U)&<_C0!W-%8>I^+='TCSFO)Y5A@D6.XN$@=XH&.,!W (7J
M,^F1G&:VU8,H92"",@CO0 M%<#XDEO3\3_#NE0ZG?6UE?VUR\\4,V S1J"I&
M<XZ]JR;77M9FM/B'HTNISW,>APLUGJ2824$Q,^QF4 %E( R!GKF@#U2BN6T/
MQ!;V?A3PRM]/-/?W^GQ-'&JM++,PB5G;C)XSDD^OJ:GD\<>'H=&MM6DORME<
MS_9XY#"XQ)NVE6&/D(.0=V.E '145CZ5XHTK6=1NM/M)9A=VRJ[Q3V\D+%&R
M ZAP-RD@\CBMB@ HK@_B-XEU70XK>;2$\Q=/9+_4P.IM=^S8/=LN?I&U=JE[
M:O8+?B>/[(T7G"8MA=F,[L^F.: )Z*\[UWQ(MWXQ\&+I]WJ,,%W=2;D,<D45
MS%Y3$'D -SCK[''>MN?XA^'((+V8W5R\=C,8;HQV<S^20 27 7Y5&?O'CK0!
MU-%8,'C+0[C5[73(KIVFNP3;2>0XAG(&2$DQL8@<X!JK::WHEMJGB6[&JWTI
MM/*:^AE61H[7"''EIMX! W';G/6@#J**YRR\=>']0O-.MK>ZE+:BF^UD:VD6
M.4[=VT.5V[L=5SD=.O%)8ZMHR:[XDG75KMI+-(6OH;AG$-H C$% P &0"Q(S
MG@T =)16))XJL(XKEC#?;[>V-T8C:2!VCZ94$<GV[=\5E:;\0M*E\,:3K&J-
M+8C4#&B![>0)O?H Q7!'/WLXX/- '845SMOXVT6[6(6\EU)-*\J);BTD$I\O
M&\["H( R.3Z@=>*I:MX_TZTT71]3L%FO8-4O8K6*2.!R%W2;7W#&0P 8!<9)
M&,=: .OHK*N?$-A;/'$1<R7#P^>+>*V=Y5C_ +S(!E>>.<$D$#D54G\;>';?
M2;'57U%38WLJPP3+&Q4N3C!P/E.<YW8Q@^E '045GZ/K5EKUH]U8M,8TE:%O
M-A>)@R]1M8 T_4=5M-+6'[2[;YY/+AB1"[RM@G"J.3P"3Z $G H NT5Y_P"$
M]>5_%/C>:ZU"[.GV<MML%X67R,Q$N K8V_-GH.>,9XKI(_%VD->7%G))<07-
MO!]I:&>VD1VBSC>JE<L,\<<CO0!N45S-I\0/#E]+IJ6]Y*R:BP2VF-M((G<Y
M(3>5VAC@_*3FIK&^TR;QCJT4.I7LE]#;Q"XM)"P@A7+;64$ 9/.2">@H Z"B
ML.+Q=H\VH6=D)Y4>]!-I)) Z1W&!D['(PW'(YY'(R*E@\2Z;<7=O;Q-.WVF5
MX8)?(?RI'0,6 ?&. C=^<<9H UZ*"< D]!7(W/Q,\*VD<\DE_+Y=O<&WG9;2
M5A"XQG?A?E&2!D\$YQG!H ZZBLB\\3:79RQ0^<]Q-+;F[6.UB:5C",?O/E!^
M7D8]>V:K7'C?P];6FF7;W^8-3Q]DD2)V$N03C@<' /!Y[8S0!T%%<9!\1=/O
MO$&EZ=96U])#>02S&9K*48V,$VA=N>I.3C P.>:[.@ HK%U#Q7I.FFZ\^68Q
MV9 NI8H'D2WR ?G900.""?0$$X%1ZEXST+2;BU@NKQO,NXFFMQ%"\@E11DE2
MH(;@C@<G(H WJ*K:=?V^J:=;7]HS-;W$8DC+(5)4C(R#R/QK/U/Q3I>DW$\%
MQ)*\MM!]IN%@A>4PQ<_.VT' X/OP>.* -FBN(\4:C(^M^";O3M1G%G?7X5EA
MD(CGC:%W!('4< \U+HEQ=?\ "T?$]G)>7$MM':6DD4,DA*1%O,W;1T&<"@#L
MJ**PAXPT4RVP-RZPW<OD6]RT+B"63D!5DQM.<''.#VS0!NT5PFMZX+WX@6WA
MJ5M2BL3I\LTAM(YXW:4NB*0Z#.T MR#MR>>@KK])L9--TJWLIKVXOGA3:;FX
M(,DGNQ Y/O0!<HKA9?%XU[3?%UK:I?V4FFK+%%,(7C;<L0;=NQA3D\ X..<<
MT_P;XRTZ;0_#&FW=Y</J-YI\.V:6*0I-*(@SCS2-K/U)&<YSWH [>BL/4_%V
MCZ096O)Y5@@D6*>X6!VBA8XP'<#"]1GTR,XK;!# $$$'D$4 +167J7B#3]*D
M>*=II)HX3/)'!"TK)&,_,P4' X.,]<'&<5S&OZP+S7/ U]I.IS-87]XRD0R$
M1S)Y+L-P[\@<'IB@#NZ*P;SQEHEA+<+/<R".UG2WN9UA=HH9&QM5W P#\R_3
M(SBFSWVF?\)Q!:MJ5ZNHI8R.+)2X@>/<N7(QM+ X YSR: .@HKE)/B/X8CLW
MO#>3FUCG-O-,+24I"X.T^8=OR#)QEL5H6GBS1[W6QI$,\OVMXVEBWP.B3JN-
MQC<@*X&1]TF@#;HHK"\8^(U\)^%;[66MY9VMXR4C1"V6[;B.BYZD_P \4 ;M
M%>?Z_KIM_&O@R[%Y?6]C<_;!/;LDD8D*PY7,1 9CN/ P<G&.U=-IWBO1]3TN
M[U&"Y9(+.1HKD3Q-$\+KC*LC ,#R.,<YH VJ*R;#Q)INH:K+I<;S17\<0G-O
M<0/$[1DX#J& R,\<=#UQ6I(@EC9&+ ,,$JQ4_@1R* '45XQ:ZMK<7PRUOQ-_
MPDMZE_IU[<+%YS(\4BQR;5C92O.1QD8.2*Z;^U=1N_&7@*XEEN;9=3T^XFNK
M$2$1AQ%&P!7U!=NM 'H-%8+>,M$2Z2$W,FQ[S[")Q"YB^T9QY>_&,YX],\9S
M45WXYT&RO=0LGGN)+JP56N((;261U#9(( 7D8!)(X'&3R* .CHJMI^H6NJZ=
M;ZA8S+-:W$8DBD7HRD9!JS0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7#?$^"0Z=X?OP#Y&G:]9W
M5P?2,.5)_ N*[FH;JU@OK2:TNHDFMYD,<D;C(92,$&@#BO&=S=:%XQ\/>)'M
M+FZTFWBN+6[^SQF1K?S-A63:.2,I@D=*Z'2-2L[C3[S5(;%K*R=FF\R6 PO-
MA?FE92 1TQEADXSTQ6E96S6EJENT\DPC&U7DY;;V!/<^_?OSS4>I:='JEH;.
MX=OLLG$T:_\ +5>Z$_W3W]1Q0!R_PEL9[#X7Z)%<(4=XWG"GLLDC.O\ XZPK
MM*15"J%4 *!@ =J6@ HHHH *YW6+F./Q9H"L'.UIRS+&Q5,I@;B!@9/ S715
MCW^@&^NWN!K&JVV['[JWN J# QP,&@#B?$'A34=$\4VNH>'TW:/JVIVC:K9J
M.(9%G1Q.@[9VX;ZY^FC83R>'/B/XEEU994L]66WGL[KRV9#Y:;&B) .&!Y [
MYXK<_P"$5;_H8==_\"Q_\31_PBK?]##KO_@6/_B: //CHM]HOA+0KF>SNA"O
MBL:DT"0L[VULSR;<HH)& 5)&,C=CK72SL]S\7+6>..YBCDT"2$3-"P"2-*K*
MI.,!L G!YK<_X15O^AAUW_P+'_Q-'_"*M_T,.N_^!8_^)H Y+P/J_P!F\/:=
MX1U30;MM<TYQ$8I+1FA^5OEG$I&T+CYLYSGIGBJ5K)9:;J>N^'O$VB:M=RW>
MH3W%IY,<TD-[%*Y=5^4[ 1G!W8 QR:[K_A%6_P"AAUW_ ,"Q_P#$T?\ "*M_
MT,.N_P#@6/\ XF@#;LXA!8V\(B6(1QJOEH<A,#& >X%<2DDOA[XI:O>ZDL@T
MW5K.W%M=;"R1/%N!B8C[I.XL,\'ZUM_\(JW_ $,.N_\ @6/_ (FC_A%6_P"A
MAUW_ ,"Q_P#$T <!JFD7EI\*/&@^RW&[6-1N+JRM%A8R;'==OR 9&=I;&. >
M<<UZS9SQW-G%+$2491C((/Y'I6+_ ,(JW_0PZ[_X%C_XFC_A%6_Z&'7?_ L?
M_$T 8/Q5+/I^@)%#/,\6MVMQ(L,+2%8T8EF(4'@4_P ;:A=>)?#MSX=\/65U
M<76HKY#W$MN\4%O&3\S,[  G&<*,GVK;_P"$5;_H8==_\"Q_\31_PBK?]##K
MO_@6/_B: .*NK:'P-XJMAJ-IJ=QH4NDVUC#=V8E;R9(-PVNL9SA@V<\\_C3K
ML+X6U;PUXAL]!N[?P_&EU!-;Q0L\ML)2K+,T8RPW%>1U ///%=G_ ,(JW_0P
MZ[_X%C_XFC_A%6_Z&'7?_ L?_$T <MXYN(]7^%^MRZ;I-Q$MY+$T*"T9)KH^
M8A:0QXW= >6&<+GIBG^+X8Y];EU/2=4O=(UN"P1H)UB9[>^3+D0LA&&8'/ ^
M8;^AKIO^$5;_ *&'7?\ P+'_ ,31_P (JW_0PZ[_ .!8_P#B: .;GEO)_&7P
M]N;VQ>WGCLKG[9'%$QCMI)(HP$) POS @ GM5'1VETGP=XF\+ZM:W#ZFTUYY
M*"%F^W+,69&0@8;);!_NXYQ79?\ "*M_T,.N_P#@6/\ XFC_ (15O^AAUW_P
M+'_Q- '):5IUSHOB_P %65V)9'L-"DM;B<(S(LA$>%+XQ_"<<]JL^%-7BT#2
M_%VH7=K?&+^WYYD2*U=GDCD9%5U7'S*3GD>AKI/^$5;_ *&'7?\ P+'_ ,35
M_3-(.F/(QU+4+O> ,74P<+].!0!I=17G_CUR?&'@IDBGD2VU!Y)VCA9UB4I@
M%B!@#)[UZ!10!PQF'_"Z4GV2^0="-OYWE-Y?F&<,$W8QG'.,UW-%% 'FFFR2
M6,/Q#L+BTO%GGO+FYB/V9RKQO"BJ5;&&)(( !)]JHX=?"?PQB^SW EL[NU-R
MGD/F$+ RL7&/E 8@<UZS10!Y):266G:CKOAWQ-HFK7<MUJ$\]IY,<TD-[%*Y
M=1\IV C.#NP!CDUZK:1""R@A$2Q".-5\M#D)@8P#W J:B@#SGQ3!;WOQ9\+_
M &FS:XLX+:Z6=VMV>*-F4; QQ@$XKHO$.G66E^ M;M--L8K>-[*=4@M8 -SL
MA PJCDDXKI** /,(-1EL[+P-:SV5U#;'3/*FO8;%I)X91&@\@84M'NP<G&3M
M &.M8$23IX ^P-I^H)/#XH$ICDMY&;9]IWELX.X!>2<D<]:]NHH XB-]_P :
M&N%CE,#: L(F\MMAD\\MMW8QG:<XS7:2RI!"\LAPB LQQGCZ"GT4 <3I.E?\
M)-8ZEJ=Q?ZA:KJCNDMKY2)MA&41&$D9893DCIES7'V4&L:C\(_$7@R"*[;4=
M.,EM9R20N@O+97!7:2 #E05P/;UKV:B@#R_4O$-OK^K>![NSL-1'V>^9KF(V
M,H-L3"RE6^7L3V^O2F6Y;^P?B:A@GW7=Q<M;J8'S,&MU12@Q\V6!'%>IT4 >
M77);[!\,P(9R;66$W $+YA MRAW\?+\QQS4RL5U_XF2&&?9<6T @;R6Q,5MB
MA"<?,0W'&>:]+HH \G.]?"OPQB^SW'F6=U:FY7R'S"%@9&+C'R@,0.:OJ(#X
MH^([7NGW-S97%G;+Y:1./M*K"ZR*AQ\QYQQSDUZ310!YIH%MJEM?7VD6>ISZ
MWH3:7(;:>ZC_ ']I(2 (#)@;LCG!Y&T9QQG&\YI?AAX)M#8WPFL=1L!<QO9R
M!D\IOWAP5R0N.3TYZU[)10!Q/B/4VA\9Z3!+:W$=C-:2D:A:6C2S,Y9<0!U4
MF-2!N)&"<#D8KBK&*Z@^&NA+)IVH(=+\2I/=(UM(72,7,C%@,$O@,,D9Z_6O
M:Z* //[.ZDT7XE:MJ6HQ7$>F:U96S6ER\3;8FB# Q-QE&.[< <=QUXKFKO2;
MK3_#0EDM+D1W_C!=3AMA S/%;>:#N9 ,J,+NP>F[UKV6B@!%8.H93E2,@UPG
MC"6XT?QWX:\03V]Q-H\$5Q;7#PQM(;9Y NV0JH)P=N"<<5WE% 'C6J0W^LWG
MC^72;"]E>6?3;NV5K>2(7*PJC.JL0.3MX'4Y&*Z32-1T#6I'U2PT74DN;>UD
M66YOXIE: $?ZI=^=S$]ER..O3/H-% 'CD"2Q_#'X?V[6MR)[75;-YXOL[[XE
M1CO9AC( !ZGUK:N[.XU/QOXTMK598WOM#CM;>=D94,NV0$!L8R-R]Z])HH \
MP\*7>E:O'H]A=^'-477=.:/S8[Q)O*M708:0.Q*8X.W')R!C&34>BPW.FZ]I
M4OARZNWTZ\NV^VZ'>Q%OL&X,6EC8@%%!R!V;=QUKU.B@ KRC1;ZR71_B%ITT
M3S7%QK%\D=NL19K@LBJ%7CYCGKZ9R<#FO5CG!P0#VS6#X9\.S>'GU4O?+<C4
M;Z2^8"#9L=\9 ^8Y7Y1CO[T <9I\=WH5YH?A[4K2ZC$.A11?:[*V9Y+F4'#0
M><H)1%QGJO7.0.N-HQE3P=\-X)K&]22QU,&Y5[60&(!9 6/'"@LO/3\C7M=%
M '#ZZTEE\4_#]^]M<R6SZ?<VPDA@:0"1FC(4[0=N0#R<#CK7<444 >:Z%,V@
MVWBW1-:M[AKBXOKFZML0LXO8IAE0A ^9OX2O;CM5'2]*N]"U?X:6%\DLDVGV
M5W'=2+&SI"SQIM4L!@<@J.>U>L44 %>;>)[R>?Q%XATR6PO(0^EJ+1[*T8M?
ML5?(>51P$) "Y Y.<@XKTFB@#R6&1WT#X7@VMXILY(1<![9P8@MN4+,,<#<<
M9/!ZCCFNCT8L/BUXED,<JQ2V=HD<C1L$=DW[@&Q@D;A7;T4 4=9M)[_0M0L[
M:3RI[BVDBCDS]UF4@'\":\QGAFU[X/V7A!;.XM]?C6VLVMWB8&!HI$S*3C 3
M:I8,#@YP.3BO7** .&GDV_&>TE*3>2NB26YF\IO+$AF5@I;&,X!.,UW-%% '
MF5J\EBWQ%L9[2\6:YFEN(2+9RDB-;JJE6 P26&, YSVZU5.]?#7PPC^SW'F6
M=Q;&Y7R'S"%MV1BXQ\H#$#FO5Z* /([)[+3[[6_#?B;0]6NY[G4)Y[41)-)#
M>Q2N74?*=@(S@[L 8Y->K6L7D6<$0C6,)&J[$.0N!C /H*FHH \ZN-5?PE\2
M-:N-6LKV73-9@MS:W-M;/.%>-2IB8("03G(X[FG>(.-4\"M'ILEG##?O*T$<
M)Q;Q&-U7>%&$ZKD= 2?2O0Z* /%_&-S=:GH'C*Q;3+^"[BO@8;.TLG6.:-7C
MQ<.ZKB1F /4G&!QQFNLN+@3_ !:T>]6&X6W_ +'G0R/ ZA69T958D?*2 3@X
M-=Y10!XW+'+)\)O&]JMK<FXN=3O&@A^SOOD#RY0JN,D$<Y]JZ7591-X]\"3Q
M1S-#%#=B601-MCWQ(%#''RY((Y]*[^B@#(T'Q'9>(1>?9([F)K2=H)4N83&V
M1W /53V-97Q,L[F_^&VO6UI!)/.]L=D<:[F;!!X Z\"NDM;**T,S)N:29_,E
MD<Y9VP!S]  ,#CBK% 'GFJ7\>I>-_ =]!!=_9H_M9>22VD38&AVJ6R,KEN!G
M&?I6#J-EJ-[!XZ.G6=Q-,-7M;Z&#:T?VJ.+RBP0\9Y0].X'M7L-% '$^%[S0
MM>U>+4],T;44N88626ZOXY4:$'_ED#(?F.>2%R!CKR,]I)(D4;2.=JJ,D^E.
MHH \R^&.AZ9=Z)>-J>C1->)JEQ,GVRSPX4OE&&]<]#P:U_$1;_A:/@^01RM%
M##>B618V*1ET0)N8# R0<9KMJ* /%=6O+C4='5YM,U&WN[/Q#%+-86MC(L,$
M8N,^9\JXE9AAB<L22< 5UFD3JGQ&\77<L,\<$UE9B-Y(6 8HLF]0<8)&X @5
MWU% ''_"R.2'X:Z+;SQ2PSPPE)(I4*,C!CP0>?2NPHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHK$\5ZE<:=HD@LXKI[NX(@A:WMWE,18A?,(4' 4$MSZ8H Y>T\5ZBGQ-CBN
MFQH&KQ26NG'/'G6['<3Z;\O@]PJUVNI:M:Z6L'VAF,MQ)Y4$,:EGE?!.% ]@
M23T !)(%<'XW\'M;^!XI=(NM3FO-(:*YTR':92)(\;0%5=W*Y'X\T:QJ=Y+K
M?@_Q@=*U'^SX(YX;ZV^RR>=:-*B_,8\;B 002 >.F<T .T#Q)#9^*O'E[?3Z
MBNGV M',5PLLC6_[MR^$Y(&<GCC'/2N@7X@:";BQB>2ZC6^B\RUF>TD$<QV[
MMBMC#-CL,Y/ R>*X^XDGN[SXF31:;J9BU'384LV-C*/.86[K@#;G.67@C/-6
M[I9S9_#;%C?DV<L37(%G*3"!;LAW_+\OS$#F@#K+7Q9I.JV.K$->P'3QMO(I
M+:2.>(%<AMF-W(Y! JE8^*_#VB^&] /VV]DL[]4BLI[B.21Y<@D;VQ][ /!Y
M]!67:^;%XU\>W#V5\(;BTM5@D^R2[9BD3JP0[?F(+ <5B007<?@GX;6[:;J(
MFL=1MWNH_L4NZ%4CD5BPV\ %A0!WMEXLTG58-55#>POIX NH9+62.:-64E6"
M8W8(R1@9XJ'0]:TFV\+Z*=/GO;V&[3;9>:2\\X )));'0 G)QV'H*Q[,R0_$
M+QC<O9WHMYK"V2*7[))ME9%D#!3MPQ&X=*P]*TJWNOAUX2T[5K?6=.N[:-O+
MO;:&6.:QF48^;Y>%8$C)X/Z@ ZO6_'4&GV.DW%K97DW]H:DMC\UNP,9$A5P0
M>=WRN .YYZ5/J'C_ $/3+R:SG%^;N&W6Y>!+&5G$;'&<;>0.<D<#!R:Y"]7Q
M#+X2T&XU:"XO9-.\213-/!9L)9K5&8"8Q*,@G.2 ,]^];UH\LWQ@EO38WT=M
M+H44"S26KJ@D$SN4+8V@[6!ZT :]QXWT6V:9GDG-M!=+9SW2PDQ0S-MPC'J#
M\R@G& 3@D5$OBT/X^E\-BRN0L-HL[3>42&+/M&/11@\GJ?ISP'BJ34M5T'Q-
M:RZ/JJWL.J(T-K:6;K"T"S1D3948F9E!)R6([* ":ZDFY7XJR79L;]+?4=$B
M@AG6W8JCB5R0YZ(0&!^8CTZ\4 ;MQXST:V3SY99A8>?]G-]Y1,"R;MN"_IN^
M7=]W/&:BU;QUHFCZE<:=<F\>\@@%P\,-G([&,G&Y<+\PZ\C@8.37$6=I??\
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MFHFYO-8NI+:'[%+OE1Y%*LHVY((!YH ] ;QUHL>J?V=(UXD[Q&6#=:28N0,
M^5Q^\/(Z9SG(R.:?;^-M$GT.]U=IY8+>RF,%RD\+))%)D#84(SDEEP!UR*Q=
M7:2X^(G@NZBM+UK>&"[$THM)-L1=$"ACM^7)!ZU@2W&J6%MXXN+31KN=I]7A
MEC$M@[YAQ&K2QHRX<KM) YY /2@#OHO%FFO)J,4HN8+C3HEFN8)(&+K&P)#
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M7=DL  <#H,Y /;%(90PS@C/(Q6'?^+M+T\7CR&XDM[%MEY<0PL\=N< D,1Z
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M4X=8TR#4+=)4@G7?'YJ[2R]CCT/45AR^*I#\0/\ A&1I]UY0L?M#SJ!SND"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *RO$NBQ>(_#6HZ1,<+=0-&K?W&ZJWX, ?PK5HH \F?2O
M%MQ:^'_%?V=X_$6187$#$XCMY%\LNP]I!YWT;':M[Q58FSU3P3!965Y+:Z=?
M!I##;O*(HA$R L5![D>_>N[HH XOQ!%/)\3O"-Q':74EO;17JSS);NT<9D5
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MXK.ZO);_ $R!!*\:7+;AL7HQ3 &!ZG''->P44 <[X5%G,EU?6/AXZ/#<%?\
M76P@FG(S\SJ.0!G W<]>,8SG?$"&Y63PWJ<-G<W4.G:LD]PEK$99%C*.I8*O
M)P6'3FNSHH \N<7]QJ_Q!NO[&U-(=1TN%+0M;-F5A#(N !SG++QU&><8.'/!
M=_V3\-8_[.U#?820F[46<F8 MN4.[Y>/F('Z]*]/HH \E@_M/1O#'C3PS>:1
MJ<UY<O?3V=Q;VKRQW23*Q!W@8# GD$@],9/%-:"\T>\\.:SJ'AB]U+3FT.'3
MKFWCM?-GM)D.0WE]<')!QZ?3/KE% 'F>MVN;/PQ)IWAJXL(%\017SVUO9'>D
M05@TDJH"%8D@XZXQW!QH>,M+M]2UN.9&UC3-3M[0-9ZMI\$D@Y9LPNJJ0PX4
M[3USV[]Y10!YLPUY-:\!:OJNE7$MS%97,-\MG#N$4LB1[0P'"@E3S]T'N!3]
M#6\\.0^*M&U'3KZY:ZOKB[LY8;9Y4NDF&0I8 A6!X.XCUZ<UZ-10!Y5H?AW5
M/!&K^%KVZAGO+2+16TN\-M&TQMI#()0VU025S\N0.,#-0:_X7UF_C\4Z_IMG
M,QNM0L;JWL9%,;W"6P&XE3R"QS@$9.T<<BO7** /.Y=1FUSXA^$]3M=&U>.T
MAMKM)WN+)XO)9Q'@-N ].O0]B<'';:W;RW>@ZC;0+OEEM98T7.,L5( _.KU%
M 'ET6G7.O?#[PQX96PO8+VT:S%V]Q:O$ML(-I<AF #$[=HVDYW9Z9-:7C#2-
M0A\6Z=?:.P1M:C;2+\!L$1[6=9E_VD59/S KOZP]-\-+8:Q<ZG/J>H7\LKN8
M4NI0R6RN02L8 &!P!SDX&/7(!LPPQV\$<$*!(HU"(B]% & !7&7:75E\7HM1
M.GWDUG<:*+19X(2Z)()RQ#$?=^4YYZ]!D\5VU% 'CEW8:A-\)_&6GII6HF\O
M-4N9+> V<@>17F#*P&WI@9]N]:VJ%](\<W6JW_AF]UC2-6M8!%+;V1FEM98P
M05:,C<H(.<^OXUZ;10!F:!;1VNBP1PZ7%I<1W,EG&BJ(@6) (7@-@Y..Y/7K
M7(W5WJ'A/XC:KJ$VCZCJ&E:S!;B.:P@,S02Q KL91R 0<YZ?KCT&B@#@?$BW
MMQ?^"YSI5S'Y&I&XGB@@:06\91U7>4! /S*#@]<XXYKF_&,>M:SHGC'3YM%U
M5[Q;D?88K6!A;R0 IB3(P)7(!R#N(XP!@U[%10!PURUQ<_%+0]0&GWZ6JZ7/
M&\C6S[8V=D*JQ (!PI[\=\&L%;6];P'\0[7^S=0%Q?ZA>O:Q&SD#3+(JA"HV
M\@D'Z=\5ZO10!YW>QW,FN?#R=+"_,=F)3<M]DD_<[K<QC=\O'S<<_7I7/ZH=
M9U32X9+S0M8_M&SU^*>6""V801PK/D-&!@297DMACDG) Q7LE% '!Z49XO'W
MB^^FT^_BM[FTM!"[6DA#LB2!U! ()!8#C.>V:YS3;#4K+P5\/9)=)U$OI5]_
MID"VKF6(%)%SLQDC+#D>M>OT4 9MKJS7.L7&G-IU] 888Y3<2Q 0ONS\BL"<
ML,<BM*BB@#@O#B7"?%?Q;=R6-[':WL5HMO/):R+'(8T(?#$8X)[]>U6&69/C
M$]\;.\^QC0OL_P!H%M(8_,\[?M# 8)V\_IUKM:* /&+?2]6@\)Z;?KH-W>-I
M>NW5U<:;+;LKS02F0;D5@-Q"N"!7H'A1K&\EN-1L/#4FD1R*J-)<V@MYYB,\
M%>NT<<GJ2<=.>GHH XSXC0W%Q8Z&MM:75RT6M6EQ(+>!Y-D:/EF.T'  K(US
M2;W6_&OB*"W@NX8[_P -_88;I[>18O-W2':6(QT8?_KKTJB@#R^ZM;[Q/X!T
M7PVVF7MIJD,MHESYMNZ);B%E+R"0C:P(4[=I.=P]\;6CK=:;\2O%;W&GWOV>
M_%K-!<I"6B*QPE6^8=\C&WJ<],5VU% 'D=O9:@OP$U'2CI>HC49!=1I:FTD\
MPEYG9>,=,$'/2MWQ5Y]Y;>"WM["_D^SZM;W$X6SE)BC6-U8L-N1@L*[^B@#S
MBPOM1\)^*?$5A>:#J>H6FJWAOK.YL[?S4;>BJT;G("8V@?-@8S4FL3:O/X@N
M=/O=(OOLTFE(+<Z;&?+EG.[<DDHQ@+D;5)"G))SD"O0Z* /(].MM2M= ^&]W
M+HNI@:5(T5W$+8F5,P,@;9U"[CC)QZ],5LW.G7FJ>/O$<:VUW;17V@I9Q73P
M.(UES)D;\8R-XZ'Z5Z'10!Y1-8:AKWPGL_!<NF7MKK$:VUG*7MW$40B=,RB7
M&PC:F1@DDG'6M[31-;?$;Q=>2V5\MM/:6J0R_9)"LIC63>%(7G&X=.O:NYHH
M Y'X86]Q9?#G1K.\MI[:YMXC'+%/$T;*=Q[$#UZUUU%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO,5 F[&<9VGZ=\5'X<FO-%'C2_DTC49?,U.2[MH$@(>X3RT4; <9.5/'7VH
M[JWF%Q;13!'02('"R+M9<C.".Q]JDJ."4SV\4IC>(N@8QR##+D9P?<5)0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445'//
M#:V\EQ<2)%#$I>21SA54#))/84 245E2:RZVUC/%I=],EW<)$ B#=$C9_>N"
M<JO'/<9'&>*LP:E!-J,^GL&BNHE$GEO_ !QDX#KZC/'J#UQD9 +E%%% !111
M0 445B:GXEBTV]GMO[-U"Z,$ N)9+>)2B*=W4LPY^4G ]J -NBN7TWQQ::K;
MV%S;:7JOV6_S]GG:%=C':2 3N^7.T@9QSBM'PUX@M_$^BIJEK#/#$\DD82<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !-K)D^OR&M"JNI67]HZ=<6?VB2 3QF-I(@NX C!QN!'Z4 <S\+5#?"_P[N
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MFS"[0 W/3G)SF@^ X9-3GU&XUO59KNXTYM/G=GC7>AW8;"H I&XX P/4$YR
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 445B^*=>'AW0WO%C$MS)(EO:PDX$
MDTC!4!]LG)]@: -JBN:U66TT\:):ZEX@N[:[EOHRAB.#=R<_NV !PASTXZ=:
MFBN=/NO&%]:1ZU=/>+9*LNGJY$<2[C^\&!PYSC.>U &_17/^'M9EN=2U;0[U
M]]]I<B R8 \Z&1=T;X'&<94XXRI/&<5T% !1110 4457OKV#3M/N+ZY;;!;Q
MM+(?15&30!8HKBO 'B/5-4EUG2M?C6'6+"ZWM$.T$HWQX]< E?\ @(KL;BXB
MM;>2>>01Q1J69FZ 4 245SMAX[\,ZG+LM-6B<_9FN]Q5E41*<%BQ  QD<9SR
M#5JW\4:3=7D]G'-,MW!#]H:WDMI8Y&C_ +RHR@N,\?*#SQ0!L45YQH.K/XI%
MWJ\NLZAIK:?J<S'Y'2W-K$^WRW#@)D@9)^\"3T Q770^*]&FNYK3[6T-Q%#]
MH:*X@DA8Q]-ZAU&Y<\9&: -FBN=L/'?AG4Y1'::M$Y-LUUN*LJB)3AF+$ #'
M'&<X(/2K$/BO19KJ>U-VT-Q!#]H>*X@DA;RLXW@.HW+GC(S0!M45SEKX\\,W
MDUA%;ZHCF_;9;,(G".QSA=VW 8XX4D$^G-7=3\2Z3HYF%[<LOD1B6?RX7E\E
M#G#/L!V#@\G'0^AH UJ*S;K7]-M(896G:99HO.C%M$\[/'Q\X5 3MY'/3D58
MTW4K+5].AU#3[F.YM)UW1RQG(8?_ *^,=J +5%<WH_C"UUCQ#J^EQP7,?]GN
ML1>2WD4,VW<Q)(PHP1C.,]1D$5;@\5Z+<W=K;QWA#7>1;.\3I'<8Y_=N0%?C
MG@G(Y% &S15#6M6@T+1KO5+I)GAM8FE=88R[$ 9X _GT'4X%<-K?BJ>YT[P5
MK4-[<V$%YJ-O'>1,IBC96B:1@2R@E00.0=I]Z /2**R=+\3:/K*7C65X&^Q-
MMN1*C1-%QD%@X! (YSTI+3Q/I%[J::=%<NMW)$9HHYH)(O-0=60LH#C_ '<T
M :]%5;[4+;3HHWN7*^8XCC5$9V=B"<*J@DG )X'0$]JS9O&&@VUK'<7&H+!'
M)<_9%\Z-T;S<@;=I (ZCJ,"@#<HK$T;Q=H/B"\N;/3-02>YM@&EB*,C!3T8!
M@,K[C(Y%.A\5:-/J%M8I>$3708VQ>%U2?')\MR K\<_*3QS0!LT5C7GBO1+"
M<Q7-[Y869;=Y?*<Q)(>B-(!L4\C@D=1ZU##?Z<WB^_2/6+F6[@LE,VG+EHXE
M#$[P OWSTX)/'2@#?HKS"WUG_A*8==O)]>U713IVI2QQSPQR)&EO'M4JP9=A
M8Y8_-\P)'&!BNSTW5=-L_"^F7/\ :<UY;30QK;W,P9YKK*Y4[0-S,1S@#/6@
M#<HK/TK6]/UJ.=K"X\PV\IAF1D9'B<=596 (/U%4M2\9>'](O9K*]U*..ZAB
M\YX51G?;G' 4')]ASP3V- &[17/_ /";^&CHUIJXU> V%W((H9N?F<G&W&,@
MYZY QWJ2U\8:%>VAN;:^,J?:6M0J0N7:51EE5-NYL#G@'CGI0!N45B'Q=H:Z
M1=:H;TBTM',=RQA?= PZATV[EQ[@5;.MV @L)O-D,=^P6V(@<[R06'&,C@$\
MXX!H T**YO2=7TA3KM[%KLUY#!=?Z0)FREJP5?W:<#CH<#/)]:M3>(-+GLM2
M5[R>S%K 'N'DA>%X5<,%<;U']UL<'D4 ;5%8>G:MIMEX8TJX.ISWEO/%&MO<
M3*SS765R#M W,Q )P!GJ:>OBO1&T^]OC?K'!8DK=>:C(\! SAD8!AQSTYH V
M:*P;+QGX?U'4;6PM=162XNXO-MQY;A90!N(5B-I8#DKG([BK/_"1Z7]K2V$\
MA9YS;*X@D,;2@D% ^W;D$$'GJ".QH U:*CN+B&TMI;BXE2*")2\DCMA54<DD
MGH*SK/Q)I5]J"V$5PZ7;Q^;'%/!)"TB=V3>HW >V<4 :M%>=KJLOB_Q/X@TB
M'4M5TTV1@CL9K>"6/8QC\QVD!4*<D@;7X(''7-=%XE\50>&/[*AGBN)Y;^[C
MM5:.!W R?F)V@\X!PHY)Z# - '145Y^WB8:7\2=16_U.Z.F'2(;F&W:-B59I
M'!VQJNXG"\\$CG-=;%XATJXT>VU:"\66RNL>0\:LQE)Z!5 W$\'C&>#Z4 :=
M%9^E:YIVMI.;"X,C6\ABGC=&CDB?T9& 93]17*>+;O4XOB#X2TNSU>[M+35/
MM8N4A$9SY409<%E..>M '=T5YM8:_K3:OXU\-3ZE)<C2K99[;4DC194WINV/
MA=I8>N!T/X;GA;Q###X$\,W.JWDDMY?6<6WY6EEGD\O<V%4%F. 23CB@#K:*
MPI/&?AZ+1QJTFI1I9F8P;V1@PD#;2A7&X,#P01Q4VF^*-&U?4KC3K&]$MW @
MD>,QLN4)P'4D .N>-RY% &O15:^O[73;8W%Y,(HMP4$@DLQ. H Y)). !R:I
M6_B;2+@7NV[\M[(!KF.>-XI(E(R"48!L'L<8- &M17.VOCOPU>W%A#;ZHKM?
M\6S>4X1VQD+N*[0Q SM)!]JV-1U&UTG3YK^]D,=M I>5PC-M4=20H)P/7M0!
M:HK&/BO1A+ID7VI]^J+OLA]GD_?#&>/E].>>W/2N=^).NR0>"M<;2=1NK6_T
MXP^8T2%,;G48W%<<JV?E.>E '=T5CV/BK1=1U6?3+6^5[N&+SF0HRAH\XWJQ
M #KGC*DBJNA:KI*Z5J=_%KLM[9QWDQFGNGX@;(S&IP/E7( Z]>IH Z*BN9U+
MQ%9:AI6LVFGW\]MJ5K9//L:%HID&TE7"R+R,C&<'\ZS_  7XRTVZT'PW87NI
MM+J]Y81-F17/FR>6&8>9C:7ZDC.?:@#MJ*S=?UJ#P[H5YJUS'-)#:Q-(R0QE
MV.!GH.GU/ ZFN,UKQ/-(W@K58[ZYLK6[O%2\A9#%&P,+.<[E#$9 P<X- 'HM
M%9&F>)]&UBWO)[.]4I9,5N?-1HC"0,_,' (&.<]*6S\2Z5?:G_9L-PZWAB\Y
M(9H)(C(G3<F]1N'N,T :U%5K_4+73+4W-Y,(H@0N2"2S$X"@#DDD@ #DUQVC
M:[+??%35[1+^[>QATR*7[/<1F(0R&1@?E95/W0IR<]>M '=45BP^+-%GOX;)
M;PK-<1M)!YL+QI.JC),;L K@#GY2>.>E4_\ A87A7RTD&K(8WG^S^8(G*J^[
M;AFVX49X!; /8T =-16%->6#>-;6T_MBX2_6TD8::C?NW3*_O&&.HX Y'6GI
MXMT22[@MDO<M/.UM#)Y3B*25<Y19,;"W!& >H([4 ;5%<?HMY>M\3O$UC-?3
MS6D-K:20PN1MB+^9NV@ >@]_>M/Q/>6%M!81WVL7&F&:]A6%K=L-,^X8C/!^
M5L@'^= &[165?^(]+TQYTNIY!]G4-,T<$DBQ ]-Q52%]>>U7KU'DL9UCF>%R
MAQ)'C<IQU&01^E $]%>=> _B!I4GA?P]::QK6_5[R( M,&.^0DX4OC:&/'RD
MYZ<5U>H>+-$TN:XCO+PI]EV?:76%W2#?]WS&4%4SD=2."#0!M45FW^O:=ILC
M1W$TFY(O/<10O+LCY^9M@.T<'D]<'T-+=:[I]I#!(\LC^?'YL:0P/+(R8!+!
M$!;'(YQW'K0!HT5DQ^)M&FT>WU6&^CEL[E@D#Q@L9&)QM50-Q;(/RXSP>.*Y
MCPWXA-QXW\9F?4;J73K&&UD6.XC9/L^5D+@(5!'0=LD8ZT =[1573=2M-8TV
MWU&PF\ZTN8Q)%)M(W*>AP>1^-6J "BBB@ HHHH **** "BBB@ HHHH ****
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M6Y4K)8M$1YC..J  , 3C.1CK7JM% &/XL@EN?!NN001M)-+I]PB(HR68QL
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNKJSE6*,JC(KLF,$GJ!ZFF?##5;G5O 5A)>2-+<V[26DDC=7,;E Q]R ,^]
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MJPR#@].#7$VOB&[U73_'&F7,AF3382L,[P&%W22 O\RD#D'/( R,<5O> ?\
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M0;00$DQE-YSUP<$=>U=FOA<W6I:CJ>IW"27EY9?8%\E"JPP\D@9)))9LDGT
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M#*X&<8!SWQG.9'\/[R+PGX>T)=9@_P")->0W2S&R/[WRF+*I7S..O)S7=T4
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M+:S'$AC-J<0^6A12#O\ FX)STY]*R&^'$\6AZ#;V.O/9ZMH:M'::A'; AHV
M#(\98A@0!W[4 -7Q)XGTVS@L=7L6%]>:H;.RN (MTL&QG\PH'VA\(1C(&2#@
M]*;?>*/$GA>PUV[U6R>>RA$0TRXN3$DDDDC!/+D$9Q@,P.0!QGO6EJ?@>;6=
M 2VU#7+E]7CN$NX=3CC5##*@PNR,<!0"1MSSDG.31<>"+C6O#E]IGB;6Y=3F
MNHQ&)XH%MQ#M(8%$&?FW $DDYP!P* ,K6+34+;XG>!#>:D;Q6-[D-"J;7^SG
M.W:/NGT.2,=30OB/Q7K.C0Z]X?LYIP]R=EDP@6&6 2%#\Y8.'P,YZ9XP>M:4
M?@[69]7T'4=3\2K<S:.9=ACL1&9@Z;#NR[?-C/(X]A46G^ K_2;RYM]/\2W$
M'AZXF:9],^SJS)N.61)2<JI)/ &1DX(/- #CJVH>)3XG2PO?L5MI4CV48$2N
M99EC#.7R#\N6"@+@\$YY&(O <&IS?#GP<VGWL5M''%$UTLD.\S18.44Y^4YQ
MS5L^"[RSUW5KW1]:%G::O\]Y:26HE'F;=IDC;<-I(ZY##VJO#X<USP[X?\.:
M1I&NR,UC,B2@V2E;F'(#*QS^[ 7)SG)Z#G% '<4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4R2&*7'F1H
M^.FY0<4^B@!  H    X ':EHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *CD@BE(,D2.1TW*#4E% !THHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *1E5U*LH93U!&0:6B@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***RO$6MP^'M%FU"5#*P*Q
MPP@X,LKL%1!]6('MUH U:*P+^6>VCTF&Z\1P6-W)=QEU,:?Z4.\"*W(!)&",
ML,=:TK?6-,N[Z>QM]1M)KNW_ -=!',K/'_O*#D?C0!=HKG=:\11V&COK]C=0
MWFGV;$7B0L''E@X=E(Z.G7'< C&<$=!'(DT221L'1P&5E.00>A% #J*** "B
MBHKJYAL[2:ZN'$<$*-)(YZ*H&2?R% $M%<AX#\5W?B2+5;;5+7[)J=A=E7MV
M&&6%_GB)_P" G'_ :VKSQ+H6GO<)>:Q8P-; -.LEPH,8/ W#/&>WK0!JT5%;
M7,%[;17-K-'-!*H>.6-@RNIZ$$=1275W;V4#3W4\<,2X!>1@HYX')H FHK*'
MB;0O[.;43K%@MDDGE/.UPJHK_P!TDG@^QYJPFL:9).L":C:-*\/GJ@F4L8O[
MX&?N^_2@"[16-_PEWASSK:$:]IIDNF*P*+E,RD,5(7GGY@1]1BLR35=2C^*M
MOI!N@=-ETB2Z\CRU&)%E1<[NIX)XZ<T =916='K^D37ZV,>IVKW3,R+$)069
ME^\H]2.X'(J"Y\6>';)96N==TZ)8I!%(7N4&USSM//!QVH V**IWFK:=I\<3
MW=[!"LN3'N<?/@9.WUXYXK*UGQIHFC6.FWDE];RQ:C<Q06SI*"KAV +[NFU0
M22>G&.] '0T5BB^AN?$MJMMX@MFC:T9_[-38S2@E2)MV=P '''!W59EU[2(+
MU;*74K1+EG$8C:4 [SR%_P!X^G6@#1HK-O/$.BZ?--#>:M902P1>=*DDZJT:
M9 W,">!D@?C5NRO;74K.*\L;F*YMI1NCEB<,K#V(H GHJ.XN(+2W>XN9HX88
MQEY)&"JH]23TJI:ZUI=[%<26VH6TB6W^O*R#]UQGYO[O'//:@"_17 Z)K]]X
MOO+F?2O$,%LUGJDD7V()'*DUK&P4L?XP6Y(8, ,@8KKM<UJQ\/:-<ZKJ,HBM
MK="['N?8#N30!H45P>J^+9I+WPA>:=J4":=J-R8[R-=C@#R6<@OVQ@9Z5UVF
MZUI>LVLESIFHVMY!&Q1Y()0ZJPZ@D=* +U%9]CKFE:E<R6UCJ-K<3QJ':.*4
M,P4]&QZ>_2KSJ7C95=D)& RXR/<9XH =17E5GXH\62>#_$>OKJ5G))HU[<Q"
MWFM0$FCA/.65@0Q&?;/:MB#Q5J&I>)/!$MO*8-.URQGN9;1HU)!6-&7YL9ZO
MVQT% '>T5G-K^D)?BQ;4[4732>4(C*,F3&=G^]CG'6HKOQ1H%@;D7>M6$)M2
MHG#W"@Q%L[0W/!.T\>QH UJ*YWQ3<ZM+X;2[\+WUL+IF22$M#YZ7*D$A%P>-
MW'S= ,GCJ-6\U?3]-VB_O;>V8J7Q)(%PHZMST ]3Q0!=HID4L<\*2Q.KQNH9
M64Y# \@BJ-_X@T;2Y6BO]5L[:18S*R33JK!!U8@GIR.?>@#1HK+N?$FB6=O#
M<7&K644,T:RQR/,H5D/1LY^Z?7I4QUK2QJ,>G'4K3[;(N]+;SE\QE]0N<D>]
M %ZBL+7-6LO[(U*.'Q'9Z7<0 ))=LT;_ &5SR-RL<9QV-:%UJECIEK'+?WT,
M2L.'D8+OP,D@?KQ0!=HK-_X2'13]C_XFUC_IO-K_ *0G[_\ W.?F_"I(-;TJ
MZGN8+?4K.::U&;B..=6:+_> /R_C0!>HJ&TN[:_M8[JSN(KBWD&4EB<,K#U!
M'!JK>Z[I.FRM%?:G9VTBQF5DFG52$'5B">GO0!H45E+XFT)M(&K#6+$Z<3@7
M/VA?+)]-V<9]NM/C\0:-+%=2QZK9O':2^3<,LZD1/_=;G@]L4 :5%5+#4['4
MXGDL;N&X2-BCF)PVQAU!]#[&HK37=)OKLVEIJ5K/<!2_EQR@L5!P2!W&>,B@
M#0HK..O:0NHIIS:E:B\=BBPF4;F8=5 ]?;K6=XM\06VD:'J(CU6VM-1BM7EB
M\PJQ5L';E3ZD8&>M '145SWA?7X;[P_H"WVHV[:M?:=#<-$SJLDI,:LS!!CC
MDG@8%7F\1Z(EG<7C:Q8"VMG\N:4W";8WZ[6.>#[=: -.BLV+Q#HTRW;1:K9N
MMFXCN2LRGRF/0-SP>V*=;Z[I-U8RWL&HVLEK"Q26591MC8=0WH>G!H T**J6
M6IV.I>;]BNX9S$0L@C8$H<9PP[''8U///#;023W$J10QJ6>21@JJ!U))Z"@"
M2BLZVU[2+M+AH-2M7%L T^)1^[!Y!;T![$]:BA\4Z!<W=K:0:U827%TN^WB2
MX4M*O/*C/(X/Y4 :U%8^OZU9Z98W$;ZI;6=WY#/&9&4E?1B#VSQD\9JMX%U.
M[UGP-HVI7\OFW=S:K)+)M"[F/4X& * .AHK"UWQ;I7A[4--LKZYCCGOY2B!W
M"A%"DEV)X XQ[D_6L.T\6BP\:>)H-;UJVBTFTBLWM6FV1JAE$A(W=6)VCOVH
M [FBJLNIV$-BE[)>0+:R %)C(-K@],'OGMCK18:C9:K:BZT^[ANH"2HDA<,,
MCJ,CN/2@"U16-XG\3:?X4T=M0OY H+".),X,CDX ^G/)["F3:C;W6MZ/]D\1
MVL<<@E;[$AC<WHVG!4YR I!.5Z]#0!N45C7'B[PY:QO)/KNFQHDOD,S7* "3
M .W.>N"..V:L)K^CR:O_ &3'JEFVH[=_V59E,F,9SMSGIS]* -&BLZ[U[2+"
M[2UN]2M8)W8((Y)0IW'[HYZ$]O6M&@ HKD_[5U&/XK?V0]V#IC:,UV(?+4;9
M!,J9W=3QGOCFK>GZU866GW]]?^*+*\M1>2!;@M'&D ."(<@X8KZGDYH Z&BL
MH>)]!-Q>6_\ ;-AYUDI>Y3[0N85!P2W/ !XJ"\UK3M0\+7-_I_B&SM+=XV6/
M4PZ/'"W3/)VD@]C0!N45S=YXPTG1]0T;2KS487N;Z,MYSLJ+L5"?,/8;B  /
M?CI6K+KFE07@M)=0MDN#(L0C:0 EVQM7_>.1QUYH OT45G3Z_I%M>BSGU.UC
MN"ZQ^6TH!#M]U3Z$]AU- &C167?>)="TUIUO=8L;=K<!IEEN%4Q@G W#/&3T
M]:D.NZ0+>TN#JEF(;PA;9_/7$Q/0(<_-^% &A1678ZWIFOV]R-%U>TN7B.QY
M+>19?+;MD URGA[7[W5OA;I>IZEXC@TS4+I_FO9(X\,1,1L"'"\J-O'/.>M
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ML>@8GC!YKU.WM;>TC,=M!%"A.2L:!1GUP*;%9VL 40VT,80DKLC VD]<8]:
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M8>W(56_NDG P<&@#T^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "N<\9Z#>>(])M[*SE@B,=W#<L\V?^6;AP  .^.O
M;WKHZ* (X8ECB"B*.,GEE3IGOV&:> !T %+10 Q(HXRQ2-5+G+%1C)]Z7RXS
M*)-B^8!@-CG'IFG44 ,>*.1E9T5BARI(S@^U*\<<H D17 .0&&<'UIU% #?+
M384V+M.<C'!SUH6*-  J*N %X&./2G44 ( !T %-6*-"Q2-5+G+8&-Q]Z?10
M Q(HXW9DC16?[Q P3]:K:?IT6GBX9#NEN)?.F<@#<V O '  "@?ASDY)N44
M(54L&*C<.AQR*0(H  4 #H,=*=10 @ !R *:D,4?W(D7DGY5 Z]:?10 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6FZ%:K<ZG>1VT3.(U9\_,Q.  !R:OT %%%0W5U!96SW-S*L4,8R[MT4>I]J
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MV\"HP;Y5)+,QQR21V].="]T+4KSQGHFN%K1(M/@FADBWL2YE"Y(.WMM_'VH
MR;+QU>PZ)J3:I;V[ZG9:N-)7[,C^7,[%-CA?F8##Y*C)^4XZU*?$_B*WN]5A
M?3EN+>#3VO+:^:RFM8]Z]8G5R3G'((-5I?A_?7NF^(;:XOH;:;4-3&J6=Q;Y
M9K:9=FW((&[&P<\=36I;Z3XMN](O8=<U'3)+F2U>VA2SC>.(EA@R2$DDGT
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MXR2:NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=-MM4M=,FOH$O[K/D6Y<>8^ 6)"]<8!YJ]7$^*U7_A8W@-L#=]HO.<?].S4
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MP#DLPS\I8[6;/3Y5_AY /8J*:CI+&LD;JZ, RLIR"#T(-.H @DO+>*YCMWD
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M02?W6DZDRVP_N0R 2*@]E)8#T&!VH [2H+N\M["UDN;J58H8QEG;ZX ]R3@
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MIKNC;#9ZA%&2 5 5@5)Y5@,%<^E/\2>&M8\0G0'>[L89=+OX[YR(W*RNF1M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***R_$>N6WAOP_>:M
M=NBQV\>1O; 9CPJY]R0/QH U**Y3P=>Z]JB-?7^M:#J6G.F(6TJ-Q\^1G+%C
MT';&:V-:.KO;QP:*;>*XE;#7-RA=(5 Y.T$%FZ #('4YXP0#3HKD/"6MZW-K
MNM>'M?%M-=Z:(98[RU0HDT<@;&5).UAM/?\ ED]?0 4444 %%%<=XPUS6=*\
M0>'+'3;BUCBU6Z:WD,]N9"F%W9&&7T[T =C17&Z5XGU-/B%=^$=56UG=;$7]
MO=VL;1C9NVE70LV&SW!Z=N:Z6YUC3+.[CM+K4;2"YE($<,LZJ[$], G)S0!=
MHJI'JFGRWSV,=];/=I]^!9E,B_5<Y%9^J:C%<6"MIWB"PLV6ZCC>=RDJG##=
M%RP 9AQZC- &W15._P!6TW2E5M0U"UM%?[IN)EC!^F3[TK:KIRW:6C7]J+F1
M=Z0F9=[+UR%SDCWH MT51BUO2I[>:XAU.RDA@_UTB7"E8_\ >(.!^-6XY8YX
M5EAD5XW4,CH<A@>A![B@!]%>?6.N>+-2U[Q7I]I>:6#HTD:P+-9N?.WQ[\,1
M(,>F0/?':MCPAXWL?$OA+3=:N6AL)+S>GDRR@9="0P4G&1\I/TH ZFBL\Z[I
M L(K\ZI9"SER([C[0OEOC.<-G!Z'\JM)>6LEF+Q+F%K4IO$RN"FWUW=,>] $
MU%5;+4[#4DD>QOK:Z6,[7,$JN%/H<'BF6>L:9J,TD-CJ-I<RQ#,B0S*Y3Z@'
MB@"[17%>-_%C:5!9QZ3JMBMX=1M[>>W)6238\BJP S\I /H>O:NJ&JZ<QN0M
M_:DVN/M&)E_<_P"_S\O0]?2@"W15,ZMIHA@F.H6HBN#MA?SEVRGT4YY_"HCK
M^CC3UU ZM8BR<E5N/M">6Q&<@-G!Z'\J -&BHX)X;J!)[>6.:&0;DDC8,K#U
M!'44]@2I"G!QP<=* %HKB_"?B74-0O?$QUF\LH[32=0>T1UC\H;0 =SL6([@
M=JA\+Z_J/BY+/6-.UFS2'[3*+K3&5'VP!W1""/G5R%!Y.TYZ<4 =U16)K'BS
M2-"U73=.OKR"&XOW8(KR!=BJC,7;/097;[DUC:;XJ>W\6^*K37-4LH=.T]K0
M6TDFV%5\V-F(+$\GIW[=!0!VE%5[B_L[2U^U7-W!#;G!\V20*G/3D\4ZTO+6
M_M4N;.YAN+=QE)87#JWT(X- $U%<=XTUS6-'U?P[:Z9<6L<>J7HM)//MS(4^
M4G<,,OITJ/3/$VKGQOJ/@_4?LC7<=D+VTOH(65&0L%P\98X8$]FP?:@#M:*Y
M/P/XDEU/X>Z;KFN7<$<LX<RS.5B3/F,H'H.@%;RZSI;Z>^H+J5F;)"0UP)U\
MM<=<MG H O453@U;3KJ^EL;>_M9;N%0TD$<RLZ#U*@Y%7* "BN.USQJ='\<Z
M-HY@S873>1<W)Z13R F%,^IV-D?[2UU\DB11M)(ZHB LS,<  =230 ZBN,@\
M4R7GQ+BTNTU2RN=);2Y+EE@VL4D61!\S@GLQ...O>NB'B#16DMHQJ]@7NF*P
M*+E,RD$@A1GYB""..XH T:*IVNK:=?7-Q;6E_:W$]N<3113*S1'_ &@#D?C5
M'3M1CM=/O+K4M?L;J%+J3%PI2)(5S\L;')&5'&3R: -JBJEOJFGW=Y/9VU_:
MS75O_KH8YE9X_P#>4'(_&J>EW?EVE_<7NMV=[#'=2$31A46W3C$;$$C*CJ3@
M\T :]%8.K^,="TC0+S6)=2M9;:U!#>5,K%GQD(,'[Q]*NKK^D&"*8ZI8A)59
MD;[0F&"@EB#GG !SZ8- &C16;+XAT6"&&:75[".*=/,B=KE LB_WE.>1[U5U
M7Q=HVCZQIVEWE]!'<WVXJ'E"A$52V]B>@)  ]2>.AH W**I7FL:9I\J17NHV
MEM(^-J33*A;)P, GUI]UJ5A9.B7=[;0.X9D6655+!068C)Y  )/H!0!:HJ*V
MNK>]MH[FUGCG@E7='+$X96'J"."*YKQUXE70O#.J2V6J6-OJMO;--%%,59F(
M4D (2#DXXZ_0T =5165!K-K:Z%8WVJWUO;>= C-)/(L:EBH)ZX'K5IM4T]4M
MW:^M@MS_ *@F5<2\9^7GYN.>* +=%9\6JV&I:=<7&G:I9R1H&0W$4JR)$P'?
M!QQP<9IFG7:V_AZUN=0U:UN@(5,E^NV.*4_WQ@X /UH TZ*IPZOIMQ8-?PZA
M:26:YW7"3*8QCKE@<4^SU"RU&-I+*[@N41MK-#('"GT..AH LT57N+^SM)$C
MN;N"%Y Q19) I8*"3C/7 !)]A4=IJVG7]DU[9ZA:W%HN=T\,RN@QURP..* +
ME%4K36-,OUE:SU&TN%AP93#,KA,C(S@\<5G:EXS\.:7I\][/K-B4B@,^V.X1
MF= <94 Y.3P,=Z -ZBJ>EZE;:OIT-[:312QR*#F.0.%.,D9'<4M]JNG:8%-_
M?VMH&SM,\RIG'7&30!;HJO-?V=ND+SW<$23LJ1,\@ D9ONA<]2<C&*+*_L]1
MM_M%C=P74.XKYD$@=<C@C(XR* +%%4;K6=+LKE;:[U*S@G;&V*6=58YX'!.>
M>U8>IZQJ5I\1M TI)XO[.OK:YDDC\KYMT87'S9Z?-V Z=Z .JHKE?">L:EJ.
MM^)[/4)XI5T^_6"#RXM@"&-6QU)/WNYKII[B&U@>>XECAA09:21@JJ/<GI0!
M)15.'5]-N;.6\@U"TEM8B1),DRE$QURP.!7(>'?$&H>+FAU/2]:LXXH[V5)]
M-94?-LKL@;(^<.=H8'.WGIZ@'=T5BZ[XJTGP[<6%OJ%W#%-?3"*)'D"\=V.>
MB@#KZX'>L6U\526_C?7;35-4LHM'M;.VN+>1]L2KYA?JY/.=H[X]J .THJO)
M?V<5D+V2[@2U*AA.T@"$'H=W3!HLKZTU&V6YL;J"Z@8D"6"0.I(Z\CB@"Q14
M%W>VMA!Y]Y<PV\6<;YG"+GTR:Y?QMXBNK#PG#K&@WULZ-=01^:JB571Y50[3
MG'<\\T =?15.^U?3=,V_;]0M;3<"5\^94R!U(R?>JVJ3OYNEFWUBULEDN5++
M(JL;I,']VF2,$Y!R,GB@#5HK/NM=TBR$YN]5LH!;E1-YMPB^66SMW9/&<'&>
MN#3CK6E"\M[,ZE9_:KA-\$/GKOE7KE5SDCW% %ZBBL?Q'XETWPOIHO-2N$C#
MR+%$C, 9'8@ #\\D]@": -BBN-N/%$L/Q LK4ZG9_P!@S:5-=EQM"AD=%W&3
M.,<GI@?6NIAU&QN; 7\%Y;RV94N+A)5,94=3N!QB@"S156QU.PU.-Y-/OK:[
M1&VNT$JN%/H<'@U-<7$-K \]Q-'#"@RTDC!54>Y/2@"2BN7\5>(6A\":OK/A
M_4+266T@DD65,3)N49(X.,_7IZ5J0ZS:6NC6-WJE];6QGA1B\TBQAFV@G&<?
M6@#4HK(U>[\S2K>>QUNSL%EFB*74@61)$+#*KD@$L. 0>_%6KK6-,LGE6[U&
MT@:&/S9!+,JE$SC<<G@9(&: +M%9QU_1E^R9U:Q'VS_CUS<)^_\ ]SGYOPJ2
M^U?3-,95O]1M+5F&5$\RID=,\F@"[15:?4;&VDCCGO+>)Y5+1J\JJ7 !)(!/
M( !)]A69J7B[0]-\-W&OMJ5K-I\*G$L,JN'8?P*0>6)XQ0!N456L+^VU*RCN
MK2>*:)QG=$X<9[C(]*LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 52U2^TRPMD.JW-K!!-((E-RR
MJK.>B\\9.#5VH+NSM;^W:WO+:&XA;K',@=3^!XH X_P_HUCIOQ"U.ZT 11:7
M/9+]LBMR/)%UO^4@#@-LSN ]5)ZUL7WC30++08]9_M2TDLYG,=O()U"S/DC:
M&)QU!R3P,$FMN"WAM8%@MX8X8D&%CC4*JCV JLVC:6UO';MIMF88L^7&8%VI
MDY.!C R: ,+PIJ&AW-W>&SUBPU+5KP_:;Q[.82JH&%5<CHJC &<$\GJ37556
MM=.LK$L;2SM[<O\ >,42IGZX%6: "BBB@ KSOXC+'+XK\"022M'OU-QE)"C?
MZLC@CD<D?G7HE<YJ_A_4=1U%KB&[TA(\ (MSI/GNN!_?\P9Y]J .9\("+PIX
MSU+0-:(DU*^8W%CJT[9DOH?^>;,?XTZ;1VP0/7)M[G0]4M_%7A_Q7KLMC<'4
MYVGM',2--&7S"T>Y"[?*$ P2>!CM7:W'A_Q!>*BW.L:-.L?W!+HA8+],S<4V
M7PWKL]Y%>3:KHDEU",1S/H>73Z,9LB@#&\2E_"?B#0O%=O;W$T4T TJ^B(S*
M^X9@)Q_%Y@VD_P"W3/'FFQZ=X'TE+CRGNDU:TDDFP.97G#2,/3)+'Z5TDFE>
M*95"R:_I;J&# -H[$ @Y!_UW4$ _A45UH/B&]55N]9T:X"G*B712^/IF:@#G
M+S4["#XB^)--\0ZR=+BN[6#[(TQB6.>#80ZAI%(X<OQD=:CU6PL?#'AKPMXD
MTEKJ6RT*;RVDF^:1[&4[&/ Y RC+QT KH[KPUKE\D27>J:'<+"<Q";0]X0_[
M.9N/PJS)I7BF6-HY-?TMXV&"K:.Q!'T\Z@#C--@U&S\3ZAX<N;9DMO%&-4VA
M,+ I.+F)O<H$7/J^:]7  & ,"N;.E>*3*LIU_2S(JE5?^QVR <9 /G=#@?D*
M<=.\6$8/B+3?_!0W_P ?H Y'P]I=OK?C[XAVLMW<I$UQ;)(EM.8]ZF'!!(Y[
M$<8[U8\7Z'H^FW_@+3K>QMX;2+51#'%MXV>5(=O/)!;&<]2>>M;D'AK7+6;S
MK?5-#AE_OQZ'M;\Q-3KGP]K]XZO=:OHL[I]UI=$W$?3,U &3:I!I'Q?2P:WA
MM+&31R-,2- D>_S2TRJ!QO.5)QR0!7(W4DVBV.HW85O^$6B\7QR2*@RBP#_6
M$ ?\LQ-MX'&5->B7GA_Q!J,(AOM7T6YB!W!)]$W@'UP9JD_L7Q+]F^S?VYI/
MV?;L\K^QCMV],8\[&/:@#FO&%QH]YX?\3:KX89+W4IK*+[;<6,WF*T*N,J<$
MKN,9D[9P.>V0SZ'K4\.N^'M?FU378=-N%LHH6B^13&2!*B(" &V@!NC$>]=%
M9Z!XAT^W%O9:QHUM""2(X=%*+GZ";%,L_#FNZ>939:KHEL93ND,.A[-Y]3B;
MF@#S^\U71+GX/>$REU;>?;WUB9E=QYB3+(/.+ \@Y+DD^N>]=19:C8V/Q+\9
MM=W4$(N;&QDAWN!YJA) 2O\ >Y(''J*U/^$4U?SY)_M^@>=*P>23^P1N=@<@
MD^=R0>]32^'M?GNXKJ;5]%DN8@1',^B9= >H!,V10!YQ8KI][\-OAB)/L\N-
M9MX9,D$@;9<H?;ID?2NGU6YT[PU\2K2UN;M-"TJXTQA9RQ1Q1P^>92TJDLI5
M68;#VS@5N-X6UEXHHFU'06CA&(T.A9"#T \[C\*DO/#VOZA;BWO=7T6YA!!$
M<VB;U!'0X,V* (_"S^&_#FB06MAJA:QN[YX[22XE7;-*YR5BP "N[=C QG..
MU==65I^EW"6T<>K2V-\\$@>W,5EY*PX&!A2S8(YY!'6M1E#J58 J1@@C@B@#
M@/AQ)&^L^.@&4XUZ4GG_ &5_P/Y59^$;(_PUTUD*G]Y<<C_KO)751Z1ID._R
MM.M$\P;7VP*-P]#QR*EM;&TL@PM+6"W#?>$483/UQ0!QOC2>"T\=^!KFZECA
M@2YNPTLK!57-NV,D\=:SK6UL;[QQ\1GN(8)MMI: &10VU3;MGKTS@5Z-/:V]
MTJ"X@BF",'42(&VL.A&>A]Z@.DZ:7E<Z?:;I<B1O)7+]^>.: /(](UA=-T[X
M<W.J:E+8Z7)I4D"W8V%(KC";=Y=6"_(K*#[GG&:]!\&6.C6<6J2:)?2WMO=7
MC3RSET:)IF W^64 7'3..,Y'4&MMM*TY[)K)]/M6M&.3 85,9/\ NXQ5B""&
MV@2"WB2*)!A(XU"JH] !TH X#XEA'U[P/$\IC+ZR "K;6'R$9!^I'YUU>E^&
MM,TC4;S4XDDDU"[ $]W<2F21E'1<G[JCT&!5ZXTRPO)1)<V-M/(!@-+$K$?B
M14[0Q/"87C1HBNTH5!4CTQZ4 >.>&]1T^U^&O@&.Y2(SRW[_ &6XGE*PV\BM
M+\[X(W<$@+D9)'(JAJ-Q97'@OXGPM=VUW(+PW"%=N#F.(;U'89X!_4U[0='T
MPVIM3IUH;<L',1@79N'?&,9]Z=)I>GS>9YEA:OYI#2;H5.\@8!/'.!P* .'O
M+:SL?B5X&%G##!YME>JWE*%WJ$C89QUYR?SKO+V]M].L9[V[E6*W@C:221CP
MJ@9)J(:5IPDCD&GVH>+'EMY*Y3'3!QQ4]Q;07<)BN8(YHCR4D0,#^!H \YU7
MPEK?B3P-?[KRRCN=1;^TD4VS>;%-PT2B3S, JJHF[;T%4-:\8KX@^&7AG7F8
M&Q?4[0:TJC(C16_>!A_=WA>.X(]:]46TMEM?LJV\0M\;?*"#9CTQTJ*+2]/M
MXI8H;"UCCE&)$2%0''H0!SUH X::\TFZ^-5@T=S9S"?098R5=6$G[U"J^_&2
M!Z5QRV=@O[/D=PL$ E745*R@ ,"+_ P>H^4D?2O9X-&TNU4+;Z;9PJ$* 1P*
MH"GJ.!T/I1_8NE>3Y/\ 9EGY6=VSR%VY]<8ZT <A-:V=G\9-+AMH((4DT*=&
M2- H91*F 0.HZUQ6H16O_"F/&H"1;(M=N/+P!A/])3&/3BO9_P"RM.\Y9OL%
MKYJ@*K^2N0 ,  X]*8-%TH1-$-,L_+8ABGD+@D=#C'7F@#C[NTLK+XO>'X[6
M""%9=)ND98U"AU#1D @=1U_6L+1[.UNO"?B6S34ETL_\)9,+6Y105BF69&B!
M4\$;@HQ[UZA_96G>:DOV"U\Q  C^2N5 Z ''%-&CZ8L,D(TVS$4F"Z"!=K8]
M1CF@#RKQ'?ZG<^ O'FGZU86L>K6<,)GNK(DQ708 JP!Y5@J\CZ=JVO$(TC5?
M'_@&1?LEU#*;U2PVNKXA! ST.#V]:[^'3[*VM6M8+.WBMWSNB2(*ASUR ,<T
MPZ1II,1.G6F80%C/DK\@'0#CB@#S7Q#<:-:7GC#2;!++2WM]'2&;S.#.ICD*
M1PQY"J!N() .2V,=ZAL]2LENOA3>37D @33IXY)FD&T/]ECR">F<YX]:]4DL
M+.6Z%U):0/<!#&)6C!<*>JYZX]J3^SK'R8(?L=OY4!#0IY2[8R.A48X/TH X
M+PU-:W,GC_3_ !"8Q,=0F><3\9LFC B//\.T'Z'-<YH]A([_  GBU^!)+MHK
ML.+A1N*"$F-6SUP-G![UZ]<Z7I][<1W%U86L\T7^KDEA5F3Z$C(IT^G6-S.L
M]Q9V\LJ?=DDB5F7Z$B@!]K:6UC:QVMI;Q6]O&-J11(%51Z #@5XXFJ6=Q\)/
M&UKJTT"ZVLUZ;R&=@',N28R >2-H0+C^Z,=*]IJE/H^F7-R]S<:;9RSNAC:6
M2!69E(P5)(SC':@#S6#7;.T\7:5_:.M?V?I]WH$"6-V&B\EG5CYJ;W5@&/R>
MF=H]JKWFB^'[1? ]IIC&\TYM<D$4MQM<2(4D+!"  8]QX&,'MD$5ZK=:987U
MNMO>6-M<0(05BFB5U4CI@$8HFTVPN/+\^RMI?*&(]\2ML'H,CB@#S^SM[1?%
MGQ+M1%"+?[):.T6T;<F!\G'3L/RK%M]372O!WPSO+R[EM-(6/9<W2*K"&4P[
M8F;<I &=PR1QFO6#I.FEY7.GVA:48D;R5R_?GCFG?V;8_8FLOL5M]E?[T'E+
ML;ZKC% 'G<^DZ#<VVJS:-XGE6YO]0M9O[0#12VZW:$E  H"DG:NX=\KWK?\
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M9[+<&12!NB?=^?&:Y2R@M(O@]X%O%BB6X_M6R;SL#=GSMI^;K]T8^@Q7L?\
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M<-E;1QRC$BI$H#CW '- ',^&X= N/%-]K&DZU)JMY<VJ)=2Q2Q/" #\F[RU
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M0 =*DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2/D4@G'0GCC.:VO"DMAJ/Q \;6,]_!J"WUO9@[=H69?*=7V@=5&0,Y/8$DT
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M,@).!P.37GMA/"?!_P 4\2IQ?ZAGYA_SP4?S%=UX.=7\$:"R,&']G6_(.?\
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M_&OBS3+VZ6:WT^2U%LHC"[!)%O(XY/)[GM75UP&@ZC9V7Q!^(=U<W,<<%O\
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MG\PJ<[=I'&WIGGVJ3QMX=NO$'A";0]+%K 96B(,K%$0)(KX 53_=QVZUT]%
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M-1V51@#\A4U% #71)8VCD571AAE89!'H141L;0NKFU@+( %;RQD8Z8^E3T4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@-UNAE!D\PPR#@E<^G7TKV:J5WJUC8W]C8W,^RYOF9+9-K'>57<W(&!P.^*
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MYAE39A>#@*.YZ^U=75*'5K&?5[G2HY]U[;1I+-%L8;5?.TYQ@YP>AH X*[\
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MUBFLQ:0T^+^6!KA(MC<QJ0I.<8ZD<9S0!S_C?3)99=#UR!&DDT:_6XE11EC
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M "LGQ%?:A8:='+I\5N6:>-)IKEPL=O"3\\IRR[MH[9&:UJYWQ?H%[KUGI_\
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MYD0 L&?<-N22HQTQDDYP(M4\;7=MJD>GW<T.@7-QI\4]E]OBW137#!M\329
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MJ8OMSQAIA$A558\E0"3TZ9SSBKU !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK*\8SG//?%=I10!YUI5O>-\6[^WU6[AN;F3P[$)3!%Y2 &=QA5))Q]2>O;@
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MZ;LX91@X-7?^$:N9]0U#5[JXMSJEU8BQB*1GRX(LEB,9RQ+-DGCH!VR>FHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MALCEW2?9]_H-QR,^@/:NPTV32[CXL>+(0]I(MQIMJ9$W*PD(W[LCN0-N?PH
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MEA;W0C>,31+($<89<@'!]^: )Z**Y_2!XP_M$_VT=#-CM./L0F\S=V^\<8H
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M2!<3E9K5;-P1&LI1BKF7J -W3VJ]X2\5M<P:FFOZE91W$6LW-A;Y*PB01L%
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M\:(^C7&996 #-Y4)ZGO0!ZC116=KZVS^'-46\F>"U-I*)I8_O(FP[F'N!DT
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M6)>332$#J0P)G+9W!0"%QC'.: ,NV\-ZY9&(VNH^'X#$ACC,6A%=BDY*C$_
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M9S\WX5!=>)="LEF:ZUK3X! XCE,ERB^6QSA6R>"<'CVH I?8/%O_ $,&D_\
M@H?_ .2*ANM%\27L7E7>KZ'<1YSLET1G&?7!N*UQKND'4HM.&J61OID\R.W$
MZ^8ZXSD+G)&.:6]UO2M-F2&^U*SMI7QM2:94)R<#@GN>* ,<Z+XD:T^RMK&A
MFVV[?).B-LQZ8^T8Q4,?AK7(K66UCU#P\EO-Q)$N@D(_U'GX-;MWKND6$DL=
MYJEE;O#'YLJRSJI1,@;B">!D@9]ZS]9\9Z)HVDV>HRW]O);WLT<5LR2J5EW,
M%W ]-HSDGH * *UKH7B*QM!:6FJZ%;VPR!##HC(@SUX$^*;8^'M>TR-X]/U+
M0+1';<RV^A-&&/J0)QDUM3Z_H]M%'+/JME''(GF([W"A63^\#GI[UH*RNH92
M"K#(([B@#E+;PWKEG=375KJ/A^"XF_ULT6A%7D_WB)\G\:2U\,ZW93F>TO\
MP[!,1@R1:"58CZB>NK=UC1G=@JJ,EF. !5"U\0:->W$=O:ZM8SS21M*D<5PK
M,R*2I8 'D @C/M0!C6/AO5[&^6YCO- C.?WC0:&8W9<C(W";C./>NDM[2VM!
M(+:WBA$CF1Q&@7<YZL<=2?6JUEK>E:E<206.I6ES-&H9XX9E=E!Z$@'I[TL>
MMZ5+J'V"/4K1[S+#R%F4OE?O#;G/'?TH O4R:&*XB:*:-)8V&&1U# _4&J=Q
MK>E6EXMI<:E9PW+,%$4DRJQ)Z#!/4]O6B]US2=-D>.^U.SMG2,RLLTZH50$
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M5^.@V[!(_APEL8R?])%=?_9>G[-GV&UVYSM\E<9]>E/6PLTE65+2!9%P XC
M(XQUQZ<4 <9\*;NW;PK+9+/&UU!?W?G0ALM'FX?&X=L]L]:WO&6A?\))X3U#
M3$.VXDCWV[_W)E.Y#GM\P%;,<$,+.T42(9&W.54#<?4^IJ2@#QUO$&I27.@_
M$2.QEV2Q+I%S:!,/(7'WOH+CY!^?>MCQ1I=I8ZGX L[L0RR?VFWFNX'[US&[
M,W_ G.<>IKT;R(O+$?E)L!#!=HP"#D''UYID]E:7+AY[6&5@, R1AB!^- '#
MZM:6.G_%7P7!:6]O;+]FU#$<2*@Y5#T'ON/YUC65S!_PB_Q1T_SD^VM>ZE(+
M<'Y]A@7#;>N#ZUZB]E:RSK/);0O*N,2-&"PQTYIZV\*2R2K%&)),;W"C+8Z9
M/>@#R>Y\06EK8_#[4)-3,.C16YM[F\@V.EO<-!&(]Y(8#C>N<<;CTJ#Q=9^'
M5\">(K[2;TWZ7>H6DL]TTB-$\WG(&V%0%SMQNQ_,''KAL;0VAM#:P&V(P8?+
M&PC_ '>E-.GV1MX[<V=OY$?W(_*7:OT&,"@#C&BM;3XU:?%;I%"&\/RKLC 7
M($R;1@>G./QKJ?$2WK^&-6732POS9S"VV]?,V';CWSBK2Z?9)*LJV=NLBXVN
M(@",# P<59H \Y\):QX0UW0O"D2&";5;!$6&S1\3VTH39(60$$ ?-DMP>.I(
MK&TV6"Z^"_B73=8VG6('O%O(G_UC73.S1$#J228]OK@8KUB*RM(+B6XAM88Y
MI?\ 62)& S_4CDTCZ?927BWCVD#72#"S&,%P/9L9H \YTRU9?B9X9CU58I-3
M3PN?M!< L9@\8)^N=W/UK":UL!\+?B2R0V_R:I?JI"CY0'!0#T )R![U[&]C
M:23^>]K TO\ ST,8+?G3!I>GA"@L;4*2"1Y*X..G;WH X,):7'Q4\,22+#)(
M^@RR;F )8[H\'W[X/UKGQ:Z?_P *Y^)[+#;Y34K]5(4?* JE0/3#$D#U->NK
MIM@KJZV5L&7H1$N1^E(-+T\*5%C:A6QD>2N#^E 'FSZY!IGC/2Y-9UB33;&]
MT&!;.\)C$1D#$R*6=2 2"A[9P/:JM[I7A^TC\$6VF9N--?77,3W!5A*K)(3L
MX&4+'CC!ZC@BO5)=-L9[5;6:RMY+=3E8GB4H#Z@$8ITMC9S[?.M8)-@PN^,'
M ]!F@#S.Z6-=8^+-O %!.E0-Y:?WC;2@G []/TJ:$KK/ASP:V@^(+:TUJVLA
M]EW@203$0QB2)QGKAATY&#7H\=E:13--':PI*V<NL8!.>O-1R:7I\UNMO)86
MKP)G;&T*E1WX&,4 <MX7\6V*>'[0ZRMII%W<7\]H(EDS'-<"5MYC)ZJS9/U.
M*[2LW4=$M-2M[:VEBB%M!(KA!$,C:00%/\(XP<=N.*TJ /);+5[-=%^(VGZW
M<01:J;J\+17#!6DA,>("H/5=H &/ZTWPSJ*1:W\/IKF9&TN7PZ+6VDW HEYM
M3<I/0-L4J >>HKU.;3[*YG$\]G;RS!2@D>)68*>HR1TYZ4Z:RM;BU^RSVT,M
MO@#RGC#)@=.#Q0!X[X@CN[+_ (3N_L8WET$:G833Q0C*R;=IN]H'7/R[OHP/
M0UVLE[X8\137VHZ))!J&IOI$D#7%K)OV0GE4< X!+'@$;N#Z5V,4,4,*PQ1)
M'$HVJBJ H'H!4=K96MC&8[2VAMXR=Q6*,("?7 [T >.1ZWI3^!_AC$NH6Q>W
MU"R\\"0?NL1.IW_W>>.<=#Z5NZ=;:?)XH^)FZ&V90D(.54X4VOS?@2.?I7HD
M>FV,)S%96Z'S/-^6)1\_3=T^]R>>M)_9MAES]BMLO]_]TOS<YYXYYH \DB2T
M@^''PQG184D.JV&9  "20P;G]#5I;_19M1\8^'O%FMR:<]Q>R.8)3&@N;9E4
M1E&9"S'  PIR,#%>H'2]/*!#8VI49('DK@9_"GRV%G//%/-:0230_P"JD>,%
MD_W2>GX4 >?:;8V"?%RP@\C/D^%H]BW(!E!$P +?[>."?K7,Q2P0_#"S<21I
M:VOBT$MD!(D%X3] ,']:]G>PLY)C,]I TK=7,8)/&.OTI%T^R6&2%;.W$4GW
MT$2[6^HQS0!Y]XGEN?[3U77/#>J6%T8].3^T=*O,&*ZMAO*NC@Y7AG /W3_/
MKM*\2:7=-INGF9+74;JQ2[2PD;]ZD9'0CU'(_ UI3:987,B23V-M+)'@HSQ*
MQ7'3!(XJ&;2+>XUJVU.54,MLI$.(P&!(()+=2,,P X'S'KQ@ O.J,C+(%*$<
MAAQBO%]&L(C^SY)>Z7912Z@D<X,D,:F4Q_:#YB@XSS&N,>@%>T.B2HR2(KHP
MP589!%,@M;>U4K;P10@G)$:!<_E0!YP+C0?$DL.K^'M>N-3UV+3KA+-8GC!@
M#1G'FJBJ5&[: &_BQCO2^#]7\):WX:\*6KF&;5]/\M8[(.1<07"KMD9D!!P/
MF)+<'ZXKT.VL;2S,AM;6" RG=(8HPN\^IQU-+%96D-S+<Q6L,<\O^LE6,!G^
MIZF@#RO2IK>X^%7B[3=;*?VI#->B]CD^^TK%FB8#J<Y3:1UP,=*EL=/$GCOP
M?:Z]##-J!\-R+<K.H8O)^[!W ]3][]:].DT^RENTNY+2![E!A)FC!=?HV,BE
M:RM'N!</:PM,"")#&"V1TYZT >>:#J6GV'B[QIINLR6UI,6C^S1SE41K(1;4
M5 >"H.[('0L:Q/"D<FH^!?!)T+7;>RUZVMKG[-',HDAG 91)$X!R#RAXY R:
M]>FL;2XGBGGM8)98N8Y'C#,GT)Z5'+I>GSV\=O+8VLD$8PD;PJ54>PQ@4 8_
M@;4GU7PM%<RZ?'8S">=)88FW1F02L'9#W4MDCZUG>+M4L+'Q;X;AN#;VUXXN
M6M]0NW(BMP$4. N0&=@0!D\<GV/9(B11K'&JHBC"JHP /0"F36T%SL\^".7R
MVWIO0-M;U&>AH \+DGL)_AGJ\#7$,[P^*OX]H8*UVO)'&W(R>@[UV&KH]I\4
M+R/1TCBO3X2F\B.,!<R"7]WP/0]*] ?3[*0$/9V[!G+G=$IRQZGIU]Z5;"S2
M594M(%D7&'$8!'&.N/2@#QJ[UK0[CX/^%D2[MEN+6^L?/CD<"2*99%\TL#R#
MDL23ZY[U[8CK(BNC!E89# Y!%5O[,T\3/-]AMO-D8.[^4NYF'0DXY(JU0!YY
MX:N;8:WX[T_Q"T2S/>M,XN" 'L6C58SSU0 ,#Z$GUKFM'-QI&D_"V77)O($4
M]T#)<MLV1M%)Y08GH=NT8/TKV"XT^RNY8Y;FT@FDB.8WDC#%#[$CBI)8(9PH
MFB20*P90Z@X(Z$9[T >=V$=C>?$#X@/,D$N+*S&9%!(4PON'/0=,US>CZPNE
MZ+\.+W4=0EL](;3IK<WB!2D,Y"!-Y96 ^574''&3R!FO8CIMB6=C96Q9\[CY
M2Y;/KQS2G3[)K5K5K.W-N_+1&)=C?48Q0!Y+XHL?#D7@V]N=+NS>VUWKMK--
M=2.C1/*TJ>88RH Z#DKQU]#CURULK2R1UL[:"W61S(XAC"!F/\1QU/ Y]J:V
MGV3PQPM9VYBB&(T,2[4'L,<581%C1410JJ,!0, #TH X?QQY*^+O SML$AU1
MU#'&<>2_'YD5FV-II\OCKXD>9!;,5MK4'<JG:#;MN^F<#->B365K<NKSVT,K
MKP&>,,1^=,.FV)9V-E;%G^^?*7YN_/'- 'D[W,8^#_P_>290/[0TT99O[KC/
MY ?I740W;6GQFO8M18)'=:5&--=SA2%<F55/][)4D=< >E=>=+T\H$-C;%5R
M0/)7 S^%.GTZRNK=+>XL[>:!,%8Y(E95QTP",4 >+:E910>"-9,@C_LF3Q8C
M:?NQM$1F3?L/9"P?IQP:Z_Q?IFE6WC#P3''96<2S:E,SJL2J'/D-R<#GG;^E
M=Y+96LZ(DUM#(B#"*\8(7Z9Z4CV%G+L\RT@?RU"INC!V@= ..!0!Y_I5KI[^
M/_B('AMB%@M<@J. T#;_ *9P,^N.:Q?#FL6%MX?^'4=Q);07C6,YM]1NY"(K
M=54*Z@;@&<C  )XP3['UC^S;'<[?8K;+_>/E+\WUXYI?[.L=B)]CM]B/YB+Y
M2X5O[PXX/O0!XF+RV_X5AJZ+=I(+7Q3OE8D HAO%(9@,!0>3T KM]:N+.Y^*
M?@>YMI89!+!?[9$(.\;$Q@]QP<5W!M+8Q2Q&WA\N8EI%V##D]21WIK6-F\J2
M-:P-(F-K&,$KCI@]L4 >7Z3/;3_#?QGINNE!J,5Q>_;8Y?OL[9,3 =3D; I'
MH,=*?I=DZ^-_ L.LQQR:FOA^0S^: 7\P>7USU88//L:]-DT^RFNX[N6TMWN8
M^$F:,%U^C8R*5[&TEG\Z2U@>7CYVC!;\Z ..^&AB$7BJ*$H(X_$5X%5.BCY3
M@#MWJ/XM);-X1MC<B/;_ &G:#+XX!F7//TS7;06=K:EC;VT,);KY:!<_E1/:
M6UT%%Q;Q3!>GF(&Q^= 'GWBJXL?#'C70+B>4:1HT\=S&UU;Q1K&ETWEX9R5(
M!*J1N(SUYQFLCQ5;Z':?"WQ-<:+>R75M=ZA#/+<M(K123&:+>8RH"XXYQQD'
MT->L2V=M/:_99K>&2WP%\IT!3 Z#!XIK6-F\"0-:P-#']R,Q@JOT'04 <#XC
MU73?^$PUBS\VWL+P:,JRW,[;GN8V+[8X4)V\$G+8))8#'>N>TK4[*/1/A3=R
MWD*V]NSQ33/( D;?9F&UF/ /;%>P"RM!)%(+:'?$NV-O+&4'H#V%'V*U\B.#
M[-#Y,9#)'Y8VJ1T(':@#B;#[(_QBUL 1%9-$MW=2!S^\?)(^A'7VKB=/BLH?
M@IX1ND2!)1K-L_F@ '<+DC.?7;Q]*]J;3[)Y&D:SMS(V=S&)<G/7)Q3?[+T_
M8$^P6NT'('DKC/Y>U 'G.KZG8:3XZ\5V]QJ6F$ZIIUO&8K^[6W\E@CJ%^;[R
M$-N.,X)Z'-=IX,TZVTGP=I5C:7<%Y%#;HGVF @I*0,%@1UZ5CW/AO7%UJ^F2
M'0-3LKF0/&-1A826RA0HC7 8%!@D#Y>6/K71:%H\6B:>UO&L*F25II!!$(HP
MS==J#[H__6>30!S'C:Y@L?&O@>[NYHX+:.[N0\LK!44FW8#)/ R:K^&;NW_X
M2/QQ9:\T2RRW(GQ<$*)+$Q!4QGJH 8'T).>37?2P0SA1-$D@5@RAU!PPZ$9[
MU'<Z?97DD<EU:03O$<QM+&&*'V)'% ',?"ZWO;7X<:/#?^9YBQOY8ESN$1=C
M&#G_ &-M=?110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !6+XH\3V'A32A?7\@&^18HDS@N[$ ?0#
M.2>PK:KB?BNPC\"O,YVQQ7MI)(QZ*HG3)/M0 E]XH:T^(&GH^L0+H$^ESW+[
MM@C#(Z*&W]?XCWKJ;;6=,O=*&J6VH6TNGE2WVE908\ X/S=.#7%WE]IM_P#&
M'P]-'<6TZ'2;EHGW @DNF"OU .".HZ5R7VX6GAG5;R"21M/L/&DL][]EPS1V
M^[.\ 9X#%6Z=LT >Q:?K&G:L9A87L-PT#!951LM&3R PZC\:NUQOA=O#>I>(
M[K6M$U";4[J6U6*YNA)NC"@@HAP -_7W ZXR,])K27<N@ZC'8,5O&MI%@(."
M)"IV_KB@!D>OZ1+J"V$>HVS73%E6(2#+%?O >I'<#D5@^%]9O9=8\6PZK?K)
M;:;>JD3R*L:Q1^4KG) ' R>36'X-USPMK7AWPQISQQRZUIHB06)!$]M.B['=
MEZ@#YB2>#]<"LRXU33K6S^*$UU:IJ5NEY'YEJLA&]3%&O)7D*#U(Z8- 'IMG
MKVE:@\R6NH6\KPH))%#C*H>C$'^$^O2L[3-;TZRT/[7?>*+2^@>YD5+UFCC4
MDN<1KMX)7[O')Q7(:1JUG+\7[>8ZS:WPN/#[1I+  (683@[(\9R ,DY+$<Y(
M[<Y/<63? K4U\Z K_;; #</^?Y3_ .@\_2@#UP>+/#S27D8UNPW60S<C[0O[
MH9QEN>.>/KQ5[3M3L=7L8[W3KN&ZM9,[)87#*<'!Y'O7$WQT_P#X7/H0!MMR
MZ-.$QMX^=-N/PW8_&H/!.NZ3HVE^,+Z]OH(+*#Q%=;GSE4#,@7@=B30!Z/61
M?VFLW6IYM-4%E9+".%@61GD).>6Z  #ZY]JUP<C(IDTL<$+RS2+'&HRSN< #
MW- 'G_@;4O%/BCP?I&OR:Q%YEQ*?/MOLJ!#&LK(V#U!VC/?GBI_"?C*%+>_A
M\1Z[:BZ76;JRMC.R1%UC?:H &/S]347P4GB?X3Z0J2(QC\X. W*_OG//IQ7'
MWDEB_P )/B)*KVY=]:O#N!&6/G ISW]10![)J.L:=I*!]0O8;=2"P\QL' ZG
M'H,C)[59@N(;JWCN+>5)H9%#))&P96!Z$$=17F=[KMCI7Q#NVUW5I;"QU+3K
M<V%V'40R!-^]"Q! .7S^/TKL_!UAIFF^%[2UT9)UTU=YM_/8EBA8G<,\[3G(
M]B* ,_XEZSJ/ASP+J&M:7<"*ZM-A4-&KJ^Z15(((]">A%4;[Q#K7AKQAX=TN
M^NHM2L=;+Q!O)$<T$B@'/RG#*<^F1ZU'\:9HH_A/K2O(JLXB" G!8^<G ]:Z
M+3_#NB&^MM<BC:ZNUBV07,US)/L4CG9O8A<^HZT 9GA36KR:[\5C5]05X--U
M)HHY9%6-8HA&C<D8&!D\FMZV\0:1=BX,&I6S?9U#S9D \M3T8YZ ]CTKS"75
M--M=$^)<UW;1ZC;KJH\RV$A 8%8ERQ7D*#R2/[IK0TS5[&3XMR32ZU:WJ7'A
MX*)HPJPL1.Q*IC.0!D\EB.<GC@ [F'Q9X>N+JTM8=;L))[L9MXUG4F4<CY>>
M>A^N*V*\,T^6Q@^#/@:0/;QNNLVCE@0"&$YW$^X'7VKW,$$ @Y![T 5M1OH=
M+TVYO[@D0V\;2/@9) &< =S[5SG@'Q->^(M*O(]6@6VUC3[N2VO(!T0YRN/4
M;2.>^#2^([E=5US3_#5I?6\5SG[?<*X#X2-E**4R"<N5/7HAKF;J=_!/Q8LK
MW4M1MFMO$D!MK@K'Y(2:+'E.06/4$KGWH [O7-9LM.M9HI=3@L[DPET9R"4'
M3<0>@SW/%8O@WQ5%<^"?#]YKNJ6ZZAJ$((\UUC:5\G[J\?H*Q-'UJRL/%7C>
MPU^YAM[RXG66W^T,%$]J8@J!,_> ^;@=V-<UIUSI\_@#X7))-;/MU6)'5F4X
MPDH((^I'YB@#U0>,_#)L9[X:]IQM8)/*EE%PN%;J!UZD _E2:QJ5I+8:=-;^
M([;3TN;B%H9@8W%TI8?NUW==V0,CGFN<TE]/_P"%P>*V=K;>-/M-Q8KGHX;/
MX;<_A7&V5W:CX+>"R]Q#\FM6X!+CY<7+9_(?I0!ZY>>*-!T^2XCO-8L87ME#
M3J\Z@Q@\#<,\9["J^L:I9SZ58W%MXDMM.CN9XF@N08W%PNX?(N[@[AQD<C-<
M]:26#?&O5F=[8NNBP<DKD?O'W?H1GVQ7%V]U:#X(>'<SP@1ZW&%RX^4"\8_H
MO/TH ]CO]=TK3'9+Z_M[<JH=O,<#8IX!;T!((&>N*SY/&.D1^+3X=:ZB6Z2W
M\Z0NX4*2P"H,]2>3[8]ZX[Q?+/8ZGXAU;1-4M)S%;H-6T2^QLN8_+R&C8'<I
M*MM'8D5?CU*WA^,<<UZPM&O?#L*Q1S'#,_GL2@]2,\CMUZ4 =5!XK\/W5U#;
M6^M6$L\V_P I$N%)?9][&#SC!S]#Z5+:>(M&OI6BM=3M976+SB%D',?]\>J_
M[0XKSKPM)H\7P]\67\EA!J"V]_J3R118WNA+# 8<KE.,CL:BTS5[";Q[X)GC
MU2TFBDTVXACCML>5"2L6V)3RQ8#J"2>,X7- '?>'O&&D>)+6[N;.ZB$5M+(C
M;G .Q#@N0?NJ2#U[5?L]=TG4)I(;34+:66-/,9%D&0G9L?W??I7D#7,C_"[7
M[*S/GW-GK<TU_:1\R"W%UN<%>H!7GGJ ?>NPUJ6VUOQOX,O]$N89VB,\T\T+
MA@+5H^=V.Q;:!GO]#0!U%OXIT"\O(+2VUFPFN+AG6&..=6:0I][;@\XY_(UK
MUY]\+HM.N+#69HDMI)H]=O6#J%9ERY (/;*G\J]!H SDUS2[B[%E#J-N;J0L
ML:!@2Q7.[;_>Q@YQT[URGA'QE#]BN8?$6N6HO3JUS9V_G,D32*DFU0%&/_UF
ML7PW=7.D:EX=M[*_MM<\-7LLAL2X N]./EN2&(.&4 LI)Y&<>F<*\EL6^#/C
MF5)+<R-K%RV\$9)^T H<_J* /8]0UW2M)?9?W]O;ML\PB1P"J9P6/HON>*P?
M%.KWUEK7A/\ L^^"V>H:@()T5%82H8V8$-@D?='2N=\1:WIDOB#Q)9)/;V-R
MVC)F<G?+J"LLA5(E.5VKD@D D[NV,UG0ZE9R^&OA05NXCLN;=&.\<%;9E(_
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M%K&$_P!"^7!4E>2203SR*YW7_%H_X2;PO:Z/K,+PWE\8;F",*WFQ['.0Q&<
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MCCS',#\Q5T ^4C^$@X/>NAJ"SFBN+.&6&1)(V0%60Y!&/6IZ "BBB@ HHHH
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MI8JJ@L<L0.I]Z9%:V\ <0P11ASE@B ;C[XZU+10 Q(HXL^7&B9Z[1C-/HHH
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#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>sangamoexecutiveseveranc011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ(<X9M@.,X.,\G!QTK@O#6K)I%EJ'@_7=&NKK4EOIY((FLVEBOEDE,BR;\%
M,MR6(QCVK3T>Z;PWXZ\4IK6^.'4I(KNSNBC,DJB,(T8('WE(&%ZD'@4 =%=^
M,_#UE!I\\^J1"'4!FUD4,RR#!/! (' /6HK'QEH&N:?J4EI?R*MB"MV##)%+
M!D'!V,H8>H..U><0Z?)X:T?P&FI1/ O]O37 A9"3!&ZRLH('3 ()].?2NG%L
MESXV\1>)+4?\2W^QDLS,H^6YFW,Q*_WL+M7([G Z&@#H]&U72[3PGI=S#J5W
M>VDL:);7%P&DGN<CCC&YF(!/3H">U26_BW1KFUNITNG!M9UMYX7A=94E8@*A
MC(W9)(Q@<YXKS:%;O3_ G@'57L;ZXM-*5H]1MK8.L\0>,IOVC#?*>H]#Z5M7
M,'A?5]$O[V'3=4@LK^>V634U69+AI$)V2C>"^(SM^8C')["@#O-/U:UU-KA+
M?SA);.(YDEA:-E8@,!A@,\$'(XJ]7'>!9=8$VKV>HWR:K:6TD:V>JB((URI7
M)5B.&*<#<.N3W!KL: ,2^\6Z-IQG-S<N(;:017$ZP.T4+G'#N 57J,Y/&><5
MC>,_$OV'5/#^EQM=B'4+O%Q);02L6B$;MM1T'4D+G:<@9['-<]I#OI?@KQ-X
M6U>WF?53+>"*/RF8WRS%F1XSCYLEL'^[CG%37=G-HK?#73[QGDGTY@MU(JEE
MCQ;E,L1T&XX!- '=Z#IC:58/#_:%[>Q22M+$;UBTD2-@B/+?,0.?O<\X-:E9
M%KXDL+OQ+=Z!&)UO;:)9B7A(C=3MY1NC8WKGZUKT 8NI^+-'TF:ZBNIY"UG$
MLUUY,#RBW1LX9RH.T<$_0$]*Q/%%].OBCP7)9:A,MK>7CI)'%)B.9/)=@3CK
MT!]*P?%MY+=7WC32GL+N"1M,Q:BSM&)U F%OF>55Y"$[0N0.N<YP%FN!+#\,
MY!#<*L$BF;? ZF,"W*98$?*-QQDXS]* .@T"YNV^)GBVSEO;B:VA@LGABD?*
MQ%Q(6VCH,X'Y5V5<1H+8^*_BQBKA);:R6-RA"N463>%/0D;AG%=O0!DZGK=A
M:2264DUQ]H\GS76UA>5XH^1O.U3MZ'&>N#C.#7-?#WQ"H^&6CZCJ]_-<37,D
ML:R2;I)9G,SA0 ,EC@= .@]!5?3]1;PW\2?$J:Q#=+%JIMYK"Y2!Y%D"1[3'
M\H.&![=\Y[\\KX=COK#PWX!UA[*\%EI%Y>+?PFW<-&LQ=4EVX^95#9)&<!OK
M0!ZS8>(=,U$WBPW.R2Q.+J*=&B>'C(+*P! (Y!Z'UJO!XNT:XOH;-)YEGN(6
MGME>VD7[0B\DQY7Y\ @X'.#GI7"^)]"O?%6K^)]1T+<T$WAX6"./E6ZG\POA
M3T;"@+GI\V,\''2^&_%-AXFDT[R]&N4U&V0BX^U631_83MPRAV7!)( PIY')
MZ4 :?_"::!_8,&N?;7_LV:7R4G^SRXW[_+P1MROS<<@<T7?C'1++4KG39+B9
M[ZVB$LEO#;22/M)P-H53NZ'IG&#FO+)+AX/A+<>'397[ZI9ZKF>!+20[5^W;
MP0<88%2,8R3Z<'';6EQ&?C!J%V1(ENVB0H)7C95W"1V*Y(^\%()'44 :B_$+
MPP]M97*:BSVUXRI'.MO(8T9CM"R-MQ&2>,,0:T]4\0Z?I!D%R\S-%%YTJP6[
MS&./GYF" X'!Z]<''0UY0ZN?@/?62V\_VMM09EMQ"WF$&]W@A<9QLYZ=*V]0
MU"UT3Q[J\^N6VIR:3K$4$EE=V0G=,K'L:)A%SDGD<=S0!V$WC;P[!)8(VI*Q
MOX3-:^7&[B9 ,G:5!R>G'7) Q6?JWQ"TNT\%:EXBL%GNULV>%H?L[JZ3#^&1
M2 4 )&2<<'W%8C6UK8^,O 45GICV%G;0W_[C82+<2*NP.>BEN>">N16-J=M<
M7WA'XG6]K;S2RW%\9H$6-LRH$CRR<?,,JW3TH ]./B*P5(,B[,LR-(L(LY?,
MVJ0&8IMW 9(Y(YR,9J]8WMOJ5A;WUJY>WN(Q)&Q4KE2,@X/(_&N"\0FPUR[T
MZ_L]5U#0=1CM&>RU(PLD;J2-T<J. ""0"%;!/4>^GH?BU[32O#=IXALY;35-
M40KMAMF$2,#@;O[F[*X![MCB@#LJQ]7\4Z/H5[:V>HW1BN+L.8$$3N7VJ6(&
MT'G Z=2< 9)K8KA_&#JOCWP2[([1P7-P\K!"RQAH652Q X!8@9- &TGC'1I=
M.AOH9;F>*6#[0%AM97D6/)&YD"[E&0>HYP<9Q5D>)=)DTZROH+L7$%]_QZ^0
MK2--QGY5 ). #GCC!SBN)UJ]B\.?$74+O7+;4VTK5+: 6UW9><RQ21[@8W$1
MSSNR..Y]ZKW?E^$=6\+ZY;Z'=6OAV&"ZMI+>*)G>S$KJZR,@RPW;>1U&<=>*
M .ZMO%>BW6E2ZC'>C[/#.;:4-&P=)@0OEE"-V_) VXR<C'6G6WB;2KF:[@$T
MD=S9H))X)H7CD5#T8*1E@?49YXZUQGB9I+ZPTCQ#I&D3KIUEK<=]<QI;&.6Y
MCVE6G\O 8D9[C) STQ5^01:K\1[/Q#929TZQTJ6*YN@I"2%V!6,'^(C#,0.G
M'<T :^G>/?#6JL!::CN0VSW?FO"Z1B)3AF+L !CC@G.#6%J7B+[7\2/!L%E=
MZA%;W7VII;>2*2&.9! Q5L,HW8/Y<<#BN>M-,U*^_9SBTW3[64ZA#$IDM"A1
MVVS[V3:1G)4'COGWK6OO$-IK_C;P+J%A;WSPPR7?GYLI082\!4*WR\$,0#Z=
M>E ';1>)=,FO(+:.29C<3/!#(+=_+>1 Q90^-O&QN_.#C-:U>5Z5'<:;K^FR
M^'+RXET^]OV^VZ%>1EC9;MQ>:-B R*#GV;=QU%>J4 9^HZW8Z9<6UM<.[7-S
MN\F"*-I)'"C+$*H)P,C)Z<CU%9\OC;P]#HEMK,FH!;"YE$,4IB?[^[;M(QE2
M&X.<8K+\5:DUIXOT6WFMIH;26";.HVUH9I@^5Q"K!6*!AR3C)V@#'6N$C$B?
M"X:>]E>I<0^(@[12P.6VB[WD\CYL+R2,CWH ]7TOQ1I.LZE<Z?9SR&[MD$CQ
M2P/$2A. Z[P-RD@\C(KD?''BJ&6RT9])U"]B\W6+:$301ND-POF@.OF8PPP#
MT.#SUP:9KD4^H?$?44T]F62Y\*RVL%P 0@G:0E5W],X.<9Z5@W&L1W7PW\,Z
M2-/U"/4]+O;"*[M/L4I>(Q.H8\+@@[<C'7/UH ]GJKJ&HVFEVPGO)?+0NL:@
M*69W8X"JHR6)] ,U95@Z!AG!&1D$'\C7%^/X;R&^\,ZU##+<66F:CYMY%$A=
MEC9"GF;1R=NXGCG!H VD\5:7)%J)1KAI]/3?<6OV=Q.H(R"$(R0>Q''O7%:W
MXOFUCP3X=U^UN;S3?.U2S\]0'A0QO(,J6(&Y<=2#CK6D]FVN?$*XUS3,R64>
MA/9-.H(6>5WW*@/\6T DD="0/6N76<R?"CPA9&UO%N+/4+%;B-[612OER R<
M$9(4#D].>M 'IVE>*-)UF\O+2TGD%Q9A6FCG@>%@K9PP#@94X/(XJ.+Q=HTM
M_;6?VF1)+M6>U:2!T2X"C)\MR-K<<\'D<C(KC]=M9]6\?>(+:P+![SPJ;2";
M!"&8O(0N[IG# ]>E-\+ZAHVM+I%M<Z%JBZYIQ0S17JSB.R=!AI ['9C@[0.3
MD< 9( .KL?'7AW4]1AL;.]>6XFFD@0"WD WH"64DKA3P>N,X.*Z.N'^&A LM
M?4QO&[ZY=S /&4+([Y5AD<@CH:[B@#GS?Z9_PF\L/]J7G]H0Z<7>PRWD"+>/
MWN-N"^3MR#G&1BJT7Q%\+S16TT>H.T%Q/]G286TOEK)N*!7;;A"6&!NQGKTK
M/DE6/XU>>X98%T PM*5.P/Y^[;NZ9V\X]*XUE<_ Z[M!!/\ :SJA<0>2WF$?
M;1(#MQG&SG/I0!V?B;Q"H\;:1X><ZBEG-!<2W)M89P[E0@0*\8R0-Y)*G@@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2]0O=$U*PAA2XM(9':WEC9SM9%^8!@^>G7\:OZMX;34OAU)%HNE_V5=6\O\
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MQFTDW3*\2*I0;>02#TIUQ,VB^(-+UC4])U*[T>\T:WM&DMH9&>UFC+'#HOS
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MHH *QM2\3Z=I=[+:3K>O+%")Y/L]E+,J(2P!9D4@?=;C/:MFL[6HT71-3<*
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MN!;#-G[I7 QWK US5I_%GA[X?ZY'<S6?VW6+;=#&J%4DVRY8%E)."#C/&.U
M'HNC:Y!K2W0CM[JVFM)C!/#<Q;&1L ]B0P(((()'-0:SXJTO0;VSL[\W(GO6
M*6ZQ6LDOF,!D@;%/.*UX4:.%$>5I650#(X +'U. !GZ 5P'Q">2/Q=X$:*+S
M7&I283=MW?NCW- '4V/BK1]2COC:7$CRV/\ Q\VYMY%GBXR,Q,H?GMQS5G0M
M:M/$.B6NK6._[+=)OC\Q=K8R1R/PKF-(\-:D/'>M>+=12&U%S9K9P6D4F]MB
MX)>0X W9 P!G [UC>#KR\L_A3X/^S7L-G!(0ES*1NE*?.0L*;6W.6 &,'C/%
M 'J%%>4WOC'Q##\/O%U_!>;;W1M1>W@GGMEWM%^[(W*,*&Q(><=NE=&FHZWI
MOQ%T_2[W44O+/4[.>81"W6,6\D93[I')!#8^8F@#LZIZMJMGHFE7.I:A,(;2
MW3?)(>PJY7%>,S8:U?P^'-0CNI+ P-<7@M[:2;.04B4[%..=SC/>(4 =HK*Z
MAE(92,@@\$5E^(/$-CX9TW[?J G,/F)'^ZB+_,S!1GL.2.217+?#/Q S^"9[
M/4F?[9X?9[2YWHRL4C&4?:V",ICKSP:Y_P 5WFI^(/A)%XAGOVCBO+BUF-BL
M:>6D37";%#8W;A\I)W8)SP., 'KU%<1-?:_>_$/4M @U=+2S338KJ)X[5&>-
MF=EXW9!/R]\CV[CG!XJ\4CX<6_BR358?-L[L03VR6JA+I1<^2Q8GE21S\N *
M /36U)%UJ/2_L]T9'@,XG$)\D ,!M+] W.<>E7:Y.;5M43XH1:*+J/\ L^72
M)+I8_)&5E$B*"3G)X)X&.M<?)XH\5Q> ]0\3-K$)?3-2DA-NMH@6XC6X$9#'
MJ.#QMP?4G/ !Z?)J21ZS#IAM[HO+"TPF6$F%0I VE^@8YX%7:Y2XU;4HOBA9
M:/\ :$.FSZ9-<>2(@&#JZ*"6ZG[Q]*R/#OBNYU778=,O]4GT_68Y)?M>DW5N
MB!H]K[6@;;EP#M.=QR <T >@AE8L%8$J<, >AZ\_F*6O(],OM:TKX?\ C/6+
M;6II+NSU"^V-<Q1N"8WP&X YP /[H[+71R3>);/2[>_NO$5IY-[-;%P;94:V
MC*G>L7#>:[-M !7UX[4 =R2 "2< =32*P90RD$$9!'>O)M8U[5M0\">/K:34
M+I'TMRD%P8DBF>)HU;:X"@#[Q&0%./0UTBZK>0:MX>\+PZA-YMW9O=S7;QQ^
M8L:!0$0;=N23U(/ /<Y !VU%>9ZGXKU[2[7QIIAO(WOM%M%O;2]>!29(F4G:
MZC"[@5(R!@^E==X9BUIK<WVJZLEXEW##)% ELL8MSM^8;@<L#D=?3WQ0!I:I
MJ=MH^FSZA>&06T"&25HXV<JH&2<*"< "L>W\>>'[@6#&YG@CU J+26YM)88Y
MBPRH5V4+DCH,\]JL^,O^1&\0?]@VY_\ 135Y6OVCQ-X<\#^"]0BCTVRNK*VN
MH[YGWFY\I ?*C&!M<CGD].F: /;Z*Y?7=;NU\366@6*W*O-:2WDLEL(C(%5E
M0!?-.WDL23@GCISD8=SKOBW1/#RSZW:7/EQ:DT<UW:1123_8MK%93&NY0V[:
M&P#@9(% 'HE%>;:EXIU-?#6DZCH6OVFH0WFM0VJ7#0*2T4C@;6  VL.0>,_2
MG3^)M=\'>*+RSUV_35M/?2I]2@D2W6%XVAY>/"\%2.A.3TH ]'HKSK4O$>N:
M+X.TCQA+?"YAF-O)?6/E((UCF*C]T0-X*EUQECGFGOJ'B?4/$OC#3+?6X[2+
M3([>2V=+-&92\;/CYL@C(YSGIQB@#T*BO-9/'5\GA;PMK>H_:K73;ZU+ZC?6
M, D^SRX7:6!5ML9^?)P<$*/KH_\ "27DK:%I=I?'4)=0@GNFO[$0[GBC90NP
M.0@)WC/!QM(QW !W-%<_X4D\1&WO8?$,.#%<L+2=C&'FA/W2ZQDJ&'(., ^E
M=!0!C:EXHTW2[R:UN%O7DAA$\I@LI95C0[L%F12!]UN,]JJ6/CG1-16S>V^W
MM%>Y^S2G3YU27"EL!BF,X4X'?'%:6NQHOA_5G55#-:2[B!R<(>M87PRC23X8
M^&]ZJVVT1AD9P>>: -SP_KUGXET>/5+#S?LTCNB^:FQLHY0\=N5-:=>+Z'J.
MMZ!\,[/6[+442VM]5DCDLO(5A,CWC(VYCR#\V1MQT[UVFH:SJ^J:]K>DZ2UY
M VF1Q*LELMNVZ61-X+^:?NX*C"@'[W/3 !VE9&O^)=-\,VD=UJCS1P22+$KQ
MP/)\QX ^4'K4GAZ;5I] LI-<MH[;5#'BYBC8,H<'&002,'KUXS7)_&$D>"82
MHR1J5I@9QG]Z* .FL/%.D:CJ<FF13RQZA''YIM;FWD@D*?W@KJ"P]QFI-#\0
M67B&.]>Q$P%G=O9R^=&8SYB@$\'G'S#KBN>E\.:IK/Q(TKQ)>0PV-II-O+'%
M&)=\L[R @[L# 4 \<DYK)T&YO;/0?'5QI]Q:6URGB*YQ/>-MBC'[H,Q/J%R1
M[XH ],HK@+'Q#JLFO^(=*BOII8K?38[RTGO;14D5CO!!4!,K\N1D _45FV'B
M3Q,FB^"==NM5CGCU>ZM[2YM!;(JD2JWS[ASN!&>,#V]0#U&FNZQQM([!44$L
MQ.  .].KFO&5[&+*VTEA,?[2E\N800O*RVZ\RG:@)P1A,XX,@H V=*U2SUK2
MK;4K"836ES&)(G QD'^1I=3U&#2-,N=0NA)Y%O&9)/+C+MM R>!S7!?#6\BT
MK6]>\'J)DMK:8WVFK-"\1^S2G)4*X!PCY&<=Z??ZIJ'BGPQXQN[;4&L[6Q-U
M900I$C"7RDP[2%@3\QR %*X&.IH [O3-0AU;2K/4;8,(+N!)X]XPVUE##(]<
M&K5>8:9J>LVT'PWTNPOHH+74M*(E#0!R#';*P.2??IQT&<CBGQ:EXKFM/%UG
M_P )"JS:#*QANOL<9>8&(2*KC&T 9P2 "?48Y ._OM22PN+*%[>ZE-W-Y*M#
M"76,X)RY'W5XZU=K@)O%.KS6W@&]BFBABUIXA>0B('.Z$R'#'H,CZ^]02ZEX
MHOM9\:6,&N1VJ:0L3VS1V:,?FA,FT[L\9X/4^F.X!W-_J2:?-91O;W4QNYQ
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M&><&@"EX2T!/"_A33=%C??\ 980KN/XW/+-^+$FMFJ6K:C_9.ESWWV.[O/*
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M2$85F7< ?ID9_.N5L/ =I!\/V\'7]T]Y8F-HQ($\MP"VX'J1D-R#[#BNMHH
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M6PM)KB*W62.XB!R T;'&0>AS_2NRHH J:;8_V=8I;M<2W,@RTD\N-\CDY+'
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MR*QVYX..QQ7H) 8$$ @\$&N/'PVT0>$D\._O3:I>+=JY/S@A\@9]-G[O_=H
MSM;U?7=/\+Z3J<6J2A[[5H 5D@CR+:64!8^%&"$(R>N2>:EMX;I_C3J"G5+S
MR4TF"40_NR@!E<%.5X7Y0>.?>NA\3^'!XDLK6U-XUJEO=1W0,:!B6C8,HY[9
M'-1S>&"_BQ?$,.I3P7!M%M9H413'*%8LI.1D<DYP>1Q0!YM8WNLZ%\.;_7]/
MU5H4LM:G/V,0H4G5KO:P<L"W1CC:1CWKO+C4]33XI6VD+>XT^?2);@0^4ORR
M+(BAL]3P3QG%5G^'BOX.O?#3:M-]EN[DW+R^2OF!C)YA [8W#TZ5K2>&Y9/%
MEMXA;4/](@LVLQ$(1L96(8D\YSN [T <!/XB\50^ =6\2G7F,VE:G+$L M8@
MD\:3A-K_ "Y^[TVXQWS7K]<3)\/%E\(:GX<?5I3;:A<O<RR^2N]2[[V [8W
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M?PQUKOJP4\.,GC27Q)]N8R26@LS;^6-GEABPYZ[LD\_I0!S$FK^*-?L=4N=
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M,J@*WF*64K@G(P.^.M;%>8"SOKKQQ\0?L>K7&GM%!9.)+=$+LP@8KDL"-OJ
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M&RM;6_E1<B.Z(P7  !9!NYP,\9[UT6I/JWA6/6-9?4VOM*M],>9+2X ,OVA
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M]0>H'2@#!N_AI:7=CJ]A_;.IQ6.HW9O3;HT>V*8N'+*2N2-R_=)(]L\UL?\
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M  &  ?K6KXJ\+VWB[1VTN]N[NWM6=7<6Q0%BI##)96Z$ \8K9AC:.%4>9Y6
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MZLRN/FO"C=1GD,22"#GO7IEIX7BAU#3[V[O[N_GTZ)XK5[C9E X 8DJHW,0
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M5L[!;I[B2Y$$\IDD< EE7D(% XQG/.:@NKOQ=HGAW2VUF.;5!;SR+J3:2_\
MI#18_=M@!22,C<%P>AZ9KH/$7@JTU_4K354O[_3-4M4,27EC*$=HR<E&R"&7
M/.,=:LKX82%;$VFIW\$UH),R[UD:<O@L9=RG=DJ#QC';  % '&7FNW=UI'A*
M?0?$]Q-!J&L-:O.T:EFC;S6"N&4$,@"KC@<<@U#?^(M:\!:SXCL9]0N-9M8M
M%.JV;W@4R12>9Y91BH&5)(/3@#BK'B_0[;2AX7LK*6Y1V\0"^N;E%#.I99"T
MK87:!N8#IM[8KLX_"]C))J$VH,^H3:A +:=YPO,(SB-0H "_,Q]23UZ8 .8U
MF^U/PW9^&M9AU.YO1=W=O:W\,K!DG6;C>@Q\C X("X&.N:SIIM=O(O'I_P"$
MDU"+^QY6>T\H1J01 ) &^7E<]AC/.2>W7V'@VVLXM.MY]0O;VSTQQ)9V]R4(
MB900A)"@MM!(&2<<'D@&FKX*M437U&IZAC7,FZR8OERFSY/W?'R\<Y_.@#G=
M2\3ZE!I7A[6=1M]0DT6YTQ)KR;3,[[>=E5A(ZCDH!NZ9'J#Q5B'7+G5-0T70
M['4#?0R:/]MDNXY_(>Z.Y4#!@N1SDD#!R1V!!WK3PG_9T5FEEK.HQ"ULTL@#
MY3!XU^[N!3!89X(Q[YJA>_#?2)]/TBWLKF^TRXTE2EI>6<H655;[P)((8,>2
M"* -/PE!KUKI4UMX@N8;FXBN76&6-]S&'@IYAVJ-X!P<#G@]ZQ/$,NK3_$;2
M='M=;NK*RO;"XDE2%(\J4* %25.#\W4YQV /-=7I.EQZ19"W2>XN'+%Y;BY?
M?)*QXW,?7  XP   !@5QOB*)[CXL^'C#<SVWDV-RK3Q(&578IM1B05Y /'7T
MH QH/%&NZ'_;'AZZOWO;BUUBTL;;4)MJOY5P PW'&-P&1DCJ1P>E;=W;>*M+
M77K@:D8-,.F236ZM<">>&Y0$Y4NG*$=0<X/3%;5SX'T>^T/4=+OA-<C49?/N
M;AV E:48VN"  I7:H  P .G7,5GX)CM]+N[.YUS6+^2YMVMOM-U,KR11-U5/
MEVC/&202<#G@4 <I=-K]I\))?% \3ZB;V;1()PFV/8C[ Q(RI.2#R<YSSQQC
M?.L7&I^-=/\ #1N)H(!HW]HSO$VQYF+A%7<.0!\Q.,$DCMD'2F\'6D_@@>%)
M+^^-B+=;;S,Q^;Y2@ +G9CH ,XS[TZ[\(VUS<Z9>QWMW!J6G1F&&]CV;WC(P
M4<%=K*>O3@\C% '%W'C+6-%77=!ENC-=6NK6FGVFH2J"5CN0&4OQAF1<\XY.
M,]\Z=SIYL/C!X=Q>74Z/IMWA;B3?M8&/)!///''08X K=N_ ^D:AH>H:9>B:
M?^T)A<7%T6 F:48VN"  I4*H  P .G7,=KX*6+6M-U>[UW5;Z\T^)X8VG:,!
MD;&0P5!G[O7J>Y/% &EXK_Y$[6_^P?/_ .BVKSF!M;\-^$O!>OVNN74\,JV%
MK<:;(J>2T4BJH" #(89'))S].*]6O+2&_L;BSN%+0W$;12 '&588//T-86G^
M#K:SATVVGO[R^M-,*M907'E[8RHPA.U06*C@9SZ]0#0!A+K5UX8\5:]I^KWM
MU=P36GV[2@[C+*/E>%< 9<.5QU.&%=EHUK=66C6EO?73W5VD:^?,YSO?'S$>
MV>GM7,R_8_&?BC3R=*O(TT&\DE:XN[=H@9 "JJA/W@20^1_<7U%=K0!YUXRU
M+4+8>*)K75;EYK"P6>UAL?E%DP1F+3$X5MQ PIR=HX7O2W.H:QJ'BKPE;)K%
MS:V^J:7-/<1PHG#JD9RI*G!^<]<X[ =:V;_P#87]_K5P=0U*"+681'>VT,JK
M'(0FP/\ =W X[ X..01Q4EKX)M;74-&O5U34GETFW:V@$CQL&1@ V[Y,\[1T
M(QCB@"OX OKZXMM<LKZ\EO#INKSV<,\V#(T8"LNX@#)&XC-7/%-S+%<Z1"FH
M-;Q37#++;0 _:+L!&(2,CE<'!8\8 Y(%6M!\-P>'YM2D@O+N<ZA=-=S"<H0)
M& !*[5&!@#CGI3->\,0:[?:9?&]O+*]TUW>WGM64, XVNI#*P(( [=J .%MO
M&&KVOAN\MY+B5;M_%']B6T]QM>2WC9EP6(R&95+ $YYQG-7KV :)\6=/N6NK
MNX@30[N0I-)YA4JR%B">>>..@QQBM=OAKHLFF:MI\UQJ$L&I77VQM]QEH)N/
MGC;&0V5!R<_D3FQ:^"DCUNRU>\UK4[^\M+=[=3.8PKQL02&"H >@]SW)H X;
MQ)+=Z]\';?Q'=:A<?:+R>VG>!'_<A&N$VQA>GR\?-]XD<G!Q797-[J"_%>UT
MT:A/]@GT>:;[. H5)!(BA@<9S@GJ355OA?I_]BW&AQZQJT6C23+-'8I)'L@(
M</A&*%L9'0D@9SUYK>;PQ"WBBV\0-?WINK>U-HL9,?ELA()S\F<D@'.: .#\
M.I>6'PT\7ZA::K?1W5M<ZD\4C.)"&C9R#\P.2<#)Z_2MFUUZ\U#4?"&@O=2Q
MB^TC[?=SHVV28A$ 4-U&2Q8D<\#GK6M'X%LH=.UO3XM1U%+35FF:6(2)B+S?
M]9LRO?/?..V.:DF\%64EIHJ1WEY%>:,NRROE*>:J[=I5OEVLI4 $$=O6@#C]
M8UW7-,LO'>D1ZI<;]'M([VQO<*T@1T)\MR0<X*G!^]CO6I#<ZMIOC+PBLFLW
M5W#K5M.+J"8+Y:LD2NK( ,KSD<DDCJ:W;OP797VDZM97%W=F35P!>W:E!+(H
M7:%'R[54#@ #U/4DT^3PC!+J.AWSZE?F;1D=+?F+#AEV-O\ DYRO'&* ..O-
M<U2TET:\AU6XO7N/$*V=Q<1<6;0O(R^4JGJ5&!N4'YE.6-;NE_\ )8O$/_8+
MM/\ T*2FI\,=-CTZ#3TU;5UM+2]6]LXA,F+9PY?"_)R,D_>W8[8YK<M/#-O9
M^)[K7DO;Q[BY@2W>*1D,>Q,[<?+NR,GG=SGF@!?%DFK0^&KN31(C-?KL*QJP
M5G3>N\*3P&*;L>^*Y&W\1QZCX2\57FCZMJ=M=V5FSFTO4_TBQE6-VPP<'(;
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MX>+? 8M_]=_:CXV]?+\IM_X8KHX_#.G&VU.&[1KQM4&+V2?&95V[0O    X
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M^T1@8/J,#!K5JAHNCVF@:1;Z98JRV\ (7<<DDDL2?<DD_C5^@ HHHH ****
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MG@?-C&>.M8WVJ7Q'XR\0Z(][<VD6F6]N(5MI6B8O*K,925()Q\H SC@Y!SP
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M;KBM,_Y+%X@_[!5I_P"AR5L^+FU9/#DS:+$9KQ7C;R5D$;RQAP9$1C]UB@8
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MSP\;.:*6VM4NO.=EVR*S%1M )/8]<?2N#T[Q?K%S!IOAZ\NW%U)K]SI,VH*
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M88#IC*^XR"/TKE8_A]IL/A_3-$COM06STVZ6ZMOGCW!U8LN3LY ))Q[UUM%
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M6:"9 $EBW##H0P((/0@@C@$=C2Q^&M-&FZA8SPFZCU$LUZ\YRTY8!26(QC@
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MY;BV*9GC!R ZLK*<'D' (^G%:&DW5Y>Z='/?Z>VGW+%@UNTJR%0&(!W+P<@
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MDUA56Y)9#@*NP;<IQA>._P"?-=%10!GZ)I$.@Z-:Z5;2S26]K&(HC,06"@8
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M2\NO-(DD\N+>$W]068C)!S@8[UV<7A'3K>\U6YMY;R%M3)>=%G.P.RA6=5/
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M1)>?;V=) 'DN-V_S&..3NYP,#VP!5F[\+VEQK*ZQ!<W5GJ)A$$MQ;,H,T8Y
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M;,WDT,]T8$\Z6#_5N^T;F7V)R16!J/P_TC4-=?6!/J-G=SJJ77V*[:!;H 8
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M1AAR<X!Z#/3CI4LEO=6Q\ 7D6L:JL^J!+:\)NV99$:W+?</RJ01PP /?)/-
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MKAYFC:1&W@,Y+8)4'&:[>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMSO"3MWIL+9YXQUSVJAX<UW1+?PEHKZ0+V>UO6>*QBE;=-*079LEV[!6/)Z
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MXHM=>U)_$;S*L<<U[).+QC.4,9B9B#\O/ !XKW&]F$%E-(R2.%0_+'&78_0
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M)NXIK. 2RS[AD!TQSM!7.3QTQ0!V^HZS;Z=<VUH4EN+RZW>3;0@%W"C+-R0
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M=0&#;5;C!((PPY!KS>PTJ*Y\.ZM8ZUHNJM;W7B2XN%:*WE6:%'+/'.F!NX(
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M.%&TGKGH*R?$":YJVC:FEUH6KOJ%MK,<B100$6XMUG4AD ($I*C)/S-DGH*
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M&>Q!!Z$$$$>U7JS= MX[;1H(XM+BTN,[F6SB15$0+$@$+P&P<G'&2>3UK2H
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MF*JK'=GDCJ 0,X)!S0!H_P#"&:9_S]ZW_P"#N\_^.T?\(9IG_/WK?_@[O/\
MX[70U6U&^ATS3;F_N"1#;QM(^!DD 9P/4T 8_P#PAFF?\_>M_P#@[O/_ ([1
M_P (9IG_ #]ZW_X.[S_X[6!X"U76(/$.M^'/$<H;4 5U.WYX\F7[R+[(^5KJ
M-0UR"*_DTJ"UNKZ\$'G2PVI56CC.0"69E )(. #G@GMF@"M_PAFF?\_>M_\
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M1V-6Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\L_-R %RK<CBK?A.+4;6[\9.+">.6ZU&2ZLOM$3(DP\M%4Y/3YEZ'!Q7<44
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M'ACRYH9[R#P]_8L,Q7;%+ D4\F,Y9U4G YP >>#ZUN2R+#$TC!R%&2$4L?P
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M<XR4D_G73ZKK'BK5?"6I7>C:)=:?=K&HMX+ORQ<2'</,( )5<+G;DY)[# R
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MJ"L8P-S%B  2<#N3GC@XS;7Q[IMU!HLR6=^J:M<M:1%XU4Q3+NRK@MD?<;D
MCWK'U$:SHGC2S\3V>C7FI:?=Z8EC=6UN%^T0.CEE8*Q (^8@\^_UF\4PZU>V
MOAS63I$SR6&JK=36,!5YHX2CIZX9AN!(![D G&2 ;$^MVFLR>(]"-O=13Z=
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MKUSH'Q"MSH5VDVKSA[-0R-OS&BXX;@C')Z>A- ';6?C&VN?$%KI$NG7]H][
M\]G/<(H2X"8+ 88L" P.& KE/B=KT.K?#37GL[*\GLXB81>QLHC\Q7"D@;@S
M*&RI.,9]1S6K?VM]<^,O!5['I]W]FLK>Y2ZD\O'DF2-%4'\5/3.*Y1M*\16?
MPGU7P*^@7MQ?0+)%;74.PPW$;2[U?<6!!YP1C/ZX /2KO7TLY&L[:RN+^[AM
MUGEA@* HAR%R791D[6P/;M65_P +(T>2ST.[M+:_NX=:+):F&('YU#91LL,-
ME2/3/?'-8FHVFI:3XQDUN;PG+K.G:I:0QRPHL4D]G-&",8+;2I!Y(/4?G;U:
MQU%]3\&SQZ(T*6=[+<7,-HBE;9'1U4''!;YAG;GG..V0#9@\9+<QLL>B:G]K
MBM1=7%DZQI-$A9U4%2XR3L8@ ],>H!K2^+;T^/-.T6#2[A[2XTYKQI%:/+9:
M, X+#"KN.>Y)X!QFL_QKH2ZOJLUQ'8ZG::K;6H_LW5M.R&9SN/E/@XVYQ]X!
M<,>1S3Q9:_;>-?#FK7E@]Y(=&:RO);8H%CN"T;%CDC"?*W(S]* ->\\;6=I9
MWNH)97MSIEA*T5U>0*A5"IPY"E@S!3U(!Z'&<&KL_B2U^UVUG81R:A=7-M]K
MCCMV7'D\ .68@ $D =S] 2.-TG3-7T/PAKWA*72[BZEE>Z6PN$ ,4\<VX@NV
M?D(+'<#Z<9J32_#FH>"_$^EWB0SZAIIT6'2[AX%WO#)$<J^WJ4;D<9(- '26
M_C?2)]#GU/\ ?QF"Y^QRVCH//6XW!1%M!P6)(Q@XYSG'-<]!<23_ !OMC+87
M-G(="E++,ZLK_OH\%=K$>QZ=/H3EZIX/UM[6]U^QM"U\?$,.L1Z<SA6DBB78
M%)S@.P);&?0=:V[9]3U/XFZ;K0T'4;:P&DRVSO<B-"CM(K#(WY_A(XY]L<T
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M>S3E@5X;Y@>OSX QGC% 'JE%<]!XJ0ZS<:+=:?<0:G';_:HH R,+B+."8VR
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M2#QCH3530?&__"0W<<=IH.II;&XGMYKF01A('CSD-AB><8R,C)'/7 !U=(6
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M7IQL$>5WJ,-G.<=14*^.K8M83-I]TNGWVH'3H+EMH)F#,H)3.0I9& /7U H
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M/>3:?;6?V?5+.":-9#*L:JFX[P&CR&R W/&0>E>DT4 >03>&?$)^&7BO08]
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M@C/'KT%O4[+Q!-KXM+O23J&DMIJQP+;R)';QW/.\RJQ!*_=V\-C' SFN]HH
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M+(Q @!?Y5VE>#MZ9Y.37KU% ''Z58ZE%\3-:U*?3I8[*ZLK>&*?>A4NF\L,
M[L?,,$BKWC4:X?#I_L&.26Y\^(S1PR!)7@W#S!&Q( 8KG!S].<5T5% 'F-OH
MVK6^N^*+FW\-3V]IJ>DQQ0+YT1?S%60$/\WWR6&3DC');/%.;1=:'AGX?6@T
M>Y,^D75M)>J)(OW:QQ,C'._GEATSQ7IE% 'F%OIOB#0[#Q?H']BW-]#J4MW=
M6-Y!)'L/G*<I)N8$$'T!S7:^#[:[LO!NC6=];-;75M90P2Q,RL0R(%/*DC''
MK6U10!Y5XMT?Q-KEIXNT^XT6:^>8?\2F?SXQ!'%M' 4MD2YW<[><XR!BO2]-
M:9]-MFN+=K>8QC="S!BAQT)&1GZ$CW-6J* .-\*:;J$&M>+6OM/GM8-0OO/M
MY6=#O3RU3^%B0<J3R*QO"-GXAT:RMO#-[X5@=[,^3'K.Z,PO"#PY7[^_;QMQ
MR1R0*]+HH XJVTW4'^).MWLVG7$>G7FGPVL=SOCP64ONX#;@/FX..U97A&T\
M0Z196OAJ^\*P-)9$0IK :,PO"IX?'W]^WC;CKU(%>E44 <=X;T[4(?&'BZXN
M]/GM[349H7MYF="'58@C<!B0<CN*Q/"5CXAT2RM_#%YX5@E:S/E1:SNC,+0@
M\.5^_O XVXY(Y('->F44 >>0Z7JZR_$!FTFY U7FR^>/][^X$?\ ?XY'?'%4
M8=)\2:#'X/URTT>6[FT_2%TK4M/$J"4+M3YD.[:<,GKR,?AZC10!P'B>P\2:
MOI^E:[;Z1$;_ $Z^^TII,TJDR0&,HR,W*^8=Q(Y('3DCGH?#<UY>++=7&@C1
M8BH5()"AE<]V;9D = !G/4G'%;U% '(^-]/U&YNO#E_I]C)>_P!G:FL\T,3H
MKF,QNI(WD X+#O533++5?#?C'7;Q]-GO+#6?*N4:V96:"94VM&P8C@X!#=/7
M%=S10!S?@;0)O#GAI;6ZVBYFGENID0Y5&D<MM![X! _ U2O+'5+;XIP:S#IL
MEU83:3]B:6.1!Y+B;?E@Q!QM/& >?SKL:* /)[GP]K\_PS\7:0NC7 OM1U*Y
MGMHC)%\R22AE.=^!P.<FM+4+36M'\93:Y;^&FUG3]4M88Y[<-$)[66,$#AC@
MJ0><'J/S]&HH I:2EPFFQ?:K:&VF;+-!#@K'DDA<C@D# )'4YJ[110 4444
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M98+6=+A&<.PRGF1CE W;KCC(%6KKQH(K.74K32KF]TN&Z^RR3P'<Y8/L9DC
MRR*V03D'@X!'-9?A$>+K&TL= U+P_;Q"Q"0MJRW"-'+$F "J?>WE1CG&#S[5
M#X;M/%OA=;KPU%H\=S8_:99++5?M*!(XY'+_ +Q#\Q92QX YZ9 YH W(-2L'
M^(.H64>CLFK0Z:DANV*CSHBY"H"">-P/7'TKC]+B@\1:=XMN?$?A\ZA%::Q<
M2<3*9%\D(%C4Y7@ 'N <GUYZF'3M23XIWFKMI\O]GOI4=HD_F1_-(LC.?EW;
ML$,!G'6J/A_2]9LM#\707.CSQS:A?WEU:IYT)\Q90 HR'P#ZYX]Z -'2/$6G
MQ>&_#<>EZ>8VU.W4V%@K !$"!CN;LJC&3SR1@$FM;0M:?6%O4GT^XLKBSN&M
MY4E&58@ AD; W*01@X'TKA(_#WB;2M$\$ZI8Z9YVI:#;-:7>G/.BF:-T56*/
MDKD% 1D\_I7?Z-<:G>6[W.IV0L&<CR[3S!(R*.[,O&XGL,@ #G.: ,;4?&4U
MKXDN= LM OKZ_BM%NT"21HDB%BN=Q;"C(/7!] :HK\3;)_#MGJ\>E7[>=J"Z
M;/;X4/:SE@I5QG)Z\8!SQTJ&>ZFM?C9<-%8SW2GP]$&$)3<O^D28.&(XK-O/
M".LPZ&C0:<T][>>)EUNX@CFC @02 [-S, 6VJ.F1G/;F@#JX?%=R\]M83:+/
M;:M<O+Y5G-,G^JCQF5G7("G('&3D].]5Y/':)I.MW']EW#7^AM_I]@'7>J;=
MP=#T92O(Z' /&>*9KNDZG#XVT?Q5I]H]VD5M)97EHKJL@C<A@R;B%)##D9Y'
M3-6-!T*8>)/$.OWUOY)U40PI;2%698HT*Y?!(RQ)XR> /<4 7X]?^T0Z+);6
MPF&J*)%V2C]W'LW[SQR,8'U91WK"T[Q3HUAIWB?5$TE].%GJ9ANPY0--.1&-
MY() !+J,YZ<U+X%\,W_AY;JWOI!);V<CVNE\Y*VI;?R?4DJOTB%9^FZ3J]K9
M>+ENO#OVI-2U;[3':S2PD3P-Y:./OX#;58@'':@#?O\ 69%T?6?[4T1Y8+:T
M\V2.&59$N8F5MP4MMS@*<@XZ]^,PZ?XCL8-"\-0:;8;)=4M$>QL58*(XQ&'.
MYNRJ"!G!.2, YK!TWPKJ.D:9XGLM+M;Y-(N[+R[#3;FX1VCF97#["7(5.5X+
M=0?;+;?PYKFGP^!]7AL'DN]%L187UAYL>]T,:J61MVTD,N<$C(]* -N7QY!;
M6.O-<Z;<K?Z''YMW9HZ$F,J6$B,2 R$ ^_!&,TZR\;FXUC1K*YT>ZM(-8A9[
M.YD="'94WE2H.5^7.">N.@K'UCPUJ>IKXPU:/3Y%N]5TO^S;.T:2,/C8P+N=
MVT99NF3@+ZG EFTC67OO 4RZ3/MTE6^V?O8OW>8#'_?^;DYXSQ^5 &[8>*3J
MDD<ME8^=8O>269G28%HF0L"SICY5)7CG/*D@9K3UK6+30=)GU*]9A#"!P@RS
ML2%55'<DD ?6N&7PO?/XGL-;T_2KC1=4-[G4Y(IT^S7=N"<ED#'+,,8X!!)S
MTS71>/?#UUXE\*3V-A*D=]')'<6QD/RF2-@P#>QQC\: )5\4-;^(++1M5L&L
MI[]'>SD$HD20J,LA( VN!SCD'L37*:3:_P#"7>*?%UAX@T=)[47$$/SS FW5
M8E954C!'S$ME2.36U<:=J'B?7O#M]>:7-IL6E2/<RK-)&Q>4IM5$V,<@$DDG
M'0>IP[PK8:G9^*O%%W>Z9-;VVHW<<UO(TD;958@AR%8D<KZ=Z '^,M?U/1+S
MP_:Z?:+*E_J"6\CM*%.-K-M&?7;R>WX\84-Q/IGQ5\0RZ?HSW5W-I5K(UO"Z
M1@MNDR6=L#/0=R?S(WO'&F:E>OX?O--LS>/IVJQW4L"R*C-'L=206(&1N'&:
MAT^RU>#XBZMK$^DRBTN-.@@1TFB;=(A8L "P./FP"0.G:@"S;>.]-O/#^D:I
M"NU]5R+>">18\%0=^]CP N"">>V <U8\,>++7Q++J5LD7DWFFS"&XB$@D7D9
M5E<<,I&?0\'(KA=.\+^*=(\*>%+NVTI)-6T*6Y6?3I9XP+B&9B3M<$J"!M(S
M[_CZ)H,^IW<$ESJ6F)IF_ CM/,61U SEF9>,G/09QCKS@ '%>/[;2O\ A97@
M9]2BM!;3->BY-P%".%A!7?G@X/3/2J>AP-/J'CJVLD>;P>;8?9%E!:'SO+S(
M(=W\&<].,XQ71>)],U:\^(/A+4[/2YI[+2FNC<2K+$O^MC"+M#."<'KQ^==1
MK*32Z)?16\+3320.B1J5!8E2 ,D@=^YH Y'P?K+:=X"\%V4%G)<W5_91I$,[
M8TVQ;F9WP=HP,#@DDBK%Q\1;:V\+76MOI=VWV.^-A<PHRGRI1($)SGYERPP0
M">>E9%KI7B>Q\.>#+!M(FGL[*$P:K81W,2L[! L;9W[60')*YYXR#TK-F\*^
M)!X*\1Z-'H*K+=ZY]MMEAN8MAB,T<G&2N  A'.#TXH [K3_%3W7BF30+S2KF
MPN#:_;+=I71A+$&"G[I.T@D<>]:&M:W!HL-L9$>6>[G6VMH$QNED;.!SP  "
M2>P!^E8<MAJ<OQ0L=8&FS#3TTJ2U>8R1_+(TBN!MW9P I!('6G^-]#U#43HN
MJ:4BS7ND7RW0MF<+YZ8*N@)X#8/!/% %B+Q:%U:]T>]TZ6+5+:U^V1P12*ZW
M,6<;HV.T9!X(;'XUEV7Q'6[M-!U!]#O(=,UB9+>.Z>1/DE?(4%<[B"1C=T^H
MYJ632KW4_%I\22:=/;K::9):6]M(\?FRR.V2>&*@   9/))]!GGX?#>OQ?#W
MP=I)T>8WNEZC;3W2">'"I$Y+$'?@Y!X'\J /1M6OI=-TFZOHK1[MK>,R>1&P
M#. ,D#/?':N>'CJ(P^&9UL6-MKY58)O.7;$[*6"OQU(!'&>0176CE1D8SV->
M6R?#O4CX?UO3U=!]@G>7PYM(S$2XG'/;Y\1\] I[&@"U\4[M-2^'_BB"2R79
MI[PJD[$-F0M&QVC&00& /U(]:Z6T\5O+XI&AW>DW-G)-;-=6DDCH1.BD!A@'
MY6^8'![>G2L?Q9X>U:]^%EWHUK:_:]6O KS!'1%,K2"20Y8CY<[L=>,"K=[8
MZI<_$;1-732YQ96]C/#-(9(LH\A0@8WY.-ISC]: &:)XGT6TT/6-1@TJ33UC
MU>6VEMP%,EQ=%E4X ."S,0.N.^<5+JVK/J-KKF@ZIHTD+KICW*R'][!(A!&-
M^  X(^[^()KFCX1\0W7A?788K3['J8\0OK.GB>5&23$@=%)5C@G!'/?%=.E[
MXEUK0]0^V>'FTYC9R1):FZCDDFE88&"#M51SR3DYZ#'(!B>#/%;:9X8\%:?=
M:5<QV=_:P6L-\77:9O*W ;,[L':<'V].:[#Q7JMUH7A75-5L[=+B>TMGF5'?
M:ORJ22?ICIWKC/[ UT>%O -C_8\QN-&N[:6\430_*L<;(Q!W\\L",=J[7Q1I
M\^K^$M8TVVV_:+NRF@BW' W,A R?J: .!UVZGN8OAYJU[8EK\W\?,>UY)0UN
MQX/ &3V. .]=59>.+=H]>_M6RETR;1-K74;NLF4==R,I7@Y'&/7BL.?3/$%W
M8^" ^@S1OI5U')=)]IA)1%A,9/W\$DG( SP.QXJ/5/"6KZUJ?CJ+[,]I#J\%
MH+&Z>1"IDA!^\%8L 6QVZ9H W[+QQ;3>)[30KF!(9[Z%Y;5XKE)E;8,LC;?N
MN!SW!YP:V-:UN#18;<O&\UQ=3K;6T"$;I9&SQSP  "2>P!K'\-W_ (GOY84U
MCPY#I)@!^T3"X243M@C$87D GYLGIC'.<B+QUH^JWDVAZSHT"W5YH]YYYM&D
M">?&RE7"L> V#QGCK0!C:==K9?%S7[W4+.+3EAT**6X=7#HX$CDR;@ 3P,<@
M'Y3[5L1_$&T_M?2[*>U")JH86CQW"2-O W!)%!^0D=.2,\$BLB[T'6?$OBC6
MI[G29M.L-4\/_P!G"6::-GBD+2'E48_WNQ/;GJ!I>%[GQ:8;73M7\.06CVBA
M9]06YC=+@*./+0<@M@?>P!D]^* ('^)JIHMSK)\/WXT^RO&M;R5I(P8=KA"<
M9^;!/.W(]ZU[K4-.'Q$T_3Y=)8ZBUC-)!?MMPL8*[E'.>I'4"N/N/#/B&;X8
M^)M%&C2B_P!0U">>",SPX*23!P2=^!@=?ZUTMU8:I<?$?1=772YEL8-/F@FD
M:6+Y'<H0,!\G&TYQG\: )!XY0/IT\NF3Q:?J&H'3H)G;$GF[F4%HR.%)0X.2
M>A(&:IZ%!%!\7O%?E1HGF6-D[[1C<Q\S)/O7.2:!XMO+'2)K_0/M&LV&MQW=
MU>-=Q'SXE=B/*Y^5 I'RG;C'0G-=;I.G:G#\2=;U2XT]X[&[M+>&*?S8V!:/
M?NX#;L?-QD=NU %GQQJ&G:=HUN^J:2VHVLEY!'L&W;&Y<!&.3G@D= :DU#Q0
M;>_U*RL+'[;<:;;K<7$(F"2$,"0$4@[C@=\#D#)/%5?B'IFHZOX=AM-,LGNI
MQ>V\Q59$3"QR*YY9AV%9'C'PW/X@NKNXCT2[@U:")3I6K6=Q'&Z-MSLD.\':
M'SG@C!..>H!W\L,5S T4T:212+AT<9# ]B*\C\#^,V\+?#30I;O1+TZ,A:*?
M4D9-D):9@#LSN*@D MCZ9KUJS2XCL;=+J19+E8U$KJ,!GQR0/KFO-;#PQK<O
MPQ3P+=::]O*289KXRQM"(C*7+IAMQ.W@ J.>N!0!T^M>,_[*_MB2/2YKBVT>
M));N4N$RK+N_=9&'(7D\CTSFK4WB='U*+3].MUNKI[(7XC>81%HB2!MR#EB0
M>. .,D9KD/$N@^(]4?Q3I[Z.+^WN+/R]'G>Y18H!Y6"NPG(D+9^;'.0-RBIM
M4\-SZYIMA;ZMX:NEN+73X_LM]8W4:W%K<#<"N[>.P0]UR3]: .ENO%L,/V2W
M2&,7]Q:+=FWN;A81$AZ!F/<G(  /W3G%5--^(.G:OI&GW5C!+)>7]P]K%9,R
MAA*@)DW,,@*H&2PSP1@$D"L-]*\8:%JFD:ZMC'K]P^E1:?JENLR1OYB,6$J,
M^ >68'IGK]+.N:7XDEU'PYXIM],BDO--EG\[2HIE!\F90I"N<*SKM![ DD X
M'( G@W?_ ,+0\;&2Q6SE,5B9$1@RLVV3Y@0!G/J0#ZUZ%7":1!K]OXP\4:Z^
M@R)%>V=O]EBDN8@[R1(_R':2%)+ 9R0/6NRTZ>YN=-MI[RT^R74D2M+;^8'\
MIB.5W#@X/&: +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!E:]X?LO$=E':7YF\A)5E"Q2%,LI!4DCG@C-::+L1
M5+%L#&YNI^M.HH **** "BBB@ HHHH R4\.V2>)7U\/<?;W@%LQ,GRF($L%V
M], DGUK6HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***@O;R'3[&>\N&VPP1F1SC/ &?Q
MH GHKG] \0:EK%U+%>>&=0TJ-$W"6[>,ASG[H"L3GO\ A6EJM_-86H>VL)[Z
MX=ML<$)52QZY+,0% QU)]ADD"@"]16!X7\4+XB6_AET^XT^_T^?R+JUG(8HQ
M 8$,O# @Y!K?H **** "BBB@ HK$\+^*=.\6Z?<7NFN6C@NI+9L^J'@_0KM8
M>QK;H **AN;J"T1'N)5C5Y$B4GNS,%4?B2*Q[;Q&T_C6[\.-8M&;>S2[%P9
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M!K$CR7JF;_6,PPQSCY<@ <8Z5S7BC1A#JVD6\VG^()-,L;)HK:^TB=_/1V8
MHX0AMNU%YP<]^E &SX M=3BM-4GU&XOY(GU"9; 7DC,WV4-^[.&Y!//)Y(P:
MN>.]/U#4/"%^-)NKJVU&",SV[6\SQEF7G8=I&0P!7!]:A\'Z==V/VMVN=9DL
M)0GD1ZQ-YLRL-VYAG+*I!7ACG(/ []30!Y5_PE\(\6:#XCCN[M?#M[:K;7.^
M[<PPW+Q^8F4SC<%&T_[X[U-XGL[E=&\'F>XNTN;OQ)!.QDE,CP;Q*P1=^0-H
M(7'3C.*[$>#-!&@#1!8I_9XN1="+_;\SS/RSQ].*L:UX>L]>>Q:\><&QN%NH
M/*DV[95SM8^N,G@\<T <#=ZM?>$;WQ[%97=W<Q6.G07MJEW.\YAD<.&(+DG;
MD!L9QQ6W::-JIU?2M2@U18M-FB:.ZC.I33_;%=?D9=P 1P>05QQ["M]?"VG?
MVOJ&I2"6:;4(!;W22MNCDC ("E<8P 3^9S5/P_X#T;PU<"6Q:^=8\BWAN+MY
M8K8'KY:,<+QQGKC//)H \R-E%;_L[:])&TV6FN%(>=W4 79 PI) /J0,GO7:
MS"YT'XG:=##?W]S#J&G7,EQ#/<-(K21E"K*IX0_,1A0![5J2?#W0I-(O]*Q>
M"POI3++ +E]HRV\A03\@+<G&,_2M&3PW:2ZW8ZQ+/=/>V4310N9!C:V-P(Q@
MYP.3SQ0!Q&C+KWB7PWHGB:TU2&TN&=;JYG:_E:-TR?,A:';L [>HV]<Y-6O#
M^FW&K>,?$JW6MZOY6F:K"]O$EVP7'E*Q1AW0D_=Z5MV/P\T#3M8?4+1+N)'F
M^T&R6Z<6OFYSO\K.W.>1V!Z#@5J:7X=L](U+4+^VDN#/J#B2Y\R3<KL!@$#M
MP,<4 :DL:S1/$Q8*ZE258J<'T(Y!]Q7C6AWTGAWX3:?-937$,E_K!L9)S.["
M"-KN16=0Q(4[01D#J<G)KVBN;A\":!%I5_I36TLMA?.SR6\L[LB%FW'RP3\G
MS?-Q@YQZ"@#*O6NO#OQ%\.6EC<74EAJZ7$5S;3SO,$:--ZR*7)*GL><'CO7;
MRNL<3NSA%522S=%'J:R[#P]:V-W%=R3W5Y=0Q&&&:[DWM&AQD#@=<#)ZG R3
M6G+$D\+Q2J'C=2K*>A!X(H \JL;Z]M]4\%7%MJ-_=PW]S+#/?3S,JWZF-V#"
M$L0JY *G@CL,&BSTG4->L/&A?Q)K,,NG:K<+9-'>,HB*Q(RYQ]Y<_P )XZXY
M.:ZJ#X;^'[:"PB4Z@R:=-YMH&O93Y(P1L7GA<$\#KQ6/X5T!K^^\7I?+JMI;
MW^JRR>4R/"ES 40 Y9<C)# [2"1UXQ0!E:;?:KXFU;P9]LU74+5-4T26:[CM
MIC$'9?+^88^Z3DG(Y&>,5G:O=:UI'A/QYI":UJ,BZ+=6QL;QKAO."2[&,;/U
M8*&Q^/TKK=;TMY?B7X<^RV]_;6=E8SPBXM(&$<+-LV+G:4Q@$8.0.^.*WKSP
M7I%_H5WH]P+AK:]E\Z[82D23OD'+-U_A7I@   <#% '/:M'+H?BC0-$35=3D
MM]>O9I;N6:Z8E?*AR(XR,&,,V#A<="!@<4^&*[C\?:OX26_OO[+N])6^AD%R
MYDM)/,,9"29W '&X G'!QQQ74ZKX=L-:T^WM;[SI&MI%F@N!)MEBD7HZL.A_
MGWJ73M&MM.N)[H/+/>7 59KF=MSN%SM7@  #)X  R2>I- '$^$]0N]9T?3=
MO+N[&K:;=RQ:I(MS('(@/4MG)$A:+@\$%L=*AC76_&=CK<UA?"ROK74Y[:"<
M7\J?9?*?"@PJNULJ,G=G.[Z =[::+86.K:AJEO $O-0\O[3(/X]B[5_2L6\^
M'N@WFO3:OMO()KD@W<-O=/%#=8_YZ(IPWOZ]\T =):.\EE \DD<CM&I9X_NL
M<<D>WI7&V-PWBCQGXITR]N+J*#2_L\%O%;W#PE=\9<R90@DD\ GH%XZG/;@
M    #H!6->>&+*YUDZO%+<V=^\7D2S6LFTRQCHK@@@X['&1V- 'FJ:OKFH^'
M/# N=5O(KE/$ITJ:XADV?:8E,@W,!P3\H]LBO5='TI-&TY;*.[O+I59F$EY.
M99.23@L>2!G ]JSKKP;I%S9Z9:!9H+?3)UN+5(92NV49PY/5CR<YSG)SFN@
MP ,Y]Z ..U'4'U'XF6WAF6:6*RBTIM09(I6C,[F7RP"5(.U0"<9Y)&>E<;8Z
MA-X:TOQ/%:W$@$_BY;-KB>8[HXW$0),AR1Q\N[DC.>M>CZWX4T[7;VSOYS<6
M]_9D^1=VDQBD53U7(ZJ?0U5C\ ^'TT_5K&6WGN+?59#+=I<7+R;VX^89/#<#
MYASP.: ,2]T?6],.N70U5K6PFTJ5H[1+Z6:1)T&?-1W *C! ('?![UD637UC
MI_PWU@:OJ4USJ36]O=K-=,T<J/;ECE,[<@@'=C)/))-=EIW@;2]-TVZLH[C4
M9Q<PFW:6YNVED2(]8T+?<7Z8_08D/@O3#9:/:>;=B'1W5[("7_5E1M7G'S8!
MQSGB@#FI-3G\'^+-;T^\N;R[AU*V%UHZSW4CYD!V-;J2>#O9",=F]J[G1[!]
M,T>TLY;F:ZEBB59)YI&=I&QRQ+$GDY^E<\@?Q5XDLY;O0+NR@T2YEDCGO44&
M:7!13'@DE,$L2<<A,9YQU] '(Z\?M?BRUL%O+J=S8R/_ &9;2M !EP!/)*K
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M^T)0I@AB)VG<Q.2ZJ,@8))V^YH UO#6^[%]J[3SO#?7!:VC>9F1(5PJE5)P
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M6QD9;)P3@\\@'#V^F:CK'AOQC=GQ+K,-UI6J7HLG2\95C\H J&'\0XQ@\ =
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M;JUQ?VNF33:98I>WBX\NW>81!^0#\Q!Q@9/X5,]Y;QWL-D\JBYF1Y(X^[*N
MQ^@W+^=>7^*-*;2?A1>ZS;:KJWV^XMK-WD-])@-N13@ X (8@@<=..*U]0TV
MVG^-NGO()=S:)*Y*SNO*S1@=#T]NA[T >@45YB+NX\+ZWXB\-27-S/-J:K<:
M*]Q</(3YA$1C!)R!&Y#<<[23VKT:PLUT_3[>S226184";YG+NV.[,>230 LU
MY;V]Q;6\LJK+<N4A0]7(4L<?0 U/7G_BS3K:Z^*?@PRB7,L5\K%)G3A8U(QM
M(QU/3KWIFCAO&4?BU[VZN8+JTU.>QM3%.T9M$C5=C* 1R22Q/?..@Q0!Z'5+
M4;B_@%K]@L4NO,N$2?=,(_*B/WI!P=Q''R]ZQ_A]K%[KW@+1M3U$?Z9/!F0X
MQO()&['N #^-4/B%)-!)X6E@N;B$OK]I#(L4S*LB,3E64'##@=: .TJ"ZO+>
MS$1N)5C\Z588P?XG;H!_GL:X&/2AK/Q(\5:;=W^I&Q6SM)%@CO9$56;S,D$'
M('&< X]0<#'-P,^O>$OA??:E-//=2ZBL+RF9PS+LE&<@]?E7GKQUH ]IHKSE
MX[OQ1KOBC1EN!$VG&*WM@;J5'@5H5991M/+%BWS'GY0/K4N-.O;OQ?X8TC4-
M=O;A9])NDO);2Y>)9WC*+N !^4\G)&,_2@#U&BO,+#PZNI>-_$F@7.KZTVGV
MME8B)!J$@8,5D&[=G.>,XZ$]0<#&+:7>KWOASPC'>:M?F9/$;Z9)<QW#*;F%
M#*,M@X)^0#=UXSG- 'M-075Y;V8B-Q*L?G2K#&#U9VZ ?Y[&N %H8/%X\'0S
MRS65OIGVN*.]O92\K23.&.X'<VT!0 3QGUYK)U;0;BT'@NQU;5'U.Y@UTP>>
MLSJRQF-V"$[LE@-HW=< 4 >N57>]@2]6R$BF[>)IEBSR54@$^PRP%3(@CC5%
MSM4 #))./J>M<"=-MG^.CR$2A_[!28D3.,L+@@< ], ?+T]J .B\*>(I/$EC
M>SRV8M'M;Z:S:,2^9DQMM)S@=3GM6]7A]S;/;_#OQCKEO>WL%]I^NWDUJT-P
MZ+&PG&<JI ;/0[@?PKL[J>X\0^-]8T.1H_*M+*W>&!KB2(GS-V^0;.20=HS_
M  XXQDT =[16-X4M;^P\-VEGJ>J+JEY;[HI+L#'F%6(YSW X)]0:V: "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *SM;T/3O$6ER:;JEL)[:0@E<E2I'(8$<@CU%:-8?B[Q!)X6\-7
MFM+9K=QVB[Y(C-Y9*Y X.T\\^U $=CX,TFPU:'55-[/?Q0&W6>YO99&,9.=I
MRV",]CQQZU7TKX?>'-$U-KZPM)8CO,B0?:',$;GJRQD[0>>N..V*@'C>2RU7
M1['6]*^Q+K'RV=Q#<>=&9" 0C_*I4G(QP1[U?T#Q#<:OK>OZ=<6<=N=*N(X0
MR2E_,#('!Y QP1Q0 T>"-$&FZII_EW)M=4E::\0W4G[UV^\<YR,X&<8Z5.?"
MFEM?Z7>L+DW&EHT=HQN7_=JP 8$9PV0 #G/2MNB@#EYOA[X<FUZ76#:2I<3N
M)+B..X=(9V'1GC!VL?J,'OFK5[X.TB]UQM9*7,%])&(IGMKF2'ST'02!2-V/
M>MZB@#-T'0=/\-:1#I>F1R1VD.=B/*TF,\GEB<<\X'%-U_P]IGB;3#I^K6PG
M@W"1<,59''1E8<@CU%:E(Q8(Q0 MC@$X!/UH P8_!NCQZ!=:,4N9+6[!6Y>2
MYD:68$8PTA.XC'&,]*;-X*T6:?3IVCNEFT^$V\,D=W(C&+_GFS!@67@<'-.\
M(>(9O$ND3WD]HEK)%>36QB20N!Y;E<[L#/3T%:KW\/VY["*1'O5@\_R2V/ES
M@$G!P"01^!]* ,$?#[PZNBG2$M9TL3<?:?*6ZD #[MXQAN &Y '&>:T1X;T\
M:]_;?^D?VA]F^R^;]H?_ %6<[=N<=><XSFJ_@[Q#+XGT :E/:I:R?:)H3$DF
M\#RY&3[V!G[OH*WZ .:/@306T&\T1H;DZ?>2F:>(W4AWN3N)SNSR>2,TX>&(
ME\8VNN1-.CV]H;9W>X9O.7G"E2<<$Y+'G('O71UR^H>)-2DU'5=/T#3H;Z[T
MI(7GBFG\KS3("P1#@@':,Y/'('O0!U%<W)X$T"2WU2W-O.(-4D>2ZB6ZD"L7
M.7P-V%W$ G&,XKHHV9HU9T*,0"5)SM/IQ3J ,1O"NF/?:7>N+EKC2U9+1S<O
M\@8;6R,_-D #G-4D^'OAR/7I=7CM)8YI9?/EA2X<0229SO:,':3GGD=>>M=
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M7<7O]H,WVJ3>MSG_ %JMNRK?2NGJM=W]M9&W6XE5&N)1#$#U=SD@#\ 3^!H
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M)[:>&[BB$/FVMS)"SQCHC%"-P^M76\+:4=7L-36&6.YL(C!;>7,RI'&0 5"
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M/RH[F&[EBE*?W6=6#,/8DU:T3P]I?ARUDMM*MOL\4LC2NN]FRS')/)..O04
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MN65EQG&T@G([]ZZ^S@L_&.N^,]+UAS]IM)UM[<9 >UA,2E98\_=8L6;=[#L
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!V7*$YV, 0'7/\+9%:]% 'GGB[P=##H.EZ5H&B.]LNKP7=S'"X'[M7W2$LS
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1161XH;5AX;O1H=OY^I/'LA3S1'@G@D,> 0,D>X% &O17
MG/PWB\/0:GJ%O;:!=Z'K]O&JW=I=W+S'RR<AD9F(921U&.GTKM]6U$Z=:!HX
M_.NIG$5M!G'F2'H,]@ "2>P!/:@"_17 _#Z">V\1^,XKJZ>ZG74(O,F;C<Q@
M0G [#)X'88%=]0 4444 %%%>;?$R*R3Q'X,FNH%>-]2:.8>47,B;"=I !+#.
M..: /2:*Y+2(_#LWB&=]$T\6]Y8VP+[+9K<2+*6PI!49YCSG''YTS3O'B:G<
MRV,6E7":G#>FTEL9)$$D8"[C*><>7C'S=\C') H Z[>N_9N&_&=N><>M.KSB
M2:32_C!K,FG:5)>7,VBP.882L>]O-?+,S$ < #UK>L_&]MJ6AZ+J-C8W,LFK
MRF&&!AM\MUW;_,;D*!L;GG/84 =317&S_$&WMO#6J:Q+IT__ !*KTV5Y KJ6
M5PRC*GHP^=3V.#TK9F\0QV_BVUT"2VD\RYMI+F.<,"N$*A@1U!^84 ;-(S*B
M%W8*JC)). !7.Z5XJ;6(+&\L].>6POU=K>X293C:I(#C^$G'3)QWP>*YW3_%
MD^J^ =?U37]$:XLH7NTFMX9$8&)&92G)&<*.3W[#M0!Z("& (((/((I:YV'Q
M!:V]KHEAI]GNN;ZT$MM:*P58H5522S=E&Y5X!))&!UQ0N?B%:VFB:Y>3:;=_
M:]$8+?62LF] 1E7!) *$<@CGVH [&BN8M/&'G>(['2;K2;NS&H0/-93RLA$V
MP L"H)*G# C./P/%;&LZO::#I,^I7K,((0,A!EF8D!54=R20![F@"_3'FBB9
M%DE1&<X0,P!8^@]:P4\4>1X@L]&U6P>QN+^-WLW\P2)*5&60D?=<#G'0]B:Y
M32[5?&'BGQ=8:_HXGMEN((1OF&;95B5P%(.02Q+94]30!Z917GWQHBB'PROY
MRH\V&2#RY/XDS,@.#U&02#6<XM)_B/H0\#8$-NTBZT;/(M1$0-JOCY3)G.,<
M^M 'J5%<]J_BJ'3[RXLK:&.YN[:$3RQO<)" &SM4%NK':<#IZD9&<RW^)%A?
M#P\^GZ=?74>NI,UNZ!!M:-260@MPP(Q_=[YXH [2BN)3Q_<26VK"/PU?M?Z2
MY%[;>;& B[0X8/G#94Y '/'..,Z;>,K"2RTJ:TVR2ZI;?:K:.:58@(\*2SL>
MGWE&!DY/3@D '1TW>N_9N&_&=N><>M<E8?$/3+_26ND@F%XNH'3/L096=KG^
MZK [2N/FW9Q@$]L5D:9),OQHU6232_L\_P#8,;-'$ZMYY\YOF5CC.1A?FQRO
MIS0!Z(CI(@:-U93W4Y%.KBO#OB?0K7P/IU_I^GG3[2[N9(+6R+*I\SS'SDYV
MC[KL>>!GK3H_B/IJ+K$=Y%Y%UI7E&5$F61)%E(5&5^!C) .<8[T =G16=IVH
M7-U=W-M=6!MFA5'619!)'*&W?=.!TV\Y _K6C0 45Y4D.B1?&+Q%%J5A'-!]
MAMG2/[(TRJYSD[54X)XY[UTVGWVGZ3X7U#7?#^DSSVKS2RM9P+Y;?NR8F*(V
M,9\O.W@_C0!U]%<]H'BN#Q&T+Z?;M):/:I</<B0%(V<9$1[[P.2.V1GJ,U_^
M$T5XK&^@TNZN-)O;H6L5W#\QR25$A0<B,D?>SGH<8- '4T5Q^M?$&QTB&^NE
M@^TVFGR^5=.DZ+("" VQ"<OMSSTZ'&<43^/-VKW&EZ7H5_J-U':1WD7EO&B3
M1OG#!F; ''?!]!0!V%%>=W_Q%EO?#VAZEHEC)_IVKPV%S'.P22W?S/GC(_O'
M!&>@!S7H,3.\*-)'Y;E063.=I],CK0 ^BN2MO',4TNCR2:;<0V6KW#VUI,Y
M?>N[&].JAMAQR>V0*MP^*?M=Q-]BL6N;:"_^P32)*-\<@8*S%/[H)ZYSWQCF
M@#HJ*IZK?C2]*NK\V\MPMM$TK1Q;=S #)QN('3WKF['Q\ESI*:M=:->V>FRV
ML$\%Q*R8F>4A5C4;L@[F R<#OP.: .PHKD[7Q[IW]LWFEZB([.:VLS?^:LZR
MQ- #ACN7H5[@CZ9I9_&<EJ^CO<:-<QVNKW,=M:RF1=RLXR#(G\.5!/&>F#@T
M =736=$*AG52QPH)QD]<"N;3Q@CP^(F_L^82Z$V)X]Z_O!Y?F90_[I[XJG>^
M(=)OYO!MU<Z/-,=4D6:QF?;BV=HBW/.<[<] 1[T =E17(KXWFGU^_P!(M/#N
MHSS6%S##<L&C 19!D2?>Y&"#@<XSD#%0W?Q(TRS2UO&C#Z5<7(MA=).A926*
MAS'G.PD=>O?&* .TI$=9$#HP96&00<@BN.\3ZVFI:'XDLK/3#J%O8P20W;EU
M $GE[BJ _>905)Z8R "3P+_P_P#^2=>&_P#L&6__ *+6@#H0ZLS*&!9?O 'D
M?6G5Y5H^KS>&M<\<-IWAZ[U"*+4EEE2TV((T\E"2-Q&YNIVJ"?IQGJ8_'EE<
M77AT6UK-)9:\#]FO"RJBL%+%''4-@$ =R,4 =916=::H;O5]0L5MF"6116GW
M JSLH;:!UR 03_O"H=3UI[+4[+3+:RDN;R[221,G9&BIC)9\''W@ ,'.: ->
MBN,?XBV2>&-/UT:;?/#=W@LFC0*6AD\PQG<,Y(R#C:#GCUJ6R\=&77+K1K_0
MM0L-0CMC=V\,C1,;F('!*L&VAAW4F@#KJ;O7?LW#?C.W/./6N"C^*<!TW2]8
MFT'48-$OW6,Z@Y3;"S' W+G=MSU;&/3-26,4=M\9M;>& ;GT6WD94 !=O-D'
ML,G '- '<HZ2+N1U89(RISR.#3JXOP_XFT2V\)B_L-+EL89]1DM8K)0OF2W!
ME*D<'&2P)ZX !YP*NR>,18C65U/2;V"32X%N&\E3*DZ,#CRVP,MD8(.,?3F@
M#IZ:CK(NY&#+Z@Y%<Y#KT>I:Q<>&]3TSR;A[ 7@1G$L<D1;80>!A@>",8]S7
M#^!_&G_"-?#CPXU]HM\-(VB&74P4\N)FD(!*YW;<D MC'IF@#UO>N_9N&_&=
MN><>M.KA+>.WM?C7J<H6.)7\/Q2RL !D^>X+'\ .?:K/_"Q=/6YTDR0[;'5I
ME@M;A9D9@[<IOC'*ANQYQD9 H [*D1UD0.C!E89!!R"*RO%,$5SX3U>*:-9(
MS9RY5AD?<)%<[X5UDZ=X'\%V$-I)<W=_I\2Q ';&H2$,Q=\':,<#@DDT =Q1
M7&3?$.WA\,OK9TRY\JWOFL+R/>N;>02>623G!3<1R.QZ5K)XE!\9GPU)9/'-
M]D^V).9%V21[MIP.N0>H_&@#=HJAH^I-JVGK>&V:!'=A&&8-O4$@.".QQD>Q
M%2:G??V;I=S?&"6<6\;2&*+;N8 9.-Q _6@"W17&67Q!2Z.@32Z+>V]AK>Q+
M>[D9,"5D+A2H.[!P1NQU'IS5^Z\6[4U2;3]-FO[?2G,=V\3JIWJH9UC4_?90
M1GD<\ DT =)1532]3M-9TNUU*QE$MK<QB6)QQE3_ "/M7.ZKXYBTN'4KQ]-N
M'T[3;I+2ZN"0K;FV?,B'[RC>N3D=\9Q0!UM%8=_XA:*_N[#3K%[^[LX%GN$5
MP@0-G:N3G+MM.!CMR1D9P+OQM?W&M>$HM-TN86FKI-,ZSD12G9$3Y94],$@D
M]\<4 =R'0NR!U+J 64'D9Z4ZN4L=8T=/%_B4-IS65W8VT$E[>RE<2QX<J>">
M %/7!]N*5O&\5O!I=]>Z=/;:5JDB1V]VSJ2A<9C\Q.J!NQR<9&<4 =517'7/
MCN5+[7;*T\/:A<W&C!&G7S(E#*R%]P);'W1P.IST%=)I&J6^MZ-9:I:;OL]W
M"D\>X8(5AD ^_- %VBN3UGQQ'I$>K71TRXEL=(DCCO)MP4Y8*28U/WP PSR/
M;--G\2:F/B7;:##8AK$Z:]T7$J@N3(B[L'H%^;CJ<^U '7$X&3TI%970.C!E
M89!!R"*PO&T$5QX%UZ.:-9$_L^=L,,C(C8@_4'FLO0=::P\+>$-.M[.2YN[W
M3(C'SLC14A0L7?!QU '!R30!V5%<:_Q"ME\-VVMC3;DP/>_8;A2Z@VTGF>7E
MCG!7=W'J.*U(?$HD\8W'AM[)X[B*U%VLK2+MEC+;<J.O7@^E &]15#1M2;5]
M+AOC;M DP+1JS!BR=FX[$<CV(K,N?%#>;J:Z9ILNH+I9VW9CD53OVABD8/WG
M"D$C@<@9SD  Z*BN/G^(5CMT!]/L+S4(M<5S:20[ "RH6V'+ AN,'. .<GBN
MDTJ\GO\ 2[>ZN;&:QGD7+VTQ!:,YZ$@XH N45Q=W\2-,LTMKQHP^E3W(MA=)
M.A926*AS'G.PD=>O?&*TKSQ5Y8U.2PT^6^@TLE;N1)%3#*H9D3/WF (ST'.,
MYR  =%2,RHI9B H&22> *YBS\:P7ESX9B%C,B^(+9KBW?<I\O;&)"KCUP1TS
M4%WXKLKS1?%27FD7$\.D!X;VW#(WG)Y>]MN2,C:?8^U '7*P90RD$$9!'>EK
M@KGQ/=64W@>RT;2@FGZI'N$?FJ"J+;EEB&>F/E.?]G'>M[3/$W]H>)-4T.6P
MEM;FPCCE)E=2)D?.UDQU'!!/8\4 ;]%9^B:F=9TF'4/L[0)-EHU9@Q9,\-QV
M(Y'L16A0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !6=K5_?:=9+/8:3+J<GF*KP12I&X0]6&\@$CT
MR,^M:-% '/Z?ITUWXE?Q%=6;V<@LA9PP2,K2;2^]B^TE1R!@ GN>^!5?0SXP
ML-/O]<M-1T:_@\U1!:ZBRL@9@.7C(#9"*?;-=/+-%!&9)I$C0=6=@ /Q-/H
MX/P7X*F\/>*?$-_-)?F&>=1:&>^:42Q^6N68%CE@P(!;G'3BN\HJ-9XF>1%E
M0M']\!AE>_/I0!)13(I8YHEEBD62-AE70Y!'L:621(8VDE=411EF8X 'J30
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M5CV^@^)M#T_PEJMKH@O;K3=-_LW4-,>:,.R?*=\;9*Y#+Z\BNT_X07PK_P!
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MW;?M\Y-Q=E>GFN=S >PSM'LHK'\30:W-XFTLQ:;)J6A>3(MS;13)'^^)&QI
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MA4<L0!R?6N06P\26]EX0M)=&GN=,MK 6^H6,=Q$I\Y4559\OAXQAN 3UR0<
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MF-Q$%%YH=Q;/=W$<&FH\R$W9=2Q.!R@4 EL\@=B>*P=?\)ZMJ>C^,;R*R/\
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M32R(REX0F P4DC)3TZ'\* .CTOQM!>^*?^$?GBMTN9+<W,$MK="XBD4'#*2
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M_E=2H) )R#[>O;2^+=1D\2:KH>G:";BYL8(IT>2[6-)0^['.#M^[QP<]\=:
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M.ZEA7I<.PS*A_P!V%L_]M#0!Z943W,$4\4$D\:32Y\N-G 9\#)P.^!S69?\
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MZ%2]RWE@JS$#T(').!5S4?$FKP>']9O[?3[%OLE@+RVN$O#)!.,.2 P0'*A
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MR1S]>F0#KJ*X9/B1;&ZT=OL]O)8ZK,L,3P7@DGB+C*&6(+\H/<[CMR,U#/\
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MT\X'3'-9OP_T:^\/>"=.TC4HXUN;561C&^]6RQ8$'CU]*Z5E#*58 @C!![T
M<BWC=AJOA>V^R6QM?$$)DAN1=GY&"!]NW9SD'@Y'/7%0>*?%#V?A+7-1NM!M
M=0T^SN/(6*2?*S@.%+$%,#:YQCGE3STK(_X5OJ$/A.\L8;N,W]G="70I&Z6\
M<<IDB4GU.YE)]-H[5N>+_#%YJ'PWG\.:4$EN9(XXQ),^P$AU9G8\\G!/3J:
M$U'6=:3XGZ=HUO%:MI[Z=+<%6F92Y#HI)PIZ9.!WR<D5R^CZY?>%['QS?Z?H
M\-U9V6NW$]P&N!#A D>0@"G+ 9/.T>YKK=1TC6)/'.D>(+.WMVB2QEL[F.:8
MJ8M[*P88!W8VD8X^HK&_X1;7&\,>-].-K")]<N[B:U/GC:JR(J#><<$;<\9Z
MT >@VTZ75K#<19\N5 ZY]",BN5\>:QJVDKH*:8L&V]U>WMI6DD96(+9VC"G
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M='&0R/@9(Y!'8^M=(1D8-9&A2:[<QR7.N6UM9.P"QVEO-YP3&<LSX&2<] ,
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M$<PSOB5P<@C@$MQ[#F@#;\-:Y%XE\-:?K,,31)>0B3RV.2A[C/?!SS6K7-^
M='OO#_@G3-(U%(UNK2,QN8WW*W).0?QKI* "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *SM8T+3M>M
MXX-2@::*.02*@E= &!R#\I&2#R/2M&D9E12S$!0,DGH!0 R-XE?[.L@,D:*2
MA?+!3D G//.T\GK@U)7DD>JRZ9X^T?Q;+>;M/\2,VGR0EQB!<YM3CL6 ).>A
M<UZ#K.NG3]2TS2;6))M1U%G\I9&VHB(N7=B.<#(  ZD@<<D &A;:E8WEU<VU
MK>03SVQ GCCD#-$3G 8#H>#U]*M5Y;INJ:AHOB3XE:I+8VTES906D[0I,421
M4@=L@[202!TQUXSWK7/C;6HI?#LDVB6QM=<0+!LNSYB2F+S!O!7 4X/0D@<]
M>* .YDD2*-I)&5$4%F9C@ #J345G>6VH6<5W9SQW%M,H>.6)@RL/4$5R^G>*
M=2N9/$FG7VEV@U'1T20QQ7+&&=)$++\Q3(.%(/RUGQ>-[FV\+^$+ZST.W\K6
MI8K=8(Y]@@+JS *-N",*><C'H: .^9E1&=V"JHR23@ 5#97MKJ-G%>65Q%<6
MTJ[HY8F#*P]017,Z9XGU2ZOO$&E7VF6B:AI<<<RI#<LT4R2*Q4;B@((VD'Y:
MH6/CFVB\)^%[S[/9:6FL?)'YC;;>VPK,%R .3C ''7VP0#O**X'Q3KWB.UT_
MP\T<%I:S7FMQ6DRB9B&3S&V;6V_=<("3C.&QBK-_XJ\11^)[CP]8:'97%[%I
MR7RNUZ51@7*$9V9!RIQZ\9(H [6BN'UOQQ?Z';W%]=Z9#!:P7R6BPSS%9KE"
M44RQ<8*@OP.X4G(Z5(FKZTWQ6NM+8VHTVWTR.=5\Q@0&D(+'C!;Y.G  [\F@
M#M**X>?QW=)X5_X2Z#3HYM"5R2HD(G, ?:90,8_VMOIWSQ3[_P 8:R_B:;1-
M$T>TO'_LU-1MYI+PHLB,^WGY.#P<#GJ.10!VM12V\,TD4DL8=HCN3=SM/J!Z
M^_N?6GH6**74*Q'(!S@_6L;6=6OK*_M[6UM8UA>&2::_N6*P0!< *2/XF+>H
MX!//2@#;HK@%^(MU-X4\/ZW;Z1')_:>HKI\D0N>8W,K1DJ=N&!*'&2O45H6G
MC*XM=5URQ\0VEM9G3+-;_P VVF:5&@.[/55.X%3VYH Z6[U*QL);>*[O(()+
MB01PI)(%:1B<!5!ZGZ5:KS#Q7?:GJ:>![^YL;:"VN==M)442%I8<ABH;C!R#
MSCH1CGK7:^+]</AOPCJNL*H9[2W9XU/0OC"@^V2* -=9HGEDB21&DCQO4')7
M/3/I59]6TZ.^:Q>^MUNUB,S0&0;UC&,L5Z@<CFN?CU%/"/@O2S*K75_=M#"J
MEMK7-W,1DLW;+%F)[ 'CC%9,7V__ (799"_AME;^PIBLENQPX\Z/@@C((_7/
M;I0!Z CI)&LD;*Z, 593D$'N#5>34K&'4(;"2\@2\G!,5N9 )' !)(7J0 #7
M,>'KYK'QYX@\-=+9(XM0M$_YYK)D2*/0;QN _P!HU1\:/<P_$7P5+8VL=Q=[
M;\1H\GEJ3Y*_>;!( ZG )] : ._HKA;3X@RVT&MV^OZ:EGJNDR0HT,,V^.?S
MCMB9&(!P2<'(X_2K-OXUEAUNXL]2M$^QI9/>"_M0[1($Y:-]RC# #(/?T% '
M8T5Q$/CF\DO]'_XEJ36>J,$_T<NTEJ6&4,GRXVGH2#\I]>M4)_B'K<>@ZUK*
MZ#:?9M&OY;:[4WIW.L;!6,?R<GDGYMO;K0!Z*Z+(C(ZAE88*D9!'I0 %
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M6?$FBZC=>)/#VN:<D$QTIK@26\LAC,BRH%RK8(R,9P>OJ*Z:**.&)8HD6.-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGE10@RQ+ 8^M $E%(K*ZAE(*D9!!X(I: "BBB@ HHHH **** "BBB@ HHHH
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M#H>IH X/PGH23OH_B"UU#3DTZZT,6;V%O&<7 52<MDX+*3@\>H[UXXEE;0?
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MQ OR,<9/N>!U]!4K>$/#[W5[=-I5N9[Y#'=28.Z93U5CW!P.#0!X3J.H7;?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW01DD+\Q!Y8@X&.QR1QFSX6\2V?BS0(=6LD>-'+(\4F-T;J<,IQP>1U'48H
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M%[JUC=6V;K3K/[=ML91<K/#T.P@ [@>"I ZCMS5ZR\5RRZ^-%O-+>&\DT_\
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M $!+<X.6//;GG)%=,?'-A+IVC3VY@6;5K7[5"EW<"!$C 4DNV#C!=1@ Y)]
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M+0^6-N<%N>3QTZ9K0TO3=3M_B/K>K36#+87MM;PQ2^:A.8]V25SD [N/IVH
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M0*0 F\*WS'.<<8 )YK!C^(K7.C^%]2M=&DECUV;R IG4&%\-D=/F^X>>/Z4
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M4EO<6%S*%6>)]N0'&0""H(/Y^AZ^]OK33;.2\OKF&VMH\;YIG"(N3@9)X')
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M[F6,@,8_DY/)/S;>,=>W2S^(7N=<71=*AAFN1:"[GDG8A(HV.$& "2S$'CC
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M%E4[?F! SCCKC-:/B.QN=0A@MAIUGJ6GN66\M;D@;EQP5R"-P/KCOSG%<@?
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MWESE64X."0,J>H..AK:JGI:7Z6*MJ<D37CDM(L&?+3/15SR0!W/4Y.!G N4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M57O[ZWTS3KF_NY!';VT32RN>RJ,G^56*YGQ++)>WUEH\%F;U,B[O(5=5_=*?
MD4[B!\T@!]PC"@";P5XJMO&?A:TUJW3R_-W+)%G)C=3@@_S^A%;S.BJS,Z@*
M,DD]*\/^&%Q-X'^)NL^"+V)[:UOB;NPCD8-@XR!D'!)3@GUCHM/#.F^(_CSX
MUTO4(W-@]E&TD,3F,.Q6$Y.W&>23]>: /6[KQ)IMKXBT_0FG5[^]5Y$C4@E8
MU4DLWH#C ]?P-5]*U77+OQ1J]C>Z,MMI=ML^QW@E#&?(YX_SBO+[[P[HEO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1TM%\3>#/&6NW@S?275V+6?^.V2 8A"'^':5W<=R3WH ]3DD2)"\CJB#JS'
M%.!!&0<BO*=&\1C7/%/AB3Q"(A:7GAT7%N)P/*>\+ 2X!XW;!QZ GUK:^&UZ
MLESXGTRUE673-/U1DLF1MRHC*&,:D?PJ2<#MG% '=Y&[&1GKBEKRRYU:^T_Q
M_I7BR6=CH>K3/HX0_=C0']S)_P #D$AS_=85ZG0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&TG:,9/;O5"U\"Z'8V,5G9QW5O%#<?:8?+NY<PO\V GS<+\[_+T^8Y!KI**
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M7,*RF%V!*$C.,CK]>]7Z ,"3P9HLEQJDWDSJVJ B[5+F14<E=K$*&PK%1@D
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M89W(,6<[=N<=>>G6M:L'QGK]QX7\)W^M6]I'=-:)O,4DIC!&<9R <]>G'UH
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M:9YC.(%(7+E]H+$A0QY(4$*">< 5JT44 %%%% !1110 4444 %%%% !1110
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M%T_POI.EZ9<Z=90S16MRS/*GVJ4DLWWB"6R,YYP143>#=!?PR/#C61;2AC;
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M\FV5&9F=SDG:N.3V %=;9:'IT4OVP0S2S20^3ONY7E=8SR4^<G /&?7 SG%
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MK>RVNK6^H3/<7D+ 36ABE.(U)!VKL"C;W!/<T[[$WC75_%VF75[:PW=I<^1
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M8;<[LYYZ\T =G17CUZ<_!C3_ !AI\S'Q#&D%U]M4YDFF:15>-C_$I+,NP\=
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M;"TNGC5IH!('$;8Y7<.#@]ZYSQ#XQ.G^'+/6M)B@O;6XO(K;S'D*C:THCW*
M#NY]QZUTE];PW=A<6]Q$LL,D;*Z.,AACH17C$%G;Q? /P^\,:Q2W%U9&5XP
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M[R6 [W;JX#$*Q]RH!_&NJH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!F?>(_[N<],\X]>>M0Q^%-"BTZ\T\:;$UG>N9+F"0EUD<\EB"3\Q/.>O ]*
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MLDS.<N7;JQ+9R#T(]J]?KFD^'_A-.%T.UV"83K&02BOZJI.%^@&*Z0 *H50
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M7)^,6LYM4\/:?.LEQ=3W;O;61<+!.4C8L9B0?E4'<  3G''IUE9NKZ!I6O)
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M#)V]LYQS7HC^#?#DF@?V&^CVK:9NW?9RN0&[$'J#CC.<XXH7P9X=30AHBZ5
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MD\;F8B-09,2.!N]<>]7?&]GJEQ>:5<:5!8ZC+:B:232+QMJW2'8"RDY =<@
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MMSPWOU&3CK67X5=)-&\(Z9>M-?7:W=\-,2XD @E@C+*))<@[MJD; .>G0<@
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M*WA7A8DPC;5'898\>]5_%VF:?=?$WP5]HL;64SF]$OF1*WF!8,J&R.<=L]*
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MNKKG&5.10)8RP4.I)&0 >HKR^VMU3QUXML+B.RBCFT2&26UM>(P_[P#/3<P
M'.!QCBL>PTNRLO!OPSU>WMT34I-0LX7NA_K&C='#(6Z[<?P]* /7+75[*]U2
M]T^WF$D]EL\\*<A"X)"_7 S^(K.\*ZKJVIV=Z=:L[6VN;:Z:$&UE,D4B@*<@
MGTR5/NI^E<]X3L=/A^)?C:1;6V2:.YM?*81J&7=;@MM/;/)..O-=#XPL'O\
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MQIVKZ%I6O01PZK807:1N)(_,7)1O53U!^E:%% &3:^%]!LENUMM(LHA>)LN
ML*_O5QC:WJ,=JBL_!WARP:T:UT6RC:T+-;MY0)C+8R03W^4#/H*VZ* ,;_A$
M?#W]O?VY_8UE_:F=WVGRAOW?WOK[]:UY(TEC:.1%>-P596&00>H(IU% &0GA
M?08]'_LA-)LUT_=O^SB(!=W9OKTYZC%7;'3;/34=;2!8O,;<[<EG.,99CR3@
M <FK5% %'4]&TS6HHHM3L+>\CBD$L:SQA@K#N,U3U3PCX>UN^@O=3T:RN[F
M 1R2Q D =![CV-;5% %!]$TR35DU5[*(WZ+L2XQ\ZK_=![#VZ4Q?#^DI=W=V
MMC$MQ>#;<R@8:4=@Q[XK2HH QSX4T$Z?!I_]E6WV.W?S(8-GR1MZJO0&I_[!
MTH:A)J LHQ>2Q^4\XSO9/[I;KCVK1HH QO\ A$M _LV/3O[)M?L,3^9';[/W
M:-G.0O0'/-%QX2\/7=Y/=W&C6<MS<1>3-*\09G3&W!)Z\<9ZXK9HH RF\,Z&
M_P#9^[2;,_V=_P >?[D?N/\ =].@_*IK71-,L;JZNK:RABGN_P#CXD5>9?\
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MO!'!!&D44:A41% 50.  !T%/HHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>sangamoexecutiveseveranc012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_+P&)&[N,D#/3%7I5BU;XC6?B&QDSIUCI4T5S=!2$D+L"L8/\1&&8@=..YH
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MQL(UD#DN!M&,CJ1UK'\,V5Q=? *]TN&VE%\;*]C^SM&5?>S2%1M(SD@C'UH
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M%\=CPS]ENMRVGVAI?LTA4EG"K@@8V_>RQXS@9X-<IXOBVZOJNK:#J5Q8ZW%
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M*H=02)87B.>_RN <5:K/T2^BU'1[6Y@641M&H7S8FC)X'\+ ']*T* "BBB@
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M3):6LYMKC-NY:&4$ HP ^4Y(Y/'(YYH U=-TTV/FRSW,EW=S8\VXD55+ =
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M\+D_)VXK;\$1ZO9ZMJ5A-J,^K:/%%$UG?W46V;)+9B9L#S-HP=W;=CV';T4
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MGA*B3 ])<Q*?JU>BUA^'_#TFC>9->:M=ZK>R*$^TW04%8P20H"@ #)))ZG\
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M:VZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *H:OK%GHEK%/>.P\Z9+>%$7+2RN<*BCU)_#UJ_7
M+>.KS4+/3-/>QLY[B,W\2W4EM;^?-!#SF2-,'Y@<#(!(R3B@ U'7+76O#?B2
MWMWN[6]T^"1)XRQBEA?R]ZD,I[C!!!(-<K<W%S_P@_PSNA>72S37NFQS%9W
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M2VEE5+N20J5W;<@*&Q@_*!G'3 KIK)["XT+6]1TWPU<Z<MQ:F/+V)CN;E@K
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MB<%E&0.A&:X*\L-1'@#QSI<>AZQY]UK)GMHVMWE:1"T)!##=NX1B3D].3DT
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M(#+@@[@#WW-TKI].2YA\;>-KR:POD@N[:U$#FV<B4I&X<+@<D%@/?MFN]HH
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M0D!B<\9.!C//  ,YO%%[_P +'_X1Q=+G-LE@+EIE:/YMT@4/RP(488>I)Z<
ME]UXYTZUL9-3:VO'TB*8PR:C&JF)"&V,V-V\J&R"P4CCTYJG=6E_;?%B/4DT
M^XGL;K1Q9^?%MVQ2"8L=V2,#:<^_05SVFZ3J]C\,-0\"3Z9<2:@(Y[.VN!&3
M!,DC,5E,G1<!LD$[OEX!H ]1\P&'S(QY@*[EV$?-Z8[5Y5KOB.\\4_"KQ;=7
M-A=67V9[B.)A*H"^6VW:2C9)X).1M]">*]-TNR&F:196 <R"V@2$.>K;5 S^
ME>82Z7K,?PZ\8: =%O3=SW=VUNRJ"LXEDW)MP>F#DDX QCK0!V6D^+;675+#
M0Y;*^MIKBU,MK//$%CN @7=MYW9&0?F XHA\=Z;,]@ZVUX+*_O6L;:]*KY;S
M L,8W;P"48 E>WTK,OH+NX\:>";R.PNS;V=O<I<R&!@(3)&BJ&X]5/3IWXKF
M9[;Q'J5CH5WJ/A[4Y=8L==BN+T@IY:QJ[\0+NQMP5YP,XR2: .WT3Q1>ZKXR
MUW2)-+GAM].:&-9"T9 +(7W-AL_,"N  <8YQS6AXB\3V/AB.RDOX[EDN[E+5
M##$7P['C/Z],GC@&L;0K;4+#XB^)Y)]-N!:ZD;::&Z&TQ@)#M8$YSG<,8Q[]
M*@^)\IAL?#<JQ/*4\0V3;$&6;#'@>] &CIWCW3+R_P!1L;JUO],N["W-W)%?
M0A&: =9%P3E?U]JEL/&=I?7UA:&QO8'U&T:[LC*$Q.B@$@8<[6PRG#8ZUBZI
M8ZIJ7BF[\2:19NLECHLUK9BZB,9N+ASN VM@[5P.3@$MQT-96G6FJS>*_!^K
MOH.K[HK>XBOY[LKO$CH@R1N^5 0V  !Z"@#L-/\ &=CJ.@ZIJZ6EY%#ILDL=
MQ%,J+(&C&7&-QY'N1FF2^-+:+6AHPTK5'U$V7VU8%A7)7<%VYW;<Y/<XXZ],
MXM]H%TGQ*\FT9/[(UB);W48L\K);LH4@>CDQ@^H1JO207*_%U=1-G<FQ71&M
M3<")BGF^<'V\?[(Z].W6@!A^)NE#0QK']FZM]BCE,5Y)]G4?8V#["),MS@]=
MF[ K?O\ 74M+F2UMK*ZU"ZCA$\D-KLRB$D*2791DE6P,Y.#7G,VDZK+\*_%N
MEKI5[]NOM1NI+> PG,B22[E/H!C/7I^57]3MKK2O&3ZU-X6GUW2M3LH(V6*W
M22>TECW#&Q\?*0W)SU'Y@&^GQ&T2>+1);6.^N8]9$GV5H8"?F0$LK<\-E2,<
M\^W-0WOQ 1/"NOZG::5>"^T;<EQ97.Q'C;;N#,0Q!7!!X))'051OK&\_X2#P
M5<1:&UI!:7%S-<0VL(*6R21LJ!MO!;)&=N<'/;DTKW1M3U ?$N&'3[D-JL*?
M83)&5$Y6W"$ GH=PQSB@#O\ 1+V?4-&M;FYMY8)9(E+++LR20#N^4D8/^16A
M67X<FFG\/V1GLKBSD6%$,5P '&% .0"<<YK4H **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJAJ^L
M6NBV:W%SO8R2I!#%&,O+(YPJ*#CDGUP!R3@"@"_16!!XIB?69M&NK&ZMM22W
M^TQ0/L;[1'G!,;!L$@\$'!'TYJKX9\;1>*?LLMEH^IQV5S%(ZW<T:B-2C[2A
M(8G=W]/?@X +Y\.0?\):/$GVVZ%T+7['Y64\KR]V[&-N<[N<YK:KA/BD(X]-
MT"Z=7)AUVR(V DX\P9 4=>G2M/3/'%G>:S=Z3?V%[I%Y;VYN@E\J*)8 <%U9
M6(X[C/'YX .HHKEO^$YLDO\ 2X+BRNH(-5.VRN'V%9&QE5*AMREATR/8X/%4
M)?B;91:9?:E_8NK&ST^\>UO9?+C'V<HP5F(W_,,GHN3@9..* .XHK&U#Q!':
MW3V=I:RW]VD N'BA=%VH20N2[ 9;:V!['I7'^*/&::QX/T*_T6"ZFL=4U*V@
ME(V(=OF@/"P+ @G:5/;&<G!H ](!!Z$4M<#86'AG1OB!:);^'[NSU>_MYKB,
M[U$,8 42!55RH8_+G Q[UI^#/$U_XBEUG[7ITMLEIJ,UJA+HRJ(]J[3ALEL[
MCG&.<9H ZNC..M9VK:Q#I/V-'1I)[V<6]O$I WOM9NI( &%8_H,D@5Q'Q"OE
MO_#5E=365S:RV>NVL9CDY;B5<D!"0P(/% 'I%%<Y8^,;:XU74=-O+"]TZXLK
M87A6Y5#YD!)&]=C-W4\'FF:=XTMK^_TBV>PN[8:Q;O<V$DNPB154,00K$J=K
M X/\^* .FHZC(KRS3+6$:!\3H-K>6M]<E1N.1BW0CG.>M=IX&_Y)_P"&_P#L
M%VO_ **6@#?SSBBO-]0O#H_QCNI[;3;R_FET!&^SVH!9F\]N<L0JC '4CH ,
MGBNATWQUI6J:'%J,$=RLDET;+[%(@2=;@9+1D$X! !)YQ@9H Z>BL+1/%%MK
M.J:CI1@FM=1T\H9X)2K95QE75E)!!_,=Q5G6=<AT8V4;PRSW%]<"VMXH@,LY
M!;DD@  *23[=Z -2BN0N?B%I]GX=U75[BPO@-*NC:7<"JA='&WG.[!4[UYSW
MZ5+;^.K63Q+'HEUI>I64US&\EC)<Q*J78098)\V0<<X8 XZXH ZJC-<$_P 5
M=.32O[6.BZS_ &9'.T%S=>0NVV*N4RPW9(S_ '<X!]>*=<"%OC-I-Q"=PFT2
M=MP;(8>9'@CMTH [O.:*X_0M>T"VLO$>H6UC<6"V^J/'>B7EI;G" E0&/WBR
MJ ,9/:KUKXPM)/$#Z)?6TUA>?9C=Q^<Z,DD0.&(96(!'<'Z\B@#HLXHKR[QQ
MK2:WIGAB]@TZ[%G-K=FUM=L5"NIE&"5W9"L!D$C\LBO4: "BJ.K:M;:-8_:K
MHL0TB11QH,O+(Y"JBCN22!_/ K+3QA9Q7>IVVIVUQIKZ=;"[F:<!D,)S\RLI
M(.,$$=<],T =%17.#Q?!%?:9;W^GWE@FJ';9S3[-KOC(1MK$HQ'(!Z].O%9M
MQ\1[:*VUB>/0M7F31YFBO=J1CRU50S/RX!&#T&3QT H [6BL.3Q-;M=V]K86
M\M]/-9B^5(F13Y)( (W$9))X'YD<9Q[WQE?#Q)X9L;72;EK;5;:2Z;+1B3"H
M#LPS#&-X)Y[8&>: .THKDH_'B7&K7>G6F@:Q<S6=VEK<&.-,1E@"')+_ '>?
MKZ@4'X@:</!X\3?8;_[%]H-NZ;8_,C;S?*R1OQC=Z$\4 =;16%JOB:+3YKN&
MWLI[Z:SB$UPD#(NQ2"0/F898@$X'MG&1F&W\9Z;J-MI4FE++?2ZI"T]O#'A6
M$:X#,Y8@* 2%^IP,T ='FBN ^&;![SQ@1;RVW_$[<&&8@LA\J/()!(//H2*Z
MK5]<ATFXL+3R);B[U"5HK>*/ R54NQ))   !_H#0!JT5R%Q\0]/M?#-]K<MA
M?;+"\:RNH%5"\4H<)S\V",LO()ZU>L/%D-WXE?0Y].OK*X-N;J![E5"SQ!@I
M(PQ*D$CA@#@]* .AS@9-17%O%=P/!,NZ)QAER1N'H<=O4=Z\Q^(VNPZWX$^U
MVEA=26+7UNL%\&4(V)U!;;NSL.& )'.1Q@@UZG0 BJ%4*H 4#  Z"EKE)?'E
MC$PE-E=FP_M+^S#=X7:)MVS[N=VW=\N<=>V.:N:EKD,MQJ&E6^GW.HR6L(:\
M6!E41A@2$RS#+$<X';&2,C(!OYS17E_@7Q3;^'_AMX/BN;6\G.HL;>)X4# .
M6<X;G/0'H#710^.C/=:E81^'-7.J6&QI++$6XQL"5</OV8.#QNSGL: .JN(S
M-;O&LSPEQ@2)C<OTR"/S%9OAO0+?POH5MH]I<7$UM; K$9RI91G.,JHSUKGM
M5\3^'M8\->'M5NM/NKRQU"_M_LN %,,Y?"%_F&,-G.,CCO6A=^,TAU^]T2VT
M;4KR_M8%N-D2QA9%8D AF8 =#UQ[9H Z?..M%</JOBGP]K/A#1=7N].N[O3[
MZ]@$* !6AF\S:I?YAC:X.<9Z=ZV=0\4Q6ESJ4%O87-Z^FQ++=K 4W(&4L  S
M DX&?Y9/% &_17*#Q-?M\29/#PTV7[)%8+<&57C^8M)MWG+9"C:1@<G)XZ47
M7CW3K-;2ZEMKC^R[JY%M'?@H4W$D*Q7=N"$C ;'OT(- '5T5R<?CJ*XUN[TJ
MVT/5IYK.[BMKEDB3;%O (D/S?=P0?7VI;GQ[IUJ+*YEMK@:7>7(MHK\%"F]B
M0I*[MP0D<-CT/0@T =71G(R*XOQ=KT-[X;\2VEI875[%96\L5S-"RJL<GE[L
M#+ L5!4G'3IR>*U? _\ R('AS_L&6W_HI: -^BL"^\4Q6MSJ4-O87-Z=,5&N
MQ 4RFY=P 5F!/R\G],G(J:[\0K'J5SIUC97&H7=K$LUQ' R+Y8;.T$LP&YMI
M('MSC(R ;-%9N@Z[8^(](AU/3W9H)<C:Z[71@<,K#L00016-J_B:_LO'>D:%
M!ILLMO<P33O(CQY?;M& &88 W9/<\8SS0!U>:*\KT77D\*7OCFX72K^\MK;5
M3-,;;:?)C$*$L2[#/<X&3[5VT_BFW^VV=E86L]_<W=F;Z-(MJCR05&2S$#)+
M  ?G@4 ;U%<)J?C]Y-&\,:EHMA//;:U?Q6^YBBN@RQ9-K-]X[&7K@<\]*[F-
MF>)':-HV902C8RI]#@D?D: '45@6_BF*[D5K6PN9K1KQ[+[2A0JLBL58L-VX
M+N4C..>.,$&JX\;V9T;7M3^P7P31)Y(;N+$>_,:AV*_/@C!'?/M0!T]&<5B-
MXE@D>R@L[:>ZO+RU%VENA52D7'S.2<#D@=22<XX!(XKQ1KEGK=MX*UV"VNXR
M-?2%H9(R)5*K*&3:,@G<HZ9Z=: /4**PM!\3QZWJ&I:<]A=V%]IS1^=!<["=
MK@E&!1F!! /?C%/\3>);7PKIB7]Y;W,L+3)"3 H;:78*"<D<9(Z9H VJ*Y;3
M_'%I=^(I-$O--U#3+OR#<P?;(U N(AU9=I/(Z[3@^U&G^.;._N='3[#=PP:R
MLC6$\@3$FQ=V" V5RHR,_C@\4 7]%\-P:)J&IWD-[=SOJ,WGSK,4VA\!<KM4
M$< "B_\ #<%_XDT[7'O;M+C3UD6&-"GEX< /D%23G [_ $JOI?B^UU2'6G-E
M=VCZ/*T5S'<^6K95=V1AR,$<@D@&J[^.(DU'3M/.BZK]KU"T:[@B*1Y(&/E)
MWX#?,.I '<T =517$'XDV_\ 8M]J2Z#J[+ILLD6HQ!(\VA3[Q)+X?@Y^0GCD
MXK>N?$=NCV\-E"][<7%O]J2.-E3]UQAB7( R3@=SSZ$@ V:*XT?$G2'TC3-1
MCM+^2*_OAI^Q8@7@GR04< YSP?NYS^-3Q^-O-378?[&OH=1TF$3M9SM&IE1@
M2K!E8KCY3GG(QT)XH ZNBL'P9K%WKWA+3-2O;9X9[BVCE8MMQ(64$LH4G Y[
MX/M5G4-<BL]2@TR&"2[U">)IE@B*C;&I +L6( &2!ZDG@<' !JT5R%U\1-,M
M/#>HZS)9WV=,G^SWMH$7S8),@?-\V"#D8()!!K<TC5Y-5:ZWZ9?62P2!$:Z0
M+YRD9#K@GCGO@CN,\4 :>:*\ZUVY_LOXOZ?=PV-U>3R:+.!!;#+.1+'C[Q"K
MQW) _'%;NF>/-+U+1YK[R;JWG@NA92V,Z!9UG) $>,XYR.<XQDDC!P =117)
M2>/K*VEU>WN["\BO-+M?MLMNOENTD'.70AL$#&""0<TZQ\=VUWJ&C6\FEZA;
M0ZQ%OL[J94$;MLWE,!MP.,X) !QQD<T =702 ,DX%<KJWCNPTBUN+^2UN9=+
MM9_L]Q>1%"L;!MC':6W,%;@D#L<9Q6/KM\^I_$G3=%N=)EOM+.FSS^03$T<S
M%XU$F&?!"@D<\_,<"@#T+-8WB#PY!XB%B+B\NH!974=Y%]G*#,B'*D[E.0,]
M*Y/1KO1/"FE>+%\/:)>BXT<*;I+B?)F*Q[E(9G/RA,>^.U=9X4U.ZUCPMIM_
M>V\D,\]M%(Y?9^\+(I+ *3@$D\'!]J -@<  MDXZGJ:&&Y2,D9&.#7-:K>Z2
MGCOP]:7>GSR:G(ERUC=#B.,!!Y@^]R2-HY!ZU/;>*8KR5&M;"YFLWO'LOM2%
M"JR(Q5BPW;@NY2 <<\<8(- $OA_PU;>'HI1'=W][/+@/<W]P9I2H)*KN/11N
M. /4UM4R:0Q0O((WD*@D(F-S>PS@5Q47Q.L)=&TW6O[(U5=*O9A!]K,:8A8N
M47<H;<<D=5!'.,YXH [BBN=L/%T-UKUSH]UIU[I]U%:_;(_M(0B6'=M+#8S8
MP>QP>1Q4&G>.+._N]&C^PW<$.M)(]A/(%Q)L7=\P#$KE>1D?D>* .IHZUYY\
M0->AU/P%XGCL["ZNK:UAE@DNHV4(LJCG W L%/WCC'!ZX.-ZSUU++2],L;>V
MDO+W^SXIS#&Z)M3: "2Q &2"!ZX/8$T =+165X<\0V/BC18M4T\R"&0LC)*N
MUXW4X96'J"*U: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *Y+Q]HVHZG8:5>:5'Y]WI.I0WZVVX+Y
MZID,@)X!(8XSZ5UM% '&O93ZSXWTSQ$;&ZMK72K*= LR;9)I)=HVA<YPH4\G
M@DC&>:D^&=A?:5X"T_3M2LY;2[MS('CDP>LC,"""0>"*ZZB@#E/'^F7VI:1I
M[6%J]U)9:I:WCPHRAVCC?<VW<0"<=LUG:OX=N?&.MRWK0S6%K'I%S80M.NV2
M22< $[>H50.^,D\<#)[RB@#SOPC_ &LD-CIFH^"HK*^L@B7&HE8C"X3^.,CY
MBS8Z8XSDGC!S)M$UF7X=^-M-&D70O-3U.ZFM(CMS(DK@J<YP. <Y/%>KT4 >
M::A9:GI/BT:X/"\FMZ;J-C##/ JQF>UECW8PKG!4AN<'J/IFYXHT_5+O0-!C
MM]#*31:O;WLMK:[,01))N()R 6QC..ISCCFN_I&=4 +,%!(&2<<GI0!Q^I6M
M[<?$OP]J45A<-8V]G<133X "-)LV@@G/\)SQQ1X)LM2TK4/$=G>Z=-%%/J]S
M>PW)9#'(DA!4#!SGKG(&,5V-(K*XRK C)&0>XH YSQGIUKJVG6MC?Z/+J5C)
M<?OO)_UEOA6*RK@@Y#8'R\X8\&N-N]"\2#P=%ISIJ&IK#KL,]DUP5,XLXW1L
MR$D<\-C/.,<#H/5J0LH8*6 )Z#/6@#A-1M=;/Q"U#5M,L)/F\.FUM9Y0!&;D
M2,ZJ1G..1SC%8]AIVMS>(O!FKS>'M1$]JEQ'J5Q=31F0R/$%W?>/[L,&P!C
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M% ' WMGJ?BZS\-6MWI=S83V%_!>WS3!0J&('Y4()W[FQ@CC&2<'BJ::7JO\
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M_= ] Q7@MW...<<XR=&BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*1ABP BWL$W8/4@L,"L#7YG@^)WA._\ [*E-[+97RM;QE"[X";06SMQR3DG
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MV\@W))/(^ S*>&VJ#C/0DFN2N/$=U8Z1=Z///(-.L?%4>G7$Y<Y2Q<[PK-U
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M*BM$JLK*6# EL8P.!U.>G!JOXQT[5;[Q?X3O+'2Y[FVTVZDFN94DC4*K)M&
MS GKZ=J;9:?JT'BWQI?OI-Q]GU&"W6T821?O3'$RL,;^.2,9Q0!U>C:K;:[H
MMEJMGN^SW<*S1[QA@&&<'WJ]7-^ +"]TKP)H^G:C:O;7=K;K%+&S*V".X*D@
MC\:Z2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBLS6]7_L>U@D6TFNI;BXCMHHXQ_&YP"Q_A4=2
M>U &G36EC1D5W56<X0$X+'&<#UX!KF8?&]G'!X@;5(C9OH3*+L*_F*0R!E*'
M )R#C& <\5SNMS75S\3/ <]YHZVDCR71242AWV_9V.Q\ 8(SG +#KS0!WFL6
M%OJFCW=C=RO%:SQ-'.R,%)0@AAD]!@GFDTRVM=)T^RTV&X+QQQ".W$C@LR*
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M@#D_+U[XYP,'-+JWQ#MM-M;ZX6UCE73L"\B:[1)E;:&98TYWE0>>0,Y )(H
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M:M;3W6Z24([;% *$8.-I;GKDCVYR=*U:3POJ_CZXL-$DNX+:^6XF2%TB6-!
MK,1GJW4X ^N,C(!ZK17-W7C&Q1-/6U:!Y[^U%Y"MS.($$1 P68YP3N   /?L
M":R(_BA93:/87\&EWDQN=3&E2QQNA\F?/3.?FXY!'!R,D4 =W15#1[V\U"P$
M]_IDNFS[V4V\DBR' . <J<8/6L#5_'(TF#4KY]+F;3=-NDM;F=GV.2VW+1H1
M\ZC>.<COC.* .NHKE[[Q=/;^*IO#MKH=U=7B60O$;S8T1U+[.I/ R#UY]C5%
M_B)&/"=AXA72IOLT]U]DN5>55-H_F>62Y[J&'4>HXH [:BLYM4<>((]*2VW@
MVQN)9A)Q$-VU01C^(YQ_NMZ<IK>M6VA6"W-PKNTDR6\$,>-TLKMM5!GC))[]
M!DT :5-DECAC:25U1%&2S' 'XUSR>*)(]?\ ["OM/^SZC+;-<686??%<A?O*
M'P"&'&01T.1FO/=>UB]\4_ N_P!6U>RA67[3OB=6#[<7NW"C&1M4;<]2/K0!
M[+17-V?BMY?%+:'?:7/8.]JUW;2RRHPEC5@K9 /RD9!P>U9C_$K3HY=+F:.)
MM.U*X6W@GCN5:12WW&>+JJMZY)&1D"@#MZ*Y"P\:W6IZQ=6%IX;OF%G?BSNI
M6EC A!4'S/O?,.>@R<?4"M3Q;XC3PGX<N=9ELYKJ*WQN2$J",D $Y/3)'3)]
MJ -NBN2B\;NGBFWT34="O; WR2/I\TKH1<[!DJ0#\C8YPWXXJ#2_B VI127K
M:%=VVE6\ES'>7LTL>VV,.<Y4'+9Q_#D GJ>< ':45RK^-/L@TFYU'39+33M6
MD2*WN#*&,;N,H)5Q\F[U!8 \'%6=,\3F_P!>UG2)K+[)/I:H[-),"LJN"59>
M/N\')['C% &\\L<;(KR(K2':@8X+'&<#U. :?7&7VOVEQ<>$Y=2T!VEU"YS9
MR.RL+9RC$$]]Q7/&/QR*T%\4M<WMW%86(NHK.^CL;DK.!(C,5!?9C[@W9SD$
MX.!CF@#H!+&TK1"1#(H!9 >0#T)'X'\J?7*VFLZ4OC77XI-,^QW=E9PRW5_(
M5_>Q?.5Z$\  ]<'VIDGCA+:RTS5;S3I(-&U*1$ANS("T?F?ZMI$Q\JMQR"<9
M&0* .MHKDI_&=U_;FL:/8>'KNZN]-CBE(,T:+(KAB"#DX^[QW.>@P33[7QQ9
MZC8:!/8Q*9M;C:2VBN)?* V %@6P>1G& #GZ4 =515/2[R:_L%N)[1[24NZ-
M"[ E2K%>HZ@XR#Z&L^Y\02/J]WI6E60O;NRB26Y#3")4WYV)G!RY )Q@#&,D
M9% &Y44%U;W0<V\\4H1MK>6X;:?0X[UYUXS\7MJWPEOM6T6.5%E(MYQ(_ER6
M[>:J.A'//)'![YKL])T6RM;R;5$TN&QU"YC6*<0OD,J$[<XP,X/7&>W:@#7I
ML<D<T8DB=70]&4Y!_&N)LM9U'6_$WBS1=0TZ Z?9+%"%,@<8:(OD@CDMN'';
M Z]:P_ 7BJ31O W@VVN-)N/L%[Y=DM[YB@"9RVT;,[MI(QGC\1@T >HB6,RM
M$)$,B@,R \@'H2/P/Y4^N3AUO2X?&6OJ^DM;7EC81SW-Z0I::'YR ,$G P>N
M#[5?T77Y]7>T<6"K9WEJ;J&YBN!*N 4 1L 8;#YXR/E/- &[17(?%&"*;X::
M^TD:.8[1W0L,E6'0CT-<48;:/4? I\&HJ:D7A_M/["N(S;;!YGG[?ESZ;N<]
M.: /8EEC:1HU=2Z8+*#RN>F13J\\T.>VT/QI\1KP6[""W^R7#QV\>6;%N6;"
MCJ3S]2:W;+Q9)-KD&DWFEO;W-S8&_MU28/N4$ HV0NU_F''(]Z .FHK@H_B9
MOT.#7&\/WD>EF[^RW$[RQY@/F^4#MSEOFQG' SP3@UWCE@C% &;' )P"?K0
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M?QIU<G\,?^29>'?^O)*ZR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=&#*PR"#D$5D:1X7TC0[Z\O;&V9;F\=GEDDE>0_,<D+N)V@GG P.GH* -@#
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M)&5>5-YP1NR 2P'Y]*K>&_"TVD^+8M0TK3KG1--FMY#J&GR3H\+S$KL,2JS
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M0F\.MOBCE"J6\]>6D(' QC.">G%=!X\T?4-8T2T&F0I/<V>H6UX(6D">8(Y
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M"64G.2/QXQ0!ZC17(ZUXV6PGU."QBLKB;3%!FCN+P0M(Q0/LC&UMQVD=<#)
M]<26_C2/4KK1[/3;1FNM2LFOMETQB$,:X!#8!);<P&!Z$YZ9 .JHK@#\1[E?
M#%]K;Z$JI8WPL9XC><^9YHB;:0G(!8'G&0?PKH9-?8>-H_#4MDACGL'O%N/-
MSD*ZH5*;?]KKDT ;%M>6UZC/:W$,Z*Q1FB<, PZ@D=QZ5-7FW@N_DT7PGK4M
MGILMY(/$-U!%;P# &Z?:"< [4&<DX. *U)/&EZ\'BNU@L[/^T]"MUFR+DO#(
M&1F'(4$$;&!7'4#GG( .ON;NVLHUDNKB*!&=8U:5PH+,<!1GN3P!4U>=_P#"
M1W,/P^\+W^MZ/:ZD;Q[%-S3A\-($VS$,G#[B3@9Q_>KI9O$%Q<:W?Z1H]G#=
M7-A%')<M/.8D5G!*("%8DD#)XP 1US0!OT5PK_$A'T32-1M-(FF-[J:Z7/;M
M*JR6TQ8JRGLQ&#W Y'([6H?&\]M<>(;;6=*^RSZ/9B^VV\_GB:$JQX.U<-\A
M&,?C0!N7'A[3KK7K;6I4F-_;(4AD%PX"J<9&T';@X&>.U.US0=/\1Z:^G:I%
M)+:.0SQI,\>X@@C)4@\$ _A571-;NM6>*3[-:-8SV_G17=I=&9&.0-A^48//
MX\^E;E $0\NUMOGDVQ1KR\KYP!W+'^9I;>XAN[>.XMIHYH9%#))&P96!Z$$<
M$5P-KJNKZU=>-['4[:S:RL\P*JS,VP>3O&%*88DMDG(P>QQ5/P=XHO='\*^"
M+6YTD#3=0AALH[O[0/,$IC)7,>W[IVD9W9]A0!Z=17$ZS\08["+49[*WM;R+
M3IC#-";P)<2%<;_+CVG=C..2,E3[$EUXXU*377TG1_#IOICIL>HP&2[6$2(S
M;<'*G:>#U]NG) !VU%</JWQ#2QMK^ZM+6UNH]/F,,\'VP+<.RD"3RX]IW;22
M.2,E3[$ZEAXJ?4/$MSH\5B@V:?%?P3-,0)%D)"AEV90\<]: .DHK@U^(TS^&
M-#UI-#9QJFHC3S"ER"8F\UH\@D#=G83VZCGO6A9>,WCU+6['7K"/37TNU6]:
M2.X\Y'@.[YL[5((VD$8^A- '37%Y:VC1+<W,,)F<1QB1PN]CT49ZGVJ:O+_%
ME]?:J_@;4+C28+>WN-<M9(I/.W31@ABJN-H R#DX8X(QSUK;UGX@1V$>I365
MO:W<>FS&*:)KP1SRLN-XBCVG=C..2,D$>A(!VM99\/:<?$0UXQS?VB(/LXE\
M]\>7G.W;G;C//3K7.W7CC49-<.E:/X>:^F?3$U* R72PB1&;: <J=IZ_CCIR
M1VB%FC4NNUB 2N<X/I0 ZBBN6TGQ9/KDJOI]G;36@O);68BZ/G6Y3> TD>SC
M)0<9X# \T =317%-X\G7PKXBUDZ3'OT2\GMI8/M1Q((L996V=\\ C\:UI/$4
MDVHVVEZ=:QS7\MF+V19IBB0QDX7)"DDDY  '\)/'&0#9GO+6U>%+BYAB>9]D
M2R.%+MZ+GJ?85-7F'BC4I]3M_!.JW.ASV>H#7DC:UE \P$)*,!CC*D@$'C(P
M:ZSP]XDNM5UC6-(U'3H[*^TTQ,PBN/.21)%)5@Q53GY2",4 ='10>!TS7GTO
MQ"UEK#6KVR\*-<1:->2V]V#>JI*QA2S(-IW'!)QZ <DG  /0:*XFX\?3S7^D
MVNBZ*;\:MI[WUH[W(B!VA3M;@[?O#GU[5>M_$VI:A/=V>GZ3 ]]80Q->Q37>
MU4F=-WDJRHVX@=6X'(Z\X .HH) !). *X=_B*DFA:+K=GIOF6%_=K97#33^6
MUG(6V?. IR PQG(ZCUKHI=4NCJE]9P6$<\5M;K(7\_!9VSB/!7 X&2<]&''-
M &A:W=M?6T=S:7$5Q;R#*2Q.'5A[$<&BZN[:QA\Z[N(K>+<%WRN$7). ,GN2
M0*XK2?&NGQ>#_#5W;:?9Z9%J\AAM[=Y1%!!@.V"P7'.W  ')-6/$GB"6Q\+I
M>:QX<@N!]OCMWMWF#QKF4*DH+)\W)5AP/PH [.BL&XU^>77KK1=)M8;F[LX$
MFN6GG,21[\[%R%8ECM)Z<#'KBL*7XDK_ &#9ZE;Z1-)*^J+I5W:F95>VGWA6
M&>C>W3.1T[ '=T5R,'C.X@U36=/UC2OLDVG6(U%/L\_G^=!\P_NKA@5(QR/>
MK^@Z_=:T;:=;6T;3[FV,\=U:W1F4,"O[MOD&#ACW_A/% &_117+P^+)K[5+V
MTTZSM[C[#?):7,9N2LZ LH:7R]I^4;B>O(4\]J .BBO+6XGF@AN89)H"!+&C
M@M'GIN Z9P>M35Y?:WU]HGC;X@SZ1I$-V8C:3.C3B!,"WR<$*V6/.!C'7)'?
MJ8_%<U_9:)<Z9ICR1ZI:F[,T[E(;9 JMAW"GYB6  [X)SQ0!T-U>6MC 9[NY
MAMX@0"\KA%R>G)H:\M4NX[1[F%;F12R0EP'8#J0O4@5YCXOUZ#Q;\'9M7^R)
M%(M[#&4W"38Z7:(VU\#(.#@X&0:W-6BC7XQ^&Y%C42/IUX&8#EL&/&3WH [B
MH1>6IO#9BYA-T$\PPAQO"]-VWKCD<U-7G&HRWEC\8[F32-+CO+N7P^A*-*(5
M)^T-\S-@GL!P">G;D 'H]%<58?$6UN]$2YN+3[%J7V]M,ELKB<*L5PH+,#)C
M&T*"V['L!FM#PYXL.MZMJ>ES6T<=Q8[&$UM-YT$Z,,@J^T<CH1CCWH Z6H;>
M[MKLS"VN(IC#(8I1&X;8XZJV.A&1P:F/2N C\9IIWACQ7K5OX<BADTK49HKB
M"*95\]U5"TK,%ZG<.Q/% '?T5R=OXNO_ /A)=-TJ^T9;:+5+>6:RF%T'8M&%
M9ED4+\O#9!!;_#*\/>,M0CT3Q!J^OQVP@M-3FM4\F<D[E=8EC4,H !./F)ZG
M) H ]!HKCK?QO+)KLFDO86T\K6C7-O-8WGG1.5ZQNQ4;&[CJ"/RK*7XDZLW@
MYO%7_"*_\2L6)N0_V]0V\-MV;=N<8R=WMTZ4 >C45QB^-[ZV\2:;IVJZ ]G9
MZJ&6QNA<K(6D"[MDB@?(2.G)_GB+3?'>H7_VVYDT 6^F:==W-M?W37BGR!"I
M)8+MRXR.W3(Z\X .XHKBH?'Y?5-)MVL[9[?5,K$]M>>;) Y&5$RA?E!Z9!(!
MXYZU3\/>,M0CT/7]7U^.V$-IJ<ULGDSDG>KK$D:AE  )Q\Q/4DD"@#T&H;B\
MM;3R_M-S##YKB./S'"[W)P%&>I)[5REMX\B379=.U&*U2%;-[Q;VSNC<0JJ<
MNKG:NU@!GOD5SWC#4KS6;'P;J<FDPPV=SKMC+!(TVZ:-6?*[EVX&X=0&..!S
MV /4J*** "D9@BEF("@9))X KC=2\<W&EE;BYTCR;$ZH-.4S3%)Y,L$\U(RN
M&3)X^;D<^U:-SKDM_JFI:3IFG6]\;"-/M?VB;RT+N-RQCY6R=N"<X R.O. #
M=MKJWO;=;BUGBGA?.V2)PRG!P<$<=014M>3^"?$TWAWX9^"XX],:Z74;DV8*
MRA#&S/(1P>O"GN![UTMOXNUVYU?5=$3P[;_VK8I',H_M#]P\3@X._P O<&RI
M&-OX@4 =;<W=M91J]U<10([K&K2N%!9C@*,]R>@J:N"N_&MIJ/@O0-=DT)+J
M#4+V"$PSNI^S2F79NY4Y*L#@@#IVK1NO%>ICQ9>^'K#0TGN8+-+J.66[$:.K
M,5^;"DK]T] <^W6@#IKF[MK*(2W=Q%!&65 \KA06)P!D]R> *FK@+SQM;:CX
M$TG7I] 2ZAN[R*"2VG=2+>7SO+W9*G=M<9! '3M6OJ'BR:+6=2TG3;.WNKZP
MMEG-M+<F*2?<"<1KM.[IU]3CCK0!U%%<<VM:VWQ5.BK#:G3X]+%R!Y[*Q#2A
M2Y&P@L-I 7I@GYN<"K<?$JWCAM-0@M[:YTRXN1!F&[W7*H6*B7R@OW<C.-V<
M$'U  .[HKC8?&&KWGB/4](LO#@E_LVZ@AN96O50".10V\ KR0"#M^O/2JTWQ
M*@2*ROX+:WN=,NKD0YAN]URBDD"4Q!?N\9QNR 0?4  [B66.")I99%CC099W
M. !ZDTD$\-U;QW%O*DL,JAXY(V#*ZD9!!'!!KC/$6N2ZSH/BBWT[3;>\L["*
M:VN))YMN^58\NJ+M(.W(Y)'S<=LUK> O^2>>&O\ L%VW_HM: .AHK.US4YM(
MTJ2[M[">^F#(B6\(.6+,%!. <*,Y)P< $UA0^-)C=^(K&33X7O-&MTN"MO=;
MTE5@QQN*C:PVD$$>E '74V21(8VDE=411EF8X 'J37$67CZ]G7PS=W6A"WTW
M7C'%',+L.\<KQEU!3;RIP0#G/J!TJ;7=<EU?2O$EIINFP7MKI\<EO<O/-LWR
MA-S(@VD$J".21SQ[@ Z^WN(;JWCN+>:.:&10R21L&5@>A!'!%25S/P[_ .2;
M^&_^P=!_Z *Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "N:\>:+>Z_X5EL].$37:SP3QI*^U7\N
M57*YP<9"FNEHH XY],UJ?Q_I6NS6$:V]OI\MM,(YPQ#NRL,9QD +@GCGH*P3
MX+\0R:+J1MQ!::K'XADUO3S)('C?)XC?'(R"P/U'->GT4 8>@3^([PM<:[8V
MNFA4V+:P7'GEV[NS;1@<8 &>IR>E;E%5I-1LHKZ&QDNX%NY@3' T@#N ,DA>
MI Q0!R_CC1M5UF^\./IUJDB:;JD5].SRA,JH(*KZMSWP/>I_'NDZCKWAE+'3
M;97N&N8)B)9 @41R*Y!///RXXS7107]I=7%Q;V]U#+-;,%GC1P6B)&0& Z9'
M/-6* ..\5Z1KLNK:/XD\/1P/?V*2136-S)L6>&3:67>,@,"H([?R-?7+#Q?J
M^C6<S6UHLHOHY;G24N?DDMP#F,R[1N))!/ 4@8YYSV%[J-EIT:R7UW!;([!%
M::0(&8\ #/4^U6: //;'0?$=AJ7BBY72M+>'4WM7BM_/RC*B(DD1!3&-H89Q
MZ<>D,'@"5-/\566F0MI.FZM8^3!I\LH=8[@APT@"DA%.5& >QX' KT"TO[2_
M21[.ZAN%CD:)VB<,%=3AE..A'I5B@#SR+1O%5YJW@Z^N=,LK9='$J7$9O-Q8
M-#Y>X$+^('/N16QX0TK4M*U#Q'+?VRQ1:AJ3WL#"4-A2BKA@.A^7/<<]:ZNH
M[BWBN[:6VG020S(8Y$/1E(P1^5 '$VOA]3\4;V\M;D'3C#%?7%LH^7[80\:-
MZ<QY)'J%/I7=5G:)H.E^'-.6PTBRBM+4$MLCSR3W)/)/ Y/I6C0!Q_Q"T75-
M?TS3[72[9)7@U""[=I)0B[8VR0.^3],>],U'0-4L?%MOXG\/01B2Z40ZM832
M!!.@'RR C(\Q>GN#C-=G10!P3:=XLT'Q7J6HZ)86>H:=K!CFFMKFZ\E[2<($
M)R P92%&<9/''O!XBBUF7Q/I T^VM=3U73[.26Y,=W]DDC,A &"58%#M?"D'
M[H).1SZ)6+JWA/0]<O([R_L%>[C78MQ'(\4@7KMW(02/;.* .-N-(O\ 7/ N
MK^&+?0DT?4H'ANDB>\%PD[&7S<F4#.YC&V=PR,@]#6K;Z;XCNO']AXBN]-M+
M:V339+62 7>]T+.K<$+AC\O3@>_:NMT_3;/2[46UE;I#%G<0O5CZDGDGW/-6
MJ /,X_#'BBW\)ZA9VT,27,VN/J#P?:=JW-L\N]H2XY4D<'M[G-6K3PKK9UGQ
M/(]EI]G9ZQID5M$L,Q/D,J2(%P%&?O@D\ =!FO0J@O+ZTTZU>ZOKJ&VMT&6E
MF<(J_4GB@#S^Y\.^([KX?^']&>PMEO-.GLRZK<@J4MRN3D@<MMX&#CN:U8M'
MU70_'&JZY8VGVVQUF&$W$ E5)8)HUVJ1N.TJ5Z\Y!'>NP1UD171@R, 5(Z$4
MZ@#S:?P3JEKI.E16T,4]W_PD0UR^VRA47+LS(A/)(!4#(&<$\=*TYM)UU/&.
MO:S:6<.VZTM+:T\Z5<&5-Y&\<X4E@._TKMJ* .(\->$SI/BZ?5K#3SHUA<6A
M2YL%F5HY;C<")$5254  C/!.>@YSV]%% '#PZ%K=CK/BYHK6WFL]7(E@D$^'
MW>2(]A4CCD9SGIV)K/'A?7%\*>"=-^Q(;C1+RWGNOWZ[66)&4[#W)W9&<=*]
M(HH X&RTSQAX:US5;?2;/3[_ $C4KM[R*:XN3$UF\ARX90#O7/( Q]16A;:/
MJL7Q).LRQ"2R.D)8&<NH=I%D+ERHZ Y_/M7756EU&R@O8+*6[@2ZN,^3 T@#
MR8!)VKU. "?PH XFQTSQAX:UK5+32K33[_2-1O)+R&>XN#&UF\ARX90#O7=D
M@#'U':Y/H^NV'CY=:L;>"_@N=,CLIGFG\IHG1V;>0%.00W0=ZZN&_M+B[N;2
M&ZADN;;:)XD<%HMPRNX=1D<C-6* /++/P?XDMO!OAW2I;.V>XT[6UU"0I<#!
MB$SR$<CAOGP!DCCK6KJ_A&_UWQ)XB>:+R-/U71UT^.;S%+(ZESN*@]/F]>U=
M]10!YI/HWC+4='\,6-UI=@L^C:E;S2S_ &WY)TB5AN4!"1D$=><GIZ7;/3/&
M'AK7M5ATFST_4-)U.[>\CEGN3$UG))RX8;3O7/( P?<5WU5[R_M-.@$][=0V
MT1=4#S.%7<QP!D]R3B@#F;?1]5B^)(UF6(2V7]D)8-.74.T@D+E]@Z*<_GVK
M1TK5=5N?$FKZ=?V$$-M;>6]K/%+O,B-D?./X6^7./3\"=PD $D@ =2:JZ?=Z
M?>PR3:=/;3Q>8P=[=E9=X^]DCOZT 6Z\]_X1*]N_$FEZT-,CTO6+>ZW7U];3
M*([NW&<JRKRS-\N<J,<\G KT*H+R]M=/M7NKVYAMK=!EY9G"*OU)XH \XO\
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MN3TX/X5D_P#"$ZY<>'O$VB,]M;"ZU.74K"\64L=YE66,,NW@ K@\GV%>DT4
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M84EEQDX!R,=>AQUK;;PG>V.O^#6T^.%]-T&UFMG:27;(X>-$! P0<;,GD=:
M'6WB^VLY_%]Q>Z9#9_V/+&)G@8,UR3&"I)VKS@JHST]:?;^-94\16VG7MK ;
M6Z@DE%W:2-(ENR#<5E)48!&<-WQC%4)O!.H:JWC:WOC#;6^NM&]M+%*7:)D1
M54L,#NH/!]JOZ79^,-4L7T[Q0FG06X@>&::RE9WN]RE<X*@(.=W<Y Z"@#FO
M&^L7NO\ @73]62P@33;K4+1X&>0^<L9F7:Y&,?-Q\H/ 8<GD5ZJQ(4E0"V.
M3C)KRV3PGXQ?P);>%'@TR4:?/!Y%\;IE$T44BLN4V$J=JX/)Z<9KU%2_E LJ
M^9MR55LC/H#C^E 'GI\=2Z=X%UG7[?P_:Q/8ZE+;S6L<^T,PE",^X)\Q+')X
M&?6MRT\2ZB/&<>@ZGID-LEU:/=6DL5P9&PC ,L@V@!OF!X)'N:YFX\%^(9_A
M_P"(="$-D+O4M3DNXF^T'8J/,),,=F<C&.G>NCNM(U6Y^(&D:X+>W6TM;.:W
ME!GR^Z0J<@;<$#;ZCK0!M:YJ-SI>E27-GI\M_<;T2."+J2S!<D@'"C.2<' !
MK+T#Q0^J>(M8T2>.V,^G+$_G6TN])%?=QC&58%2".:?XUTO5=7\.M:Z/+$MP
M)XI'BE<HEQ&K O$S $@,.#^7>L[0=!UJQ\;W^KW-MIUO8WEE!#Y-O*S&$Q[\
M(/E (^;.>/3'>@#1\6>)+GPVNE/#IZW:WVH0V3?OMC(9#@$ C!Z'J1VK.B\4
M^(9/$6H>'CHE@-2AMTNX'^W,8#$Q9?F;R]P8%<8"G/M5OQKHVI:U'HJZ=' Q
MLM4@OI?.E*92,DD# .2<TR+2-5C^(UWKYMX#92Z8EFBB?Y]ZNSY(VXP=V.M
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M\^3!$Y6-#Z_NF<D>K8[5O>,/#=YJ/A.TT;18H,03VS*)I2@5(G5L9 .20N*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-B821E\$?PXQCO68GCW4I['PA<6^D6[_ /"0*<JUR5\IO++X^[TX^]UZ_*:
M.]JI/JNGVVH6VGSWL$=Y<Y\BW:0"23 ))"]2  >:Y.'QY+I]GXG;Q!:0Q7&@
MO&)!:.7282*&C"[@#N)(7GO5#7&U9OB'X#;4H;-0TUTP\AF)C;[.V4)/WO\
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M/B+3;"XTWS;6_1\S6T4O^ANHR%D+* 0>@88Y'2@#L:**Y&\\73GQ#J>BZ?\
M8OM]BB.EI<N5DNPRAB8_89QT/(.=O6@#KJ*Y#6/%UQ#>ZI9Z5##+/IJ*9%E2
M1O-D*;Q&NP';\I7YCGENE11^-;YK_P ,>?I?V.QUP,A:YW++;SA2WE,I Y;!
M /'3I0!VE%<O?^*Y--@OKF:&)X%ODL++:6S-*Q .>#@*Q8' )^1N.@K/_P"$
MTU6"XUBVDTI+C['8-?6]VBRPP2A?O1L64[7'4=<CTH [BBN(T_Q1XHO="M=6
M'A^V>"]M[9[98;@LZM*1N:08X10=W!)P/KA(?'%RZ>*HHX+&]GT*!+A98)RL
M5PK(S8Z-M8;&&.>W2@#M98EFB>)]VUA@[6*G\QR*J:3H]AH6GI8:;;_9[1"=
MD0=BJY.3C)..?2N3LO&FKM<>%IK[3+2+3]?151HYV:6.0Q>8"1C&TX(QDGH3
MZ5<N/$^K7=GJE]H&F17T.G736WD,Y$MTR$"38>BX.0,YSM/3B@#KJ*Y'5?%U
MPE[J%EID$1N;")'E6=)&WR,N\1#8#@[<?,<_>'!K<T#56UO0;/4I+*>RDN(P
MSVUPI5XFZ%2"!W!YQSUH TJ*YWQIXCNO"^AIJ-M8QW>;B*%D:781O<*".,$Y
M/0D?6J%GXKUBW\:0>']?TJVMA?P23V$UK<&4-LY:-\J/F YR.* .QHKAX/&U
M_'JV@VNHV5M;MJ\KQFR\P_:;3"LR%QWR%YX&,]ZMZ;XLN7OO$EGJ\-M93:,H
MERK,PDA*EEEYQQP00.A!&: .MHKBYO%6OV^L>']*ET>S6ZU:UFF;-RP$+HJD
MH?EZ#<.1G.#P*HKXU\2/HVOSII&G?:]!FE6[W7+B.540/^[^7.2I_BP <=<G
M !Z%17)S>,TG.F06*HEQ?6"ZANF1W6*-L;0509)))'8?*?8')/Q!U9=(TJY?
MP]Y=Q=:NNE31RR-'\Q)Q)'N4;D8#@G&,]\4 >A45Q*>*M<\_Q+I=S9V$&IZ9
M:)=V[QR/)"Z.&QNR <@J?3/M5'2?&%WI?@7PK=:Q<6L;ZHL4?VZ<MY<>8B^Z
M3IR2,8R!SUXH ]$HJAI%S>75D9+Z*%)?,8*8'+(Z _*X/N,'VSCFFZ_?S:5X
M?U#4;>..22TMY)PDA(#;%+8R.F<=: -&BN0;QA<K'X0F^QQ&+7]BN-YW0LT1
MDXX^8<8[5FW'C?Q";;Q/-:Z-I_\ Q()G$OF7;8E18Q(=N$^\03U  XZ\X /0
M:J66JZ?J3W"V-[!<FW?RYO)D#[&QG:<=#[5AGQ6;ZZT:PTN)#>:G9?;\SD[;
M>#"_,P'+$E@H&1W.>.>5\.ZX^@7'CB^U""/[3_;,4*Q0L=LDCI&B8.,@$D$\
M$@9ZXY /4:*XJ+Q?JJZK>V#Z6ERJ6+7=O=QI+#"64\Q.64[6QR",Y]!5OP=K
M^N>)+*SU.[TRSM=,N[)9HV2X+2^83T*XP%QD@Y)Z9ZX !U5,EFBA"F61(P[!
M%W,!ECT ]S3Z\T^)8FUM+JTL-02VN=#B3481Y@4R70.Z-,=\(K<>LB'M0!Z7
M17-6_BL:A\/1XITZ".?-B;H0O*4&54ED+ 'D$$=.HKD?$/BSQ=+\.)=<BLK"
MQMKFSM9(I5G9Y1YK*K#;@ 'Y\@Y.![] #TFXU&RM+RUM+BZBBN+MF6WB=@&E
M*C)"CO@<U:KE=2UN\L/%/AC3+O3K*4ZC)<*;E7):%DB9OE!7N !G/KQ44_BC
M5[RQU'4=!TN*^M["Z:V%N7(ENBC!9"AZ+@[L9SG;VXH Z1=5T]]4;2TO8&OT
MC\UK99 9%3(&XKU R1U]:MUPSNJ?&N.5QL \-.6SV'VA>M1KX_O)H]*U&TTQ
MKK3;^=$,4,,IGAB?[LQ.W:1C!([9ZF@#O:**PM8F_M*\&A0R[$90]]*&P4B/
M1 >S/@CV4,>#MH U[6[MKZV2YM+B*X@?.V6)PZM@X.".#R#4U<3\(B/^%6:$
M 1Q$_ [?O&KKK^[%AIUU>&)Y1!"\OEH,LVT$X'N<4 233Q6T+S3RI%$@W.[L
M%51ZDGI4=C?6FIV4=Y8W$=Q;2@F.6)MRL,XR#WZ5SWAWQ%/XCMX;J&33KK3;
MBT:1I;5R3#+\O[IP>^&;G@_+T%<7X(\1ZIH'P_\ !KMI]L^DW4\=B[F8^<&D
MD8*X7&W:#VSGZ4 >NU4DU73X=2ATV2]@6^G!:*V,@\Q@!DD+UQ@=:Y;Q1XPU
M'P_#K%X;*VBM--5&B^U2%6O\KN<1$=-H..AR<]*@UN5+GXE> [A!@2P7[C/7
M!B0T =A9ZKI^HS7$5E>P7,ELP2=89 WEL>QQT/M5IF"J68@ #))[5Q7@\ >.
M_'8 Q_IMM_Z3I7;4 5-/U.PU6!Y]/O(+N%',;20.'4,.HR..*MUY%H>M:_H.
MA>)]0TO2+2\L;+7+^:Y62X*2N@D);RU"D< 9Y/T%=;)XV2_DBAT;RM[V$-\9
M+B.1E"R@F-,("<D*23GCC@YX .PHK&\+:W-XA\/6VI7.G3Z=<2966UG4AD8$
M@]0,@XR#CH:V: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *YKQKHVJ:UIUC'I;VQ:WO8KB:VNG98K
MJ-<YC8@'C)!Z$<<BNEHH \YN?!WB2X/C3+Z4!XAM8XXP))!Y3"'RB#\IX'KW
M]%[:,WAK6I=0\&W(6P"Z(KBY'VA\N6A\KY/W?/KSCT]Z[6B@#S'_ (0KQ-8>
M%->\)6)TV?2KP3FRN9IW22$2$DHR!"&P2?FR.N<=J]"TJ"XM=(L[>Z\KSXH5
M1_*)*Y QQD U<HH YOQMH5[K^B00Z<\"W=M>P7D:W#%4<QN&VD@$C..N#59-
M$UL_$"#Q%,FGF!=):Q=$G<-O:19,@%,8&W'7GK@=*ZVD)"J68@ #))[4 >:K
MX"U]?#S)#=V-MK%KK4NK6,JN\D1+LQ,<F5!P0Y!QFNQT%?$,BO<>(#8Q2[0B
M6UBS,B^K,S $D\8&.!ZYJ[INK:?K$$D^FWD-U#'*T320MN4..HSWZU=H *Y'
MQ1X?U?5O%/AO4K);+[/I-Q)-()IW5Y-R;< !"..3UKKJ* .8\9Z'J>NP:.NG
M"TW66IP7TGVB5D!$39VC"MR?6JOB70=>;Q%8>)?#<UD-0@MVM+FUO&813PE@
MV RC(8-R#C_ ]C10!Q.M:#XHU.QTJ=Y].GNK>^%U=6#NZ6LB;=HC#;2QVG#9
M*\MS@8 J+3_#GBC3KGQ%<(=(F.IWD5RD;,X5EPBR1ME3@;58 X.20<#I7:W5
MU!8V<UW=2K%;P1M)+(W1549)/T HM;J"^M(;NVE66WGC62*1>C*PR"/J#0!Y
M_P#\*X9M'\6V5HMOI=OK4*+!91.7BAD4'+] %W$C(4=%_ 6UT+Q5>^)/#.L7
ML>DP_P!EPW$4T$4\C[O,1%W!B@Z[2<8XQU.>.QU'4K'2+&2]U&[AM;:,9>69
MPJC\34\,T=Q!'-$P:.10Z,.X(R#0!S'A#2+_ ,-V6LG5GLHX[C4;B_62*=F"
M)(V[#%E7&/6J&@:);-\0=:U:QNQ+IOR2"%"#&MXZ8E=2._EA,_\ 71J[.[M+
M>_M)K2[A2>WF0I)%(N5=3P013-/TZRTFQBLM/M8;6UB&$BA0*J_@* +-<CXP
M\/ZMK>K^';FP%EY.EWZW<GGS,C. "-H 0^IYS7744 <?+X:U33/&1U_0&M%A
MOT"ZK8SR,B2./NRH54X?J#D8(]^:IVN@>+] UW4QH<^E2Z1J=TUX1>&3S+25
M_O[0HPZD\@9'X=3WE% 'FVLVNJZCXVD71/[-OI],T^.UN3<7DMK.&D)8Y>(9
M8%0IP> 3QR3B272M4U[PI;6-GING:;?Z!JD$L-M'.7MI/*VMM#A<C(8@\9!%
M=;JGA/P_K5VMWJ6CV=S<J-HFDB!?'H3U(]JT[:UM[*VCMK6"."",;4BB0*JC
MT ' H Y/3=$\0Q>.+WQ#>)IHCN=.CM_(BF<E'1F8#<5Y'S?>P/IQSC6W@GQ)
M9^ M#T9)--DN--O_ +1/ T[^1>1;W;8QV9'+ XVD96O2JJ:9JECK.GQ7^G7,
M=S:2YV2QG*M@D']010!Q#>"]=NQXUCNI].2/Q!;JL1B+DQR"$1X((^Z,=>IZ
MX'2K.H^'/$6I:1X7AD32TN-*U""[F"W$FTK$I7:IV9).2<D#'3GK7<T4 <?:
M:!J^@>)]9O\ 2DM+JQU=EG>&>=HF@G"[200K;E;@GH01WK.3P'?Z=:>%;:PD
MM)ETJ^>^NY)I&C,KN'W;0%;NYQD] ![UZ#10!Q<>@>(;7Q'XHU6T_LT'4Q:_
M9EDF<X\D;2)!LX# GIG%2^&O"7]B^)]1U>"TM],MKR!$>PM92T;2AB3+C: I
MP0  /4G&:V[;Q'H]YJ?]G6^H0O=E#(L0."Z@X+*>C 'J1FM2@ KST^#]?30?
M&&C1-IK0:S<74UM*\KJRF?LX"'&WGIG/MCGT*B@#BIO#>M2ZIX-NMM@%T1)!
M<C[0^7+1>7\G[OG'7G'I[U5T;PYXP\.RW&BZ?=Z8_A^2>22WN9=_VFU1V+,@
M4#:Q!)P2?<^E=_10!R^CZ'JECXYU_6)UM/L6I1VZ1A)F,B^4K#Y@4 YW>O&.
M]9&A^'/&'AUIM#L;S3'\/M,[V]S(7^TVT;L6*!<;6()."3[GTKOZ* .)N/#N
MO6WBOQ!>Z=]@DLM;MXE=YY'#V[QH4X4*0X((_B7'\Z&G^#?$%I8>"8)#IK-H
M#$SD3N-X,90!?DZ_-GG'2O1:* /.]5\ ZCKDOC..[FM;>#7?LS6TD4K.\3PJ
M I8%0,$J#P:GDT7QAJFL^&-1U*+1X9-(EE:<Q7$CB??&4+*-@V]<[>?K7>T4
M <!H_AWQAX>FN='TZ[TQ] EGDE@N)M_VFU1V+,@4#:Q!)P2?<^E:^D:'J=CX
M[U[6)A:&RU&*WCC"3,9%\H,,D% .=WKQCO7444 9^EG5RU[_ &JMFJBY<6GV
M8L28.-I?=_'USCBM"BB@#D/$?A_5]3\9^&M7LULOLVD/.\BS3NKR>8@3@!"!
MCKUY]JL>,-#U+7&T(V M<6&J0WTOGRLFY4W?*N%;D[N_I73T4 <-J'@N]UC7
MO$LMZUM'IVL:='9*T4K-+&4W88J5 ZMTSVJYX:M?&L7V>U\07&EFVM!C[1:%
MS+=8&%W!@ G8G&<D8X%=;10 5POB_P (WWBI;^VN+/3VRZMIFH^:R3V1VKD\
M+DX<,P ;G(!QUKNJR[CQ'H]KJ,6GSZA#'<RR"%%8\&0C(3=TW$$';G/(XH Y
MFX\/^*M&\5WFJ^')].NK74TB^V6^H,Z%)44()%* YRH&1[?EI^)O#5WKO@YM
M/^V*=6B*7-M=E=H2Y1MZL!SM7/'?"GO73T4 <IX@\(3:EX/M]+L+[[/J-E+%
M=6UVZY!N$;=O8=]Q+9_WN]1K9>,-4T+48=8_LB*YFLY+:&"UED\MF<8,CL5)
M&.R@'J<D\8Z^B@#A;SPMKTOPYT;0X);%;[3_ +*LT32N8+N.+ :-FVY"MCD8
M/IS4#>%/$;ZAXIN3_9*KK>G1VR1K+(!"ZQN@&=O*C?G=CG&-HSQZ#10!P;^%
M-<.G^"K<+I^[07C:X)N'Q)LB,?R?N^^<\X]/>BP\.^*_#VLZK!HMQIDFC:E=
MO>*]T7\ZT>3EPJ@8<9Y )'O7>44 <-=^'O%&C^++O6/#4^GW-OJ4<2WEMJ3N
MI62-=BR*R@]5 R,=OR[&QBN(;*)+N<3W&,R2!=H+$Y.!V'. .>,<FK%% '#_
M !9\S_A!CY6WS/M]GMW=,^>F,^U7Y]!U#6/$EEK%\(;-M.MIXK1(9#*WFR@*
MTA)4# "X [Y)..E;>J:-I^MVZV^I6J7,*L'$;D[=PZ''J.WI5Q$$<:HN<* !
MDDG\SUH \SLO!?BJ&S\-1RMHPGT>^,\LHEE8W6Y65I6)4'?\V2.<G^(=*T]?
MTFRU_P =:)/8WR&6-)(]12%@PEMD96"/CI^]"C'<,_H:[NL_3=#TK1FN7TW3
M[:T:YD,L[0QA3(WJ2.O4_G0!D:OH>I7OCK0-9@%I]CTZ*XCE$DK"1O-"C*@*
M1QM[GG-9</A;7$L/&D#+I^_79)7MR+A\1[XA'\_[OMC/&?3WKI[/Q%H^H:@;
M"UU"&6Z$?FB,'!>/.-ZY^\N>XR*??Z]I&E3+#?ZE:6TK+O"2RA3MZ;B#T'OT
MH XQO"7B?3/^$?U719M._M73]-33+RVN)',%Q$N,%6"Y!# GIW_._K7A_P 1
MZQ::&\TFG/=VFK0ZC<+YCI&BH"/+C^4D]>IQSG@9P.OM;NWO;=;BUGCGA8D+
M)$P93@X."/<$5-0!Q_\ PC6IS>+]=U*4VB66I:<EDFR5FD0KO^8KM YW^O:J
MVE>'_$%GX1TG1+^ST:^M[6(6MU;-(Q2>)5PK LGWL@'!&.O//'<U5U+4K/1]
M/FO]0N$M[2$;I)7/"C./YD4 8W@KPV_A?1I[$L%A>[EG@MUD+K;1L1B-6/)
MQGZD_6M;5[#^U=%O].+[/M=O)!OQG;N4KG]:N*P90RD$$9!'>EH \X@\+>+)
M+7PC#<KI$7]@3)NV3R/YR+$8]V=@VDY^[@_7M5Q/"NN"R\:P%=/W:\\C6Y%P
M^(]T0C^?]W[9XSZ>]=W10!Y\/".OZ;=^&]9TTV$FI:;IHTR\M99G6*>$8Y1]
MF5(89Y7^7,$O@/6]2M?$Z7=U9V<^I7L-_92V[LY@FC";<Y49&4QG\<#I7H$-
M]:W%U<6L-Q%)/;%1/&K M&6&1N';(YJ*+6--GOVL8K^V>[4D-"LH+ CJ,>HX
MSZ9H P+&W\9WFG7*:W_9$<PMWBBBLY)-DSL,;W9ERH'.% /7V%7_  9I-[H/
MA#3-)U#[.;BS@6$M Y96"C /*@_ABKU]K6EZ9(L=]J-K;.PW!990IQG&>>@S
MQFKX.1D=* &R%Q$QB56D .U6;:"?<X./R-8&@:%)#8ROK=G82ZE/<23321'S
M5;<W !90<!=J@>BBMR*XAG>58I4=H7\N0*V=C8!P?0X(/XBI: //-%\(^(=(
MT/Q/HJ)IGV#4'N'T^-;F3_1A*""A_=_=&<\>_P!:N:AX1U34/A+%X6:2TBU&
M&TMX5<.S1,T)0@D[00#L].,]Z[>JU]J%KIT(ENYA&K':HP2S'!.%4<DX!. .
M@- ',ZEHFO:EXA\+:K(FG*=,DFDN8UG?GS(RFU/DYP#G)QGT%4=-\.>+/#NJ
MZG::/<Z8^BZA=O=I+<E_.LVD.7"J!AQGD9(]Z[/3=3LM8L(K[3KJ*ZM91E)8
MFRIP<']>*9>:QIUA>6MG=WL,5S=OLMX6;YY#[#J: ,&3P[J#_$%-986SZ;_9
M)TY@\S><Q,@<MC;CMCK[UF^&- \9:!!#X?>]TR70[9ML%[\_VKR <B,KC;NQ
M\N[/ [$UWM% !6!JG@GPQK5^]]J>AV5W=. &EEB#,0!@<_2M\D $DX [UD+X
MIT!V(76K @9&[[0NTD=0#G!(P: ,OX>^#X_!GA6WT]XK47Q!-U-;@XE;)P<D
M G ('2NCOTNI-.NDL72.[:%Q [_=5\':3[9Q4ZLKJ&4@J1D$=Q2T </8>$;J
MV\5?\)#!I]AIMRUG)#=P6MPWEWDK%2K-\@P%PQS@L=WMSG0^!]?A\ ^'- SI
MK7.E7\-S))]H<(ZQR%\#]WG)SCIQ[UWD>L:=+J\FDQWL+ZA'%YTENKY=$R!D
MCMR1UJ[0!YSK7@[Q)J,GBR%)=,DAUF );W,\CF6W&S'D[0N-F[)R#W)()XK2
M;P[KLNO^$M1E&G;=(@FCN569P6,B*OR?)SC;U)&?05VE% ',>'=#U+3?%'B3
M4;L6GV?5)XI81%*S.NR,)A@5 YQG@FNGHHH X.U\+Z]9Z9XAT6(V/V75[RYG
M6],K;X4G)W Q[>64$X^;![XIMSX2USP_K=IJ7@Z2Q>$6$6GW-EJ#LJND61&Z
MLH)W $CI7?44 5--BO(K%!J$\<UVV6E:)2$!)^ZH/.!T&>3C/>K=%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %<=\3-0U/3?"@FTRXC@9[NWAE9E))1Y54@8(QUY/IGZCL:Y[QK
MH%SXD\,RZ?931170FAGB:;.PM'(KX;'.#MQQ0!EZKXB\2VOBBT\/65EI<US<
MV$MRD\LCHF]&4?,H!(7YNQ)/M4=WXPUAK?4ET^SAEO=+"QSPK:SSK<7 C5WC
MC=!A -P +9)/4 <FXVA:W-XXTO7ISIYCMK*2UF1)'!)=E8E05[;0.3SUXZ54
ME\.>*=(\4ZCJ'AJ]TLZ?JKK-<VVH+)F&4*%+Q[/O9 &02.G6@">\\4ZL;:"Y
M2RATNW?3A=&34U/,YSBVVAE(88.3SU&!6+>^*=8UF/P%?:<\%G!K$V^:%U9_
MF$3M@D$94$?4D#Z5K7'A?7E\4?VA!J%G<V\NFBR=[Q6,D#Y)9XU7@[L\C*]!
MV %9]GX'U^S\.^$K=;K37O\ 0+C> =XBDCV,A&<9W?-GH!V]Z -#4_%VHYU=
M-&MDN)M*;RFC-G/+]JE"*[(K)PG#  G=SV &39M?%-WK.I6NF:?:BRO&T]+^
M[%]$S&V#G"QE 5);(;/(P%[YJBWAOQ7H_B:_O_#M_I3V6J,LUW;WZ2#RI@H4
MR1[.N0!E21TZU+<>%]<T[Q;!XAT:[M;J66R6SU"&_9HQ-M.1*K*K8;)/&,8H
M B^%IG.F>(3<JB3_ /"07OF+&<J&WC(!/;-7/$_B75-&;4Y(HK.VM;*T$\,M
MX2?MLF&)B0!@5("CG!^]TXYG\%Z!J>@0ZNNHSVDIO=3GOD^SJPVB1LX.[^7;
MU-9VK>%-=N_$&OW-M=V#6>K6"VBM<AVEM,(RE4 X*L3N/(YYP<4 /N/'<>_0
M(VFM-,&L6 O(I[X%HRY"$0@@J-WS9R3VZ'-=7ILMW-IEK+?1)%=O$K31QG*J
MY'(![C-<C;^%]8_X1S3]$U2TT75;&'3X[6:WE=T42(,!U;8QZ=\ ],8QST'A
M71I/#OA?3M(EN6N7M8A&93GGV&>PZ#V H YS6_&NIZ(SW%U;6<,(U)+1+*1B
M;B:!G">>K!L $G(!7H.N37:WDDT5G-);QI),J$HDCE5)]R <?E7G-[X$\37&
MD:MIRWVEN+G5%U"*YE$GFR@2JX23 XVA< C=P ,"O0Y5NCIS(/)DNC'CDE$+
M8_$@?G0!PNF^,/$^I>"I/$\FDZ3_ &>=+ENA"9W$AD7)P1M(VE0??IG&>-1?
M%LQM?"%M#;PQWFOPAPS*?*@"P^:W ()[ #(^O',6E>%M5L/A6WA61[-KP64E
MFDJR-Y9# @,?ER,;NF.W6L;6;*_BM?"'AB&?2/[6LH?.,=U)(J.(D$89)%PZ
MMELX SUSP#D -<\0ZEK/@SQ]87UI:QC2K>>V,T,C?O6\O<K!"/E&UAQN)!K2
MTGQ#K%AJGAC2;VTLQ9:M9LMLT;L98GBB#_/G@@C/ Z'N>M4UT[7=0T'7_"<M
MCHEO<WEJ[&YL[J61 TF5)EW)NWGJ,YR >1BM6;PUJ\NK^$+W_00NB)(LZ^<Y
M,A>+R_E^3MUY^GO0 SP!?ZSJ,_B.34[JWF6'6+BW CC92-@11MRQ 7 Z=<\Y
MI/$]_K4/Q \*:?8W5O':W0NI&22-CN:.+^(AAD8?@>O)SQB_X7T#4M!U/7/.
MGM)-/OM0EOH=@;S0TFW*MG@ 8/3.<]L<GB/0-2U#Q'X?UG3)K5)-,:=72Y#8
M9)4"DC;W& <<9]10!"/$>JZLFMSZ##:/'I-P]KY=P&+74L:@NJD$;!D[02&R
M0> *V/#>O6WB?PY8ZU:*RPW<0<(W53T*GZ$$?A6%I_AO6?#VI:Y_8[V,UCJM
MPUX%N9'1[:=QAR %(=20#C*XZ>];OAK0K?PSX<L-%M69XK2(1AV&"YZEC]22
M?QH YG5O&NIZ//'+=VUG#$^J)9+8NV;AX&?8)PP;&">0I7IWS78:I>MIND7M
M\L#W#6T#S"%/O2%5)VCW.,5Y[<^!/$TNCWFG"]TJ0MJZZC%<RB3S9P)0X60X
M^4@# QNX '%>@WL5]+HUQ%:SQ1Z@UNRQ2E2$64J0&QR<;L''- '-:5XR%WI$
MVN->Z=>Z/#8O=32V8(>%U )C92QYQN]#QT'>*W\6:VVJ:2ITIKBSU$$2>39S
MH;)BN5WR,-KJ>A8!<=<&H?\ A %O]:OM0O+6RTX7^FRV-Y'I\K,+EI,?O&RJ
M@%<''!)W<GCFSX:TGQIIT5MIVKZEI<^GV0"Q3VZR+<7"K]Q9,_*O;)&2<8[D
MT 1>'/$OBGQ#)--'IFE16EK?7-G.&N)-Y,>0I0A3QN R2,\]!CEFD>.7G\#:
M)JDEE%#>:K<O;0V\*,Z(P>3)PH+$!8R>!R?3.1I^$-#U3P_I^J0W8LY)+F_G
MO8O*E;'[QMVUB4&,=,@'Z5@6_P /]8B^'^DZ1'J%K;:UH]V;RSNH]SQ,^YSA
MP0#M(D*GKZ^U %N7QQJFF6NO2:CI,KQ:=''+!?):30Q3(Q ;*N"04SD@$Y /
M2NA\/ZK/JPFG%WI]]IY2-K:\LLA9"=VY2"S8(PO?O^%4H+7QC-I<TM]=:2FI
MYC$,%MYGV?:'!?<S#<2R@KTX]\DTSPSX3&B>(-5U6.WM;"*_CB4V-FY:+>N[
M,G*J 3N P!VSWX +FHZ[,/$]KX<T_P D7TMJ]Y++,I9(8E8(/E!!8LQQC(Q@
MGV.%/XGU'4= \6Z<R06FM:+&ZSE=S1NC1%TD3D$;E[$G!'>M36?#E\WB_3_%
M&D26YO(+=K.XM[EV1)X&.X88!BK*W/0YZ<5 ?"M[]B\476;4ZOKZ;'&]A%"J
MQ>6B[MN6P,DG R2>E $G@"S9O!7AVXO(K226+3H!;2)%AXT:)<C))Y.!G& :
M@E\7W$_B34M%LI;"*^LI8U2QN@PEN8V56:1&W 8&Y@  >4Y(SQM^%]/N](\,
M:;IE[Y)FLK:.W+0N65]BA=W(!&<=*YWQ1X.O_%*7-M=Q:=Q<+)8:DLC+<V:@
MJ3@!.3D-CY@.1GI0!-JWBZ_\W6(]$MEGDTIO+,;VDTOVF4('**T8PG#*,G/)
MZ #)KGQCX@O=?L=)L-%MK>6]TDWZB_E=&@;<JE9%"Y&,D8&23CH,T^;PYXIT
MCQ5J.H^&KW2S8:JZRW-MJ"R?N90H4O'LZY &02.G6J=S'J%K\7=)CMFBO+A/
M#\HE:YD,?F?ODR<JK8.<'&,=J +.D^--:U'2+V)](A36]/U%;"\19,P1*2"9
M\G!*!3G&<\=NM+;>-[R:S\6>5'87L^A(LL<T+LD-PC1&0?WB",$=2#ZBH-0\
M"ZK-ITT]M=6?]J76L1ZG=0REOL\R(-JP$@9*@!3DCDC.!T$G_")>(3=^+IWN
M-,?^WK2.)57S%\IQ$8^3@\ '.>IQT6@":Q\1>+;K0K;53I&GM#>P6KP"*9MT
M/F8\QY <#8H.[ .>V>XJR^,]2NM*\9PV<]@]WH=LL\%["A,4JM$SC"[CR-I'
MWB.A]JM:AX4UJY\!:)HT,]DE[IKVIDC=G-O=K" "C_+G:V <8/0=:CC\'ZU/
MJ7BN:\O-/6'7[%+<B%'+1.L31\9Z@;LY[XZ"@!=,\1WNG^&_#%I</'-J&I6J
MO'*L$D@2-(D+,RJ2SME@.",[NHQ6QX6US4M6;4;?5--DMI;.?9'<>1)%%=(1
MD.@<9'H1DX]>:Y^?P=XE.B>'9[6_TZ#Q!H*^5 =KM;S1%%1D?^+YMH.0..GO
M77:)#K*P/-KD]JUW)@>59AO)B4=@6Y).3DG'88XY ,'4O$GB#_A-9_#6E:?I
MQ<:<M[%<7,[[1F0I\P"Y['@9Z@Y'2H-(\:ZMJ_AZ25=)CBU:TU,Z;?H9,PVQ
M4C?-DD%D"D'&<\XSWJ&Z>^3XW.;&&WF;_A'$WI/*T8Q]H?D$*W?MBDN_ NJ#
M2$-G=6;:A+K7]KWL,^X6]P3_ ,LC@$[5 3!(.2F2/0 FM/&&KZC8^)H]-AL+
M[4-&D7RFBW"*\1HPX"C)*MU'4C(]ZT;'Q//JVF>&[G36M99-57S904;$<:IE
MR.<C:VU.<\L*KZ/I=]X=\0^(-=UK4=+CL=2:"0L"T?ENJ"/!+' '8'J?;I47
M@70K:RU#7-2LK@S:?/=R+IZY&R)"0TNS'\)EW?@@H SI?''B5M \2:K!INEJ
MNA7T\,L;S.?-CB52=I 'S8).3QT&.]:D?BO5H_$F@6]W96::;KBR?9_+D8S0
MLL?F#>?NG(&,#H>YJHG@_6AX8\7Z4S6'FZ[=7,\3B9]L0F4+AODY(QGCK[5;
MN?#6L3W_ (0N1]A T3=YZ^<_[PF(Q_+\GH<\_3WH J7GCK4VT^35M'TR2_M(
MKIH19QV<[S3QK(8V=) -@.02%P>!U!X%AO$WB.\\2:_HVFV&FH^G0030RW$K
MD,) QPP !R=H&.W/)Z5!I?A?Q9H%U=Z9I>IZ;_PCUQ<231-.CFYM!(Q9E0#Y
M6Y)P2>"<D'I6E9:#JMEXPU_6 +-X-1MX(H4,[AE,08 M\G?=VSC'>@#G;WQ9
MJ^MZ9X$U'3G@LXM7NU$\+JS_ #!';&01\N5Z=3Q]#M7'BZZ;Q#J.AVLVGQZE
M9",QV=RK*]X&0,7C.X# R1C#<KR1FLRT\"ZW9>$_"EA%<:>;_0+P399G\J9,
M.#SMR#A_0]*N>*/!^I>*;:[L[Z+2Y 9$>QU ,Z3V9"KN*J%/\09@-XZ@'I0!
MV\PE,+B H)=IV%P2H/;(':O*_#6KG1_ FM:WK<5K>V]MJUU*D7E_.US]H*I@
ML2!\Q !QD?A7JA#I#A,.X7C><9/N<?TK@;;P!>7?@/5_#.K36T?VVZENHKBU
M=F\MVD\Q>"H^ZV._(]* -6\\1ZIH6N:/9ZQ%:26VK2&WCFM@R>1/C*HV2=P;
M! 88Y'2JWA[Q)XFU_4KM1IVF0V5AJLUC=,9W+E4 P4XP3D\YQG/08S5EM!UC
M6KG1)?$'V%1I,WVK_196?[1.$*JQ#*NP#<6Q\W..>.9O"&AZCH;ZW]N-JRZA
MJ<U_'Y$C,4$F/E.5'3;U]^E ">,/$>H>'GT865A!=#4-0CLB))BA4L&(QQC^
M$\YX]#61%XPU^TU?6-#UBRT^+4;;3FU.SEMV=X9HE."IS@A@>,_CCUD^)AG
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH:TE4NDAX!7)&?H<9H O44Q98WB\U)$:/&=X.1CZT++&SE%=2P )4'D ]#0
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MQ*8]7GTQ6>.T<>6D:G'F[5X#;2V&[A3CH:37[2SM!X&U3PU%'%/+J%O;HT
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M\'/#4V^*"V?4T75)$125@\^4 R#NH8*#GMD5TU[H.BSOKL]IXG"3ZI8)%.\
MC,"?.%CD=4&,G.WD\KN]* /1+>\MKM2UM<PS =3&X;'Y5*[K&C.[!549+$X
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M[&O*/&]U97'A3QQ<Z>T47DZDB3RW3[YGN$,0Q$,CRU7'!YS\V !S75,FG/\
M&T3.MJ5;0 ZN0O,@N< @_P![H/6@#L---^9[\7MS:3*+D_9UMU(,<>T85\DY
M;J>W45:@N[:Y:18+B*5HSAQ&X8J?0XZ5XW>23Z3X'^(YTJ,Q+'KS"06XVE(2
M(?,*XZ?*6^G-=3XBM+>+Q1X(O-!CA5YIV@;[.H"RV1B+-D#@J,*1Z$C'6@#N
MFO;5&"O<PJ2_E@&0#+_W?K[5/7AMSHFE_P#"M/B#<BQM_.M=7O?L\FP9@VNI
M&P_P<^F*]LLW,EE;NQRS1J2?4XH 475N1(1/%B/[_P X^7Z^E+]HAVHWFQ[9
M#A#N&&/H/6N"TXVEM\2?'8N3#%')8V,C"3 #*$E!)SU'05R&EV=E>^"_A898
MHI";X0LW<H4ERA/7!(&10![9!<07*%X)HY5#%2T;!@".HX[UR^O>)KBR\3^'
MK"PN+*6WO;QK:[3&Z1"(V88(; ^[W%</K+S>'6^**>'X1:F&TLI8XK90@C+(
MPD=0. =H)R/3-:VM1Z&NL?#>[TQ;58#=,MO)'@9B,#<9[C./QH ](DN[:&>.
M"6XB2:3[D;. S?0=Z);NVMR1-<11X )WN!@$X!Y]^*\HMX])\36/BG3?$&MI
M8W<6IS?:%<1K-&BOF%T9ANP$"@$>E7H/#NCZK\4]2M=1L8[N)]#M9'6YC&9'
M\QQO9?[^ .>HH ]/KB=)\2Z[XDT6[UK1#I;112S1Q:?*CF5O+8KAY ^$9L9
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M[O? /05QU[!(?@!JJW8$T%K>/%I\LOS-]G%TJH03SC ('MCM0!ZII/\ ;?\
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MJM#4K!KXV*WML;P#)MQ*OF >NW.:6;4K&VNH[6>]MXKB7_5Q/*JN_P! 3DT
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MLGA[18[&ZLH])L4M;MBUQ"MNH24GJ6&,$_6DL_#NBZ?+!+9Z396\D$?E0O'
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MC>K#&"?<UHP00VL"06\210H-J(BA54>@ Z5SP\0Q>(?"3ZEH.K6=HSX*7%R
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MK;P6^H:/8W4-O_J4F@5A'_N@C@5B>$O%$U[%JRZY>V4<UOK-QI\!&(A($V@
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MI,R@LA5E(VGMSSQ70S:K OQ":UUO5C81W6C0&QDE$7ERC+^<N9%(W$E,@8R
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M)&.:9_;ND?:+:W_M6Q\^Z4-;Q_:$W2@]"HSEA]*IZYJUH=(U&*V\26.EW-N
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MNHUU&T+V@!N5$ZYASTWC/R]#U]*7^UM-.G+J(O[4V3XVW F4QMDX&&S@\\4
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M=+I>GSWT=]-8VTEW$,1SO"ID3Z,1D5#=^(-&T^2>.\U:RMW@023++<*IC4G
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M-KI>G6/G?9+"UM_/.9?*A5/,/^U@<_C7.>,_"DNK>%)])T.TT^WDGFAD<O\
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M=>1(8IO)D#^6XZJV.A]JCO-<TG3I)([W4[.V>*(S2+-.JE4R!N()X&2!GW%
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MY5NKF)0WDNT96-VR" ,EAG'&:YCQE;^'6^'OC34M)OVU$WGV=[B[,B/"\H<
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MW"1QKA0JBW8  >G05Q?BO6=-N?"WBA+2>WL/)UU3+9E]T\LJSQ!YGW$E%..
MH &!SSBO:I;2VGD$DUO%(Z\!G0$C\32-8VCM*S6L#&8 2DQ@[\=-WK^- '"6
M7]FWGQHOYD%M,#H4$B. ISF5\L/JI'/H:B^&^OZ1HWPWT<7^H6]LDU[<6T&]
MN"QGDVJ/3BN_-C9M(TC6L!=LY8QC)SP>:IZAH%CJ%JMH]O EOY@>15A7+8[
M]L]">N"0,=: -2O&-#NM"UCPJ- \2:Q=QZS:WK^=I8:-)WN1*65H_EWMN)!R
M#W.3BO9Z@^Q6INQ=FVA^TA=HF\L;\>F[KB@#QCQMJVG7/AKQY;VLL%A+'>A9
MK5FW7%U*OE?O<,3MCP!C:/X<Y'(KIO\ A)M,TSXGW4^LWUO#I^H:5"-,O)I
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M?2@YO9+.18E3[S<<@>Y&0/K7(ZO=6?B3P]X(_L&6-KZ/4+66%(B-]NB*1,&
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M^RX8?3/!]ZR;/6(=*TKX=ZGJ-[/!HO\ 9#6DEW"V5MYRL6W><'&0C+[<].:
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M372(FX#:OV<J /;.!7/6NM6=KX9^(>D:W<PP:R]Q?2&&X8*\\;QXB9 ?O+M
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M6L>)?#NJZW\/KK3;^S>%+QL!'7,*M P"L/X><#!QR/:@#U-F5%+,0J@9))P
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MKIKW5]-TV6&*^O[:VDG.(DEE"E_7 /6N+\':AI]U\3?&YL[F"43?870Q.")
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M:PN@X$,J(&#INP1G<Q./]KW&0#O)O$>B6[P)-J]BC7$1FB#7"_/&%+%QS]W
M)STK/U#QQH%EX4N_$46H075C;AAN@?=OD'\ Q_%T_GTKBC::'IWB?X;6-BIC
ML8FOVMDNVR^TIE&^;G!."N>>E4-4DAG\/?%J&U=)#Y_F;(R#_P L4W-@>X.3
M[&@#UW3[^WU.QBN[:6.6-QG<C;AGN,U:JAHE_::EH]K<V5Q'<0-&H66,[E;
M&<'H?3ZY%7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *YOQIH-[XBTFWLK*2WC:.[AN6>9FQ^[<.
M   >N,9[>]=)4-U=6]C;27-U-'#!&,O)(P51^- "V\*01!4ABA)^9EC'&[OV
M&?KBG+#$H 6) %)884<$]ZH6WB#2KLW(CO8U>U4-.DN8VB4]&96P0#ZGBJ^G
M>+?#^KWD5II^K6MS<31--''&^2R*=I(_'_'I0!L+&B$E452>X&*9';01',<$
M:');*H!R>IKEOB'J-_I.BV-W87TEJ?[2MHI=JJ0\;R*K D@D<'MBM?2/%&A:
M]<7%OI6JVMY-;_ZU(GR5'K[CW'% &O4:00Q2/)'%&COR[*H!;ZGO6<GB71I-
M0CL%U"+[1+N$2G($I7[P1CPQ'< G%4Y?'7A:&,R/KUB$$YMRXE! <8R"1V&X
M<].>M &^L4:'*HJGU Q3JI:AJ]AI:*UY<!"REE55+L5'4[5!.!D9.,#-<YXP
M\:6VD^#EU73+R&5KMHTM9D^=2'D5"XZ@[0Q.#W% '6100VZE88HXP3DA% R?
M7BCR(O/\_P I/-QM\S:-V/3-<=8D0^+;,_\ ";S3V]UODM=)E1-\F$(<EL;B
MH(W#@8(/)S6KH/B_3O$.IZI96C-NL;@P992/,(52Q&1TRV/?&>E &[Y,7/[I
M.>ORCFD:"%XC$T2-&W5"H(/X5G>)=:C\/>';_5),$VT$DB(<X=E4L%X]<5SW
MAZ_D>SL/$5UXED>TGM$2ZM)HAM:Y8*08R "#R1M&<\=Z .S\J/8J>6FQ> NT
M8%'DQ$ &),#I\HK.C\2:-+8W5Z-2MTM[0E;EI6\OR3Z.&P5/L<4FE^)M%UJY
M>VTW4K>ZF2%)V2-LD1N,JWXY% &IL7?OVC=C&['./2AE#*58 @C!![U1U'6]
M+TF2"/4-0MK5[AMD2RR!2Y]A_G%4[#QAX>U2SN[NQU:VN(+/_CX>-L^4/5AU
M X//3@T :\D$4T7E2Q(\?]QE!'Y4]5"J%4  #  [5G'7])"Z>QOX=NH[?L;9
MXGW#(VGH21S5.;QMX8M[G[/+KMBLOGBV*^:.)#_#GU_EWH VY88YXS'-&DB'
MJKJ"#^!IRJJ*%4 *!@ #@5SQ\>^$Q+:Q_P#"06&ZZ8I#B8$.0Q7KTQD$9Z''
M%:=_K.GZ8RI=W 20J7$:J7;:.K;5!.T=ST% %N*"*!2L,21J3DA% !/KQ7/^
M-=!O?$>CPV-E);QLEU#<,\S-C]VX<   ]<8]O>M4ZUIHT^"^6\BEMK@@0/"?
M,\TD$@(%R6. 3QGH?2DCUS3)=/:_2\C-LKF(N<C#@[=N.N[/&.N>.M %J"WC
MB@V+!%%NY=(P-N3U[#/UQ4BHB#"*J_08K-MO$>CW=G<W4-_$8K5_+GW95HF_
MNLIP03D8!&3GBK%CJMEJ3S):S;Y("!*C(R-&2,@,K $<<T 6([>&%G:**-&<
MY<JH!8^I]:>5!() )'0^E17=W;V-L]S=S1PPI]YY&P!V'Z\54L]=TV_-RMO=
M*TEJ,SQ,I62,$9!9" P!'3CF@"^T:,P9D4D=R*8]O!+)ODAC=]I7<R@G!ZCZ
M5P>C:Q>>,K_47L==EL)K#57BAA2$/');Q[0P=2.2V6YR",C'3G;\>^()_#/A
M9]1@.S]_%%)<&/>+>-W"M)M[[03@>N* .CDABFB,4L221GJC*"/RI6CC>(QN
MBM&1@J1D$>F*YK3QJ4E[I=[I_B%M6T6XW^<72)C]QBK*\:J-NX8(QUQSU%:5
MWXDT>PNUMKJ_BBD,BQ9;.U7/1&;&U6.1@$@\B@#2CABB&(XT3@#Y5 X'04YE
M5U*NH93U!&0:SM2U_2M(+"^O$A*)YC\%O+3IN? .U>#R<#@UG77C/2[;Q/8Z
M&)=\MU;M<>:H)0+\H7! P=V[MV'N* -^:"&X39-$DB9SM=01G\:DZ5B:/>VM
MQJFLO!KPOUCE0/ "I2S(7E00.^"3D\5/:>(](OKR.TM[Z-YY4,D*G*^<HZM&
M2,./=<B@#3**Q4LH)4Y!(Z4SR(L$>4G/^R*P[CQSX6MHY9)==L0D4WD.PE!"
MN,9!QZ;AD]!GFM]6#*&4@J1D$'@B@!DEO!+%Y4D,;Q]=C*"/RJ3&!@5S?C77
M;K1] O/[,"MJ?V6:>+<,K$D:DM(WL. !W8@=,D9,_BB_70/!MI%,/[5U]85:
MX* [%\H22R!<8W8Z#&,MTP,4 =N88BVXQH6]=HS3F170HZAE(P01D&N"U#QG
M<>%K[Q'I]^[7S:?I@U2SD<*KR(24*/M '#@<@=&]LE][K>J^'D\,ZE=:DU]:
MZK<PV=W$T2*L;3+E7C*@$ -QABV0?7F@#N/)B_YYIT"_='0=J41HJE0BA3U
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M 'V50"WU/>AX(I)$D>)&=/N,R@E?H>U.=2\;*KLA(P&7&1[C.17!>#/%4O\
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M$T$7G2QM(-R)D $CKR2 !U- #_#FE-H^A6-G/';_ &FWMHX))81_K-BA0<D
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MEI_PD'CBUU#PS+%)+;:/>17%Y;N"A:10((]XX)#;FQV'/<5Z12*JHNU5"CT
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M<[6MY9#>6S+@@DA85&1]&S]#7>A%'10.<].]#[A&WEA2^/E#' S[T >*6/\
M95]\%M<TD"WFU&>\NTBM5P97G,[>5A>I/W>>P![ UTNAW,GAOXB:K#XBNDB%
M[IMD+*ZG<*C^2A65 QXSO8MCK@YKI?!GAVY\-:*;"[FM[AQ/+,LL2E>)'+D8
M/H6]:Z)D5QAE##.>1F@#Q_3])CBT!!+K$NA//X@N[O0;O V1(0P565N-CKO(
M!QG</7EMYK6IC1M*UG6K<?8]+UR:/4+K2]P29/*9!=+CG:&?G'<&O8F4,"&
M(/4&@ !=H QTQ0!YA=1>"]4TC6=4LK^]2"]DM$N-92=R%F61?*(+\?(=I)[
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MA25,['4,N00<'V/(KR[1;ZULO#OC/0O$,B1ZBUY>2/#*?GNHY1^[:,=7!&%
M&>0!7JE(44L&*@L.AQR* /)--@.F^)?AII^LRQ?;[;2KF.596!9'*1A5.>^
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M Q4ON*X)QA<D$ G&<<9KB-+U:SE^(7AB_6_DN;>729XA*ML8X4;,9V( O"J
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MA".<$[0"2!U/'0&O.[?1])TGXA:/=^ ;Y/+O)F&K6%G-YELL.TGS& R(R#@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/SI$@@DF:-.<,P13M'!Z]<'T-5[KQ?X?L[?3[B?5;=8-0(%K("663(SU' &
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M@ HHHH **** "BBB@ HHHH **** "N&^+#I'X/@>52T:ZG9E@%W9'G+GCO\
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MVPO/'/!#8O'!9,UNRB%%"]CQDDGC)(%>RH&"*'(+X^8@8!/T[4M 'CS21/X
M^)<0YEN=2O&@3;\TH9$"%1_$"0<$>E;'VI;;QSX0U!TF>VET66V22.)G!E)C
M.PX!P>#UQT->DT4 5[\HNG7+21&6,1.6C'\0P<C\:\Z\("ZTOQ#I>GZ3JCZQ
MX=FMI&6*Z3-QI0 &U"_4 G"[6P>/8UZ;10!3U:[DL-&OKR&/S9;>WDE2/^\5
M4D#CUQ7EGC2PT+5X8]?\+F:Q\:[T:WBMT:*XD<L,K-%CIC.688XY)'%>OT4
M>8:K?P>'?B#J4OB6/44T[5+:W^RW=FT_EJZ*5>)A$<Y).1D=SZU%=+I6A^*O
MAVL5E_9>G1KJ1BBFS^Y5E4@MNY7.<G/3.#7JE<]JOARYU'Q9HNMI?Q1+I8F"
MP&W+&3S5"MEMXQ]T8X_.@#AM31[,^/?$MGI4>H:=>FSCBB>$R1SLF!)-L'WU
M7=G(ZE#SWJSIM_;K\3;F^-Q?7-K<>'U"WEQ;NBNPE8G'RA5&".P'U)Y]1HH
M\FT>[.F_L_6972TO9;>%$FM)K<R",^:-S/'U.W._'?&?>K6DSI/\3KV6&34+
MR.]T!$BNI[=U$K"1R<?*%48([ ?4GGT^B@#Q66X63]G:'3A#<"\@6V@>%X'5
MO,6=2R@$9) 4DXZ"NL:[&C?%2YU/49 NDZIID4=I>L?W4;QLQ,9;HN[=N&>#
M]:[ZB@#Q?5=/EM?">M7#1NMOJ?BB.\M("AR8A+'NDV]0#M9NG3![UURSPO\
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MMH;0V<44*JEL6W&)0.%S[=*O44 <!(9+?XL:M&5GB?4-'ACM)EA9E+J\F?F
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M3P.S &M"BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@8 3(X^6NH\"3&7Q-XQE^S7<45QJ"30O-;/&KKY2#(+ <Y'3K0!TVL^(M+T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB#.HE(PS=2>>H/?B@#MZ*P=3\8:3I"S2W33BUMY1#<720LT4#D@89A[D D9
MSSBMT$,H92"#R".] "T5P/CJ2ZC\6>$+:WO[VVAO[R2&Y2WN702($W <'CD=
M14&B>(;G2O'WB71KS4WN]"TVR2\-S<D,UHW!:-G R>,MSD\4 >BT5AV/BO3;
M^_2R47,5Q):_;(4F@93+#D#<OKU'R_>Y'%9B_$G09HFDLTU&[QYP_=6,F-T0
M)922 %;@\-CWQD4 =?17!OXKTW6? .FZIK+:EIT=XUNVZU25#YC,I50ZC[I.
M!DX!KI]2\066FS/ RSSW$</VB2&WC+LD?/S-Z#@X'4X. <&@#5HKD[OQ!X?U
M.X\,W*ZC>$7L_F:>;;S%CG.QOED(&, 9^5L'(Z=:+[XC>'K"2_C=[V633W"W
M20V4K-$,9W,-O"@8.[ISQF@#K**Q&\5Z28].:UF:\?4HVFM([9=S2HH!9N<
M 9'7')QUJM)X\\/Q:+8ZL]U(+.]N!;1/Y#\2;MA5^/D((.=V.AH Z2BN>M?&
M6F7DFI0PQ7WVK3XA-);26CQRNASM9%8 D'!&?SQ3O!OB,^*?#=KJK6TL!G7?
MM9"!@DXP3][C'(H WZ*SM?N;.T\/ZA-?S7$-HMN_G2VZN9(TVG++L!(('.1T
MZU2L=:T^VTG1X;5KN[^U6:RVJ$%YI(E5<NQ/LRY)/5O4T ;U%5=.OX-4L(KV
MVW^3*"5\Q"C<''*GD'CH:M4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5S/CBSL-0TFTM=1AOS#)=
MKMN; /YMFX5BLP*@D8(QG&!NYKIJ* /)-2M?$=Q\/=7@NS<:LMCJEO+:70MM
MD]W;H\3,Q0#+%<,,X^;;WJ_=/-XA^(4L]E9ZC#:7GAJ:SANY;22-1(TN1G(!
M7H?O 9QQVSZ910!YYX*UR>31='\.WOAR_AU;3$C@F\^U(@B$8V^:LI^4Y4'&
MWDD^F3608;I_!/Q(MQI]_P"=?7]V]K&;.7=,KQHJE1MY!(->M44 9^A,6\/Z
M<2DB,+:,%9$*,"% ((/(-5-=U4Z?=V4,VGSW=A="1+DPV[3>4,#!95!)4\@\
M'KZ UMT4 >6:/X7@@\;ZC)X12XL=$O--D2\4QO';_:6.$,:L!R!DG;P.G&<4
MSPBUK-I^E>']5\'WHUO36BC=I[9C;H8\#SUE/R]!D8Y)X'K7JU!S@XZT >6:
M'?VZ6'Q"L'MKBXFGUB\6.&.!G\XM$BA 0,9SUR> <G YI^FVVH>'[K0/#VH6
M5\;:'1$C^U:? S--<!N86F49C08!'*@]2<<5V?ASPZWA^;57^V_:!J-Z][(#
M%MV2, "!S]W"C@\^];M 'BVD17D7@KX>VLVE:FDVGZNKW*-92DQJ!*"QPO3+
M+S_A7::_?7,?CJRM)K"^&FRV#%;NPMF:268O_J6D49C7 #=5!/4@"NUHH \7
MTRVO[;X<>"A-I.I(VDZZDEW']D<R(@:;+! "S ;UY /7O763+/=?%J*Y6VO8
M89/#SV_V@V[[8Y6F5@I;&T, ">O:N\HH \BM;2]D^#UQX'N=-N1KL<;6*Q&!
M_+<[_EE$F-NS!#%L\8(ZUOZ=!+8_%.5Y(;Q[>+P_#:FZ-M(4>1)&8C=C!."#
MU[UWU% '&?"V*:W\$Q6]S;7%M,EU<L8[B%HF :9V4X8#@@@UN>*B1X2U=5CE
ME=[.5$2*-G9F*$  *"3S6O10!Y5>K.W@+X?0"PU!IK*^TYKF(64I>%8EPY8;
M<@#_ /56YK*76E?$W3/$4D$\VDS::^GRO%$S_9G,@D5V4 D*V N<<8&<5W-%
M 'D/B31KV?0?B+JEM97;QZV;>*RMDMW,DAC0*S[ ,@,<\D#A<]"*Z+5F>X^(
M7@FZBM;QK>""[$THM9-L1>- H8[?ER0>OI7>44 <5X)65/$GC!Y+:ZA2XU(2
MPO-;O&LB>4BY4L #R#TKJM4GGM=)O;BV3S)XH'>-,9W,%) QWYJW10!Y/XWT
M[3/%.F1:CI>E:A9>,U,;6C):R0S1R9'$C8"E ,_,3C X/K=UIY?#_CV74M8T
MB]U'3-1L8(1<6,+RFWFC+Y4HO(5M^0?7\:]+HH \SOK6.VU;P.UCH%S86<-]
M/.\$-HY$"/&ZJTFT$*22"1VSST-;7CZPOD72O$>D6K7.IZ1=!A GWIX),)+'
M^1!]MM=E10!Y_P"/M+N8/A+>Z9#!/>7TOEEEMH6D:64S*\C *">3N-,U#4KG
MPU\1IM:N-.U"[T?5M/AA2>UMGE:"6-F(5D W $.3TZ_C7H=% 'F?B/[39ZGX
M>\1R>';J32(XKFWN;*VBS-;+(R,DGEKW^3Y@.F?6NL\*I8O;7-[IVC/IL%U)
MO_?0F*6<XY=E/(]!GGC/0BN@HH Y?XBZ-?>(/ &KZ9IO-Y-$#&N<;RK!MOXA
M2/QK'U9W\:3>$VL[2[MY[+4H[^[\^W>,VRHC;HV+ ?,6(7 SGD]!FO0** .)
M^'XDCOO%@EM;J#S]:FN(C/;O&)(RJ ,I8#(RIKMJ** .&^&T+Z;:^)=/N 1/
M;:W<LP(Y9'VR(V/=6%<S]FO'^#_B^R&G:A]JN;V\,,!LY \@DE+(57;D@CO7
MJ9TV$:K_ &C$6BN&01S;>DRC.T,/4$G!Z\GM5R@#@/B,K7WPEGLX(W-Q?+;6
MT$3H59I&D0 8/(/4_A7>0Q^5!''G=L4+D]\"JT^G0W5_;W=P3(;8EH(S]U'(
M(+X[M@D9[ G'4U<H XGQ()[3XD>&-2^Q7<]JMM=V[/;P-)L=_+*AL#Y0<'DX
M'J16&D=P=)^)J?8;[=>O,;539RYG#6X0;/E^;+#'%>I44 >1L9]%O/#6LZAH
MNHWFDR:%#I]PL%N[2VDR'=EHQAL')'3M],^A>%X+2+2WDL=(.EV]Q,TRPO'Y
M<C9 R[KV8D=#SC&<'(&U10!QOQ*LM1N?#MG<Z;;27<FGZE;WTMK$,O/'&^65
M1W/0X]JS#JG]K_$S0M4L=/U)[0:9<Q&66QEB579D(5BRC'3KT]Z]%HH \7%Q
M?W]GX3O;C1]82]M-:5[VUBL9(X+08D&U$  8<CYQNZ\L,@5L3Z7J%Y??$;18
M[2[BN-60/:3-"PA<&V"_ZS[OWAM(SGGI@''J%% 'G7A>]L-;GTU)?"%]:ZQ9
MX,[WEJRQVK 89D=N#GH-O)SDX ->BT44 ><Z"\_AQO%FDZO97<KW5_<7MH\=
MN\BW<<H&%!4$;@1M(.,<=N:SKO1;_0? /@32)[>ZN;NQU2SFN1;P/-Y2JS,^
M2H/"YQ^%>KT4 -1@Z*ZYPPR,C!_(UQGC%9[?QGX.U06=W<6MI/=),UM TI0R
M0E4R%!.">,]!WKM:* /.;/S5\2_$.=[*]6*ZAM_(8VDF)=MN48(=OS8;CC-8
M%I%>:+I?@K6+W1-1O-/MM);3KZWCMW\ZU<["'\OAB,I@^WX5[+10!@^%8[(V
M=Q=Z?HSZ9;W4QD"RQ&*68X&9'4\@D\<\X&>]2>+F/_"'ZPB12RR2V4T<<<,3
M2,S%"  %!/6MJB@#C/AWHNGV_@_0YWT>*VU."SCBF>6S\J97"@,"64-U_.N0
M\9OJ6K:1XVTV32=36[5_]#@L[1Q%<1 )^^:11B1C@C:2<!0 N037L5% ' VT
MTEQ\6;"_^PW\=L^@M!YLEI(JK(9E8*QQA3M!.#TZ'!XJ;1S-IWQ.\6&XLKP1
M7R6DL$ZV[-$RQPE7^<#&01C'4YX!KN** /&;&SUBT^'GA^^M]*OI9]&UR6]N
M;!K=DE>%I)>45@"QVR BNSO-8CU[PMKUW9:1>Q1R6$D2R36;)-<.48!53&X@
M9QG&,MQT-=G10!Y*T_\ 9]O\*#=07,;6ZF*:-H'$B,+3:V4QG@]>.@S5S5;;
M4/[2\8^*-(THWBR:;#:6]O- 2+QU)+ML/+A5( _O8(%=AK/AQ]7US1]3%[Y#
M:7(\L4?E;@[,I0[CGI@]L5O4 >8:5,P^)6GZJEIKD]G-HDD+7=U:2+F3S48@
MJ0!&, \!5![9SSCQ6UXOP4TNP.FZB+V/4T=K?[%+YBJ+LR$E=N<;><U[/10!
MQ%F9K3XLZG/)97AM]1TZU%O.ENQC)1GW!FQA2 0<$@^G.*Z'Q/';2^&=0BO+
M&6^M9(BDUM"I9Y$/!"A>2<'(QSQ6M10!P?@NWU33M?NK"/4;S5/#ZVBO;W-_
M$5F@DW8\G>0"XV\\\KP.._:7\,MSIUU!!)Y<TL+HC_W6((!_ U8HH \4GNKM
MO@_;^&9-%U5-9TZ6UAFMTLI&!$<Z'>K@;6! SP<_SK:NYDT7QOK3ZUH&I7^F
MZSY,]G<6MK)+@B)8VB=5Y4_+D9'<UZC10!YY-++IVO:+IW]A76G:2VGOL.FV
MQ>19#("+=I$!,2[<,2" 6_BP.>:TZUO[;X:^$TETG4D?2?$*S7<1M7:18Q-*
M2P4 LP =>0#U[X->T44 <+:RR/\ %RYU!K*^CM7T&*(2O:R!?,$KN4SC&X*1
MQGVK.\(:\G@_X;VTVJ:9JJA;^X21$LGW1*\TCB1E(!"!>2:]+JO=V<-]"(;@
M%HMP+)G ?'9O4>W0]^* +%<5XG65OB-X+F2VNI(;=[LS2QV[ND6^':NY@,#)
MXYKM:* .(T1I%^*OB:9[6[2"XM;2.&9[:18W9 ^X!B,'&X=Z[>BB@#S*W%S9
M0?$6PFT[4#-=SSW$#):NR2H\"JNU@,,2PQ@9/MUJ%H[@:)\,H_L-_P"98RVY
MNE^R2Y@"VY1M_P ORX8@<UZG10!Y+IZPZ9=ZOX<\0>%=0U&:>_GGM)8[=I8+
MN.60NNYONJ06P=W Q7JUO'Y-M%%L1-B!=J?=7 Z#VJ2B@#SSX@6_VSQ9X.5M
M/N;NVM[V22ZV6CRQHA3 +$*1C)KH=<M5T;P;JQT#1+26;[.[I9);@),Q'0H
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M$D  5<KC/B-9:E-8:-J.FVDMZ=*U6&^FM(1EY8UW!MH[L-V0/:@"C9ZE)/\
M&AHG2_M4&@M));74AV!O.0!U 8ITXR/0YYKH!XRTO[9I\,B7,4&I/Y=C=R1X
MAN&QD!3G(R.1N W=LURET+GQ)X^DN+33M3@L[OPY-8K=7%F\*QRO(",[@",
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M"-@X)[$]!G)QVYJ;Q?=ZA;ZYH4<=C>RZ7(TPN[BP@,DT9VC8N5&Y%8DY88/
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MW* %XB<;U()!&>#SD=Q7G=YH^K7]CXQ:RTRX><:Y!J5M;W,#QI>1Q^62H+
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ML8(PQ##D<J3^AQ>FUZS@\06FBRK*MU=Q/+ =GR.J8W<]B,CKZUYS?:)XCN_
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M#:13%GFED,K+M&XDDE@V,G@=< '&C;^*[*2_O-/GMKNUU"T@%PUI+&&D>(G
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR ,<_AFN5TCP[JNH? ^X\/BUEM-5'G%8KJ,H"WVAI5'/!## _'FO4J* //\
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MRM%=7D"HR1E3AS@L&8*>I4'H>N#C.U.*^O?B%X3U(:9=I;6T%VMPS(#Y)E5
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M+$HC$K E4;YMV3@\@$9[]:G\1Z]!/IVN6%M97M[]CMV%W):LJB%BFX+DLI+
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M>4:5;3O$K92 ;I#L3V &,]SD]\4 >BT5X^MY=/\ !Y_'9?'B L=06XSRJB;
MA_ZY^6-NWIWZ\UO:==VOBKQ]KNGZO$LMO!8VDNGV\W3RY$+22*/[VXJNX<C
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M:!PY625@H3(X)&>2..">E=M5>2R@FO(KJ52\D(/E!CPA.06 _O8.,^F0.IR
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M/O<^'9O"46H*+F5[+5B8C$8W<L#+GY@5W'@ DXP/6O3RZAPA8;B"0N>2!_\
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MBSN;B*6XCMSY !V%V"@D$Y(R>P)K<KA_BLSIX1MVCC,CKJEF50$#<?.7 R:
M+MAXX2;Q'-H>IZ1>Z5=_9VNK?SRCBXB7J1L)^8?W>M%CXV6[OM%@FTR>WCUN
M*22Q=W!8[%WXD7^ E>1C/X56U'2M4UOQ3::W;VC6+:787,=J;HKF6XE  R%)
M^1=O)/4GCUKG;'1?$;ZKX.U2X\.2K>V#RKJ=Q<7<322N\)3?D,?W>XY Z@<!
M>E '8:9XQBU"SUV>:RELWT:1X[B*>1=V57?NXR-I!R#WJ*3QG+'K%CI)T"_^
MW7EDUW''OCQP5!0G=P1NYS@>F>*S==\/33?$6QDLYD2UU2V(U:#'^L2W=61O
MQ+",Y_A:K^H:?J+_ !/TK5(M/EDT^WT^:WDG#Q@!W9"."VXCY3VH IGXD'^P
MK[5%\.:@RZ9-)#J4>^,?9C&?FP2W[S@Y^7MZ<5MW_BJUMYX;:T$=Q<S6PNE2
M2=85$9X4EF[L<X&.QSBN270M</@[QYIYT><7.KWMW+9H98?G65%523OP.G.:
M=/IOB+1=9TO7;/0/[3BETJ'3[[3S-&LL+QDE74D[2/F8$ T :</Q-T^ZT[1K
MRUTV_F74[IK,*@3,4RYRC?-U^4X(XQSD5))XYN#I?B8KHLL&JZ'%YLEI/,A#
M*R%U;>I(Q@'('/&*JZWI^NZC-X6N?[&VM:ZH+RXA@ECQ;Q[&4*26&YOF!...
MN,X&62Z#J]WKWCQO[/>*#6-/BM[.9Y(]K.L3H<@,2!EQU% &CI/BNX.A>'!>
M6P.J:K IB629464B(.SDC.,YX !//3&2.CTN]DU"P6XFM)+23S)(VAD()4HY
M7.1P0=N1[$5P_P#8UQJG@_0='\0>$YIK>"V6&8)/&9K>2-$59$*N."=_W23C
M&1U%=%X*T_5=+\.+::M<SSR)-+Y#7+AYA!N/EB1AP6VXSUH Z"1UBC>1L[5!
M8X&3@>U<M8>-DN[W1(IM,N+>'6TD>QD=@6.Q=^)%_@)7D<GWQ727PN3I]R+(
MHMV8F\DO]T/@[<^V<5Y?9:+XDDU+P?JESX<E^WV$LHU.XGNXFDE=X63>"&/[
MO<<@=1T"T ;LWQ)\O3M7OX_#NI/;Z1=O;WI+Q QA I9A\WS?>Z#/ Y(R*W[K
MQ#$=0MM,L(/MMY<VQN@F_8B0Y #NQ!QDG  !)Y[ FN-_L'76\(>/+#^QYQ<Z
MO>W4MFAFB^=9$55)._ Y4YS4\.FZ]H?BS3]?AT>>]MKG28M/O+6*6(36\B'(
M8;F"LIR1PWO0!8^%.!IWB3;:FT'_  D%W_HYQ^Z^[\O'''3CBN]90RE6 ((P
M0>]<AX"T_5-.'B#^T]/:T^UZQ<7D.94?<CD8^Z3CIWKL* /(_#/B5O"6C^(Y
M(?#][=Z;::]?&XFM=@6WC$F.%)!; &3@8 [UW-UXPL@T,>G>5>32VB7BA[A8
M5\I\[#N;NV#@8['.*YVRTG7+#1_%>B#2)'FU2_O)K:Z\R/R/+G)PS'=N&W/(
MVY],U"WA[6O!FMV5UH^D#7M-;2[?3KB$2)'+&T((20;S@@ACD9H U(/B9I]Y
M9Z%<V6FW]PFL2R0QA F8Y4#%D8;NN5Z_=[Y J_8>-K66VUQ]3LYM,FT5A]KA
ME97(5DWHRE20=P/ ZYXK,U;3M<O=5\)7AT@#['>R7-U';RQ[;=&C9%7)8;F&
MX9(&.N.U4-0\)ZOK5[X^A-J]G'K"6IL;F1T*L\,8'(5B0-P'4=/RH W[?QQ;
MOXBM=$N+3RKF]A>:S*7"2B0H,LC%3\K@<]Q[UR>F16_B2R\6W/B/P^]_'::O
M.P*RIYB"%4"QJ=P(P >A .3ZG/4^&[[Q%>R0C5?"T6DO;J?M$PFCD$S8(Q$%
MY )YRV, 8YSD4/#NFZQ9:/XNAN='N(Y;_4+NZM4\V(^8D@ 49#X!X[T 5Y/%
M4EAX>\%?\(]I AT_59H8DB,B@Q1E"XC&>Y"\G_'CHI_%3+<ZC!::<]U+IBQF
M\B291(A= X"K_$ #DG([XR1BN5'A_78/!?@:-=)DDO=#NX'NK031!RJQNC%6
M+;3RP/45)XK\-WVM7MW?6FCW6G^(8/+&G:K97"*KC8I*RG<"5#;@=R\J!C/2
M@#TFL[6M9MM#L!=7(=R\J00PQ@%YI7.U47.!DD]^!R3P*OQAQ&HD(+@#<0,
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MK)IK#69)RYD=4?,<3YCP>A##).?X>,YJE8ZA)H'C[Q]-8:+->,%LIGAMV2,
M"%BQ)8@9/H,DG\ZU=9TS79-3\(ZQ'I23RV%S</<VEM*B^4LL;(N"Q ;;D9(Z
M\D"BRTW5X/%'C2^ETF80ZE!;K:E98CYC1Q,C#[V1R>,XX]* -8>,]/FTW2+J
MUP\FJP?:+:*:18L( "Q=CTQN4<9.2,#J:R3\3]/&BR7_ /9UV[P:BNFW,,3(
M_DRE@ <@_,ISP5!SZ"L&S\/>)M#T?PCJ=MHJWEYI5D]A?Z9)-&&>-MIW1MDK
MD% >O-:WB6QU_7/"]OY?A\PW!U*VN!91S1;HHHW5B78L%+'!X!../>@#L='U
M&[U*VFDO-*N=-DCF:,17#HQ=1C#@H2,'/KV-3:I=RV.E75W!;_:)88F=8MX7
M<0,XSVJTC%D5BI4D9*G&1[<5!?0-<Z?<VZ$!I8F0$],D$4 >4ZSJEQKOP_\
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M2"05(]0016K5/2Q=#3HC>PQ07#99H83E8\DD+GN0, GN<FKE !1110 4444
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M"_QX)Y X]SS@ [^BN<U#Q0\&IZCIVGV27MWI]LMS- ;CRY'#;B!&NT[C\O?
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ML^Y0R%".NX,/I5RR\0&^\1W?AK4M/CANDLUNL)+YT<D3,4(.54@@CD$=#UH
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M?I?/831Z;+HLVGRS>9'N1Y'5NF[/ !&1W_.H?"0\::;967AW4='MEAL0D/\
M:Z72LDL*8 Q%][>5 '. .OL>WBN;>>26.&>.22%MLJHX)0XSA@.AP0>:)+F"
M&6**6>..28E8T9P"YQG '<XH Y?P7INI:;?>)&O[![>.^U62\@9I$;<C*B@'
M:QP?E)_&LJ?X>R7^I>);&Z=!H-_NNK6,<E+J5-DC^VT@L/>0^E>A44 <GHNE
MZO9^!)8]23[3KMU;DW(C9?GE*! ,DXX55!.>Q-8MMX9N)O WA[P_KOAG[?;V
M]J8;M%FC\R"50H1XVWC_ &^A!_D?1J* /+QX7\6Z5IF@ZE9,=2U'1[FY"65Y
M<#S);.4X$;2]/,557GI[G'/=Z'<:O>027.K6":<SX$=H)A*R 9R6=>,G/09
M '/)QJT4 <A?:?J=E\2%\00:=)?64NDBQ9;>2-9(W$I?)#LH*D''!SGM6%=^
M"]=MK#^VM-%NVOKK;ZQ]D>3$;*Z&,P[_ %V8^;IG/;FO3** .'U;3O$?C/PA
MJ-K=V,6AW+K&UI"TZSL)4<2!G91@+E5  SW)["KVB:GXLOHP=8\.QZ;Y"'S!
M'=I,;E\8 0#A5SSECGH/4UTK7,"W*6S3QBX=2Z1%QN91U('4@9'YTMQ<06D#
MSW,T<,*#+22,%51[D\"@#R^W\+^((/AGX8T0Z4YOM.U"">=!/%@)'*7)!W<Y
M!X]_2N_\2$GPEJY(()L9N#V_=FM4$$9!R#5;4+&'4[">RN-_D3H8Y CE25(P
M1D<CB@#SK2=,OO%/PZ\':4^GR6UK%'8W$]S)(A5HXE5@$ 8MN;"CD# )]!FK
MXB\->*]8TOQ):3Z/%>WDM\LMA>R7: "V65&6*-3RA 4@YV@\G)->CZ-:Z?I=
MBFDZ=,&BL46(1&;S&B4#Y5.22.!QFM&@#B/'>FWU[I^C:G821V6OVMY&ML2=
MX_>G9(A]1M)8_P"Y4_B72-5MM(T.QT&V>ZL+2>-+RS6<1// JD8W,0#S@D$C
M=T[FMB+POH\7B2;Q MJ3J<P :5I&8#"[<JI.U3MXR!G&?4UL4 >53>#-?NM&
M\<Z8FEV=E'J[)+9[;@;,A$&S '&-IR2 ,],CFNFGTS4/$FK>'[B]TV73K;29
M3=.L\D;/)+L**J[&8;1N))..@&.3CK7=8T9W8*BC)9C@ 4D,T5Q DT$B2Q2*
M&1T8,K ]"".HH \V;PAK>H:'XPLO(-A=7^K?VEI\TDB,I*F,H&VDD<Q\\=#7
M4>'M0\4:DZ'6M"ATA(E_>8NEG,[]/E"_=7J>3GH/4UTE(2%!)( '4F@#E/'N
MF:CJVFZ9#IMFUR\.IVUU(!(B82-PQ^\1R>U,33]37XGSZV=-E^P-I"VBR"2/
M)D$C/C&[.,'&?7VYKJUGB=MJ2HQ] P-24 <I\/-+U#1O"_V'4[1K:=;JXEP9
M$<%7E9Q@J3V85SOB?P_XFUA_%EI)I45^EW;[=*N9+E%2!?+P4"'E7+9^;'.>
M6  KTVB@"AHJW2:)9)>0"WN$A57B#A]I QC(X/X?KUKA]+\*WT?B?2];M-)E
MT.]9F.M+'.AMKI=AZ(K'+%\$' QSGG&?0HKFWFEFBBGCDDA(65$<$H2,@,.Q
MQSS4M 'F,WAS7I?"/CO3AI4@N-9OYY[0&:+!21$4;CNX(V$GZBM>[TO5KCQ3
MX,OUTR46^F0SK=DRQ90R1*@P-W.".<=O6NRM[FWND+V\\<R*Q0M&X8!@<$<=
MP>,5+0!Y%#::G=)JBQ>$[G4M!OM2DNPEGJ4"V]P%?AMKX?DH&(#;2<]C73O'
M>ZUXT\+^([/3YCIB6$WF2.Z*R><$*Y4MGC;SC\,UH6W@'P_9R-]EANX+=F+&
MSBOYUMB3U_=!]F/;&/:NE551%1%"JHP !@ 4 >>>'+/QEX:CD\-1Z3;W.GI-
M(;/5S=*HBB=BWSQGYF9<G@<'@9'6NVU@7)T:\%G:QW=P8F"6\I 24X^Z<\8/
M2KU-=UC1G=@J*,LS'  ]30!Y[H_@N>RU#5TTNUN=(T6_TYXFT^>971;EC]^-
M59@H"Y!Y&<C XJA!HOBN70_!-C)H*POH-Y!YY>\C/F+'$R;UQGY>1UYR>G>O
M4(9HKF!)X)4EAD4,DB,&5@>A!'44^@#@[32-8AU#QS.^ER[=5VFSQ+%\^(1'
M@_-QR,\]O?BJ+^']<_X1'P+IXTJ0W.C7EK+=J)HL!8D*MM._G.<C^E>E44 8
M/C/P^?%7@[4]$640O=P[4<]%<$,N?;(&?:L6ZTS6?%47AR#5=,>P;3;V*^NY
M6EC=9'B4X$>UB2&8@Y8+@>]=F;F 72VQGC%PREQ%O&\J."<=<<CGWJ6@#DO!
MNG:EIVJ>)9+ZP>WBO]2:[MW:1&W(41<$*Q(/RY_&G?$72]0UOP?-IVF6AN;F
M6>!POF*@ 25'.2Q'92/K75T4 <@;#4S\3X]<_LV;[ -&-F7\R/<)3*),8W=,
M#&?7VYJ3P!I>HZ1H]];ZE9M;22:C<7* R(^4DD+#[I/.#S75T4 <C=:;J1^*
M%IK"6$CZ?#I<EHTHDC'SM(KC"ELXPN.G4US%QX7\03?"[Q#H0TEQ?WVH33PH
M9XMNQYA("3NXP!S[UZK10!Y[XO\ #EQXEDN96T"YBU*&(-I6J6MS'%+!)M^Z
MY#@[0V>FX8)QSC-U='UVT\?Z;J[01WL3:,NGW=P)5CV2B0.S[3R0>< #KZ=:
M[6B@#R1_#GBZZL=)DOM$BN-8L=;CN[F]>\3-S$KL1Y?]U I'RG&,< Y-=9IN
MGZI;?$37=7FTZ06=U9V\43K+&=SQ[R1C<#@[N"0/?%=?10!Y3%X7\0I\+K#0
MCI+_ &^#4UN703Q;=@N3-D'=_=.,>OYUT[Z?J9^*$.MC39?L"Z.UF9/,CR)&
ME63INSC"XSZ^W-=?10!Y6GA/Q*- N)K6T2WU:S\13:S9PSRH4N$<M^[)4G:2
MKD<]^_>MS5/^$H\2>"];MKG05T^>ZL9+6"S^UQRNTCJ1O9QA54=ADDY/M7<5
M$MS ]R]NL\;3QJ&>(."R@]"1U .#0!Q$^D:Q)JG@2X72Y=FDK)]LS+%\A: Q
M#'S<\\\=O?BFZ;I.NZ5'XKM3HEO>P7VIR7L/F3ILN8Y-@:,J>AVA\EN.G6N^
MHH XGP=X8F\/Z[J$EA;W6G:#/ ACTZXF63RY]Q+,@5F"KC QGDY[ 59\7Z9J
M.H:SX8GL;%[B*PU#[3<,)$7:FQEX#,,GYL_A74W%Q!:0//<S1PPH,M)(P55^
MI/2H;34["_.+.^MK@[!)B&57^4D@-P>A(//L: ./MM)U>'7O&]VVERF+58X1
M9D2Q9<I#Y9S\W'///;\JV_!%A>:5X*T?3K^W,%U:6J02(65N5&,@J2,5OT4
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M.S*5R@7[J\D\G/0>IK/\)#QIIUG9>'M2T>V2&Q"0_P!KI=*R30I@#$6-V\J
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M.W:N3UCPWXLU/3-2BN=&BO-1754N(+U[M/WENLRLJ1@_<PHP0=HXSR37K-%
M'(0Z=JI^*"ZU+I[)9-HRV32K,C 2^;YAXR&*X.,XZ]JBTBR>]^*FO:V!_H]M
M90Z8C]G?)D?'^[N4?7([5V;*'1E)(!&.#@_G4=M;0VD"P6\:QQKG"CW.2?<D
MY)/<F@#F?&&B1:_);65_H#:GI_ENWG0R(DUM+D;2A9E(R,]#V'!K"M_#WB6#
M_A"/MD<VH2Z3//)=SM-&7".KHBDEAN8*R@D>AY->D4R66.")I9I%CC099W.
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M@ $'@C^=0V/Q#GFT"/7[W0)K729K2.6"87*.\LSN%6$)P<DGACQ]*GN=%O\
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M.FZ=9:CI-_>27EO=2W7E&T:4[G5TP2X#$D;?SYX[Q?,AM@&+3R(G)  +D#\
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ME12?,BV#:"><'DYQ^--MM.U2V^(FKZT=/=[*XL(;>(K*FYGC9B>"W .[CZ4
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MM\O3@ =^35<_$B(_V7>0VMO<:;J$Z0CR+G?<Q*_W9'B"\+TR,Y&1]* .Z P
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MO(0*Y(0 X)).UNW 'N!5WPMX@7Q/X>MM5%I+:-)N62"7[T;*2",]QQD'N"*
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MGG;(B.X*;60@*%7 ZY[@5TT?B+>^DZ9IUG";V[L1>>2TFR*WA 49) )ZL%
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MC7O_ !*[-7(D5'W9DP><#!YSZ<8!KT.LR#0--MM:N-8BAD6_N%"2RF=SO4=
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M?SM?LK+3U1-@@MIS-YK9'SDX&T#'"\]3D\"M74TEETN[B@C$DSQ,B*6V@DC
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M6A,>Y7"GIG.,5IV>BZQ;>)O%NHR6D31:K!!';[9AG='&R'<#T!+9'7BNTHH
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MG4DXZGK7HE<3IOAW6/"&M:G)H<-M?:-J5P;M[268PR6TS?>*':0RG X.,=J
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MV8T.RZBW_9YTE8*&W%<KL+?,.< <9J_XI\+7EWI.D'P[/#:ZCHLR360GR8W
M0H8WQS@J2,U(L?BZ[T>>6]M]*2\<QJE@LK/"T>\>;O<KU9<@#:0/?/ !J:-J
M%W?M,TJVDEKM1[:[M)=\<X.<_3&.F3U!SSBK]W++#:32P1++*B%E1GV!B.V<
M''Y5R_A#PI_PCNK:Q=VUNFGZ??>4T>G12;TC=0=[@=%W9 P/[OX#J;G_ (]9
MO]P_RH \Y7XEZO'X;TKQ3=>'H8M NF1;B5;O=- ';:'V[<% <#KD^@K8N?%>
MOR>*M5T+3-"M)Y;&."822WI17CD)S_!PV!P.1P>>@/,^$M&U#Q3\'="T*>""
M'3YTB:>X$N2T*2[]JKC[QVA>> "3D]*[#3M%U2V^(6L:U+';?8+VVA@C*S$R
M Q[N2NW&#N]>U %>;QC?3Z-JFN:5I\-UING2RHRM,5EN%B.)&3@@8(; /WL=
MLU9A\7QZQ?V-CH2Q32W6GC4C+.2JQ0L0$R!R6)SQQC!YZ Y6G^%]<T/2=;\/
MV*VD^G7TLTEG<R2E6MA-G<KIM.[:22,'GH<=:=;^"[KPUKVE:IH(CN8;?3%T
MJZMII-C21H<I(K8(W9SD' (- $.J^++S5? 7BP0VT=GJVDQ7%O>1&8D)B-B)
M(V"Y((P1D#WZ5N^$+!7T#1KZ\L;-;R&PCA@FB^9A$44XW%01DCD#BLJX\(Z@
MWAWQ8(Q;'5O$7F!U,I$4*F/RT&[;DX').!DDUT^@6UU9:!86=XD:7%O;QPOY
M3EU)50,@D#T]* (_$6O0^'M+6ZDC,TLLT=M;PAMIEED8*JY[#)Y/8 ]:SQXE
MN['Q79:!J]K CZC#))97%NY*.\8R\; C((!R#T/M3_&OAN7Q/H*VUK<);WUM
M<1WEI*X)198SE=V.<'D?CFH1HVH:SXET;6=6MH+3^R8YC%#%-YI>610I.=HP
MH4''<D]L<@&%X6@NM:\1>,[76;*PNK1[^..>-W,@&V%-JJI7!'0\XYS7HK;@
MAV %L< G S7+>%M&U72]=\17=]%:K!J=X+F+R9R[* BIA@5'/RYX/>NJH \B
MO-3U?6OA7XXFU<6SB*6\A4QLQVF,[0 I'"@#@YS74Z9XEU*UUS0=&U#38(K7
M4[1VM)8[@O(K1(K$2+M &0>Q/2LR3P=XA7PGXKT"-=.:/4[FYEM9C.X.)FW?
M.-GR[>>F<^V.=6YT#6;CQ'X0U'R;18M(BF2Y'V@[B9(PGR?)SC&><4 5+GXB
M2+:0ZI96"7FG/<^28H2[7!CWE?-"A<$<9VYZ<Y!X'>UY_P"'] \8^'%?P_:S
M:;)H2RN;:^=V%Q!$S%MFS&&89(!SCN<]*] H \Y\<-;Q?%+P!+<1-)&/[0W*
ML+2D_N!CY5!)Y]JJ^'X=2T37O&OB#3M#O5T:58WLM-\HQ/<S*N'=(R,H">Y'
M.<XXQ70>(=!UC4/'GAG6K2*T-II'VGS!).RO)YL83@!2..O)YK5\7Z;J6L>$
M]1T_2+L6E_/'MBE+%0.02"1R,@$9'3- &?IWBJZN/%EUX<FALI+N.P%ZKV\Y
M*@[]AC?@E2"1SW!Z"L*'QQXHU7P7<^(++1+"VMTM+N0R2W9<I)$S 84+\PPO
MJ.0>@QF[IWA_7[;QE::X;#2;6V3238-9V\['RB) XVG8 <XQT&,]\<R>'?"F
MJ6?PSO/#%^;6.YEBNHDEAD9T_?,[ G*@\;\?A0!5/B&_L/!?A.ZU+3;._:^N
M+& N\Q8H9 FV7!3E\Y/48..36Y>>(;^>]U>ST.RANIM*C4S":0KYDK)O$28!
MYVXRQX!8<'G&'=^&?$EYX.\-Z9)!IJW6EW=I+(%N7V,D&WH=F=S8Z8P/4U/-
MH?BC1?&.I:MX?33KJSU@1M<V]Y,T9@F1=N]2JG<" ,CK0!;N/$<Q\0>$;>ZT
M*.)]525P]PX,UFZPEV7&WJ>F0?7BLV3QQXDGAUZ33O#5K,=%NWAG5[XCS55%
M8^7\G+$$\' ''4GC2U/0-9NO$OA34%>VN$TIIWNY'D,;2-)&4^10I& 3G!/3
M ]ZQ/#1U9]0\>6^G6MO)YVKR(DLLQ41N8HQEA@Y4#!XY/(XZT ;L/C";5++3
M;W2[2..QO+ WKWUZQ2&$Y4"(D?QDD]^ I/-9R_$6YG\,^&-9M='21=:O5LVB
M-SAHG)<''RX8?NVY)';BDM?!NK:#JF@)IAL[[2].TW[&([R1D\F;=DW"J%(+
M$<8X/8$9-9]AX)\2VGA;POI,BZ:[Z-JXO79;AP)(PTAX^3[Q\SIT&.O/ !LC
MQ;K7_%3Z?/I]C;ZKI-JMU"4G:2&1'5B,DJIR-IR,#/M1HMA/XQ^%^FP:[':3
MM>64$GF2*9LY13O((&'Y)[@'UIY\-:I/XK\27TJVT=GJNGQV<3"4LZ%0XW%=
MH&#O]>U:G@S3]4TCPIIVF:JEJDUE;QVR_9I&D#*BA0Q)5<$XZ8X]30!6U#Q!
M%HNLZ;X;MWM8)9;4O U[*56380HC4]V.<GT'8YXW].FN+G3;6>[M_L]S)$KR
MP[MWEN0"5SWP>,U@>*-#DUZ1K.]T>RU32'@QY<LNR6*;)^93MX!!&2"",< \
MUH^%]+NM$\,:=IE[=F[N;:!8Y)B2=Q'N>2!TR?2@!-?UU=&6QACB$]]J%RMM
M:PEMH9B"2S'!PJJ"3P>F.]<;!?RZ5\5=?O\ 6$@ACM/#T<SR6Y)#QK([%L'D
M'J,<].O-=!XU\.ZAK']DZEH\L"ZII%V+F%+@D1S*05="0"1D'KBLJ;PKK6N^
M)-4O=6M[*TL=3T3^S)$AN6DDB)9SD?( WWO;\: +=MXUO'UC2+>73DDM-3RN
M^V9W>T;&5\SY0"#TR#P?7K3'\<7MK>:,+_38K5-5OS9):22D740RX25EQ@J=
MG0=-PY-2^&+3QO:Q6NF:U)I?V2S 3[;;.[2W*J,*"A&%)P-QR>X YR.?A\&>
M+1I.CVTZ:3+>:=K*7\UVUP^^^P7^9SL^4X<#'S=., 8(!K:9JFLZEXH\96-\
MMJUE9".%$5V^16A+C (P2=W)X_05B^"_$NI:'X*\$I-IL!TJ^:&P$WV@^<LC
M[MK;-N-N1C[V>>@Z5TEMH.N6'BCQ->PI8S6>KI$Z,TS(ZND/E[2NTC!(!SDX
M'&#GC)C\':_'X+\(Z.([$W.BW]O<SM]H;8Z1$G"G9G)SW Q0!Z116?9OJS:M
MJ"WD-HFG+Y?V)XG8R-\OS[P>!@],=JON6",5 9@. 3C)H X#XCVMQXDMYM"L
M+W[-/9V_]H[E<*6G!/D)]"5<GTVKZUMZ#XI.O> ;;Q%:0QRS/:F1X&?8!(HP
MZ9P<88$=*-%T!G6]NO$&FZ?+J%S<O*SKB8!/NHH+*"-J*H^N3WK&\/\ AG7M
M F\36D-M8?V1J,TEQ8PK<L&@=UPRD;,!2<'CI[T -L?'VJSV7AC5+K1K>'3-
M;FBMMRW1:6.20$J=NW&W(QUSWP.E;.F^)[F;Q/K>BZE:V]FVGPI<12"8L)X6
MS^\Y48 (P>N#6 O@_7D\'^#])$=B;C1+ZWN)V^T-M=8L\*=F<G/<"K?C#1K;
M7_$F@_9+U4O/,EMKU(F#&2S*YF1_09"+[%_>@#JM"OKK4]%M;Z\MDMI;B,2"
M)6+;5/*Y) YQC(QQTK1HZ# HH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKG/&WB*[\+Z$NHVEE
M%=_Z1%"Z/*4(#N$! QR<GN1]: .CHKCY?$VL6-U#INIVEE!J-W),\!MS+<(E
MN@3YV 4,6W.%QP.^1TK,N?B!K-GX=N;Z;0=MQ:ZE'9.9/,B29'=566(,H)!W
M="1CU- 'H=%<6?$OB-/%TOAU]-TW[1-9&]M95N'V(H<(PD^7)(R,;1S[=0NF
M>+]5U+PX]Q'I,;:G!J;:9<I'(3#$4DVO-DX)0#YL=>WO0!V$TT5M!)/-(L<4
M:EW=C@*H&234=G>6VH64-Y:3)-;3H)(I$.593R"*Y&P\97%];^*85@L;V?10
MK+)#*5AN4:/>.S;3P01SR.M5_P#A--0AT7P9/::1:,NNB)#&)B@A9HBX4#:?
MEXZ]AV- '=2RQP0O+*ZI&BEG9C@*!R2:CLKVVU*RAO;*=)[:= \<J'*LIZ$5
MRNG^*=6F?Q/I]]I]D=1T94D"Q3,(9DD0NO)4D'@@\517QM?Q>'/!UY::1:%=
M;>*$Q+,4$)9"P"C;]WY>N>/0T =_17&V7C*\MI/%,&N6<"3:# MVS63LZRQ-
M&S@#< =PV$5#_P )AK$=WX70V%A,GB&,O&!.\?V8B/S,$[6W_+GD!>1V!H [
MBLV'0-(M];GUJ+3K=-3N%"2W00>8P  QGZ ?D*O3M*L#M B/*%)17<JI/H2
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MD C+$DC.1]T]:RYO'L]U\.M/\1C2;67S[Q+::&24E4;S_*W+\OS?,,C.,<4
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MM5TVTBNYK2,S-!(Q7>B\M@CN!S^&* -NJNH:E9:3:&[U"ZBMK<,J&25L+EB
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M"\.?]@NV_P#12UNT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6LMU=SQP6\2[I)9&"JH]230!B^-= N/$OA>?3;2:**X:6*6-I0=A,<BO@XY
M.W&?>H#H-YK/B"PU;6H;: :?!-'!;6\S2Y>4!79F*KQM!  '<G/:M^QO;;4K
M&"]LYEFMIT$D4B]&4\@BH;#6=.U6:ZBL+V&Y>TD\N?RFW!&QG!/3- '(>&?#
MWC'0(8M :_TR70;9ML%W\_VL0YR(]N-N<?+NSP.V:?'X6UM8/&B$:?G72YM\
M7#_N\Q"/Y_W?MGC/I[UW5% 'G;>$?$^F?\(_JFBW&FC5M/TU-,N[>X=S!<Q+
MC!#!=RD$$CCO^=_Q/X=\1>(? UQI3SZ>VI7<L<LC%W2&$(Z.%3Y2Q'R8R<<D
MGCI7:U3U'5+'2+=)]0N4MXGE2%6?H78X4?B: ,'6]$U?5/$?AG4XH[%(]+FE
MEG1KA\MOC*87Y.< YYQZ>]5X/#WB#3=:\4W6G7&GB+52)[9Y2^^.81! &4#&
MW(!R"3CC'<=E10!QVA^$7T_QC-X@6SL],$]F8;BULI2Z7$I8-YA&U0, $ XR
M=QSCO>\;>&YO%&@+:VERMM?VUQ'=VDSC*K+&<KN'IU'XUT=% '$Q:+XGOO&6
MBZ]J,6DVZV=K-;SQ03R2%MY7YE)1?[O0]/4YXQ+CP+XG;P;J/A:"72A:M??:
M;6X>23>ZFY$VUUVX4CGD%LX P.M>HT4 <->:!XJTWQ9=:YX>GTN1-3BB6_M+
MYI%59(UVK)&R@G[N 0?3\NQL8;B"RBCNYQ/< 9DD"[06)R<#L.< 9/&.35BB
M@#DKS0];M_'KZ]I1L'M[NQ2SN%N7=6B*.S!U"@[^&QM)7IUK L_ OB&U\)>'
M-(:33))=*U==0=_.=0Z"1WVCY#R=^/3CO7IE% '"ZGX*OM:U_P 12WC6L>G:
MMIB6 ,<K-+&5+$/M*@'ENF>U4Y?#7C*^TWPW9WK:-OT74(;@W"3R$W*1JR@E
M=@VL01QDY.>F.?1J* .#MO#WB[0-=U,:%=Z5)H^I737;"]$GFVLK\N5"\.">
M0"1^'4Z-KH&JP?$)M<9K:2Q.EI89:9O.)5R^\C9MYSC&??VKJZ* "O-IO WB
M$^!-?\,1RZ88[VXF>VF:20';)+YF7&TX(Z8&<YZC'/I-% ')W>A:Q=^,?#NL
M[+%(--MYXID^T.68RA1E?DP<;>^,Y[54TGP]XBTFQ\0+&-+:?4=7:_C1IG,9
MB<H'C?\ =\$JI&0#R>G%=O10!RGA/PF/#VKZQ>PP06%KJ!B9=/MI"T4;J#N<
M9  +9' &/E'X'Q$\/:EXJ\)S:-IAM$DFDC=I+F1E"A'5^ JG.=N.U=710!'"
M96A4SHB2X^94<LH/L2!G\J\]E\%^(G\/>*+&*YL(+C5=4-_"5FD9"A*9BD^0
M$ A""1G[V,5Z-10!PL/AKQ&GBBZUAET>..YTE;'[-%)(!$RLQ #;>5^;[V!Z
M;>]5$\%Z]'X.\)Z.#IQGT6^M[F5S<.%D6(GA?W><G/?I[UZ+10 #.!GK7(OX
M)CF\8ZEJ<\BOIE_;*);,CAK@(T1D_P"_3;??.>PKKJ* .:\'^';OPOX76PEN
M%O;U<CS78J&50$C7."0!&J#H><GO7-KX&UY?A58^% ^FF\MYXW:7SW\LJLWF
M\?N\Y.,8Q[YKTFB@#EKK1-5N/'^EZ\%LQ:6ME+;2H9VWY<J25&S! V]R,Y[5
MOZE:&_TN[LP^PW$+Q;L9V[E(SC\:M44 <)9^$M6NO#6B>'-6%E'8Z8T!EEMY
MF=KD0X*#:4&P$JI/)Z$#KD%OX>\7:#KVI_V#=:5)H^IW37;+?"3S;65_OE0O
M#@GG!(_#J>[HH 9#&8H(XVD:0HH4N_5L#J?>O./#0U>75/'D&FPV;"75I$66
M>9E,;F%!DJ%.X8P<9'3'O7I54-/T33=*FN)K&T2"2Y;?,R9S(W]YO4^_6@#D
MH?!>J:+J/AS^QYK*YT_2[!K0PWS,NR0D'[0@4$%^",<<$@$9K/7P)XB3X>IX
M;,VEO-'J/VI)?,D52@N#-S\IY.<8[>IKTRB@#C)/#^O:9XXN_$.C"PGAU2"*
M._M+J9X]CQC"NCA&R,$C! _PN>!=!U+PYH4MCJ4EK)(UW-.K6Y;&)'+\Y'7G
M_P"N:Z>B@#F/$FAZEJGB/PY?V8M/(TNX>>432LK/N0IA0%([YY-9\7AC6HY_
M&<A73R-< ^SC[0_R8B$7S_N_;/&?3WKMZ* ,CPMIUUH_A72M,O?),]G:QV[-
M"Y96V*%R"0#SCTKF-9\)>(;[5?%#07&G26FLV(MH);EG\VT'EE2BJ!C:S'=G
M(P3G#8KOJ* /.W\(^)[&70-9TJXTPZQ8:>-.N[>9G$$\/!&& W @C.<<_P [
MNN^%_$.IVNE:K!J%FGB33;IKF(,K?9BK+L>'^]M*_P 74G)P,\=O10!Q6L>%
M];\4^&9X-7O+2TU/S8I[06FYX;>2,[E)+8+$DD$X'&,#C)MG1-4U?7-(U;6(
M+*!])25HH;>=I!+,Z[=Q8H-J@9P,$\^W/544 <+I/@F\;P+K/AK6'MD&H2W+
MK+:R,^T2L6&0RKRI(^N.U5)?#?C*_L/#=K?'1M^BW\-PUPD\A-RD:,N=NP;6
M((XR<GTQSZ+10!YGK7@;Q-J6G>+-.2YTN1-7N!/!=SM)YJH"I6%@%P%7;P03
MU/R\UOPZ)K@\?#Q#.NGF'^R?L+(DSAM_F>9D IT[=<]_:NMHH \R3X?Z_'X<
MM4@N["WUK3M6EU*SD#N\+^8S%HW^4$ AL9&>E;6I^&]>\4>&+RUUF\M++4)#
M&]H+'<\=O)&P=7)8 L2P&>!@#CN3V=% '.^'HO%KNK^)9=+01+M5-.+D3-_?
M8L!@=<*/7.> *Z!T62-HW4,C AE(R"#VIU% 'FZ_#2ZB\'G38=3 U.UO4FTV
M\//V:**1C$G3G",^?=SU%;GB_P ,76J^#(M!T<6T8C>WVFYD90J1.K <*Q).
MS'XUUE% '*W6A:O_ ,)]:>(K1K'RCIIL;F*5WW)^\$FY,+\W<<X]>>E84O@G
M7IO!'BC0R=-6XUB^GN8G%PY2-96#8/[O.1CMU]J]'HH AM%E2SA6=4654 <(
MQ90<=B0,_D*Y6'P]K5CXH\2W]LUA)9:NL;JLDCK(CI%Y>TX4C:>#NY/;'.1V
M%% 'G,?@K7H_!OA31@=-,^BWT%S*_P!H?;(L1)PO[O.3GOT]ZMQ^'_%NA>(M
M3ET"YTJ32M4N#=21WWF;[69@ Y3:/G!QG!(_#DGNZ* ([>-H;:*)Y6E9$"F1
M^KD#J?<UQ<7AC6TD\9N5T\_V[_Q[_P"D/^[_ '0B^?\ =^V>,^GO7<44 <!9
M^#=8TN7PQJEHUDVIZ5IPTR[@:9A%<P@#E7V95@PW %>^,]Z-9\#ZCJFC>*F1
MK--6\0".-@TK>5!'&H51NVY8]2>!RV.W/?T4 <EXFT'6-;TG0X($L4N+*_MK
MR</.^P^4V=JD)DY]2!BI$T35E^(DWB'99?97TM;%8_/??N61GW'Y,8RV.OO[
M5U-% 'FD/@CQ);^%[+3TETQYK;6'U"2W>:0P74;.[^6YV9&"P(X(RH-7HO"G
MB%9?&3R2Z6PUV%1$%:1?+?R1&0WRG@>HSGT7I7>T4 97AFPNM)\+Z7IMYY/G
MV=K%;L87+*VQ0N02 ><9Z5JT44 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S7C;Q%?>&=(M[VRM(
M;DR7<-NZR.5(#N%X'<\]R*Z6N&^*_F?\(C;^25$O]J6>POTSYRXS[4 26OBG
M7K+QDF@:]IUE_IMK)<Z?+8R,0QCY:)M^/FP<YX'3CGB*R\9:F/$.@:9J$5BL
MVK)-YMK#DRV$B1^8%<[B&XR#PO/-:%YX;U#6M975+Z:&RGM;&>ULA:R-(8GE
M #2EBJ\@* !CU.>>,/3_  5XDMV\)-+=:.AT%I$811R'SE>,H9"3C+G.2..<
MG)SB@#3T_P 77PB\40ZLEK#?Z*_R1PHQ$L93=&X!;)W]-HZ$8R:)_$7B.'Q1
MIF@&STWS[S3I+EY2[[4D4J",?W1N]>?5:K7MAI7B7XAZ5J&F:C%.+:W?^T!;
M2*Z2(DBM"KD$X(E!8?[C5KWNA:A/X_T_7HC:_9+6SEMF1I&#MO*G</EQQMZ9
MYS0!S9\;^*#X7US4UL-*$V@7,\%X"\FVX\K!/ECJN5(Y8GGM6[>>+7FOX=/T
MU?+G>Q2^>1[.6Y"*Y(1=L>#D[6R21C'0YXS5\':S_P (SXNTMGL/,UVZN)XW
M$KXB$JA<'Y.<8S[^U+=>$_$EGJ.EZWH-YIT6I0V":?>VUWO:WGC4Y5@R@,&!
M)[=\?4 B/CGQ"+#P\\OA]+6ZU&_:QGANFDC*L Q#("N=A"YR<D9Q@XITWBGQ
M +#QG8S"P@U70[9;B*XA1FC='B9Q\K'.X;2.N.AQVJ]JGAO7=1D\/SRW5G-<
MZ??B^N22\:,=K+Y<8PV% ;J3SC)ZTC^$M0N-9\77$TMJEMKUFEJFQF9XML;I
MD@J <[\]>,=Z -7P6]Y+X,T>6^FCFEDLH7#HI!P8U^]DG+=<GCZ5EWNNZAK<
M'B2'1Q:+;:7YEI(UPC,9YA'N=1@C8 & R0W.>..=GPMI^HZ5X<L=/U.2U>>U
MA2 &V#;=J*%!RW))QGH.N/<\_%X4U[2-7U_^Q[G3Y-+UJ1[B2.Z+B2WG9=K,
MNT$.#@'!*_X@%/PEJ=_8?#_P?%;);06DNGAKG4+HYCM]JC:I7<I)8G YXP:H
MZIXPUG6/ 6G:E:26]G/)K4=A<[49@X%P$RO((!QD@Y."1GO5_3?!7B/2XO"A
MCOM,G;1[5[:2&99/+^8 "1,<EP 1SC()'&:C7P!K:^$;C2CJ%@URFKC4K5_+
M<(V)O-P_4C/3 SCU- &Y?>)+Y-4GT:T:(WUI;1S7$_V">>,NY;:@6,Y7A"22
M>XP#SC,7X@7"V>@?VM;)X=N-3282/J<+^7%+&5 CY*XWY+ DC@=R:GU'PWXH
MM_$B>(M!OM,%Y<VR6^HVMVCB"7:25=2N6!&XCW%:-[HVKW5M;VUZNFZO:R12
M"^M[O=&CR,P*E!M?"K\P /.,'.>H!MZ7+>3Z;#)?I"ETP.\0G*=3@J>X(P?Q
MKF+'Q?<:IKUYIUI-8)<V=_\ 9YM.G5EN/)# &926 8$?,,+C'?-;'A'06\,^
M%[/2&G,QMPV#DD*&8L%!/.%!VC/85A:KX/O]=OK6:_CT];BSU+[3;:G"["X2
M$2EQ%C:/X?D/S8[XR* *S>*_&%])XBBTG2M),FC7)C*S32'SE"*^U< ?,<]3
M@#@<\D6++X@+K=II']F1&&>_L3>N7M9;D0*&V;=D>"26W#.0/E]P*H>'!J[^
M(_'<6FK9D2:D%$D\C*8G\E/FVA3N'3C*].O/$\O@'4M"&A77A"^MHKW2[,V,
MD=^K&*ZA)W'=MY4[LMQZT 6K'QKJ4]A8V]YI+6>M7FH26$23QO'&X12YG4,
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M'?M+/(^]E:!Y6=PHP"'^; SQQ0!V=%%% !1110 4444 %%%% !1110 4444
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M74/"(\+V@$VKZQ/#%:VZ\MA9%=G([* IR>G-2:3;VME\5?$$,_DA#HUHTID
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M*LMF8BS9QU5=H(ST)]ZY:1[37?@AXIU#4XH9-9\VZ:\,@'F13+(0BY/(VKL
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M)#HFEV^EOI<.GVR:>ZE&M5B'EE3U&WICVH S_%-W,VC)8Z=*GVW56^S6SA\
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MDNQBY98AF8?[?][\: ..@T+0[C64U2WU6UN?M6G20&ULX46&XA R&=5SD*2
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M4W;QF%IC$"[)_=)[K[=* /--+$%IXO\ AZ]NMK:VTVG7*QQHX:5H?*1E,SC
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M0*-D,Q$9F"?W<%@..G2@#W 7EL5F87$)6$D2G>,1D<D-Z?C38[^SEM?M4=W
M]O\ \]5D!3\^E<!XET_3] \3^$H[>Q@MM(OM2<WY1 %EG$1$&\]SNYYZD ]:
ML1:7&_Q7UJQCA5M(OM%C?48,?NVN#(RJ2.@8Q@_7 - '<&]M1"LQN81$QP'\
MP8)],U6M6O?[9U!9[NTDM L1MX(U(EBX.XN<\Y(XX'0UP?@M)95C\%WL1?\
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MIK+<B2Z9%\MKPA2'?<"H+9E(/JQH ]#6\M6M5NEN83;MTE#C8>W7I0M[:/\
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M!"B3%/OQLA8E6 P?O$$>AXK#\$0OHGQ$\9:5>_)-?W2ZE:,W_+>)L[MOKM.
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MM,L.'=7C52,L&/7=TP.G>@#9;PEX;:1Y&\/Z47D.78V<>6/N<<U=.E:<=/\
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MT32K33WL+?3+*&R<Y:WC@58V/NH&#36T+2'ABA;2K%HH3F-#;H50^H&./PH
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MF(#U# ,H]F':O4K[2=-U,QF_T^UNS'DH9X5?;GKC(XJVJJB*B*%51@ #  H
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M?('7%=?9:/I>G2O+8Z;:6LDF=[P0*A;)SR0.>:FCL;2&[ENXK6!+F8 2S+&
M[@= S=3CWH YCQW>V%JN@QWD0>:;58A:-)*8XHY@&(:0CJ!SA>YQTZCG?#%S
M;R:C\0X'O;6Y8S";]U@*W^CKN8+D\9XSD_6O2+VPL]2MS;WUI!=0$AC'/&'7
M(Z'!&*C.D::?/SIUH?M"JLV85_>!1A0W'( X&>E 'EEXD(_9D5]L>?[(B^;
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=+J^FP&,2ZC:1F6,RQ[IE&] ,EASR .<]*\NGO[*RTOXJV5S<PQ7,LL[) [
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M.Q6+5["1A"9R$N4)$8."_7[H/&>E<4FH:7?_ !DO%6ZM9XI/#JI]]65R)W)
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MP!_[2B(D &<_;"N<_P"[D?2NPU&#['\5_*TJ.*"Y?PQ.L21J%!82KLX]CTH
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M2[])FL]2M+A80#*89U<1@C(W8/''K26NM:5?7"V]IJ=G<3-'YRQQ3J[%,XW
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MD"-Z'!.#[58FGBMH7FGE2*)!N=W8*JCU)/2N)T)(;;XO>)X8%CC5]/LW9$
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MY[%E1AY@R[D$L%'<*,9(]3Z5>AUW2;F^%E#J5I)='=MB692S;?O8&><=\=*
M-"JT>G645[)>QV=NEU(,/.L2AV'H6QDU3\37%U9^%]4N[*<0W-O:RRQR% ^&
M521P>.U9OA7Q7I^IZ3HUK<ZQ9RZW<:?!/-;^:@E9FC5F.P=.N<8H W9M,L+F
M[CNY[&VEN8O]7,\2LZ?1B,BDN]+T^_=6O+&VN&7A3-"KD?3(]ZBO->TG3[E+
M:\U*TMYG(4)+*JG)Z#GIGMZU=EEC@B:6618XT&6=S@ >I- #9;6WG,1E@BD,
M3!H]Z [#ZCT-0C2].%Y]L%A:BZSGSO)7?G_>QGN:IQ>*O#\UY;6D6MZ>]Q=+
MN@B6Y0M*.F5&>>AZ>E.N_$^@V$LL5WK-A!)"RK(LEPJE"V0H()X)P?R- &K5
M8Z=8F_%^;*W-X!M%P8E\P#TW8S4%UKNDV-R+:[U*T@F)5=DDJJ06^Z#D\9[9
MZT]]7TR+4DTV34+5+]QN2V:91*P]0N<F@!_]FV!G><V5MYK@AY/*7<P/!R<<
MYK$\1>';FZTZWAT)=.MC%<K/+;3P?N+H 'Y'V\CG#9P>5'%6M;U6S_LG4HH?
M$5GIES NQ[IVC?[*QY!96.,^QZU>GU&TT^SAEO;Z%%<!5D=@OF-C/ [D\G H
M Y_2O"K'4;>_U'2-"L9;??L738LE]RE"&<JIVX8_+CDX.>*Z2+3K&"&2&*SM
MXXI.'1(E"M]1CFN6\#^(I]6@\27%_J<%U:V6JRPP7"A$C6!8XV'(XQ\Q.2:Z
M6PUC3=5:9+"^M[EX2!*L4@8IGID=L]O6@"2UTZQL;=K>TL[>W@;),<,2HISU
MX Q1#I]E;1R1P6=O$D@PZI$JAOJ .:X_Q%XM$?B#PS:Z/K-LZ7>I"WNH(]CE
MTVN20>> 5 X[]ZV_&U]>Z9X*UC4-.N!!=6EI)/&YC#\JI/0\=J -:SL;/3X?
M)LK2"VBSNV0QA%SZX%/N+:"[B\JYACFCSG9(@8?D:R-"\1Z=J,5I8G5+2;5O
MLD<T]NLJ^8,J"25'3KZ=ZN3:]I%M?I8SZE:1W3N(UA>50Q8C(7'J1T'6@"<:
M=8BT>T%G;BV?[T/E+L;ZKC!I(],L(K+[%'8VR6O_ #P6)0GK]W&*J77B?0;&
M66*ZUFPADB9$D22X0%&;.T$9X)P>/8U+<:]I-I?)97&I6D5T[A%B>50Q8\A<
M>I[#J: +=O;06D7E6T$<,><[(T"C\A3+FPL[TJ;JT@GV_=\V,-CZ9J)=9TMW
MNT74;0M9X-RHF7,&>F_GY>AZ^E1G7]&$=K)_:MELN_\ CW;[0N)O]WGYNAZ4
M 6KFQM+VV^S75K!/!Q^ZEC#+QTX/%-DTZQF@C@ELK=X8AB.-HE*I]!C J+3-
M:TO6H'GTO4+6]BC<H[V\JN%8=B17*ZWXMSXM\+V6D:S;26]Y=O%=01;'+H(W
M((;DXRN,C\Z .M_LO3_-\W[!:^9C;O\ )7.,8QG'IQ31H^EB(Q#3;,1L0Q3R
M%P2.AQCW-,N=>TFSO4L[G4K2&Y=@BQ22J&+'H/J>P[U%>^)M!TZ2:.]UFPMW
MAV^:LMPJE-QP,@GC- %FXTG3;N"*"YT^TFAB_P!7')"K*GT!'%3RVT$]LUM-
M!') R[6B= 5(]"#QBH[?4;*[NKFUMKN&:XM2JSQHX+1%AD!@.F16?K^M'3&L
M+*W"/J&I7'V>V1N0, L[D=PJ@G'?@9&<T 7UTS3T7:MC;*OEB' B4#RP<A>G
MW<D\=.:%TVQ2V>V2RME@<Y:(1*%8^XQ@]!6?+,8_$6G6O_"01JZPR>9I[K&9
M+K@8?L5VX/08.:CL9)KU]8%GXC@NW$X\E8XT869"C]VVTY;)Y.<'!XQUH UK
M2QM+"(Q6=K!;QDY*0QA 3ZX%,M]*TZTCFCMK"UACF.95CA51)_O #G\:J>'-
M<37])^U"/RIXI7M[F'.?*FC8JZY[C(X/<$&I+SQ#HNGRS17FK65O)!'YLJ2S
MJIC3(&Y@3P,D#\: )?['TORA%_9MGY8.X)Y"XSZXQ3UTVP2=9ULK83( %D$2
M[@ ,#!QGIQ21:II\^F+J<5];/8,F\7(E'E[?7=TQ26.K:?J9E%C>P7#0D"18
MW!*$],CJ,^] #X].L8KV2]CLK=+J08>=8E#L/0MC)J,:/I@1T&G685_O 0+A
MOKQS5BYNK>RMVN+J>."%?O22,%4=NIJO::OIU_:RW-K?6\T$)*RR)("(R.H;
MT(]Z )1I]DJP*+2 + =T($8Q&?5>.#]*G(!!! (/4&J5CK.F:G+)%8W]M<2Q
M@,Z12!F /0X]#V/0TQ->TB2Y^S)J=H9OFPGFKD[?O8]<8.?3O0!(-&TL1M&-
M-L]C$$KY"X)'0XQ[FG#2]/66.46%J)(\;'$*Y7'3!QQ63H?C31->M+V[MKZ!
M8+65T9GE .U3C>0>BDYQGVK6LM4L=1,HLKN&<Q$"01N"4)Z!AV/UH M$!@00
M"#P0:JQZ7I\*1)%86J+%N,:K"H";OO8XXSW]:2]U;3]-*B^O8+<L"P\V0+\H
MZGGL,C)Z#-<OJWB2:Q\=:#'_ &I FA7MC<W$I8($PBH5?S#V^?/4"@#IQHVE
MB,QC3;,1L0Q7R%P2.AQCW-9%SI&LWFLBVDDTV+PU$T4L<$,3BX=DPVQCG:$W
M '@<@8[DUJ0:[I-UI)U6#4K233P"3=+,IC&#@Y;..O%1MJMMJ6FWS:3J,#S0
M*59D(<Q/C(W+V/?!H U*BN;6WO;=K>Z@BGA?[T<J!E/U!XKS8^*==;X9>%=;
M6_"WE[=6D=T_DH?,620*P QA>/05Z1>"4V<P@E\J78=K[=VT^N.] !!:6UM;
M"VM[>**!1@11H%4#TP.*A.D:84B0Z=:%8AB,&!<(,YXXXYKE? OC2TU3PSH:
M:OK-F=<OH/,,#2(DDA).,(,>G8=JZ?4=<TK22!J.HVMKD9_?2A>,XSST&>_2
M@">*PL[>=IX;2".9\[I$C 8Y]2!4<&E:=;),EOI]K$LYS,L<*J)/][ Y_&K0
M=#&) RE"-V[/&/7-9D'B70KJ[AM+?6+"6XG9UBCCN%9I"OW@H!YQWH OVUG:
MV:%+6VA@4G)6) H)_"I6571D=0RL,$$9!%4(->TBYU#[!!J5I)=X)$*RJ6..
MN!WQWQTJC8:M9VZ:M>7?B6SN[..Z/S%HT2S&U?W3,#R1UR>>: -6VTZQL[5K
M6UL[>"W;.Z**)50YZY &.:2/3;"$1"*RMD$2LL86)1L#=0.. >]5(_$VA2WC
MV::S8&Y2+SGB^T+N6/&=Q&>!CGZ5C>)?$\<WP_UG6O#.KVLLEG!(ZSP%)E5D
M&=IZC/3KZT =+!I]E:I(EO9V\*R##B.(*&^N!S3(=)TVWM'M(=/M([9SN:%(
M5",?4J!@UGZ+XETK4%@L1JUG-JBVZ23VZS+YBG:"25'3K^%6_P#A(-&^PRWW
M]K6/V2&0Q2S_ &A-B..JLV< \C@T 2'1],*HITZT(3[@\A?E^G'%.GTO3[JY
M%S<6-K-.JE!+)"K,%/49(SCD\57O/$>B:>Q6\U>Q@81>>1).JD1\?-UZ<CGW
M%$GB+18O+WZK9J)%1D)F7#!_N<Y_B[>O:@"TVGV3^1NM+=OLYS!F,'RO]WCC
M\*8^D:;(H5]/M&4,7 :%2-QY)Z=3WIFH:YI6DD#4=1M;4D _OI0O&<9.>@SQ
MFI+W4[&PA22ZO((%EXC+N/G.,\#OQSQVH M*H50J@!0, #M7/7NFZ[J6O&*Z
MN-/7PZCQ3)'&C_:9'3#;6).T+O / R0,=S5/X?ZY>:[8ZS-=WT=ZMOJ]Q;6\
MT:J%:%=NW&W@]<YYZUOZAKFE:4X74-1MK9MF_$LH4A<XW'/09[]* +DL4<\3
MQ31I)&XPR.H(8>A!ZU#%IUC!9&RAL[>.T((,"1*$(/4;0,5SWC/Q9!X>TZQ\
MJ\MHY[^[@MXW=U^2-W :4 ]0JY.>F<9XJGH_BFWM/%DN@7?B6WU,7,7VJTD8
M1HT2DHHC++A7+%B1@ X'.<B@#JQIFGA546-MM6/R@/)7 3KMZ=/;I4MM:6UG
M&8[6WB@0G)6) H)]<"JLNO:3!J"6$NI6B7;OY:PM*H8MC(7'KCG'6HIO$^@V
M]PT$VLV$<R2I"R-<*")&SM4C/WC@\>U %^XM;>\C$=S;Q3H#G;*@89]<&F-I
MUB]FUFUE;M:MU@,2E#_P'&*S_%'B6P\*:%/JNH2 )&,(F<&1ST4?4]^W6L/5
M?$[VOC;P\L.KVW]A7MM>2SL-FS]TJ_-YGH"QSR.E '6+IUBMF+-;.W%J.D B
M78._W<8J6"W@M8A%;PQPQCHD:A0/P%5K'5]-U+3O[0L;^VN++!)N(I0R#'7)
M'''>DL-:TS5)9HK#4+:YDAQYB12!BF>A(]#V/>@"ZRAE*L 01@@]Z;Y,6(QY
M28B.8_E'R<$<>G!(^AJ.[O+:Q@,]W<1P1 @;Y&"C)Z#GO7)>.O$LMO\ #C5=
M<\-ZI!YMJORS1!90"&"LN#D C/?I0!U<FGV4UPMQ+9V[SKC;(T8+#'3G&:C&
MCZ8$=!IUF$<@LOD+AL=,\4Z\U*RTZ)'O;J& /POF.!N.,X [_A2+JVG/IJZB
ME];-9, 5N%E!C;)P,-T//'UH 6;2]/N+-;.>QMI;53E87A5D!]E(Q3IM.L;A
M8UGLK>58QA \2L$'H,CBH[?5]-NK6>Z@O[:2W@8K-(L@VQD $AC_  D @G/K
M1I^L:;JIF%A?6]RT+!95BD#%">F1VS0!)'I]E#<FXBL[=)SG,JQ*&/XXS4L]
MO!=0M#<0QS1-U210RG\#3+N]M;"#SKNXB@BR%W2,%!)Z#GO[5677=*?3)=23
M4;5[*(E7G$J[%8'&"<X!S@8/>@"Q;V%G:6YM[:T@A@;.8XXPJG/7@<4RWTO3
M[01"VL;:'R0PB\N%5V;OO;<#C.!G'7%<AX.UC4O%=MI>O0:]#Y,BNU]I8CC<
M1AMWEA6 #JPP,[B<\\"MN;Q=I2>+!X;^V0K?&W,QW. %8LJHG/5CDG YX]Z
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M2,QVT$4*$YVQH%&?7 H \JUCQ!X<OK?X=3Z??67E1:E" HD4&!/)==K#^'G
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M1KMYHQ=_%_3+[2Y$>--*E74)(F!4H6'D@D<9)W$>P-=HEM!&C)'#&JMPP5
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M1MQ!Z9"[=WU&:[R:&*XB:*:-)(V&&1U!!^H--6VMTMQ;K!$L &!&$ 4#Z=*
M.2^%$B2?"_P_L=6VVP4X.<$$\55N;RVLOC=&;J>.'[1X?6*'>V/,?[2?E7U/
M/05W$4$, (BB2,'KL4#-*\,4CJ[QHS*"%8J"1GKB@#Q"]^Q/\(/B!,I@,C:S
M=G>,9)$X*<_J*Z2^URRTSXCWZZ[K#Z;9ZAI]N;"Y)C$,JKO\Q"SJ0#ELXXSG
MZ5Z/]AM-I7[+!@G)'EBB6RM)XDBFM89(T.51XP0I]0#TH R?!UAINF>%;.TT
M?[1_9R;_ +.9V)9D+$@@G^$YR/8BMVBB@ HHHH **** "BBB@ HHHH ****
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MWTR-=4G$[*V(%8I*H=6/17/S#V:@#TFX\0:3:2^5/?PHV5!R>%+8V@GH"<C
M/)R,5I5Y/X@O)M+U'6M8T#4H+Z%KJ(:GX?O%^>20K&JM"?O*Q79@$8)'J,5Z
MQ0!1GUC3K74[?39[V&.]N03# S8>0#KM'?%16_B'1[N.[DM]1MY4LR1<E'SY
M)'4-Z$>AK ^(T$EOI-GXDM4+76@W2WF%'+P_=F7\4)/_  $5SD5IJMKXOFLY
M()1:^,8/M$R[<"U9"!(IQT)@95SW<4 >A7/B'2+.TBNI[^%8)8_-C;.=R=V
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M2;4-3\AHL%PS;@I!Z@D' /O5GP]J7A3Q0=!DM;F[N-;L!F*R=V#63A=K[UP
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M@ZQTO3O#5O!HD4T>F[G>W$S,2REB=PW<A222/8@]ZWJ "BBB@ HHHH ****
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MMXLT!-+BU)]5MEM)9/)21GQNDSMV8Z[@>",9%.LO%6A:C<7<%IJMM)):+OG
M? 1?[V3P5]QQ0!JE$*;"BE<8QCBB...*,)&BH@Z*HP!6%#XW\,W,ME'#K5H[
M7K[+?:V1(V2,9Z D@@9Z]LU>U#7M,TIV2\N0CI'YKJJ,YC3^^P4':O!^8X'!
MH O1Q1PKMBC5%SG"C S3ZYS7/&FEZ*-(S+YXU2=(X'B!="AY+[E!&, X]?SQ
MOY$]ONCD91(F5=1R,C@@$?S% "^5'YOF^6OF8V[\<X],T/#%*RM)&CE#E2R@
M[3[5Y[X*\>:?'H-K;^(O$$)U2>\N(E,[!68"9U7. %7@8'3IQ7::GKNFZ.";
MZY\O"&1@J,Y5!U=@H)"_[1XH O2PQ3+MEC21?1U!%.*J0 5! Z#%1V]S!>6T
M5S;3)-!*H>.2-@RNIY!!'45R>FZI>)\2?$5E=Z@[Z?;6-M/$DNU5AW%]W( X
M^7J<GWH ZTP1-*LIB0R+T8J,C\:DK T'4K"+PNM^?$ U*R5Y"=1F90&'F,,9
M  P#\H]<5/!XHT:YNI;6*[/VJ&(SR6[0NLJQ@@;BA ;'(YQSVZ4 :Y 8$$ @
M\$'O1@$@X&1T-90\3:*;&QO1J$1M;^016TPR4E<G 4'&,D]/6HK:[M9O%]W#
M%KAFGCM5$FF*5*P_,?WAP,ACG&": -B2*.90LL:. <@,,X/K3BBL<E03[BN!
M\>>+$MM.L_[(U>2&X.IP6[&*/,<P,H62/>5() SD*<C!SWKJ=0\3:-I<TL5[
M?)$T(4SG:S+"&^Z9& (0'MN(H TY(HYEVRQJZ@YPPR,T^N=OO&&GV/BRR\/N
M7,]Q \Y<(Q50"H49 Y)+?ACGJ*NWGB71K"Z%O=7\<3F182S [%D/1&?&U6.1
M@$@\B@#4(##! (]Z3RTX^1>/:LS5]9L+%9+:>_:WG,1D+1)YCQ)T\PC:P5<_
MQ,,<5E?#;4[S6/A[I&H:A<-<7<\;-)*P +'>P[<=J .I"*IR% /L*;'%'"I6
M.-44G)"C'-4[_6;#3'6.ZG(D9"XCC1I'V#JVU03M'<XP*@G\4:%;V5E>2ZM9
MK;7SJEK)YH(F9C@!?7G\N] &FL,2G*Q(#NW\*/O>OUI0B@Y"C/TJEI.M:;KM
MFUWI=Y'=0+(T1>,\!EZBHM2\1Z1H[,+^]2'8 9&*L5B!X!<@$(#V+8% &F%5
M?NJ!]!35BC1W=(T5W^\P&"WUK/;Q!I2:M%I1O$^W31^;%  2SIC.Y>.1[BGQ
M:[ID^E?VHEY']AS@3ME5/..,]>>..IXH N&"%G+F)"[  L5&3CI5>;38KC4[
M>]E.YK8$PK@?*Q!4MGJ3M8@=N3^'->*_$D<W@CQ%<Z'JCP:AIML\CA8]LL3!
M2P#)(N0"/8>QK0T+Q3I-^;33!J<,NJ&U21XMWS-A1N.>A()Y Z=Z .AII1"V
MXJI;&,XYQZ5EMXGT9+U;1K]!*T_V4-M;89O^>>_&W?\ [.<^U07GC/PY82WD
M5SK%JDEGM^T(&W-&6S@$#)SA2<=0!S0!MB-!C"+QTXZ4H15Z*!]!5%]:TU-.
MM[_[9$UK<[?(D0[O.+?=" <L3V YJ*R\2:+J$\]O;:I:O<6X9IH#(%EB"G!+
MH<,N/<"@#0C@AB $<2)@$#:H&,]:DK+LO$6DZA?FQMKQ6NO+\U8F5D9X^F]=
MP&Y?]H9%<IX^\6):Z7;?V1J\D-S_ &E!;L8H\I+F55DCWE2"P&<A3D8.>AH
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M9"6<.5).<X&-HXQ728XQ0!XX-2LUU;XC[M0DN1=:/"\4\R;1,!#*,C"A=N2
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MPC/>V'B*PTFVU>W\0Z)+8RFUN\#[38H-F$D9>"&^4#(!ROM7IE(  20 ,]:
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M >::O'8ZGXUU368I/M&B1>&YK?4IK5MRRY8L$##@N%#'U&1ZBCPS/J5OK?\
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M\TARD:L.&P 22.F11X9U/POXA?1U-CJ3:YIQ5I+:ZDN0+!U7#LQ<[ ."!ZY
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
E110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>sangamoexecutiveseveranc013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(\,V=I8^'[:"PTTZ;:?,T5JP(9%+$@D'D$YR0>F<5KT %%%% !1110 4444
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MY<1RD9 <[?E'/4X!P<=#0!TU%8#^,M&C,+O-*MI//]GBO3$WD-)G&W?C'4$
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MV<6TGF"0,P )"MC&>F0,XKEO$^CWDWAWXAZG;6=V\6M2VR65LENYDD\M45I
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M;&VNEA9UC>(,#$V 2I.XL,XSSWJ'1?!C:CX+\2Z?>I);)K6I75[:HZE7MPS
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MD61@QQ\;G)/]T8P.>2!0!<B^)/A^6TTZ]W7BV.H.(XKQ[5A"KDD*K-T!./\
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M36+2=UMX'E*HD@9F.T'  J.T\U/BSJM\UG>BT?288EG^R2;&=7=BH.W!.&%
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M$D,PV,&QV#;&]@I-9N@^%]1T;QG=:9^\FT&1HM6\^0YW76THZGW+@2^Q ]:
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M7I0!OZIXT2UU_P .V%I9SW4&K)).+B),AHUC+ +SDG)0^P^M=97EL$%]9_\
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M,HZE6'J#7GW@6*[\!:?+X6U>UNFL[:>1]/OX8'ECEA=BV&V ['!)R#@'/&:
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M[T5;HR%B-O3:<YJ[XN;5-6@\9Z=)I&JEVMO^)<EI;,L5POE#+NXQO?.1L8\
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M"2$LXC;.&4)NW#@],XQSBH?'5SJ-IX3N9=+L6O+@/'F-(1,RIO&YU0\,RC)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<21DE05.<<D$<XJM9^,=+OM"M=6@\\QW<[6UO 4Q+)*K,I4+G&<HQSG  ))
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M')&P7<"W.-N"#D$\=!F@#LJ*H:)?2ZCH]K=3V\L$DD:EED"@DD Y&TD8-7Z
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M8VY"D-G/J*].HH \ZO+*:/Q!X(FMM DL;6VN;J::"UMODMDDB94W[ 5#$D9
MS@D]N:I7VE:C?K\3H8-/N]VI0I]B+PL@GVVX0A20!G<,>]>I44 97ANXDN?#
M]BTEG<VK+"B&.Y38X(4 Y7J.<]?2M6BB@ HHHH **** "BBB@ HHHH ****
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MRNHA"L"=Q)8G.>O?)]9O GA[4M&ENK/4!FRTJ22UTIB<EX'(DW'Z#8@]-C4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP10 H.T '  [5?HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML%SR0,9./Q'YTZ@ HHK$N?%6F67B.TT*\:6VO+P,;4RQD1S8ZA7Z9]NO3U%
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M^UI_LOVG[3YOE+YF?-\W'IC?[=.* *D(N(OB_K4LFIWA@@TF"?R?D*[=\F4
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MO;761JUM),WE3E CJO'R.H5<,/IGH>];]9.A:#!H4=Z8VWS7UT]W<.%"JTC
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M%P$4Y9F.,9&2!0!VM%>2/XF\0O\ #P7J:G+#?6VO?V>TCQ1EI(_M C ? QD
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ML0(#*#N/! '3 K)T"34M-^$'B'5+36+U;NWDOY8WDV289)9#GYE.2<<Y_#%
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M1KWB.W\/OIJW-O<2#4+V.RC:)051W.!NR1@=>F>E;%<5\2/]3X7_ .QCL?\
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M,LD07)RZ@CD'L3TP?>NOK(\3>'K?Q3H-QH]Y<7$-M<8$AMRH8@$'&64XY H
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M\ASO Z+WX7 YZ<5T$7@'2Q<:S+=7%[>C6($AO([B4%9 J[0W !!Y)XP!G@#
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MC1H5;<J[MNYE5L$ L>@SD#% &5X=LV_X6SXP<WEVPBCLF"-+E2&20[<>@R<
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M<,S )\N,9=OO!CSUX%6X? FG1W>LW$M[J-P=8MA;WB33 JX"%-W &#M8^P[
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M[O3] LK2^N9;FYBC"O+*^]SZ;F_B(& 3WQFM*@ HHHH **** "BBB@ HHHH
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M9OIJ022 B=U.8U)Q)D'@$#-:->+:Q/>:G\&M;EO]0N[B:VUEXEE:4J65;I4
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M8L*59L!P"5+%0N0,_-Q@X-=369K^@:=XFTB72]4@\ZVD(/#%65AR&4CD$>M
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ME(]B1^-0Z3X4TW1M8O=4M7NS<WJH)_-N7=6*C ;!/WL=S^&* ,#Q<E[/X_\
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MP@@ CMQC%:5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M% '7T50T6_;4](MKMXI(GDC5F61-IR0"2!Z5?H **** "BBB@ HHHH ****
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MO_@UG_\ BJ/^$0M?^@IKO_@UG_\ BJ .7OM,O]2\6>.K:V@NH3J&CQ6MK<O
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M^WT748VOP)K3SQGS1Y*# 8L2S$@]SZ'!XKT[0[IKS1;65K6YM3Y:CR[E-CC
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MFE@CM+J^N(8A/+#:*K-'&<X)W$#G:V "2<' J?1]7L=>TBVU339Q-9W*;XW
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$#3Z5(SPG[+][*XPWS<\A6^JBI-$DL=*UK5+VT\/ZY'-J]PDL[/:852%"^O
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M^1=PM$Y'5<C@CW!Y'TJ@_@_2GOM!N_+82:*C);<YW!E"_-Z\@-]1F@#&FO\
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M[49=0@\B>[E**X7!P$50%7&2>G)ZYK9TFPDTW38;26]GO'C4 SSA0S8&.B@
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MK!A@D''('- &W7F/C/Q!K&DV'B/4+357DN-/FB:WAM(U:&WC^3*SEA@NV6R
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M;F:WB;,C$8X7RV0@CNP]: /8J*P](N&U/6+[4(+N233E6."! P,;L!N>0?\
M?2KUZHWK6Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB@>25.8V4#8P" 8PHYZGN3Q2/\/+&3PQJ>@/J>HM::C</<SMF+?N=M[ '9@
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MG18!#*]NZK)A91P2.,[A@'!.>,U5WHG@[X81X(DMKRT,Z[3F$+"RN7'\(#$
MD^M 'HTGB32XKK[.TTI;[0MKO6WD:,2D@!"X7:#D@=>#QUK6KRJX\_3O$$M[
MX:OY)#<:OLO_  ]=IO#MYN&GBR,IT\S<,KWSQBO5: ,4>+-%.G:AJ NW^S:=
M*T5XWV>3,+* 6#+MSP"#G&*FF\0Z;"L)\V63SH/M"+!!)*WE?WR%4D#GO_2O
M,[V[73](^)NC3PW/V^\ENKFWB2!V\R)[=0'# 8QD'//;'7BKEY#%<0:-=V6L
MW7A[7;;1H?*N)XB(;A.<PR(XY(9<XZ_-D T >@R>(--CL[6Y$LDJ7<7G0)!
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MZ?.D<:#+,QC8  =R30!B>%O'.B75GHFDS:KOU:XLHC^\5\3.(P6 D(VLV<Y
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M?NQV5VCOCA&;9M!/0$X./6@"^?B+X6733?\ ]I.;=7:.4BUE+0E3@^8H7=&
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MX"JN-Q;((QC/!]* *W_",7/_ $-.N_\ ?R'_ .-4?\(Q<_\ 0TZ[_P!_(?\
MXU6+X<U:6^^*/B*W%S?&VBLK=A;7.Y1"Y9\[5/ R-O(Z^M=W0!SW_",7/_0T
MZ[_W\A_^-4?\(Q<_]#3KO_?R'_XU6%<>,/\ A(-!\8Q6J7]C)I@GBAF$3QMF
M.%6W%L84[B<+D' '%6O"'C'39])\-Z7<W=P^HW>GQ%9989-D\@B5G E(VLXY
M)&2>O>@#3_X1BY_Z&G7?^_D/_P :H_X1BY_Z&G7?^_D/_P :J74O%VCZ29&O
M)Y4@BE$,URL#M#"YP '<# Y(!],\XK<!!&0<B@#GO^$8N?\ H:==_P"_D/\
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MW&<X!XSGB@#>HHK \57FFVMOIZ:EJ-[8B:^A6%K0N#))N&V-BH/RL>"#@$4
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MR87\AY<D;!)C;G((ZXR",YK=H **YK5/%T6G>,=-T VET[74,DSRI;NX 7
M7:.>6&3T'?K7-:'XNM= O_%W]M:A?SPVNJE58QR7'D1>6AR=H.Q 2>3@=: /
M2J*SKO6[*T6'YI)WGC,L45M&TKN@QE@%!XY'/3D#J13]'UBPU[38]0TVX$]M
M(2 V"I!!P00<$$'@@\T 7J*I:OJ]EH6F3ZEJ,IAM(%W22!&?:/7"@FLBR\=^
M'M0UJ#28+U_M5PA>W\R!T28 9(1R K$=\&@#I**X'0-;_LG4_'%QJM]=RV.G
MWJ$-)OF\F/R58X !(49)X%=0WB72DN]*MFG<2:JI>S_<OME 7?\ >Q@':,X.
M#0!K45S,/C[P[<7_ -BBNYFF%V;-Q]EE CE"[L.2ORCW. <'T.+%CXPT;4+N
MRMH)Y<WZNUG(\+JEP$&6V,1@X'/N.1D4 ;U%<;X/N+I_%?C*VGO+BXBMKZ)8
M1-(6\M3"K$+Z#)/ KL6.U2Q!.!G@9- "T5S[^-="30KO6FNI186<S07$GV:3
M,3J<,"NW=P>,XQ3[WQAHNGZK_9<T\QOC;_:5@CMI'9TR!\H53N.3T&3P?0T
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M GHO7O6QX=U70]>U"QOH] U.'4+%7::34(IA]ARA#!6?@DG PO4<G&*] HH
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MWK<0CU"1%L]H.1MA)5F'^])YC?3;Z5V%0V=I#864%G;)L@@C6.-<YPH&!4U
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M>O7 )Q7K]%% '$>(FDLOB;X:U![6ZDM?LEU;EX(&D D8QE0=H.W.#R<#CK6
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLPF38V]#AN.O7UK5H **R?$?B*R\+Z/)JE^D[6\;*K>1&7.6(4>PY(Y)%:U
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M/=KJ,4#OM"EO+O50$@< X SCC-=E?:MJ5O\ $W2=*6Z7^S;JPN)GA\L9WH4
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MA\N.(-C<P7<26; !.>@P ,G(!P^@:Y+H/A#59K=-UQ<^*+BSBX!VM)<[=W)
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M0%48 SC/?FI?^$T5] LY-(ULWYU?68]/MKB6)1)9AE!973:/G7:^,CG<N<T
M=@/$5J?%O_"-^3<"\^QF\$A0",H'5.#G).6].QJUI>HG4[5YS97=IME>+R[J
M/8QVL1N R?E.,@]Q7%0V4]K\:T1M0N+@/X=E*-,%+1G[0@." ,COS[]N!4TS
MQ?JR^$K,W-[YM_?^(7TE+MHU'EKYKC<% VY"H0.,9(SF@#TVJ%]JJV=O:3Q6
MMS>I<S1Q*;1!)M#_ /+1N?N#J3Z5RGB:PUVQ\.^*W?797L/[,DFM"-JW$4BH
MQ<;@H&PX'N,G!%9\]YJNA^"/!$EGJL^+J]TZWF62.,[HI H* A1@<=>O)YH
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M],9P!DU/XCT"W\2Z0VGW$TT \V.:.6'&Y'1@RGD$'D#@BM:B@#$M_#J-J/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M -Q!QAB#UP3CO2:1JNF8UN\C\0&^MH;EC,9&7R[3"+F-2 .!U[]:Y6ZNK/\
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MO;H$-UN#8C8+P77_ &?[P]:VKVZLSXW^'1AFAV+:W:DHPPH:% HXZ9(P/<4
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M : -[X;:E>:O\/-&U#4+A[B[GA+22OU8[FK2\47=I9^'+R2]U=M(A*%?MJ,
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MWUKJ5E#>V5Q'<6TR[XY8VRK#U!KF/B5?WVE^$OMUA?2VDL=W;JQCV_.KRHK
MD@D<$],5J>$K+3-/\.P0:/92V>G%G>"*4N6VLQ.[#DL-V=V#V/;I6-\587F\
M W06%Y52YMI'54+819T+$@=@ 2?:@#:TGQ;H&N7]Q8Z9JD%S=0#=)$A.=O\
M>&?O+[C(YIX\3Z,=0AL?MRB:=VCA+(P25UZJCD;688/ )/%<GJ\$?B;QQHFH
M>';B&;[#8W@N+VW8,@$D86)"XX)W$MCL!GN,XGA.\\,ZKI&AZ!J=EJ3>(M+D
MA5M.EEN1Y,T7R^;UV!0,MGI@XZD"@#NY_'WA6VCFDDUNVV0S&"5ERP1QC.2
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M/'/!H R/^$=U;_H<]:_[\6?_ ,8H_P"$<U7_ *'/6O\ OQ9__&*Z*B@#G?\
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MB9&A1D:)G;.]02N0.<X(]: /1:*R-*\3Z/K*WILKP-]B;%RLL;1-%QD%@X!
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ML%S';&\C\MI7C+[1WP 1S^-1:)JFDM_;EY!KLMY!#=L;EKA_W=H0BDHI( "
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M<GBO7** .-\"7.KO<:O9ZE>0:K!:O$MMJ\483[4I4DJV."R< D>OKFNRHHH
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MEIAWW5WI=JD 4X$S()-Z ]S@A3Z9K7\-ZIX:\3ZKIEU:Z=JCZO9!RXO6N?\
MB7EEPX)D.W)X7 R3U[''H=% !3)98X(FEFD6.-1EF8X 'UI]% 'EOPJT/1]2
M\'H=0T^&:ZAOIY?+N(\E29&*-L;V(P<5<\2:BK>+=8TR2VFM&?2E$$UM:EY=
M0)WY3>%.%0GH,'YB<@"O1J* /&](NX&M_A3Y@=1:(ZS>;&R^6?LQ0$Y' W\
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MGVZSZ?:W*6=Y;H"7N@,KYX7NR%OEXR5!.<;37J]% 'F.NZO9:3X]36=5-^=
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT1;I(#=/M>[^PK,(7\HW&<>7OQMSGCKC/'7BI?"=SJ%WX4TR?5;1;2^>!3-
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MHUYIZWEO<M(K7!M/*$3^:)QG,9C(W!@ 201P!GIS7*>,(AX<\0>'=4:QOIM
MM;26PF^PF3?:AC&4<A"&*_N\'_'%17NG^'-0T2*6&SU/2K:\U(30:G&)8YTG
M$;$7#!@653RF6QG.3Q@T =_IVIVVJ12R6QDQ%*8I%EB:-E<8R"& /<5<KA?#
MFOZAI/A^]G\0F2_6+41;6]]:6A#7B'8JRE%]SM+#@[>,]^ZH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N:O?#6I?V_<ZMI/B"
M:R:[2-)X);=)XSL!"E<X*]3T.,DG%=+10!2TW3OL$<A>XDN;F9M\T\@ +G
MX4      ?J22;M%% !1110 5S_A[PY/H>H:Q=27Z7(U.Z-TR+ 4\MMH7 .XY
M&%%=!10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+@D8W 9X&<].16I0 4444 %%(S!5+,0 !DD]J6@ HHI&8(C,<X R< D_D.M
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MMVP =HN[:-P ;'(!R,TM9L%A>PZV]R-1)TS[,L,>G^2H$;@_?W]3Q@8Z5I4
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M&&"Q"DY?I\QZ=AR<YX\ ZO)I^BV%UXH\Z#1KR*YM6%BHD98U8*KMN(8@$#(
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MHY/+ _>*TR*0<CISVZ].F15LZK>W?B\^%H+]XC:V N[F\6-/,=F<JBJ""H
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M5'3&T'Y2,C'8_7:T?Q#+XDB\-R:;>R*D]NUW>Y1"=JC9Y;?+\K&0XXQPC^V
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MA&D2XMGB.&SM(W 9'RGD>E9A\;:4MQ '6Y6RN/-$6H>7FW8Q E_F!RN K<L
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 45D3>*M!M[^2QFU6UCNXQN>!GPZCU(ZX]ZNV&I6.J
MV_VC3[RWNX<E?,@D#J".HR._M0!:HHHH ***AM+J"^M(KJV?S()E#QN 1N4]
M#S0!-14-U=06<(EN'V(72,'!.69@JCCU) _&IJ "BH1=VYO39B9/M(C$IBS\
MVPD@-CTR"*K:GK6FZ,+<ZC=QV_VF98(0V29'8X  'N10!?HHHH **** "BBJ
MU_?VFEV,U[?7"06T*EI)'. H% %FBH;.[@U"QM[VUD$EO<1K+$X!&Y6&0<'G
MH:FH **.@K#/C+PVMQ- VMV2S0G$J-* T?\ O#M^- &Y15>RO[/4K9;FQNX+
MJW;[LL$@=3]".*L4 %%4(M<TN;5WTF._MSJ*(7:UWCS HXSMZX]ZL7M[:Z=9
MRWE[<1V]M$NZ265@JJ/4DT 3T57LKZUU&TCNK.=)[>0921#E6'J#W%6* "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/$GAC2VN&F\3V-Q(ZQ0I(TX+>5&@50Q]2V]C[N:/$OBW1-4T.>PT[Q)I,3W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *9+%'/"\,T:R12*5='&0P/!!!ZBGT4 0VMI;6
M-LEM9V\5O;QC"10H$51[ <"IJ** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,?V?LV?9?[,D\K;Z;?-QB@#E_$.B:)%X:\<WEIJ0U&6[TPSW$2B,PQR*C!'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>sangamoexecutiveseveranc014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^CU[-I6HQ:MI=M?PK(B3QA]DJE70D<JP/((Z4 7**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH P
M_$VAW^NVD$.GZ]=Z.\<FYI;502XQC:<]N]<Q_P *]\2_]%(UO_OTE>AT4 >>
M?\*]\2_]%(UO_OTE'_"O?$O_ $4C6_\ OTE>AT4 >>?\*]\2_P#12-;_ ._2
M4?\ "O?$O_12-;_[])7H=% 'GG_"O?$O_12-;_[])1_PKWQ+_P!%(UO_ +])
M7H=% 'GG_"O?$O\ T4C6_P#OTE'_  KWQ+_T4C6_^_25Z'10!YY_PKWQ+_T4
MC6_^_25U_A_2[O1])2SO=5N-4G5F)N;@ .P)X''I6I10 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 >3V_B34/'GQ9U'PY!>
MW%EH.BH_GBUD,4EU*K!""ZX95W$\*1POOQV-UX:N[?4]-N=(U6_BMHK@->6D
MUT\J31X/0N25(.#@$ C.17&6/AR_\ _%K5-?%G<7F@:TKF26UB:5[:5F#G>B
M@MMSNY /WAZ4NJ_\)!K/Q=T=]%DUT>&_*5K\AYX(=X+_ -[;VV<+_C0!GZWJ
MUQ;?'VVT:ZUR^M=#DM#--$=0DBC#>6YSNW#:,J.A KO?#.G"YCFU.WU34KC2
M-5M(7@AGO)':$_,248G< 0R=\\5P.MZ;<3?M VNL7.AZC<Z)':&":;^SI98R
MQB<8P%.X98#@&N\T#54MKB+1K'2]4BT?3;''VFXL98][ JJ(BLH9L+NSQZ4
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M?['YGV?^T9_O>7NSNW;NOO7I/A_69]5O;Z(:=?6MA:I%'!+>6S0M.WS;V56
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X,_#6Y))_P"$
M]\8#_M_7_P"(I/\ A6ES_P!#]XP_\#U_^(KO:* ."_X5I<_]#]XP_P# ]?\
MXBC_ (5I<_\ 0_>,/_ ]?_B*[VB@#@O^%:7/_0_>,/\ P/7_ .(H_P"%:7/_
M $/WC#_P/7_XBN]HH X+_A6ES_T/WC#_ ,#U_P#B*/\ A6ES_P!#]XP_\#U_
M^(KO:* ."_X5I<_]#]XP_P# ]?\ XBC_ (5I<_\ 0_>,/_ ]?_B*[VB@#@O^
M%:7/_0_>,/\ P/7_ .(H_P"%:7/_ $/WC#_P/7_XBN]HH X+_A6ES_T/WC#_
M ,#U_P#B*/\ A6ES_P!#]XP_\#U_^(KO:* ."_X5I<_]#]XP_P# ]?\ XBC_
M (5I<_\ 0_>,/_ ]?_B*[VB@#@O^%:7/_0_>,/\ P/7_ .(H_P"%:7/_ $/W
MC#_P/7_XBN]HH X+_A6ES_T/WC#_ ,#U_P#B*/\ A6ES_P!#]XP_\#U_^(KO
M:* ."_X5I<_]#]XP_P# ]?\ XBC_ (5I<_\ 0_>,/_ ]?_B*[VB@#@O^%:7/
M_0_>,/\ P/7_ .(H_P"%:7/_ $/WC#_P/7_XBN]HH X+_A6ES_T/WC#_ ,#U
M_P#B*/\ A6ES_P!#]XP_\#U_^(KO:* ."_X5I<_]#]XP_P# ]?\ XBC_ (5I
M<_\ 0_>,/_ ]?_B*[VB@#@O^%:7/_0_>,/\ P/7_ .(H_P"%:7/_ $/WC#_P
M/7_XBN]HH X+_A6ES_T/WC#_ ,#U_P#B*/\ A6ES_P!#]XP_\#U_^(KO:* .
M"_X5I<_]#]XP_P# ]?\ XBC_ (5I<_\ 0_>,/_ ]?_B*[VB@#@O^%:7/_0_>
M,/\ P/7_ .(H_P"%:7/_ $/WC#_P/7_XBN]HH X+_A6ES_T/WC#_ ,#U_P#B
M*/\ A6ES_P!#]XP_\#U_^(KO:* ."_X5I<_]#]XP_P# ]?\ XBC_ (5I<_\
M0_>,/_ ]?_B*[VB@#@O^%:7/_0_>,/\ P/7_ .(H_P"%:7/_ $/WC#_P/7_X
MBN]HH X+_A6ES_T/WC#_ ,#U_P#B*/\ A6ES_P!#]XP_\#U_^(KO:* ."_X5
MI<_]#]XP_P# ]?\ XBC_ (5I<_\ 0_>,/_ ]?_B*[VB@#@O^%:7/_0_>,/\
MP/7_ .(H_P"%:7/_ $/WC#_P/7_XBN]HH X+_A6ES_T/WC#_ ,#U_P#B*/\
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MJ >HP6A_W<4_Q%9W>D>/9-:E\,R:_I-_:102+!"DLUM+&6P0K8^4A^<'J/S
M.CL?&>F:KI>GWNF+/=M?AS!;HH63Y#A]P8@+M/!R>I&,Y&:,GQ(T:'2I+Z6W
MOU,-\-/N+?R09()BP&&P2,<CD$Y[9K!US2K^TO-!\0P>$H;FS@2>&ZT:"*-I
M(HY2K*ZK]UG!0;@/7 )'-/\ $5G<ZCX2B.G>%Y;#S=3M9UM([=5F\N.169Y
MAV@X!P,D\>IP #K=*\56VIZ[=:,UE?65[!"MPJ7<87S8BQ4.N">,C&#@CTK>
MKC$@N7^+JZD+.Z^PMHGV47!A8+YOG;]O(R/E[].W6NSH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M &Y1P>*YFS\<:7JFF:3=Z8LUW)JN_P"RVZ@*_P G^L+9.%"D8)SUP!G(K%\
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M*"%#))(QP%4#))]@*\V\7:K_ &M?>![Q=,O(()];MW@N)2H#(58X*ALJ6X8
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MOB(7<:1M&5,(N!)E>1P%'&<9["O8:* //]9T2_UGQU?R):W$-E>>&Y--%V0
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MO59H@HVQ.K%#O^9<G.>/SKTVBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME:PMWX_D;2+@+JJC[%^\B_>X@$?]_P"7D9YQQ5==%UM=+^'D/]CW!DT=HS?
M2Q?NML!C/\?S<G/&>* -6Z^(+QW&L6]GX:U:\FTB0+=)'Y0PI7?N!W\\$8 R
MQ]!5^U\:V&J1Z3_9*?:I-3M7NX$=Q'^[0J&!)S\P+8P/0\@#-8&@W]S9^.O'
M@@TRYO";JW*>24P7^SK\IW,,=N>G6JL7@.*U\*Z'X=U72)[V.SMWD&H6$@26
MTN6?<=AW!L$L<$ CY1D>@!Z+IMXVH:=!=M;RVS2KN,,N-Z'T..,U#K>L6V@Z
M1/J5WGR8MH."!DLP51D\#)8<G@5S6F:EXB\.:/X:L-8L)M2FN'-O>7PG3=;Y
M?$6X?QMAE#$?W6.370>)(GGT"YA32UU02%$DLV*CS8RZAP-Q R%W$9(Y H S
M]2\5S:/I>JWU]I$ZIIT*W#^5*K"5#NR4)QG&WD'!_3,\WBB&'6M#TUK2;.LQ
MR/!*"NU=B;R&&<],=,UQT/@O4T\/>+-&TLWD6C7ECY>FV=_+N,4Q5MRH225C
M^X.3USVY-A+?Q!J/B#P3?OX<N;6#3$GCNA-/%N4M"$W !B"N>G.3@\#N ;US
MXUBBMO[0@TV[NM*%W]D:Z@ 8[M^PNJ=60-D$^QP".:GU+Q4+1M3%CIUQJ']E
M('O/)8 J=N_8@/WWVX...HYR<5S?A2#Q7X8M9/"O]B>?;Q3R&SU;ST\H0NY;
M+KG=N7<?E YZ9 YJ:"'Q)X5\7ZVUGH;ZOI>L3K=Q20W"1FWEV!663<1\IV@Y
M&<#L30!O3^+K;%O'90&>YFM$O!#+(L!2-ON[M_1C@@#_ &3G%5=-\?:=K5GI
M,FF1/)<:F)O*@F<1E3%@2!CSR"1P,YSGIDUD:M8>(M'\71:_!HL>NP7MC':W
MUO"Z(\4J%B'3?@%?G(QU[FK.N:*==LM.MM<\-&2W<2S,;&11+I\F4\O:P8$D
MC=DKD9 ZCF@#9/BD9TVW^PR1:AJ#3"*UGD5"OE'#Y;D>F ,YSZ9-.;Q1&EOI
MZO8W":CJ$TD,%BQ4/NC+;RQS@* N2<GJ,9)%<K_PC=]>^&=(TGQ5IEUJZ(9V
M-XDJ_:K0AQY!+!@2VPD,5SR!G(YJ&#PWXHL5\*ZU<&?4[S1YKJ*:WEE0SR6L
MORJ2V=K2*H4D9YZ9/< Z5O'%O##KBW.GW4=_HL7GW5FI1F:+:6$D;$@,N ?0
M@C&,U!;^/5EL[>[FT6]M;>\%N+*:=T5)WFZ+G.5QW)'3H.1G.U3P_J.IWGBC
M78]/F6:]T8Z79VK,@DDR')=OFVJ-S*!DYP#5UM,FG^'FBZ1J?AQKY%A@MK^R
M9X]Z*L>"ZG?C(8*1@YQTYH Z;3+^:^^U+<64EI+;3^259@P?Y%;<I'5?FQV/
M!X%9^J^)38:C<6%MIT]W/;6?VV;#!%$>2  QZN=K<=..2*I>!M'U'1(-2M9Y
M[Q]+^T Z;'>R!YHHM@W G)^7=G:#R .:I>(+/7;WQ3=P2Z4^HZ--8!+,"=%A
MBG^;<TRL<G^'!PV,<#))H N2^/K)8_#LMOIU_<QZ\A:U:-4X.POM8%LAN,?W
M?4X%267CFRDL=;GU2UGTN317"WD,Q5RH*AE*E"0VX$8 YSQ7*Z3H?B&"Q^'L
M<^A3HVC,XN\3Q'8/),8/W^<DYP,\>_%&M^$-<UUO'L$=F]K_ &H]I-832R(5
MD:!5RI"L2,E,<CO0!:UJXGNOB=X$FN=(DLY'>[*2.ZL2OD-\C8Z,,YQR.3@]
M:Z_Q5XCA\*>'[C6+BTN+F"#;O6#;D9(4$[B.,D=,GVKEKEO$.N^)?"&IR>&+
MRT&GRSF]66>'"%XBF5PYW+D]>#CM5WXN9_X5;KF!D[(\#_MJE %RU\;QOXJM
M]"O](O\ 3GO4=[">Y";+D(,L!@DJ<<[6P<=<'BH+GXBZ;:BRNGA8Z7=W(MH[
MM94)#$D*Y3.X(2.O7H<4:AI=UXF\3:!=RV$]E:Z499Y6G*AFD=-BHNTG.,DD
M].!C.>,;PE9^)=#LH/"]UX9@E%H?*AUGS(_*:$'AROW]X'&W')') YH VX_'
M,ESK-[IEGX<U2XEL;N.VN2IB C#J"'Y?!&".ASCKBJ;_ !-A309-<_L'4AIM
MO=-;W<I,8,&V3RR=N[+<]=N?K5OPQ8ZE9>+/%MY=Z9/#;7UQ%-;2,\9\P+$J
M$8#$@Y'?%<O-X<\02_";7]#&BSC4;R]FEAA,T/S(\_F [M^!QUYS0!VMMXL\
MSQ/%HEUI-Y9O=0//9S3%")U0C<,!B5/S X;''7!XKF[CQ5;Z7X+\8:SX?T-[
M:ZLK^=+E)F4;K@*NZ4X)!'(X!YQVS6KJ=EJ=W\0?#&J1Z5<?8[2VN4N)"\0\
MMI0FT8WY/W3G&?QK"_X1K7+OP9X^TUM-D@N=5O[FYLEDECQ*KJ@495C@G:>N
M.HH UM2\5ZS::QX4L4TE_P#B9/*9LS1[G"0LVT<X'.&SQTQWJ]K/CFUTF+49
MTM7NH=,.+PI,BLI"AF"*Q^<JI!/0=@2<@9FJ6FN75]X-UF/0IRVG2RBXL_/B
M\U%>$QAB=VW /H2<>_ K6]IXB\-^)-7BC\,1ZUI^IW1O+>X2>-# [@!TDW\[
M01D$ \=B>  =,?%%KJ$T%GI-N=1DN+-;T@,$18'^X6)[MS@8['.!6)\)-O\
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M^8%.20F=N 3G@_4@'94444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT8!E93D$'N#3JXJ#Q;;:7X>\)S6FC>3IFK+;P0!90JVID7**W'3'&1WK:O\
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MM#U%]7T.RU"2V-L]Q$LC0E@VPGL&'!'H>XYJ[+#'/$T4R+)&PPR,,@CT(IP
M4    < #M0!Y-J7A[Q9J.G2"\T-;O5+?68[I;UKN/]];K,&58@3\@"@ J=O3
M/)-=/IECJ]KX[\1:M/I,HMKRTMHX3'-$VYXP^X#+ XRW!('3G%=G10!Y)I7A
M3Q-HFB^"M0BTOSM0T!9[>ZT\SQ@S12\%HVW;<C ."1FNH\-6.LIX[\1ZO>Z4
MUG9ZC#:B$R3HS@QHP((4GGYO7''4UV=% ''^*O\ D=_!'_7[<_\ I-)3-3T[
M5=3^)>B7LFF2_P!CZ7#,4F\V/YIY %W;=V=H7/.,Y/2NAU30M/UF2UDO8Y3+
M:.9()(IY(7C8J5)#(P/()'XU?AB6"&.)"Y5%"@NY=B ,<L223[DY- &=XEMK
MZ]\+ZK:Z8X2_FM)8[=BV,.5(7GMSWKBCH_B*\3P7:C0Q9Z9ICK)<6S7$9*21
M18C+%205#G("Y/&2!7I-1QW$$TDL<4T;O$VV158$H<9P1V."#0!SF@:)<P^*
M?$.O:C$$GNYDM[4;@VVVC4!3QTW,78CZ56TS3]9MO%OBG5I;!2;@1QV3M*N)
M(XX_D50#D9=I"=V.W7MV%% 'E\7A?Q!!X#\,PG3A+>Z=J46H7MEYZ;[@Y9I/
MFSLW>8Y8#.,*.0>!U/B)]>U+P9K":=ICPWT]JT5K!+,@DW,,$DAB@P#D?,>G
M:NGHH \WO(9$\0^#O#T>G22PZ1;M?RVT+(2@1?)@R68 G+,3@]5XSC-+XC\*
M:UK&E>(]56%?[8U"VCL[6S$H'EVJN&:,OTWOE\\X&0,\9/7)H^F:=K\VM/<2
M)>WH2W9I9_E< G:BJ>!R3@#UK9H X:33]?U+QQX?OYM)%MI-C;RLD)FC)AF;
M"?/M)R=A? 7(''/)QF7?A/6F\'>)W6S+:WX@O6\Z-9DW1VQD"!0Q.WB$$]>I
MKTRHX;B"Y#F":.4(YC<HP;:PZJ<="/2@#DIM)U23QYHMW]@C&FZ?ISQQNLHV
M0S.RAAC[QQ&N <8^;M2W_P#R5W1/^P1=_P#HR&NPK*@\.:;;ZS_:ZI</?!'C
M62:ZEE"*Q!955F(4$@< #I0!@?$BQDETO2-5C4LNC:M;ZA,!U\E6(D/X*Q;Z
M UV8(90RD$$9!'>@@,"" 0>"#45K:0V5NMO;ILA3[B9)"CT'H/0=!VH YSQ_
MI.H:QX<BCTRW%Q=6][;W0AWA#((Y%8@$\ X!ZU5^Q:Q+\2;+7)-)D2S329+6
M1EGC;;(TBN!C<"<!<$XZ],CFNSJ/[1"+D6_G1^>4+B+<-Q4'!..N,D<^] 'E
MJ>%/$RZ!-/:V*0ZK9>(IM7M(+B5"ES&Y;Y"58[25<CGO^==UX?N]:U /<:KH
MR:.@7:ML9TFD9N[%EX '0#.3DYQQ6Y10 444R66.")Y976.-%+.[G 4#J2>P
MH ?138Y$EC62-U=& 964Y!!Z$&G4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:C!ON9UY"SX7;TZA=J+QU"U:\.7GC&[>"'7](M-/6W'[^XBNA+]J.,#8@'R
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M*N!<):W+@+*I0H\989 )#'!K$\=W.N7WPI\1W.LZ=%IF;95CLTN!.P.\99G
M YX  ],D\X !MIXWN8/$]EI&J:!<6,.I*YT^Y:9'\YE&XHRC[C$= 3_]:'3?
M'USJ"7-V_A^:WTNRN+F&_O)+E,6_D@DG;U;.,<=,]^<376EW_B'6?#]W=:>]
MG;Z2[73AY$9II2A553:3\O))+8Z#CDXIZ'X6OYO"/B?0]4MS9G5;N\DCD#J^
M$G)*G@]1GD?K0!9M_B#;R:WI5C-;VXBU3(@DM[Q9GB?&0LR ?(2.,@L,\>]7
MM$\5R:\ME=65C%)IMU+)'Y\=SN>$J&(\Q-ORD[<8R<$BJ7A>;QJ(K33-;TNS
MMDM%"2ZC%="3[2JC V1XRI;C);IS@<C&9IWA2]'B?2M<@TIM$U#<QUAX9T-O
M>+L(P$5CEBY!R0,<\DXH M:A\3;"QMUU!8[:?3!<_9W>.\4W"C?L,@AQRF?]
MK..<58N/&U^=4U_3K'PY+<3Z.L;OONDC6170OP<'!P.!SGOBL_PYI_C/PU$_
MAJ'3[2XTQ)G^R:N;H PQ,Q;#Q8)9ER<8P#QSWJ[::3JUOXH\97[:<Y@U2&!;
M0B6/+&.(H<C=QDG(]O3I0!6U#QGJ-Y/X*GT:VA-GK;F1A-,4<XA9_+.%( Z$
MGGD8QWJ_KOC:?1+;5[Q]'=K+26C6XEDF,9D+ $^2"N' ##J5R<BL.T\+^(++
M0/ NS3XY+S09"MS;M<*NY3$R;E;D8&0?7VJ'Q'X9\4ZS;^*[.?3K6\DO4_XE
MUY)= +!'M'[I$(RIR#SP#GD\ 4 =#<Z_K!^)EEHUM;VS:<^ER7>6G*L_[R-=
MQ&T\KDX'?)Y%,L/$**/%MSIWAM4O=.N?](B615DNV$8;=E01NVX !S]133I.
MO)XUT77%T^!D&EO874?VD?Z.3(CALX^;A<8 Z^W-6_"NEZC8>(?$]U>69A@U
M&\6XMV\Q6RHC5,$ G!^7- %JR\3G4='T&_L[6.4ZMM*QB?\ U:E"Y).WG: 0
M>!SQ61K'Q)L],M[N]AAMKJSL[@V\X6\5;@E6V.T<6/F .>I!."1Q@FQX/\*7
M7A[4M36:16TZ*>0:3&/^6,4I$D@_[[X'LOO6=I%CXR\,7U_I%CIEG?Z3<W<M
MS:7\ET(_LHE8LRR1X)?#$D;>OJ,\ &S+XO,U]J5KI5G%>R:<D;S1&Y\N5PZ!
MP43:=PVL.21SD=JZBO.O%OA.]U^XNWCTIX]7MR@TK7+>=(F3Y%SYN"&P'W\!
M6X/&*Z>WU;55\7MHUUIR?83:>=#?+,"9&4J&#1_PC+<?0_@ 8/Q+2..;PC="
MV\V>/Q!;!-BC>05?Y03ZD#N!6A:>-U2;7X-;L#ILNC0I<RXF$RO"RL0P( Y^
M4C&.N.32^-M+U'5)?#QL+0SBQU:&]G/F*N(T# @9(R?FX'MUK(U3PCJ.N:]X
MM6:!K:RU?38K2"X+J=KIOY*@YQEA^1Z4 :-MX]B?Q%I^DSVUO_Q,4=K>2TO5
MN"KJ-Q24  (2.A!()XS6?%XUM-(\&Z_KUIX;,"V.I3PW-M%(BEY0X5Y&(&,E
MCSC)XK4\.7?C2?R+77M)M+,6RXGNXKI9?M9 P-B8^3)P26/; '.1S5UX5U^X
M^'_BW1UTW%YJNJ3W5N#/'M\N24.-QW<$ '(^GX '32^,+RUNX+6_T9;"2]NO
M(L6NKQ529=A?<Q4$H>-NW!))K?TN[N;VR\V\LS:3B22-HM^\?*Y4,#@9! !'
M'0UC>(]/;6["SM+[P\NI:?*&^UVKO&)(C@;60E@,@Y'##@]>Q?X(T:^T'0&L
M;V>:1%N)6M4GE\R2& GY(V;N0/<XSC)Q0!4U_P :S:'#K%W_ &0[V.DF,3RR
MRF)I=P!/D@J0^ PZL.<BI;[Q?<0>*(="L]&ENIKBQ:\AE,ZHC ,HP>I ^;D]
M?0'-<SXF\,^)]83Q;:/IUM>_;8\:9>2W( @CV >4J$?*V0<G@'/)X%;%KI>M
M?\)SI.L7&F;+>#1WLYO+G1MLC.K#&2"0 N"<=3QD<T 6++Q[!<>&QJ,]C+#>
M_;SIGV 2!F-T'V; W ([[NP!/:LJR^TGXY;KO3[>UF;P\Y+P2^8LH\],$L54
MY'3D>E9K^#/$3Z+/+!:QQ:G:>)9-;M(99EV3HS$^664G:<,?;..?3?LK+Q!>
M?$:U\07.C)968TEK.19+M'=',H?HN0?N^O?J.E '1ZSJLVF?8H[:PEO)[RX$
M"!<A(\@L6=@#M4!3S@\XK"C^(%LNBZK>W=LD$NFZ@NG3+YX:+S&9%5O,P,)\
MX))&1@\>MCQG9:U>'23IENMY9Q76Z_L?.$1N(]I &X\$!L$J>#C%86F>']=T
MY/$L,_A_3[BSU#4$G6U$ZLDD)6-70!@!P%/7'('&.: .AOO%4FD:7>WVJ6,4
M$<$D*1RI<[H9?-8*K;RHVJ"PR2. ">>,LU76YH?#FN3ZGH<=Q;6MJ96CBG$L
M=U$4);!95XP"",?TK#TKPI?:)8:W;V.EM-HUU+!]GT2]G20(F?W^"690"#D+
MN/*]LU%:>#K_ $WP]XNT_2[6X@T[4K4PZ=ID]PK>1(T;*[ [B%0EEXW'H>.U
M '0Q^)K>VM/#%E96"+<:Q &M+4/LCAC2(.V6 . HP!@<DCIVSI/B'+#I'B*]
MDT&??H3M'<HMPA5F4 _*3@[=I!SM_"LW5[35(K3P98VFE)<:SIL!E>)+Q(9X
ME2,1%E<AD*%F (/7CCKADUIJ6H>$_$GAU/#%Q8:OJ,+SEI;R*87#2?*79U(
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M[B)7^[(\07A>F?FR,CZ"SI_C#5]4UR^T^T\.;H[#4%M+J9KU1L0J&\P#;\Q
M/W?UYX .KN;RULHU>ZN88$9@BM*X4%CP ,]SZ5-7"_%9$_X1BRF,(DDBU6S*
M8 +#]\N0,],UHV/BN\;Q)?Z)J>D?9KB"R%_!]GG\\S1;BN,;1A\C&!D<]?4
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M1110 4444 %%%% !1110 5S'C?P]=Z]I]A-ILD::CI=]%?VRRDA)&3.48C.
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MWTG2[K4;M]EM:Q--*P&<*HR?Y5B6NNZU)?:3Y^B#[!J,;.TL,I9K/"[E\W(
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M58GD228X??*!N*E".&887T'7BM;3?#FMQ^,WU6:STRSL)](6Q:"WF9C 5=F
M7Y%#?>Z\8]\9.6W@[Q+)\(U\)/#IPNX?*BCD6Y;8RQRA]Y.S(R%QC!^O8 '7
MW6O32>(I-!TN&&6[@MA<W$D[E4C#$A%X!)8X)[8 SSG%<_<?$B6+PW)J,>CA
MKRTU-=,OK1KC!AE+JN5.W#@[@0?EZU>FT/5+#QPWB;3H8IX[VS6VOK-Y=K*R
M'*.C8P<9((./7VK)U+P-JDOA^]BMEM7U+4M935+G=,5CC"NK!%.W+85 ,X&2
M2: -_2_$FH3>,+GP]JNG06THLQ?6\D%P90T>_80V57# XZ9'/6L_XMSWEO\
M#C5&M1'M=4CE9I"K!6D12  #G()!R1P:NKH^J-\2H]?:"!;'^ROL)'G9D#F0
M29QMQCMUI_Q T74?$7@Z\TC3$@-Q<F/#3R%%4+(K=@3_  XH CDO_L_BBWL8
M=,L!XBO+1I9Y5<E8[:-L*6;:&;+, %P._/'-"Z^(,]IH/B2=]*C_ +5\/L!=
MVAN"$92NY)$?;DAAR 0#P15O4]#U3_A+],\6:?#"US':O8WMD\V-\);<"CXQ
MN#<\@9'<5FZMX,U+4-&\7S1I;#5?$2I%Y9E(C@C1 B MMR3U)P.IQVS0!U.A
M:AJ^H>?+J6F0V5N5C>U9+CS&D5ER=PP-I'''/7J<9.'%JVM3_%.]TATM6TV#
M3HY53S6!P[L"Q&W#-\N,< #OR:ZK34GCTRUCN8UCG2)5=4?< 0,<' R/PKGI
M=%U>W^(LNNVD=K+97.G1VLHDE*R1LCLW VD-D-CJ,=?8@'&>&?$E_P"%? \V
MH1Z7!-I-OK%Q'<NUQLD"O<E,QH%((!8=2/ZUV>L>+VM=0O[#3TM)+FPB5Y1<
MS,@=F!98UPIYQ@Y/ W#KSCG)/!?B&3X9:EX;\FR%[=7S7"/]I/EA6N!-R=F<
MX&.E:EYI'BK2?%]WKF@0Z?=6^JQ1"]LKN=HS%*B[0Z.%.1MX(QVH Z?P_K U
M_0++5!:S6OVF/<8)U*O&<X*GZ$'ZUP>A7$%I\5/'X?39[K=)8D>3 )-O[CG/
MIFO1K".ZBLHEO9DFN<$R.BX7<3DA1Z#.!GG &:X_2-'\1Z5XS\3:U_9]C+!J
M[V[1I]M*M&(H]G/[LCGKQ0!9;5+G3?!ESKV@^'A+)(SW4NGO)Y+\?*V %/SX
M7)7USWJYH?BM=<M9M5ABA&AI;K*M[YC9=MNYP%V]%Z$YZ@C&0:)$\43V5PIB
ML[:6XN%15AN"?L]OQN<,4&Z4Y;'  ^7K@YR])\(WNC:EK.D6T</_  B6HQDQ
MQ>>?-MI'7$FP$?<;KC/!^M "1>/Y9+G195L(YK#594B MY&>:VWC*/(NW&WH
M&P?ESU-6V\6ZE=:<^KZ/HW]H:<EV;<)'*?/F59/+>1%QC 8' )Y SQ53PKIW
MC;2K>TT+4&TQ].L=J)J,4C>=-"GW4\LC 8@ $YZ9QD\U!H.@>+O#3W6A6+:?
M)H<EQ)-;7LDK":U21BS)Y>W#L"3@Y YR?2@#;M/$MW=:]XDTD6,*RZ1'!)&_
MGG;,)%9@#\ORXV^_6N;NO&>LZII_@B_TZVMK>+6;H>="\[9X1V";@OW?ER3C
M)X&.M:LNAZ[8^-=:U'3H;*>SUBU@C>2:9E:W>)67.T*=X(;U'/<=:R;/P;XB
ML_"7@ZV6/3WU#0;M97B-RPCD38ZGY]F0?FZ8(XZT =#%K,S^/KK1VTFS2\CT
MI;I+L2Y,BF0J(R=F0H8,>_KBH-)\97>I^%[O4&TV&'4[:]:P:P-P3B82! I?
M9QG(.<=#FI8-&U4?$E]>FCMOL3Z4EB2LIW[Q(7+;<?=YQUS20>$I;?X@W>MQ
MSJ--N8TG>V];M5:/S/IY;?B<'M0!'J_C.6UGU*VL(;.:YTU%,T<T[+YLA0/Y
M<>%/.TCD]R!CKBS+I]AXZT71=2N;'R=KQW:+<Q?OH""&*C^Z<J 3Z?@1FW.C
M>*M$\7ZEJ?AZ/3[W3]6,;W%O>3-$8)E4)O4A3E2 ,CKQ796<<\5G$EU,)K@+
M^\D5=H+=\#L/0>GK0!S>G^+9M7U"YBT^"TE6TOVL[F SD7$*J^PRE,=#C('H
M<YZBM'Q9KDOAOPO?ZS#:+=&SB,IB:7R\@=><'^5<U?\ A"^U;7;'4Y;&ULM5
MM-1\T:K;38:6U#DB-U !9BF%(.0.3GL=3XF?\DS\1?\ 7C)_*@"F/&VJV>O:
M/;:MH<=KIVL'R[.Y2ZWLLNW<JR+MPN[M@G^>$TSQMJU_+J$\FBVUOINEW]Q:
MW]RU[DQK$N2ZC8-WOTZCKSB1='U#Q"/#,E_;0VUMI3I>MMEWF:58RJ!>.%^8
MDDX/ &.]&@>%KY-*\5:9K$<*6^M7MU.I@F+D1S*%VG*C# ?6@!+CQQ=6&B:;
MXBO=-CCT.^>(,ZS$S6T<N/+D<8P1RN0#QG^*I6\4ZY=>(=?T73M%M'N-+C@D
M22:\*I*) Y&<(2#\H&,8ZY/3.:OA/6]0\$V?@W5DM?LENT,4M]'*3YUO$ZLH
M5,9#D(JG)P.3D]*UM.TC5['QMXDUEK:W>VU&&W2W43G=F)6'S#;@ [NQ/2@#
M+@^(E_<:+H.O_P!BQ1Z/J<\-M(6NLS1O(VS<%"X*!N.H)]!6NFNJGC[4-,ET
MJ%9+?2UNQ>1MNEECWL F-H(P0QQD]:YN'P7X@A^&N@>'1#9->:=>0S2M]H(1
MECEW\';G)Z=*WFT;6?\ A/[W78X[>.WFTE;*(^=EUD5V<,5VXQEL=>U $GA[
MQ=)KMG:ZFB63:5-;//+-!<%VM6 !\N08ZX)R>,%<8[U0C^(,DDNC7$=A'/I^
MJ3)$!!(SSVX<9221=N-O3=@_+GJ:AM?!$D_B2#5I-/M])DEM)H-66RFS'?%U
MP,* .A);<0#G P>HF\*Z9XUT>VM- O7TU],LML<>I)(WG20+]U/+Q@-@!2<\
M#U/- %_2_%LVM7DJV$%I+';W[V=U#YY%Q;A79?,9,="0"!Z$'/45N:WJ$VE:
M+=WUM83W\\*;H[6 9>5N@ _STKC[KPA?:GK^FZM-8VMCJUG?^;)J=K-@SVP8
M_NV4 %F9=JD'@<D'L>B\8Z;JFK^$[^QT:Z6VOY541NS%00&!921R-R@KD>M
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M!-'O] \%:9I.IK +FTB\MC!(74CMR0.>?_KT ='1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%9>N:]:>'[:&YOEF\B69(-\:[@KNP5<]\
M$GK0!J45D/XCLHM?FT61+@7D5H;W B+!XMVW*[<DG/&,9K'M?B1H5Y;Z;=1)
M?_8]0F%O%=-:L(ED+%55F[$D?AD9Q0!U]%8>J:Y9I+=Z<L5[=2PPB2Z%ED-
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M7J)J'V*>X^S&Y-HPCA??L D)^[EOQ&1G&: .PHK(OO$-K9W\M@D-Q=W<-O\
M:98;90S1QY(!.2.I!P!DG!XJ30M>L/$FF)J6F/+):2'Y))('CW^XW 9'N..O
MI0!IT5REEXF?5O&6M^'7T^[B@LHH%\Y3M)+B0EMRME00J@8YSGI7-_#WQG:6
M'@?P]!J;7\LEU,]N;UXF>,2M,X57D/<\#O[XH ]/HK$U;Q19Z2MXS07=REB@
MDO&MHPXMU(W9;D9^7G"Y(&#C!%:EG>6^H64%[:2K-;3QK)%(O1E(R"/PH GH
MKG;CQII=K);-,MRME<W'V6*_\L>0TN2 N<Y )! ;&T^M-TO4-&E\6>(1;RWB
MWMM'!]N^T%UB0;6VE W X!)(&#QR: .DHKF&\>:1&FG3217XMM3)%C,MJT@N
M#C/RJF6&1R-P&17-V'B*+P[XQ\<FY&IWD%O+;2+%$KW!A3R-S'D_*N23C/T'
M% 'I=%<AJGC=+?5O#-M86<]Y;:R'E6>)008Q$S@*"0=Q^4^PS6)8^((_#_CG
MQPUPNIWD,/V.1((@]PT2F$LY )^5<DG&1[4 >E456T^_MM4TZVO[.02VUS$L
ML3@8W*PR#^1K"T35&\1>(=8E5V%AI-S]AA0' >95!E=O7!8*!VP3W& #IJ*\
MEL-<OKZ.32?.OHO'<.H#S89)7$?E>;DN%SL,/E<=.N/XB">Q'BB2Y\>77AK^
MS[I88;-96G7 W%V(# @Y"C!YZY^@) .IHKR_P5XPM-$\+A=4?49D_M6X@>\9
M'E2',[*GF2'\!W/(SU%=3KNIMX<U_2+DNQL-4NUL)XR<A)64F)U],E=I'0[@
M>HY .GHJ&[N[>PLYKR[F2&W@0R22.<!5 R2:\_UG66O/B%X(\J'4[2.XEN&V
MS$I'.GD,02@8@$$CA@&&>E 'HU%<VWC?21-&,7!M9+[^SEO @,7VC.W9UW?>
MXW8VY[U<L?$=GJ&OZAHL45PEY8*K3"2/:NUL[2IS\P.#R/3G% &Q15+2M3AU
M>R^UP1RI$7=!YJ@%BI*DCD\9!P>_7I7%:A>G7_B+>>'+VUOSI\>FJ56([-LC
MRLIFR&[!1M/4<\<T >A53U32[/6;"2QU"'SK648DBWLH<>AP1D>U8$/BO2=&
MTB R37]QI=NZV;:O, Z%U.S+MU/S#!?;MSWJI=-(GQDTQ%N)_)FT>=VB\YC'
MN$D8!"YP#@]0* .QM;:*SM8[: ,(HUVH&8L0/3))-2UP?@J_BTVV\9W&H7L@
MM++7+C,MS,TGEQK'&<98DX'I700^*K)]4M=.N+>[L[B\C:2T%S&%%P%&2%()
MPP'.UL-[4 ;E%<N_CW28]"U'67AO1::;<-;7?[GYXG7 ;*YS@9'/OGIS6L^L
MPQW=I;-!<F2ZA>==B!]JIC=G!/\ >4<9R2,4 :5%<3IOBWPUHG@[^UH)-1.F
M->R1[YTDD<2&4J<[ONKN.!NQ^=;6F^*]/U/7)]'2*\M[R*$7"I=6[1>;%NV[
MTSR1GCG!YH W**Y>;Q[HT%K;7K+>-875P;6WNXH#(DTN2H50N7.2I .W!QP>
M1GH+B\BMK![V02^4D?F,%B9GQC/W0-V?;% %BBN5TWX@:+JD N84ODLS:_:5
MNI+5Q$PW!=BMC#/D@;1DYXZ\5=MO%>GRZM/I=TD]A>PV_P!K\N[4+NAS@NK
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M!MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.GP]NK6\LK6P2^<Q6:2[VM4:.3B61B26)Z]!G(YQFKZV.G-HGQ78VUL626X
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M06EMX#^%MQ#'#',VJ68,B@!CNC<-S[\ _05LB/3QXT^),5U)]GM7TNU-R\.
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M=% .>3P-H-6=(@TC6?%'B#Q"MYI5P+FRCA%M#<13NH0-F1RI(&<@#!/ Y/8
M'9VVNZ1>3>3:ZI93R^5Y^R*=6/EYQOP#]W/?I3K'6-,U-Y4L-1M+IXL>8L$R
MN4STS@\9KR.RM(+7X :=JMC91M<)!";J:")6F:W$ZM,N2#D;5.0>,#D5ORMH
MVMS7>M>&]?GU;7_['GA@,$D>(U*DH) BK@[\8#<Y[<' !WD.M:5<7[6$.I6<
MEXH):W2=3(,=?ESGCO4,OB70H0IEUK3D#RF!2UT@S(,90<_>Y''7D5Y]X;N/
M"WB33_"K_P!MW$^HV#1^1IR&)98) NV1614#; ,[L\$#OQ66UGIY^&7Q+<06
MY*ZIJ 5MH^7:05 ],'D4 >N1:OID^I2Z;#J-I)?Q+NDMDF4R(/4KG(ZBDEUK
M2X+]+";4K..\D(5+=YU$C$C( 7.<XKA+R&TMO%_PV>!(8FDCN@2@ +@VV?QR
M>?K6%I=QH>L^%[W0/$VN74&J0:A*;C3E:))Y)_.+HT64WL3E<$$^G2@#U6Z\
M0:+8^?\ :]7L(/LY43>;<(OEEL[0V3QG!QGK@U2UCQAHNB7.F6]W?6ZOJ,FV
M',J@;-I8R$]-O'7N2*Y33K'3IOB+\0!-;6SE;2SSO13@-#)N_/C-8.EW<,'A
M3X47=U<)'!'<%7ED<!5_<R  D\#IB@#V*2YMX;5KF6>-+=5WF5G 0+ZYZ8]Z
MX'2/%LNOPC6X/$VG65I;WTJW-E.8RGV57*!BWWE<X# YV\]*]!1UDC61""C
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M2W.H1J7C:Z:<HL08ER68E5^8#TR1ZF@#4CU_1I8(YX]7L'AED\J.1;E"KO\
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MEV'ZKC%/:]MUOTL3*OVEXFF6/OL4J"?S85#83ZA-+>B^LDMDCG*6S+-O\Z/
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M?910201V=ND,@P\:Q*%;ZC&#26VFV-D5-I96T&U=B^5$JX7.<# Z9).*M44
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MC@^SB!AN4IC!!SUR.N>N:R_#_@70?#%P9M,MYE(!6-9;B2585/4(K$A<^W-
M&-\5+.&YTG1&E#DKK=FHVR,N-TH!Z'KCOU':J]]I-O=_%VUT]Y+E;8>''#+'
M<.K.OVA>"X.['T.3CTR*[/6]$L/$.FFPU&)I("ZR#9(R,KJ<JRLI!!!'4&JT
M?A72X=8CU:-;E;V.V^RK)]JD/[K.2""V#D\DGDGG- 'G6FZ[?VOA;2=,>]D,
M,OB.XTLW%Q,V[RD:0HAD'S<E57.<XXKMO#FBW^BZ]J)FU*-K*[19(=/5G?[.
MPX9E+'(5LCCIGI4I\!^'7T*\T66R>:PNYFN)8Y9W<^83DNK$Y4YYX(J[H/AK
M3?#=N\5@DQ:3'F2W$SS2-CH"S$G R<#H,GU- &)?WHU#XFQ>';R1A9+I)O$A
M#E!/(9=AS@C=M4<#_:)[#&3=M/HNJ^%/";:Q=WEE>7MTMS<22$2;4C\R. N#
MG&64=<D+CH2*ZSQ#X1T?Q.UK+J,$GVBU8M!<03-#+'GJ ZD'!]*=<>$]%N=&
MM]*>T(MK:030%)&$D4@.1('SNWY));.3DYSF@#C-1:[TKQ-XGT*UNKM=,DT!
MM2B"SN&M)@S)A&SE0=N[&<9!]ZHV4<UAI_PUUB/4+][S4&M[>Z,MT[)+&]LS
M%2A.W@@$'&<\DD\UZ&/#6G?9+Z"03R-?H([J9YF,LB $!=^<@8)X&!R?4U7/
M@O1FM-*M3'<^3I+*]DHNI/W1487^+G XYSQ0!R%SJ%SI'B?9XAMKK[)<ZL#8
MZW9SEXP#)A;>9 ?E QLZ$9YZY-+<ZU>Z!K/Q,O()IYS865K/;132M(L;&*0G
M ).%SR0*[)?">EB5BPN'A:[-Z;>2X=HO.+[]^TGCYCNQTSSC-20>&-*@U34M
M1$,CSZFBQWGF2LZ2J 5 *$[< $C@=Z ."US3;9+#X?:DEQ//<3ZO9M+.\[-Y
MY>-F+,"<$YZ>@) P.*M"#4?&LWBBWBOEM;NSOWM+>03R)):!578ZJI Y.6R?
MO<C.  -Z'X;^'(8;6!8[XV]G<"YM86OYBD#C.-@W?*!DGBIM3\ >'=6UHZO<
MVDJWCJ$F:"XDB$ZCH) I 8=N>W!H Y=],EUKX@VVEWVM7TMO/X96:=K2Z>))
M9?-5?,0 _*#P<#K@9R,YSO%]Q+;>'O$^HZ7?WMW<:=>1(M\\[1BS9#&IAC )
MWGD[B0 =YR217I(\-:8OB!-<6.5;](/LRLL[A!%G.S9G;C//2LZ\^'GAN_;4
M_M%I,8]3?S+F$74BQM)Q^\"!MH?@?,!F@#';3;:3XYM*PEWG05F)$SC+"XP.
MAZ8 XZ>U84VO:EX?\&?$.^M;JYEGL]8>&WDFD:5H480KD%B>%#$@>U>AOX4T
MA]4LM2,$HN[.'R(Y!<2 LF[=M?YOWGS?-\V>>:+/PIH]C%J<4=N\D6J.TEY'
M/*TJRLPPQ(8D#(P./2@#F?$$3^&]:\)WFC7%PR7U^EA=Q-.\BW$3HQ\QLDY9
M=N[=UY.>*YBXLY9O!OC^_?5-5-QI6JW;6+?;I?W)C2-E_B^;T^;.!TQDY]-T
M[PKIFF/:M$+B7[&I2T%Q</*+=2,83<3CCC/7'&<57'@G1!IVJ6'E7)MM4E::
M\0W<G[UVX8YW9&0!G&.E &QILSW.E6<\AS)+ CL?<J":YCXIO+#\-=:N+>XN
M+>:&'>DD$S1L#D#JI&1@GCI5L^$;9/$VCZG;>?&=-MV@#M<NV^(JP$94G!Y8
M,6//RJ.>VMK>BV/B'2IM,U*-Y+.; DC21DW#K@E2#B@#C/&^GV]UXC\#O+YQ
M:2_,;;9W7CR9#Q@C!SW'-=GJLD5AX?O)&O#90P6KDW1^<P@*?GY^\1U]\55O
MO"NF:C-ITUT+IY--;?:L+J0%&QC<<'YCCC)S6E>65O?V$]C=Q":VGC:*6-^C
MJ1@@_A0!YMI3W-IXR\(0PM>1VFHZ;<B9Y[AC)>;$C(ED3)"L2Q(.2WS8.,8K
M!NH[F/X9^)=;&J:H=0TK5[G['*U[(?+"3A0",X?CCYL\5Z1;?#_P_:RZ=,D%
MTTVG!EMI)+R5V12 -N2W*@ 87H/3DTX^!-!;1+W1F@N387LQGN(C=RG>Y.XG
M.[(R>2 : ,CQ',?"_C?2/$<]U.-'O0;"\1YV\FWE;F.7;G:,X*$]!D5T'A6"
M3^RVOYC,)=1E:Z\N5V;RD8Y1 "?EPNW('?-9>M07.MW#>$Y-#N7TO,+S:C<R
M*T3QJP<J,DL7)4+TXR3V&=#6_#D>KZYHNH#S(Y].E,B3+,RA5.-R[!PV[ '/
M0$T 9_Q4MX[CX8Z^) 2$M6D4!B.1TSCK]#6;),(O%/A7PSOFCTVYL9KJ13,Y
M-Q(JKA"Q.2H!+%<X/'85W.HZ?:ZMIMSI]]$)K6YC:*6,DC<I&",CD5DR>#=&
MDT^RM#%/FQ?S+:X^TR&>)L8R)"=W3C!., #& * ,CPM-=V7CKQ-H FFFTNV2
MWN;;S7+F R*=T88\[<KD#M2>,6;1?$_A[Q UQ.NGFX-C?Q^>PB E&(Y"N=HV
MO@$_[7M75:=I5II8F-NC&6X?S)YI'+O*V ,LQY.   .@ P,4:MI5EKFF3:=J
M,"SVDP DC;HV""/U H \RT._N#=:YX9FEO%FU>>.ZTN22YD:06<N<E6)RIC5
M'8#L2!6K+HUMJ7Q;U"QGDN5MAH%NI2*X>,L/.D RZD-^O/?-=P^DV,FL0:JU
MNIO;>![>.7NJ,5)'YJ/U]358>&].&O3ZVHN%U">$6[R"X?'E@DA0N<#!)/ H
M \R74+^?X.:!>2:C>&ZBU6*W,PN'#2(+LQX?!^;Y0!SFNJ1T\3>-_$^B7\\R
M1V%O;I:Q1RLFT2(6:48(RV2 #VV\8R<Z@\!: -"AT407(T^&?[1'%]KE^63=
MNSG=G[W.,]:?K/@?0]=U&WU"\AN%O8(_*%Q;W,D,CQ_W&9""P^M '*ZKIQ;Q
M=\/].FU6YO3'#J$,MX'V22[8T#99>0>""0<^^>:U_A\TD%QXGTOSYY;6PU9X
MK83RM(T<9C1MNYB20"3U/>MR3PMI,FHZ9?>1)'-I:&.S$4SHD2D $!0<'( '
M([5+I7A[3]&NKZYLEF66^E\ZX+SNX=\8W88D X ''I0!R>JZ;;3_ !ITB1Q+
MN?2)V)69UY62/'0].3QT/>N:N-/$WAWXE:B+N]AN+'4[J>V-O<O$(Y$AC8-A
M2-QX ^;(],9.?4-2\.:9JNJ66I7<,AN[,,L4D<SQ_*V-RL%(W*<#@Y%4QX*T
M466JV?EW/D:J[27JF[D_>LPPQSNXR !QCB@#F_[2N]?\46>C7#Q&-M"AO1#+
M*\8F=V(=ODQG;A<>FXFNG\(6%]I6AC3]1U4:G/;RLGGG)8+U5&)))(! R?:H
M-4\!:!J]KI\%U;SA].79:W$=RZ31+C&!(#N(QZFMO3M.M=*L(K*RB\JWB&%7
M)8\G)))Y)))))Y)- ' _9[JX^.6IK:WIM6&APDL(U?(\T\<UT@TAYM O=)UC
M6)7N)#--]KAD\B2-"Q*L-I&W:./3Y?K4DO@W29=<FUG-\FH31B)YHKZ9"4!R
M%PK 8SVIY\(:2]M>P2?;)!>[/M#R7LK.X7.U=Q;(7D_*..3QS0!R?PWNY[^\
MEMM9NYVU728$MXHV>15N+<Y*715C\Q<'DD97'8FJ6DQ:MXN\)VGB.#5X;"_2
MX:>2Z,TA,6QSNA9,A=@48V_CR3D]_<>&M-N?$%MKLB3#4;:+R8Y4G=?DSDJ5
M!PPSZ@UG1_#[PW%KTFL164D<\LOGR1).XA>7.=[1YVDYYZ=>>M &+I\)\;'Q
M9#=:A<VM[9ZE)9VSP2LC6:(%V.J@CECEB>_3H*GL)'/Q5-H+Z>XM)O#D<S R
MG9(YF*^8%S@$C'( K6U'P%X>U/7'U>XM)5NY5"W'DW#QI< =!(JD!Q]>O0Y%
M6M3\*:5JNJ6NI3I/'=6\9A62WN'AW1$Y,;;"-RY&<&@#RV>,ZE\.=&DO9[BX
MDB\4B)'DN'+!?M97&<YX48!ZCM7:7\;6?Q3\.6D-Q="UETZ[WP-<.R$KL ."
M2,_,>>M:B^ _#R:#+HJ6DBV4D_VG8MQ("DN[<&0ALH<\_+BKG_"+:7_:UCJ>
MRX^UV,;10.;F0[5;[V06PV<<DY)H XNVGN-#USQ+X3DN;F6XU!DN=)DFG=V$
M<OR, 2<@1,&; YQ5V<2:AXUO/"^]3:V6F0/!#/<RJTFYG#R94Y8C"#)/!Z<F
MNSGTBQN=7M-5EMU:]M(Y(X)3U17QN_\ 01^OK69XA\&:)XFN;:[U""47=L"(
MKFWG>&55/5=RD''M0!+X2LK_ $WP[!8:EJHU2ZMF:-KK!RP#' ;).2!@$^WK
M7*VW]H2>)_B-8V>IRPRK;6HLY+B=F2V=X7.1DG:-QSQ7>V-C;:;916=G$(K>
M)=J("3CZD\DGJ2>2:RF\(:.]SJ]P\4[2:O$(KW-S)B50I4#&?EP"0",8H YW
MP;J@?Q))IFHZ9>Z/K<5ENDM'F,MO<(& \Z)LD$Y.#WY&<XJ[XLU&X_X2SP[H
M:R1I;WZ7,C"21D69XPFU"5YQAF..^!6_8Z#9V-Z+T-//="'R$FN)6D9(\YV@
MGU(!)ZG R3@5'XB\,:3XIL4M-6MO-2-Q+$ZN4>)QT964@@T >>>)]+U7P_X.
MU*-M>G8C4[66UCMYY UK'),JF,DG+KUP&R!6W;6*Z?\ %6;2(KJ]>QO]#>XN
M(IKN23=*)E3>"6RIVL1\N!6X_@;0I="&CR07#VGFK.^;J3S)) 00SONW,00.
MI[#TJZ/#FGC7X]<(N#J$=O\ 9EE-PY'EY!*E<X/(!Z=: /*;&V%E^S=<WMG<
M7=M<B"5Q)#<R*05G<#&&P!@G('![UU&K:=;7/Q9\+R2B4O)IER6*S.N=OEXZ
M'@<GCOGFM\> ?#RZ)=Z,MM.-.NW+2P"ZEVX+%BJ_-\JY).!@9-6[SPKI-_<:
M;<7,4SS:<&6WD%Q(K;6 #*Q!^=3@9#9!Q]: .%OM5NM#U/XJZG9?\?-M%:/&
M<9VG[,/FQWQU_"M9-,O;"^T[Q%9ZI$+-;:3SK=)Y9O[1!CW(?F.-XP3N R1G
MM736_AC2K;4-3O5AD>;5 %O!+*SI, NT JQ(QMXX'2J>@>!- \,W)GTRVF4@
M$1)+<22)"#U$:L2%SZCF@#SO6436O@I:^([JXEFU&ZFMKB643-M):Y0&/;G&
MQ>@7H"H/7FO8+^,3:?<1EY$W1M\T;E&''4$<@US+_#3PS):W-G]FNDL;B43/
M9QWDJPJX8-E4#87)';\,5TEUMMM,E"K*X2(J%4-(YXP/4DT >,"WU"V^$6B>
M-;;6-4DURV\AQYEV[).K2A#&R9VD'=UQDGO79Z<TDGC'Q]9/<7!MHH+1XHS.
M^(BT3EBG/RY(SQBD^'GA6.'P3HD&JV]ZEQ98=K.Y=]D<P)(8*>#UR.H!Y&"*
MZ&^\'Z/J&LR:K-%.+F:(0SB.X=$G49VB1 0KXR>H- 'G=I)>:AX<^&3RZGJ"
MO>R^5<NEVX,J^4Y.[GD\?>ZCL16GK]G=^%90%M-1UCPY!9>7)Y%ZS7EBQ=V,
MP!(+9#  YR G89SU4/@/0(+72K:*&Z2+2G\RS O)?W3=,_>YZG@\<FKU[X<L
MKZ^FO'DNXYIX!;S>3<.BR1@L0I ./XFY&#SUH Y33KQ+CXC:)]COKB?3[SPX
MTPS(P27YXPKE2<!MIZ]>:S-.OC_PB6KP76KW\0_X2>6S@$;M)-,HF 6W0E@0
M& *YR,#)Z9KM[[P=HU_)ILAAFMWTZ,PVS6EP\!2,@ QY0@E< <>U53\/O#9T
MNYTY;.1+>>[^W$)<2*4GSD.A#?(1_LXXH Y*.6]BE^)%@9+BRBM+"&YM88+Q
MS]G=H9"2K#!7)120.,YZTEG%-IS?#?5(K^_>ZU%8X+OS;IW25&MBV"A.T8(!
M& #W.3S78CP'H EOI1;W'F7]N+>Z<W<I,J $98ELEL$C=UP3SR:F;P;H[0Z3
M$4N=FDD&R'VJ3]T0-H_BYXXYSQ0!SWP^TVVM_$7C*2(2AH]8=%S,Y&#%&3D$
MX)R>IYI?'.GV]WXY\$-,),O=SQDK*Z?+Y#GC!&.>XYKJK3PYIECK=YJ]M#(E
MW>$--^^<HS !=VS.T-@ 9 S^9I=9\/:=KWV0W\<I>TF\Z"2*9XG1L$'#(0>0
M2"* .5T<+XLUSQ9::C+<I_9]TME:QQSO&8(_+!$BX(^9B6.[KP!TK3^&VJZA
MK/@33[O5',MV#)$TQ&/-"2,@?\0HK0N/"FESZF^HQK/:W4L0@F>UG>+SD'W0
MP4C..@/4=C535_"-G>OH*VL)M5TB=9+=H96C6)%*Y7:.&W!=O/ !)]B 6O&-
MS':>$-3FEU272T$)7[9$FYXB2 "H[L20![FN6TA;F+XES:48KFQL+G01.;7[
M6S-O$VS>2#\CX)!VL>QSFNXU?2+'7M)N-+U* 3V=PNV2,DC(SD<CD$$ Y]JR
M;?P/HEMJ$.H)'=F]BMS;"X>\E=V0G.&);YL'IGIQC&!@ \UTT747PU\)>(SJ
M>I2:G_:<,;2R7<A5HWN"C(RYVD$'DD$^]=CIDB^*_$OBRWOY9@NFS):6T,<S
M)Y*^7N\T;2/F9B<-U 4 =\ZZ^ ] 70K71%@N1I]K,)X81=R_(X;<#G=GAN<9
MZU-=>#='N]:.KE+F&]>,1326]U)%]H0=!(%(WX]Z ,OX3?\ )+/#_P#U[G_T
M-JI6@FD\>>.;-KR\\A;&T>-?M+_NBRRD[#G*<C/&*Z[0=!T_PWI$.EZ9&\=I
M#]Q'E:3&>3RQ/?G'2JX\+:8-3U'456Y6ZU&,17+BYD&]0"  ,X& 3C&.M 'F
M>G+<VWA#X>Z^-2U!]1NM0M+:=Y+MV62*3<&0IG:>W.,Y&<U[-7.?\(-H0TK3
MM,$-R+/39EGM(Q=R_NG7[ISNR<<X!KHP, "@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH ***Q?$]Y>V6F12V=S;6H-S$EQ<7# >7"6PQ0'AG[*#
MU)Z'I0!M45YLOCR^TRR\7-<%KO\ LF>WCLWN8?)=_/5=HD4!< ,WH#BN@NY]
M=\/376I7E['?Z);Z?+<7 =%29)4&[]V%4#80#PQ)&.IH ZFBN3TN3Q/>Q:#J
MT=[;2VU[&);^U= J1(Z;E\D@;B02 =Q(/M60OB;6M6\"W_C+2[M(T@:>:WL7
MB4QR0PLP(<XW;V",<@@#(&#CD ]#J&[N8[*TEN9M_E1*7;8C.V!Z*H)/X"N
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M(#"4NP<9.<;=N!CK6AIVM:M<>/)]%NV,$+:-%?>5A"]O,[LK*& PP&.^?QH
MZ]F"C+$ =,FJ<NIPQ:Q;Z8T5P9IXGE6186,8"D @OT!YX%>77VMZSKG@3PW?
M3:D\,\WB*.UF,,:J)%6Z95R,'IL4XZ$]:[&;5M5L_B+I6BR7<<MA<:=-.^80
MKET*#);./XCP /QH ZVBN'TK5/$?B;0+#Q%H]W;HMQ=;A8S*!%]F$A4Y8 OY
MF!NR#C/&*@F\6SCQ?/HMYJ3:3>B^B%G;W$"B"\MLIN*R$<N07& PP<#!YH [
M^LK7?$FE^&[>*?59Y((I9!$CK;R2 N>@^13@FM6N!^+G_(K:?_V%[/\ ]&4
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MB8O FH:?K-]-H_B:YL-)U"=KBYL%MT<AV^^8Y#S'N^AQV[8[1$6.-8T&%4
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M#[\4 <<W@?4;3Q!?7^A^)KC3++4I?/O+,6R2@R$89XV;[C''/!Y_#%N[\(W
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M#Q ;?0]1,C+;/:"1[<N<L$?</DSV(S[CK7H%% %:QMI+/3H+5IS-)%&$\UE
MW$#&<"N?T/P@^EW^O3W=[#?0:U,9IX&M=H&5VE1\QRN.,$5U-5(-5TZYO9;*
MWO[66[B&9((YE9T&<<J#D<T <K;_  ]1?"E]X5N]4EN=%ER+6-H\36HW;D"R
M;OF"D#&1V].*LZ=X6UR*PG@U;Q9<:A)]G>"UE%JL/DEE*^8V"2[@=R1W[G-=
M62%4LQ  &23VJ*VNK>]MUN+2XBGA8D+)$X93@X."..""/PH P;?PL[^(K?7-
M3NH+B]M[1[57M[;R=ZN027^9MWW>!P!D^O&+#\.+JV\.Z3I<'B*02:/>+<V,
MK6BE5"[L*Z9^?AR,Y'08 YSWU(2%!)( '))H XP> 'D/B<76MSSQ^((!',OD
M(IC<1B/<".O X''OGK3;_P "7MY8:/)'XBFM]<TG*V^HQVR[=A4*R-%G!4A1
MP3U_*NM&HV3$!;RW)/0"5?\ &K- '':GX&FUC1(H;[7+B368+I+R'4UA5?*E
M3A=L8XV $_+GG).<U/8>%=1B\71>(]0UM;FY6P^Q/%#:")&7?OR,LQ'.._KT
MZ#JJ* .=\:^&)/&'AV71A?BSAF=&DD\GS&^5@PQ\P Y4>M23Z7KMZ(HKK6K1
M;82*TRVUBT;RJ#DIN:5L XP<#.":WJANKNVL;9[F[N(K>!!EY9G"*H]R>!0!
MS.L^"CKVFZI!?7Z-=W<J26]VD!5K0(<H$^?JIW'.1RQSUQ46L>#-0U*72M3M
M_$+V7B#3XS#]OCM04GC;&Y7B+8.2,]>#D^F.Q!!&1R** ..U7P++JVDVBRZY
M<KKEI<B\AU18ERLN-O\ J_N[-H V^W))SF:[\'3ZOX6U/2M:UF6\NM0B$;W2
MPK$L84Y39&.  >3DDG/7ICI+R^M-/MVN+VZ@MH%ZR32!%'XGBGP7$-U D]O-
M'-#(-R21L&5AZ@C@T <K!X0U-O$>DZYJ/B W-U802PLL=HL:2*^WH,G;]WGD
MY[8Z5%#X%GM_#^O:)'K)^QZHUP45K8$P"<DOSN&X\G!XQW!KLZ* ,"Y\+Q7_
M (&;PS?3"6-K,6IF6/;T7"N%R>00#UZBFW_A"QU+P6?#-S),8#"J&<-^\WJ0
MPDS_ 'MPW9[FNAHH YSP]H&L:<ZR:WXDEUAH5V0 VRP!>Q9L$EVQQDGN>.:Z
M.BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KEOB%INJZIX2EATB)+BXCFBG:TD;:MU&CAF
MB)]& Q[].]=365KR:N;:V?11 US'<H[I/(41X\'<I(!/(/'!YP>U ''^&=>\
M+^+/$=G/%9G2/$NG!UFL+B'RIMA0@KVW*"00>HQT&:MZI\2(+*TGU"VM[:\L
M;>Y,$B)>#[4P5]C.D.T[@&SQD$@9J6^T"[\1>,-"UB?2UTW^R7>1[AY4:6;*
ME1&NPGY,G)+$>@')JGHVE>,O#5Q=Z)86VGW6CS7,LUI?RW!5[19&+E6CVGS"
M"QQ@C/<CL ;UEXGFN/&EUX>N+". 1VBWEO<"X+?:(RVW(78,$'J,\9'6J[>,
MQ%9Z<]Q#:6]SJ3RFU66\VQ-"G/FLY48!!4@ $_.OOAOC#PM=ZW=Z/>Z=<^1>
M6DK0S2DX+6LJ[90,?Q8P1Z$4SQ;H6L-?:)K?AI;9KW2?,C^QSMLCGAD"AD##
M[I&Q2.U &=/\37M_#^IZ@VC>;-IMY':SI#<[HG#L%62.3;\X.[I@'@BMD>(=
M>6XAM;CPT8)KBXD2.0W6^%(43=YDCJIV$GY0N.HZUE^)M+\4^)O!=Q:S6%K!
M?7$\#QVB7(9($CE5SND*C<S;3T&!Q[DWO$^G:WJ&JZ%=6EG#=Z? TAO=.N)Q
M&&9E&QR<,&V'/'/4$<@8 *$GQ(*>#Y=>CTGSFM]0.GSQ1W(*AQ*(]R/M^926
M!' ZUJ6GBZX7Q/=:-K&FII_EV!U&*9;D2AH5;:V_Y1M89' +#GK7)S>#O$S>
M$]:TDV=F9;O73J$+)<_*4,ZRG.1QPN!UZ]L<]!J7AZ^U7QTU_+:E-,GT273)
M6\U=ZM(X8G&>@ QUZ^U %RU\4ZE=#1KR/099-+U5@(YHI2TL",NY))$VX52.
MOS'&16?JOQ'AL;6ZOK2WMKRSM+DV\L:W@%T^U]CM'%M.X!L\$C(!/ID\(V?C
M/2[&R\/ZC;6"V>GA8QJ<=P6:>%/NJ(MO#$  DGIG&34&DZ7XR\,WM]I&G6NG
MWFCW-U+<6M[-<%'LQ(Q9E:/!\S!)( (SW(SP =ZC)/"KC#1R*",CJ#[5X#IU
MC87?PAO+6RTF:?7SJ$_V%[2T;S4D$QVL) /E  Y.0 .*]]8O#;Y57F=5Z @%
MC^@KD_AQHFI^'?#;Z;JMND<PNII@T<H=2KN6 ]<C/I0!ER6UQ!\2/!!OMC:B
M=)NENI5 ^>0+%DY[\Y_.M&Y\<W%E-827>CFWM+[5/[-B$TQ2XR7*"7RRO*$C
MLW0@^U6=5TG4;GXAZ%J\-LK6-C;W$,SF0!LR[<$+W V\_7C-<G+X3\6SZ;;Q
MW%C87&HVNM17TE\]V=]Y&DI91]WY %(&.V.!S0!T<_C+5GUGQ!I>G^'EGGTA
M(I"TMZ(UE5U9NH4D' X&#WR1WZ'P_K,/B'P]I^L01M''>0+,$;DKD<@_3I7.
MV.D:Q;>*?%>I2V*F+4X+=+<),N2T<;*<YZ EN/8<XZ55T4^(?!_A?PII+:7;
M3!)$L[YOM'S("P"M&!][J6/3 4_6@#K]:U%](T:[U".SN+UX(RZVUNNZ20]@
M!6);^,'3Q#?Z+J-G%'<6FG?V@6M;CS@4R0R$%5(8'''<$=*O>,+'5M2\)ZA:
M:'<"WU*6,"&0N4_B!8;ARI*Y&>V<US%IH'B*W\6+K-II&FV$)T1[)8$N=WDR
M^9O4G" -D_XY/0@'0^'O$EQKZV=U%:6K:==VS3K<V]T9?+8%,1N-@PV&/?\
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M#[>NQ?:Y+J5QK&F:9IL%^FGH$NC/-L5I&7=Y:C:V2%P23@ D#UQS,7A/7HO
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M60Q%1\I*]FX# \YQ4DVDZIXDU70+O5K%+!=)E:ZD43+)YLVPJH3'\ R3DX/
M&.]<Q_PB?BZ33=-2YL=/GU*QUJ.^GO7NSOO45V(_@.P!6 QSC' H Z5/&&KW
M7B75-&L/#?GMIL]ND\C7JH/+E&[>,KR0.=OL>1QGFOB)KDOB+X5:Y?66FP3:
M2-T<5Q)-^\;9)L,JIM(QN!Q\P)'/L>J\/Z3J=GXU\3:E>6J):ZG]F,++*"1Y
M4>QLCMD\CK[XKD6\'^*[3X<:IX%@LK2YMP'2QOS=!-T32;P'3&=PR?;WXY /
M5E=8[8.[!45,L2> ,5QUQX]>W\.0^*&TL'P_(XW3"<^>D1;:)3'MQMS@XW9
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MU:&_N;FV6&XAGM@ADCGCVD!LX(/1AP>03^= %^BLKQ%?S:?HTK6FTWTY6WM
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MR<#>&!P<@=>*]2HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6S:PV4-O$K9+K\@ "DB/</<>M=$!8Q?'2W> P+)-X=<,4(!?]^FWIUXZ>PH
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MS^6 .U '7SWEM;9^T7,,6%+GS'"_*.IY[#(YIDVH65N8A/>6\1FXB#RJN_\
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M92Q-'!#Y2S^?C$D;C;O()+%L]0"Q/>@#U>BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 44BL&&5((]0:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BD5U?.U@<'!P>AI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BD) !). .YH5U90RL"#T(/6@!:*** "BD# Y
MP0<'!Q2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML/[8_L_BV$6\?ZS;\F=N_P!\X[XKT+6?'4=AK.I:586/VZYTNQ-_>YF\M8T
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MQGBKOAWQ3%KM_J^FR6_V;4=*G$-S")-ZX895E; R" >H!X->67GPR\5-\.]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N.
MU[X7^%?$NKRZKJ=G/)=RA0[)=2(#M  X! Z 5V-% 'GG_"DO W_0.NO_  -F
M_P#BJ/\ A27@;_H'77_@;-_\57H=% 'GG_"DO W_ $#KK_P-F_\ BJ/^%)>!
MO^@==?\ @;-_\57H=% 'GG_"DO W_0.NO_ V;_XJC_A27@;_ *!UU_X&S?\
MQ5>AT4 >>?\ "DO W_0.NO\ P-F_^*H_X4EX&_Z!UU_X&S?_ !5>AT4 >>?\
M*2\#?] ZZ_\  V;_ .*H_P"%)>!O^@==?^!LW_Q5>AT4 >>?\*2\#?\ 0.NO
M_ V;_P"*H_X4EX&_Z!UU_P"!LW_Q5>AT4 >>?\*2\#?] ZZ_\#9O_BJ/^%)>
M!O\ H'77_@;-_P#%5Z'10!YY_P *2\#?] ZZ_P# V;_XJC_A27@;_H'77_@;
M-_\ %5Z'10!YY_PI+P-_T#KK_P #9O\ XJC_ (4EX&_Z!UU_X&S?_%5Z'10!
MYY_PI+P-_P! ZZ_\#9O_ (JC_A27@;_H'77_ (&S?_%5Z'10!YY_PI+P-_T#
MKK_P-F_^*H_X4EX&_P"@==?^!LW_ ,57H=% 'GG_  I+P-_T#KK_ ,#9O_BJ
M/^%)>!O^@==?^!LW_P 57H=% 'GG_"DO W_0.NO_  -F_P#BJ/\ A27@;_H'
M77_@;-_\57H=% 'GG_"DO W_ $#KK_P-F_\ BJ/^%)>!O^@==?\ @;-_\57H
M=% 'GG_"DO W_0.NO_ V;_XJC_A27@;_ *!UU_X&S?\ Q5>AT4 >>?\ "DO
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LG6-973
MKBQL(5674-0D,=M&QP %&YW;_94<^Y('>M:N"O#(?COI@ESY T&8P9Z>9YPW
M8]]N* .W>XBM8X_M5Q$C-A=S$(&;V!/Z5G:_K#Z!:KJ<RJ^FQ$"[(!WQ*3CS
M!Z@9Y'ID@\8/(:^VG7_B?Q+!$D3W5MI*)>2W[!HH8V#LJQQ\$D_Q'< /EZFD
MTJ9+K]GLFXE$@'A^19"S9(Q">OX8H ]&5@RAE(*D9!'>EKGO C7#?#_P\;K/
MG'3H-V[K]P=??%=#0 4444 %<G;>(M3E^(]YX;D6S%I;V27OG!&WL&;;MQNP
M._/Z5UE>?VJ)+\<]8CD571M!A5E89!!E.010!V&CZU8Z[:/=:?.LT"RR1!U(
M(8HQ4D>HR#@]Z6Y.HC5['R)K1; K(+E) ?-=L#9L.<<<YSVKD?A-;V</A)C%
M#!'<->W:L44!BJSN #WP,BGZ_!"GQ>\'3K&@FDMK]7<#E@$3 )[XR?SH [;[
M1!YQA\Z/S1C*;AN&?:G,ZH,NP4>I.*\NMFNM"US3/[0L[35M%O-6=M/U:W^6
MXMYY6?Y)5/WAEF7(Z <]A70?%F%)OA=KVZ-7*6^]<C."&'(H ['>F_9N7=Z9
MYIIN(%8*9HP6;8 6'+>GU]JX+5FLY?BIX+VF!Y)+"]WXP2RE(]N?4?>Q^-<1
M=Z-IL?PE\87Z6<(N[+5[HVD^WY[?;<#;Y9_@_#&: /<[B=+>$O)+'%V5I&PN
M>U<_X)UZ]U_0KB\U$6Z30WMQ;GR5*IMC<J#R2>WK61:W,6H_%S5].U9(Y!;Z
M; VG0S %61]WG.H/4YVJ3Z#%<5IM[!I/@_2H?.BMM%;Q1=07,C*'C1-TOEAQ
MTV;@AYXX% 'ML=Q#-%YL4L;Q_P!]6!'YTGVFWVNWGQ;4 +G>,*#R"?2O+_$/
MA_2K3PWXXN(-0BO'N],:XFM8HT$,3K&P20 9"N<=>^,U<G\*6\?AC1;G0/L%
MEK5RUK,#<H6COI(X78)+CD\%VSURH/84 =OJNO:=H^FF_N[F,0EUC0JP.]V(
M"J/4G(_G5Z2XAAB\V2:-(_[[, /SKQS7+BVU'P)J"W>A1:9J%IK]LE[;_*\:
MR-)#N9& QM92"?J<UU,;6\OQ;.DW,$'V&'1]^G0;!Y6[S2)BHZ;AP#W !]30
M!WH8%0P(((R"*9#/#<(7AE250<$HP89_"O%KB>ZTC3K_ $\%E\,Q^+H;5\GY
M(K5B&DC]HQ(0I'3DBNG\017.B_$6RN?#UNJRW.D7C7D$2X5_*53"S*.,[VV@
M]<<4 ;OC?Q)=>'],AGT][-Y_M<$4L4V68))(J9 !&#\W4\5U->*WJZ7?_!?P
M[JH\F:\:]LY9KEL&0W#3*)26ZYR6S[?2O6/$%U;67AO4[J\DFCM8K25Y7@.)
M%0*<E?\ :QT]Z +L=Q!,[I%-&[H<.JL"5/OZ4IN(%8*9HP6;8 6'+>GU]J\I
MTU(+7QKX%$:6=M;3Z3<HL,;!G,.R,IYK\!R>O0#.[D]:P;O1M-C^$GB[4$LX
M1=V6KW1M)]OSV^VX&WRS_!^&,T >YW$Z6\)=Y8HL\*TC87/:L#P1KM]XAT.:
M[U!8%N([VXMR(%(7$<A4'DD]O6L>TN8M1^+FL:=JR1R"WTV Z=#, 59'W><Z
M@]3G:I/H,4[X31P0^$;F&W"B&/5+Q$53P%$S8'Y8H [62X@A=$EFC1G.$#,
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MO &JZ-:I!K4UY:QR2Q??N(&CS-O/5@%&<G.,59NHCX-\6ZMH^GVJ)!XI3S+
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M1P<<5V=EIUEH_P 9Q!IUK%:Q7&@-+,D*A1(ZW"@.P'5L,>3SS0!WS,%4LQ
M&23VIL4T4\8DAD21#T9&!!_$5Q?C[48['5/"J:@P319]1*7I?[A;RV\H/VV[
M\'GCY16+XV33M!T#7[K0Y747=W:/JH@DRD,18*Y4#A2RCYL<X.?2@#TV*>&?
M=Y,L<FT[6V,#@^AQ0;B ,JF:,,S; "PY;T^M<)KEA#9_$#PA-HT,,7VM;BWN
MXX5 2:U$>X;@."%.,>[8[UPUUH^FP_"#Q-J,=G"+RRU:X-K/M^>WVW0QY9_@
M'TQ0![I+<0PLJRS1QL_W0S 9^E5)CJ']M6OES68TXQ/YL;@^<SY&TJ<XV@9S
M^%<'XUM[ZVU'6M5@M++7-*-FD&J:;,=D\"*K-OB8C&-K%L>HXYZ66>UNOBQX
M9U&VBV_:]$GDW,N'9<QE=WN : -SQYXAN?#?A+4=1T][0WUM#YJQ7&3N7.#P
M"#6_]JBBM8YKB6.(,!\SL%&2/>O%KA[37/@%KVI:C'#)K)DG>]:0#S(K@3$*
MN>HPNT >G%=--=07WQ"N])U2[M(8WTJW:PCNX5D25#O\W;N.,YVYQR0H]* /
M2&D1-NYU&XX&3U-1O>6T<*S/<PK$_"N7 5OH:\GO?#VE6P^'^G1W3:I:Q:E-
M;+<SX+21!),QY'WDR-N.A ]*V;O3="LO%!T33;.VA>TT9RZ71S:V\#RDDK'U
M9V8')R !CGM0!VNI:W8:5+90W4ZK+>SB"W3(R['D_@ ,D_XTH;4/[=.9K/\
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M]JC3PUH<>ES:8FD62V$YS+;"!1&YZY*XQGWJ_<2M!;22K"\S(I81QXW-[#)
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M)R0H1549(!)QDX'88IGA_P -P>'?MHMKR[G6\N9+N47!0_O7(+,-JC&<=.E
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M 52J[?DXPI([]?6DM/"$.GV>E6UEJFHP#3(6@@=6C):-MORN"A# ;%QQGWH
ME\'ZA::IX9MKNRU*74;=VD*3S9\S&]L*V>=RC"_A7/>*;6/Q5J.HZ7/IMW=V
M%K:-;!X%0A;F102WS,.439@C^^P[5UNDZ-;:+IS6=F9 'DDF>5L%WD=BS.>,
M9))/3';&*31=&31+66WCN[FY$DSSL]R5+;G8LW*J.Y/7IT' H YOX?:]?ZKX
M!*31YUS2Q)8W,,AY,\0P,_4;3GW-<]9:CK&JV'A)[#6-0&KW=P8]:B1@3$@5
MC(6C<,L6UP /E&<XYS74R>%QH$OB'7M+?4+V_OXFDDLC*BI/(JD*!A05/;(.
M?7-<CHNGR)8VMMH6O>-8M0@C5([2^M&6WB8 ##F2+;L'H')QTR<4 ;.G6VJZ
MQX]\3V4OB/4XK73;FSE@CA9%R&CWLA^7E3R,=^Y.!533+CQ1XH\-:=XETN^@
MMKF2;[0YFOW\CR0Y#0M$(RHP!C/WLC.:[73?#<&F:]J>L17EW)/J10W"2%"F
M47:N %!&!QUY[YK)M/AUI5AJLUU:7NJ0V<TQGDTM+K%HTA.2=F,X)Y(S@],8
MXH R'F\0^+8_$#:3>"TN[+4);.TD%Z\:PF/ ^>,(0X8\G=G@\8J16UC4/B)'
MI-UK=S';R^'TNI8[)P$$IE"L8VVYP<<$\X[BM6]^'VFW/B"XUBWU#5=/EN\?
M;(;&Z,45R1QEP!G..,J0?SK13PM:Q>)1KD-U=17"V8L4B39Y20@[@ NWL><Y
M_3B@#S:;4-=B^%^IZZ?$.H-?:+>S0VYW*%E6.?:/-&/G)7@Y]!QG)/6WE[J&
MO>+=7T2WD:**PM8&41WKVS[Y0Q\S*J2P&  #QUR#D8MM\/M.?PQ?^'WO]1:Q
MOIVGF^>/>69M[8.S@%N?Y4_6/ =CJ^I6NJ#4M4L=3@A\@WMC.L4DT><[7^7:
M1GGH* .<E;Q5;ZMX&TO5-?(N[IKN"^>Q*F.79$Q5N4!W8QG(P#SBLS6I+T^"
M_B/H]SJ=[<Q:6_\ H\LLQ\W8T*OL9A@LN2>#U'!XKOY/!UB]]HUW'=7L3Z09
M#;A9%8,T@(=G+*2Q8$Y)/4D]>:C/@C3I%U])[F\GCUU<7B.R ?=V KA000H
M_"@#4T*V%KHEG&LDL@\I6S+(7/('<]JA\4W,EIX7U*>'4H=,E2!BMY,FY83_
M 'L=SZ#UQP>E95SX5N(Y= 2RU;5\Z=,&>1[H;)8_EW+*N!ORJ[5   R2??:U
M_0[/Q)H=UI&H!S:W*A7,;;6&"""#V((!_"@#D-'O;_\ X6'+HR3ZI;V$^B"Z
M5;R022"02A/,7>6*Y!^Z>X^Z*YO3M3UU?A[X7\3RZ_?S7DFHQ0RQ,P\J6-[@
MQL&7')QWSQCC%=];^"+6WUJ#6/[5U:74(K0VAGEN QD0L&&X;<9! .  /4&H
M$^'NG1^&++P\E_J(L;.X6XA^>/>&5]XR=G(#<T 5[*[F\5>(/$]L][=6L&E2
MK:6\=O*8R'V;FE;'WN3@ Y7"].33_A-_R2S0/^N!_P#0VJ]-X*LV\03:U:ZA
MJ-C=74:QW@M9%5+H*, N"IPV.-R[35_PUX>M/"VA6^CV,MQ);VX(0W#[FY.?
M0#OV% ' ^,=9U'3]+\1:I8ZK=W-U87T0BDMF*6]HFZ,&%U)VR,<MGAB-PSMP
M*T_%&G+<?%;PEFYNT\V"^SY<[+MVI']W'3/?'6K][\-=(OH=9MGO=4CM-6G-
MS/;17 6-9B02ZC;G)(!P21[=*T[CPG;W&M:7JK:CJ N=-C>.#YT88< .6W*2
M2<#OQVQ0!Q^F2'0_$'Q(U99;J=].VSI%).S*^+4/@C/// ].U:&G6OB>Z;0-
M:M=3A6WF5'O_ #;YY$N8Y%&"D9CVHP)!7;@=CFNBB\*6$7B#4=762Y+:BJBZ
MMC)F"0JFP,5QUV\8SCOC/-9^A?#[3O#]PIM-1U:2SB8O;6$]UOM[=CW5<=L\
M;B<'GKS0!E>"+?5=6O-0OKWQ%J4HTW6[RWC@W((Y8U.T!P%YQP1C &.!UJ7X
MDVHGO?!Y\^XCW:[#$1%,R#!1SG [_*,'MSZUTGA_PY;^'5O5MKNZF6\NGNY1
M.4.)'.6(VJ,9].E.\0>';7Q';6L5S-<0/:7*7<$ULX5XY%S@C((Z$C!'>@#D
M'TM[_P"+.IV::A>6L8T*V#26\FV5OWL@'SD$CUXY/KUS1T+Q5J^H>&?!ME-<
M>;=ZI-=13SM,86E6 N -ZJ2K-M7) SP<8SFNV@\+6]MX@FUJ*_OA=2VJVA#.
MC*(UR5ZJ22"2<DG.><UF-\-M%?PM;Z UQ?F&TG-S:7*RA9[>0L6+(ZJ.['J#
MU]A0!=\+V.O:=>:I!JMY#/9-(DEA']H:>:%"#N5W902,CY2<GKD\53DU&76O
MB'?>'I+B>WL[#3XY]D$K1/-)(Q&[<I#84 # .,L<YXK;T/0HM#MW07E[?3R$
M>9=7LWF2OCH,X  &3@  <D]2:AU'PS:WVMV^M0W-S8ZG#$8/M%L5S)$3G8X=
M65AGD<9!Z4 >=7GB+Q"GAZ^M!JTZ76E>)(M-6["+FXA9TV^9QR0&P=I&>_6M
MLIK.@?$.TT@:_J%[8:U97$F;DH\EM-%@[T^7 !# ;<8S3?'VAPV'@^WT^QBO
M)))]7@N9I(D:29V\T-)*Q4=<<YQ@8  P *ZN+2;6SN9-;N;NYO;H6WE)-,JY
MCC)R0JHH')P3QDX'IB@#S!;_ ,2P?"?3/':^([^:_M@DLMHY7R)XS+L967&2
M3GKGV&.,=IIUW/XM\0>)[22]O+.+3)DM+9+:4Q,C% QE./O$D\!LKA>G)K,^
M'/AD7GPZT2UU6;4/+MV$DFFW"!%$BR%E# H'(!PV"<=.W%=9/X5MFUVXUBRO
M;S3KR[C6.Z-J4VSA>%+!U8;@. PP<4 <!;^(_$&LZ)X-FDU2>TN;G5I-.O&M
MU4+.$$@+@8ZG8/\ 9SV-: T%K+XI:#9S:QJMX5TJZ?SI[D[S^]0@?+@=#@\<
MX&>E=3<>"=-E@T:"":ZLX='E$UJD#+C?@C<Q926)W-G)YR3UJUJ?AFSU37+#
M5WGNX+NR1XU-O+L$D;8+(W'3*CI@^] '$G5=2'@?X@S?VC=^?I5_=K9R^:=\
M2I&C*N>X!)ZYJW<7&JWGC'PQ8C6KV"UO](EEG2(J,LHCY!V\$[CR<X[8ZUKW
MOP]TV]DUH&_U*&UUC<UU:0S*L1D90ID VYW8 XR1QTJY%X.LX-5TO44OK_S=
M-MC:P*TBL"C8W;LKDDX'?MQB@#B)M7UF#X8>-"FLWGVK1=0N;>VNRRF4QIM*
MAF(Y/S$9X/ YK4U>T^U?$WP<SW5VIETZZ9@D[*,JL?( /&<G/KWZ5M/X!T]]
M&UK2GO\ 4#;:Q</<W?S1[B[8W;3LX!P/RXJW>^$K._NM(NI;R^2YTM7CBFBE
M"-(C@!E? Z$*.F#QP10!S@UBY\+>)_$&F:G=7=Y'<6PO-($LQRXSL:!3_>#E
M<'KAASQ7:Z19SV.CVMK=74EU<QQ 2SR,2SOCYC^>>.U<U_H_C'Q/832:+?6\
M>A7,LGVB]MS%ODQL41Y/S*?OY_V$]:[.@#QVQU.;PCX-\?:Y:S7$US:ZU<P1
M">9I%!+1(KL">2,@Y]!BNGUV:^\*ZOX8N;34+N[M]0OTTZ\AN)3()/,4D2KG
M[A!4G"X&#TK8B\$:3&VM)(;F:TUAWDN;.67,.]P [*  03@<Y..V*DL/"=M9
MOIYGO[Z_73L_8TNV0B$[=H/RJ"S!20"Q)P3WYH WZ*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*<!L=2.,C.1V^EC4!IEN-6-L;_8//-J&\HM_L[N<?6@"W1110 4444 %%%%
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M:6*55#8))7<I4$<U1\3V6N>(/ 5_!;>&S:7%U+;^39+)%Y@5)5=F=MP49 .
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MA!<0V6T$L['[V"&PO7! XZ  [Z>9+:WEGD)$<2%VP,G &3P.M<WI_C2.\O\
M1K:;3;FV76K=[BQ=V4E@JAB' /R-M(..?KFMW4_MK:1>?V:4%^8'^S>9]T2;
M3MS[9Q7FVGZ1K[Z[X-U>;PY=)<V:SQZG/<7432O(\6W>2&.8]V< = <!1QD
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M%L>B@X'IQ7>:CXF@M+O[%:1"[NQ;BY:/SDB 0DA?F8]6*M@>QSBN)DT#79/
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M)@90Q5GW%<$XP,D$#.,XXS6AJFLV%@6MI[N2*=HC)B")I7C3IO("M@ ]R,4
M:=%<C\,M3N]8^'^G7]]=O=W$K3[IWQEP)G /''0#I6M?^*M%TR>:*[OEC,!1
M9W\MF2 O]T2. 53.1]XCJ* -BBL^_P!;T_39#'=3,'$?FLL<3R%$_O-M!VKP
M>3@<'TIEQXATRVCC>2X8K)"+@>7$\A$1_C8*#M7W..A]* -.BN?N=3TZY\0Z
M"J:\\,TZ22P6,9&+Q#'G+C&<*!N'3FK-]XHT737G%Y?)$MLRK<2;6,<);& [
M@;4)R/O$=1ZB@#7HK#E\9>'(9(8WUBU+S1-+&%?=N4'!(Q[\>YX%36GB?1K_
M $@ZK:WR2V8D\HNJMGS-VW9MQNW9(&W&3D<<T :U%4]/U6SU/S_LLC,T$GER
MH\;1LC8#8*L 1P0?QK+U/5WE\3V7ANSD*3RP/>74J]8X%(4 ?[3,<9[ -WQ0
M!T%%96I>)-(T<R+>W?E^2H>8B-W$*GHTA4$(#SRV.AJ6[UO3[+R?,N"[3(9(
MD@C:9W08RP5 25Y'.,<CUH T**X;Q]K[-\,KW7/#VKLFWRVBN+8J0P,BJPR0
M<=2.,$$5:UF^O[;XF>&+.*^F%E>079FMOEV%HU4J>F?XCU.* .OHK(N_%&C6
M%TMO=7HB)E$'F%&\I9#T1I,;%;IP2#S3M3\1Z3H[2"]NO+\I!)-MC=Q$AZ,Y
M4'8O!Y; X/I0!J."R,H8J2,!AC(]^:RM \/6GARUGMK.6X>*:9YV$SAL.YRQ
M!P.I.:H3^--/B\666@H)97N;5KKSHXG=-N4"X(!!SN)R.!CGK26>N:1:R:]?
MMX@DN[:WF4W"D;X[+"#*C:O3C)ZXH Z:BLX:[IQL;.]$[&WO2JV[B)SYA;[N
M!C//:H;WQ1HVG7'DW=Z(CYHA:0HWE)(>BM(!M5CD<$@\B@#7HKC%U.\MOBK?
M64]]/)IJ:(MV(-H(C?SBI("C)X7OD]:W+?Q/HUUH+ZY!>B33$R3<JC;< X)'
M&2 >X]#Z4 :]1S6\-P$6:-9%1@X##(W#H<>W7ZTY'$D:NN<, 1N!!_$'D5S^
MI^+[+3?%>GZ \<YGNHGE9UA=E55QC! Y))'3H.N,B@#HJ*\[T3QC;:/J'BA/
M$>MNT5MJIA@:=<E(_+0]$7 4%NN .>37;7NKV-A'$\TQ/FJ6C2&-I7=1R2%0
M$D#(R0,<B@"]1533=3LM8L(K[3KF.YM91E)(SD'!P?H0>".U<K<^(/$,=OXD
MV:'J37%E.@M]D:%9X"^"8/[SA,M@_P 1 ]J .UHKSW5]5UF7QIX.L+?4M0TV
MTUBVN)+FV:*$RQM'$K $LC8.3@]:M^%=?U2;QSXB\-7ET-1MM.6*2*]\M4=2
MXR8Y-@"EA[ =#^ !V]%9%SXHT:SNTMKB]$;/,( Y1O*\T]$,F-@;_9)S6/IM
M]?GXIZUITM]-+91Z=;SQ0OM"QLSN#C ']T=<GWH Z^BLB+Q1HTVHP6*7H\^X
MW?9]R,J3[>OEN1M?'^R32?\ "5:+]MCM?MR[Y+@VJ/Y;>6TPZQB3&POP1MSG
M((H V**R[GQ#I=G<M!-<,&25(798G9$D?&U6< JK'<O!.?F'J*34_$FDZ.7%
M]=^4(P&E81NZP@]#(5!" ^K8H U:*S[W6=/M%A62Y)>X0O"MO&TSNH'+*J@D
M@9'.,<CUKG?AMJUSK.AZC<7-_)?!-5NHH9Y,9:)7PG0 =/0"@#LJ*X/6[S6#
M\3])T2VUR[M+"\L9IY$AB@)#H1C!>-CCFD\*>,+G[9XJT_Q!>0/#H%RD8U$J
M(Q*C@D!@.-XQ@XZDCB@#J?$.@6GB;1Y=*OWF%I-CS%A8*6 ((&<9'(!XK1B0
MQ1(C2/(5&-[XR?K@ 5F0^)M'F6]/VU8C8J'NEN$:%HE(R"RN 0#C@XYK!U;X
MH>&;#1KR]M;X7LL%H+I((8W)=6X4DXX!)&2>F>: .THKF[W5]-NKW0@=;GL9
MIK@F*U"E#=X4@HRLN=O?/'2KVI>)M'TAW6^O!$(RHE?RW9(=W3S& *IG(^\1
MUH UJ*R[_P 1:7IGF?:KD@11":5HXGD$<9SAG*@A0<'DXZ'TK.NK77G\6/+:
MZO(NE2V#*8#:J5@D_@=6ZNQ.3MZ8'/44 =+17#?;M=\+^#8=9UB^DOGLI&^U
M[X1&TUL9"!)L'W9%4AL=P"#SR.W1UEC61&#(P#*P/!![T .HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *X7XLM$G@Z!IP#$NIV9<%<Y7SESQWXKNJY[QAX>N?$VEV]E;
MWD5KY=U%<EY(3)DQN& P&'4B@#"NA9ZG\4-'UG39X'MM/TZX%_=QN#'M;;Y<
M98<9SO;'8#/<5SFBVMQ>_L\FVTJ#S;^-79H(^)&Q<%V3CG+(/J<BO7T#!%WX
MW8YVC S3J /-;#4_!GB60:K8VNHWUW:6<_G^=+<;K6-HR'1MYV[C]W SZCIF
MJ.CKJEO<KH>C:U'KNE7.E7"V5Q( +G33M4(DCCL3M W '*_[->L44 >3>%+_
M ,,:U8:#I5W9:DWB#2GAW6$TMR/LDL0"F3D[ H&2.Q&!C)Q5-Y[5_A[\355X
MC)/J=Z8P",R!E0(1Z@D'&/>O9:* /-OMT%MX^\(WTKL;:?1);>.5%+AY2T9V
MC //!_*MGXGVFH7G@6[&G0O<212PSR6\8RTT:2*S*!WX'3OC%=A10!Y_J=Q:
M^*_%_@^^T*YCN/L<LUQ<31'/DPM'@H_]TLVT;3SP>.#3O!VH6?\ PF?CAS=0
MA&O875BX 91 H)![@$$$^U=]10!X]I=U;M^S]K< E3SO+OU\LGYLO+(4&.O(
M(QZYJ]-K</ASQ+X9U[42_P#84^A_81=HI=+>?<K?-C.-P4#ZCV->IT4 >6^)
M+JRLXM!\166EW,/AV#49I;MK2-X782QE?M.U<,!N+9/4@YZ$50\6MX<O/AUX
MMU/P_%/)_:,4"/>2R3-]KD5N%42'+%5[@=\=CCV&B@#B/%\6EWT&BM#K3:/<
M[VET[4H-OEHX3&U@?E*LI(P<=,>U1:#XS32_#<$_BEX()9M2DLHKJUA;R;L[
MCB88!VJV"<].">E=Y56^L8M0A$$[/Y.X%XUQB0#G:W?'J!C/0\9% &9XTM;^
M]\$ZW:Z9N-[+92I"%.&9BIX'N>@^M>>:CXFTC5= \!)9LWG6>L6:W%L(F\RV
M*1NK*R@97!_,#(R!7L%% 'G-I>VL?Q!\>.\\:(UA:@,S  E4D##ZC(!],BLJ
MTM[BY_9[L$TJW:>ZMH('EMX?ED?RY5>1..0Q /'4_C7K=% 'ES2^'O&=A?W7
MA9+^ZUL:7<6Z7$\MP#:ET($;&0[=Q8C@9Q@GM5_PCXET'7[#0K!=.9]:TZ-(
MWMI;5E:P=4V.Q8KA1@$#GG('T]"HH \6GBO+SP#XWT?3X9I-3BURXNI+41MN
MDA^T*^.F#N7.!_$,XKI]8N[/Q;X@\'7FA7*3/:7;75Q+&>;>#RR'63^Z6.U=
MIYZ^AKT*B@#S7P?+ISZ!XY,Z+-"=7U":5(_OR1$=5]01D T>$KF\TOQ#:Z=#
MK,7B#0?L$DD%VR@W%@JE,1R,O4-QC(#$H>/EKTJD(R" <$]Q0!F>'_$.F^)]
M)34])G,UJ[%0S(4((Z@@@$?_ %Z\]NM2TC1_&7B73/%WV^&'5)5FLY8WN/*N
MHC"D9B B/+#:1C&3GZ5Z;96,5A"T<99F=S))(YRSN>I/_P!;@  #@59H \T@
MCL+#XC^$[6"W^Q06^CW$<=O*Y9H<E-B,220V >,^O6LF.>T/@/XH*LD6^?4+
MXQ@$9D#1*$(]06SC'4YKV&B@#RR+4-/@\=>"KJZN($B.@2JLTC *K_NQ]X\
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M%%% !1110 4444 %%%% !1110 4444 %4-:U6#0]#OM5N0S0V<#SNJ]6"@G
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M;.VDG$<KE58(I8\@'T_^O5G1[Q]1T2POI%59+FVCF95Z LH) _.O+B+7Q/\
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M5G"-H7=:6K![X.O*2L9&+D$$DD$@@GCFJ.@/-HOB+1+37=-AG-Q-(=.\063
MB[+HY"SC[P8J2<\@D<=#0!ZI17&_$G4I].T/30DCQ6MUJMK;7TJL5*6[/\_(
MZ X"D^C53O+)=$^*/A^#1X$@L]4M;I-0MH5"Q%8U4I(5' ;<P7/<'% &E+XA
MUG4+S5(_#UI9W TJ[2UFBN6*-.2JL^QP<)M#CJ#D@]._65Y_\/=+T^WU_P 7
MRPV5O')#K+QQ,D0!1/*C^4'L.3Q6CXI^QW?B?0=/D1KN\99Y8K&1@+9U"@&2
M7(.=N?E !.6_$ '7U!>7EO864UY=3)%;P(9))&. J@9)->.Z;JTEAX3TFQNK
MC9I<GBF:QN6#$(L >0K'G/$98*.N-O'0UT'C7PYHNG>$_&9M?O7.G?:6L,+Y
M$#(I"R(@'R,Q'7N5SV- ';W%SJ%Q;Z=<:3';/%-+&]Q]I9E*P$9)7&?GZ8!X
MZUI5YEX@L;2STOP UI$L'_$YLPRPG:IW1L3E1P22 <FKNCPVOBKQ5XQL]=MT
MN'L[B.W@AE&?)@,8*LG]TL=S;ASP.>!0!Z!17BE@UYJ^B?#V35;FYEF;59K7
MS_.96FA590K'!ZD*/FZGKFNN\&P6VC>-O&NFVH6VTVW:TG2'=A(F>(ER,],X
M!- '>T4BL'4,I!4C((/!%>8Z';:7XP\+ZK>ZU=/;:I:ZG.;B\B<+/9&*4E%1
MB"44(%&.^6[DT =9!X@O'^(5UX=EMH%MH].2]CE5R7;=(4P> !]T^O;FNCK@
MY)XH/C!J$\TABBC\,H[OCE5$\A)_"N;TQ([76OA]>V"&*WO'G7[3*X-S>QM
MS[Y\ #DX;!+8XZ'B@#U.S;4S?WPO([5;0.OV-HF8NR[?FW@C .[.,=JNUY8M
MN@;XJP!YMB*KI^];*G[+NX.<]3FJ+Z/:0:5\--0A$L5[>-;6MQ<),RO)$]LQ
M9"P.<<# [=L4 >PT5Y=:Z6EGK_C_ $'2KH:5;26-J\+*2$@ED212X';)"Y(]
M,UH^#KW[-XFN]-U;08=%UF.Q61VM&!M+F%7QYB8QM(+8(/."/2@#T"BFHZR(
MKHP9&&593D$>M>.>*GMY-"US6=,W2R6^NQ#^TKEQYZ2B:-&BAP,B-1D<GGYN
M"#F@#V6JESJ=I:7UE932@7-Z[)!'W;:I9C] !U]QZUQB&R\1_$3Q+H>M(DR6
M]I;BR@E ($;J?,D0'^+<0"W48%9=[HFD+XR^']MD:G"D-] ;F\"R/,L<8V[F
MQ\V#G';N* /18&U,ZM=K<1VHTX)']F9&8REN=^\$8 Z8Q5VO,)[JZTCQ3\2;
MS30[W,&DVT\*EB^'\N8\ Y[C.!5;5((K3P!X7\2:'_R&#+9$7"',EX92JR)(
M>K[MQ)![CMB@#UBBO*3H&G:IXG^(\%]%)/#$EL\<<DK%48VQ;<!GKGD'MVQ1
M;C6]0\(^#M4M+>TUR2'2@UUI5ZX#7 94'FH6R-XVXRW]\^M 'JU%<[X,U+3+
MWPGIDNGK+;V\@=(H+DXD1E9@R'U*D$?A4/Q&C$GPY\0DEP8[":12CE2&"$CI
M0!MZLVI+IDK:.EK)?#;Y:W3,L9Y&<E03TSCWQ5VO)/%WAS3=,^$=[J=K',E[
M=6]BT\WVB0F0AT )&<=&8=._L*Z7749OB-IPOX#?:0VF3 6BQ^;Y4V]?WK1C
M)(*G8#@X)/3)H T_&OB"\\-:)'J%I;03YN887$KD;1)(J9  Y/S>HKH\UXYJ
MN@7>B_")H;\31W,^JV[A'F+O%$;I?+4G) (4CI_2NAM=)L=.^+EQIMM;J+*_
MT%IKJ!R76:03A=S!L[CAB"3UH [?3=3M-7L5O;*42V[.Z+(.C;6*DCU&5.#5
MNO'_  II$L_P=T1=&73XM1EN#(8;A<)?>7+*?*D(Y(P#U_NUUW@;5;*2VU>)
M]+;0[V"]'VZRE==D4C1H!L8<%6 !'N3ZT =E5+2VU-H)CJL=JDHG<1"V9F4Q
M9^0G(^]CKVJXRAU*G.",'!Q7B=W&L7P@\2."=]MX@E$4C,2R 7:+PQY^[Q]*
M /;:YSQOX@O/#'AN35+.W@G:.:)'69R,!Y%3( '/WO45B:O-]D^+EK+;('F_
ML&YD:->LC*Z;<@=>X%<AJ4%CK'P-M?$,PCN-5FGMYI[P_P"L,IN5#J3UVC)
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M_P"W)='MFU+<&,Q!Y8=&*YVEAZD9K>HH S3H&F-K$FK-:AKZ2+R'E+L=T?\
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MKM &5=>&])O=$31KFT\W3D"@6[R.5PO*@\Y(&!@'I@>E<AXI\-2:AXD2:_\
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M%E;3>?#$ ?DD_O YSG''7IQTK>HH S8-!TRUU:358+79>R1B)I0[<H.BXSC
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M<>?>N6\1^$(FU.PA'@^#5M"M+3RK:&VN%AFMY"V6)W,NX$!?XLYSG.:]&HH
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M^T91/W?R;/DXX^7CG-,;P-#]G\.K'JM[#-H4;0V\\83<\;($*L"I'*J.0 :
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M268LQ.,#DDG &*R?^$,CM[K5FT[4KFRM-6<R7=M&JD>8PPSQDC*,PZ]?48H
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MXX NQI%N=A<94GJN1SCGG-=^_A00:]?:OI>HSZ?+J"JMY&B*Z2,HPL@##Y7
MXSR#W!J#4/ UC=^'M-T.UNKBRL[":.>/R@K,SHVX%BP.<MR?4T =%% \=F(&
MNII'VE?/?;O/OP ,_A7E5]XC\1V7@_6K?^UKJ7Q'H^IM&0D,6ZY@QYH.W9@
MPACD#.5/7I7K4898U#MO8#EL8S60OAG3U\57/B'83=W%HMJZG[I4$G..Y((&
M?08H R'U%M;MM0O;*_E?2H]*&$PNV622,ODG&00A0\''S^U<GH-WJVB>&/AW
M>Q:M*]M?O;6$MB8D$7EO$Q!!QNW J#G=SZ <5WNE>$K+1?";^'M/EDAMV61?
M-X9P')SUXX!P,]@*H?\ "!Q?V-H&F#5+H0Z'/'/;-L3<S1@A0_'(P3TQ0!SW
MBSQ#K.DV.MZC;:J\UQ8ZA$L45JBFW@A+1KY<Q8<N=S$A22,KT%: AG_X77=$
MZE>")-$CG\H%"O\ KF!4 KP#M'3GWJ>]^&EM>66M6']M:E%8:I=&\:W3R]L<
MQ8.6!*[B,J/E)Q6N?"B?\)-;:\NIWJW,=HMI,N4Q<H'WC=\O!W$_=QZ=* .7
MT_5/%GB'0])\0Z0\BO<2K-)!-)$+9K<L=T>,;PP'\77(/;@7H]<OM"\9Z[IV
ML:A<7-J]B+_3 4C!VC*R1C"C<X8KC.>"*L:;\.X-)O9%L]:U./19)C,=(#KY
M 8G)4'&X)GG:#@]\C(K;UCPU8:WJFD:A=*WGZ7.9X2#URN-I]L[6^JB@#GI-
M0UB+6-+\,RW-U/=G36O;N>!HDD=MZIM4D !02W09^[SUSE:I?>--(T32DO=2
M6&[D\0P622!(W,]K(XV^: ,!^QVXS^-=5XG\'P^(KJQOX=0N],U2Q+?9[VT(
MW!6^\K @AE/H?\:@O?!"7VFV-K-J]\TUM?1Z@]TVQI)ITQM+97  P!@ # %
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M)SZ/N7_@.>^*I2Z[=WWB._T/2!;+/I\$<MS-<AF4-)DI&%4@\A22<\9'!SP
M= [K&C.[!4499F. !ZFJ&GZ]I6JW,]M8W\,\\ #21JWS*#T;'H>QZ&O._%_B
MFZ\0_!WQ!=00I9W-JTECJ,#,6,<BNJNJL,9!!')'0UZ/9691Q=W=O9_V@8_*
M::"/!,8.0N3SCOCI0!/>WMKIUI)=WMS%;6\8R\LSA54>Y-.M;F&]M(;JVD66
M"9%DCD7HRD9!'U!KS6UU'6M2\/?$7^TYK:2&WEO+=516&P+;)@+D_=P<GU))
MJSX;\1:KI6G^![*ZLK0:9J=G%;1.DK&9'6 ,K,,;<':>!T]>U 'HU,EECAC:
M25UCC499F. ![FN&U'QW?BSN]1T?36O[>UNFM_LJ6TS2W 1]CLCJ-HP0V <Y
M ZC.*[F*02Q)(%90ZA@&&",^H[&@#,@\4^'KF58K?7M+ED8[52.\C8D^@ -:
MU>!Z=J%K/\+KGPM_9[W&H:QJ-Y;6/F($A$OF$AC(V%!7J .21@"O4I-1F\(>
M%]"T^[E-YJ4@AL5D(9@\@C)9S@%B $8],G@<9S0!T=Y>VNG6DEW>W,5O;Q#<
M\LKA54>Y-.M;J"]M(;NVD66">-9(Y%Z,I&01]0:X:Z\0:CJ6B^+M,U#3I%2V
MTZ5X+Y+:6*&X5HVR,.,AE/49-.T;Q#_9OA/P?I< !O+O2(I0[0O*L4:1Q@L5
M3D\NH R._/&" =Y17%V/BS7;S2Y=V@R17L6HBS>62-XX/)//VD!P&* =NN>,
M]ZKQ_$)H](\37,T5O<-HD\<?GVI)BE1PI$F.2 H8E@">%.#0!WE%<FWBU[+0
M[[6)Y;+4-/C2(VES8$[;AW8ILQEL$,4'4_>_"H(O&-[::W);ZI9,VF"SDNCJ
M$-I-&D!099'WCT!(8$9QC% '3W^K:=I9MUO[V"V:YE6&%9' ,CD@!5'<Y(Z5
M8FGBMH6FGE2*)!EGD8*JCW)KS#Q;J6JZQX?\*:I+!:Q6-[K5A,D//FQ*T@*%
MFSAB01D #!/4XKU,\B@#+M/$N@W\ZP6>MZ;<3-]V.&Z1V/T .:U*\#TBRFU_
MX Z;H>F:7<W6K27#FVF6%D2W873-YGFD!1A<C@YYQ7I.M>(=8T&TN]Z6B1Z?
M8)*+J\8@7\VUBT<>",'Y>O/+#B@#LZ*XB\\::FTWA-=-TRVD7Q# TB&>X*F)
MO)\P X7H.,GD\' Z55L-4\53?$JTT[4CI\(71C<RV\!=D!,RJQ#'&6^7C(P,
MGKUH [>SU.RU"2ZCM+J*9[24P3JC9,;@ E3[\BK5</9^-C;Z9XFOK[3H('TS
M4_L2QVSEO/<B,(2VT')9P,XX'KBI[;Q7JD>O26-WI<MS:&S>YCN[6TFC577D
MQ,''4CH01GT% '8U3O=6T[39K:&]O8();J0101R. TKDX 4=36#X4\3S^)DM
M;RWGTZYL)K9I)3;$^9:S93$3@DY."W.%^[TYJA\36D2'PL\,0EE7Q%:%$+;0
MS8? SV^M '<T5Q-GXH\1#Q#?>'-2T[3X]5^Q&]T^2"9V@G0-M*,2 RL"1SCO
MG'K)I?C"\U?PCIFHP06ZZG>78M&M'#8BD#$2*><Y15=O<+[T =E169X@U&XT
MCP[J&I6\$<\MI;O/Y<CE%;:I8\@'TKF+?QEK,6C66JZEIME';ZG':K8)#*[R
M&6498. IPH +?+DX&.30!W5%<5!XMUI;G6;5]"GOI+2T^TV<UO;RP1W1Z>5^
M\'RN#CH3D<]L5)I_B^Y;Q5<:%="TNI(]--_OL2<JRN%:$J2<MDC!R/H* .QH
MKC_#?C!]=LX=46XTZ73#:O-=>06\RR< 'RW!)SQNR<+]WIS52Z\<W]GX4M/&
M$ME =#F*/)"I;SX8'8!9<YPQY4E,#&?O'% '=T5QLGB77[OQ7JV@Z9I^G;K2
MVAN(9Y[A]K!]V-P"YS\O0<=3GH#K^$-?_P"$H\*:=K1@\AKJ/<\6<A6!*L ?
M3(- &W4=Q<0VL#SW$J11(,L[M@*/<US7_"0ZEJL^M+H$%I(NDS&V87!;-Q,%
M#,BD'Y -P&XAN<\8&3RWB?Q)-XG\&>%=7TKRXK2_U>S#Q39W!Q-C8<<$!UY^
ME 'HFFZSIVL+,=/O(K@P/Y<RJ?FC;T8'D'ZU>JE;P0V4<][/#:PW,BA[N:%-
MN_:, D]3@>M<C<>.;^#PC%XQ%E ^B,P=[<;OM"VY?:)<_=)Z,4QT_BH [NBN
M)U'Q5X@?Q9/H.B:;IT[_ -F)J$$]Q<L%=6D*X;"\'@X SU!R.E=/JU[=Z?H=
MS>6U@][>11%DM(FP9'Q]T$^_?'X4 7ZCGGBMK>2>>18XHE+N[' 50,DG\*Y3
M3?%=[<>++GP\_P#9]W<)I_VU);:0HBL'V-$_WL$$CD?E6=HGC#Q+K?A0>(3H
MVF+8-93RF-KIPY=&( ^Z1M(!]\CMF@#N;.\MM0LH;RTF2:VG0212(<AE(R"*
M9?:G9:8L#7MU%;BXF6WB,C8WR-]U1[FN/7QQ';Z%X3FG-EI@UJV$@FF4_9X&
M\M6$?4<G=@9(^Z?I5G6O$6IZ9I^@2WFF6,LE[JT5G+^\)6,-(561!CG*C()(
MQD4 =C17&S>)/$-SXLUC0--T[3O,LK>*>*>XN'VL'W?> 7.?EZ#CJ<] 8K3Q
M\U]X9\,7\5FL=WKUP+9$=B4A8;MY)ZD#8<#C.1TH [>BN7T'Q%J6H^*=;T.[
ML[51I)C#W,4K R^8N],1E3CC.?G."/>KFLZ\UEK&EZ+:)&VH:B9&1I<[(HXU
MRSD#D]0 ,C)/48H W**X6[\;W^GP^)K2YM;8:KH=K]M&TMY5W!M+!E[H>"I!
MS@]S5^7Q5=Q:IX3@%M"8==1R_)W0LL)DX[$'I0!U=%<5X%U'6M2U'Q,=2GMI
M([?5I;=1&K#9MCC "Y/W<<^N236QJNO20>(+#0+%8C?W<4EPSRY*0Q)@%B 0
M6)9@ ,CN<\<@&[6;#XATBXU0:9%J-N]Z0S+"'Y<*<-M_O8/7&<=ZYZ+Q1J%[
M!XETEXK>VUO1T!9@6,4L;H621>X) /'.".IIOPVLS-X$\.7-[!:220V49M)1
M'F2,,F&Y/0D=<=: .UHJMJ#W$>GW#VAB%PL;&,R@E0<<9 Y(K@O#'BW48/ /
MAZ[OS#=ZCK,R06HR5W.Y9F9SSP ">!V [T >C45R8\2ZA:^)Y?#E_':_:Y;-
MKRQNHU81S!3AD9"258<'@D$'/'2L^+QW>S>$/"VO"RMQ_;%[;VLT)8_NQ*^W
M<I[XQT(YH [RJ0U?3FU<Z2M[ VH"(S&V#@R*@(&XCL.1UK!N?$6JWW]MGP]9
MV]S_ &1(8&CF)W74P0.T:$$!,!E&XYR2> !DXE[/J,OQ6TN:SLHH[Z;PY(3%
M=286$F9"0Q7.<'C ZGN!S0!WFHZE9:182W^HW,=M:18\R:5L*N2 ,GZD"K76
MO.[SQW??\*UU'79M)LI;RPNGM+NV>4F(NDHC++\N6&2#@X^M;&J>(]8@\:V_
MAZPT^SD%Q8274<\T[#!5E4[@%X'S=LYXZ<F@#K**X2'X@3Q^#KO4[VPB&HVN
MIMI4D,4A\HS"41A@Q&0G(/K6C;>(=5'CQO#-S:V<JK9"^^UQR/&?++%,",AL
MMN']X<'/M0!U5%<]XJU^Y\/G1WAABFCOM3@L)%<D%1(V-P(]/2JMQXHOX/$V
MLZ0EI;3?8M-6_A8R,F_+,-C'!Q]T\@?A0!U=%>:K\0M?M]#T+Q)?:-9)H.H&
M%)S%<,9X3)@"3&-NS)Z9)Z=,X'0#Q%J>K2ZT- @M9$TF<VS"X+9N9E4,R*0?
MD W ;B&R<\8'(!U5%<"GQ#N=27PG-H^FPRV^O^<O[^<HT4D:,2I 4C 9<$\]
M#@=*V?"WB"_U6]UK3-4M[>*^TJY6)VMF8QR*Z!U8;N0<'D4 =+1110 4444
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M[SDYQ^M7_%/@_4?%4=U;WEMIH?SD?3]129A<60 4G&$Y(8,1\P!R,XQ7=T4
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M\V3CTQWK7O-!U/\ X6%:^(;*6T-L=/-C<),6#J/-\S<@ P3U&"1CKSTKJ**
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M6<S6X*3L%W%% );=CU ![$CFL>^C;5O!'B)M-\(3:4]WI\EM##):)'<SR,I
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MGKY>_P#N[LXS[4 ;%-D4O&RJ[1DC =<9'N,@BJDNKZ=!-%#+?6\<LL1FC1Y
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M;EI#$J>8/FD'5 >A8=UZU!=^+_#EB+@W6N:?%]F=8YMUPO[MCG"GG@\'CVH
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MXM\.W>MKI"V/V2);'4H;]_-)&_RR?D& >N>O;T-=%#;Q0PB*.&.-.Z(H"^]
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M')]!STKA[F>Q_P"%(>*94EM_,;6)FW*PR3]K!4Y]<<CVKW,HC,&9%) (!(Z
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M:. W<=M-923L%66W1"K!2>/E8G(_VB:['3=,ATV.?R\&2XE,TSA0H9\!> .
M %4#V'.3DU9FMX;@*)H8Y-IW+O4'!]1F@#Q)+:/3_"7@^"_:-+23Q:);.*<@
M;;4M+LX/\)R#]&%>VPPPP1[((HXT)+;8U &2<D\>IYISQQR8WHK8]1FG4 >&
M7&OZ5=Z+X<N+>YM]/MX/$\4DFF*<M:#SGW/.S9(8DD_PC#8YQFNEL)M-E\9_
M$F5WMCFUM068@';]G(8'/;.,BO2O(B^;]TGS-N/RCD^OUH\B+)/E)SU^4<T
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M/RJ?1[UM2T2POW0(]S;1S,J] 64' _.LSQLH3X>>(D7.%TJY R<G_5-WKE/
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MUL#XG\<Z3#K+7:+?^%O/N[9+F1%\PO'D  _+@GMCD#- 'JM%87B:UBB\#:K
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M+W3?MVA3Z9(\8$T!@9A%\NTC:<+GT[9H Q?&'B&?3/#UA?Z=(HM[N\MHI;P
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MC)]^*0HH9G"C>5 +8Y(&<#]3^=4+33KJWU>ZNY-4N)[:6*...TD5=L17.6!
MR2W?_.+MPDLD#I#(L<A&%=EW!?PR,T <)\&D63X2:('4, TYP1GD7$A!_,9K
MEXKS6M&\&^,-=TS5?LW]GZ]>2BW$".L_[T;E<L"<$=-NTCU/;TCP?X9_X1#P
MY#HD-ZUS;P%S$\D8##<Q8YP<'ECZ5E/\/Q)X7UO0GU5S!J]U)=32" !T:1MS
M!><8R!C.<<]>P M[K>HZIXDU#1M.-] ME:0R-)9"W+F27>1GSCC: HZ#DDY/
M3.YX7DUN3P[:'Q%#%%JP!6<0L"I() 88XY&#CU-8VJ^!Y[O5[76M-UZYTK5X
M[<6T]Q!"CI<1@Y :-\C(['_ZU=-IUBNG6,=LLLLQ7)>64Y>1B<LS8XR22>,
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M;-6*&3;$"1QD+DY)/09KI+[P/,_B$ZWI'B&^TN\N(4@OFCBCD%T$&%8AEP'
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M0%<J\/EDMP>S$Y'OS7*>*]0U'Q/\%+[Q&^H20Q7961+)8T,:Q>>%52=NXM@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(VQAM=5DMT$;M^["QQX501TY))SU)XJ]XGUEM*U;P[ VFV]U%?:@MNLTC_-
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M,;.N1M?'.TAB.*Z:B@#EOLWB?5/#^I)J<6GP7=Q:O;P6L$S-&I8$%W<KGTP
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M0^,@=O?CU"B@#D;[3O$VM^$-9M;]-/AOK^T>UAMHIF,4.Y64LSE<DG=T"X
M'J:I7GAO78XO!U_9PV4U_H2-%-;27#)'(KP^6Q5]A/& >5KNZ* /,[OP!K>K
M67BR"\N+*WDU6ZAO+2:%F;RY8U3 92/NY7&<Y[X'2M%M*\6:IXF\,:QJ%GI5
MM_9?V@7"17;OYGF($W+\@QZ@'\Z[NB@#S_1= \8^')+C0[";3)-!>>22VNY6
M<7%JCL6*;,8<@DX)('KZ4[Q1X/OO$LDHFL[**\BN5?3=8BF*SVT8()W *"2/
MFP,D'(S@\UWU% &#9ZCK#^,K_3KFWLSI:0++;30NQE4_*")0>!DEMN.R&J_B
MK1-0U'4=!U/3A!)+I5VT[032&/S5:-D(# '!&[/(Y]JZ55522J@;CDX'4TM
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MOB75FCMSJFLJB+#YI\N)$CV("^W)/+,2!WQSC)ZRB@# \%Z5?:%X0TS2=06
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MBQMX;72)K[3EC@\MIY"LT2C'RG:#YC?* N#R>IZ5W](55BI902IR"1T/3^M
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MQ83PQ10QEV9VC95& /4]:YBXNM5M?#G@Z&+3=2-FBQPZF;>U;[3!MAP HQN
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M[K,I /X$UY;/-JMU\/- T)_#FKIJ>E7EC'<1BU)0K"Z@NK_=8$+G@G&>>.:
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MNH)I;>%I3&S[-N54%L':>0,#O0!)_P +)T$>&K[7'6^CBL)?)N[9[9A/ _\
M==>W4<DX]ZOP>+K*X,JK9Z@L@G$$$<EL4-TQ4N#%NP"NT$Y. ,<XKA/%&@:C
M=^'/'FI6^GW1FUY[:.TM$A8RLL05=[*!E=WS'!P0 ,X)Q6_XZM[N=_#WB"TT
M:75K73YI#=:<8<RO%(FTLL;#EE(!QUH UE\=Z,++4)I_M%O/I\Z6US:2QCSE
ME<@1J "0=V1@@X]^#5RQ\3V-W<ZI;3++97&EJLEW'=;1Y:,I97W*2I4@'D'C
M!SBN2O[FZ3PY<:GX<\(2Z<L]S;+.HL$2\>)6^>01<Y*@C;NYSDXQC.6^@:AJ
MNI^-;.UTS4[:'6=)@CM;F\SAF59 0[,Q()+ 8/(!Y H [J+Q;IUUJ5AILL-Y
M;-JL3O8R2IL6X55W-M(.Y3M.?F"FN.\&>+[30/##C4AJ,T(U:Y@DO"C2I!F<
MJGF2$Y[@=SR,]170^&/$FI:G;65K=^&M1L+JUC O9;J#;$A5<'RB#F0L>FT=
M"<]@>-GT[4I/@YK>F+I6HF_GU.26*W^R2;V5KH2 CCIM&?TZT >IMJT2Z^FC
M_9[HRO;&Y$XA/D@!MNTOTW=\>E9_C:]TJQ\(W\VMB[_L[9B;[('\S&1T*\CG
MOD"I6\21IXFM-&;3M0474'FQ7C0%82V&/EDGD/A2<$5F_$VVN;[X=:S96=M/
M<W5Q"(XHH(R[,VX=A].M %R_\7:;I6K6NCO%?2WD]NTT,<5NS[U7' /<\CZ=
M2161K/Q$A@\"WNOZ98W4LMO.;.2&9 C6TVX(?,!/8L.!G.1]0VZ$\WQ(\-7R
M65Z;6'3KB.68VL@6-GV;0W'!^4_3O7-7NDZI=^ _'=K!I=\;FYUQKRWB:W9&
MFB\R)MR9 SD(W'7CWH ])FUY(O)B%A>27LL;2BR0)YH13@L<L% R1C+<YX[U
MDGXC>'QIVG7P>[:*_NOL<86V8LDPSE''9A@\=3VS6!X@:X@\7V/B>X\+7FJZ
M1=:?]CEMQ:"6XM761F5_+/.&#$'N.^#Q1K=HS6OA:33_  U-80IK\5]);6UG
MAHH0CJ9)1&" Q+ XZX([@T 3>)/%TUZ/#4-OI>JPVVH:EY5Q%-"(I)$029CP
M6!Y* ^A7OR16Q:76G>$K2^M[*WU6[2/-[/;*PE-DCC.P;F&!\I(12QZ\8(JO
MXU2>77_",D%G>3QVNI>?.\-N[B-/+=<D@>K#CK6/J,3Z)X\U>[U+PG<ZYIFL
M+#+;SVUDMP\#I&(VC=3RH.T'/3GZX .CN/B%H43::L'VR\.I6[W-H+6V9_.5
M1DA?5N>G4=\58E\86B6#7<5AJ,XCMENKB)(0)+9&&1O5B/FP"=HRW'3D9Y^6
MSF@\;^#9(=$DL[2UM[Q98[6V/DVOFA=BDH-N>#G'&<]JJ:A"^A>/-9GU3PG<
M:YINK^5+;7%K9K<M"ZQK&T;@_=!V@@].?K@ Z9_'VA_:--@@-W=-J5NUS:&W
MMF82J #@<<GD<=N^*GL/&6DWVA7>KEI[:&SG:VN8KB(K+%*I V%1G+$LN ,Y
MW#%<\]E/!XZ\(R1:*]G:6MG=I+':VQ\FV,FPHA*C;G@YQQGZUA3Z-K5WH7BI
MK#3[D7L?B5=7M(9XFB%U&GE$ %@.NQN/8>M 'H%OXMT]]4NM-NXY]/N[:U^V
MO'=A0#!G!D#*Q& 1@Y.1Z4D/BZQ?6+'3;BWO+274$9[)[B,*MP%&2!@DJ<'.
M&"GVK%O[F^\>>%-7L+31;_2S<6$D._4H?)8RL/E11G)7KENG3&><5_"MQ%J<
M]C'/X!?3-4M>;FZN+"-(XF P3%)U8D]-O8Y/3D ]!HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHJI?:II^F+&VH7UK:+(VQ#<3+&';T&2,F@"W15--6TV74'T^/4+1[U!N:V
M693(H]2N<UG:AJMK=II[Z?XEL;53?(C$-'*+G!PT"Y/#$D#(Y% &[17/Q>+=
M*O?$E]X=MK^!;^VB0DLX/SMN^0+D;BH7) Z9%9/@3QC%J/AC23KFKV?]L7KS
MJD;.D;R[9G0;4X[*!QZ4 =M115"#6]*N;XV,&I6DMV,GR4F4OQP>,YX[^E %
M^BJ$NN:3!?+92ZE:)=,P00M,H<L1D+C/4CM27>NZ182RQ7FJ65O)#%YTJRSJ
MI1,@;B">!D@9]Z -"BN?UGQGHFC:/::G)?V\MO>2I%;-'*"LI9@N0PXP,Y)[
M 5;F\3:#;(7FUK3XU$7GDM<H (\@;^OW<D#/N* -6BLV;Q#HUO*D4VK64<D@
M0JK3J"=WW>_?MZ]JGO\ 5=/TN-7U"]M[56S@S2!,XZXSZ4 6Z*Y_5/&>AZ5?
MZ3:3ZA;;M3),3^<H01A&;S"W3:< #U)XK236M*D2Y=-3LF2UQ]H83J1#GIOY
M^7\: +U%49=9TN&SAO)-1M5MI\>3*9EVR<9^4Y^;CGBN<\=^(KFQ^']QKOA[
M4;<E&B,<\:K,KJTJH<'D?Q'UZ4 :NL^&TUC6-)U%[ZX@DTR5I84C";69E*G=
MD$G@D<8K<I&8*I9B  ,DGM64OB70YW6&'6]/,LBNT86Y0DA,AB!GD+@Y^AH
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M$6[#G>!Z$UZTUI;.92UO$QEQYA* [\=,^N*0V5H;9K8VT/V=OO1>6-I^HZ4
M>8Z]:J=>^(-U;[#IC^']MT>-ANPCX]MP3;GO\PI@2SMK;X420+!$[,@W)@$[
MK4[OS.,^IKU!+&TCM1:I:P+;CI$(P$'X=*3^SK$A1]BM_D^[^Z7CZ<4 4=*O
MM!NM5U6'2Y+-K^&51J A4!]^,#>0,DX!&?8CM6-\1K"=] BUNPCWZCH<ZZA
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M;!)!(R6R>>*ZRS\/3Q>(--U2WUB&&PN(7AFMX))6%\&0LCAB_#C!;>.2,\T
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M[4M/N;FXBO-8,+ZG-*5DOHW$I.8QD>7P-N2"-HPHH [[2/$4^I>*]?T6:S2
M:4+<K*LN_P T2JS9Q@;<!1QSWKH*XKPY_P E4\;_ /7+3O\ T7)7:T %%%%
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MO+#,\,D;8P<,A!&1P>:SI/A[X9DM-0M#I[BWU&02W,:7,JAV&.>&XR5!..I
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MJTD<4:X4.5X+9+'@]"!VKH:* ,#3?#<-AXLU77(5:)KY$65?.9_-9?XR#PN
M, #U.?07-8T#3M>6U&HQ2R"UG6XAV3O'MD7[K?*1DCMFM(G )/;TK%M/%>EW
MVDZGJ5L;B2WTV66&X MW#AXP"P"$;B1G'2@"2/PUID6KW>JQI<+>W<8BFE%U
M+\RCH,;L#&3C [U)H^@:;H6CKI.GP,E@H8+#)(T@ 8DD?,2<')X]ZO6TZ75K
M#<1APDJ!U#J58 C(R#R#[5+0!E?\(WI'_",CPZ;)#I0@^S_9R3C9CUZY[YSG
M/-4+?P)X?MKNUNTM9GN;6%H(Y9;J61BAQ\K%F.X# P#G';%=)10!C6/A;2]/
M>U:%;A_L<;1VHFN'D\A2,'9N)QQQGJ!P.*C@\':%;Z5?Z6+(R66H2-+<PSS/
M*)'8Y9OF)P2><C'/-;F1DC(R.<4M &38^';"PE$R?:)9UA,"37%P\KQQG&55
MF)(S@9(Y.!DG JB? GAXZ#+HAM9SILLOG/!]LFP7W;LYWY^]SUZUTE4M4U2#
M2+:.>X2=D>9(0(8FD.YVP,@#ID]: +:1B.-8P6*J,?,Q8GZD\FL.T\&Z)8E%
MM[:1;>.?[1':&=S!')G.Y8R=HYY Q@'D &MZB@#)?PWIDGB%->:.?^TDB\A9
M1<R "/.=NW=MQGG&*QOB?8W>J?#S5=.L+6:ZN[E%2**)<DG>I//0< ]:Z^B@
M#'L-#T^.6*^5+IYEA,4+74KL\*'&57<<J3@9/4X'/%.TKPWIFB6ES:Z?'/#%
M<R-+*#<R,2[<LP+,2I)YXQ6M10!G:)H6G^'=*CTS2X7ALXL[(FE>3;DY."Q)
MQDFFVWA[2K30&T*&RC73&C>-K?\ A*N26'X[C^=:=% '-6G@'P[93Z=/%:3-
M-IV1:R2W4KLBD ;<LQRHP,*>!V%%OX"\.6FN2:O!8-'<22^>T:S/Y)E_YZ>5
MG9N[YQUYZUTM% ')[+WQ)XA@&H:#)9V6CWCSQ3W#HWVAPI1&0 DA<,6)..0H
MYYQ=\0^&X==U'1KIE99].N1<1SK,R[ "I8;1PVX+MYX )^AW@0<X(..#[4M
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ME'BD7HZ,I!4CU!J >&M,^QWUL\<T@OTV74KSN995Q@ OG<!@G@$#D^IK7HH
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M2=Q-#Q@@/G<01P020>],NO".BWNB7.D7-J\EG=2>;<#SY \S<<NX;<W0=3V
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MAU73T>)I[B/S5N8W.76105ZM\PP1@]L<57U3P(=4T37[63442_UTI]KNQ;Y
M1 %543=P !W)Y)/?@ ;'J^NV'CK1].O[NVN;/5[6>18HX-AMWB"'ALDL"&QS
MCD9XZ54\-^+;G6]7BL9=26SU:*247VCW=N$:-0K;#$>"X!V$G)R.?EZ5M7'A
MF\NO$FA:Q)J4(;2HI8O*6U.)?,"ACG?\OW1CK^-5X_!]Q->:)=:OJ,%W+HSE
MX;A+7RYI/D*X=RYXP<D <D#IW .6_P"$D\;W'@[5?$=O?Z8#I%U<B2U^R'%S
M'"Y#?-NRGR@X R>.O/'10^)]0O/&'AZW@>%-,U;2I+T1F+]XK (1EL\CY^@
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MX''3/- %2?7?%EP/&8@U.QM_["D+0D6>[S (1)L(+<#L3R?3&.7ZKJ+:O?\
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M;#<8Z D]@?.]!U6VT;X2W]W?:!'>VJZQ.LEC(4V1YN<*#D$':Q'0=J /8:"
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M/N(PON,GKQ7HM9FG^'M-TO4KW4+2*5+J^(:Y=KB1_,(& 2&8C@<<#I0!Q?\
MPA6HZ3H?@S2[*$7?]CZ@+V[D5U0'(DWA QY^:0X]A6EIFDZQX7\0Z_)9V/\
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MZ=J=K;JTC38>%HM^5V@'<3N'0XK1\+:MJ>K65T=7TZ*QN[:Z:!HXIO-1@ K
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M/)SVX]^*[ZB@#RB_\*^++W3;J*XTZSNM035X[M;Y[L;KB%9@ZHHV_( HQC(
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M%<GI&E^+O#&IZIIFG6-E>Z5?7DEW;7LMSL-IYARRO'@E\')&",]R,\=^
M  .@%+0!Q=MHVJ^'?&NK:M:6S:E8:Q%"9E21$EAGB79G#%5*L.N#D'M63>^"
M=4M_!T-A:P1W%_/K2ZM=A)0J(?.$C*I;&< !1QSC/%>E44 <;%I&J:)XZU37
M;.R:]L=9@A^T0)(BRP31+M4C<0I4J><'(([UC7/@O5;71]/2VMDN+U_$@UV]
M"2A43]X6**6QD@;0..<$\5Z710!A3:OJD/B^STTZ9&=,N;=G%T)AYB2+DD%/
M[H&T9]6%+XHLY-0L(+0Z1#JME+-MO+:4J"8MK<KNP-P;8>H[\BMD11B5I1&H
MD8!6<#D@= 3^)I] 'EX\":[8^'D&CS^7<:;J_P#:&DV5[-Y@CAV;# S@G .Y
M\8)QD<]374V]_P"+I]+N;NXT6VM+S9LM[%;M9<N>LCO@# [*/?)Y&.GHH X?
M2?#VJ^&/%[S:9%)<Z-J48DU$33*'2Z[S*,_Q#[P&!TQTQ6WX>U;4]1N=5M]4
MTZ*S>SN?+C,4WF+(A&5)/9L8)'N*W:9%%'"FR*-8UR3M48&3R: ."\4C4YO'
M%I/H6FQWUW86+"<PWJV\T8E;Y58LK*RD(Q"XX(SQQFB^D:GJ7AN"RTC1UT36
M= OX[^&VN+D3QSL0^=TB\DN'?.<'..QS79:KX0T/6;];^\LV^V*NS[1!/)!(
M5]"T;*2/8UIV&GVFF6PM[.!8H@<D#)+'N23R3[GF@#DM1B\5^(_!VM6M[I%O
M87%W8R6L%G'=K*2[J1YCO@  =@,GKGMB*;1-8DU#P/.NGG;HZO\ ;,RID%H3
M%\O////;CWXKNZ* /*QX7\4Z;X+\0>#K;3H+RTN!<&PO?M2IA)26V.I&=P+'
MGH?45I7.C^*](UC2_$&DV-I>S_V;'IVH:<UUL!"$LKI(5QD%FSD=^_6O0J*
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M\N"74X&WGUK/\:2WVJZ1XWTY]+U&.[63_1;>SLW$=Q& G[]Y%&)&.",$\!0
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M'A8(LN9.-^,9&X'@UDSV]SKWPALO!XL;FWUV-;:S>%X6'D-$Z9EW8QMVJ6#
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MUI/;M<@6TF80MNR,7X^7#$#F@#L['QCHM];:G/Y\ML-+&;U+N!X7A7;N#%7
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M(TD*A'4DH!NP"PZ#O0!W]_XQTC3C="9[AOL<*7%YY=N[?9HV!*F0 9' )QU
M&2*R/$%Y+_PGO@A[2^G^R7CW/F1QRGRIE$!925Z'KD5@>*+R[U*7QCI\FE:E
M TNF#["EK9N/MN83EI9%')4G;L+ =1AB<5/YDDNI?#.;['>JEM%*)R]K(/*S
M;;!OX^7+<#./RH ].HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ.>>&VA::XE2*)!EGD8*J
M_4F@"2BL75O%>C:/H[:I/?V[V^\1H8Y5;S'.,*.>O(^@YZ5>FU;3;:".>?4+
M6*&3A)))E56^A)P: +E%9&K>)=*T673X;R[B22_F$4"EP-W&2W^Z!W^GK5Y-
M1L9%E9+RW98AF0B52$^O/% %FBJTFHV4-H+N6\MTMFX$S2J$/_ LXJ6&>&YB
M66"5)8VZ.C!@>W44 244$@ DG '>JUIJ-C?[OL=[;W&W[WDRJ^/K@T 6:*J1
M:II\\D\<-_:R/ "9E2928_\ > /'XT#5=.,7FB_M3'NV[_.7&?3.>M %NL#7
M/#D^IZG::I8:Q=:;?6T;PJT:))&Z.5+!D8$=57D8/%:XOK0M,HNH,PC,H\P?
M)_O>GXT-?V:6?VQ[N!;7_GL9 $ZX^]G'6@"IINE2VDIN;V_EO[PIY?G2(J!%
MSDJJJ  "0">I.!SP,:=<WXMUV>P\"ZGK>B7-I));6[S1R,/-C;:.<;6'YY_
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MY<YJU0 45%<W5O9P-/=3Q00KUDE<*H_$TT7MH;/[8+J'[+MW>?Y@V8]=W3%
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M6Y@4[3*)5V@^F<X[T 6:*165T5T8,K#((.012T %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M<UXULI[^PT^*RU.*PU%;Y)+)YDWQR2JKL$<>A ;WR 1S72U6O=/LM2A$-]:0
M742L'"3QAP&'0X/?D\T >2>(-0DOO &NIJFDP:?J=GK5H+[R6WPNYD@/F(3T
M!7:2#SZ]:Z35;_2)?&LUM:R6<5S'HS"6YN),PK TA!1(\@%BRG<V0!@#GH.T
M&DZ:-/?3_P"S[7[%)G?;^2OEMGDY7&#36T72GFM9FTRR,MHNVV<P+NA'HAQ\
MH^E 'D&D3VLW@[X6RS20N([]8I&=@=O[J7"D]NW!]JZS2[NQMOBAXL>:>WBA
MFTVQD0LP"N@$@R/4<@?E78G0='-@E@=*L39(_F+;_9T\M6SG<%Q@'/>GW&CZ
M9=WT%]<Z=:37=N,0SR0JSQC_ &6(R/PH \I\)P7M[\/O!4N@ZI9PZS9PW$D-
MM=C=#<#.UT;'*L PP1R,GMFNT\(>)-./AVV%Y#;Z)<27T]I]CDF7:;D2MO6,
M\;@6SC'TK=/A[13;06QTBP\BWR88_LR;8\]=HQQT'2H-3\-:=J=M96CVEHEM
M:2K+&HMU)CVD$",_P9Q@D=L].H %\5V]O=^%-4M;N\:R@GMWB>Y'_+(,,;OH
M,\^U>>:GJ/B2SL?$NF:A8VYU^/0VEM]3TW(%S K%>5ZHXW,1CU..E>KSV\-U
M \%Q#'-"XP\<BAE8>A!ZU!9:7I^FAA8V-M:AP WDQ*F0.F<#M0!P^C0^%]9U
M;PWK.G>(9;FY@B>.TMH# O[MD^9)$1 0JXZ'&#CN:R+6*Q\/^-XK@QD>$-3O
MV:T)(\F'4,;=^,?<;#!3TW D#&TUZ3::!HVGR7$EGI-C;O<@B=H;=$,H/4-@
M<_C3I-"TB:QCLI-*L7M(CF.!K=#&A]0N,#K0!R4%Q:V7QCUMKJ:*!9-%MGS(
MP4,!)(">?3BN4\)ZAIJ>#/ MHWEM?/J%V;1I)=D,+JTV6D ZG:WRKQDD<BO6
M9]%TJZN;6YN--LY9[3_CWD>!6:'_ '"1\OX5&_A[19+%+%]'L'M(W\Q(&MD*
M*W]X+C&?>@#RF&YA;X<_$^$7=O,_VZ]<>20%8&*/+*N3A22>Y^M>MZ-SH>G_
M /7M'_Z"*:^B:3(MPKZ79,MRP:<&W0B4C@%N/F(]ZMP6\-K D%O#'#"@PD<:
MA54>@ Z4 >4Z8;?5/A-XM360O]IQ3WK7Q?[Z3J6:(COP/+V_08I;32(]2\;^
M$X_$-E#/>S^&G-ZD\8/FR Q [P?O$9/7H?I7I4NB:3/?B_FTRSDO!C%P\"F3
MCI\V,\=O2GR:5ITM^E_)I]J]XGW;AH5,B_1L9% ' _8UTSXF:]#HMM%!.OAB
M,P1PH%&\/($X'T4?@*S_  W'X;\0Z!X3NG\0W!O[&:)H[2-H5F%QC$B,-F\J
M26+9/(RQ/>O3UTO3TU!K];"U6]88-P(5$A'INQFHX-#TBUU*74;?2[**^FR)
M+E(%61\]<L!DT >1OHVEMX"^)TIL+8O;ZG?"%O+'[K;'&PV_W>>>*Z)I;8?$
M;PI<WCPCS-!F8R2D#<V8CG)ZFNX'A_11#-"-(T\13G=*@MDQ(?5ACD_6I#H^
MF,+0'3K0_8SFVS O[@^J<?+^% 'D&M:CI]QX?^U:?+;VUM_PE*2;)I-]R\PN
M 'D))^0=<+@G;CD9Q76:0VGM\6O$F\VQ$]A9-%NV_O,^9DKZYR.GK77/X>T2
M1KEGT?3V:Z8-<%K9#YQ!R"_'S$'GFK#Z9827JWKV5LUTD9B6=HE+JAZJ&QG'
MM0!XTLIT_P"&]QY2!=*C\6NFH*@PJV@N3N! _A^Z"/0^E=IK5F&^*GAF6P1&
M6YLKM-250"LEL%7R]XZ$;VP,^IKK[;2-,L[>:"UTZT@AFSYL<4"JLF>NX 8/
MXTVRT;2].ADAL=-M+:.0;72&%4##T( Y'- 'B\>FZ?!\#QJ,5K EY!JP,5P$
M&^/%_M&UNH !/ ]3ZU[8FIV$FIRZ:EY;M?11B22V$@,BH>C%>H'^-5O^$=T/
M[+]E_L;3OLV[?Y/V5-F[UQC&:9%X>LHO$0UE+>VCG2W-NABA"L5.W[S=6QM
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M)Z# '%>AV>@:-IS7#66DV-L;GB<PVZ)YO^]@<_C3X-&TNVLY+.WTVSBM9?\
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M)_AV:2&VNA-H,K2,0'$C*\8&[^]@YZ]"/:J^A>&;?Q'X'\6Z%&$B$6NWJV)
MXMG5PT94=@&[#L2.]>C+H>DI/%.NEV2S0H(XY!;H&10,!0<<#':L_4=/OM+M
M%_X1'3-&AN)9P;@3J8D9,'+?NQDMG'7WH Q_!>J3>+YH=;O;5H)M.@-DT;KC
M;=$C[1CV&U #[L*3XAW3VMYX5-QQI#:O&MZ3]WH?+W_[._!YXR!75:/IW]EZ
M9%;-)YLN6DFEVX\R5V+.V.V6)..W2K-S;07EM);74$<\$@VO%*@96'H0>#0!
MP=]9LGQ6O#9(/L]QH+-J* ?*T@?$3,/[^-P'LIKE4:SF^"7A*&-XBQO=/$P1
MAN&9L<XY!X/Y5[#8Z;8Z9"8K"SM[6,G)6",(">F3BJQ\.Z&;<6YT;3O)$AE$
M?V5-N\]6QC&3ZT <1<VO]E?$O6X-"MHK:9_"WFQQ0(%#3+*X0X'?H*H^'(_#
M7B'1?"5V?$,[7UC+$8K2)H5F$V,21N F\J?F+9/(!8GO7IB:3IL=Z+V/3[1+
ML+M$ZPJ),>F[&<5'!H6D6NH3:A;Z790WLV1+<1VZK(^>N6 R: .(^'F@Z/)?
M>);EM.M6GM/$=U]G<Q@F'"KC9_=ZGI5SXFPP7"^$X;E5:"3Q#;JZOT8%)!@^
MQKL+/2M.TYI&L;"UM6E.9#!"J%S[X'-27EE::C:O;7MK#<V[_>BFC#JWU!XH
M \OU>QTKP]XS\1W%I:-!HP\-NVJP6 \L&0L0F ,!9"F_GCCGO2Z;=P1?$3PB
M?M6GQQOHLT4<-M)GRX_W7EHSD_.?0X&>PKTRVTRPL[1[2VLK>&V?.Z&.)51L
MC!R ,'-0VV@Z/9_9_LNDV$'V8L8/*MD7RBWWBN!\N<<XZT >>^')+W1M3\-:
M=>I::QHUUY@T?5H!MFC!B9MLJ_Q97.2.X!/-0:/IT%QX6\8Z?!?1Z7GQ5(MO
M,(P4CE$D)C4KT*E@H(]Z]*L]#TG3Y/,LM+LK9\%=T,"H<'J.!WIH\/Z*+>>W
M&D6 AG8--&+9-LA!R"PQ@G/K0!SW@S4=0GUK6[#6],MK76;80-<W%FQ,-TK!
MMCC/(.%((// K.U[2],O?C)HB7MI;S";2KC<DB B4JZ%0P_BQR0#G&,]J[NS
ML+/3XVCLK6"W1CN98HPH)Z9..IX%<MJ_ANYU3X@Z;JL]A:7&EVUG);N)F!;<
M[*P8*1CC;ZYYH \YUW2+:P\&_$*WMH471[?5K8V( ^6&0M%YPC_N@$[>.G(K
MLO$5E8:!XS\'QP6-O::/=7TS79CC"H]SY6("_J<YQGN >M=O)HNE36*6,NF6
M<EG'REN\"F-?HI&!4D^FV-S8&PGLK>6S("_9WB5H\#H-I&* /.-8LVB\7>.$
MLT']G3>'O.NT ^7[60X4X_O%%R>_0^E43JMG8Z!\-WEOTM-*,*)=W,6PK%<?
M9E\KS-P('.[DCC@\8S7JUII]G86YM[2T@MX223'%&%4D]3@5"-#TD:8VF#2[
M(6#9W6HMU\HY.>4QCK[4 >8>(H-,T/0=:U#2M4N=1LKG4[.;6=C1M$L6\"4*
M(U !90N\<Y!&>M=1J">&=1?5=2TR6"[U";1I(W:VEWQ^2N2FY0=H.3\IQG .
M.AKK+73+"RL/L%K8VT%G@K]GBB58\'J-H&.:9IVCZ9H\#P:9IUI90NVYDMH5
MC5CZD #- 'E$.JVEAX-^'$DMZMKI8$2WT\01A%*;<B(R9! &[/+#@@'J!3_%
M,.FZ/HFNZAI&KW%_;W][9-K+1M&T,<1;:^WRU #,H&[N003UKU)=$TE--DTY
M-,LEL9"2]LL"B-B>N5Q@T^UTG3K'3SI]I86L%D00;>*%5C(/7Y0,<T <1J<N
ME_\ "W/"$]K):YETZ[4/&R_,F$\L#';EL?CBK?Q7"-X,C$AQ&=1LPQSCCSTS
MSVKI;+PWH>G/$]CHVGVS1%C&T-LB%"V-V,#C.!GZ"KUQ;07=N]O<PQS0R##Q
MR*&5AZ$'@T <#/H%AI_Q8T3^Q+&WMDDTZY&J16\85&A^41;U'&2^0/7:?2L_
M2+233]4N_ALT#&Q%T+ZW?;\O]GLQD9#])1Y?N']J]#BTRWTK3YX]%L+*UE*$
MQHL8CC9P/EW;1TZ?A5'P_8:L)9=4\0?8QJ<T:0^79EC%%&I)P"W))+$GZ*.V
M2 ;U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !117.^,9_)TVS3^TIK/SKZ&/9;J3+=#.
M3"A!!4MC[V1@ G@9H Z*BO([O4M6M]&^)%LE]?VG]F)'/: W1DD@W0!ROF')
MQGG /'(!JY>PZKH&H^#]8M]<U.Z.J74-E?6MQ.7B=9(R=ZIT4KM)X_'/.0#U
M"L*_\1_8/%VCZ"UB[?VDDSI<^8 J^4H8C'4]1Z=:\^@L-6U?PUXOO?\ A*-9
MANM*U2]%DR7155$0!4.!]Y>,8/ '09)SI1:C<:QXF^%^I7:A;B[TZ[FE &!N
M:"(G _&@#O[.ZO9[Z^AN-/-O! ZK;SF56^T*5!+;1RN#Q@^E7:\KO/$>I^'[
M?XD7<=Y/</ITT M?/;>(=\:9(7I@%R<>U=:FD?V?J-IJEOXCN4LS:NDT5U,T
MR7#;=RR LV%( 8_* "/0"@#IR< G&?:L/PSXC_X2./4V-D]HUAJ$MBR.X8L4
M"Y;C@?>Z<]*X;3=0O[?7?!$D&H:A=6^HM/'<7=Q,P2_'DLX=82Q"+D J?E..
MV*K:?H=QJ6E>.+RWUS4M.N+37+V6W-K<>6BNJJV7 ^^#@ @Y&.F.: /0=1\1
M_P!G>*]%T-K%W&J"8K<^8 J>6FXC'4GIZ=:W:\P@U*YUG7OA9J5XH6YNK2ZE
ME & 6:V4D@=L]?QI8#K_ (QT74-0T[4%L=0AU&:.&?\ M"55MA%*5"/ %V,"
M@&=V<[L^@ !Z7*S)$[)&9& )"*0"Q].>*R/"?B%?%7AJUUE;5K43M(!"SABN
MR1DY(_W<_C6M Q>"-V9&9E!)0_*3CM[5Y5X5G\KX5^&HO[1GM3-J4B>3; ^;
M>#SY284(8%<XR6R, ')Q0!ZS17F.G0ZSK.G^.-%AO[^UN;2Z']GD7CM) S0J
MX3S,Y*[CT)(&3CH#5)?%K3WW@[Q!%<7JZ:\:6VK1FZD\J*63*1E@3@E9$8,3
MV*D]10!ZW17+6>D2:YX>FD?5-4M/[0N!=QR073*\<6X&-5SG:"H&0/[Q%=0[
M!$9F8*H&23T% "T5Y1:ZC?V]_P"#;JWU._O8KZ_D@N+Z65EBOE9)&RD!8A5!
M48.%Z<9!S3)H=0O+#XAR2:_K"MI4\LEGY=VR>6RVZN/NXRN?X>GMGF@#UJBO
M-]9U"_L]'\)>-)+V[^RQI =6MXYW6)XY4 \TH#CY'8'IR,YZ5U7A]FOKW4]7
M%Q,]M/.8;6,S,T8CC^4NJYP-SASD=1M]: -ZL+Q)XC_X1YM*!L7N%U"_AL=Z
MR!1$9#@,>Y[\ ?B*S+J^;5?B-+X=N+B>&TM]+6[6*"9H6F=Y"I8LA#84*!C.
M,L<]!C%\365SIGA_PG87>K/JL]OXELT:ZD4!R/,)4-R<D*0,GDXS0!Z55*YN
MKV+4[&W@T]I[6;S/M%R)546^!E<J>6W'CCI7GWC6\NEA\7W-CJE_/<6%JDD0
MMIF@BTYECW88AL2.Q^;&T\8!P#6C>7]\WC7P$WVZX6*_M[EKF!7Q'(5@# E1
MUP6)H [VBO*S;WNH'X@1S:[JZC3IBUH8KQHS$1;AQ@KC@$_=Z>H-"76HP67P
M]\0'5]0DN]6GMH;R-YSY$B2P,Q'E#Y000,$#/J30!ZI17/>.Y)8/ >NW-O/-
M!/;V,TT4L,C(RNJ$@Y!'<5S]S?7JZY\.F6]N@+Z.1;I1,VV;%J6!9<X)W<YQ
MF@#T&@G )QGVKQZ==2F\*>/KYM?U@3Z/J5T;(I=LNSRXD8 XQN7MM/R]>,G-
M=+:ZO/XA\:6FBW,\T-M%HD>H2)!*T1GED;;DE2#M4#H#C+<]!0!T'AGQ'_PD
M<>IL;)[1K#4);%D=PQ8H%RW' ^]TYZ5N5XYI.HW'A_1=7M+:=R;OQG)8-/-,
M58(VW.9,$@G;MW8S\V>O-;VJ:;KVCV/B:Z_M=[>R?2I9[>V2_DN)H9XUR71Y
M%!"G(R/7'K0!Z+45U<+:6<URX++%&TA"]2 ,\5QF@>&IM3\'P3W'B/71<:II
MMMYDJ7A!B8*&W1\':3G!/<=><FNW1=J*N2V!C)ZF@#C[GQS=6>HZ1I]SX9OX
MKK5=XMHVGASE%W,&P_'%:=MKNI73QHGAZYC9;W[-="6>,>2GEAQ*,$AP=RC
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M@BN+IPS1QD@D+@ <D#)QDX&2<4W1/#EIH,U]+:3W+&^N&N;A97#!I6QENG'
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M*\9<(<@A@N1R" 1S65<^$]9O8_#9NM9MI;C1IQ,TIM&!N2$*<C?\I())//-
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M]ZIL#9)/WG&3^E7(-6\4P:\D3:?)?Z;+:R.TAMQ;M#,HRJC+'*MT'4@]Z8?
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M<@GG)Z]!CF:]U+5=2\<^#)+>^6WM;[3Y[K[.T.]5;8AR>1DX<@>GXUH+X*U
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M1110 4444 5CIUD;K[4;.W-SG/G&)=_YXS5FBB@ J.:"&X55FBCE56# .H8
MCH>>]244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>sangamoexecutiveseveranc015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM;#9Z[]Q3&.P/X\?X^T*ZT31]*U[3[^^O;W0KF-[2U,47SQDA'C41QJ>4_#
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M;*@XY)R,+U/8'%8":1<Z'X&\&6EQ;31.OB.*]-N$)-O 99'^8#[H567.>A-
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MX'6&9Q_"DA&TG@XYY[9J3Q6\L7A+5KBWGE@G@LY9HI(FP5=4)!]^1T/%>?\
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MK%O""ZGHNCW<-F=;M+V9VBD,LZK(I>8HWSX^HR<9Z8-:^I727/Q1\+7:1S+
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M(G:WO092Z2 @[%7D$DXP1GK6_ILL</CWQU+*K+%):VBQNR';(4B<,%./FP2
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M=O7D<4 =/>>+M"L9M.BGU!,ZBI>T**SK* I;(901T''KD8ZU2_X6%X<-I=7
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M(QQQ*;*<J9'&50,$P<YX/0\XK,L$>?QUX_2..0_:;2U2!BA"RLL3JP4]#@D
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MJVE2:"9!)'(ARKJ1D$'TQ4M9^AVL-EHEI;V]C]AA2,".USDQ+V4^_K[^M:%
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M@#K**;)(D4;22.J(HRS,< #W-9FK>(]+T;0I=8N;N(V:#Y71P1(W0*OJ2>*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KC_BIQ\+O$/_ %Z'^8KL*JW^F6&J
MV_V?4;*VO("<^7<1+(OY$8H YFTTBRT_2=&UNXU.^CAL(EG=9;IWC8&%DQM)
MQGY^,=^!UK+T>^TZ_P#$_C6#7FMOM<$RQ)%=;?EL_*4KM!_A)+$X[GGM75IX
M2\-QO&Z>']*5HF#1E;.,%".A''!%/U/0M+N[E=3ET>TN]2MTQ!*\2&13V 8]
M.?RH \KT$1IX5^$\[A5Q>LGF-VW1RX&?<U=O]0T>UU3XIS7CNUCY%DDPLY K
MMF(H0#V.XX)[<YKK/"7A-(?AYIOAWQ)IMK<FU3:\4@66-B"2&&?K['K6^GA[
M14$X32+%1<1"&8"W3]Y& %"'CE0 !CI0!P^DR"W^,,$<DMA&7\.X\FT;Y5Q.
MFQ2Q/SG!.#@<'I6I\+CGPO>?]A:]_P#1S5T5MX;T.S:!K;1["%K=&CA,=LBF
M-6^\%P. >_K5C3]*T[28WCTZPM;-';<ZV\*QACZD #)H X?Q7$\_Q?\ !D4=
MS+;.;6^Q)$%+#Y%_O C]*D\2Z#X?\+>#/$%W>_;;G^TGC^VW#3@37#%PJ*7P
M J9..  %)XKL+C0='NK]+^XTJRFO$^Y<26Z-(OT8C(JU=V=M?VDMI>6\5Q;R
MKMDBE0,K#T(/!H \[TQ(I?BYJEC?-ISK=:#")K>W'[LGS7&P@GYB%/7 X(X%
M5O#MJ\-PWPWN8"\&FW@NA(R962Q#>9%D]"WF;4([A6KNI-"LM-MFN-$T;3(]
M1M[9HK/,*QA>I";E&54L><>IIGA^QU)7GU36TMDU.Z1(VCMF+)#&F=J!B 3\
MS.Q./XL=LT 7M7U*+1M(NK^5=RP1E@@X+MT51[DD >YKS7Q9X?\ $6F^$+35
MP+"34-"N#JK21%]\K$EIASQM8%N/0 5Z=?Z98:K"L.HV-M=Q*P8)<1+(H(Z'
M!'6G7%A9W=DUE<VL$UJR[#!)&&0KZ;3QB@#A/$GB2QN-5\"ZA-,O_".W\LDC
MR2$>7YIBS!O[=2W7H0#VK,\?:=H%OX"\5RZ7LD:6ZM[BY*OOCCE,L8.WLIVC
M) _O#/6O0_\ A'-#_LI]*&CV TYSEK46Z"(GUVXQFI(M$TJ#23I,6FVB:<5*
M&U6%1$0>H*XQ0!9M5MD@"6@B6%20!$ %!SR...N:\FT\6^L?!GQ'<:LJC689
M+V6[D;B6*Z1V:/!Z@J!&%QVP!7K5M:V]E;1VUK!'!;Q+MCBB0*JCT ' %4Y-
M T>;4#?R:9:/=L5+3&%2S%?NDG')'8]J ."O[9KGQ%\,GUFVA?4)HIOMGF1@
MEI!:9(.>N&S7IH 50   . !VJC=Z)I5_=175YIEG<7$/^KEF@5W3Z$C(J_TH
M XKPS_R4_P =?]P__P!$M65XBTF[\(V>NR:)J6XZ],[0:6UMYDC7<BX)C?<-
MH/WFRI  )XKO+;1M+L[V6]M=-LX+J;_63Q0*KO\ 5@,FI8]/LXKQ[Q+:(73C
M#3;<N1Z;NN/;I0!Y=!X4CTCQAX&TG5/WUG;Z//;1'<0C76 7''JN[@]0/:M_
MP:&T;Q%XMTXW170K6[@%D9I<K%))&&DC5F/0%EP.VZNSO+&TU& 0WEM%<1!@
MX65 P##H1GH1ZU!/H>DW.EMID^FVDE@QRUL\*F,G.<[<8SGG/K0!REAIMYHO
MQ3E2TU&[N[#4;%[F\@N9/,^SR*RK&RD\J&!8 ?[+>G"?%G?_ ,(G:=?L_P#:
MMG]H]/+\T=?;.VNPL-,L-*@,.GV<%K$3DK#&$!/OCK3=7TJUUS2+K3+Y"]M<
MQF-P#@CT(/8@X(/J* +A .,@''(K \<@#X?^)#@#.F7.3_VR:M;3DO(K)(KY
MTEGC&PS)P)0/XL=B>XYQ3KVPL]2MFMKZT@NH&^]%/&'4_4'B@#B?#>B6B^ ?
M#6ISZI>01VME:7<GF7;F'"QJQ#*3C;C./0@>E5=<#7WQA\,&&ZGM#)I-RZNB
MKO )4XPZD?I76CP=X8"!!X<TC:N,#[%'@8_"K<NA://J*ZC-I5E)?)]VY>W0
MR+]&QF@#FKS0[?PUI-W9Z/+*VL^(+GRC=W$FZ621@2TA(' 1 [   #'3FL#Q
M##>^#?%'AWQ3.EC!IT071[P6Q8!;=_\ 5LV[LC ?G7I%UI.FWMW!=W>GVL]S
M!_J9I859X_\ =)&1^%&HZ3INL0K#J>GVM[$IW!+F%9%!]<,#0!<X/-<[X^$?
M_"N_$@DQM_LRXZ^OEMC]<5O06\-K D%O%'##&-J1QJ%51Z #I6;KVD'7K0:9
M,573Y65KKGYI5!!\L#L&QR?3('7( ,?PU#I3V'A2;4S:_P#"11Z3&(1(X$^#
M&OF;5SDCU./6H?BU$DOPNUXO&KE+?<N1G:=PY'H>M;M[X?L[[7M.U66"W$]A
MDQ2B(>;R&7;N[+\Q.!U./QT[BWAN[>2WN88YH)5*21R*&5U/4$'@B@#S[Q%:
M:;=^-_ 5HL-O):,U\&B0#8W^CYP0."/4=^]<Y?2_V'H_CV&Q3[/IUOK=LTT=
MNG$<#B$S84<8(SD>A->JIX;T.,VA31M/4V8VVQ%LF81_L<?+^%26^B:3:/<O
M;:99PO= BX:.!5,O^]@?-^- ',:+IVB/XOM];T_75N[J>Q,1AM/*$<D(((=P
M@[$@ GUQ57XP*'\)V"%BH;5[094X(^?L:Z_2M T?0EE72=+L[$2G=(+:%8]Q
M]\#FGZCHVEZNJ+J>FV=ZJ'*"Y@60*?4;@<4 9T>D6V@MJFJR7U_-"]HHD$T[
M2LBQ[V)0DY!(8]/05YUI\]I#J_PUN+9[6VL76X,$9D#3"%H&.99,@$DX)&,!
ML\FO84BCCA$21JL8&T(HP /3%9<'A7P]:K$MOH>FQ"*;[1&$M4&V3^^,#AO>
M@#@[6QL\_%.U^S0_9]V[RM@VY^RALX]<\_6NC^'6B:79^$-#U*VLH8[ZXTJV
M6:X5?GD&P'!/?G^0'85O#P[H@^U8T>P'VL8N<6R?OO\ ?X^;\:M65C::=:K:
MV-K#:VZ?=B@C"*OT XH XCQ:P'Q:^'F2!_R$?_1*UU&OZOI^FV%RE[-(,VLT
MS) ?WHB1"78=QC@9]2/6I-0\-Z'JMP+C4=&T^\F P)+BV21A^)!HL?#>A:9+
M)+8:-IUK)*ACD:"U1"ZG^$D#D>U 'FFFRVUOXJ^'#P/9VUJ]A<K#"D@:18?)
M4KYLF0&)(ST # \GK56'P_H6H_#WQM?:A:0/=P:EJ+0W+#,L3JY*!&ZJ=V.!
MU)[YKU*V\+^'[,0"VT33H?L\IFA\NU1?+<\%EP.#[^U2?\(]HW]H-?\ ]E6?
MVMF#M-Y*[BPZ,3CDCUZT <-X:GO9_'UO8^)$W72^';9K=)AD%SQ<$9_BW8![
MX'I7,:EIZIX*UNU>,'3K/Q5'%IK'_EC&9HPZQGJ%#%QQ[CM7LNH:1IVJ^5]O
ML;>Y,+%HC+&&*$]2I[?A3+G0M'O+**RN=*L9[2'_ %4$ENC(GT4C H =IFC:
M;HL,L.F6,%G%+*9G2! JLY !; [X _*N+UGPAI?B[4KO6M"U*;1O$EC,UM)>
M6K<EEZ+*G1@1@^N".N,5Z B)'&L<:A44855& !Z"LRY\,Z%>2O+<Z1922.27
M=H5W/DY.XXY'L: /,KW5;KQ)X$\(ZCKD%LUVOB.WMY9E4>7*JS,A=?\ 9;;]
M#6QKT^E7.NZ_;V?V59K?0UCN);I@T*0MO*I%&",D]VR /EX-=]<Z3IM[IPTZ
MZL+6>Q  %M)"K1@#H-I&.,<5%+H&C3WD%Y-I-C)<V\?EPS-;J6C3^ZIQP.O%
M 'E=C;6.J1?"8W,<-P[6\D,Q;!+*+3.QCW'3@\<^]1:U-)X?TOXF0Z1&;:VA
MO;,F.V&T11R1Q^<R@=,J6Y'U[5ZK'X9T&(6HCT33E%IG[/BU3]SDY.SCY>?2
MIH-$TFVFN9H-,LXI;H8N'2!5,P]'('S?C0!Q&L1Z/'\1?AY<:>MHD;I>+$\.
MT!HOLYV@8ZKSQ]:YJZO+"?2/#6H::\,%E+XK1XC.^^ZD8SL)'9LC:.2-N"=N
MW)[5ZE:>$?#E@\3VF@Z; \3EXVCMD!1CU(XX-./A3P\?/SH6FG[1()9LVJ?O
M'!R&;CDYYS0!Q>B^']$U3XF^,_M.GVMQ'&=/GB!0%0YC9MX'3)('/U]37-RS
MVFL? 3Q'=ZBL+ZQYUPU_Y@'F1W F.T'/((78 /3 KV&WT;2[2_EOK;3;2&\F
M_P!;<1P*LC_5@,FJMSX3\.WE[->7.AZ=-<SKMEEDMD+./<XY]* .+\1Q:C%<
MW>KZ4EAK-H-*BAU/2;D[7,(#L&B?D#(+<'@[>YQCO-'O;>[\/V%]"'BM9;6.
M9!+PRH5!&[W ZU'+X;T2=P\FD6+,(Q$#Y"_<'1.GW?;I5ZYM+:\M7M;FWBFM
MW7:\4B!D8>A!X(H \\O_  ]JGC3PQK,JBQ$6MXEMGE+B2.- /((QP.@?'J[5
M0U#Q?/J_P9MM5FWAXKF"VUI4^\BI*JS@@=,CK[-7J%M86=G9BSMK6""U5=HA
MCC"H!Z;1QBJMGX>T73XYX[+2+"V2X!$RPVR() >H8 <_C0!SM[9^%[NXOM0T
M][>>\N-'>(I;N&B:%?F5F4?+G) 4]>N.AJ;X9"U7X=:"+<0AS80M+Y>,D[<9
M;'?@]?2M[2]"TG0X9(=*TRTLHY&W.MO"J!C[X'-2Z?I>GZ3;FWTVQMK.$L7,
M=O$L:ECU. .M ''^$=__  LOQ[YV?-\ZRVY_YY^2=N/;K^.:[K:I!!48/7CK
M63-HYB\1)K=EM$\D(MKN-N!-&"2IS_>4EL>H8CT(UZ /.-9LTO\ XXZ; \]Q
M#_Q(96W6\QC;_7#N.<5H>+M+71OA'XALEN)IU6TNG$D[EG.]G?DGDGYL9KIW
MT'1Y-2&I/I5BU\O2Y-NAE'_ L9J>^TZRU2V-MJ%G;W<!Y,4\8=3^!&* ,K0;
MVVL/ >E7EU.D5M%IT+O(QP !&O-8?B#PSH7CG5)0L]QIGB+2U3R[RV?9/$KK
MN7(!Y7)(QZ@X(S6\G@OPM&R,GAK1U9"&4BQB&TCH1\M6KSP_H^H3M/=Z9:33
MMUE>(%^@'WNO0"@#D_"/B?5+;PUKS>))H[R;0[N2U^V0J%%V% (P.F\DA<#O
M@=:Q?%7AWQ':>#8-4 L&U+1KDZP7B+[WDR7E7TVD$C'HH':O1Y- T:738].D
MTFQ>QB.4MFMT,:GU"D8!JS/8VES9-93VL,MHR[#!)&&0KZ;3QB@"+2-4MM;T
M>SU2S8-;W4*RQGV(S@^XZ&KM5=/TRPTFV^SZ=8VUG!G/E6\2QKGUP !3KX7;
M6CI9&-)W&U9).1'G^+'?'IQGU'6@#S?P3!H\_A74X]?-I_9P\27)LOM3A4+"
M7*;22.=V[ [\UZ=)&DL;1R(KHPPRL,@CT(KG+KP5I5QX2M_#9MX9+*+ W7$8
MD8'G=(,])"68[NQ8GVKI0,#% 'AJ):+^SC(L8A6=IU\W9@.0+_ SCFNLN[&'
M1OBK"-&M(;>:?P_<DI$@7S9%D0J6_O')ZGGFNP;POX?>">!]#TUHIY?.EC:U
M0K))_>88Y/N:G&B:2+Z*^&F68NXEV1SB!?,1?0-C('M0!YCX:@T/Q#X8\,7T
MWB!H]1LKB*0QQ+&MQ]JZ2(W&\[F)W9ZCD\<UT_Q<T>\USX9:O9V"-)<!4F$:
MC)<(ZL0!W. >/45T<'AS1+;5Y-6@TFQBU&3.^Z2!1(V>OS8SSWK3H S-!UJQ
MUW0+35+&:-[::(."I'R<<J?0CH1VQ7*ZYJ:7/Q#\'I,=VCW*7+0EQ^[DN0HV
M$YX/R[BOKG(KI6\*>'FO7O#HE@;B1MSO]G7+MZGCD^YJ]?Z;9:I;?9K^T@NH
M-P;RYD# $=#@]QZT >4>(M/6$_$ZUAA0Z2-,2Y\HJ-D5V8F)*CH&("L<=R#W
MK073;'3?%7PWN+.VB@GN8;A)Y47#S#[+N^=NK<@'G->A'1-*.G-I[:;:-9.<
MO;M"I1CW)4C!/N:8?#VBE[5SI%ANM!BV/V9,PC_8X^7\* //[)[S0=9TA;R"
MUUC0KS5)&T[4H?EN;:>4R?+*I^\/F=21Z<],57TQ;;6?A=XNDUE4_M6*XO6O
M'?B2&9"3$0>HVJ$V_3BO2;;0-'L[D7%MIEI#,&+AXX54ACU88'!.3D]31-H&
MCW%^;^;3+22[.W,S0J6;;]W)QSCMGI0!PD4E_)XF^%[ZIN_M!M/NC<;OO>9]
MGCW9]\]:RM1FN=&M?BO-HB>3<1/ R>2,%-T"[V&.A +-GUYKU2XTC3+N^AOK
MG3[2:[@_U4\D*L\?^ZQ&1^%%MHVEV=S<7%KIUI!/<_Z^2*!5:7_>(&3^- 'G
MNM)H8U'X;7>F"U$!O-MO(F!F(PMQGZ[<^]8GB"[L9_#MY?Z<\,, \3QMON'W
MW,DXG4.RG(\M0 0!\QV^E>H6_@_PU:.KV^@:9$RR>:"EJ@P_/S#CKR?SJ23P
MMX?FDNWET/3G>\(-RS6J$S$'(W\?-R >>] ''VZVJ?%3Q)/;QVK7#:3:RVS$
M+\TA,F"#W))'/?-8_AJ#1/$7A;PU>W'B!H]1LKB*1HXEC6Y^UYPZ-QO.YB<Y
MZ@Y->I-I.FMJ$.H-I]J;V!/+BN#"OF1I_=5L9 Y/'O4$/AS1+?5WU:'2;&/4
M9,[KI(%$ASU^;&>: /,X9[35_AW\0Y-56%]5CGO5N5FQOCV*?) SR% "[??.
M.<UZ/X397\':(RL&'V"#D'_IFM.O/"^@:A?/>WFC6$]U)&8WFDMU9V4C&"2,
MGCBM&VM;>SMTM[6"*"",82.) JJ/0 <"@"6BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2K %<?-M).1QGO7 C?H?BOQ1X*0E4\0.EY8 =EF.RY(_W0&8#VI_@>:5HX?
M=RS/-H6I2&8MU>UB(D@;\6>+'LAH ]4A=I(4=XFB9ADQL02OL<$C\C3Z\XL+
MR^\5>%_$6LIJ5Y9WUM=W45F(9F1+<0\(&0':^<9;<#G=VXQ0AU35O%&J>"B^
MJW^GQ:SI-Q-=16KA,,JIADXX.6)!.<#ICK0!W5GXC6[\7:AX?-E+%)9V\=QY
MSLI617) P 3_ '3UP?:MRO'M5U1O"GCZ^MWN+EXY-*L;*75)SN-N&>1?.D(P
M<YQSP,D9(KK-;N;C2M0\-^';.YFF746F,DUS>NDDOEQ@[?- )4DG/R@?=(&,
MT =K17E?B>+Q1X=\!>*Y9=;:,1&.?3_(NVFG@1F 9'D=0Q7.<'KUYXKT#1])
MDTQKJ275+Z^:Z<2$74@98CC!$8 &U3UQ0 SQ+XDT_P *:*^JZG(4MTD2,[>2
M2S <#VR3] :UE8,H92"",@CO7$>)(5\2:S=:9-I5W?Z=:6KPR?9S%A;B9,?Q
MNOS+&W&,_P"M]JH^"?$]S9_#345U*)FU7PS%-;W4+GYF\E24/&>J@<Y.2#0!
MU7B7Q&OAN&PD>RFN%N[V&SW(R@1F1@H+9.<<]@?PJ^EY=MK4UFVG2+:) LBW
MID7:[DD% O4$  Y]Z\PUVWEO?!/@[6[C4;J>\N]3TZXGS.QB8R.K;1'G:H!(
MQ@ \<DY.>G@FNY/BGJ^F2W]T]D=(AG2'S"HC9I'4E=N,<*.>OO0!VM%>26VM
MZK+\*/".JOJ5T;Z;4K>*:;S2#*C7!5@W8@CCFM'Q)K=SH_B"_&NMJ=II<\L0
ML-7LIF,%M\J@QS(IXR^[YB#D-U&!@ ]%%Q";IK82*9U02%,\A22 ?ID'\JEK
MSW2=.23XN^*6%S=HPLK-U*W+X!;S.Q)! [ C ]*YA;W6D^$MMXG_ .$@U-M2
MM;\JI:;]VZF\,9#KT<;3WZ8&,4 >TT5P#3WGA[XCK:C4K^]M+K1Y[N6"YEWC
MS8W7#(,83(8C  'M532%\3:[HOA[Q)9ZE;P22M'<WC2:A*T,L3#YXO)V;$(S
M@$'(*\D\F@#TJHI+B&*6&*215DF)6-2>6(!)Q^ ->53_ -K76D?$"=_$6K*^
MD7,SV9CG";2D"N < 97/\/3D\9JW.AU?QUX"O;F:Y$MYI-Q++Y5PZ#=Y<3<
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M @M(._:J7PC_ .25:!_UQ;_T8U8.IS:U;?%KQ#/H,%K<7T>@1,D-QNQ(1(W
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M9+9@,I%'MQA^% XQC.><\U-IGC:]U#0_!Z;+=-6\0JS;BA\J)40O(P7.3Q@
M9ZGKQ6A8>%]2TR^\1/;ZA;-::K.]RD3P'?'*R*ARV[!4;<X !]_7.@^']U;^
M'O#4$6H0IJ_AY\VMUY1\N12-K(ZYR R\'!XQGVH DG\5ZOIVJZ]H5R+26_L]
M,.J65QY3*DT0R"KKNX8,,9!Y!S@54LO%OB)8_!NHWW]G-8Z]Y4,D$,3B2-WA
M+APY;!&5/R[> <9/6MFX\+75]<:OJ=S-;#5+[3_[.BV*QCMXOF)]V)9B3TZ
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M->K;S1^2^PJ;DPY7Y\@XYY)YJ]<:WXJO?&.M:!I3:3 +2V@GAGN(I'QOW<,
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M4LBR!F5P-Q4]P1GOBKD'AWQ+?Z-?67B#Q!#))-:26L,EA;F+:77'FMEOF;T
MP!S[8IV/@O7(M0\+WEQJ]AG1(9+;RX+-E5XV15XR_#?*.>@]/4 YR2ZOK'P7
M\3;K3KH6UQ%J]TXDV;B!Y4>0.1@^_.*TM<744U?X>#S;6:\,\VQ_+:- #;-C
M(W,3@>XS[5JQ^!KN30O%NEW5]#MUZ>:X62*,Y@:10N""?F VCTSS4LOA;6;F
M\\,7=SJ-D\NC.SN$@95EW1F/ ^8XP#G)SD^@XH L^$];U.^U37](U=K:6ZTJ
MYCC$]M&8UD22,.OREFP1G'6I/&FH6T.G6^EW%W%:C5)?L[R22! L.,RG)Z94
M%0?5UIVA^'[S3/$^OZM/<021ZM)%((T4@Q&- @&2><@9[5:@TR__ .$KGU6Y
MGMY+;[.+>VB5&#PC<68YS@ECMSP/N"@#DOA7J,%J-9\(QW<=RFCW):SE20.'
MM9"63D=2I)!].!6H==\0:U9ZQ>>'$LV.GWCVD%M<*<W+1D"3+[@$R=P''8$]
M<";4O"^H3^/K#Q/I]Y;6_D6K6EQ"\;,;F,G=@D$8P>1P:IP>#]>TC7=3DT+7
M;>VTG5+AKJX@FMC)+!*WWVB;<!\W7Y@0/0T ,@N=9E^+\MJ]["MK'H\<XMS"
M6V!Y2&4$,/F.P?-CTXJS\2M0FM?#UG80.T;:OJ5OIK.IP521OGP?=0P_&KC>
M&;N'QO#KUE?1QP&P2QG@EB+NRHY<%6W<$Y(.0:3QYHEQK?AY#9)YE]I]U#?V
MR9QO>)MVWZD;@/<B@"WJ/AM+W6=)U*"_N[%M.W)Y-LP6.:,[3Y;C'3*KT_PQ
MY]\0-(F\.>&H-,BU6_N+#7-?@AG2>3(@@D+,T:D<A21S[?CGU:SO(;^TBNK=
M]T4@R"1@CU!'4$="#R",50\2>';+Q3H<^E7X<12899(SAXG!RKJ>Q!H L:CI
MMI?:)<Z9/"GV.6!H6CP-H0KC '; KR;PS;^)O$OPN\)Z[I=Q%+K6C33-#'=G
MY+J,%XMI/8[> ?KR.M>A7&F>);W26TJXU.RC62/RI;^&)A,ZD8)5"=J,1WR0
M#SCM0WAF?38=&@\.W,%C!I<;Q"&6(R+,C ?*V"".1NW<G/8\T 9?A+Q;8>)/
M$4L-]I=SH_B>TM3'/9W Y:(L#N5L?.H/0\?>/KFLOP!?7=KJ/C1+?2;J\4^(
M[HEX9(E .$X^=P?_ -==/;>';R?Q6OB34WM?M<%HUK:P6X;:H8[F9G/+'@ #
M  &>N:9X1\-7_ARXUR2XNK:X74[^6_ C1D,;/CY>2<C@<T 8WPVD>7Q!XXDD
M@>!VU?)C<J2O[M>"5)'Y&N?\?ZE;75U=>([34[==1\-7:?8;4S@-*$/^D#;G
M/S;MO3_EEQUKL=%\,:UHMUXCNH;^Q:;5[@W,9,+8@?&T9&?F &/3I6YI&EOI
MWAJWTN7R9GB@\IS@[93CEFSS\QR3UZF@!)$L?%GAJ,HX>QOX%<-M!)1AGC.<
M'!Z]JF31K1-7CU(1J)HK<V\6% V(2I//4_=7KT XZG./X$\-ZCX2T!='N[^&
M\MX78VS)&R-&A).PY)R 2<&NFDDCAB>65U2- 69F. H'4DT <!X<N]55O&7A
M[2'MEN],OLV!N@QBC291($(7G:"6QCH,#H*[Z/S?(02E/.VC<5!V[L<X]LUP
M>GZ7JEMH_B?7;2Y33M2UF\\^WDG@,GEPKM2,&/J6902%ZY<#&1BNTTI[R32+
M)]118[YH$-PB=%D*C<![9S0!YE;W&K7?@CXE2:C?Q7*13:C!@0%&RD"J,'<0
M%VC&W&>^36IHNMZWI=QX+L;HV,FFZM:"%8XXV$L#) '5BY;#9P<C:,>_4W#X
M*U./3_%FG0:G;?8]<EN)4#VYWQ-,H5LG=@@8X  Z\FIY/"6HO-X2D^V6H_L$
M'<-C?O\ ,7E\<_+QSWYH S[CQCKM[I<FKZ!9&\1+IHX[#['(3/$DIC8B;(56
M^4L.,#H<FO0%.Y0V",C.#U%<-8>#?$&BW]Y::3X@AA\/W<[SF"2V+3VQ<Y=8
MGS@ DG!(.,]">O;2"18"(-OF 87>3C\: .%^#G_)/8O^ORZ_]'-6QXDUW4-(
MU_PW:VRVYM=2O3;3[U)<?(S94YP/N]P:S?"OA;Q-X4T'^RK;4])G02R2K)+:
M29!=BQ! D]2:LWWA75+U_#DLFHP23Z5=&\G=XB//D8,&"@'Y%^<XZXX':@"#
M1/\ DKGBO_KQL?\ VK7->'M7UC0/@I8:MI*6TB6EQ</=QS0M(?(^TR;V3:R\
MJ,GGJ!7;67A^_L_&>L:\+BV>._@BA6':P*>7NVDMWSN.>*H:+;Z=X!\&V^C^
M)-7T\0,\R++*?*67>S.5PQ/]XCK0!LPZK<7WB*WM[&:VDT];(7-P_EDLQ<XB
MV-NP 0')X/0>M;=<K\/= 70/"L,69RT[&8"<_.D?2)#Z;8P@QZ@UU5 !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !117&?%>&.3X9:Z[HK/%;EXV(Y1@1
MR#V- '9T5F>';:"T\.Z=%;PI$GV:,[44 9VCGZUCZWXXM=).I>3"EU_9@S=K
M]I2-Q\H<JBM]]@I!QP.0 2<@ '5U&9X0K,94"JVUCN'!]#[\BL"/Q;:ZH]C;
MZ/!]OFO;(7P5W\M(X&X!<X."3D 8/0],5Y48K?\ X5WJ5PUAY#0>,2T<.P%X
M/](0%1COCCB@#WBBN4L?&PD\1OHFKZ1=:/<- US;-<NCI/&OWCN0D!AU(STJ
ML/B-IZW>D^9"!9:M,L%K.DZ,X=AE/,C'*!NW7'&0* .THKSRS\:ZZ^C>,=1?
M28V.D75PD*&X&U1%&AVGC)_B8D>N*U=/\6/!X:T.74HT74=1@0Q+).JK)B,,
MTC-T5>?<\@8.: .NHK@Y?BA8PZ'JFH-IUP\NEW26MW##(CA"[ (X;/S(=PQ@
M9]JZK1]2N]12Y:[TFYTXQ3%(Q.Z,94P"'&TG'7I[4 :5%>57T6B6_P ;;Y-3
ML(YK9]$CE\O[&9QYAE(+;54\X&,XKI-.O])T31H;_1--F\K6KY5@MHT**LC#
M;N(Q^[7;'D\<>F30!V#,J*68A5 R23@ 4*RNH92&4C((.017(S^*[2]T#Q,M
M_I$TITD20W]FCJXD3R]Q*L2H*E#WP>O%1_\ "8VNDV'A:ULM#NGBU>V46<4!
M3;$!#O6/DCL ,X '4GB@#LZ*I:9<S:EI,,][I\EE+,A\RTG*LR=1@D9!_P#K
MUXM:0>'X] \?BX\J+5(=9O4T[R#BY1@!Y2Q!?FQN[#CKVH ]VI"BE@Q4%EZ$
MCD5QN@ZYK5OHN@Z9J%A+<Z_/IYN+@R-Y:(%V@[WP?G)8<8ZYSB@_$.W;P[HN
MN0Z;<-8ZG<+:EV=5^S2%RG[S_9W C(SV]: .SHK.&J,WB%M*2V+!+87$DP<8
M0,Q55(ZY.UL?0TNMZD=)T>XNT3S)E 2"+_GI*Q"HOXL5'XT :%%>?_#JXOM)
MU/7/!^KW37-Y8S_;()WX,\$QW%OP<L#]:WM1\4M;R:HFG:=+J+:5&'NQ&X4@
ME=_EH,'>^W!QP.1SDXH Z*BN)D\7:C<>--#T^STY_L%[ISWI\UA'(?N8RI^[
MMW<CJ2?;GI]9U>TT'2+C4KYF$$(&0HRS$D!5 [DD@#W- %^HY)X861998T:0
M[4#, 6/H/6L)?%!MM?L='U6P>RFU!&:SD$HD21E&6C)&-K@<XY![$URFF6W_
M  EWBWQ?I^OZ.L]HLUO!AY@3;J(0X"D<C+$ME2.30!Z9365' W*K '(R,\^M
M9FLZ!9Z];PVFH;Y;%"6>VWD+,<87>0<D#DXZ$X)Z5Y_9^9X%T[X@7&CEQHM@
MBMI\+L72*X\HF0+G^$,R9'J".QH ]5S1FO+-00>%?"_@_7;;C4'N[2._G_CN
MUG&)?,/\66.X9Z$#%6=(AC\8IXUU"_4-+;W\^G6+G[UJD*##1G^!BY+9'.0/
M04 >E$X&317D>A>)G\3ZCX(77@CV5_I4T@651Y=Q>(P4Y!X)"AB!ZM]*Z'P)
M>"/Q/XOT*UD#Z9IUU"UH%.5B\V/<\:^BJP.!VSB@#N^E("" 000>017*:KJ!
MU'Q[I_A<'_1DLWU*]7_GJH81QH?;<2Q'?:!TR##=:)XIDE\2I!=Z8(KU5.GR
MLL@E4@ &.3'1, @;>?F)ZF@#LJ*\G\76T=MXH^'K:]:633-]HCO4M+=GB<K"
M,*$P690>@(.*Z73[GPUI\.L>)-+TZ6WCL(WM[B.WM3$9MJI)Q&0#D;L X&<G
MMB@#LZ:DB2@F-U< E25.<$<$5S]AXI>?Q -%N]-DMKQ[#[?$%E#AX]P4J3QM
M<$CCISUK!M?&>DZ)X'U#7K+P_<V]I!J,L4]O&4#"4RA&=OF[L?X=U 'H%5(]
M,T^&\:\BL;9+I\[IUA4.<]<MC-0:1J5WJ(NC=:3<Z<(I=D7GLA,R8!#C:3CK
MT/2O.KVU\.I\9M736H[!+0Z-%+BXVJOF&0@L,_Q8'4<T >KT5YCX#UK5-(\(
MNU_;ZA=PW&L-::,LX;S6MV/[LN6Y5!ACD]AWXKH7\;F/3=?G.D3R7>A2;;NU
MAD5B5V!]Z,<;AM.<'!X/% '6T5AKXC6:TT.>WMO/_M8KY824?(I0OO)[@ <^
MY [UM22)%&TDC!40%F9C@ #J30 ZBO,=!U;4M/\ B-%<:E*_]G^++8S6:.,>
M1)%G8GL6A*D_[61VKN=0UH6NIV^E6L'VG4;B)YEBW[%2-2 7=L' RP P"23T
MX) !JT9'K7 :QXYU(:3H]Q8:1/;RW6M1:=<1W1"-&1)A@N>&# $!NF#GK6I)
MX.M+W7[_ %F>U\N34=-:SO(1<O\ O]P48..%VA2 5Y.XGZ@'5!E)P""<9QFE
MKS[5]//@#P#;ZC8EC+HK!RH<L'MVER\.3R557.TGD%%/K77IJDTNM0V<6GSO
M92VGV@:@"/*W;L"/'7..: -*FET5U1G4,WW03R?I7,?$'7K_ ,.>%)K[3K=9
M)C+%"79P/+#NJ;@.Y^;C\^V#A>(I9+?XF^$+X:6S7TMI?JT,14N^%CV@OP,#
M).2>,F@#T:H9K2VN)(I)[>*5X6W1,Z!BA]5)Z'Z5S5CXZLY]#O=0O;66RGLK
MTZ?/:NZLWGY4!5;.T@[UYR!SDX J71_&5MJ?B6X\/RQ)%?Q6XND,4ZS1RQ%M
MI(88P0>""/S% '34FX'."..OM7">-]3N;GQ7X8\(6T\EO%JTDLMY+$Q5S#$N
MXQAAR-V,$CG ]ZV=2\$Z-=::UO96-O83+@Q3VL8C8$$$ E<%E)'(/6@#HZ:7
M1656=0S?=!/)^E<MK7C4:0NL3C2[B:TT?R_MDNX(3N ;]V"/GP"">1Z#-9VM
MI _Q8\%W<2)OFM;[,@7!90D97/TR?SH [I9$=G575F0X8 Y*G&>?2FB>$SF
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M3R\[=V6Y(SMR!GJ>< '>T5B7GB'9KSZ)86OVN_CM/M<BF01JJ%BJC.#\S$'
MQCCDCC)X5\2P^+-$CU:VL[JVMY"1']HV;FP2#PK-C!!'.#Q0!MT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %<O\ $/3[_6/ NJZ7IEF]U=W</E1HKH@!)')+$#%=110!
MR<&J>((-#MK.W\*WR7BPI#YDUQ;>5&V "QVREB!UP!DXK)6T\2^&?%>KM9:
MFMZ7JTZW4<@N(XGMY=BHP?=U4[0<CIZ5Z%10!P,FF^(-"\=IK\6G?VK;7^GQ
MVE[%:.B/!*A)#*)&4%.2.N>]8W_"+>(Y_"6MVS:4([J3Q$=4@B-PA\V+SU?
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MY4!B/[S-4NM65QK/B+3[*ZTN:31H T\DWF(%>; " KNW8 +GIUV^E=( %
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MK:1S,B%]S+&78 #J0&7\Z[C2M2M-8TJVU"Q<O:SH'C)4J<>A!Y!'3% ',_\
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M5B@NOL(@E*G9)LB8/M8#!P2!0!Z'J.I6>E6ANKZ<0Q;E0$@DLS'"JH')))
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MEOJMDTR8YB"AMY8?P@9Y)]:OZ?JT>BS^.=&UH2QWU[=W%Y:,8F874#QA4"$
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M"WEO]#D8/M[5GW;IXC^%>B^';)&BU^![. VI4K+:21.@=V7JJA58[NAR,=:
M.[N_'/ANQFOH9]37S;#;]ICCB>1H\@D<*I)& 22.G?&:T)-=TR.QL[W[6CP7
MI46K1@N9BPR-@ );C)X'0$]JXS3[BVC\>_$"65T5'MK0*[<!]L3A@#WP2 <=
M#7-VMW;:5X&^'6JSS207&G2&,[X7>-<Q.'20("RG'0X.#VQF@#TR#Q=HMTEW
M]FNVFEM,^? D$AEC((!!3;N!R1V]^E<=X:\11W^E:%XHU+7-1LY+ABES;M!*
M;6<R$B-!E=JX.W#+UQR3FKGA'5?#\W_"3:E:ZU;W%U>2?:KJ)5:,0*$"* '
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MEK=D/<0X^5I  -X]&( !]<#OR;]("#T(-!( ))  [F@!:* <C(HH **0,"2
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MBZ9-J%]*(K>$98GJ3T 'J2< #U-9&J:_?6'CG0=%6"W-GJ4=PS2$DR*8D#8
MZ '</6@#I*P-=T'4-0U2RU/2]9:PN[6.2());B>%U<J3E,J0?E'((].];P((
MR""/44!@W0@]N* ,O3=+NH+C[;J=\M[?>68E>. 0HB$@D*N2>2%SECT'2M6N
M8\:^);WPO96-U:VL%R+F]BLRDKE-ID. V0#G'I5Y+CQ!'?VB7%I8/:RN5F>"
M5]\8VL0V"N",@#KWH V:**0L%&6( ]30 M%!( R>E ((R#D4 %%!( R3@5CG
M59M8\-S7_AJ2TFF;>ML]T6\EF1RA)*\[?E."/:@#8HI%W;!NQNQSCIFEH **
M0,&&001[4M %:ZL8KR2!IB[)"XD$6?E9P<J3W.#R.V>>H&+-%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7#_%2./_ (1:UG9%WPZG9E9".4!F0'![
M<<5W%5=2TVRU?3YK#4+:.YM)EVR12#(8=?Y@&@#BY8+:7XU3P;4Q+X;/G*AP
M6/V@#)QSG&/PK@8M!ME^!FE>)[/S5\16GEO:78D8OO-QL$8YZ')&WN3GKFO8
M(?"^AZ5(E]8Z+";NWA,43(H,FW). S'J2>I.?>L'X>>#UTCPCI5MJ^F&'4;,
MEF1YA)&)-Q(D558KNP?O8!H @T>*V\3>,O&-CK]K%<O:R0P003+N$=NT>04S
MTW-N)(YZ>@KD[-+G4O#W@(ZG-/.ZZ[):1W#2L'E@43!22#W"CGJ0!7K5]X>T
MK4KU;VYM%:Z6,Q><C,CLG78Q4@LOL<BBZ\/:3>BR$]C&18D&U525$! P"@!&
MT@<9% '+>#;*VTGX@^,],L(5M[&,64R6\8PB.\;[B!T&=HS]*7Q3>>9\0-$T
M>\FM(K&YLYWA6\A\V*:X#( "NY06";L9]3QDBNKMM$TZSU2YU*"V"7MR )Y@
MS%I .F[GG';T[4W6_#^D>([(6>L:?!>0!MRK*N=I]0>H/TH X#4O L?_  A&
MKV&GWB7][87K7UC'Y.$M9!MD^SH,GY".-N?XJO?VNNO^&]4\:Z3;J9K?2'33
MVV LLGEEWQZX;:F/5&'>NYTW3++1["*QTZUBM;6(82*)<*.Y_P#UTZSL;73K
M1+2S@2"W3.V-!A1DDGCZDF@#SS1=%T[48O#/B.UUFSB("J&L[8K+>;UPT<K;
MR7/4G(R"">,&N4N]'L5^%GBW4Q"?MNGZQ=-9SER6MRMP,%#GY?<CKWKUG3?!
M?AO1]2FU'3=&M+6\F!#2Q)M(SUV_W<^V*=_PB&@?V=<:=_9L9LKF3S9X"S;)
M'SDLPSR2>3ZX'I0!S$FGZ?+\;XII[.U9SH'G[WB4GS!<* ^2/O 8 /6LW2C-
MH?B+1H]9TZWO;6ZO9&TSQ!9D;W>59"$G4C.2K'D''RCTKT&7P[I$]Y97DUA#
M+<V2[;>:0;FC'7 )]P#ST--L_#6D6$L4EM9JGDLSQ)O9DC8YRRJ3M5CD\@ \
MGUH P?B=J-QIOA2*2-WBMI;ZVAO94)!CMVD <Y'3(^7/^U5#6K,Z#\0_#<GA
MZUC@^W07<=Y;0*$CE2.,,C,HXR&( ;K\V*[VZM;>]M9;6ZACGMY5*212*&5U
M/4$'K5/3="TW26W65L$<((@[.SLJ#H@+$D+[#B@#@O"5KH?B/P3H&OWMTR:K
M#=)//=Q,%G>ZW%6B<X)*L3MV>FT#C%)I-MI'B_2_%*Z_/Y-_:ZK.DUP'"36<
M<;@Q&-B#L4*H((X)W'N:[.W\'>'+377UNWT:TCU)R6:X5.=QZL!T!/.2.>31
M=^#O#E]KB:U=:-:2ZBF")V3DD=">Q(XP3TP* .=TR*U'Q8UU&C003:-;2R+(
MH ?+R LP/?IG-<9:6\5U\(_ Y9GS_;\48=)""%-U(#@@_3\J]<O_  UHVJ:G
M;ZC?:=!/>6Z[(Y77D+G.#ZC/.#GFJX\&>'!80V*Z3;K:PR^?'$H( DZ[^#RW
MN>: .+USPAH=CXZ\':;:V(ALKI]0::!9&VOF')!YZ$D\#CDCH:NP:-8:1\6=
M)L+" PVJ>'YXUC#L0%$L8 Y)/2NRNM!TR]O[2^N;42W5GG[/*SMNBSP=ISQD
M=?7O2RZ'IL^K+JLEL#?I&8EG#L&5#U48/ ]J /&+O2+*+X3>)=56'_3]/U>Y
M:SN"Y+VY6Y &PY^7WQU[UWVL1[OB5&+^V&HZ:^CLJ6JH)3!)YG+%#V<84-_L
MD<#-;_\ PA^@?V9/IITV,V-Q)YLUN6;9(^<[B,X)SS[D#TKE/$?A62^\2/-?
M^$;;7M.6WCALW2Z6.:W R6#[R"V2<@AC@#IUR ;GP\T"Z\.^$+6TU!2+YB[S
M R;RH+$HI.2"54J....]<ZGAO2==^*7BJRU.W-S:M96;F!Y&VECYGS8SU';T
MS76>$M 7P_I\\,5N+.&:7S8[-)VF6 ;0,!F[DC) X!/&>IQH/#=Q=?$G6M4O
M],G2QN;6"""Y2Y"$[-V\'8^[:<C@CG'(H X:VLY)O"GA"VNYIYHH/%AL;:=I
M#NDME,P SZ?+C/H!BNKUG0=,T#Q9X#MM+M1;0+?W.V-78@;H9&/!)[DUV5UX
M;T:\@LH)]/B,-BRM:QKE5A9>A4 @ CL1TJ6]T/3M1N[6[N[82W%H=UO(6;,1
M[E>>#[T <+HEK9^*[?QJ-=B1[V#4[BV#R#Y[:%5'E%#U08^8$8R<FL*P@E\1
M3?#"77UDEN+VSO%N=[D><@A^7=SSE<$^NX^M>HW?AG1KZ^DO+BPC:XE01S,"
M5\Y1T60 @./9LU)=:#I=[?VE]<6BO<V>1;2;B##G@[<'C(X..M $MII&GV.C
MQ:1!:H-/CB\E8'^==F,;3NSD?6O'-(EATGX0>%W@BBMX+_5XK?5)HE",;?[1
M(#O8<[> OT)'>O<*R(/"V@VUE>64.DVB6MZ2UQ#Y0VR9.>1Z9)..V: .9N;(
M:)\5M!CT:%+>VU&SN1J%O H6,K$%,<A4<!MS;<]<'%+\4[.UN=*T-KBWAE*Z
MW9H#(@;"M* PY[$=?6NMT[1-/TIF:SM]CE!&9'=I'V#HNYB3M'89Q3]4TJPU
MJP>QU*UCNK9R"T<@R,@Y!^H- '#7FCZ;??%^WT^:TA>Q7PVX^S 8B(%RHVE1
MP1['C(]JYJQU%M,\':38/<1P:2/$UQ82O.I>-(0TOEHXW#Y-P7J<8&#QQ7JJ
M>&](BU!+^*R2.ZCA^SI+&S*5B_N#!X7OCIGFF)X4T)-*NM+&F0-8W3%YK=P6
M1V)R6(/?/.>N: ,OPUH$&A^(M4D@U*%A>QQS/I]K!Y4,)' D"[FVEN<],X)[
M52U*YCO_ (N6>AZDJ26":0]U;02@%)9S)M8X/#,J#@=MQ-=-HGA[2/#=FUIH
M^GPV<#-N98A]X^I)Y/XT:QX=TC7Q!_:EC%<M;MOA=LAHS_LL,$?G0!Y?8QZ3
MI^A>+-/E\^*UE\5BW@M[5@GF.WD[8B3P(SC![;<CVJREJBZK\1].N+>R2#^S
M()OLD"YA20Q2G(!'+?*IS@9P#BN\/@GPP;*[L_[#LO(NW$DZ"(?.PY!SUXQQ
MZ5/:^%M!L;MKJVTFTBG:'R&=8QDQ\\'ZY.?7O0!YQ!-:Z;X:^'5DOV&ST_48
M4-V\L ,4DWV<>6)0"N[<V>IZJ/2NU\*:##H&IZS%!J,<R7#QW!LH(?+AM6((
M.P;CC=C)&>V>]7O^$/\ #O\ 83Z)_8]I_9CMN:W,?R[O7USZ'M5O1]$TSP_8
M"QTFRAM+8,6\N(8R3U)/4GW- ''WNG:?+\;K26>SM78Z')*7DB4G>LZ!6R1U
M Z'M7)7VD6-WX'^(VHSP![NSUF]EMI2QS ZA"&3^Z<]QR>E>NWNA:7J-_:WU
MY8P375IGR)77+1Y]#]0#]154>$M"%G>6?]GI]FO9#)<Q;VVS.>K,,\D]\]:
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M6_EU6+[+?P27,C$?:$1%"Y&>1R1Z,/4&N\UOPCX?\2303:QI-M>2P<1O(OS
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M1S\N.<]>W-7=7T#2]>2./5+-+J.)@Z)(3M5AT;&<9]^M10^&-&@O(+M+%3/
MQ:)W=F*$@C(R3@X)H \XUC3M-T+QM-F$#PGJ5U!'J@$8\J"[&3&N>R,=F[C
M) SR16[JKI?_ !*;P_>/IZ6W]E1R65M>VWFQR$NXD*KN4;@ @[G .,<YZN3P
MSHTVD2Z3+81R6$TAED@=F*NQ.XDY/.6Y^O/6HM4\'^'];LK:SU/2H+J&U_U
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MGUH ] ICRQQO&CNJM(VU 3RQP3@?@"?PKR^>Y\075MX\<>);Z$Z+,[VGEQQ
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M8X#=3K;0;S_K)6SM4>YP:MT 80\*V<EOJZWDLUU/JT'V>[G;"L8]I4*H PH
M9L>Y).:2#PK;)X0E\-W5W=7MK);FV:2X*E]FW: -H & !CCKR<GFM"\UC3K"
M]M+.ZO88KJ[?9;PLWSR'V'7\:O4 <^W@W26DT!S$V[0\_923G.4VG=Z\A6^J
M@U-J?AN'4_$.DZR][=13:69##%'LV-YB[6W94D\>A%;5-DD2*)Y)&"H@+,QZ
M #J: .:;P3;"XUUXM3U"&+6=S3P(R;$=D",ZY4G)4="2.^.F&GP-;&R\/VG]
MJ:@(]"='M3^ZRQ1=B[_DY^4D<8K<M=7T^]TA-6M[R)]/>/S1<;L)L_O$GH/K
M4>G:[IFK3W-O97:2SVI GA(*O'D9!*D @$=#T- &9+X/BN<0W>HW5S9+?_V@
MMO*$^63S#(%#!<[ QSCKVSCBH;KP%IUY<Z\TMY?"VUM,75JKJ(P^P)O7Y=V<
M <$D9YQTQU5% ')6W@2.'4]*U*77=6N+S3H7@221XQOC;;\K (!QM'(Y/<FH
MV^'5DWA&Y\-MJNI&RN;@W#OF+S-QD\P@'R\8W<]*[&B@#F;KP;')XB&NV6K7
MVGW\D*P7;P",BZ1>A=60C<.Q %4E^'%BOA5?#PU74Q:+=_:PVZ,N'\SS,9*'
MC=SZ^]=G10!A#PQ&/%3>(O[1O/M;60LMF(_+\L-NSC9G.XYZUR.O^'X?#/AN
MQTJ.\UTV$NIFZGO[9%DDM#EI-Q5$Y4O@<J0,Y["O2Z* .&\*?;WU6-[3Q'JF
MKZ8483?VA9")5/\ #L;8A+9Z@9&,YP<9W->\,1:YJ&EZBM_>6%[IKN8)[8IG
M:X =2'5@00!VK3U'4['2+&2]U&ZBM;6,9>65@JBIX98[B".:)@T<BAU8=P1D
M&@#C9?AKI\ND:MI?]K:JMKJ=X+V8>8C%7W*QP60]613SD\?7.K=>'X8_$,/B
M:6_OGN+*S> 1(J%70X9OE";BQ*CH?I6KJ6J6.D6RW.H7,=O"TBQ!W/!9CA1^
M)-6Z .,T&*Q\2^*_^$P@T^X@6.R%I!)=0M$\A+%F.UN<*,*&[[F'05K3>%X9
M/%1\00W]Y;W#VRVTL43+Y<JJQ92<J3D$GH1GH<C(.[10!QI^'5DWA&;PT=5U
M+[%+<&Y9\Q>9N\SS,9\O&-_/2M5O#$;>*HO$)U&\^UQV9L@F(_+*%@Q)&S.=
MP!ZUNU1U76-.T.R-YJE[#:6X(&^5L D] /4^PH YQOAU9/X2O/#;:KJ1L[NX
M-Q(^8O,W&3S" ?+QC=STK!\1.H\:W!O=9\0Z*T-K#!;W-M;>;%>#EF;B-E#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[#Y;2*64''!(!!(_$5YYX6\6ZE;?#WP_>W\D-YJ&LW"6]J""O[R1V+,YR<@
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MY'0@-&><9 .[/<>E<WJG@/Q)>Z5XDTQ+_3&CU+4!>PW,RR&4@2(ZQ/C@!0F
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M25@(G$'F8P!]T'ZD@$8[U+=^%=>36_$\NG7&G"QUZ%=[3[_-AD6+R\  8((
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M0M@Y((/&,8X/7&#59/B#%)%J:)X?UEK[3'Q=V0CBWQKMW!]V_805Y #$GL*
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MJ /V1[@)ME8#)3*L=KXYP<9[<\4 =!17G7AY[>PU/XAF:*>>UBO%+Q(2SE3
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M2JGF$GYNGRG.>O2MZ_\ &]AIFO3Z1>V=[!-':/>1R.(Q'<(G41G?DM_LD T
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M0HA'L(N(HTFD;(/ 0G"#'?J2.!CFAXOT#4?^$FT3Q=HUN+N\TP/#<6>\*UQ
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MY)/+^U1823&=C@AE/T# 5G:!KNJVVEVVGZUH.HIJ=O&L3M;QB2&<@8WI(#@
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M+%U%]O6+SC;Y^?R\@;L>F2!FO&9KFWF^'7C%[=@T<'BEKEPBGY8OM,3;\>F
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M\]M=2",L 3M="V-RD8.1Q3_B!?RW.AZ5JEI'++I=CK-M<WCJN1);H26<#^)
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MI2-&C*59%*GJ".#3J* $50JA5 "@8  X%!52<E1G&,X[4M% "8 ["EP!110
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MJ(JKUPHP*=10 4UXTE7;(BNN<X89%.HH ,454BU*UGU.YTZ*4-=6L<<DR#^
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M$MQ;QZKI5W933R3"6]L&>==[$D$K(%;&<#@< #H*Z;3-.ATK3H;*W_U<8/.
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M'G&<4 7>M-2-(]VQ%7<<G QDUS\GB"[C^(4'AUK6$6LVGR7BSAR7)5U7!&
M/F/<_A714 (0&!! (/!!I%140(JA5'0 8 I6W!3M +8X!. 3]:Y_P=X@N?$>
ME75U=VT5O+!?3VI2)BR_NW*YR0,]/04 =#@>E<]XWT"Y\4>$K[1+66&![M50
MRR@D( P;.!UZ8[5T-% $5NC)$#)'$DK<R"+H6^N!FI< 444 ,6-(PWEHJ%CD
MX7J?4UAZ!HVJVMPU]K^IPZA?^688F@M_)2.,MDX&3RQ"Y/\ LKZ9._5*P?4F
MEO!J$5M'&LY%J8'+%HL#!?(X;.>!Q0!=P/2DP/2EHH :\:2+M=%89SAAFG8%
M%% !@53O=-AOS;K-_J89%E\L 89E(9<GK@$ X'7 [<&Y10 UT62-D=0R,"&5
MAD$'L:HZ1I@TBQ6PCE+VD/RVRL/FC3LA/<#H#UQ@'.,G0HH ,#TK.L=*2VU"
MZU*9A+?7(5&DQ@)&N=L:CL 23[DD^@&C10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME3L ( X.,@$@'J!T-1P>$]#M]&N-'33XVTZX8M+;R,SJQ)R3\Q.#GG([\]:
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M0"<D#<3M&>PP.!6]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5D>(/$
M5IX;MK:>[AN)$N+F.V4PH&VL[!06R1@9-:]<1\5 Y\*V@C95D.JV6TL,@'SE
MQD<9H [>BO.KK6=<\&^+H[;4M5DUC3+ZPNKI%DA2.2"2!0[ % ,J0< '//ZR
MZ==^+M03P]J]F\KP77ER7\5PT @,,BY)BVY<%<C )Y'7F@#T"BO);C5_%#>%
M?&6JKXCF270M2N4ME6VBQ(D80A7RO(P3TP<DDD\ ='/KU_K&OMI%H+N%8M-A
MNY&LVB#EY2P',O\ "NWL.2W/3D ZO5-3M='T^2]O'*Q(57@9+,S!54#U)( ^
MM9-CXL^V:^=&?0=:MIT+>9--;KY* +N4F16*G=R!@GD$'%<7XKA\12^ =''B
M&[,.I1ZM:Q2_9O+*R@SKL<C:<,!@X'&>Q'%=)J%[JFF^/_"^E#5)IK*]@NS.
MDD<>YVC52K$JH_O=!@<"@#L%D1V=5=69#M8 YVG .#Z<$'\:=7EWAP:Y;:7X
M\NM-O;N_U"'5KF."&8QG>RI%AL[1\P P!G;P!BNA\%^(K;7KR^^SZK>2F&.-
M9=.U"$1W%I)EMVX!1D'*^HR#CTH ["BN+\5WVM1>-?#&EZ;JGV2WU(72S#R$
M?&R+<&&1UY^F0,@]#S%_XA\3Z'IOC?2Y]9DN+O1;>*\L=0\B,.R2 _(Z[=IP
M01G'- 'K=%<;?ZMJ<'C3PC9Q7KBUU.WN3<PF-"&9(E96!QD<L>^*RO#L_BS5
MXM9O5UYI9-,U.]M8;1K:,)<A!MC5V !7YL<C'?/7@ ]'HKSSPSXD?6IYK1M8
MU&TU2WL7^V:;?01I-%+E<2I\F&7[P[CE>!5.#Q1KDO@#P1K!U%A=ZAJ-K!=D
M11XF21R&!&WC@?PXH ]/HKS3QIX@UG2+/Q)?6FK%I]/\N2UM[2-7C@3"EA<%
MEQN8D_*&SC:0!6E>WFM7GQ)AT6WUF6TL+C17NRL<,;/&XE1<JS*><'N".3QT
M( .WDD2*,R2.J(O)9C@"G5XYJNI:MJOPV7[;JMP;FR\0K8//$$0W"I=! 7&W
M&<8.!@9'(->NQP2):"%KF61PI7SV"[R?7A0N?PQ[4 2)(DF[8ZMM.UL'.#Z&
MG5Y!H6MWWAOX=7VHK?W%S=7&LS6</VK:RH[W)3S"0H).,GDXXQQ75W^HZGX;
M\9^'[-[^:_T[6&DMY%N%3?#*J[E=2JC@X((/ ZC% '922)%&TDCJB("S,QP
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MER".#W!H N3>(K2#Q3:^'WAN/M=S ]PDFP>7M3&><]>1T%:]<5JW_)8/#?\
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M]->46UPJB;[0N3D,J@;".H['IQ65JNM:UH/AW0?$K:F]XEQ+;+?VK1H(V2;
MS'@94J6&.3D=<]: /1*:TB(R*[JI<[5!.-QP3@>O )_"O-Y;OQ'?:KXXM(_$
M4]M'I(B>U,5O%N!,'F;22I!7)YXR>.1WJS7E_P"(-5^&-_)J5S;2:A!+-*EO
MLV"3[*6+!64C/S$<YP#QCK0!Z/%J)EUBYT_[%=H((DD^TO'B&3=GY5;/+#'(
MQQD5=KC+34=6F\?>(](;4G^S06%O-;#RDS"SE\GI\WW1US7+Z=X@\2_\(CX.
M\2W&N23/?W]O:W-KY$:Q21RR%23A=VX<$$$#CIZ@'K=%<39:IJDWB/QOIKZE
M*8=/CMWLV\N/="7B9VQ\O/('WLU2TO7=6U+PQX/N[K5A&;^W9[M8(P;JZ?9E
M1$H4@ ')8X& !R!F@#T&21(HS)(ZHB\EF. *J7&HF#5;.P^Q7<@N5D;[1''F
M*': <.V>"<\<<X->4:IJNK:U\-$EO-0NH[BV\0+9.RB-6E1;H*/, !4D#'3@
MD=Z[/4+[5-.^(/A?2UU.6:RO;>[,\<D<>7:-5*L2JC^_T&!P* .QHKSJ#6]9
M\0>"M7\4:?J;VLUO)<M:6HC0Q;(6("R C)+[3DY&-PQC'+(/$.L^(/$GAQ+3
M4Y-/L=8T1[V2%(8V:)_W?*LP//S'KD>U 'I%%<GX!U/4-0TS5+?4KHW<^FZK
M<6*W#(JM*B,-I8* ,X..!VIHU2ZUSQQK&@PWLUC;Z5;0,[0!-\LDH8@Y93\J
MA1P!R3SZ4 =+J%_;:7I]Q?WLRPVMO&TLLC=%4#)-4--\0#4-4FT^33-1LY8X
M5G5[B)?+D0G&59689SU4X/M7FWB+5]2UWX/^+(M1NG%YH]U-83RPHJK=A&7#
M$$'&0PR%QR/3BO5]/@DMK*..6[FNFQGS)@@;Z?(JC]* +5%><?VOXI\1Z1=:
MGX>:>.ZCOI8K:)F@%L4BE*%9 ?GRP4DD8()&..K_ !EKNN>%=7L-1;4=VD:@
MAM7MG\H"TN&'R2[]NXQ@\-G..O.0* .WU343IELDPLKN[WS)%Y=K'O9=S ;B
M,CY1G)/85=KB?&%WK'A_PQI4EOK$LER+^U@N)WACS.KR*K<!<+U/2J7BSQ-=
MZ/KMW::C?7NCV4T*+IFI1PJ]L)2#N$Q*MM.['7C'/!YH ]!,B"18RZB1@6"Y
MY(&,G'XC\Q533]1.H-> V5W;?9KAH,W,>SS<8^=.3E#G@^QKCDAN)?C7/MU2
M[$(T2.=8P4*8,Q!4 J<*=H.1S[]*R[CQ'X@B\">.;U=6?[;I.I7$-M/Y,>5C
M14PN-N.YYQF@#U*BN$CO]:TSQSX<MKG5Y+RUUJUN#+;O"BI"\:(P,>!N_B(.
MXFL74?%.O2>'-8O[;4'M]=M=7^QP:8J(=R>8J*FTJ2Q9#OW?B.!B@#U6BH$B
MF6R6%KEGF";3.4 );'WL=/PZ5Y&FM^,C\+X_&B^(?,N+)YGDLVM8Q'<1I.RL
M&(&0=HXVXX [\T >QT5YUXHUW58;77KVTU22-K73%O+*ULXU=H2(V=FN"ZX
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MUS^UKB6Y@L#8@2QH0Z%@Y8X ^;<!TP,<8KI** .,/P]MV\-W^C/JET5NK_\
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MU634I#+I$<D<2")0L@=0K%O?"CIBNBHH **** "BBB@ HHHH **** "BBB@
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M[F3R5MU1LO(CG!8XXPF3SGM7MNIZA#H^CW.H73$Q6L)D<]VP.@]ST_&N)C\
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M+=2N$,<BNNQ7"DG8& &1R%[57UGP5XFU&W\668N-+E365!@O)FD$L2A0!#M
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M"&+16QSM1-O(.S!)')))SP, ':45R=KXITK2M*\+V]O9WXL]5BABL';:P7*
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M(R'782&4X/()QWQ52R^(.EWTVC!;/48K?5P/LMU- %B9RNX1DYSNP#VQQUH
MZRBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHXQ4W@>+68-!DAUJXFN7CN9%M9[A-DTMN#\C2#LQYZ\XQGFNDHH X)],O_\
MA/O$\;65R+76=.@AAO$4&.,JLBMN.>"-PP.IK.\'QSQVNFZ'J7@/R=5T\QQR
M:A):QFV(CP/-63J6(&0 ,[CV&37IU% '%>!TN+&X\5O=V5W MQK$UY"9+=QY
MD3(@!7C).5/'7VKE(]*U1?@II^CG2K[^T8[Y'>V^SMN"B[\TGIC&SGK[=:]@
MHH XJ>.X;XLV6I+9W9L5T:2W:?[.^T2-(KA3QUP#_+K7)W&EZI)\*?$&FKI-
M^;ZYUB2>&#[.VYXVN5D#=,8V@G]*]AHH X?4DO9?B9INI6EC<O#'I-Q")7@=
M4$KLC(K$CC.WGT[US$$.N7DO@_4KO0-8?4+.^8Z@9%550F-UQ&N[:L8)'( &
M,9)->OT4 <)H,-]I6M>,H;G3+SR[J\:[AN$CW1R(T2* N#DME2, 5SVF:)K-
MAX7\ ZFNG737&@/(E[8^61+LD4HS*I^\5!R .N3BO7** //[_3;C4_$NL^)8
M;2Z6V&@MIL"/ R27$C.SDB,@, /E&2!R3V&:S38Z@OA+X=6O]FWWGZ9=VKWB
M"W?,*QQ,C$\=B1TSGM7J5% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1W%Q#
M:V\EQ<2QPPQJ6>21@JJ!W)/05)7"_%"ZDL=,T.\D#'2[?6;:742HR%A!)W,.
MZAMA/T% $MEXEEO_ (IG2[75([C3/[(:X,"*N8Y1*B\G&[[IS@^N?2NCM?$&
MCWMT+6VU.UEG969424$L%.&*^H!ZXZ5P5[KNC2?%>2]@N;>]B/AB8$6TJL9B
M)0VQ2#RQ7.!UYK%T[6M,FUGX;74%_9QVBB=$M+=MR68:W(6)G.6,F<+R1DCA
M: /2M \8:1XBN-2AL;J)C97#0GYQEPJJ6<#KMRQ&>G'O5^QUW2=2NGMK+4;:
MXG1 [1QR MM/1L=U]^E>5R7$C>$OB/IMBWF:H-8N)S:1G]ZT&8BQV]<,FX#C
MGI72Z#?>%/$WB+2M7TW5[G4]1@@D" . ;>-E^82JH&.<  ]^G<T =I>:G8:>
M\*7M[;V[3N(XEED"F1CP H/4_2JEGXHT'4+6ZN;/6;">"U.+B2.X5EB_WB#P
M/>N8^*8M/LGAAKT1?9QXAM!*9<;=OSYSGMCK52\TN.;XFZG=:/$GE_\ "/20
MWOD ;6E9OW2G'&_:#[XQZB@#N?[<TD+9L=2M-M\0+4^<N)R>FSGYL^U5Y/%.
M@0W/V>36K!9O.6W\LW"Y\QNB8S]X^E>4Q:[I3^ _AI NH6[2VNJ6(N%#@^05
M212'_N\^N.A]#75^%X=,O/B9XZW1VL\BSV3("%8C$"\CZ,.OJ* .Q77M)>[%
MJNHVQG)8",2#+%<EL>N,'..F.::WB/1%TXZBVKV(L0YC-R;A?+# XV[LXSGM
M7GOARYNM(U/P[;V=[;:[X;OIY/L)8 7>GMY;D@D'#* 64D\C./3//ZGJ=C;_
M  F\:Z5+=1+J"ZK=$VN[]X ;@,&V]=N".>E 'LNH:YI6E-MO]0M[9MADQ)(
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M<U:WE:VM9I8[B K*H=$+8/4=AU]:MZ=KEO#X:TB[U6]BCGNK6)\N0#(Y0,V
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MU#6(;1;HV<+3&)I?+R ,GG!_E3[G5VAT2UO4A#3W1A2.+=P7D*CKZ#))]@:
M,[QAH-_K_P#8RV9M0MAJ4-])Y[L-XCS\@PIZYZ_H:Z&WMX;:$1P010IUV1J
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MI/L4)=7E[91BC >OS CCKVJ_0!&T$3PF%XD:(C!0J"I'IBE2&**$0QQHD0&
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MHQ_O9.<CBLRPNK_Q1JO@234;V_@_M32+B2\B@N7B64J$PP /RY!)RN#@]:]
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M6+WL<\SR+*V ,X8G!X'(QT'I2^'?!^C^%P_]FPS!F4('GG>9E0=$4L3M7V%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN)( R"!SP:;>^)M;TJ_\3Z&]U%-=6.E'5+"\E@!+1X8%9%7:I(9< C'!Z<4
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MNL'\M5PJ$B96(')7Y2/8\YJ#5=7\0Z19^$WENT\S4=4AM[R.2!=ZI(&;8",
M8"X)QDG)R.E '8P7]O<74]JK$7$&/,B888 YVL/53@X(]".H(%FN)\8W;Z3X
MQ\'7\)P;B\?3I@/XXY4R ?HR*?\ ]==M0 4444 %%%% !1110 4444 %%%%
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MS9ZA%!&D4D4MO/;F:.8,5() 92"-I_[Z-<^/A[%;:3H=IIVHM:3:1>/=Q2B
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M0(,-N/\ "!VZ^E= J*I)50">20.M10WEK<S30P7,,LL!"RHCAC&3T# =#]:
M.&MOAM>6^EZ+I_\ PDTQBT:\%Q9D6: A0&&UN3N;#'YNG^R:TH_!MT@\3C^U
M8S_;V=Y-J?W.8_+X^?GY1^?Y5UU% ''?\(/.L/A<PZRT-UH$36\<RVP(EC:,
M1D%23AL*.>1GMVJ;4?!\^L0FSU'4H[BP%^+V-3:_OHL2>8$63?P,\9VYVDCT
MQU=% &3XGT&+Q/X:O]%FGD@2[CV>;'R5.00<=^0..XK'M_"&IQ^)+37[CQ"T
M][#8M9R#[&BQR*6# @ Y497D9)/8BNNHH X1/AY.G@>T\,#64\JVNA<K.;3Y
MF(E\T C?C[WZ?G5__A$+RT\4W>MZ3K7V(ZBB#4+=K42I*ZC D3+#8V/7</4&
MNLHH P?!WAQO"?AFUT4WSWJV^[;*T83JQ;&![D]S6!J7PWFO[/Q'IZ>()H=/
MUJ<W30_9E9HY3MS\Y.2ORCY>#QU]>]J WEJMXMFUS"+IT+K"7&\J.I"]<<]:
M /,/%$T,GBY;+4/%MMI,ME9(BOJUC%)#=,Y+,\8?:H(PJG!SV[9.M'HNK^+/
M#\=I=:W:R0VE_%<6M_#8%%N%CVLN$WXP&R,@X('&.I[YD5\;E#8.1D9IU '+
M^)O",VNW6G:G8ZO)I6M:?N6*\BA$BLK8W(T9.&4XZ9XJ'4_ [:SX>6SOM:NG
MU6.Y6\BU-$5'BG484J@X"@<;?<\Y.:ZZH+J\M;&'SKRYAMXL@;YG"+D]!DT
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MN4*VT],XKDF^&MU_9!TN/Q),MI%J(U"U4VJ%HV\WS"';.7Y)P>.O.>E>@44
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M)KJZ* .6L/"5W!XM;Q#>ZT]U/)8"REB6W6-& =FR.20.>G)Z\G-9G_"NI_\
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MU+Q++J5O'';ZG?FYAS(K94HJ;6'8_+TY'-5/AWH)TJ'4'^U&XLX[B6TTW/\
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M^']0N=5T"SOKRW6WN)H]SQHVY0<XRI[J>H/H17'ZKX2O=7UN#41IL=AK-MJ
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M]WE3M/)SST'6[9>%]:_M_7YWL=/LK'5=+CM42&8MY#*LBA<!0#]\$D8 Z#-
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M"\.Q0751C(SE>XJO)XOOIM/?5=*T1]1TV.[-MF&4^?(%D\MY$C"D%0P/5AD
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MW28O%7@;X:QVJZ;IUQ<Z:VT W9 FBWLQ8?+P2" %Y.?R/HBDR1 E2I9>0>U
M'C_@[Q?J'A7X8>'[VXT(R:#&HCN;U;D>9$&D(W^5CE02!U!]O7T"R\2SS>-;
MWPY=6$=L8;9;JWG%P7^TQEMI(7:,8/!YXR.O6N7L/!^M2?#NW\#7]M#% A$=
MQ?).&62$2;SL7 ;<1QR !DG)Q@Z?CS13JESH3Z?>?9=42[-JKQ_>,$B$3+^"
M#<,]"H]: .DT'4YM8TI+^6V2W25F,(24R!XP2%?.T8W#Y@/0BM.F0PQV\$<,
M*!(HU"(JCA0!@ 4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML'8AMG"=?O<8QG-10:AI4GCBZB2XU#^U(M.5I;9Q((1%O.&52,,Q)(RN>F*
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MJT1\P!QE2 ,A@<'H3TKS)?$\C^!!XVG_ +9_M2UN9W'DEU@D4S/&D;@_*8U
M3..<CKDF@#V:BLJ77K:*. ?9[MKF=7>.U6$^:54X9BIZ#D<G'4=R*S7^('AU
M-*L]2:ZE%M=W0LT/V=\I-NVE'X^0@Y^]CIQF@#IZ*S]'UBWUNR:[MHKJ-%D:
M(I<P-"X93@_*P!KC+KQ;)XB\+^-5B@O[%],%S%!,NZ)@8X5;)8'AMQ)QZ8SW
MH ]#HKC/"GC#3Y-.\.:3/)=?;+O3XS%/+ XCG=8@7"R$89AR3SZ]ZU-2\8Z3
MI0DENFG%G#,()[Q8BT,,A(&&;ZD D9 /!(- &_12%U5"Y8!0,EB> /6O-_&'
MB2*^D\)3:=+J,4-SKMJD<Z;XX;F(M\PX.&!P"-PY R,B@#T=XTDV[T5MK;EW
M#.#ZCWIU<[?^-='TY[PS/,8+&9(+RYCB+1V[MC 8]?XES@'&><5%+XMV>/X_
M#0L;DK]B-R\PB)!)D55Q_LCYLGITH Z>LJS\-:-I^M7>LVNG0QZC>?Z^X )9
MNGKTZ#.,9Q56[\9:1921&=YUM9+C[*+WRB8!+G;M+_[PQG[N>,UOT %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7*^.[V]L=,T^2TLY9XSJ$2W,L%M]HEMHN<RHF#\P
M.!G!QG.*ZJB@#QC48Y;?3OB@38:G%;7=C'-;S7D;_O%%OM)W/SG/\/4="!C
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M98)%M9) 70N60[ <-\PX/)KGK[0;_3? D:'3[HSWOB1=2%I! TK6\1N ^&"
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MRC_>^1\]PH_>8!V<G[W(XZ\U3O?%6D6'B&TT.XO8$O;B-I=C2 ;%&,9SW).
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M;P#:K>WMO:0'4KJUM_-D"J29Y-J+GV[5V^KQ13Z/>QSQI)$T#[E< @C!Z@T
M)'K&ES7$-O%J5F\TZ;X8UG4M(OJHSDC@\BG7>JZ=I\B1WM_:VSR?<6:94+=N
M 3S7C]C9V=M\.OAK>Q00QW+:O8AIU4!VW;@P+=3D<8]O:NI\,O;7FJ^/=/\
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M@(!\UW 7!Z<].:;;7UI>H'M+J"=3G!BD##T[5Y#IEVEMX"^&FHSWT %M,/\
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M:%9Y[5C&\0;&)-@8*3VR&7\Z339[NYTVVGOK/['=21AI;;S1)Y3=UW#@X]:
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M 4/[$TD>=_Q*[+]_Q+_HZ?O.<_-QSSZU:MK6WLX%@M8(H(5Z1Q(%4?@*EHH
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MM+,DTG]FV>^<8E;R%S(/]HXY_&K%M=P7D;26\JR(LCQ,5Z!E8JP_ @C\*FH
MI?V/IGV5+7^S;/[/&XD2+R%V*P_B Q@'WH;1M+:]^VMIMF;K<&\\P+OR.AW8
MSFKM4FN;X:U':KIX-@T!D:\\X?+(& $>SJ<C)W=.,4 7:SSH.CF!(3I-B8D8
MNL9MTVJQZD#'!/K5JWNX+OS?(E6012&)RO9QU'X5-0!4CTO3X;LW<=C;)<D8
M\Y85#X_WL9I+72--L;J:ZM-.M+>YG_ULT4*H\G^\0,G\:N44 %%%% !1110
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M]KO!:W)^TQ'E_,B^8$DOMS@\#.!GD6/"VDS0ZM%=V,_BB.S56$\>M7+.KY'
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MU97+P2[#R4+*02O_ ->I+GPEI5PVE';-$-+?S+18I2 CX(+'^\2"<YSG)]:
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MQSI?)+<,T<F+?S%(C^ZA##C:!6/;Z7?ZQX;\8W;>(]9BNM+U6]%BZ7K@1^4
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MF0/DG<C]0<DGKWH Y#Q98ZYX>\#^)W;7)4426\]C#!=R/):J\@1U,C89D/.
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MA@E"V JDC@D*%SCC<6(ZT ;M%%% !1110 4444 %%%% !1110 4444 %%%%
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M5]EU!9!:77V2X;8RB*7.,,2. 3P&Z$\9K<K.;1+.6/4DF0R_VBI2X+@?,F"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSO4*P \SGA1CI6HV@ZIY$,']H64]L+);2>VN;,M%*1G#@;^.#@CG/KTKHZ*
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MVX8'S8(P<CH1U&*?AW>'P%)X6.M0[7N_M/VC[$<C]]YV-OF?WN,YZ?G7?
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MEIXD7[/8ZHNHVA:Q!?(E,F)#O^?ECR-OOGMT5EX;N;7QI>>('U&.5+FTCM3
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M^H&3C\S4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZSBO;J*W$]T)IO+CC1R0JDA6)9L-QCH,D],\5/X5U^;X:>(]"&FXOM0U":>
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M"3R()5W;/HK!@/0$#M775QGAFR>Y\?>*]?Q_HTK06-NW]_RE_>$>P<E?JIH
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MG+'/<;?2NUH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-'-("054@')X..QP<9JW>^)=-L9)8W:>5X(A-.MO;O*84.<%@H.,X/'7@\4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJEM MO=62RN(I(]P,;K'SSNR./ZX]#M;**S\TQ[FDF?S)9&.6=L 9/X #'0
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M&' /! Z].]>GT4 >5Z5<^;\0O#NI)'JUQ!+I4T+W$UG)&BR%HSM"[0(U ![
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MY$\5NXCD9&E10N[^%<LN3T - 'K,%];7\,IT^\MIF7Y=T;B15;MD _ID5B>
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MQ,!TU+402-#-(TFYBTAV%@HVD)UR1GMC(!VL5]:32K%%=022,I9460$D X)
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M['&90F,YY'S8^AZ^E %N/6]1_P"%FR:!(T!T_P#LG[;'MC(</YNS!.3D8!Z
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M-8ZA.\]PID7<S.=S8.W(!//'IQCFKLWA>VN-6TK4Y;R\>YTM'2W.Y0,. 'W
M+SD #\.,4 >>W>JZFGPC\5WJZG>B[L-3NH[:<7#^8BI,%5=V<D <8.:Z"^CO
M;[XJII3:QJ,-A-H33O!!/Y8WB95R".5..XY]^35^\^&^B7L6JV\LVH"SU.4S
MSVB7)$0D8@LZKC@DCOD>F#6E'X6M(M?BUF.ZO1=Q6GV)2TH<>5G=@[@23N&<
MDY_#B@#SRZU;5T^#.JW"ZQ?"\TW4Y+6.Z$O[UXUNA&-[=2=IQGK77O>-KGQ
MU/0+BZN+>VL;"&:..WG>%I7D+;G+(0V% 4 9QECGMB9_A_I4GAZ\T)[F^-C>
M7)NIE\U=S.7WD[MN0"P!Q[5-K7@C3M<O[349;K4+74K6/REO;*X\F5X^I5BH
MP1GGI],4 9,T5W9?\(]I%YXCN]4N46X$L-J/)FO2N &9U<;!'GG+?,<=3Q7(
M7LMUJ_PTLCJ5S=2S6OB5;57-R^XHMUM 9@1O(' 8\\9ZUZ/=>"=)N)],GC>\
MM9M.5TBEMKED=D?EU=NK;CR23G/.<U77X>:&NB7FDJ;T6UU=?:_^/EBT4@?>
M"A/W<-S[]\T 9]S-=ZCXPO\ PW \OV:PL(9(U.J36\KF0ON?>H9GQM4<G )[
MY&.A\*6^K6?AZWM-<OX;_4("T<EQ$<[\$[<\#YL8!XJAJ_@+2M8N+*[:YU&T
MU"SC,4=]:7;1SLA.2K/SN!.3SZFN@T^PM],L8K.U5A%&.-S%F))R2S'DDDDD
MGDDT ><7TM_8ZGXL\-MJ>H_:KN&*[T23[6^]2Y\O8#GA5EQG_9;GI6GX0U63
MQ19Z&XGNXI;&U9M03[0^?M&3'L?)^;YDE;G/1>QKK+K0]/O-;L-8G@#7M@DB
M6[_W0X ;]!^IHTS0[#1Y-0>QB\IK^Y:ZG([R, "?TS]2: /*-;DN;_X2>.UO
MKZ[N6L]8N8H7DG;(1)$55." 5P?N]/:ND\2:<J^./ EE#<W42G[?^]\YI) #
M""<.Y)]L]NV.*WX_ ^DKHNL:3*]U/::M-)/=+)(,F1SEF4@#&2 <=..E2?\
M"'V?V_2;UKW4'N-+#_9WDF#DEQM<L2#NR./;MB@#-\!SW27OB;2I[VYNX=.U
M,QV[W4IDD5&C1MI8\D DXS3O$#/<^)Q91W]Y*1IS,-.LY6@,;%\>>\JL,#C:
M%Y.<D X.-K2/#MMHU_J-Y!/<R2ZA*)KCS64@N !D  8X 'IQ4%_X2T[4/$":
MT\EY#=^1]FE^SW#1K-'DD*X'7!)Z8H X"UU?6=3\+?#B[?6;R*?4+I8+IXF
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MWZ_$4>'B+8VDFE->H_EMYBN)%3!.[!'.>@H Z6L\ZYIHUU=$^U+_ &DT)G$
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M[S7K37=4^R&[L+:2&T@@9B@>3&]RQ&>0H &.!GDYX=X(T"[\+^&(-'NYX9S
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MYAC&$E#*0=P'!!X/-=E10!YU_P *_P!7_P"$"G\.-J=D\DM_]L\[R64(//\
M.VXR<Y(QVQ[UOR:#J+^.[;Q'YEJ(XM.:R,&YLDLZN6W8[%<8QTY]JZ:B@#RW
M6-*G\.>$KS2;[4].A?7-::6.6>(F >8_FM')DC"X4C.03D 8/-:OAF;5[#7X
MK2=O#5W%=@^=)I?F"= JDJ[[F;*<!1R,%ABNXN;:"\@>"Z@CGA<8:.5 RM]0
M>*AT_3].TZ%HM-L[6UBW?,EM$J#/N%'6@#)\7^'[GQ!I]BEE<Q6]U8W\%]"T
MR%D9HVSM8 @X.>U5X?#^J1^.#XBDN+24'2Q8&(!D+,',F_O@9.,<X'<UU-%
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M=PB9 5 ([J5)!'\^E4[WPYXEUKPIJFGZOJE@][?6YM5^S1.D$*GJV"268^^
M,<8YSV=% '):[X9U+6/#&DZ8MQ:13V=Q;SR2$,5?R6!  ZC=C\/>I7T'4_\
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MFTN;B*6XC@S  =A=@H)!.2,GL":W*X?XK,Z>$;=XXS(ZZI9E4! +'SEXR>*
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MDL0EA"D+Y@(RO)Z9XK@;.S\1>&M?UBSC\,QZQ8:A>R7MI>">-/),ARR2AN0
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MLX*,2HR"I!!Q^-<WJ>B>)-WBGQ!I%L\&H:DUK%!;>8J3&"+ASNSM5V#-CG(
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M>(?M45V%BMKNZ;Y[DGH3P/SP!ZU(OCOPT\=VZZHA-HP6:/RG\P$@D83;N8$
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MA'#:  RS2M(1&57JWS;>>V/8UM:3"MC\4-&LKV6.2XM_"RVLCD@YF$BY7/\
M>(!..N*ZKPCX=N?#=A>6MQ>177VB\FNPT<)CVF1BQ7!8YP370T >=>']0M]
MU[QAIWB.1('N]0>]MVGZ75NZ*JJG]\J%VE1S[5FV_A?5K/X+:/F-UUW1,:E:
MQO\ >4J[/Y1^L;%"/7Z5ZO10!QERYF^'>NZO=(8)M4LYI_+D^\BM$5B3Z[0N
M1_>)]:Y2WU :./AMK-Z6_L6WTHVL\P!*VL[0HH+X^[T*Y/3G.*]>HH \8U)Y
M=9N?B3_8D4US)-_9\\(B1U%PD:(SA6QSE00,=<C&<UL0W7A[Q?!->>&8M0GU
MZ+3[B**:YEN,V3/&1M8R';N+8&!GN>V:]/HH \4N?$&FW7PU\*Z;&)(]0TV_
MT^*[LS"WFP-$ZARRXR.A(/?/K7KNK*UQH5\D2LS26T@1<'))4X&/6KU% 'C5
MG>N/!GP\U.-)I-/T6:)-341-^Y/E&/>1CD(2<XSC-=;91)JOQ7.NZ7,DVG1:
M/]FGN(6#1RR&7<JAAPQ !)QTR/6NXHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@D
M $DX HKE?'<MB+#2[:]$TC7.IP1V]O'($2>4$LJ2D@CR_E)(P<XXR>* .H5U
M= ZL&4]P<B@.I. P)QG /;UKQNZ@1=+^*]C*+81PPK,D-OE8HY#:[B5&>N1R
M>Y&<#I6G%I5EIGB?X=7=G;K%<7L$T5U*/O3K]EW .>K $#&>F.* /4\CUHKR
MI[=?"7B/6_"UG:HD/B4"?3&6,$)(V(YU/J$!\P#H!D5Z7:6$&GZ;%862+!!#
M&(XE4?= &!0!@V'B.]\27]]'H*6R:?93&W>_N0SB65?O+&BD94="Q8<] >M:
M&EWVJRZM?6.I6<$:P11/#<P.2L^XN#P1\I&T<9/7KS7'_!=S9>$9_#MV/*U7
M2+R6*ZA;[WS,65_=2#P>^*JW^M^(+?Q!\0;>UU&YG72M,CFL8"J'8[Q,Q/"Y
M;!&0": /4 ZEBH8%AU /(IV1ZUY1JMM;0>!?".O: J+JOVBR\J>/_67'FD"1
M';JV[)+9[C/:KFH"/P3\0[J>VLXC#XEM-D"A./ML? 0XZ*X8$^ZDT >E,RJI
M9F 4=23P*-R[0VX8/0YKS;4;>WT;Q7X:\,R26<&FMI\WD_:[</%/=!DR2NY1
MOV[B,_WCW-9'B#PY9:3X?LK&'4&NXU\4VQ41@QK:>9(I:*/!.%&00,\9H ]?
M#J<88')P.>] =67<K KZ@\5YEK?A/0].\>^#+*RT^."VN)K]IHHV8*^8<D$9
MZ'TZ8)'0UBZC86MIX0^*.F6\*16-I/YEO G"1,T",=H'09YQTH ]H#J6VA@3
MC.,]J%977<K!AZ@YKR[4= TN'QIX&,5HJ'4(;F*]920UT@@#!9#G+C('!SZ=
M*SKF9_#.D?$FWT=#:VMG>6S1Q6ZD"!)$C\TH!C'RECQC'M0!["KHY(5E8J<'
M!S@T;TR!N7)S@9ZXZUPMAX=TB77].U>VU.Q,5U:/!]ETZW$<=Y$5SE\,<A>Q
M[9QWKA=+TRSM_A7X*UN.%1J::K;*MWDF0*UPRE0W92"<KTYH ]H@U:SN=8N]
M+AF#W=I'').H.=@?=M!]_D)QZ$>M7 Z,S*'4LO4 \BO.;"VTFR^)GC>^N8((
M1;V=I/YZQ+OC)27>RG&0Q]1R:Q]+2WM?$'PYNK*..VM+F.YV.[AKFXB-N7WS
ML, DG#$8.#WH [SPUKU]JVM^(K"]BMXQIEVD$1AW?,K1A\L3U//8"MO4+Z#3
M-.N;ZY8K!;Q-*Y R< 9./>N2\&?\CEXY_P"PC#_Z(2M#Q*]U?ZCI^C6,4,S!
MQ>W232F-?*C8;%)"L1NDVGIR$84 3^#/$J^+/#-OJGDFWG+-%<6YZPRH2&4_
MEGZ$5OY'K7FOA^2[\,?%+4-+OX8+:U\1H;^U2&8R(+A !*H)5>6&&/'856B@
MLXC\5()(X$@4A_+90%&;4$''3D\_6@#T6[U>RLM0L+":8"YOW=((\\MM0NQ^
M@"]?4CUK'T+Q#>W_ (H\2Z7?1VT<6ER0+"\9.6$B;_F)[\@< 5PUM86%Y=?"
M5KNTMIQ+ILBR&6-6WA;12 <CD Y(JU+HNF:SXG^)(U"UCNDCBMFC63YE4_9>
M& Z;AV;J.U 'JC,%4LQ  ZD]J P*A@00><BO)M#U"74+SX<V&JGSK"ZT9I@)
M?F6>Y5$QNSPQ"[B,]SGK4>K67V2#XGZ5!'C1H-.6Z@A'"07#0NS!!VSA6QV)
M'K0!Z?JTFH'2[@Z,]E]O !B-V6\H<C.[;STS^E+)JUG#K%OI+S+]MGA>=8@>
M0BD L?098 >O/I7EWBSPUI%C\%[W4K>S5+VYL+-II]S%I&4I@GGKAB/H<5OZ
MKI^GR_&?2I;FTM7)T>>1FDC4Y99(\,21U Z'M0!V5F=2^W7XO39FU#K]C$.[
MS FT9\S/&=V<8[5<5T8L%925." >E>17=Q/HMI\4Y],WQR0SPL#'G<BF%-[#
MOD L<UO6NC:4-5TSQ!8ZY9VR26DL2+IEL(UN8RA;+_,V=F-P/8\=Z ._#HQ(
M#*2#@@'I5+6=7M]#TN6^N=S*I5$C3[TCL0J(ON6( ^M<!X4%QH?B;1](UO2K
M0W3VDL6G:U8$;+R,!682KU#X4-G)!)..M:GQ&9_[1\%H<_9V\00>9Z;@K%,_
MC_*@#II3K>-/,9T]2TW^FJ^_B,@\1D=6!P,G // Z5I,Z+G<RC'7)Z5Q'CR&
M/_A)?!,^W]Z-8";O]DQ2''Y@5A+X>TG4O%7Q'AO;*.>*..V=(Y,LJN;<DL >
M-V>0>HR<=30!ZJS!5+,0 .I/:N;\<^(+WPWX5EU?3X[:9XY(E(FR1M>14R,8
MS][/7M7$:#JHN9?AY8ZW()+"[T9GC$YRDUTH0+NSP2%W8SW;UQ5OQKI>EZ-\
M,/$%GI4TCP#4X)'C9]R0.]Q"QC3C"J,@[>V30!ZCD49KA7A@3XW#]W&HG\.O
MO^4#S"+A1SZ\5Q5CJ,=IX0TVU#HFD7OBV:VNV4X3R?-<A"1P$8A0>V..AH ]
M)A\0WDGQ&?P^4M38_P!E_;DE0DN6\T)@G.,=>WXUL:4VI?8"=7:S^U"1\FTW
M>7LW';][G.W&??-<9;Z9I]I\;9XK:UAA2?PYF6.-0H8_: ,X'L /PKCS:0M\
M$(05(,6N$1D,05S?;>#]#0![@&5B0&!(X(!Z4@="Y0,-P&2N>17 V.FVFC?&
M1[;3($M8KK0&FG6,8$DBS@!V_O-ACR>3FN=TOP]<^(/"WARU-JLU_;:J9KW4
M]RE+B$2/YC!\[G$@P,?3H #0![%1D5#%/;>:UI%-$9857=$K@L@/3(ZBN.^)
M5@D>EV7B:*V66ZT&ZCO#\H+/ #B5?^^26^JB@#M\CUJC='4O[3L/LIL_L!,G
MVOS=WFGY?D\O''7KGMTKRZ&[73/&.HW%E:0+9^,+;;ICK%D&5"(]Q_V75O-]
MP/7-;FJZ39:1\0OA[;64"Q1PI>PJ%X^58./YD_B?6@#I=0\1Q_V5KTVDO#<7
M6DJXD60G9YBQARI(]B,^_%6?#6J2:QX9TG4;@1K<7EE%<2)'P 60$X!).,FO
M/]'T_3[:T^),D5I:Q3)=7,<;+&JLJFV4[0<<#J<53LM,L].T_P"%NJVD"QW]
MP]O!-<C[\D;6K91FZE>!@=!CC% 'KY=595+ %N@)ZT[/->8:/;6?B?0_&CZY
M%&VH0ZA=0M)(/WELB >5L/50!A@1WR>YJIH,UW=>(?AK?ZFN-1N])N_/D88>
M7"1E2Q[G!S^)H ],U?5K+0](NM4OYA%:VT9DD8GL.P]2>@'<FKP.:\-UFWLY
M/AO\31'# \<.M2-"%4$1G;",KZ'D]/>O:[.VM+2V6"RAAA@0G$<*A54GD\#C
MOF@#GM!U[4]6U7Q-8316D<FF7"PVY3=AMT8<%SWZCH!6[IK7O]F6QU-K7[:4
M7SS;9\HOWV;N<9Z9KA-,ACN-3^)<4JAD:=,C_MV6L$6D-QX&^%;R*=S7UK$6
M5BIVF&0D9'N!0![%YB;6;>NU>"<\"J>J'4A;Q'2S9B7SX_--UNV^5GY]NW^+
M'3MFN!TKPOH<GQ(\4:0^F6YTPVEI/]BV?N/,;S 7\O[N[ '.,US\ ^T_!OP3
M/.S22PZQ;1H[,20HNBH'Y #\* /7EU:S?6GTA)@UXD N'C!^XA.!GTR<X^AJ
MX'0N4#J7')7/(KS^*STV+XT:M<SVMJICT>WG$C1+D/YK@N#C[W &>O2N;MC:
MQGP%J6FA8[6XU5Q%<SN&O+F-UD+M*P &"<97G^')!XH ]8M-6M+^]O[.TF62
M:Q=8YL'(5RN[;]0",_6ETDZB=*@.KFT-_@^<;/=Y6<G[N[GICKWS7#^#])TI
MO%7C=6L;0'^T%C7$:@A6@0D CD \DXZ\US6@WKQ> ?AK97'_ ""KV]:*\+?=
M<YD,:-ZAGQP>NV@#VE75U#(P93T(.12!T) #*21D#/6O-[[3TLOB%JVG6,*Q
MZ5>Z ]S>6R#;&LP<JC@#@,P!''7;GM7/Z?IEE9>#OAGK%O J:E)J%G"]UDF1
MHW1PR%NNW'\/2@#VJJ-YJUG8ZAI]C/,%N;^1HX(\\L51G8X] %Z^I'K5F.Y@
MFEEBBGC>2$@2(K@E"1D CMQZUPOC/3["[^(W@<W=G;3"26\23S8E;<H@8@'(
MY /('K0!LZ)XAO;[Q9XETF]CMHX=+:W$+QDY82H6^8D]>@X KI6954LQ 4=2
M3TKRYM%TS6O%_P 14O[6*ZB2WM#&LGS*I^S'# =-P['J.W6J.E:K+<V_P^L=
M3N[=;2\T=BC7L7FQS7*B,*&!8 L%W8R>I]<4 >O@A@"""#T(I&=5^\P'U-<W
MX-T6WT&'4K*UU'[5%]L:7RD3;':LX#&)!DX49!VYXW>]<U-X:TC7/BUKMIJ5
MFMQ;/I5M*T3,0I?S'^;@]1@<T =[:G4O[3OQ=FS^Q I]C$.[S0-OS^9GC[W3
M':K@=&9E5@2O4 ]*\YTNV:'Q/\38+&X2RD,=N8IV;"PNUJ3O)[ ,<FJ6C^'6
MUR+P/<1Z6+=;" MJ$SE0)@8P ,@Y?<^'R>G).#Q0!U_AOQ#>ZIJ_B&SOX[:(
M:9>K;Q&(GYE**PR2>3\W8"MBZU:SL]3L=.EF N[TN(8P>2%4LS?08QGU(KR^
M[T73M43XHRWUK'</!([PF3GRG%JI#*.S9'4<U.;:SU+Q#\,;K4;>WN)+G2;A
MYY)XU8R$01,"Q/7!+'GIDT >HW=W;V%G-=W<R0V\*%Y)'. J@9)--LKR*^T^
MWOHB1#/$LJ[N"%89&?P-8?Q @AN/AYXA6:))573IW4.H8!A&Q!&>X/(-<@K6
MUM=?#G2?L\$>CWT+R7,:(!'-<"W4QAP."3DD ]2 >U 'J2LKJ&4AE/0@YS02
M!C) STS7#:!;OI?Q2U[3M/7R](>Q@NY(4&(X;AF9?E'12RKDXZ]:@\;:99ZA
M\0_!$5U$'2:2\CE7) =!;L=I]1UR.X)'>@#OS)&J!RZA3T)/!I6944LS!5'4
MDX KS"'3M/?QIJGA*0:?;V=MI\"Z=9WMN9E,+!O,,>7'.XX)Y/ ]*CT<6EEX
MNT#PSJ.I'5=,CTF;[#-=@%;BX6<J>#PS+&,*>>,D=: /4]PV[LC&,YJIJ#WC
M:5</I+6IO#&3;M<$F+=VW;><?2O.=573?#LOAS1;*^5="EU.XCF>\'FP)+L+
M)$>5&P,Q &<!E&>13/$?AVRTGP3XZ2*_CG6:V^UFS@B\N&UDVMR@!."V,D9[
M9[T >HPF0P1^<4\TJ-^S[N<<XSVJ3->;>++*'3--\,>-$MT>71C";H[ 2ULZ
MA'/N5R&'I@TSQ-<BP\(W7B.-4@CU74;9KJX$>=MEYBH,XP2K( 2,_P#+1A0!
MZ4KHX)1@P!P<'/-*SJBEG8*HZDG KCM$T*RL?%XU6TU2TW7ECL-G80".&558
M$3$!FY&X*&]#BG^*397/BKP]8/&US?M]HEM[:5P+8@( SR @EBH/R@<Y)Z#F
M@#KMR[=V1M]<\4!E8D!@2." >E>&2113?"RYA9T<6GB<Q0>42JQI]K4809^5
M<$XYXKM=.TVST7XRRVVFVZ6L%UH/GSQQC DD6< .WJV">3SS0!WQ(4$D@ =2
M:%=64,K J>A!X-<KXWDL6.AV=TLLT]QJ*?9K82!(II%5CB4D'Y!UQ@DD+BN2
MTCP]#XBT[Q_X;F-MAM08VZPKB."4PH=R#)QA^N/?IG% 'K&1ZTA8 $D@ =23
MTKQ0:[%+)X8\</8PPPZ3LT[67\K!1W_=M]!$RH?I)@=*Z?4;/3[;3=$CO+1A
MJ.KZL+Q;12L22RD,X2<E3E$7 Z$DH,<T >B*ZLH96!4\Y!XH#JV<,#CK@UXQ
M+"@\'?%&RD,!2WGEDCB@&V.-_(5CM7/'S=?>M'6;#3?#^F>&&AMUM[;7+ZSA
MU>X+G]^JQL55R3C#-P?49!XH [&#Q#>2?$67P^R6IL1I8OHY4)+EO-V8)SC'
M![?C5[Q3KR>&?#=YJSQ>;Y 4)'G&YV8(HSV&YA7,65A9:?\ '"X6SMX8!+X>
M5W6)0H+?:,9P/8#\JD^+]I;3_#N]EGMX9)(I;?RW= 2F;B,'!/3(X- '2::^
MNQZC=Q:L=.DL@JM:W%LK1L3SN5D9FZ8SD'OTK5,B*H9G4 ]"3UKSCQ)X=TB7
MXD>$K V$*6<UI?K+;QKL1U"H<$# QEB?QI_A_3].NO''B7P_?V,+VFFVMI;Z
M=:3KO5+8QG<5#9ZMP3UX /2@#T4D#J0.W-)YB;6;>N%^\<]/K7B20S7/A7PQ
M'>O+-';>+Q9V<[2-O>V61U7YLY_AQG_9%=)8^&-$_P"%I:YI7]F6_P#9LFF6
MUR]EL_<M+OD7>8_NDX'7'OUH ]+!R,CI17%_"AV;X<Z<K.S"*2XB3<<D(L\B
MJ/P  _"NTH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *HZKHVG:Y9?8]4LH;NWWAPDJY 8="
M/0^]7J9--';PM+,ZQQH,LS'  H QSX/\._Z3C1K-?M42PS[8@OF(HP%..HX'
M'L*F/AO1V>Q<V$9:P&+0DG, _P!CGCCCCMQ44GB.&+Q?!X<:UN!//:O=).=O
MEE5(! YSG+=P*VJ .9TFWUK5-7CU/7]-M; V0DCM(8KCSRQ<@&0G:-OR@ #_
M &FSVKIJ*R]6UV#2KBTM/(GNKV\+"WM;<+O<*,LV6(4  C))'4#J: '7N@:5
MJ%XEY<6:?:T78MS&3'*%]-ZD-CVS4FGZ-IVE&9K*SBADG(,T@&7E(Z%F/+?B
M:J:=XB34+R^LO[.OK>]LHXY)8)T0$ARP7:P8JWW&Y!Q^.:H:1XUCUVQ>]TW0
M]6G@61XBV(%.]3AA@R@\&@#3LO#6BZ=<+-9Z=#"R,SH%!VQLWWBB]%)R<D 9
MR:O7%G;74EO)/ DCVTGFPLPSL?:5W#WPQ'XUFW'BC3;/0;75[II8(;K8(86C
M)F=W^[&$&27SQ@>AJ"Z\5#3X([C4=%U2T@DD2-9'6-P&=@J[O+=BO)')P/>@
M"_K.@Z3XBLA9ZO807MN&W!)ESM/J#U!^E0/X4T%],M=-;2K;[#:MO@MPF$C;
MKN '?/.>O)I'\1V\?BN/P_)9WR32P&:.Y,'^COC.4#_W@ 3C%;- &?<Z'IMY
M>VMY<6B2W-H"+>5B2T6>#M.>,]_7O59_"FA2)>(^F0LM\0;H')$Y'0OS\WXU
MLT4 9;>'-(>>RG>R1I;$;;5R23".AVG/'''';BGVV@Z5:7%Y/!8Q++>C%RV,
M^=V^?/WN..:K7GB.&R\4Z9H,EK<>=J$<LD4XV^7B, L.N<\CMWK1U&ZDL=-N
M;J*TFNY(8RZV\.-\A ^ZN>,F@#-TKP?X=T/[3_9>D6MF;H;9FA3:6'IGJ![#
MBE_X1'0/[.AT[^RX/L4$GFQ6^#L1\YW!>@.>?SK6@D::WCE:)XF= QC?&Y21
MT..XI7FCB>-'=5:5MB GEC@G ]\ G\#0!1?0-(DU1=3DTZV>^6+R1</&"^SD
M8R>O!(_$U2M_!/ABT6 0:%8(+>7SHL0CY']1^?X5+I_B.'4/$NJZ&MK<13Z:
MD3R/)MVR"3=M*X)X^7OBMAV*HS!2Q R%'4^W- %&RT73M.N[F[L[1(;BZ.Z>
M1<YE/JWJ?>ECT?3XM5DU1+5%OI%"/."=S*.@/J!GI57PUXA@\3:9)?6]O/;J
MEQ+;F.?;N#(Q4YP2.H]:2;Q'#!XMM?#SVMP)[FWDN$G^7RRJ$ CKG/S#M0!-
MJ'AW2-5O;>]O["*XN;?F"5P2T1]5/8\#I45WX4T&_P!2DU&ZTJVEO)(O*>9D
M^9EQCGWP<9ZBMBB@#'D\*Z!+96ED^C61M;-]]O%Y*[8V]0/Y^M/'AO1UFO95
ML8Q)?#;=,"09QTPW//''/;BM6B@#)?PSHKZ7!IK:=!]CMV#P1 $>2PZ%#U4C
MVQ4IT#2FTR;36LHFLYR3-$<D2D]2YZL3WSG-:-% &9/X=TBYT=-(GL(I-.0
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M.*8GAG1(]%.C+IEM_9I.?LI3,8.<\#MSSQWYK2>:.-XT=U5I6V(">6."<#\
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M.>G?'KS5;Q#XDMO#V@7VKO#+=Q60/G);%2R].N2!W'OSTK5@E$]O'* 0'4,
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M&4,""0?7FLRT\-QQ:K:ZG>7US?W=I ]O;R3A 55RNXG:HRQVCD_@!DT 9?Q
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MS9;D((W1%.Z1=IWAF;G/&,8 .2>N3P]I\?BF7Q$L9%_):+:,W;8&+?GR!GT
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M2ID4IV?=@%0<=:V=3\*0:CKUEK2ZC?VE];0-;,]LZ#SHF()5@5/<9R,$?E@
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M%UN\M]/?11=>7"$#(YF*':VWC@#DY/7!%<I-J_B*'X7W_B%O$-XU[HUY+#$
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MB"9Y%8R6TQ!VID$ AF4J#CC\:ZG3;^ZOM6U1#Y/V&UE6")E4AV?:&?)S@@9
MX'7([4 3SZSIMMJUKI4UY$M_=!FAM\_.X4$DX]  >35ZN)\3?\E/\"_]O_\
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M.?>N$\+7UQ9^/_'H@TF\OLWL!)MVA7;^Z'!\QU_3- 'H5CJ%EJ=L+FPNX+J
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M9E^89'&5/ ]>M4]%\6ZGJOA5KB2*TAUQ-0;3Y+4(Q2.42;2#\V3A/GSZ=N*
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MEN+)U2YC&<QLR[@#^!JY7'6/B#6]0O/%MG;6E@E[I4J);+\S+,6B#@.<CDY
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MP@=26;)/7^'WKF$^(.JW'A'PSK-MIUF9=4U)-/GC>1@%)D="5XX!V'KTST-
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MW8R1[2Q#\K@\MT]N]4'\)>+KS3/#UC>W^D'^Q;^&X6X5)"TZ1JRC<O 5L$9
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MV:_L9H=I63S1S&Y)&P@CJ>"#UJCIGA74?#^H?#ZS6VFNH='@NEO;F/!1'E0
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M,%C]JA*,;EY4#;Y KY?)#$;@6SV&:[[Q1'-/X5U:WMH))YY[26*.*,#+,R$
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M6@W>KWN\PVT9<JBDLQQP!CU_(=ZY36/%,O\ :_@Z]M]3-OIM[-*MY$0JQD+
MSY+,-PP??'% '?T5F:9XATC6+*>\L-0@FM[=F2:0-@1E1DALXQQSS2V/B#2M
M2O9+*UO$>Z1!*86!1RAX#@,!E?\ :&10!I450U+6M,T?R/[1O[>U-Q((H1*X
M4R.3@ #O6*WB31-9O-(?3O%,4>ZZ=%MX64_:RJD%"",X'7(]/I0!U-%9E]XA
MTG3))4O+V.(PJKS$@E85;@&0@80'L6QTKE];\3K'XN\(SV.NPMHEX]V+GRY(
MVA<1PLP.\#/!]\<4 =W17-WOCK0K;PK?>(8+Q;NSM-RN(02WF ?<(QD'IUZ
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M/IFI>$?%O]H-JXOIRVG^;,/MNZ9I(WC"G!!R.>,8R<#FO9J3:NX-@;AQG'-
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M*]PB?O /4#"G'&5([5FK+83?'*ZBD>W=SH"1;6()W>>Y*_7!!(]*[X *
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MA#Q-K]CJVCS7E_J-O"ZF2668_948<JX8[<DX&WD]2.!FN^I JKG: ,G)P.M
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MNRWN-%F@A<J?GDW1$(..6X/%>DE%))*C)X)Q2T <!X3>ROO''CZV+PS1S7$
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M^S?G=G&[UY^O/6K8T#3!JXU7[.QOQ#]G$[2N6\O^YR>1GG'KSUK2HH R=/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ@E<[>V[K[5NZAHNN:AXM\,:R\5@L>FK<_:46=\YE4* GR?-MQU.,^@KKJ*
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M+R'57_T>8S6["*%?.WF3S,;& 7D;223@?3I]'@N(?BGKUPUI=K:SV5M#%</
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MRUDFU* 31ACME#0LY(C1B&!;&.,]J[GQ59SZAX0UJRM4\RXN+">*),_>9HV
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M4C117WE V<D>\E93)GL#]W[V1ZGC4T5+S3/B+XMDN-.O/LM^UM/#<I%NC*I
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M@8(H ]/HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6U=5!9FLI@ .YV&K?]G6)4+]BM]H)('E+@'\O858      '0"@#QVYO=-O\
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M'5G;1M]FCM+U8%N\&0H$3RR<\]!D9Y'L15>VAT\V/Q5/EVW$L^3A> ;8$_\
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MXTO%O;M[M)B 7B=?W3C/52H 7_=%4=.LF37OAC::\D;WXTN[$R3@%L^7'M#
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M>K"D*W>I+-=1*IDAC9G4E3V^0_E27$_BF*WUG0GEM=5OSH,LNFZQ9#9))'D
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M;CYOF]/FSQ0![4V0IV@$XX!.*P?"?B&;Q'9ZA+/:):R6>H3V11)?,!,9P3G
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M0!ZG17FZ6")XP?P=%*&L;33%N+:WOII)#*9)9-[9W MMPH&<[>U5D&I:7?\
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MZI:,\]J3Y,\4KQ2)GJ R$''M3=2\%>'M5T.WT:[TY&LK9@\"J[*T3#^)7!W
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M3[.C&)_-$A#,>7&<XZ=><UN)X9N8_%[>(1J8>4Z>+#RY+?.5#%PY(8?-N/.
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MYP >.XKZSK?C;0_">H7-T8X98-1ABM+B:.)GN())%7YPA*JPW') YXP!5_\
MX5KY?AO1+"UUN>UU'0V8V&HQ0C<JM]Y70DA@1U'&<#WS=U+P5=ZMX=?3K[7I
M9[N:>*:>\>V4%O+8,BJBD!5!'OU//- $5K?:Y!\0)_#UYJPN(+K2FO8I8[9(
MVMG$@0A>N1\P(W;NG>F?"7[5+X LKNZOY[IYWF8B4+\K>=)DY !))Y.2?;%;
M'_".3MXT@\1O?H7CL39&!8,!E+!R<[L@[@/P_.E\)>&6\*Z6=-749;JU1W-N
MCQJOE*SLV,CECECR?0<"@"F=7N]:\9ZKH%G>R6,6EVT+RRQ(C2222[B -ZL
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M HHHH *" 1@C(HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>sangamoexecutiveseveranc016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHJIJ3WZ69&FQ0O=,0JF=B(T_VFQR0/0=3CIU !;HK
MEO"NMZW>ZMK6D:[;6@N=->+;<V0813+(I8##$D, .1D]174T %%%% !1110
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MND.UH5F4NIQG!7.>@/Y5;H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 22>I)/4G\Z^=!)=?\*'O+V5I?[</B3>TA_UPN./QW=:]9^W?%K_ * WA?\
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M5P4P.A!R#5W3;2WTO]HK[-IT$5O$^B#,<2A58X'7'7H.?:K/_"/>-?L@M/\
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M9%,PE!TK.99#]XOGOTYH ["BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY71RP5E8J<, <X/7!_,4ZO./!U_8>&['QM=S*L-I!XAF 2, <LL055' R6(
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MP@&\0[R#D@[CCJ>.<D]: .Y9@JEF(  R2>U"LKJ&4@J1D$'@BO._$>O1>)/
M'C6QO=,>TOM+M95FMYF63:3%OC=6'!R,'VQ6]H&L/)::7IUG9M<K%8PFXG60
M!(6V+A#ZL1S@=!C.,C(!T]%<)-\2C'I>K:BGAW4'MM)O)+:]8R1 QA-NYA\W
MS'GH,\#J,UT%SXB0ZI%I>G0?;+Z2V^UE3)Y:)$3@,S8/+'(  /0],4 ;=%<9
M<?$2UA\+W>MKIURW]GW1M=0MBRK):N&"DGG!49!R#T.?6M3_ (28+XQ@\.R6
M;))/:-=Q7'F@HZJ0"H[E@2./3F@#?HKD;WQR+"'3I9M&NW2_U!K"!H71@S L
M W4'#;&(XZ8)(S5[0?$QUC5=4TJYTV;3[_3S&TD4DBN&20$HP921V.1VH Z"
MDW YP1QUKA/&VIW-UXM\,^$+>>2WAU1Y9KV2)BKM#$N[RPPY&XC!(YQ]:V=1
M\%:-<Z<8+*QM["="K136L8B8%2" 2N"RDCD'K0!T.]/,\O<N_&[;GG'KBG5P
M=HD%I\9M:F6,(&T."638O+'S9,G ZG 'Y5HV'C5;J_T2"XTR:VBUN.22R=W!
M;Y%WXD7^ E>1@G\* .I61'9U5U9D.& .2IQG!]*=7$VGB73+%?&&HVV@7$,^
MFS;[\*8_,N"L0;?][&-N.^?;-/'C\I-HIFT&_2VUB,&TF5D8M(8]X3;G(R,@
M,<#CG YH [.BN2@\=P);>(&U33Y["XT-5DN8&=9-R.NY"K X.<$>W>MG3M4N
M;JZEAN;$0(D*3)<1S"2*16+<!L#D;>>.XQF@#3#JS,H8%EZ@'D4M>7^,-";7
M/AM?Z[#"K:EYQU>W)7DQKC:A'H854%>YK.\9:KI7]H>!_&5K:JT(VS79"C:E
MK)LC!?W5I!M]P?2@#V&BN,UNYL+;Q!>:_<V37*:%9A1Y$6^1YI2&V@>JJ$QZ
M>::T[+Q*\WB"ZT*[TYX=0@LUO52*59%EC9BN QVX8,,8.![T ;T<B2IOC=77
M)&5.1QP:=7G]AXQTS1OAW%K^FZ!+;Z4+F5)+=&56@_?,A=N<8W9)P3C-=;<Z
MP+;4H;5X1Y;6SW,T_F#;"BXZ_7/'KAO2@#3HKC%^(M@+[28Y( MKJT@BM)DN
M$=P[#*"2,<IN[<G'0XJ;2/&T^MZE+;6OAW4!%;ZA+874[O&%@9!G) ;D$\<9
MQQZXH ZVBLS6-;@T@V<31M-=WLWD6L"$ R/@L>3T4 $D]@.YP#1LO%!N=6O]
M%FL&@UBTA6<6QE!6>)C@.C\9&>#D @T ;IGA$X@,L?G$;A'N&XCUQ4E>;?#Z
MQB\3:+;:MK.F*][#J-S=17IE^?S!,ZX^7G 4!<'C"CC@59UB\D\1?%.V\)2.
MRZ59Z>=0O(E8@7+EPB(V.J#(;'0]\T =^&!&00:19$=G575F0X8 Y*GKSZ5A
M7/A'2S<V-S86L-A-:7"2C[,@C611P5<+@,,$XST.*S+#7;.*\\6W&G^'IDO[
M"5#>(&0273",,",$C[N,<\^QH [*FK(C.Z*ZED^\ >5[\^E8%GXI34-"T74[
M2T,HU9D$40E&4#*6.3T^4*21VP>M9]E<Z3JNI>,;)=%^SW,7EI?/,%/VDF(E
M"<$C 7&/KVH Z]'21 \;*RGH5.0:=G R:Y'X6_\ ),/#O_7FO]:RM*E7QK\0
M?$46I*)M*T-X[6VLGYB>4@EY'7HQ&,#.0![\T >A @C((.:6L$>'--TS6H=9
MM%CL4@@ECFBC^2)E;:VXJ/E##8.<=.O05GR^.X+?3+'6KC3YHM"O9$2.]+C*
M!SA)'3^%&.,')/(R!0!UU-1TD4,C*RGNIR*Y_4=;2\N=3TFSTS^T_L<0^VHS
MJJC<N1&,YW.5YP<#D9(S7+_#[7[;1OA?X5MW*&ZNX76".241J0K,69F/0#CU
M.2.* /2J0D 9) 'O6#X7\5VOB=;^.*,PW6GSFWN8MX< XR&5APRD=#QWXKD?
M&^H1Z%XUM]4\2Z0^H^%GLQ"DHA\Z.RFWG<[Q\_>&T;NO&!WH ]-HKC]%O/#W
MA_PUJ.M:=?1SZ-<7(N(?)DWA2RQQB-<GCYA@*< ;L<8IUOX^T\:Y-I6HB*UD
M2S:]2:.X6:)HE^_EEZ,O4C'3H30!UU(S*BEF8*H&22< "N;@\5S27FEI)HMX
MEMJJ,UK.I#%<+N E _U>X=.3[XK"TOQ7=ZIX2\37^N:*9[.UFNX9;>&5&S%'
M\K)R1G@$D]\G [4 >@JRNH92&4C((.012US-GXBLK?2O#UIIUEB;4K17LK)6
M"B*)8U8EF[*H*C@$Y(P*K3^/K>UTS7IKC3;I;[0QNO+)&0L$*[ED5B0&0CG/
M7@\4 =?17*V?C0SZ[I6G7.CW5I'JL+RV5Q(Z$2%%#LI4'*_*<C/7T%=2ZAT9
M#G##!P2#^8Y% "T5P_PSC$5EXCB#.RQ^(+Q%,CES@, ,D\G@=ZYG58K/_A-_
MM7COPO<I!<W@AT_5$OF>!%!Q$DB(P"9QG)SDL>W0 ]>HR,9SQ7+>,+JXNM-U
M#2K"5HF6SDFNYT.#%'M.%![,Y!'LH8\';FEX8T.UU_X9>%[2_+O9#3[=I;=6
M*B;]V,!B#DJ.N.Y ],$ [8'(R**X/P/HRZ'XK\3V6EF1/#\;0"" N62*X*DR
MJF>@P4R/4X[5WE !37=(D9Y'5$49+,< "O*_B)X7T?2=%T5K>QA\^;7;59YV
M0&24.Y+AFZD'/3I4_P 3?"VC:7\//$5W96$$!EBM\QQH JLDO#*!T;#D$CJ*
M /3Z*YRT\5F7Q2-#O-*N;%YK9KFUFE=")D4@-D DJ1N!P>WITK-E^).F0MIU
MPT:MIE_<+;0W*7",ZEB0KM'U"''7.1D9 H [6BLKQ)KB>&_#]YK$MK-<Q6L9
MD>.$KNVCJ?F(&/U]JPX/'H_MW3+"_P!$OK"VU48L;R8H4E?&=I .4)'3=@GT
M% '8T5R4GCE(FM9Y-,N$T^YU/^RXYV;:_F[B@8QD?<+ C.<]\4EUXVGC\0:C
MHMEX<U"\NK%87?8\:ADD)&X$MT&.AY/H,$T ==38Y$EC62-U=&&593D$?6N+
MT'Q/JFJ7GBE+[22]MI]VT"112HQVK&AV\D D[B>N!G':I-$\4:+:>#-!GT^S
M2S@U!=EC9M(J!0 6.YCP  "2>>N!DD @'945Q=M\1]-EM]16:(17MA=PV<L/
MG*T9>4@1L)!QL.<Y.",'C/!Z73;ZYNY+J*ZL6M9+>0)GS-ZR J&W*<#(YQR
M<@T 7Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XC
M5K)[#XN:'KC#_1KRPETMG[)(&\U ?][# >XQWKMZANK6"]MVM[F)9(FQE6]0
M<@CT((!!Z@B@#B=;T[7[WQ5J45QI/]I:1-9JFGDW"+#;RX.\R(3DL21A@K8
MXQDU4@AU'0_@9+IVI6!M]0BTUK&.W$BR-)(Z^6@&W(RS,  "?Z5Z*BA(U0%B
M% &6.2?J:BELX)[F&>5-[PG,>XY"GIN Z9P2,]>3ZF@"AX7TI]"\*:3I4A#2
M6EI%"Y'0LJ@']<UK444 %%%% !7 )X?O+[XCZ]=:EHDCZ)J.G1V6]Y(B'VD[
MLJ'W <\'&>*[^N?;P-X59BS>'].))R28%YH Y[3- UZ/PYK'@G48I9]->WEM
MM.U82(2(70A5D7<&W)G&0,$#M5KPK/XL,5GIFK^'(+)[0*D^HBX1TG"C&8T'
MS9; ZXQDGK@5K?\ "">%/^A>T[_P'6C_ (03PI_T+VG?^ ZT <@?">NW_A_Q
M=:"T-C>7>M?VII[SR1LC[3&R!MK'&3&>OJ*W+:\\7ZIH][CP]!H5_':2")I9
MXY?,N"I";=N0$!YRWL,$9K3_ .$$\*?]"]IW_@.M'_"">%/^A>T[_P !UH Y
M'3=$U[_A)/".K/X<>![2&XAU&6>\C>5I'1!YC,"2RY4XY)YZ*,5-IGAB^B\3
M:7K.GZ5<Z%=R2L=:B69#:W"[#DA%8Y8MM(( QSGGKU'_  @GA3_H7M._\!UH
M_P"$$\*?]"]IW_@.M ',>%K+Q7X=M5\+OH$%Q;6\C):ZR9TV"$L2"\?WBZ@X
MP!S@<@<TFM^&+[4=;;5=-TJYTOQ!%>J(]2MYD6&YMPXYF4-EODR,%<Y [=.H
M_P"$$\*?]"]IW_@.M'_"">%/^A>T[_P'6@";QAH+>)_".J:*DHB>[@*(YZ!N
MJY]L@9]JYVYTS6/%.G>';#4]+DL)-/O8+N]F>2-D8P@\1[6).YL=0,#.>>*W
M/^$$\*?]"]IW_@.M'_"">%/^A>T[_P !UH H:78ZG!\2]<U.;3)DT^[M;>&&
MX,D9!:/?DE0VX#YN..U7_'/AV3Q7X*U/1(95BFN8QY;O]T.K!US[944?\()X
M4_Z%[3O_  '6C_A!/"G_ $+VG?\ @.M %;^U?$%[HWV/_A&[JVU.6+RGDEFA
M-O&Q&"^Y7+,O< +D^@JGK.AW\6M>"QI]C+<V>CR-Y\JO&NU/),8X9@2>0>*U
M?^$$\*?]"]IW_@.M'_"">%/^A>T[_P !UH Y74="UV=_B((]&G8:W!'%9'SH
M1O(@\HY^?Y1GGGM^53>%='U[PEJ5O!:Z7<3:)?VZRW4!GBW6-T  Y7+_ #(^
M,D#.#R/2ND_X03PI_P!"]IW_ (#K1_P@GA3_ *%[3O\ P'6@#D6\/Z\_@GQS
MIO\ 8TXNM7O[J:T0S0_,DH4*2=^!TYS^M:-MI.L:/XOM/$,6FS7%M=Z7'8WM
MJDD?FV\D9RKC+;67D@@'/>MW_A!/"G_0O:=_X#K1_P ()X4_Z%[3O_ =: *.
MB>$]]GXF.JP[/^$@N)'EM]P)CB*!%4D9&[ )."1D]3C-<T/!/B7_ (1[1[XW
M$8\4Z=<1P1SYR!:@&$@\\Y1C*>^3BNS_ .$$\*?]"]IW_@.M'_"">%/^A>T[
M_P !UH S/%>B7CIX3MM(TZ2>WTO4X)Y-LB+LAC1E_B89/S#IZ&IM(T_4H/B1
MX@U.?3Y8["\MK:*&<R1D,T>_=P&+#[PQQ5W_ (03PI_T+VG?^ ZT?\()X4_Z
M%[3O_ =: *'C/PW?W^IZ+XBT41/J^C2NR02ML6XB<;7CW?PDCH3P*U;?5=4U
M!%C30KRPE/#R7CQ%(_7&QV+'TX /<BH?^$$\*?\ 0O:=_P" ZT?\()X4_P"A
M>T[_ ,!UH RI=-UP?$/6-4M+%HX9M'6TM;J1XRGGJSL"5W;MOS#MV-8%AH?B
M1]3\'ZI<>'76^L))1J=Q/>1-)*[PE/,W G*;CD#J,X"XKM/^$$\*?]"]IW_@
M.M'_  @GA3_H7M._\!UH YHZ+K9MOB$G]D3[M9#?8OWT/[S, BY^?Y>1GGM^
M5/N-'UI[/P$BZ1.7TF2-[P>;#^["PF,X^?YN3GCM^5=%_P ()X4_Z%[3O_ =
M:/\ A!/"G_0O:=_X#K0!A?V9K,/BCQE?_P!@FZMM1@M8[>.:2+9<"-6612-W
M&0W&1]:I:;X3U#2Y]4M=%M[ZQT&_MXX?L-S.K>1*\F)7BPS;0L98XSRV,5U7
M_"">%/\ H7M._P# =:/^$$\*?]"]IW_@.M &\(HQ"(0B^6%V[,<8Z8Q7G7A[
MX<26OA+Q#H.HR;X;HRVEB2<^5:AF:+\0TC-^7I73_P#"">%/^A>T[_P'6C_A
M!/"G_0O:=_X#K0!@6^B>*=,^$QM+*3?XHEB229O,569R5#*'Z!A&-@;U /O3
M='TC5+3X@C6HO#;6>GS:.+9U-S&THE64N=^&.YB#UR<\98=NA_X03PI_T+VG
M?^ ZT?\ "">%/^A>T[_P'6@#*\%^'+E?AY-X?U_3WMS,]TLL;.C[DED=@05)
M'1A^-+X9\,:F/!EYINOSAK^YMFT\S)SB!%:.,^Y(+/\ 5ZU/^$$\*?\ 0O:=
M_P" ZT?\()X4_P"A>T[_ ,!UH P_";>+;6ULM$U3P[;P&Q"1/JBW"-'-&F "
MB#YMS 8YP!DGVJ_X%T_4M-?Q"-1T^6U%YK$][ SR1MNC?;C[K'!X/!J[_P (
M)X4_Z%[3O_ =:/\ A!/"G_0O:=_X#K0!3\9:+J-WJ7A_7=*B^TW6CW32-:[P
MIFBD78X4D@;@.1D@=>:+32[JZ\<S>*Y[&:W2+3!806SLGFR9D\QF.&*@?= R
M?7IQ5S_A!/"G_0O:=_X#K1_P@GA3_H7M._\  =: *7PXT[4M'\)II^J6$EI<
M1W$\F&DC<,'E=Q@HQ[,*@\0>']3L_&UEXQT.W6[G2V-E?61D$;3PEMP9&/&]
M3V) (&,BM3_A!/"G_0O:=_X#K1_P@GA3_H7M._\  =: +=KJ.H:@\872KFPC
M!!D>\,><?W55';)/3)P![UC^%].U*T\7>*[R\L)+>VU"XAEMI&DC;>$B5#PK
M$CD9Y'2KO_"">%/^A>T[_P !UH_X03PI_P!"]IW_ (#K0!F>$/"U[H.L:E%.
M5.DV\\C:0@/W$FP\@(]%;Y5]MWK3=*T[5K7Q-XTOI=*G$&H^2UH1+$3+LAV$
M8W\<],XXK5_X03PI_P!"]IW_ (#K1_P@GA3_ *%[3O\ P'6@"+X?:=?:1X$T
MG3-2M6MKNUA$4D;.K<CN"I(Q66-%U7PKXWU37-*L&U+2]9"->6T,B+-!,@(W
MH'(5E()R,@YK9_X03PI_T+VG?^ ZT?\ "">%/^A>T[_P'6@"6XCO/$.G7=E/
M9S:=:7%M) WGE#*Q=2N0%8@ 9SR<D]AWX_\ X1W7=4^&UOX&U#36AEC$-I+?
M"1# 8(G4B1?FW$E$  *CD\\<UU?_  @GA3_H7M._\!UH_P"$$\*?]"]IW_@.
MM &'86&N>&?&.O-!I,FI:7K$J7,,\,T:FWD"!660.P.W@$%<\=C7/Z7X9\5Z
M-X7\(7T&CQSZEHB3P7.FR7" SPRD$E7R5##:IP?_ -?>?\()X4_Z%[3O_ =:
M/^$$\*?]"]IW_@.M %O0IM1NK>2YU#34TPR$".T\Q9'4#N[+QDYZ#. !SDD"
MM=WFKVVNW2/I$M]H\EO&$:%XRRR9;>"C,,J1MZ?E3?\ A!/"G_0O:=_X#K1_
MP@GA3_H7M._\!UH XR/X>Z@WA_Q0NF6\>DMJ%]#?:;I\C*5@>$JWS;25&]EZ
M D 8],5N+!K_ (NT#4-,U70(] 6XLY;>1S.DQ>1U*C9LZ(,Y)/)X&.IK7_X0
M3PI_T+VG?^ ZT?\ "">%/^A>T[_P'6@#-\)W?B[[)8Z5J^AI9&S18Y[[[2DB
M3A!@&-1SEL#.[&!GOQ698Z+KUGX4\8Z,VD.[WD]_):2K/'B<3D[, MQC/.[&
M.V>W2_\ "">%/^A>T[_P'6C_ (03PI_T+VG?^ ZT <U%X?UK3YO!NN0Z?)+/
MI>G_ -GW]AYD?F;"BC<AW;20RYQGD4W6O#&J:E;>,]4BT^07FLV*6-I:&2,.
M%5"-[G=M&6;IDX '<X'3_P#"">%/^A>T[_P'6C_A!/"G_0O:=_X#K0!B7.EZ
MO+KO@6Z729_*TN.87A,L7[LO#Y8_C^;GGC/'Y5W;$JI(4L0,X'4US_\ P@GA
M3_H7M._\!UH_X03PI_T+VG?^ ZT 4O FG:EID>NKJ.GRVINM7N;R$O)&VZ.1
M@5^ZQP?44R\35?&&COI&I^'9M+229/M$DUQ%*FQ'#?NRC%BQVC&57&<\XP=#
M_A!/"G_0O:=_X#K1_P ()X4_Z%[3O_ =: ,_Q!X L-235;N&?54O;R-V,<.I
M2Q1O)LVC*A@O91^%9VEZ;X@\(?#O2M-TC2KN^U-XHQ=![Y#]E;8H?89&QVPJ
MC*@\].#T/_"">%/^A>T[_P !UH_X03PI_P!"]IW_ (#K0!7\-W6MI'):S>%3
MI5K!"S1^9?1S//*3G&5)Y/S$LW4GZUN:1=7E[I-M<ZA8'3[N1-TMJ91)Y1]-
MPX-9?_"">%/^A>T[_P !UK4TS2-.T:!X--LH+2)VWLD*!06QC/'T% '+_$?2
M]4UC3](@TO3I+M[?5+>[EVR1H D9)/WV&35CXBZ;J.O?#_4--TVQDGO;I8PD
M7F(NW#JQR2P'0'H376T4 <7J>F:EJ/Q T?41IEPMA'I]Q;SRF2(&-I=N.-^3
MC:<X!_&L[PC;^+=%L;7PQ>:!;M'98ACUD3IY;0*>&\O[^_;QCIGDG%>BT4 <
MM\2?^2:>(_\ KPE_]!K-;3;WQ/'X2673Y;.WTR:*_FEE=#N9(R$1-K$G);))
MQP/7BNLUK1[;7M)N-,O3+]EN%V2K&^TLIZC/7'TJQ9VJ6-E#:QN[I"@13(<M
M@=,GO0!Y5>:#XLO["U>^T W6KV>N17<EXUW%B:!)MP6$$_(H7'RG;TSR2:ZS
M1[#58?B/KFIW.F2165Y:6T4<_FQLN^/?NX#;L?-P<=NU=A10!Q.BZ=K&DZSX
MM5]+>6VO[MKNWN$FCQ(#$J[ I.0V5[X'O7/VOAGQ-IG@[P?=6NEI)J_A_>D^
MG33(!<1NNUPK@E0>A&?_ *Q]6HH XVY75-9T&4:EX2B:VN)(XY-*>6)Y#%SN
M<MD+NR5(&?X>H)X?X&T&]T!M4MM]VFC-*ATVUO)1)) NWYQG)PN[H"<C!]:Z
M^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "JFHZG9Z5;"XO9Q%&SK&O!8N['
M"JJC)9B>@ S5NN2^(&I#3-,TR9[1)(FU*%7NG@\T60Y/G!?48P#T!8'GH0#:
MLO$&EW\-Y+#=A5L6*W0F1HF@(&[YU< J,<Y/&*K+XPT%KJVMFOO*FNE#VZS1
M/'YRGH4W*-PZ=/4>M>=QK:7,OQ-MKHZI);75I#,)OLS>;(@ML%ERH&<]!QGZ
M5:T'Q!H6L^(_#$U_KMJM_IEL]O!"D,T7GRR(JDDR*H'"\+SDGKVH [6#QUX:
MNK^*Q@U6.2YEN6M%14<YE49*YQ@<=SP<''0U8B\5:+-J%M8K>$376[[,SQ.L
M<^.HCD(VO^!-<?X3B:_TKQ]:63JEY=:K>F!NA(>-51P>ZYS@]*I>%+WP]K5K
MH>F7>F:JWB#3'AWV5R]SMM)8P 9<D[ H )'KD#'- '>W?BK1;&Y6"YO#'NF%
MOYIB?RA*?X#)C8&SQ@GKQ5[4]1ATG3+G4+A96AMXS(XBC+L0/11R:\FT:71C
MI=SX.\4:=JEQK,=U*!9%[GRKW,I=)%*G8%.023C!!)KU37(I)O#VHPQ(7D>U
ME15'))*$ 4 <+K7BZ?4/#?@_7;6[N=/CN]5LENXRIC1HY/F92S*-RX[@X//6
MNSTSQ1HVL->K97JLUCC[2LB-$8P02&(<#Y2 2#TXZUYF]_;7'PZ^'L(W[K34
MM.6X62)EV>6,2$Y'1>YZ#UK9O;Q8/B!XMN(;1=0_XD$>VV R+ET\PF/W." 1
MR<&@#L;+Q5HVH745M;W3F6> W$ >"1/.C&,M&64!QR/NYZBJWA;Q;;>*5OGM
MX+B);>ZD@7S8'3(0A222, YS\O4#J*X+3-2@NO%O@*^CDNIHOLES"PCLWCAM
MW,: 1(H7@#!'))&.3Q72_#B80CQ!ILL<R74>M7DKJ\3 !&DRIR1@Y!R/6@#7
MU7Q=:Z7XJTW07@N6ENXY)6D2WD=550.FT')R1G'0=<9%<[HWC"VT35O%B>(-
M9G>&UU(1PF1#(8H_*0]$7Y5!;K@#U-6_$\PL/B9X4OIXYOLWV:\@WQQ,_P"\
M81[5X!Y.#CZ5A)- VG?%,;E)N&E\KUE!M@HV_P![YLCCO0!W&I:AIK:]H,+Z
MW-;W$SN]O:P-E+P>63\_!RH&6'(Y%6I/$>EQ70MVGDW&<6V]8)&C\TD )O"[
M<Y(&,\&N!-Q$9OA8Q<?N8SYI_P">?^BE/F_N_-\O/?BF3O-IGB"6\\.:B9TN
M-8V7_AZ[0.2_G8:>'^).GF9Y7J<\8H ]6K@K+QA>M\33IMRH71=0ADATV3^_
M/;L1+^>6'N$&.M=%XKUD:-HDCQRK'=SD06Q89 D<A0Y']U<[B?0&N)\<>%I=
M*\$6E]I^LW<\^@O%=:?',L.'9,?+E$#,67/&3D]<T >C7^IV>F)$UW-L\Z01
M1*%+-(YZ*J@$DX!/ Z GM66/&WASR;R1M4C0608W2R*R-#M.#N4C(/(XQ7*>
M+-?TZYL_"'BB.:6$Q7A==\#NB;H6WI*%!96QP#@X/;&35!=1T*_\+>/[RQUB
M"[U#4[6626VC1T\O]R8XU57 9B<=<<D]!0!W=GXT\/7_ -I^RZDDGV9(WDPC
MC D^YC(^8D\8&3GCKQ5FQ\1Z3J+7J0W>R2QYNHYXVA>$$9!97 (!'.<8KAM<
M,J_#;PEJ-G;7%S:Z9+:3WD%F667REB*/C:0<J6!QQT]JAU.WTKQ3X8\07_@^
MTO+J^GL1$]Y.TX,VU@WDKYIRQP&''3('>@#NX/%6C7%ZUF+MH[@0F<)/"\6^
M,=73>HW#W&:IQ_$#PM+%9RIJT9AO)/*AE\M]A?<5PS;<+D@XW$9[5@^'M6\*
M^(]5T_4K2TU%]1L$D:5[Z2X_XEX9"'#&0[<G@8&?7M7)AHO^% 06I7_2/[0!
M,)7Y_P#C]W_=Z_<Y^E 'J^F^*-&U?4Y].L;T27<*"5HS&R[D)QO4L '7/&Y<
MBD_X2K1?M]O9F\*R7,AB@=HG$4KCJJ2$;&/!X![5RVKN+KXK68M+A TN@7$,
M<RGY1(SH4&1WP"0/:L3PG<Z#J.DZ+X>U32]4;Q#I;PJUA,]SLBEB^43 Y\M5
M RP/O@ Y (!V\_Q!\+6T=Q))J\92VF,$[)&[B-AC.["G"\CYNGO3M6\8V>E^
M(](T<PW$KZ@LDGFQ6[R*$5,_*5!W')7IG .3CBN(66!O#/Q24%2]Q<W1A&.9
M08%5=O\ >!8$#'>K<MTEKJ_PUU&196M8[&X@>2.)GVR-#&%4@ D$E2,>H- '
MHNJ7%O:Z5=375T;2!8FWW .#&,?>'N*S=,U?3;3P_I++J-S?QW$"_9YVC>6:
MY4*#O*JN3QR3CO5KQ%(D?AG5&D(5?LDHY]2I %><VMO9W7@GP1&VLSZ)JMOI
MY^RZ@N-D,BI&KQ2AN"#D?*V/N_F >H:?J%MJEDEY9R&2!RP5BI4Y5BI&" 1@
M@CFLZ\\6Z)I\\T5S>[/(E2&>01.T<+MC:KN 54G(ZD=1ZBJ_@>]U*_\ "\,V
MJP0QW?FRJSP(42<"1@)5!Z!_O>^<]Z\V\::@-0\/>.+$6T]G=0W@*V-M:-_I
M"@Q_Z3(X7YMP!QR!@#J: /:7<1HSMG"@DX!)_(<FO-+?Q$->.NZA<:QJNE+I
M6INL4D-M-Y26\2H6$B[=IW9<G=\PR.@%>CP7,5Q:I<H6$3KO!=2AQZD'!'XU
MYEHX.H>$/B396H,ES=7VHM!$!\TJO$%5E'<$\ CB@#T!O$.EK<:; ;K#ZFNZ
MS_=MB8;=W!QC.WG!YKE](N]1G\0>/+*35+IDM'A%JY*YA#0!SM&W'4^E<[%K
M=GJ#_#4V@N9EM)/+N"ENY\I_LQ0J>.H/7'3OC(K:T6Z@3Q;\0Y'E58W:!D8G
M 8+;A6(/?#<''>@#=^'M[=:E\/M#O;V=Y[F:U5Y)9#EF)[DU<O\ Q9HFF37$
M=W>[/LS(EPXB=HX"^-HD< JF<CJ1U'K67\,#CX:Z%&>)(K58Y$/!1AU!'8UP
MOC:_%_H_CS3A;3V=U&_R6EM:MF[4*G^D2.%.0<8'( "C.2: /3K[Q;H6FZD^
MG76H(MZD/GF!49WV9 X"@Y.2.!S[<5+;>)=&N]!77(+^-M-;I-@CG=MVX(SN
MW<;<9SQBN1M[ZUN?BYI]X&Q"?#KH'D0IAC,K '<!@E03@\XYKDXI)[?PY;ZC
M%#+/8Z;XOFO;V*)"S"W,C[9 HY*C(;CZ]J .UT[79;[XNSV,-]>-9+HOG-:3
MQ-$(Y?. R%95/W<<G/4\UH_$+Q'+X8\'7M]:[Q=[52%A"SA&9E7<< @8W9&>
MI&.:Q+#5[+5/C)'>V+R3VLOA_P I;A(7V%O/W8W8QTS^1'6KOQ;=1\.-1A&6
MEE> 1QJ,L^)D)P!R< $_A0 V%+*U\6:;)_PEFLQK>N3;:3<;\2NJ,'+>8N\+
M@9P<#(R.HK5NO'WABS^U^;JJ'[&_EW CB=S&<9).U3P 1D]!GDUC^+;NVE\9
M^!IHYD>);R=V=#E54PLH)(Z L0/K63!-;^?\4"63]^/W9/\ RT'V8)\O][YL
MCCOQ0!W]UX@TRT^RA[@R/=1F6!+>-IGD0 $L%0$E>1STY'K7+^-M?-QX+L-:
MT#5I%@EOK95EMR )4:9493D9'<8X.>#6'I6L16R>"K.>-[16T%$.HQ6QEF,H
M$8:V4[3L/&3QG@ 8-8L$RI\%K&R:.=+B#6EWQR1,&&+PN>HYPO)QT[T >W2R
MQP1/+*X2-!N9CT K L/'?AC4YHXK/5X9#)#).K;65?+C.')8@ 8]STYZ'-;S
M3Q+ 9VE00A=_F%AMV^N?2O)=$LKN_P#V?9K'3(6;44$S&W *NV+AG*XZY9!Q
MZY% 'H]KXCTO4;]M,@NI(KUH?-2.6!XG9.F]-Z@, >XR*P? 6LRGP;/>ZQJ$
MDS17]S$9YSEB!,R*, <GH  .N !53PYJGA;Q'J]CJ=A::C+J-E'(99+U[C_0
M RD,K&0[22<# SW/:N4MC<K\.;>\MK>YN4T[Q'+>WEO;%EF:W\V3E0"&Z,K#
M'I0!ZI;>*-&NA?[;T1-IZ[[M+F-H7A7&=S*X!"X!.<8IUAXDTK4[TV=M<.+D
M0"X$4T+Q,T1. ZAU&5SQD5PMSJ'AV\T+7O$/A[1;G6I1IS0S278G99AD$18E
MY8#ECCIC&>:K6.H6TOQ$TR^$UYJ%M/H,\0E-HT<;-O0[$ 4!5 !]<=R30!Z)
M9^(M,O[J"WMYY&>XC:6 F"14E08RR,5"L.1R#W'K43^*M%COH+22\*/<3&"&
M1HG$4DHR-BR8V%L@C&<Y!'45POA;[7I^L:5INB:N=5T"YMI3'%<H#<Z1A/E!
M;KMR0FUL$=NE4/"LVAW>BZ;X7US3-4D\1:<Z1M82R7)C\R,_+,&SL"?Q9^N
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M_FQ^5_PCRQ^;GY=WGLQ7=TSM(./3F@#6'Q \+&VL[E=7C:WNR%CE6-RH);:
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MO(1F&0OUQ@_C5TG R: "BD!!&0<CUKD]!U_6_$,6EZQ906+:)>M+OC?<L\*
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M2(8%/S2O@D*/P!)/8 GM0!JT5S%KX@U74O"&C:CINFPS:CJ=M',(Y)2D,.Y
MS,S8)VC.  "22/<AGA7Q/J&J:KJNB:WIT5EJVF^6S_9Y3)#-&X)5T) /8\'_
M /4 =511TI 01D$$>HH 6BN2T/7];\0Q:;K%A!8MHMW+*DD;[EGBC5F59 V2
M&R5Y7:,;NIQFN@?5;5=8725E5KYK=KD19Z(&5<GTR6X^A]* +M%<WX.\07>O
MV>I27\5O#+::G<606$G:1&<9R>I//I]*Z,L%&6( ]30 M%%<RWB6XU+Q'>:'
MH4$,CV 7[;>7#'RX6896-5'+MCD\@#USQ0!TU%8EGJ.K+KZZ9J%E (FMGG2\
M@<[9"K*I781E2-V>ISZ]:VMP.=I!([9H 6FN&:-E5MC$$!L9P?6N6\/:_K&O
M:;XBQ!8Q:AI^H7%C;*2_E,452I<]<$MS@#BKFM:[/H>C::]S'"^H7MS;V2B,
MGRA-*P4GU*CYCZD#'&: '>']#OM,,ESJ^L/J^HR((C<M D(6,$D*J+P.223W
MX]!6[65I$FM![R/6DLML<N+:>UW*)4(ZLC$E2#QU.:U2<=: "BDR#W'I4-V;
MDV,YL/)-UY;>1YQ/E[\?+NQSC.,XH GHJO:-<"PMVOC"+KRE\_R2?+WX&[;G
MG;G.,]JL4 %%<YJ/B:0>)(_#FD6\=SJ9A^TSO*Y6*UBS@%B 26)Z*.O4D"I1
MJ&M6FL:?97EI:S6UVSJ;RW9EV,J,P4QG.,[>#N/0\#B@#>HJEIIU,BZ_M,6@
M(N7%O]F+']SQLW[OX^N<<5=H **YO5]4US1O#&OZI/#ITLUD)Y[5$9PK0(FY
M?,R/O\'(''3FM?1KR34=#T^^E55DN;:.9PO0%E!./;F@"[17,IXEN=7U^_TG
M0H8&73F$=Y>W!)C24C/EHJ\NP'7D >]7+'4=5.NR:9J-E D8M_.BNH)"5F.[
M##:1E2,CC)ZCF@#:HI 020",CJ*S?$6HW&D^'=0U"UCADGMK:2=$F8A6VJ6Q
MQSVH TZ*S=!U&35/#6F:G<!$DNK2*>0+PH9D#$#/;)K2H **** "BN=\=:]>
M^&?!VH:S806\TUJ@?9.2%QD#MR>O3(KH$;<H.1G )% #J*I:<=3)N_[2%H,7
M+_9OLQ8_N>-N_=_'USCCI2ZE<S6VE7=Q:K%)-#$SJLC$*2!G!(R: +E%8OA+
M69M?\)Z5JURD<<]Y;),Z1YV@D=LG.*VJ "BD# G (SUHR,XR,T +129&[;D9
MZXI: "BJ6IG4Q##_ &6+0R^>GF_:BP7RL_/MV_Q8Z9XS5J9G6)C'L\S'R!S@
M$]LF@!]%<]X'U^Y\3>$;35[V*&&>9Y@Z0YVKLE=!C//1170!@5W @CUH 6BD
MW+MW9&.N<TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]HDF\VC;YV?O;L>O<=^]/F\-Z//IEMILMC&UK:E6MTR<PE?NE&SE2.@P1@4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU3!!4#G;GKWQ[UEZ1X(@T#QGJ6N:8X2VOX#OLR2$2<L"67L V!GW'?H #G?
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MH4GG!*"/WZ9H [&-%BC6-!A5 4#V%.J"RAEM[&"&>8SS)&JR2G^-L<G\34]
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M5EB<HP#2JK#((."#4WB_PZ^F>&[S5O#M[>:?J.GPM<Q[;EWBF"#<4>-B58$
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MBNTU+0=;NIYYO#^K/ \RR&-KJ-0PC+E2#GG)]=HSU- 'HM%>7^'="L=0\?\
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M.JG^%FZ;AR.:3QGH\>@>%+W6_#X^P:EIL1N5>-CB94Y9)1G]X"H/WLG/(.:
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M?BKQ+X1O;B2Y&DR126D\K%G,$J[@C,>6*Y R>3GGI0!W-%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>?V&G:C
MX)\7ZW=0Z=<7^AZU.+LM: /+:SG[X9,Y96ZY7..F.]>@44 9MMJ5Q<EI_L-Q
M!:(A/[Z,B61NVU!R .>H!]N]>:Z!X*U&^\!"VDMI]*\1:??SWNG3RJ/D9G+
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M8)&<U;\7VEWXZTA?#MI9W=M974L9OKNYB,7EQ*P8JBM\S.2H' VCG)]>XHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF4/.3@&+ SN/&2<4S4[G0)_CL_\ :MU8&W3P\(\W$JA5E^T$[<D_>P<XZXH
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MSMI?->61SA$4D+EC^0YH ZO%&*YC4]>UO0M*?5]1TJU>RA7S+J*TN&>6"/\
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M>#P3/=2Q/##J&H3WEK&XP5A8@+QVS@GZ&I?C)_R3FY_Z^[7_ -')7>@!0
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M@>73;C UVPB'WE_Y^$']Y>_J,^YK!UP_\4I\-==R3IEG?V\MR^.(T? 61O0
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MP<1F1E7<.AP",D4FJ^'=+US35T[4[=[JT&"8I)G(;!R-W/S8([YH Y7XF_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;5HK.9K#4TM[N2*.*9K8[,R$!"2"< EAR?6F)XRLI=:OM(AL=1EOK$(;B-(
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MD9SR2!Q3=9\26F@:"^M:C!=16D8#2X0,T8) !(!]QTS[US?QH_Y)/K7UM_\
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MWA81&- 5^49;<<\8'<_SXKQV_P!2U/Q9\.-,-J=NM>&HS?7>1EEGMFV*I]W
MD;_@->E>'-3@\4ZF=>MCNM(K..&W]GD599?T\D>Q5A0!+'XUTV2[UFU\B]67
M1H_,O@8?]6"I<8P?F) .-N:CD\=Z?%J=MILFG:LE[=1M)#"UF0SJOWCCVS61
MX357^*/Q#5U#*7L 01D']P:77/\ DM7A3_L'WG\EH UKOQWI=C86UY<6VH1Q
MW%W]B16MB'$^2 A4G(SC@]/>KNO^*++PU807NI0W2PS2+$#'&'*NW"J0#U)_
M#WKF/BRK)I/A]H(T,I\0V1 8[0S9.,D ^@YP:I_%*76&\,V0O;2PBA_M2TRT
M-T[MGS!C@QJ/UH ]%N+V.TTV:^N$>..&)I9%(!9549/ SS@5S\GCS3X;^QL9
M=/U:.[OE=K:%[-@T@0 M@'T!'6NH95=&1U#*PP01D$5P7BC_ )*_X"_ZYZC_
M .BEH UKWQYI>GZ:+^ZMM1BA^U"S8-;$.LIQA2O7G(P>G(YJ[X@\3V7AG25U
M/4X;I+8LJ,4C#E&8X (![DXXS7,_%Y=GA*T:)$\QM6M#SP&;> ,G\ ,U1^+,
MNM-X N!>6=A'!]IMMS0W3NP_?)C ,8'ZT =AJGBRST>[TZUO+2]6?46*6R)$
M'+L!DKP>#CUJU::[%<ZDE@]E?6TTD;2H9X=JL%(!^;)&?F'%<E\1#./%O@7[
M,(S-_:4FP2$A<^4>N.:ZK33K3:O>'58[-;988OLIMV+?,3)YF2P!SC90!L44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%GX:U/P_XNO+[0VM#HVI'S;NQFD9#%<=Y(L*P^8=0<<CK0!A^'KU[+XH^/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOZ1%J*:?)J5JMV[^6L)E 8OC.T?[6.W6K5Z)6LIO)F:&0(2LB@'!^A!%>/\
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MC;6+== GTR>Y<DH(PR,@#>9Z?,>^*T]8\<:'I7A@:\+Z"YM)"$@:&0,)7)P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%N&MH6F7[LA0%A]#UK!LO%$^N7-T- L(KNTM93 ]Y<7)AC>1?O"/".6 Z$X
MST)J]H^L3:E<7]M<Z?+93V4JQLKN&$F5#!E(ZKS@'@\'(!XH O3VV8Y7MTA2
MZ*GRY7CSAL<$]R/QK*\/Z7JELTE]KUY;7>J2HL1:UB,<4<:DD!023DEB2>_'
M' K=K \9>(IO"OAN;5XK);L1/&CHTOEX#NJ ]#G!8<<4 ;](%4,6"@%NIQUI
M:* &>5&8O*\M?+V[=F.,>F/2FBV@  $,8 38,*.%]/I[5+10 R.&.$$11H@/
M4*H%.550850HR3@#')Y-+6!HWB*;5/$NOZ/-9+ =*:!1(LN_S1(A<'H,<8XY
M[T ;26T$<[SI!&LLGWY%0!F^I[TD=G;13F>.VA25A@R*@#$>F:FHH ;)&DL;
M1R(KHPP589!'TIAMH#UAC/RA?N#H.@^E2T4 0_8[8@ V\.!T&P426EM-*)9;
M>)Y I0.R D*>HSZ5%J=U+8Z7=7<,*SR01-((V?8&P,XS@X_*JOAK6#X@\,Z;
MJ[0B WMNDYB#;MFX9QGC- &H %4*H  & !VID=O#$Q:.&-">"54"I** (EMH
M$N&N%@C69QAI @#$>A/6C[+;@L?(B^;[WR#FI:* (?L=L0!]GAP.@V"G+;PI
M)YBPQJY_B"@'\ZDI&)"DJ,G' )QF@#E_$GAJZU&^T.;38[*&/3]1%]*')0RD
M*RD?*IY.[.3Z5TCVMO)+YLD$32%"A=D!.T]1GT]JQO"?B&7Q)I]Y<S6:VLEM
M?36;1K+Y@S&VTG.!U/M6]0!$UM ^W=#&VT87* X'M2?8[;[0+C[-#YXSB38-
MPS[]:FHH A^R6Q+'[/%ENOR#FAK6W>!H&MXFA;[T90%3^%8S>(ID\>Q^&VLE
M$4FGO>K<B7).UU3;MQQ]X\YK?H B>UMY(! \$30@8$;("H'TIT44<,:QQ(L<
M:C"JHP /84^F3-(D$C0H))0I*(6VACC@9[?6@!&@A:0R-$AD*[-Q49V^F?2D
M-K;G;F"([  OR#@#H!46G2WD^FVTNH6R6MX\8,T"2>8(VQR W?ZU:H C6"%)
M#(D4:N>K!0"?QHDMX96!DAC<C@%E!J2J6FSZA.ER=0LH[5DN'2$)-YGF1 _*
MYX&"?3M0!9:"%Y!(T4;..C%02/QKC+3PSXBMFEM9YM!U"W>5Y!=WEFS3X9BW
MS*#M8C.!R. .*[8YP<#)]*P?"OB*7Q%#JC3V:VLEAJ,UB467S QCQELX'4GT
MH OZ;HUEIFGVUG##&5@0(K%!GCZ# ^@X':K:VUNJ,JP1!7&& 088>]2T4 02
MV5K/L\ZVADV8V[XP=N.F,]*GHKEM)\3ZCK;:=?6&DI-HE\\BBY%P!)$%+!79
M" "K;>@)(R* .D^S6XW?N(OF;>WR#EO4^_O2?9+?+'[/%ENOR#FIJI23Z@NL
MP01V4;:>T+-+<F;#)("-JA,<@C/.>U $[VEM) 8'MXFA;DQE 5/X4^.&*+=Y
M<:)NP3M4#.!C^0 I]% $<]O!=1&*XACFC/)610P_(T]554"*H"@8  X K$O-
M6U2PTO6KZ?2XMMCODME%S_Q\1*F[<3M^0]1CGI5O0-3.M>'=,U5HA$U[:Q7!
MC#9";U#8SWQF@"W'9VL,)ABMH4B8Y**@"D^N*/L=L0!]GAP.@V#BIJ* (GMH
M))TG>"-IH_N2,@++]#VH>V@D?>\$;-_>9 34M8NKZXUEJEAI%G#'-J-\DLD2
MRN414C W%B 3U90!CO[4 :RP0I(9%BC5SU8* 3^-->TMI(3"]O$T1))0H""3
MUXKD+?Q?KM]%>V]IX<C_ +8TV*.2\L9;T#YG+;4C<*0253=DX^\H]<=E$[20
MH[QF-F4$HQ!*GT..* %CCCAC6.)%1%&%51@ >PIU%5UO;=[^2Q653<QQK*\8
MZJK$A2?J5;\J +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7&?$V26W\-VMS!--#,FI
M6BAXI&0[6F4,#@\@@XP:[.J&LZ-8Z_I,^F:E#YUK,!N4,5((((((Y!! ((]*
M .7DWO\ &&6Q^T7"VTWA\RO$D[JN_P \+N !X;'&1@UQ&G+<P_#+PMXC.I:C
M)JBZG%'YLEW(0R-<LC(5SM((/)()]^E>FVO@K1;34DU*-+MK];<VWVE[R5I&
M0G)W,6RQSCDYQ@8QBF+X#\/KH-MHBVUP-.MIA/#"+R;Y7#;@<[L\-SC/6@#(
MTN1?%?BOQ7;:A),%TV:.TMH4E9/)4Q[C*,$?,S$X;J H [YY3PCJ,X\)_#S1
M%DCCM]0M[IG$CLBRO&?EC)7G!W,<=]H^E>CW?@W1KO6AJ[1W$5\8Q%+);W4D
M7GH.@DVL-_XU5?X=^&9/#-OX?>P<V%L_F0 SR%XG_O*^<J>3T..: ..\5:5J
M?A[P3K2'7IB1?VLUI%;SR!K1))D1D)+?,A^; / YKTC1]$M]$CN4MYKN47$Q
MF<W-PTQ#$ '!8G XSCW-9S^!= ET Z++;SO9-()I ;J7?*X((9WW;F(*CJ>,
M#TKH8T$4:H"Q"C +,6)^I/)H \^UOPC>W&N7GB7P1K7]GZQO\J\MI1NMKID
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJFP,"&VH<OS@\@#/6M&3Q)?8\/Z9;W0OKC4HIYVO;$1'?%'C!C#D)D[UZYP
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M>8HF?YF(49P,#D@9.!7-)J^M)XRT'3;;58KVPU"Q:[GD>V5B@0KRI0J%5]V
M3NP1WI_Q:S_PK?4-N"WG6N,],_:(Z .VHKA'U+Q)HOCG2]*U/4X+ZPUM)DB>
M&U$+VDL:;^.6W*1G[V3_ %S/^$PUP_">'Q%]K3^T$O\ R'(A79(GVOR>1CCY
M?3'- 'INY=P7(W$9 SSC_)I:X.W6_D^,]_$=4G^SQZ3#*D.U-H#2L"HXZ':#
MGK[X K1^(.L:IH7AI;_2IH8YA=01,)8]VY7D5" <\?>ZX- '5T5PH\0:KH7C
M/4-/U>^COK%=&?508[<1&$QOM9%P3D$'(R2>.M4K_P 4ZYIW@"P\<M<I+"ZP
MW-UIWEKY8@E(&$;&[>H8<DD$@\#H #T;<-VW(W8SC/.*6N#T47TWQ;\1A]4G
M>WAM+-DA*)M"MYIVCC( /.>ISR:[R@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "L/Q?X>;Q5X9N]%%V+1+H*'E\K>0 P;@9'/ K<J"[O+6PMFN;RYAMH$^]+,
MX11]2>* ,.7PW=S>+K'Q ^HP^9:VCVIA%L<.'(+-G?P<J,?UJ7PQX=E\.KJ:
MR7JW0O[Z6^.(?+V/(<L!\QR../ZUL27EK#=0VLMS"EQ.&,,3. \FT9;:.IP.
MN.E34 <CJ'@J>ZUW6+^WUJ6VM]8M4MKNW$"N?E5E4HY^[PQR,'.3R.T-CX&N
MK.;PM(=:$W_"/PO#&'M /-5HQ&<X;C"@8Z\YR3TKM*ABO+6>XGMX;B&2>W($
MT:."T9(R-P'(R.>: .6CAL_ DNMZ_K6L1+::E=)+(?LS*(G("* 06)& .U/\
M#Z)::>FJZK:1211ZK>/<1)(""D63MP#]T,Q>0#MYE=60&&" 1Z&EH X?XDZE
M97/A;6/#D5S&VLW5EF"SS^\EW-M&T=^?2M'5O"MU?:CHNJ6.J"PO]-B>'<UN
M)DDC<*&4C(P<J"#G\#6^UU9K?1VKSP"[9"R1%QYA4=2!UQ5B@#@I_AO+-X=U
M_1_[>D,>LWQO)9)+92R$E2<8(R?D7GIUP!6YXD\.7/B/3;"U?4(X)+:ZBNVD
M6V+!WC;< !OX&1SR:Z&B@#E];\*7>N6VJV%UJ<+Z;J04/!):;VAPBJ3&V_"G
MY=PR#@\_6)O!<]EXFDUK0M7.GM<P1P7L$MOYZ3B,;48?,"K@<9Y'M76U!:WE
MK>QM):7,-PBL49HG# ,.HR.X]* .*3X<S1^#(/#BZXS1Q7HO!,]J"<B7S0H
M8<;CSR?PJ[J?@R^D\3-X@T77WTF]N(4@O@+59H[@+]T[6/RL.@.3Q^.>OHH
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M:[.B@#GT\-20>-+GQ!;ZB\:7<$4-S:^4IWF/=M(8\@?,<C'/K70444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5P_P 7XHY/A;K1=%8HD;*2,[3YB\BNXKF/
MB%HU]XA\$:CI&FQH]U=!%7S'VJN'#$D_04 +JNKPVWCKP_IDVD0S2W<=RT%\
MS#?!L0%PHQD;@5'45D2^/M6.F>(;ZV\.1NNA7,L5RLE\%WI&BNS)A#EL$\'
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M?V4<P#(5;<CHS !L [2#M]1Z5I^%M!ETA]6OKK8+S5;UKN5$;<L8P%5,\9(
MY/J30!G/K&LR?%230S!:-IJ:4+C:9F!(>7:6(V$%AL("],$_-S@<GX>\27?A
M+PGK-_%HZ3Z5::[=BYD^T"-D0S[?W:;3NQD9!*^V>W976CZM#\2H]?M(+>:R
METM;&;?-L>,K*TF0,?-D-@<CGK7-W'@_7Y_AMXCT#[)"M[J5_-<0DSC8$DE$
MGS'KD 8Z>GX '4ZQXN2RU*ZTVS^PO=VL*RR+>7GD*2V=J*=K$DA23P ,CKGC
M2\-:['XE\.V>KQ6\UNMRA)AF&'1@2"#^(//>N9OM-\4Z3XON/$&@V-K>V^J0
M11WMA<W/DM%)&"%=7 (Q@X(QV_+L=/2\2QC%_)&]V<M)Y0^0$G.U<\D#. 3R
M<9H Y33_ !KJFHZA?Q1^'U2TTW4&M+VX>]4".-4#&0#;\W7E?IUR<1I\18WN
M-&D6TMY;#59DA0V]UYD\&\91I(PORJ>_S?+GO4_ASP_?0MXKM]3MQ%;:Q>RW
M$;)*&(C>-4P?1OESW'-5_"EGXVTJUL_#]_!IQL;';&FJQSDO+"GW5\K;PQ4
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M"O\ RQ@<^8RCTR[$?1%KGI_"&OS_  Y\2:#]DA6]U._GN(29QL"22[_F/4$
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ML)&CN QD@N T3'*,5'S*1@C'''/-6_'&@:EK-EIUWHLL*:KI5XEY;K.2(Y<
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M_I46OZ<NBZ=<B"]MXK()?7[2D2&90 "%QR#SR?\ ]8!OT444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9EKX?T
MVRUBZU:WAD6^NPHGE,\C>8%X4%2V.,G''&:TZ* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K&UK6C8WNG:7:A'U'47985?
ME41!N>1O4*,<=R0.,Y&S7!7@D7X[:8\N?(?09E@ST\P3 MCWVXH [*ZU"RTN
MW1]0OX(%^[YMQ(L88@>^!GZ5G:_K3:-IBZXC)/ID(#72IR1$3S*A'7:#DCN
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M?VB!)=F<[=R@XSWZU:H I7FE6&K0PC5-.L[HQ_,JSQ+*$;OMW#]<"JVMZ/\
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MH 9'#'"&$4:(&8NVU0,L>23[FJR:1IL>I-J*:=:+?,,-<B%1*1Z%L9_6KE%
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MX') S@$^@R?S-/HH A-G:FT^R&VA-MMV>24&S;Z;>F*A&E:<M@]@-/M19O\
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M>@"M>:?9:@L:WMG;W*QL'031!PK>HR.#[U%+HNE3+(LNF6<@ED\V0/ IWO\
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M*[[';9L#.00V0"#G(]>:Z*\\&:1?:%=Z1<).UM>R^==L)2))WR#EF'/\*],
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M.XENQ+ME9XQA#E<  #L!CKD<G*3^$=-N[#4K6Y-Q-_:8"WLS28DF4#:%) &
M!Q@ =_4T <QK[W&AV/A;Q2EW>#3[,0Q:E;)<.(C"ZA1(4!P2C$'IR,YZ5T_A
MTM?7&I:QY\SV]U.4M4:9F011_)N52<#<P9LCJ"M9VNBX6Q7P?9:-?7<%Y9&
M7TFUH(%.4/F,3DE5Y P2>!ZD=19VD%A8V]G;((X+>-8HT'1548 _(4 3T444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<=:NMN*-L(#8X)&0#]*\DUSQ!KFJ_"/5[Z:^C@NH=3:SD:WBVAXQ<K%MP22
M0>>2>V: /7**X?Q%XHF\.ZO8V&JZF;"SGMV*:JUJ#$]QNP(WZA %P>V?48KK
MM,>>32K.2ZDBDN&@0RO"<HS%1DK[9Z4 6JS-5UVRT@[)_.EF,33""WB,DAC7
M&YMH[#(_/%<</%'B?5M(@UW0+&2Z1[D[;$QQB.6W$A4GS"P(? W9Z9XP>I>8
M+]OC>X74 JC0ED \D'"?:#\G7VZT ;<WC_P]#IRZB+N6:RV1R23PP.ZPK)]P
MO@?+GT/([XKINHR*\MT2^N= U#X@ZO>7?VF&PN/,EB$(4S%;9" #GY>PK=M]
M5\51ZMI<SVKW.F7",;\M%'&+7Y<J\9#DLN>"#D]Z .UI,C.,\^E<7I6J^)-?
MT72?$.F26OD7EPKR6,JX5;4L1D/U\P#!].HQ47A!M2F\<^,!=:DT\5O=Q1K&
MT0'RF$, /0#<?KU/)H [JBBN!N/$.MVNI>+-+GO8$NK*U2]TMS;\2Q,",,,Y
M8AQL.,=1CK0!WU4M/U6VU)[Q;<3 VEPUO+YD3)\X )VY'S#D<CBN9\.^([WQ
M%I?AJ:WN56>YB>?4 T(^4)\KH!_"?,(4>P;O7/ZOX@UV_P#AYX\DDOHH+G2[
MRXM8I;:'9F)40X )."=QYR3SQVH ] O/$&G6&L:=I5Q)(+O42PME$3%7VJ6/
MS8VC@=,YK3KS37(K]-:^'B)<Q271GGV2R185<VS=5!YP.V1GU'6I&\<ZEH.E
M^+5U5H+^[T6YAAMY4C\H3><J&,, 3C!?DCL* /1Z*XW4]9U?PWK^A6]]=I>V
M.KS&S=Q"$>WG*DH5QU0X(P<D<')K)F\7ZW'X \5ZL)X/MNC:A<V\+>3\KI$P
M W#/4YZC% 'H^1D#/)I:X">;5+CXM:3$NI&.W;19)Q#Y0*@^9$&_$^O;MWKO
MZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG_%?AV?Q#;:?]DU
M 65U87L=["[Q>:C,F1M9,C(^8]QVKH*CGN(;6!Y[B:.&%!EI)&"JH]R: .)F
M^'1U"3Q*NJ:NUS;Z]'#YJ1VXC,<D:@*ZG)X!4$#';DGOIZ)H/B&RC7^UO$BZ
ME)!&4MC]C$:@XQOD ;+MCCJ!R>IY'1/<P1SQ0/-&LTN3'&S ,^.N!WQ4M 'G
MNF?#6ZT:TT V&MQ0ZCI&^+[6+,_Z3;LQ8Q2+YG(R<YSQVQ6W:>&+^T\1:]K
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MGV7S(;B+.[:T9;C!)(.>]&J>";N]&DW\&MNFOZ9,\R7TL 9)=X =&C!&$(
M .0!U)R:[&B@#S_4=*O_  O#XJ\4WFL&66^LHT=;.SVF%T4HKKEF. 7R<YP!
MFL?PZUQI<]B-%\3^%M8+&.)K:SL%2>2,L-QW1R$C RQ)&,CFO6*BAM;>W+&&
M"*(L<L40+GZXH XZ/P3JVG:Y?SZ)XE>QTO49VN;FS-JLC)(WWVB<GY=WN#@U
M9USPA<ZW8ZGI4]];/I5ZJ*D4UL9)+7"*A*,7QGY=P)'!.>:ZA;F!YY(%FC::
M(!I(PP+(#G!([9P?RI8+B&ZA$UO-'+$20'C8,#@X/(]P10!6N]-CNM$GTOS9
M8XY;9K?S%;YU!7;D'UKD++P%JMO)X9DF\11.^@!XH1'8! \31^7@C>?GQWZ?
M[/KWE1O<01310R31I+*2(T9@&<@9.!WX&: .+/@*\;PSXDT9M8@QKEW-<O*+
M,_NO-QN4#S.>@P?YU-+X-U&#7K+7=*U>"VU%+-;*\$MH9(;F-3E3L#@JP]=W
MM795%]H@^T_9O.C^T;/,\K<-VW.-V.N,\9H PO"7ANX\-0ZE'/J(O/MM_->Y
M$/E[#(<D=3G]*H:CX*O;O6]=O+;6_L]KK=HEO<PM:B1TVH4!C<M@##'((/?&
M"<CL:* /)]=M?[+/ACPQ>>)[&SDL+,R+<:E8H;6X*A8T4*S ;U 8_>R,Y[C&
MG9:;J?B7POK'AS^V-'GT^: 11:AIUD5C7<6WH%#[21@'(/&>17H,T$-Q'Y<\
M4<J==KJ&'ZT]55%"HH50,  8 H Y;7?!\NN>'M.LSJC6NJ:;(DUKJ%O%C9*H
MQG82<@@D%<U%<^#+O6_#E[IWB36GO;FY50D]O"(%MRC;E9%!/S;@"23S@#@5
MU]1RW$$#QI+-'&TK;8P[ %SZ#U- '+V'ASQ&-.N8=6\5&\N3;/!:S16@A$3,
MN/-8!CO<?4#KZYJQ9>&)%\4Q>(K^:U>_CLVM-UK;F+S0S*2SY9B<;1@=LGKQ
MCHV944LS!5 R23@ 4V&:*Y@2:"5)8I%#(Z,&5@>A!'44 8GBOP[+XBL[!;>]
M%G<V-]%?02M%YJ[TSPRY&003W%5X/#5]#XQE\0MJD,COIRV/E-:D?=8N')#]
M=S'C X_.NBGN(+6/S+B:.),@;I&"C)X R:DH \_M?AUJ%AI>BP6NO1"ZTF^F
MNX97LB8W\TON5D\SG&\X((Q^M2R?#J:XTGQ3IUSKCR1:[(9MWV95,4A502<'
MYAE!@<<9Z]:[NH_M$'VG[-YT?G[=_E;ANVYQG'7&>] $.G0W=O8Q1WUTMU<@
M?/*D7EJ3[+DX'XFN7_X0F\CA\46MOK*)9ZZ\LOEO:;FA>5 CG=O&X8&0.,'K
MFNRHH X]O!EZT7A5/[5@']@%2#]D/[_$?E\_O/E^4^_/Y5)#X3U&WU+Q)?0Z
MU'%-K+1.C):D&W:-0JG[_P PP.1QFNJ:2-3AG4'T)H61'.%=2?8T <_IOADV
MWBF?Q%=26QOIK06C"U@,2N VXLV6)+< #T QS5IM)O)/%4>K27L+6L5NT$5K
M]G.Y"Q!9M^_J=JC[O0>YK8HH Y;Q!X4N]6\4Z+KUCJ<5C/IGF+AK4R><K@!D
M8[U^7 XXX)S7&:I<P:EXQUJ<^*M#TZ6WE2V%IK5C&[JJ*,M&7=2$9B2,9SUS
MTQZY44EK;RRI+)!$\B?==D!*_0T <;#H^L^)#X>UB\U"SAGTNXED'EV;[+H$
M,@< N"@*'('/KTJSKGA#4;CQ,GB'P_KG]E7[P"WNEDMQ/%<1@DKE<C##)YS[
M5UU13W$%LJM/-'$K.$4R,%!8G  SW)[4 <EK'@B\O/[*O]/UZ:TUW3C)B^DA
M$BSB0Y=7CX&TGH!]WM3M4\':EJ^B6]I=:ZLEXM[%>37+VF58QL"J(@<;%X]2
M>2>IKL** .<_X1R\_P"$X'B3^T(.-/\ L'V?[,>F_?NW;^N>V.GYUB'X;2R>
M')M.?6BEXNIOJMG>V]OL:WF9BWW2QW#YB,9'!KOJ* ./N?"6M:KX9U+3=7\0
MI<WE];FV\];,)'%&>NV,-RQ[DGL.!WFF\)WLVJ^&;YM3@!T-)%V"T/[_ 'Q^
M63_K/EX^O-=-#<07 8P31RA&*,48-AAU!QW]JDH YWP[X;N- U'5Y5U$365_
M>27JV_D!6CDDP6R^3N''' ZG.:=KWAVXUC6]#U&*^BMUTJ=IQ&UN7\TLI0C.
MX8&">QYKH** .1U3P?=:V@M=3O[>>TCU 7L#_9B)X0)-XC5]Q _N[L?=XQW'
M2ZC;27FFW-K#*L4DT31B1DWA<C&<9&?SJS10!Q"> [R/1?"^FKK$&- N(YD<
MV9_?;%*@$>9QPQ]:T(O"<P\0^(-2GU"-X=9MH[=X$MRK1JBLH(;<<G#G/'I7
M3T4 <$_P\O'\*Z1IO_"0-'J>BLC:=?PVH7R@J[0&0L=P*\-SSQQUS9U3P;JV
MN>$M0TG5/$"37E^J1R7*V>V.-%.0$C##G.<DDY_  =A//#;0O-/*D42#+/(P
M55'J2>E/!# $$$'D$4 <W=^&;N]\4Z1K4VH6^+"WE@: 6IQ*) H8YW\?=&.#
M^-<[)\--27PE>^$K;Q%&FARONMEDL]\T"^8'V;]X#*"#CY<\]:]'HH XS4?!
MNK_\)%_;VA^(1IU[<0)#?K):"6*XV?=?;N&U@#CKT_'+]0\%7;:GI6LZ7K!@
MUBQB>"6>YA\U+J-VW,KJ"N/F)8;2,=/3'844 <WX9\-7>A:EK-[<ZFEV=3N!
M<,BV_EA&"A>/F/'R]/U/6G:MX;N+[Q3I>NV>HBTELX9;>1&@$GF1N5)P<C:P
M*\'!'M7144 <=!X+N].CUFQTO58X-*U6629X7MR\ENT@Q)Y;;@,'J 0<'UZ5
MU&G6%MI6FVNGV<?EVUM$L,2^BJ,#^56:* .(?P'>2:+XITYM8@QK\\DSN+,_
MN=ZA2 /,YX4>G-79O"E[-JWAF_;4X =$21=@M#^_WQ^63GS/EX^O-=510!P^
ME>!=2T6XN+*P\1/'X<FG:;[!]F!DCW'+1I+GA"2>V1DX(/-:]MX;N(/&NH:^
M]]$\5Y:QVQMA;D%50L0=^[D_,<\5T-% 'G4/PWU.+0--T3_A(H_L6EWT=U9X
MLOGVHY<+(=_S'G&1M]P>VJO@[4=/\0ZGJ.CZS%;6VK8:]MI[7S?WH7:9(R&&
MTD=001GL>E=A10!Y['\-;NU\.Z!;67B!K?6-#WK:WZVPVLC_ 'D>,M\RG []
MJZ_1=/O;&V9M3U$W]]*09)A$(D '140$X Y[DDD\^FG10!ST_ARZE\<P>(TO
MXE6*Q>R%LUN3D,P8MNWCG*CMTK#D^'EY+X'U3PTVM0[;^[>Y:X%D<IND\P@+
MYG/(ZYZ5WM% $:"40 .Z&;;RP0A<^N,]/;-<3_PKV9_!&J^')M71C?7;7:7*
M6NWRG,HEP5+G<-P]1Q7=44 <Y=:'K%V'2XU.RNX)[007-O<V):)GW,=Z@/P,
M-C:<Y"CG/-:6@:/%X?\ #]AI$$CRQ6<*PJ\GWFP.IK1J+[1!]I^S>=']HV>9
MY6X;MN<;L=<9XS0!Q>F^!=4T:ZN+/3_$LD/AR>9ICIYM@9(@QRR)+G*J23VR
M,\<\UK?\(Y>#QXWB4:C#L-B+'[+]F.=@DWYW[^N21TQ71T4 <E9>"W27Q*NH
MWT-W::\Q:>%+<QE 8_+P&WGL!VZTWPYX4US2!!::EXG?4M+M!BW@-JL;L ,*
M)'R=P4>PR0"?2NOHH XC0? VI: ?[-MO$;GPXDIDBL3;#S44MN\KS<_<S[9P
M<9%74\,WNFZWXAU6SUE8(M402^6UJ',,RQ; ^[/S*,!MN.2.N.#U51S7$%N$
M,\T<0=PBEV"[F)P ,]R>U &9X8&JKX>M5UJ?[1?C>'F\D1&1=YV,4'W25VDC
ML35?5O"MKJWB72=:DE9)+ .K1KTG4E656]E=58>XK?HH P/#WA6U\/:AK-W;
MR,W]I71N AZ1 C)4>V\NW_ O:LJ/P)*VA^*=+NM422/7IYK@O';%# TBA>[G
M<!M'IWKM*B>X@BFBADFC26;/EHS ,^!DX'? H Y63PCJEQ>>&[NXUJ"2;1F=
MSBR($I:/R\ >9\HVGWY]N*AN?A\FI-XICU.^6:VU\Q,R10&-H&C4*C*Q8YQM
M!Z=1Z<5VM% ',P^&KZ[NM)GUW48;TZ4QD@\JW,7F2[2@D?+-R 3P,#)SZ 8U
M]\/+^YT_Q'I,&NQPZ7K,\EUY?V3=+'))@L-^[!3(SC /OZ]_10!RTOA2\;Q#
MI.LPZNL=Q9V;65QFV#":-F5LK\WR-E>OS?2NIHJ"[O;2P@\^\NH;:+./,FD"
M+GZF@">BFHZR(KHP9&&593D$>HIKW$$<T<+S1K++GRT9@&? R<#OQ0!)1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7#?&"&*;X7:R9(T<QI&R%E!VGS%Y
M'H:[FN6^(FD7^O>!=2TG3(!-=W01$!=448=6)))]!0 _5=4M(/'7A_3I]'6:
MYN8[EK:_8KF#:@+A>_(V@]/QK*E^(-]_9NOWMMX:ED30[F2*Z#W:(2D:*[,N
M <G!)V^@Z\XJYJVG:G?>.?"VK1:>XM;".Y%R6ECW*9451@;N<$<_IFLJ'0-;
M7P_X[LVTUA-K<]S)9CSH\8DA$8W?-Q@C)]O6@#6B\:RMK&BP3:/)#IVM BSN
MVG4L6V;P'C ^4$ X.2?4"JO_  D0AG\;2Z;H5O;ZGI:QO-)-(%^U'RBRLQ4$
M\+T&3Z<5!<:)K,D?@4+IKYT=U:\'G1\8A,9V_-SR<_3WXJ:V\/ZK+K'CEY;7
MR(-:B1+21I%(RL'E'< 21SS]/2@"?0_$FKMX3\,RW&F_:K_5(80LB2L8\&$.
M9)6V?)G!X /) S65K_CZ_?X>Z]JFEVD,-]IMVVGS[I]RHP95WQL%^?[ZD9"^
M_3!;'H_BQ/#GA*SDTJ&2VTU5M]0TX7BC[2JQ!$<MC!4,-VSG/&?:I-X+\0W'
M@_QGH_V&SADU*_-Y9B.XRK#,9V?=& /+(R<=>@% '4:IJR6_B3PQ9ZIH4$EY
M>33""Y642+:LL;$[25#$E1Z#KU.*DN/%D[Q:M<Z3I8O[;296AN&^T>6[N@!=
M8UVD,5SCDKD@CWJGK%AK>J:_X2U(Z6$%A<2S72+<(WEAXV0 $D;B,Y../0FH
M=)T?6_#$_B&QM; 7]GJ5W+>V<PF11$\H^9)0Q!VAN05#'!Z9H LR^/HI;SP]
M%I>F37T6N02S6TRRJ@&Q-Q!!Z=0#G&.>I&*T_"_B-_$$>HQW-B;&]TZ[:UN(
M/-$BA@ P96 &00P["N9L?!M_H6I>!H+2!KFST."XCNIPZKN:5 ,JI.<;LD^@
M(ZU-96_B'P__ ,)AJ<&CQRS7EZMW:1SW21JR;41MS G:0%+?UH [ZN.'CF1)
MM(>ZTA[:TU6^:R@,LI6=6!8*SQ%1A3L/1C@$>M=-IUV^H:3:7C0M;R7$"2F)
M^3&64':?<9Q7F*>&/%TUAH;7FDVDVJV&L)=W=Z]Z"UVH+_,#M)50&'RGIC 6
M@#>T"TMO^%I>-XOL\7E2VU@9$V#:Y*RYR.^:E^$2A?A?HZJ, >> !_UWDJ?2
MM.U2R\>^)-7FT]S:7T%LD#)*A+-$K@\;N,EN,_CBIOAUI.H:#X)L=*U.W\BZ
MMVEW .KJ=TC.""#Z,.N* )[_ ,2W"W.J6^D:;_:$NEQA[E3,8R6*[Q&F%;<^
MW!QP/F7GDXY_5IHM0^('P[U06<EM+<I>,4GCV2H#;9V..H(ST]<U,VG>*/#G
MC35[_1],M]5TS63'*Z/=B!K695"$DD'<I !X!/MZVM5TG6;CQ;X1U VXN4TW
M[0U[*C*@W2Q;!L4G) /Z8ZF@!=1\<R::KW4^D/'IR:FNG&264I*Q+!/,2,KA
MDW'KNR0"<59_M:U_X6--IO\ 8H_M"/2?M"WV4WR1>;@1CN!NR>2.>U<AJWA?
MQ9J.F:K!/I=K=WYU1+F"^>[4&6W6976- 1\@"C!!P.,\DUTZ:=JP^)8UV33S
M]C_L86;&.9#^]\SS#@$@E>V3CGL!S0!G?\+,N!X83Q&WAV9=,2Z:WNF-TN^(
M";RMRJ!\_.,C(Z\9K;M/%5RWBQ-"U'2'LC<6SW-I+YZR>8J$!E90/E8;@< L
M/>N2?PIX@?X27OAS^S<:C->-*@\^/9M:Y\[);/IQ]?;FNDOM.U.Z^(>BZS'I
M[K9VUE/!*S21[E:0J1P&Y V\_IF@"UH/BJ7Q!#I][:6,3Z;>[ML\=SO>' )
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M5N+V&":93'<12L^Y-RD[3M?&3W'XUWNA7.N7J27.LZ?%IF0%CLTN!.PZY9G
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MIGV)-"R;&0-V. ,$^E %_P +^+8O$=QJ=F8$AN]-E6.7R9A-$X895TD &X$
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M 750,GJ23TXK(\.Z/K/A;7)(;'3W?P]>QB=[<S1AK*Y/WP@W8*-U(SP3QW%
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MU0[A"TG"@'N5 4Y]0:QY/ NMW>G^'[ZXND&O*YBU693]^WDC$<B ^H54Q_M
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MW/"9!F/S4V@*#P,AFP3S6?+X3U*[UKQI9SPQKI?B")-EVLHW1D0>61LQDG<
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M;/!IVIZ(--6?>A*/ESN*ALX^<?E5WPO-XU\NUTW6]+L[9+0!)=1BNA)]J"C
MV1XRI;C)8^N!R, $WQ%UO4M \(3WVEI$9?-BB9Y'*F,22*F5 !R?F]L=><8)
MJ&K1P^+_  S8ZCH<+7UW]I,%V)%<6Q6,E@I*AOF7 / Z]\5+X_T6]U_P9>Z?
MIR(]VSPRQH[[0YCE1R,]LA2*IZII^LZAXN\):J=,"1:>;EKL+.AV>;'L4#)&
MXCJ>WIF@"";Q]?FU\036OAN27^PYF2X62[1-R*@<D8!RV#POMU'2K,7CB1]0
MT+S-'EBTO6\+:7;3KOWF,NH:,#@$ X.<^H%9\&A:RECXZB;36#ZS)*]F/.CY
M#0B,;OFXY&?I[\4V;0=:;2O ENNFL9-%EA>\'G1\!(3&=OS<\G(]J +>L_$>
MTTR&^NX(;:ZM;"X,$Z"\5;ABK;7,<6#N"G(Y*YVG'8GKVOK9-..H/*%M1#YY
MD;@!,;LG\.:X?3+'QCX8U34M-T_3+/4-)O+R6[M;R6Z\LVOFL6973!+@,21M
MZ^HSQV.IZ8NK:!>:5<3,5N[5[:24  _,I4MCIGG- '/3>.6M-,TW6[S2S#H>
MH/&J7/GYDA63_5O)'MPJG(Z,2,CBL^]GU&[^,$>GRV5K/9KHDA$4MP=I1YU5
MGQL(W$*!M].]0_\ "-:YJW@.R\&:K9+$L#00SWZ3(T4D$+J04&=^]@@&"H R
M3GCG8;3=3'Q376A8,=.&E?8?-$J9WF8/NVYSMQ^/M0!%XUN9O!/PTO'\.VT,
M*V<(CB5G($*DA=R\')&> <?T.7XD:YA^(O@F\;3(FU%XK]3%!*#NQ&NT&1E7
M@9SR.,G&>_2>/=%N_$7@?5=*L-ANKB("(.V 2&#8SVSC%9M[8:YJ/C#PIJ\N
ME>5%8)=?:E6X1BGFHJJ!R-V-N3CUXS0!-9^/(&T74[S4[(V-UIU]]@FMO.5P
MTI*A-KG PV]>3C'.>E2Z/XTBU'Q1+H$T-L+@6WVJ*:SNA<0R)NVE2VU=K@]L
M=.<US=QX.UV_M/% BB6RO+G5HM5TV66167?&$VAPI)&2A_.NM\/WOB?4'$FN
M:1;Z2D:;3%'="=IGX^8$#"J.>,DG/;'(!T-%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4457O;ZWTZV-Q=2;(]P484L68G 4 <DDG  YH L45@)XRT9HM19I+B.
M330&NX'M9/-B4C(;8%R5(YR 14]AXHTG5&L%LIY9OM\!N;<K!)@Q@XW$XPO)
M'WL4 ;%%85]XOT;3I,74\B0"<6S77DN8$E)QM:0#:.>,YP#P2#4FJ>*=*T<W
M/VJ64BT02730P/(+=#R"Y4'''..N.<8H V:*R8/$FE7.JIID%RTET]I]MC58
MF*R0Y WJV-K#+#H<\UBZU\0=.L?#3ZO8)/=@7@L<"WD'ER[PC;P0",$_B>!0
M!V%%<W<ZGI4_BK0XGO\ 4;>^DCG:WL]DD4<Z[?F,BE<$J!D X(S[U8OO%VCZ
M=]I:XGE\BUD$5S<) [Q0-QP[@8&,C/IGG% &Y3)88IX_+FC21,@[74$9!R.*
MQK_Q?HNFZE%IUQ<R&[FA,\4<4#R&1!C[FT'<>1P,FK6B:[I_B'3_ +;ITK/$
M)&B</&T;QNIPRLK %2#V- &E16=?ZW9Z?=+:OYTUTT9E$%O$TK[ <;B%!P,\
M<]3P,US_ (I\:V]K\.;_ ,0Z).;@^0_V>5(68))T^<8^7!ZAL<C!H [&BN=\
M.Z:B7)U6#4-7:*>!8WM+UI"GF#GS L@W*3TXPI]*QY/%PU[3O%MI;1W]D^FK
M+%%,(7C;<L0;=NQA3D\ X..<<T =U17#^#/&6G3:%X8TV[N[A]1O-/AVS2Q2
M%)I1$&=?-(VL_4D9SG/>M.QU;1DUSQ)<+JMVSV:1-?Q7)<0V@",04#   J"Q
M(SG@T =+16;9:W:7UZ;.-+F.<1";9/;O'E"< @L,'GMU'<"IM6U&/2=*N;^5
M2ZP1E@B]7;LH]R< >YH N45Q?P\US4[^WU71_$#J=;TJ\:.XV]'C?YXV'^S@
MD#V45NZAXETS39[F&:25Y+2$3W(AB:3R(SG#-M!QT)QUP"<8H UZ*YR7QUX=
MAM+&[>^<6]_((K:3[/)B1B,C!V]QR/7MFI;?Q?I5Y80W5M]KF\X2%($M)/.(
M1MK$IC< #QD@<X'>@#>HK'M_%.CWFDVNI6ET;BWNF*0"*-F>1QG*A,;LC!R"
M.,'.*IR>//#L.DW&I37DD<%M/]FN%>WD#PRY VNN,KR1R>.>M '245SG_"<Z
M"-0FL#/<K=1Q^:D1LY0TZ9QF(;<R#/\ =SZ].:MV'BG2-2T635H+HBTBD:*7
MS(V1XY =I1D(W!LD#;C))&.M &Q16"OC'1A)?1333V\]C"+B>&:VD601'_EH
M%QEE]QG'?%0V7COP_J%WIUO;W4Q.I)OM)6MI%BE.W=M#E=N['5<Y'3KQ0!TE
M%<UH7BZ+7/$.L:8EI<Q#3YEA#26[KN.W<23C"]1@'!/7O72T %%8-WXRT2RE
MG6:YD\JVN%M;B=87:*&5L81G P#\RY[#(SBDOO&6BV&JSZ7+-</?PPB=K>&U
MED=E)P"H53N[],XP<XQ0!OT5CP>*=&N?#]OKD-X'L+@A875&+.Y;:$"8W%MV
M1MQG(KF]#U:6]^+.L6JW-]]FCTR%S:W(95BD,C9VJ>.5V\C\Z .\HKG/%'BN
M/PY=:1;&UN)GU&[6 -'"SJ@P2?NCEL X Y[]!7/IXB72?B1KPO+O49K/^SK:
M>&T6.29D+%]Q6)02. ,\<=Z /0Z*Q1XKT9].TV^ANC/%J9Q9+$C,\QP6("XS
MP 2<XQCG%96N>/\ 3]/\'WFNV*377D3&U,?DN#%/N";9 0"N&(SGKVZB@#KZ
M*AM[E+FV6X1951@3B2)D;C_98 _I7GVJ>,7\0>!?&$]D-0T^;31<I#(L;Q,#
M$@Y+XP&W9^7.<8XZT >CT5RWA[Q=I=V-*TEKF<W\]FLD;2PR!)RJ OLD(VN1
MGG!-.TK6=$BD\0WL6JWDT=O<C[6MSOVV[A%^2-2 0.AP,Y)XH Z>BL^PUBVU
M"[N+6-+B.XMT1Y(YX&C(5]VTC(P<[&Z9Z4FNZBVE:/<742"2XP([>,_\M)6(
M5%_%B!0!HT5Q_P .=<O=5\/S66KR;]9TFY>QO2?XV4_*_P!&4@Y[\UK:AXKT
MC3'O1<3R%;!5:\>*%G6W##(WE0<<<^PY.!S0!M45SEQX[\/6IL1)=S9OD=[8
M"UES*$!)P-O)XX'4Y& <BI/^$QT@Z='>Q-=31O;BZ*Q6LCND1S\S*!E>AZ\G
M!QG!H WZ*RAXCTN2PL[RWN#=17J;[86R&1I5QDD*!G [D],@&J#>//#B:9!J
M#WY6WFNOL0+0N"D^=I1QCY"">=V* .DHKFE\=Z$]U=6@DO/M=NJN;4V,PFD4
MYPT:;=SC@\@$<>E7K/Q/I%_H,6M6]UOLI6V(WEMN+[MNS9C=NW<;<9S0!KT5
MSS>-M"BM]2EN+B: Z8 UY%+;R"2)2,ABN,E2.XR*6R\::'J&J6VG07$WGW<1
MFMB]O(J3@ %@CD;6(!Y )Q0!T%%<UX7\6Q>);K5XDM;F 65Z]LGFP.N0BIDL
M2,!MS-\N<XQQ6Q?ZM::<\,4S.T\Y(AAB0O))@9)"CG XR>@R/44 7:*Q;?Q;
MHMUI"ZG#>;K=I_LP'EMYGG9QY>S&[?GMC/?I2P^*M)F%^#-+%+IZA[J"6!UE
MC4C(;9C)!'<9% &S17,V?C[P[?SZ;';W<Q74L"UF-M(L4C$9";RNT/@'Y<YH
MTGQA#JGBC6=(^S7,*Z:8T,DD#J"Q4NQ+8PJXVXSC/)[B@#IJ*PHO%^CRZA:V
M?G31R7B,]H\L#HEP%&3L8C#<<^XY&15&3XC^&8[.2\-W<&VBN#;S3"SE*P."
M%/F';\@R<9;% '5T5AVWB[1KK6AI4<\HN6C:6(O;R*DZK]XQN1M?&1]TFLR;
MXG>$X(C,^H2^2LY@DE%K+LA8';\YV_(,\<XS@^E '7UEV?A[3;#6;W5K>.9;
MV]"BXD:XD82;1A?E+$# )Q@5S^IW5PGQ3\-Q0WTYL[JRNW>!93Y3%0FUMHX)
M^8\UJCQEHAN881<R;)KLV,=QY+^4TX)'EA\8SD$>F1C.: -^BN:TWQ?%J/C'
M5]"%K<QC3UA'FO;N S.'9B3C"KA5P3C)SC/%68_%VCR7]G:>?*AOB1:2R0.L
M5P0,X1R-IXY'/(Z9H W**R(O$NFSW<%O&T["XF>"&80/Y3R(&+ /C'&QN>AQ
MQFH/&7B1?"?A2^UDV\EPT$9V1HA8%CP-Q'1<]3_7% &]17G_ (@UPVWCCP==
M"\OH+&Y%X)[9DD02%8OE_=8W,<G@8))(QVKIM.\5Z/J>E76HPW+)!:2-#<">
M)HGB<8RK(P# \CC'.10!M45DV'B33M0U6;2XWFBOXHA,;>XA>)VC)P'4,!E<
M\<=#P<5;O]2MM.6,SLY>5MD4<:%WD;!.%4<G@$^P&30!;HKFY/'?A^'1KK5I
M;J9+6TF,%UFUE+V[C@B1 NY>HY(QS6A'X@L)KF:WA-Q++#;K<.([>1AL897!
M P6.#\O7VH U**X)/&NE^(/AS>:OJ4VI:39OYBO/;Q2I)$@E95*N%/S849QD
M G%=!>^*]&T>\LM.N[J47-S$7@3R9':4*,G! .YNG Y)(XYH W:*Q++Q=HM]
MHEWJZ79BL[-WCNC<1M$T#K]Y75@"#R.,=Q35\7:3_:B:9(UU%?R1B9+=[20,
MT9XW#Y>F>/8\'% &[17/MXUT%/#[:ZUW(--28PO-]FD^1P^PAEVY'S<<BEEO
M--;QU;6AU&]74ELI&6R!<0/'N7+D8VE@< '.>30!OT5CP>)-.O+BWMX7N"+M
MGCMYA XCD*ABVU\8Z*V/7'&:XSPIXSLM&T[5EUS4;V81:Y=6XGD2280H)-B>
M8X!"#H!DB@#TNBL.]\7:/I^L/I,TTYU!;<W/V>*VD=G3('RA5.XY/09Z'T-4
M#\1_#']FQ:@+R<VC/LDE%I*1;G=MQ-\O[OYN/FQ^5 '5T5G:CK=GIK^7()YI
MO+,OE6T+2N$'\1"@X'IZX.,UFMX[\-K%I<HU$/'J@8VCI$["3:"2,@<'@C:>
M<\8S0!T=%<K<^/M)3PSJ^LVR7<_]E[EN+8VSQRHX7< RL 5&,')XQ6UHFI?V
MMHUK>^7(C2Q*S*\31_,5!. PSCG@T :%%8NH>*M*TUKKSY9F2SQ]KDA@>1+?
M(S\Y4''!!/H""<"L7QMXH%A:Z%'923M%JFH6\3SVL3ON@;+'8Z _,P7 P=V#
MD>M ':45B:/8KHMC=W"WFIW=M,YN(H;K?+)"I4?(H8;^O\)R1G%<-X@\8RZ_
M\)Y/$%C+?:;*MW%@J'B_=FZ$8!;HWR=<$@$T >J45C:;XITG5=7GTNVEF%Y#
M$)MDUN\6^,G&]"P =<\9&141\8Z*KP;KEU@N)OL\-T87$#R9(VB3&WD@@'."
M> : -ZBLB^\2Z;I\MRDS3L+7:+AXH'D6(L 0&*@X."#[ @G -&J^)-.T?S_M
M+3O]GC$L_D0/+Y*<_,^T' X)]< GM0!KT5#:7=O?V<-W:3)-;SH)(Y$.0RD9
M!%34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %<7\28+TZ3I>H6=G<7J:;J,=U<VUL2)9(0K
MJVS!!)&_./:NTHH X72=6T )?>(].T74=JVXCDN9K>7SISGB)%?YFQW/09'/
M7&=X3MI_!'BJ32)[7?I^L)]JMYK:%V2RDR2;<MCB/+$J3@9+<#->ET4 >/Z,
M+*WLKOPCXC\/:G>ZDMU+Y2%)GMKU6D+I)N!V*.1DG&,9Z\5JV.J?\(KXH\2Z
M5KFEWUQ;ZK=_:[*6"T>X2X5HU0Q' ."-N,-@8]!7I=% 'GM[.=%^)&BZI>V$
M\%I-HCV2K;6[S+%-YB.(_P!V#C@$#C!Q7,O!>R_#77E_LV_66+Q*UVT1MGW&
M+[6K%EP/GP <[<]*]HHH X/6;D7OQ&\$WD-O=>0D=[O=K=U$>]%";\CY=V#@
M'!K)T=I=)\(>)_#&K6MQ)J337GD((6;[<LVXHR$#!R6P?[N.<5ZE10!YAI6F
MW.B^+O!-E=K+(]AH<MM<3K&S1I(1'A2^,?PG'/:MGX=[E?Q2'BEC\W7KF>/S
M(F3?&P3#+D#(.#R*[:B@#A/,F\/_ !3U._U%)!IFJV,"6]T$+)$\1;,;$#Y<
M[BPSP?K7.:EI%W:?"[QNPM;G=K.H7%S96JPL9-CLH7Y ,@MM+8QP#SCFO7J*
M *VGSI<:?;RQDE3&O52"..X/(KSNU>2QE^(EE/:7@EN9I;B$BV<I(C6ZJI5@
M,$EAC .<]NM>FT4 >3XD7PQ\,(_L]SYEG<6QN5\A\PA8&1BXQ\H#$#FKRB%O
M$_Q':]T^ZN;&XM+8>6D+C[2JPLLBQG'S'G''>O2J* //_!D6HZ?XD?3H-4GU
MGP\++S(+F[C_ 'UH^Y0(2^ 6R,G!Y&T9QQG6U]QK'B+3]!66ZMXXC]MFGBBX
M+H1Y2!F4KG<=^/\ IF/6NJHH \SU6VG\)?$W2-9CFU'4(-2A:RU(^1O,:C!B
MD/EH!@-D$GG&:KZYJEKHOC?Q'MFN[9-4LK=)I&TV:Z0N$90Z&/IA2 5/4^F.
M?5*Y<^%M3MM6OKS2_$ES:PWTWGSV\MO', ^T*2C-RHPHX.0,4 <E?MI7_"/^
M 8-"DN+VPT_5H 9! Y9$C1U9I!MRF&(SD#&:O>*9_P"P_B##K&IV6H7&B7FG
M):^?9"1C;RI(S#<L9SM8/UYY%=[I]A'I]L8EDDE=F+R2R$;Y'/5C@ ?D
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M&[$L@A;;'OA55#''RY((YK TFZMKCP)XWT<023WMUJ>I0PVRQ$M,[N0I7C!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;9XU+%6$A.X, <$=^M1VOBGQ!<7.AW,6GFZL=091<PQV,T;6BN,J_FL=K@9
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M/  &><\5SI^'FO#PHOAJ/5[!+&VOEN;23[.QD*B?S<2?-CC)'&,\<CG/I5%
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M)8)#+YJLV6PQ!XP,<9_#7T[2_%3V-P-<U33[BX\AH($M86BC);@R29));V
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MV:FG>4Y8R$*Y<.6[DDD$?CFNGHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRDJ;E(?86$>=S*&X)Z\$@$<U?E\5*;K4(K&R>]73I(XKDQRJ'4NJL"%/50K
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M& <\'TJ2_P#$FD:9).EW=A#;(KW!6-G$"MT,A4$(#@_>QQS0!JT5@S>-?#4
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ME()9\\ #'!;)%<)H.ID>$O &EWDRMI5WJ=S!=%F^1PCR^3$<G[I8#@]0N.E
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M[CX4^*M>CBC#ZJ$E20+@M"'18^>N"HW\]W- 'J892Q4,"1U&>E4M-.ID7?\
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M4'& .1ACW)XP 4?A?:O%:Z_(]Y=3;=;O(L32;@=LF Q[[L#K2>);1YOBQX4
MO;N)9+6].V.3"KM$?08[[CDUT>B>&;;0;W49[6[NVCOKB2Y:WD=3''(Y!<J
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M-S)=/]H*$AW.6QM4<$TV3PU#)XOC\2?;KM;F.U-H(1L\HQE@Q!&W=U .<]J
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MT::YGB@5/W;@)RA*D]6[YXZ8/-=QJE^_ACP;=WTTDE[)IUBTC/)@-.R)U..
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MT>5"4#'Y5_OLH_6NGL;J\U.ZU&;^RSIU[;8@@:["N74JK9/EN05SQP<C!^E
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M Z?,..<]..M9UEX[NX]$U%]3MH#J=GJ_]DJMLKF.:1BNUPO+ 8?)')^4XZT
M=V[*B,[$!5&23V%5=,U*SUC3H-0T^=;BTG7='*N<,.G>N:L/$.O2:U?:?-IW
MGPI9_:;6_P#L<]K$7!P8G#[CN[@@\BN=O?$^M:MX,\$ZI:RVMB=4U2VBGB2%
MF7!<D ?,"%^09'4^H[@'HD6LZ;/K$VDQ7D4E_#&)98%.61<XR?3FKU>=7/\
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M +?+WW=NF.]=510!YK;_  _UW3O#GAI=-U*SAUW0!)'%(ZLT%Q%)]Y'& 1G
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M[[PYXGU72?#T&H7.FRWNEZA#>37"NZBX\L$8V[?E)SR>1QTYP'WO@N?5]?\
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MDCYCMSC@#/>MOPKX?U'P_=ZRDUS;2V-YJ$]["$1A(#*VXAB>..1QUSVKIJ*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#LN?TKS&UT_Q#<WW@[5;OP[J#ZC97,G]I3W$T19G:)E)3Y\"(,<X& !C )H
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M5CU]AV%+]FO?^%K_ -K_ -GW/]G_ -A_9?/VC'F^;OVXSGI[8SQ6'I&A3?\
M"O8=&UWPU<W44FISM<P<>9%&[R.LJ%6Z@E.ASR>* /0=,U%M06Y$EG/:26\Q
MA=)MIR=JMN!4D%2&'_UJO5RG@;3M4TNRO[6]NKRXL$NO^):U\<W AVKPYZXW
M;@,\X';@5U= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 45PUGXSNI/B9)HT\832;N!
MX].FX_>SP,?.'ZD?]L_>NPO;^UT^))+N98U=Q&@/)=ST50.6)]!S0!9HK$'C
M'PV8[ECK=BAM06N$DF5'A .#O0X9><#D=Q3K7Q;X?OC<BVU:UD^RHDDV'^XK
M_=S]>F/7CK0!LT5G6.O:7J(NOLU[&6M#_I*/F-H>,_.K8*C'.2*BM_$^BW-Q
M- FHPK+#%Y[K+F,^7_?&[&4_VAQ[T :U%8$?C;PS-)9)'K5HQO6VVY#\2')
M /3D@XSU[9JWIGB31M9N[BTT[48+F>W ,J1MD@'H1ZCW'% &I164GB71GU&.
MP74(OM$I81 Y"RE?O!&(VL1W )(Q5.7QUX6@C:237K$1K.;=G$H($@QD$CL-
MRY/09ZT =#17/7_C#3K#Q79>'Y&;[1<0O,S;3M0#  SCDDM^&.>HKH: "BBB
M@ HHHH **** "BBB@ HHHH **** ,71?#%CH=U=74$MY<3W#,3)=W+3&-2=Q
M1-Q^5<\X'7C.<"MJBB@ HHHH *Q;KPQ8WOB&'6;B6\>6)5"VYN6^S[E.5<QY
MP6!.03W /49K:HH **** "BBB@ HHHH **** "BBB@ HHHH **** "L6[\,6
M-]XAAUFXEO'DA156V^TM]GRIW*YCS@L#R">X!ZC-;5% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8\'ARWM_$]SKZW5T
MUW<0K!(C%?+V*25 &W/!)YSFMBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K$\5Z]%H&B23FXABNIB(+42L #*Y"J3GL"03Z $UMT4 >5>./#E
MUHG@BRU2UUD32^'I([RS$D:)YA7[P+#DEE)S_>-6O%OB32+JS\'^*H-1BCBC
MO?,C,V[R<-"P=9&4$HP&0.#\W&,9(]+KG]?T75KW4K#4M(U2&VGM%D7R+JW,
MT,H?&20&4AAC (/0D=S0!PWV_0[KPE\0M3M==TZ[N-2M99)+>VFW+#B QH.0
M"2Q'7 R3CM4VLR1V_P -/".K6<3S6-C)937_ -B^^(%C(8C;S\C,&QVP:[K2
M](NHKW^T=4GM)K_RC"IM+<PHB$@D<LS,257DGMP!SG9H \EUJ/1=?\.>(-6\
M'"[U2^DLXTGN1-*PE1)%<PC=U8H'X R.AZBMC0-6\&>(=:L=:TVYN[N^LX9-
M\L\\N+.-E^82;CM!S@8.?4< FO0555&%  ] * JKG  R<G ZT >%P3Z>/@#H
M,3R6X/\ :,.Y"1G(NLMD?[O)]JZS5YTN/BO)#874*W4WA::*!ED'^L,H*#/K
MW'MS7I-% 'D?A2^\*ZYIGA[2KM=0?7]*DASILDLP:UGB 4N1G:$ R>>,<=>*
MJFYT]_ 7Q2Q-;%Y=2O-N&7+@QILQZ_-G'OG%>RA5#%@!D]3CK2T >9#4;6V\
M<>"[V>=1;SZ)-!%*/F$DA\H[!CJW!XZUWVG:UI^JW%]!97'FR6$YM[E=C#9(
M #CD<\$<CBK]( !G  SUH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVB!Y7Y PH)&>N:M@Y4'!&>QH 6BBB@ HJEJVH-I>G/=I8W=Z595\BT0/(V6
MR 2.!G)]@:NT %%%123I&2N=TFPN(U(W,!UP/Q'YT 2T5D^&_$%KXGT2+5;.
M*>*"1Y$"3J X*.R'(!/=3WJR=08:V--^PW>TV_G_ &O8/)SNV[-V<[^^,=*
M+M%%% !16=I>NZ?K,^H0V,XD?3[DVMP/[L@ )'ZX^H/I6C0 4444 %%%% !1
M110 4444 %%-\R/S?*WKYFW=LSSCUQZ4Z@ HK'\1>([;PW:VUQ=07$J7%S';
M*85!VL[!06R1@9-;% !117.6_C.RN;'7;M;.^"Z+*\5S&8UWL50.2HW<C![X
MH Z.BJ6D:E%K.BV.J0(Z0WENEPBOC<%=0P!QWYJ[0 4444 %%8^O>([;P\=.
M^U07$@OKR*SC:)00KR-@%LD8'Y]*V* "BN:NO&4%AI5A?WFE:G;B]O5LEBEB
M4/&[2;%9QNX4]0>>*Z6@ HK/T_51>Z:U[/:7.GJKNK)>*$8!6(W'DC!QD'T-
M:% !1110 4444 %%%% !138Y$FB26)U>-U#*RG(8'H0:J76H-;:E8V8L;N9;
MHN#<1(#'!M7/[PYXST'!YH NT44WS(_-\K>OF;=VS/./7'I0 ZBBB@ HHHH
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MF>:+H2;=QE4K@_<& , =.G% 'HW@W4HM7\*V=]#J;:E'-O9;IT"LPWM@,
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M63+17MNR01A!G@GZ<9Z=*[[5=(?4[FPF6^EM_L4_GHL:*0S;63YL@\8<],4
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MQM4 J0PP".OZW8?A[9Q>$HO#W]HWK1077VRWN/D$D<HD,@/W=I&XDX(K7M-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M."U>.WMXW,LDC#]XQ/R< ]%&<_[2\<T 6/[=TG^U%TS^TK7[<^0MOYHWL1U
M'<CN.M:!( ))P!U)KQ[P]K%UI7PDTKQ!?:98:A]GNO,B:5SYH>6Y9&<$J<-E
MSTZC->A/X@GC\>1>''MHS#-I[WJ3ASN&UU0J5QC^+.<T 71XAT9M/GOQJUD;
M*!S'+<>>OEHPZ@MG&>15^*6.>%)HG#QNH96!X(/(->3Q(O\ PK'XF+M&!J6J
MD#'3BNF7Q'>:)_PB%F]I =-U.*.V-XTA!BE\O*J5Q@[L8!SUH [6F2RQP1-+
M-(L<:#+.YP /4FL[3]2N+[5]3M_)B%I9R+"LRL2SR%0S#&,8&X#.>N1VK#U"
M_;4?BAIWA\G_ $6RL&U25>TDF\1Q@_[OS-]=I["@#K]R[-^1MQG)]*2.2.:)
M)8G5XW4,KJ<A@>A![BL#Q=<*^G0Z0+@02:K)]F,F\*4BP3*P/8[ 0#_>9:Q/
MA9J#KHMYX:NIQ->>'[@V>\'/F0=87^A7C_@- '<0SQ7,0E@D22,YPR'(XX/Z
MU%?:A9Z7:FZO[J&V@#*IDE<*N6( &3ZD@5R\E\VC_%.VTY.+36[*24H.@N(2
M,N/]Y" ?]Q:N>.=:?0/#OV[^SK>_B%Q#')'.^ NZ15# ;3D@D'''UH Z6JU_
MJ%GI=FUW?W4-K;(0&EF<*H)( R3ZD@5SE_XEUA/&S^&[#2[21SIWVV*XFNF5
M?]8$^<!"1CGIG/'3G&1>>.IIOAL^OSZ):S20W7V6[M)9LHKK.(MR_*=PW8;!
MQ]>* /0ZK6VH6=[-<PVMU#-):R>5.D;@F-\9VMZ'!KE;G5=:_P"%LVVDQ&V_
ML\:2]QY99@3F:-2QXY88P![GGFDL/%%TUOXLFA\/H][I=V8A;6;[FNWV*02V
MT<G([' '>@#M*K7]_9Z792WM_<Q6UK$ 9)I7"JN3@9)]R!7-67BJ]N/$]]X<
M*Z?+>PV O(YH)28U;>4,;CD@@X/N#T%<U9>+M6@^"I\3:G866IED,KQ2RD!P
MTQ!R"I'!(POH.HH ]3!!&0<@T5RNJ^)=5M?&5KX>L=+MIC=64ES%/+<E "K*
M"& 4X'S=MQ/'3K5"'X@21^#[W5;[3T2_LM1;2Y+>*4F-IQ($!#D9"'<#DC(&
M>M '<T5RUOXCU-?'7_",7-C:/_H0OOM<<S)^[W;,!"I^8-_M#@Y]JTM<UL:2
M^GVT40FOM1N/L]M&S;5SM+,S'!P%52>G/ [T :]%<E=^+;_0[+6)M<TK8+*2
M*.UF@?Y+XR8"A<\J0Q"G.<=:DF\2W^D^(],TK5[2V":J'6UN+>1MJS*-QC<$
M=QT8=<=!0!U-%><S?$'7$\-:OKJ:'9>1I%[-;W49O&W.L;!6,9V<GJ<G'TK9
M3Q3J</BS2]+OM-MHK75X9GLY([@M(K1J&(D&W RI_A)P>.>M '6T5YU-X_UT
M>'M<UB+0[+RM%OIK>YC:\;+I$0&*'9R>2><=N#6LGBO4X_$^CZ?=Z;;Q66LQ
MRM9R).6E1D3?B1=H RO]TG![F@#KZ*X:3QW>1^#O$>M_V= 9M$O9[9X?..V4
M1$ L&V\$YZ8JS<>*M7;Q;%H%CI5H[SZ7]OBGENF51\ZKA@$R ,GIG/'3G !T
M]_J%GI=E)>7]U#:VT>-\LSA57) &2?<@?C5FO/+WQU/)\-;O7KC1+6::TNC:
M7=G+-F,.LPC)4[3N&<'!Q]>*Z6[UNYFUZ?1-)B@>ZMK9;BXDN&(1-Y(1,#DD
M[6/L!WSB@#>HKE8_$>LRZ?I,DNAG3IKM)7O'NWS%8^7_ 'B,9W'&WD<<]L5S
M>K>.-5U/P%:ZIIJ6UM,^K)87!$I<'$X0F-@.C>IZ GKUH ]%EU"S@O[>QENH
M4N[A6:&%G >0+]X@=\9%6:Y:ZUJYMO&V@Z3=Z99L][;W$BW:2%FC*!2RJ"HP
M#E><\XZ54F\9WTV@:CXBTNP@N=*L9)5*-*1+<1Q$B1TXP,%6P#G..HS0!VE%
M<7)XTO;OQ!IFG:/IUM<P:GIAO[:YEN2@QE?O@*2!\W;<3QTY(@B^(31^&'U#
M4K:"SN8-5;2;EC(6@AD#[3(6P#LQ@\XY(&1UH [ND9E1"[L%51DDG  K.T>\
MO+R&=[N.WVK+B":V<LD\912''IR2,<].IJE<:[<77B.YT+2HH'GM+=)[N6<G
M9'OSL0 <DD*Q)[#'7.* +O\ PD.C?V6VI_VK9FP63RS<B9?+#;MN-V<9W''U
MK2KR'0=;FT'X376HRZ3:W076)DFMI9/E0M=;1CY3NVL1Z=,UUVL>*-<M_%[^
M'=*T>TN9FTUKZ&6:Z* XD5,,-O'4],Y)'09P =A17#:CXZO(K;49;"Q@N)=-
M;RYK;=(7GD509$C*J1QG )ZD'@#!.C%XHNM7NI+31+1/M$-E#=S_ &W<GEF4
M$QQ%1SN(4Y/\/'7/ !U%5(-3L+F^GL8+R"6[MP#-"D@9XP<XW =.AZUQ%_XC
M\23ZYX)C2QCT[^T6N'N+.YD.\.D+_*S*/N\Y'&2<=,5+8^>GQ5\5-:1Q-<_V
M79E$D8JK-F3@D D?7% '>T5QNE^,[K5/!]OJD=C FIRW@LFL&E/[N7S-C*S8
MSE0"QXZ"NFU.:]MM)N)[&WCN;R.,O'"SE1(P&=N<'&>G2@"Y4-W=VUA9S7=W
M/'!;PJ7DED;:J*.I)KB1\0I6TWPCJ(MK06NO2I!(QF(-O(P/&,?,-PVD\8./
M6K_B#Q%=V>A^);W^S+2\L],0C9+*0)\(&<$;2,#.,=R".,4 =5%+'/$DL3J\
M;J&1U.0P/((-5[34["_FN(;.]M[B2V8).L4@8QL>S8Z'VKC=4US6O^$I\%VM
MBMI'::A!-.T19ERR0@X) ^Z-_ ]0/2LNWU#5=)\5?$.ZTBPM;@V\MO/(+B8Q
MJ56V4E5VJ26//7 ]Z /4:*HZ+J<>M:%I^JQ(4CO;:.X5&.2H=0V#^=0^(-;A
M\/Z/)?RQM*0Z111*<&21V"(N>V6(Y[#F@#4HKG/[<U33M0NTUK3XH]-@L6O3
MJ%NY,:;3\T; \Y Y!'4=A69<^-KW3M%TOQ%?:?"FBW[Q!]DA,UJDN/+=^,,.
M5W 8QGC=B@#MJ*YD^(M0U*\UB#0;6VG_ +*<0R&XD*^?-M#&-<#Y< J-QSR>
MG&:QU^(TU_#X8GT?25N(]=,T:B6X\MX98U8LK#:1@%<%L] < \4 =]17!VOQ
M"GLCKUIXCTV.TU'2$CDV6TIDCN4D.V,HQ (RQ"G([_E;M?%NIR>(DTIM-BN%
MN+9Y8+F RK$DB\F.1F3C(Z-W]* .QHK@-%\;^(]7\,1^(H?#,4MG+:/)'!!=
M%IWE#[54+M^Z1GGKP3CH*T;/Q5>W'B74?#VW3Y;VWL!=Q30RDQ@EBA1QR000
M#UY![4 =+?ZA9Z7927M_<Q6UK%C?-,X55R0!DGW('XU9ZC(KRVS\6ZM!\%E\
M2ZG866IET$KQRRD!PTI!)!4C@D87T'6NHU3Q+JMMXS@\.V.EVLQN+&2ZBGEN
M2H!5E4A@%.!\W;<3QTY( .JHKAH?B Z>$+K5+W3T34+746TM[>.4F,SB01@A
MR,A.0<XR!GK6A;>(]3'CIO#%S8VKXLQ??:XYF3,98I@1E3\P88^\.#GVH ZF
MBN=\7^(;KPS96E]':PS6;7<4%W))(5^SH[!?,X!R 2,CCK4$'BN4^.=1\.74
M=K"MM9"]BF$Q)D0G!R,?+MXSST(- '076H6=E+;175U##)=2>5 LC@&1\$[5
M]3@&IIIHK:%YIY4BB0;F=V"JH]23TKCKOQ+>QMX3>^T:T)U:Z"!C*2UL2C,I
M *_>VCGD8R1S4>CZGK-_XX\6V%Y]E:QLA;QHBLWR*T;., C!)+<GCH/2@#L;
M*]M=1LX[NRN([BVE&8Y8F#*PZ9!'6IZ\E\$>)-3T'P%X+,FG6[:5>2Q6#2^>
M?.5Y&8*^W;C;GWS["O6J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N<
M\<:%>>(O"\MCI[PK=K-#/%YY(1C'(KX) )&=N,XKHZ* .1?1=<G\=:7KTT5@
ML-O82VTR)<.6#.RM\N4Y VXR<9ZX'2L-O >O2:)J2)<V5IJ@U]];TZ5)&D0,
M3PD@*@XP2#C/6O2J* ,/0/\ A))BUQXA6PMV";$M[%V=2>[LS >G '3)R3GC
M,\<:!J^O7&@/ID=D5TS4XM0D^T3M&7V;AL&$;KNZ_I77T4 89;Q'<7UJ'M-.
MM;56+3O'=O+(X .$4&)0 6VY.>@/'-<[JOA77[N:R\0VK647BBWNB<M</Y!M
M22# 3LR5*X/3[V3[5WU% '#:AHGBK3_%DOB#P\--E&HP11:A8WDSJJNF0KHZ
MKV!P<C_ZR:OX;\2QZOI/B32KJRN-8MH)+:\@N"T<,\3MOVJ0"5VMTSG( S[]
MU10!Q?B#P_X@UGP_9R/+9-K%IJ4&I) '98!Y9'[H/C=C&?F(Y)/ '0LO#^O2
M^--0UK4%L(;>^TQ+-HX9G=HF#.>"5 <?-U^7Z<<]I10!YJ_@WQ++\*8?";C2
MQ=0&"-)!</L9(I%?<3LR"=H&W''7)Z#I/&/AZ[\1:/:?8ITL]7L[F*ZM9_O"
M)P<,.G(*EACOQ7344 <EXH\*75[H>E1:!<QVNH:-/'/8M/DHQ52A1\<X9203
MUK3T'_A(95>X\0+96\FT+';63LZCU9F8#)/& !P.YSQM44 <MXMT75=7U/P]
M/8):&+3;];R7SYF0L K+M4!3S\V><=*(=%U5?B3-K[QV@L)-,2RP)V,@99&?
M=C9C'S8Z]JZFB@#B=.\.ZWX<N=?MM+2SN;#5+F2\@::9D:VED'SA@%.Y<\C!
MSV]ZAMO!%YI&H^"TTXVTEAH$,\<S2RLLDID0*650I'7)Z]Z[RB@#B+?PWK<4
MGC-VCL?^)V<VP%PWR_NA'\_R<=,\9]*W_"FG76C^$]*TN]$/VBSM8[=S"Y96
M**%R"0#SCTK8HH \_N?"?B*8^-VMKJULI=;\LV<\4[EHRD83#?*,9 Z@G&:E
MTSPWK\/B_2=8DM-(L[6WTU[&6UMI7;R@75LI\H#9V].,9ZMW[NB@#BG\ Q7/
MB#7Y;J4/H^J1;EM /N7#QF.63V.P+@^K-6GX3T6_\/>%(+2ZF2]U0(#/*S%1
M*X 49.#T557./X:Z*B@#S>#P-K7_  J#_A$YGL4U"$AXI4E9HG99_. .5! X
M Z&M2VT?Q)<>.['Q'?0:;!%'ITEI+;Q7#NR%G5LAM@W?=]!C/>NTHH \^B\(
MZZO@[Q?I+K8"XUJ[NYX&%PY1%G[,=F<CV!S5KQ-86\GPV?1]4GA@U"&R0PB&
M7<XGCQY;1Y ).\*!P,YQ7;UG7.@Z3>:O;:M<Z=;3:A;+LAN'C!>,=>#VZG\S
M0 F@:=)I6B6UK/)YMUM,ES+C_63,2TC?BQ)K U"Q;3?BEINOL/\ 1;W3WTN5
MNT<@<21Y_P![YE^N!W%=C3)H8KB%H9HTDC<89'&01[B@#!72+N^\57-[JMG8
MRV*0+#9 R&1D^8EV92@ +83H3P@K*;POJ>G_ !(BU_1;?3H=-FLQ:WT!E:-I
M"&RKA0A&X=.O(]*[4 *H Z#BEH XZ:P;5_BI:7ZC-MHEC(C/V,\Q'R?4(N3_
M +R^M6_'FAZAXC\,/IFFBV\YYX9"UQ(R*!'(K]E;KMQ^-=%#!%;QB.&-43).
M%&.2<D_4GFI* .5_L75O^%C#Q#Y5G]D_LG["4\]O,W^9YF<;,8[=??VKG9?!
M'B&3X=:EX>QIPN[K46NT?[2^P(;@38)\O.>,=/>O3** .4O-$U<^/M/\0V@L
MS%_9S6-U'+*P,>9%?<F%^?H1@[?K6-<>$/$DFF>,H;:YL[2YUFZ6XM9(YW.T
M (I1_E!&Y4(R,_>KT2B@#B-+\.Z[#XWM=;FMM)M+/^R?L#VMM([>3B3>-OR*
M&S]%Q[XYR?\ A"/$9^$=QX,8Z9YX7R8)A.^UD\W?O;Y.#C V@'USS@>FT4 <
MI<:-J\_C[3->\JS6UMK"6VE3[0Q?<[*V1\F"!MQU'6N8U'1=1TGPGKFF7PTG
M[1K^N-)9QRRLT;^:ZML8[058*C'<,X(R.<5ZE534M*T_6;)K/4[."[MF.3%.
M@=<]C@]_>@#C]"_MK2O$<"ZMH-C')J ^S_;8-3DN90$5G (D4-LX/0]6&1S6
MEXU\.ZAK4&FWNC7$,&KZ5="ZMO/SY<G!5D;'(# ]16KI/AS1M"WG2]-M[5G&
M&=$^8CT+=<>U:E '$ZQX:UWQ?X5O;36I[2PO9#&]HEHS2)!)&VX,S$ L2< \
M<#ID\U:?1=5UW5M$OM:M[2V_LEGG\N"<R":<IM!!*C:@R3W.<>G/644 ><-X
M,U]_ OBC0RNGBZU>]N+B%A<.4196W?,?+SD>PY]JU[[0=9NO$WA34UBLEBTF
M.=;A3<-N8R1A/D^3G&,\XKL** /._P#A#]>;P;XNTAET\7&M7MS<0,+ARB+-
MCACY><C'8<UI7?A_6;C7/"%\(K(1Z.LHN5-PV6+Q>7\GR<XZ\XKLJ* /,[_P
M;XE;1?%VA6BZ:;/6+J>[@NI)G#J9<$QE N!@@_-NZ=C6U::#K<7CBSUR:.P\
MB'1O[/=4N'W%]ZON *=/EQUSS7944 >9S^"/$$WP]UOP^!IPN[_47NXW^TOL
M5&F$N"?+SD8QTK5U30O$EEXP'B7P^-/E>[M$MK^QNYF125)*NCA3R,D<CI]>
M.WHH XO4]"\2S:MH.H"73[\6OFFZM9Y'BB$CXVR)A6SLY R,X]"2:QQX%\0_
M\(??Z6TNFM=#6?[2M2'=4D'G^;A^"4STP-V/4UZ910!R5YHNM7OC3P[K4D=B
ML.GP7"7"K.^[,H4?)\G(7;U.,^@Z5FV'A/6]&T'6?#-E]CETV\><VEU)*P>V
M2;.Y63;\Q4L2,'GOBN_HH XNU\)7NE^+-#NK%+8Z5I>E-IP$DS"5LE,-C;C^
M#U[U7TKPYK^FV&J02VFE727^LSWLMM),S));R@Y0YC^\#M/3!QVKO** .6\%
M^%SX835$C5;:RN[KSK:P20NELNT @$_WF!.!P,XJK<:#KFE>/+OQ#HB6=W;:
MI!%#>VUS.T)1X\A'5@K9&"01BNSHH \Q;P/XC?X=:AX>/]F_:[G4C=I)Y[A
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MG [U;TSP[KD7C:#6I[?2K2S;218/;6TCMY.)"X"_*H8<^BX]#CGMZ* /,O\
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M]-;%8$6-L,"_][OC^O%07-LVL>/])UV*VNHK/2+.X$DLMM(C2O+M"HJ, S8
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M5"[&.4D[HG$8((X4E<8Y(!'>6:+7I[GX>W&K6,[WUK(\FH-! 66(M"R MM&
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M^G6NTH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW.IVD5M*N^.5YE"NOJ#GD>] &A16?-KND6ZP--JEE&+A#)"7G4"10I8LO/(
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M_+-P;E/+#?W=V<9]JHS^+](A\5Q^'&O8$OGMS,=\@ 4[E5$YZLVXD <X'N*
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MH7D73K'QM+)>&V4,8K</G<%P1@,4;&.U;>K+X9U#1O%FLZ9JS:M=2Z%-'<7
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M.:,QRQK(AZJPR#^% 'EEAK&FVFE?#>*9[6VNGTG,&HW4A$5N!!&'4#<%9VX
MW'C!Z]#6\/:;'XE^&_B;2K*Y$FH0:M=SVS<!XY5E+Q,0 -N2OH.">*]7^PVF
MQ$^RP;(VWHOEC"MZCT/O4L<4<6[RXT3>Q9MJ@;B>I/O0!Y&VNZF^I:)\0+6Q
MD\K4X!I+6FS#,S+NC8]Q^_W)G^[@]Z]4TNP73-+MK)6+^4@5G/5V_B8^Y.2?
M<U8\F(1K'Y:;%(*KM&!CI@4^@#S3P]<V@MO'NF^(WC2X_M"XEN%G(!>U= (F
M&>J[1@>F*QM*LI(K[X4VNO(C7HM;P2)< ;L>4"BL#W VC![BO79K&TN)XYY[
M6"6:+_5R/&&9/H3TI9+.VFE$LMO"\@Z.R D?C0 ZWMX;6W2"WACAAC&U(XU"
MJH] !P!4E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !117$?%3S4\'+-!=7%O*M]:J'@E9
M.&F13D X88/0@B@#MZ*\ZU*SCT;Q7H_ARUN)!9ZI]JNW6^N)95FF41@)DMG&
M"S;<X)YQ5?5-,UOP[X3U*VM]7:[C&I03&WA+"6"U>1=\$;%BQ)'W1G/.!U%
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M#S2'S0H 4G+?>&,[NN23G)I]IX)T&RU"WU"&UF-Y!"8$GDNI7<H3G#%F.[!
MQG.,#&,"NAHH YX>!] &@7.A_9)CIMS(9)H#=RG<Q.X\[L\GDC/-4]?AOK\-
MX3@T2>33+JV$<VI33JR1QDX=<,2Y?;T]R#VS76T4 -CC2*)(XU"(@"JJC  '
M0"G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M);0RQVOE;@^,M)\QW?=X V@9;UX .7TOQMJTO@C1);B>)]7U?5I-.2?R@$C
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MQ 6VA\-GYL[@>1U'09P-_4]:O[OQ1<:%I_VR+[+91W$DUHL!D+2,P4?OCC:
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M!)')"WV;F4QH44-\_P#=)SCOZ53NFT+QUXNTMK%I+B30;J5KJ41NBH5X$1)
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MP1NX#2D#)"@\G YXJ>N4U+69;3Q1X8L-0T6SDGOY)U2Y6;S/LS+&S'9E >5
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M!6EA5P7C#?=+#J,X.,U/7'Q>)H;;Q%XM6;1XX9-(LXKB6XA(:6Z0H[ 'Y0>
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M_":ZR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFI6]S<69F*I);1 *("X'5E&6.,<D<CD]G-H.FW&M0ZQ+"YOX%*1R^<XVJ>H
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MFS^SRJ&W!&VXR#WP>16W10!YQ)X U.[T[P]/=7J'68I"NJSC_EO!)&$EC'_
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7 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>sangamoexecutiveseveranc017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM*87$4[CJJ28VL>#C!Y[9K@4WZCXZ66RDU2=;_PU/:0WT]K)&OG&12,#: @
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MUP0"HY&2>,'C.17$:#?S:5\./!D,UC+&JWCQW5T;(RRV!S(0RH5)5FR%W$'
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MR6T N+A88'E\F+GYWV@X'!]^">U87Q2W-X2BCC2220ZA:L$C0NV%F5F.!S@
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M&9@[-SC 7"K@G&XYQGBET#6-%@\+OJ,&LW5YIXN)1]JO"S.7,A&P9 )PQVJ
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MVT+%9;B)&!4$,X!!;A?SP<>M $U%0M>6R72VK7,*W#C*Q%P'8>H'6IB0!DG
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ME0QIN/"*<$@#W(&3UXJQ437,"2B)IHQ(>B%QD_A3EFB>1HUD1G7[RA@2/J*
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M)(X]MQ&: .*^)17Q#K7AGPOIQ$VH)JD5_<;.?LT$8.7;^[G=QGK5_P 6;_\
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M:9;0:E:6J022(JD[@H#,K#^\1D]">];-MHVEV5[->VNG6D%U/_K9XH55Y/\
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M,Y]Z .*T:>UU77/'UMK:Q/>0R^2(IP/EL_*&S /122S''<UL_"QE?X8>'MK
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M6AC,D.?*8J,ID8./3B@#@KW2=.F^+FDV$MG"]G%H$H2W9 8P!-& -O0@>A]
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MJLE]XQFMM7U'^Q[>W4Z=+YH=?,,9:3:S@E@&"X.<#) Z< 'HU%>3VMYJFE^
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M$L]@ZI<J%8;&89 R1@\>E:- '++X"TU=#TK1UN[Y;32KA+FU =-RNARF3MY
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MG[O(OUE#3X;[P8L"K ^A&/3%:.EZ1;:2MP82\DUS*9KB>4@O,^ ,L0 .@
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MR?P]9Z%<P)9PR+#<VLD1=YH1M!8-_#M7<<GJ<#O@]-0 4444 %%%% !1110
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M2*^)",K'(!]QB,XQN&1C-4)OB!*+?79;;P[?S?V+,R72F6)<*J!RP^8@\'(
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M0$XP" .1P?3D8)H UJ*Y[Q#XK3P_J>EV#:9>7<FI.\<)@V8W*I;;RP.3CJ<
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MS%_>!8Q(2A_W3WQ0!U%%<C=^.T@?P]'#H][<OKL#36PC:,8(B\S8<MP>@R<
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M@# )."?I7544 <)=:;K'BJR\.6>IZ5+82:?>P7E[*\D;(S1 \1[6).YL<D#
MSWXJO;Z/K267CU&TB<-JTLKV0\V']X&A$8S\_P O(SSV_*O0Z* /.9M%UMM&
M\ 6ZZ/.9='F@>]'G0_($A,9Q\_/)SQV_*H_#MW>Q:QX]@M-*FO'DU-A&RN@3
M>84&UMS @=#G!XSWXKTJLG2/#MGHMW?W-K)<&2_E\^X\V3<&DP!NQVX ''%
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M<7LR^4AB=%,6[@OEV R!D@=R!6K##';PI##&L<4:A41!@*!T 'I3Z .#\5>
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M0.U244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+E?FQ@=^?8CK4?A2^\.ZS::'IEYIFJ-X@TMXB]E<O<[;22, &7).P* "1ZY
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M\Q4].@-<'?\ B33-?\=^!+_36FGA1KSS&6W<F(M#@*W'!S@$=N]>FDX&3TH
M\XT+^W=8\2>+M+?Q3J42:9-%%:NL=N2-\>XELQ<\_2N@A\<^'X98=/N=8A?4
M!-'9R!$8@SL!@9"XP2>O3D5B>!KB)_B!XY*N-L]W T)[2A8L$J?X@".U3>$9
MHO\ A.?'+Q@.\ES \>/^6JK"JG:>X# CV- '10>+=$N;NWMHKW<UU(\5NYB<
M1S.F=RI(1M8C!Z'L?2J'C'Q':6.@ZS##J$\%[;6CN9;:%I/(8J2F]@K*F>/O
M8X.?>O.H]6BO+'P;>""XMC;:VOGZ=;V3I#8<2C9@+DMDCDDDY)  .*TK354T
MC2/'F@ZRLT6J7-Q>W, :)F^U0R)\C(0#G &".P'M0!V_A_6XX?!/AZZU&XEE
MN;JP@?Y4:669S$K,0J@LWJ3BM?2M7L-<L1>:;<K/ 6*$@$%6!P593@J1W! -
M>51WRZ-;>"-9U2#4ET5=#&GW$L FC:TFQ&=SA,-M.S'<<#VKT'PA!I"V%W=:
M)93V]I>7+3^;,9-URY W2XD^89/&3UQGH02 85_XC23XCW/AW5=7GTB$6T3Z
M<(V6,7;-G>V]@<D'"A>AYX/;I-+:\T?2[M]?U'S_ "KARMU(JINB.-G"@#/.
M.!R>@YK$\1R^%O$%SJ.@^++:"."V93!<7(,:$,BD[)3@!P2<@'.,5QL-EKEI
M\/9S&=1U33-+UV.XLP2PN+BPC8'Y2,$X.2IX^[D<8H ]3L?$>E:A<7=O#=%+
MBT4//#<1/"\:GD,5< [??I4=MXJT6ZO4M([S;-)"9XA+$\8EC'5D+ !P.N5)
MXYZ5P&JP:/XQ\.:[>>$;:^NM2ETMK9KR=I\E=RM]G'FGYB<-TZ?\"KI= \6:
M%XHFL+BVT]S?6D3>>UQ:M&=.!7YU+LH )("X!Y'/04 :-CXZ\,ZE=P6MIJT4
MLLXE,8", ?+SO^8C Q@]3TY%6(?%>C7%ZMFES(+AX6GB1[>13,@Y+1Y4>9_P
M'-<#H-E<:K\'/$>G::O_ !,)IK[;'C:S[I&*C_@2X /O6EX:U3PSXGU+2KBW
MT_5)-9L=S/'>/<_\2\E</DN=O/W<#)/X' !O>'_'&GZYHLVJ,D]M EP\*B6W
MD!;$IC0#CYF8@?*,G)QC-;>GZM9ZFUPMJ\A>W<)*DD+QLC$ @$, >A!_&O+]
M$&FS?#JXT75VO[-X-6E$LT*/&]I(;EGCD#8QP=ISS@<FNK\"76KR7&KV>I7E
MOJD-K)$MMJ\,83[6I4DAL<%DX!(]?7- &UXGO[JPT.;^SPK:E<$6UDK=#,_"
MD^R\L?935+P%XA?Q+X/LKZX!6^0&WO$(P4G0[7!';)&?Q%59W7Q'XR:WMM3E
MM5T:+<I@5"7FDR&(WJP(11C('60CM6%H3CP?\4]5T:6[EN+'6HUOEFD50([K
M)#JVQ0JEP >@S@>M '9W?BO1;&X\FYO=F)A;M+Y3F))3T1I -BMR."1UJKI_
MBZUU'Q?JF@1P7*O8)%F1K>0!G<.3SC 4!5P3C.3C-<;X5UFRLM%G\&>(-+EN
M=:@O)BMI+:-(MYNF:1)0VTKMRP.XGC&:V]'F%E\6O%$,\<RO?063VQ\IBLBH
MCACNQ@ $@<F@#L;[4+73;?S[N811E@B\$EF)P%4#EB3T Y-5;/Q!IE_]L%O.
M[2V?_'Q T+K-'D9&8R W(Z<<]LUS?CX75KJGA;6A')+ING:@7O5C4ML5XR@E
M('92QSZ9IMG''J/Q3E\16$\;Z7#HWV:>Z1@8I)#+O #=&VJ"21TR!0!6\,W]
MSXREEU%-4U*RN+3590L:1.L#VT;[!$RL-A) R3]\$GIC%=+KNDZOK$RPVFN7
M&DVJ1YWVB(99)"3U+@X4 #@<G/48YP_A=/&^@:A&&P_]JW<FP\-M:4E6P>Q!
M&#5SQ=XRL=#GBTR2YGM[BX4LUQ%:R3>0GKA%/SG^$'CN>!@@'.P^--<T_P"'
M=S->O%<:RFJOH]K=>7A+A_-\L2[1QQ\QP.I6M\ZE=^'_ !QH^B7%[->6FL6\
MWEM/M+QSQ ,3D <,I/'8KQBL+7([+Q'X!A/A:TNI(-#OK>YBC:!XVF,3!G"A
MP&8[6)SCD^IS6G=(GBCXD>'-1T^036&C6]S--<)RADE4(L>?[P 8D=N,XR*
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M;+J9_,$9E,<,+RNJ#JQ5 2%]SQ5.?QIX<MDL'DU:WVZ@ADM2N6\U0I8D8![
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M^G6NH+)=7$1EA7RW D4#)VL1M) /(!R.XI[^+=$2\6V:]PS7/V,2>4_E>?\
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MT/ID,Q/_ !\-D'S?^_0B&?5GKOZ "BBB@ HHHH **** "BBB@ HHHH ****
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M.A_QH Z2BDW DC(R.HHR,XR,T +12$@#).!ZFC(QG(QZT +129!)&1D=:6@
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M'(/>@ HKF[[Q!>6OCS1]#6&W:SOX+B0R[B9 T07C'0?>'K^%='N&[;D9ZXH
M6BBD# ]"#]* %HI P)(!!(ZCTHR-VW(SUQ0 M%)D9QD9HW#=MR,]<4 +67KM
MCJFH6<46DZR=*G697>86R3[T&<IM;@9R.?:I[/5;._N[VVMI1))92"*?;R%<
MJ&V_7!&?K1>ZK9Z?<V5O<2A9KV;R8$[NVTL>/0 '- #]-L(M+T^&SA9V6,'+
MN<L[$Y9F/<DDD^YJU7-Z1X@O;WQGXAT:ZAMX[?38[9X7C)+.)0Y.XGC^$< ?
MB:Z,D*,D@ =S0 M%4M4U6ST;3WO;V81PJ54'/+,Q 51ZDD@5=R,XSS0 45!>
M7EOI]C/>W<JQ6\$;22R-T50,D_E4&E7D]_I\=[/"+=9U$D<1^^B$9&__ &L<
MD#ITYQD@%ZBJUY)<K9O)8I'-,HW+&[8$G^R#V)]>:CTC5;76]*M]1LV)@G7(
M###*0<%2.Q!!!'J#0!=K.URRU*_TTP:3JO\ 9=UO5A<_9UFP >1M;CD<5)G4
M_P"W ,6G]E?9NN6\_P [=_WSLV_CFK@8$D C(H IZ5IR:5IZ6JRO,^YGDFDQ
MNED8EF8XXR22<#@=!Q5VBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XKXN?\DLUW
M_KFG_HQ*[6J6J:38:W8M8ZE;+<VKD%XG)VMCD9'?GF@#D_$,2+\6/!4H!#O%
M?JQR>0(EQQ^)_.N1UAK273(-:TOE#XHCVZA<N#<R.9]CJN -L8&5 ))*CH!7
MJDGA_2YKZSO9+7?=60*VTK2,6B!X.#GN.#Z]ZI2>!O"\QNC)H=DWVJ7SILQ_
M>?(;/MR 3CKWH Y6#P[I/B7XE>-;?5K5;NW$&GXC9V"Y,<GS8!ZCL>HR<=:P
M;9[MOAYX02ZGDG2+Q3!%;32G+20+.ZQDGOP./;%>HW/A?1;N[^U2Z?$)_+$+
M/&3&7C'1&VD;E]CD5+?Z!I6IP6L%W91R0VCJ]O'RJQ,OW2H&,$=CV[4 <)-;
MQ^*_%GB[1-2N+!)8?+C@CNK;S'CMVB4B2([QM^<L20,@XR>!7<>'[=8O#5C;
M-?-J2) (_M4J\SJ!C<?7([]^O>H-8\&^'?$%S!<ZMI%K>3P#;')*N6QZ$_Q#
MV.16VJJB*B*%51@*!@ 4 >(WR6\?P2\6JPC7[/K%TL0.!Y9%R  OH<>G:NJO
M='L-2^,H@O(!/!+X>+R0NQ*2'SP/F7.",8X/' ]!733^"?#-U<7L\^C6KR7I
MW7!*\2'())'3)P,D=>^:MIX;TB+4%OXK)(KI(?LZ2QL4*Q?W!@\+WP.,\T >
M46&H-8^$M"TB21DTB7Q//I\Q9C@0++(4B)_ND@ ^P(Z&MG4[=-!^(^OSZ):Q
M0W*^$GN(XX4 #2K*VT[1QGY5KN!X2T :3<Z4=+@:PN7,DMNP+(S$Y+8)X.><
MCG-+8>$M TN]2]L]+MX[N.+R5G(W.$R3C<<GOUZ]NU '%:%H]AJMEX7\1V^M
M6<+J4'F6EL5FNRX >*5MY+$G).1D$$\8-2?#SPYI5Q=:QJ,UL9+O3_$-\MI(
MTC?N1G;@#.,8/?/;T&.MT[P7X;TG59M3T_1K2VO9<[IHDP1GKM_NY]L5=TS1
M--T;S_[.M5M_M$AEE"L?G<]6.3]X]SU- &%XP:RFUGPY83))<7<]S*]M9LX6
M"8I&=S2Y!R%!R  3NQ^'G%_$I^%'C6W=TQ9^(72!8252(>=#D(,\+\[<>]>Q
MZMH&E:ZL"ZI80W0MW\R+S!RC>H/^<U2?P5X:>"Z@.C6@ANY!)<1JFU9&'3('
M7& <=,\T <T='L-+^+EE;V=LD<.HZ/<?;$.6%P5D3#/G.YOF/)R>:RM.LX]+
MN-4^&K0#R[N[%Q:N5SNL9"7DR?5-C1@GG+)7H<VA6"WB:I'9B74K>(I!(\S;
M@,?<W$G /?\ K5'0+;5;Z_;7->TV#3[W[.+:&VCG$QC3=N<EP /F(7@9P$'/
M)H W_L\(MOLWDQ^1L\ORMHV[<8VXZ8QQBO'+98M"\"^/M4TRTA@N[?6KN%9X
M(0)(H/,C#!2,$ *20 1C%>S,H92IS@C'!Q6;8>'=)TQ+E+.R2*.Z9FN$R2LK
M-]XL"<$GN3R: .+ETN#3)XO%.C:E8^=_9LX@M-.M/+CO@(RZ%\.V=I (/OCO
M7/ZA::9>_"SPGK:K%/?RW]A+->G!E>5I5\W<W4_-D8/ P/05Z;HGA#P]X;GG
MFT?2;:SEGXD>)>2,YQ[#V'%5CX!\*$RYT*S*RRB9D*_)O!SD+T'/7 Y[T <F
M]K%XN\1>,-&U.ZL8[B"58H4N;;S)8;<Q(5DB;>-OS%FR!UQD] (;K0[#4/&G
MA"QO;F35+>;1KF.:>1F7[6JB,!F /?.??K7<:MX+\-:Y=V]UJ>BV=S/;J%C=
MX^BCHIQU'L<BKDV@Z9/JEOJ<EHIO;9=L,VX@QKW"X/ /<=Z /+O%5CI2Z/XT
MBTN .-+L8H&ENWW"T,<68X[<8W ]"6+?>/\ %S6_?3-/XT^&TKOO=[>\9F)R
M23;KFNIN_"/AZ_O[F^N](M)KFZB\J>1TR9%QMY]\<9ZXIZ>%M$CEL)(].BC?
M3U*VA0E?(!Z[<'C/?U[YH Q_B?J5WI7@#4+JS>2-@T22RQDAHXFD578$<@[2
M>>W7M6;KEA!H_C'PA<^'X8K<WD[VMS'; *D]OY9;+ ==N 0??WKOIH8KF"2"
M>-)89%*/&Z@JRG@@@]16=IWAW2M)96LK01LB&*,EV;RT_NIN)V+P.%P.!Z4
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M>31X=.A&FR*5:T8%HL$Y("G@<G/'>I+'0M.TY9!:VY1GC$32-(S/L'10Y)8
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MGL+6#RH82,KY@7<VTM@Y]<$]JVIM"TNYT7^Q[BRBFT[8$^SRC>NT=!SZ=O3
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M!,B-I(%F(_YYF9 WZ5?\<26)@T:SNA-))<:E$MO:HX2.X<!B$E)!'E\9/!/
MP#TK?U;3+76M)N],OH_,M;J)HI%[X(QQZ&LW_A'X=6T2#3/$=K!?_964K*P_
MUC*,+(.ZMCK[D\D4 8'P^#6_B+QE8Y@2.'4(V2"WXBC+0J6"CMSUZ<]A3OAB
M7\CQ5%S]GB\1WJP>@7<"0/;<6KHH] L-'DNKS1-)LX=0N$6,NJA 0!A=V/X1
M@<#KBIM T6#P_HT.GP,9-I9Y96&&ED8EG<^Y8D_I0!RYB2+XW2NI*>9X<+N<
MD\_: ,X^@'Y5D>%_/T3Q#H6F:WIEM++-'(NFZ]8D;;T>66(F!^8.5&[))R>G
M>O0FT/36U@ZLUJIU Q>3Y^YMWE_W.OW<\XZ9YJ+3_#FDZ6\+6=F(_(4I I=F
M6$'J$4DA,]]N* -6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Y#XDW^HZ7X4
M^VZ9?26DZ7=O&2J*P=7E5"#D9Z-V(/O0!U]%>?R+K,/Q&&@CQ'?-97VEO=N6
M2+?$Z2*O[H[<*"&[@]/7D5=+UO5I/"=[%<ZX(Y;'7WTXWDL>Z:>!)0-JA5YE
M93M&%_7F@#TJL;5/$4&E:YI&E36UP\FJ2/'%*@7RU*J6(;G/0>E<+-XVU+P]
M9^.Y91<2QZ1]E:QBO2K.AF0 !BI.5W$'DYQQ5S7]-N++QMX#>75+J[9KN82^
M<5*L_D/\X  V]^!QTXH ]'HKS6/4/%7BC0YM7T&<P7BWLJVZR3H+<1QS%"DB
M;23E5))ZY/! XKL/%6I3Z7X*UC4H,"XM["69,'(#A"1^M $SZW&]IJ%S9VMQ
M>K9AQB  F:1<[HTR>2",>F>,Y!P_^V(HWL4NH9K4WJCRO-  $A&?*;!X? /L
M<'!KDT-QI'P-BN--NY+:ZMM#%RDR*K$R"'>2=P(.6SGOS2>,)9KKX+3WKS-]
MKCTZ&\6;^(2ILD#?7<* .^JEIE_)J-O)+)87-D4F>(1W*@,P4X#C!/RGJ*73
MKE]0T:TNFS&]Q;I(=O52R@\9],UYA<^(?$"?"C5]4769QJ%IJTENLYCCRZ"Y
M6+!&W ^4_P .* /6Z*XFUN-4TOXG0Z5-JUQ?6=]IDERT<ZH!%*DBCY-JC"X;
M&#GZFM'Q9K,^GW.AZ;;3?9WU6_%LUP "8T",YVYXW':%&1WS0!TM%<%XDU#6
M?!&B:W?G5%N[>5X$TU+A=SVS.P1R[?Q*"P89^E3:O=ZEX8\4>'8X]0N;RQU6
M=K*YCN-K,LFPLDJ$ ;>AR/NXZ 4 =O6=JFL0:7):0,CS7=[(8K:WC(#2,%+G
MDD  *I))_F0*\PNM5\2+X)\5:V/$EY]IT75;F.W411!9$CD "R#;R,<8&WKG
MFMWQ5;27?Q$\#2"]NH?/:[($97]WBW)RN5/7H<YH Z70/$DNN7-Q#)H.JZ=Y
M PSWL2HK/N(*J03NQC.1P014OB'Q%!X<CL9+BVN)DO+N*T5H0I"/(P4%LD<<
M]LUS<GB"^T?QCXJ%U>376GZ;H\=]%;L%&T_O"P!4#.=G?-8?B%+V_P#!WA#6
M[O4YY9[S5-.N)HACR?WCJP55QP%R #U..<YH ]9HK@;N_P!;\1:AXDL]*FGM
MI--E%M:M%,B!9/*5][@J2P+-C'3"],\U USXFG\8Z%I%[K+6K76D2R7D=FL;
M*LR,BEHV*Y&<G[V<<X ZT >BT5Y=8^*]6M-".GSZ@\MT?%#:%'?RJID$>[(<
MC&TOM!4<8R02#6UK]UJ_@S2]=U;^U!=V(@C-I!<C<\$I8(S%N,IEE.#^E ';
MTR66.%-\KJBE@N6.!DD #\20/QKD["T\3VWBFSF-P[Z/+"Z7<=W<([^9C*/'
MM48SR".!CH*I_$Z&22T\.;+NX@#:]9QLL3 !LR=3QS@@$=L]J .[HKC;>^N=
M9\::MX=^WW4%MI%I;DO&P66>24,=Y;'10HX&!DG.>!4_@+6M0U;3=3MM4<37
MFE:E-I[W 4+YX3&'P. 2&&<=Q0!U=%>?>,-2U&V?Q&]MJLYDLM.$]I;V(&;5
M@KL7G+?*02!A222H.%[UV.A7DNH^'M-O9\>;<6L4S[1@;F0$X_$T 9^K>*XM
M.FO8;;3KW4I;!(Y+N.S56:)7SC )!9L G R<?45O1N)(U<!@& (##!'U':O,
MM-=]$\8?$75#=W<XTZ.WN#&S+B;%J6PV%[=!C'XUHZ:?%=W)X?U>VNMUM<!'
MU!)YT,4L3J#F-0N5()&!GD<$GK0!U'B77H?#&@7>L7-M<7$%LN^1( I;'KR0
M,5IPR":&.4 @.H8 ^XKR+7KZ[\6_!C7/$CZA<0B=9S#;1D>6D*2% C#')(7)
M)Y!/& ,5TSZEJ&JZ_<Z%:-<116.G6\I-O.L3L\N[YLD'(4(, <9)SGB@#NJ*
M\SO;KQA9V_@ZSU+6%@U&ZOVL[UK549)%V.RORO#X X^[GL1Q5Z]CU33KE=*E
M\17U^T6G/)'';JJW32%VQ+(P 0(JX49(!(/!- '2Z[XC@T"?2XKBVN)!J-Y'
M91R1!=J.^<;LD'& >@/2MFO*;S5;K7/!/PWU.^</=7.M6+RN% W-M?)P.!FO
M5J "F22QP@&1U0,P4%CC))P!]2:Y7QMJNH:0=.NH[2_N-(5I/[0.GC,\8P-C
M8ZE <EL<].V0>6UBX36+3P)=V?B&ZO;>XUDJMS&0N]2)2"R[1\Z@!>1Q@\4
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MHL&HRI VUWDE)& QYVKCMU+#/3! ._K'\4>(H/"GA^YUFZMKBX@MP"ZVX4L
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M28K^ZM)].,A(,%X KH=VT9P2.>,<]Q59?$<!\8'PV;:X6Y^Q&]$S!?+9 X3
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M-_:RSVPM;J*!U"3Q@DC.5)4C)Y4@UJV>L:=J-Y=VEG>PW%Q9E5N$C;=Y1;.
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M]*@U#PW#J'B72]<>]NHY]-6188H]GEL)  V[*DG( Z$5/JOB'2=$&=2OH[<
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MG2>%\Q>9N5]Z@GR\$!O:NQHH Y'4? 4%UXADUJQUK5-*N[E%CO/L4BJMR%&
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MH+<B&WWL8S&FW&YL9ZGG'.,\=*B\0V#67CG0/$P_X]HDEL+QO^>:28*.?8.
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M;_2W6ZU1=0BN95D,L@$JN$DQTVA< C/  P*])B$@A03,K2[1O*# )[X&3@4
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MAT^.\9-.O+LV$0EO%@,>8 5W;3N<;FV\X7/&/49 -2'2M.MM1N-0@L+:*]N
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MY<*Q7<-K$;20<'N.:PK75M'C\6>)&@TV]75+2W@:\DQGSDP_EA!NQP W8=:
M.GMK:WL[=+>U@B@@C&$CB0*JCT ' J6N-LOB-I]['HMR-,U.*QU>18;>\EB0
M1B5L[4;YMV3C&0"N>]=-JNHQZ1I5UJ,T4TL5M$TKI"H9BH&3@$CM0!<HKE=/
M\=V=]8B^.F:G;V<EO!-!/-" L[2D!8TPW+[B!C@=\XYJ6/Q'9ZKJ=]X;N[2Z
ML[];3[1Y,K+^]A)V[E:-CT/!&0?PH Z6BO._ >O0:/\ "SPH;A)IY[[;;01Q
MX+22,7/4D #"DDD]JNZWX^-MX.\0:G8:=<?;](=[>:WF*#RI, AR0Q#+A@>,
MD],#L =O17(:IJVFR77A<:SI%\MW/>#[&25Q%-L;YF*/C!7=QS]*T+SQ5#!+
MJ"6EA>:@--Q]K:U"?NSMW;1N8%F"D$@9ZCOQ0!OT5RT_CW28VT,V\5Y>Q:TK
M-9RVT6Y6VH6P<D$'C&,<'KC!Q>\/>)8/$#7\(L[JRN["?R;FVN@N]"5#*<JS
M @@Y!!H VZQX_"?AV+4?[1CT'3$O=V_[0MH@?=ZYQG/O69KGB>^TWQKH>B6^
MF3SPWJ3RO)&\>7"*/E 9AC!8$DXZ#&>:LWOB^VMDU*:WL+V^MM,8I>36P0B-
M@ S  L"Q4$$X!].3Q0!T5%5[&^MM3L+>^LYEFMKB-9(I%Z,I&0:YUO'FGJ\4
MGV2\-C+J/]F+>;4V>?N*=-V[;N!7..OMS0!U5%1W$*7%O)#("4=2K ,1D?45
MYY\/]=AT?X6^%A.D]Q<7SM;P1QX+22%Y&Y+$ #"DDD]O6@#L+WPKX>U*^%[?
M:%IMS=<?OIK5'<XZ<D9-:RJ%4*H 4#  Z"N3N/']A:Z!JNK2Z=J)72;DVU]
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M3]0MK4Q2S.C'*!PV\[B2Y+#U]R*Q9? 6K/H.MZ6OR1:5<27'APJ>0Y99U/\
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MMT!)Q^52:'!J/A/7O$L,^G7=Y9ZE>MJ-G-;('W,Z@-$W/R$%1@G"X/45W=%
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MBO0F^6^0N^(H0000#D\!BV[C@9KG+34[)OAO\,P;J(&+6+17W-C&U7#=>PR
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M<'\2(/,^'^F6-I;&VFFOK&&VM^\3>8N%X] #^5=SJ$L4.FW,DSHD2Q,69S@
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M^[ P/E'&,EAFM'3_ !#9Z=\0-.U#5+N.'2[W0(X=/O)CLA\Q7S(FX\ G"GW
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M ,#TIKQI(A1T5E/56&13J* $*JRE2H*D8((XQ0$54"*H"@8  XQ2T4 -6-$
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M;6LL6IRQ2HB9+0F- @Y(YR!G/&/>NGHH 1E5U*NH93P01D&@*JJ%50%'  '
MKGO#'B"[UJ_UZUN[6&!M,OOLJ^4Y?<-BMDD@<_-Z5T5 "$ C! (]*7 HHH 3
M ]!7,ZIH>NGQ ^JZ3J5B8Y8$@>TU"V:1$"DG<A5@03GD'.<#T&.GHH RM'TA
MM.:XN;AX)+VZV^<]O!Y4>%SM 7)/&3R22<^F -3:I;=@9QC.*SX;F^@FU*;4
MQ9P6$+!K>5)#GRPN6:3(P,'/3M5JRNX=0L+>]MR3#<1++&2,$JP!'Z&@"8
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MW9MI)6<[D^1FX7&#]WKG\*U;5]2;4KY;N*V6Q4I]C>-R9'&WY]X(P/FZ8[4
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M[KOB"[TKQ+X>TV.UA>VU2>2&25G.]"L;/PN,=NN?PH Z*BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *X[XA:H=.MM"BEE,-A>ZM#;7L@;:/*(8[2>REE4'V)'>N
MQJIJ>EV.M:=-I^I6L=U:3#$D4@R#_P#7]Z .!\:V\7@OPYXGU/P_<3V]U<V\
M+-:08$5LN\1M,B@?(Q4DY[E<]C4WB"R@T+7?!]]X=186O+];.X2 \7-N\;,6
M?'WBH7<&//O75Z3X6T/0]-FT_3].ABM9QB9&S)Y@QC#%B2PQQ@GI3M-\,Z1I
M+Q-9VS*84*0"29Y!"IZB,,Q"#@<+CI0!Y;)HUG=>"OB-<3^?)-8:G>R6CO.Y
M,+)$C*RG/4$#GKCBMA[.*Q\3^ -3@:47NIB2.]F,K%KA3;%\-D\X8 CT[8KM
M5\(Z(EG?V@LW^SZ@[27<?VB3$S-]XM\W)/?U[TZ3POI#G3W:UD9M-'^A_P"D
M29BXQ\OS>G'TXZ4 >:VGA?3]:T#QU+>SW?FV.KWIM)C=29MF1$96'/7@<G/
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M.]\>^$;%[J>^LQHURGG22'=<*#$,LPQNW=3V/T-=7JW@CPUKE]!>:CI$$UQ
M@C1^5^0=%.T@,OL<BKLOA_3)M5M]4:V(O+>/RH9%E=?+0]5 !P >.,4 <W\,
MU^SZ?K^GQLWV6QUVZMK:-F)\N(%2%&>PW&JWC+2["[^(_@DW%G!*9YKM9=Z
M[PMN2 ?7!KL-+T/3M%-R=/@,/VJ4SSYE=M\AZL=Q/)[GO3+_ ,/Z9J>HVNH7
M<#R75H2;>03.IB)&"5P1C(X/K0!S.DQ+;_&#7(HV?RSI-LX1G+!27<< G@<#
M@<5Q=RF?V=]:D#R(\=U=,I1RO/VMAS@\C!/!KUI- TV/5Y]62!UOIX_*DF$S
MY9.PZXP.WIVJI_PAF@?V)+HOV#.FS/YDEL9I-C-G)S\W<\_7F@#G-=TVWO\
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M^&-)N[B6>:"8R31+#,1<RKYJ#("N WSCD]<]3ZUJ"&-8! BA(PNQ53Y=HQC
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MG-X9BGAAO(#+%/-A 1MW*"RJ,C.< GBNV\&Z0V@Z7<Z8=6.H+#=OL^0J+=6
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MERT C*LN0\.SY@0>Q)R.O/- '<T5PFB7FO\ BGPWI?B33M72V>XN/.>UE13
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M#79)Y-6C9M2B6*)O*Q'N9@-OR!7^0@^H'7F@#TZBBB@ HHHH **** "BBB@
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M>([4ZI,4UYG:Y/E+F,NFP[/3Y1CG-=94<\T5M!)//(L<4:EW=C@*H&22?3%
M'-'P;F?PW-_:<V[04*0?NU_>Y3RSO_X#Z8YYI]QX0^VJ+:^U&2YL%U#^T$A>
M)=Z/YAD"A_[@8],9QQG'%=!:7=O?V<-W:3)-;S()(Y$.5=2,@@T^66."%YI7
M5(XU+.[' 4#DDT 9NO:/)K=I#;"^DM8TF29PB*WF[&#!6S_#D#([]*;XET&/
MQ-X<N]%N9FCAND"2.B G'7C/ .0*T+*]MM1LH;RSG2>VF0/'+&<JRGH0:GH
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M;2V0!L(&">61R&&XG//L.@KE] :YB6UA\.^-KS49(_+0V4VD(H91@$2-L5D
M&>2<_4\'UFB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YKQ[K<OAWP;?ZK'86]\L
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M&LN.&_=YR,=NOM6I-X>UB?Q1X5U,K8K#I-M-#<*)W+,9$1<K\G(&S/.,Y[4
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M:>,!KM[8V6AK%YESIJ:D\MR"5BC<@(NT')8G/<8 [\"J-KX9U[3[;Q)IEL;
MVVL7MQ<QWC2L'@$P 8&/;ABO;Y@#WQ3H?!ESX>\0:;JOA[R98H--32[BTN9"
MF^-#E'5@I^<'J",$'M0!4OOB->6GA?5;X:5"=2TB^2RO;8SG:"SJJO&=OS [
MP0#M[^G/8:/-K$R7)UBTM+9A,1 +:8R!H\#!8D##9R/PKCM8\":G>^&M<@MW
MLO[5UJ_BO)VDE<11+&Z%4!"DM@1XS@<L3[5Z#&9#&IE55D(^95;< ?8X&?RH
M \MU#6M/\/?%KQ)J.HPS26L>B0-)Y-N9<#><Y ' ]SQ6I\.;";PWX3U;4]0V
M6VG75U/J5M:QR"1;6V8;@H*DCH,X4XJ_;>&]4'Q%U/7;J*P?3;VQ2S,7G,SX
M4YR5*8(.2,9J+1/".HZ1::IX<>6WN/"]RLB6H:5A<6L<BG='C:0R@DX.01[T
M -M_&VHRWNBN-+:>QU1U1A!#*9+/<,HSL5VLO8D8QGJ15+0+VXTR[^(5Y96$
ME]<Q:GNBM8CAI6\F/ SVJ_X7TGQII<-IH^IWNERZ78[4CO(=_P!HFC3[JLI&
MU3@ $Y/'N<U2N/!WB*;3/&5O!=6=I/K5R+BVECF<[0 BE'^0$!E0@D9^\: -
M2P\4WMUXIO?#F=.GNX]/%Y'<0,3&K;RAC=<DY!P>#R#T%<U8>+M9MO@F?$^H
M6EEJ;E&F:.5V4,&F8'(P0<$C"\<#K6]IGAS7H?&UKKD\>DVUJ-*^P26MJSGR
ML2;QLRH##\%QZ'&3DCP+XB_X5+<^##)IAEV^3!/YL@4IYA?>WR<'&!M /KGL
M #K;S79I/$P\/::L/VM+3[7/-/DI$A;:HVC!))![C &><@5SE[\1KRU\,:I?
M#2H3J6DWZ6-[;&<[06=55T.WYE.\$ [>_ISJ7>@:K!XSM_%.G+:O-+9?8K^S
MDF9590VY71]I^8'(Y R/2LK5_ FIWOAO6H('LO[4UG4(KR=I)6$<2QNA5%(4
MEL",#.!R2?:@#7M?$VJ1>,)M#U73[9 ]@U_;-:RM(VU7"LC9 ^;D'CBCPKXJ
MG\3Q6=[;/8364\1:=8'/FV<F 1&X/4]03A>G3G-)>:%K,_CJ#7HA91PQZ7)9
M8\]BX=V5MP&S! *XZ\_I533O"%V/%VG>(KBTL-/O889$OWL96(OF90!N7:O
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M"RO)7"!TR%='5<G )&"!^O%C5_#FN7.H>&=4M[FSN+[2YIGN!.6C1Q*A5MF
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!116/XC\26/A?3DOK]+AH6E2+,,>[!9@HSV R10!L45@Z;XLLM1URYT=K6]L
M[N& 72B[B$8EA+;=Z\DXSP0<$>E5SXXTQ(+.\E@NX]+O)1#!J+(ODLS'"D_-
MN56/1BH'3GD4 =-17)VGB6YU+QQK'AU],NDM;2WA_?+(@Y??ER0^X A0!CGK
MG%<Q\/\ Q?:Z-X%T2&_@U&2.>[EMFOO+WQ1R/<.$#N3DYR!D @9Y(H ]3HKF
M1J&C_P#"P;B 07O]L0Z7O9\/Y;0>9P%7.&;=GD#L1FJ4/Q,T>>PL]06RU06%
MQ<_93=-;8CA?S#&-YSD L.P.,C.* .SHK&O?$EM::C<:?#;7-[=VUN+F>*V5
M28T)(7.YAR<' &3Q]*ET#7K+Q+I,>IZ>)C:R_P"K>6(IO'J >H_P- &I17,0
M:EHP\;ZLD5O??VK;V,9N&VN4>+<VT(N>3G/('XU4M/B5H]Y;:5>1V>IK8ZE.
M+>*[>W B21F*JK'.>2.H! S@D'- '9454U2];3=+NKU;:2Y,$32>3&5#/@9P
M"Q _6O,M;UZXUOP3X.UV[@NK2635["1]K_)(K."<*C'</3<,^U 'K%%8&F>+
M;34M0U#3_L5_:WEC&LKP7$&'DC;.UT )R#@CUSU%9WAO7]"MO!^CRZ/!>&SO
M9Y(+&WE;,TC[I"PR[?[#GEN@QUP* .PHJEIFI+J<,SBVN+9X96A>*=0&##'H
M2".1@@\U@^/9-4N=#;1="F,.K7\<ABD!P8T1=S-[9.Q,]C(#0!U=%87@WQ"G
MBGPEIVK@!9)HL3ITV2K\KKCV8&J4_C_28+&#4/L][)IMQ=&TAO(H@Z22;BH
M ;=@L" =N"1[C(!U5%<G>^/]/L]3N=-33-8NKRW@CG>"WLRSE'.,@9!.._\
M6K&J>-=/TFWGO)K:\DTZVF\BYOHD4Q0MD*<C=N(!(!*J0#D=C@ Z2BL+4_%-
MKIZW;16EW?K9Q":Z-H$;RE(W#.YAD[?FPN3C''(S4;Q[H[7>FVUJEY=OJ5JU
MU:-;P$K(@ . 3CGD?3OB@#J**XP_$G3/[)N]072]89;"5XK^(6PWVA3[Q?YL
M8 .?E)..:WKC7[=#;I:0SW\]Q!]HBAMMNXQ<?.2[*H'( R<GMT. #5HKD?\
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MMX:] ]OI,T=M<2+J9'DA-A*@H7RWS=-H)R,_F10!K45S5]XWTW3HTNIX+O\
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MTMN[#F.7;N^ORDC]:YC0/&;ZC<>(Y-1L9;"RTJZ>(S2M'MC1(T9MY#$YR2>
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M]RLCO=7"6MO%$ 6EE;.%&2 . 3DD#BJ5MXPTN6QU:ZN3+9#29#'>QW"C=$0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N/^)=K=7WA1;:RM+BZG-[;2;(8RQVI*KL3CIP#7844
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MJ3C!KTBQB,&GVT+0PPLD2J8H!B-"!T4>@[58HH **** "BBB@ HHHH ****
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M %?+C*CCMG./QKES<:/=Z%K/A*X\1Z1;I)K<DOVJ[NQ%.BB<.V8V'+[E*@Y
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M% W9'!SC->/:UKFEW7A^22VN+?3XX/$R22Z>&S*C"Y&^:8L25R>1C:!D#)H
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M:7R\@=><'^5:=I.;FR@N"NTRQJ^/3(S0!-1110 4444 %%%% !1110 4444
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M^;:A[R9O)X(VKEN$P>5Z'N#0!@Z-$/&?AG4M3N=6N;#4X=2G!N8I2#8B*7A
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M GAZ#PW<>'X[27^RYVWM US(VUMV[*$L2IW<\8YH R;NZ:S^+-RK7LMO:?\
M"./<29D)C1A,!YFT\9 '7%86E37%KXD\!R6LUVUMJ*7*S75Q,?,U!?(,@D>/
M) R0&7)R <8'2NU@\#Z%!?B^-O//=&U-H\MQ=22-+$3DARS?/G_:ST&,8J"V
M^'?ANT&G^7:W#'3G+VIDO)G,0(QL&6^Y@XV]#W% %/P7_P C?XY_["<7_HA*
M@\96RWGQ#\#V[22QH[7P9HG*-CR!D!AR,],C!]"*ZC3/#VG:1?WU[9QS+/?N
M)+EGG=P[ 8!PQ(' QQCBB^\/:=J6KV&JW*3->6&[[,ZSN@CW##?*" <C@Y%
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M$FNC5;17T34[B%85LQMG2)P-K$G*@C/3G/?M7J89I[4,C&-I$RK  E21UYH
MS_$'B'3_  UHT^JZ@TOV6#AS#$TA!SCG'3GN<"M4'(!]:\1F^VR_ +Q'<WFH
MS7;23W /FJO471!;( //Y#MBNY75M9TGQ[8:;J%_#=6.HV,\XC2W"?9WB*GY
M3G+ AN_<=NE ':T5YW9Z_P"+=8TS2->TBRGFBNY4DFLY/LZP_9F/\+;O,W@8
MY/!.?E'2NK\5ZX?#GAF\U1(Q))$%6-&Z%W<(N>1QEAGD4 ;-%<=:OXN_X2*.
MW9;IM(N+=Q+<W*VRR6LPY4H$)W*>F""1ZU2T'Q#J^H^''LKJ\V>(XM4;3IRD
M2!596W%E4C[OD@N,]?6@#OJ*X.]UOQ!JTNO0Z +H3:7,;6W*);LDTRQJY\WS
M&! )8#Y<8QG)S@,.L>*[KQ?I>CR36VFF[T9KJ>(0B5H)E9%;#;B&Y)QVYYSB
M@#OF944LQ 4#))/ I:\@UK6M:U/X9WIN=29+RPUT:=--!&J?:56X5,D8.,@\
M@=<>F17K,,4L=H(GN7EE"D&9E4$GUP!C]* *>N:]8^'M'N=4OVD^S6PS(8HV
MD*_4*./J>*OQ2K-"DJ9VNH89]#S7C>+V3X/>-Y[S4I[L_:+Z,^:J\E9,;L@#
ML!QT'8"NLM=3UO2_%_AS3KN^AN;'5[.8B!8 GV=HD1@5;.6R#@Y^O'2@#NZ3
M<I8KD;@,D9YQ_D&O.+CQ3K5A>Z,TU]%/-=ZT-/N[6"(/;11NSA0LNT'S  I(
MW'DG('%7/"RW[_$GQB)]4GFBMY+5%B=4QM:$L%X&0 6.,=>^: .[9@HRQ &0
M.3W-9EOX@L+KQ%=:%$9OMMK"L\H>)E7:Q(!!(^;H>F17-?$;[:+GPHMMJ$UM
M'/KD$,B1JI#?*[ G(.<%!@=/4'C%*2UU*?XLZG;V.I"UG_L*V#730+(W^MDY
M"G"Y)_#VYR #T:BO.-'\;ZGJ?AKPLKQEM3U>2XCEDME3($!<.R!R%W':.O R
M>#C%=)X7F\1FYU.WUVW?[-%*IL+J4Q"2:,CD.L9*@J>,@#(/2@"UJ?BK2='U
M2TTV]EN%O+S=]GBCM)93+M&6VE%(.!R:FLM?L;^_^PQ"[2X\HRA+BSFAW("
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M[#:06YR%Y.>.P[UO^-M1O]'\%:MJ6G311W5I;/,K21[Q\HSTR/Z_0T =!17
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M^;2I;I4\GYA(LB*"6SR.3P,?UH ZNBO)9O%?BR+P/JGB5M4M=VE:E+"UNMH
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MDNC +52\4CD,WS[N5R,@8!]R.#V%GJ&EZJ9'L;NSO#$VUV@D638?0X)P:O4
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MRU*V:+^[VLNT\G+8;&[IQ]VNXM[RUNVF6VN89FA?RY1&X8HV,X;'0X(X-3T
M<O;>#_L^H^()/[2E-CK19Y;41*"CM&(V(?J1@9 P.?6LV7X=S2^&-)TTZ_<1
MZCH[*=/U&*!5,(5=@4IGY@5X.3S^E=M//#:V\EQ<2I%#$I>221@JHHY))/
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ME+*/N?( I QSC;P*Z?3M(UG3?'NMZI]GMI;'5(+8LZS$/&\2,I4*1SDD8)(
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M);YH8BXMD8$J6_ $X&2!SB@#?HKE=0\9):^+-(T:"SN)X[VWDN3<1Q%E*@#
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M&S ^;D]L@8.<8J]H>MV/B'28=3TZ1GMY=P&]"K*RDJRLIY!!!&* -!E#*58
M@C!![T(BQHJ(H5%& JC  ILTJP0O*X<J@+$(A=OP !)^@KEK7XC>'KR/39H9
M+LVNH3""&Y-K((A(6*JK.1@$D<#Z9Q0!UE%9%_XCLK&XN+<1W-S-:QB6Y2UA
M,AA0YP6QW(!.T9;'.*R-8\=VEHGA^33HI;^WUFX5([B!"R!,%CCN6.TC';G/
M3D ZZJU_86^IV,UE=JSV\R%)$5V3<IX(RI!P:X.+7ETCXD^(C</J=Q!_9]K-
M%9QK).R$E]VV,9VC@9Z#]*V-6\0^']1T;0K^2_O5L[^]MS9RV@D7S)"PVHY
MX4GJ&QT/I0!T>G:=:Z3I\-A9(T=M H2)&D9]JC@ %B3@#M5JN=O/&VD6>JWF
ME[;Z>_M(EEDMX+.1W*G."H ^8<=1Q[U/'XLT>;0K#6(;DR6NH.L=H%0[Y78D
M! O7.0<YZ8.< &@#;HK&TWQ/IVJ:K=:5"+E+^TP+B"2W<>5D9&7QLY'(PQR.
ME5_$U[I=O=Z)#J-S?022ZC&+7[-O59)><([*,;3R2I/./:@#H:*YJ[\=Z-:7
MVI6.V^GN].5&N((+*1W 8$@@8Y&%SNZ<CGFMO3=1M=7TRVU&QE$UK<QK+%(!
MC<I&1P>GTH M45QD?BDZ[J'B?1UM;ZU73T$2S*K1MN,9<MN!^7.5QW_/%9_@
M3QG8IX5\+66H37CW=] D2W4L+M%)-@G892,%S@]^H(ZT >AT5S5IJFC+XJUY
MEO;P75I;1->QSEU@A0!R&0, .0"21P:T+#7K:_O([58+J*26 W,1FA*K)&"H
MR#_P)>#@C/(% &K1574K^'2M,N;^?/E6\;2,%&2V!T [D] /4UR'P^UO5Y[K
M6]!\1NIUBPN?/X.0T,WSKM/<*2R^P % '<T5DW_B*RL;R:TVSW%S;P?:9XK>
M/>T47(#'ZX. ,DX. :S7^(/AQ=/L+_[3<FUOYQ;VTOV*95D<C(P2H[=/7!QG
M% '445@VWBZPO+.*:WM[]YI?,*VIM62;"-M8E6Q@9[G&<X'/%.M/%ND7^DVV
MHV<[SQW,AAAB2,^:TBYW)L/((VG.<8 R>.: -RBN7F^(&@6VD7NHW$MQ$EC.
M+>ZB:W?S()"0 & ' .1AONG/6GGQSHR:I)IKB^6[$7G0QM9R9N5!P3$,9?GT
M[<].: .EHK#T_P 6Z1J.C3:I'-+'!!,;::.6)EECF!"^64QG?D@ #DY&.M1?
M\)II$<FHPW7VJUN-/@^TSP2V[&00_P#/10H.Y>#DC..^* +^F:!INC7%W/8P
MR1R7DGFW!:=W\Q_[Q#,>>!S[5I5S-CX[T34+S3+>%KI1J<>^TFDMG6*0[=^P
M.1C=CM[$=>*30_%O]L^)]:TH6-S"FGR)$'>(C<2FXDGL#D8!Y_.@#IZ*QM;\
M4Z5X>N+.#4II8WO'*0[8'<,0"<9 (SQTZGL#5&R\?Z#>V6J7(>[A.E#=>P3V
MDBS0KC(8QXW8P"<XH Z>BN;L?'.BZA$\L+7:Q+%#*LCVKJLHE.$5#CYVSQ@9
MYXI3XUTJ,:FLZ7<-QIL0FNK9X#YBQ'GS !G<O!Y7.,<T ='163'XBL9=,TW4
M(EG>#4B@MML1+-O&Y21U P,^PZXJMJ7C'2=*$DMTTXLXIA;S7BQ%H89"0,,W
MU(!/(!X)!H WZ*YN[\<:/:ZC?Z>%OI[VQ19)8(+.1W*MG!4 <CC[PXY'/-4]
M5\?6EO9^';K38)[VWUJYCCBFCB)"H06/'7=A2 /KGIR =A16)=^*;&T^TEHK
MN1;55-TT4);R-P# ,.N<$$X!P#DX%:MU<"TM);@QR2"-2VR)=S-CL!ZT 345
MY3KOBR;7_AGI_B",WFG.U_;,2KO$IC:<+@D'#C;U[9KN],\5:9JFJW6F1?:8
M;NVC$S1W5N\)>(D@2+N RN1C- &W16 GC'26OK"V9IXUU E;*XDA*Q7#8SA6
M]QR,XW=LTOC9Y(?!&MW,$\T$]O8S3120R,C*ZQL0<@^HZ=* -ZBO.=%DTS4?
M!VC2/XFO$UB]M( &359'?SW5?^6>_!Y))&.F>E=7<>*],M-?_L2X,T5Z;=[E
M0\1"/&H^8ASP<>F<T ;=%92>(+)]*M=0VW"QW9"V\3PLLLI() "'G. 3ST )
M. ,U7M?%^CW-OJ4KSM:MIC!;V*Y0H\!(RN1WR.A&<]LT ;M%8"^,--^VW-C+
M'=PWD%K]L-O+ 0[P9QO4=P#U'4>E+_PF&D?8=&O1),;;6)(XK.00MAG<94'^
M[D ]?2@#>HKEM,\8C4/%.N:4;"[CBTSRUW^0S%F*LY/&>"-NT8R?QJII?BKP
M]HW@RQU*"ZU*XTJ>X>**YN$DEDWF5EPQ/S ;L@9QVH [2BJ,NJ00ZE!82+*)
MIH7F!V?*JKC<6;H,;EZ^M9T?C#2GO[&U8SQ#4,BRGEA*Q7! SA6]2.1G&1TS
M0!OT5D^)M6?1/#6HZC%$\DEO;R2($0M\P4D$X[<<FN+T?5]+TK3_  _XCU34
M-:@N+ZWAM95E65H+F:15.]@05&"6P1CC(&0,4 >E45@6_B_3;J"!XHKWSYY)
M(XK1[9HYG,?WSM8#"CCDX'('4XJ.;QSH4&@7NLRSSK;6,AAND^SN9()!U5T
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M;G[) WDMQ.,YC88RI^4]?2K1\4Z4EWJ]M-,\,FDQ+/=F6,@)&P8A@>XPIZ4
M;-%8X\2V,?VK[7'<V0M;8W<K7,14"(9^;(R#T/'4=P*=%K]M++-!);7T$D<'
MV@J]NV3'G&5VYR?8<CN!0!K45QFE^*_#>B^$-%N8[^^ETV]E%O:7-RLDKNS.
M0-[D<<Y^]C@>U;&E>*M,U>]OK.+[1!<62J\T5W \#!&SM<!P/E.#S[<T ;=%
M<TWCO18TL99#>"WU D64RVKR+<D?W0@+=.1D#(Y&170W%Q#:VTMS<2K%#$A>
M21S@*H&22>PQ0!)16'!XLTR:^LK1Q<6[WZEK-[B$HMP ,X4GH<<[6P<=JJP>
M/=$NM3;3[?[=+.EX+*3;92XBD(!&\E?E'/4XS@]@30!TU%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5QOQ5@N+OX;ZO:6EM<7-S,J+'%;PM(['S%/103T!KLJ*
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M&UDD2)6CV@DJI'4TVP\V/QEX]N'LKX07,%J()#9R[9BD+*P0[?FP2!Q7H-%
M'+?#B*:W^'FAVUS;SV]Q!:K')%/$T;JPZ@A@#7!>)Y-3U70?$-O-HVK+?0:L
MCQ6MK9NL!@6>,B7*C$S,HR>6.>@ &:]FHH \[TZ^N?#_ ,1=>N=1T_439:VE
MM-97$5I)+M*1[3$X0$HV>1GCK7+Z-;:MI?AKP5JSZ1J+0Z-J-ZU]:"V;S0DS
M2!953&6"A\\9ZU[910!Y]I%Z9_B5KFJ+8ZBMA/I=NL4[V,J!RI<D %<YY'&,
MG\JYVRL=0M_A+X,$FF:@)M+U>VGN[?[))YT:)*Q8^7C<< @\ U['10!PURTU
MQ\5]'O%LKY+?^R)HFF:U?;&[NC*K-C . >">.]<]IMK?6OPGU+P/>:==OK4<
M=Q9Q 0.8[CS&8I*),;=OS DD\8.<5ZU10!Y[IEE<:7\2[!)8;N6"U\,I9/=B
MVD,;2K*IQNQC) SUJMX7UY?"/@R[N]3TO5@AUBY+*EB^Y(WD=Q*0P'R!1DGM
M7I=07=G#?0^3< M$2"R9P']F]1[=#WXH DDD6*)I&W%5&3M4L?P Y->.6UI?
M1_!OPU8/I>I"\M]3A>6W^Q2^8BK<EV)7;D#;SFO9J* .!T:6?PWXT\3'4K>[
M:TU26.]L[J*VDE#CRPK1G:"588& >HZ5S\&@:CX>\,>#7GL;IQ:ZX]Y<06\+
M3/;1R>:5&U 3QO7..A)KUZB@#A-+DE3XG^(+Z6QOHK:73K9$D:TDVLR;RR@@
M$$C<.A/MFN4L[2^B^%/@VS?2]2%U:ZQ;RSP?8I=\:).S,Q7;D *0<U[-10!P
M]DTD?Q8UF]>TO%M7TN"-)S:R;&96=F ;;@D!AQ7'VD,MA\+O"C7&GZI#J-AJ
MYDC1;)VDB/F2MEHCAG4H3PO/(.1@U[16)K_ATZU/8W=OJ=WIU]8LY@FM]K#Y
MP P9'!5A@>F1V- &!X,U'2;SQ+K%VLUX-8U)8Y)8[FPEM5\J(;%"!^N-W)R3
M\W85+\0DFEF\*^1:W4_D:[;W$I@MWD\N-5<%FV@X W"N@TS1YK287-_J=QJ5
MV$*)+,B((U)!(544#G Y.3QUK5H X/33)!\0_&=U+9WJV\]K:+#+]DDVRE$D
M#!3M^;&X=*O?#"&>U^'&BVMU;3VUQ!!Y<L4\31NK GLP!KKJ* //;(W&G>+O
M'4<^GWY6]\J:WECM7>-U%N%.& P3N&-HY]L9(PXK>\3X>_#RU;3=1^T66J6<
MES%]BEW0JFX.S#;D 9'->O44 >>;77QSXUN)M*O;FTFTJ%$0VT@2Y*))OC5L
M8).X#CUI/!]E?:1XEALM+O=0O?#3V;MY6HP,LE@X*[8U=P&((S\ASC;],^B4
M4 <OXC)U76=-T$I?1VQ?[5<7,4#[ 8\&-/,VE02Y#?2,@]17.>(M/N?#'CW0
M/$5BFK:EYP>PU%4@><BW;E7^1> K<XZGM7I=% 'F6N:F-%^(&HWEK#J4?VS3
M8$GDCTR2[1CE]APA!1E&>&ZYZ#&33N%TT>%O!-EX>AU&\M-+UN S9LI3)$J*
M^]I%VY4Y<'D#[PQQ79S^%+M-:O-1TOQ%?Z?]M=9+F 1Q3(S!0H9=ZDJ<*!P<
M<=*V]/L(]/@9%DDFDD;S)9I2"\KX W-@ = !@      "@#A?%9DT?Q[:ZY>:
M/>:EHMSIXLY#:0M*]M*LC.&*#G:0V/J*H:U9&P&@^(=/\*7 TBWN;AKK3H(<
M7!29% F,8YW IDCK@C.#G'JE% 'E/BF"VU'X=Z[-H?AJ]MFOY+8*!9.+BZ*2
MJ2S( 6VA>A;'0]L9WM2:2;XJ>';N.TO&MH["Y2286LFQ&<H5#-MP"=IZ]*[B
MB@#QR;3=5GT3Q--::5>330>*?[5CM)8'B-Y HCR$+ 9SM;&/3Z5NBXTS6-%U
MC4=+\+W]K,=+FMVGN;%TG9F'RPHO+,,Y)QP#CKSCT:B@#RQXKD>'_AG'_9^H
M>98SVYNE%G+F +;LC%_EXPQ YK=\-K<6/Q$\6PSV5VJWL\$\$_D-Y+((%4G?
M]W(88QG/MC)';44 <)\0;A+77O!4\BR,B:L<B-"YQY+\X')QUXK.UG3Y=0UC
MQ=K]I:W)MI= .FQ!;=]]U,=YRJXW$#*+G&.OI77Z[X<;6M3TB]%Z8#IEQ]HB
M01!@[[2OS<],$\#'UK=H \SU6QU&?X6>%YK/3+FYN-)-G<7.GM&T<LJQQ[9$
M"L =PR2/IQFMWPQ)I&L7LVH6'ANXLE:W\B6YOK4PR."0?+ ;EE'.>V<8SSCK
MZ* ."\#Z)J6F7MSI-]$PTW0YY8],D8Y\U)<,I^J(Q3/^T1VK!TJ.+3CJ/A?7
M_"-]J-TUY/);3+;&2WO(Y)&D4L_W5P6YW=,>M>MT4 <)I(DM/B9XBN);.[2V
M;3[6..5;23RW:/?N"';@XW#I7*Z99W]G\// +S:7J(;2]762\A%G(98D_>C=
MLV[B/F7H#UKV6B@#RWQ1:7+:MJFL>'O[5TWQ @B7[,UNTEMJB^6I"LN"A(R4
M)!^7:<\<UZ=B1[;#J%D9.0#D XJ2B@#QB**^_P"%,Z-I#:1JJWUE>6RS0FQE
M)!2?<Q "\@*,[AQSP2<@=%K-E=:K\1KY;>"[CBN_#$ME'=M;2"-9FDR 7VX!
MP<UZ+10!YAX2FM;VWTG2K_P9>0ZWIS1"62YM3Y$+1X!F24_*<@$KCG)],FNP
M\<;V\#:Y#%#/--/83PQ1P1-(SNT;  !03UK?HH \^T._TVQ\"Z)'>:)JDE_8
MV=N?(329_,$R(O .S .1C.<>^*3QMI-UXMC%M!;FWU#1XA>I<26SM'),0?W"
MG&'0@$/C.<J,'G'H5% 'F.OZCJ&LZ/X9\4#P[J,@T^X9M1TIK=UF57C*,R*0
M"^TG(QU![<X9K6G_ -N^$M3U#POX<FM;CS;6X N8#!-?&&0.4*M\Q   !/4\
M"O4:* .3L-<'BRVG:ST6^M&-H\<DVH6I@968<1KNY;GDD<#'J:X6VGNI?!?@
M33ET;5_M.DZK:"^4V,@\KRPX;J/F'?*Y '4C(!]FHH X?1&GT[XD^+3<6-Z(
M;[[+/!.MN[1LB0;6^8#&01C;U.>!UJCX.\/_ -L_!^3P]J=K<VKS?:D=+B!H
MVC+3.Z, P'3*L*]&HH X/0M.US7/ ^HMK$9M=:O+!].7<?N[%9-Y]-SEV^A7
MTK.\)SVFH1:3IM]X-O(-;T]HQ-)=6I$,#)@&5)#P<X.W;DY/IDUZ;10!B>,=
MQ\%ZW''%--++8S11QPQ-(S,R,  %!/4UQ.JK<2>!? <2Z?J#RV=_ISW,2V4I
M>)8@/,++MR /_P!5>HT4 <-K:7>E_$K2?$;07$^DRZ=)I\S11,YMG+B1790"
M0&P%)QQCG%<WXCT:]N-%^(NJVUE>.FM+;PV5NENYDE,:!2^P#(!)/) X7/0B
MO7:* ."U5I)_'G@:ZBL[UH((;OSI!:2[8M\2JH<[?ER01S5CP6DR>*?&+RVM
MU#'<:@DL+S6[QK(HB525+  \@]*[6B@#@=6ENM ^*D.MW5G=W&D7FEBQ$UM
M\QMY5D+X94!(5@>N.M<W+#>S_#_XB6RZ5J8GOM3N9;6,V<FZ97"!2HQD\J?I
MWQ7L5% 'G/B&P@U*YL+B&?6-&U:WTY&M=3MK:0JV2<PRIM(."H.P\G/%48[_
M %_0M?T'Q-KFCW4L-WHJV-ZEA;F1K28/O!,:Y(!!P<="/85ZI10!YWXL:XN-
M*\/:Q%HUU!:V>NQ7DL$=N3,L.UP9&C7)SELD#)P>><BJ@D^U^*?&=W=:#J=Q
MIM]I=LB1M:R*;A560,HXR&(884X;V%>GT4 >7:=9WFG#6-.#:EX@\*G2G9(;
MR!Q<1N3C[.K$!GRN>.JX X[W_"4%_HNNSVMO?ZCJ7AE+$RQ-?6[^?:2;@!"K
M%0S@KD[<9&T?CZ%10!XS86E]#\+/ ]G)I>I+=6>L6\EQ#]BEWQ(DS,S,-N0
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M*E@ >5-=M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,D @?2[)H0YD$;6Z%0QY+8QU/K5FUNX+V(RVTJR1B1XRR]-R,58?@P(_"IJ
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M^G[?L4JS,LUOM&!M<<\  ?@/2M;1M%M-#L?LMH9G#-ODEGE:625NFYG8DDX
M'T % '-Z?KL6OP+XCT]YWL[+3/,6%9WVR3.H?8Z@X+(H YS_ *SVK(T:VUK6
MM'\->)+;5HK>1VAGO)FOI9$N4?B2(Q$!%.XX&/ND8%=WH^BV&@V!LM.MUAMS
M+)+L']YV+']3^6!6+I?P\\/Z-JAO;&*ZC3S3,EG]I<VT<A_C6+.T'T].V.*
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MD5D&3\WS#YNG&,]\8,7A?^V7^)?B:&_U43BUMK ,BP!4.Y)3A1G*C<2>Y.:
M.PT36K'Q#H\&JZ;*TMG/N\MV0J6 8J3@\CD&M"O&?"FK:WH'PU\+:E!<VIT]
MKY;66T,!+.DEPREM^>""> !CCG-==J'B#7-2N-=@T!)%ETN3[/"%@1UGF$:N
M0Y9@0OSA>,'@G)Z4 =Q17GMQKOB^[\1Z3H\1L=+GO](DNI$E@\UK:92@(R'P
MXR<#IUR<XQ4MGJ/BV_\ $VN:!_:FG0R6-I:R)<I9$_.ZON^4OW*]<\ =.<@
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M0GD/*/E>,CG:#P0V20>HH [BBN"MO%T]WXJN-&FU!-.U.&_V)IUU"%6YM0V
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M N\H8@LQ?</F)4'[OK4EIX<O;/Q9K.NQZC ?[1ABB$+6I_=>6&VG._YOO'/
M_"NCHH X)/AY=Q^!--\,+K4.VQN4G6X-D<OLD\P#;YG'/&<]*U5\+WNG^);_
M %K1]0@@?4HT%[!/;F2-I$&%D3#@J<<$<YKHY[B"V56GFCB5W"*9&"[F/  S
MW/I4M '%W/@'&D:'I^GZBL"Z7J"ZBTDUOYC7$H+,2<,N 2[?ICI5CQ'X2OM2
MUNRU[1=8_LO5[:$V[R- )8YX2=VQT)'0\@Y_^MUE% '):EI_B*RL=-73]<:2
M_-XLEXSV:L+I3@,N.D2 =QS@=23STM_9IJ&G75E(Q5+B)XF*]0&!!Q^=6**
M.&'@34SX?\/:7)KT#_V)=07$3_8<!UA&U%(\SCCJ<G/;%:D/AJ]@\6ZGKR:E
M 3>VD=L(3:G$>PL5;._G[QR,"NAEN((#&)IHXS(P1-[ ;F/0#/4^U24 <AH?
MA+5/#WAW2-*L]9@?^SRZL9+0[+B-L_*RA^""<Y![=.M:?ACPW#X9L+N"!H\W
M5W)=NL<>R-&?'RHN3A0 .,^I[UN44 8^AZ3>:;-J,U[>PW<U[<>>7CMS%M&T
M*%Y9L@!0!T[^M8]KX=NO#OBC7_$Z:BKV5]&);C3XK,ELQI@,IW\N0#GCG/2N
MO)"@DD #DDTR&>&YA6:"5)8FY5XV#*?H10!XUH5S<06,.IZ7XO\ #-[?R!IE
MM9M/1KR21\DQLR.'+G.TG;^&*]%TWP]>6OC#4/$,M["5O[>*%[00',?EYQA]
M_/WCGY>?:M]+6WCF:9((EE;[SJ@#'ZFI: .(@\#ZMIFL7S:-XFDLM'U"=KB>
MR-LKO&[<N8I"?DS]#BGWO@O4[?Q+<:SX;U_^R_MJ1I>V\MJ+B.0H-JNN6&U@
MO'O7:44 <Q<>%+B3Q%H&J)J8VZ1',FR: N\YE #LSA@ ?ESPN.35:+P;>QV_
MBF(ZK 3KS.Q/V0CR"T8CX_>?-\H]N?RKL*1G5$+NP55&22< "@#A;CP!J$=M
MH-QI6O"RUG2+06(NA:[H[B  #8\9;_9!Z]?PQ<U+P?J&IV6E)/KBO=V>I1:E
M-/):Y$TB<!54. BXP,<GC.<DD]9%-'<0I-#(DD4BAD=&!5@>A!'44EQ<06D#
MSW,T<,*#+22,%5?J3TH YT>%9W\5:IK$VH1M#J%BMD]NEN5**N[!#[SS\Q[5
M:\):'=>'/#UKI-SJ"WJVL:PPNL'E8C487(R<G'4Y_ 5N44 <EX@\(77B.UU+
M3KZ_MY=,O95D1'M29;7 4'RWW8R2I(.."QZ]*LVOAJ\M/%VIZ]'J,!^VVT=N
ML#6Q/EB/=M);?\WWCG@?A7256N=0LK*2*.ZO+>!YCMC6655+GT )YH XBP^'
M6H:5IWAJ*SU^(7.A//Y<DED6CE27[P9/,^\,\,#^%/?X=W;^&_$FBG7MT>M7
M4ER9'M 3%O(+=&&X_*,= /2NT_M&R-G]L%Y;_9>GG>:NSKC[V<=>*LT <Q?>
M&+V]USPYJ9U*!'T;S,H+4D3%TV'^/Y>.G7FM'Q/H\GB'PUJ&CQW*VWVR%H6E
M:/S-JL,' R.?QK6J..X@EEDBCFC>2+ D16!*9Z9':@#F)?"=[-JGAB^.J0 Z
M&DB[!:']_OC\L_\ +3Y>/KS^55K?P-<V.F:KH=CJJ1:'J+R-Y+6Y:6W67_6)
M&^[&#DXRIVY[UU\EQ!#+%%)-&DDQ(C1F +D#) '?CGBI: .7G\(&/Q%I&JZ7
M?+91V%DU@T!@\P- 2I 4DC:1M')!^E:GB329->\.:AI,=RML;V!X&E:/?M5@
M02!D<X/K6I10!R1\(7K:CX6O#JD&="B>/;]D/[_?&(R?]9\O ]^:NZ!X=N-&
MUG6[^6^BN%U2X6X,:6Y3RR%"8SN.1A1V'-=!10!S%_X8O9O&*Z_8ZN+4260L
MKB%[<2DH'+!HV+#8V3W##VK'L/AW?6.C>&].&NQ2+H=W]IC9K+_6<, O#\<.
M>>>:[J&X@N/,\B:.7RW,;[&#;6'53CH1Z5+0!R?V&+PMKNO^+=4U>WCL;R.!
M95:W*^2(\JIW;CG._GCTJ'P;I6GMK>N^)=.+M::G.#;$D["-J^9(@[!W')[[
M >A%=2US93P7&Z:WDAB)2?+J50CJ&],=P:FB>.2%'A96B9049#D$=B,=J 'U
MPQ^&EBOA74M$BNY8S<W9N;><#YK3$GF1JG/ 4DX_WF]:[FB@#FO$/A1]3L]&
MCTN^73Y=(N8Y[;?#YL9"J5"LFY<C!ZY!%4;6PA\#WVN>(M;\0QFRU"6)Y/,M
MQ&(Y-JIU!/' P,<=R>M=G4!DM+MIK8O#,T9 EBR&*$\C<.WKS0!R_@;1;*TD
MUC6;(2"WU6[:6V5\X6+U4'HK.9''LRUK^*=%D\1^&;_1X[I;7[9$86E:+S-J
MGK@9'/XUL44 <M>>%;V\OO#5T=3@5M%+,1]E)$Y*&,_Q_+P??G\J9!X1O8+G
MQ/.-4@)UW!Q]D/[@B,1_\]/F^4>W/Y5UE% '%/X&O6T#POI8U> #0;B"=)#9
MD^=Y2E5!'F<9!.>M:-GX8GM_%6MZQ+?QR1:K!%"UNL!4QB,, 0VXY^\<\5TE
M% &#X0\/W7ACP_;Z3<:BM[';*(H&6#RMJ#.,C)RW/)SC@<#G,4GAJZ3QI-XA
ML]36%;BT2VGMWM]^XHS%2&W# ^;!&#D=".HZ.B@#@3\.[P^ Y/"YUJ':]W]I
M^T?8CD?OO.QM\S^]QG/2K>H>#M67Q-+KV@^(%TVYO8HX]0B>T$T4Y085PI8;
M6 XZG_'LZ* *]E:FSLHK?SI)F0?-+*<L['DL<<<DD\8'IBN7TSPIK.D^(-<U
M>VUJQ9]6ECDDCET]R(]B[0 1,.W7-=A10!SDF@:M<V<L-YK,,K7-RKW.VT*J
MT  'DH/,RH.#DDDG<:KV?@TV6O:S<17D0T?5T_TG3!;D+O*[6=6W<%AU^7GZ
M\UU=1O<01S10R31K++D1HS ,^!DX'?CF@#C_  YX.UK0OL]A-XHDO-#M&!MK
M5K95E"J<HCRYR57 Z 9P!TXJ/3/ NI:-=75GI_B)XO#MQ.\YL/LP,D>\Y9$E
MS\JDY[9&>"#S7<5%]H@^T_9O.C^T;/,\K<-VW.-V.N,\9H Y>Z\(W_\ PDVK
M:GI^KI;6^K01Q7D+VV]]T:E5:-MP"\'!RI_PIP^ +NVT'PS90:T@O-!F#PW#
M6F5==A0J4WCLW7-=S10!SMMX;N8/&\WB)]1219;%+(P&WPV%8L&WAL9RQS\N
M*=#X4M8/&]UXE25A)<6R1/!_#YBY'F_[VPA?IGUKH*I)K.ERRF*/4K-Y!((B
MBSJ2'.<+C/7@\=>* .9O?!NJP^*+O6O#OB'^S!J 3[=;RVHG1V4;0Z9(VMCC
MN#WKK;2V%I:16XDDD\M0#)(<LY[DGU)YIPN(#<-;B:,SJN\QAAN"^N.N*DH
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M?]>@_F:I66D>(?#OB7Q +/3X]1TS69?M4<OVA8VMY2H5@X/)4X!!4''I6O\
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MO'IFH:.NG"<2(2&RY)VYSC#\>XIGA-?&UC:V6@ZIIMDEO8A(CJT=T&\^),
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M=^!N/&2<=3@<#-7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ/O8'.[.!C&#S0!Z-17GMCXLD\7Z]X?TRWDEM;6ZT?\ M>\$+E7()"+&''(
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M5=#D$>H-/KA_ ]O)9^*/&=K;#;H\=_&;5%^XDK1!IE7T&XC@=#FNXH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *K7VGV6IVYM[^SM[N D'RYXED7/K@
MC%6:* *']AZ3]JCNO[+LOM$2[(Y?LZ;T7T!QD#VHAT/2+>WN+>'2K&*"YSY\
M:6Z*LN>NX 8;\:OT4 9UKH.CV.FR:=::5906,F=]O' JQOGKE0,'\:27P_HL
M^E_V7+I-B^GYW"U-NGE ^NW&*TJ* *5MI&FV<KRVNGVL$CHL;/'"JEE48"D@
M=   !52W\)^';1P]MH.F0LLGF@QVB*0_][@=>3S[UL44 9W]@:-NN6_LFPW7
M0Q<'[,F9A_M\?-^-(?#VB%+=#H^GE+8Y@4VR8B_W>/E_"KMS<PV=N]Q<2+'#
M&,L['@"I: /.G\(ZA+J5Z=5\*>&-<:XN'E34;E]D@0GY593$Q^5<*,'G [Y-
M=IH>E1Z)HUOIT179"#@*"%7+%MJ@DX49P!DX  K1HH R+'1SI>L7MQ9E!::A
M)Y\\1X*3;0"Z_P"\ N1ZC/<UIK;PI-),L2++* )'"C+XZ9/?&34E% %9M/LG
MT\:>UI UD$$8MVC!CV 8"[>F/:H'T'1Y;".PDTJQ>SB8/';M;H8T8="%Q@'W
MK0J*2YABFAADD599B1&A/+8&3C\!0!5_L/2?M,US_9=EY\XVS2_9TW2#T8XR
M?QI/[!T<:8VFC2K$6#')MA;H(R>N=N,9K0HH K6FGV=A;FWM+2""$DDQQ1A5
M)/4D#K5*V\+Z!9K&MMHFG0B.0S(([5%VN>-PP.#CC-4=3\43P7>HVNDZ4^J7
M&FI%)=Q)*$<"3)"H"#N;:,X)'48))Q711OYD:N59-P!VMU'L: *\6FV$-_-?
MQ65M'>3*%EN%B422 = S8R1]:;>Z5IVI/$]]86MTT)W1M/"KE#ZC(X/TJY10
M!1.BZ4;N6[.F61N95*23&!=[J>Q;&2*A/AO0C9I9G1=.^RHV]8?LJ;%;U"XP
M#[UJ5A^)O$8\.1:?(UE)<K>7T-GN1U41F1@H8YY/7L/RH O?V+I1O!>'3++[
M4$\L3>0N\+C&W=C.,=J;'H.CPV,]C%I-BEI/_KH%MT$<G^\N,'\:T** ,]M!
MT=Y;25M)L3)9#;:L;=,P#T0X^7\*:?#VB&P2P.CZ>;-)/-6W-LGEJ_7<%Q@'
MGK56P\1B^\6ZIH)LI(7L(8IO.=U(E#EL8 Z#Y>_/M6Y0!372=-343J":?:K?
M$;3<B%1(1Z;L9Q4<>A:1#?M?Q:99I>,Q=IU@4.6(P6SC.<=ZT** *)T32C=S
M79TRR^TS+MEF\A=\@]&.,D?6L_4/#5I<Z0=$L[6VL=+G/^E);QB/>F<E %
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MM[6"*"%/NQQ(%4?0"I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>5\$J\3,H*,,'.T@$=N*R/#M[?3:=<^$;V_O)-:M-4,$UR;AQ*UOGS5ER#D
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M$,;2,XPP*X!!!!QS1=>#M-O='U'3IY+EAJ;;KV?>/-GX P3C &   H  '&*
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MK*-+V622")YT4H[G:7'7:6S^8%=3K$/_ !4$>EP:CJ,X33F9=/M[J1'C8O\
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M\0:NBZ8^^T\FY,?EM]G$@Y7'&3]WH>X/;M-/\':?IZ6, N+RXM-/?S+*UN)
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M3.#@EMH!7//)''7MTU_K>L:&GA.!FL;A-1O([29Q"Z%5*,PVC>><+C))Z]*
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M?9H]I._8-S<@8&!ZXKF_$'B\Z3XE@T>2]L],%Q:":VNKZ)FBGEW$&/<&4*0
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M&M+N-$\-:;I=S<1W$EG;I!YD<90,%4*."3Z?_JK5HH XEO"&IM'XQ7[3:?\
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M(IX#(RK(5) )VD<$XR*Z.YL+[Q1X@\.7]SIEQIT.E227,PN&0L9"FT1KM8Y
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MS3],N[+Q#;F--.U>SE2-)UVKD3#=]T-N!#+T QGI7HKH[VK1L079-I('&<4
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M-"76UUBV.G,_EB;)^_G&W;C.>1QC/- &_17)7WBKP]JJVT=OXF-JT>J16_\
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M!_IVWY&ZKP3TZYS7:OI&GZ3\7-,AL+5+>._TFY%V$X\\JZ89SU9N3\QYYZT
M>@[TR!N7)X SUH9T0@,ZJ6.!DXR:\)A\-Z9-\$;G6PC)J]A-<R6=VLC>9"ZW
M+[50YXR>W<MGK6_XD%MJ5MXP+Q)-J-KHL0OY+TADM7\EW58%QD,2<DY SMQD
MC% 'K!(! ) STH#JRAE8%3T(/%>4M9VVK>)/ANUXOV@W6D7'VG<Y/FX@B.&Y
MY'S'(/7)SUIVC>$['7M \<^%Q%'%:1ZO,MDH'RVK&.-E*#^$!B3@>I'>@#U7
M(]:I:MJUGHFG/?7THCA0A>>K,3A5'J22!7%>$+Y?&$^F3WEC'%/H$30W,9C
M$=[GRR%]-JHS8'_/1/2I_BY;6\_@8O/!%(8[VTVET!VYG0'&>F02/H: -:ZU
M^^M_B#I^A>5;?8;JRFN?,^8R!D*C'H!\WO72!E90P8%2,Y!XKSS5])TVY^*/
MA[3VM(#8C2KP&V10(R \>5*C@C.<@\5A:<=.L_"VI:3<"?[(OB][*PLX9 B.
M?,5DA8D$"+.<C'3..>* /6I[VVM;*6\GN(X[:)"[RLPVJHZDFDL+V+4=.MKZ
M#=Y-S$LR;A@[6 (S^!KR>2WC ^*UC/%9^6EC%,MO"G[J.4VSDE0?XLJ"3@$D
M9P*]!\$VUI;>#-'6TAAB#V4$D@B4+N<QKECCJ3QS0!;?68;BXU.QT^2*6^L(
MT:16/RJSABJDCG.%R1Z$>M5/!>O3>(_"&EZO=K#'<WD/F-'%D*.2. 237->'
M=/T^+XC^.Y5M+5)HWM3$PC4,I>WRVTXXSR3CKS7(Z5IEG:?#SX=ZS# JZD=4
MLXC=?\M/+=V5DW==I!^[TH ]P9T4J&906. ">M*VXH=I ;'!(R,UY:+6W\7Z
MEXQTK5KVQ@NH+MHQ]HM]TUO;[%,<D;%QM'5@0/O9)ZUZ+HR[=#L%^UR78%O&
M/M,@PTWRCYR/4]?QH YGP[XDU_Q#/K4<5OIL/]F:C+8$N9#YA3!W>V<]*Z?2
MI[V?3T?488H+K<ZND3%D(#D!@3S@@ _C7GO@72WU&]\<;-4O[//B&Z3%JZKV
M7GE3S_A6EXIT+3-7\"IIKRB;4=/\NVL[B- SB[15VA<]<G[PZ8W9Q@D '>YI
MH=&9E5E++U /2O+K3595^&_BO5;> 0>+84F&I[4 DCF5< KC^ ( 4]0,\G)J
MY9:5I\MQHGB72-4LA*()$MHK"VV?;0T9.R7YV+8(SSR#G- 'HN]=^S<-^,[<
M\XI<CUKS/PE;:!X@\%>'=<O+DKJD%TDTUU&X6=[O<5:-SC)#$XV^F.P%4/)M
M(?"_Q6@>.!(H[BX9$( "L;92I ['=T]Z /3KG5[*TU.RTZ68"[O=_DQ@\D*I
M9F^@X&?4BBV.I?VK?"Z-G]@ C-H(MWFC@[_,SQUQC'OFO-OL&GW/B7X:/=6E
MK*)-'N#(TL:MN"PPE<Y'.,DCTR:UM#TRRN_B'X_L9[=)+6XBL1+$PR&W1OG]
M>?K0!Z#D>M-+HK*K,H+= 3UKR_PA;I/;1^ [ZWCD?0;YFN"\8Q) A#P/TZN7
M3ZB-_6H8K.V\8'Q=8ZKJ-C:W=MJ,J-)+!_I%M"A'DR(Y<;%V@$$#&=Q[F@#U
M67S/)?R0AEQ\N_.,^^*Y_P #^(+CQ-X0T_5KY((KJY,NZ.'(4;9&7C))Z**V
MM.S_ &9:9G><^2F9I%VM)\H^8CL3UQ7B6GZ990?"7PQKD<"C4X=6B\NZZR(I
MO&4J#V4@G*C@Y)ZT >Z,Z(5#.H+' !.,TK.J8W,%R<#)QDUY3XU6POX_'KVZ
M)-<6>GJMS->L&%NPB9XTMUQD$Y!+$@;B, X(JYJ4.KW<&B:KIUO8ZZ\&DH+S
M2;QL-(K@'S(V((#DJ0<]10!Z6"",CI32Z!PA8!CR%SR:QO!U[8ZAX.TBXTV*
M6*R-JBPQS??15&W:?<8Q7G6GV=MXO\+ZA<:EJ]I8ZG::A,]U<K;_ .F6DD<S
M%0'+Y VA5 QC'% 'KS.B@EF48&3D]*4D*I8D #DDUYE:^'M*U;XB>.+?4+..
MYA-I8N8I02NYDERVWIN]#U&3CK6=I4UW<> ?AS<32_:H%G47%FS#?<@(X4@'
M[VS&[!_NYZ@4 >O*P90RD$'H1WI%='SL=6P<'!S@UY?<:-::%I'CC7-4CN=.
MTN^.VW2T95GCC955]O55WR<@'IG)QDU9T:%M/^+8MEALK%9?#NYK:T/RJ5G5
M4+'@,P!(S@<'% 'HX=2Y0,-P&2N>10SHF-S*N3@9.,FO']+\/7/B#PMX=M3:
MK-?VVK&:]U/<I2XA$C^8P?.YQ(,#'TZ  UI&UMO$WB/Q=H.IW-A%+ R101W-
MOODBMC"NUXB7&WYMS9 X.,]J /3I'$:%F95 [L<"N=\':]>Z]!JYOXK>.2QU
M2>Q409VE8\ 'D]3D^E<MH\D-UX^L-"U*[_M*SM=!26P>Z4$73%RKS8/#-M &
M?0D]S6E\+K>"TLO$UM;(J01>(;Q$1>BJ"N /PH ZV4ZD-:MQ&;/^S#"_FAMW
MG^9D;=O\.W&<YYZ5<+H#@LN2<=>_I7#ZA;Q#XT:0X3YI='N0YS][#Q@5P5YH
MVGK\+/&6HBV7[98:Q=FSG)):W*3C'EG^'\.O>@#W>FAT+E ZEAU4'D5').D-
MD]Q,VV-(R[L.P R37D%B+:"]^'M_IZK#:W%U,(IIG#7=Q$T3LSS,,#DX)7GG
M&3GB@#V,NB]64<XY/>G9'K7C$OA_2KK0/B=)/9QRM:7=S);%\GR7%NC!DS]U
ML]QSVK7UN!;#2O"?C\PK-<:?!#_:+E<M);R(%=_4LA(8>VZ@#U#-(SJI 9@"
M3@9/6N?\*VT4L5YKPA1)M7F\\,%P?) "Q9[\H Q'JYKFO&UM?PZQ?:I!I]EK
MVG+8+#?Z9,=L\" NWF0DC'()R.IV#'3@ ]%!!Z$4M>;Z7)877Q0T:\M(\6U[
MX6+H9% :13)&1N]3M-<W;:E%IO@F0K(L>D2^,9(+QXSA%M3,<@D=$.%!]CCO
M0!ZMXBU.?3/#&IZG8+!--:6TDZK(3L.Q2Q!Q]*ET'4'U30-,O9_+6>ZM(IW1
M. "R G /.,FN4\0:/HFFZ5XLNM-?R[B\T25I;:!@(0JQL%DV@8#'.,]PIQT-
M8-KIEGIEW\,=1LX%BO+I%AN)Q]^9#:D[6/5@"!@'ICC% 'K5%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %5M0T^SU6QEL=0MHKFUF&)(I5#*P^AJS10!BV'A'P_I=W%=6>D6L5
MS"GEQS;,NJ^@8\_YQ267@_P[INLR:O9:-9P:A)G=/'$ V3U(]">^.M;=% &7
M;>&](LYTFM[&-&21I44$E$D.<N%S@,<GY@,\GUJ&3PCX>EUY=<DT:S;4U((N
M3$-V1T;ZCUZUM4A. 3@G'8=Z *$&B:;;:K/JD-I&E].,2SC.YQV!/<#L.U-M
M_#^DVSWKQ6$(-]G[5E=PGSQ\X/WN..:@\.^(H?$<%]+#;3V_V.]ELI$GV[M\
M>-WW21C)]:V: ,S3O#VDZ2ZO8V,<+(I2,C)\M3U5,GY5X' P.*KS^#_#MUKJ
M:W/HUG)J:$,+EHANR.A/J1V)Y&*VZ8DT<CR(CJS1-M< \J< X/X$'\: ,R_\
M+Z'JFHQZA?:7;3WD:[%F=/F*_P!T_P!X>QR*LZ7I&G:)8I9:7906ELG(CA0*
M,^ON?>KM% &8?#VDF]N[S[%&+F[39<2@D-*OHQSR/:H?^$3T'[#:V7]F0?9;
M602V\/.V)QT91G@CL1TYK9HH :T:21-$ZAXV7:RL,@CT/K6*G@[P[%:6UK'I
M%JD%M+Y\,:+@1R?WQC^+WZBMRB@#,_X1_2A?7-Z+-!=7*>7-,"=TB_W2<\CV
MJ)/"NAQV=M:1:=%%!:N7MUC)3R6/4H0<J>O3'4^M;%% %>SLK;3[<06D*Q1[
MBQ"]V)R23U))Y)/)KCK+PQ+<_$'Q%J>I:7(+*]BMX[>83J"0BL'#!6W;6R.#
MP<<BNYHH RK_ ,-:)JD%I!>Z5:3Q69!MD:(8BXQA1V& !CIQ4#^#?#<D%S"V
MBV?E74OGSH(P%D<=&8=\=O2MRB@#,U+P[I&L0VT.I:?!=I;-NA\Y=Q0].">?
M\:P/$OA&+^QIX=!T/2Y#=7<<VH6LJB,7<:G)7=@@'(7&1CKTSFNRHH \^\/^
M";.#5K>_@\*P^'C"6\PQ7FYY@5*[,(=NWG.2<Y48'<=;;>&]&M-*GTN#3;=+
M"<$2VP3,;9ZY7IS6I10!AVWA3P_ICV]S9:':K/9HPMS'&H=<]0">YP.2:P?
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M,N[,BK_=!)Z'ZX/>M.B@#A? /A :;X?BAUG2A%?17<MP0TH=&9I6='VJQ4L
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHS0 4444 %%%% !1110 4444 %%%&1G% !1110
M4444 %%%% !1110 4444 %%%&<T %%%% !1110 4444 %%%% !102!UHH **
M** "BBB@ HHSGI10 4444 %%&<=:* "B@'(R.E% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF^"]1M/B+I6OZ)IU[HS32.VLV[%?LS)URA!.=QZ+S@X/RXH U/!GB#0M.O\
MQ]J3W&JQ"SO/,OQ?R*Z1L#(,1!2>,@CU/RCM6_IGQ$LKV_T6UN[&XL/[<@,^
MFR2LK"50 =K8/RL000.1SUSQ7!6/@+7=4LOB587%C+9?VY="YL))BNV3;*[@
M'!.W.5Z^OM5ZW\)ZUKFK?#M9].GL8?#5JOVV2? !D0( B8)W9,><CC!ZYXH
MVKCXO6<2>(#'H&IS-H,PCO2IC"K\Q7<#NYY7IC/MUKN](U.WUK1[/5+0L;>[
MA2:/<,':PR,CUYKQ=?"?B/['\3T_L2ZW:Y.'L!E/WH\US_>^7A@><5ZEX#L[
MK3O FBV-];O;W5M:I%+$^,JRC!Z$B@#-U'XCV%I>:Y#:V-S>Q:$BOJ4T+*!%
MNS\J@GYF !)'&,=<\5R?Q6\5W%QIGA,Z.9I=+U2]AD:2)U47*$Y$1!(//<$
M=CT-0S^$-;T63XBV4&G3WJ^)/WEA+#@KN<R;E<DC9M\SJ>"!^%,\1>!=;M/"
MG@/1K*REOY=(NDN+QXBNU1NW-@L1GDG'L* /3O#GAZTT+16L81<F":1IFANI
M1)Y9?DQC' 4=,#CKUKS'X.%KCQUXX2>229;*\\NV65RPA7S)1A<].% _"O9C
M)B$R;7(V[MH'S?3'K7D/PXTK7O"_BOQ=?ZCX>U 6^J77G6S1^6QQOD/(W\<.
M* .L^*]Q96WP\U!]1.H+9$QK*^GNJRIEUP1N.",X!'H:DB\86&GQ>'=%LXKF
M\U#4;!9K2&:10[1K'G+N>-Q /3.2#7.^.;;Q-XO\!^(K1-"NX99[F"*PM)&C
MWF-&1VD;#8&3N[]A3;VR\6-=^"[.'0Y)M(M[!$OU29(I!*$VE'?.1&"%)"_>
M&1STH K^,_&=GXP^!FJZ]I/VBV>&6./#';)#()4! (/]UNH/0UL>'?'\5A#X
M2T75]/O;5M4L85M+V9D9)Y B@@X8D$DC&>3N&<5Q>C>!O$\'P1\1>%YM'DCU
M*?4$>!3(FV52\62"&X V$Y..*W)O">K^(M3^'MO+I\]E!X;B62^EFP 9$$>$
M3!^;)CZCC!ZYXH ;]JTVYU_XE1POJXU&/3V:>.XE4P(50[3%M.0> 1GI7.1:
MI:#X#>%9]>N=:,<FI./M%A.HE,@EEVABQY7 /T(%=#;^'==B\7_$2^;1[K[/
MJ]D\-DXV_O6V[0,;N,GUQ6#J'@OQ//\ !+P[X=CT.Y;5+/4VGFAW)\J9E.<[
ML'_6+^M '<:YXYU:U^+&F>%[/2II8!;O<R!)8P]P"K!<;F "J03R<DCIP,[.
MD>/;;5O%6K>'/[.NK74-,C,DBW#( Z\8*D$Y!R#GT(K UK1-:7XTZ+XIM=*F
MNM/_ +.-LY1T5HG._P"^&(P/G'(SWX/2F>-?"-S??$GP[K.DS"+[6)-.U/:?
MO0[&)_';N7/8[* /0]'U ZMI%KJ!M9;87$8E6*4C>JGD9P2,XJOJ7AZQU>_@
MNKX22K!&R)$)&5<L02Q (R?E &>G/K5"#4_$1\=SZ8^BQ)X=CM0\5^'^9I./
MEQGZC&.V<\UT,K^5&S[6;:,[5&2?H* /+_AOX?M-9\)F[N7N/MD.J3&.X\]]
MRB.;*KUY&!C![4SP_P"(8O"2>-;C^R[^[M+;7)I)WMPI$$?EQY8EV&['/"Y(
M YP,5T'POT_4-)\,SV6IV$]G<?;9Y@LNTY5W+ @J2.]8PTG5F\+?$*T_LF[$
M^K75S)9(0O[U9(E13UXY4]<4 =M=^(H(Y8;>R@DOKF6W^TK%$ZIB(\!B7( R
M> .IP>P)#_#GB&Q\4:-'J=AY@C9FC>.5</&ZG#*PYY!KA+G3=6TC6-(US_A&
MGUBSETB&PO+,+&9[:2,DAE#'!'S$'!]\UW^AK,--5YM.BTYI&+BTCVYB'8,5
MX+=SC@9QDXR0#S^Y_LF'XS:E;ZFRK9MI,4JQ,6V>:9""P XR0.M=+IM]I>G:
M)J6N:':WE[9F1MUO;G<Q,65<HKL/[O0=<<#FLU8M2M/BSJ.M?V-?RZ?)ID=H
MDT:I\TBN6/!8'&#UK:_M?4XX-1FM/#MTBQ@>1%)L#W$K$[F.&.U!QD]3D\<#
M(!)H?BZS\1-9G3K6YD@N+1;II\ILA#$@(^&R'X/ !QBJNI>/=/TNU.H36UPV
MDI<_9I+]"A1&W["VW=N*!_ER!],CFLOPWH^I^#O%5QI]M:SWFA:F/M4DZHJ"
MUNSP_P N1\C8!P,[3QTK,\/Z=K&@B;PW<^#XKYDGD-GJY6(PM$[E@TN3N!7=
MT ).,#UH [#4_%T%@NI/;V%W?Q:6 ;U[;;^[^4,5&6&Y@I#$#L1WXJ2U\5VE
MYK\>D16UUYLVG#489&50DD18+CDY#98<$"N:L?\ A(/"/BC7;>+0+G5=.U:[
M^W6MQ;2(HBD955TDW$;0-HP1GCL>@M:A;ZQIWQ!TO76TN?48Y-(:PG-EM_=S
M>8KY(=AA#@C/;O0!%K7Q"D7PDVJZ3IMR9/[2&G2"8Q@Q,)1&QQN(/.0.W<X%
M:EYJ6F/XT\/07VCW::M+#<M9S.5VQ */,4[7()(V]CUZUQW_  CWB!_A[JEH
MVC3"\77S?QPB1"9H_M(D.PY'8'[VW-=+JD&HWWC[PCJ:Z5=);6D-V+EFVGR3
M*J! <'D_*<XR!ZT :FF>+[;4H];8V5W:OH\C1W,=P8PV0N[(PQ&TCD$X!J63
MQ*,010Z;=27\ML+IK-FC1XD)P-Y+;0200 ">0?0FL75O#-^_CZ*]LE7^R]5M
MQ#JXSWA8-&<=]P)C/^R357Q+8:EI?CI/$$/A[^WM-NK)+2X@C"-- Z.S*ZA\
M @AR",T =9X<\0V/BC18=4T\R"&0LK)*NUXW4X96'J"*SM8\:VFD6]]=_8[F
MZL]/?9>3P%,1GC=A2P+;<C.!Z]2"!JZ(DRZ:K3Z?%I[2,7%K'M_= ] Q7@MW
M...<<XR>#M;'5?#WB+6;*;P>-:M=0OI+RROH_*PGF'<R2E^5"G///'0&@#I;
MKQUIMGK-I87$%Q'%>6KW=M?,4$$R*NX@,6SG'."!QS2ZCXUM])TO2K^_TK4X
M%U*XCMXXC$K21L_W=ZJQQQG@9/;&:S/%'A^[\4VO]E21/9C3(4N;6\BB7:]V
MH.WRQR0B]QQG<!T!SD>*-4U6\\+>$+O5M'GM-437[+S[4%3O<%L[#G&#VR>^
M#0!T^F>.;>_U6_TF?2=2L=3M(/M*VEPB;YXLXW(0Q4\\=>#^-0:5\1;'5-.3
M5!I>IP:7);&=;R6)?+)WA!&,,27)(P,8/8TAL)]0\='Q+]CN(K6RTQ[2)73;
M)/([ACA3R  ,<XR6]!FL*P\+:S=_ ZV\/_93:ZS:HC+#<X*M)'*) "02"&P!
M^/- '51^-+--;DTG4;6?3[D6K7D9E9'62)?O8*,?F7N/RS4]CXHCO!!*]A<P
M6<]F][%=,R,AC7;P=K$AL.#C'0'GBL;1KK4+ZVFF'@A-(GAMWWBX6(^=)M($
M<>TY*D]6...,'.1EZ)X?O-%UG[1X=LK^RTJ6SG>]TB].8(Y\ QK$"3R3NSM)
M7 ZC@4 ==IGB!=8:U0:==1VM_:M<P7#,A1D^7@[6)5B'!Q]>>*XOPGXA@\(?
M#J\U&XLKNXM(=6NTD-OM8Q*9V4,=S#CISSBKGAK0+C1O$UM<Z':ZEINC2P2O
MJ6EW)W0PR\%/)&3\V=V=I*X';@5>\$Z',?"&IZ1K>G2PI=7=V7BEQ\\4KL1R
M">Q_"@#I9M76+5;#3Q:SR27D;RAD*%8E3;DM\V<9=1QGDU6\3>)[;PM:6MS=
MVUU-%<7,=L#;H&V,YP"1G./H":Q/ASINH6^FRS:K<+<RV[-IMK,/X[>!V56/
MNQSGU"K4_P 0[*^O]*TR*PL9KN2+5+:Y=8L<1QR!F/) Z=J +D'BSS@D+Z/?
MV]_(\HCL[CRT=DC(!DSNV[,LHSGDG@&HK'QWI=_IOVB**Y%U]N;3C8D+YPN5
MZIUV\ %MV<8&<UE>,+#4H/$^D^);+1/[:M8[:2TO+'"^:J,RLKH&X)!&"/\
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M\K1H)SM)_>,J<'J2%S@9QF@#&_X4[H7_ $%O$/\ X,F_PH_X4[H7_06\0_\
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M6R@:S66?8UZVRW!4YD;&<#CK@$_0$]C4]S=065M)<W4T<,$8W/)(P55'J2:
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M/6KG6-1\3B747OK>UU$16SNJKL3RU.W  Z$D<C/K7:4 %%%% !1110 4444
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M!"LI3JX4DYX."X-.L/"_V'P9XNDU&R AN9+N:RMYSO\ )MPI,8VDD+@Y( Y
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M@]!0!Z51110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ%IDFA+HC6BC35B$ MU8JOE@8VG!Y&/SK1HH R#X8TAI-/D-JQ?3ABS)F?\
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M[;$9+^6[#ET4AFB$9!;)P%R3C!)Z@"NLHIHDC,K1!U,BJ&*9Y .<''IP?R-
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M0MX@G-YHMY+ JK!$$N5CGV?O1M))*\?*5_$\UZ%_PC*+XM/B&.]F2;[%]A6
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M$GT+4=2FN=9@E0Z9*Z1J9(IL+"0%4 X<D,<'IFO0+6*2WM(HI;A[B1$ ::0
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MJ&R.64QJW[I?X@K8_*CX<1KK.LZYXMO)/+UFYD%E<Z>%V_8?*XV'G+$X!W<
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M>AQ0W-GJ!AC\QXY5)V.-NW(P1G&:T_$%O+;^/? UI_;$K7%K%>*]W*J%LF-
MOF# 'S8([9[<UT-]X'M=1T?6+*XO;CS]98&]NU50[* %55!!"J , <]^2230
M!E7EYK6CW6E6DFL7%[+KMP H$<4?V94A9W6,D8^8@ ;LD#/4\TD\GC?2]-UQ
MDCEO(5D@DL%WQM=^5N'GIP-I(&[83D^N:W-=\'VOB#0;33KR\NDGLW26VOH&
M"312+P'! QG'7C%,@\)3IIKQ3^(-2N-0>2*0W[[-Z^6VY5"A=H7KD8YR<GT
M,&V\2W6I^&-9OO#-[>ZE<020@V$\:I=VHW#S4VLHRVW<5)SSQSC%1G7K37O
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MTJ[110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !117.^,O$=SX7TJWOK>P2\$
MEU%;LAEV,N]PH(&,$\]"1]: .BHKBH/&FH6'BEM&\3:;;6"36DEY:7-O<&5&
M2/EU;*@A@.>!BF77CF\L?#=CXJN=/B70KEHVD"R'SH(9" DK<8/5<J.F>IQ0
M!UL>IV$VHR:=%>0/>Q)YDENL@+HN<9*]1^-.LM0L]2A>6QNH;B-)&B9HG# .
MIPRG'<&N0B&WXUWQC52Q\/1$ G )\]^II-)\:I_PC+7K:5!;74VKR:;!:02?
M+).9"N2^T=2"Q..@/!- '<T5S$NK^)[>35;?^PX;B6UMUN+29)2L5R><Q<@E
M7&/<'(Z4S3_%DVJ^'O#VH6,%O)/J[JIB,AQ$-K-)SCJFT@\#)XXS0!U5%97B
M/7;?PWH-SJMRC2)"%"QJ>9'9@JJ/JQ K+N/$M_I'B#2]-UBTMA'JNZ.WGMY&
M*QS*-WEOD<@C.&'<=!0!U-%<9X=\4Z_X@OYPNBV<-E::E<6-W)]L+,OE\!D&
MP;AGUQUZ=35[Q7XEO?#USHT5KIJ7@U&\%H,S[&5BK,.,8Q\IYSQZ&@#I:*X2
M#QOK%M?:YI.K:-:Q:MI]B=1@6&Z8PW, R#ARF001C[O)]*2V\=:JN@6>MZAH
M]M%::A!;"Q2.Z)DEN)B $8;<*O.<\X ]>  =Y17+MXHN=+\46>B:W!;QK?P2
M2VEU QV%HQN>-@>A"\@YY]!45IXGUC4+32=6L='6XTK49U0*DA\Z&%L[9VSQ
MC@$KU /4T =;39)$AC:25U2-!EF8X 'J37#:IX_N(+:]OM+L$OH+*Y:W:W7>
M9Y]C['*84J,$-@'.<=JUE\17.K:M>Z=HMO [6,,4EP]V64;Y%W)$ !D';@DG
MID<'G !NV-_::G9I=V%S%<VSDA)H7#(V"0<$<'D$?A5BO*/ GB"XT+X=^#4%
MG')%J6I26+@R$-$6FF.1Q@XVD=JZX>*+W^W?$6EK80.^E6L5S$WGE1,'#G:W
MRG:1L]Z .IHK@=/\>:K+X=M?$&H:1;0:=>6\/V8)=%I'N)'"*A&WA3NSD9.!
MG&>!J:/XIO+OQ1)HUU9!HC;?:(;ZV23RB<X,;;@,,.HYY'I0!U5%%<HWB?4+
M]=:FT*RM[F+29WMW6:0JUS*BAG1, [<9P"<Y.> !D@'5T5PC_$&XOG\+G0],
MANH=?BF:%Y[@QF-XT+%6 4X /!()Z' /%=99W=S'HD=WK$4-I<)"9+E(Y-Z1
MX&3AL<B@"_5:^U"STVW\^]N8K>+.-TC 9.,X'KP"?PKC[GQU=V?ABT\63:?%
M_8,[(SJ)#Y\,+L LI&,'JI*CH#U.*AUNXU1OBSX?B@6U:$6%U)"KR, <^6&8
MX'7L.O!H [BSO;74;.*[LKB*XMI1NCEB<,K#U!'!J>LB^*^&O#EP^C:-YY@4
MM#86BA-[,V2  ..223CUK(LO%EW-XDU+06BL;F[M;%;R.2WG(1LL5,;\$JP(
MZ\\'H* .NHKSNP^(6K7.C^&];GT:UBTS5[J*T;;<EI8WD8JK ;<;00.^?85O
M6'B6ZD\8ZKH&HVUO:_9;=+JVE$I;[1$Q(+8(&W:1@]>30!TU%9N@:A<ZKHMO
M?W4"0-<+YB(C$_NS]TG(&"1@X[9Q6)9^+9]4U:\M-/2S=[*_^R7%H\A6X2,,
M%,V.Z\Y Z8YSGB@#K:*X31-=UV3Q'XQ-U#%=0Z;(JQ6]NS;R!#O5$!&"Q+<D
MXY/IBK-AXPO7\2V&B7MM9K=7UB]T(XIB6MI%"DQ2C'HWWN.AXH [*BO.O#?B
M_4K?PIJ.L:WY$S?VG+:Q+$S#=(9O*1 "#M7..>3C)P:V](\4WEWXH?1KJR5H
MFMOM$-];))Y60<&-MP&&[CGD>E '545BZUKQT_4]+TFVC274-2>00B1L(B(N
MYW;'/'  '4D=.2,2?QM>67_"16-UIT!U71K3[:J+.5BNH-I.Y3M)4C!!4@\]
MZ .UJ"[O+:Q@,]W/'#$#C=(V!GL/K[5B^%]7UK6K:*]O]-MK2QN;2&>W:.X+
MN2RY8,N!CMCD\'ZXP_%\^J+\1/!D%LMLT32W;QK)(P#.(",M@'& QQC/6@#M
M+#4;+5;-+S3[J&ZMGSMEA<,IQP>15AF5%+,0J@9))P *X*[\5+I,&L?\(_I5
MFXT^X?S[9%=6NIL!I-FQ2 ><9.22#P."=:#Q1-K&I)IVD6RK,+&*]N3>!E\@
M2?<C*CG><-GI@#OG% &]8:C9:I;FXL+N"ZA#E/,A<.NX<$9''%6J\M\$^(!H
M?@]O/@C2\O=>N[>.'>2B/YCLV2!DJH5N@YP.F:UI/'>I6UAXDDDTA)9='M_M
M4<RM)'!=1[2QVED)#+C!7GZT =Y4-U=6]C;/<W<\5O!&,O+*X55'J2>!7*6_
MB/Q-+807C^'X/*O#;"V:*X+^6L@R[S#;\JH.>">H&>]56\3?\)!X>\::?*EL
M\FF021&:VDWQ3*\!<,/0\D$9/(ZT =M;7,%Y:PW5M*DL$R"2.1#E74C((/H1
M4-MJ=A>7=S:6MY!/<6NT3QQR!FB)S@,!T)P>OI67X%_Y)]X;_P"P7;?^BEK
MTF=K+XB?$&YBMI+AXK:QD$$0^>4B&0[1[G&!0!WU%<;8>+[Z3Q+8Z'>6UFMU
M>V+W02*4EK61=I,4H_X%][CH>*SKGXB7]IX*U#79M,M$N-,U!K*]M3<-^[PX
M7<&V_-PP;&.0: /0Z*RH=3N+C7%LX4@DMEM%N)9E<Y!<D(%&,$':QSGC'O46
MMZ]_9E_I>F6\2RZAJDKQVZ.VU55%+N['T '0=20..H -JBN-D\9WEG=:[I=W
MI\!U73++[?$JS%8KJ#GY@=I*D$%2"#SCGTN^$];UK7K.UU"]TRUM=/N[&&Y@
M>.X+N7=02&7' YR.3QC/.0 #I:*X_6/%&N6_B]_#NE:/:7,S::U]#+-=% <.
MJ88;>.IZ9R2.@SBMJ/CJ\BMM1EL+&">;3&\N:V+2%YY%4-(D952.,X!/4@\
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M\MW;@&:&.0,\><XW =.AZUS<OBK5;O3KK5=#TA-0LK:[:V$(D(FN C[)'3L
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG3)=%M6V07X9_M/D \)LQMW8^7=G '/)KO:** "BBB@ HHHH **** "BBB@
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M01+55S]GS@/\[*.3P!UX/%20^+-.O++2[FP$UX=4C:6UBB"J[HH!8G>5 QD
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M+;F[-E]J15,8E#%"#\VX ,",XQD?2L>Z^)FBVT>H2+9ZM<)ITYANS#9,?)P
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ME8MYW.I-MA"!3M^0OEOFX&T$Y&?S(SSG@BQ=E\6VVH6%Q'#?:Q<S(MQ R+-
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M,=Y;K*I1GP-LD1!Y&]25QW.*ZC0;"73M'ABN"&NWW37+#HTSDL^/;<2![ 4
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M;[.YMK=Y@Q*!6C;:#M(VC&[ ([T :]SX[T.!-'D26XN8M7S]DDMX&=7PI;'
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MWC.>2.O-4K3?'\:-0B$TQB;0XI?+>5F56,S E03A>%'2N,M[76(OAOH7A_\
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MXY1':HK2W+%?*&Y0P 8-R=I!/H,>HSBR7\D^@RV-MH5Q%;7$OV&VBGM'($9
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M(A11(S;_ "\;2W7=Q@\^U9FGQ7/_  MG4KU[*ZCM9=*@@69H6V&17=F7=C'
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MMI]DZA6M+<@$L 8QU/)/3O0!Q6GQ6C?%_P 0V@2$QS:/;"6( 8?YI <CO\I
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M4&7[1YS>2J]\Y*X ['WK3U;4;:.3Q)I=S-!9:K'H,,5[-,^^6_;R7(6)2=N
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M_A1<$([?[(<@_7%=A;V-G:R/);VL$+R??:.,*6^I'6IG19$9'4,C#!5AD$4
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M%#&D<:C"HB@ #V J.&QM+>>2>"U@BFE_UDB1A6?ZD=: /,[*'3VO/BENCMB
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MUB&ZAOK4.VS]V@99 ,_*V3@D=<CO1\([&WMO!GF0QE6:\ND/S$C"SN ,9P*
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M>5!U7AL_49HN],O_  _/-XCL-3MEA&FS_P"@0[W2\=8VD1_F8_,-OWNI&>:
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MBZ.6D.R"9<Y4#.P#E<@>A-#7EQI'B>*/Q#9S/;W6K$V&NV<Q=26D.RWF7.5
M^YW7(!Z@F@#T.UFU!]2OH[FTBBLXRGV699=S3 K\^Y<?+@\#DYJ[7E=YJ]_H
M-[\4+NREGFEL8;:2V661I1$6@+$@,3@ DMCIQ5G6D;1=)\):YHMQ.UU/>VD$
M[&5G^W13##;\GYCSN#'ICB@#TND.<' R>PKR2;2UOD^(_P!HO=1<6$K26@^V
MRCR7%L'!'S9.#T!R!V%>B^%;J:^\(:+>7+F2>>P@ED<]69HU)/YF@"OX4\0S
M>(K?4WN+-+62QU&:Q*)+Y@/EX&[.!U)/:M^O';3P[;ZIX>\<7[WU]:W5GK6H
MS6TT%T\:P.GS!MJD ].<YXZ8K0FO+S3X/!OCG4))EBGMX;?6(R["-/-10LY3
M.U2KD G'1O:@#U*JSWT"WZV D4WCPM.L6>2BD D^@RP'Y^E97A:+SK6YUAM^
M=4G-Q&K,2%AZ1X!Z94!R/5S7.G3;1_CH\K1G>=!28D.PRXN" >OH!QTH Z'P
MEXAF\1V-]//:):R6M_/9F-)?,&8VVDYP.ISVK?KPZ[LQ#\.O&6MPW-W%?V&N
MWDMJ\=PZ")A..=H(!SSG(-=E=R3>(_'6KZ%/)!Y5K8V[P6\S.-P?=OD7:PY!
MVKGM@8QDY ._HK%\)V=YIWAJTL;_ %7^U;FVWQ/>;<&3:Q&#DGD?=)SU%;5
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M9-/OTD>UDX=(YGCW#T)4@X]JEGL(+G3GL9O-:"2,QM^]8,5/!^;.[\<U9HH
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M20R-G*8).-I &3ZFI(/!&AP75Q=+%=/<W-N+::>2]F:1X^>"Q;)ZGGK7144
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MQ<;!N0(,EL[\9)[ CO765E'Q#8CQ0OA[]]]O:U:Z&8B$\L,%X8\$Y8=,UJT
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M6XCN?-A3S)-D3.OS   9QT Z=:KO\.%DT'Q#I,NMW4D6L71O-[1)NAE)1L\
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M')4AOXB3QUKGU\6^(;SPMHFM6MZL5_J&K?89M.:W5UA!D92H'#[T50QRWJ<
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MQBNOL<9><>4)%5Q]T 9P2!D^V.="V\6ZAK(\/V=M'/%<:AHRZI<-9B(NN[8
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M0 1GN1VDN]&\4Z'XON]8\/QV>IVNIQ1)>6]Y.8626-=BR*P4C!7&1CM7=T4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>sangamoexecutiveseveranc018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHJAK.L66@:/<ZIJ,OE6MLF]VQDGL !W). !ZF@"_1
M65HUQJ][ EYJ$$%FDJ[DLPI:6,'IO?.-WJ O'3)ZUJT %%%% !1110 4444
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M&%Q((V6S\M?**$] /F;CH3GO5J:WM(OBCX/EMHV7S-(N5WR#]XRJ(]N\GDD
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M>5O,MT9E&QGW$R+G=C=_2@#T2\O+JWN[&*WT^2YBN)"DTRR*HMUVDAB#R<D
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M>]O&N[*!H(B63:4;&[(V\DX'/M6Y10!Y_P")/#*:1X:OX+*#5[^'5-32ZO\
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M>:A_Q)0PM-\P;&Y=ASE>?E^7' ';!YKJ:* ,C2O#MMI&JZGJ,-Q<R3:DZR7
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M8WF73YBR[#M^7Y?EXX_GS725FZOK^EZ"D4FJ7:VL<KA$>13M9CT4'&,\=.M
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MMV8V\6T?NU7D ' Z#I7*Z7XJCEL?"FE:):?8AJMNTEN+D!_(MHD!R54\DY4
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MCD)N(TE,;'SLA58[68<8'0Y-3MKGBS4/&&LZ)IATF%+**UGC>YBD)*R%MRL
MW7"]1TQTYR"Q\&^(-&U"]M=(\00PZ!>7#W!@DMBT]L7.76)\@ $DX)!QGH>^
MMIOAZ]L?&NJZXUS UO?P0PB *V]!%NVG=GG.XYXH Y:?Q?XM.@>*=4A.D(-
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M:+=O;Z[C["8I8RYRN]1(&*A25Y&&/3'6EUOQ]9Z1'J,T<"W4&F/MN]MPB29
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MP,$OC)QC:<XQ5"U^(.F?VEJ=AJ/EVDVGVGVYY(YUFB>#."RL.<@\%2,\C&:
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M5BU/3VFF1U9H_+*JP4G',>#VY[]:Z/3[WQ'J=A<-?>%AI;);NIB%S%(\\A&
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M]K)?7+3Y.5.V$"7[QSGITX'\50R3P+9?"W:R@P-'YN/^60^S%3N_N_-QSWH
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M,>H- 'JE%9]CK-GJ.H:A96YE,^GR+'.'B90"R[A@D8;CTK0H **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M /##D<@GJ*\U\<?\G&>#/^O9?_0Y:@^(7F1?M!^"WT_(NW2(3;.IB\UPV?\
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M.6*TBO/,E"A7CD)V[<$GL>H%;U>=2Z?-?_%O5[6WU"?3T_L2V!DM5428\R3
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MU)96AF 7RQY:[F!YSGD=N];-<#JUO+:_$+X?P3W+W4T<-^LD\@ :1O)3)(
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M4EM=H$=H=.*L,$$$')[@5S.GWWA#3=:T35HK?QW)=Z1!]GA:6TWAX\$!2".
M Q&%Q_6O?:R9?%/A^"YDMI=<TV.XC^_$]T@9?J,Y% 'C'V[PD/\ A)?W'CC_
M (J'F]_XER<?,6^3Y./O$=^#^-27NI^$+SPQI&BFP\9(^CR"2PO1IP\Z(@Y'
M;:1P.W85[=8:II^JQ/+IU];7<<;['>WE60*V <$@\'!''O5N@#P[2/$7AK2O
M&-SXI,'C:ZU.YA$,QFTY=CKA1R HQRH/& ,5LW_Q&T:_UG3]1-KXPB^Q%FCM
MX],7RV9E*DMD$YP2.",9/K7K%% 'AWC+7_"GC:ZT^YOK+QG:RZ>Q>W:TTY5*
ML2#G+*3U44NJ>)?#FH>(K#Q##;^,[+5[6'R&NH-,7,\?.0ZE2N>3R /T&/<*
M* /%/!WBCPMX*%^+#3_&,XOIC/*MSI^X!O4$ '\R:OZ'XY\)^'KO5KFP\/\
MB5)-4NC=3G^S#]X@<#GIG<?JQKU%]4L8]6BTM[F,7TL33) 3\S(I +?F15N@
M#PO2M9\':6_B'?IGC"]B\0,SWT5SIPVLS%B2NT*1]]N_\J=X4\0^'?"D/V6%
M/'%Y8(6\BSNK',46[.> !GJ>#QSG&>:]RHH \'\-ZQX8\+7DO]G1>.!ICS>>
M-,:QS"K]NV[ P.,\X&<UTNN?$;POXCT6ZTG4O#WB66TN4VNHTU@1SD$'/!!
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MRP0+(V#([' 51U)R10!X[<^)= U#PK=:%J7_  G5X+I4CENI+!?-V*<A1QM
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M?",OAE(2NG26[6Y&<MALY;)ZMDEL^O-1-X/TEKC09O*;=H@9;7G.04V_-Z]
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M1M)(RHB@EF8X  [DT 8"^$T'B*SUM]5U"2[M;9K8;S&5=6(9BWR=20#Q@#H
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M&NVJC8ZQIVIW%U!8WL-S):.$G$3;O+8C."1WH O4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<UX]UVZ\-^#;_5K6TMKIK<*6CN&(4@L%Z <]>G'UKI:YWQUH5YXG\'W
MVBV+P1S785?,G8A4 8-G@'/3'XT 5-5\1:U!XVM?#UA9V+)=6,ERD\\K?*RL
MH^8 =/FZ#.>.17,ZYXNUV]^&^I749M;+4;+5/[,O#$K,KXF6,F/)!4$,.N3U
M^HZJ?0]5G\=:=KY%DL-M8R6LD7G,6+.RL2/DQ@;<>^>U8<O@/5[GPEXBTI[B
MQCN=1U5M3MW5G9%)E20(_P H/\&,CUZ4 =!)KE^_B*+PW;/:?VBMF;RYN&B8
MQHA?:@";@22<_P 0P!WS3_"OB277&U.RO;=+?4M*NC;7*1DE&XRKKGG:P.<'
MD51G\.:Q'XIL_%%I)8OJ!LS97UJ[/'%+'NWJ4<!B&4\9*_,/[M:?AW06TF?5
M+^Y:-[_5+G[1/Y>=B *%1%)Y("CK@9))P.E &-/?:TWQ?ATV.[MQ8)H[7 A:
M)CUF16R0W+?+P>@!/'-<MINO:QX:\/>,-8L+2REL[+Q#>RW"3NP>1?, 8)CA
M2 <Y.?IWKN+[0-3/CZU\16$]H(AI[6-Q'.&W!?,$@9,<$\8YZ=>>E84G@C6I
M?!GBC1&DT\3:U?3W22"5RL2RL&(/R9)&/QSVH W;SQ!<P^.]%T@6EN;6_M9Y
MEN"Q,B[ I(QC !W#N<X[54T'Q?<:_J7E6LUAF&\E@O=/=66YMD7>%<Y;YLE5
M_AQ\W4XJ:?0-5N/%WA[6&^Q+#IMK+!,@E8LQD"@E?D[;>_7/:J<O@Z_U+6=&
MU+48M.BO]-NO-;4K5V\Z>(!@(V78."" <L>AP.> #L;Z\@TZPN+VZ<1V]O&T
MLCG^%5&2?R%>3Z#JD>B?$BPO9=3@N%\5P%;R)+A9/L]TI+1KP> $81CU*UZ)
MXCT_4=3AM+6T6U-K]HCENUGD93(B,&V#"GJ0,Y[ C'-4/'GA>?Q-X;^PZ<;:
MWOTN(KBWN9"5\AT8$,, Y.,CMUH M:QK\UIXDT?0;5(UN-16:3SYE+)&D0!(
M"@C<Q+#N,#)]JY>Y\?Z[;^$?$VK'3-/:70[M[,_OG"RLA7+A=O PRD#=ZC/%
M.\4'5=2U[0--BFT1-:M;>2\EAN)944YQ&K1R)AQ_'\HXQUZ#,,VD:WKWA+7?
M"!M-#M)W1#]HLKB1XLNQ9M^Y-WF97)SG.X$GU -NX\2:WIUQ!;:E:V4<VHS[
M+ 6PEG,<8C+NTJ@98C&,+P<CD#FJT?CC4;.WU)-5TJ4307<%M97"VLT,5Z9C
MA2JL"P*G.X#=TXSFKWB?PWJNLV>DWVG7=O8Z]I<OG0,VZ2%LKM=&X!VL#UQF
MJVI^%]?\2^&IX-8U*TM=5\R*>T>P1C#;21-N5OGY8D]3QQC XR0!!XJUZ"^U
M2UDTL7,4%@UY;7WV6>UA9E^]$^\,0V.00>1Z503QQXB32_"NKRZ=ISV>N/#;
M^2DKK(DLL996W'("Y'(P3CUZ5L6VG^,+S2;V/7+G23<O:O;PQ67F+$S,,&21
MF!.1V4#')Z\8SG\':R?#'A#2E>P,FA75O/(YF?$HA4K@?)QG.?;'>@"Q#XSO
M=,O_ !':^(H;4?V19)?K+9;L21,&^4AOX@4QZ'/:GP>)]=_MO3;=]*:YM+Y'
M\QXK.>+[$X7*AW<8=2>-P"^N.U-OO!MUJWB/7[B^:W73M6TQ=/(CD8RIMW?/
M@KC^/IGC'>I?#>E^-+*."SUK4M+N+.S7$<MLLBSW.T842$\+V)VYSCZY ,(_
M$#Q$GA.;Q))INFK9V5^UM=1"1R[H)O*)0] 1D')Z\\#OK_;M:?XOOIHN[?[!
M%I"W"Q&)L@--M;G=RWR=>@';J3G2^!=;E^'6I^&C+IXN+R]>X6;S7**&F$N"
M-F<C&/U]JWI-!U7_ (3Z#Q'!+9I#)IRV-U"^YF7;(9,H< '.XCG&.O/2@#J:
MXF2^UI_B^NFK=VXL(](^T+"8FSAIE5LG=RWR\'H!VZYU_"MYK5Y;7PUHV,CQ
M7;)!-9!A')'@$8W=2"2I(XR#Z57O- U/_A/[?Q%8SVGD'3_L-Q%,&W "3S R
M8XR>1STZ\]* .&TS7]8\,>&/%.L65I92V-EX@O7N$F=A)(IF (3'"D ]3G/I
MZ]MJ?B:X.L7>E:4$$]I;QS22RV<UPI:3=L3$?W>%R6)[C /.,2;P-K4W@?Q+
MH+2Z>LVKWT]TDHE<K&LK[R#\F21C'O[5=O\ PWXGM/$B^(/#MUID=Q=6T=OJ
M%G>F0PN4SM=&4;L@$CD"@#H?#&K76N>';34+[39]-NY5/FVDZE6C8$@]0#@X
MR/8BN-M+N:T^-7B1H-.N;TMIMKE;=HP5Z\G>Z_IFN_TZ"ZM[&-+VY%Q=<M+(
MJ[5+$Y(49.%&< 9/ &237*P:!K]GX]U7Q%#'IDL5[;16ZP/<R*RA/XB1&>N3
MQ^M %V.\U6X\-7NK:5I45OJ\DLQ-G=]93&[1J&*M@,51>02.G;FHO"7BF[\4
MP1W\<<46GQP*MSOB9)%N?^6D8!/ 7C)]>/7%F6W\4S6U\_G:?#<3%(X$CE<I
M!&,[WW%.9#DX^7 PO7D&EIGA.[T#Q9<7.D?98]"O84%W9O(V[S@,>:ORD9*X
M!R?FZDYH H+XZU2YM=-U;3M+EO=.O)U5K:*QG\Y(&.!*),;#QABN.^-QQFK\
MOB/6]1L]5O?#ME;72:==M:K;2Y$EVT9 DVON CP<@9#9V]LU2\.>%_%OAZ-=
M"BU73I/#L3GR)F1_MD<1.?+'\/L&Z@=NF'6?A?Q1H.MZHNAZCIHT;4[I[MQ=
M1NTUK(_W_+ ^5@3R 2,?GD U;77[^?QK?>'WB@C6+3X[R*3:2REV9=K#=@XV
M]01FN3OO%NNZQX.\+ZG;/:V4E]KL5I<(J,P(6X91@[@0I\OD=\XR*Z2Z\.ZS
M;>-DUS2;BR:&;3TL;A;PN738Y99%V_?/S'()7ZUC6W@'6[;P/I6DB]L'OM,U
M5=1A8AQ&^)6DVL<9_C/(':@#>?7-0B\>V6@S6]GMFTR2Y%TH8MO5D4C:>BY.
M<9.<#D53TSQ;J5QIOB);V&TCU;2;HVR6\:MMD+ >2>6SB0L .F*N/H.K2^.]
M.UZ1[)H;>P>TE56969G96+*,$  KC!/XTZY\(B7Q]!XBCN-D!M@EU;#I-*A_
M<N?7:&?\0M $-]XEOQJ-UI-EY/VZRMXY)Y393SQM(X)5 (^5&%SN)/48!YQK
M^&M5NM;\.V>H7NFSZ;=3*?-M)U*M&P)!Z@'!QD>Q%8.K>'/$=IXNE\0^%[S3
MPU["D-]::@'\M]F=DBE.0P!(QTKJM.@N;>QCCO+@7%SRTL@7:I8DDA1DX49P
M!D\ <F@#DQXQO+>7QJTVF0L^A!&1+=BS3@Q;QN./3'0<<]:U?#>MRZX6N8;[
M3=0TUHE:*ZL@5._)W(REFP0-I['D\#%9]KX>UZSUCQ5J5O-8QS:L\,EJ2[MY
M;1H$PXVC((&3CZ>]2:%X3.F^+;S7Q:V>GFZM5@EM;&1FCEDW;C*V54;NW [D
MDT 9WQ!O[32_$W@R_OIT@M8+VX>25S@*OV=ZT=2U_7=-\(:MX@>TLB+>&2XM
MK9RRMY2C(+D$C<1_"/SIWBSPS=>(=8T.81V4MC8RR/<0W#M^^5XVC*X"D8PV
M>:RXO"'B&#P7K7A475E/8SQRV^G2S3/YEO"X("/\GS;0>/RH M6OBK6D\0>'
M;74;.Q6RUR"1HO(=C)"Z1B3YL\$$9X'0]SUIDGC'5+OPQJ'BC2;:TFTRSDFV
MV\@;S;F*)BKN'!PA^5B 5.<#D9XFF\-:O+J?A"[_ -! T1'$Z^<_[PM%Y?R_
M)VZ\_3WJK9>#M8TG0]7\-6$]DVD7SS?9YY782VB2YWKL"D/@EB#N7KS0!<B\
M77-SXET2VA%N-)US3WNK&X9&+F0*K>6PW8^ZV[\"/>JNB^--0U?0=1E"V/\
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MEA@ Y& <?AFGZ[X.O_$4B+?1Z<)K>^6>SU2-V%S;Q"0/M V\G&5^]CD'!(Y
M.YHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHKF?'?B*[\,^'A>65F]Q+)<10;@R@1[W"[L,1
MD\\#UZX% '345YSJEXUK\5]'O1I]\T\VCW/^AJ59RPDCP/O;%X[[@/4UT>G^
M--.U#0CJ8AN876Z-DUI(JB87 ;;Y> <9SWSC')( . #HZ*PM)\46VIZW>Z+)
M;7%GJ5HBRO!/M.^-NCJRL01G@]P:YCXIM%;2^$[B25H$DUR""X=9"FZ$ARRL
M01E>* /1**Y+31X<N/$,8T6X=[NTB::189F9&1@5"L"V,D\CTV]LTMKX^LKN
M:[MH],U(7]K>K9/9,L0F+L"P8#S,%-H)W9Q@$]J .LHK&U'Q"EE<36UM8W-_
M<P0B>:&W* QJ<[<EV ).UL 9Z=N,U;/QII>J6&F7.E+-?/J43RV\$8"OL0X<
MMN("A6(4Y/4X&: .CHKDX_'^G/9V5PUCJ""YU,:4R-&@:"X+;</\W3/==PJY
M<>*XHM5U32XM/NY;ZPM!=[,QJLR$D#:V[CE3UQ0!H:IH6D:VB)JVEV=\L9R@
MN8%DV_3(XJQ96-IIMJEK8VL%K;I]V*",(J_0#BN D\56>K?"VUU?Q3HUY):7
M1A=TA*X9FD!0@JX(4-M'.#[&NL?Q-;Q>+H?#DEG=I<S6[7,4Y">2Z*0&P=V<
M@D<8SWZ<T ;=%8C>)K9(IG>UNE*W9LH5.S-S*.HCPV,##9+8QM;/0TFC>)[7
M5]5U#2C;SVFHV&PS6\^TDHXRKJ5)!!^N1W H W**P-6\5VVDZ]9:,]C?3W5[
M'))!Y$:E7V $KDL.>1UXYY(K*_X6/;'2]0O5T+6&?3)7CU"W$<>^VV $L27V
ML,'(VECCM0!VE%8,WBJT^TV%K8V]Q?W%]:&]A2':O[D;?F)<@#.Y0!UY_&J!
M^(6F?V+HVKQV6H2V>JSK;12*B#RI2Q0+)N<;?F!&1D<=>F0#K:*H?VJAU[^R
M5MIVD%N+AYAM\M%+%0#\V[)(...Q]*Y'Q^R6OB;P7>%9G9=29-D>YBP\ES@*
M."<XH [VBN8M/'&GRV.N7%[:WFG2:)S>P7**712F]6&QF!!'3!J:S\6176K?
MV7)IM[;WK67VZ&*3RSYL60I (<@,"0""1UZT =#17-Z?XTL]3\,3:[!8WPBB
MF: VSK&)C(K["NW?C.[C!(/YBI=3\51:>MX8]/O+QK&(2WBP&/,(*[MOS.-S
M;><+GC'J,@&_15/3=3M=8TFVU.PD\ZUN8A+$P&"P(R.O0_6L%_'NGQ^&]6UQ
MK&_\C2KF6UNHML?F*T9 8CY\$9/8_A0!U5%<U>^,[:TUZ+1DTW4;F]FLS=PK
M#&N)%! P"6 !^;J<#CKTHL_&^EW?APZP8KF'%R;,VDB#S_M ?9Y0 ."Q;WQW
MR.: .EHKSJUNV?XV&2XL[FQ*^'W9Q<2*RD>>GS JQ X&#TZ?0G=;QS81W.E"
M>TNX;/59!%97CA/+D=AE 0&W+N'3*CWQ0!U%%<IIOCJWU;4I+*TT;5W\F_>Q
MN)?(79 ZJ#N<[N%.<<9]\9&7^-/$EYX=BTG['827+7VI06C.K(-@9QD ,1EF
M ('8=21W .HHKS>>]?3_ (P37$6G7UQ//X=23['$59]YG.>2VQ<!0"=V..,\
M9Z:P\9:=J.@6.K6\=P?MTI@@M64+,95+!D()P"-CDDG&%)S0!T5%8FB>)[76
MK_4=.$$]KJ&G.JW-M/M) <91@5)!4CW^N*?XEO)[;2#!9/LO[UQ:6K8SM=_X
M\=]JAG/LAH V**XSX9ZK=7?AI])U)RVJZ).VGW18\ML^X_N"N.>^#5S4/'%A
M86^K7:VMW<V>DR^3>SP*I$;X!8 %@6VA@3@<9[X. #IZ*PSXFA=+9;:QNI[J
MX@-PEL-B.L8.-S%F"@$XQSD_@<3>'?$-CXGTE=0L?,5/,:*2*5=KQ2*<,C#)
MY!]": -:BO-_[.M[WXV7]E/YIM!HL=P(%F=4$AE*EMH(&<4Z\N;SP1\0]"LH
M;VZN-#UXR0&VN9FF-M,H!5D9B6"G(&W.!S[4 >C45QNE^(?#]C!XGU*"SNK3
M[-J&R_\ .^]+.50 J"Q !R@_A'TZUKMXE@M8M1EU.UN-/CL(4FE>;:RLK;@-
MA0G)RI&.N2..: -NBN?A\51MK*Z3<Z7J%K=R6K74*R*C"5 <$ JQ 89'!QUK
M*L_'UAK^CM=1:'K,FF36L[O-Y"A<(Q5D)#?>(R1CCWR#@ W]0\+Z!J]TMUJ.
MB:=>7"@ 2SVR.V/3)'2M2.-(HUCC1410%55&  .P%<;9>+=$T7PWX7%GIU^E
MAJ:10V,:)YAC!3<JM\Q.< ],U/%X[6>YU&QC\/ZP=4L-K26.R+>48$JX;?LP
M<'C=G/&#0!T,.E:=;:C/J$%A;17MP )KA(E$D@'0,V,GH*N5Q.J^)O#NK^&_
M#^J75E=W=CJ%];_9=@VF*<OA"^&&,-G(Y'!ZUH7?C2&#7KW1+?2-3O+^U@6?
MRX8TQ(K$@%69@.QZX]LF@#IJ*YFW\<:9>Z/HVH6<-S,=8D,5I;A0KEP&+!LD
M!=NQL\]N,UE:_P#$!K?P-K.L:9I]P;O3[AK*:*8H#;S A=Q^8A@-RD;<YR.G
M. #NZ*Y35-3TQ_$7AB+5-(OH]0GFE-BS%=L#B-MV\HY4Y4' ^;J.E6;WQ=;V
MRZE+;V%[?6^F,4O);8(1&P4,P 9@6*@@D 'TY/% '145S%UXZTR&\T>WMX+R
M]&L0O-9R6T899 J[B.2,'!'7@9Y(P:O>'/$EOXC@O#':W-I<65PUM<VUR%#Q
MN #_  D@@@@@@F@#9HKFM6O=(3QQX>M+RQN7U-UN38W*\1Q@)^\!^89)&!T/
M7M5"?XDV45IJUTFC:Q-%I-PT-Z4A0>4% +/RXR,'H,GC. .: .THJ.&:*ZMH
MYXF#PRH'5NS*1D?I7EF@RZ)'XT\9V^LW02*WO8Q;1RW#A8U,>6"C/ SV% 'J
M]%<:GB'2/"_A:QU*%+^XTW4;A#;E09#&)B-N2QSMR>.IYP!5@>.(SK%SHYT+
M5UU*. 7$-L8X\W$1.W>IW[5 (YWE<9'?B@#JJ*Y!OB-I*>'+76WM;]89KS[$
M\7D@R03;]A5P#@8/H3[58TOQE9:QKUQX?N-/U'3KX0&:..\C$?GQ9P60JQ_+
M@C\#@ V]0TK3M6BCBU&QMKR..02(EQ$L@5QT8 C@\GFKG08%>=?#_5K70_AT
MD]TTC ZG<P0QK\SRR-<NJ(N3R2<=3[DXR:Z:'Q5"VKSZ1/I]Y;ZFEO\ :8K9
M_+)N(\X)C8-M)!X()!'TYH WZ*YJQ\:V6H>$CXB@LK[[/YAB%NRQB<N)/+V[
M=^ =W&"0:9+XUC&KZAI-OHNJW-_8PQS/#''&-ROG&UBX7C:>I&>V: .HHKC(
MOB3IDVG:9JD>G:F=+OI$A^VM$JI!([;0K@MNX;@E00#WK5U;Q3#IIOA%8W5\
M;",278MMG[H$;L?,RY;;\V!GC'J,@&]17)GX@:9)=Z9;V5I?WK:G:-=VC01#
M;(HQE<EA@\CK@#N16=K7Q$:/P#J6N:9IMR+JTN39307&Q6M9MP0EOF(;!92,
M9SD=!G !WM5K_3K+5+5K74+.WN[=OO13QAU/X'BGVTSSVZ2R6TML[9S%*5++
MSWVDCWX)KS[XBZSJUE<PZEI3L;3P[+%>:C&G697RI0?[L99CG^\IH [C2]$T
MK1(FBTK3;2QC<Y9;:%8PQ]\#FK]4+O6M/LM$;6)K@?81$)1*H)W*V-N .23D
M #N2*RSXM"ZE-IDFCW\5^MF;V&%_+Q,@." X<J&!QD$CKWH Z.BN;\"^(+OQ
M-X4L]5O+.2WDN$\P$E-K DXV[23@# ^8 U"-1.M^/KO10?\ 0M(MHIKA.TD\
MI)0-ZJJJ3CN6!["@#JJ*X2:Q\;?V)JL*PZ;+>?;_ #;<M.X%W!NSMD/\/&%P
M., CIUZ'7KV[M-"6. I'J=X5M8-O(65^-P]0HW/]%- &U17%_#/5+JX\.S:-
MJ<A?5=#N&L+EF/+A?N/]&7'/?!K)TG2[6_\ BSXMM+@3-;6]O:/#")W5(RZ'
M<5 ( S@4 >E45YU#=7GA7XG6/AM[RXO=$URVE>WBNY3*]M+&"64.V6*%>Q)Y
M/YY/A2YT"/4/%Z:[>A?LVM3I"LUP_P"[B 4@*,\ '/ H ];HK)\/I:6OARVD
MMY939NAN8VG<EE1R9 "22< -CD]!7&>&]>U.#XAO'JLC?8/$MK]LTQ&X\HQ\
M>7C^\8MCGWH ])H(R,'I6!J?AXWWBO2-9BGN(GL@ZR;9R(W0J1M*="22#D_W
M?IC&C\+W'A_POJSV%U<"ZBFEO=/\^=IFB(1?W;,>JN5)9>GS>H!H Z"U\*>'
M;&_^WVFA:9!>9SY\5JBN#Z@@9!K8K-\/:S#XA\/:?J\"[8[R!)@I.=I(Y7\#
MD?A3M;UBT\/Z-<ZI?%_L]NH9A&NYB20  /4D@?C0!H45S\/BR%]1O]-GT^]M
M[ZSMENV@8(YDB8D H58@G*D$'%9ME\1]/O8=%NAIFIQ6&KRK!!>2Q((UE;.U
M&^;=SC&0"N>] '3+I6G)JCZHEA;+J$B"-[H1+YK*.Q;&<5<KE]?UZ">SUK3[
M:QO+[[) 1=M;,JB(E-P7)8$MC!(7/!'<@%OPU);X:^'22238QY)^E '54UT2
M6-D=5=&!#*PR"#V-<$/$5YXAA\9Z==:9<6]O8AX$<2I\N(0WS%7W9).>,C&!
MGK47@GQ;!8^&?!VF75A?QQWUG#;PWS(HA:819V?>W<X.#MP>Q- '7:?X7\/Z
M3=FZT[1-.M+@YS+!:HC<]>0,UK5RM[X\T^R%Y.UI>/86-ZMA=7:*FR.4E1T+
M!BH+J"0._&:1?$]\_P 1YO#PTR?[+#8K<&57C^;>^W><MD*-I&!D\GCI0!U=
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7)_$;3;W5/!\L6GVSW5Q'<V\XA0@,ZI*C,!
MD@9P#7644 <1,E_<_$O1]6;2KR*TCTR>&5V0'RW=U95.TGG"\XR!G&:YB3PY
MKL^@:I+;Z2TEW;>*)=8@LKH!5O("2-N3P"59N#R".E>O44 <QX6E:]E>[3PJ
M="B$>PBXBC2:1L@\!"<(,=^I(X&.<SXBVE_?77A?[!IUU=_8=9@O;CR4'R1(
M&!.20">>@KNJ* ,#^UI[C5+46^AWJ,V5FNKB(*L40&XCALDD@  #OGM@\IJ=
MAK,>N6GCK3],N&U'S39SZ9Y:AY++/4GIY@(#@YQR%[<^E44 >;:K;7VE>.+O
M6G\+2Z[I6K6\(*QQ1M/:2Q@C!5R/E((R<\$?F[4+/7-#\0Z+XGL] \^W%G+9
M7NF6&SS($>02(R#(5F! #8/7...:]'HH X+Q9%K6L^'M,U)='G$MEK%M?C3U
M*F?R(V&0<';OZG /3 ZTVRMM6O\ X@ZKJ3Z-=VME>Z-';Q2S%!M<,YPP#9!.
M>@SCC..@[^B@#R672];E^"-MX?.A7J:E;_9H?).PES',K,PPQ&W"\$D9KJ_'
M&EZA?V>E:UH4(?6-+NDGMXY,KYD;_))&WH"IR?\ =KKZ* .#\7^&[]/#VB/I
M5I'JEQH]VMU+:38'VP%663KQO.\MSWS6QX7D-V9;M/#)T.$H$"3Q1I-(W<D(
M3A1VSR<]!CGI** ./URUO)?B3X7O8K*XDM+.&[2XG5,K&9%0)]>5/3IWK&@L
M-1&F?$.,Z9>!]4EF>R4Q_P"N#0",8]/F'?'%>DT4 >;VB:]!_P (Q876C:A/
MI$>CI#/! 50K=J%4B7+#,>T'OM)/(/%.\*^%;B^^$DGA;6[&2PD'GQY<J=K&
M9W21<'H"5(SCITQR?1JQM=\-VOB%K3[7=7\4=NS$Q6MTT*S!A@K(%^\N.WN?
M6@#.\ 1ZA/X<BU?6&1]3U!$>5D^[L50J8]B 7^LAJ#QC:WESXB\)S6UE<3Q6
M6H&>X>-,B-#&RY/KRPX&377HBQHJ(H5%&%4#  ]*=0!YM<V_B.VUCX@7VC:?
M*MW>PVQTV25!ME:.,J^,\9&>-W!]Q1I%A?K\0]+UB/0-3AM)-*DMII[R1&E$
MAD1LR'>3T! _0 5Z310!P]EX:O[+X@:AY:C_ (1Z[D35",]+L H5QZ$A9,^J
MBLV\LK[0?'&L7,_A-]?TW5WCF@FMXXGD@D$:HR.'(PIV@YS@?R]*HH J:9%)
M#IL$<MO!;N%RT, ^2//.T>N.F>,]<"O+=1TO78_"WCKP]%H-[/<:A?W-W;3I
MM\EXY2K#!SG=U&,?D.1Z[10!PD5OJ!^(ND:E+I=W%:Q:*]M,Y4,(Y6=&"G:3
MGA3R,CWKFF\/Z^=$GN[72YS=V'BN368[.3"&Z@+-@*<XW88G!YX^E>P44 ><
M7%KJ7B+QR;P:+J-G877A^;3VGN%1#$[R Y*[L\ 'W]L<TSP?%J5O;Z?HNH^!
MX[?4+#9'+J9CB-NZ)C]XC [B[ < #@G)Q7I5% ''> [6\L[CQ,+RRN+87>LS
M7<#2I@21,J $>GW3P<&G_$"POKS3M'GL+.6[:PUBUO)88<;VC1CNV@D GGIF
MNNHH XF&*^/Q4;6)=-NXK)M#6V,A3<%E$ID*?+G)VGJ,C/ )KDX/#NNP>$]*
MNX]#:YO-)UBZNI=,N0H^T02M)G;G*E@K@CW_ %]BHH YWPNYNEFNU\-_V'"X
M55CFBC2>0C.2P0D!1P!DY// XS7NK-M>\7E+VUU"&QT^#_19DD>$2S.2'8,C
M _*H &<9WM7544 >=Q:1>>&/BG]MTO3]0N-(U.S$>HR&1I?+F0_NY-SL6;Y?
MEXSBL>]#_P!H>*K :!X@FT?4[T^?_9<<,T<I"JLA#%P59B"K  XQ@8.:]<KE
MX/ ]G9W$K6.J:Q9VLLC2O9P7A$6YB2V,@LN22?E(ZT <QJ:2_P#"0:7XJT_P
MU+K.C3:<-/GL?)7[1:M'(Q!"/W!+*1GM7=Z CKIOF/I<6F"5RZVB*H:-< #?
MM^7<<9..F0.<9J_;V\-I;QV\"!(HQM51V%2T >?[+^U^+M[K7]D7\NG/I*6:
MS1Q @R"0L>"0<8[XJ=]$U3Q3XYTO6]3LFT_2M&#M9V\KJTT\S@ NP4D*H &!
MG.>N.E=S10!YQ8Z?=);>-5OO#]Q>6VH:F)4MI$ ^T0,(T8KDC! #$ D'@5FS
M^#-:G\/^(M$T:[OFTAX;>73(M3)#Q7"2;VC4M\WEX51\W&3QG!->LT4 <SH7
MB'5]617O/#E[I2PH3<_:=K%WQ]V(*26&>=Q Z 8.>,?P;8ZAIWPF;3+S3KJ&
M_BBN4-NR99B[NRXQP<AAWX[UWU% 'EL>EZI'X6^'EHVEWGGZ5=P27J"/_4JD
M3(Q]^6'3-;VFPW=M\2/$FI2V%T+*XM+:.&81$B1H]^X =?XACUKM** /(;71
M=8A^%WA72WTB\^W6.JPSW$ 092-)RY;.<'Y2.A_K756D-U%\4=5U1[&Z%C+I
M<,$<_E'#.CNQ '7HP[5VE% 'DVB6WB72/"'AG3VTC41;1WER-4@MBJS[6=VB
MVMN'RDL"Q4@]O6H)?#6N2^!O'6D0Z#-;RW>I&\M(]\>V1"8B%7#=<(V>V<8)
MKV"B@#AM=74-3\2>#=1CTB]CBM;F::Y5E!:%&B9%W8)&23T!) ZU!HEKJ?A>
M7Q-ID^EW5[%?7T]]830*&67S1DQN<_(0>,M@$'K7H%% 'F.F>%]0\/ZC\/;/
M[/-<Q:1;W27MQ&N4C>5 ![D;LC@<#&<5O>#;6\MO$'BN:YL[B"*\U 7%N\B8
M$B>6JY'IRIX.#7844 <=XAM+R;XB>$KR&RN);2R%W]IF1,K'YD85,^N2.V<=
MZP1INIGPS\1+7^R[P3:K<7+V2&/_ %RR0JBGVY!ZXXKT^B@#,\/+)%X:TR.:
M*2*6*UC22-UPRLJ@$8^HKC_#)O\ 2?%OBV]N=$U+[-J-Y'+;.D0.]53:3C.1
MSZUZ'10!YWXIBU/5_#$$%IH5U"D.JVSP6VP;Q#$ZLSM@X'1L#.< >N!HM!=?
M\+935?L-U_9XT0VIN/*./-,P?;CK]T>G7BNSHH \7U&VOM,\"3+=Z?<Q3-XL
M2ZBB=0&D1[D,F#G&2/4\=Z[A[&76/'VG:^+6X@L]*LITWRQ%'FDDV_*$/S84
M*><<EAC/-;'B+P[;^)+6WMKJYN88X)TN%^SE02Z'*D[E/0C-:Z@JBJ6+$#!8
MXR??B@#R.U\-:ZW@33?)TZ9-2TC7FU06<N%-Q'YLC;0<XR5?UZC%=9]@FU_Q
MYH^O"TN;2TTNTG7-Q'Y;RR2[1MVGG"@$D],D8SSCL:BNK=;NTFMF>1%EC:,M
M&Y5E!&,@CD'T- '"V6@7-M\2;^TA=#H<C1ZS)#W2Z.Y,8]&*^9_O)5S3X+NV
M^)FOZE+8W0LI[&WBBF$9(=HRY8#'/\0QQS6]H.@6GAZR-O;RW5P[D&2XNYS-
M+(0,#<Q]   .@K5H \ACT76$^#.FZ(=(O/[2AODD>WV#(477FDYSC[OO[5IW
M5I?:)XUU:\F\)2:]IFL&*>"6&*-I;>01JC(XD(PIV@YS@?GCTNB@#A'L+]/'
MWAJ[.EF*VM;"YBG-M'^Z@>0H508ZXVD$@8[\=L"\T#6;WP/XYLHM+N1=7NLM
M?6L;@*9HM\3 C)ZD(W!P>E>M44 4H[^1M+^VR6-U$^TM]F(4R^PP"1D^F>.]
M<UI'AFVU30IKG6K?48KS42\M];_:YHQEN-FQ'"L%7:@..0HKLJ* /([#0O$M
M]\*KSPL]G<0ZAIDZMILMR %N8HI0\0)SP<#;@XQQ[UV^C:UJ^OQ%;CP_=Z0B
MQ$3?;2F6D(QMC"DDKU.XX[8!R<=+10!R/PUMM0T_P/IVEZEIT]E<6,7D.)2I
MWD$Y*[2?EZ<G&:KZ+:OIGQ:\3^:,+J]I:75N>Q$0,3CZ@E3_ ,"%=M5:ZL(+
MQX9)%(E@??%*IPR'H<'T(X(Z&@"S7+7=FVO>+Q%>VFH0V&GP9MIHY'A$LSDA
MV#(P8;5  S@'S&KJ:* /.UTB[\,?%)+_ $K3]0N=*U*S$.I2&1I=DJ']W)N=
MBS<?+@9P*=I@O]/^)OB?5I-&U%[&^AM8[>6.(?.8U(;@D$<GN*]"HH X:UT/
M4]:\>P^+-8M#8VNF6[PZ=9LRR2EGSOE?82!D<!02?I53P8VH:)?>*'O=#U,)
M?ZQ-=V[)$K;HV"@'[W!XZ&O1** .+U&>_O\ P[%IHT2\MK6\N!;/$BC?;V8(
M5B^#P64, %R0''<&L[Q[X2DBT>SU+P]!J%SK>FW<5Q9QM=RS X8!U/F.0H*Y
MS] *]%HH KV5RUY917#V\MNSJ"T,PPZ'N#_]:JWB"\CT_P .:G>2G$<%K)(?
M?"GBM&JUW8P7QB%P"\<;B01D_*S Y4D=\$9';//4# !Q/A2>\\&^&O"&@7>D
MW4OVB$1SW*$;;:1OF",.O5B./0UT'C1]:C\*7C>'XFEU$;-BIMWE=PW[-W&[
M;NQGO6T]M#)<13N@:2+/ED\[2>"0.@.,C/7!-2T >:Z?97UMX[N]4B\/:C#8
M76B+"))F5Y#()&/[SYRQ8@@=2>F<=J$.CZM%\.?!.FMI5Y]MT[4K6:ZA$?,:
M1N2S9S@\$="<_G7K-% 'G&GP:QX=U;Q782:->WUKJ]S)?6=U;!2N9$ ,;Y(V
M$;1C/6NA^'MI>V'@'1K+4+.6TNK:V6*2*4J3D#K\I/Z\^U=-10!Y[;V6J6&H
M^.H'TFZDBU%S/;7$>TI(# J!1SG=N&.F!US5#^S-47PG\/+3^R[S[1I5W;27
MJ"/_ %*QQ,C'WY(Z9S7J-% 'D7BC3_$NMZ-XCM+O0KZZOTU!'L75T\@6RRHR
M^6-WWRH;)QGDY.,"NH2WU.'XI+JQTFY-G>Z1%;&0,F('65F8/\W]UATSD\"N
MUHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "L3Q3XGLO"FDB^O"27D2&) #\SL0!]
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M=Q*T?G" R-;R;01F,C)."#M([BI= _M-O#UF-7D#:B8AYSJ@3+>NWH#C!(Z
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M6.FE!=W"QNX)1 "SL!U(49) R,G'&:@E\2:)#86M])JUF+6[8);R^<NV5B<
M+ZG/I7*)J*:9\7+NXU.>..QU'2XETZYD<"([&)>,-TW'=NQW KCM4@BL_!FK
M23/$FF7WBR.>Q20@*T/G)N90?X"0Y],<]#0!Z[IGB+1]9N;FWTW4K:ZFMB/.
M2)PQ7/0_3WZ5>NKF&SM)KJXD$<$*-)(YZ*H&2?R%</'=V9^.(2*X@)?PZ% 5
MQR?/R!]<<_2M+Q9>P7][8>%H[^""YOG\V8,06$,>&(VD\[FVKCN"WI0!!X"\
M57VOMK%CK%O]EU.QN=WD$ %;>4;XL^X4[3_NUT6HZYIFD?\ ']>1PD(9"#DE
M4'5B!T4?WCQ7GGB25_!/Q$T+Q)?ZI%)!J0.EWN46+"'YHY" >0K=6["IQXCT
MO0OB%XE@\23QPV>K06\EA<2C,4\*Q[6C!Z<,6..^X^M '4W_ (UTBQUS2M+-
MPDCZA&\R2H<H(PN0VX<')*X]CGTST=>::E/IVC^,O ,P@_LW35M;Z&"-U*[=
MRQ^6F.H9@.%ZYXZUV^F^(M)UC4-1L+"\2:ZTZ017<04@QL<X'(YZ'D9'% $&
MN6>O:A(EOI.JII,*IN>Y%NL\CMGA0K< #J20<Y&,<UR%OXXUJP\#ZG/J@MY=
M6L=6.D)<JFV*9BZJ)2O8#?D@=UQQVZ'Q;XVTGPRT%C<ZE;6M]= F,S<K$G>1
M@.2/0?Q'C@9(HZ=%X.\6>#;S1K2Y^V:1&<7%SDKF4G>7WD#Y]V')]6'TH L3
M:MJ'A_QIHND7E])?V6L1S)&\T:*\,T:ANJ*H*LN>",@CK4WQ%U34-#\"ZGJV
MF71M[NTC$B'8KJWS 8(8'L3TQ6#H^B3ZSXYT_5CJ-]?Z1H<$D=K=WA3-S/(-
MK%-BJ&15XWXY)ZG%;_Q&TRZUCX=ZY86432W,ML3'&HR7((; ]SB@#9L4N)M$
MMQ)>RFXDA5FN J!LD Y V[?TKAKWQ=?:7X1\)7.H:H;<:R\0O-4>%,6P:+?A
M1MVC)PH+ @#).:W=+\;: WABSNQJ5N9/(1?LRN#/Y@7!C$?WB^>-N,U4>33-
M&\)^'?#_ (GM[<VMS9I:S_: #&CI&O#'H!D$;O7% &M8)JUKK >;5_[0T5[1
MI$EDCC#K(&7JR *5*DD8 Z'.>*RO"^K:GXXLI=<AU";3=)DF>.QBMXHS)*B,
M5,DC2*W4@X4 8 Y)KG?#NAQ:/XUNM \-:K+=^&;O3Y7N;;SO.2PD)PNQ^Q;)
M^7.< DYXJ[\--6M?#/AN/PEK]S!IVJZ7))&4N7$8GC+LRR1EL!E(;MTQSB@#
ML]'CUB"\U"'5+E+F!70VDRQ!"4*\A@.-P8')&!R.!TK7JI8ZA#J*O):DR6X(
M"3C[DGKM/<>_3\JMT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %! (((R#V-%8_B;Q!%X<TI
M;MXO.EEGCMH(R^P/)(P506_A'.2>P!ZT ;&!Z4F!Z5@QZIK=OK-A8ZAIMJ8+
MLN/M5M.S!&5"VTJR@Y..#GL>G&=^@!CQ1R8WHK8.1D9P:?15274K6'4[?3GE
M'VNXC>6./N43&X_3+ ?C0!;K)\1Z1<:UHLEE:7YL9BZ.LOEAU.U@VUER-RG&
M",C(-6;-]2:^OEO(K9+177[&T3DNZ[1NW@C .[.,=JNT <S:Z'JUY/!)KTVD
MR)!*LR+8V;(S.IRI+N[$ $ X YQUQD'IL8HHH :L:*[.J*&;[Q Y/UH\M/,\
MS8N_&-V.<>F:PW\0O=Z[/H^D6Z7,UH%-Y<2/MBMRPR$X!+.1SM&,#J1P#'K>
MJ^(;>4V^A:)!J$D48>:2XN?(0D]$3@Y;C/. ,CGF@#HL#TI,#TKF]&\:Z=J?
M@O\ X2:Z#:?;1J_VE)SS"R,593CKR,#'7CC/%:.CW^H:G"MY/8BQMI5W112M
MF8J>A<#A#C^')]R#Q0!I-&C,K,BEE^Z2.1]*=@>E4=7U6WT73GO+C<P#+''&
MG+2R,0J(H]22!5#6==FT6QTX3Q1&^U"\CLXD4DHCOD\GJ0JJ3VSCMG@ W"H(
M((&#U%+7-Z9KFIPZQ_9/B&TM[>:=Y!87-N^8[I5 )&TDE&P<[23G:V#Q724
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M!IV :** # ]*,"BB@!J1I&NU$55SG"C I2H(P0"/0BEHH :B)&@1%55'0*,
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M^TY&Y0<&GT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVEF>4QH<95=Y.T' X&.@]!4%GX3T2PF62VL1&$E,\</FN88Y#G++&3L4\GD
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M,DF@#RWQLMK=6'C>ZL0;B>PA0-<3N%%BZ1AE2W &0>C$Y RW?D5LZ@6?XA>
M+AI9&>XM+LR@R$JQ$*D';G&?F/;O727G@KPYJ%[>WEWI,,L]['Y=RS%L2#&
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M+TX&#UY/2@#U2BO-_#OC6^\777A[3O,:P>[T=]3NY(5&YR)!$$3<#@$[F]<
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M\M[&;*[MOLLYAW7$>T38 .].>5YQGV-<?)!<R?&\*-3O$B70Q,(AL*#]^ 5
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M Q'.,^_2N OM?\2VOA[Q3IZZQ</XBTN^ M"L$):X@<!XQMV8Y0/D@<%2>V*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(6()4X.[YSR&'XU47P1ILVFZS:ZD\E]+K1!OIWPK/A0J!0.%"@#'YDDUTU%
M'*Z)X,DTZ+R=3UW4-:MTC:&"&\V;8T(VG.T NVTD98G@G&,U%X>\"GP^T5NN
MO:E=:3;/OM-/F*;(CG(RP&Y@IZ G P..!747EY;:?9S7EW,D%M"A>25SA44=
M234D,T=Q!'-"ZR12*'1U.0RD9!!]* .:M_!B6BZ]';ZK=I!K$DLSPE4*PO*
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M<V="'[C$2_O/D\OY_P#@/'&.>:W)M5T^WU*WTZ6]@2^N 3#;F0>8X ))"]<
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M^HW6E6S;K33Y]A2$YR,L!N<+V!.!@=P*Z.;5=/M]1M].FO8$O;G)AMVD'F2
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M9E;S 55N<K]W K';P'KLG@S7M(DN=/-W>:NVI6S@N$/[]9</P2N=O;.,]\4
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M@<-+M8GU;Y..P'XU+\3-3U/2?!5S=:7+'%)YL,3NV=P1Y%0[<=#\W7M]:?\
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M1R0 23TSWKG];\):YJJ)K,,EE;^)[6\$EG+Y[F&* ''E'Y,D,I.X8Y8YS@
M UM5\32V^KOH]GY/VR&V6XFDEBD=%W%@BX09YV,<D\ #KGBEI?C:[U:VT>V&
ME26.L:B)B]O=A@L"Q$!W/ + DKM'&=W48-1:KH7BB#Q-#XET%]-%U/:+:ZA8
M74K^4X4DJZ.%SD;B.1TI-:\,>))[G1M?L+ZR?Q!IYE$L4P9;::.3&Z,$98!<
M#![D9/6@!^H>+==T?1S=ZAH\,4L>JI8$>8=L\;NJK-'U('S?=/IUK2EU^^_X
M3:X\.106^?[+-_#.S-PWF;-K#T[Y!JAK_AW7_$'A*6&YN+%=7^TPW4,2%OL\
M9B=6";L;CG!RV.IZ8%.L=$\0/X_C\1Z@-.BA;2_L4EO#*[LC>;OX8J-WUPO7
MIQD@'.Z=XLUFW^"TGB;4+2RU-RKRM'*[*&!F8'(P00"1A>.!UKK=2\17NF>+
MM%TN6WMQI^J!U2Y+'<DJKN\LCI\PS@Y[$8KFE\#>(1\*+OP:9-,,N##;S^;(
M 4,I?<WR<'! V@'IG/:NF\5^'KKQ'X66VBDBM=6MY([JTF#%EAGC(*G. 2.H
MZ=": ([[Q7)I]O=7$T,3Q-J"Z?8[=V97Z,6P"0%(<' ).PXZ@4N@^)+^_P#$
M-[I%[8-Y<4*SP7\4$D<,H)P4(<<.#CC)R.>*9XC\(S:CX4LM.TN]%MJ&FS17
M5G<RC<#-'W<=]V6S]<\U>T!?$TA,_B(Z="ZIL2WT]G9"<C+LS@'/' '3)R3G
M@ P/&C3Q^/\ P,]K"DUP);T(KOL4DVYZG!P.YP#TZ&K.G^+M6FTSQ$LVCI<Z
MQHT_D?9K.0E;C<JLA4L,CAN>O0_2KFO:'J6H>+_#>JVHM/LVEO.\HEE97?S(
M]GR@*1QG/)K"OO!OB*YM?&26]U96LNM3Q36SI,YVA BLC_(,!E4@D9^]0!IV
MGC*9?$.J:/<I:WCV6G?;Q)8,3NPQ5HBI)PP(]><]!5KPMXDG\1I:WD$NGW.G
MSVQD>2U<EK>7*XB<$]<,W/'W>@K*A\-^)D\4-K47]CV>_13IZ00,["!PQ9-O
MR@,N2.<#'3!QDV-*\(S0>,H?$1LK+2YOLLD5ZEC*S+>.Q4AB-J@!<,<]23[<
M@$/Q+:2-O"4D$(FF7Q!;[$+;=QV2X&>P]Z(O'=[I.J:MIWBJPM[6:RT]M3BE
MLI3)'/ IPP&X A@<#'?/;OK>,-"O=:@TF73V@^T:;J45\L<[%5E"!@4W $KG
M=UP>E4;_ ,&R>)+O5+W6C';R7>F-ID,5NYD\F-CN9RQ RQ;;QC "]\T );^+
M]2&NZ;:W.F^997Z.7FMX9?\ 0F"[@)&90&4]-PQSVJH/']Y-#I>IV>F/=Z;?
M3HABA@E,\43'Y9B=NTCH2O;/4U>\.Z?XS2*'3_$5SI<EE;+L,]J7,UV ,#<"
M $[$XSDC' JEX9\/^,?#\$7A\WVFRZ%;MM@O/G^U"'.1'MQMW8XW9X'.#0 V
MX\:>(F3Q0;31]/SH,AW^;=.1*@C$F%POWB#WP!QU[=GI.H)JVC6.I1H4CN[>
M.=5/4!U# ?K7)1^%];5/&@*Z?G72QM\7#_)F(1?/^[]L\9]/>ND\-6%SI7AC
M2]-O/*^T6EK%;N87+*Q10N02 ><9Z4 :M%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9VLZU
M::':PS70D8SW$=M!%& 6EE<X51D@<^I('O0!HT5@VOB[3)H=7>Z\VP;1VQ?)
M=  Q KO#94D$%3D8)KE=:U22\^)'@9OL.I6@E>Z8"=@$E7[.Q'RJY 89_B /
M/Y 'I%%8&F^+;+4[;5YDM;N'^R97ANDG"*P95W''S8Q@@YX![&JEQJND7/BS
MPVMW9ZA%JD\,\ED'!5$78#(' ;:3C;QSC/:@#JJ*PX?%%M<S1>19W<MK+=/:
M+=H$,?F*S*V?FW ;E89*XR/<9KZIXVT[2;>:\GM[M]-MY_L]Q?QHIBA?=M.?
MFW$!N"0I .1V. #I**PM1UZU::[TV"UO+^2& 27(LB 8D8';\Q93N(!("DG'
M;D9R?A/*\WPPT.621Y':-R7<DD_O&ZDT =G17E^G^(H_#/B[QP7LM7U".*ZM
MWV6L;3F)/(5F)+'@9)XSGK@<5U:^.=*EGT);=+F>#6P?L=S&J^42 258E@58
M '@C/&!D\4 =+15"#5([C6+O34@F#VJ(\DI"^7\^< '.<\'C'IZC.)K7BF[T
MWQGHVAPZ7<3QWL<TKRHT?S!%'RJ&8="P))QVQGG !U5%>7Z1XBB\,:UXYEFM
MM3O8+:_61Q #,88_)4LQ+MT')QG/7 XKI]4U;0KC6_"QG2ZFGO)&ETV:+<L6
M3$22QR <KG@Y^E '4T5AGQ1;&X=(;.[G@CO%L9+F((424L%((W;L!F )VXJ[
MK.JQZ)H]UJ<\$\T-M&9)%@4,X4<D@$C.!S0!?HKG3XQLA=Z%;_9;L_VVF^TD
M 381LWD,=W!V\^_;-,UCQMI^AVFH75[:WRV]C<);R2I$&4N^W&"&Z?.N2<=<
M=<T =+17$ZMXET:_73DU72M:@ UJ"WM?,@>$-/D>6^01F/YN_H>,BK=MXJNK
MCQ[J6A'2[D6UE;12><"AR7+?,1NSMPH  !.<Y XH ZNJ&I:)I>LFW_M/3[:\
M^SR>9#Y\8?8WJ,URMCXN\.:%X2U/6[:VU);"+49EN%=&>3SBX#G#,=J[CCD@
M#TK:L?%MG>^(FT0VE];71@-Q"US#L6>,$ LG.>"1P0#STH WZ*Y6Y\?Z5;6*
M:B8+V339+HV:7D489&D#%, !MV"P*@[<9]L&NC>Y86)N8[::5O+WK  %=N,[
M<,0 ?J10!/17D6N^);CQ-\(H->GM[FR=KV!T99<(R&Y"XPK?, O!W <\@5WU
MAXNL;W6KO2I+:]LKFWM_M8^UP[!+#G&]>2< ]00"/2@#?HKFM/\ &^G:A=Z5
M"EM>11ZLDDEA/*B[+@(NXXPQ*G;R-P''OQ4?A'Q1=^(KS6XY],GM8[+4)+6-
MG:,A0B1Y5L,3N)9CP",$#- '4T5S/B+5I#XAT7PW;2-')J+22W$B'#)!$N6
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MPP=1:_\ [ T[[4S;S)]G7EO[Q&,9]^M1:MXRL=(@N[J2UO)[&RD$=W=0(K)
M>,Y!8,V,C.T''X'&]'-%- D\<BM$ZAU<'@J1D'/IB@"2BO,/'GB"+5="T>ZL
MK?4!:RZO:K!>JVV&4>: > VXJ0#@LN#VZC/:WGB2"VO+NTMK*\U">RC62Z2T
M5"8@P)4'<RY8@$[5R<8XY&0#:HJEI.K66N:5;:GITZSVEPF^.0<9'T[$'(([
M$5S]U\0=.MY]7@CT[5KF722OVI(;7E5*[MWS$<8YYP3V!YH ZVBL5O$^GM;Z
M9):^;=R:I'YUG#"!OE3:&+?,0% !&22.H'4@5D:MX^@MO"NNZG965Q)?:0&2
MYLI=J20/C(+_ #8*XP<J3D=,T =C15+2+N:^TNWN)[>6WD= 627;D\=?E)&#
M]:Q;CQUI=L\SM!=M9V]^-.FO%1?*CG)"[2-V[ 9@"0I&: .GHKEK_P >:?9:
MM?Z5'I^K7M]91I*\%K:%F96SRN2,@8Z].@&2:C/Q&\/_ -B:5JZ/=26FIW"V
MT)C@9BDA)&UQV((/')..,T =;17-:1XMT[Q)J%_HC6VH6%_!&'DMKN,P2-$W
M ="IZ=L@@BN7\$>*(?#_ ,+/#5SJ$5[<+=RM;^<F'VR/,P7>688!/<\>IH ]
M-HJ@^JQIK<.E?9YVED@:<R*%V(H('S'.022,<<\^AQC^+O$UUX?N-$@MM.FN
M3J-^EL70IA1@L5 9AEB%..W7GID Z>BL6X\21174MI;V%[>7=O"LUQ!;A"T
M;.T,68 L<'@$GCW&;>C:Q8Z_I,&IZ;,)K6<91L$$$'!!!Y!!!!'M0!?HKF-3
M\<Z9I9U)Y(+N:VTN1([ZXA12D#, 1D%@S8#*3M!QGZU+?^,;&Q\0'0Q9ZA<W
MYM#=HD$&X2*&"X4D@9R>O3CDB@#HJ*Y)_B'I2>&[?7?LM^;26Y^RR#RE#V\N
M_9MD!8;?FXSR/?D5O2ZJD6L6NF&WG::XA>8,H4JBJ5!W<Y'+*. <Y]C0!?HK
M%\0^*+#PRMBU^ERRWEREK&882X#MTS^OOZ UC2^(='U/6?#GV[2]8M+Z6ZG6
MR2XA:'8ZHP8OAMI!4''7J* .SHKG=0\9:?IXU1_(N[F'2L?;I;=%98,C<0<L
M"Q"D$[0< _A7,ZYK$$WC?P-J]NM\8+E+TB$*^90(1LQ'TR<\''0Y)Q0!Z117
M#ZM\0XXO!&MZWI^FW9N],=X)K6X54>"4 8+_ #8*_,I^4G.>*W%\1@-9VS:=
M>-J%Q"TXM08MXC4J"Y._;C++@9SSTX. #<HJKIM]'J>G07L4<L:3('"2KM=?
M8CL:Q[[QC8V45_<+:WMS9Z<YCO+JW162%@ 6R"P9MH(SM!QSW!P =%17,ZEX
MZTK3[VQM$AO;V6_MGN;7['!Y@G55#80Y&3@CIZ\XK>L+L7^GV]V(9X!/&LGE
M3ILD3(SAE[$=Q0!8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YCQQ<:M;Z;8MI=K<7$
M9OHA>_9$#3I;\[C&/7.T9'(!..>1T]% 'C>H>&-:U2#Q[8V&D7EK_:'V.YLF
MN6!$OE*A*%BQ)9BIZGOR16[>:AJ.O^*/!FI1^'-7@6SGG:\6: )Y)>$IC+$9
M&3U'!'3GBO1Z* .%U3PYJ ^('GV4>=(UJW5=5]%: @J??>I,9'ID]JL>(;>Y
ME^)/A&[BM+F2VM$O!<3)$Q2,R(H3)QW(/T[XKLJ* /,8='O+?Q-;:GX>M]4T
MRZN-2/\ :NGRQO\ 8YHMQWS D;0Q # J<Y.,=:KZ197&BW%_X>U/P.VJRO>3
M2V6HBVC>":.1RX\YV^X5+<]3@< \9]6HH \^TI=3\+>-_$"7.DWEY9:L\5Q:
M7-E#O566,(T;\_)C P3QCO6C\+K2]T_X=Z59:A8SV=S KJT<X ;EV(.,\<$=
M<&NPHH X73VN]!\9^+;BXTN_FCU&2":S:W@,BS;850J6'"'<,?/M'?-4F\%3
MZ?\ !Z#29)XH=4TQ&U""<'Y8+A7:48/]T$E<^F:]'K$U?PS;ZWJ5M=75_J*P
MPJ4>RBN"EO< G/[Q!][IZ\C@Y% ">$X+I=$2]U",1ZCJ+?;+I!_ S 83_@*!
M$_X#61XFM[Z+Q]X6U:WTZYO+:WBNX)3;@$QM(J;"V2, [3ST%=G10!YK':7O
MD?$<'3KT'42YLP;=_P!_FW$8V\?WAW^O2FBSOA'\-0=.O<Z:H^V_Z.W[C_1S
M'\W'][T^O2O3** /,;[1[Q/$3ZMX=M]4TS67U(+=VQC<V5]"),&5B1L!\OYL
M@ALC&,D&O3)(TFB>.10R."K*1D$'J*=10!Y"W@[7XO"EQ$(W:[\,W);0!DEI
MT23S 2.^Z/;$!_LGUK>\::3?GX7R:=#:37>IW$\,\L=NA?=)]H263Z 8;&>P
M KT"B@#B_'L5Q?VOAQK.SNKCRM:M+N41P,2D2-EF(QD8';K[46T-[8_%/4[U
MM.NI+*_T^W6.YC0%$,9?<&YR#AA@8R:[2B@#QZ[TO5)OA;XJTY-*OS>WFL2S
MV\'V=@TD;7"N&'&,;03[?E76WL=Q<?%'0]0CL[LV<>G7$4DYMW"H[LA4'(X^
MZ?IWKM*9+$D\+Q2#*.I5AG&0>#0!XU82P)I"Z3>:#XD.AQ:D]Y'%;6 GCVB8
MNH$JL2T><-PN>V2.OL=O<17=M%<P.'AF02(P_B4C(/Y5S>G^"(M-@2SAU[6V
MTV-=B6+W"%%0<! P3S-H'&-W2NG1%CC6-%"HH 55&  .PH \>BTW6$^#%EX>
MDT/4%U"SNH59/*W;]ESO8KC.5"C.> <\9KJ+]-1/Q-.J6%A<2(/#TMO#+)"R
MQFX,BNB,2!C('/ITZUW=% 'D=E!K-SJW@C5KC0=9:[M))EU%YU50DCP,F$7=
MA8PQX( &,=374^"K>^TW6/%%G=Z=<Q+<:O->Q7+ >4\;J@7!SR>#QCC'-=G1
M0!Q&N6KVOQ7\,:JP/V>>UN; MV60CS%'XA6_*I;VWN6^+6EWJVERUG%I<UN]
MP(F*+(SHRC./13STKJKVQM]1M3;W,>^,D,,'!5@<A@1R"" 01TJ94*Q!#(S,
M%QO.,GWX&,_A0!Q26KWOQJEOHP3!I^B+;RM_TUEE+!?^^5S^(J;Q[:7DDWAJ
M^M+*XO$L-7CGGCMUW.(]CKN [X+"NHLK""PC=80=TKF261CEI'/5F/<\ >P
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MDO\ PC=Y:64]XMAK,5S/';KN<1['4L!WP6%=9!!%;6\<$$:QPQ*$1%& J@8
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MM_N*5'_?1./?-:U\UTTEAJGA_7;2'5X-"@>>ROL-;WEO\Y'.<J0P?+#U&>M
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M8X/(KRVTF@N_@1J6C7V/[=A\^":U8_OC>F4LA ZEF8JP(ZYH [3Q/XMM]/\
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MR$'! .>QX/I7&V=OIMI\3?"UI$A2.#0)5ACNB#*@#Q[ V>0VW/OUK$']G?\
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M/4>]24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[57:,GOP*G%K;B-HQ!%L;[R[!@_45+5>XO;>UGM89I522ZD,4*GJ[!68@?\
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M27,A9W)!SNW;NH'&>U0ZQX&T+78+&.^@G:6Q&+:Y6YD6>,=QY@;<?Q)H Y6
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ML(I5CNIFGF66=Y0TC?>;YR<9[XH X_1]+OKZ'PUXCM=;BA4B-[F7S9)/MRR
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M'V<7$UU)([IG)W$M\W..N<8&,8H \QL;867[-EQ>VD]U;7(@D<20W,B$%9W
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M02%T^9P Q'*H2.G7D=*K>#?#5M!X9\/M>P7?VJPMHP+>ZD<K!,(PK%5/&>6
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M\)WUS=)%#-!J4,-K//'&7N8))%4;@C%48;CDXP>P% 'IE5[V]@L+2>YG+^7
MGF2"-"[!?7:H)/0]NU5='M=5M8;A=6U**_D>8O$\=L(1'&0,)C)S@YYZ\UQ6
MBK?OXA\?FXU2>>."18UC=4QM-N& X' &XXQ^.3DT =UI&JVVN:/::I9EC;74
M0EB+K@E3TR.U7:\D\-:GK>A^$OA_<K?0OI]_);Z?)9>0.%=&P^_.=P*^PYQC
MC)V[O7O$NLPZS-X<BG\ZPO)+6VB"P&&9HR PE+L'&3G&W;@8ZT >@5SEQXYT
M*VM9[R2:Y^P0EE>]2TE:#*G!PX7!&1C/3/&<UN6KS3V$+W4'D3R1*98MP/EL
M1RN1UP<C(KR8S:Y\-=&DTG6+'^WO!#(T:7MK_K[:%\\2+_$N#U'Y]!0![ #D
M9HKC[WQ'/J.NPZ3HS7)A;34OS<V:PL[+(Q6/'FG;CY23P3R.E8MQKWCBSM?#
M5O?I9V=_>ZDUE-OB#B1-K,DORN0O"C*CN.H% 'I5%>>6NN^*=,U_7O#E[=V6
MH7<6F?VEIUY+&+=,9*%90#@ -W] <GGB;1_$6I3>,X-&&HF]MKG2&NUN)K8*
MJS*ZJ3&5";XSNSWZ<-0!WM%><^%=4\8:SX4'B!]5T]V6.\06DEL(TDD21UC9
MI,Y4#;@CT'7/-3Z1XBU*;Q?9:.=3>\MKW2I+@W#6ZJ$F5E!:)@H#H=W&0W0<
MF@#M-0U"+3M-N;Z1)98[=&=T@0R.<=0%'4^U6(91/!',JNJR*& =2K#(SR#T
M/M7E6@ZCK>F?![6-<AU9IKR![V96N85<;DFDR>,<G'?('I73CQ#>:AX@T?P]
M!<&WFGTK^TKJY5%+[<JBJ@8%02Q))(/ ]\@ [&BO+=8\9^(-,T#QI:"X@_M7
MPZ8GCNV@!$T,HW(2N0 X&03C''2MY-4US3O'VDZ;?7\-U9ZM:3R")+<)]G>+
M8?E;.6!#8Y^O'2@#I-9UJQ\/Z9+J.I2O%:1#,DBPO)L'J0H)Q[UFGQSH$<$,
M]Q<W%I;SX\N>\LIX(CGI\[H%&?<U4^*'_),?$7_7D]:-G96FH^![:SOT1[2;
M3T297Z;3&,T ;:L&4,I!4C(([T,RHI9B H&22> *\B^'>L:O_P *T\+^9?I;
MV;3SP27!&^X>-2XB2%"K;CD8Z'"KP.]-US7]7UCX7ZO++?RPSV.M?V>TB1*C
M3Q"X1!O&.#AN0,=/3(H ]@HKC[[5M2/B$^'+2:]DEM[%;J:ZMXX/-8N[*@Q)
MA0!L.< YR.G.=7PI/KUQH,9\26B6^I([(^PJ1(H/ROA20,C&1GKF@#2FOH(+
MN&U+%KB;)2-1D[1C+'T49')]0.I JS7$^"KM]6\4>,=1F.6AU$:=$#_!'"@X
M'U9V;\:H+XGUK5? -[XTTR\2-(3//!8/$ICD@A=@0YQOWL$)R" "0,''(!Z+
M17G4GB'Q!KWB?3['1M2M["SU/0/[2A:2T$CPL63&<GYC\V.PY/4XKM;Y[^U\
M/W#P/;RZC%;,4>;]W$TH7JW]U<^_ [T :%8.I^+],TJ:59A<R1P3)!<S00ET
MMW?!4/CD<,O0'&1G&16!HWB/4)?&5EI#:B]]:WFE/<F=K=4"S(R@F)@JAXSN
MXX/;DUBZ+#J<.D_$2XAUJYCE@U"Z(=8X\EU@0AL[>#QCCB@#U965U#*05(R"
M#P:6O.-%UB_TWPIX*TN&:XN;G5K-&#JD6^*-(%9@F["DY(Y;/!)YJ'7=>\;:
M#X/\1WLZI";*6)K"[N8XFDGB=@K!EC8JK*3UQ@\<4 >FU%/<1V\4DC[B(UWL
ML:%VQ[* 2>AZ"J.D6NKVQNCJNI0WGF2[X5BM_*$*X&4ZG=SG!/-<MX<6_D^*
M'C 3:I/+#;BS"Q,J;=K1NP7ID %B>.O?- '6:%K5GXBT6VU;3V=K2Y4M&SKM
M) )'3MTK0KQCPEJ>MZ%\./!6H07T/V&:\BLI;+R =R22LI;?G.X$Y&,#MSUK
MKK_7-=U:\U^VT%;F.32Y!;P&)(&26;RU<^9YC [?F"_+CH3D]  =S67XA\06
M/AC1IM5U(S"UAQN,432$9.!T''/<X%3:3<7LVB6MQJULMI?&%6N858,L;X^8
M @G(S[UY;XNU/4?%/P7U/Q$M\8+:Z!:*R$2E/)$P4;FQNWD#=D'&>,4 >P Y
M&:0L 0"0"QP,GJ:XOQ1J^JV-QJ AU%;6.#3O/M(K:(332RC<6,BE3MC&%&?E
MZGGTQ;K4=3US6_AK>C49;0:E;2W,D,**463[+NW ,#G[[#G.![\T >GT5P%Y
MKOB36(];D\.QW FTZ[>TMHU2 PS/'C<)2[!ADDCY=N!@\UVENUU=:3$TZ&SO
M)8 9$4JYA<KR >0<'Z@XH JZ_P"(M/\ #>DR:GJ#2_9D8(S0Q-)ABVT XZ<G
M&3@5JUXC(;V;]GB_N[N_FNY)K@MB4+PWVXY.0,G)YY_"NX&M:QH_CP:;J=_%
M=V%SIDUZ%2W$9@:-E!"G)+*0W?)R* .VJM?WT&FV,UY=%Q!"I=V2-G(4#).%
M!/Z5PUCK?B_5+/0M;TZSGF@O7CDNK23[.L*6[C.4;=YFY01UZ\\#I78>(?\
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M&X@_,Q]..*6T\&:A%K^DZS=^(9+BXL+9[5U6T2-94)4\#)V_=&>N>VVNPHH
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M4J2.< 8;/KG-9[?#@OX=UW1WURX=-3OC?I*T"9AD\Q9,D#&[YE'H,=A7=44
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MM;N.:0^>/+*I/YO!ZY(XZ=:W=0\/7VI^/&U&6UV:9/HDFFRMYJ^8K.X8G'H
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MZYL%?>(G8@>87"_ZO!R6QV_&E'CN1;7Q3NTZ*:Z\/())5@NMT<R&,OD,5!!
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MPL=/2%<,+:X,QN'Z9Y V+U.,DDXZ8YZ2@ HHHH **** "BBB@ HHHH ****
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M>$3W4=M$9# A!.6Q]#P,G SB@#:HKF;KQ]X?M6LE%Q<7#7ULUS:BWMI)/.0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5QOQ'L[Z72=,O[&PDU#^S-
M1CNY[.+EYH@KHP4=V ?('M7944 <7HMUI5W%?ZQIWAR\LE^RF.2XN+)DGE/9
M%3!9@._&,D8SSCDKBVO3^SK%I(TS43J0MHH3:"RE\S<)03\NW/0$YZ5[#10!
MYWXODDL_%.C>)7TB]U/1C:2V=S'! YEMRS*RR>7PV/EP?3\JHZO;2VUMH_B?
M0O#-Q%:66JM=W%DD&RXN(WB,;3&/KO&XX!YQSQ7J5% 'G_B>>;Q9\/?$C:7H
MUW'Y]GMB\^V,4URXY("'YB , 9ZDG'O%K<-EX@71YS_;FC7L5JS6>J0VTB-$
M?E#1R)MZ-@?*P&=IQU&?1:* ,/P?-JT_A/3Y-<B6/4F0^<%CV9^8[6*_PDK@
MD=B2.*Y#1/M.@Z5XIT#5+"\FN9[NZGM6CMWD6\CFR5PP!&[)(()&.IXYKTNB
M@#RVZTB]T/1?AUI4MO=W4^FWD+W3V]N\JQ*(G4DLH( !8#Z5Z>W[R$[<_,O&
M1BGT4 >+Q17W_"F-&T=M(U5;ZRO+99HC8RD@I/N8@!>0%&=PXYX).0.P+2?\
M+B%]]DO/L?\ 8!A^T?99-GF>=OV[MN,[><?UKN** /)M&TZWN/AU!IVM:;K$
M(;6)W$D-O+'/:$R2O'.N%R ..<8&[FNM\"_VU':ZE;:K=27T$%ULLK^:'RI+
MF+8O+# R0<KN[XS7644 <C#"WB+Q7>W3OJ=E'I\8M;4B%X1)NPTK@LN&!(11
MC_GF3T-8WA:&X\*_$37=%2VU*;1]1*WL-TUM(T<=R>)5+A=OS8#9Z<8ZUZ/2
M,H=&4YP1@X.#^= 'BL=QIJZ3?>'M0CUJWT3^UI)_+72)92%2??M$Z94J77.0
M"0"1DGFNPM9Q=_%Y-2MX+F2PGT!(HKQ;=_)9C,7 #XV_=(/6M#3/!U[I-O'8
M6_BG5/[+B&R.V9(=ZI_=\W9NQVSU]ZZ>""*VMXK>!!'%$@1$7HJ@8 'X4 >7
MIY6B^(_$&E:_X8U#4X=1O7NK.XMK5IXYTD S$W92""/FP,=<#JMS&?"WB^2?
M4_#=U<:1J%C;10G3H&G6SDB4J8BJ\[3G@X_KCU.B@#S:YLQ:^(O 9LM!N+"R
MMI[N5X(+5BELDD;!-^P%58DC(SP2?K4MB)H_$/Q#F>ROEBNEA-NQLY<3;;?8
M=GR_-\W'%>B44 >-6D%[HVD^"=7O-"U"\L;32VT^_MDMW\^V<["'\LX)&4P?
M;\*T_$-O!<>&;6?2/#=Y:1W&MVMR8TLG\Z14=2\LB*"5X!^]R0/>O4J* .'"
M32_%Z>Y6TN_LTF@+;K.UM((S)YS-MWD8S@@]:E^%GGP> =-TZZLKNUN;*/R9
MEN8&C^<,V0N[[PZ<CCGKUQV=% '":A-)H_Q:74I[*]EM+S1EM(I+:V>4><LS
M-L.T';D,#EL#KS7&*9[#X?\ AI;VQO+>6#Q;'(T4D#!V5KB1QM&/FR".F<U[
M=6%XE\.GQ$NG+]M-L+&]BODVQABTD9RH.3]WU'7WH Y/Q!H-SXN\2ZA>:6)(
M8QX?N-/%S)&T8EFE.549 )"@$DC@%L=<XK7<-UXG^'VB>'%T^\M=7AFM([A9
M;=T%KY++ODWD;2,*=I!.=PQWKU$9VC<03CD@8I: //+,31^*?B%.]E?"*ZBM
MQ;O]DEQ-M@*-L.WYL-QQ6[\/(YH/A]H5O<03P3P6<<4L4\31NK*,$$, :Z:B
M@#S:U%S8W?Q!LYM.U O>2O<6[QVKNDB-;JHVL!ACN&-HR?; .*/DW2^%?AI#
M_9^H>=8W5JUT@LI<P!(61BPV\ ,0*]7HH \GLUBTG5-;T'Q!X4U#4GNM0GN;
M.>&U,T-U'*Y<*S?=4@G!W8 KU"!5M-/B5HUC6*( QPJ2%P.B@#)'IQ5BB@#R
MWP*;.UT+6[36]'U%?M6J7<H272;AM\3G@\1G@BM[5V3Q5X=@T.72[R&+52T8
M,UM(#;0H>)&)&$D.T%0<$$C(X-=I10!Y6L&N:I\,]8\*&PG75],Q%!,]N\4-
M^D<BLK*Q !+A<$9ZDGH:N6?V#Q=9S)8>%KW3=3^QSPM=7]JT1M&>-DVH[<L2
M2/N\8!)QP#Z110!P'@O7;FXTC2-!O/#E_!JNG)'!.;BU*P1>6-ID60\'*@XV
MY.3Z9-<UJ*WEMX2^(.@?V5J4NH7=_=7,"Q6CLDD4FTJP?&T^F =V>U>R44 >
M?2-<V_C_ ,-:HVG:@UM)H\MIE+9R8Y2\9"OQ\G /+8''6K?A**0^+_&C3V=S
M'!=7<3Q-/;.B2H(51L%@ 1D$5VU% '!>!]$U+3+ZYTF]B8:;H<\J:9(W/FI+
MAE/UC1F3/^T1VK!TN.+36U+PQK_A*^U&Z:]GDM9EMC);WD<DC2*6?[JX+<[N
MF/6O6Z* *\B^3I[+Y*OLB(\I1P<#[H]NU>=>$[&[TKQ#I46A3:DWA^XBD>ZT
MW4H'!TPA<J$=P"/F.W9D\9/(Y'IM% '&?%2&>Z^'M_:VMK<W-Q+)!LBMX6E8
M[9D8\*#T"D_A61K4QT7Q]/JVH:)J&HZ-JEE!''/:VSRO;2QE_E9!\P#!\].O
MXUZ510!Y?KT=MI$/A/4+'1+O37MKR>2""ULS-Y,;HVX20H<Y<8S@_*3R>,&.
M'4[=?#7BVYT2UN=2U^[/VN>SO--DBW@[4&R)Q\ZJHZ9.3UZ@5VVM^&Y-3U.U
MU2RU>\TR_MHGA62$(Z-&Q!961P0>5'(P>*N:9I+V3FXN[^?4+QEV&>947:N<
M[55  !GD]S@9)P, '"Z.[_\ "T+75([/7)K.XT-H?M=W;2+ND\Y6.5('E\ \
M84'^$'(SL?#&.>#PQ<0W-K<VTHU"ZDV7$#Q$J\K,I 8#(((KM** .) E'QH:
MY^R7?V8Z&+87'V9_*\SSRVW?C;G;SUJ"P@,GQ#\9M<V-Y]CNK*VB60P.B3;$
MD#JKD!2?F Z]Z[VJFJ:=!J^DW>FW)D$%U"T,AC;:VUA@X/;K0!Y%H.JZ7_97
MA>VUM]6M[/1Y$N+?SM(F15(4K'YDPRI50WW@%!P#P*Z.U$R>)OB),]E?"*ZA
M@%N_V.7$VVWV-L^7YL-QQ706?A:^CB%KJ'B74-0L NS[/+%"GF+_ '7=4#,/
M7D9[Y!-=+0!Y+8P7MCI/PQO)M,U$IIJO#>1I:2-)"S6Y093&[&[C.,5/K-G>
M0ZU>ZOX9_M.RUEKQ%N-,E@=[74!E5W\C:#MZNIXVGZUZG10!@>.-.GU?P+KE
MA:@M<3V4JQJ.K-M.!^/3\:YCQ!%/KWP&"Z;!)<S3:9;ND42[F;&PD =R,'CV
MKT:J=AIL.FF9;4LD$KF00_PHQ)+%?0$G)'3.<8S0!QNJ73ZE\0/!6H06&HBU
MBCO?-D>RE41[T4)O^7Y<D'@X/KBN=N],U:\T_P 7R66F7<LT?B"'4H+>:!XA
M>11^62%+ 9SL/3T'M7L%% '&^%KG2M8U-=1L/#-W82QP&.6ZO[0PR+D@^4N[
MEN<DXX&!ZUV5%% ''?$CPY>^(?#UL^EJKZGIE[%J%K&QP)7C)^3/;()_'%:%
MAXOM+ZW7%AJL5Z1\UE+8RJZM_=+%=F/]K=M]ZZ&B@#@[E;[1?B=%KE_;2OIU
M_I2V;RVZ-*+:9'+[6P,A3DX;'7KBN:U[1+X>%/%UY#87K?VSK%O<6MK';.TA
MC22+=(4 RN[:S<@' 'KBO8:* .#U%I&^*=I>I87DUJ-#GB+_ &63RR[2(P0M
MMP"0#P:SO"EE=Z/X@TR+0YM3?P]/#*]SINHV[[M-(7*A&8 C+';LYXR1GJ/3
M:* /&3INL2^";^6TTR^>>R\5/JALWMWC>Y@$V\! P&[(P<>WK6]<7QU_XAZ)
M?6-EJB6C:7=0-<2V,L8B=RF VY1C&.O3T/6O2** /)O"2P#2].\,ZOX-NVUK
M3BD)DEMBUL?+.!.)3\N,#/KG@5O^$3<PZ[XUD%A=*T]_Y]MY]N\2SJ(E4;68
M 'YE(_6NZHH \:MYK^\;P7J$VCZR+JUU _;8%L7BAM28W4(D> NT$CYP#Q]Y
MJZSPLTVE^)O&$%W8WJ"?4#=QRBV<QO$8D&58##'*D;1D^W6NYHH \:T?3=6L
M_ G@34/[-OBVAWKO?636[K*$<NI<(1EBH;. #P3BNFNK5M3\;77B2VAN?L-O
MH;V9?[.X:>1WW!54C<P4#J!U8#L<=_10!Y%';WB?#SX>VK:;J/VBRU.S>YB^
MQ2EH53=O9AMR ,CFO4]0F6'3KB5ED8",_+'&SL>.R@$G\JM44 >>?"?0;2V\
M":.;[1%MM6M5<2-<V7ES(2[8Y90>F.1534&&@^/=;?6M U#4=-U?R9;2YL[9
MIPK+&L;1.J],[<CZUZ=10!YRUJ;7QSX,^SZ)/96=M:7B/'!:LT5KYFPHK,H*
M@\'.#@'/-6[NWN)_BY*Z07<<$GAY[078MW\M93-N WXVYQSUKNZ* /(X+.^N
M?@])X'GTRY37(X_L(B,#^6Q$GRRB3&W9C#;L]L=>*UM,>Z\(_$'6QJ=K?W%E
MJL-J;2]@MI)QNBCV-&VP$J2<D9XY->C44 <7\*X[BW\"6UM=6=S:SQSW!:.X
MB*'#3.P(SU&&'(KM"<#)Z456O[-=0M'M9)'2&3Y90AP77NN>HSZCGTQ0!R/P
MJMI(O"$MVX*IJ&H7-Y"#_P \WD.T_0@9_&NWID44<$211(J1HH5$48"@<  =
MA3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K-U[6;?0-&GU&X
M5G$>%2-?O2NQ"H@]RQ _&M*N$^)X?[+X7?G[/'XCLFN/0)N(Y]MQ6@#K!>#3
MM/2;6;VUA=C\[LXCC5C_  J3U_'D_I6#X\\0W>E> ;O7="N[5FB$;)+M$J.K
M.JG:0<=^O(XZ5%XJU"QMO&/AR"3R8M1*7,EM=74A$,*A5#_+D;V(( &1@9.>
MQ\]ENK=O@=XN@CNHI3#JTWW&'"F[7:<#H#R10!ZU=^*M(L_$EOH,M[ E_-"T
MVQI -@!4 'W8MP.^#6/X6\523MKB:_J-C$]MK4MA;$XA5U54(4 DY/S'N357
M5)K6V^,NDRW,D42/HUPJM(0 S>;'@#/4URMS86-SX)^*=Q-;023)J5[MD=06
M7;'&1@]N>: /7KR^L]/A\Z]NX+:+.-\T@1<^F337U/3XX(9WOK989L>5(95"
MR9_NG.#^%<'I5]*?B;I2:B^8;CPZAT]W/RM+N!E"G^^1M)]A7+ZS;/9^#/&X
MBPNC1:_!):_W$Q-$9MOHH<MTX!#>] 'LZWMJ]XUHMS";E5W-")!O ]2O7'(_
M.HCJVFK=&U.H6HN!D&(S+O&.O&<UQ;:E83_&VQ,-Y;R9T&6/<D@(+&:,A<^N
M.<5RNEVUCKGA+1_#DFI:7,UGK)N6O9+J(F=%F=B?+)W[WSM((QR3GM0!W4'B
M:>V\>:UI^J7]G%I5K8P7,3L!$$WLP^9R>?NCT'M76Q2QS1)+$ZR1N RNAR&!
MZ$'N*X*UTZPN_C!K4-Q:6\L<6CVH2-T#*HW2#@'@<<?0^]6_A(^_X7Z+\VX*
MLJ#G. )7 'X "@#7B\4Z;J.LZEH>GZA:_P!HV:)G<0X\Q@QV[006*A<D \9^
MM9_@3Q4-;\)Z+<ZK?6BZM?Q-)Y(=49\.P^5,Y( 'Z50T":U@^*GC6*62*.:1
M;$Q(Q 9OW+9VCOT.<5Q.F6=G!\(O U_'!"EU_;-HWGA1OSYY!^;KTX^E 'M%
MYJNG:?)''>W]K;/*<1K-,J%_H">:M-DJ=I ;'!(SBO*FNM)O=>\::%XGUTZ:
M]Q/_ *N9H466T,2A"C2(3QANAX)SU)KT;0H(K;0-/@MWN9(([>-(WN?]:RA0
M 7X'.,9XH Y?PUK?B7Q!?^(+<WFEP+I>HO9H18R,74 $,?WPYYKH;+5#::;"
MVO7^G17,CN%D1Q%'*@8[&4,QZKM)&3R:X7P5IEAJ6M^.?M-S=1G^W)5Q;W\L
M QM7LC@9Z\UKZU9Z+JW@'^P$E-V82EA92QL [74:C:R-ZJ02Q[;7SP#0!V<5
M[:S7$EO%<PR3Q<R1I("R?4=14=OJNG7=W):6U_:S7,7,D,<RLZ<XY .1S7G-
MAJ-_)X \6Z?AE\96<4POBI_>32;#Y<J8 ^4H%V\<8Q]9=(;PSK[^'-4TWQ!-
M<ZC:1,+&SB:!6CS'ADD1$#! !SG Z=R,@'H)U73A?BP-_:B\/2W\Y?,/&?NY
MSTI!JVFF"6<:A:F&)MLD@F7:A]"<X!KS?P=J'AG6? ^BVFKRH^LV5Z))+1I=
MMS]N60Y8J"&))))SQ@G/ .(WO+.SA^*EM<SPQ2R,Y6)V 9@UJ-N!U.30!WFH
M>+M%TW5--TZXU"W6>_#/'F50!&$+;R<]#@ >I/'0U-'=M;ZQJ<EWK%D;*..(
MK;857MNN6=L]&/3('2O.[:[L4O\ X57,L]NMN-,G5I6<;01;1\$],\&M[P_;
M6I^*?C> 0Q>7-;6)D0*,/E),Y'?.>?K0!V/]JZ=]D%W]OM?LQ;:)O.783Z;L
MXS276K:;93Q07>H6L$LV/+CEF56?/3 )YKS_ ,(03P7<O@2>-VM]#O3<"1AD
M26N?,MP3_>WG_P @FJ*SZ-J=WXST'Q3KS:=+)?2&2"5H8_-MBJ^4R,Z$G"@=
M#P1[T >M50.MZ2'A0ZI9;IW,<(^T)F1@<%5YY(/&!3M-@B71+2W_ 'TD0MD3
M_2AF1EV@?/\ [1[^^:\7EL+!/@+K%REM LT6HRF.4* R8O,+M;J, \8]?>@#
MVN#4K&ZNYK6WO;:6Y@_UT,<JL\?^\ <C\:;'JVFS7QL8]0M'NUSF!9E,@QU^
M7.>*XN_MK+2OBSX>-G;Q6ZOI=XL@A0*753&0"!U[FN1BU;3'L/ -W975I::>
M-8+0VQFWS1(RR[FED)ZD]1@ $XR>M 'L=OJ>GW1E%O?6TWE#,GES*VSZX/%3
M6]S;WD(FMIXIXFZ/$X93^(KSO63=^$?&MRVEPDP^*HQ%$43*PWZ\!S_LE"6/
M_7,UZ!IUA!I>FVUA;+M@MHEBC'L!@?C0 V75=.@O8[*:_M8[J3&R!YE#MGIA
M2<FN9L/$\\'C3Q/8ZS?V4.G:?':/;NX$(7S0Y(9F/)^4>GTKF?#FH>'=4\(Z
MCI'BB6,ZK%JDSWEJ\NRXEG$Q:,H 0S9&Q5QZ8Z5I6=A8ZA\3?&XO+:"<+8V0
M E4, #')G@^U '?RWEM!:_:IKB&.WP&\UW 3!Z')XI+2\M;^W%Q9W,-Q"20)
M(7#J?Q'%>/>&;Z6*P^%3WK_\2MH9XR['Y!<["L(;WQN"^]3>+X-5M;_XAR>'
MA((7TRW>X6'M<$_O"N.C>2"3CGE3Z4 >KVNJZ=>SR06E_:W$T?+QQ3*[+VY
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M&-Q/)''!Z@5%:Z=X2$'BBY.I2:K9ZDL?]H?/&\+.0554$:@>8?EX'))0]2*
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M3DV_DKY><Y^[C'7FDO=(TS4EB6_TZTNEA.8Q/ KA#[9''X5=JD+F^_MLVO\
M9X_L_P"S^8+WSAS+NQY>SKTYW=.U %T    8 [53DTG39GG>73[1VN !,S0J
M3+CINXYQ[U<JD;F^_ML6O]GC^S_L_F&]\X<2[L>7LZ].=W3M0 W^Q-)_<_\
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M*?2MZ@"&TL[6PMDMK.VAMK=.$BA0(J_0#@5%?Z7I^JQ+%J-A:WD:-N5+B%9
M#Z@,#S5NN8N_%-XUS?QZ-HYU--.N4MKL+<".3<55F\M2N&VAUSEE[^E &^;"
MS,\,YM(#-"NV*3RQNC'HIQD#Z4R+2M.MYIIH;"UCEF!$KI"H,@/7<0.?QJW1
M0!3;2-,?3O[.;3K1K'&/LQ@4Q=<_=QCK[4UM&TI[.*S;3+-K6'_5P&!2B?1<
M8%7J* *:Z5IR72W2V%JMP@"K*(5#@ 8 !QGI4MM96MGYGV6VA@\US))Y487>
MQZL<=3[U/10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNTZ\B1V))=OJ3_*@#EUM6M/$_B[0?MM_/ISZ1'=B.>[DD9)#YBMM8MN .T9
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MFHV6I7MXEWKGV>;4I)F1+R-S+E5AW$;!@ $X^Z"!@YKU:&WAMK:.WAC6.&-
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MX;*N&W [NIPV3@F@#F?$VJ76C:[J$VN1Z@-$GFB^RZM87#%;'"H#'-&I&%+
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MF,"NJH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBL'Q3KLNBP:?%;1[[K4+Q+2+Y=
MVTE68MC(R0J' R.<4 ;U%<=8S^,+B[U>Q=?*@$2R:=J-S#&"7[QR(K<C.#D
M<57\$^(]9\3L1=/';3:8&M=4@,:DM=!C]W!X0 9SWR #P: .YJE<:I;6NJ66
MG2";S[P2&(K$S)\@!;<P&%Z\9ZUYX/$'CB^T/Q%J5E>Z4CZ)J%S$(3:,?M20
MX^7._P"3C/J23U K7@\7W]_KW@O[/Y,>FZ]937,D31DR(RQ*X&[.",OZ#IUY
MH [FBN"T#5/%NMZGJW^G::MOI>KR6K1"U8&>-8U(4'<=ARPYYZ^@P8;#Q9JZ
M>(?#5E=W=O<MJIGCO8H8LPV\J1EPL4HX;!!4@EOPH [^:9(8996R5C4LP4%C
M@#/0<D^U0Z;?PZKIMM?VPD$-Q&)$$B%&P?53R*X+PI<:VMMXWNVU1)Y[;5+E
M(_/M\KE(X]IP"#C  P#[U9T[QC?W^E>"[7?$FI^((&FEGV?+$B1[W*KZDD 9
MX&2><8(!WU%<!=^*=:TN_P#$NB2RV\M[8:6=4L;J2'B2(9!615(&X,N,C (.
M<<<Q67B3Q'%+X+O;ZZLYK3742*:VCMRK1LT!D#A\\G(.1@#G'O0!Z)16%XP\
M0CPMX7N]5$0EDCV)%&QP&D=@BY/IE@3[ UEZCK6K>&O$6A6]]<QWUAJTQM'8
M0B-H)]NY2N.J'!&#DCKDT :VL^*]*T(3F\DF*VR+)<F&%I!;HQ(#/M!P.#^
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MT ;^NZ_I_AO36U#4Y)([965"R1,^"Q &=H.,D@9.!S6G7D7C#4M3\2?!^;Q
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MRJD>H& ??- &I17GUQXBUZUG\7:;+>0#4=.B2ZTPFWXGB=3M!7.6)<%#COC
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M!!R#T(I:P_!T<\?@_2/M%QYS-9PLIV!=J^6N![_6MR@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ K!\6^&4\4Z0EJ+R6RNK>=+JTNXAEH)DSM;'?J01[UO44 <Q:Z'XD73+D
M7GB5)M4EC\J*Y2R"1P+W(C#<N>.2<# P.N8X_!K6'BJTUK2+V&QC2T%K>6PM
MRRW2@_*2=XPP[-@GDY)KJZ0@,"" 0>"#0!YAX0L+[6;'QI8VVI6\-I=:[>Q2
M$0[Y45B Q4[L9(/&0<'GGI743^$"-=\-WUC=Q6UIH4,D$-J8"Y='14QNWC&
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M+'(P.*Q$^&L\7A;3]-AUTPZEIEW)=V.H0VVTQL[,S*R%B&4[R",CC'X^@T4
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MVYQG'7&2.:DH \XT!=0N/B%X\73=0M(29[56\V$R%3]G4;AAATYX/I]<ZJ^
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M_MK36FD5D?&W"/M)QD*0>W(YH W+?X@))?ZKI[V,4UW961OH_L-VL\4\8."
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MJ+DL." 4DR@*'YAV(Z^E84^C^+[K6_$VJ65G%ILVHZ5%!:2272L\<J;^H4$
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML[^/R6WVS2 !79,9QD8)QP#FNMTK25U;QWXAUD1$Z1>6$-B=RE5NF&[<PSU
M4A<]#DXZ5W%% 'C1T7Q%#X329H9VO/!ER5TX#.;V.-\L<=P8-JCWW5T?C>PN
MH_@_JUNT$LNI7L?F210H9&:9W#%0 ,D#H/917H5% 'F>OWB:1XXMM;U"RU&X
MT*^TR.V%Q9K*3;RH[MAU3YL$/Z=15:^A30]6\*>(;'0[JU\/V\]W]HA2%VEB
M\Y JSO'RPR0<]P#SR2*]5HH \M1[;4]?^(DDUGJ+:;?:7 %=+5T,JK#('"%@
M!N^88SUSZ55T#6]'O;_PG_;&I3Q76DQ>3;(^F3P"261!&-\C#;TXP, DY]J]
M+UW2(M>T2ZTN:>>".X3:9(&VNO(/!_#H>".*S[3P_JA*)K'B&74;=&5A$+6.
M$.5((WE1D\@' P#WR.* .%LWL].O]<\.>)="U:\FN=0GGM?)CEDAO8I7+J/E
M.P$9P=V ,<FIO$EE+9WVI7_A^XNM-UVVABB?3S$TUKJBB)=J!2,,0"4R#D8Y
MQG->JT4 4+Z:Y30+F=;)9[M;5G%IG(D?:3L]\GBO+=/NWN==\ :F;35#Y(N(
M[I!8210VKM!M$21[0%4-D9YX'+<5[#10!X_(DK_#KXB6ZVMR9[O5+Q[>+[.^
MZ97V[&48RP.#R/2M2WOY-!^($&JZA!=MI6I:/!;07,=N\@AE0DF-@H)7.<\C
MK7IE% '#_#1G^R>(1):W4&_7;N9!/;O'N1GR"-P&>_TK+\4W=Q<ZUXJTN33[
MV+?I8%FUE:,3J#&-\[Y5'1&.T*2!R<YSBO3** /(I+^+3-.^'FJM!J$%S9V#
M0.6L)9%">2BNK(HW@E@NUL8X)Y&,D\^DW7PU\:0:3=W%_J5^TUU<0_8Y8G\V
M484)$PW;<)@'GH3FN\UCPY=WVM0ZOINMW&G7D<!MV7RDFB>,MNY1NASW!'05
MH:9I<ED\EQ=WLE[>R*J/.Z*F%&2%55  &23W//).!@ XOQ:+D>'O"NLVMC=W
MMIILZ2W=K;AEF\HPM&651ALKNZ?7MFL_6;2VU[POJ>J>%=$O&G#VL[R7"RQ2
MWODRJYC7?\QP%Z^I &:]5HH \XM;SPYKUG>ZE;>&]4G:'3IDN3>13+($*G-N
MI?)9FYX7('KDC,G@Z&_TSQ*FG66IW&K^'39,\<EY$?.L7W*!$9" 3D?PGD;1
MTQSZ'10!Q?Q'246GAZ[2">6&SUVUN+CR8FD9(QN!;:H)(&1T%5[6X#_%ZYOF
MAN([9M!BC$DD#*H<2NY7)&-P4@XZUWE% 'CFAWMUI7@WPW!+IUS%%_:UU]IN
MOL#2S62L\K(R(5)4ON W8. Q[FH+FRO+CP5\2-.M].U-II[TW,"S02%I(RL6
M""W+$[6..HQR!Q7M5% %33;Z+4=/BNH4F6*1<KYT31L1Z[6 (_$5YO"TMIHO
MQ)TR:SO1<W-U>3P@6SE9$D@54*MC#$D8 !)]J]3HH \ND+_9_ACB"XS:E/M&
M('_<C[,4._CY?FXYJEIIL[+^U/"OB30-5O;U[V>2W5$E>"^CDE:16R#L7EN=
MV ,9)SFO7J* (04M;12X5$C0 A<D# [5Y5X"AT1/!EY9Z]I<JRS7=T76;39"
MYC9R00=F>AXKUNB@#B-?,7C30K716M+BVDU,F:.66%PUK&C967H-LA &U201
MDYR 0>?DEUC6?A;>:+'ILJZUH\L2M"D;QI>K!*K;XFP,APN>.<_45ZO10!YC
MMTOQII.H'0]&U&'5&TVXM_M6H)+&;=G0@1!I#R23SMR  23TSI^$?$<.KV.D
M:;+H-Y%JUA&L=PMU9LB6A5=K,)&&.<$ *<G/89([NB@#Q'5&GB^''C7PY_9]
M^^J-J5Q*L26KD-&\X9'#8VD$'@ Y]J[.>X:'XMZ?J36EZ;6\T-K:)Q:R<2^>
MK;6X^3Y>?FQ7=T4 <+X+@2YU/QK!<V\GD7>J.RB6)E6:(Q(I(R.02".*9X!T
MS5+1I-,U2-_L_A]Y+*QE?_ENC897_P" QE$!]V%=[10!X_HBV4%A<^$/$?A[
M4[S5([F41QE)GMKQ6D+I)N!V*.023C&,]>*]5U(HFD79DMS<(('W0CK(-IRO
MX]*MT4 >;>$;>\TGQ)866D:A=:CX<EM9&,-]$?.TPC;M3>0#@]-C<C;[9K1^
M((O+2_\ #.MQVT]U8:9?F2]B@0NRHR%!)M')VY)XYYKN** /)]36;Q-XK\4)
MI4-WMU'PT+:VN'M9(XWDW2<%F4 9SU-7?#5[I7B!M-A?P]JD.N66/-^VQS!+
M)PN&<.YVG/0 <G(X SCTNB@#S#P/JQL_#]CX/U70KM];T^3RO+DM&:!MKDK.
M)2-H7!SG.<] 3BK<!1?&WQ EN+"XN+6;3[8+&(F N0D4HD1&Q@GY@./6O1**
M /./"4=YH_B&"SL-3N=4\-&RDD'VV(^=IQ!7;&7(!((_@/(V>W//6%EJ2?#O
MP[=PV5VYT?7WO;NS\EA*T/G2G<J$98@.& _PKVBB@#A9%CUCXC:;X@LB_P#9
M^GZ;.EQ<^6P60N5VQC(^8C#,0.G'<UR%K%/'\&_"MHUG=BZ@U2W>6#[._F1A
M;@LQ*XR %YS[U[310!3U)&N=&O(X1O:6W=4 [DJ<5Y59B^'@SP%J$5A?M%H$
M\:ZC;M;.KJ/+,;.$(R^S.> >IQT./8:* .*M+;^U_BBGB&QW&PM](-H\^TJL
MTC2;@HS][: 22.A('7-2>.+&QU"YTJ.XN[_3+I#+)::K:9_T9P%!5^"-K ]&
MP#MQWKL:* /)KJXUFZT?P<VKP-+=V_B,22306K*)(%\U1<,@'R!L@\XZY[TN
MO:5?:WK?Q$L=/299K_3+6*V<HRI,Z!]Z!B,$\A>O>O6** /-M3D/C'2O"=K9
M6]Q#?6NHVUU<QR0LC68B!,@;(&#_  @=\\9&36EX()'BCQD6AF03ZBLL3/$R
MB1!$BY4D8(R".*[>B@#QFVM=3_X5G]BM]+OY;[1M9:\N;3RGC,R+<L^U&XW$
MJ0PVD]!WQG>2[T/6=*U?5=*T;4%G&E36[W=W#,),L.(%#Y+<Y)VY ./6O2**
M /*&WKX9^&,?V>Y\RSN+4W*^0^80MNR,7&/E 8@<UW'CBUGO? >OVMK$\L\N
MGSI'&@RSL4. !W)K?HH \PO+P7R_#R6*UO0EM=*9B]K(OE@0%2S C(&XXR?Y
M<U3UG3M1U74?B3!IMO,UQ<I826NY&1;@Q*"ZJW /W=O![UZW10!P?AF_T3Q#
MJUE>VF@ZG%J%JC^;+J$<JFSW+AD#/PS$X&%[9)Q@5+\1]"O]0@T;6M*MS=7N
MAWZ7@M5.&GC_ (U7_:P!CZ5V]% &!:>+]-U"$&S2[ENF'_'HUK(DJMZ,& V_
M4X'O6##+<>'_ (GZM?:K&ZV&KV5N(+E59XXI(@P:(D#C.XL,XS]>*[VB@#QN
M[TF[L?#9F:UN0FH>,$U*&W$#%XK?S5.YE RHPI;!Z;AWK?U-XV^).LW$MC<7
M=DWAGR65(FVSL))&:(-C&XJ>G7FO1:* /./"4=YH_B&*RL=4N=4\-?8I) ;V
M(^=IQ!7$9<@$@C^ \C9[<\W90:E;?#GPS>QZ?>2KI&O27E[:"!A+Y)FE(<(1
MEL!U;'^%>UT4 >77LQ\2>/[V32X[SR;WPM+9PW;6DJ()6D)7)*C'U/IZTGA2
M[TS4[;1]-OO#>J+KNFM%YL=VDWE6SQX!E5V)3& 2N.3D#IS7J5% 'G?A&6>W
MT;QO)%ITL]PVJWUS!;30L@N5*C9C(Y5L8K$TZZ>Z\1> =2%IJCB*.XBN1]@D
MBAMG:$ 1)'M 50<C/(P.6.*]?HH \QTAY+30/'^G3V=XEP]_J$Z VS[720?N
M]K8PQ;/ &356RCO--@^&^MRVURVGZ?IOV*^00L7M7>%%#LF,X#+@G'%>L44
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MQ@^W^3+']JV R;3*WR[NN.!Q7HM !1110 4444 %%%% !1110 4444 %%%%
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MZC]:?/X)TF74+"^A:\M)[. VRM;7+(9(B=Q1SU;GG.<YYS0!YRTUSKOP_P#
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M=_=6\1A@FNW5FB0XW ;5 R<#+'+''6H],\+V^D3ZE/:7UZ)-1E,]PS,C9D(
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MD\VVNK:4Q30-ZJPZ?Y]* .:F\/Z\GA/6[.]\3/:3PN]SI]S%>R,]K'C(25R
M77((R03C/<5-X)U"?Q+I%_J=W=7=IJ0_T2>Q$K_Z$Z* ?E?^)OO;B.A Z@D[
MD/A*R@T^"S%W?NL=PMS)+-/YDEQ(N,&1F!W 8'' X'H*23P]9:?KFH>)(I+Q
M;JYA"7$40W)*%&%^15))'8]>W3B@#S(3Z];_  DTGQS'XCU274[81R/;R39@
MG0R["C)W)SU.3Z8XQW%O->O\5]4TYM0N_LC:-%.D6\;8G:5E)48P#A1SR:SO
MAUX7\WP!HEKJXU)!:D2/IUW&8T657+*2&4,0#A@"2N<<<5UG_"-VX\1SZ\EW
M=I?36PM6(9=HC!)  *]B2<T >?\ AM;Z;X8KXGOO&.I6MU]EN8C//)YD,>9F
M57,>,LXQ@'.><#C K7TF6[/Q$FT61M3ATVYT+[08+J\=Y-XE";P=Q:,D'H&[
M \&MV'P+H\7@Z;PJQN9M*D!PDDN63+;\A@ ?O?-SGFGV7@O3K+6[;6/M6HSW
M\%N;;S9[MG,B9#8<=#@C..G?&: /.+ 7&F?LX2:EI^H7UK=B!Y!)'<N2")V'
MRY)VY!.=N,UVTVHRZK\1E\.33SPV=OI O2L,S1--(TFS)92&PH'0'JW/059'
MP]T9?#-UX>26^73;EB6B^T$[%W%MBY!VKN)/'/J:OWOA:TO;NPO_ +3=0:E8
MH8XKV%E$A0]58%2K ]<%>O(Q0!YQK.LZY:>$O%]@NK7HET34X(K6\63]X\4K
MQD([=6*AR,YR<C-=5;"[TCXJP:>NJ7UU:7VE2W$L5U,742I(@#(.B<,1A0![
M5K7W@K2[_09]'E>Y%O<S_:;ETD DGDW!MS-CU5>F.@'08JTWANW?Q%;:[)=W
M;WMO ;="64*4)!8$!>Y .?RQ0!F>-M8N-/F\/Z=!*\"ZKJ<=K-.APRQX+%5/
M9FP%SU&3CG!JDLEUI?Q)CT!+J[GTG5--DG,<MP[O;R(P4LDA.Y00PXSP>1BN
MGUS0K#Q%IWV+4(V:,.LL;HQ5XI%.5=&'(8'O3++08;2[EO7NKFZOY(1!]KG*
M%UC!R%4!0H&>>G)QG.!0!ROPLL(8--U>='N"_P#;%[%A[F1UP)CSM+$;N/O8
MR?6CQ)I\-Q\6_"A>2Y7S+.]W>7=2(/E$>,!6&.ISCKWS@5T_A_PY:^'(;B&S
MN+EXIYWN'6=PW[QSEF!P#R>W2C5_#5AK6I:?J%PUS'<V!?RG@F,9*N '5L=0
M<#\J /.Y;*:>3XF7<.IW]G)9SF>'[).8OWBVRL"Q'+#@<'CKQZ;$6O:CK5]X
M:TMF4F]T,:C,!=O:F:0[!@.BEN-S':,9S[8KH5\&V*IK:"[O<:UG[9\Z_-E=
MIQ\OR_+QQ_/FH-0^'^CZEI6E64LM]%)I2A+&\@G\NXA4 +@.!TP .1VH M>$
M;+6--TZYL]9U"*]DCNG,#+*TKQPG!1)'8 LPSU(Y&*YCP>67XP^/$O#_ *4Z
MV;6^[O $8?+[9*Y]Z[G2=)M]&L1:V[32<EWEN)3))*QZL['DG@?@ !P*I:QX
M6T_6;^WU%FN+34K92D5[:2>7*JGJIZAE]F!% %_4KB*SLI+N2-9'@1Y8D/WF
M8(QPOOC/X9KS2ZU34Q\([?QS;ZI<G5TC2]<>>Q@D!<!H3%G;MP2HP,Y .<YS
MZ/8Z2EI)YTUW<WUQM*B:Y9254]0 H51GO@9/?I65;>!M*M(#91270THS_:!I
MA<&W5]V_@8W;=W.W=MSVH P4AO=:^(VKZ;/K&JV]BVEV]P((;@Q&-G9P0I7E
M>@Z<G')(XK-TO6/$=Y\.?#.J+%=ZOY;S#48+:X,5S/&C/&K*006((4D Y8XK
MO$\-V\?B&[UR.[NTO;J 0.0RE0BY*@ KQ@DG^>:I:?X)LM)L;"TL+_4;=+!I
M#;LLJDJ)#EP<J0P)YP0?T& #DM3UQ;CP!I6H:'K6I%/[:BB<RNRS /<?-#)G
M+?*&V]>0!UK?MKQ_$?CWQ%I-Q<W,-KH\5LD<5O</"7>5"[2$H03@84#.!@G'
M-:%UX(TN[TI=.>2Z2+[9]OD=' >6?=OWL<==W.!@=L8&*??>#K"\UV/6TN;Z
MTU$1""::TF\O[0@Z+(,8/U&"/7@4 >>^$M3N['P=X3T:"7_D(ZG?Q2RO.82X
M229@OF*"5+$#D#/! QFKWBFV\2^'O!7BV=M<DAB58[C3XX;UYI[8$[74R.H8
MJ3R.XY&:Z<_#?P\WAD:"R7;6J3FYBD:Y8RPREBV]&_A.2>GKSFI9/ >F3^';
MK1;F\U*YBO-HN;BXN3)/,J]%+L#A1Z#'?U.0#/U/3WTF:Q1O$>KSOJ-Z'>S\
MPM)<;8VS'"05\I<X=N0 !C(!YXS79[N_^%7CJWOY[IO[-U9HK=9+IW:-,Q$(
MS9RX&]OO9[=<"O3]5\*66L)IIN;F]6YTU]]O=PS;)5)&TY(&"".#Q5,?#[0O
ML&M6++=O;:PV^Y1[EV^; RRY/WOE4Y.3Q0!0\0_:-*\4^"[:SO[U+6>]EBFA
M:X9Q*/*=OF+$LW/J<<"H-*EN?&47BJ5]1O;.XLM2GL+,6]P\8MQ$HVL5! 8E
MB6.X'@XZ5OS>$;.XETF:6]U!Y=+<RP2/,&8N0068L#N)!(],= *)O"%BVI7U
M[;7-Y9-J"A;V.VD"I<8&,D$$JV.-RE3[T <+IVNZQXEE^'5S-J5Y9G58+L7D
M=NP19#'&<-C'?!/MGC! -=/X$FNH]1\3Z3/>W5W!I^HA+=[J4RR*C1H^TL>2
M 2<9K6F\)Z=)J&CWD336YT=&2RB@*K'&K+M88P<Y4 <].V*FTGP[;:/J.HWT
M$]S)+J,@EN!*RD%P  0 !C@ 4 :]%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %4M3U:PT6S:[U*Y2VME^]+)D*OU/0?C5VN-^+'_)+/$'_ %[?^S+0!O:?
MXET35;G[-8ZI:SW&SS!"L@WE?[P7J1[UJ5YK?Z1JGB77?!5S:Z;-90Z0RW%Q
M?3L@)3:O[I K$MNQST&*M77C36[K3)=6T&Q^V1Q731)8BQF9KB-)#&S"8'8I
MX+#@@ 8//0 ] JE9ZM8ZA>7UI:S^9/8R+%<IM(V,5# 9(P>".F:Y-M?\5W_B
M_6-$TR/28ELHK:>.2Z60DI(6W*P!^]A>HX&.^>&-X\N-+MO&=WJT$!AT&5$B
M6WR#+N164$DGDE@,XH [RJFIZG9:/I\U_J%PMO:PKNDD;. /PYKF=1\0ZSX<
MU'0O[7^Q3V6JW*64AMXF1K:=P2F"6.]200> >_M6/XDUO4?$GP]\6WVGO:1:
M;!#=VR))$S/.L:E9'W!@%R=VT8/0$]<  ]$MKB*[M8;F!M\,R+(C8(RI&0>?
M:I:R_#?_ "*VD?\ 7E#_ .@"J_BKQ!_PCVF02I&LEU=W<5E:HYPIED;:-Q]!
MR3]* -RBN2E\0:KI/C#3]!U$VEPFK02M97,,31;98UW,CJ6;((.001Z8/6JW
M@K7?%'B6VM=3NTTF+3_-N89XXUD\TLDC*K(22 .,$'TSWP #IKG7--L]7LM)
MGNE2_O=WV>'!)?:I9N@P, 'K6A7!>-_M8\=^"/L A-T9;T1^>3L!^SGDXY..
MN.,],CK4=OXF\6EO$6B26VF2>(-+A2ZMFCCD\B[B8$@;=VY6RI'4C- 'H-%<
MGIOB>YUO3?#,^FRVKR:FAFN=T+82)%_>8&_@ARJ<D\M[5H^*O$ \-Z,+L1"6
MXFGBM;>-C@-+(P5<GL!G)]@: -NL?5?%.BZ+(4U"]$(5D61_+=DB+_=\QE!5
M,]MQ%9<VOZIHWB[2M&U1K6XM]725;:Y@A:,Q31KN*LI9LJ1T((.1CWK#\)6^
MKW6M>-4DO=.<_P!IA)/-L7=680QX('F\*!@8.?KVH [ >*=%.JP:;]M'VFX9
MT@S&X25D^^JR8V,PP<@'(P:V*\I\%:O/HWPI\/W=T;>ZDNID@L5^S.6CD>1P
M68AB7XW'Y0I.".^1MR^)O$MI_;H>PCGM[33VO;2^DLY;>-F4'=$Z,22>X(.,
M?2@#L-4U.ST;3+C4=0F\FTMTWRR;2VT>N "3^%64=9(U=#E6 (/J*\ZN_%/B
M^S^'UQXKECT4Q'3(;N"$))N#,H+[N<$<@@#&.G.,G5U3Q#KL7BW1=&L8]/$>
MI6<TWFSJY,;(%YP",CYNG?'44 =E17GJ^/=1L?!7B#4M1MK:;4-'U%M.8PAD
MBD;<@60@DE5Q("1D]#S6I'KFMP_$"#PY,;&>WDL#?&=(71E <(5QN(ZD$'ZC
MMF@#KJ*YGQSKVH^'-#AO].BMI'-W# ZS[ONR2*G&#UYK..M^*4\:R^&V;2"T
M]@;ZWN!#)B "0(RLN_\ >=1@@IWZ=* .WHKS^R\>WI\.Q&[@MCK,FMMH:^6&
M$+2AROF8)R%"@MC/.,9&:U!X@U33_&4'AW4?LLW]H6LD]A=11-&-\?WXW4LW
M8@@@CTQWH ZRBO-M*\;^(I/"1\5ZE#I:Z9 MRLL$(D$LDB2LD>TDD $@ YR>
M_? V[+7/$'_"3V-G-9_:]-NHG\VYCL)K?[)(HR QD)W*W(&,$&@#JYIH[>&2
M::18XHU+N[G 51R23V%9NG>)-*U74)K"TN6-W#&LKPRPO$VQNC@.!N4^HR*Y
M[XMFZ7X9:VUO-'&H@Q*&C+%E) (!##'7J0?I5N^N]7TZ;3A))ID<<L;K<:FT
M&T)C'EQ+&9-S%B2>"?N].: .KHKS=O'>N2?#>W\50V]D&@N6BU"-H)& B68Q
MM(@W@C &[:<]^>*Z;4?$36%Q>79E@?2=/T\W=TRQDNQ()4(V['W5)(QW7UH
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MWQ=5*AF +'"@GJ?:EH Y?3-,\5FTF_MS5-/N;@0M# EK"T4;$\>9)DDEO8
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M)J;^;%(D9;[.[*L2[@W##.TDG ZYXK/T%=6T*[TT0S>$+Z%C':HMCY@N#$6
M/EDNPP!\Y P,*3QUKTUQ'(##(%8.IRC<[AWX[CG]:JV.C:7ICN^GZ;9VC/\
M?:W@6,M]< 9H Y1?!^J#2_%]F;FSSX@DED5AN_<;XQ&0>/FP!GMS4Q\*:F;S
MPA/]HM/^)!&R2#YOW^Z+RLCCY>.>_)Q[GLJ165U#*P92,@@Y!H XM/".IK;>
M+X3<6F=?9V0_-^XW1B/GCYN!GMS6#K-O<V]WX8\-IJNC0:AI=AYN-0C;RI<
M1(Z,&5@V%?@$XSSVKU.JE]I>GZI&L>H6-K=HIRJW$*R 'V!!H Y_P7<Z@!=Z
M==QZ*T-MM:.;1]PA+,6+(P;.'& QY/WQGWFU3P[?7'C/3?$%A>P0^1:R6D\<
MT1?=&S*V5P1ALKWR.>_2NA@MX;6!(+>&.&%!A8XU"JH]@.E24 <'_P (5JA\
M.^+-+:ZL]VOW4UP)!NQ!YJJI&,?-@*.>,YI;SP?KUOJ.FZUH6J6=MJD%BEA=
MQ7$326]S&IRIP"&!!)/XXSZ]W10!1TZVO+33MMU="[O6R\DFW8A<]E7G:HX
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M*<8(.?7K3KKQ3MDU,:=IL^HKI9VW9B=5(?:&*("?G<*02.!R!G/%6+;5M0U
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M=-NXL"S#<,D=\X[41VOBH>!O$'AF_P!-N;V:.VGM-/OA+$/M<;(50N"^589
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M$6EWEU#;07#,\X8PDPN$E"\DHY&UA[@F@"73-(M=*1Q"9Y)'QYDUQ,TLCXZ
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M5K2W-A?6TLPB)0,&C)B/4EMPSZGUJN;C3_ _B#PYJ@TZYL?"IT^XLXRZR/\
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MH>+Y[5FDAN;>Q,4RQMLDVI)DAL8/4<]^U>@444 %%%% !1110 4444 %%%%
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M%LK!E!Z-GN.:U+F+6;S3?#^KV-M9:[)'HD7VS2;TX>19%!,D;$$;R5(.>H%
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MCHDJ.W5MQ9MP/<>U 'I]OJUG=:M>Z9!,'N;)(WG4'.SS-VT'WPI./0CUJ\2
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M*JG9*6..@]3]<UWL<B31)+$ZO&X#*RG(8'H0: '4444 %%%% !1110 4444
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M;H;JVC:,*0&+HREFR,(Q!SVQB@#OJ*\UT/QQXH\1VVDZYI>DVUQHU[J#VTL
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MWAU^;GOQQR =CIFKZ;K5LUSI=_;7L"N4,EM*LBA@ 2,@]<$?G5VO)/V>,_\
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MBN(@\;SWM_X6N+>.!-%U^)@DLB-YD,P0L(R=V.<,/JI]:9IGC/4+VS\31/\
M83J>E7OV."*.-]DI8A8B<MGYV.WCH0>M '6#6=-;6CHRWD3:B(3.UN#EEC!
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MCC).>>-'14U9-*A76Y;274 6\U[166,C<=N W/3&?>K^><44 %%%% !1110
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M\.,9]\]JR?#OA;Q7X>1=#BUBQD\.0N?(D,3_ &Q(LY\H'.WVW<D#H.F.\HH
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M8#(SXCV;VY)XQD^]<+8>!]3_ .$-L_!^HS63Z3;L@DN(6;S;B-'WA"A&$R0
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MMG.3U]!7344 <C:^'=5MM>\5:CFS9=92(0IYK QF./R_F.WG/7CITYZUC1^
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M7@Y '>K^C:ECQ/:7VM:)XDCO?(^PP7=[!#Y2 G)'[IC\SD 9(QT QGD O?\
M"S;'^RFU4Z-JHTZ&[-K=7#)&!;L)/+RPWY(W'^'=COZ5M:CXHBLKK4+>WL;F
M^DTZ!9[I("FY58,0 &8%CA2?\3Q7 W&A:W+\)=?T=='N_P"T;O499H8#MRR/
M<"0'.[ ^4>M:OB[1)-:OKN_L],U2PUV"!?[,U*R.TRG;GRI><8#9!W@#!X/6
M@#T.61D@>1(FE8*2L:D L?09('YFO(?$.OW7BOX(W^K7]C);R"X#1L'4K@7>
MP*-IR<*-I) SVKUNR%R+&W%XR-=")?.*?=+X^;'MG->3OH>OCX.7GA?^PKHW
M\5R0F'C*S#[5YNY3NZ;>YQSP,T =]9>+(KKQ')HDVF7UG<_9C=V[3J@%Q$&"
MDKAB0<D?*P!YZ"LS0_$>@V6A7U]8:?<6<;ZO);/!(0'DNVD"MU8@98^N !2W
M=O>S?$_2M533[DV,6F3023%0 KNR, 1G/13VK&TO1[G_ (1;6[#6/#4]W;7V
MN3SO:MMW-;R2;A(I#=5X.,YXXYQ0!WNFZE)?2744MC/:2VT@C82E2'RH;<I4
MG(YQVY!XJAXMEN9-(_LJPF\F_P!4;[)#*!GR@02\G_ 4#$>^!WK.\#:5J6CM
MJEK)<WTVC"5/[,%^<S(NWYP2>=H. N[G@_4RFP?7?%EU+J-E?P6ME"(;*03-
M$)"QS*P*,#SA  ?[I/>@"/X;ZU<:QX1AAOR1JFFR-I]\I/(EB.W)^HP?QIVH
M>/M/L-/U'4_LEW<:;IUT;2YN8@GRR A6PI8$J&(!/KZ@9K)TS2+[PS\3[Y].
MTV]ET'5+:,W,QDWB*Y4D!LLVX@KU//)]JP'C>0:]I\GAK7[G0K[5))WCT[R)
M89@'&XABP<!F3+ >X&.<@':W_CJ*QU2/3!H>K3WTMDU['#'&A+JI *CY^O/Z
M<9) ,E_XVM[*PN[Q=-O9XK",27H3RPUO\@=E(9AN958$@9^I/%9L#3ZG\1M'
MU^TT^Z.E/H[P>>R!0CNZ. 5)R,!2#QP:SOL6J>'O%FLI)X2.NV&J77VNUNH1
M$6B=E56CDWD;5!7(/OW[ '6/XLM9XXCI4$NI/):)>!(61,1/G827(&6PV!['
M.*S8?B1I-U;Z%<6EK?W$6LLZ6YCB7*N@8LC#=D-E2/3OG'-8VHZ;JN@^+1J[
M>&8M;L+^QA@N(+1$+6LT>[&Q7Q\A#$=NG..]O4]/U.;6/!UTNB&&.TO)KBYB
MM@NVV1XV50<$!F^89VY[^V0"]'X^\T:I#'X=U=M1TQA]JL@(MR(5W!]V_801
MT 8D^G>M.+Q;87>FZ5=V*2W+:I%YUK"-JL4 !8MN("A<@'GJ0!G-8FGVE_;^
M+_&U])IMT+>_BMQ:N%!\TQQ%& &<CDCKBN8M/#^O:3X?\&ZC_P (^=0ETFUE
MLM0TN389"C[3OCR=I(*#OSGZT =9)\2M+ATF>^DL;\/:WXT^ZMU16>"4L%&<
M-@J<C!7.:T+/Q<+O6;W1VT>_M]0@M1=PPS^6/M,1;:&4AR!\W&&P1D5SGB2R
MU/5_!ZBS\,O9/+J%M,EDBQB41QR*S/)@[0< X4$]O4@:PM;U_BS'JHL+@:>=
M%-I]H*@*)3,'VD9ST[XQ0!:\ ^(KSQ3X5M]5O+-[=YR[J2R%6'F, %P<_* !
MD@9KHYW>*"1XXFF=5)6-2 6/H"2!^9KSKPS>ZSX)^&,,-WX:O)KC3&:.6-)8
MQO3>[-(IW'Y0N#SCK^->CQN)8DD (#*& 88(SZT >/\ B#7[GQ5\$Y]9O[&2
MWD^U1O&P=2N/M@3"[3DX7Y3D#->@V'BR&[\1S:)<:?>V-PML;N%KD(%FA#;2
MPPQ*X)'#8//2N!.A^(%^#<OA@Z%=_P!H07*A0'C*R@77FEE.[[NT=3CDX%=-
MJFF7NI_$2VNELKE-/DT6>RDN=H C>1E(&,YZ ]NM %]_'EA%+I<DUK<QZ?JD
MRP6EZ2A1W;E,J&W*&QP2/KBMCQ!#'/X=U%9%# 6TA&>Q"G!'H?>N&\'V^L6-
MI8^']0\&0QWECLA;5ML1MWB3 $@/WRY4=,=>3BN[UWS#H5^D,$D\KP.B1QC+
M,Q4@#F@#S+PC-X7N_AUHJ:I*TFH7D<=NTBN_FF21]@.[/7)'/M7=:AXKM=!U
MO3=&O[:Z07BLL-\Y00%D7<0S%LAL#H1SVK#\(R7^B?#[2]*O_#.IS7=G H:%
M%B(+JV1@E\=0#FK/B/1;SQGI\>AZE;26D:VZW4EW$H8"Y ^58\G/RDDD\9P!
MGEJ -I/$T']B6VISV5W;?:I%CM[:4()96;[H #8&1D\D8 ).,53B\=Z8L^KV
M^HQRV%SI42S3QR[7W1M]UD*$[LGC'7/&*YO5+?Q5XA\%Z3=W6B#^WM'O8[F:
MRG*".]"JR-M.2!N5B>>AX]*EU72=2\7^#=4M[#PXN@3O'&T"7*QK)+*DBR '
M82 F4QSUSG QR =,GBK&K?V7<:/?P73VINX5;81*H."NX-A6&1P2.O6JR>/=
M/D\/Z)K:6=Z;/5[B*VB^5-T;2-M7>-W3/IFI=!UK6]<"+?>'KG2%1"+@W3HV
M]\8VQ[225SSN..@ !SQP5KI7B./P'X;T#_A'+TW6C:K;23L7C"2+'*6)C.[D
M8YR<"@#M=-\4:A>>.M>T=]+G%KI\5OL97C)RXD8L?FS\V%  SC'.,UG:?XNT
M+0O LVN:?HNH1:7'>3+/$NPO&YE*N[!GZ%SV)Q["K>G6NI:=\2=?O7TN=[+4
M[:U:.X1D*QF)7#*PSG=\PP #FHO!6@S/X)U'1=;T^6!;JYN]\4N/FCE=B"""
M1T;\#0!T\VKI#J-I9FVE)N(7G,@9-D2)MR6.[U8#C-8S>.["*?2FFM;F*PU6
M98+.];9L=V&4RH;<H8#@D?7%4_"/AW5E\*W5GK\@%\UNVF1RKR?L\>Y$?ZMD
MM[@KZ5F>#X-8L[6PT'4?!D,-[8[(GU7$1@>-, 2*?O%R!TQU.3B@#8^*T22_
M##7BX.4MBZX)&"*LZ7XLB?6+'0[C3KZT>YM3+:3SJH2X"!=V &+*1D'# '%+
M\1+&\U/P#K&GV%K)<W=U 8HHH\9)/N2 !6;?6FH7/C7P;?Q:;<_9K*VN4N9&
M4 1-)&BJ#SD\J<XSB@"]#X[LIFTZ7[%=K8:C>M86UVP7:TH+#E<[@I*, <=N
M0,U</BF)[F9+:QN;F""^2PFFB*8CE9E4DJ6W;07&3CUX(YKS^73_ !1J-EH-
MUJ7AV^GUJPUR.XO9C+$5:,,_$ +X"8*_W>G.3DUIZKH%[<:Z^L:+87^D>(A?
M*KR0M_HM[ ' +2\[3^[SUPV1P#Q0!W7B#4Y=&\/W^IPVK73VL#S"$.%W;03R
M3T''U] :\[UW4YM2\/\ P^UN_M)X[I]5LV?&&,H:%F)54)X)Z X/'05Z)X@L
MYM1\-:K96X!FN+.:&,$X!9D('/U-<%+8ZU<^%_ ELVA7L4VDWUH]TC%"52*(
MHS\,>,G@=2.U '56'C2RN'UJ._M+G2IM'19;I+O8<1,I97!1F!!"GH<Y&*6+
MQA;C7[#1[VQNK*;48W>S>4H5E*#+*=K$JP!S@_GGBN8UCPSJ>NZ[XV@2VFMX
M-5TR"WM;J0 (TD8<D'G(&6'./6M3PK<:E>SVT=[X*31[JW'^EW3K%L9@"/W)
M4Y.3SG@ 9Y/% &[XH\2VWA32AJ-Y;7,T'FI$Q@4,5+,%!.2.,D=,GVK"U7Q%
MIUXVDC6_#>JPDZW%;V9G55"S]4EX?[N"WKT((JQ\2;&^U/PDUGIUE-=W+75O
M((XL?=25'8Y) Z*:9XYM;[4D\--8V%Q<?9M9M[R<* #'$F[<3DCGD<#F@#3O
MO%4%M?:C9VUG<7LVF6ZW%XL.T>6K E5&XC+$*3CT[\BN/\2ZY9ZTW@7Q!:VU
MV(9=67R@R_/(AB<C"J3U..O/'.*76Y+NV\;ZY-I^CZQ-#=6D-M=3:5Y,F]@K
M'YA(1L=58 8[')!R*6:$7UEX-BT/1-1AM-&U)?M%O/&%DMD2-E^8$\GYU/!.
M0<T ;LGCHG2?$<T>C7D6I:''YD]C</&"5*%U;<K%2I )X)/!XK8\*ZE=:OX8
MTZ^O;>2&>:VB=R^S]X2BDN-I. 23P<'VKE)M&U2[UWX@[;"9(M6TZ*WLY7P%
MD=89$(ZY'+#KBNF\&_;$\(Z7;WVGS6,]M:Q0-%,5+$H@4GY21C(.._L* ,[2
MO%=Y>>,O$6FW=@]O8Z6L(\YI(]J HSEW^;.&&W &<8YQS4Q\<6<<&G7MQ97<
M&EZC(L=M?2!=A+_<+ -N16[$CN,XK&FT#4KGQ1XWLGLIDLO$%I%'#?JR[(\6
M[1MD9W9W$< 53ET?5]?^'>G>#[W2Y[6]A:V@NK@X,2QPNI,B-GYMRIP!SEN0
M ,T >A:G?II>F7-_)#+,EO&TK)" 6( R< D#I[USNG^/K6_L([]M*U.WLIK>
M&:WGEC4+.\I"K$GS??W$#G [YQS6YX@267P[J44$+S326TD:1H.68J0!S[FN
M'N?#VLWGPDT*QM[$+K&D+:2_8KK:%F>'&Z,G)&&&<'ITZ4 = /&\"ZAJ&FRZ
M7>KJ5G:?;1:H8W:>'."T9#8)!X()!STS5FT\66U_X?TK6+6SNI8M3=%@B4Q^
M8-V>3\V. "3@D@ ^E5O"]Q<7\YN6\*?V%&D95_/6,22.2.%V'[@P>3C.1@<&
MJ/A+PS?Z+KVHVTRJ-%L[B2?25ST\\!G&.VP[U'M(U &I>^,(+>+4KBVT^\OK
M73',=Y-;[,(R@%PH+ L5!YQ]!D@BL#5[RPN_B+X%U>VN$:UN;2^E$^["M&(D
M(//3 8_F:-&L=6\,Q>)='DTNXOH[R\GN[">':4E$W.QR3\A#9R3@$'BL/4/A
MY<R0>"_#TT5W)9Z?8W,%Y?6S8$4DB+M9>02 ZGMT S0!Z#%XH@.D2:I<65W:
MVOF". RA-UP6;8FP!B?F)&,XSD'@4W3O%=O>>(YM N+6>SU%+<721RLC++$3
MMW*RDC@\$'!^HKD[^T\6>(_ AL;W30->TN[BGB:;:(-0\F0$'K\N\#E6QSZ#
MIT/A>XN+^?[0_A+^P42,K(9UC$CN<<)L_A'.2<9XP.M !XK\2W^B:SX?L;/3
MY+A-1NS'(Z.@. C-L4,1R<=3@8'J:YZTU!]&^)?C":VTJ]O97L[*4V]N5+#Y
M9"Q)9@H^@.3V!K<\:V.H2ZGX8U*QL)KY-/U$RSQ0,H<(T;ID;B <$CO5?3+?
M4+?Q_P")M3GTRY6UN[.U2%U 8.\:ON YSU88) S0!KV_B_3[[2-*O[))9SJJ
M>9:P#:KD 98MD@ +T)SUP!DD5-X>\36GB(7J0Q2V]U83FWNK>;&Z-QR.5)!!
M'((->;6'AW7]*\+>#+[^P#?7&BQSVU]I<NS>\<A!W)DE21M4^^<5Z3X<:6:V
MEN7T1='CE(\NV94$N!_$^PD G/ R< >^  ;5%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 445S'Q"U*_T;P-JNJ:;=M;7=I#YL;!$<$Y'!#
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M2;S#!)Y4JE2K1O@':P(!!PP.#ZT 6Z*S]0US3=+=EO+D1E(_-DPK-Y:<_,^
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MK^*73X0QDN4R44+]XY]!W]*+OQ)I%BA>YO B+$)G;8Q$:'HSD#Y <'&[&<4
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M.0#@ 9&.E;EG906%LMO;J5123EF+,Q)R26.223U)YIM]J5IIJ1M=3!#*VR-
M"SR-C.%49+' )P!T%<=X/\3_ &A_%=UJ.LB?3['4?+AGGVH(X_+0[3@#!#$C
MIG/O0!W=%8__  E&C_9;^X^U\6"A[J,QN)(@1D90C=R.G'/:H=#\6:=K/AFW
MULR""&6-'97R-A;&%]SR!QU/2@#>HJAINLZ=K G^PW2RM;OY<T>"KQ-UPRD
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M7!\-,D\5Q<6S,#;22*FPN$Y&-K*?3)]:H:T=(M-)@\2^'+>[NM*CURWOM3N
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MTLK(%W K'\_!;J>.1WQD9[.D55484 #T H X3XF7EM;MX36:XBC8>(+20AF
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M\E!.4>0 ;F5< GU )./SH KZ5IT.CZ/9Z=!_J;6%(5)[A1C)]^*Y'X1Q2)X
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M&_S#*Y"C!/\ ",Y&10![117D/C'PW'H?@KQH(]31DGMXKI=/M8F@BM6SMW*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,.,4 /?P?X?>'4XCI4&S4R3> 9'FDG)/7C)Y.,<\UL0PQV\$<,*!(HU"(HZ
M 8 JMJM^VF:7<7JV=S>-"NX6]J@:63V4$C)JQYR#R@[!'D^ZC'!)QG&/7% &
M??\ AW2M3U&VU"\MC+=VI)MY?-<&(GJ5P?ESCG'6I-2T/3M7DMY;RWWS6S%H
M)D=HY(B1@[74AAD=<'FM"B@"O96-KIUL+>TA6*($M@=V)R23U))Y)/)-5-0\
M/Z9JEY#>75L?M<*E([B*1XI54]5WH0V/;.*TZ* ,Z;0=)N-%;1IM/MWTYEVM
M;%!L(SGIZYYSUSSUJ/0O#6C>&;1[;1K"*TB=MSA,DL>V222<?7BI]8U2+1=*
MN=2N(II+>VC:67R@"RHH)+8)&< =N:31M5AUS2;;4[:*:.WN8UEA\T %D8 A
ML G (/?F@"#7O#.B^)[:.WUK3H;R.)M\>_(9#ZA@01^!ID_A30KC1(M%DTZ+
M^S(L;;5253@YY /////?GK6S10!E7?AS2K^6SEN[=YI;-MUN[SR%HF_O [NO
MOUJMK/@KPWXAO(+O5M(M[JX@7:DKYW;?0D'YA['(Y-;U% &-K7A+0?$4-M%J
MNF07"VQ_<=5,?LI4@@<#CIQ4EWX9T6^TRUTVXTVW:SM'5[>$+M6)EZ%<8QU/
MYFM6B@#-CT#3(=7&K1VH2^$(@$JNPQ&.B8SC;GG&,9YJS]@M/[2_M'R$^V>3
MY'G8^;R\[MOTSS4<6H-)K%QIYL;M%AB2073(!#)N)^56SRPQR,=Q5V@#"UOP
M9X<\27<-WJ^DV]U<0C:DC9#8]"01D>QR.33;SPM8W?B32=7%M#%-IJ%8I4)#
M;"K+Y8 X"_-G\,5OT4 5=1TZSU;3Y["_MTN+2==LD4@R&%48_"VBQ7-E<QV0
M2:Q4I;,LCCR@?O8Y[]_7OFMBB@#)M_#6CVT5_%'8H8]0):[21F=9R1@E@Q()
M([U'H'A+0?"XF&BZ9#:&;'F,F22!T&22<<].E;5(S;4+8+8&<#J: ,_4M"TW
M5Y[6:^MS+):OYD#>8R^6_P#>&",'WZU7U[PIH7B=(5UG38;OR#NB9\AD]<,"
M".W&:J7OC&#3= T_5KW3-2@6]FC@$$D2B2%G;:-XW<<GU-=)0!6M]/L[33TT
M^WMHHK-(_+6!% 0+C&,>E$&GVEKIL>G0V\:V<<0@6#&5" 8"X/48XJS34DC=
MG5'5FC;:X!SM. <'T."#^(H R]-\,Z1I,D3V5IL,*E80TCNL(/41AB0@/HN*
MKW/@KPW>:ZNMW&CVTFH@@^<0?F(Z%AT8C P2"1@5O44 8=YX/\/:AJ%U?7>D
MV\US=1>5.[ _O%QMY'0G' /4>M.;PCH#1:=$=*MRFFY^R#;_ *K/7'KG SG.
M>]79-0:/68-.%C=LLL+2FZ5!Y*;2!M9L\,<Y QVJ[0!G6FA:;8ZC>7]O;;+J
M\Q]ID+L?-P,#<"<' X'H.*@L/"VBZ9+')9V*Q")V>&/S&,<+-G)C0G:A.3]T
M#J?6MBB@#('AC2%DU"1;5@^HC%X1,^9AC'S?-SQQ]..E7=.TZUTJPBL;*+R;
M:%=L<88D(.P&3P/:K5% &,OA714@OX5LR(]0):[7SGQ.3P2WS<Y'!]1Q2MX6
MT9TT]&M"5TX@V8\Y_P!Q@8&WYN,#CZ<=*E.LI+/+#8VT]ZT3%)'BVB-&'52S
M$ D=PN<=\5)!J8:Z2VN;::TFDSY8EVE9,#)"LI(SCG!P< G& : *-YX,\.W]
M_>7MUI<,EQ>1&*X8EAYB[=O(!QG:<;NOO4@\*:(GD>39?9S!!]GC-M*\.(LY
MV?(1D9.<&MFB@#)NO#&B7L=A'<:9;.FG_P#'HNS A&,8 ';  QT.*T;FV@O+
M:6VN88YH)5*21R*&5U/!!!ZBI:* ,O3O#FE:3)&]G:E6B0QQ&25Y/*0]53<3
ML' X7 X'I52?P1X9N=?&NS:-:OJ08/YY4\L.C$9P2/4C-;]% #)8UFB>-]VU
MA@[6*G'U'(K%'@W0%TVUTY=/"V=I+Y]O")7"Q29R&49X(.2/0D^M;M% &=%H
M6G0ZPVK) 1?O&(FG,KDL@Z*<G!'?'KS5VX@BNK:6WGC$D,J%)$;HRD8(/X5)
M10!3_LFP_P! _P!$B_T YM>/]3\A3Y?^ DBHKC0M-NM7M]6FMRU];@K#-YC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,1KXL7Q!#>2Q2I8_8$MU1/*6+<&Z8SG('>LH_#C3I?#5SHEQ?7DL<MXU_%<
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MN9;FX?;'O5I#EPORX )]CBKL_A07&K:%J,FI7'G:,KK" B;9-Z[&W\?W?3%
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MD1E8L %&# AEXZ'_ !I^I^"8=5\*3:#<:K?%;EUDN;LE#-,P96!)*X'W5&
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MMHDB>-N2=PWJ<-SU]A2W>@+)X=DTC3[ZZTW<<BZMV_>AB^]FW'.2QSDGKN-
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MUC:OXUUC4/AW9ZM8PP65U)J26-VAD+;")Q&P0@="1U/0'UYH ]"_M.P_M/\
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MW$:KDL%(& 3D+SSC/0B@#I:*XVV\8WQ\0:;8W&GI):WZ/F:U$C?9'49"R$J
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MK>13'*V8V2-8]IW #''7OZ#.!V-4]4TJPUK3Y+#4[2*ZM),;XI5RIP<C]0*
M.4\"Z!#IVI:W=VUP9M-^UR1::G\,*$AY@GL9=P_[9BNIUJWN;O1+ZVM%B:XF
M@>-!*Y5<LI') )[^E6;:V@L[:*VMH8X8(E"1QQJ%55'0 #H*EH \]/@K6/\
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M( P!Z_A5'P();'X?:-;W=M<P3VEE'%-%)"P=650" N,G\,YH Y3X?>,;72_
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M;>2ZBE>3RV&/F4@_GC'(J_X@U#4/$>@^%[EM"U.VO(=9M+F[M6M7)@5"2[9
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M8DNE4"6,'!*LK$<=P<$>E<*="U;5/"GCFQMK*:.\NM::_LTNH61+A%:)E&6
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M/NC<?V[#J5M#-$T8NXXQ'D L .2AX]A0!N7FHRW/Q<\,(;;4;/?9W;O%</\
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MT<N@08,5M([+^^D."J@L/Q%9D%AK>@:>D\>FW@M-6\07%]>1VD6^YMH) 0@
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MG&?:J4_B_1[?Q9%X<DO(5O'MVG.Z0 *=R*J<]6;>2!UPON* -ZBBB@ HHHH
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M0R>'50,'!1R)W) /1L#KCI@^AKT26*.>)HIHTDC<89'4$,/0@U&MC:(NU;6
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M<1>,=?U?4K;3I[;46@>!<F1X3%'LZ,@'/7@\>]=/-:6UR09[>*4KTWH&Q^=
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MLWEEE>T@:24 2,8P2X'0$XYQ4K0Q/(DCQ(SQYV,5!*YZX/:@!]%%% !1110
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MNAW'82<KR<C'2JGA"YEU;3-/\,7SN=1T:[D34FWMN80GY&SG/[S?&>?O .*
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3 HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>sangamoexecutiveseveranc019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYP.XKC*C W'/3<,\UO:E);M\1M?FGM9;NR?PUY3I&C8G(>1FC5AP6*GH.>:
M.TL=?L=0O%M8?M"S/";A!-;21AX\@;@6 !^\..O/2I=2UBRTHVZW4K"2YD\J
M")$+O*V"<*J@DX ))Z #FN(\'1WVF^)8=.L=5EUKP\;)WCDNH_W^GL&4+$SX
M!.X?PGD;.V.=3QKJ3V&K>'@UJZVLMQ*)=1BM#/):'R_E" *VTN25W8/&?7(
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M@\]..6)%3>"=72R\/6G@[6-%NIM=L)C&(9;-GBD(D++.)"I0+R&W$YSTR<9
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M-VH%[<LUS=<YQ*YW%<]PN0H]E% &K1110 4444 %%%% !1110 4444 %%%%
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M1BV0<XR"/I0!L:]X=N=?DEMI]59='N(!#<V/D*=_S9++)U4D?*>HQTP>:WP
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MI+:Z>UM]EDMU(W+)&7.3N.3T&1QQ0!U5%5M1OH=,TVYO[DD0V\32O@9. ,X
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M",X!^HK2%]:%"XNH"JXR?,&!0!/14,]Y;6L(FN+B&&(D /(X53GIR:=)/##
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MG'B'2M LM-\*P:4B26">*8E#NWF)\WF%U5CQLW'&!QD$=16LT5O%\9X)K"*
M/)X:E*F, !\3H%Y'48P/I797&BZ7=Z:FFW.FVDUBFT+;20JT:XZ84C Q0-&T
ML:@FH#3;,7J($6X\A?,51V#8R![4 >41"'4_@%<ZA-G^VX&DFDFQB=+Y93CG
MJ'W8 'H0.E;-KH]I??%LKJMA;2S2>&H);F-XP4>;SF!8KT)XQD^@KN_[ T?^
MT6U#^S+3[8SAVF\E=Q8=&)Q][WZT]M%TIK][]M-LS>.AC:X,"^8RG^$MC)'M
M0!R_PH^7P#;PJ?W<-W=11C/W5$[@#Z 5B^-1XJBTCQ=<RZ)83VLMC<0QW1U
MJT5L$/2/RSSU8C=R<#. ,>BZ?I>GZ3"T.G6-M9Q,VXI;Q+&I/K@ <U//!#=6
M\EO<1)-!*I22.10RNI&""#P01VH YSPGJI@\):$FLFST^XN(8X;:+[4&\[Y!
MMVY"Y8CG: <>]6/'%W8V7@C69]3^T?8A:LLHMFVR$-\N%/8G.,U-J_ANPUB/
M3X9K6V$5E,DL1,(+1;""!'_<S@ D=N!ZC5N+>&[MY+>YACF@E4I)'(H964]0
M0>"* /-M)D6V^+FGH\NGQ;_#S((;5LJH$T>Q2V?G."<' Z\"N8@\/Z3<_ V?
M5#:1_P!LQ3W#6EV@_?K,+IQ&J-U&20-H]>F37L-IX<T.P>V>TT>P@>U#+ T5
MNBF(-][:0.,]\4L/A[1K>^:^ATJSCNF?S#*D*AM_3=G'WO?K0!R'A]Y+_P"(
M_B2PU^*.6X2PLQ:QRJ&4PE#YI4'C!D)#?0#L*Y^R\/WFJ_"V]2!?.N-&U6>X
MT%Y!O)C@ES&H)Z@[64>V/2O4[_1=+U22*2_T^VN9(LB-Y8PS*#U )['N.]6X
MHHX(DBAC6.-%"HB# 4#H !T% 'GMSJDVO^"=<\8Z1$ZW$FE-%IY"_O$ 0LY'
M?=O)7_MDI[TW1+/PYJMWX8UNPUX-/ A2U@M5B5G5D^>.0*,D  D@]"/6O0K>
MV@M+=+>VB2*&,;4C10%4>PJCI_AW1-)O)KS3M)LK2YG_ -;+! J,_.>2!Z\T
M <O\4-_V/PQU^S_\)'8_:/39N/7VW;:[H@$@D#CI5'6](MM>T>XTV[W"*8##
M(<,C @JR^X(!'N*GLOM0M46],9N%&UWB^Z_^T >F?3G'3)ZT <E\6@%^%?B'
M@#, S[_.M7+#PG9W=QH^L:A=W=_/90AK1)V01PLRC+!4503[G-;VH:9I^K6_
MV?4;&VO(<Y\NXB61?R((J:VM;>RMTM[6"*"!!A(XD"JH]@.!0!Y#81:5XG\-
M:M:Z]KOV'4K?4IGNU58UN8I4F)C*,1N^Z%5<=OE%;&G>'-&U3XI>+(=0TZWN
M4%M82[)8P1YA$A+D=-W YZ\GU-=Q+X<T2?5TU>72;%]23&VZ:!3(,=#NQG(J
M6+1M+@U&748=-M([V7B2Y2!1(_U;&30!Y*-#TF7P/\3G?3[9FMM0OS 3&#Y)
M6%&&S^[R >,=!Z5KR6%I9:[\-[ZVMXXKNZ+BXN%'[R;=:DG>W5LGGG-=ZOAK
M0E@N(%T73A#<MNGC%JFV4^K#'S'ZTX^'=$8VI.CV!^R#%MFV3]S_ +G'R_A0
M!YV+.V0_%B".WB$00.(P@P&-INSCUSS]:@O;;3&\)_#1DAM"#J%@LQ"KR6MV
MR&^O'7KQ7I]OHNEVD]Q/;:;9PS7/$\D<"JTO^\0/F_&H?^$;T+^RQI?]C:?_
M &>'\P6OV9/*#9SG;C&?>@#@GETW5?&GBC1=5U.WM(I+>!;1)4B*26C1#/EE
MAC <N3CV]*-%>UM/'_A[19KV6\TN'0V;2IKL@^?+YNTL#@!F$8&#_=)/>N^U
M+PYHFL- VI:18WC6_P#JC/ K[/89' ]JDU/0]*UJ".#4]-M+R*)MT:3PJX0^
MHR.* .1^&D=K!<>,;>T$21)X@G*I'C"C9'T Z#.:3Q8?^+M?#T?]A'_T0M=C
M8:1INEF4Z?I]K:F4YD,$2IO/O@<U#?>'=$U2Y6YU#1]/NYUX66>V21A]"1F@
M#B/BR5UVUTOPC8$3:K>WT4IC3DP0H<M*W]T#CKUSQ4PAM;?XJ>*&W"U23089
M)I8AA@=T@+\=2 !^0KN;'2M.TP.-/L+6T#G+BWA6/<?? YJ,Z)I)O9KTZ99_
M:YD,<L_D+O=2,$%L9(]J /-]/FUKP_<P:3>6%G=WPT:YCT35[ 8$Z(BMLD3L
M?E0Y!P3TZU?\*-X5UKPMX1OC<(VHVS1LGERXG-T5VRAP#N;)+,V>H&3Q7<V.
MB:7IC[['3[:V;;L!BB"X7.=HQT&>PXIEIX>T6PU.;4K32;*"^FSYEQ% JN^>
MN6 SSW]: /,-7N=0M-&^*L^E%Q=I=1X:/[RIY,8<CT(3<<^U;GB*WM$NO >H
M^&TCCE?4(H8C  -]DT;-(#CJH50?8UW%KH^F6,\\]IIUI;S7',TD4*JTG^\0
M.?QIEAH.D:7*9+#3+2U<@C=#"JD G) P. 3S@4 >>1/>:%K%@;J"UUGP_>ZT
MQL[^+Y;FSN)9&&UP?O*&++D<@=>@%5V:TM]!^+$,QAC_ '\Y"-@<M:KM./4G
MIZFO2H- TBUNOM4&F6D4^\R;TA4'>>K=/O')R>O-,N?#>AWE_+?W.D6,UW+$
M89)W@4NR$;2I;&<$''TXH \X.F:;J>O_  S6YM;>>.XT>X64,H(E"P1$*W]X
M#)X-3I!I+>,/$?AF_O+?3;:.TMX;&WECCVM:&+YA&7'9]^<=\>E>@CP[H:S6
MTPT?3Q+:C%NXMDS$/13CY?PI=4\/:+K;POJNE65Z\)S&UQ LA3Z9% ' OI5_
M90Z9-X6O8-<^PZ68'L-4/-W;,YVO&X& 3LP#C! 7/:NV\(7UIJ/@[2+JPMY+
M>T>TC$4,G+1J!@*3WQCKWJU=Z'I5_,DUWIUK-*B>6LCQ L$_NYZ[?;I5Z.-(
M8DBB14C0!551@*!T '84 >+7MY8W&CZ#J&FO#!9R>+(WC,[[[J1S<,)'9LC:
M.HVX)V[<D=*W++1-&U+Q[X_$]A:7$)MK.159 R9:&3+@=,G^]UY//-=PWA7P
M\QN"VA::3<R"6?-JG[UP<AFXY.>>:F&@:,)[F<:38^==#;/)]G3=*/1CCYOQ
MH \K\.ZF6A^%UIJ<F=.FLI64RGY'N44"(-GC(!.T'OCN!74>#X[2W^)?CR&U
M6)%,MDY2/ &XPDL<#OG.?>NIE\-:%-I0TJ31K!M/#;A:_9T\L-ZA<8!]ZEL-
M#TG2YGFT_3+.UE=0K/#"J$@  #('0 #B@#(\2-<ZEJ>GZ)8F NK"_NA,3M\N
M-AL4XY^:3!]Q&PKF]):[\*?%>XL]0-O':^*(C<0B$G8+J( .!GNRD$^IQ7?)
MI.FQZD^I)I]JM\XVM<B%1(P]"V,U'?:#H^IW,5S?Z58W<\7^KEGMT=D^A(R*
M //]-FT+6V\<:5XIG@CN1J,BR^?((W6U 7R64GD* ,C'<D]^;=O!IZ?&.)GA
MC53X<B=#<*-^[[00"<\[^@SUKLKOP[HM]J4.HW>DV4][!CRKB6!6=,=,,1GC
MMZ58GTK3[J^M[ZXL;:6[MP1#/)$K/'GKM8C(_"@#Q^[DFTKP)\0SID9BBC\0
MN)1;C!2 ^3YF .GREOH,UU?B*T@C\7>";O0XX5>>62"00 !);+RBS9 X*C"D
M=@2,=:[*TT72[#[1]CTVSM_M!)G\F!4\TGKNP.?QIMAH6DZ66-AIMI;;EV'R
M8E7Y>NWCM[=* /&[K1=+'PO\>W2V-OY]IJ][]FDV#=!ME4KL/\'X8KJ_%,6J
M17U]K&G1V.L6W]F11:KI%T=K^4-[!XGZ D,W!&#M[G&.T'AC0!:S6HT331;S
MOYDL7V5-DC?WF&,$^YI9/#6AS.KR:18LRQB('R%^X.B=/N^W2@";1;J"_P!"
MT^\MD=()[:.2-9!\P5E! /O@UC_$01GX;^)/,QM_LZ?KZ[#C]<5TH 4    <
M "LG7M(.O6Z:;/M&G.ZO=#/S2JK!A&!V!(&3Z9'?( (?#.H1#1-%T^[NX1JK
M:;#+);M(/-(V ,VWKC.>:P_BO%"_A.VDFCC8)J=G\SJ#M!F3/7H,5T4_A^SN
M?$MKK;P0"YM8RD<JQ#S3D,,%^NT!F^7U.>U7[VQM-2LY+2^MH;FVD&'AF0.C
M=^0>#0!PNH6&FW_Q<TBV>WMY[1=%N,0[08\B9!@KT.#G@]QZBN4CO%T?PC+#
MYGV;1K?QG/;7!5 4@MO,<J"IXV!]F1TKUQ= T9+J*Z72;%;B&,11RBW0,B 8
M"@XR!CM1#H&C6]K<VL&DV,5O=$FXB2W14E)Z[@!AOQH P?#NEZ5;>*]0U'3]
M9^V7%[;H;B*#R_)&TX1R$'#$9 )Z@'TK-^*T:RQ>#XF9E#^)K-2R,589W\@C
MD'WKL]+T;3-#M3;:5I]M90%MQCMX@@)]3CJ:34=#TC5V1M3TNRO3']PW,"R;
M?IN!Q0!G)IMGHNM0WKZA=R/<I]DC@N+AI=S$ALH&)QPI)QV&>U<'JUII^A>-
M)M0\C_BD+Z\BCU0!5\E+U2=CG_8W;0_0;P,G@BO2+7PWH5E=)=6FBZ=!<("%
MEBM45U!&#@@9&13V\/Z*^FMIK:18&Q9]YMC;(8BV<YVXQG/.: .,U.]MV^*%
MSIFJW\-G#)I<1L!/&C1R L_G ;QC<?DR!R0H]*R;0Z7X:UOP=I+:G)=>'0+Q
M+:YNF4QFX!&P;L!<*"ZI]>.U>C7WAO0]3LX+.^T>QN;:W_U,4MNK+'_N@CC\
M*FO=%TO4M-73KW3K6XLE "V\L*LBXZ87&!CM0!YQXNL-"T_PS(^D,K6X\1VM
MS<.'W1Q2M*A?:>BCD9 X&?K6N#97'QONH?W$F[PZJRIP<G[0>&'K@CK[5V!T
M72SI']D'3K7^S=FS[)Y*^5MZXVXQUYJ.S\/:-I\L,MGI5E;R01>3$\4"J8TR
M3M4@<#))X]: /'1;:?)^S$Q\FV:=+99&(5=X87! )[YZC/UKM_'<,6AZIH?C
M=8EQITPM[]@N2;67Y2Q[G8Q4CZFNH_X1G039S6AT33C;3R>;+";5-DC_ -YA
MC!/N:NO8VDEB;)[:%K0IL,)0;-OICIB@#SOQ7*VE^%;+5;H&UAU/68+C59/+
M!\N!LA XQR% A4@\'!]:W/#VEZ3!XMO=3L-9^V7-Y:)Y\5OY?DX4_)(P0?>(
MR 2>0#Z5U=Q;P7=O);W,,<T$BE7CD4,K ]00>"*K:5HNEZ';-;Z5I]K90LVY
MDMX@@)]3CJ: .;\07%D_CS2;0"/^TTL;B9)+I_\ 1XHB5#-LXWOQC&1@;B37
M"Z5,#\)= \N]MV6TUX,]LTJHMS&+J3$0R<#.-PR<?)UP*]>OM%TO5)[>;4-.
MM+J6V;= \\*N8SZJ2..@_*N=\2^%WDL[6'1='T>>S6[:YO=-N(Q%'=DJ0"6"
MD;@3GD'.!Z4 9=KX=L]0U_Q7XAGLK(V]Y:)%'$_E2OE48.Y*E@N[@8SSMR>U
M<W;Z?9Z3\#+'7K.S5+YK&WCO+N)-TS6QE0R@GJ1M!X[ >@KLM#\%64=_]MF\
M,:1I"^4\3VUHPE\\-CB3Y%7:,=,'G!R,8/5VFEZ?I]D;*SL;:VM#G]Q#$J)S
MU^4#'- 'GM_:6"F[\0^'==^UZNVBW$=M#8B(+(@0LC,J#/RMM )[D"F^'[7P
M]K,'A/6+77P;FVVBWAMEB61BRXDC< ;B.I;/H37?:5H&CZ&)1I.EV=CYQS)]
MFA6/>?? IMEX<T33=0FO['2;&VO)\^9/# JN^>3D@9Y- 'G^C/>:%K'A^WOX
M+35M'NKN0Z3J]O\ +/&\B2-MF4]<J7R1Z9/-;/Q@MX9OAEJC2QHS1M R,PY0
M^<@R#V."1^-=39Z!I&GSK-9Z9:6\BYVM%"J[<]<8'&>^.M3W^F6&JVWV;4;*
MVO(,@^5<1+(N1WP010!PEYI\&C?%73_['LX8)I]$N]RQJ%\YU="N_P#O')ZG
MGFN>(AU'X KJ29_MJ$^<)P/WZWPFP>>N\MQCT..E>KC0])%[#>C2[+[5"NR*
M?R%WHOHK8R!]*:N@:.FH-?KIEH+MG\QIA"NXOTW9Q][WZT <;I\-NGQANWO8
MK9+EM#M7)*J/WIE<$CWS@9^E6OBS%"_@H231QMLO[3YG .T&= >>W%==+I>G
MSZC#J,UC;27L"E8KAXE,D8/4*V,@<G\ZDO+*UU&TDM+VVAN;:48DAF0.C#W!
MX- '$1S0/\7UT^X2'[$NCEM.C 'E[_-(FVCIOP #W 'UJ;X>02V=UXILHLC2
M;?5I%L5_A0%09$7T4.2,#@'-=1<Z%I-W:V]M<:;:206V/(0PKB' Q\G'R\<<
M5;MK:"SMTM[:&.&%!A(XU"JH]@* ):*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Y7QSK5QI
M=OHUG;3- ^K:I#8-.OWHD;)8KGHQ"[0>V<]J +P\1J?&W_"-&RF5_L)O1<,R
M[&4.$P #GJ>^.E7]+N[J]M&EO-/DL)1*Z"*217)4,0&RO'(YQ[UQ4&FK9?&H
M1PW5VR2>'7(\Z=I6C/GJ,JSDGWP<C-4=(U#Q'=?#HW%I)<ZI>1:O.LT9N/+G
MG@29P41^,-M Z8X! H ]0HKR35?$9N? .HW^@ZQJUK<1:K;QR6UX6$]H6>)&
MB?=EL?>;AOXNM:\HU3PM\1](MAKE]>Z=K5O=>>E]('6"2) _F+@ *IS@@8'Z
M8 /1**\KL-4U"#6?!<D6I7]Y%J,TT5U>2R$0WH\IG#1Q$G8H(X("\=,@U=\-
MVVH:GJWB*XO/$NII%I.M2"%3*HC*")#MD&,%.>G&,$]Z /1Z*\LT[4]0@UWP
M4T6HW]W#J33QW5W-(PAOOW3.'CB).Q01D$!>/4&FZQJ>LSZ?XNC%[?6_B*UU
M#9I-O;R,-T6$\K;&/E<,"Q8D'&3G&!@ ]5HK@IKG4KOQ4OA@S22BVTJ.Z?=?
MO;22N[LI;?$F2%V@<8'S<YXQT/A*VUFQT);/7;Z"^OH)&0S1.6)3JH<D#Y@I
M&3CG@]Z -RBO*_&VJW]IIGBK4M/U6]N+K3Y8S"]M(8H+':$)B<;MLK'))&UN
M&&<<5KWPO[_XJ)I?]L:A!83Z$UP\$$H0!O.5<J0,@X[]>N",T =[17E-LWB#
M4_AE>S6>J7TNJ:-J%RD3B=@]W%#*<QN1]XE!C/7./>NLT358?%.L6^J:==3G
M3+>R0[5E;;)+* P##.-R(!G/_/3VX .JHKD_%NKSV^O>&=#BE>"+5KJ19YHV
MVL$CC+[ W52QVC(YQG'K5.SEN[+XCWOA9KN[GTNZTH7\1DG=I+=Q)Y;*LA.[
M!Z\G@]* -.W\5RWUS;26&DSW>ES7<EF;R%P3&R,5+LF/]7N4C=GMTZ9Z![F&
M.XCMVD432*S)'GE@N,D?3(_,5P_PCLTA\$0SK).S/<W2E7F9E&+B0<*3@'W'
M6FZA81S?&S3F:6Z&=%FDPEPZ@%98QP < 'N.A[YH Z3PWXC7Q$NJ$6<MHVGW
M\EBZ2LI+,BJ2?E)'\7J>E;=>-/!=Q^&/B)JMIJM]9SV&M7=Q +:78N]8XVRW
M]X'&,'CVKJ'U;4-?\3+HR$+&FD07I1+Z2T9WD9@6#1J6(7:!C(&6YSQ@ [VN
M7;QGGQ+>Z#!H6IW%Y9PK/)Y;0!2C=""T@S]*N>$[;6++08[37KZ"^OX'9&GB
M8MN7.5W$@?-M(SQSU[UPVHSZW:_%/Q5<>'[>VN;Z+1;=T@N V)"&;@8(Y_G[
M4 =[X<\2Z?XITY[S3S*/*F:">&9-DD,B_>1AV(XK8KS?PI<:?H/PLU?Q+I,\
ME_<SI<ZG=/.H5FN=I+*RC[N"N,?XU<TVQ\12W6@ZU;ZG"MI(BM?";49)DNTD
M48*H4"HV2"-N!SB@#H?#GB-?$7]J@6<MJVGWSV3K*RDLRJI)^4D#[WJ>E;=>
M36^M3Z!H/CB]MG6.5O$Y@$K' B$A@0N3@XP&)S@\XX-=+%I^OZ3K<]\^J6]I
MI$EDZR0W-_+=;)E!82J9%&  #E<XP,T =I17F&DZE?V_BGP9%'>ZA<6VIVMP
M+FXNI&V7K)$'$J1,3Y8SDCA>#C&,5+I.MW-MXJL=-\1MJ=CJ3W<S07 F9['4
MD8/L1<':I 92%P#E1W- 'I507MR;.QGN5@DG,2%_*C(#-CL,D#\S7FUG+XF\
M6>&H]?TJ_@L[W[5)(LDNH2B%(TE93%) $V8VK@D\YYS6E:74OBRY\7>=>W=O
M'IMP]C;16\[1[-L8)D(4C>69CPV1A0,=<@'5>&]:3Q'X<L-8CA:%+R(2K&QR
M5![$UD/XW_XJ#4=%@\/ZK<W>GQ)+-Y)@P5<94KND!/?CKQ3?A?\ \DQ\._\
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MK;2W$[A(HD+NQZ*H&2?RKD]1U*6_^)-MX8>::"S72GU!_)E:)IG\P1JNY2&
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M^8@.%D&WH&ZX/-<Q9Z5X@AU_3+^'4XTTR2)TO(Y=1DN?M!9<H\89 J,#S\N
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M49 /:M=W6-&=SA5!)/H*I:/K6GZ_8?;M,N//MO,>/>%9?F4E6&" >H- &./
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MTFXT^:YM8[2%+N/RYS&I+,SKDXR2!@\X0'N*Z*_M%O["XLWDDC2>,QLT9 8
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M;2Y@PV22 LA+%R58 '.XYYSS3K3P38VVL6>KR7^IW5_:PM L]Q<Y+*Q!^8
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M#H#S0 2ZYXJOO&6L:'I;Z1''9PVUQ%+<12-E9"V5.&ZX7J.F.G.1K>/=<O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK XY'49H ZBBN/U'Q_;V.F:KJT=A-<Z9I5T;2ZEC=0^]2 Q1#@%5+ $DCH<
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M:%2W:5)9';NQ*< =@,Y/.<<5NT4 %%%% !1110 4444 %%%% !1110 4444
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M,@(J@ECC)P!T!]*X&>YMK'78]%739](B&B(EL88&EGN!EL6_F8; 3N!SDYR
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M^F2PQ]#Z4 7:*YOPAX@O->@U9K^*WAELM4GL5$))#"/ SD]2<GT^E=&2!C)
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M6B;&M;FV#(7!SN5T8M@@XYSSGM0!K449&,YXI,C!.1QU]J %HI 00"""#W%
M8,,@@CVH 6BDR-VW(SUQ5/.I_P!N 8M/[*^S=<MY_G;O^^=FW\<T 7:*3<,@
M9'-!8+U(';F@!:**;)(D,3RRNJ1H"S,QP% ZDF@!U%<CKGC"6VTOP]J>DQP3
MV>K:A;6Q>;<"(Y6QN4#OCU/X&NM!!S@@XH 6BD# D@$9'4>E+0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5S)#N7=L8C&1G/3MZ=L4 <;X5TC3%TSQ\%LK:)QJMY"C1H$94$:-M!&"!GG
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M[;3M*)3E9Y8EQ$C9Z@9R >I ]*]0C\-Z1#=W5U%9B.>Z01SR([*9% P%.#T
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M0<D'A=G;NW-9%WJ7BW0M"TF37X;B]AADF34YM)(:8)QY3D  X )W;<= >G!
M/2**QO"E_!J?ANUO+;5?[4AE+LEV1AG7>V PP,,!@$8'(Z5R(?6]3U_QQI__
M  D5]!#IOD-:F%(@R%H-^,[.5R?3)P,F@#T>BO*X-;U[^P/ _B2769WEU2\M
M+6ZM!&BP,DH()P%SNR <YZYX X$GC37M6TO3O$NHV>JS37.GS1-;I:*/(M4^
M3*3;N&=LMD#<0"IXH ]0HKC-7U"_T/Q]H\]SJ$QT'5%:T\EMH2"ZQE#G&<,
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ME7/UQ@XQIWFK:OI7B37O#JZC</#_ &*VJV-TZHTMNRL49"2I##(!&X$]1GT
M/0ZI:MJ*:1I%WJ,L,TT=K$TKI" 7*J,G&2!T'K7G5CJFNVNG^ -9FURYN3J[
MV]M=VSH@B99(6;< %W;@5!SGDD]!Q5FYO[OQ9X6\9WW]H7%K'9/=V5M#"0%
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MS>>)?$EKK9T:[FBO-/O9+*UD\Y$C#Q8!,B;3NW')/H", =2 >CT5QFG:E?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD\$GH1GH>,YSX? -C;V%SI,5[=KH=S,97TWY-@RVYD5L;@A/5<]SR <5UE%
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M\;_,#G(P>0<@UZA10!R]MX)M8];N-5N]1OKZ>ZL18W*7!39,F6)RH48^]T7
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5SGC;7+_PWX?;5[**"6*WD3[4LJL2L18!G7!&=
MN<X[C/2NCJO?64&I:?<V-T@>WN8FBD4]U88(_(T <VOBF>/XB+X=GDLQ:S6!
MO;>50=SX."A.[&0/FSW'I7/>(;W4;Z;P+?R16[W$^K.\"+F-2AADV%LY(RN"
M>N,XYQS9_P"%:S2>&-&L9M3+:G8W*O->C(:2+9Y3Q@]LPX7ZJ#[UN^)=!O\
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M V]*FO)]-ADOTA2Y.=XA.4/)P5/H1@_C7.?\)+JNJ6^MW>A0V;PZ5<26PBN
MQ:ZDC +A6! 09.T$ALD9X%:?A#0&\,>&+726F\WR"Y&"2$#.6"*3R0H.T$^G
M;I618^&=9T"\UV+1Y+*33]5N'NT^TNZO:S2##X 4AUR 0,KZ9[T 8?BK7IO$
M?AGP;J^E2116E_K%BWES(2P?S,@-@@$!EY'?'6O0X;1X8)I42T2_F4&69(L*
M[@8!89R0..ISCO7):AX'N8?#GAG1-%>V\C1;VWNF>Y=E,OE$DC"J<%B2<]O2
MNW0L44N &QR%.0#]>* /&+Z_U75/@!J=_JEQ%</-<%@4C*MD7N#G)(QP, 8P
M.*[VV\0ZQ#XW70=3M;$1W5D]W:M;NQ9"C*I1R1S]X'( ^E8+^ M>_P"%<WWA
M);O361[@M;S$N"$,_G9?@\_PX''?/:NAN=#U6X\=:;K^VS6"ULI;9XO.8L2Y
M4DCY,8!7'OGM0!DP>.YX/">K:O>6=M;-9:P^GR&(,\<2B54:5\8+ 9+'&,X[
M=:ZC0-0N=2AFGDN+&[M2P-K=61^29"HR<;FP0<CJ>E8.C>'/$&CZ7J<4;Z:\
M]WJ\M_L:1S&\4K9>)ODR..,X/KCL;OA/PHOAR^UBZBBM[.'494D6QM7+0PE5
MP67(7ECR0 !P* $\;7=I)9VNA7=[':QZJYCGD>41XMU&9<$^HPG_ &TSVK*^
M%&K?:/#MQH,UU'<W6@W#61E1PPEB'^J<$=BO'_ :Z*STV_/B:_U'4([-H'B2
M"T"2,S1HI).05 RQ.20?X5'.,UEGPUJMK\2F\1Z<;&.PN+-;6\@:1@\I4DK(
M,+@,.GN/3- &=J?CW4(/#NO^(+*UM7M-'OWLVMI=PDE",JLV\'"\MD#:>!UY
MXM:CXE\3Q^)K70;+3M*^TW.FR7:22SR%%=648/R@[?FQP,\CI7-6<&J:M)JF
MMZ8?"U[IES?/<?Z9/-#D1MM0R(N4R-@(+#/ )P>G4V6GZMJWBO1O%C06MO -
M,:WEMVF8R R%7)'R8(!7CID'MTH @O/&&L/;:G_9MG%+>:7B*6!;2>9;F<1J
M[HCH,(/F"@MDD]0!R;#>,+J^F6SL;5[.\6QANYUNK*:<PM+NVQ,L>"#\K9)/
M'& ><0OX;\4Z/XHU*^\-7^E_V=JL@GN;;4$D)@FVA2\>S[V0!D$CIUHU'POX
MCL?$4.N^&]2LY+J2T2TOX=3#;+@(25DRG(<9/'3F@"NGCG7I(O"^_0$L[C5I
MY;>>"\=XWB=%8Y *_=.T'/)P>E26WB7Q7=7OB#2([32/[1T@QN9RTGDR)(F]
M %^]NX()S@>]6]1\.:W>ZAX;O'NK.>73;I[JY9V:,.71EVQJ V% ;C)SQSSD
MU)9Z!JUIXF\3ZKBR:/5HX5A3SG!0QH4^;Y.^<\=,=Z *]MX[^WZ'X<N(+?RK
MS6X&F"^4\ZPJB@N=J?,V"5 Z=<Y&*S[_ ,>>(--\,ZM?3Z(HGT^\B@666*6"
M*ZBD=562-7&<Y;E2>,=33(O 6O67AGPRNG:A90:]X?#I#(^Y[>XC<8=7X##(
M Z9QC\1H:]X;\3>(O!]SI]]=Z:-0NI86(B,BP0K'(KX7(+,25Y)QU'''(!:M
MO$&N+XSD\/7]OI\;7&GO>V<L)=PA5PA23.-WW@<C'>HOAA?ZKJO@V&_U2YBG
M>:>Y(*QE6S]HD!SR1CC@ # XYJY)H>IR_$"R\0$6BVT.GO9O&)6+Y=E<L/EQ
MP5Q[]>.E8MEI/B?P9X%N;"QO-(:6VG=[-YTD(='E:0A@.=YW%0JYY[\T =Y<
M0BYM98&9D$B%"R'!&1C(/K7)0>"]4@T_1(?^$JNC<:7.6\_[-&/.A./W17H.
M !NZ]?6NMM7EDM(7N(Q',R*9$!SM;'(S[&I: ///$>NW_B#P1XON-,6T73K2
M"[M/WRLSS[$(D92" H!R!D-G;VS4^GZ[=:</A_I:VEM);:E:!&G=B9(REMO^
M48P,XZY]>*K_ /"%^(=/TWQ+H>F7.FR:1J_VB2!KEI%EMGF4AEPJD,N3P<@C
M/0]*NCPIK*W'@R0S6$G]@HRS'<Z>;F+ROE&#T'/)Y]J );'Q?<:KKMYI]G-8
M+<65_P#9I].F5EN/)# &93N ((^887&.^:H-XL\7WTGB*/2M)THR:-<F,K-.
MY\Y0BOM7 'S'/4X X'/)%G5?!U_KM_:3W\6G)<6>HBYMM3A=A<) )"XCV[ /
MN_(?FQWP:S_#@UA_$?CN+34LB)-2"B2>5E,3^2@W;0IW#IQE>G7G@ U;3QE=
M:SI.C:G816UCI]]:-/->WIWQPR A1#M#*2Q8MSGHO3GC-7XA:I<>$/#6M6NE
MVK2ZKJ26$T33, C&1D)7CH=A//3(X-6;7P/J.A:EH#Z+=6DMEINGM9&*^5CL
M9F#&= O\9Y!&1QQGFJ%KX#\06OAC1-(^U:9*=+U@:BK[I$WH)7DVGY3R=_X8
M[T ;\FK>)K,6L.I1:3:;_.:?4 S/;Q $"-=K,K%FSZ]CU[9]I\09KGP9HVJF
MSB2]U/4ETQ5W$Q)(960N>^W"$XZ\@9[UI:SH6M7/B[2M;L)[)HK:WD@DMKO>
M5C9R#YL>WJV!MYQQD9&:Y&\T/4- \(6'A6ZU#1GNKW57DM1<(ZQ2()&G(9L@
MHW3&WD' !.<@ Z6+Q=?VGB+7M.U2"T-GH]HM[+=PEE9HV5FP(SD C8P/S<]:
M9;>+=:DU'1F.E27%AJ1"S"&RG5K+<,JS2,-KKV) 7'7FJNEV6IO=7V@:Y8Z,
M8M7M9!<7&G7<LLV-NS,GFC)&#@')P>,5<\,:+XRTN.UTO5=5TV?2K+:L5Q!&
MXN9T7[JOGY5Z#)&20,=\T 79/ VCRZ1=Z:]I:""\NOM,R):J%4[0G[M>B-M4
M#<.>2>IK6U_5&T7P]J&J);O<M:6[S"%.K[1G%:-4]4COI=,G3398HKTK^Y>4
M$H&S_%CG% '*MK<NN>%-;N(;[3=1TQ],D:*YLU*_/L;<C*6;&!M/8\G@8K)\
M,>(=7T?0_ =O<6MF=*U*U@LU*NQG1_(W*Q_AP=IXZCU[5H+X(N5U#6]2M;73
MM.GU+36LWM;:9C#)(Q/[YSL'(!P,+SDY/-!\(:S_ &/X,L@UANT"6%Y6,SXE
M$<9C^7Y.,@YYZ=/>@ U[QKJFA">[N;:SAABU!+:.RD),]Q SJGGJP; &6) *
M]NN34S_\EPB_[%Q__2E:RM0\!^)+O2-=TU+_ $QTOM26_AN9ED,K@2JZQR8X
M 4+@$9X &!71)H6K?\+ A\0R/9/ NEFP=5=E8L9 Y<#:0!D8QGWSVH I?#?B
M'Q1_V,E]_P"ABK>J>(=8@\;VOAZQM+(I<V,ERD\TC95E91R .GS=!G/J*F\'
MZ%J&@IK"WS6S?;M3GOT,#LVT2'.TY4=,=>_M27FAZC-\0+#7HC:_9+:RDM61
MI&$C%V5MWW<<;<8SWH YP^./$_\ PBVM:JNGZ4)=!N9X+T&23;/Y6"WE#JOR
MD'+$\]JWKSQ9)-J$6G:: D[6*7KRR6DMP$5R0B[8\')VMDDC&!P<\98\&ZR?
M"WB[26>P$NNW=Q<1N)GVQ"50,'Y.2,?CGM3KKPKXEL]3TW6]!N]-CU&*P2PO
M;6[+M;SHARK!E&X,"3V[_F 6;+Q5KE[HVF7%QHXTF2666._GOE*Q6H0'#[6*
M,P<X Y&,\].<V7XB:DO@>ZUN&QLYKBSU0Z=, [*CXF6,.@Z\[@<$\>IK2U'P
MYXCN=0T#4UO["YNK&2:2YMYU=8&9U #1@9(* $#/7).02:R)O /B!_#6LZ0;
MS3)#?:Q_:*28D3 \U92",'DE<8[>IH Z'3O$&KCQS)X>U:VLE66P-];26KL=
MJB0(R/NZGY@<@#Z56^(M_JMA8Z-_9ES% +C6+2WF+H6+!I!@ @C R.?4<<5<
M;0]3?XA6WB%OLBVT>FM9/&)6+Y9U<L/EQ@%<8_'CI4OC/0+OQ!I5I'8301W=
MG?P7L7GYV.8WW;6(Y /M0!&-<U"]\07.@6#V:W=A:QS7EQ+$S('DSL14# \A
M222W QUSQ-X1\2'Q)IMT\]L+:^L;N2RO(5;<JRH>=I[J001]:H?\(YJ^G^+I
M/$>GR64TM]:I!J%K*[Q(S)]R1&"N1@$K@CD=ZU/#.@?V#:7ADD62[O[R6^NG
M087S'/1<\X   ]<9[T ;=%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8
MWB7Q):^%M,74+R"YEA,J1'R$#%2[!03DCC)% &S17*_\)Q$-;FT=M$U9;\0?
M:;:$QQYN8]VTE3OPN#UWE<9'TI;?QWIL^@+JGV:\1S?#3C9LB^<+G?L\L\[0
M<]\XQWH ZFBN'\1ZY;:YX/\ &>GM;W-K?:78R^=%(P!4F$O&RLC$$'KU[<BK
MWAK6D32- TN&TN;J8Z9!)-)#LV0#8N-Y+ @GL "3@^E '545R^J^.M/TFUEO
MYK6ZDTJ"X^SSWT80QQMOV$XW;BH;Y20#SZUTX(8 @@@\@B@!:*PO$'BNS\.W
M>G6UU;7DKW\IBA-O%O&X*6P><Y.. ,UF6WQ$L)K;6FFTS4[6\T:+S[NQGC19
MA%@MO7Y]K# /0_TH Z._T?3=5:%M0L;>Z:!P\1FC#>6PZ,N>A]ZNC &!VKGW
M\6V2S:!&;:[VZXH-K(%7:I,9DP_S9!VCL"/>N(\/>)HO"B^,';2M5OK:#7KA
MYI+6/S!!&(X^6+,,XP>!D@#)P,4 >KT5Y_K=S:ZCX]^'NIV4QE@NC=/&ZL=K
MH;8E3C\?3-:-IKOA^RUGQ?>BTN;2YT](9-4GE!Q(!&Q0H-QZ(.P&<T =?17,
M:IJ?]IZ1JEC<:=>6N[3I)UD=TVNN#]UD<\CC/U'7-8'@CQ;!8>%_!VFW5A?I
M'?6D-O#?,B^2TWEYV?>W<X.#MP>QH ]&HJMJ.H6NE:=<:A?3+#:V\9DED;HJ
M@<UCKXMMX]3T^QO["]T]M1!^R27 3;(P&=AVL=KXY .,_7B@#5ETK3IM3BU*
M6PMGOX4*17+1*9$7T#8R!R?S-7*Y33_'5OJFIR6-IHVKN8+]K&XE\A=D#A0=
MS'=]WG&1GISC(SN:KJ]OI,<'FK))-<RB"W@B +RN03@9('0$DD@  T 7Z*YN
M/QKIRP:P]]#<V,FDNB7,4R DEP#'L*DAMV0!@YSQ@5-'XI@76X-(OK&[L+RZ
MB:6U6;8PG"C+*I1F&X#D@]NF: +&H>%_#^K7:W>HZ)IUW<C $L]JCMQTY(S6
MHB)%&L<:JB*,*JC  ] *XJ3XFZ?'H]QJW]D:N;"TNGMKN;RD'V<JVPLPWY(S
M_=R0.N*U8/&%O)XBAT>;3M0M7NH9)K.>:-0ERJ8W;0&+ @$'# '% '14C*KH
MR,,JPP0>XKBI?B981Z5>ZH-'U=[.PNGMKR01(/(*,%9B"^2,G^') &2!Q6G#
MXQMI/$-MI$FG7\#7L4DME<2HHCN0@!8+\VY3@@_,%H UM.TC3M(C>/3;&WM$
MD;>ZP1A S>I [U=KE)/'VGQ^&=4UYK&_^SZ9<R6MU$%C\Q6C;:Q WX(!]#^%
M3WOC*VM/$":(FFZC<WLEF;R)88UVR*&"X#%@ <MU.!QUZ9 .DHKA-:\6^']7
M^'%[JNJ:9?S:8)#!>687;+'(D@4JV&&,.!R&KI;[7([34%TVVM9[V^\CSS!
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MW&EV4S0W-["J%$*G#D+NW,JG() /0XS@TS4_'5EI^JQ:;!I^HZA<3V37MO\
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M* # ]*3 ]*6N=TKQ!=WWC37-#GM88HM/BMY(I$<LT@DW_>R!C[HXY^IH Z'
M]*,#.<#/K2T4 -"*H "@8Z8'2EP.>!SUI:* &LB.A1U5E/52,@TH4!0H  '
M '2EHH 0CC@#/:J&FZ4EC<7=V[>;>WC!IYL8R%&%4#LJCH/<GJ36A10 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"",': <<C@^O>@#A)))M%\2Q-KFFQWNGW>L$V6NV; R1.TI"PS \[0?DR.
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M[G3-(AL[68&U8EH'DC<,T8/1B0OXU:T>U:R^)MI9+:1Z?;76@.TEM!+RY65
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M>.Y@VE)"HYNP#D X/!/6O6!X=TQ=4GU)89!>W$7DRS"XD#,G9?O=!V]*J_\
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M6)+=C?P)LBF$KC8IZJ #C![C'-1-X8T=[R_NVM6:?4(O)NF,S_O4P1M(W8P
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M">$],T11H<]IY$E_)=@B!"2K1B-LLQV?=[9(["NKBBC@A2*) D:*%55&  .
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MX&3UX'('%,TGQ1=2^*H=(UF_O-+U87DI^QW$*BWO8/GV>2^WG *'[P.00<T
M>B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEU<PRM>C4&O%VF1KD/O\P@C:>1TQC'':ND@A>"U2)IWF=5P99,;F/J< #\
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MIK.F(Y+>X8[MT9'3!Z9]ZL)X,N)="O\ 3]2\0WVH3WMLUHUU,B QQ,,,J*H
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MTYJ?0O"VO:1X4M=&NX-(U" 7,[75O*S;)HI'9QU0C<&8<8QQU[U4F^'VI1>
MKSP_IS6D8N-36\A@EN',=I$)$<1*VTD_</88+'TY .DG\0WMGX]M-!NK>".R
MOK:26UN@QW22)C=%CH" =V<]!6CHFHW.J17=Q+'$MNMS)%;LA.9$1BI8Y]2#
MCV&>]<]X^MXM7TJTM+>_BM?$$%Y;R67E.'DBE+8)QP2NPN3D= 3CBMT6>HZ:
MVC6.D1V8TJ!3%=>>6\T(J83R\<$Y'.: -BBL_3CJYN;_ /M);,0"?_0OLY;<
M8L#_ %F>-V<].*T* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** *6J:/INN6@M=4L;>\MPXD$<
M\8=0PZ'!^I_.K:(L:*B*%10 JJ, #T%.HH **** "BBB@ HHHH H+HFEIK+Z
MPNGVPU)T$;77ECS"HXQNZ]/Y5?HHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ IDHD,3")E60CY6==P!]QD9_,4^D9@JEF("CDDGI0!RG@KQ%=ZGX,DU?
M6I8O-AGN1*\2;4"QR.O R>,+ZFL;_A,=4MO!MCXWNI%&GW$\;36.Q<0VTDFQ
M6#?>+C*L<G!Y  X-)\/X(]9^%^I6$$Z%KB?4(=P;.W?+( 3^!!K#O4?5O@?I
MGA.(;=8G:WTQ[4_?C>*5?,+#J %0L3Z8/<4 >Q451@U;3YM5N-)AND:^M8TD
MF@'WD5OND_7%7J "BBB@ HHHH X3Q_X\N/#E_I6@:-;Q7&O:M($@$Q/EPJ6V
M[WQR><\>Q/;!NZE9>,--T"XN;#6X]2U*.(L8;BR14<XY$83!!]-Q;)X/K7"_
M%33;O1OB5X9\<F&2;2K0QPWC1J6\A0['<0.Q#G\1[BO4#XIT0P0RP:E;W1GP
M(([:02O*3_=5>3_(=3@4 2ZGXBTC1YEAU#4(()6C,NQF^8(.KD#D*.['BDO_
M !'HNEVEM=7VJVEO;7./(FDE 23(R-K=#QS7ELI?3?B]XYN-8D$<-QH9:T>4
MX5X@J A<^A!R/7-</KEO>6?[//A>#4\HSZOYD,<O#"$B4C@]N<_0B@#Z'T_Q
M3H.JW-W;V&K6ES-9C=.D4H8H/4^WO7F5I\0->\4:GXB.C:YI.FP:3=8C2[3=
M'+;+N#2,0"WWMAR"  :ETF6W3]IC5EBDB5#HZJ I&#@1''Y#\A61X+N8/L7Q
M>;SH\&>Z8'<.01-@_2@#TKPSXA,/@*UUCQ+KFES, WG7UM(! WSD  \ GH.!
MUK!TKQU>:E\8)/#]K?076BM8FY0K&-ZOQ\N1Z<\$9KRTM(OP<\ 7;$MI=GK#
MO?XY"?OF*EA]-W7U'K7:66IZ?>?M)RW%C=V\L<ND[$EC<%)'P.A'#=.V>A':
M@#U7_A(M'_M,:=_:5O\ :_,\KR]__+3&=F>F['.WKCM52[\:^&+"6ZAN]=L(
M9;3_ %\;S -']5ZUXKX#@T_5]"F\-^(]<O+#6K'6C=_8D"":6<'AERI9CG=G
M'3&>!S5Z>2U;XK_$]Y&A.-"D"LQ'!\F,$#^1H ]/\5?$#1?#/A'^WS=174<Z
M9LDB;=]H;' !';U/;Z\5GZQXLFNM2\+_ -A^(=%AMKNZ"W<5P_SW"Y4;(O5L
MDC YR5KR?4 T_P"RKI7EYD\F]8R;>=@\Z7KZ?>'YBNH^(^IV-[XF^%UQ;7<,
ML']I*WF(X*X$D(SGTR#S[&@#U34_%&AZ-(\>HZI;6[)M\S>W^KW?=W_W0>V<
M9KE/B!XMU3P_KW@^+2[B$VNKWRV\ZL@<,A9.5/;(8_I7G/CO5M-EOOB)I^G1
MR6EPT4+78DWR/>.C#E%^[&BCDGJ<C&!4OB"]MI="^#;K<1L$FM]YWCY=ODAL
M_0@@_2@#U"S\078^(&MP76NZ.VBV=H)%M%;%S PV[FDXX7D]^ZX[U'X>^*/A
MS7;+4+U]0M[2VMKAHT,[[2T0V@2,#T!9L#\.]<MH,L;_ +27BU5D0EM+15 8
M<D+!D?7BJ_P1MK#5OACJGAN^93++<SI<6Q^^BLJ+DC^$YZ9[@XZ&@#U:/Q#I
M$MM9W,>HV[P7K^7;2*V5F;T4]SP?R-:5>._"Y]1TS3=1TO7HV^R>#Y[C;-M)
MWDJ2"HZG:AD/TE7TKTGPMXGT_P 7Z##K&F"86TK,H$R;6!4X.1DC\C0!A+X@
MN-7\=ZOX=36!I4FGI$8(5B1I+K<FYG^<'*C(&%P>"2>>-C3=5GT_2(CXHOK*
MWO7N980YQ"DO[UA'M#'NNTXR>M<]XCTSPCXVU34-,U22.SU?29%6*ZCF$5Q&
MIC20.K=U!<C'(!':N6NKW5;CX/SRZQ=F^CT_6XDAU$C_ (^;6.X0"8^H^]SW
M SD]: /69=0M9KF?3+?48$U)83)Y096D1>F_9Z9(YZ5RO@/QM::EX8T--9UN
MS.N7T1<PO(B22'>P&$&/3CCM52'6=-OOC3%):7UO/')X>>..2-PRR-]H!PK#
MACC/3/0^E<A:6.GZE\ ]/TVTCMWUUY52VCCQYZ7(FZ\<@A022>B@YXH ];BN
M5D\630IKL,@2T&[2E"%HVW?ZTD?,,@A<'BITU_2'U)=.74K4WC%@L(E&YBOW
M@!W([@=*Y"[BN#\6]26T(%VWA51&PX_>>?( ?SQ6!X6O/#.O:%X;T^]U&]?6
M=,FAQI98)-#<Q_*S;0H;:/F)).,9SS0!Z=<Z]I-G>+:7.I6L-PS*@C>4 [F^
MZ#Z$]AWJC;>+])NO%=YX>BNHOM=K&C/EP-SL6^11W("Y..F:X7P_K'A^30M8
M\+^*Q&^JKJ<[3V,N1+>,TI>)HQU;(V 8_NCM6[IEY;VGQB\0P7$R13W=A9>1
M&S?-+CS-VT=\=\=* .A\2^*=.\+6MM-?RJK7-S';Q(6QDLP!/L%!R3[>XJY<
M:YI=K;Q7$^H6R13*6B8R#YU'4KZ@>HKE_BC(D&@Z5<RL$@@UNRDED8X5%$HR
MQ/8>]5K'5(H?BW?RWMP@M-0TN$Z5<,V(W1&8R*C="26#<=1@]* .[MKJWO;:
M.YM9XYX)5W)+$P96'J".#6)_PEVE2^*I_#<=Y$M]' '9BPX=CA4 /WFX)([<
M5D_#:TDMK+7GCXTV?6;F73P/N^22.4_V"P8C''?O4,=[:V/QIU!+J>.%[G1[
M<0*[8,A$LF=H[X[^G6@!W@KQE#/HMO'X@UNT_M2XOKB"%962)I0LS(H51CT
M]_K75ZCK6F:0H;4;^WM006_>R!?E'4_3WZ5XU))8K\"M7G1[<2_VRS[P1G<+
MT8.?7;^E='?:QING_$+Q#9^(]7DTVUU"W@>RF9E6&>$1[73<RD9#%CC/\1H
M].26.6%9HY%>)E#*ZG((/.0?2L>7QCX:@,?FZ_IB>9*84)NDPSC&5'/49&?K
M3_"UE8Z?X8L;334G6PCC(@%P27,>3M)SS@CD \@$5YI80:%/X+^(L-Y':M*=
M5OU*E09-V?W04=<[ONX[]* /4+_Q'HFERR17^K65M)'%YSI+.JLJ9 W$$\#)
M _$47/B+1K.*.6YU2TBCDC$R,THP8ST?/]WWZ5YWI=G'%X[\'Z?K(@DOH_#+
M13I-AB9/W8(.>IQO^O-:GANZMM.\8>,].UIH+=I)(YH!.0B268B"J%SP57#
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M\GF_877RG!WXB(8C'7!X)J?7+IM.^+.@7.H,$TN:PGMK>5SA$NF96Y/0%D7
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MLVJWHW#;D_=*_KG'O0![515/295GT>RE5Q('@0[@<Y^4<YJY0 4444 %%%%
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M/2I:;(7$;&-0S@':I. 3Z9[4 ,GMH+E EQ#'*@.0LBAAGUYI[QI(H5T5E!!
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MQ!97.[]X"0"=V<GKU-4Y/A]X;DU^76?L+K<S.))D2=UBF<=&>,':Q[\CGJ:
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MQRL#N\WYB3N X)[Y&:\Z\/ZK/9?#GP/IZ2R06^J:O):W,J,5.SSIFV!AR-Q
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MN[66UN$$D$R&.1&Z,I&"#^%8">!- 2RT^T$%UY.G3+/:@WLQ,;J,*<[LG X
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M 8<@XP/:NAH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "L3Q9H,GB?PW>:,MXMK'=IY
M<DGE>80N0>!N&#Q[UMU'-<06X!GFCB!X!=@N?SH YXZ%KK:5%IK:_;I;K&L3
MO#8%)60  @,92%)'&0.,\4ZT\-W5EXIU?7(M0AW:A#%#Y+6QQ&(PP4YW\_>.
M>F?:MI=1L78*MY;LS'  E4DG\ZLT <*GP\GC\#Z?X8764\JRN4G6<VGS-MD\
MP C?C[WZ?G5'2GNI_BWXL2PU2SBF%G9*ZR0^:'(5\D .I!'U/WN:](I@BC5M
MPC4-Z@<T <C=> HVT#2=)LK\P+87Z:@TLL/F-/,KER6PRXRQ)./H,5<;PM<6
MOB:[UW2-1CM)[^)([V&:V,L<K(,(X =2K <=2".W>NEHH XZZE\,^"= AT'4
M9GD&H"<+$T3/)>R-S(,*,;F+]..H J?0O!MI:?#R+PQ?*\D<UJ8KK<^6+,/F
M^;VS@'T45U$C1HADD*JJ L6;@*.YSVIEM<P7EM'<VLT<\$JAHY8F#*X/0@C@
MB@#E_#WA'5-*$-OJGB:XU:PME*VUO);)&0,%1YCC)DP"0,X'?!(&*VA> [[0
M9%L8?$UU)X>BDWPZ:\";D&=P0S?>*9[8''&<9SVU% %;4+"UU73KBPO85FM;
MB,QRQMT92,&L#1_#FN:'9QZ;:>(HIM.A&R$7=CYD\:#HHD$B@X' )0_C7444
M <UJWA%+Z?2;ZSOI+75-+D=X+J1/-WAQB19%R-P;V(QVQ4-YX-:_L=>$]^AU
M'6K<6L]RMOA8X@I4*B;N/O,>6/)], =710!RDGA"ZDN/#,QU2('0@0@%J?WV
M8_+.?GX^7]?RJQIOAN[T[Q1K6M?VE%(=4$0>$VQ C\M2J8._GKSZ]L5T=% '
M"#X;J_A,Z)-JS^='?G4;2]AAV/;SERX;!8@@%B,<<'\:NP>#K^7Q+!K>K:VM
MY*E@]C+#%9K%'*C,&.068C.!GGZ8KKJ@N;RULU1KJYA@$CB-#*X7<Q. HSU)
M/:@#D?#_ (&U#06BLE\475QH-N^^WT]X$#( <JC3?>90<<8'3'3BG#P-<_V)
MXFTPZO&5UZ>6>5_LAS$9%",%^?GA1C/ZUV9( R>!4-K=VU_:QW5G<17%O(,I
M+"X=6'L1P: .:?P?<'4-!OXM7,-SI=L]H[);@B>-@N>"3M;Y1SS]*K7G@$Z@
M/%27.J'R_$*H)!%!M,)1 JX.XY& ,@]?:NTHH Y"U\':C'XBT[7+KQ"\]W:6
MCVDBK:(B2H2K# R=O*C/)SV*UH^%?#LOANUO8)+U;H75Y+>9$/E[6D;<P^\<
MC/3^M;U% '->(/"]SK?B#1=5CU*.W_LF5Y8HC;%]Y9=IW'>.,>E+;>&;NU\2
M:WK,>I1%]4ABB,;6IQ%Y88*0=_/WCG^E=)4,UY;6\T$,]Q#%+<,5A1W :0@9
M(4'J<#/% '&'X?7 \$:7X93646+3YXY5G-IEG\M]Z@C?CKU]?:M6]\+SR^)+
M;Q%8ZA':ZHEN;6X+6YDAN(L[@"F\$$'D$-]<BNBDD2*-I)'5$499F. !ZDTR
MWN8+NWCN+::.:"0;DDC8,K#U!'!% '(ZEX!%_P"';W3$U$17&H7JWUY=FWW&
M2165@%7<-JC8H R>!Z\UI:[X<N=;O-$N3J$4+Z7<BZP+8L)7VE?[_ PQXY^M
M=#4$][:VKPI<7,,+S/LB61PID;T4'J?84 8=IX;N[/Q/K.MQZC"7U.**/RFM
MCB/RPP4YW\_>.>F?:L6Q^'-SIECX;BL]>,=QH7G)#,;0,LL<OWE9"WWO1@?P
MKO:* .%;X<%_#NNZ/)KEPZ:I?&^21H$S#)O63)QC=\RCT&.PK4N_"][>:YH&
MJS:NKS:3YQ(-J/WQE7:W1AM '0<X[DUTU55U.P>[:T2^MFN5SNA$JEQCU7.:
M .;B\%SV#ZQ!I6K"UT[5I'FGMVM][12.,.T3[@%SUP58 _E4H\&K!KF@WUC=
M1V]KHMJ]K!:^06W(X4'+;ASA1CCUSFNH5@RAE(*D9!'>EH P/#?AV;0;G5Y9
M+Y+D:E>M>LH@\ORW8 $#YCD8455O_"$]SXGO-7M=9EM8[ZS6TNH! KEE7=M*
M,?N'YCG@]:ZFB@#A[#P!=6-OX8B&N"4: S&(O:#]X"A3'## "GW.><]JDN_A
M]#JC^)UU*^\ZWU_RC)''#L:%HU"HRMN.<;0>1U'IQ7:44 <7'X,UB;4M!OM3
M\3FZFT=Y#&R6*QF4.FP[R6;YL9Y'Y"NFUBQEU/1[NPAG6!KF)HC(T>_:&!!(
M&1SS5ZB@#B1X"N5\.^'M'&L1[-$NH;F*3[(<R>5G:K#?TYYQ^E:UGX=GMO&5
M[X@>_1_M=M';-;B KM5"2I#;CSECGBN@HH P=,\*V>E^*-6UR%W,FHA"T1^[
M&P #LON^U,_[HK);P-?VFOW]]HGB:YTRQU&7S[RR6W24-(>&>-F_U9/?@\_A
MCM** .;A\+S6WBY]=@OXU7^SUT]+9H"P5%8LIW;\DY//J/SK*C^'DD?A2UT8
M:SB6SU(:E;70MA\L@E,F&4M\PRQ[CM78WE]9Z?")KVZ@MHBVT/-($!/ID]^#
M4D$\-U D]O+'+$XRLD;!E8>Q'6@# ;PS<OXMT_7GU,.UI:/:F)K?F0.068L&
M !RHQ@8%9T'@)K/1[_P_:ZKY?A^\=R;4V^98DD.7C23=@*<GJI(R>:[2B@#G
M%\+R0^,(]>MKR**.+3O[.CM/LY*K'N#@[MPYR!VZ?G4OA3P[)X:T^YM'O5NA
M-=2W6X0^7M,C%F'WCD9/%;U% &1I&DW=AJ.IWEW?1W3WLJN-L!C,:JH54!W'
M*C!/U9CWK.@\)W-KX[O?$L&II&M[ D%Q:"V^5PGW6+;_ +X'&<8QVKJ** .5
MMO"$[7VAW>JZE%?3:.&\B9;7RI7)0I\[;SD8))  R<'VI+?P?.]YH=SJNI17
MLVC;C;S+:^7*Y*%/G;><C!R0 ,D _7IYIXK:%IIY4BB099W8*JCW)I+:ZM[V
MV2XM9XIX)!E)8G#*P]B.#0!P&L:3+X2\'^)7DU28KJ]ZT[W%M:E3:-,51G/+
M?(H&3QG //(Q5\,S7,&I6Z:'XMT/6H9'59[:RTR.,K'W=GB?"[1R PYZ#DUZ
M=3514&$4*.N ,4 <1)\/IY?"&M>'WUA/+U6[DN9)A:?,AD?>P W^HX_K6JGA
MJ\'B^'Q"^I0M+'IYL#"+4A2I<.6SOX.X#\/SK8N-6TZTNDMKG4+6&X?&R*29
M5=LG P"<G)JY0!P[?#^>3PCK?A]]83R]6NI;F286F"GF-N8 ;_7IZ>]3:GX)
MOY]8M=;TGQ"^EZLELMK<RI:B6*YC!R,QLW!!)P<FNLFNK>W($]Q%$3T#N%S^
M=,34+*1PB7ENS,<!1*I)/YT <]<^$)Y]0T&\&K,TFDRR3LTT&]KB212K%B&
M PQP ,#CL,5$_@<W$GBO[5J0>+Q%$(Y5C@VF'$?E@J2QSQZCKZ=*ZBVO+6]$
MAM;F&<1.8Y#$X;:XP2IQT/(X]ZGH S='TZ\TS1(;*;4!=W$4819VA"+P !\@
M/3CU]>1V9X?TFXT;3WM[F\2\F>>2=YQ#Y9=G8L<C<>F<#V ':M6JIU*Q4D&]
MM@1P095X_6@#C1H5UX)L/%6KQ:A-<V]\9;TV=I:;7BE(P6C.YN3P3D'IFN=\
M.RS6?V4Z!XWT36+C"*UE%I<8FF7(SO=&WKZEF''4UZU#/#<*6@ECE4'!*,&&
M?PIRHJDE5 )Y.!UH P=#\.3Z1KFM:C)?I<+JLRS/$(-GELJA!@[CD8 [=:R-
M(\ WFB3O9V7B6Y3PXTK2#2C;H2@)R467[P0GL!G'?DFNWHH XMO U_:>(+Z_
MT/Q-<Z99:C+Y]Y9+;)*&D/#/&S?ZLGOP>?PQH0^%Y;;Q?_;T%]&JKIRZ<ELT
M!;:BL6!+;\DY/Y?G7244 <*_P]GD\$:CX9;6$\J^N7G:<6GS+OD\Q@!OQ][I
M[?G5G5/!>H3Z^FO:/XA?2=2D@6WO"EJLL5RJ_=)1FX89.#D\?KU;WEM'=Q6C
MW$*W,JL\<)<!W48R0O4@9&?K4U '+3^$9I-8\/Z@FJL6T@S-^^AWM</*I#LQ
M# #J2 !@'VXJM+X#-U;>*K>ZU/?'X@^:3R[?:86V! 02QR, <&NRHH I:39W
M-AIL-M=WIO)T4*TWEB,' QPHZ?F:P?#FG'PUKVM6#C%IJ5ZVH6DG8NZCS(_8
MAEW =PW'0XZNB@ KEI_",UKXCN==T#4ETZZO0HO8);?SX+@KP&*AE*MCC(;G
MN*ZFB@#-M[&^3?/<WT<UZ4V(RP%(8QWPFXGG SECTXQ7/:3X&NM)\$7WAE-8
MCDBNA,//:TPR"7._C?@GYCC^M=G10!R<'A&_M_#NBZ*NKPFWTQX22UF3YZQ8
MV*W[SCD G'4@>^;OC+PR/%WAN;1S="U$KH_GB+>R%6# KR,'(Z^F:WZ* .?_
M +#U274=(NKO5X9UT\,63[&5\YV7:7)W\-M+ 8&/F;CIB+Q=X4E\3-I4D&HB
MPGTV[6[BF$'F-N (V_>'RG/([X%=+10 V,.(U$K*T@ W,J[03[#)Q^9KF_'%
MI+K>@R^';4G[1J6V*1A_RQAW#S'/_ 00/4D#UKIJ* (X(8[:WC@B7;'&H1%'
M8 8 KAF^'$__  A=UX6376%C+/YD1:U!:)?.\W;PPW'=W/;L.M=U--%;PO-/
M*D42#+.[!54>I)Z40S17$$<\$B2Q2*'21&!5E(R"".H(H YR\\+7%_XHMM:F
MU%!Y5C)9-#';E=RR8+,&WG!R!CKCWK'M/AS>VUGH%LWB65ET.??:E;-%_=[6
M7:>3EL-C=TX^[7?44 <_H_AJ31_$&KZA%J+M:ZE/]I:T,2_++M"D[^I&%'&!
M^-+XC\-OKEYI%[;Z@UE=Z9<&:*01"0,&0HRD$CJ#U[>];]% ',6OA:[M==UW
M5$U2-GU:&*(H]K_J_+4JIR'&3ACGISZ5DGX;21:!H5I9:[+::IH>Y;+48K<'
MY&X97C+$,",9Y'2N]HH S-%TVZTZV;[?J,FHWLIS+</&(P<< *@X51Z<\DG/
M-:=%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV"6" @@J<C!^O>J?A[Q??)X(\/7>I0Q3ZEJ_E16J).?WSLI8L^5^0  DXW8
MXSP*M_V%J4_CO5]3>W6.QO=+2R1S("RNI<Y*CM\WKVK#M_!OB)?"7AE#%9Q:
MOX;F1H(Q<%DN44%7!;:-FY3QP<8YZ\ '5Z?XEDD\4S^'-3LTM;];87<#12F2
M.>+.TD$J"&!X((]\T[Q)XCF\/W>D V*36E_>)9R7!G*>0S_=)7:<@D8ZCDCU
MJ"TT:ZO_ !HGB6^MOLGV>Q-G;VY<.^6?<[L5X'0  $]R<=*N^+=#'B3PKJ&E
M!MDLT1,+YQLE7YD;\& - %"T\8-+XA\0Z3=VEO;-H\"7!D^U%O-1E+!L;!M
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MH96!V# <$;>"33;K2M8NO'FA:R]I"MO:6D\-QLF!PTFTC;D#<!MY/&?2B_\
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M[O3H!<PW=JBRO%=6[PLT;$@.H8#*Y!&:A'C/1\VCM),EG>2^1;7K1$02N3@
M-VR0<$X![$T =!17,6'BW[=XXU3P^+&Y1+&*$^<8CAF?>2<]EPHP3U.?:NGH
M **P-3\8Z3I,M^DQGD&G(CWSPQ%UME<94MWZ<X&2!R:JW_C!+;QCIFAQ6=Q-
M'=VTER;B.(LI V@!<=?O9)Z#C\ #J:*IZKJMEHFF3ZCJ$PAM8%W.Y!.,G
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M19(Y7VX4GK_&N2!@9Y(H V:*Q-6\5:=HZW3SK<RQ60#7<D$)D6W!&<OCV()
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M=S;QPV4L5M&LEPT8*.SE5YVKW/0=!Z"@#T.WMX;2WCM[>)(H8QM2.-0JJ/0
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M.Z_X3O\ 4II[^>>TFCMC+!=QRR%U#/\ =4@M@[N!7K"JJ(J(H55&  , "EH
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MF5<2$]-ISS^%<%K5]:Z/\2["SO\ 46TC37TCRK"7$:Q"02'S$S(I"DKY?IT
MK$U/0O#]GI_A"VTV5KZP;Q,JI-.4975DD+HA4 &/=Q@<$YZT >HOKVCQVD=V
M^K6*VTN1',;A CXZX;.#BK+WUI&D+O=0*DY"Q,T@ D)Z!?7/M7"7QT/2O'(T
MNQ@L-+N$TEW>:7"PB%Y266.+(4L6!);MQP<X'':>MAJ'PU^&JR^1.Z:U;P29
M(8@'S<H?;&./I0![59ZC8ZBLC6-Y;W*QML<P2JX5O0X/!]J;;ZKIUW=26MM?
MVLUQ%S)%',K.G..0#D<UY;KD5Q8:W\1H=!C$%P=$MI$CMEVG=B0$@#^+;Z<]
M*Z/3;[PGKD6@7^BR6\VIVUG(FGQ02_- K1X8.@/"C 'S#@X[F@#KQJNG'4/[
M/%_:F]QG[,)E\SU^[G-9'CO5-0T3P3JNJ:9+#'=6D!E4RQ[QQVQD<^_/TK@/
M#+^'O$/A3P_%J'B&[75M/N8W-@K0I<+>*<,-NS><L6))/())/!-=K\3?^29>
M(O\ KRD_E0!MZ=J]E>[+9;ZVEOEB5YH$E4NF0.2H.1UJ:35=.BOTL)+^U2\?
M[MNTRB1OHN<FO/=3T73XM9\!W.A6MO%J7VD/));* 7M/*)E9R.HR5&3W;U-8
MVDOHFO\ A.YTKQ%X@NK75;?4)'N;)&A2X^TB8LACRF]B?E P3UQ[4 >LW.L:
M79B8W6I6< @*B7S9U7R]V=N[)XS@XSUQ4\UY:VUJ;J>YABMP 3*[A4P>AR>*
M\YL=)TRX\??$-9[*VD"VUH<-&I +0/N..Q/<UAZ9JPL/#_PSN-1U"6RTIK26
M)[L;"L4^Q1%N+JP'RB10<<9/2@#TS6_%.FZ3X5N]>2ZMKBWAA>2(I,I69E4D
M(K X).,<5A6=YKU]+I>H0^*])_LRY,)N(GA4OYIP6AC((&&#8YRP('7-8^K:
M?HEG\/?'<^D:E)J$=U!+//*7C:$3F,YV;%"Y^[G'J.^:F\50VW]@_#^<1Q;Q
MK.G!'P,X*G.#[X% '8P>*M(N?$MUH,5[ U[;1HTB>8/O,6^0#NP"Y([9%7X-
M5TZZN6MK>_M9IUSNBCF5F&.N0#FN(M9[*V^*GBQ;J9(3+IUF4^8!VXER4]3]
M*J^%Y-1T77?#VCW_ -CU;3IK21='U>V&R1(E16*RKTP5"_,.X&>30!VOB#Q)
MIOAJTAN-1N(XO/G2")68 NS,!QGL,Y)[ &K<^K:;;6D=W<:A:16TGW)I)E5&
M^A)P:Y/XI&-/#^ERR[1''K-DSNW15\Y<DGL*BL+Y)/C!>Q7+HT$VDQ_V6P(*
M,@<^<$/0G.W..<*.PH [J*6.:)98G62-QN5T.0P]0:K7FK:;I\B1WNH6ML[\
MJLTRH6YQP">>:Y3X:V\MK:^((8^-+76KD:>H^ZL61D)_LA]X'T-8'B_4-.EF
M^(%M ]O:7,>EI'>/=/N>X/DNT:1(2 H&[[W.2>G&: /3I[ZSMI%CN+J")V5G
M59) I*@9) /8#K4(UK2C91WHU.R^R2':D_VA=C'T#9P>AKS2WAT[5/%'PWD=
M+:Z\S2;@2L0'WLL46 WK@YZ]#5OP_P"'K'Q!I'C_ ,/2(B6LNM3I&J@8A8QQ
MD,H[8;GZB@#T9K^S1H%>[@4W'^I!D \W_=]?PI\]S!:QB2XFCA0L%#2.%&3P
M!D]S7#^"=0OO$\UO<:K;M'=:%&]E<!EX:\SMD8?1%!!'_/8CM1\6X;9_"=K+
M<JF(]3M/WC<% 9E#$-VX[T =G:ZE87TLT5I>VUQ) VV5895<QGT8 \'ZTD>J
MZ=+?M81W]J]X@):W693(,=<KG->=ZYHHTWXBV<OA6TBMKHZ)>?:H[5 BD  0
M%@.,E^GKM]JJ^&F\,^(M#\)R2>(+E]0L)8C%8(T*S).!MD1E"!ROWBV3R 23
MWH ]-&K::;A8!J%H9GD,2QB9=S. "5 SG(!!(ZX-+;:KIUY<-!:W]K/,H):.
M*968 '!R <]:\Z\(:-H<D'C6YN;.W!M==O-DR1J7MU$:\Q\?*0"V,5'I\VOZ
M+<VNC2I9:I(^CW*Z%J]H-KE%1"%D3ISB/##CIZF@#TE=5TY[\V*W]JUX,YMQ
M,ID&.ORYS27.K:;9^;]JU"T@\E0\OFS*NQ3P"V3P#[UY3=^5J/P%T>73#_Q.
M(&M1:D?ZU;X2JK^^XL7S[$DUT%EI>G7/QBUY;BRMI?\ B5VSLKQ@@L6D!;![
MXXSUP?>@#OXI8YXDEBD62-U#*Z'(8'H0>XI)IXK:%YIY4BB099W8*JCW)K@?
MAEK&G:=\,O#J7U_! ;B26WMQ+(!YC><X5%SU. !7H+ ,I# $'J#0!YS9^(M9
M\5:'_;.B^(]+TY?-G6:"ZC618(5=T20G((?Y0WS':<^W/='4;2T@A%[J%JKM
M%OWM(J!P!EF )Z=_85Y/90VLW[-5^S1Q/M@O6!(!PPGEP?KZ5LZK8:?>^._A
M^MS;6\PFL+L.KH") (HR P_B Y(!H [UM;TE(3,^J62Q"(3%S<( (ST?.?NG
MUZ4XZSI8>U0ZE9AKL9M@9US-_N<_-^%</8:)I$'QAOK2'3K-+>/0H"D*PJ$4
M^:ZYVXQG&!GTKCS8V,/P#N[R.W@6X@U$^5,%&Z/;?87:W48!XQZGUH ]UIDT
MT5O"\T\J11(,L[L%51ZDGI59=6TY]6?2EO8#J"1"9K82#S A.-VWKC_&N2^(
M&I)I6K>$[N_;9HJZD1>.WW$<QL(6?T4.<Y/ (![4 =C:7]G?VYN+.[@N(02#
M)#('4$=1D'%,L]4T_43(+&^M;HQXWB"97V_7!XKS?QO)I$?AS7=2\/D7"7%W
M:2:U-:R&2-X@P#@8)&=@&X#^%N>M:_B"!+GXA^#;K2S&[2Q7*W+1X*R6?E@_
M-CJNXKCMDT =:VMZ2C1*VJ62F60Q1@W"#>XZJ.>3[=:EAU*QN+V:SAO;:2ZA
M&98$E4O&/]I0<C\:\6N=.T\?!7QC.MK;B2+4KORY @RFVX^4*>V.V/7WKL=3
ML;&R^)W@Q;6V@A%Q9W\<H1 /-79&0&_O<Y//O0!V;:WI*211OJEDKS.8XU-P
M@+N."H&>2/2I+W5=.TTH+Z_M;4O]WSYE3=],GFO'+70]!NOA+XNDFL[8W,%[
M?K#($'F1R+(QB1#U7YBN%'7=[UJW=]#OU:RO)(+76(?#D$6HW%Y)N,VY'.R)
M"0/O$Y;GD@8/6@#U*6]M('B2:ZAC:4$QJ\@!? R<9ZX )^@J!=;TE[$7J:G9
M-:%M@G%PAC+>F[.,^U>4Z;%IVIO\)#*MO<L;26*4G#$[;3.UO7!QP:W-"T/3
M]6U3XB:!+"BV$]Y&IB0 !"\"98#L<\Y]10!W[:C9(D#M>6ZK<$"$F50)#Z+S
MS^%6:\Y\'W]UJ?D6VN+Y3^%%DBO)I!M1YP"B2 GL(=S'_KJ/2N]T_4+/5;&*
M^T^ZBN;649CFB8,K<XX(]QB@!D^K:;:W:6EQJ%I%<N0$ADF57;/3"DY.:6\U
M33]/95O;^UMF<9433*A(]LFO'O'&I6%QX6\>K92V]HR7RI<).Y>XN)T\OYD!
M/R( !C .=I/%=#XI>\6^UG7-!N]/U6T%@B:KI-RW$L"AR&BD'3(9QSP2#WH
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M?V98>1<0?8;;R;EB\\?E+ME8]2PQ\Q/O5JB@"FVD::\L,K:=:&2 !86,*YC
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M)UP.NW/XUN4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=X^I]: .)ETB'4?BWJ%C)<7D=N- MU/D7+QNP$L@&9 =_P"O/?-4=!U6XO\
MX>>%A?:O>M=2W\D)BB),^H+%)*HC+[EVC"JS,3T4YZUW@\.6:^()]<26Y6_G
M@%N[B7CRP20 O08))K,'P]T)-)LM.C%Y'%8W#7-K)'=.LD+L26VN#G!W'(]Z
M //]:>YNOAQ\1+*^DG*:?>G[/$UT\GE*4C;9N."R@L>#D#\!75^(UU+1_P"R
M[BRL;[5M'@MW^V6=M>R?:4+%2LJY;=)C# +GC/'3C:3P'H"0ZO#]GG:+5UVW
M:/<R,&X )&3PQP"6ZDCK5B/PI:6[6LEM>:C#/;PF%9OM+.[J2"=^_(;H,$CC
M'&* .2T_7H-8UCPGHMIJ-W/I%UIT]T9WD9);ET(4([9W97YBPSR1SQ6?J?B/
M5/"\OC#3(KN:2RLY+%K6XN)2S6J7#A74N<G"\E2<X]Z[N;P;HTECIUM%!);G
M37+V<\$A66%C]XAN^[)W Y!SSFK \,:4VG7]E<6_VJ/4,F\:=MS3G 'S'V
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MJZO=+M_-6XN6>/.T'<%/ ;G&>_4\DDT;K3H)?CE;2,UP&.A/(=EQ(HRLZ #
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M2&9HF7<,,N5(R"."*KS^$=-EU&\OHFNK62^0)>+;3&-;@ 8&X#H<<;EP<=Z
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MC*T2D\+N/7U/;)..*EF\,Z=-X@;7!]HCOFA$+M%.RJZJ25+)G:Q7)QD''Y4
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M\V>GS= !TKF)?$_BV3PQXKU6._T^.30=0N8U069(G2(*=IR_RY&><DY/48H
M]0HKAAK^NVWBCPRMS<6DEAKR2C[,D!!MF6+S%(?.7Z8.0/8"LJ3Q)XLF\/\
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MQ+J^A6=\ML=(A@$]R(%9III5+#Y3P%  R.I)ZC'/.OX\U^YT#3)X$LH-17Q
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MRQX))/88 [Y]OX)UDW?ANZOO$$,LFAEEC$5CL61#'Y?.7)W8SDYQTP/7N**
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MH8;E&_./G.!G/J333X'O?[%\+:<-7@ T">*9'-F?WWEH4 (\SCACGKS7:T4
M<;=^!9KFZ\3A=8:*RU^/$L*0#?')Y7EY#[N5P,[<#ZXSF.U\%ZO'J^A:G<^(
M(I)]+MI+79'8!$D1@H&!O)4_*,G)![!:[:B@#@I/AY>2>!=0\,MK4.V]NVN3
M<"R.5W2^:1M\SGD8SGI6S)X:NV\9V_B.+4TB?["ME=0BVR)5#EP5);Y.20<[
MN/0\UTE% &)XJ\-P^*-'%E).]M-#,ES:W,8!:"9#E7 /7Z>A-0P^'[N?6;76
M-5N[:>]LK>2&U$-N4CC+XWN06)).T#&1@9]<UL6NH65\TJVEY;W#1';((I5<
MH?0X/%6: .?\'^'9_"^COITU]'>*;B6=72 Q8\QRY!&YL\DXI/%GARY\26UA
M!!?Q68M;V*\R]N9=S1MN4?>7 SUKH:* .<O?#EY>>+M)UXZA"G]GP2P^1]F)
M\SS-NX[M_'W1C@_C64W@*\?PSXDT9M8@QKEW-<O*+,_NO-QN4#S.>@P?YUW%
M% '&GP9J*ZX=1AUU(Q/IR6%TGV3<2$SAHR6^0_,>"&']*NG_  _O[&R\+VQU
MR*4:!(SH6LL>:"A0+P_'!/KS[<5W N(#<FW$T9G"[S%N&X+ZXZXJ2@#B[OP
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MQ[_N/)"!\JG_ 'B1D9':I[GQS/9Z_?Z'<:1LU".-);&(7.?MX9MO[L[>-O\
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M!FM?6M7M- T:[U6_<I;6L9D<@9)] !W). /<UQ.I^%+W4]>AU6WTIM,UN#4
M1JMO.BQSVHDZ2*&W,3&,8*]<<XS73^-/#I\5^#]2T19A#)<QCRY#T5U8,N?;
M*C/M0!7E\57&G:MI5GK.F"SBU1O*MIH[CS0LV,B.0;1M8C.,%AD$9[USUA'=
M:_\ $/Q?INKZ;9W-C]GL[>2-[@L(XBLC?*-G)).3R,'')Q6E<Z7K'BEO#J:O
MIWV Z7>QW]R_G(ZRRQJP41[23M+-DE@IP,8YJ?0]-U.U\?\ B34[BP:.RU);
M98)/-0D>4C*=P!R,D\=??% #?&VJZCX=T_0X-&@@\NXU.ULF,DI4JA<84?*>
M" 5)[ ]#6/<27=G\8GFL]*BFU";PXI>&.4(A?[1R6D(SCC&=I/3CTZ#QUI&H
M:MI>G-ID*3W%CJ=M?>2T@3S%C?)4,> <>M5HM/U?_A9(UZ;32+0Z,+-C',C$
M2^;YF!D@E<<9XY[8YH HZEXTL=0^'2:Y>^'_ +7;M<K!<6,SHPBD681\DCD!
MP""!^5;FH>*'AUJ\TC3[.&[OK2T6Z:"2Y\IY5;=@1C:=Q^3GH!E>>>..D\*>
M('^&-[H(TW_3YM3-RH,\>W8;D3<G/7 QCUK7\8>&Y?$SW GT"1[B.!6TS4;>
MXCBGMI<'(9MP(4-@\;N_'3(!W43F2%'*E2R@E3V]J\Q\<ZCJ%MK$'BVTED.F
M^&[Q(+B%.DR2#%PWOM#1@>A5Z[T?VGI_AJ)0@U'58;94/S!!-*% +$G& 3R?
M:L2S\%:/-X8$&J:%;S7TT#?:W>*-II96!WMOZ9+$D'/&1TH V-?\16>@>'9=
M:FW30*$\L1$$R%V"H >G)8<UG#Q7>1>+$\.W&C'[4]H;Q)+>Y5T,8.T_>"G(
M; QCN#ZXY-;#7+/X/GPWKVG6\M^/+L;19;E=MR"X\L!ER5D51P<8!4'.,XU-
M&N=4LO$<%UK7A6]CNKF+[%%?-J,-P0H#.(]J[< E22V.3C)P. "?3/B'/?:6
MVLW&@36NC0BY^U7;W*$Q-$Q& G5MV,<=#QSUJS:>/(9/$EAI%S!:C^T(W:":
MTO5N C(-Q24 #8<=""02",UFZ/X/U&Y^&.J>&-2B^Q7-R]R8Y!(KJ/,D:1#\
MI[$C(K4T"?QC?I%9>(=*M+&.)"MQ=0W0E^U_*1\B ?(">22<\8 YR "G)\3+
M&/\ L^[2*WFTR^N%@22*\5IT#$A9&AQPA_WL@$9'823>.M0)\0K9^'))GT23
M$PDNT3>NP/D$ \X/ _,BJOA2S\:Z#9V_AB?3[.2PM#Y4.LBY&?(!X'DXSO"\
M>GUQS):Z+K$4_CB1]-?&KG=9@31_-^Y$?S?-QR,_3WXH M1>/)))M N'T:6+
M2=;=(K:[>==XD="ZAHP. <$9S^%,UKXB6NEQZA/;PVUU!ITQAN$-ZL<[%<;_
M "X\'=MSCDKD@X]\V3P]K?\ PC'@6P&FL9]%NK66['G1XVQ1E&VG=R3G(Z>^
M*GL+'QAX8UO5;33=+M-2TG4;R2\@N9;L0FT:0Y=77!+*&R1MY_/@ T6\;7%Q
MX@?1]+T22[E;3TU""5[A8DDC=L#/!*C@]B?;N,G4O'>HWWA3P[JVD64<!U'5
MH;*XCGF(:)A-M9 0I!!*,-W8'.#VU;?2]6@^)$NLRVCS6G]CI9><KQAI)5D9
MR=N[@'./K[<USL'A+Q!%X$TRR&GI_:&G:X-2\@SH!+'Y[28# D X;OZ4 >GP
MF5H4,R*DI4;U1MP![@' S]<"GU' TK01M.BQRE0716W!3Z X&?KBI* "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *S-:T#3O$-M';:E%)+#'(LJJD[Q_.IRI^4C.",BM.JVH:A:Z79
MM=7DPBA4A<X))8G 4 <DDD  <DF@"PBA$5020HQDG)_,]:6LBU\3:9=7=S9A
MYHKRVB$TEM- Z2>6>CJI&6&>,KGGCK571?&^@^(+J"#3+F6=IXGEC?[/(J%5
M;:?F*X!Z<'G!'J* .@(R".>?0UF:/X?T[0C=G3XY8_M<[7$^^>23?(WWF^8G
M!.!TJIKEYIL6O:%:W>HWMM=R7#&VA@+B.X;8V5D(&" ,G!(Y JQ+XETV&Y,)
M:=@+E+1I4@=HUF8@!"P&!RP&>@)P3GB@#7HIDTT5O!)//(L<4:EW=SA54#))
M/85D6WBO2;F^M;,2S12WB%[3SX'C6X &3L+  G'..N.<8H VJ*X2;Q?_ &_I
M'B^WM4O[*331-%#,(GC;*1!MQ;&%.X\ X.,''-2^#O&.G3:+X9TVZN[A]1O-
M/A*S2Q2%)I!$&<"4C:S]21G.<]Z .SDBCFB:.5%>-AAE89!'H13@   !@#H!
M6)J7B[1]),K7D\JP0R+%/<+ [10N<8#N!@=1GTR,XJMJ7CWP]I5[<V=S=3?:
M+9$DECCM97(5C@,,*<CW' H Z6BN>_X3?0?[-U+4#<7 MM,E,-XQM)087 R0
M5VYX!!) QS5_^W;#-@-TQ-^I>WQ;R'< -Q)X^7CUQ0!I45R^AZWHL.D7U];:
MI?7=L=1DC9KK>SK,S@>2BD!L!B%"XK3B\0Z<]O>3N\L"V;B.<3PLC*Q ( !'
MS$[EQMSDD 9- %S4+"WU2PGL;I7:WG0QR*DC(64C!&5(/2FZ9IMKH^FV^GV2
M.EK;H(XD>1GVJ!@#+$G  JII_B/3M2U.XTR)YHK^",2O;W$+1/Y9. X# 97/
M&1T/!INL>*-)T&ZM+;4;AXIKPE8%6%WWD D@%01GCIU/&!0!L45A0^+M*N=/
MMKRV^U3BXC:6.&.UD,NU3M8E,9 !XYQGMFI(?%6C7.D6FJ6]X)[:\;9;^4C,
M\K\Y4(!NW#!R,<8.<8- &S17/+XVT0PZK(\MS'_9**]\CVL@>!6#$$KMR1A2
M<C(Q@]ZMMXETI+K2K=KAQ)JJ[K(^2^V4;=_WL8!VC.#B@#6HKEK/7=#M+OQ+
M?C5+^5;21&OHYED9+7"=(TVY (&XXR.]3V/CG0-121[>ZE*)#%/O:WD =9#A
M I*_.Q/R[5R<\=: .BHK'LO$^E7MS>VHG>WN;%!)<174;0M&A&0_S 97@\CB
MN3U[Q&MYXO\ !BZ?=:C##=W;[D,<D45S%Y3$'D -SMZ^H..] 'HE%<C\3IKF
MU^'.M75G=W%I<00>8DMO(48'([CFK.E^-]"OM4BT>.\D^W-#OB62!T6< ?,8
MV8 28_V2: .EHK&TWQ3I.K65_=V<TSPV$CQ7)>WD0QN@RRX9020/05HV=W#J
M%C#=VY?R9T#H70HV#T.& (_$4 6**X+PAK:Z;I?BR\UG4IGMK'7;B%9;AVD*
M(/+"H.IZG  [GWKH4\6:4W]HJ[7$<NG1K-=0O;2>8D; D,% RPX/3/0T ;E%
M8'_"9Z)Y&DS"XF,6KD"Q86LI$I(R!]W@D<\XXK4AU*VN-2N;",R&XME5I08F
M"@-TPQ&"?8&@"W13)8Q+$T;%@&&,HQ4_@1R*\Y\$^(+R'X<:AKNHW5Y?W4,U
MTJEPTG$;,%&U1P..3CZF@#TFBN(\$0R:OIVC>(GU/5OM,EBAO()C((+AW0-N
M".,  DX*8&..E7[;Q5%J?C#5O#8M[R+['#%^_$#C+OOR0V,*H"C#'&3G&: .
MHHKS7X?^-K*#P=HD.LZA=S7MU<2P&YECDD7S#.X1'EP5#$8P">F.V*[/5?$V
MFZ/YYN6G86R"6X,$#RB!#_$^T' P"?7'/2@#7HJ&VN8+ZSBN;:59;>= \<D;
M9#*1D$'Z5YYX;N7OO$OBRTU+7KV."POQ%;(;S9L0H&(]3R>IH ])HKEU\0:9
MX8\,PZCJ>K7-SI\S[X;UXGE.QSE Q13@?, ">O%;-OK%E=7UW9Q/)YMH%,Y:
M)E1,J& WD;2<$' .1F@"_16'#XMTB?4;2Q$TL<EZI:T>6!TCN !D[&(P>.?<
M<C(I+OQAHMC+MN+EUB^T"U:Y$+&%9B<;"X&T'/!YP#P<&@#=HK(C\3:7+-JL
M*2S&72@IO(_L\FZ,,-RD#;\V0,_+FLC4/'UA!+X<^Q17-U;ZTY,<\=M(P$81
MFR !DL<#Y<9QDF@#KJ*YN'4]*/B_4!'?ZC)?06*--8[)#$D>XD.J;>7.2.,G
MC%6;3Q9H]]X=&O6L\LNFEBHE%O)DD-MX3;N/S<=.M &W16-J?BC3-)29[EK@
MK;QB6X,-N\GD(1G+[0=O'..N.<8K4M[F"[M8KJWE66"5!)'(AR&4C((/<8H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<9\1K2_DL-&U&R@EN4TO5H+VYMX5+/)$N0VU1]XC=G'M79T4
M <+*L>M?$72-?L6?[!INGW"W-SY;*KF0KLC&1R1AF([<9Y-2_"='@^'.F6TT
M$L$\)E$D4T31LI,KD9! /((-=K10!Q/C7<?%?@QEBF=8=0>25DB9A&IB906(
M' R0.:PK^&YL=?N-2\,W-W'=RZHJ7NA7,1>&Z_>!3/'D?)P ^\'''/2O4Z*
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M &A(IP(FB(5_IYD;!/7//:K'P]L-4M;1XM91@VC!]+M9'ZRQ*V?-'LRB(?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLELG,@FC8;GG^7Y?+8'C!!)X/%6X[ZSFW^5=0/L&7VR [1ZGTKB-?AL1\3/
M<]K';@EK^/?$!R!"?ER/0YX]<U5U$S>$?B!>+80@1^*;<"W*ID1WR?+D@?PE
M&WG_ '&H ] ?4+**T-W)>6Z6PX\YI5"?]]9Q4T4L<T2RQ.LD;C*NIR"/4&O.
MM5>ST+QWH.D7-[_9NE+I3Q6,CJFPSAU# EP0&*8YZ\D?Q<]'X)TO3-(TJ[M=
M(OYKVS-[+('=E*(S8+)'M &P$G@=#N':@#<FU"RM[A;>:\MXYF&5C>0!B/4
MG-<YI_B2Z'C;Q'IFIW-G%I^GPVTL$FWR\>9OSO9F()^4#M]*YGQ+)>Z'>ZWJ
MZ1VNM^'I+N)]1M&^6ZLY56-0T9Z,  C!3SSQU)J];Z7I^J_%'Q?'?VD-TBV%
MEA)D#J,K*"<'C.._7D^M '?3WEM;6_VBXN(8H./WDCA5YZ<GBN<\=>(+S1?
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MJQFEU77ULTU*:)(1%:%FCBC4DX!;DDEB3]%'.,G>HHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KG/&C:O'HT,FCP/<R)<H\]K%/Y,D\(R61'XPW0\$9 ([U
MT=4-5TJ/54M@UQ<6\EM,)XI;=PK*P5E[@@C#'@C!H \]7Q=$^B6RZ3=7RM?Z
M['8SP:E*\<]D6CR8B[;F7)3 (SC><'(S5C6;#Q%HFC>*[HZPUO9G3)+FT@2^
MDN)H)HU)++)(H;8>,CL<8QFNFN_!&BZCI6H6%_%)=#4)1/<SR-B1I  %8%0
MI4* , #CW.8[?P+I\.B7NF2W^J7:WL1@FN+NZ,LQB((V!F'RKR>@'6@#F[9]
M0T[7O =S_;&H7']KPO%>13SEHWQ;[U(3HI!'4<GN36=J-S)XM^$_BG7KF\NT
MF(O%BABN&1(8XRRK&4!VMD+DE@2=W; QW;^$+)Y=%D:[O2VC#%F=Z\?+L^;Y
M?F^7CG^?-4KGX<Z-.=62.XU&VM-5W-=VEO<[(7=AAG"XX)[X.#W!H W=%4/X
M<T]3G!M(P<$@_<'<=*\ITV_D\*?#?Q!J5A-<)<G6Y[1999WD6%6N0F_:Q(W
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M(P2<Y'AG1M0N?@5876B7M_#JJ0FXC$=Y*!*4=B8]N[ ##(XQR0:](T/P[:Z
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ML258#H2S9!SUH K^!KV^DUSQ5IUU)<>397L7V>*XG,SQ*\2N5WDDGD],G&<
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M\+S7NJZ:&T)B L-LY$J>5Y>3EL[B/H![UWI90P4L QZ#/)H9@JEF(  R2>U
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M20G>CIU (P.">F>_'H]% '%:YX6U_P 0^#+_ $O4-4LSJ%\8P\D43+! J,&
M1"2221R2><^@ KLH?-,*><$$N/F"$E<^V:?10!RC>%)[GQ9K6HW<D#Z?JE@M
M@\"[@ZH-W.>ASO/';U-5O#/AOQ3HZ6VEWVOVMUHUE@0%+=EN9$7[B.V[: ,#
M.!D@8SR:[/>N\)N&XC(7/.*6@#QZQFN]1EO]=T_5_"$UM<7KW 74XW26/:V$
MWA7P&4*,$KD<'K73Q:!KNJ:M_;ZW=M:#4]*CMKFVGA:1[8\D^4<K@'=R&'4
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M4."3OP, <YK4OK37M&\8SZY:>'#K%AJMK#'<6WFQ+-:RQ@@'YCM*D'G!Z_J
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MY@KGC /K[XKF-&-SI^AZ7_:?A+7'TG3YSJ$$<$]O+!#RS*RC(D95#$@,<^W
M  .[UCQM;:6FH-%:-<C35#7BB>-&3Y0Y503\[!2"1TY !)XI\?C.UOWC31[=
MK]WL$U'8LBQLT+DA=H;JQ*GC@#C)&17/K;:]X?\ %>KRVOAM=<TK6)EO(94E
MC1[>0HJLK[_X3M!R.GN:?XH\-RZTZ+=Z-<C4+:S5K'5=*E6-XISNW1@E@=H.
MW&1CD]#0!WMI/]JLX+C8R>;&K[6ZKD9P:FJCHL=_#H=A%JLJ2Z@EO&MS(G1I
M HW$?CFKU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !116#XM\3V_A31Q?3Q2RL\J0QK'&S#
M<S!1D@<#GOUZ#DB@#>HK@]1\1M8_$;36FU.>/2)]*GF:WDCVC>KHH(7:'+')
MX.3Z5TD'BG1+G1$UB'4(WL'?RUD .2^[;LVXW;MW&W&<]J -BBL"Z\8Z/;:-
MJFI"6:5-,!-U"L#B6,A=P!0@,,CG) &.<XYJ[H&K)KFB6FH(CH9HD=E9&7:Q
M4$@;@,CGKT- #/$'A^T\2Z6VFW[SBU=E=UB?:6*L&7)QG@@'BM.-2D:J79R!
M@LV,GW..*R+OQ5HEC<2PW-\$,,J0S/Y;F.)VQM5W VJ3D<$CJ/6M:6588GE?
M=M0%CM4L<>P')_"@!]%9%MXGT>\T-M:M[SS=-4D&X6-RO!P<<9(!XS[&H(+Z
MQN/&<D,6M3/=I8 OI?\  B[_ /6D8R'Y"X)Z=J );WPOIFH:_;ZS=+/)<VZ*
MB(9W$7RMN4F/.TD$Y!(ZX]!6S6.WBG14N8X&O@IEF-O'*8V$32@XV"3&PMD$
M8SG((ZUD+>WR?%\Z<U],]@^AFY%LVW8DGGJN1@ GCUSU- '7T5C6WBK1+N\M
M[6"^#27+.MNWEN(YBF=P1R-KD8/0GH:HZ9XUT[5;_6K4&:VBTV3RFGEA=!P@
M9FRPP,9XSUQGH10!T]8VL>%],UV_L[O4%GD:UW!8EG=8W!QD.@.&' X/XU#H
MNJ:;:>$K&[.M2ZA:, L=]/S)<$L0.  6)/  &3[U9A\3://!>S"^2-;'_CZ6
M=6B>'(R-RN PR.F1SVH UJ*P+3QMX<OKRRM+;58I)KY=UL K 2<;L!B,;L<[
M2<^U;LDB11M)(ZHB LS,<  =230 ZBLFT\2Z1>WL-G#=_OYT,D"R1/'YZ#JT
M98 .,<Y7/'-<K-K,GB;Q?K>@0ZEJ&G"SMX!:36T,BD3/O+.^5P0-J@!OE//K
MD 'H%%<YXB\31>$M-TXWOG75Q<W,%H'2%B&9F568[00O!)QW/ K%N?$O]G?$
MW;=ZI.ND2:$;I+>2,@"3SE7Y4"[RV.QR>M '>T5R^L>(-$O_  >NHQ^(VL+"
MY9/*O[8X?(<?*H()R2"I&,]:UM0U[3M+>1+N=U:.+SI0D+R>7'S\S[0=HX;D
MXZ'T- &E148GB^S?:#(HAV;][' "XSGGVKG/^%B>$=UJO]NVN+IS'"WS;2P8
MKRV,+R"!G&<<4 =/163J7B;2-)EFBO+LH\$0FG"1/)Y,9SAGV@[!P>6QT/I4
M>H>+O#^E2PQWNJV\3S0F>-<EBR 9W#&>,=/7(QF@#8D021LC9VL"#@D'!]Q6
M5X?\-:;X:M'M]/68[R"\L\S2R-CH"S$G R<#H,GU-5V\:^'EM%NAJ(>W-NET
MTD<4CB.)ONN^U3L!P>6QT/I6C<ZQ86BVQEN 3=?\>ZQ*9&EXR2JJ"2,<Y H
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M$\L0=K#/RGT&*]6HH \RT'4?#'BN;3&L[;4FU^R5CY5S)<_\2YRFURV\[1Z
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M21G:.2,=7#%U^8>GM7K]% 'F=^#I7B'X:6>HW*-<V44R74A;(5OLVS+'MEN
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU:Y.IZ=>^5!=[_WFW=%]X_Q<.PY]O2KG_"1Z'_PFG_"5_P!E>._[2^S?9O\
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MVVN/*\S((Q*=@&.G' '<GUJG=ZYK,7PLMO'<&I2M?JB7DML2/L\D;. T.W'
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MIDGA_2=+34-1AET@DV%_%*JW$(/!&0H!!'!!'- &#KDWC#0?"TQNM8$<JZO
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>_@NV:9F (C8-M& >N.O;WJCJ7A75M0\4ZEJD=W!:)>:*=+1XG8R0MN9A(.
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MNVD5) BK$CHZE75OO?*,]\]!GU.J.IZ-I6LQ+'JNFV=[&ARJW4"R!3[;@<4
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M HHHH **** "BBB@ HHHH *H:QK%KHEB+JZWMOD2&**,9>61SA44=R2?IW.
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MMKZ$%>9AG:0%R#G#?*,9X%=E::[//XJO=%GTJXMTAB$L%VS*4N%^7=@#D8+
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MD_EWXKHE.Y0WJ,UYMXI\.S:A/-/!IU]9>(+.U1-.U32OD65MF?*89QL#Y^^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@)(4,A159V"#JQ"@D*/4\5'/XDT2V@LIYM5M%BOF5+5_-!$Q;IM]>M &I16
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M>B:D+#P?X%U.XW_V/I^K79U$["1"SO*(G<>@+YSVR*]T*@D$@$CH?2C:-NW
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M^U[UZI2%5;&0#@Y&1TH \LO;&TTV33O^$:UG_A'=1LM-S;VVI'=#<VQD<A)
MYW @C/7<H;'T[SPI>2ZAX2TF[GL/L$DMK&3:@$"+CH >0/3VK795;[R@]^12
MT >&7NO:?>:-I$\<B6"VOBB%Y]+BC_X] +ALO,Q!.YN6Z@?-@ XS74:9>Z:W
MCWXA3//;@-:6@W2$ [1"X8<^AP".QQFO2\#THH \2T#5H]*L?AKJNH3!=%@L
MIK:6X)S';7#* ID/\/ *Y/3)Z5UO@S4+*\^)'C=[.=)8YFLGC>/E7 @P6!Z$
M9[^XKORH92K $'J"*  ,X &: .%\<7-O#XS\#B6:-&&H2L0S $ PN,_3) ^M
M8UO=:>=4^*;M/;?.B#)9?F7[*%/U&[(^M>J44 <W\/YDF^'?API(K[=-MT8@
MYPPC4$'W!XKE]4T:X'C+6?#44+_V7XIMQ=22JH*P,F$N/Q9?+P?[S ]J],HQ
MSGO0!P?P_EU"YT\7&N*8IM%B?2C)(<!VC;]Y+GT8+%SZJU</!=6*? C3L3P+
M*-85R P#9%Z3D]\[,'Z>U>Z8 Z"B@#Q_QAK-C=?\)]81NEC<_8 VR*/?-J(\
M@D2$D']VH^7Y1Q@DL.E7X]5LXO%G@/4))MMK-H\\$<I4X>3$6%'').#@=^U>
MHX'I10!XW97GAYH=;\)^,&O_ .T7U"=_L0DF OD>4R1M&%.#G('MBNC\5Q7O
MASQ#HGB72[-YI)8O[(NK<-NW;^8"3Z+)@%O1J] VJ6#$#(Z'%*0#UH \X\9Q
MCPQ%X4O+EKM]'T^XD&H3P%@Z-)&5$[;>?O,Q)_VSZUA^+G\,S?#KQ=JFAR23
M#4$MUEO))I&6YD5P J;SR57J5]?4''L9&1@]*0*%    '0"@""R^RM;1RV?D
MF&105>+&UAC P1UX%<4U]:+\<UC-S"'_ + ,6"X^_P#: =O^]CG'6N]HH \@
MTRZ@C^%7B+PSK++_ &]&U[%+:O\ ZVYED=WC=%ZON++@CT]JO6R+9_$#P38:
MK/!)J%OH,D$V]@3YQ$8_,X;Z\UZAM4L&VC<. <<TM 'G^D7.GP_%WQ1NFMD"
M:=:)RRC:%W[A^ VY].*XNVN;&+X":&HFMTD74X6(# $$7>2?J%Y^E>Z44 9-
MKXET>\\07.A6]ZDFI6\*SR0A3PC8(8'&#]Y>A[BN8^)<]I'=^#DNI85 U^"0
MB1APH20;CGL"1S[BNR&GQ_VI_:#LSS",Q1@XQ&I(+8]<E5SGT&,<YMT >:^)
MM2L?#GQ&M[S6I;BRT6\TT007<#ND<<XE9V5BG3<&!R>N*S]?30M,\*>'_P"R
M%:VTZ;Q+:W,1N)&S*/,R\@WG(7.3Z8YZ&O6656&& (]"*6@#R'QAK%E<2>/=
M.1DL+H:<#LBCW3:C^X)#Y(/[M0=ORCC!)85;BU6SB\3_  _U"2;;:2Z1/ DI
M4X>0K%A1QR3@X'?M7J>!Z44 >6K?60\0?%0FY@ -M!_&.<6I4_7!X^O%4!=V
M$/A/X5;;BW1H[JUWX<#;_H[!\^GS$ ^YYKV&B@#QK6-4TBQU'QQX=N=;L+1-
M6F^=M0+I)"SPJKE1M(D4#!7E>01TP3ZOHQM#HEB+&Z6[M%@18IU<.)%  #9'
M7I7/VWA_Q+I]U=QVNM:=/8W-R]QF^L&DFC+'.W<LBA@.@R.  .@KHM,TZ'2M
M/CLX,E5+,20!N9F+,<#@98DX''- 'DMRMU>^$/B5H6FESK#ZK<3BV4'>T)\H
MGCT90P'KVK?UN]LO%USX*G\/SQR74.I1W3B(C=;VX1O-5P/N?PH0<<X%>CT@
M55)(4 GDX'6@#E/B=%)-\,_$*1(SN;-CM49/')_2N?U?5]*U'Q=\.IX;NWE@
M\RY8.2-O_'N0I&?]K !]1CJ*],HH \8U.62Y7XBKI>;IXM2LKIK>V?YY8D$1
MD"X_W6!QZ8KJ_#5]X1\1^(;;6-$FN]0OX;9HWGDEF(MXVYV/N.,D_P /7@GM
M7>4@55SM &3DX% '#?$5H8;[PC=7>Q;.WUE'FED'R1CRW 9B> ,D<GO67J.G
M_P!K>*/%FJZ,BS6<WAQK*22#E+BZ.\@ CABJX!(Z;@*].(!!!&0>QI  H
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M*P4TV33=8BO[W6[JZA>$VJQ70C #NZ8VA$7.<8.<]NG-<!?V-AHGCJ2V=?\
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M>SMKJRDLIX(Y+62,Q/"R@JR$8*X],5G:]XBMO#QTX7,%Q(+^\CLXVB4$*[G
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MR?F^;Z\]:NW.HPVUW;VGS27,^2D2<MM&-SGT49&3[@<D@4VSU!KN]OK<V-W
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ME\*:'-=7]TVG1>?J";+IU)4RKC!!P>X&#ZCKFD/A313#I\1LSY>G$&S7SGQ
M0,#;\W&!P/;BM=)(Y"X1U8HVU@#G:< X/O@C\Z=0!%=6L%[:36MU$DUO,ACD
MC<95U(P01Z$5D1^#]!B2Q2+3U1;!MUKMD<>4W3(P>N.,]<<=*W** ,R'P[I,
M%W?W26:F;4%VW9=F<3@# # D@X' ]!Q5;0O!WA[PS+-+HVE06DDPP[IDG&<X
M!).!GL.*W** (KFV@O+:2VNH8YX)5*R12*&5@>H(/45DV'A+1=-,8M;1UCC(
M:.%[B1XHR.A6-F*KCM@<5MT4 9NH:!IFIW<-Y<VY^UP*4CN(I7BD53U7>A!V
MGTSBH[KPSHUY8VMC-8H;6T<201(S(J..0P"D<@\YZYS6M10!F?V!IHU9M5$#
M_;VA\@S^<^[R_P"[G/3/./7GK7)>+_!R_P!BZ=IN@Z+)-;C5X+RZB2=0NQ7S
M(?WCCD^W4UWS21K(D;.H=\[5)Y..N*=0!FVVAZ;#'<?Z(7:[C$=P;EVF=TP1
ML9F))7D\9QR?6J%MX%\,6ALS!HUNK6;%K=N2T9(QP2<X]!V[5T-% &'_ ,(?
MH/\ 9MWIWV &SNY3-<0F5RLKDY+,-W))Z^N!GI5#5++5-3NO^$<_L:-?#V(C
M)?RW8D,B*0S1",@MDX"Y)Z$GJ *ZNB@#"USPU::WJFD7LT,?G:=/YT5QN;>G
M*DJH'&&V@$GMD8YR-VBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KEOB!/J]CX4N-3T:[F
MAGL"+B2.-$;SHE(,B_,IP=NX@CN*ZFFR1I+$\<BAD<%64C((/44 >?'Q<UK\
M0[?S-5FD\.WNGM)$S(@BCN%02E=P7=S"0V">_?H*GB"'4VD\"?:[V7[=/JK2
M%YHT+0[H9"$P  2H.,GN,G/2NA3X=Z(OAG3-!*R/:Z?<I<QLS99F5B<,>X()
M7'IQ6CKGAM-;U'2KQ[V>!M,G^T1)&JD,^TK\V0>,$],4 <<_BG5?#,?C>WN;
M^34?[':U:TGNE0./M"CAM@4$*QST'%;EO9^*5\0PK]JNAH]Q;O'=&YEA,L<N
M,I)%L7OT(/'<"K+^![&YO?$,][<3746NQQQ75NX4*H1=J[2!D$ ]<GGFE\.>
M$)-">(W.OZGJL=NNRTCO&4B$8QGY0"S8XR<X!.,9H \V2.X/[.L5Q)>SSR3W
M,#8FPP1OMPR00 3D\G)/X5VAU74_#_CR[LKO4[C4;%]%EU(QRQHICDCD (3:
MHPI!Z')XZFIA\-[8>$W\-KK.HC3C.LL:GRR8@LGFA5.WD;N<G)[=*UY/"Z3>
M*8=>FO9GFCLFLC 43RWC8AFR,9R2!WH YS3;KQ;JEIX>URQF<I=&*:^BGDB^
MSM!(N3Y8 W!ER-N3SCYLT[PLWB#6=9UE[CQ'<"WTK6Y(%A%O%B:((AV,0O\
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MS@>".%54H5?!;.1G/ []J .)M_&&KV'AVXLY[UKB]'B?^P8+Z6-=RHS#$C
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M4/EX38-G']WCG/K51_A];I:Z%]CU6\M=0T2+[/:WJ*A=HL %'4C:PP!VZ\T
M5? $$MMXF\;0S7,ERZZG'^]D #$>2F,X &0,#..<5H^(+F]_X2&*SCU*6.![
M)W2SL5!N7EW "0EAM6,#C)(!8X.>!5S0/"RZ#J6JWXU*\NY=2D6683B,+N"A
M<C:HP<#Z>U,O_":7?BA=>@U.]LYVM1:7$<!3;-$&+ '<I*G)/*X/TH XBZUB
M\U_X<> ]4OW5[NXUNQ,KJH7<PE(S@<#.,\5T@_Y+@W_8MC_TI-$'PYMK?PYI
M.B)K%^;?2[Q+R!V$9;<C%D4_+C:"3[GUK97PVH\8_P#"2&^G-Q]C%D8=J^7Y
M>[?Z9SN[YH Q/BH_E^%+5]K-MU6R.%&2?WR]!ZT[3/$;WOAO4_&0OI9;.."6
M6+3 % @\I3E7.W=YA(Y&<#.!GJ=OQ-X<C\36$%G->3VT<5Q'<9A"DED8,N=P
M/&152T\'6UGKFIZA'=S>1JB@7ECM7R)6V[2^,9#$=2#SWH Q[!_%EY)H.J6U
MQ(]M<JC:@D\D7E-&Z@[H@H)4J3P,\CKDU7M->U?3&\4:%J.I37.L02(VER.D
M:F6*;"0D!5 .)"58X/3-:V@> D\/RQ1)KNJ7.EV[;[73IW4QQ'.1R!N8*>@)
MP, \D56T\Z9XT\7:?XBM;*Z6/289HA/<V[PEY'( 4!@-P4!CGH"PQSF@"GXF
MUV^\-Z@D&KW^IV^DM9(D.LV\".D=SE@S3@*<9^3 QMZ_AWMB_FZ?;2><D^Z)
M6\U#E7R!\P/<'K63J7AZ6_N;YTU2:*"^MQ;SVYC1TVX8;ER.&(8C)R.!QQ52
M'0+K3_$>C?V9?7L6E6-F+62R8@P%%5@AYY,F=G/HISU&0"7Q?K5QI$&EP6FX
M3ZEJ$=FKKMW("K,2-WRY(3 SW/0]*YW4]9\3>$+#7=1N\3Z<(XO[/%Y(C2Q3
M.ZQD-L RF7#<G/&,UUOB;PU9>*M';3KUIHP)%FAG@?;)#(O*NA[$?UK,7P+!
M=Z%>Z9KNJ7VLF\B\EY[EE5HT!R-@4  Y .>22!G. * *.IR:KHWC+PI9+K=W
M<6^HRSQW:2I'ARD+,",*-O/8<<#\<F3Q#K:^ /&]Z-5F^V:1J5W%:3^7'N5(
MPNU2-N#U/;--O]+ET+QKX'AO=>O-3:&>Y'F7>P>4A@95SM ZD@;FR2>];M[\
M.X+N/7;5=9OX-.UEWFGM(PFU97 #,&V[L' .W.,^HXH ;>:MJD7C7P;:K?N+
M34K:Y:X@V)AF2)65LXSU8\9QP*P89?%NKZ1XLN;?Q1-!/H^IW,5HHMHL2"-%
M8+)\O*]N,<DDYX ["3PE&VJZ%J3ZI=L^BQ21PAQ'B0.H5B^%'. .F.E<KX/T
MYM9/C2U7598+6\UJY\R*-5W/$RH-Z,1D!AD;N1QQ@\T .LO$6M:_K7A'RM3E
ML;;6=(EN9X8HD.R10G*%E)_B.,Y'M507WB23PEXPG_X2:[6;PY=726TJPQ;Y
MQ'&LBB4E2&ZX^4+[Y[=LWA*V77])U2WN9;==+MFM;>UC5?+$;  @Y&>BC'/:
MJJ>!XDTOQ#8?VI=&+799);EBB90R*$;9\O V@#G- &?_ ,)%J&LZM8:5 )XS
M)HT6I3?9'C1V:0[0 7Z*N#TYR1VX.=J-]XSTK1/#L=_J<<.H3:[%8RND<;B>
M!R2I< ##8 R%([^M;5_\/H;I-(FM-8O[#5-+MQ:PW]OL#O%_<=2-K#C/3K5J
M]\%17MEIEN^J7N^QODU SML:2>9>A<E<8YQ@ #  & * ,(7.KP:OXOT"?6[V
MYBATR.\M[EA&DT+,'#*"J@8RHQQD=O6MKX:PR1?#O07DNII_,L87 DV_)\@X
M& ./KD^]6U\*0_\ "1:CK$M[/(U_:K:30%5">6N<8P,@_,><]ZL>&= 'AK18
M-+2_NKR*!1'$UQMRB#A5&T <#N>3Z], &!X7N7U'XD>,YYB2;,VME #_  1A
M"YQ]68G\JSVUK6UM/B(!JTOFZ1EK*7RH\Q@6XDQC;@C)[C-=!#I;:)XXO]5C
M1FLM9BB6<J,^5/&"JD_[+*0,]BHSUIA\$Q%/$:G5+K&O@BY^1/D^39\GR\?+
MQSF@# M-3UVSU#P-=W&M3746M1B*ZM7BC6,$V_F!EPNX-D<DDYSV'%7=/N]=
M\7:#=:QI.L"QNUOY([:!T5H$CBEV%9!C<2RJ23GC<,8Q6H_@M'7PZIU.Z_XD
M6#;_ ")^\PFSY^.?EXXQ5:/X?06VKWMQ9:SJ5IIU_,9[O3(F7R99#]X@D;E#
M=PI&?6@"#:9?C5<JLC)N\-1X=,9'^DOR,Y%847B?77^$>D:Z=4E_M%]02&67
MRX_WJ&Z,1!&W'W?0"NY7PVB>,6\2"]F\YK,67D;5\L1ABX[9SN)YS6 WPRMV
MT>31QKNI)I@NQ=6UNGEC[.?,\P@';EOFSC=D#/0G!H MVNHW?B3Q7X@TZ&_G
ML;;2/*@3[.%W/*Z;R[;@>!D #H<'.>,<7H.HZEI/P?\ "$]C?/ [ZJEO.%12
M)4>Z96'()'X8KO)?!@3Q)+KFG:Q>V%S=1)%?")8V6YV#"L0RD*X'&0/PJE#\
M.;:#PKIWA]-7O_LUC=K>1N1&6WJY<#[OW=Q)[GWH AFDUK4/B1JFA)KUU:6"
MZ9%<H((HM\;,[*=K%3_='4$^F*R[/Q?K4GPX\-:E<W&'NM2%GJ-^J*/*A$LD
M9DZ;5SL4$XP-WTKL8_#7E>*;GQ NHS_:;BT6T:,HFP*I)!'&<Y)/6N.UW0X?
M"OAK1="&HZS%IR7SW#:G!")#;'YG =50@JSOQE<#'L* -SPS>:I=>,]?MCJ<
MUWHMEY*VK%492[IET+A<L5.._&[!KLZ\_P!!34[I;J*U\4ZEJ6ER6<J&X?3U
MA>"0X"&)@B[F^\<8(&!T.,]5X:M+^P\/6MKJ=U-=7488&6<@R,NXE-Y'!8+M
M!([@]: .#T[2M8U/7_'(TG7IM*ECU)6C,4*.'D\A,;]P.5]ACZGI4V@>+]7U
MF_\  -S)<-%%K%M=F]ME1=C/$HPPXW#G)Z^E=.?"/E:EJMU9:M=VL>JL'NXD
M5#\P4+N1B,J2 !W]L4FH^"K2X31/[,NIM)ET7<MG);*K;49=C(0X((( Y/.1
MF@#B/$NHZI>^!_B-;SZI<LNG71B@90B-Y?EH2A*J,C+'W[9KU'2H'M],MXWN
M9KAM@/F2[=W3I\H _2N<7X>V/]G^(;*;4;^>'726N [)E6VA=RG;G/ ]O85T
M>EV4FG:?%;2WD]Y(@PT\^T,WX* !^ _7F@#S6?4/$D^B^.;M?$MU$^AW<YM/
M+@A^81PJX5\IRO;@ \G)/0;UKXBN]>\3Z9H@G>S231$U6X:# >1G8*J D'"C
MYB<<].>N;J^!XAI_B&S_ +4NC'KLDDER=B90NH1MGR\?* .<T]O!4*2Z1>6N
MH7$&I:7;_9([L(I\Z' &R1<88< \8P>10!P7BS5]5N?!'C71;Z_G:?1+N"-;
MJ,*AN(960JLF!@D*Q!QC/'OGU^UA>WMUB>XEN&7.99=NYN>^T ?I7/7G@?3[
M_P .ZMI-Q/<,^JR>==W8*B1I!MVD<8 78H QC ^IK?L;:2TLXX9KJ:[D4?-/
M-M#.?4A0 /H * . T>2X@?XDS6EPUO<17SR1RJJL59;=".&!!Z>E1-KFNRZ#
M\.[F+5GCEU9H([PF)&$I: N6Z<'([$#VKIK;P<ELOB )J=R3K;L\Y*)^[8J$
M.SC^Z,<YJ$>!8EL/#MFNJ78CT%U>V.Q,N54HN_Y>?E)'&* ,?3TUZ\\3^)O#
MC>*+X6]DEO/!<B*'SP958E2VS;M!7/W<]LCO2M_%6N7O@OP%JYOS'/J.IV]K
M>JD:8G4EPW;*D[!TQU-=E;>&/LOB'5M:BU&X%QJ4<<<B%$*H(P0A7C.1N/4G
M-9</P\MX- T/1H]6O1;Z-=K=V[%8]S.I)4-\N"/F/0"@#,LWFL?B7XSOI;^\
MDBLK"UG\@LA5EVRML^[P!SC&.2<YJ73;KQ;J=MX=UNRF=H[HQ37\4\D0@:"1
M<GRP!N#+D;>><<YKHO\ A%8!XIN=<6\N5-W D%U:C88IPF=I.5W#&X\ @'O6
M;H?P^BT&X2*WUS5)-'AD\VWTN613%$V=P&[&XJ#R%SC(YS0!S6L:A>^+?A=X
MJUO^T9[>$)=QV]M&%V"&/<I#@@DLVTDG/&1C&.?1-#!;PUIH#%2;.(!AU'R#
MGFN;F^'$/D:U8V6M7]GI>K^8T]C&L;(KN,,R%E)4'J0#76:;8C3=,MK%9Y9U
MMXUC62;;O8 8&=H Z>U 'E6D:U>>%_ 7B+5DOKBYN/[;N+2$715D5VG$8D;
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7(121M\:FG VJWAE7)8;3C[03S6#X]UR]\1_"F]U:UM;<:3<31"+>Y\XQB=
M)>F!DC[OH<YSQ0!ZQ52^U.PTQ8FO[RWMA*XCC\Z0+O8G 49ZGGH*GN+B*TMI
M;F=PD,2&1W/15 R3^5>7>,M6U'7?!VB:M]CMX].O-4LI859SYR1F52CGC&6&
M,J.F[J: /5:*XW6/&D\$NK1:5;P7$FE_+)'*7W3R; YC3:IP<,HR<\G&.,TZ
M+QE=2:[X=MI=-%M8ZW;M)%+.S++%*J!C$R8P&QG!SS@T =1?7]IIEE+>WUS%
M;6L0S)+*P55'3DFIU8,H92"",@CO7%^)_$]WI_A+7]5;2;*^L[*4Q1QRRD"=
M5(5R05(X?*X[[2<CBM>YUR>375T/3(H3>+:"[FDG)V1(6VJ,#DDD-Z8 SZ @
M&]17(#QC=QV.E17^F?V=J]^90;>=RRQ+$<,^5&6!RN!@9W#IUJB/B));Z5=3
M:G8K926^H1V)N9 XMF5_NS!B =O7([' SSF@#O:*S='O+R\AG>[CM]JRX@FM
MG+)/&44AQZ<DC'/3J:O3S1VUO)/,X2*-2[L>P R30!)17)V?B36;Z#1=3MM&
M6;2]4D4823]];Q."4F?/!&,94=,]35#5/'UQ!;7U[I=@E]!97+6[6Z[S//L?
M8Y3"E1@[L YSCM0!V U33VU)].6]MS>I'YKVXD!=4R!N*]0.1R:6PU*QU2)Y
M;"\@NHDD,;/!('4,.HR.XS7'Q.D_QIAG12!+X9W89<'!N >16)I.OS>%/!?C
M'6;>UBN!:^(KPM"[E,@S*O! ..OI0!ZJ2 ,DX JK8ZG8ZI'))87D%U'%(8G>
M"0.%< $KD=QD5E77B">U\;Z?H#6T;07MK-<+,'.Y3&5!!7&#G=US7+^%+ZYT
MK1O&5S8:=)?7"^);I8[:,XW%G1<D]@,Y)QT!H ]'HKC;7QE<RZEK^FB"QN[K
M2K5+I)+>X*QRAMV4;ABC J1WZCI5GPAX@UOQ'9V>I7>E6MIIMW9)/$Z7!>3S
M#U4KMP!C)!R>V>3@ '4U4O\ 4[#2H5FU"]M[6-F"*TT@0,QZ 9ZGVKG=6\3Z
MQ;>,4\.:;I-K<2S6#W<4\UT44$.JG> A( R>FXGCIR1R'BGQ/-XC^&FLI?Z<
M+/5=+U2VMKJW5]X#BXB(9&.,A@>/\F@#URBN3M?%5]!XMN=%UJRM;6,:>VHP
MSP3F0"-7"LKY4889!XXJE<^.KNS\,6GBR;3XO[!G9&=1(?/AA=@%E(Q@]5)4
M= >IQ0!W-%<=+XHUVX\4:OH.F:38O+9V\5Q%/-=L$=7W8SA,@_+T&1UY]8[+
MX@1:AX>T"]CMUAN]95RD4K%EB\O_ %A)498 X P!G(Z<D ':T5P8^(4MMH^I
MW.I:?]F>QO8K4W!#BV=)& 68,5!VC)R.<$8SSFNHT:^N[Y)WN%M7A##[-<6L
MFZ.X0J#N'IR2,9/3KS0!J45S>O:]J&FW<\5O:6\5M!9_:6O;QRD3ON($*D?Q
M'&2>V1P<UDGQ]>3VGA*YL=(CD3Q ,!9+G:T+^67Q]W!''WNN,_*>E '=54GU
M.PMKZWL9[R".[N<^3 T@#R8!)VKU. #7*0>/'L;3Q,WB"SB@N-!:/S!:2&1)
MA(H:,*6 .XDA<'O6=KCZJ_Q"\!MJ5M:1AY[EAY#EC&WV=LH21\W^\,=#Q0!Z
M/17/^-?$-QX5\*7NM6]G'=FU +1/*8^"P7((!SU'''UK-7Q=J]CXOT[2=;T>
M"UL]6#BQN(;@R,KJ-VR4;0 Q'H2,\9/6@#LJ*X=O'%]:WVBKJ&GPVRZK?-:+
M9O+BZ@&7"2,O0AMG3C&X<FIM0\972+XFFTZSAEB\/#,Z3.5:<B/S'"D#Y<+T
M)!R>P'- '945QZ^-7FM]*C$%M;WNHV9O@&D>6.*'Y=I.$!+'<.,#&&YX&<U_
MB)J<>BV5VWA_;<2:RFDS1O*R EF $D6Y!O5@>"<8/KB@#T*H_/B^T"W\Q/.*
M[Q'GYBN<9QZ5R#^+=3LM3LM'UB'2]-U&[$TD+/<L\,H1E"HK87YV#9]L=#G
M7QA<7Z_#Q]=:!;36-.A6_5%;<(I$Y=,]U*[E/J#0!V5%5M/O(]1TVUOH@1'<
MPI,@/HP!'\ZJ:YJ%[I]O;&QL6NI9[E(2<X2!3G=*_P#LJ!^9 XZT :E%<1:_
M$*(:;KT]U%#+)I-TEJK6<NY+II OE[2>A)< ]<<\UJ?VWJNG:E<)K.G1)IL5
MBUXVH6[DI&5/S1L#R3CD$=?04 ='17+V>OZY=/HMV-&5]-U0;F,<F9;12NY&
MDSP01P0.A/5N^3>?$.9+)=5L-/%[I_VGR6@A61KAHP^PRJ NT\C.W^[SD'@
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MGT4 <IXD\)RZYK>BZC'.L!@\RWOU'/GVSC+1^X+*H[<%C2^'?"3Z'XDUN_\
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MRX_'I[RTAO[&XL[E \%Q&T4B'^)6&"/R-3;5#%MHW$8)QR1_DFEH \U'PWU
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MN6QMQWQUKEI/!/BU/AY=>"8_[+FMHW06=_)<.K-$)5<*\80X( QD'\*]5HH
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MX>\8>'#-H5E<:9)H!F=[:[D9_M-M&[%BFS&UB"3@DX[GTKT"B@#@?$O@^_\
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M][K3:OH0N-&OH],GCF,ZZ>NZ:-R1Y<;NIR@(^\5(&X8S@<\K!I&KQ?#PVO\
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MR,\9':LS3?%EEJ=MJTT5O=1?V5*\-TDRJC!U7<0/FZ8(.>ASP:W0 J@   <
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M_:A%!;%MZ;MORDX!Y[]..M<!XQ@UW6]%\8:?/HFJ2W8N!]@2WCQ;O "A#Y!
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M V<<EM<1NY=6ED/W<;N1R>.,GB@#UFBD4;5 XX&.!2T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%8/C#Q/%X3\/OJ+PFXG>18+:W4X,TSG"KGMZD^@- &]17/K8^)A8&<
MZS;-J13=Y!M1]E#8^[_STQVSN]\=JMV^K1VFAV%QK=Q#9W,T"&596"?O-H+
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M,SL#D]3]WU_"MN+7-)GU'^SXM2M'O/F_<+,I<[?O8&<G'?TH T**\\O?%_\
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MU# XY P:[Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K@OBQI=[?>'-/U"QMWN9-'U*#47M
MXQEI$3.X =S@Y_ UWM% &1:>*="OM,CU&VU2UDMI "K+("<G^';UW=MN,YXQ
M7,M?O;_&&VDU(-!:WFB^78&;  E$FZ2/T#D;2?9179IIFGQ79NX[&V2Y;K,L
M2AS_ ,"QFI+FTMKV+RKJWBGCSG9*@89^AH \5U^U2#P/X[F!C&DS:W"]CG&W
M=YL7FE/;=N''H:[#4K?3U^,?AU%BMAC2;D*H5>SH5P/;YL?C7=/:6TL2126\
M3QI]U&0$+]!VIOV"S#J_V2#>N-K>6,C'2@#Q35C:?\*X\>C,7E0^*"1C&$!F
M@SCT[_K77:QI]C!\2?"]]HMO$#;65V]Z+-1\UMY8$8.WKES\OXXZ5M^-/"\V
MN^&+C2M)AL;>6>2)FDDR@ 217_A4YSMQ^-=#9V<%I$?*M+>V=_FD6!0 6^N!
MGZXH \9M=:TF1/A]=6MY9VMC'?MY=C%)O^R(T<@VR.Q+%R>.< G( .,UHK!I
M[:)\6&\NV+"6X&<+D#[,I _[ZS^->KK96B !+6%0)/-&(P/G_O?7WIHTZQ 8
M"SM\-U_=+S^E 'GFK0RP>!O"WC&Q4S7NB6L,\@3DS6S1J)T_[Y^;ZK78^&(G
M?3I-3G0I<:G*;MU88*H0!&I]"(U0'WSZU6U;1M7O[Y+&WN-/M_#DD06ZA$#>
M>YW$LJD$*%8<'C/)^HZ3I0!PNOF!?B]X/R8Q(UI?ANF3\L>/Z_K7(20:>WP[
M^*,@CMBW]J7HW87/ 0J/^^LX]Z]C>TMI)A-);Q/*,8=D!(QTYI@TZQ"E196X
M4]1Y2X/Z4 1Z1()M%L) ^_?;QG=G.?E'->0R7UJ/@YXVL3<1"ZBO+[S(=PW)
MF<XR.V<\>M>TQQQPQB.)%1!T51@#\*B>RM7W[[:%M[;GS&#N/3)]30!P-ZMG
M;?$3P +401;[&]3$>!N7RXRHXZC.3^=<[X>N="UGPK;:'XAUB\36K.\/FZ6&
MC2=KI9"P9!LWG).=V<<G)ZUZ^+"S#(PM( R8VD1C*_3CBE^QVOVO[7]FA^T[
M=OG>6-^/3=UQ0 MY(D5E.\C*B+&Q+,< #%>2_#FP\-7?PHTAM1U"*"5%:1RU
M\R!&29F!*[L=AP17KLL4<T9CEC61#U5QD'\*K_V7I_\ SXVW_?E?\* .)\8Q
MIXML-+.@2>5XA13J&FSE@C0QXY9NOR."%VGKN&1\IQD:IXCL[WX8:5J6F1S6
M]GI^HV_]JVT.'EMEC?\ >;@0=Q#X;)!SU/6O4Q;0"7S1!&)-NW>$&<>F?2DB
ML[: ,(;>&,.,,$0#(]\4 >5>(4TO5]%\1ZOX5U:XUC6)=(,,TL$B,HB# [&"
M*!YA7?@?>QGVKJM&UKP?XFU#1K_2FM[J_AMV$*P-\]G$R_,)%!^4<!<$=3QW
MKJ[:TMK*+RK6WB@CSG9$@49]<"B"SM;4R&WMH83(VYS&@7<?4XZF@#PY-6T^
M#X*Z9I\EY MY:ZLGGP%QOAVWQ)+CJH (Y.!R/6NYL;ZSA^,6KI-<0J;S2K3[
M.K,/WPWR9V_WNO:NV%A9!Y'%I!OD<.[>6,LPZ$\<D>M2-!"\HE:)&D"E0Y4$
M@'J,^E 'F_A#1[+Q)X,\7Z-(4-O<ZUJ$7RX.S+_*P^G!'T%:'@F]U/Q!IR76
MH1-%?Z3!)IS>8.&NU.V1_<85,'_;<5V\-K;VV[R((HMW78@7/Y4]45 0BA<D
MDX&,D]30!X[X8NO#VN>%]%TK5]8O/[:T^YCSI6Z-)UNT8Y8 *'(SEBV<8))/
M6NY\;6GVM=(CMM8&DZJEX9-/G= \;R^6X*.IZAD+CUKI!9VJW;7:VT(N6&TS
M",;R/3=UIUQ:V]W'Y=S!%,G]V1 P_(T <WX$U*\U+2[_ /M&QM[6^MK^6"X:
MU8F&>10N9$SS@YY]P>]8=E;:3)\8/%$=]#9LS:=:N%F53E?G#G!_#)KT**&*
M")8H8TCC485$4  >P%<K;>%[AO'.K:SJ%MI\]C>PP11QL2[H8MV&P4QSN]>/
M>@#SW0DGT*W\%W%SN3PTFM7QB,GW(TDW+:LV>BDEB">/F!K?UJRL[GQIXLFD
MN6@T*?0(X-3G@886<NP5L]-RQ<GV(]:]-DABFA:*6-'C889&4$$>A%,BL[:"
MV%M%;PQP#CRD0!?RZ4 >9BXO!_;F@^+;FVN[9M%:0:[8C8YMBQ7$B\@-R6&.
M" >O-5KV?Q0MEX@T*X>VU74/[!DFL=7L5V22Q9QL=0<!SDE2.N#CO7J<-A9V
MT3Q06D$4<ARZ)&%#'W '-+;65K9*RVMM# '.6$487)]3B@#SS0[[PGXFOO#^
MHVFLW-[J-FC&WM$:-7M5*8D$BHJE5 &.>,XQU%5O"\]YH^I>&M/2ZMM=\.WB
M2?V7=@;;JS41$[7QPR[?ESUSC/.!7ID-E:V\LLL%M#%)*<R,D84N?<CK206%
MG:RO+;VD$,CC#/'&%+?4@<T >:>&)[S2-2\-6,=U:Z[X<O?,_LRYQMNK,"-C
MM?'#*%RI/4'KV%8MRTH\ ^.38)YL,7BF62ZBAY+6X>(R# [8!S[9KV2#3[*V
ME>6"SMXI'&'>.(*6'N0.:?#:6UON\BWBBW==B!<_E0!P^NF#5O'/@N]T::*9
MQY\DTL+!@;1H^=V/X2VT#/<UQ5W%8CX,>-YHTMPXU>YPZ@9XN 4P?;M]:]KM
M["SM%D6VM((5D.7$<84,??'6D_LZQ"E?L5OM)R1Y2X)_+W- "7C3RZ5.UBZF
MX:!C V>-Y7Y3^>*\C>2'4_@#!809&MP-' D.<3I?+,,\=0Y;+9]"3TKV1$2)
M D:*B*,!5& *B%C:+=F[%K +DC!F$8WD>F[K0!P-C8Z?>?&#6;>^@M+F4Z-:
M[T=%8,V]]QVG_@/Z5J_% W2?#_4)+6*281M%)/%&,L\"R*9!]"@;/MFNJ6SM
MEG\];>$39SY@0;OSJ:@#@=1U+0_$MG?ZCX3FAOO$!T::&WN+5\M"A&55L'"L
M7Q@$9SGL#6%J$EMK/PF\*QZ,R#58I[)+2-.)(9T*B0$=1M42;O8'->JVUG;6
M:,EK;PP*S;F$2!03ZG'>DCL;2*Y>YCM8$N)/ORK& S?4]30!YU90:?)XW^))
MDCMF*VULI+!>%-N=WT!P,_2L?3;VWMM#^$U[=7,<5M%O1YI7 1#]F90"QX'/
M%>N'3[(ER;2WR_WCY8^;OSQ2BRM1$(Q;0B-6WA1&,!O7'K[T <%H%II5_P#%
M7QF);>UG;R=/95D16(^1B3@]\A3]<5BZ;-!<?!WQ/I6LE?[8ADO5O(G_ -8]
MPSLT3 =223'M(ZX&*]82SMHYC,EO"LISEU0!CGKS2/8VDEVMV]K UR@PLQC!
M=1['K0!YXOVFW\:_#BWU.4'44TJZ6XW-\QD\J+=GWR&_(UT/Q%O;&P\$WLVI
M68N[4O$C1-(R)DR*%9V7D*#@GV&*Z-[2VDF$SV\32C&'9 6&.G-221I-&T<J
M*\;##*PR"/0B@#RNTU&RF^).NB?5K.]^TZ!'\\841.5>3(09.0!ZEL<Y/IEV
MBV<'PS^&DR"".0ZQ9$N, DDL&R?T->Q_8K3 'V6' 3RP/+'W>NWZ>U-.G6)4
M*;*WV@Y \I<#]* /-M,U>R@N?B%I^NW$$.HR74SJERP4RVIB"P[<_>& 1@=S
M[UT_PSGBG^&OAXPRI($L8T;:P.&"@$'W%='+8V<\R32VL$DJ JCO&"5!Z@'M
M4R1I%&L<:*B*,*JC  ] * /)#'8S:1\6I'6!Y!).NXX) %LN.?\ >'YBKEAK
M>G1ZKX9@DGM[*^D\.1N=2N'SOC8H#%$I.TN67<202,#@YX](_LZQ 8"SM\-U
M_=+S^E.%E: Q$6L(,))CQ&/D)ZX]* /'O"*KJ7@#PC#I6OQ:=KMH]T;4RJ'B
M=@[!H9%]2K X'('(KT+P+J5QJGAUY+NPALKJ*\N(9UMV+122"0[W0GJK,2?K
MFMV33K&:'R9+.W>+).QHE*Y)R>,>M3QQI%&L<:*B*,*JC  ] * /.KMIY/B5
MXLAT^0?;SX=C6 *WS"3,NW]2OYBL[PQ>>%_$6F>%HY-8NI=5TZ2+RM,!C2:W
MF0;7#*$#;!\V23@@>M>I"TMEG\];>(3=?,"#=^=)'9VL5S)<QVT*3R</*L8#
M-]3U- '&>%YHI/B5X]1)$9M]EP&!/^HQ_.CX07EM/\-=(MXIXWFMXBLT:MDQ
MMO;AAV/'0UV<=E:12^;':PI)_?6, _G4D<,4(811I&&8LP50,D]2?>@#A[HP
M+\;[%28P[Z!,&!QEOWR8S^ -<-<QV*?!#Q7/&MN'&KSD2*!D$70V\^PZ5[:]
ME:R2F5[:%I#U<Q@GTZTW^SK':5^Q6^TG)'E+C/Y4 <7-?6MK\;$:>XCC%QX?
M2.#<P'FM]H/RKZGD<"N*?7=)N=%\'W5I=6MA91>(T<:>)-SVJEY=S3.Q)#$D
MG' &['.,U[:+: -&P@C#1 B,A!\@/7'I3196@W8M81N?S&_=CE_[Q]_>@#S+
M2M:\/BX\9:!XOFABGN=2DE,-RQ5KJV<*(?+[M\H  7D8%:45U:V/QBMEF*VB
MS>&XHH(I6 );[0?D'/+#(X&:[R2SM9KB.XDMH7GB_P!7(R LGT/44]H8GE25
MHT:1,['*@E<]<'M0!RWQ$O['3_#,<FH6J3PO>VR*99&2*)_,!620J<[%(!/K
MC'>N=\.:E:GXB^+]VJV]T\]A:.LJ;523:LNXJ!U5>!G)QT)KTN6&*>)HIHTD
MC889'4$'Z@TS[';'/^CP\H(S\@Y4=%^GM0!XXD\2_ CP@3*@ O;(9+#J)QG\
ML&O6]96ZDT+4%L"1>-;2" @_\M-IV_KBI?[/LC&$^QV^P'(7REP#Z]*L*JHH
M50%4#  & !0!Y-X7O/#'B'2?"T,VL7<NK:;+#Y>F QI-;SH-KY4(&V#YLDG!
M ]:@OWN9=*^*(T[=-<+?1,T<1!9HQ'%Y@ ]U#BO6H[.UBN9+F.VA2>08>58P
M&;ZGJ:6*TMH'+PV\4;MP61 "?RH \X%SH/B:2/5O#VNW.IZ]%IMPEH(WC!@#
MQG'FJBKM^;: &[XQWI_@_6?">M^'/"MHWDS:QIXC5+(,1/;SHNV1F3(( ^8D
MMP?KBO0[>SM;0R&VMH83(=SF.,+N/J<=32QV=K#<27$5M"D\O^LD5 &?ZGJ:
M /+K6[LDT?XH6%Q-"+DWE[-Y#L-VPVR8?'IGOTJ'4[>WLOA/X1U.SM8?LL3Z
M;+JDD,8+/;+AGW$<D!\$CZ^]>KO:6TC2,]O$QDQO+(#NQTSZXIT<$,41BCBC
M2,_P*H _*@#B-3CCOOBIX:O=,DCE1;"Z_M&2)@RM;D+Y08CC!<DCZ'TKAH4L
M(O@-!<1BW20:PKB1< AA?8!SZA?TKVR"PL[6%X;>T@AB?.Y(XPJMGKD#K2?V
M;8[=OV*WVYSCREQG\J .(NB/^%T3+:/$MV_AA]G(R7\_Y<UF>#-8\,:KX/\
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M-.1+'0H=0N5BDD8K& \4FTY8\!F)(SU!%9M[J&G7O_"VC'<P2K)9QR1_,/G
MM,!E]1GH1QR/6O7KBUM[N$PW,$4T1P2DB!EXZ<&FM9VK!PUM"1(07!0?,0,
MGUX % 'F-]!IQ?X6@Q6VUGX&%P0;8D_7+8_'%4]<\_[;\5(=*4O.(K"0PPXW
M,OE_O<#U*AA7K!TZR(4&SM_EX7]TO'?CBGQVEM%*98[>))#U=4 )_&@#A-&N
MO"?B37]*UBRUN;5+Z&WD"INC'D0LOS"955<#.  W?&.]<98K8P_ [PU<1B!)
M!K$#^8, [A=D9SZA?TKVR*PLX%E6*T@C$QS*$C WG_:XY_&D_LZQVA?L5OM!
MSCREQG\J .&M[VRM/BIXKBO)UC-SIMH8DW8>50)=VP=3CVZ54\*3:AI&N>']
M)DNK37=%N;27^RM1C&V>WB5%.V0#AEP%7=ZXS7I'V:#>'\F/<J; VP9"^GT]
MJ9;V-G:2/);VL$+R??:.,*6^I'6@#C_B/<2V3>&KV7/]E6^L0O?M_"BX(1V_
MV0Y4_7%)Y/G?&.&]TYU,"Z.RZ@\9RIS(#$&QQN^\1WP/2NW=%D1D=0R,,%6&
M0144%E:6UN;>WM88H#G,<<853GKP.* .-^%LT4V@ZL8I$<?VU>GY6SUE)'Z$
M5W-0PVEM;$F"WBB)X)1 N?RJ:@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO?7UMIMG)=W<
MJQ0IC+'U)P!]22!^-6*X3XM6L-QX.B:5-QCU"TV_,1C,R ]/8D?C0!MS>(IX
M?'=IX=:SC\FXLI+I;D2DME&4%=N./O=<FN@KSS5])MKCXJ:'IY,R6O\ 8]T&
M6.9E+#S(^"P.['T/MTR*P;36;O2O"\FG+>R):+XMDTD33RL3%;[B0I?.X#("
MYSG!ZT >PUC>(/$=MH"VD3127-]?2^19VD.-\S]3UX"@<ECP!6;H&@W>B^)K
MR5M2A%G>0!ETR)6VQNI ,B[F. 00" !S@UA^)MUK\;/!UY=G;92VMS;0.WW5
MG(/'L6! 'K0!TMYKFLZ7#!/?:)"\,D\4+-9WAD,6]PNY@T:_*,Y.,_3'(Z*H
MYY(HX6:=E6/@$MTYX _.N"T6-/&5[XOCU229)[349+&V"2LC6L:HNR1,'Y6)
M+-NZGIT&* /0:*\<TO4-2\06OPTN]2O+Q+B]DNH;GRIWC$RI'(%8@'&2 #N
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MEX0]1C=@YP,Y]*UZ* .?_P"$(\/'2M1TQ[ RV>HS-/=133R2!Y&.2^68E6R
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MQCV!QC. 3C.>.E  _A329)9F>*=HY[@7,L#7$AB>0$,&*$XZ@'&,<#BJFJ^
M?#>LZS_:]Y8$WI4)(\<SQB91T$@4@./KVXZ5TM% "*JHH55"JHP !@ 5S;^
M?#;Z;>:<UC)]CO)3+-"+J4*6+;C@!OE&[G P,]JZ6B@#(D\,Z7-JUMJDL4TE
MY;1&&*1[F0X0_>!!;!S@9R#FLR'X<>%H(+6!-/D\JTG\^W5KJ5A"W/"9;Y5.
M3E1P>X-=510!E6WAS2[/7+K6(+8I>W6#,PE?:Q VAMF=H;'&0,X^M.UG0--U
M]+9=1@>0VLPGA>.5XGC< C(9"#T)'6M.B@#&A\+:3;ZC>W\$,T=S>QK%.Z7,
MHW(HPH W87 )QC&,U3G\ >&KGPY!H$NG%M.MGWVZ&>0M"WJCEMR]>QKI:* ,
M_1M$L-!L19Z?"8XMQ=B[L[NQ_B9F)+'@<D]@*J:AX3TC5-8@U:ZCN3?6ZLD,
MT5Y-&8U/4*%8 9[UMT4 8J>%M+26>4_;7EG@-NTDM_.[B,D$JK,Y*Y('W<=!
M27?A+1KU=+$]O+G2L?8F2YD1HN ."K G@ <YK;HH YK4_ 'AK5M;.KW>GDWC
MJ%E:.9XUF Z"15(#CZ@^AXJ76_!6@^(+ZWO;^S;[7;IY:303/"^S^X2A!*^Q
MKH** ,34O">C:I;6$$UL\2Z><VC6LSP/#QMPK(00".",U%#X)\/06VJ6\>GC
MR=4!%Y&97(DXQTSP<#J,'O6^K*Z!T8,K#((.012T 8+>#=$>'3HF@N&&G2"6
MV)NY=R.!C<3NRQQQSGCCI6E?:59:E+9RWENLKV<XN("W\$@! ;\F-)?ZG'I\
M]E$]O<RF[G\E6AA+A#@G+D?=7CK5V@#'\0^%]'\4VD5MJ]IYZPOYD3J[(\;>
MJLI!'YU:TG2+'0[!;+3X3%"I+'<Y=F8]69F)+'W)J]65XA\0V/AG2VU'4/.^
MSJZH3%$7.6(49QP.2!DX% $&H>$='U+64U>:&:._6/RFFMKF2%I$_NOL8;A[
M&JW_  @/AD^&3X=;30VE[_,$+2N2KY)W*V<J<D]".I]:Z6B@#+T/P]IOAVS:
MVTZ%T5VW.\DK2.YZ?,S$D\=.>*L:?I5EI?VK[%;K#]JN'N9MO\<C8W,?<X%5
MD\0V,GBA_#R^=]O2U^UG=$53R]P7ACUY/;/0UJT <S;_  _\,VNNOK$&G>7=
M/+Y[*LSB(R==_EYV;L\YQUYZUHV_AS3+75[[5(H'^UWZJMRSS.RR!1A05)*X
M ) X[UJT4 86G^$-&TPVXMK>40VTAEMK=YW>*!CGE$)(7J<<<9.,5SFDZ ]Y
MX^\77EY;:C;6U\;802I))"LR)"$<':1W'&<'GCO7>RRK#"\K!RJ DA%+$_0#
MD_A7-GQ[HH\)6_B;_2CIUQ)Y<9$#%L^9Y8R/X06]2* +6K^#= US2+72[W3H
MS:VFTVRQ$QF# P-C*05X]*;)X+\/S>'6T&73Q)8,WF%7D8N7_O[R=V[_ &LY
MK?HH P=/\':/INK1ZK#'<R7Z0?9Q<3W<LKF/.<$LQSSZ^@J_J^BZ?KMD+74;
M?S8UD65"&*-&Z\JZLI!5AZ@U?JE:ZG'=:E?6*V]RCV90-))"5CDWKD;&Z-CH
M<=#0!63PYIJ6]Y"R32&]01W$SW#F610" N_.X 9/ (')]35G2=)L]$TR'3K"
M-X[2!=L4;2L^U>P!8DX]JNU2MM3CN=4O;!;>Y1[01EI9(2L<F\$C8W1L8YQT
MH @F\/:;/KT>MO'-_:$<)@25;B0 (3DKM#;<$@'I5/\ X0CP\=(O]*>P,MC?
MRM/<Q3322;Y"<EP68E3GG(QS7044 <_IO@O0]*TFZTVUMYA!=IY<[/<R-(Z8
M("[RVX  G ! Y/J:YSQ)X:2&_P#!NGZ;87S:9IETSR&&21C!'Y;*F'SNX..
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MNDDDO,9['A06(!'WD]\PO<>'_ .EB+4[ILZG=R/)(T+.US/)EF^5 <9Z >@
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M/:O:P6HAW QL%!RV[KA1CC\Z .376?%DGAKQ9,->C6X\.7%PJ3"S0M=+'&)
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MC4JH;Y^F&.<?I56^^&TMYIVNZ:OB"XBL-5NS>^4+=&,4I=7/S'EERHP./J:
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M>E 'H%%(H*J 6+$#!)ZFEH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU8KRWPMKB>'+;QI?7UFD<PU[R4M;=P0\KI$JJI('!)!R0, Y(XKK#XGN=/\
M$UAHNM6<-N=1CD:TN()BZ,Z#+QME5(..0>A]J .FHKDH/%NHWUGIVJZ?HC7>
MDWUR(5:*4F98B2!.4VXV\9QG(!!]0$C\8W3VGBISID0FT!V!3[2=LX$0DSG9
M\IP<8P>: .NHKC'\;WC7/A6&WT99#X@M&N$)NMOE,(A)M/R\CYA\WH#P>!55
M/&^O2VFNI'X>M3?Z)(PNT-^1$Z! X,;>7DL5/0J /7M0!WM%<HWCBUFM=':U
M\A)]4LA?(+N;RTBBPOWB <G+@ #T//%91^)%R-&MKS^PF:9M772IXQ/A=S,
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M"]F,0<';B-2 <O\ -SZ =#71:=//=:9:W%U;&UN)8E>6 MN\IB,E<\9P>,T
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MMV[HY%*@@X;K['BEM_%FI7UKI>J6.B-<Z3J%PL2M'(3-'$Q(6=DVX"< D9R
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MEV-!<6\QDCG4C.X' QSQCGUSS0!IT444 %%%% !1110 4444 %%%% !1110
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M&<X'7G'+;SPYXB@O_&,%C;6<UGKT9>.XDN"K1/Y/EE"FWG) P<@<\^E>@T4
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M;W2;.[GMVMYIX$DDA;K&S*"5/T)Q5JBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>sangamoexecutiveseveranc020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc020.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KC?BI<W=C\.=6O+&]N+2X@5&22!]C<NH(S
MUZ$]*[*N+^+"/-\--8@BCDEFE5%CCC0LSGS%. !R> 3^% '2:AK-GIK+',9I
M)F0R"&W@>9]HZMM0$X]_PK U#X@Z7 - DL/.O;?6)]D<\%O(ZJH#%N ,[OEQ
MMQD<Y'%8>OZA#HOC\:QJ<&HRZ%J.G10Q7EEYQ$$J.YVNL9SA@^1QU_&HM5MK
M338O!]_I^C75EI<.L/,T:P2/(BO&X#N@!9=S'IU&1G!XH ZJP\8V]_XRO] 2
MUNT^R0PMYKVL@#,^\G)VX50%&"V,DG'2K0\7:*;ZTM3<NIO',=M,\#K#,X_A
M20C:3QQ@\]LURZK<?\+$\3P>3=0R:MI5LMG+Y#[=RK(&)8#"[2PSDUE^$KG2
MK_3M&T+4] U0Z_I;0J]M<B<Q0O%@>>'),8  )&/7 ZT =G%X^\-SWPLXK]FF
M^U&S8?9Y,)*%W$,=N%&.YP#@^AQH6/B/3M1NH+>W:??<0F>!GMY$66,;<LK$
M $?,O?N#TKE/!LD:GQP9+=W$NJW$ZQLA7SXC&@!4D<@D,,BJ7A-+K1]?TZTT
MC4;C4_#DMK*[6]Y$3/I6T JF[&X GY0C<\<9QF@#TVL"[\9Z'9W]Y8/<S/>6
M:+)-!#:RR. <X("J2W0],X[XJSX=\0V/B?2_[0L!.L>\QLD\1C=&'8J?8@_0
MBN<L)DB^+FOSR;DA.F6Z"5E(0LC.6 ;H2 1D4 ::?$#PS*EA+'J#/!?,J0SI
M!(8@S<*KOMVHQ/\ "Q!JWJ?BS1])FNXKJXDS9QK+=F*!Y!;HV<,Y4';G!/T&
M>E>7HKK\!K.R^SSB[74%8V_DMY@ O=^=N,XV<].E:GBR^>_E\:Z=]BNX7?3/
M]$%E:,3J.8&^=Y57D*3M"Y Z@[LXH [N^\7Z'IU];V5Q>_Z1<PF>%(XG<R(
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MZUK$%U>JD$\+PSFUN9IA\B@%2BX)X9,#U)KNM>E2'P_J#N3C[/(!@9))4@
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M*!\H"C!/R')ZU:T/7]#T'POJ5_<>(]0U*VM+MX[N\O4=F28*NY%4*"%'' &
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MA<0,BRD'8SJ64'W (S^8KFO OB67Q#X1TK4-2EMH[^]$C>5&=H;;(R_*I).
M /6@#J**@FO;6WFCAFN88Y9/N(\@#-] >M+/=VUJ4%Q<10F0X02.%W'T&>M
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M@9ST^E &G141N8!Y>9H_WGW/G'S?3UI#>6PNA:FYA^TD;A#O&_'KCK0!-16
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M&7T>Q/EQ"!/W"C$8Z)T^[R?EZ4 .\.W=O?\ AG2[NSCDCMIK2*2))?O*I4$
M^^*\\\*3:!K_ (&B_M^9%UBVU)I;Q1)LN1=K,=H'\1)^50!VP!TKU555%"J
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M:OHNG-;M*9S$UJA4R'J^,8W>_6ISHNE&_BOSIMF;R)0D=QY"^8BCH V,@>U
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M()43Q"\D3+@[<O!\RGMU/(]:[.?2]/TSXN:-'96<$"7>DW:W 1 /. >,C?\
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MO!+K(5T8\,##)P?4'ICO7+^(-/E\-ZWXS_X12W^RVG_"/I+<PV@VI'<%R 5
MX5O*#'CV/>O6;_3;'5;8VVH6<%U 2&\N:,.N1T.#W]Z=9V%GI\!@L[:&"(DL
M4C0*"3U)QU/O0!PFEZ=X:U;5] UBRUN.X8020P6UM'$JS0LGS)*JC.U<=#T/
MN:XN#2M/M_@G::I%:0K?6^K*8;D*-\>+\J K=0,$\#CD^M>QV'AK0M+DN)-/
MT>PM7N01,T-NJ&0'L<#D>U-_X1?P_P#8?L7]A:;]DW[_ "/LB>7N]=N,9]Z
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M]&N[]KZYTFQFNWB,+3R6ZLY0C!4L1G&"1CT- 'G(L]/U7Q=\/I+B&"Z,^CW
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MT<"KM;U&!P?<4 <U9W(O?B[J=IJ<0*?V3"^G1S+QY98^<0#WW;0>^ *XF\L
MG@N^MY$#6%GXO2'2V/6*'ST!5&ZA0V]>/0^E>RW^CZ;JIB-_8V]RT))B:6,,
M4)ZX/49]J;<:'I%Y9PV=SI=E-:P8,4,ENK)'CIM4C _"@#ASX?T=?C(+-=,M
M%M9= ,TEN(@(Y'6X 5F3HQ )Y(KDI[2T_P"%=- T:+!9^+VA@Q\OD1_:L80C
ME1@GI7LO]AZ3]N%]_9=E]K">6)_(7S O]W=C./:N7\8>#X[O08=.T'1;&,/J
M$%U<(B)"CJCAFW #YB1QT^M &-J6DZ9X7^)%M=:3;"RLWT6[DU6*R78/*3&Q
M\#^/)(!ZG%9NG2VD/B'X;2P-:6UE);7(AA$@:40FWR/-?(#$D D8 # \GK7J
MMCI=A91O]FL(;<S*/-"H,L,<!B.N,X]*JV_A7P]:K"MOH>FQ"&4S1!+5!LDZ
M;A@<'WH \GGT32F^'GQ'G-A;F6UU6^^SOL&8-NPC9_=Y],=JZGQ1&FB3^'_'
MJQAC:1I;ZFX7+/:R@ N>Y*-AOH378CPSH(MY[<:)IP@N&WS1_94VRMZL,8)]
MS69J.EZM>7BZ)!9Z;;^&#&@D9&(E*@Y:(1@;0K  9SP">] %KPU8+_9SZC<V
MRI=ZE,;Z4,@W(3@1J?=4"+]0?6N*E>\T+6(YKF"UUKP[>:Z3#=1_+=6-RTQ7
M# _?4/E..<<=,"O4ZSHM TB"\-W%IEI'<&0S&185!,AZOT^\<GGKS0!HT444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&M]XKU30?L4T,EA%%*9792)!)NQM )X^7OS[5KS7$-N8A+(J&5Q'&"?O-@G
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ME<)-MGMG))RC@>I/7/Z#%N;P7I]SX:NM#N+N_FBO/^/JXEGWSS=."Y!P. ,
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M0"<@YX)XZ<UKT4 80\)Z>=7U/49GGN&U.!;>ZAE*F-XP" N-O8,>_?FH]/\
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MJ%O,L5U&C,<*S*-I.S:&P,$@XKI-)TJ#1[%;6!YI.2SS7$ADDE8]69CR3T_
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MRO%=2QR*&)3_ %GEJ?O[><Y(Y! S0!U%%<C?>/(8K[2[73M+N]2.JVCW=E)
MR*DJJH;&6;C[P^]C\3Q27GCN.UM9V%A_I5I;I/>6LUU'')$63?Y:Y)W.!SC@
M<CG)Q0!U]%4=&U:TU[1K/5;%BUK=Q"6,L,'![$>HZ53\6>(D\*>'+K69;.>Z
MBM@"Z0E00"<9.XCC)'3)]J -JBN7?QB;<E+[29[&2:X$-D+F:-1<C87+YS\@
M !SGD<#!)Q6<_P 2K=-*UVZ7399KC0W7[=;P3(^(V&1(C=&7&3V(P>* .YIJ
M2))NV.K;25.TYP1U'UK,.LDW&F10VPG^W1--NCE&$0 $M[CYE'U8?6L#1/$V
MB6FBZWJ4.F/IL<.KRV\\)*;YKHLJD\';EF8#.<=R0* .THKCH_'T;:I?:5]@
M\W4;>S-]#%;7*2K<1@X(5AC#@_PD#ZXYIP\>PM8>&KY+!S:Z](D4,GG+B*1@
M2%?WP".,\@B@#KZ*H6>I/=ZI?V@MBL=FRH9MX(=BH;:!UR RY^HI^JZ@-*TF
M[U!H)9UMHFE:.+;N8*,G&X@=/>@"Y17"P_$I#_8=S=Z%?VFE:QY207\C(466
M1<JK*#N [;B #C(XYJY#XWGN]=O=*M/#NH2O8W<5M=2;X@(E< ^9][D8(.!D
MXZX[@'745Q4_Q*TRW^PW31JVF7MRMM'<I<(74L2%=H^H0D=<YP1D"F7/Q#F7
M^V!9>%]3NVTB8QW85XEVJ%#%A\WS<'A1D\<XXH [BBN;B\80:A%H[:/:R7AU
M6W>YA9CY<:(H&=[8.#E@,8/.:SW^(UHOAK3-;72[V2*]O18M&FPM#)YAC.>>
M>0<;0<\=,T =I17+?\)B\?E6UYI;6&I3-*8[6[NHT'EH0/,+@D $L  ,G/;
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M.LM\0M-UB;1YH[6/17M)&$\3;)&D5P,;LGA<$@8SZCFNXHH XGPEX>N3X?\
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MUD<\LY]RQ)/UJ[110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4XWFO /LY56,<A*[@!)C;NQSC.?:GWGBW1+">:*YO=GD2I#/((G:.%VQM5W
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M%8+#4[BTBU'4/LMPL:H=R;2>-RG!XJUX2D\.ZGJ5WK.@6]U+YT2QS:A<-/\
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M8(Y!^E '<WOC+P[ITZ0W.JP+*\'VE%3+EH^,,-H.<[A@#DYXJ-/'7AF3P_\
MVZNKPG3O,\HR[6R'SC:5QN!Y'!'<5R4C:;HGQ%\))+ NFVD6BW$<4<SY$'S1
MX5F/0XXY/4XR:PO$E@%\)>/]0@C(L=6U&V:RB"G]_L:/S)%7N&8,<]PN>G-
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MQQZ?%+$+<VY8N)-NX[]XP?E&.*Z+I2 @D@$9'6@!:*3(SC(S0""2 1D=1Z4
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M,/*X61K<LV0(L\,/3/4GFP+<1W'Q/L)$MX8DT^&9;>T)6..0V\A)7IS\JDG
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MJ?EVD;D],X-)/>^(]$_X0_77UVXOH-5N+6SO;&6)!&!,O#I@;@0>3DG/L.*
M/4**\OUS7M6T]6OH-5FNI8]=CMV:W4?98X&E">0P;&YP#R5R0W<=*TO^)SJW
MQ \1:*/$-[:V4-G;30B!(@\;/OR%8KTX[@GISZ@'?45Y4GB'7Y_AAX=\8'4)
M\VS(^JQ0HO\ I%N'*2-C;PP W<8XS[5V^EW<FJ>(+^[M[QWTR"..")%(,<DI
M&]W!QD@*R#KC(:@#>HKF-<U:=O%^B^'(IWMH[R&>YFECP'98]H"*3TR6R2.<
M+QC-9&JZAK?AFVL=+N-6%S+JNMI:6MT4'F6]L^6PV1AG 5E!([@\XH [ZBN(
MDO-2TGX@6OA\:A<S:?JUC++"\FUY;6:,C)#$'*D,.&S@^W%<MIVM^(O^$$\*
M^*)]?NIKBXU"&WGMS'&(I8Y)RC;@%SNQT(( P,"@#TK5-=CT^\CL(+6:]U"6
M%[A+6$J&,:$ L2Q '+*!ZD^Q(9X=U]O$%M+<'2-2TY$90@OX1$TF5!) R3P>
M/PKE[FQDD^-T&+^[3.A2284KP/M"?*/E^[^OO5*X\8:GX?TSQ_?7%T]\=)NX
MXK,3*H";T3:#M X#/SWP* .UU3Q%!I6N:1I4UM</)JDCQQ3(%\M2JEB&YST'
MI6S7G&OZ;<67C;P&\NJ75VS7<PE\XJ59_(?YP !M[\#CIQ3(]0\5>)]#FUC0
M9S!>+>RK;K).@MQ'',4*2)M).54DGKD\$#B@#TJF22QPA3(ZH&8*-QQDDX ^
MN:X&(ZWK'CCQ+I!\0WEK:06EK-"+=8MT3.')"L4^[D=QDX'/7//MJ.H>)/#O
MPTU.\O[A+FZOU28PD*&8))\^,8W?+]!DX% 'J@OY#K9T[[!<^6+?S_MFT>23
MNV^7G.=W?ITJ[7'0W^HP?%6;27U&66P&ABZ2*54 23SMA;( )X7OZFL&RUW5
MH-7\(G^U)[Y=1N)H+VX50+6X/ENP\D$!@%*C# 8([F@#MM(\1P:OK&KZ9';7
M$,^ER1QS><% 8NNX%<$\8P><=:V:XKPK_P E'\>_]?%E_P"DRU:US6)W\:Z+
MX:AG>VCNX)KJ>6/ =E3 "*>V2<DCG XQF@#JZ*\NU;7]<TN#QSI"ZG.9-)L5
MO["]*(9 C(Q\M\K@X*G!QG'>NQ\+66H16BW]_K-S?F]MX9!#*B*D#;?FV8&<
M'(ZD].M '045Y_<#6]7^(6MZ''XCO;*QBL8+B/R(XM\;,SC"L5/'RC.03VR*
MP(O$OB>X\.:*DNK-%J,/B<:+=S)"FVY568;R".#P.A /- 'K]%<);SZA#XSM
M?!LVM7MQ&FGRZE-=N$2:4&4(D>Y0,!>22 ">.@R*Y[7/$_B'3?#WC6P35)A>
M:!<6WV>]\M-TL,Y4A7^7!902-PP>A^H!ZY17G]U+KWAWQ]H<$NN7&H:?KAFA
MFAEBC7[/*J%U:+"\+P1@Y]R33/!D>O:Y]LO;OQ/?;;+5+RT$210@2(I**6^3
MJ.",#''3DT =MI-_)J>F17DMC<V+R;LV]TH$B88CD D<XSUZ$5;=UC1G=@J*
M"68G  ]:\PT/Q9J]QX(\)+-<O/J.LWL\$MSE4;:AE; XV@G8JCCH3CG%1>+K
M7Q+:^"/&*:A>RKIOV82V/^D!KA>,21NP490D\=\<$T >JJRN@92"K#(([BEK
MC+LW-H^@V0U>Y>&6&1GM8L?:KEMJ[=K  *BY.22H^[D\UR[^)?$,WPNL]235
M)8=0CU<63R-'&3*GVGRP' '7&,E2,^M 'K=%>>>(H];\(066M/XCU&^TV#4
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MH^,?#(MKBY'B#3&AME#3,ETC; >F<'OVK8BE2>%)8V#1NH96'<'D&@#E-1\
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M%@:7RAE74*0V$&>!R>I]:VO$&@V'B;1+C2=21FMIP,E&VLI!R&4]B" :TZ*
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M;QV[A_+955,[2,IG(R>23G-= 2 ,DX JEINKZ=K,<\FFWD-U'!,8)'B;<JN
M"5S[9% '+!--\!>'++PNEOJNK1W$<T5M$;?S=^>2CLBA5!+=6[9R<"M[PMH4
M7AGPOIVCPXQ:PA6(Z,_5C^+$FMBB@#G_ !/X2M/$WV*=KJZL=0L)#):7MHX6
M2(D88<@@J1C((J&Z\$V%_H)TV^N[VYF,ZW7V]Y!]H6=<;9%(&%(Q@ #&.W)K
MIJ* ,6V\/>7?MJ5U?SW6H_9S;1W+(B^4A.3M4+C)(!)(/0=N*R$^'=E'X5T[
MPZFJZD+.PN%N87S%YFY7WJ"?+P0&]J[&B@#!;PQ&WBV+Q&=2O?M4=K]D$7[O
MRS&6#$$;,Y) YS55? NFNFOQ7=Q=7D&NMNNHIB@4$*%!3:H(P .YZ9KI)[B&
MU@>>XE2*&,;GDD8*JCU)/2HM/U&TU:PAOK"=+BUF&8Y4Z,,XR/RH Y>#P!ME
MT>2Z\1ZO='2)"]IYAB! V[<,0F6X.,GGZ<TB_#NSAUB\N[/5M4M+&^E,UWIL
M,P$$SG[QZ;E#=\$9KLJ* ,&#PO';>(=3UJ'4;Q;C4(HX9$Q&414!"[1LSD;C
MU)ZUFQ?#RQ@\.:/HT&IZC&ND7(N;.Y!C,J,-W!^3:1AFZK7844 <\WA&UD\1
MR:U+>WDDDFG_ -G/"S(4:'.>3MW9R2<[JRK;X;6MO;:/ =<U>1-'FWV6Z2,>
M6FTKY?"#(P<9/S#L17;44 8NE^&X=*U[5M7CO;J:;5&C>>.79L4HNU=N%!'R
MC')-&N>&K;6KK3[[SYK34=/D9[6Z@QN3<,,I!!#*PX(/Z5M44 <W=>#+2]TS
M6+6XO+HSZP@CO;M=@D9 NT*HVE54#...Y.<G-;6FV7]G:;;60GEG$$:QB27;
MN8 8&=H S^%1Z?K&G:L]RFGWL-R;63RIO*;<$?&=I(XSS5Z@#SN&.2Z^,6LM
M;:A):DZ;!$K(BLLC!G++\P(++D'CIGFMJY\!Z?-INEV,5[>VT>GWHU!7C*%Y
M9P2Q=RRG))9B<8ZUU5% &'JWAF#4]4L-6BNI[/5+%62*YA"DLC?>1U((93U]
MCR"*Y+XC:+;Z9\-/$"1/-<7^I2Q22RL 99W$D8X"CHJKP . /J:[O4]8T[18
M$FU*]AM8W<1H9&QN8G  '<_2KU &%:Z'%<7]IJUQJ,NH2V\+)9R,$"QAP S@
M* "Q  STQG &3DT#PS'X=M+ZWMM1O)1>7,ETSS>62DDARQ7" 8SS@YK=J"\O
MK33K9KF]N8;:!/O2S.$5?J3Q0!RG_"MM*/@VV\-/>W[0VDWVBTNO,59[>3<6
M#*RJ!G+-U'>K:>"K>;P_J&EZGJ>H:DVH0F":ZN)%\P)S@+@!5QDGIR>N:N_\
M)AX9V!_^$ATK8V,-]LCP<].];5 '*-X&0WNEWZZ[JJ7]C"UN;D-'NGB;&48%
M-H'RC&T ]^O-5?\ A6M@-!?1DU;55M6OOMR_O(V9'\SS  60\;N><D]S7:T4
M <QXJU:WM[3^P);"\U&ZU*VDBB1;=FCD)&W$C@;4'.2>,#)]*UM!TB#0-!L=
M)M^8K2%8PQZL0.6/N3DGZUHT4 8NL>&X=8U?2=2DO;J"33)6EA2'9M9F4J=V
MY23P2."*IIX,@1_$#C4[_.N#_2<^5\GR;/D^3CY>.<UTU5--U2QUBS%YIUS'
M<VY9D$B'C*DJ1^!!H P)O MM-I&@::=5U%8=#EAEM2OE;F:)=J;_ ).< XXQ
MFK5SX6C?7QKEE?W%EJ+0"WN)(U1EN$'(WJP(W ]",>G(XKH** .6N_ FGW.E
M6.GQWE[;):7PU#S(BA>:X#%][EE.26))P!Z=.*O:CX:BU+7](UB2_NXY]+\S
MR4C\O8Q==K%LJ2<CT(K;HH YJ+P;!#+K\BZG?EM;_P"/C/E?)\FS*?)Q\HQS
MFJL'P_MK231I;/6-3MYM+M#8I*C1;I;?CY'RF/X1R #[YKKZ1W5$9W8*JC)8
MG  H XY/AQIT7ATZ-'J6I+$E\+^WE,BE[>02&0;<K@C<3]X$G/)Z8TV\*Q/X
MCT_7'U*^:YLK=K=$8QE75L%BWR9R2 >",=L5IZ9JUAK-H;K3;N*ZMP[1^;$<
MJ64X(![\U<H Y1/ =G#;:AI]O?7<.CZA*TL^GKMV9?[ZJV-RJW< ]SC&:O'P
MM;CQ5'K\5Y=13Q61L4@01^4L18-C&W.<@=^U;M% &-X<\.0^&K6ZMX+RZN4N
M;F2Z8W&S(=SN;&U1QFH[WPS'>^*;+7SJ%Y'<6<3PQ0IY?E[7QNSE"3G []JW
M:* ,/1O#,.C:GJM]'?7=PVIRB:>.?R]@8 +\NU01P .2:S[?P#8VVFR:.E[=
M'0GF\[^S6V%%^;>8PVW=Y>[G;GVSCBNLJC9ZQIVHWMY9V=[#<7%F56X2-MWE
M%LX!]^#Q0!17PS$GBNX\0I?W8NIK06AB_=^6J EA@;<Y!)/)K*;X=63>#I_#
M!U74OL,TYG9\Q>9DR>:0#Y>,;^>E=C10 V-2D:JSL[ 8+L!EO<XXIU%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7'?$R_U/3O"@FTRYC@9[NWAE9D+$H\JJ0,$8Z\^V>G
M4=C7/>-= N?$GAF73[.:*&Z$T,\33 [-T<BOAL<X.W'% '.:O_:B?%30Q +2
M6_.CW0+L&2(?O(^<<G'MGGU'6K%GX^N?^$>,M[:0?VO_ &R=$6*)R(I+C?M#
M GD+CYCU/!K0;0M:F\;:9KT[6!2VL9;:5$D=22[*V5^4\#:!R>>O'2L4_#W4
MKC1M1@ENK6"_.NMKFGSQ%G6*4MD*X(&1U!(]>G'(!MGQ+?:7XL@T'5H89S>V
MLEQ97%I&R>8T8R\11F;G!!!SSZ"J_AGQD^OVD.I)=Z=+8_9WEO8H@RS6+@ [
M'!8Y_B!.%^[P.:M/H&I:IKEIK6I_9+>ZT^TFALXK:5I%624 -(695/10 ,=R
M<U0A\%3WGB.SUK4K;3[6ZCM9;>]DL';-_O7;\X*K@#ENK'.!GB@".#QKJ]Q_
M8E_;Z5+=:?J4L:R016,XEM8Y!E93(1L8#C< !C/!/6ND\4ZY_P (YX<NM5\K
MS!!LW?*6"*SJI<@<D*"6..P-<]X8\.^+]#BM]$N-6TZ;0K0A8+A8W%VT2GY8
MS_ . %W#)Q[\CJM8BU";3632W@6[WQL/M&=C*'!=3@$\J&'3O0!S\NO:Y+X<
MU+5-'?2=66&%9K.2WW;+D $NF YVL,#')ZCUXL6?B2;5;7PW+ILEM-_:D9GF
M)1L)"J99@-W!#%$P<\M[55T/0+/PCJ6LZS<MI^D6E^80;6&?$".N07RP4!F+
M 8 '0=2:C\ Z%;:?-K%_9SM+I]Q=R+IZ\;(H=Q9PG^R93)CU 4T .\/^+[GQ
M%>JMI-I_[NYFAO;!E9;FT50X5FRWS994_A ^;@G%9.@>*-4T_1O%>L:S/#=I
M::O/:I'%$R%G#1Q1JO)PI.!C!/.>:T3X.O[_ %O1=5U&+3H=1TV??)J-H[>=
M<QA67RV78!@Y&<D]#@#/$!\ WUSI7BG1KJ^MTL-6O9;ZVFA5O.BD=E==V<#"
MLHZ=?:@"_:^(]>/B)=-?3?M5M/;-)%>+9SVT<,J_\LY"X/!'1A],5AP?$#Q#
M)X1T/Q.^FZ=]BO;E()[=9'\WYY#&&4G@8..#G/MTKH]#M?&:H#K]YI,IMT(B
M6R$B?:&Q@-*6'RCV4'GGMBL&/P+K47PYTCPR)=/:XL+J.=IO-<(ZI+Y@ &S(
M)Z>W7GI0!L6GB76+?Q;>Z'JUG:.RZ:=2MC8ER2H?88SNZMG&" ,^E.\(^*9_
M$ZVUW;W6FW-G+;L]PD 99;2;*XC<%CGJ_.%^[TYHN_#^L3>-Y->ADLXD.COI
MZ#S6+JY?>'^YC (QC\?:HK#PE<_\)?9>([JWT^RO(;>2*[>P=C]M9L8+@JN
M,$_Q')'/% '95YW\6[2"S^&=[';QA%>^@E8#NSW"LQ_$DUVFBKJRZ5$-<>S?
M4,MYC68818W';C=S]W&??-8OQ \.ZAXJ\,/I&GO:Q-)+'(TMP[ +L<-@ *<Y
MQCM0!%\2;.W/@/Q%>>4OV@:7-%OQR5(S@_B/Y^M5=+\0ZO8ZWX:TF_M;,6.K
M6;_9S$[&6)HHU;YR>#D>G0]SU.WXITJ_U_P=J.DPBVBNKVW: EY&*)N&"<A<
MG\A6;/X;U:?6_"5^?L2IHL<J3KYSDR%X_+^7Y.V,\]>G'6@"A/X[U.73XM8T
MG3)+^Q:Y\O[)%8SM,\(<H9%D V9XW;<=/XLUWQ^Z?I7!:+X6\5^'WFT:PU73
MCX<:9WADD1_M=LCL69$Q\IY)PQ/&<X/2NZN#,('-ND;RX^59'*J3[D X_*@#
MRKX::W>:9\'[!H=!O;I(Q/B96A\K'G/DD&0/@=_ESP<5U7B?7+KP5%I4\=M;
M_P#"-I(EM=R!',EHGW5;@\KT!/4<=:K>#M!\3>$?"-KH21:1=-;^85G-U(@.
MYV?E?+/3=CKVK2ET&_U2*SL-<:UO-.$#->H&8>?.?]G&/+7)P,Y^Z?X>0!MQ
MXDOM+\-1ZEJ=M']INKA(;2VB1@?WCA8]^-QS@[F !Q@@9[YS^-[[2+G53K.G
MRR:;9V!O8]0ALIK=&(.#"5DS\_0@@X(/:JT?@?6[CP._AV]U.%);.=9M)OHV
M:22'RVW1!P5&[;C;D=1VXYT/^$>\1>(M!O\ 3?%UYIRI<6K6ZIIBOMRV/WC%
M^XP,*!@<]>, %^"]\3C4[".>QLWLKR!VEEAR#8R!05#9;]Z#G&5"\CM6!+X\
MU./X<WGB86MI]HL[Q[=X<-L<+/Y60<Y!YSW]*U_#.F^+[5;:VU_4=-EMK-=J
M26:N);G VJ9-W"\<D#.3CD#@\Y>> ?$<OA36O#-O>:6MC=7K75M._F&3#3"4
MJXQ@8YY!.>!@=0 ;#7VM/\7CIJW=O]@CT@7"PF)NC3!6R=W+?)P<8 [=266G
MBC7+S0O%5U9Z;8C4-(U":!+=2S+.(T5OO<'<<\''8#'>K\GA_5AX\MO$,-Q9
M&-M.%C=QNK C$GF;D^N2.3QUYZ5+X3T+4-$N==>]-JRZCJ,E]'Y+LQ0,JKM.
M5'3;U]Z #3_$,^KV?AV>PDMI!J47VB<F-L+$%!8K\W!#,JX.?O9[8K%E\=ZG
M-86^L:5I<E]827.PVD5C.TS0[ROFK(!L)XW;<=.-V:V/"/A$>%Y=3 N/-@FN
M&-G%VMX"2_EC_@;O^&WTK(T/PMXK\/&31;+5=./AOS7:&1T?[9;QLQ8QKCY3
MU(#$\9SCM0!W-P)S;N+9HUFQ\AE4LH/N 0?UKR+P]J^HZ+\';#7IH=.O1;W1
M>-)H6+AY+ID9MV[AOG)R![5Z_*91$QA5'DQ\JNQ4$^Y ./RKS^#P'JI^$\GA
M">YLUNT.^&YC9F1F$WG#<" 0,X'&?6@#?N-?OH/'D.@)#;R0SZ=)>1N=RL&1
MU7:3R,'=G.*YFS\6^,-9\'W6N6UKI%G!%!>;V9I)'5XF8*57@$?+CDCGG&.*
MUH= \2S>,['Q'>RZ4K06$EK);0F0C+,K<,0.Z]2.,]#C)D\.>%+_ $[P)>^'
M+^:VWSBY59H&9@!,SMR"!TW_ (X[4 <MJ4VHR^!_AQ<W+Q75U)JFG21XRF[,
M#$;V)/.>I'Y5T47C:\TRX\3V_B"WM@VBVT=XKV1;$L;AL+AOXLKC/0Y'2JS>
M$?$,OAWPIITTNF-)H=Y;SL4>15D2%"@ ^4\MG.> .F#UJS?>"KK5]<\2RWSV
MZZ?K5A'9CRI&,D>S=AL%0#RV<9[=Z )8/$NO#7["SDTLW-I>QONFBL[B%;.1
M5RJR.X(93TW #GM3?!WB/Q)XFBMK^>QTRWT[S;B&?;*YEW1NRJ4&,$<8.<'J
M>.E3>'M/\:VJPV^NZCI=Q;VBXCDM5D66Z(&%\TGA1W.T') [9!L^!]"O_#F@
M-IU^UL[BYFF5X'8@B21GP<J,8W8]Z +6NZG?V%U916R6\-K*)&N=0NCF*W"@
M;05W*26)P.>,&L'3?'TM[X8L;QK6'^TKS4FTN*-6(B,BNP+\\A=J%L=>WO6C
MX@T+6+SQ/HVKZ;<6;1V2RI);7F[:"X $B[?XQ@CG'!(R,USJ_#K6?^$:DLO[
M5LXM1M=8?5=-N(XFVAR[-B0$]"&((&<>K4 7_%-SKC>$?&=GJMG ;:+2I7MK
MZ#Y%FS$VY3&68J5(ZYP<]JM>$M8NM6T[38])>T?3;2TCANIW!8F8(N8TP>PZ
MD]#@#/.%O-&\4ZUX5U:RU6XTM;V]M'M(XK4R""(.I!<E@69N1Q@8QCN3531?
M".L>'=:M;[37L4MYK1(=5M#*^R:5 %6:/Y/E; YSU^O- %&?QSXF&A>)-5AT
MW2Q'H5]-#*CRR$RQQA20IP,-@DY/'08[UT;>))M0U^+1=)\F.<V"W\TUPA=8
MT8X1=H9<L>3U& .^:Q3X-UIO#'B[2B]@)-=NY[B-Q*^(A*H7!^3DC;^.>U7(
M_"VJZ?X@T_Q!I[6;7BZ>NGWUK+*RQRJIRKHX0D,#ZKR#CCK0!0NO'^J1>&-7
MODL;9=0T*\^SZE =SJ8\C][&00<;3NP>P([9.N/%4Z?$.V\/2R69L[NP-Y;S
M(K;W(."GWL=,MGN ?K5K1_"T5K:ZU_:'ESSZU,\MXJ9V!64((QGD@*,9.,DD
MX&<#G!\,YV\)Z5ITFJ,VIV5TDAOAD,80/** XX_<?+_O#/?- $?BJ\NM1T#P
MK>W8A_?>);)X?*4J#%YAV,<D\E<-[9QVS6QJWBR_^UZO;:+ LDVEX5E>SFF$
M\I0/Y8,?"<,HR<\GIQS:\7>'[W6K;1H=.^RQK8:C!>D3.R@K$<A!A3U]>WO6
M=<^'/%&F>*[[5_#5[IGV;5-C7EIJ"R$1RJH7S(RG7( R#C./R +5GXLO-8O]
M/TNSL_L&H3:>+^[2^C9C:J6VA"@*EF+;NXP%SW KE_#OB&?PQX5\9:I=6\4M
MTGB2:,QQL1&9',2 Y/(7+9]<5T-WX5UNS\567B/1[VUN;S[%]BOXKXM&EPN[
M>'4J&VL&)XP1CBL+4]'U#P_X4U^SU*_T@2^(=8W6_F1L8MTI7*.6/ VHW(Y'
M8DXH Z5/$6K6_CI?#EU#8RPFP^WM=H7B*H&V%=AW9.<'.X#!]JSD\<ZK<V^E
M:K8:5+>:=?3(K6T5C/YT4+])?,QL; P2N._#'&:31(];TS7;>WU2PT&9-04P
M--97DTMPL:JS#/F@DQCI@-@%O?E_AOPQXM\/Q1Z$NK:?+X>@?$$Y1_MBQ9R(
M_P"Y[;NH';I@ M67B^XU37;S3K.:P6YLK_[/-ITRLMQY(8 S*=P!!'S#"XQW
MS72:U=WEAHUW=:?8M?W<49:&V5@ID;L,GI7*ZMX.O]>OK6:_BTY+BSU$7-MJ
M<+L+E(1)O$>W8!]WY#\V.^"16[XOT:[\0>$]0TJPO!:7-Q&%24YQPP)4XYPP
M!4^Q- &3IGBN]N?%EWX?+Z=>RIIPO8I[8M&@8/L:-N7Z'!R/RK%L?B!K\_AO
MP_XBN-.TY-/U"\CM9XD=S*N^0QAU[  XX.<^W2M6S\.>(H?&%OK\CZ.@72OL
M#VD D"IA]X"G'3WP,#L>M9T/@76X?A]HOAP2Z>T^G7L=RTWFN%=4E\P #9D$
MYQ[=?:@#??7;_5]2UJQT9;0)I>(I7N59O.F*[B@P1M ! +'/)Z<<U?A/_P D
ML\/_ /7M_P"S&F6_AK7M&\4:M?:1-I[Z?K#+-<073.&MY@NTLFT?.#U(.WZB
MM/P+H5[X9\&Z=HU_-;S3VB%-\ .W&2>_)Z]<#Z4 8OB7QKJGAZWU"^GMK.&"
MTNTBBLYB3/=PDHK2HP;"C+G *G[O)YK8NM>O)_%TWAS3EMXIX+ 7KS7*,ZMN
M<JJA01Z$DY]!BN9U;P'XCO\ 3/%&FQW^FM%JUX+N&YF5S, &1EB;' 5=N 1G
MCL,TW68]6U?QO)'IMSH4M]IUBD%S'<R36[*TA+MM:,[F4KLX/ [<DT /C^(>
MMS^#]$UZ/1[('4M2CLO)-RQ*AI#&3]T#.5..<#@\]*V7\1ZS9W=MI&H162:K
M<+-<>9:0S7,4<",JJ2@ 8L2X'4#@G/0');2]9\1Z!I^GPV>C6;Z+JT$O^BSN
M;:18=KA8_DR.3M/H5/7ML>*/#FLWFK:9X@\/7EI;:O9(\+Q789H)XGP61BHW
M#!4$$"@"G:^.-0%A%#J.DRVNIS:B]A#FVE\N954OYZIC>5VJ?EZYXR.H9+XX
MU73+#79M3TJ3R].,+0WRV<T4,T<C!6;8_P P\O)+ $Y XQ4^L^%?$&M:19W3
MZK:P>([*[%Y;211M]FC(4J8L'YBA!.3U)/3'%7HK3Q?+I4TM[=:4-3+1"."
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MA<AUP< CN>15G1_"_B/1K*^M_/TF\2YU::\>*171)H9=Q9&X;!RRD#!''4T
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M/SP< &K?Z=9:K9O::C9P7=LY!:&>,.AP<C(/'6IXXXX8DBB14C0!511@*!T
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M+ZR$^WR_*=(6'S(Y8 @A<^W?'?H-&@U'POXI\1-/IUY=6.JSK?6LMN@D*R%
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M*/<LCF%!L+=%[<M@8/7K7I=8VB^'(-#O-2N8+NZF?49S<3K,4(\S &1M48X
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ME//A>+</X=P(S^M<3X)O?$MAI.G^&+_P[<0W.GJEO)J!9#:O"G 93NW%BH
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M-B9%VB;; $(!/0[AWQUKT^B@#SW5=-A\0Z9HD.L:#JUKY5NS17MM_P ?-C*
M@&/+)(W?-V/W1D#M<TK6==\/Z%X>M=>L+N_N;J<V]Q>)M_<!I L+2C/WB&0'
M'<'\>VJ*6VAFFBEE0.\)+1YZ*3QG'3/OVR?4T 2T444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7,QGLYE7R+J/:^U8_ERI7Y2.<,!G))X /6M0O[72]/N+^]F6&UMXS)+(W15
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MU1\H]\GWKJJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7GBJ#Q/8W7BS3-8$(AN9[?2@1<* !\RL",X ]1P..*]YHH \,UOQ)X6UO5M
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MD[#LSDL^W[S]L\#':O:Z* /)KKXEZ+<^(K/5=OB-4M8W1+7^RB4.[&YB>N[
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M\9[-(F22*1+#865 %5,* . .#UZ]<U[Q;3K=6L-P@8)*BNH88(!&>1V-2T4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117+Z[J\DWBO2/"]M(
MT;7<<EW>2(<,L"<!0>Q9R!D<@!L<X( .HHKG[[Q19:7>W&FV]E=7<UC:"YGB
MM53]S%R%^\R@D[3@#)X^E4M>U83^"QXOT.1G:VM?MT6<J)X0-S1N/=<X[@X(
M]P#K:*JZ;?P:KI=IJ%LVZ"ZA2:,GNK $?H:M4 %%%% !117GMH6C^-.J0M<7
MC6L6CQW*V_GR,@D,A!8)G&<#TH ]"HKC(_B9H\FGP:B++5!827/V62Z:VPD#
M^9Y8WDG(!;TSC(SBKTE]I/\ PL-;7[->MK<>EO(K#*Q-!YBY RP4MN(YQ^(H
M Z6BN6;Q[I:>%&\1FWO?L$<YMY1L7?&PD\OD;NF[CC-37OC.RL]?GT-+'4KK
M4(K870B@M\^8A;;\I) Z@\G XZYP* .CHKG[/QEI5]H%CJ]OY[)?2>1;V^S$
MSR@D&/:3@$%6SDX 4G..:Q]?^(:6'AKQ%=V>G77]I:. D]K,$!B+KE')#$,G
M?Y23[4 =Q17)ZIJNF2:AX:75K#48;V>[_P!#7.%278W+E&VD8SQD_2M+3?$M
MMJ>MZII$=K=Q7>FA#.)50 AP2I4ACD$ \]/7!H VJ*PXO$]O<6=E+!9W<D]Z
MC2V]J GF/&N,ORVT+\R\EA]X>HJ;0/$-EXCLYI[,2H]O.]M<03+MDAE7[R,
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M]2M$65[:Y"[FC;HZE692,\<'@]:BUKQ=I^A:K8Z9<P7LMU>K(T"P6Y?>4&2
M>YZ<#UYP.: -^BN1M_B+H\^AZMJ;V^H0-I+%;VSEM\3P\9R5!(P0"0<XXJ>W
M\<Z?-;R3M9:E!%F!;=YK;:+MI?N+"<_,?7H!UZ<T =/16%;^*;>;4;O2WLKR
M#5+> 7'V*4)OEB)QN0ABK#/'WN#UJ.P\8V.I>%XO$%K:WCVLL@BCCVH)68R>
M6!M+<?-Q@G- '0T5R]OJ>B?\)OJ:^5=PZG;Z?&]S++N$0A#,1@9P3G=R!VZU
M=L/$L.H2VP6POHXKJU:[@F=$*21C;TVL2"0ZD @'\J -NBN0\/Z_X>L_"DVI
M6*W<%B;Z6/RY]S2O.TI4JH))R7. /Y5IV_BFUDU>72;FUN[+4%@^TI;SHK&:
M,'!*%&8-@\$9S[4 ;E%<9;_$O1[FPL-02SU-;"\N/LWVI[<".&3S#& YSD98
M=0#C(S@\5KWOBBVLY[^..SN[H:?M^UO;A"(BRA@""P)^4@\ \'ZT ;E%-=TB
MC:21@J*"S,QP !U)KG!XVTT+I]Q-;WD&GZC(L5I?R(HAD9ON=&W*&[%E /XB
M@#I:*\^U>\DUCXF#P[?:5=7.EC27D,.Z,*7:8)YWWQP " ?O#)P*T_%&IR^
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MF<C*@8;<-P'R[E&:34_&VFZ5;R7MQ!=MID5Q]FFU!$4PQ/NV'/S;B WRDA2
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MGFTPL4DA#;_.;(Z$C"DXQG@DU5L6N=+^ <UOJ%A<6ES;Z3):^3,H#O(4**
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M226"9I 60'AF"N"![FNF\4-JOB_X=:_%::+=VIGM@MM;W:!)Y6!RV5!.!P
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M^#]5TJVD\J:\M7CC9L@!B.,^@[&N1N[34/%?ACP]HLNF7EE?6MW;27IFA*I
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M)EWE<94%FP-V.%R<9J_X@TS4[SPSX4U&PLYY;C1KJWNIK%EV22(J%'4 X^8
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M3$+NUPQ0;S]UN<<XQQZ5ZE5#6M'M->TBXTR^$AMYP-QC<HP((8$$<@@@'\*
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M7=I'%(6./DCV\E>I+' X'!SQV%% !1110 4444 %%%% !1110 4444 %%%%
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MEJFJZ/>V^J::^I1+J6B7('G1S[D4-"PYR<(P4\<<>E>B>(%9_#>J(BEF:SE
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M^S;@#=Z^6V/QS7%ZTUMIGP[\):Q:Q;+&"6RDU&>SC4N(1&?F/!W!796[\\T
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MD>(H--FL8X!:21B*7SY6#,^X,#N4 *,+@CGGICJK?7M,:YBL'U2SDOFRFQ)
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MO!;7"1Z;*9K0"\E_=N>,_>YX..>W%7$\*:0M[JMV;>1Y=5C$5[YD\C+,@4J
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M* "BBB@ HHHH **** "BBB@ HHKE/'^LZKH6AVUWI4L"2O?6\#B:/=N5Y N
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M!M 3L,G/48YQGU[QK%+X/M-06ST^^U&:>WO(C$)02D;LK@JY&" #M&.>,XH
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M\RWQMW%G"':"6/)Y.!P.!W[6H(KNTNIIH8;B":6!@)41PS1D]-P'0_6@#GO
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M'."3Z<'\:[FB@#D1X+N=3T.^T[Q1KDVL&Z@-OYBVZ6XC4D'(5<Y;(4Y.?NC
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M'A76/#T>M-]BU!I_+#6P)@65BS#((W'+'!X^E=9)J%E%<M;27ENDZ1&9HFE
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M%ULSY8E)3=CINVYQ[[?PKQ[6=4U/Q#\"=9U#6(+5I//D,;I(6(*W>W 4J-H
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M4-0U72M,TZWOO[/11=&XFV(SLNX1K\K9.W!). ,CKSCE/ 7B*WT7X9^$[1C
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M%V-!A=V3V(VG((R#5=?&6E#4+.PF2]AN;Z,2VJ-:2-YR<?,-H.T#(SNP1D9
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M;8HKSHT14 -G:03P<X/3TH UZ*J:9J,&K:=!?VPD$$Z[XS(A0E>QP>Q[5;H
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M.B7T#^79Y5BTD;,!L^;@ '#;N*ZKXCQ37'P\URVM[>>XGGM7CBB@B:1V8C@
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MM)X[=YA("@5HCL!PR[0,=^U-\)SGP#X3\.Z/JME?>=?7#KF"'S([0R2DJLC
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MP.TS3K.:'^T8+6.>WD4@M!<(24)].00?8FMSPOX@BUVUD\8:JJV$%I:_9?\
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M+I3645DVF61M(O\ 5P&!=B?1<8%6OL\/V;[/Y,?D;=GE;1MVXQC'3&.U244
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MNGKI\FGVKV2@!;9H5,8 Z?+C%7** *\6GV4,LDL5I;QR2($=EC +*!@ G'(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=MPD4@7&2V4XSZG/>N@&M:Y8^-]#L;VYM9['6H9V6&. H;9HU5QA\G>"#@Y
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M[V2SMK>9 5G:(@.9&Z@$[@-N,8!).>(KGS'^,6F;\1RMX?GSM.=K>='TSUH
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MFR>*.5,YVNH8?K0!Y[::9J?B?PMK'APZQI$^GRPK%#J&G616)=Q;>@4/M)&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(H5R!N"G(!]CQFJ.HZM%I3P/=H4M)76(W&?EC=CA0WH"2!GU(SCK0!H4444
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MAE!/\0(##/7!'?( ,Y+QO$/C[7M#N;JYM[;3+6W,,5M.\+2-*&+2%D()QA5
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MO'A*S6^UF\6[O!-K$:QW9#K@A5VKM&WY<*2./7UYIMMX1M;&TTNWL[_4+?\
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MPYIZZ<D,VF/>)/.CLR,LBIR 1N')XR.O7C!N^"M>O-?T.:748X4O;6\GLYS
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M9'<$$@CWKHJ* ./N_"FI^)O#6H:;XJU"WDDNXA$HT^)HXX2"&#@,Q+-N"GG
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M"C2ZKIH.@;XT6*U8"2-H_++'+??(Y[#.3STJ4^"=4;PQXJTAKJSW:[=SW(E
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M:!]!N+>9G.[$WDH4  Q\N0<YYQ[UUVH6@U#2[JR9]@N(7B+ 9V[E(S^M6:*
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ML&V,IA#N VG<6.>Y/%5I/ ^N6T?A_4=,U>SBUW2;,6+M) QM[F' ^1@&W#!
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MW2.LB!T8,IY!!R#2T <=-X;\0R>)=,UT:IIYN(;-[2XB>V<Q+N8-OB&_(;@
MY/('X5F6_P /=5M?!^F:0NK6CW.EZJ-0M9&MVV-B5WVN V3G>>F.@^M>B44
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M@'.,<=:M6$/B;PIXEURWM-";5=-U6\:^MKB.Y2,0R. '60,<A00#D \=B>
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M3K5[F[NK=HHHU95R3W)8@ 4 ._MU[5].TFTL);N]DL/M.-P2-47:O+G^(E@
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M6LW-Y#O=&W1R,"I^5C@\=#0!L7VN"#54TFSMFN]0:'[0T0<(L<><!G8],G(
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M I]QXSD77M3T6RT#4+N^L(8YBJM&JR*^[!#%L ?+WY.>G!-<T/#^NZC\,H_
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M3JBMKB.ZM8KB(DQRH'0D8R",BI: "BBB@ HHHH **** "BBB@ HHHH ****
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M>84;RA*>D9DQL#?[).: -BBN;L/&=A?>)M7T<+-'_9JQAY9(752Q5F;DC 4
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M&9HV7CS61,9'S,<#A<G)Q0!U%%8<GBW1TL-3NQ-,_P#9B[KJ 6\@FCR,C,9
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MI'+!8?\ 'T0CAH1ZLI&X#KSC'!]*N_\ "0:9_9-MJ@N2;*Z9%@E6)SO+G"8
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MA8GBB"@;'5L$D-N.X$YS[ 5Z15#5]7MM&MHI;C<S3SI;PQIC=)(YPJC/'Y]
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7"_%F)Y/!T;+<3Q;;^T!$3[0V9D'/KUSCUQ7=5E>(]
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M!8D [0!P#CIVK&N/ VG2VFBVMO=7=I#I%P+FW6%D.Z7G+.64EB=S9]<FNGH
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M&EW$MLL5PK%KIX@"^&# (,Y4<-TSWH ZJZN[>QMVGN95CB! W-W). !ZDD@
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M6?H/A?7-"\'Z9HH;3+K[--+]ICE+>5<PN7;;]T[2"X[$?+[UVY.!DT9&<=Z
M/-V^&<]OHRC2KJWL-0MM7.JV,0W/;P$@*8>QV$ DX Y/ K7L=!\0_P#";_\
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MCO71:_X?U+4/$N@:UI]Q:Q2Z<)XY$G5F#+*J@E<8R1MZ'&?:NGI"0" 3UZ4
M<:W@RXO=9\72:@\!L-?MHK?;$[>9$$1DSRN"3NS[8[U)X:TGQA8BVLM<U?3[
MBPLP%CEMHG6>X &%\PDX'8G&<X'/7/7T9YQWH XBU\'WUQK^AZSJ::?%J6G*
MPGOK-F\R]!0IM<%1@9.[DMTP,9K4\<:#>^)?#;Z79201/)-#(9)B0 (Y%?H
M<YVX_&NCHH Y.\\-7NH>-4UBX%K]B;2I-.F@$C%R'8,S [0.V/UXZ53\,^'/
M%VB16VC7.LV$^AV9 @F2)Q=O$I^6-CG8!@ $C)QQQG([BB@#EO#_ (<O;"^\
M1MJ'V62VUBZ-P$B=B4!0(5.5&>%ZUG^&?#7BW0HH-$EUFPFT"T8""81.+PQ
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MDT\FX6>*%D.Z(2NNT$.#\H4 DXSU&:ZM]=M;1M.TZSMI9[NYMO.AM8R 4B4
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M P\91%SP3@Y4\'% '94444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:H7WA@,[B6[@CC'0YZ^T\1Z1?7D=I;WT;3RH9(5(*^<@ZM&2,./=<B@#4HK
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MUB_PQLXIY(U \5;GCF&WY?M98Y![!3D^G>NX\97-IIWC/P/J4SQPV2W5UOG
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MMQMP'99W)5<>@()]!STKB;JZLC\$_%OESP&1]8G<;6&YB;H%3[\#(]A7NE%
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M:(>5!@95%SU)'+-P<YK<U70-.UWXOSV&HI+/9S^'M\L/GNJLWVC&>#QT'3N
M>HH [R!M3.K7:SI:C3@B?9F1F,I;G?O!& .F,5=KS>SM5@\;>/K:"\>R3^R[
M7;<-(S?9R8Y?G&3QCK^%'A0M9^)4T/7=!BT[5CI\B1W5@_\ H]]$&3<W&&5P
M<=>?F/M0!W>DMJ;:=&=82U2]RV];1F:/&X[<%@#]W&??-7:\0A@$OP3\-LTL
MP==;50ZRL#@WS@YYY./6NMT[3H=&^+6H6&E#[+#=:$MS(FXLK3B9E$C9/+8Z
MGO0!Z%17D&EZ#=Z[X>\**MI+_:4-_P";J>H!BJW$ +^8?.!'F"3Y2N">QX K
MT#QI?7ND>!M9O=-!^UV]G(\1 R5(7[WOCK^% &_17EVL6MOIWA[P?KWA\!=0
MEO+.,S1GYKR.4 .LAZOD'=DY((S38XX$LOBE RHL,3NR(<!4/V4,"!V^;GZT
M >D7.IVEI?65E-*!<WKLD$?=MJEF/T '7W'K5NO)(M/L;[5OA5)>6EO<--I4
MHE::-6+A;5"-Q(YP22,^IKL_B+J=_I'P\UN_TLL+N*V)C=.J D L/H"3^% '
M45R^H:]JESK&J:1X?AM'O=-MHIY!=[MLK2;ML8((V\(3N.1R..M<_K]G:Z/<
M>#-5\-(L4USJ,%K(T/\ R]VTB,7,G]\@+NW')')J?P[I.FI\6O%KKI]J'AAL
M7B80KE&99-Q''!/<CK0!WMN\LEM$\\0BF9 7C#;@C8Y&>^#WJ2N+\?W\EO=^
M&+&0E-.O]52"\;. Z[6*QM[,P&1W QT)K.GL%TWXD3Z7IT9ATJ_T62>[M824
MC217"K(H7&TL#@XQG'M0!Z+17GWPHT'3X_!^AZ]Y<C:G-I_DO</*Q)0MG;C.
M."!V_F:9XJTBSU7XH^'[2\662VNM/O%GB$K*L@'EX! / Y/3% 'HE<YK_B"\
MTCQ%X>L(K:![;4[EX))'<[TPC/P,8_AZY_"N3CTRVUGQ/X@\*2O8I!I]M;P6
M-O>0-.\=N8A\\9,@((8G+<GA<G@5)?6[6ES\.;5M3?4S#?R1?;'7!FVPR#/4
MYZ=<G/7O0!Z750ZG:?VNNE"4&\,!N#&.JH&"Y/IDGCZ'TKR3QD]O+X?\5:OI
MN99K/58U.HW+CSH9DDB4Q08&51>F21U;@YS72C3=.?XXW$KV=L7_ +"CFWF-
M<^8)V7?G^]@ 9Z\"@#M-/;4V>\_M%+55%PPM?L[,28<#:7R.&SG...E7:\8N
MK=%^''Q-0/+B#5KHQGS6R,)'CG.2/8UO?V;;:-\1/!<UBKQRZC9W27C[R3<!
M8D9=^3S@]/2@#TFBO(;K1M1UO0->L$MWG\0-K3?9M33[JQB5>1*/NJB;D*9S
MD$8->KI9V\=D+,1!K<)Y?EO\X*XQ@YSGCUH CTW4[35K5KFRE$L(EDBWKT+(
MQ5L>HR#5NO$-/FCT+X007%E%':"YUEK:]N8%".EL;MU;YAR!C"^P;BNQU&R7
M0?B5X7_L2!+6'44N8;^W@4+'(B(&5RHXW*Q W=?FQ0!V>IZG::18O>7LHCA4
MJN3W9B H'N20*QY_$%Y#\0;/P^;:#[)<6,MT)MY,FY&48QC 'S>_X5C_ !:M
M;:X\'1//;Q2F/4;389$#;<S(#C/3()!]C5;5M(T^Y^*FB:<UM&+$:/= V\?R
M(1YD?RD+CCU'2@#N-5;45TNX;2$M7OPO[E;IF$1.?XBO.,9Z5;7.T;L;L<XZ
M9KQ2^A6/X,>-[)&D6WTW5;N"T02,/*C65=JCGH-QX-=5XPM]2CU=-2MM+M-?
ML8;!4N]+D8":)2S'SHL\9(!!'!.P8H ]"KFO$GC*T\-ZSH>GW"%O[3N?):0=
M(000K'ZN5'/OZ5H>&KNSO?"VE7.GM(;.2TC,)E&'V;1C=[^M<3J^B:IXVT'7
M9H;*R>+5 JV%Q)>,CQQQ$^2P41D8+[I!\W(?'% 'I=%>=#Q!?^*/@I>:A:7:
MV6K+9/%<.[^68IH^)!G^$G!P>VX4^R\/"_\ &.C:E9:7/INGV]@PO(V#0;YL
MKY:[01N9?FRW(P<9- 'H5%>/Z)I-O;^&?%?B""&6;5](U'5&TYVE=O**A@ %
MSAOQSGCT%;&B:):W@\,^)K/6K.'A07M;4B2^WKAHY6,A+G.2202"">,&@#TB
MBO(="L/^$M\(66OSZS9V.IV]T9KB\CM";J&57.Z)F\S)!^[LQ@C  Z5;BT#3
MM4\3?$6VOH6N((_L[)')(S!&-ONW#)ZY)(/;MB@#U.BO&8+6./PE\./$ :1M
M7GU"Q@EO'D9I'C<%60DG[I':M1; >-KSQ=87U]907EI?/"C36Q>>TB"KY4D;
M>8-@ZMD#KG.: /4JJ:EJ=II-JMQ>2B.-I$B7/5G=@J@>I)(KSN#1[34OB;9V
MM]<2:E!+X71Y7D9E6Y/G*-[)G&#P=O3IZ5SKVEO/\--,@N(4GCLO%(M;?SE#
MF.(797:"><;>/IQ0![C67INKC5KR[^R*ILK65K=ICUDE7[P7_94\$]R".V3;
M,:6NGM'8Q1H(HR(HXU 4$#@ #IS7GW@>[MK3X#07=Y=SVT/V*Y>>YA_UJ$O)
MN9?]O)./>@#TJBO+-(MA8^/_  W%!:Q6-O>:-.KQQ2?O)E7R]K2E0 7Y/(S@
MDX8US<NEVL/PCU/6E$G]I:?J\K6EPTK%H,7@7Y<GC()SZ]^U 'NLA<1L8PI?
M'RAC@$]LG!Q6!X*U^Y\2^&TU*\@B@G,\\31Q$E1LD9!R>OW:Q+5[?Q!\3O$F
MEZQ#%<1:=:VPLK:=0R;)%+22!3P3G:N>P '<U)\)(TA\ PQ)G;'>7:C)R<"=
M^] '<45Y)XX6TO;+QS=V:FXN+*%!)<W3C_0Y$C#*EN -P/1B<@;FXSR*V[YI
M;CQ7X;EU!#J&F2Z5*7M53S2DWR?OFC&2PP=F<'!;MF@#T"BO&=:\.7.C?"'4
MFO!<07$FI120(;ABT,#72K&AY*Y",1CG&<=JW=<T_3] \4:%HUH(+33]7FN9
M[@7@>>*>Y"($#AG&21N(!."P!P30!Z317E.L6K>"M&GM8]:B-C=:S;?:8U@9
M(+"&0G<H ?A"0N5W# 8]FK1N?"ALI=9-CX@M-/?5=.,:6UI;&&!7W!5GP';!
M.X*2,9!SVH ]%HK@O!=WY7B:^TO4O#\6C:VMG&[K:$&UN8E9@)(\ 8.6P0>>
MGIPGC:RBNO'?@E)&E"RW%S&X25E#*(&..#_]?!H [ZBO%]2NI_">C?$>UT3S
M+:UL[NT\I(2?]&29(_-9/3@L>.G6NFUZPM]$\3^$+OP]#'#]MNS:7,4  2YM
MS&S%G ^]MVY#'GGKS0!V]CJ=IJ3W:VDHE^R3FWE*\@2!5)&?;< ??(HN=3M+
M2_LK&:4"YO6=88^[;5+,?H .OJ1ZUQ?PRTZPM7\3R6]G;0RIKUY"C1Q*I$89
M<(,#[HXXZ4GBS3=/NOBEX,:ZLK:7S8KY9#+$K;PL:%0<CG!)(],F@#T"BO-]
M$MK3Q<GC,:Y&KWEOJ<]K&[_?M855?*:,_P '=LC&3DUT/PZU#4-4^'NB7NJE
MFO);8%W;JXR0K'W*@'\: .GHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+D!B.#S65H?@NT34K:ZL_"=QX=E@D5WF.H[BRCJBI'(P(8<'=C .1SBO1Z*
M,[2]"TW15N%T^V\E;B0RS#>S!W/5CDGD]SWJCI/@GPUH>J2ZEIFC6UK=R9S(
M@/&>NT9PN?8"M^B@# 7P1X97Q =>71K4:F7\PSA3]_\ O;<[=WOC-64\-:3'
M<7\Z6S++J  NW$S@S # W<]AP/0<=*UB<#)Z4V.1)8UDC=71P&5E.00>A!H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4K@W-E;/;*FQ-CJV"Q/&<G:.A'2@#D(_%&OV7P_\13"Y>\O-)U>6P%XT2EQ
MLB RLH&"RHQ/3'&2.M:^FWNHS_$5K"QUF:\T*/3ENI"!'(JS%RH0R;<_,OSX
MSGCT-4?$6@+X<\+ZE"EWJTT&KZJMS=W%M$&>TW,&=PJ+DI\@&,'KSQFI?"\E
M])J]JVF^*[[6=/W-]JCN=.2)$7:<$2!%^;=MXYX)R.] &UXOURXTN;0].M)/
M)FU:_6U\_:"8DP68C.1N(&!D$<YYQ5%=0U/3/B /#;W\]Q8ZAI[W-M-(J&6V
MD1@&&<892""-P.#[5O>(_#MIXEL(K:Y>6&2"=+FVN(2!)!*ARKKD$?@1@@U'
M:^'S'J,FJ7-\]SJ;6_V9+@QJHBCSDA5'')P23G.!V&* .>^&TFNZUH&E^(-4
MU^:X\Z"5)+3R(U1F\P@/D#.0 ?;IQQSJ^(+F[&OV%HFHO%;2V\K&TLQFZFD!
M4*P)!"QJ"<DE1DJ"><5>\+>'8_"N@0:/!=SW-O;[O+:<+N +%B#M !Y)[5!J
M?A5;_P 36VO6^IWEC=Q6QM)/(V$2PEMVT[E..>XP: .2\/\ C#5=4T'P=:7-
MT8[[6;BZBGNPBAMD!DS@8VAFVJ,XQRV.U-^(5CK5C\.O%*W6MR3VP:-[/9A9
M1$S*K1R$#YER3C')'!)Z5K#X8:<OANVTA-3U%6LKIKNQNU=1+:N69L*0.1EC
MG.2<]>!C1N/!4.H>&=0T?5-3OKZ34$"3WDA42?*<KM  50#R !W.<YH IZY=
MZGI'B7PA9PZK<26UY=RPW*2I'F4")W&2%&,$#ICH*AL-0U3Q;!XEN++5)K"3
M3[^:QLDB5"H:(#YI P.[<Q/'9<8P>:UKKPD;VZT2ZN-8O9;C296F21ECS*[*
M5)8!0,8)&%Q^=)_PAZ6^I:G=Z9J=S81ZH=]Y#&J,IDQ@R)D?(Y'4\@]<9H Y
M*R\5ZWXCF\!7%OJ#Z?'K<-T+N%(48!XXS\R[@2.<D9)'3(..>C\$7^H27OB/
M2M0OI;[^S-0\F&XF51(T;1JX#;0 2"QYQ5IO!=DFH>'[FSN);2+0HWCM+>-5
M*%738V[()/'OUYJUHOAQ-%U35K];V>=]3F$\R2*H56"A1MP <8 ZYH P?$<^
MMR_$#2]%L=;FL;2^L+F1_+AC8HR; &4E>OS=\C\>:@-[KNJ7FLZ-9WUX;G2(
MX;9;F$PQF2=H@_FR*P/!+ ;0,<'KVZ2\\-K>>*[#Q ;Z>.:RB>%(55=C*^-V
M<C/8=^U9^K>!DO?$;:[INM:CH][/&L5V;0H5N%7[NY64C<!P#VH Q;YM3?Q3
M\-SK*PKJ0>[%SY!RA<6[ D?7K5;Q)XAUC2[?4-0@U5[B:UU>*():HIMH8&D1
M/*D+ 9DPQ)VDD$CH*ZRZ\(6\^I:'>Q7MS"=&+F!!M;S"Z[6+E@2Q()YSU)-9
M-S\-+:XT_4M/&MZG%8WMY]N6!#'B&4R"0D$KDC<.A)'/3/- $26]P_QLN@-2
MO%C718IA&"A49F8%0"O"G:#QS[UDW/B'7XO 'CF]76)?MNDZI<0VT_E1Y$:!
M,+C;CN><9S7:/X5C/B>VUZ/4KV.YCM%LYE!0K<(K;QNRN0=Q.=N,].E9S_#^
M"30M>TE]5O#!K=R]S<MMCW*SXW!?EP!\HZYH JI>:QI?CSP[:SZQ->6NLVEP
M9H)(D5(GC5&!CP-P'S$8);ZUB:AXGUV7P]JUY;ZC+;^(;;5_LD&F(J$F,RJJ
MH$8$ME#OW_CG Q7:3^%A/K6BZK)J-RTVD1R1Q($0+('4*V[CJ0HZ$5Y_I4[S
M23R0>*O$&DZG/<2S2:7)I8G>)F<G8"T1+#ISG&.X% 'K:P2BQ$#W4C2^7L-Q
MA0Y.,;L8VY[],>U>*M%./V=M5GEOKFX:2>7Y9BK $7QR<XR2>IR3^%>SZ8;P
MZ59G4-GVWR4^T;!A?,VC=CVSFN4D^&]J_A>_\.#6-073KJ8RK'^[S"#)YA53
MMYRW=LG' QS0!&VH:IH?Q#@LKK59[ZQO=-GNGADC11%)$R_ZO: 0I#$8))]S
M5+3;_P 6ZWI.A>(--D<&Y>.>Z@FEB^S&W;ED4 ;@R\8.<Y!SZ5U$WAD7'B:P
MUV;4)VGL[=[=8]B!'5\;MW&<G Z&LK2/AY!HET8[36M3&C"4S)I)=3"C9W8!
MQNV9YVYQZYYH S=*N->O]<\1O/XCN5L]%U(%84MXLS1")7:-CMZ<X!&#USGC
M!IM]XMUG3- U_3I'_P!):.>\AFEB^SM;N,LJ #<&7(P<YX.?2NHT7PTFC:EJ
M]Z+V>X.J3>?-'*J;5;:%^7 !Q@ 8.:RM&^'D&AW7EVNMZG_8RR^=%I+.IA1L
M[L9QNV \[<X]<\T <UI^J7/AFW^(FNO>W=XUA?/LAF*E9&\F/;NPH( ) P"
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M\Y7F91A/.8F65L8  #-@#O@"MBVT 65UI9M+^ZALM/M3:K9*1Y4@P K-QG(
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MQ[DDDD^IJQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6#'+<V]Y*Z&VF50I92JG<I &1P?I5F?PWJUAXNL_$EA+#>SM8_8=0AF;RO-
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MO+;SLB.0C(9&(R0&!(R <40:+>WGBN/Q'J$$$$MK9-:VMLDQ?EV#.S-M&.@
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MZU.WU+0EM[*]GTN2>07\EA&6GC^3Y ,?,JDD[F7! '49K@[K2]57P#XSTI-
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M -9T\S+.+<QBY3<)3T3&?O>W6@#4HK.LM=TC4X;F6PU6RN8[8E9GAG5Q$?\
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M/O(;I[B&'8YRB*4);DX.XXQC.WO6KXX\12>%O"MQJD2IN22./?(I9(M[A2[
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M88'2KMGK>E:C,\-EJ5I<2HN]DBF5B%_O8!Z>_2@"_16-+XN\.0C]YKNFC)<
M?:4R2@RP'/) ZURNM>.FU#PAIVN>'=0BC674+>&5-JR/Y<DH3# _<)'/3/-
M'H=%4;#6M+U6:XAT_4;2[DMFVS)!,KF,^C 'CH?RIL>NZ3+J/]GQZG:->'=B
M 3*7.W[V!G/'?TH T**R3XHT 2K$=;T[S&D:)5^TIDNH!9>O4 @D=LBEC\3Z
M#-<6MO%K6GO-=Y^SQK<H6FP2#M&>>01QZ&@#5HIDJ/)$RI(8V(X< $C\#Q7
M^"]4\5^*?"*ZO_:]C%=-+-&L;V.8_D<J,X<'G'8]Z /0:*XG1/&,FNZ%KEO?
MSP:#K6EN]K=RLRO% Y!V2KNP"IZ@'TQ[UTB:I9V.F64E]JMN_F1*1<NRH)_E
M!+@=,'KQP,T 1Z[H9UR&WC&JZEIXAE\PM83^49!@C:QP<CFM&UMH;*TAM;:,
M1P0H(XT7HJ@8 _*L+4?&^@Z;?:1:RZC:DZH6,4@F78(PC-YA;IM)4*.>2>.A
MJ]+XET*"9H9=9T])5D2(HUR@(=\[5QGJ<' ]J -2BLC2+CSKW56_MR#4(EG
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MYU&ZBA>=W0&.(ABTP4\ ?*0"1C)[XQ5S3]1&BVDAU[Q+9744TC36=Q)Y<3&
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MK]*[2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"6<!0-Q/4GUH Y#PU_PCFH^*;C6M(UB75KV6S$-Q<)(C1*@8%%8(H ?KC/.
M<]J@\0W3V'Q3\,3WS;-+DMKB"&1N$2Z;!&3T!*@@?4@5VEM:6UE%Y5K;Q01Y
MSLB0*,^N!3I[>&ZA:&XACFB;[R2*&4_4&@#SW3XO(\2?$*]@=5TB2&++ _NS
M<"$^:1VSC;N]_<5N?#1TD^&GATHP8"QB!P<X(&"*Z06EL+86PMXA !@1;!M
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M:"%)#O;R4"AC@#)QUX 'X4Y[2VEB2.2WB>-/NJR A?H.U2(BQH$10JJ,!5&
M!0!Y[I%]:VOCWQ_;3W$44\IMY(XW8!F46HRP'H,'FN7LELX/A?\ #:9!!')_
M;-D2XP#DLP;)^G!KV=[6WD=GD@B=F78Q9 25ZX/M4?\ 9MB5"FRM]H.0/*7
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MY"G^]VKT^VTZRLI))+6SMX'D^^T42J6^I YJ7R(?,>3RH][KM=MHRP]">XH
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MQ<G/(!/;FO37M+:28326\32KC#L@+#'3FFQZ?917)N8[2!)R,&58P&(^N,T
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M_LM)N+[Q?+);6<LD7B&X8,R*Q0!$P1GIU;\S7'V"V,'P0\*W""!)!K%N_F#
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M 2R^A/<>U 'GD$NFZA\6=!N%:VN WAZ1TDX;+"5 "#W_ (N?K7+?;5L?##S
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MS.N]FO5< -%)EL9+' X^4C  Z4 =5X3\0S>(K349;BT2UDL]0GL2B2^8"8R
M3G ZG/:M^O&K7P]!J/A;QMJ37U]:WECK&I36LT%T\:PNC%L[5(!SCG()QZ5J
MSWEWIG_"'>-]1DE2&YMH;;5XVD81Q-*B[)MN=JX?@G'1O:@#U"L;6-<:PU/3
M=)M8XY-0U'S3")6*HJQKN9F(!/=1CW]JB\+1&6RN-6?>&U28W**S'"1'B, '
M[N5 8C^\S5SGB;2[2Y^+'A0RQL?.MKXOB1AG:D>.AX_"@#L=%NM1O-+CFU73
MQ87N662!9A*HP2 P8=00 1G!YYK0KS*!G$'Q-MS--Y5JQ:!?-;]S_HP;Y.?E
M^;GBJLD<VH#X7)-?7RB]M"MSY=U(OFC[(6.<'J3GYOO<]: /3GOK=-02P\Q3
M=R0O.D6>2BE03[#+**R?"?B&;Q%:ZC)<6:6LEEJ$UB427S ?+(&[.!U.>U<G
MI_AO3M,^,-K:0+.Z0>'MZM+<.[EEN !EB<G [=*YN[L0O@+QSK$=S=Q7MAKE
M[-:O%<.@B=95.0JD D^^: /;Z*\_N+B;Q%XXU#0[E[?RH--MYH;>8N ^\OYD
MB[6&2"$&>W;&361=:3?6M_X$TB^\0WE^_P!JNK6YN(9Y(O.18G(5@&^\/N[O
MO<'D&@#U>J6FS:A-'<'4;2*V=;AUA$<OF;X@?E<\#!([=J-+TNWTG28=-MWG
M:"%2BF65G?&3U8G/>O([^2Y7X1>,Y%O[X36FMW,<,WVJ3>%6=5 +9RPV\8.:
M /::*\S\9Z!%HT&C26.H:I'+?>(;,3N;Z1MVXX;@G'. <8P#TP.*EGLH[#QG
M9^$K:8_8);&:^2&^GDE$TID *Y+9;:N2%)/4GJ,@ ]'HKR_5_#6JZ;X$O#%J
M\NHW^BWQO;=$D=?W"[9#:N=Q+C83C/JM:.H:]]I\/:WXTT?,L=KIA%B<DJS;
M-[.5Z'&Y5]04<=Z ._HKS#6 ^D^%_"OB+1[F=[^6YLTF?S6;[<DV RN"?F)W
M9![8XQ5K3;>/QM;^*5O;^XM;^TU2:UAFBE*O9)&1Y909XS@L3_%DC.!P >BU
MS^I^(I]/\8Z'HGV.-X-46<_:/-.Y#$FXC;COD<Y]>*YCQ"8=2O-82WN9]3FM
MM&1BCR>5%9[E=EE##GS7QD8' 7J 168%DU^Z^%9O[FX9[K3KAIY8Y2DCDVR%
MOF'(SW((//6@#TCQ!J4VC>'M0U2&V6Y>SMWG\II-@8*I8C.#V'I4FBW[:KH6
MGZBT8C:[MHYR@.0I90V,_C7FRV\^C6_Q(\/P7-S/I%KI?GVRSRM(;=I(9"T8
M9B21P#@GC/O5C5;6>U^'?A7Q+:&=Y-&M;6XN+>.1@MQ;"-?,4J#@D [AG^[[
MT >GT5S?AV6'6=3O_$-O*9+2;;;6C*YV.B9W2 =,ERRY](UJKXA$%YXMTW3]
M\EY/]DFE_LPML@*EE7SI6]C\H #'+9 X)H ZZBO%K>XOKSX<>"I9M1O5N#XB
MCM&E2Y?+1BYD4!N<-@*N-P/2M6\O9_!FO^-!I;W#PV^B1ZA'#/,\P6?,@+?.
M2>< GGG% ':>)O$4^@7&BI'9I/%J.HQ6+N92IB+Y^8+@[N%/<=JZ"O*-:TVS
M72?A]JD4LDUS/J]BTMRTI8W!=&8LW."<]/3.!@<5W'C@$> ]?D5G62+3YY8W
M1BK(ZQL5((Y!!% &_17FTUQ,+KX93"XF$ERNV<B1OWH^REOFY^;GGGO6+-IH
MNO#OQ&N)K[4FDTR]N9+,_;9?W+) CJ0=V3@^N<#IC)R >QT5YY8:F==\7Z7H
M^K2%[=O#T5^L).U;B9VP[$#[VT 8';<3Z8AN=^CZQX1\)-JMW>Z=<W5V+B>:
M3YV\M-\<#,.2,L.,\[<'C(H ])HKR[4Q<Z7K_B[0[2XN4TLZ =2B6.=U^R3Y
M=<(P.5#;=VW..#QUJO9V[:=%\-=5AN[QKR_\FWNFDN7998VMBVTJ3MP" 1@=
M>>O- 'H_B'4YM%\/:AJD%LER]G;O/Y32>6&"*6(S@\X'I5:QU74M0LM!O;>P
MA:WOH5FNV:;!@#1[AM&/F^8X[5P;O'XK\">.=4U!I&O+>2^MXE$A!M5B0A$4
M \9 RW][<<Y'%68VDBO?A68YYT66W*21K*PC<"T)&4SM)![XS0!Z+%?6]Q=7
M5K!*KSVVT2J#]PL,@'WQ@_B*CTF;4+C2X)=4M(K2]8'S8(I?,5#DXPV!GC%<
M1X-T>R/BSQPJI*A&H*H:.9U8!H4).0<YR2<]:P=!UJ\;P/\ #RQN+J?R-6O'
MBO+@R'?( 9&5"V<_,P //(!'>@#V*BO.;J*;2_'FHZ)92W$>DWNAO>-#',R_
M9ID?:&C(.4# ]!CD9K T^&2T\*?#G74O;YM1NKZTMIY9+EV#Q2*P9"N=N.!V
MSD9SF@#V6N?F\13P^.[7PZ;./R;BRDNEN?-);*,J[=N./O=<FN \:73C0_%>
MK:9<W%S<V-_&!?O*8_L;JT8,$(&2P&3NSM!WG[Q%=3J'_)9=$_[ ]U_Z,CH
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M<X&[!0_AZT =]16+X7M);?1Q<7"R)<WLC74D;L28MY++'STVJ0N!QD'UK:H
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M!\-S:%*-'BE@EDU"XE5TF5"'VJ"2Q8LH4D]MQSTSUM% !1110 4444 %%%%
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M;EM7,0F!1DV.&4D9)'.<]>: ,#4O%.OVN@>/)H+]#/HEQMM9)(%)">6KX(&
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M;QK'OB1E3:1@X!!.><^]=5K6HZOHNL^$K*+43-;WUXT%R984WN/+9QR   ,
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ML^'_ +'J>M7<VJ"=+J/4T58WAE3[A11PJ@$\?[1YR<T 9>H>)/$WA33]>O\
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MP<]!6GX$CO6\2>+WN-4NKE8M5,024)@CRH\=%!&!P ,#VSS5UO!4YM/#%O\
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M#]MJT5I9C2TNXW2U5WC8R,O&XD$_+U/'MW&,/%'B2?X8V/B9;O$UE<NNIK#
MA\^".9HY'4$':P5=WIUXZ5UEOX9NH/%DFOG5!+,]@MB4DMQR%8L&)##G<3T
M&...M9EL='^'7AV#1=9U$W,5Y-.($%HY:9G)=DPN[.2Q Z=<<T ;5GJ$VI^)
M)#9WF_2[>UC+A54K)+)\RX;&>$VL>>=Z^^:'C7Q#/X>.G3R?:X-(=W%]>VD
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M2/Y\+!BLA"L0I(7!4>^"*V_#6I:LOC'7] U._%_':16]Q;S&%8V42!LH0O!
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MYU/0 @ '0 4M%% !1110 4444 %%%% !1110 F!G.!GUI:** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ (!&#R*,8&!110 4444 %%%% !1110 48H
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>sangamoexecutiveseveranc021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc021.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5O+9[IK9+F%KA!EH@X+J/4CK577-:L?#VC76JZC,L5M;(78D\GT4>I)X ]:
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MC.'5'#%3Z$#I0!-14#WMI$P62ZA1F?RP&D );^[]>1Q3Y;B&'/FS1QX4O\[
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MHE#R0JX+HIZ$KU .#BIZK1Z?91:A-?QVL*7DZ*DLZH [JO0$]2!5F@ HHHH
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MK(V>N6 SSW]: //X'O-"UC3OM<%KK.@7NLN;+4(?EN;.XED<;9 ?O ,67(Y
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MU[7?L.HV^IS/=JJQK<12),3&48C=]T(JX[?**]=BMH(99I8HD22=@\K*N"[
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MMO+=Z;9W$EO_ *AY8%8Q?[I(X_"F#0-&$MU*-)L1)>+LN7^SIF9?1SCYA]:
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MO&DX4;FQDG!QG@UTFL"_N?B?IVF)K%_;V-SI4\LD,$@495T&0<9!YZ]1V(H
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MAE E@F+%BZ, ,'))_&K,/@NRCT&^TJ6_U.Z%_$8;FZNKGS9Y(\$;=Q& ,$\
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M=M<17=K%<PMNBF02(V,94C(-5M7U>PT+3)M1U*X$%I",R2%2V!] ": ,.^\
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M<BG(92,@CV(JD-=TTZ__ &$+D'4O(-R8-K<1@@;LXQU8<9S0!HT444 %%%%
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M[NYT7XL:G?ZK/%/%:>%S/OABV'RUF+$$9//#?ABM*U\1^(Y[S1)XK'[58WY
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M!YH WK:UM[.!8+6"*"%?NQQ(%4?0"I:X2;XDF/3-7U&/PYJ#VVD7<EM>DR1
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MF1CE W;KCC(%)K'Q'T[2;>YOC$L^GVEP;>XE2X02 AMC,L?5E5N#T/!P".:
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MH4D[\#H<Y_6M,Z7K4'BSPUJ\6E/+%#I<EC<H9XU,#DH0S<G*_*?NY/M7=T4
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MR<;3G&?QK.\)6WBS1+*V\,76@6[Q69\F+61.GEM #PQC^]O"\8Z9ZG%>BT4
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MV%]Q7:6VX4D@@;B,]LUQ^E:E:M\2]&U 7=U=6TVB31"Y:U:.(-YD;;5&T!5
M!Z].Y)%8R/&OP*@MP,7(U4.8MIWC_3=^=O7[G/TH ]:U36K"Q9[2:ZF2X,1D
M(MH6E>-.F\A5;:,YY(QP?2L7X8:C=ZM\/-+OKV[DN[B4S%IY#EGQ,X'Z 5CZ
M;K$6@?$KQ(NL,\<6K"VFTVY",Z3HL>TQJ0#\P)/R]3G/>KWPC;_BVVFQ&.6-
MHWG#+)$R=9G(QD#(P1TH W_^$JT;=J:_:GW:6 ;T?9Y,P@C.2-OISQVYZ5+'
MXATR:RL+R.=WM]08+:N()#YA()&!MR 0"<GC S7*>([#4+'QU!<:9"S1>(;0
MZ==LHXA=,LLQ]2(S*/?:!3? >F7]E>W&BWD4GV+PY/+#8RN<^<LH#1G/JD;%
M?^!^U &D/$VD:3IOB768M5O=5ALYF:>%5,@MV"#]VF%X7N3R!DDGK63K?B>9
MY?!6IQWUQ96EW=A+R%D,4;#R6<YW*&(! QS@UFHK7NB_%2"V5I9;B2=H409,
MH^SJN5_O?,"..]/OM2M+ZW^',D;,8X;R,R%XV7:! RECD< ,0,],T >@Z-XA
MTOQ EPVFW/FFVD\J9&C:-XVQG!5@"./;FI-0UJPTR:""YE?SYPQBABB>61PO
MWB%0$X&1DXQR/6N6\,2QGXG^-MK#;*+(H>S[8B&P>^#@''2E\3:K'9^.=(M;
MB)[2*6TFVZE%;&65FW+_ *.A"G;D#<>"3@ 8/- '6:9J=EK&G0ZAI]PEQ:S#
M,<B=#@X/7D$$$$'H17(Z[X@6Y\=6WAEY=1@M#82SRO:0S+(TF]%3#(N=H#,<
MCC.,^E)\)7V^!TM6CGCEM[NY619HV4@F=R!DCDX(S]:2YNH4^-=D6D4*-$EA
M+'[HD,R$(3TW$ G'6@#4TGQ!ING^%I;B[UN:_CTQVMKR]EMV5U=>3O4+D$ C
M)Q5/6=1ND^(?@Z.UOYOL%_'=M) I CDVQ!E)XR?O=SZ5Q=_>QV/A;XEZ),DX
MU*XO;NYB@6%B7BDC3:X.,;>#SGVZD5OW5U%)XP^',F754MKKS/,0H8]T"JNX
M$#;D@@9Z]J -CPI>7TOC+QC975]/<PVES;K LI'[M6A#$   #DUT-QK-A::K
M9Z9/.8[R\W?9XRC8DVC<V&QC( SC-<KX1EC?X@^."K B2XMFC/9PL"JQ'K@C
M!QT-)XYN(],\6^#=7N]R:?:W5PD\X0LL9DA*IG'0$\9H WY?%VA6]MJ-Q/J"
MQ1Z:X2[,D;J8F(R 01DY'/%%EXNT+4=533+74%DNY(C+&GEL!(HQG:Q&UB,\
M@$D=Z\UU"[2YTWXJ;8;A?M2H8!) Z^9FW50!D=2>W7VK<N[BW/BKX;/'(ACB
MAN [+TC#6X4 ^F6&!GN,4 7OB-XIAL?!NN?V=J=S;WUK&5\^VB9E27C"-)M*
MJ3D<9!Y'K72/KEGIUA:F\EE:5K<2E(H7FDV@#+%4!..>N,5Y-_::V?PA\1^%
MM429/$,'VKS86A8M<%Y6<2J0/F4[A\WM]*V;K5K30_%\>HZZNIPZ/J>EVT5M
M=P_:(Q%)&7S&ZQX89WY&1_6@#N)?&OAN&"PF;5[<QZ@I>U9<MYH ).,#V/7N
M,=>*(O&F@7&GI?07CS6S0_:"\5M*^R/+#<X"Y095OO8^Z?0UQ-Y!I&GZCX#C
MT^Q:QT]-1GG2&;=N1&C<"1@W*!F((STR.AR!<\9H(/$%[J.D:V=*URWLDW07
M"A[;48QO*QE3U8'</E^8;AQS0!TDWC.SC\86>@)#<NT]FUT9EMI"H&Y H! Y
M!W')Z# R>:MGQ;H@O$MC>_-)<_8TD\I_*:?_ )YB3&S=G(QGJ,=:Y)+R:#XB
M^&M0U&QEM#=^'V@\I(F81SEXV,7 X(&>OI7,:EJL=_HUI*UM<64MIXEBDN-,
MM[-ECM5%QR[D+\S,/FSG!W<#@T >FWGCCPY8W%]!/J:^=8[?M,<<3R,FX$CA
M02>%).,X[XK0?7M+33;74?M:/:W>W[,T8+F8L,J$502Q(YP!V/I7&Z3=VH^(
M?C>XD=4CDL[/:T@V[ML;[QSW&0".QX-<KH-W)HNE?#C6+U)?[)LK>XM;QPA/
MV25P K.!R!U&>V?>@#JM"\0BZ\1^.OM>LW:Z99K;"-YU,;6NZ-R^%*C:0?49
MX'6MVS\3:#I.AZ*MQKIGCO(4%K<W1/F7 VYWL<#&0,Y(%<K8:C:S^)?B-<Q^
M9]GN+.V,4QA<))BW8'#$8/)&/7(QFL^&6$>%?A;&Y&ZWNH#,K#F+;"ZDM_=P
MQ Y[T >E:5XFT?6HKN2QO0PLVVW(D1HFB.,_,' (&.<]*@'C+0#/:PM?^6]X
MN^V\V)T$Z^J%E 8<CIG@@]#7'2):7?BCXEP7!F-M<Z;;H3;KEW"PR!_+_O,,
M@8]< UG^'=?T+5=2\'C4-=MH[O2(3#!$L$T9N)7C$8R74!>/X03DD<]B >M7
M%Q#:6TMQ<2I#!$I>21V"JJCDDD]!6=9^(]+OM06PBN'2[>/S4BG@>%I$[LF]
M1N'TS6-\3;#4-1\ ZA#ID3SW"M%,8$ZS(DBLR#U) /'?IWK-U6XMO%WB3P?=
MZ),)6LKI[JXE0<V\1C(9'_NLQ*KM//!XX- $::K-XO\ $WB#2(-2U336LF@C
ML9K>"5-C&/S':0%0IR3C:_! XZYKIO$MW8VEKI\5_K5QISRWD*Q/ <-.^X8C
M(P?E8\'Z]:PO"%U#)\0?&Q612)KFV,1[2!8 K%?[V""#BG_$]U71]'!/S#6;
M.3 &2%60%F^@'4T :J>+K63QM-X;6"Y\R"W65Y3;R;2S-@ '&,<'YCQVSP:O
M6OB/2[RZ@MX)Y&>XW&!C!($E"C)*N5VL,=P:YE+A+3XR73S)+LOM'@2W=8V9
M9"LK[AD#' ()SVK%\)//IVLZ%:Z'J1U/P]=J['3[I0UQI'[LD?-U"Y.S#>N!
MG- '2_%&\O=.^'6KWVG7T]G<P1JR20D!OO $9(XX/;!KH=0UBRTS:MR\AD92
MXBAA>9RHZMM0$X&1SC'(]:YGXMY;X8:U$H+22QHD:*,L[;U. .YP#^59'B#5
M;/1?B FK:PU]_86HZ;%#!?6<DVR*5'<[6\HYPP?(//3ZT =NGB71Y=*M-3BO
MXY;2\8);O$"YE8Y^55 R3P<C&1@YZ&H8/%^@7'VW9J42FQ5GNEE#1M %^]O#
M %<9'7UKA-;31="TKPQJNG6MSIEK;ZJ\UL)HII%97C?>TBX+IO&=O!(R"0.<
M1KK6BR:#XVU?3I+;7M1O0D]QI@A?8L:JL:_(P#. /F8X&?:@#T6R\0:;JMW+
M86MS*EVL(F\N2!XG\MN ZAU&1GO@C/6L7X;WU[?^&)I+^[FNYDU"ZB\V4Y8J
MLK*!QQT':N>T?4+=_BK97RW=Y>6]QH+QK=R6S1QLPF5B%&T!5 _+N2:V?A8Z
MMX8NTSAQJ=VY4C!VM*Q4X]"#D4 =+J>NZ?I&X7<LFY8S*R0P/,RH/XF" D+U
MY/'!KG?&'C&&RT/2I]+N'DCU6]MH$N;>)I (9) &92H(W;<@#KD\#BL;6-1L
M_#OQ&U.7Q&-1BTS5+>#['=VSS^6&0,K1,(CU).1D=SZTSQ)#IVE^$?"=KI]B
M]A9QZ[:SQVK[B\<(F+%V!RRC!W'/W<X- #[O5&TKQ9INC#5=;GTO5&GN&22"
M?SH52,8C23;YA!9@QYRNT X!.>EM]9T_PIIWV/5]=N;PV\FV2\G@9O*#'*++
M(J[5(!498C/!/6LOQ#>VQ^*7@Z03(8X[>^\R0'*IO2/9D]!G!QZUS\-WI%AJ
MWB+P[XNM=5::]U":>UCB-PT5]#(<JJB,[21]T@XZ#G@X /2=1\0:9I9(N9V+
M"(SLL,+S,L8_C(0$A>O)XX-9-]XZTVVUC0K&W$UU'JJ/,EQ! \B>4J%LJ5!W
M'.W@9P"2<<5S%MJMMX+\;ZK#KMI-:Z;JEG:+8NL3W"+Y4>QH"5!)())'KD^M
M6-7>#3?%/@*^73)+#3HEO8EABMS^YWQKY:E5'RLV/NXZY% 'I%%9]EK-GJ&I
M:AI\!E^T:>R+.'B90"Z[A@D8;CTK0H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2V< D9;GD=<5U/@>PU^>+3O$.J^(YKN&\TJ'.G^2JQQR,%;>&'4XZ\<DGM@
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M;HBVLEH"NWAMWWL_-D ^F />N/\ #.IZU/XKN/"NJZU(]QIDSW/VI=@:_@.
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M=O  !/.&X.*K:/XFOM?F\*:9/<M;O?Z+_:=W+#A6E;"*$4_PC+,QQSP,8YH
MZCQ#XC@\.1V,EQ;7$R7EW%:*T(4A'D8*"V2..>V:V:\P\9P:GI?A6PCU2_\
M[3DB\1VKP.D8$GD^:"B-_><#C/&>*W] OY_$FA7?B"#5YXUN4;R+:,(19%1C
M:P9>9,CY@> > ,<D ["BO)-.UGQ GA;P/XBFUVZGFU&^MK2YMF2,0O'*64G
M7.[H<Y_ 5TFG7M_XOO/$RP:G<:?_ &;>M86@@V_(Z(I,C@@[\LQX/&!TSDT
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MDB-O)IB^7&JEB N &'+$GGG\!6%>:WX6N_'47C!;?QM;ZG& H$.G((V4 C#
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M%M?Z5:V,VJ:B6@O$OGN-Z-+-,A!5G)0C P.  , "GVW@V"RU;5=0L]3O[?\
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M6]H^FG2=,ALFO+F\,2A?.N"N\@# ^Z !P!T'YG)J]10!S1\&VZZCK5W#J5_
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MQ"EB6<D\#H!VR:<GA7Q#/I_A2&>33#+HES'-)L>15=4C,8494\G).>,=,=Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=G=3*FQW8916 8LA8=-P'H<'BJT_CZWCFUJ&WT75KJ;1V NDBB0$*5W[@6<
MC;V^\<\"@#KJ*Y.+Q_I\TVCLMAJ T_5V2.UOWC58FD==RH06W@G!&=N,]ZAO
M/B+:6\^K00:)K-Y-I3A;I+>W4E5*[MW+#C';J>PX- '945S<?C33;R+2&TR.
M>_?5H7GM4B"K\B ;BQ8@+@D#'7)^M59/B'I2>']/UG[+?M;WMX+((L(+PR[R
MA#@'LP/3.<<9H ZZBN:M/&,5U?ZEI[:/J<-_8P+<BUD2/?/$Q(#1X?'4$8)!
MIUIXRLK_ ,*6OB&VL[R2VNI$BBA C\TLTGE@8WX^\>>>* .CHK&\5QK/X.UA
M7##_ $&9N&*D$(2.0?6N8\'>+8+30?!^DW-A?Q+>V$,-O>NBB%Y5A#%/O;AP
M#@E<''!- 'H%%<K=>/-/M?M$S6EX]C;7XTZ>\54V),2J]"VXJ&8 D#KTSUJY
M?>*8;2XU&&&QN[PZ:JM=_9]F8]R[@,,P)^7G@=.F3D4 ;U%1SR^1!)+Y;R;%
M)V1C+-[ >M<?9_$K3;VTT>^33-433M4G6WBO)(D$:2,Q55;YL\D=0"!G&>N
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M<#3+;%H@Q1-NY\[]N,NN!G//08. #H:*J:;?+J6G0WBP30"0$^5, '0@D$,
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MYQBI[*TOH=9\>W#Z==B+4!&;0^7_ *[; (SCT^;UQQSTKOZ* /+3I>J+X'\
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MQZ4M[=VL?QNTY7N(5<:'.I!< @F5"!^0)_ T ;W_  FWAC, &O6!\^4PQ$3
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M .8V>)L[6'4'T/M7E.CV\FF7GPHL-;>-;Z""[+QSD;H\Q?NP0>A'R@>XKJ?
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MC<=&4C(/Y50G\1Z/:W?V:?48(Y/,$)W-\JR'HA;H&.1\I.>15+P);7%I\/\
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MMF\Y?WK9QA?7!Z^G>O-(=:M-(O/"&I:O>SV^BW/AZ*TCO89#LBN!M9E<KTW
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ML[S"NPRK'R]OT)P<?C7'/>;= \475FSW%O9>,?MEW%:-ES;#RRS*!Z,-V?\
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M(T$AD"*'(P6QR:P_!6OS>*/"&G:U<0)!+=HS-&A)"X8C&3]*WJ # %(0",$
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M02;%W@8#8YQ]:#%&9!(44N.C8Y'XTZJNI:C:Z3IMSJ%[*L5M;1F21SV '\Z
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M40 *HP!Z"N5L?$6L:U*E[I%E:S:6NH264RR.4E"(Q1IE/0@$'Y,9([Y.!UE
M#3&AD$A12X& V.1^-#QI)MWHK;3D9&<'UIU% !@4F!Z5B>,-:NO#GA/4=8M+
M:*XEM(3+Y<KE00.O0'/TX^HJG?\ B:\L]>\+6*VD#6^LEQ)*7.Z,K$9,!<8Q
MP.<_AWH Z9XTD0HZ*RGJK#(I<#T%8WBW6+GP_P"%=2U>TMXKB6S@:;RY7* A
M1D\@'\N/J*TK"X:[TZUN7 #31)(0.@) - %C II1" "HP#D#'>G44 %&!Z52
MN7U(:G8K:Q6S6#>9]K>1R)$^7Y-@ P<GKG'%7: # ]*,#THHH :D:1KMC147
MKA1@4[ /:BB@ P/2C ]*** &O&DB[7167T89%*R*ZE74,IX((R#2T4 )M79L
MVC;C&,<8I%1$QM55P .!CCTIU% "8 Z >M! (((!!X(I:* "FI&D:[8T5%]%
M&!3J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\C^8GT<'=V'?M3[SPEH-_HUOI%QID)L;8AH(ERGE,.C*RD%3UY!SR: .)LK
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M;64300">0+&X.01\W&#R/0UKW-G#>64EI.&:"1-C@.P)7N,@Y_6@#R*"VM]
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M6S"1E\J1($8.H!^]D#FML7LNO>*M+T;49K-HYM ANXH;ZW,R3RLQ$A"[E!8
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MN+8:3$D%S.+F6.-F0/(#D' (Z'D#H#R*M7.AV<-Z^MV]D]QJT-LT4):Y<%U
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MV[-V?O\ ?&.E>6P>(/$Z?#RR\53:_))/#J7DR6XMXECGC-V8B'^7.<'@J1C
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MLVS"C)(  W;NN><4 >J45PTFJ:MI?C:;PXVH2SVU[ICWEI<21H9+>1&PRG
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M'Q=K.FZ#KVG&4BZ>.>[@F> 6QMW&65,?.&7(P3UP<^E=IX@_Y%O5/^O27_T
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M5.%'*@ >Y!IVGCQ#>>)O$WAQO$]V(;%+>>"Z^SP^>/-5CM)V;=H*Y^[GGJ*
M/0Z*\TT?QGJNKZ#X.A?S#?:Q!/+<2VPC5V$. =N_Y06)!/H < =1'KVH^--!
M\':Q=7%\87M[Z 6,\BQ/*\$DJ(5D"C;D;CR.30!Z?34D252T;JP!*DJ<\@X(
M_ @BN*@N-8L_B,VA7&M3W5K?:5)=J3%&K6\JR*O[O"_=PW1MW3J:9\)([@^
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MFEA28HPEBQN1E8.I&>.JBM:B@#FSX5D?Q#IFLRZO<37-A!)"OF1IB02$%RV
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M<;FR<9QC)SC1?#-(])L-*/B'439:;>1W5E&%C!AV,65<[?FY/5L\=J[RB@#
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MVNNWGBFXU(J_]FFR>-D58Q&"6!SUSN/K[5U%% 'FGP^T$:S\-_#]M?7[3V,
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MO$3W[F>"T:T\H1@(R,0S$]\Y [TOA?PRGA:RDLK>_N;BT\UW@BF"XA#.7(!
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M - 'H5EK.F:C.T-G?03RJGF%$<%MIZ-CT/8]#57Q!<K!#9I_;L.DR27<05I
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MX7L;?P'\+'C:WC?^TK/+*0#DQ.'_ %QF@#T33_&FBZEK6J:;#>P!]/*K(S2
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M'$BND9.XH -I*_(S8&.!GH<:%S+X6U.S\0ZYIFJR:G<MH<T%Q<F4&)$P2J.
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MVFEZ7>I_:EO9WRV[21ERI*\':2#V)&.>,T>"]0NM5\$Z)J%[+YMU<V44LLF
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M)#$AD=ST50,D_E7D-M>Z#<Q^)?#/B[5+FVNGU*=GLF(4W4;R;HFC^7<V1M
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MZ9J/[/4%K:QV[ZM).4MA%CSOM/V@[<8YSMQ_P'VH ]EOM?TC3)C%?:E:V\@
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M!G+'KSDUVM% 'FR^&/B2C!D\4Z(K#H1I2@B@^&/B222?%.AY;J?[*7FO2:*
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MCMEB3CMFKM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR1DV!R@5E)PW'<Y/ YXK?T;X?^'/#]ZUUIMI+$V6,<9N)&CA+?>,:$X4G)Y
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M*T739].L[=_L<[.TD,TSS*Q?.[[Y/7)R.^: .9ATF\M+_3/$-AJL*VOV=Q+
MDLDHU$,FY,[F^\,9W#G&>U9FAV>I>(?#GA[Q/!K<-M=;X[FZN1)(WG9XD@9<
M[<;CM _A(&*ZS0/ GA_PS=&XTRUE1AD1K)<22)"#U"*Q(7/MS3+'X?>&]-UE
M]4M+%XI6E\[R1._D"3^^(L[0WX<=L4 <8=-^WV7Q%^T:AJ;?V?<RO:8OI086
M%NK@@ALG!Z Y ].M2K]HME^'>O"_O7U#5)8(KQY+EV29)+=F(*9VC! (P!Z]
M>:[A/!^C1QZK&L5R%U8DWO\ I<O[TD8/\7'''&.*:_@W17MM*MFBN?*TEE>R
M7[7*/**C"G[W.!QSGB@#CH+;4O&UCKLL.II9:A:ZI/;Q7 ED#V7E/A %!"X*
M@$_WMQS4\&G_ -L?$F_L+[4;V>SDT2VG>.&[ECC=V=P67#94' . 0/7-=%>_
M#[PWJ&NR:Q-8N+J;'GB.=TCN,=/,12%?\1SWS6B/#>FKKD^M*DZW\\(@DE%S
M( 8QR%"[L#!)(P* /*55M7^'_P /Y]1FGN9U\0QVWFO*VXH)94&2#UPBC/7B
MO8YX_L^ERQP3"#RX2J2R'<(\+PQ)ZXZ\UB+X$\/KH,6BK:SK8PW N85%W+OB
ME#%MRONW*<DG@]S6XUE VGM8E/\ 1VB,17<?ND8QGKT[T >>>%KEX?$%IH7B
M/3KRPUDV4D8E2X:6VU(#86E#9_U@VYY&0&/-8UK?7C_!KPK?O?79O#J<"-.9
MWWLINBI#'.6!'&#7IMCX;T[3[BVGC$\KVD9BMC<3O+Y*'&0NXGK@#)R<#&<5
ME'X;^&3;O;-:W!MC<"Y2 W<OEQ/NW9C7=A,MS\N/RH PH]%3Q!\1/%VF7NHZ
MH+&.WLW2&*^D0(S+)D@@Y !&=OW<]0<#&-X?U[5[JQ\+Z'J-[YRSW5_;-<W#
MLOVO[.VV,,PY.<GO\Q09SSGH]/T.2X^)7B*[FBU.VM9[:UAM[B-I(UDV*PD&
M?Q7!//H:Z'4_!F@:MH-OHMUIZ?8;8JUND;%&A8=&5@<@^^>>^: .#\6Z5J?A
M[X?>*%.N3';+#<6D-O/(K6BO(JE-Q;+(?FP#P.:V]?T&_P!&\BXT2.XUA6N7
MNK[3+J_;?<KL"DQECCY20VWIDCT7&X_@;09/#LNA2VT\EC,X>8-=2[YF&,%W
MW;FZ#J>P]*T+O0;2\:SD>2Z6:S#""9+EPZ[@ <G/S9P/O9H \_@\1V][;^&-
M-TV:YBL[^^O([B/47=)$E3<PMW.=W!; &>=H'0D4:U_:O@W3KJV_MD?9M4U2
MSACCC9BVFPRL5D*NQ) .T[>FTYQ79WW@GP_J6AMI%W8"6U,QN"3(WF><229-
M^=VXDGG/?'3BB/P5H">'[C0Y+(W%E<\SBXE>1Y3Q@EV.[(P,'/&.,4 <Q?:?
M;Z-\6=(ELHI.='NV\GS&8%E*<@$GD]SWP*JZ'::EXC\->'_$\&MP6MUOCN;F
MZ$DC>:"<20,N=NW)V@=L#%==9>"-&L=1L]047LUY9QM'!-<7LLC*IQD<MR.!
MQTJ.R^'WAO3M:?5+2Q>*5I?/\D3OY(D_OB+.W=^'';% '+S7]SI'B<1^(;6Y
M-M=:OFPUNSG+Q\R?);S*#\H'W.A7//4$UVGB^YBL_".J3S:G)IB+ P-Y$FYX
MB> 5'=LD >YH3PGI2REBMP\1NS>_9Y+AVB$Y<OO"DX'S$MCH#SC-7M6TJRUS
M2KC3-1@$]G<)LEC)(R.O4<@YP<B@#AM'2X@^)ATLPW%C8W.@F9K;[6S,7695
M$C8/RR8)!*L?K7+V"W,/PP\,^)#J6HR:HFJ1IYLEW(04:Z9&4KG:P()R2"3Z
MXP*]+MO ^A6M_;W\<-T;R" VZW#WDKN4)!PS%LM@@$9Z8&,8%(/ ?A]=!M]$
M%M<#3K>83Q0B\F^5PVX'.[/WN<9ZT 8.KWJ>"?'_ /:M[<7#:-JUJZ8>5G6W
MN8P7PJDX'F*#@#JR^]=9X:T^;3M#@CNF<W<N9YP\A?:[G<5!)^ZN=H]@*R+V
M*[\1:S%I%WH4T6FZ==QW)O;ET99]@W)Y8R6SNQDGL"#R<5UM 'F=MH*>(_''
MC;3+W4]5%I UH8(XKZ1?*9X2VX$'/!)(7[O/3IC#TR[U36=(^'IU'4K[SI[Z
MYL[B6*Y=/M$<:R@,0#U(4?-][N#GFNHTK0Y+OXA>+KRZAU*UMKT6RP31M)"L
MRI%M<9&.AZ'@^AZUTMSX2T6Y;2RUL\8TK!LE@G>)8<#' 4@'CCG/% ')066_
MQ7=^$$G:2ST_3HI+:*\NI2\@D>3?)N!RQ7Y%!/W>W6JNLZ=JGAWPCI&L7.LW
M&J7&@78^W21R.HN+7>0ZNH;#,@(.3_<.>]=GX@\&:)XFN;:ZU&WD^UVP(BN;
M>9X9%4]5W(0<>U:4>D6$6CG24MD%@8C"8>H*$$$'N<Y.2>3F@#F+U5U+0O$V
MN075PL<MK)':207#IA8E/[Q=IX)<-R.JJM8>FZK<7,?PVT2ZFE^R:CI7VBX;
MS"#<.D"$(6ZD?,6(SS@9XS7H!T2P.@#0Q$R:>+<6PBC=D(C V[=P(/3CK5*3
MP?HLFCV&EFWE$&GE6LV$[^9;E1A=CYW# XZ].* .#UN6\TN3Q]HUO<W)T^VT
M<:C:$3-NM)2C_*K9R 2FX#.!SCBM6YN)UU_X;.MS.#=1RK.!*V)@+4L-PSAN
M>>>]=C!X?TV&UO;=H#,M\"MV\[EWG!7;AF/.,< =!VK*M/A_X?M'TZ18;N23
M3F+6KRWLKM$,;=H);(4#C;T]J .8M[^YTKQ1:6WB*UN0+K4V.GZW:3EX;G>S
M>7!*H/RX!"@$$94$=,UZ?6)!X3TJ"2(A;AXH;@W44$MP[QI*23O"D^I) Z G
M( -;= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/7!K'UZ-&\ ZA(4!==)F"MCD Q<C]!^5<EH6IZWHUA\/M]]#+IVIV\-H]F(
M/+_T?<KA\Y)^7GMST% 'I]([!$9B"0HR< D_D.M>?W6O^)]9M=5N_#D,YFLK
MV2UMH=L!@F\IMK"0NP<9(;!7;@8ZUWEL\LMK#)/%Y,S(K/%N#;&(Y&1P<'B@
M##L_&VB:@+@V37]P+>9K>;RM,N6V2+]Y3B/J/2M?3]0MM4L8[RT9F@DSM+QL
MC9!((*L 0001@BO./ 4^MPQ>-#I6GV-SCQ'?%?M%XT1+Y7C C88Z<Y'X5O\
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MV_M2>)+G2IKAHD1-@<+'DX([[B.>G;'.=33M3UW4_$/C+1Q?PQR:>;<6,J0
M!#)%O^8'.[D@'V'&* .SHKAO#OB+4=?\-Z*OVIXM8EN7AOP(TS$8B1,"N, 9
MVJ/3>N<\U6N=?\4:S9:E>^&X)VFM+V2VMH"L'D3")]C"0NP<$D,01MP,=>I
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]AW#MGJ.OX4S7M+UR?QCIM_;6UK?Z5%;O&UK<3F-89RP(FQM.[ &!QD9..M
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M[$9ZCJ.XJIXL\5'PW+I$*V<\[ZC?1VP:.,LJ Y)^K$*< ?7M0!IZWH.E^([
M6.KV:7=L)%D$;D@;AT/!%78((K6WCM[>)(H8E")&BX55 P  .@K)U#Q/8Z='
M*SQ7<I@A$]PD$!=H(R"<N.QX/')XZ53NO'WA^U>R07%Q<-?6S75J+>VDD\Y
M 3LP/F/(X'([XH Z:BN6C\?Z+/*\$$>HRW26T=T;9+"7S2C_ '<*5R?KT'K3
M4^(OAV6TL;R.:Y>RO'6-;I;63RHG8[0LC8PISQ@].,XR* .KHK&U#Q-8Z=)>
M*\=S,+) ]TT$1<0@C(W=^G/&<#DX%;)( R>!0 45SX\9Z/FT=GF2TO)?)MKU
MHB()7/  ;MG!P3@'L36%K>KG4/B);^&[B'4/[/\ [-EFD6W61"\AD1%;<I!V
MJ"W/3)]0* .]HJGI5@=+TJVL3>7-X8$V>?=/OE?W8X&3[U<H **** "BBB@
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M?09-:U<1\5]B^"#))M")?V;,S=%'GIDD]A0!/<^)IX?']A9"_LSH=QIDUV7
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M!?IJ%HUF>EP)E,?I][.*0:QIADN8QJ-H7M!FX43KF$?[8S\OXUY3XPTK0(/
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M[$@'EJ "0%WCN&&>M '8'Q3)<_$;3-*L-1L;K3+BSGED6##LLB%,9<,?[W3
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MJ:[:WT'2[=4*V%N\HB$1F>)6D=0,?,V,G(ZUHT4 4ET?2TLI+)=-LUM)?]9
M(%$;_5<8-20:=8VMC]AM[*WAL\%?L\<2K'@]1M QBK-% %"ST/2-/:-K+2K&
MV:/=L,-NB;=W7&!QG S]*MSP0W4#P7$4<L+C#QR*&5AZ$'K4E% %!=.CTS3+
MB'0[.RM92C&%!$$B\S'R[@H'&<9QSBJ7A_3]5C:;4=>>S;5;A$B9;,-Y42+D
MA5+<G)9B3[@=LUN44 %9YT+1V@6 Z58F)'+K&;=-H8]2!CJ?6M"B@"I'I>GQ
M7?VN.QM4N<8\Y85#X_WL9I+;2--LKN:[M-.M(+F?_6S10JKR?[S 9/XU<HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HI%96SM8'!P<'O399HH$WRR)&N<9=@!0
M ^BBB@ HHHH ***9+-%!&9)I$CC'5G8 #\30 ^BFI(DBAD=6! (*G.0>].H
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M=N"">0&P<_K63_PB.JW?P^B\"WEN/)C>.!M0#KL:W20.&"YW!RJA<8P#SG%
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M&C,M@\J[YM*DDNXV4.1]QP&X!.".V2<F@#V"O.+&S@C^..NRP6=N9UT:%TR
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METYQ'I$<JW>98\J7A\L;?FYYY^GOQ0 FI?$VQL+8Z@D5M<::ES]GD:.\7[0
M'V&00XY4-_M XYQBNMUC43I.BWFHBW>X%M"TQB1@"P49/)..@KBO#VG^,_#2
MR^'+?3[.YTL32-9ZJUT%,$3L6P\6"79=QQC /'(ZUUGBG_D4-:_Z\)__ $6U
M ',Q?$>=1H-Y?^';BTT?6?)CBOC<*WERR*"JL@&0I/ ;\<"KEMXTU&^UV_TV
MS\-S2#3[V.VNIGNHT$<;J&\S'? .=H.<?E6+I.E7_BCP!X-TV6Q:VM+>.RNI
M[AY$*ND2*RA "6RQ"YR!@9Z\9V_#VCZA!XA\637]DT-IJLZ20OYJ$E1$(R"
M20>,B@!MQX]\GP^OB9=,,GA[S,-<K-^^$>_9YOE;>4SS][..<=JT(_$[-XT3
MP_)9HD<UF;RVNQ/E9D! ( V_>&02,]#FN7M/"VOQ?#R?P)-:JR8:UBU02)Y1
MMV?.XKG>'"DC;C&0.<<UM>+/"UY>V6BRZ#,MOJ6DSH+>5^<0L/+D!]?D.[W*
MB@"'Q#XDA7PU]NU+P_%>V1U%+=$,JNIQ,$64[E_O<C /K6CJ/BJ2'5=1TS3K
M**\O+"U6YDMWN?*DE#!B!&NT[ON]>!D@54\:Z!=WO@^UT?1;/S3#/;,BF15"
MQQ.K=6/7"XJAXQ\,S^)9+K?H3_;8XU;2=4M[A(I;:3;T<[@VT/SQNR"<#ID
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MB_1]+6[DN)9S!9G%U/#;R21P'&<,R@C(R,CMGG% &#_PIGX??]"['_X$S?\
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MG'7'/2J7CWQ/-X5\.K<6<22ZA=W$=E9))]TS2' +>P )_#% '445SZ>&[E;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KC/B-'J$>GZ/JMC:37JZ5JD5Y<6T*[G>(*RL5'
M<C=G'M79T4 >;^*6;QUX'US_ (1O39EFE@CQ//;- ]R4</Y0# ,PP&&3QEL#
M/.+&KRKXSO\ PC+ID5Q'+9Z@M]=&2%D-M&J-NC?(&&+%5V]^3T&:] HH \FC
M$A\$?$J'[-<^;=WU\UM&;=]TP>)50H,?,"0<$5?O&+:A\-G6&X*VY8SD0/\
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ML]GJ$,"2+-;%RI5R@PQ *8/L:]LHH YSPFFF20WE_I6ES6=O=R!S+<(Z27+
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M:2+,C?W2I'KWSM[YQ6)=/=Z-\4+?6]2@==-OM)%F9D!D2VG60OM8@<*0>&.
M2*[VB@#QW5]"U<Z7X@URPLKB6VF\06VI)8JA#W$$.W>P0\_,PW 'DA0>XK9N
M=5AU[XC>'KW3HK\VS:==PFX-E*JQN^S&XE1C&.O0'O7I-% 'D7A,V#Z1IWA?
M6O#>IR:[I[)$89DF:WRAPLX?.P+CG/7L >,]7\5]/N-3^%^O6UJI:40"7:.I
M".KD?DIKLJ" 001D'M0!#9W,=Y9074)!BFC61".X(R/YU1\0:I-H^E?;8;2:
M[*S0H\4$9D<HTBJQ"CDD*2?PJ?3--BTFV^R6S,+5#^YB/2%?[JG^Z.P[=.F
M+M 'E5UH>E_\)YH>K^"HY;:_DNQ_:J01/' UM@ES*I "OG  X))SCC(AM'L]
M-U+7?#OB;0]6O);K4)[BT\F.62&]BE<NH^4[ 1G!W8 QR:];HH \SMM0;P9X
MVUF+5]+NSIVK0VS6<EI;/<HICB$;0':">HXR.0?>K6KF2R\8>"=1.DW%O9Q0
M7D)AMK<OY!=4\M&" A20,>@(/.!FO0J* /+;W3;W6-<^)EC9)+'-J%C;16LC
MQLB2LL+JRAB,'DA3SQFGWY?Q;X1\,Z3:VMQ!JEO>6DEQ%)"R-9>3_K&8D8&
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M9WI<6EW!.8SA_*D#;3Z''2O-?')TNP\.^(M0T%S(UU<6CZP]M*701;@K8 .
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MTFV:9"@*R$O)DL.^1BN)TK3K&#X2>!M3CMHEOAJUI_I(4>9S.5(W=<8XQTH
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M&5E4C:>J\^E=-<:C;R?$:ZL=:U);)+C28#8F98S'*I+^< 9 1DG;D#J /04
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M+8P131621WLEV^YI'$),:1)D;1S][G+$X'>K"VFG:KX[\%RS0V]UY^B3&9F
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:9I\6E:7;6$))C@C"!FZL1U8^Y.2?<TV_P!'TS50@U'3K2\"'*?:(%DVGVW
MXJ[10!3N])TV_M8[6\T^UN+>,ADBFA5T4CH0",#K4%[X=T34FMVOM'L+IK8
M0&:W1_+ [+D<"M.B@#B_$_A_4M0U^.\.BZ+KVFK;B)+/4#L:!]Q+.I*.#N&T
M'@$;1COF[X?\)V>G6U^LVDZ;:17ZJLVG6B[K<!0>N5 9CNY.T<!1CC)Z>B@#
M-M?#VBV)A-KI%C 8$,<1CMT7RU)R0N!P">OK2#PYH8LI[(:-IXM+@[IH!:IL
MD/JRXP3]:TZ* *-OHVEVDWG6VFV<,ODB#?' JGRQT3('W1Z=*B_X1S0OL*6/
M]BZ=]C1RZ6_V5/+5CU(7& ?>M.B@"C>Z+I>HK"+W3K2X$'^J\V%6\OC'RY''
M''%%SHVEWEO!!=:;9SPP8\F.6!66/'3:",#\*74;N\M!:_8]/>]\VX2*7;*J
M>3&<[I#GJ!Z#DYJ[0!GMH6D/<R7#:58F>6,Q22FW3<Z$8*DXR1CC%/L='TW3
M&+6&GVMJ2H4F&)4^4=!P.GM0+N\.MFS.GN+(6XE%[YJ[3)NQY>S[V<<YZ5=H
M K7VG66J6QMM0L[>[@+!O*N(ED7(Z'!&,U"-$TD7;W8TNR^TR+L>;[.N]EZ8
M+8R1[5?HH SET#1ETV335TFQ6PDY>V%N@C;ZKC!IJ^'=$72UTP:/8?8%.Y;7
M[,GE@^NW&,^]:=% %2?2]/NM..G7%C;2V)4*;9XE,>!T&TC%,@T;2[72SI<&
MG6D6GLI4VJ0J(B#U!7&#GO3-;UFWT+3&O;D,P\Q(HT7J\CL%51]21].M1Z3J
M6H7EU?6VH:2]B]LZA)1*)(IU89RC8!XZ$$#'O0 ZV\.:'9B$6VCV$(A1DB\N
MV0;%;[P'' /?UI/^$:T'[&;/^Q--^REMYA^RIL+>NW&,^]4_$WBJ#P]X9U#6
MHK=[]+$E98X75<$'!R3Z'KC)]JWD;?&KXQN .* ,^\\/Z+J+VSWNDV-RUMQ
M9K=',0]%R./PIPT+2!ILFFC2[+[#)DO;>0OEN>N2N,&GZ==WETUX+O3WLQ#<
M-%"6E5_/C&,2#'W0<G@\\5=H S4\/:+'I8TM=(L!IX.X6OV=/*SZ[<8S4RZ1
MIJRVDBZ?:J]D&%JPA4& ,,,$X^7(X.*DU"^M],TZYO[I]EO;1-+(WHJC)_E5
M;0=9M?$.@V6KV9)M[N%95!ZKGJI]P<@^XH FO-*T[47B>^L+6Z>$[HFGA5RA
M]1D<?A3K[3K'4[?[/J%G;W<&<^7<1+(N?7!&*LT4 9MQX?T:[TQ-,N-)L9;!
M#E+9[=#&I]0N,"IWTK3I-,_LQ["U:PV;/LIA4Q;?3;C&*MT4 5++2M/TZP^P
M65C;6UG@CR(8E5.>OR@8YJ.PT32M+#C3]-M+4.-K>1"J9'IP.GM5^B@"G8Z3
MINF&0V&GVMH93ND\B%8]Y]3@<FJ:^$_#BS23+H.F"2202.XM$RSCHQXY.>:V
M** *!T323=2W1TNR-Q,NR27[.N]U]"<9(]JB/AO0C:1VAT73OLT3[XX?LJ;$
M;U Q@'WK4J*"YAN1(8)%D$;F-BIZ,."/J* .#U#PKJ$^O7\][X8\.:_;W$@-
MM->/Y4EM&% $9!B?@8)R#SD\5T&D^$-*L])AL[K3-/E6.9IXX?(#16[,<XC#
M [0/PR<G SBNAHH YLV.N:CK^S4H]/BT2SG6>U$+,TLQ4?*'!&%"L=W'=5_&
M]=:#:7GB*QUB6&#[19*PBE$0\WE67!?KLP[?+ZG/:M:B@"&ZM+:^M9+6\MXK
MBWE&V2*9 Z,/0@\&JUQHFE7=I!:7&FVDMM;X,,3PJ5BQP-HQ\OX5-J%T;'3K
MB[6!YS#&7\I" S8&<#) JIX<UE?$/AS3]82$P+>0+,(RVXJ#VSWH OV]M!:6
MZ6]M#'#"@PL<:A54>P' J*XTRPN[N"ZN;&VFN;?/DS21*SQYZ[21D9]JS=-\
M1C4/%6KZ&;*2!]-CAD,KNI$HDW8( Z#Y>_//05N4 9@\-Z$+:6V&BZ<()FWR
MQ?94VNWJPQ@GW-+>^'=$U*U@M;[2+"YMX/\ 4Q36Z.L?^Z",#\*T'=(HVDD8
M*B@LS,<  =2:P=3\4QZ?JN@V:6DD\6L2F..Y5P$3Y"_3J<@>GXT ;T<:11K'
M&BHB *JJ,  = !5"XT#1[O4XM3N=*LIK^+'EW,ENK2+CIAB,C%:-% %0:7IX
MDN9!8VP>Z&+AO)7,PQC#G'S<>M0?\(]HG]G'3O['T_["6WFV^S)Y9;UVXQGW
MK2HH SM1\/Z-J_D?VEI-C>>1_JOM%NK^7],CBI9=(TV>\AO)M.M)+J$8BF>%
M2\8_V6(R/PI-6NKNRTN>YL-/?4+I -EJDJQF3D _,W P,G\*NCITQ0!GQZ%H
M\,=S'%I5BB70(N%6W0"8'KO&/F_&K=K:V]E;1VUI!%!;QC:D42!54>@ X%2T
M4 9\FA:/-+=2RZ58O)=@+<.UNA,P'0.<?-CWI#X?T4_9LZ18?Z+_ ,>_^C)^
MZ_W>/E_"M&B@#.FT#1KC58]5FTJRDU"/&RZ>W4RKCIAL9J6/2--AU!]0BTZT
M2]D^_<K"HD;ZMC)JY10!G2Z!HT^K)JLNE63ZBF-ETUNIE7'3#8S5^6*.:)HI
M462-QAE89!'H13+:YAN[=9[>19(GSM=3D'G'%2T 9G_".:&+..T&C:>+:-_,
M2(6R!4?^\!C /N.:NVMI;V4 @M8(H(5)(2-0H!)R>![U-10!GSZ%H]U>R7MQ
MI5C+=21&%YY+=&=HR,%2Q&2,<8I$T#1HYH)H])L%EMU"0NML@:)1T"G' ]A6
MC10!@:AIUWI-F7\):1H\=Y-.IG$R^0KKSN8E%R6Z=?>K^BZ<VEZ:L$LBRW#N
M\UQ*JX#RNQ9B!V&3P.P ':M"B@"KJ&F6&K6OV74;*VO+?<&\JXB61<CH<$$9
MJN_A[19!.'T>P83JJS;K9#Y@484-QR .!GI3M0U:*RLM0GB1KJ6QB\R2")@&
MZ;@.2 ..:30-677O#VG:NL)A6]MTG$9;<4W '&>_6@!3H.C,ULS:38EK48MR
M;=,Q#_9X^7\*=#HVEV\UQ-#IMG'+<C$[I H:4>C$#YOQJ]10!0T_1-*TDL=.
MTVTM"PP3!"J9'7' Z>U9FM^&UET/4X- MM.L-0O4VO,;<*)1D;E<J,_,,C/)
M&<UT5% 'G]AX+6XO+::X\'^'=%DMYHYOM5A)OE)1@V%Q$FT'&"23P2,5UL_A
MS1+F\GO)]'L);FXC\J:9[="\B8QM8D9(QQ@UIUA^+_$8\)^&;S6FLI+Q+90S
M1QNJG!.,DGMSVR?:@"ZVAZ2TUO,VEV1EMAB!S;INB'HIQ\OX5!J.GO:Q7VHZ
M'ING'7)HP!+.FSS<8P'=1N(QT_"K%Q=WD6I6%O#ISSVT_F>?<B55%OA<KE3R
MVX\<=.]7J ,C0=/O+6.XN]3,!U*]<23^1DQH H544GD@ =3U)8X&<5HW5K;W
MUK):W<$5Q;RKMDBE0,KCT(/!J:L.X\1BW\967AUK*3-U;27"W)==N$*@@#K_
M !#KC\: +47A[18-GE:/81[(3;IMMD&V(YR@XX4Y.1TYJ6QT?3-,8M8:?:VK
M%=I,,2I\OIP.GM57Q/KG_"-^'+W6#:272VD9D:*-E4D#J<G_ .N?:M&TG^U6
M<%P%V^;&K[<YQD9Q0 R^T^RU.U-M?V=O=VY()BGC$BDCH<$8J*]T32M2\G[;
MIMI<^0,1>;"K;!T(&1P*O44 -CCCAB2*)%2- %5%& H'0 =J=110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5ROQ"@U ^$;J]TJXN8KRPQ=*L$S)YR(07C.T\Y4,/KC%=52
M,H92K $$8(/>@#S)O%D%IX[L]7%[=OX;O[ HK-.QBCNA&)N%SCF(@?[W3G-+
MX@T^[BD\"07-U<I=S:JTDKM*9'B9H9"54MGA<[1],]:ZR/P3H,6@:?HBV8^P
MV%PES A.<2*^\$^N23GV)JUJ_AVVUJ^TZ[N)[F.33Y?.MQ$R@!\$9((.>"1C
MIS0!P%QKVH>%(O']O#?W5S%IALWM'O)C,T/GJ QW-DD*3N .<8KHK?0]:3Q#
M;3G4!%I%S \%U;'59YWF8J2KQ,RJ488.=I''TK5'@_3&OM9NK@S7/]LQK'>Q
M3,"DBJI50  ,8!(X_GS47AWP3IWAJ16MKO4KD1J4MX[V[:5+93VC4\+QQGKC
MC- 'F,-JL7[.4$R23>9-/!N,DSNH(O@!A6)"^^,9[UV$EU>>&_B'=VZ:A?WM
MK+H,U^\%U,9!YT<B@%!T3()&% '3BM7_ (5UHP\/R:&D^H+ISS"80BX)"8?S
M JY!VJ&YXY/<FM,^&K9_$<.NR7-T][%;&U&XKL,9()!4+W(!S_3B@#D=(A\1
M:QIGAOQ%:ZI# 93%/>O)J,LD5Q$X^>,0E-B-DX7'0C'/6I/"-C?:MK6NSW?B
M#5V32]>E2"$7&$9!&GR.,?,OS=.,8R.IK8TCX=Z+HFH?:+*74%MA*9H]/:[8
MVL4F<[ECZ9!Y&<@'D=!6IHOARVT*XU":VN+F1K^<W,XF92#*0 6& ,< # XX
MZ4 97C+6+BSU'PYI,,KP1ZM?^1/.C;6"*A;:#U4L0!D<XSCGFLNXGU#2O'-[
MH%O?WC:=>Z-)>QF28RR6LJ-M)5WR=K C@YP>F*Z[7-!L/$-BMI?HY$<JS0R1
MN4DAD4Y5T8=&%0Q>'+=#=S2W5U/>W4 MY+R4IY@C&<*N%"J,DGA>2<GM0!YS
MI]UJMOX6\ :^VN:E-=WU]:VMRDMP3%)'*&# IT)X!W')SWZ8UV;7/&'_  D:
MZ==_9+JRU"2SM95U"6'[.8PNTM$J%7!.2=V<@XXQ70#P)IHT;2=*6ZOA:Z5.
MEQ: 2+E'3[F3MY R>#Z\YIE_\/M'OM>EUA;C4K.YN JW:V5VT*70' \P+UXX
MXQ0!LB\N+3PT+VY,5S<PV?FRFW/R2N$R=GL3T^M>=7FJ:G'\)+7QS;:I='5T
MCCO9%\]C!(&<!X3%G:%P2HP,C .<YSZI'%'%$L4:*L:J%5%&  .  /2N=M?
MVE6D'V**2Z_LKS_M"Z:7!MU?=OX&-VW=\VW=MSVH YZ[M+_7/B3?Z2^NZO8V
M3Z-#=".UG\MHI#*P^4XXX49XR?7'%=)XYDN+;P%KEQ:7<]M<6]C+-'-$V&#*
MA(Y^H[5:C\.6T?BB3Q"+BY^VR0"V92R^68P2P7&.Q).>OO5K6-*AUO2+K3+E
MY4M[J-HI?*(#,A&",D'&10!Y[.FHVVI^!YHM>U0-JZ&"\#3[D9?L^\%4/RJP
M(^\!GU)-5;[Q%J7@^Q^(4=M>75VFDFU>R:\E,[Q&= #\S9)52=V#Z5W4OA"S
ME;1F:\O=VC_\>A#IP=NW+?+\WR\<_P ^:5?"&F?;M9NIS-<_VRBQWL4S I(J
MKM48 &,+QQ_/F@# U]KOPOJGA:\T[4+VYAO]0CTZ[BGN&F699%)$@#$A64KG
MY<#!QTK.T1=0F;Q5JMSKFKS#0]8N6M[87&$D5(4;RW&/F4YZ<8ZCDFNQT_PG
M9V#6.^ZO+Q-/!%DEU('%OD;<C !8A20"Q8@$X/-2Z-X;M-$FU&2WGN9?[0G:
MYN%F965I& !8  8R !CIQTH Y+2+?Q#JECX:\0VNJ0Q"4PS7SR:C+)'<Q2 ;
MD$)0(C9/RXZ'CFM7XIW5Y8?#C6+VPO;BSN8(U9)8&VM]X#&>HX/;%2Z/\/-%
MT*_\^REU 6RR&6+3WNV:UB<G.Y8^F<\C.<'D=JA^*MO<7GPWUBSL[6YNKFXC
M5(HK>%I&8[U/10>P- &;J,&J^&_'WAZ2#6]1O+;699;:\MKF3>@81EUDC7&$
MQ@\#C%9ND2ZC#HOB;Q'<:UJUU)H.HZC]GM3<?NI4C4A4D7'S#IZ8QQCG/=V.
MAVK7-KJ4ES>W4T$31VK78 :!6QG"[0=Q  )8%L=^3EVB^&;+0X;^&&2>>*_G
MDN9TN&5PTC_?/0=?3I[4 <1JM]J.D^ ="\7V>IWEQ?,;26Z1YV:*Z68J'01D
M[5Y?C: 1BM.]U*3PK\1)'U"]NY-(U2PDEMD>9W6&>+YI$52<?,G(]P0*VK#P
M5IFGPVUJDUW+IUI,)[:QFD#10N#E<<;B 3D!F(!Q@<"M'5]"T_7/L7V^ 2_8
MKI+N#_9D7.#].>E ''>(5U31M+\(_P#$RO8[F?7+6.[7[0S!Q(Q+1DGDJ,!0
M,XP.>IJOXGUBZT;7M0;7/[3M]'FDB%EJUC.YBM/E4%)HU(P"^3N(.0P'&!CM
M-=\/6OB#[#]JFN(Q97*7</DL%Q*GW6.0<XR>.GK5>\\)6=^U^EQ=WK6FH.KW
M=IYB^5*0JKC[NY00HR%(S0!B7&IWEA\4=13[5<SV4?A[[:MH7^0.)2,J!W(4
M#/6L*ZU34Q\([?QS;ZI<G5TC2]<>>Q@D!<!H3%G;MP2HP,Y .<YSWZ^'+1?%
M!\0":X^V&V%IMW+Y?E!MP7;C^]SGK[XXJE;>!M*M(#91277]E&?[0-,+@VZO
MNW\#&[;NYV[MN>U &"D-[K7Q&U?39]8U6WL6TNWN!!#<&,QL[."%*X*]!TY.
M.21Q6;I>L^([SX<^&M46*[U?RWF&HP6TYBN9XT9XU92""Q!"D@'+'%=XGANW
MC\0W>N1W=VE[=0+ Y#*5"+DJ "O&"2?YYJEI_@FRTFQL+2PO]1MTL&D-NRRJ
M2HD.7!RI# GG!!_08 )?!6I66J^&X[FPO;J[A\Z49N]WG1'>3Y;[LG*Y"\]@
M*Q]+FE\7ZUXJM[B^O;4:==BRM4M;AX3$ @/F':1N)8D_-D84#'7/5Z5I-KHU
MK)!:ACYLSSS2.<M)(YRS-VR3Z8'88%4+CPK9R:S<ZM:W5Y87=W&L=TUJZJ)U
M7A=P8'Y@. PPV.] 'F^HW]UXG^%OAS4M6>;[<-8M[:1XI7C67;<["^U2!D[<
MYQP<XQ7KT5K'#9BU5IC&%*[GF=GP?]LG=GWSFL;4?!NEZAHUCI \^UL;&2.2
M"*V<+AD.5))!)P>?<]<UO1J4C56=G(&"S8R?R % 'B2V45O\!_%4J/<,QGO$
M(DN)'&!<$#AB1GU/4]R:[$"\T;XCZ!;)JM_<0:K8W)N(IYBT8>,1E61.B'YB
M. !6G)\/M&DTK4]+$M\EEJ,K2S0K<':NYMS! 0=H+<G'/OCBK\GABVFUG3-5
MEO+Q[K3HWC@)9,;7 #9&WG( _+C% ''Z7<^(;GPSXQCL+R:\U"VU^6&V%Q<;
M&:)3$3$K_P !*[@",8+9X/-;?@?6K/5KG5$B;5+:Z@,2W.F:FSM):MAN5+$Y
M5NH(/;\*NP^"K"WL]0MH[R_47]Z+^5Q* PG#*V]2%XY1>.G'2M+3M%M]/O;J
M^\V6XO;I42:XFV[F5,[5PH  &3T'>@#*\4W,MQ?:;I$%E<7JM(+N[B@* B*,
M@J#O91\TFSC/(5N.M<]\.KB31/$6N^$+BUFLXDD.I:;!.4+"WD;YE&QF&%?W
M[UVMKHL5KK=YJJW5U)/=HB2)(RE J9VA1C@#<W0\Y.<U4O\ PG9:AXFL_$#W
M-Y'?VD9BA,4@50AZJ1CY@??- '$ZQJ&L3V?C"(W=_!K]M>[=(AMI' :+:ABV
MH/E?.6W9!QGG  Q=U6TU1_&?AO19->U2"&\TVZ-T(9PK%U"<A@.H+'G\L5FQ
MZ>9M5U%[R/QQI6H7-Y)(T.F/(;9^<*RN 4Y4*221SGH *[+3_"SR7.CZMJE]
M>2:K80M$C%TQM;J' 7#$@*"?49&* .>BCU76[W7]"M;ZX+Z0(;.WGDU.6"92
M8583.(T_>%F)^]P=O0<Y?#>ZU?Z_;^&;ZZ@N;BVTA+B=[:^DM!/*9&C9PT:[
MCMV#C@ L>.!C=UCP'I6KZX-9%QJ-A?E!%-+I]VT!G0=%?;U_0^_ I=:\!Z-K
M)T^0&[L+G3T\NUNM/G,,L:?W-PZCZ_U- '*W\7B72;7PG8W_ (BEDNVUH6DT
MMK+G?$R.ZB0E1N< +U&#P2#FK6FZ9<W/C3Q-X=DUW6?[.A@MKB("]?S4>0.&
MQ)]\+E0=N<?AQ72S^#-.G@TN+S[Q!IL_VJ!A+N9IN?WCLP)=CN;.?6K$/AJW
MM]=O]8BO+M;R^C6*8[D*[5SMP"O&,G\^<T <%H7BC5M3\.>!K*>X\VXU5+GS
MY7N&@:;R<A5\Q06!/!..3MZ\FE\46_B7P[X(\0R2:[)'LN;>6Q6&[>6:"-Y5
M1D>1E#,O7'?J,\5U#_#C0I/"]KH#F[^S6<OG6DPFVS6[Y)RC@ ]2>N>OL*FG
M\":9<^'9M%N+O49X;ATDN)YKDO/,5(*[G8$X! P!@<>YH S(H[K3/BC#IG]J
M:A<V>HZ3---'<7!8+(DB@,F,>7PQ&%P*9\)K**W\+W$J/<,QU"[0B2XD<8$[
M@<,2,^IZGOFNE;PW;R>(K77)+N[>]MH#;H2RA2A(+ @+W(!S^6*71/#5AX?D
MNVL6N0ES,\QBDF+)&SG<VQ>@!/- &#XDN)M#\<Z'J,]]<IH^H"2PN8C<,L44
MQ7=$^,X!.UE_$'KS6#X;U6]NX-3\-75WJ*ZC+J$;VLLMR_FBRE'FHV<Y!6-'
M4_[0 /6O0];T.P\0Z:=/U*$36QDCE*^Z,&'ZC!]B:#H=@?$0UWR1_: M3:"3
M_IGNW8_.@#E],F?Q3XC\46%Q>7UM#I<L5I;);W3Q,F8]QE)4@L23QNR,*..3
MGG=+\1ZSJ%CX)N;N\G%U)K$VGW3QN52Z2,2C<4'R\E!VZ@UW]SX6M)=;FUBU
MN;NPO;B(0W,EJZ@3JOW=P92,CH&&& [U'?\ @S2+W1;#2XUGLXM/E6:TDM92
MDD+KGY@QSDG<V<YSDYYH Q+&ZN6\5^/K&2ZGDM;>VMF@BDE9UB+PN6VY/&2.
ME8?A[59D\.?#7P]'-);PZK;.T\L3E'*0Q;MBL.5W$C)'. <=:[2T\%:;97>I
MW<$]^+G4HDBN9&N"Q8*NT'G()P3R<XSQBH9? &CS>'].T<R7BQZ8X>QN$FVS
MVQ'3:X'\\_RH RO"UDMA\5/%\*33R(;6Q9?/E:1ER).-S$DC.>I[U?U[5)I?
M'F@^&_.E@M+J">YF:*0QM*4 "H&&"!R6.""<#MG.CI7A*QTG6KG5X[F^GOKJ
M)(II+BX+!PN<948'<]N.V*L:UX>LM<>SGG,L-W92&6UNH&VR0L1@X)!!!'!!
M!![B@#SCQ)->)IWQ#\-W%U=7-A9::M[9R/.YDBWHQ,;/G+KN4D!B>,@Y%7=8
ML!&?AU;P7%S'YEWGS#,TCKFV;."Y./;L/2NV_P"$7TY]/U.TN1)<G5$*7LTK
M?O)@5V<D   +P H 'YU3'@BP"Z0/MNHLVE/YEL[SASNV[<L2#GY>,=/;- ''
MSZ_J'A6W\>V\6H7-Q%IDMF;22]F,KP>>JACN;)(4DL,YQBNCM=%UV#Q%;W"Z
MF+;2[B!X9[=M2ENGDDP2KQ&1/E88.<<$<XXK3'@[2VN]:N+@S7(UE%2]BF8%
M) J[5P !C XX_GS4&A>![#P\I%K?ZK,5C,=O]JNS,+53VB5OE7L,X)QQ0!R/
MA+1=7\2_#>UU=O$^M#5KBQFCB(O"L8D\QMC$#J00!DGH2.F *Z^+)9?^$-UU
M;B^6S0);ZW$;E]D3N3$A<$\D2H^<]NO45Z1X=T"T\,:-#I5A).UI#GREF8,4
M!))&< XR3UJI)X+T.31]7THVN+75II)[L X+.^"6![8(!'I0!RGC"XOX/ACK
MVOV>IW]M-<2BXMFCN&^2'>J(%S]T,OS\8Y?V%7?&NI7^D:R;N[M=3N/#WV,+
M)-I<[++92[FS*Z*064KMYY V'CGGI]=\.6/B'09-%NC+'8R!5=(&"$JI!"YQ
MP,@=/2F7/AM+FZDN?[3U"*2:V6UF\MTQ*BEB,@J0&^=N5P>: .7CU2?7=?AT
M6SN_M=G'HL%W'*M_+:-<F0LIEW(I8X"KQD8+'.3C'3>$K75['08[/6]0AO[Z
M!V1IXV+$KG*AB0,L%(R<<]>]4=4^'VAZDFF&+[7IT^F1""UN-/N##+'$!C9N
M[K]??U-=!ING6^E6$=G;!_+3/S2.7=B3DLS'DDDDDGUH XJP%YXUMO$C1ZS=
MZ=?6FJ365J\$K!;81%0"8PP#[N2=V<AL=!4UA?2>)?&NN:/<WMP+72[2U\G[
M).T'G-*C,TN4()Z* ,X'/K5^[^'^C76O7&K++J%K)=X^V06MVT4-UCC]XHZ\
M<<8SSGJ:OWGA>SN=9CU>VFN+#4$A^SF>T*CS(LY",K*RD ].,CL: /.'US7K
MCPY902ZO=QW5AXM71VNHR%-U$)0-S\<G!P>QP<YYK=CAGM?%_B7P^^I:C<V$
MNCQW@$]V[/'(6D5MC@@J#M!P"!Z5T=WX+TJZTVQL%:X@@LKH7L?E2#<TX8MY
MC,02QW$DYZD\U83PS:+XBGUMI[F2ZGMA:R*[+L:($D+@+ZDG/7F@#S2U6[T[
MX0^#;C3=3OK2:XN[&.0I.S AW (PQ.!_LC /<5U=WIQTO5].TM==UB_$OVBX
M-@;EO/DSM 8S!E*1)D\$\EAC)P*NK\/-(30[71TNM1%G:SI/"IN=Q1D.4 )!
MP%/0?GFM#4_"ECJNK66J2SWL-]:1M")K:<Q-)&V"4;;U!(SQCGIB@#AK277]
M9^#KW]OJ-Z=8TZ>X9&2X8-.D4S QN1C=E%VY/.<'UKH&\0IJ%A=>*-,EFELM
M.TAIXXA,VR65H_,VNH."54+_ -_#W QO>'O#6G^&;.:TTXS^3+,\NR64N%+$
ML0N>@R3_ %S4NC>']-T'2/[*L+94L]TC&,\@[V+$'U'./I@4 <AI=GXAOH_#
MNNVVJQQ0RK&]ZTFHR3)=1R*.%B*!$;)&W;C!XYKF[J75O^$%\8ZO_P )#JPN
M]'U:Z%F1<D!1&RX# ?>&.-IX] .<]WHGP]T?0+P2V,^H_9T<R06,MVSVT#'^
M)(SQGDXSG%//@33&T75=(:ZOFM-4G>XNU,BY=W.7P=O .!P/3C'- &7/J%]K
M_BV]T5#MBMM.MYUC34);1F:4ON<-&I+ ;5&,X!/?/'1>%+?5K/P[;VFN7\%_
MJ$!:.6XA)(?!.W.0/FQ@'BJ&K^ M+UB>QNY+K4;;4+*+R8[ZSN?)F:/^XS*,
M$?A_.N@T^PM],L8K.U5A%&.-S%F))R2S'DDDDDGDDT ><:%I\,-[\1Y%DN2T
M=Q(JA[J1@0;92<@L03SP3G'0<50T<7FC^'?AKJ-OJE\3>R6UE-;M,?(:)X&.
M/+Z9&T8;K[UW[^#M..H:K>QS7D,FJ+BY2.<A"=NPL%.0&*\9_+!YJ$^!]/\
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M#(RQ'!178@$L >N.1@UOU2TO2[?2+%+2V,K*"6:2:0R22,>K,QY8GU_I5V@
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MMO;F-Y88MI^94QN.<8&,CJ:\UU/Q7K>M^ ]%U&&>"RGEUR*RN@D#%9-MQL!
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M\IKR<6T VD[Y""0O XX!Y/%7:XJ_\1Z]IMOX5>YAL=VK:A';7"^4ZM$KJS
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MEVFA>(-*N8;9HM7N;AR\$(C:.*0Y1 ?]GJ.V>U7(/#-[=ZAHMSK5S!.-&5C
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MAU/"V@)ID<@91-+*%3(2+>Y;8@/.U<X'TSWK(UWP?>^(E-KJ+V+QQWRW-K?
M,+FU02!]B\=>-N[(P#T..>TI-R[PNX;B,@9YQ0!R4'AG4X-;\4Z@)K1AK<<2
M1IEAY.R,Q@DX^;(.>WI[UFV'@?6],'A=[74[$RZ-:/9NL\+O&ZL /,4 @J^%
MQUY'<5W[,J*69@JCDDG %+0!YR_P]U<^!]2\-_VI:/\ :[\W4<QA8;%,PEY
M/))&., >]=!>Z#J%YXST;7O,M4CL+>:%X<L2_F[<D''&-HQQS[5TU% &)XO\
M/GQ3X6OM&6Y%LUP%VRE-X4JZL,C(R,KCK5<:#>:IK.GZGKC6N[3DD$%O;;BA
MD==K2,6P?NY 7'&3R>,='10!PGA_PAXD\/A=&AUZV?PW%(3"K0-]K2/.?*#[
MMH';=@G'3'&.NUBTFO\ 1;VSMV19;B!XE:3.U=P(R<>F<XJ[2$A022 !R2:
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MSPN9K<2'<4X."N2<'KSTKT#3X)K73K:WN)4EFBC5&DC0HK$#&0"3C\S5FB@
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MB=UC:1E!(1,9;V&2!^9KR6;3/%<GPWLO"LGAN=K[39[5!/'/%Y$\<4JD,I+
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M HT_Q)J=Y\1-7T1]/*V5E;P,KB12?G+DN>^#@  9QC)ZUSW_  C^N:I\,X?
MM_IDD-P@AM);T.A@\F-U/F*<[B2BC"XSN/.!S6]9Z=J>G_$W5+Y=/>73M1L[
M:-;I94"Q-%OW!@3NR=PQ@'ZB@#3\4>)X?"UK:7$]E=7,=S=1VH, 4[&=L D$
MY/X U57Q>P\NWN=)GLM1E:7R[2ZFC3,:$ R%PQ 4EE QDDGI@$U!\0=/U'4M
M,TN+3;"6\DAU2VNI%C=%VI&X9OOL.<=*J>++#6;;Q/I?B?2M)758X[9[.\T]
MG19-C,K!T+?+D$<C/^( +6G_ !"T[4[*!K>%UO9=0?3/LLLBKLN$4LP+@D8P
MN01G.0 ,FK-[XO\ [-M[.6]TJZB^T:DFFE=Z$H[MM5^O*'KD<XQQ6=JFGS:Y
MHD%OK7A-9;*YN"TMG%(GFVB!/EDW!@"^[KL)(#=\'.+/X8\1Q>"XH,7>HOIV
MNQ7UC;W,RFX:TC=2$9B<%OO$9/3 Z\  [9-<M[SQ/>^&9[-_,BM%N69]K1R1
MNQ7'KG(/!%>=>'M>OO#7P<T*33;02M-J36I8N!Y:O=NO /4D<#TSD].>GTZ#
M6I/B3=:]/H=Q;V,^CQP)NFB+JZR.VU@&QD@]B1R.>N,&W\,Z^GPFT_3&TF4:
MG8:FEVUJ9H\R(+DR_*P;;G:>Y% 'J4,DCVRR20-'(5R8BP)!],@XKA;;QAH^
MA^$O$&O6>@7<$%GJ<Z7D"&/>TX90\A^;&"Q'0GZ5W-O+++:I+-;M#(RY,)8,
MR^Q(XS]"1[GK7EMYX<\07'P[\9Z4FBW O=4U2>XM8S+#\T<DBL"3OP. <@\T
M =K:^+!+XHBT.ZTJ\LGN8'N+2:8IMG5" W )*GY@<-@XZX/%:.MZS'HEG#,]
MO-<23W$=M#%$,EI';"Y/0#N2>@KG]0L]3N_B'X;U2/2K@65K:W,=Q(SQ_NVD
M";01OR?NG.,U=\;+KC:5:?V)#-/B]B-[#;RB*62VYWJC$C!SM[@XSR* +>B^
M(4U;4-5TZ2U>VOM,E2.XC+!E(==ZLK#J"/4 ^U,U7Q*ND^(=(TF:RF9=4=HX
M;H,HC5U4L5;)R"0...:P_!^DZCIGC+Q)<R:&-/T[4!;26Y66,A=D>UE(4_>S
MR>W7D]]7QUH=QKOA>>.PXU.U=;RP?^[/&=R_GRO_  *@!GB#7+5-'\1I?Z1/
M>:=80,+I8V0^:ICW,H!8=$()^HQFI8/$%G;6>AV.GV;-<7]J)+6S5@HCB5%)
M+-V494=R21@55U;2-0;X;:KIT=N;G5K^RG$B1LH#3RJV<%B!M!; R> !6.FB
M:SIVJ^%/$,.GRRM9Z9_9NH60=/-12%(=?FVMAEY .<=* +6NZ[9>(_ _C"QF
MM7@OM-LYTNK2?!,;>4S(X(X*GJI]NU6]%ULV'A[PIIL%G)<WE[IL;Q@';&JI
M$A8LW./O  8.2:S;OP[J-S#XXU=+&476MV0M+2SWH'PL+(&8[MH)9CWX '?@
M,%GXBA@\)VLVC7-SI4%@(+^RCGB5A.JJJF3+@/'PW )'.2#@"@"75_']Q)X3
MTW5M'T^3==ZG'8S+,ZAH6\[8Z]2"3@@'ISGVK5GU*P;QWHUI>:+,FK26<\EO
M=,R%8T&W>@(8DGD=OH:XZ#POXBA\ _V?_8FVYL=?%_';QSQ_OXA<&0[#D #:
M1C=M/L._47MGJUW\1/#NK?V3,EI;V=Q'</YL9\II-FT$;LG&WG (]">M %F[
M\<06^F7>L0Z?<7.C6<KQ3W<3+GY&VNZIU9%(()Z\' (IUUXUBCU^#1[+2[R^
MFN;$WUM)"T8CF3*@88MQ][.6QTXSD5SFEZ%KFC^!]8\%_P!F27/F?:8;&]#I
MY3Q3%B&DR=RE2YR,'..,U>T_P]?Z-XWT-H;&>?3-.T#^S3=!XQEPR$?*6W=$
M].IH Z7PSXAA\2Z2;V.WEMI(YI+>>WFP6BE1BK*2,@\CJ*;=>("-6N-*TZS>
M^O;:%9KA%D5%C#9V*6/\3;3@>@Y(XSF> =/U'3;36DU&PEM&N-7NKN(.Z-NC
MD?<I^5C@XZ@U7CT[4_#_ ,0]8UB*QFO]-UJ&#>8&7?;S1*4 *L1E64]1T/7'
M6@#-\9>,CJ'PFU+6-#6X0NIMY22(Y+5MX1U89R&&2.,]C[UUFC:%I]E=S:K;
MZ0NG7MQ$L,T:.,,J$[<A3MSSUZXXKB=5\(:O'\,=?TZUL&N-4UK4)+XVT<J
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M6TN[N1;)=K,A(8DA7*9W!"1UZ]#BK][XL6%-3FLM/GOK;2BPO)8W5<,J[G5
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M$DTA26+SD6.WD=S'W<HJE@O(Y(QS5>3QCX<B2P=]8M E^A>U8/D2* 22,=
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MI^MVN!/'+*SXCF4C)'S%<@X  ].)M.MWBN?BA!8726,N\&*X=MJPL;4'>3V
M)SGM0!Z8KHQ8*P)4X(!Z4%T7JRCG')[^E>8Z3X=.LWO@N^BTG['!I]FQOV?:
M!*3& B_*<N=_SY/3GN<5C2^']*N?#'Q.FFLTD>SO;N2V+Y/DNMNC!DS]UL]Q
MSQCI0![.[I&N795'3+'%4]1U:STMK1;J8(]W.MO F>7=NP'L,D^PKAE>SUG6
M=(MYU6\U+_A'UFF6^8-;11.5S)LQEI"01P0-N<D<9Y;3X;;4O 7PODOHH;J0
MZHD#-,H<F/;, ASV^4<>P]* /;F=$QN95R<#)QDTZO,&@M/$?BSQ3H%]/IT:
MPQ0QVD-Q;!RMJT*G="=P PQ8D@<';Z"NY\.6R0>&;&U%^^I11PB-;J4<SJ.
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MUI+GS8DC&),C!W9^]QQSVJM:>"O#-B+<6^B62?9G,D.8P=C'C(S^GIVK>HH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"!EBG/HWM0!Z)167H=W?7T-U/=M;F'[3(EL88V4F-6*Y;+'))!Y&!C![UJ4
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MQ#KVGV6JZC;Z;#I]Y8Q3QK SF42, 3G/&TCD<Y'?- '4T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !39"XC8QJK/CY0S8!/N<''Y4ZB@#F_
M!.A7WAS0GTZ^>WD;[1-.KP,Q!\R1GP00,8W8]_:KT&E3#Q5=ZO<.C(;:.UM4
M4G**"6D)]V)7\$%:U% &? FK#6[MYY;0Z48D%LB*WG*_.\L>F.F,?_KT***
M"BBD!!) (XZT +7!:_XBMM$\;O<_\)-HEN%LXX)],OI_+9VW,ZON&=F _'RG
M.3TX-=[67>>&M!U&Z:ZOM$TVZN'P&EGM4=S@8&21GI0!Y>#X%U'4O$NIZKXH
MT*"YURT^Q-%9W2LL28&6+$#>Y(!S@= .>M2> _$=KX9TZWT;4_'GAFXTRR)$
M#P2_OI$YPK;CA0,]LG@#->B_\(9X6_Z%K1__  !B_P#B:/\ A#/"W_0M:/\
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M2,L<B@[E97"DA@<CE>1Z5F:IX#O;SP[J=K!/:C4=5U*._NI7+!$V.C*BX!)
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M@# ZDUV=&1G% '+:)9^,ECSK]_I<[01E85LT>/SVQ@-*3G''\*C&3GL*PX_
MNL1?#W1?#0GL3-IUW%.TQ=PKB.3S  -N03T]NO->BT4 <E>>%KO4?&D^JW7V
M;^S[C1VTN6%9&WX9]Q8';CVQ^/M5;PSX?\7Z/%;:3?:QI]QH]EM$$T<3K=2Q
MK]Q'.=H' !(R2!COFNVH)P,F@#S]O!6L/X4\5Z.TUB)-<O)[E)!(^(A+C((V
M\D8_'/:M%_#6K#Q)H>LV]Q91O:6#V-U&X9P5)4[D/&3E>AQUKKZ* ,WQ#87&
MJ>'-2TZV,:S7=M) K2DA5WJ5R< ],YQ6''X?U6/0M)TFXM]*U"RM[ 6EW:W+
M,$E90H5U.PXX5N"/XNO%==D44 8GA'03X8\,6>D&<S?9]^#DD*&<L%&><+G:
M,]A6&GA35EC\8J7LLZ]N,7[Q_P!SF(1?-\O/ SQ]/>NWHH \^D\&>(;%/#^H
MZ)?V$.L:9IZZ;<1W =K>ZA4#&< ,IR,C'KC/K?UWPUKNM^'+:TGO;.2_^W0W
MDSX=(D\ME8)&O)Q\H&2>I)[X'949_2@#CG\-ZWIWC6\\0:+/8F/588DU"UNR
M^%>,;5>-E'/'&"!GU':YX&\/W_AGPZ--O[FWG=9Y95:!&4 /(SX.3SRW_P"N
MNEHH Y1_"UX?&6JZEY]L^F:M9Q6]U"ZMY@V!QA2.,$/R369!X(U5O!R>#+VZ
MM9M'1EC%V&83O;JX81E-NT-@!=V[ISC-=]10!!=6PN;&:U!V+)&T>0/NY&.E
M<78^#-3D\+:7X7U66R.F6#1;Y8&8O=)$P9%*E0$R57.&;H0,9R.[HH X8>&?
M%&C>(]2N?#FIZ:NF:I/]IG@OXG=K>4@!GCVD;LX!P2*[2")K>TCB\QIGC0+O
MD/S.0,9)]34M% 'GZ^"=7_X0;Q'H+36/GZM=7$Z2AWVQB9MQ!&W)(_7VK2O_
M  YJMYJ?A2\5K-?[&+M,ID;]X6C,>%.WC@YY^GO774F1G&>?2@#AK;POXIT/
M6]2&@ZKIRZ-J5R]TZ7D+O-:R.<N8\$!@3R W _/.7K,-[JGC>[AT>]T:673;
M**TFCU*26.4;LNWS1L&=64IG=D9''.:].K,U'P[H>L3K-J6CZ?>RIPKW%LDC
M+[9(- '&QZ;KNO6FCS6RZ-;2:%?LOV:%G>QN4$8 9, $%"Q &#AE/I4G_"$:
MY_8GB_3GOM/D_MZ:25'$;IY9D148GKP-O YSZUWT<<<,:11(D:*,*BC  '8"
MGT <HS^(=-O?#=C ^G/;"/R;Z$;VD("X$B'  48R<CJ0.216IXHTRXUKPOJ>
ME6K1)+>VTEN'E)"IO4KG@'.,]*UZ* .,/A?5FU/P?=[[+&A0R1S+YC_O2\0C
MROR\8 SSZX]ZO>'-"O\ 2M=\07UTULT6J7*W"+$[%H]J!,'*C/"YS72T4 <Q
MX1\)+X6;4E6X\V&:X9K2/M;P%BXC'T=W/TQZ5S4/@'Q+'HNE:<VIZ6[:9JZZ
MBD[12%[G#LQ:4Y^]\W;.<#D5Z910!R]AH6IV7C76=<9K22&^MH84C#LK Q!L
M$_*1R6_#WKGX?AWJL7@K2=-2_M(M8T:_:^L[E0S1.S2.Y5UP"%(<@XSTS[5Z
M110!R&GZ!KY\=IXDU&?344Z8+%[>W#N<^87R&;'YX[XQQDV_%7AN?6;C2=2T
M^XC@U32;@SV[2@F-U8;7C;'(##N.E=)10!R4_AJ^OM0U/6;H6B:E<Z:=-MX4
MD9HX8R2S$N5!8EB#]T<*![UJ>$]+NM#\*Z;I-XT+RV5NEOOA)*N%  /(&,XZ
M5LT4 %%%% !1110 444 Y&1TH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'\
M1>(8/#=G!=W5M<30RW$=N6AVG8SL%4D$CC)[9K8KE/B)IE]JGA)X].MVN;F"
MZM[E8%(#2".568#/&< T :#^)84\3S:!]BNVNX[$WRLH0K)'O"87YL[LGH0/
MK6):?$NQN]/TK4ETG5(],U&X%LMW(B!(I&<HH8;MV"1U (&<9SD5!;?VM<_$
MR/7WT&^@T]M$-MF0Q[U?SMX#*&ZD \#)Z9Q6!!H6MQ_"30M&;1[O^T;748II
MH!MRJ+<&0G.[!^4^M '=ZOXM@TM=0:*RN;U--7?>&!D'E?+O( 9AN8*0V!V(
M[G%5#X^L)=0L;*PL+^^>_L3?6K0(NV5/EXRS#:?FYW8 ]:P'L]3T'QAK$K^$
MFUW3=7F6ZMYXEB,D$FQ49)!(1A?E!ST'OVTAI^I1_$31;Y],*VMOI4MO-);*
M/*CD=D8*HX) VD9Q0 :MXU>\^&VMZUI5G=PWEI'<P21/L$EI-&K EOFP0I /
MRDGD<5#HB:1I(T;4QI%S!KFH6JVD<"2)NNP$$C2. ^TXP3O8[N<=2 <Z/2=7
M'@/QU8'2;L7>IWU[):1$+F1)A\ASG ]\XQ5Z]TO58[KP9XAMK">5M(A>VO;'
M@2A)(U5F7G!*E1P#R.E &T?'%E%:ZTUQ97D5YHR>;>6>$,@CVE@ZG=M92 ><
M]L$ \4RT\=VUQ9K=R:3J=O;S) ;226-<7;S?=2/YN6SZX&.<XYK%U;0K[4KK
MQ9KL5C<*U]HITRRMB ))3AR78$_*,LH&<'@GCBEU;1=;N?A[X8?3[)O[7T.6
MUNC8S,%,IB38\><XY!.#GM0!T<7B^T6XU6WU&VN=/DTR%;B<S ,C1,"0RLI(
M/0C'7/K3(_&-LNOVFCWUE<V,][$\MHTI1EE"#+K\C':P'.#V[UF:M%K/CKP=
MJUC_ &5/HWGVVR!+UE\QY00PR%)"IE<<\G)X&.8] N=8O8U#>"H=&U"WB;S;
MB98O+:3:0!$4.X@M@D\ #(Y- &C8>.;+4+C1T^PW<-MK7F"QN'"XDVJ6^8!L
MKE02,CZX-<CX<\2IX3A\7N-&U.]M(-?N7FDM$#+!&%CY.Y@3C!X7. .<<4VV
MT_Q%=7G@_5+SP[J#ZE973G4IYYHBS,T3*2GSX$0)S@8 &, FMC3K35M)B\7Z
M<='N9I]3U"XN;.1=IAD25%4;FS\N"#D$9QTS0 [6;BTU'XA?#W5+.3S(;I;Q
MXY 3AT-OE3C\?UK7U?QU8Z1:W-^]I<S:;9S^1<W<10B-@VUB%+;F"L<$@=CC
M.#6&OAJ]T75OA]:V]M/=VVBPSQW=R@&U2T.P'!.>6STS@54TJPU;P]J.I:-/
MX.358Y[V:XL=2'E>7LE<OB8M\R[2QZ D]ATR >D7%VL.GO>1QM<*L?F*L1&7
M&,\9('3WKGU\=6#Z+H&K+9WAM=:N(K> [4S&\APN\;NG!Z9KH7@9[!K?*AC$
M4RJX&<8X'85Y-;:;XB_X0OPEHQ\-WHN=$U6U>Y+/$%=8V8EHSNY&.<G Y'6@
M#L[GQY'%?ZU8VVAZK=7.D!&G2-(P"K*6W EP,8'3[QSP.#B\OB[3Y]/T>YLT
MFN9-80/9VZ !V7;N8MD@*%'4D^@&20#AV-IJ,/BOQO>R:9=+;ZA!;K:MA3YI
M2)D8#GCDCKBN?TK1?$&@VO@C6!I%S<-I=E)I^H6*%?-0.!\Z#.&P0,X/3] #
M2\*:E;Z=XK^(-_>PRV,%O+:O+',=S)B'G&"<Y.2,==P^E=(GC*!==AT>[TZ[
MMKRZ@>>T5FC;SPG+*"K$!P.<'CWKD+OPYK?B";Q_&-,GL!JRVDEC+<M'M9XH
MU^5@&)&2H'0CD]QBM_PW>7]W)%)=>"?[&FMD)N962([VVD;8=IR<DYR<#''.
M: +GAKQM%XI^RRV6CZI'9W,<CK=S1J(U9'*E"0Q.3C/IVSD'&MJ6M1V-W#91
MPO<WLR-*D$;*N$7 +$L0 ,L!ZDG@<'&)\,[&^TKP)8Z=J5E+:7=NTH>.3!^]
M*S @@D'AA5#QAIVI6?B[3O$EIH@URS6T>RN[-0AD0%@ZR(&X)SD$>GZ %F7X
MDZ;%X9EUT:=J,EM;736EZB+&7M)%(4B0;\8!(Y4D8.:WK/74U"2_%M97,L-J
M=@G0H4G; )6,[N<9P2<#.1G@UCNM]=:"+)?#XL4U64Q/$L<;?98"H#/* =I<
MC. ,@9&<@&J_@NWU/PS_ &AX<N+"ZETFQ<MIEZ IWQ'YO+89SN4D@''(H =X
M:\1:%;>#M"?1+":"TU"9X+"S=@&W9D9LEF('W&/4]@.<"D\3^,K[3/#@O;32
M+E+@ZA'9.DS1@Q[G5=WWB&R#\O;D$XK"T;P[(?AEH6@>(?#EU.D<T@N40CS;
M4[G9)4*MD]0/ER?F/'447?A_Q(WP\GLI/MFIO:ZO%<6*7++]IDM(Y48!B2 6
MX8C.#C'0\4 =1=ZEIC^-= @OM(NX]6D@N'M)G*[8E"CS%.UR"2-O8]>M4IOB
M5:1:?JE\NAZO);Z5=O;7S!(QY.P+N;E_F'S=%R<#) &,KJ4&HWOC_P *:H-*
MNDMK6"[%PQVGR3*JA <'D_+SC('K6(=(U=O!?C^Q_LFZ%SJM_=2V<9"_O4D1
M54YS@<J>N,4 =Q=>([:+4[/3;6-[N]N[=KJ..,A0(EP-[$D8!+ #N2?J0WPU
MXFMO%%I-<VMI=VZ0RM"XN553YBDAEX8\@C!_#&:XW5GO;/7/#EY9:+J4M]:Z
M4T=Q]B,32HI*@1R([ ;258@@YRO' -=%X%ELH].N;"VT[4["XBE-Q<1ZE&JR
MR-*S,9,J2I#$-TZ;<8% &G>:^D.J/I=G:37U]%")Y8H611&A)"[F8@98@X'L
M<X'-9$_Q%TB+0;/5TM[V6"XO%L71(AYEO,6VE9%SD$'TS[9R*@%CJ&@?$?5-
M9%G/>:7K%K"CO;KO>WFB! !7KM8$\C.#UQUKG[WPMJUKH!>+3IYKN_\ %"ZS
M+;1%28(A(IP3G&[:HS@GDGKC- 'HVCZG+JMI)--IEYI[I*T?DW:J&('\0VD@
M@^N:X.8_\)3X[\2Z1J^A7-Y96]G;1PQ%XOW&_P QC(#OX9B%P5Y&T9QBO2U;
M<@;!&1G!&"*X[1+:^@^)7B6^FT^YCLKV&TCM[A@-KF-7#=\C[PQD<T +:>.=
M,A\%:5K<5GJ#:?<2I:('*-+&?,\H%\OS\PZ@D]Z?!XHU&;X@:EH8TF=K6SM(
MI%9'BRQ<M\QRPP/EP!UZDXKBETCQ%%\.+;PPGAV\>[T_4TD:7?&(YD%UY@,9
M+<_*>^ ,')['L;:TU.T^*%[J)TN=[+4-/MXQ.'3;"R,Y97^;.<,,8!S^H )1
M\0-//A"V\2BQOOL4]Q]G*;4\R-O-,.6&[&-P[$\4[4O',5CKEYH\.AZM>WMK
M EPT=M$C;XV8KN7+#I@]<'T!KAWT?Q%'\-I/"L?AZ\DN[34A+YN^,1S)]K\T
M&,ELGY3W  P<GL>QL+:__P"%IW^IR:;<Q64^EPVZ3/MQYBNS%3@GLW7IQUH
MLZMXZL=)M+J_>SNIM-LYO(NKJ(H1&P8*V%+;F"L<' ['&<&NE_=7=MP0\,J=
M0>&4CU^E>::78:MX>U/4M'G\')JT5Q>S7-CJ2^5Y>R5R^V8M\R[23R 2>P]?
M2ES!:KN&XHG(C7&<#L/Z4 >=_#_6K?0?ACI#2QS3/<ZA/:011\L\C7,H R3@
M#@DDGM6]-XZMK?2]<NY=,OS+HDFV]MHPC.J[0^]3N 9=ISUSUXKE=*L_%&D?
M#W1[&+2KY'BU21M1MX'59VMGED?]VV['\29P0>O3K6QX1T:[MO$GBR.\T)[3
M3-2>&2+>Z%67R0C*=K$[LYSVZ\GN ;;>+[9=8T73C8W>=8A:6VG!C,>%4,P)
MWYR 0> <]LT^;Q7;PLR-9W =K_\ L^WW,@%Q+M+':=W  5LYP<@@ GBN$'@K
MQ##X31L"75_#MT!H@+?ZR"*0XW>GF1G:1Z(M=7KF@V[^%M/T?4-)DU>V><?;
M&BXD1BKLTZX(.?,QTY^8X!H Z'3-1;4$N/,LY[22"8PO'-MR2 #D%2000PP?
MY50U3Q-'I\MW#;V5Q?36<0FN$@9%V*02!\S#+$ G ]LXR,T_ VGZKIFG7MKJ
M%U=W-HETW]G/?',_V?:N YZ_>W8SSC&<=!@ZE9:EH?CS5-1/A=M?TS5UA96@
M$;2VTJ($*D.1\I !SGB@!?%OBL:GH/A>ZTB"XN=-U?4[5'9"B^;&6),)#,#D
ME<$'Y<9!-9SV%M:?$6UT>+PW<#3+RTGO9].=X6B:4F-"X0R;0%!88'=B0#6W
MXIL-3N+#PJD&D$R6NL07MS#:!=D$2E\C)(R1N XZ\G%6;NWOI/BGIFJ)IUTU
MA%IDMO)<;1A7=T8#&<]%Y.* &?\ "1Z1X,T!XK2SO9M%TJ4V\URLHD\GYL-@
M,V]@A.#@'&,#.#C6O?%=O UXMC9W&I-96ZW-Q]F*_(C*64#<1N8J,A1VQG&1
MGD--L-6\/:MJFDS^#DU>&YO9KJQU%?*V!96+[9BWS+M)/(!)[#UN11Z_X1\:
M:M<1:'<:OINL""1'L2BF"9(Q&597884X!!SQ[T 79_&]Q/XE\-VFG:;<36&J
M6LEV),HKNH5<+M9AC&\$YP?3/-6M-U33!XB\5M8:->_VI:BW-\!MW7/R$Q[
M7Q]W_=ZU3U>SUL>,?"NLG3&N_(@NH;I;9UQ"\@0KRQ&5&T@M[9QSBK'AVSOH
M/B#XMO9[&>*TOC:_9IG VR>7&5;H<CGU S0!=L/&%KJ7A>QUZTLKN2&]D2*&
M >7YI+/LY&['!SGG@ ^E,UCQI:Z3;W]T+*ZNK33FVWDT!3]T< M@%@6V@@G
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M,6$2G($I7[P1B,,1W )Q1>>)-'T^Z%O=W\43F18B6SL5VZ*S8VJQR, D$Y%
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MO/"N@Q:UK,+ZU?*WRR$!I&WM@<# ) X'&>U=[0 4444 %%%% !1110 4444
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M7=)\/^+/%FB>*@(4U.99;4RQ,R75N8EC\M< YVX(V^YQ7I](54D$@$CH2.E
M'EE_J>G>&?&UO+KBW>D:->:1;P6,D;O'';M&7)A;9T.&!].*KR-I7A;6O!VH
MVT$]GX21[Q5FG+E8I90-DK;N55OFP3V8GC->MLJL,, 1Z$4%0P(8 @]0: .
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MNQ&%).!MSGJ>@-=B !G Z]:0*JYP ,G)P* /#;&ZLH?@OX,_?0))'K-L[#<
M5(N"6)]P.3[5[DK!E#*001D$=Z6B@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^"4ZQOCT92#^==)7F):]\*_%6RO[RTM;/3O$42V$JVUP9$%S&,Q,<HF"5^0
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MZ^T7"P$VZ!O)#9^=\D808Y/N* *]WX:T>]CL8YK)/+L&5K1$9D6$C@%0I !
MZ&M7I15)=09M:?3OL-V%6W$WVLH/)8EB-@;.=PQG&.E &7<>!?#%U-?2SZ/
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MHUSGSQO;=*3P2[9W,2."2>1Q56[\'^'[_0HM$N],BGTV''E02%B(\<#:<Y7
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M3+^/5-*L]1A5EBNH$G17^\ RA@#COS5J@#+?PYI<EY97CV[M<6*E;:1IG+1
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M2]6T9"MP%& 2&4@,!QN% &?'K&NZEJZZ#="2"\MM,AN+S^SY8U+3.S*2I?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2P3()(Y$.5=2,@@]P14M<G;>*C+:^&K*RM8$O]7LA=+$3B*WB$:LQXY(!95
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M0BXM F\!G7W*CCC&[J:ZV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOD\EN<>G/6H;_P #:EK%WXS6ZEM[:WUP6S6LL,K.\+PJ I92H'WE!X->@T4
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MFTGM;23>C3ELB;;@ ;>@XYR<X[^BT4 <EX:@\:H;>U\0RZ6(+48:XM'=I+O
MP,@@!/4]<D8X%.'A)T^(4FO1SA;"XA1Y[;^_<Q@HC_38Y_%5/:NKHH X>^T/
MQ1I/C&^UKPVVG7-KJJ1B\M;Z1X_+D1=BR(R@\;0,C';\K%UH&N3>+O#6JM)9
MSQZ;%<+=.TC(SM,%SL7:0 NW@%NG?O7844 <!K?A7Q%?ZKXH\EM.FM=7L/LU
MK/<R/YEF/+*LBJ%(VLQW9!'7)#8Q4EEX9U^/6O"-[<)I^S1[&6UN!'.^275%
MRN4YQLSSCK[<]W10!YK<> =:O=+U^)KBSM+VXUH:QITT<C2".10FT."H_N]L
M]?;G<_LCQ!XET'4+#Q/]ALTNK1[416#M(,L.9"6 Z8X7W.2>W744 <AX9M?&
MT(MK+7Y=+^S6@"FZM6=I;H 87*D )V).3G& !G-:7C+2KW7/"&IZ3IX@^T7D
M#0*T\A15W#&20I/X8K=HH XK4O#^NWDGA*6.&P#:/,);@-<O\W[LQD)^[YZY
MYQTJS>Z!J-EXZ_X2;25@G6YM!:7MI+(8R=K921&P>1R"#CBNLHH \[U7P+JE
MSX:U6"V-F=3U;5(]0N#)*RQQA'1E12%);"H!G R23[5M3:+JTOQ#LM?$5H+.
M'3I+1U,[>9N=U;(&S&!MQU[UU5% ',>#-$U+0TUH:@ML/MVJ3WT7D2L^%D(.
MTY5>1BF7FAZLGQ$@\0V/V.2U?3?L,Z32,KIB7S R@*0V>F"1CKSTKJJ* /-9
MO!.OS> O$VA$:<MUJU_/<Q/]I<HBR2!\,?+SD8QP.:WKC0]7N/'&AZT8K-;:
MRLY;>9?/8ONDV\J-F"!M[D9S7644 <$/!]_>^(-'UFZL[&RU:RGW76H6<IS=
MQ;2-C+M&2WRYSTP<$UWM%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%8GBJ]NK31)([&&ZDNKDB!'MX6D,(8A6D. ?N@EO?&* .3M?
M$VHP_$RWENI?^*?UR.2ST\=EE@8_,>W[S+X/<;?2NWU36;726M(IM[W%Y-Y-
MM!& 7E?!)QD@   DDD 8KB?&W@J!?! _L7^TS?Z:8KC3(Q---LDC(V@(20.,
MCH,9I/%&I2WUAX4U@:/JL>J0W?F>5#;;Y;<^4WF*8B09%/W201USGL0#?_X3
MW21#J[R0:A&^D*S7L9M&8Q8&<97*G@YX/3FG6/CC3;Z%IDM-1CA*0M!)+:E5
MN3+]U8CT8YX/;OG'-<FMQ:7OA[QG%!8:TNO:Q9S2/%=Z=)"TQ\KRD$:\_*N5
M!Y)&[)/-6]<TS4[OX=^&9[/2WN[K2)+6XGTV>/:TRI&4DCVL.OS$CZ<9XH Z
M>W\8Z9)<:G;78GT^ZTV,37,%THW",]'4H6# ]."3GCK1'XNLAK TJ[M+ZSO'
MMVN8(YH@3.B_>V;"V2.ZG#>U<GJ>F'Q9X2U;^PO"9T:Y>!-AOK-+>6=TD601
MX'.SY,'=P2PQT-:?AN^M=1NH;Q? L^CW%JC&XGN;!49"5(*0E?F?)[@8P#W(
M% $\7Q,T.73M/U,0:BNFWTHA6\:V(BC<L5 <YXR1V!QGG%:FF^++'4=;N-(-
MO>V=W# +D+=P^7YL.=N]>>F>#G!'I7GD.FZE'\%M%TIM*U :A!?1/);_ &5R
MZJMSYA)XZ;>?TZUT6K6%SJ?Q(D>*WNX[6X\.36(NS;N$25Y P!..#C)_3K0!
MN'QKIJ76FI-#=PVNIR>597KQCR9W(RH&#N&X#Y=RC/:J$WQ*T:*SU"[%IJLD
M&G736UXZ69_<E0N6;.,*-WUX/&.:PO""M]ETS1=2\ M#J^GF-);Z6RC-M^[P
M/.27J6(&1@9W'TR:@^Q7[>"?B):#3;_[1J-_=R6D9M7S,LD:*A''<J?IWH Z
MN^\6S0>-M,T.WTZ>>WNK22Z-Q&4(8 J!MRPX&[)/TQGFNKKSSR;ZV\6^$=37
M2[Z:W729;.39"0893Y9 <'&T?*>3Q79Z=J;ZA<7\3:?>6HM)S"KW$859Q@'>
MG/*\]: .+^)-R+'7/"4DFIW5C:W&H^3=F.^D@C:/83AMK =0.:TK*\T2UDU#
M7M*U6^U"ST^!XKJ*._>ZC)PDFY=\A&Y5!Z<_,157Q[#<W'B3PA);V-Y<1V>I
M>?<O#;NZQIM(R2!ZGH.:Z;6--%YH.KPVD2K<7UK(F<;=S&,JN<_@* *Y\7:<
M(]!EV7'DZYL^R2;!C+)O ;G(.WGI5(>/]-EU*XL+73]7NKBVNEM9A#9L?+9A
MD,V<;5]SC\N:X^!M4NM(^'MNGA[5U?2+F".\\RWV;"D#(2,D97/\73D<YXKI
M_!T5Q%XJ\7R36=U#%=7R36\DL#(LB")4)!(]0: .8\1^)[KQ/\'->U-[6\T]
MXI)!$RR[!A9]@4E&Y.!R#QGUKO+#Q98WFO#1?(O8+EH#/ ]Q 42X0$!BA/)Q
MD=0.N>E>>3Z=JR_!_P 0>'3HNHF_%U.(U$!(EWW!=2A'4;3G/3WKJ-4AGO?B
M-X<NX;2]^RQV%U%+/]F<")I FT$D<'Y3].] &M/XUTRV>S>:*Z2PO+@6T&H;
M%\AY"2 ,YW $@@,5VGUQS4+^/M,&K76F0V6K7%S:7$4%P(+)V\OS!D,>X7IS
MCZ9YKDO"5K)9:=:>%]5\!F75+)A"NH/91M:2*I^68RGOCG'WB?KQT?AF.XA\
M>^,KF:SNXK>[EMGMY9+=U64)"$;!([$?CVS0 Z3XF:+'IDVI?9=3:QM[EK:Y
MG%H=MN5;:2^3D#/IDCN!Q6G:^+K"Y\0Q:,;>]@FN(GEM99X"D=RJXW;#U.,@
M\@<<UP$VG:C)\*/%^G+I=_\ ;;S4;J2W@-JX:19)=R$<=,?EWKI-42XN?'O@
MN\BLKUK:V@NQ/+]F<"(R1HJ!LCC)4_3OB@#6N_&VF6=M-?/%=/I<$Y@FU"-
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M=S=6Y6/<< MU"D^AQC\: "+Q?8F]T^WN;>\LUU+_ (\IKB,*DYQD*,$E6(Y
M<*3]>*YFXG/BGQ_K6@ZE87YL;>R@2'8ZIY#NSDS9#9!.%P1DC'09.7ZA%>>,
M=-\+V9TV]LKNSU"WO+W[1;M&MOY()8*Y&')/RC:3P<\"KVD)<)\4_$-T]G=I
M:W-I:Q0SM;N(W9-^X!L8XW#GH: .AN;ZWT&QL+>1[BYED9+6!2P:6=PI/))
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M[5!%;23"W(2UD"H@$F<$98X%:WBU))?!VM0PPRS336,T4<<2%V9F0@  >Y%
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MPPM)]EA8R'!*@C@,N0.Y.,T =Y;>+;:Z@MO+T_4A>W/F&.PE@$<^V-MK,0Q
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M">WO+4ZDK-8S3Q@)<8&<#!)4XYPP4U9\1>([#POIHO\ 4O.$!D6/='&6P6(
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M.H3->V\,U]'!'MN5>4*2H&57@XXS0!WM%<I+JVI1_%.VT?[2ITV;29;GR!&
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M><[(D"C/T%(EG:Q7,ES';0I<2##RK& S?4]30!S?Q$OK'3_",DNHVBW-NUS
MFV21DC1C*NUW9>0JD GUQCO7!WVHW$GB#QRNE:I'>ZG<Z%$;=[8 >8RB7=Y0
M!.=HZ<D@\9S7LDL4<\312QK)&PPR.,@CW%-2W@B</'#&C! @95 (4=!]/:@#
MR;5=>\.W>@?#F6QO;()#JMH-@D4- HB<,&'5<' .>^*EL-8LH],^(NG:W<00
MZH]W=MY=PP5I;=HPL!7/WEV@  ?UKU!-.L8I#)'9VZ.7\PLL2@E\$;LXZX)Y
M]Z6:QL[B8336D$DJJ4#O&"P4]1D]J /(-+UVUTT> [J_U5['29?#RVD=Y&4,
M<5R!&61RRL%R%QV^[]:GOVT?0F\/WVGW,TWAB3Q!)<WUW(P:%IF3Y) 0 HC$
MAZCY0P^E>M36=K<6WV::VAD@P!Y3H"O'3@\4K6T#VQMFAC: KM\HJ"N/3'3%
M '!:3J&FW'QJU4VEW:RM-HT&#%(I\QED?/3J0,?A5_QKJEAI^N^&([I;>&YE
MN9C;7]VY6&U(B(8D @,S!MJ@G'.>V#UL%G;6N/L]O#%A0G[M ORCH..W)_.G
M36\-RJK/#'*JL& =0P!'0\]Z /#;BY@E^&GC^&*Z%R\7B$W#$8W>7YT#>80
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M8@!N4",J !U'7 ^M=M_9UCL*?8K?:3DCREQG\J46%F'5Q:0!TQM81C*XZ8H
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M^5=!XMDN],U'Q)K&CWMI?6\:1KK.B7G&]?*7#1,.5)0@ 8P2#U/%>C_V=8E
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MO,DU_;MYT2MT3 R&"@ #E>!71:5H5GI>FVUHL$#^0[RH1"%5'=B[%%_A&6.
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M?-N8_-U^4"B1=1M=4\)V>JWKZQIJVUQ%<R01,WG3K@+(\:Y+*!D9Y 8@GJ*
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MKJX7>S78?"O"X+;>6.!Q\I& !0!Z;1110 4444 %%%% !1110 4444 %%%%
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M;%=-10!GZ;HMCI$U]+9Q,CWUPUS<$R,VZ0@ D9/'0<#BM"BB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
,@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>sangamoexecutiveseveranc022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc022.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/]'#JI*+@;CC&>.1CE/A+YD7P[L+2:WN()K9YDD2>)D(/G.<?-UX(Y&1[]:
M-.Z\>>'+/4;BPEOG^U6TL44T:V\C%&D.%SA>GOT&1SR*L7?B[1;&=([BY=$:
M?[-]H\AS")<XV&3&T'/'7KQUXK#\..H^*?C%RCA9X[(12%"%DV(X<*V,'!(S
MBN6T$Z>FER>#_$FAZI=ZQ#/(J0,)VM[L&0NDH8'8J\@DG&,$]: /1-1\8:)I
M4MVEU=.!9[/M;I [I;[_ +N]E!"YR#[ @G JU?:_I^GRO%,\KO'")Y!! \IC
MC.<,VP' .UL>N#CH:\R\9W4^H6?CK36T^\M[E8_]'@M+-L7BB-?WTDJK\W0C
M&0 % P35[7!'<SQ:KI.J7VB:Y!I<1B>6!O)ODRY$+QL.6!!P!\PW@X- '?W&
MOZ?;BV!DDEEN8O.AAAA:21D&,MM4$@<CD]R!U-4YO&OAZ#0TUF345%@\OD^8
M(W)63=MVLN,J<\$,!CO7*:?<W^D^.;#6M>LS9VFI:%#;EE4^59W"'<T3?W =
MQP3QD8K#US3+B+PCXKNUMY_)U;7H+FTMQ$Q9T66+?)LQD!MK-TZ 'O0!Z;IW
MBO1]5U.YTZUN7^U6\0F9)87CW1YQO4L '7/&X9%1V?B_1=1NK.UM[J3=?*[6
M<C0.J7 098HQ&&P.?<<C(KG-2N2OQ6BO+>W:Z4>'9XU"J=DDAE1UCW8QE@#Q
M7,V-\;J_\ ZC]DU &">5+FWBT^2*"R9H&40H@4# ;C// R2!0!L^'/'.GZ"O
MB&+Q#J]U)Y.NW$,<DJ23>3$-@7<5!"+G(&<#K[ULZW?7"_$7P8+74)C97J7A
MDACD_=2A80R-@=>N?RK#TV:.QTSQUI-[:3M>WNIWDEO9F!MUTDJ*$*<88$]^
M@ZG%+%IT^B:[\,]/NBTDFG6=Q#<R*I9(V,"J,MT + @9ZXH [34/%VC:6[?;
M+EXXHY1#+<"!VAB<X 5Y -J\D#D\9&<5M$@*6)  &237D6FR6%F-4\*>)]%U
M:[O7OIY((D6=X+^.25I%8%3L'+<[L 8R3UQZ+XBTVZU#P9J>F6)6*ZGL)((<
M-PK%" ,^F>,T ,B\7:+-<6D2W3JMZVRUF>%UBG;T20C:Q/;GGMFJ=_\ $/PQ
MILE['<:@_F63!;A([:5S'D9R0JGY0,$MT&1SR*Y&\+>)_AUH.@6MO/!K4$UF
MDL#Q,KV;0LN]VR/E4!6P>^0!G-:&C:IIVG_$+Q\M^P4/):$*8RWFC[.,JO'S
M-_LCDYZ4 =/<^-O#MH-/,NIQ[=1C:6T9$9Q*H7<<$ \X[=22!C)IVD^,=!UK
M3[R^L[]1!8DB[\]&A:# R=ZN 5XSR?2O-=,L'\*#X86NK*T+0RW[NC#=Y(>-
MF4-CIM# $]!@]A4_B;P[J.OGQQJFA0L\5W#9I"%&!>O"V^3;_>&W"@]"<@4
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M,D8Z=<&@#K**\LEUC6=!T7Q?K*W]W-I]O<I!I<ER^Y CLBLX+ LP1F;#$D$
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MN%NKBYD;9>LL0<2I$Q/EC/(X7@XQC%5=4U/7+G1?$:Q7M]#XIM]6,-A:PR,
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M*$>7\RER<$Y''3CIUJCX934;KPO?Z]>^+=0@EL9M0A22>0- JAG57D3'S;<
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MVFAEV[54JF3M*L^3@] .YKN:* .&T'0OM\-]:W-WKFHZ#=VQBDAUT8=G)'W
M55U&,YSCDJ1T-:6A>![+P^I6WU+5KC9&8[?[7=>:+53VC4C XXR03CCI73T4
M <HO@#3$\.6&@I=WZV-C.MQ /,3<'5MZY.WD!N:74O &F:CKK:RE[JEA>RHL
M=R]A=F#[4JC \S;UXXR,&NJK+O/$6E:?J<&FW5WY=[<9\B$QL6EP,G9@?-CO
MCI0!7;PK8G7=/U:.:XAET^ V]O%&5$:QG&5QMR0<#OVXQ5&_^'^D:A<ZQ+)/
MJ$<6KIMN[>*Y*Q.VW;OQ_>Q^!QR#7544 <\O@ZR6]T6[%Y?F71XWCMBTH;AP
M ^[().0 /;MBK^O:+;^(M%N=*NY)DMKE=DODD!F7N,D'%6-1U&TTG3Y[^^F$
M-M I>20@G:!U.!S3[*\@U"QM[VV??;W$2RQ/@C<K#(.#R.#0!EZIX7L]8\/P
MZ1=SW12!HWAN4D"S1NARCA@,;ACTJ&P\'6.GZY)K*7FH2:A):BU>:6XW;@"3
MN(Q@G)],# P!70T4 <J/A[HC>%)/#<_VF>P:4SIYD@\R*0L6W(P (.XD_CCI
MQ6CH'ANWT"-]M[J%_.X"M<ZA<F:3:.B@G@#D\ ?7-;-% &-K/AJRUN_TZ^N)
M+F&YT]G,,EO,8SM< .I([$ >_'!%5D\'6:/K;+>7N=:&+OYDY^79\OR\?+Q_
M]?FNBHH Y6/P#ID,VE30W>HPS:;:_8HI(KC8TEOQB-R ,@8'(P?>F1_#O18M
M 31HI;]+>*\%[ XN3O@E#EP4)X !8]N_.:ZVB@"LUC!)IS6$H:6W>(Q.)&+%
MU(P<D\DD=ZYBU^'&D6J:2HO=6D_LIRUF7O&_=J5*^6,8^7!QZXP,XKJ[FYAL
M[:2XG<)%&I9VQG J#2]4L]:TRWU+3YO.M+A=\4FTKN'K@@&@#&3P58II^M60
MO+XPZS(\EYETRS.NUL';QE0!Q^&*?)X/LY?[$W7M[_Q)B#:$,G!"[?F^7GY>
M/_K\UT5% '-MX+L//U(Q7=_#:ZG*9;VSCE'ES.P 8Y*EUR  =K"K5YX8LKS5
M=(U#S)X'TD,+2. JL:!EV,,;>1MX]NV*VJ* /)_L?G:WJCWC>-](O[F]=_)T
MP2/;R 85'5PK)RJJ3DC!XX %=8/"3ZK8Z-<:K?W\6K:=YGE7<$JI-L?@HY *
MDE0H; ZC(KK** .63P!I$>EZSIT<]^MOK$C278-P6)+ !L9!QD 9/4^M6;OP
M?87O]CM+<7JS:2&6WGCFV.590K*Q4#(( '&#QUKH*SM,US3=8FO8K"Y$SV4O
MDW "L-CXSCD<\$=* *L'A:QAUG5=3:2>:35(EANH92IC=%!"KMV] &(Z\YYS
M5#P_X!TOPY<H]I>:I+;PDFVL[F[:2"V)S]Q/H2.<XR:ZJB@#G[+PC9VATT27
ME[>1:8VZSBN75A$VTJ#D*&.%8@;B<9]ABSXA\.V7B6PAM;QYXC!.ES!-;R;)
M(I4^ZRGUY/;O6O10!RI\ Z7YVK2_:]2\S5;=;>\8W);S%"E<\@\E6(]L\8JW
M=>#]*O\ PDGAJ^$US81QI'&9' D0)C80P Y&!S^>:WZ* ,3P_P"&;?P^CE;[
M4;^=E"?:-0N3-($'103P!]!SWS3]:\-66NW>G7=Q)<PW&GR,\$MM*8V 9=K*
M2.Q'![^A%;%% '/R^$;/^U+V_L[N]L)+]0MXEJZA9\# 8AE)5L<;E*GWK9LK
M*VTVQ@LK.%8;:!!'%&@X50, 5/10!SLG@ZR-[J,\%Y?VT6IMNO;>&4!)FP%)
MR5+*2  =C+3-<\#:/KD>G#-SI\^FC;9W.G2^3)"N,;5(&-N .,5N7VH6NG0K
M+=2; [B-%52S.QZ*J@$L>#P!V-0:/K>GZ]9O=:;<>=$DK0R!D9&CD7[RLK %
M2/0B@!^E:7!H]BMK \TG)9Y9Y#))*QZLS'DG_  < 5AZCX"TN_U^76H[O4K"
MZN%5+L6-VT*W07@>8!R<#C((/O6QJFNZ;HIM!J%R(3=SI;0#:S;Y&.%7@'')
M[\5HT 85YX4L+C4K/4K:2?3[ZTA^S13VA4'R?^>;*RLK+QD C@],5#>^"=+O
M=$_LII+J.!KD7<KHX\R:;<'WNQ!R=P!XP. .@Q6MI.K66N:9%J.GRF6UE+!'
M*,F=K%3PP!Z@]JNT 8-SX4M+O6VU>:[O&N7L6L&^9 IA8Y(P%ZYYS_3BGV?A
MFWMKVRNY[R\OIK&)HK5KIE)B# !L%5!8D*!ELG\S6I>WMMIME->7DZ06T*[I
M)'. H]34] '('X<Z/_PCT^@K=:BNG2S"7R1<9$>'\P*F0=HW\\<GN36KKGAJ
MU\065I!=W-W'-9SK<07<#A)4D4$;@<8Y!((QCGI6U10!S5MX&T>WNM5N)/M5
MT=5A2&\2YG+K*JKMY'K@GGMGC P*;X?\"Z;X>8>5>:G>11J4MX+ZZ,T=NI&"
M$4\#CC)R<9&<$UT]% '%?\*PT8:8^E)?:LFE^>L\5DMUB.!@^_Y.-P&>Q)]1
M@\UUEU86][ILVGW*&2VGA:"168DLA&T@GKT/6K-% ')6GP\TJUDTB7[=JLTF
MDEA:M+>$E4*[=G&!MQQQ@^I-<?86)FGNC<2>.](U2XNI9I+.RWM;AV<GY'*M
M'@\<E@/ITKUVB@#DK?P5%<SP:GJ=Y>C4Y;%+6_\ L\_EI=;1_&% Y!)Y7'Y<
M4Z+P!ID.DZ/IL=YJ(@TFX6YM<S!B)%!"DY4\ $C P/:NKHH PHO"]M!J^JZI
M%>WBW.J1I'<'<A&$!";1MXP"?SYS5>P\&6NEV>F6UAJ6HVZZ;')#;LKH3Y;E
M258,A##*#&1D>M; U:R;6VT<2G[<MN+DQ[&QY9;:#NQCJ.F<U=H YJ?P/I$V
MF6-DK74'V*[-[%/#+ME\YBQ9B<?Q;VR,8YXQQ70^1']G\@@M'LV88DY&,<D\
MFEFFCMX9)II%CBC4N[N<!5'))/85F:=XETK5-2ETZUN'^V11+.T,L$D3&,\!
MUWJ-RYXR,B@#(3X>:5'H=GHZ7FI"TL[A+B &<,4*'* 94_*IZ#\\UI?\(O9M
MXBEUN::XFN9K3[%)'(4,;PY)VE=OJ2?Q].*VZ* .4T'X?Z5X=NEDL[O4Y+:)
MB]O8SW;/;VY.>43\3C.<9]:VM=T.P\1Z/<:5J</FVLX 8 X((.001T((!!K1
MI&8*I9C@ 9)H YBV\#6D.IZ?J4VJZO=WEA$\4$MQ<@D*V,Y 4 ]!U'/?/%2V
MG@G2[7P[J&@M)<W%A?M(TR3."09"2Q! !&2<^QZ5IZ1K>GZ[;2W.FW'GPQ3-
M [;&7#KPPY Z5H4 <O:>!-.M=1TS4#?:K/=Z?$T,4LUV6+(<?*PX! VC@8SW
MS5K3?"=EIKZJ5N+J=-5D:6[CF92KLR[21A01P ...*WJ9+(D,3RR':B ECZ"
M@#E9?AUHD_ABWT&:2_D@M75[6=KD^=;E1A/+;^' X''YU)+X#TZY\.76BW5]
MJ=S'=[?M-S<7/F3RA3E5+D< 'LH'?U.=O1]8L-?TN+4M,G$]G,6$<H4KNVL5
M/! /535Z@"."(PP)$TKRE1C?)C<WN< #]*P[OPC9WWVV*XO+V2RO9A-<63.I
MB<C''W=P!VC(##/XFN@HH PXO"]O#K.J:K%>WB76I1I'.0R%0J A=H*\8!/Y
M\YK.C^'FDPV.C6T%WJ,+:.7^Q3Q3A9$5QAD)QRI]QGWKK:* .3/P\T?^R=7T
MM9]06TU:=IKE#<EN6QNP6!QD@9/4^M7[GPO;7>HZ1?RWMX;C20WV=@R '<NU
MBPV\Y7C^7-7+#7--U/4+^PL[D2W-@46Y0*P\LL"5&2,'(!Z9J34=6LM*-H+V
M4Q_:[A+6'",VZ1L[1P#CH>3Q0 S6](@U[1KK2[J25+:Z0QR^40&*GJ,D'&:H
M/X3M9+W1;M[V],VCJRVIW)C#+L;=\O.5X_\ K\UOT4 <T? ^F ZA%#/>06&H
MR&6[L(Y%$,K-]X\KN7=W"L :MWOA?3[W6K#5=UQ!<V430)]GE,:O$2#L8#JN
M5!P,5M44 97B'P_9>)=);3KXS+&725)(7V21NIRK*>Q!%8&J^$;'3+;6-9BF
MU2YOYM->U<-*\IF(5MI* <M\Q&!P.P%=I10!PW@GPY'-X/\ #1U&74':P@AD
M6RNTV+#.J 9P5#':2<;B0.,=!BEX=TF;4/%?C-GGU:Q@O+I-NV$Q)/&(E4E6
M=..=PRI!_2O1J* ,&[\(Z=<G1A&T]K%H[![.*W*A4(7:,@@Y^4D?C67<B/Q?
MXCL[>?0KZ"#0[]K@W5[ (TD= 53RCG+ EMV>F$'J*[*B@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@8X^7!SZ\X&_;>&->C\6P>(I]4L&F7338R016K(GWPXVDN2.>N<\= .HH1>
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ML0B4@E<9^;&.#D=:MR^$]7M?$MOX@TG4+2*[>S2SOX)XF:*95^ZZX(*L/Y4
M0?"P3C1-:%R8S<?V[>^:8P0I;S.< \XS2R7&KO\ &5;-=0A%E'HWGK"T!. T
MX5AD,/F.P?,>!Z>NKX/\.WOARUU**\OH;HW=_->*8H3'L\QLD'+'/]/>B[\.
M7C^.[;Q':7T,2?8?L-Q#)"7+()/,!0[A@YR.0: ,-O&.L7G@>X\:::MH]A"9
M9DLI(VWRV\;E6)DW?*Y"EA\I X'/6NWT^]AU/3;6_M\^3<PI-'D8.U@"/T-<
M=:>!;[3_  ]J'A:UU" :#=M*(RT9\^WBD)+Q+SANK88],]#BNUM;:&SM(;6W
M0)#"BQQH/X5 P!^0H \<\.:SXF\-_"BSUVQCTV;2K&6X>XM'5_.EC^TR;F5\
M@*1G@8/3.>U=G>^*[^_N]5MM"PKV$<>TO8R3B:5XQ(%)4@*N&4>N2>F.8;+P
M+?0^%6\)7%_;R:*TKEI4C99Y(FD,C1GG:,DD;AV[ \U-?>$M;L_%-SK?A?5[
M6R6_CC2]M;NV,L;%!M5TVL"&"X&,X.* .ET*]O-1T.SN]0L7L;R6(&:V<Y,;
M]Q],]/:N.O/&.LZ;?:8+P62R7>L+I\VGQJ9&@B=BL;F56(#D!6P0,@XP,9KN
M;*W>TLXH))Y+B11\\LG5V/)/H,G/ X'05Y_'\/-<CT6QTP:[9M'IVK+J-M(]
MFQ>4B0R?O3O^8_,>F,^M %[^W/%%_P"(O%.D64NEV_\ 92P/;S20.^X2(S[6
M&\<\ ;L\8Z'/%"W\;>()="\+>(Y$TY+#5;JWM9[-8W,BF4[?,63=@8;G;M/'
M<UOV/AO4K+Q#XBU7[7:R?VM'"BH48>68D* DYYSG)'%92^ ]2C\%^'_#ZZA:
M;](NX;GSS$V)1$VY1MSQGH3DT 4K=/$$GQ#\=+X?ETZ&<?86+WL;N&(@.% 4
MC&>[9./0]IX?'VIWOAWPKJD-K;0-J6K)IM]#(&8QMN97*$'U0XSGK[5MIX>U
M:P\4:QK&FWEGC5DA$J7$3$P/&FP,N#\PQS@X^M5+OP(Z:+X>TS3+N../2=0C
MU!Y+A"S3NI9FSC&-Q=CGMZ4 2WGB/4KC7?$>FZ>UM;-HUG%.K7$9?SW=6;^\
M,(-N#CG)/(Q@YUEXRUN>T\&7DT5BD>OS!)8A"X:-3$S@J2_7Y>XY!K+UB1]8
M\::P]KK'AR-K58[*2UUFW)8 +N;;AU)C8OW!!(/8#.R^F:SXJT72+Y+C3;?4
M])O_ #K>6&-VM+E I3*C(8*0QQR?N\$@@T +>>.[C1;GQJVI1P2VN@QV\D A
M0HTAE0D*Q+$?>VC( ^E6=2\0:UX<OM";5&L[FRU6Y2QE\B%D:WG<$H02QW)D
M$'.#W]JK-\/[C4+GQ1_;.I0W%OK\$,<J0VY1HVC3 926. "<@$'H,GK5^+PQ
MJ5^FBP:]>VUS%I$Z7"/#&RM<RHI5'?)PN,[B!G)QR!P0#-'B_6O^$6\9WY^P
M_:M!N[B*$^0^R1(XU<;EWYR<D9!_"GZCXW>RO-'MKV\M=*CU#3UN([RY@9H)
M)S_RRW;@%P.>3SD<C'++WP-J\D7BJPLM5M(M-UXR3$/;LTL<KQA&&[=C:< ]
M,XR/>M&7PWJCZ;'IMS-IFI6!L([26WN8&5"Z[OW@&6[$9'^R,$4 =)I[W,FF
MVKW@C%TT*&81'*;\#=M]LYQ5FN-L=,UGP[=>&-&T[48[C2[6V\B[BEAS(P"G
M$N_/RC(  ]\<]1V5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445FZUK5KH=G'/<GF
M:58(4W!=[MT&20!P"23T - &E17&1_$6P4ZW#<VLGVO285N'BM'%P)XVX!C(
MQGG@@@8^E:-MXJ0:[=Z/J=K]AN;>Q&H%_-$D9AW%22V!@@CD8_$T =%35='+
M!75BIVM@YP?0US4'BQ[B?22^C78T_5\BVN!\Y4;=RF5 /D##IR?<"N,\.>(A
MX/T?Q7<QZ+<3Z=:>(;MIW@*(L$>Y1\JD@MCT Z=Z /6J*8908/-C4R KN55Q
MEN.,9P/SK@&^*:+H::Z?#>J#2$G:&ZNB8_\ 1\2%,[0V6&1DE<@9ZDYH ]"H
MKF]4\6&SFO8[+3I+Q;*R%]/)O\M#&=Q 0D$,V%)QP.G-5;OQY#%)X>6STF^O
M/[=@:>T*%%SB+S IRW!P1UX&2<\4 =+>:=8ZC&L=]9V]TBG(6>)7 /T(J:&&
M*WB6*&-(XT&%1%  'L!7$6/BW7;[QS!I4NAM:1'2A=O!+.F]6:0+EB,CY=I
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M9Y/M75W/B%+7Q5IVA26K[K^"6:&96&T>6!N!'4'YA0!M4T.AD,892Z@$KGD
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M[/3G8X7;(OJ,C(/3(K0\ -JVI(;W7HRMYIB-I2L3GS61_P![,#Z/MC'U0^M
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MUQ*\$$GE.(I9%SN59,;&(P> >Q]*KW7COPU9F]$NIJ38L%N1%$\ACXSDA5/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8Y4=00T2JORD$\ 'D=<]: .ZHKR^;7]6M+CP_<IJLUZ]WKOV*[GA4"S>-VD
MCC!P25"K\RYY5LL:V(+G5/%K>)EL-6ETZXTZ]>QLA&!M1T13YD@Q\VYF(P>,
M#@9R: -\>(X#XP_X1HVUPMS]B-Z)F"^6R!U3 .<YRW<#I6S7G-U:7E]\6;&
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M")UQ\VY4Y/7+<$ 8IFK22:_XI^&^IBYNK7^T(YYQ&C+^YW6A;C*GGG!SG\*
M.^T35CK%@UP]A>6,B2M$\%W'M<,IP2,$AE/9@2#536_%%IHD.G3/#-<PW]Y%
M9QR6^TJKNVT%B2..O3/2K>MQ.WAZ_C2XFB?[,^)8FVN,*>0>Q]Z\J:"9/A%X
M&9;J5Y)=1TQE,P#",EAT QD?4_C0![-5+2;^34]-BNY;&YL7<L#;W2@2+AB.
M0"1SC(YZ$5RND3:G:_$#5_#TVLWEW;/IL5[%+.L?F0NSNC!<(!CY0<$$"L;2
MO$'B*?X7:+K!6]U24WDO]I?9 HN'@$DJYC QR"$X7!P#C'6@#U"BN=\&:M::
MUHTMY8ZK+J-NUPP1IEVR0\#]TXP""OOR1@\YS714 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4V12\;*KE"1@,N,CWYXIU% &+X:\-Q>&
M-+>PM;VYN(FE>8&YV$JSL6;[JKQDDU)!H,"ZNNK7DLEY?(ACA>4 + I^\(U
MP,]R<L>F<<5HK<P-=/;+*AGC19'C#?,JL2%)'H2K?D:EH SX-,DAUN[U$ZA=
MR)<1)&+1W!AB*Y^91C@G/-:%%% !1110 5QGB+XAZ5H>IW&DWFDZS=,J@.UM
M8F6)@R@XSGG@X-=G10!Y#HOC;PCH?A8>';;P]XE;3]DD;J^FL2X<DMDYYSN-
M1IXQ\)IX&_X1)=$\5+I_V3[*633B'((Y;/3<3D],9/2O8J* /GRRF\'6-UH5
MTD'CQY]&R+=Y+3=E3_ 1C 7K]W!YZ],;.A^*?#.A>*=5\0067C*6ZU0YN(YM
M-7R^#Q@!01CZU[510!Y'IOCKPGI/B#5M:M?#_B5;O5#&9S_9AP-@QQSQGJ?4
MUB/K/AB/Q;=^(--A\<:9+??\?L%I8[8Y_<Y!()]0<\G&,U[9J>J6&C6$E]J5
MW#:VL?WI96"@?_7]JLQR)-$DL;;D=0RGU!Z4 >*S^)O"T_C>Q\5"P\8QWEC
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M)N%7/R/M!/4@C@\J.*P+GP7XAN!XR#W>F,/$,"1K@2+Y3"+RSGKP!^?^STH
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M<J,A@2<''?\ -NK^'->U1-!EFNK&6ZL=334+@EGC0[59?+C&&(&&ZD]1G'/
M!6;Q1K_E>+M.G33X=3T>T2Z@N(5=XF1T9AE6.=PV$=<'CCM6WX%EOI_!&BSW
M\\<TLMC X=5()!C4_-DG+=<GCZ5GGPKJ$_B+Q/>326J6NLV*6B;'9GCV*Z[B
M"H!SOZ9XQWK6\):;J6C^&;#3-3DM7FLX$MU-L&VE44*"2W.3C/04 45U_4]8
MOM:M]!6S TJ46[&Z5F\^?:&9!@C8!E1N.[DGCCG&7XB7NI6/A:[TC3;<IK<T
MENZ7,K!H)45]R\#H"AYZD=JU+3P[JV@^(]9OM&-E/9ZLXN)(+J5XS!.!@LI5
M6W*W!(..1UK/3P'>:;!X4MM-EMI(M%N7N9WG=D:=W#!\ *<<N3U]![T =CI+
M:F=*A;6$M4U#!\Y;1F:+.3C:6YZ8ZUS/ACQ==>*5MY[.XTXJQ=;NTV,+BQ8
M[0X+?-\PP3A?;V[(Y(..M<19^#[Z;Q'HNN:C%IUOJ5@C+=7ED[;[[*%<.I10
M!D[N2V,8% %63QYJ:?#BX\3"UM/M%M>-;R0X;8X%QY.0<Y!YSW]*Z"YUN^O=
M>U#1M&%LL^GV\<L\MRC.I>3=LC"AE[*26SQD<'MR=WX!\22>$]7\,V]YI:V-
MQ>FZMIG\PR%6G$I5QC QSR"<\#CK6O?^&O$EGXM?Q%X>O--\Z]MHX-1M;U9!
M&Y3.V1"N3D D8/;O0!;M_$NJW<^DZ3)I\6GZW=VCW=S%.WFI:HC!3]TC>69A
M@9'&23Q@L?Q3JNG:9;IJ^FI;ZI<Z@UC;B(-)'*H#-YP5<MMV*QV]<C&1G(KZ
MSX4U]M1TC7M'U.U;7+*.2&X^V(RP7,<AW,ORY90&^[UQ@9SBI-<\*ZWK>B6L
MK:K!!XAM+Q;ZVFCC;[/&X7;Y>T\E"I()ZDDG':@" >.-0TV/6?[6TN5H[,P_
M8[N.UE@CNS*P14VN"58,P!QNXY [5,GB_4+#5[B/5K)Y-)CL9+LZC#8S0+"4
M!+1N),YR!D$$9Z8HOO#.O^*/#%]8>(]0L[>[F5!;_P!F*_EP.C!UDR_+'<J^
MF ,#J33[70_$^LZ3=Z;XNO=--O+;26Q&FJX,N]2I=RW (!)V@8R<]@* .>\5
MWVKZKI'@W4[F.TBM+S7+"9;=5;S80SY3+YPQP><*,$]ZZBWU_4)O&NMZ,MC9
M@VEE#/!)YC9EW%@ YQP!@\ 'KUK ;P?XOG\/Z)HUS>:.R:-?6T\5T#)OFCA/
MRADQA6P #@G/J*W[?0M6M_&^JZZ/L3PW=E%;1Q^:ZL&0L03\IP"6]\8[T <_
M8>/]>N/#_AOQ!<:?IZ:=JEW%:31H[F53(Y0.O8 ''!R3[=!N7OBB_EU7Q'8Z
M9%;*VA6T<LGVE6/GNZ,X48(VC"XW<\GIQSCP^!M:A\!>'_#PET]I]+O8;EI3
M*X618Y-X &S()SCV]ZJ:A;ZEK_B[7)](?P_<QPJEA<0WLTT+C:NYT;R_]8F7
M/WAZC&!R =SX5UBX\0>&;#5[BWBMS>0K,D4<A?:K $9) YYKA=-N/$EMKWCF
M3P[9Z?.\>I+(ZW<C*9,0)\B!1U/J3CI^'=>&+ZXO]#C>ZM;6WDB9H=MG)O@8
M(=H,9P/EX].,8K'MM UW2M9\03Z=)I\D.KS"=99G=7MG\L)]P*1(/ES]Y?3W
MH S4^(&I:J?"C:-IUH8]?@G=3<S-F&2-,D' Z!NXR3CH,YJV_BG6F:YTY(;5
M-6L+>-KKR[6>YA>9U+"-2@!48P=QS][H<4V+P1<Z7J/A#^RFMS8:!',C">1A
M)-YJ;2>%(!SEO?..*DU/PYXDL?%]SKWA>\TX+J$4<=]::B'V%D&%D0ISG;QC
MI_0 EB\3ZO=Z9H]TVFKHZ74,DEY-J2G;:.I"B,H60DL2<'(X'3FJVD^/9M4\
M/Z+,MK"NJ:K>2V4<>XF)6B+[Y/7:%C)QUR0,]ZL7OASQ ?$&BZK!J%G=-:02
MQ7$=XC! \A!,L:KG!'*@$_=XW<YK#B^'>NV_AVTAAU2QCU;2]3EO]/G$;^6P
M=G+)*.N&#X('3'4T 3>.KG6Y/A[XSM=7LH5CM[<?9;R#Y4N58 GY"S%2IX.3
MSVK5L_$.KV?BK1]&U&ULUM-3M)9+5H'8R1M$%)#D\'(;MT/KUIFL^'_$WB'P
M;JNG:C=::M_?Q"!4@,@MX%SDL"069C]!T [$FS=>']5NO%7AG5B+)(M*AGBF
M03,6<RJJDK\G;;GGKGM0!I>)M?7P_I]O*(A-<W=U%96L3-M#RR-A<GL!R3["
ML_\ X2'4=.\7VGA[5%M7;4K>26QNX(V12\8R\;H6;H"""#STP*L^,?#3>)]&
MBMX+D6U[:7,=Y9SLNY4FC.5)'<<D'ZU$FAZAJ7B/3=<UB.SBFTR"5+:"VF:1
M3)* '<LRJ0-JX P>I.: ,+P%;W=_=>+4U/[%=6_]O3+*C0$Y=4BVD;B0%&!@
M$$C'6KWBV^UF#QOX0L=/N[>*VNY[@NDD3-N9('(W8897GIZX/;%7O".AZGH=
MQKC7QM&34=2EOT,$C$IO"C805&<;>OZ4OB;0-0U+6?#^JZ9-:I/I4\KE+D-M
M=)(RA^[SD9R!W]10!S$5QK-KX\\?S:/%9-/'%92,UV6V'; QV@+SD^N>/>M2
M;QK<SZ1X-U.'3[<PZY=012"5R6@+H6.T8YQ@C.?PJS:^'-8M]>\5:B38NNL1
M0I"OFN"ACC*9;Y.^<\=.G/6LZ/P7K4?AKPAI8DL#)H5W%<2N97 E$:LN!\G!
M(;OTQWH OOXON+CQ+J.C6<UA%?64\:+8W2L);F(A6:5&W 8PS8 !^YR1GCLJ
MX?Q-X.O_ !0D]M>1:=\MRLMCJ2NPN;-0RDA0$Y/!Q\P'(STY[B@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JEJ>C:9K5N(-4TZU
MO8E.0ES"L@!]1D<&N!MO$.HVWQ+L[^ZF)T#Q CV-DO:-X22C'_KIF0CU#+Z5
MW&K:Y;:1+8P2+)+=7TWDVT$>-TC %B>2   "23_/ H LZ?IEAI-J+73;*WL[
M<'/E6\2QKGUP!5JN3_X3ZQ6'6WDTW4D?159KU/*0E,#=P0V#E?F'M[\4^R\<
M6MY;_:#I>IP0R) ;62:%5%VTOW5C.[DCOG  YSCF@#J:*YJ#QOIOVK5;2_BG
MT^ZTR)9YXIPK%HV^ZR%"P;)XQUSQBG)XPMUUQ-'N].O;6]FMVN+9'\MOM"K]
MY5*,1N'H<4 ='17$1?$[39=(TW6/[+U5=*OIA"+MH5VQ.7**&4-N.2.J@CG&
M<\5K:=XMM[W7KG1KBPO=/NHK;[6GVM4 EAW;2X*L<8/4-@C(XH Z&BN7;QS8
M17&EB>TNX;/591#97KA/+D=AE 0&W+N'3*CWQ5*;XE6,5CJEZNC:Q);Z5=/;
M7K+"@\G:%+.<N,CYN@R>,D 8R =K17(WWBR[B\<Z5HMKITT]G=6<ET9XWC_>
M %0,!F&%&[)[GC -=%JNJ6FBZ9<:C?2^7;0+N=L9/H  .I)( '<F@"Y16#'X
MJ@36[72;^QN]/NKR-I+3S]A6;:,LH*,V& YP?PS5+2_'5OK&HM9VFC:NPBOI
M+&>8P+L@=!DESNX!Z<9]\9&0#JZ*S]6UFVTA;82K)+/=3""W@B +RN03@9('
M !))(  JE9>*(;R_O]-^PW<6JV2+*]D^P/(C?==&W;64GC.1@\'% &[17FW@
M.TA\5Z=:Z]JFG7*:G!?W$\>H>8BE\3.HBRK%B@4!=I&WY>,UUFJ>)X=/U.73
M8K*ZO;N&S-[+'!L&V+)4<LP!)(. /3G% &[17*S>/M+C@T&>*VOKB+6US:-%
M#GG86VL,Y!P,=_RYI(_'ELVFZU=2:1JD=QHS 7ED4C,R*5WAQA]K#;SPV>#0
M!U=%8J^);>33]'O(;2ZE35F1;=$\LL R%\M\V,!5).">E7=6U6TT73)M0OI"
MEO"!N(&222   .I)( 'J: +M%8$?BF%=;@TB]L+NQO;J)Y;1)O+(N HRRJRL
M1N P2"1Z\UPNN>(;OQ3\*?%UQ>Z=<6GV9[B.(B5-J^6VT+E6R3P2<C'/!/%
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MWF$>T>8P=0"I5P=H? ))'((QP:VK[Q%'::C<6$%E<WMS;6RW4T=N4W*C%@N
MS#<24;@>G/49 -FBN5NM4T:X\8^&TN+"Z.I7%O/+87!XCC4HID!^;DXVCH>M
M2WOC6SM+6^ODLKVYTZPE:*ZNX%0K&5X<A2P9@O\ $0#T.,X- '2TA (((R#U
M!KF[OQM8V^L6>F06=]>S7MH;NV:VC5DF08^ZQ8#^(<G ]35[PYXAMO$NG275
MO!/;O!<26T]O<*!)%*APRG!(_(GK0 6GA3P[I]]]NL]"TVWN\Y\Z*U17![X(
M&16O61>:_'!J;:9:VD]]?)"+B2& H/+0DA2Q=@ 20<#.>#VYKE_%?C7[1\+=
M6UO05NO-6*2%FPJ26<@.UMX+ AE)[9YP>G- '?T5SOA[0-.L[EM7MM+FTVYG
M@6&:%G4*X7D.51F4M_M=<=:YU_$5YXCTCQO9W>F7-M!8^?!&XE3Y-L(;YBK[
MMQ)SP",8&: /1**\_P#!WBV"TT'P?I-S87\2WMA##;WKHHADE6$,4^]N' ."
M5P<<$UHVFN^'[+6O%]Z+2YM+G3TADU2>4'$BB-BA0;CT0=@,YH Z^BLNPUA[
MR^^RRZ==6K& 3H\AC9'4G& 48\CC/U'6I-;U(Z3H]Q=HGF3* D$7_/25B%1?
MQ8J/QH T**X3X<7^H0/K/A;6KHW.J:3=%O/;@SP2Y='_ #+#VX%;E_XLM;2[
MU.V@M+J]DTN!9[T6X7]TK L!\S#<Q4$X';W(! -^BN1?XAZ:MIHUREAJ<D6L
M/LM"L*_.=I8?Q=P./UQ5N#Q;]IMXO*T;4OM[0F>2PD$<<L*;F4%]SA1N*MMY
M.<9H Z.BN;L/&VEZMI6GWNFI/<O?[_)M@%60%#A]VX@+M. 3GN,9R*HR?$G2
M8M(GOY+2_5K:^&GW5N(U,D$I8*-V&P5.1@@G/:@#LJ*Y7_A.(O[:GT=M#U9=
M06#[3;P&./-S'NV[E._"X/7>5QD=^*L:?XST[4- _M417,.+DV;6LB@3"X#[
M/*P#C.[WQCDD#- '145RDGCRQMIM6MKRQOH+S3+7[;+;81VD@Y^="K$$#&#D
M@@T6/CRSO+_1[=M-U&WAUB+?9W4T:B-VV;RGWMP.,\D8.."1S0!U=%<IX5\3
MWVO:QKUM<Z9/;0V-\;:-B\9"A40X;#9W$L3P" "!FNK(!!!&0: "BO)]0OM2
M\#^--6UNV\ZX\,++%#J-F&9S:AHU83Q@DX +'(';].Q1;*\\;V%];LDL,VER
M3(Z-E'^>+:^.A."<'K@T =/17+3^/-.M]/35GM;O^Q&F\G^T@$,0^;8'(W;M
MF[C=M]^G-=)<3&"UDF2&2<HI81Q8W/[#) S]2* ):*Y%?B'ISZ!I&M)I^HM9
MZI<K:Q$+$#'(S%0),R?+R".^.^*TM4\566C'4VO(+E;?3K5;F>=55DPQ("@!
MMQ;Y3QC'3GD4 ;E9-_X6\/ZK>"\U#0]-N[D8_?3VJ._'3DC-067B>*YUJ?1Y
M["[M;^*T%ZL4FQO,B)*Y4JQ&0PP0<?C7/Z=XNT#0? ?]MZ?I&I1Z0+N5)$&U
MGB<S%69M\G +D]SC/:@#O$18T5$4*JC 4#  ]*6LZ;5XX-2MK)K>;=/"\YE!
M39$B;<ESNSU8= ?TK(/CFPCN=*$]I=PV>JRB&RO7">7([#* @-N7<.F5'OB@
M#J**Y2R\=V^HZK-86FC:O(]O??8;B00+L@;:#O8[ON\]?;D#C.WJVKP:1';>
M:KR2W4ZVT$2$ R2$$@98@#A2>3V[G H T**\X^(M^NH>#'N)+2[M);+5K6)H
MY2,Y\V,D@(Q# JW%=-8^+[6ZUN\TFYL;ZPN;:V^V#[4B@2P9*[UVL>A'0X/(
MXH Z&BN8T[QO9:A>:/!]BO((]9B>6PFE";90J[CD!B5)7YAD=/0\5S6DVT>W
MXEV^9/+%TQ'[QLC_ $=3USGK0!Z917-_#TD_#GPV2<DZ;!_Z *Y#2]>7PQXF
M\<-'I.JZC''?12.MFGF&-/(4DDLPSR3P"3[8H ]3HK!B\6Z?>V6G7&F"2_;4
M(3<6\46U6,:XW,VX@* 64')SDXQ4_AWQ'9^);&>XM$EB>VN'M;F"8 /#*A^9
M6P2/3D$CF@#7HKS.'53H'Q,\8R0:7J6I.UM9/Y%FOF,/ED+'YF 'TSD]@>:U
M-2\5>&M;\/Z!J<]K=WEE>ZE EML!4PW/F;5\SYAC:V<CD<=Z .XHKF+KQI#!
MKM]HMOI&J7E_:0I.8X8TQ(K$@%69@.QZX]LU);>--+O/#^EZM:K/*-481VEL
M% ED?G*X)P-NULDG VGF@#HZ*\WT&[Q\2_&4TUA>1%+&U,EN[!V8_O,E,,1@
MC&,$?A5[3/%_A_0_!OAR?3].U"/2M0E2ULXU3S&C+,<;OF)[$\;C0!W5%<]I
MGB^TO[W5;.ZM+O3;C3(UFG2\"#]TP)$@*LPQ\I[Y&*J'Q[9*ND2MINH^1K'_
M !X2*B'S>-PR-V5ROS#/;T/% '6456U"_M=*TZXO[V98;6WC,DLC=%4#)K'7
MQ;;QZEI]E?V%[8'40?L<EP$VR,!G8=K':V.0#C/UXH Z&BN*G^)-E%9ZK=IH
MVL2PZ3<O;WK+"@\H*%+/RXR/FZ#)XS@#!KLH9H[B".>)@T<BAT8=P1D&@!]%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !6)XKN+V+1)(-.MKF6YNB( ]NN3"K$!I/JJDD
M#N0*VZ* ///&O@>VE\%,FB1ZC_:%GY<VFQB[FD$<L9!3".Y5> 1G'&:9XGO;
MV_L/"NH-H>H+K$-UYS06^PSP$1GS-JLP#H20I.>C#OBO1JQ-;\+V>N75K>/<
MWMG?6JLL-U93F-U5L;E/4$' X(/2@#BEECO- \76<.B:[#KVL6<TC"_ME0W!
M\ORE";25"KN0<G(W9.>M7-<T75K[X>^&VLM-$^H:/);7$FG7("^=Y<91X^>,
MX8X/3BNSTS1H=,+2?:+J[N&&UKB[E\Q\>@Z!1[ #-:- 'G&HZ5>>+O"&JP:=
MX8709I(4\I;N*-))I4D60*0A.$^3'/7=T '.CX:O)[N6.>7P.VBRVR$W,LD,
M>6;!&V'8=S9)ZD 8&.<\=M10!Y%#HNL1_!O1M%;2;S^TK>^BDEMP@RJK<^83
MG./N^]=!JFEW>J?$629;6YCL+CP]-IYN_+(5)7D# 8Z].^,9XKO:* /-/!\.
MI6UMI^B:CX(C@U"PV1RZF8XC;NB8'F*P.XN0. !P3DXJ#^R]4;P9\0;+^R[P
M7.J7]U+91F/F5)(T53[<J>N,5ZE10!Y_]BU2W\5>$]5CTFZF@BTJ2RG"[5:"
M0^61O#$87Y3R,]._&=CX@Z%>^(O!UU9::R_;D>.X@5SA7:-PX4GWQCZXKJ**
M .(O;6Z\6:YX9O#IUW8Q:7,]Y<FY3:ROL*B)?[W)R2,C"]>14W@&UO+-O$:W
MEE<6WVK6KB[@,JX$D3[=I'Y'@\UV-% ''^-=+U&35O#FOZ;;O=MH]T[36J$!
MI(I$V.5SP64<@=^:+33Y;SX@3^+&MKB"TATH6$221E9)B9#(S;.H P ,C))/
M&,$]A10!QWPSM+S3O!\=AJ%E/:74=Q<.T<J_PO,[J01D'AAWJ#Q FM77BN>S
MFTJ[O=&EL,6HMW58O/).[S\L"1C;@'(Z\$UW%% 'DVD:7K,.D_#N&XT6]B?2
M9F^U@JK>6OE,@;@GJ6Z=<#.*ZCP]9W2>/?&%U<V,\=G?FU^SRR)\LH2+8_Z^
MN,UV-4-9TJ/6]*FT^6YN[9)<9FM)C%*N"#\K#ITH Y#P-H5UINL:E9S2K+I>
MC3R6^E8.2JRA96!]T!5 ?3<*U?B%H5_K_A.2WTO:;^">*Z@C=MJRM&X;83VS
MC\\5O:9IMOI-A'9VH?RTR2TCEW=B<LS,>68DDDGUJW0!Q5W:7/BKQ+X9U 6%
MW90:4\MS.;I-C!V3:L:_WN222/EPO7FN<ETC6T^'OC#0/[%NS=7-W=O;.NTK
M.)9-R%><XP<DG&.G6O6** .$O;:]N/&7@F]CT^[^S6-O<I=2&/ A,D:*H/XJ
M>F<5C>'M-U+0TE\-7G@N.^FCGD^R:L8XF@DB9RRO*2=P*YY !)QQZUZI10!Q
MOA^UO(/B-XJNYK&XCM+U+06\[)A)#&C*_N.2.O6K/Q'TJ]UKX?ZOI^G0&>[E
MC4QQ @%RKJQ SWP#74T4 >;^((=37Q/IOBH>%IM3L9;(V=UI[K&]Q!\^]) I
M)4GD@@'IUIVO65_=Z?X=DM?#DEH(M=@OY+2"--T," @M)M.W?SG ).,#G%>C
M44 <=KMM=S_$;PI?0V5Q)9V<5VMQ,J?+&950)GOU4].G>LBWL-16R^(2MIEX
M&U.25K(&/_7!H!&,>GS#OCCFO2** ,7PC#-;>#=%M;F"2"XM[&&&6.08*NJ!
M2/S'6N-TG3-7T/PAKWA*73+FZFE>Z6PN$4&*>.;<07?HA!8[@WIQFO3** /.
M].T&\T3QCX5@6VN+BSTW16L)KM4^02'R\>^#L/TR*[/7_P#D6]4_Z])?_0#6
MC5;4;)=1TZXLGFDB2>,QL\6-P!&#C((Z>U 'F6FV4_BKX7>$M$ALKF,A;*6>
M>6/:D44>UBRMT8L   ,GYN<8-=)X>M;R'XA^+;N:RN(K2^^R_9IW3"R>7&5?
MW')[XS71:'I$.@Z-:Z5;S32V]K&(HC,5+! , 9 &<"M"@#R[3-'UC2_ASJO@
M:73+B>[*7-K9W(4&&:.8L5D9^B[=YR#S\O&<UK^(_#&H6GAKP]+H2BXUCP\T
M(MMYQYR;1%(A/8,O)_W:[JB@#AO'6AW;?"ZYT33K>:^O'$0 C4;I7$JN[G/
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MLM3U;3VNY/-N(;6ZQ'(^ "VU@<$@#)7'2@#F)D2\B\$_V'HVI1V6D7VV>"6
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MH\<@PRL% (/XBM&B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUTS$HH8<%PHZ]MRTOAO4_"/B5]!DCGO9M8T[#+9R22*UBP7;)O' 50 1SP>
M.M &CX0\:6T>GSP^(M=A-ZVK7-K 9RJ,ZK(4084 #IC.!S76ZCK^E:3(T=]>
MQPNL?FNIR2D><;VQ]U<_Q' KQR[NK!O@KXT:.>W,CZQ<,"K+EB;D%#[\#(]A
M72>)-<TZ?7_$MC'-#8SOHZ%9D7?-J2E)"%CSD%%R0< DYZ@+0!T/BC5KVUUW
MPB=/U BRU"_\F:- C),AB9P=V,]AT.*K:IXC&I>-Y?"]OJ[Z>J6'F"> *7-P
MTFQ5^8$87&<=\UR\6J6+Z!\*#]KB^2:%6+-C!6V93U]&.WZ\=:Z2"_M#\<;R
M+[5#YG]A11[=XSO$[DK]<$<>] '7V[R:9HL3:O?Q2200C[3=LHB1B!RY&<*#
MUIMEKFF:A--#:W:/- H:6(Y5T4]&*G!P>QQ@US/Q/^U1^'M/O(8Y);2RU6UN
MK^-%+%K='RW Z@':3]*AO&@UGXH>&=3T6YAN(;6RNC?SP.&7R75?*5F''+Y8
M#_9)H AL]<N_&&K:S;:7X@;39K"]6&S6.)9$D141G+J1EMQ9AU&,#'?/H5>=
M^"];TRUOO'EW+?0""#59;B1E;=B-84RV!R1\IZ>E=QI6JV6MZ7;ZEIUPMQ9W
M"[XI5! 8=.AY'/&#0!7G\2:-;7GV6;4(4E$JP-D_*LC?=0MT#'(PI.3D5'>^
M*_#^G3W$%WK%G%-;*&FC,HW1@],@<Y/IUKR;Q7K=A=>&?%4,,L>GR6VM(TNG
MQIF20K/%NN)202%;&01M'09).*ZZQO\ 39_C1?W"W%N?^)##M=F (_>N3UZ?
M*03[8H ZQ_%&A1V]C</JMJ(;\@6C[\B<GH%]3[=:O-J%HNHIIYG07;QF58?X
MB@."WTS7E_A71T\3_!.*RL)XUO[:YGGLI$89AG2XD>(^W;\&KK?!%Y<>(;1_
M$U[:O:S7D:01P.,&-(\[N/>0R?4!* .DO+ZUT^$37<Z1(6"*6/+,>B@=23Z#
MFLVY\6:+;Z%>ZQ]M22TL@WG^6"71E'*E>H;V.*Y_QC<2:9XZ\(:K=G9HT+W,
M,\S?<@ED0+&SGL#\RY/3)]:Q=5M'O=6^(6HZ8?-T^XT'R':'YEGNA')]TCAB
MJ[0<>H% &GJ_BV:>'P;JECJ/V:TO[Z.*]A^4IM:)I""Q&1C Y!%=?I>OZ3K<
M,\VFZA;W4=NY25HWSL.,\^G%>:7^KZ3?:!\--MY;2QIJ%J'RPP"MNP/7T8@'
MT/'6F:X9;[6_B?9Z2ZS7LMA9%88F!:7:C>8H ZG;\OX@4 >EV_B;1;JXDMXM
M2MS+'%YQ5FVYC_OC.,K_ +0R/>H[#Q9X?U2\@M+#6+.YN)T>2*.*4,756*L1
MZC(/Y5R>@ZMX.\2ZSI6K6-Y=W>HV4<C?O9G'V%&0A_-!P!T"X/?D=":F^#XL
M9?A]8O ('FCGNM[)@LI,[]>XRH7\,4 =;J'B#1]*N$M[_5+2VF=&D$<LJJVQ
M02S8/8 'FF6'B71-4TF75;+5;2:PASYMPLHV1XY.XG[N!SS7+>,Y;.'XD^!)
M+YH4A#WN&FP%#>4NWD]#G&/?%<[JOV/3Y/B)KD>G1W^B3BTC:(9\F:8<2/\
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M6VM^<D$,T:,RN>49@,+[MR!@=37)//!-\2?&%O;RQO-+H4*B-&!+N/,XP.I
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MD;74$''.1@\$ ]A6Y10!S^G:)?-?P7^LR:<]Q;;C"MC:F,*6!4EF9F+<$C'
MYYSQCH,9HHH ,#TI"H(P0"/2EHH :\:2@"1%< Y 89YIU%% "8&<X&>F:,#T
MI:* # ]*:L<:,S*BJS?>(&"?K3J* #%&,T44 <OJ6AZ]_P )#-JFE:E8M%<0
MI"]IJ%JTBQA23F-E8$9W<@@Y_+&IH^D?V=]HGG:"2\NF5IG@A\J/@8 5<DX]
MR2>>N, :E% ",BNA1U#*>"",@T!0%V@ +C&,<8I:* &I&D:!$154=% P!2X'
MI2T4 &!35C1-VQ%7<<G QD^M.HH 3 ]!1@9S@9Z9I:* $551=J@ #L!2T44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR, L?IDBLGPCJ":IX6LKZ/4_[328,RW90(9!N.,J  & X(QP0:V)?]2_^Z:
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M1,SE0RJNU@4']W.1ZUHZ_:7M[#;PV]K8WEJSD7EK>'"RQE3P/E89#8/(QP:
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M2;'6OB58ZEIU^DL*6F_4HX&#QRF.0&WW$?Q!]Y'_ %SH [6U-P;2(W:QK<%
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MY'3IS[5WMBDT=A;QW"HLR1A7$;%ER!V) S^5 %BBBB@ HHHH **** "BBB@
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M;00_NPTIBSO927QM&T\DC/;K5*X2[\0:OX:U:T^VVEK9W=TEW;R'83A'C^8
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M3Y,9;J2.PS7IM% '&1ZEJ?C30KW3FT*_T9I[*6">:_0+M=T*@1X.6&3G=@#
M]3Q@3:;J?B#X86'@RXTR[M=4C^S6L\CQ$11)"Z%I5D^ZP*IP 2<MC'6O4J*
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M'='(P*X51C .%/)P3@#$TG05N_ OA;2M=T76;*>SAE"7UHC">SE4J 1LRP#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:^S6MTVAP-;S-%N\F]+.B.0-VTQC. <D9[&J9\<06?CF/PKJMJ+.XN(1-:7
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M9B1;:!!'$KR-(54# &6). !577_#NF^)],;3M6BDFLW(+Q+,\8;!!&=I&<$
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MRWTUS#<Q;NLEOM(4CU"Y ]LUU^L>%=)U[4+&^U"*=[FP8O;/'<R1^6QZD!6
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MKF[ANHX8K9'C5"KKYC, %ZY!!_X"?2H[_P &Z)J3Z<]Q!< Z: +/R;N6(0X
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MO=6M(YUO;[;]ID>YD<2[1A<JS$<#@<<59T[1K+2KF_N+5)%DOY_M$Y:1F!?
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M\0VPBO)9K:2(-?IEM_SJ/O@L,#O6U=_\4E\6[>]^YIGB>(6TQZ*EW&/W9/\
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M\U-XT_Y$3Q#_ -@RY_\ 135Y:#/XH\/>!_!5Y"NF6T]E:WB7TC[C<")!F.(
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M>*O1E1B48^^<#/X5@>'[75=7\$^--%TW3HYGOM:OX//GF5(HMQ +$<L2!R,
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MSD8+%=FTE\F0DX&U]N""> >A[$UF:)JFE>,+S6;RTN-VGWVD6JLX.UD!:Y#
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M&-)U#[-9R32,3+#YI$3N6,7WAQ@[<]<>_-=>"" 0<@]"*C^U6_G^1Y\7G?\
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M3C//\(K9HH YSP=X7F\*:?<V;:@MXDUS)<[O(\LJSG+#[QR,UT=%% !1110
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MSD\8XX]Z .P "@   #H!7F7Q$EU.:9]>TN1S'X3FCN&A3I<,1F93_NPL.?\
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M"UT^V13XCLD=O*7=("6W;CCG)Y.>M=WX7TJ70O"FDZ3/(DDUG:1P.Z9VL54
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M=VC":UN%(\RUF7[KJ0?7WY'I0!2\*Z!I5YX5\/3W-A;RM;616)7C5E7?M+$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***Y7XAZGJ&C^$9KW3UN"$FB^U/;#,L=OO'FLG^T%SSVZ]J .
MJHKC/#YL-7N=-UCPSX@NKS3 7%U;R7KS Y0[2PD)=6!Q\O YSCC-9VE:B]C\
M1/&QO=0O7TW2+6VN(H7N'=(@T3/(0">?NYYZ=J /1**X?P@MUXMT&+Q)K-W>
M1_;MTMO:6UW)!';0Y(4?NRI=B!DLV>O&*L+:!M,UVV3Q'<7:$-<6CQ7O[ZV
MC V[E.2 PS\V<YYS0!V%%>=_#_Q3J$P3PMXI<C65MEGMKG<0+ZW89#J?[XZ'
MOQGUKI?"".-)N'DN+F=_M]Y'NGF:0A4N)$0#<3C"J!^'- &_17GB>*M1A^)M
MLMP^/#NJ"73[,YX^TPG)8^FXF1!Z[!2?$:SO=&\%>(-=M]9U-+Y,20>7=ND<
M(W*H54!QT]<\DT >B45P>NW)\#>&;GQ4M]?W206.TVEU=/*DDSL@1OF)(P<@
MX[$UIZ=X=N;O0X)M2UC4SJTT0DDN(+MXUCD(SA(@?+VJ> "ISCG- '4T5Y%J
M'B[4]4^$/B*\DNI;77M"N'LYI[61HMTB.HW@ XPP/0\9SBK^J:A?:'XB\(6^
MBZK>7EQJ$Z1WVGSSFX!@(!>;YLE-O7((!H ].HK@_'DUS!XF\'QV]]>6\=[J
M/D7*0W#HLB;2V" ?4=1S5/4[E(?C FEWNL7=MI<FAFZ\HZA)$GG>=MR#N'\.
M>,X]J /2**XV66:V\/\ B._\+ZA/J<T<!2VBDN&N56=%).PL3G.Y>,]5Q63X
M9O-.\4Z987?A[Q'J1U&WF@?4+:YO79V4.OFJ\;DA>-W* #L..* /2**9+$LT
M31L7"L,$HY4_@1@BO*? ]_8ZIX3#ZUXEOQJ4M]+:(1JLBRY,OEQX3=C/([4
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M9=R,1DD<UA:AJFHZ-IO@NZT?5[VZU?49+9;G3YK@SBXC=,R.5;)3!_B& ,T
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MY"[]N.@ZYQ6G=(?$'C$6S'4K6WTJ+?%,D+QK+.^58J[+M.U!C@\^8?2NLHH
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MY%<-X?M5G^*OC"XN],N3:WD=FMM-<63B.39&0^&9<<$@>]>B44 >?_%:Q?\
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ME8+GYCG)[#(KH_ NF6W_  AOAUY]/:"^LK2)&\ZW,4B2"+8P.X ]R/0UUE%
M!7 :")A\7O$]T]G>I:W-K:QPSR6LBQR,BG< Q7'&:[^B@#SWQI";KXC^"Y&T
MZZNK.S:[-TZV<DL<>^(!-Q"D<G\JC\8V$4'C;P;-8Z3/Y=M>227,MI8NRQJ8
M]H+,BXZFO1J* . OO./QJTN\6SOFM(])EMWN!:2&-9&D!"EMN.@J/75T'Q9I
M%W9^*M$O5N8)YX[=TL93(55V"/"ZJ<Y 4XSUZC%>AT4 <[X$M=7LO ^D6VNN
M[ZE'!B8NVYAR=H8]R%V@^XKHJ** "BBB@ HHHH **** "BBB@ HHHH ****
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MS=%YHDE:)HV,.2H8$,,$XZT =O:C7(M62.[O-/N;,PL9!#;-%(CY&P\R-E2
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MI\&DPV\MY<W"+(UPI9(8F8)N(# Y+,,#/9O2NPN+I-/TZ6[O95$=O$TDT@7
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M!;VCQ21-M#* 3*P8'D8P#G%3:5<^)M<T2#5TN++3VNHQ-;V<EN90J,,J)&W
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M8,5+9ZE@1NXQUKG=*^(-S'\,;#Q1J\4$][J#"*UL[1#'YDK.52,%F;KC)/8
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MW+,,2*.R,>".QQ["NX\3--JFHV'A^RF@29B+ZX\U"ZB&)AM!4$'YI-O?D*U
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MN8\@JNXAL'CBNATC4KC44NA=:=+8S6\WE&.1U?<-JL&!7@@[OT- &@RAE*L
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M'3!QD8K2HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JNIW\6
ME:9<W\^3';QM(0O5L#H/4GH!ZFK59VL:-;:W;Q074DZQQRI,!#*4RZ,&4G'7
M! ..G% 'EVO1ZCX;CT'Q=/HUY!=Z;<L^K3EX662*X;$HPKEB%8C;D< =L5L>
M.Y_*^(OP]OYV#:3]IG0OGY!,\8$1)Z<GI]#7=ZOI%MK>CSZ7>F1K6X3RY0K;
M2Z]QD>OM51?"FD-X:7P]<V[7>FH@18KES(54?= 8\C&.#G(H SOB1K>H>&_
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M2T>QU;[*;V!9&M+A+F!N\<BG((/Z>X- ''WG_)>-,_[ $W_HX54^)H^T^*/
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MTT5H6Z><')<#WV8_2O0YC"(P9R@3<N-^,;LC;U[YQCWQ5#6_#^F^(K2.WU*
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M5GNI-QC0G)50  N2!G R<#)XK7H **** "BBB@ HHHH **** "BBB@ HHHH
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M '!5@".&!Z=ZY#QH OQ#^'P   N[H #_ *XUW:11QO(Z(%:1MSD?Q' &3^
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M'7AW44M7M;R:2*Z?RX)?L<PCD;)& Y3:3D$=>U;SQ1AI9@@$C(%9NY R0/\
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M9"HB**57!\PY&.O]*ZFB@#B-+\"WVF^']5TL:XN^_OVOUN8K38T,C2*YP"[
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MCL*C\7>%[KQ,^D&'48K1=-OXK]0UL92[QYP"=ZX7GZUTU% ")N"*'(+8Y(&
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MJ<<@#)'&171T4 9%_I=Y=ZYIU_#>0Q16?F9A:W+&3>N#\V\8_(U4\1^#]/\
M$6HZ1J4O[J^TNZCN(9U')56#-&?4''X'GU!Z*B@#"\8^'YO%/AB\T6.]2T6[
M4(\K0F0@9!X&Y>>*CU'0=1O_  _::4-2MH_+:+[0YM"PG1"#LV^8-H;;@\G@
MFNAHH P_%WAW_A*O"MYHCSQP_:D"F5HB^T@@@A=PY! (YK(UGP;JVMZ)HMC=
M:] 9M,NX;LW/V$DSO%]W(\SC/?\ I79T4 <QJWA2:\\0:?X@T[4$L-6MD,,\
MGV?S([J$\F-TW X!Y!SD4VX\+7]QXYL?$IU2W4VMHUK]G%H<,K').[S.#G&.
M*ZFB@#C;+PEK>F^*-<URTURP\S5S"98I=-=E3RDV+M(F!Z=<_I6YI>GZE:I=
MRWVI17=[.^5D6V,<<2 85 F\G .XY+9)8UK44 <SX,\+W/A32KFQDU&.\6:Y
MEN0ZVQB*LYR1]]LC-:^BVNH6>DP6^JZB-0O4SYET(1$).21\HX&!@?A5^B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.I^3&S^7)#(P49PHD&3^%36%[;2_ JS\J9',NA):QA6R6F,(C$8]6W_+CUH
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MZU['H'AY]#U+5YC?75W'?21RJUS)O="%VE<^@P,?6@#>HHHH **** "BBB@
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M> ">U6-2OVTW2;B_-L\WD1&5XD8;L 9(&2!GCUH @'AK05L39#1--%H9/-,
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M)C8QL1D*PW#G'ID>] '27'A[1;NUAM;G1]/FMX/]5#);(R1_[H(P/PIB^&=
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M*Q!*Y]#M&1["LO1M?DU34;^PN-)O-/N+-8V(N"A$BONVLA1F!'R&M@D $DX
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M,PV4NI2^6MY=QVD7^^YZGV R2:?K6LOI+64<.FW5_->3^2D=N4!7"LQ9BS
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MO&O1/$7_ "+.J_\ 7G-_Z :SO"7@K2_!5I+9Z/)=+:RR&5H99 XWD ;LXST
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MWO\ 9\ A6\N6NI47[OF,JAB!VSM!^I- &C1110 4444 %%%% !1110 4444
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M.::$*TD7*NJL,JQ4X.".AZ&O,/&6DZKK/[/.C6VD0RSRK964LL,0):2-8UR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !W#=T[D58C\ 7F@>,[WQ)X5O;:$:@#]MT^[1O*D;.=RLO*G.3T/4_2N^HH
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M&\&GVQFN;PDB,$$#"\<@#))Z=.N> #L:*Q(_%_A^73+/45U6W^QWLWD6TI)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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=** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>sangamoexecutiveseveranc023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sangamoexecutiveseveranc023.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW7CTPSPYX\7QYX)&^YGL-=LKFWAO(X)3$WS3(A8 ?PL"1@]#GV- 'JU%>/\
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MKB*4@ %'+*1T)#+C..U 'M=%<7;6:7FK0)I7B'4&N=/-O/>0->&6*2.3<"K
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MA<X #L!@<D9/09YQ4=WXVT6TU*[T[==S7MK$LKV\%G+(Y5LX*@+\PXZCCWH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9H//CO$^PR116LC0%1$D> JJ&XW8Q@<L<5[!10!Y_J.AW]O\09X;.!FT?Q%
MK:@P^[$\) ;/_72,A/U[57\1R'0?B')JFJ:7?WNC:A8Q0+/9QO(;>6-G.UE3
MG:P?KZ_C7I%% &1X9MK6UT6,66E?V7;.[21VQ7:P!/5E[,>N.HSSSFO/XFM]
M(U_Q!HWB/P[J=^M_?2W-G-;P/-%<QR8/EG!V@KR#NP,=>*]7HH \Y\6Z$WB7
M3[?1K*T6QNM&MEN8Y6@<Q*^S:+=&P Z$9#XSQ@8.>*NNZK?Z[X=\-^)5T'42
M=.N_,U'2O)=)E5HVC8H#@MMW9&.H/;FO4** /+-:L(O$7A#6;WPKH%Q#<O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR09'06_RD\#MC''3%0:*;;4_!WCNVUX)]L2]O/MHE^\JA<Q,,_PA0NT_[/%
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M>6OV:ZM89[<X_=2QADXZ<'BN5\1>&+F233AH^EZ)<Z;;&0RZ5>1^5%([  2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%17*J]K,CR&-61@7!Q
MM&.N>U &,_C/P_&DLKW^VVA<I)=F&3[.K X(\[;LR#Q][KQUK<CD66-9$.4<
M!E/J#7S[;:UXH^$MDWASQ1HPU;PDY>*.[A7I&Y.1GISD_*V#SP<5[#J&OV=I
MX-MK_3[N)8[N***QFF8!<R !&.>P!W'V4T ;=G?6NH1/):3I,D<KPN4.=KHQ
M5E/N""*RKOQEX?L-=BT2\U*.WU&8A8H)D9"Y)P,$C!R> <]:\L^$FJ#PWX_\
M0>!YK];NWEE:[L;@2!_,.,GD<%BF"?=&KI/B)X"A\=W]] C"'4[2P@ELIR<!
M7\R;*GV; ^F >U '>WFLV-A>VMG<R2+/=$K JPNV\@$D @$9 !/T&:BU;Q'I
M&AR01:A>K'/<'$$"*TDLI_V8U!9OP%>8?#WQU=Z[J&D>&]?CDB\1:3=R),)!
MS*@@E7<?]H$@'UR#WXJ?#6XEUSXW>,M2U(E[JSWVUNK_ /+*,2E<+Z8"@?B?
M6@#U2#Q7HL]_#8?;&AO9SB*UN89()9."<JCJ&(P#R!BM.\O+?3[*>]NYEAMH
M(VDED;HJ@9)/X5S>K:]X5?Q1INFZA<D:U;3>=:0_9Y#(25925PO*D%NG''M6
M7\4-FLZ-/X7CU*"RFN;62X=I953<$_U<?)_C?'X(U '>B13%YBG<A&X%><CV
MQUK$TWQGX>U?69M'LM3CDU&$-YEL49'7:<-D,!R#VKE/@EXJ/B/P%#:SONO=
M+(M903R4 _=M_P!\\?537#>.K:;PIKNC_$.QC)\C5KNVO57^)?M$N,_52ZY_
MW: /:-?\6:%X62!M;U*&R$Y(B\S)W8QG& >F1^=6KC6M.M-).JW=VEK8A=QF
MN,Q #MD-@\]O6O#/CA/%K/@^VU^)Q);3ZDD%FXZ&%(Y<L/\ ><M]0JUH?%2X
MFO?B/X!T*Y).ER302O&?NR.90I!]<  ?\"/K0!ZM'XPT*2:UB>\:!KLXMC=6
M\D"S'L$9U 8GT!YK<KSOXX6\,WPGU6211O@>"2(GJK>:JY'X,1^-;?PXU"[U
M7X=:%>7[,]S):@.[=7P2 Q]R #^- "2_$CPE#:PW4NKA+:<[8IF@E"2'T5MN
M#^%7XO%VB3&\5+J3?9QB6XC:VE5XT.<,5*YQP><=J\L^/UK#9>'_  K:VT8C
M@AO/+C1>BJ%  _*O6->M8/[*U.[\L?:#82Q%^Y7:3C\\_G0!!IOC'0=8TVXU
M'3KUKJSM\B6:*"1E4@9(^[R0"#Q2:;XST#6-.N-0TV^-U:6^?-FB@D95P 2,
M[>H!!QZ5Y/\ !N\U&#X4:E':Z2;F$W%QF7[0J8/EKG@\U<^!?_)(=:_Z^[C_
M -$I0!Z';_$+PO>6,E];:DT]I&2'GBMI6C4@9.6"X'!%6K_QCH&F:/:ZO>:B
ML6G72JT-R8W*,&&5Y XR.QKQ_P"!^IZG:^%]/LK:P9K&ZUR5+F[WC"#[."%V
M]>2HYZ=N]='\<[2WL/A)'9VJ!+>"ZACC0=% R * .\A\:>'9KNUM3J:0SW8!
MMTN$>'SL]-F\#=G(Z>M;U?/7BJ]_X3NY\(> XH)-)O(8H;AKN]*J&7RACRMI
M;=D9(Y'*XX->V>)=4&D:(SK<QP7$[+;6\DS *LC\!CGLHRQ]E- &C9WUKJ$+
M36DZ31I(\3,AR Z,58?@0163J7C/0-(U6/2[Z^,-]*,Q0&"0M(.>5 7YNAZ>
ME>7?"#51X=\;^(/ TU\MU TS75C.) XDZ$\C@DIM)]U:I?B/*\/QU\$R1P27
M#K%D11E0S?,_ W$#\R* /4[#Q1HNJV5Q=Z?J$=U%;'$X@!=XSZ,@&X'KV[5G
MVOQ"\+W]I)=V>I-<6T1(DFAMI71"!GE@N!Q7,^#/!FL:=XT\3^+-4CCLEU-7
M6&Q20.0"0=SD?+GCL3U-</\ !#5-3LO#"6]I8,]I<ZZL=S=B08B4QIQMZG)
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M\WY<Y_\ '_;[N.] '1T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M .+H_MC5O^A9O?\ P)M__BZVZ* ,3^V-6_Z%F]_\";?_ .+H_MC5O^A9O?\
MP)M__BZVZ* ,3^V-6_Z%F]_\";?_ .+H_MC5O^A9O?\ P)M__BZVZ* ,3^V-
M6_Z%F]_\";?_ .+H_MC5O^A9O?\ P)M__BZVZ* ,3^V-6_Z%F]_\";?_ .+H
M_MC5O^A9O?\ P)M__BZVZ* ,3^V-6_Z%F]_\";?_ .+H_MC5O^A9O?\ P)M_
M_BZVZ* ,3^V-6_Z%F]_\";?_ .+H_MC5O^A9O?\ P)M__BZVZ* ,3^V-6_Z%
MF]_\";?_ .+H_MC5O^A9O?\ P)M__BZVZ* ,3^V-6_Z%F]_\";?_ .+H_MC5
MO^A9O?\ P)M__BZVZ* ,3^V-6_Z%F]_\";?_ .+H_MC5O^A9O?\ P)M__BZV
MZ* ,3^V-6_Z%F]_\";?_ .+H_MC5O^A9O?\ P)M__BZVZ* ,3^V-6_Z%F]_\
M";?_ .+H_MC5O^A9O?\ P)M__BZVZ* ,3^V-6_Z%F]_\";?_ .+H_MC5O^A9
MO?\ P)M__BZVZ* ,3^V-6_Z%F]_\";?_ .+H_MC5O^A9O?\ P)M__BZVZ* *
MMA<W%U SW-A+9N&P(Y'1B1CKE21_^JK5%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'G7CZ
MS@N/'/@B.2,%+F[FCG4$CS5$>0&QU ([U#\0(7\!Z;#XLT&6:W2SN(UO;$2L
M8+B%F"D;"<*P)&&&._6M+QI8ZI=>+O"=]8Z3<WEOIMS+-<O$T8P&3:,!F&3F
MF^*M'U?QXMKHTVGR:;H8G2:^EN9$,LZJ<B-%1FP"<99B,8X!H Z'Q'>S)HRP
M6,A2]U%UM;5P.49P<O\ \ 0,_P#P&N7\#[]?\%7'A?697-[H]R+"\VL5:1(V
M#(<@YPR #/?FMF?3I-;\6L-0TZZBTZQ@VV<HF"+)(Q.]OD?<,*J@9 ^\U8T6
MAW_ASXH_VAH^E7<VCZC9B'47$RMME4G9)\[[FP/E/H* *2:#IA^-,VEFT7[
M/#ZSBWW'8)//*[L9ZXXS47C;3-/T/4/!-J=WV,:D\4F\LQ:(AF"-U+ < 9ST
MK<CL-3'QDEUHZ9<#3&T<6(N=R8\P3;^F[=C!ZXI/'-AJE[XA\*W-AI5S>0Z=
M?&YN&B:,;5VE>-S#)YH O:(GARX\1RMHT?E7-E;KYOEHR*RREL @XR<Q9SV_
M&MO2=2EU.">273KJQ,5P\(2Y4 R!3@.N"?E/:J<6H7]SK%NL6A75K&X/VF[N
M3%PB@E5 5R22S>F ,U<TB^O+^"=[W3)-/>.X>)$DD5S(BG D&.@/I0!H4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !11378JC,$+D#(5<9/MSQ0
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M'\LD#?DC=QD?RYH ZJBN17X@V+:);ZT-)U<Z;.%9+A8%9=K' 8@.2![D5UU
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<.D2QS"0/$#\KDXX)';M0!H4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '&^+=#U
MK5/$_AO4M.M[22'29Y)I!/<&,R;DVX&$;ISUI-<\,ZKXQN;.WUO[)::);3K<
M26EO*TLETZ_=5V*J%3/4 '/J*[.B@#G&T>YU+Q5/=ZMI]E-IT-N(;(,_F%26
MS(S(5P"V$ P3@+[UE2>%M1TSXCV^NZ#9V$.FR6?V6_A\PQ&3YMRNJA"-PZ<G
MD<<5W%% ''IH6KCXJR>)##:_V>VEC3P!.?,R)=^_;MQCMC-)XQT+6=7USPY>
M:;!:/%I5X;F03W!C+_+MVC"-ZUV-% &+$^OW&J6WG6=E:62[FG>.Y,LDG!"H
M!L4 9.2<]L=ZM:0^K203G5X;6*47#B$6SLP,6?D)S_%CK6A5/4-+M-41$NUD
M8(<KY<SQ_P#H)&: +E%8G_"):/\ \\KK_P #I_\ XNC_ (1+1_\ GE=?^!T_
M_P 70!MT5B?\(EH__/*Z_P# Z?\ ^+H_X1+1_P#GE=?^!T__ ,70!MT5B?\
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MB6C_ //*Z_\  Z?_ .+H_P"$2T?_ )Y77_@=/_\ %T ;=%8G_"):/_SRNO\
MP.G_ /BZ/^$2T?\ YY77_@=/_P#%T ;=%8G_  B6C_\ /*Z_\#I__BZ/^$2T
M?_GE=?\ @=/_ /%T ;=%5;#3K;3(&AM5D5&;<=\KR'.,=6)/:K5 !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
3!1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170411061376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Oct. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANGAMO THERAPEUTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">68-0359556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Marina Blvd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brisbane<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">970-6000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGMO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,346,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001001233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170250161200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 56,514<span></span>
</td>
<td class="nump">$ 100,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent', window );">Total marketable securities</a></td>
<td class="nump">75,597<span></span>
</td>
<td class="nump">177,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableCurrent', window );">Interest receivable</a></td>
<td class="nump">602<span></span>
</td>
<td class="nump">794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,148<span></span>
</td>
<td class="nump">3,678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">13,715<span></span>
</td>
<td class="nump">18,223<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">147,576<span></span>
</td>
<td class="nump">300,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">29,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">28,436<span></span>
</td>
<td class="nump">63,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">37,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">27,211<span></span>
</td>
<td class="nump">62,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">14,974<span></span>
</td>
<td class="nump">17,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">219,697<span></span>
</td>
<td class="nump">562,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">15,457<span></span>
</td>
<td class="nump">22,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Accrued compensation and employee benefits</a></td>
<td class="nump">17,306<span></span>
</td>
<td class="nump">21,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">14,234<span></span>
</td>
<td class="nump">16,007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenues</a></td>
<td class="nump">1,485<span></span>
</td>
<td class="nump">51,780<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">48,482<span></span>
</td>
<td class="nump">111,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenues, non-current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">109,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion of lease liabilities</a></td>
<td class="nump">34,975<span></span>
</td>
<td class="nump">38,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,318<span></span>
</td>
<td class="nump">1,207<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">84,775<span></span>
</td>
<td class="nump">267,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">1,773<span></span>
</td>
<td class="nump">1,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,485,811<span></span>
</td>
<td class="nump">1,450,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,346,081)<span></span>
</td>
<td class="num">(1,148,545)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(6,581)<span></span>
</td>
<td class="num">(8,404)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">134,922<span></span>
</td>
<td class="nump">294,958<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 219,697<span></span>
</td>
<td class="nump">$ 562,509<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170344162640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 9,398,000<span></span>
</td>
<td class="nump">$ 26,460,000<span></span>
</td>
<td class="nump">$ 174,190,000<span></span>
</td>
<td class="nump">$ 84,069,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">57,089,000<span></span>
</td>
<td class="nump">65,116,000<span></span>
</td>
<td class="nump">183,351,000<span></span>
</td>
<td class="nump">183,719,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">13,918,000<span></span>
</td>
<td class="nump">16,238,000<span></span>
</td>
<td class="nump">48,068,000<span></span>
</td>
<td class="nump">46,239,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment of goodwill and indefinite-lived intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">89,485,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">44,799,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">65,232,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">115,806,000<span></span>
</td>
<td class="nump">81,354,000<span></span>
</td>
<td class="nump">386,136,000<span></span>
</td>
<td class="nump">229,958,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(106,408,000)<span></span>
</td>
<td class="num">(54,894,000)<span></span>
</td>
<td class="num">(211,946,000)<span></span>
</td>
<td class="num">(145,889,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income, net</a></td>
<td class="nump">3,515,000<span></span>
</td>
<td class="nump">1,769,000<span></span>
</td>
<td class="nump">9,610,000<span></span>
</td>
<td class="nump">5,754,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(102,893,000)<span></span>
</td>
<td class="num">(53,125,000)<span></span>
</td>
<td class="num">(202,336,000)<span></span>
</td>
<td class="num">(140,135,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">1,270,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="num">(4,800,000)<span></span>
</td>
<td class="nump">170,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (104,163,000)<span></span>
</td>
<td class="num">$ (53,155,000)<span></span>
</td>
<td class="num">$ (197,536,000)<span></span>
</td>
<td class="num">$ (140,305,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per share (in dollars per share)</a></td>
<td class="num">$ (0.59)<span></span>
</td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="num">$ (0.93)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per share (in dollars per share)</a></td>
<td class="num">$ (0.59)<span></span>
</td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (1.14)<span></span>
</td>
<td class="num">$ (0.93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in computing basic net loss per share (in shares)</a></td>
<td class="nump">177,171<span></span>
</td>
<td class="nump">158,042<span></span>
</td>
<td class="nump">173,375<span></span>
</td>
<td class="nump">150,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in computing diluted net loss per share (in shares)</a></td>
<td class="nump">177,171<span></span>
</td>
<td class="nump">158,042<span></span>
</td>
<td class="nump">173,375<span></span>
</td>
<td class="nump">150,850<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170243208128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (104,163)<span></span>
</td>
<td class="num">$ (53,155)<span></span>
</td>
<td class="num">$ (197,536)<span></span>
</td>
<td class="num">$ (140,305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(1,144)<span></span>
</td>
<td class="num">(6,028)<span></span>
</td>
<td class="nump">981<span></span>
</td>
<td class="num">(14,040)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Net pension gain</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable securities, net of tax</a></td>
<td class="nump">494<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">840<span></span>
</td>
<td class="num">(1,101)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (104,808)<span></span>
</td>
<td class="num">$ (58,993)<span></span>
</td>
<td class="num">$ (195,713)<span></span>
</td>
<td class="num">$ (155,316)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170247165776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,921,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 375,343<span></span>
</td>
<td class="nump">$ 1,459<span></span>
</td>
<td class="nump">$ 1,334,138<span></span>
</td>
<td class="num">$ (956,267)<span></span>
</td>
<td class="num">$ (3,987)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in at-the-market offering, net of offering expenses (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,711,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in at-the-market offering, net of offering expenses</a></td>
<td class="nump">66,448<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">66,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax</a></td>
<td class="num">(1,838)<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="num">(1,847)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">1,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">23,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(14,040)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,040)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net pension gain</a></td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized (loss) gain on marketable securities, net of tax</a></td>
<td class="num">(1,101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,101)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(140,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,918,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">309,154<span></span>
</td>
<td class="nump">$ 1,619<span></span>
</td>
<td class="nump">1,423,105<span></span>
</td>
<td class="num">(1,096,572)<span></span>
</td>
<td class="num">(18,998)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153,352,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="nump">318,281<span></span>
</td>
<td class="nump">$ 1,534<span></span>
</td>
<td class="nump">1,373,324<span></span>
</td>
<td class="num">(1,043,417)<span></span>
</td>
<td class="num">(13,160)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in at-the-market offering, net of offering expenses (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,483,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in at-the-market offering, net of offering expenses</a></td>
<td class="nump">42,174<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">42,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax</a></td>
<td class="num">(101)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">7,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(6,028)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,028)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net pension gain</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized (loss) gain on marketable securities, net of tax</a></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(53,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,918,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">309,154<span></span>
</td>
<td class="nump">$ 1,619<span></span>
</td>
<td class="nump">1,423,105<span></span>
</td>
<td class="num">(1,096,572)<span></span>
</td>
<td class="num">(18,998)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,793,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">294,958<span></span>
</td>
<td class="nump">$ 1,668<span></span>
</td>
<td class="nump">1,450,239<span></span>
</td>
<td class="num">(1,148,545)<span></span>
</td>
<td class="num">(8,404)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in at-the-market offering, net of offering expenses (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,249,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in at-the-market offering, net of offering expenses</a></td>
<td class="nump">15,106<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">15,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,481,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax</a></td>
<td class="num">(1,404)<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="num">(1,419)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">719<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">21,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net pension gain</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized (loss) gain on marketable securities, net of tax</a></td>
<td class="nump">840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(197,536)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(197,536)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,279,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="nump">134,922<span></span>
</td>
<td class="nump">$ 1,773<span></span>
</td>
<td class="nump">1,485,811<span></span>
</td>
<td class="num">(1,346,081)<span></span>
</td>
<td class="num">(6,581)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,074,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2023</a></td>
<td class="nump">233,642<span></span>
</td>
<td class="nump">$ 1,771<span></span>
</td>
<td class="nump">1,479,725<span></span>
</td>
<td class="num">(1,241,918)<span></span>
</td>
<td class="num">(5,936)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax</a></td>
<td class="num">(101)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">6,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(1,144)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,144)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net pension gain</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized (loss) gain on marketable securities, net of tax</a></td>
<td class="nump">494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(104,163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104,163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,279,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="nump">$ 134,922<span></span>
</td>
<td class="nump">$ 1,773<span></span>
</td>
<td class="nump">$ 1,485,811<span></span>
</td>
<td class="num">$ (1,346,081)<span></span>
</td>
<td class="num">$ (6,581)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170246772240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (197,536,000)<span></span>
</td>
<td class="num">$ (140,305,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment of goodwill and indefinite-lived intangible assets</a></td>
<td class="nump">89,485,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">65,232,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">13,238,000<span></span>
</td>
<td class="nump">8,765,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion of discounts and impairment on marketable securities</a></td>
<td class="num">(2,031,000)<span></span>
</td>
<td class="num">(324,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization in operating lease right-of-use assets</a></td>
<td class="nump">5,945,000<span></span>
</td>
<td class="nump">6,357,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit</a></td>
<td class="num">(6,195,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">21,256,000<span></span>
</td>
<td class="nump">23,402,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash adjustments</a></td>
<td class="nump">1,119,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Net changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet', window );">Interest receivable</a></td>
<td class="nump">192,000<span></span>
</td>
<td class="num">(175,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">2,530,000<span></span>
</td>
<td class="nump">1,491,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">5,159,000<span></span>
</td>
<td class="num">(5,848,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and other accrued liabilities</a></td>
<td class="num">(5,220,000)<span></span>
</td>
<td class="nump">9,443,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and employee benefits</a></td>
<td class="num">(4,182,000)<span></span>
</td>
<td class="num">(1,225,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenues</a></td>
<td class="num">(159,671,000)<span></span>
</td>
<td class="num">(64,956,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="num">(3,737,000)<span></span>
</td>
<td class="num">(3,298,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">112,000<span></span>
</td>
<td class="nump">95,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(174,304,000)<span></span>
</td>
<td class="num">(166,578,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(59,551,000)<span></span>
</td>
<td class="num">(225,621,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities', window );">Maturities of marketable securities</a></td>
<td class="nump">193,858,000<span></span>
</td>
<td class="nump">254,990,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(18,484,000)<span></span>
</td>
<td class="num">(12,697,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">115,823,000<span></span>
</td>
<td class="nump">16,672,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(1,404,000)<span></span>
</td>
<td class="num">(1,962,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">124,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">14,421,000<span></span>
</td>
<td class="nump">65,125,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">130,000<span></span>
</td>
<td class="nump">479,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(43,930,000)<span></span>
</td>
<td class="num">(84,302,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, beginning of period</a></td>
<td class="nump">101,944,000<span></span>
</td>
<td class="nump">180,372,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, end of period</a></td>
<td class="nump">58,014,000<span></span>
</td>
<td class="nump">96,070,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental cash flow disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Property and equipment included in unpaid liabilities</a></td>
<td class="nump">2,757,000<span></span>
</td>
<td class="nump">3,927,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability', window );">Tenant improvement allowance included in contra-lease liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,531,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=sgmo_AtTheMarketOfferingMember', window );">At the Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from at-the-market offering/ issuance of common stock</a></td>
<td class="nump">15,106,000<span></span>
</td>
<td class="nump">65,848,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from at-the-market offering/ issuance of common stock</a></td>
<td class="nump">$ 719,000<span></span>
</td>
<td class="nump">$ 1,115,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_TenantImprovementAllowanceWithinContraLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tenant Improvement, Allowance Within Contra Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_TenantImprovementAllowanceWithinContraLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the maturity, prepayments and calls (requests for early payments) of debt securities designated as held-to-maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=sgmo_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=sgmo_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170248732688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization and Description of Business</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo Therapeutics, Inc. (&#8220;Sangamo&#8221; or &#8220;the Company&#8221;) was incorporated in the State of Delaware in June 1995 and changed its name from Sangamo Biosciences, Inc. in January 2017. Sangamo is a clinical-stage genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients with serious diseases.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of these financial statements for the periods presented have been included. Operating results for the three and nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. The Condensed Consolidated Balance Sheet data at December&#160;31, 2022 was derived from the audited Consolidated Financial Statements included in Sangamo&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (the &#8220;2022 Annual Report&#8221;) as filed with the SEC on February&#160;23,&#160;2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in the Condensed Consolidated Financial Statements. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements and related financial information should be read together with the audited Consolidated Financial Statements and footnotes for the year ended December&#160;31, 2022, included in the 2022 Annual Report.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity, Going Concern, and Capital Resources</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo is currently working on a number of long-term development projects that involve experimental technologies. The projects will require several years and substantial expenditures to complete and ultimately may be unsuccessful. In recent years, the Company&#8217;s operations have been funded primarily through collaborations and strategic partnerships, research grants and from the issuance of equity securities. As of September&#160;30, 2023, the Company had capital resources of $132.1&#160;million consisting of cash, cash equivalents, and marketable securities. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Accounting Standard Codification Topic 205-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Presentation of Financial Statements&#8212;Going Concern</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC Topic 205-40&#8221;), the Company has the responsibility to evaluate whether conditions and/or events raise substantial doubt about its ability to meet its future financial obligations as they become due within one year after the date that the Condensed Consolidated Financial Statements are issued. As required under ASC Topic 205-40, management&#8217;s evaluation should initially not take into consideration the potential mitigating effects of management&#8217;s plans that have not been fully implemented as of the date the Condensed Consolidated Financial Statements are issued. When substantial doubt exists, management evaluates whether the mitigating effects of its plans sufficiently alleviates the substantial doubt about the Company&#8217;s ability to continue as a going concern. The mitigating effects of management&#8217;s plans, however, are only considered if both (i) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (ii) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued. Generally, to be considered probable of being effectively implemented, the plans must have been approved by the Company&#8217;s board of directors before the date that the financial statements are issued.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s history of significant losses, its negative cash flows from operations, its limited liquidity resources currently on hand, and its dependence on additional financing to fund its operations after the current resources are exhausted raise substantial doubt about its ability to continue to operate as a going concern within one year after the date that the Condensed Consolidated Financial Statements are issued. The Company&#8217;s current operating plan, its cash, cash equivalents, and marketable </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities as of September 30, 2023 are expected to allow the Company to meet its liquidity requirements only into the third quarter of 2024, which is less than one year following the date these Condensed Consolidated Financial Statements are issued. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Successful completion of the Company&#8217;s development programs and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to support the Company&#8217;s cost structure and operating plan. Management&#8217;s plans include, among other things, pursuing one or more of the following steps to raise additional capital and reduce costs, none of which can be guaranteed or are entirely within the Company&#8217;s control:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">raise funding through the sale of the Company&#8217;s common stock;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">raise funding through debt or royalty financing; and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish collaborations with potential partners to advance the Company&#8217;s product pipeline.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company is unable to raise capital on acceptable terms, or at all, or if it is unable to procure collaboration arrangements or external direct investments to advance its programs, the Company would be required to discontinue some or all of its operations or develop and implement a plan to further extend payables, reduce overhead or scale back its current operating plan until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan would be successful. Additional capital may not be available to the Company on a timely basis, on terms that are acceptable or at all. In particular, the perception of the Company&#8217;s ability to continue to operate as a going concern may make it more difficult to obtain financing for the continuation of its operations, particularly in light of currently challenging macroeconomic and market conditions. Further, the Company may be unable to attract new investments as a result of the speculative nature of its newly reprioritized core neurology preclinical programs. If adequate funds are not available to the Company on a timely basis, or at all, the Company will be required to take additional actions to address its liquidity needs, including additional cost reduction measures such as further reducing operating expenses and delaying, reducing the scope of, discontinuing or altering its research and development activities, which would have a material adverse effect on its business and prospects, or the Company may be required to cease operations entirely, liquidate all or a portion of its assets, and/or or seek protection under applicable bankruptcy laws.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Condensed Consolidated Financial Statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts of liabilities that may result from uncertainty related to the Company&#8217;s ability to continue as a going concern.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Significant Accounting Policies</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. On an ongoing basis, management evaluates its estimates including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, income taxes, fair value of assets and liabilities, including from acquisitions, useful lives and impairment of long-lived assets, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company recorded additional revenue related to a change in estimate in connection with the collaboration agreement with Kite Pharma, Inc., a Gilead Sciences, Inc. subsidiary (&#8220;Kite&#8221;). This adjustment was driven by a reduction in the estimated future level of the Company&#8217;s research and development services and as a result, future project costs. This resulted in an increase in proportional cumulative performance on this collaboration and an increase in revenue of $8.9&#160;million, a decrease in net loss of $8.9&#160;million, and a decrease in the Company&#8217;s basic and diluted net loss per share of $0.05 for the nine months ended September 30, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2023, the Company recorded additional revenue related to a change in estimate in connection with the collaboration agreement with Kite. This adjustment was driven by a further reduction in the estimated future level of the Company&#8217;s research and development services and as a result, future project costs. This resulted in an increase in proportional cumulative performance on this collaboration and increased revenue by $4.9 million, decreased net loss by $4.9 million, and decreased the Company's basic and diluted net loss per share by $0.03 for the three and nine months ended September 30, 2023.</span></div><div style="margin-top:9pt;padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its revenues pursuant to the provisions of Accounting Standards Codification Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC Topic 606&#8221;). The Company&#8217;s contract revenues are derived from collaboration agreements including licensing arrangements and research services. Research and licensing agreements typically include nonrefundable upfront signing or license fees, payments at negotiated rates for time incurred by Company researchers, third-party cost reimbursements, additional target selection fees, sublicense fees, milestone payments tied to ongoing development and product commercialization, and royalties on future licensees&#8217; product sales. All funds received from the Company&#8217;s collaboration partners are generally not refundable. Non-refundable upfront fees are fixed at the commencement of the contract. All other fees represent variable consideration in contracts. One of the Company&#8217;s contracts also contains a provision where the Company reimburses its customer for certain costs they incur which is accounted for as a reduction to the contract transaction price as the Company does not acquire any distinct goods or services in exchange for such payments. Deferred revenue primarily represents the portion of nonrefundable upfront fees or milestone payments received but not earned.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under its agreements, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations based on estimated selling prices; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company&#8217;s performance obligations in its collaboration agreements represent distinct bundles of licenses of intellectual property and research and development services, with these components being individually non-distinct. Options to license the Company&#8217;s intellectual property and/or acquire research and development services also represent performance obligations when they grant customers a material right, e.g., a right to a discount the customer would not have received if they did not purchase the Company&#8217;s services under the existing contract. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from bundles of licenses of intellectual property and research and development services are recognized over time using a proportional performance method. Under this method, revenue is recognized by measuring progress towards satisfaction of the relevant performance obligation using a measure that best depicts the progress towards satisfaction of the relevant performance obligation. For most of the Company&#8217;s agreements the measure of progress is an input measure based on a level of effort incurred, which includes the value of actual time by Company researchers plus third-party cost reimbursements. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration allocated to options that include material rights is deferred until the options are exercised or expire. The exercise of such options is accounted for as contract continuation, with target selection fees and estimated variable consideration included in the transaction price at that time and allocated specifically to the respective target&#8217;s performance obligation. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant management judgment is required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations under the arrangement. Changes in these estimates can have a material effect on revenue recognized. If the Company cannot reasonably estimate when its performance obligations either are completed or become inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. For variable consideration, the amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint and, if necessary, adjusts its estimate of the overall transaction price. A cumulative catch-up is then recorded in the current period to reflect the updated transaction price and the updated measure of progress. The estimated period of performance and level of effort, including the value of Company researchers&#8217; time and third-party costs, are reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current expectations.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price of each performance obligation identified in the contract. The Company uses key assumptions to determine the stand-alone selling price, which may include forecasted revenues, development timelines, discount rates and probabilities of exercise of technical and regulatory success, and the expected level of effort for research and development services. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract modifications occur when the price and/or scope of an arrangement changes. If the modification consists of adding new distinct goods or services in exchange for consideration that reflects standalone selling prices of these goods and services, the modification is accounted for as a separate contract with the customer. Otherwise, if the remaining goods and services are distinct from those previously provided, the existing contract is considered terminated, and the remaining consideration is allocated to the remaining goods and services as if this was a newly signed contract. If the remaining goods and services are not distinct from those previously provided, the effects of the modification are accounted for in a manner similar to the effect of a change in the estimated measure of progress, with cumulative catch-up in revenue recorded at the time of the </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">modification. If some of the remaining goods and services are distinct from those previously provided and others are not, to account for the effects of the modification the Company applies principles consistent with the objectives of the modification accounting.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from collaboration and licensing agreements as a percentage of total revenues were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kite Pharma, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen MA, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis Institutes for BioMedical Research, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other licensing agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Goodwill, Indefinite-lived Intangible Assets and Long-lived Assets</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of consideration transferred over the fair values of assets acquired and liabilities assumed in a business combination. Intangible assets with indefinite useful lives are related to acquired in-process research and development (&#8220;IPR&amp;D&#8221;) projects and are initially measured at their respective fair values as of the acquisition date. Goodwill and indefinite-lived intangible assets are not amortized. Intangible assets related to IPR&amp;D projects are considered to be indefinite-lived until the completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs if and when regulatory approval to market a product is obtained, the associated assets would be deemed finite-lived and would then be amortized based on their respective estimated useful lives at that point in time.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite-lived intangible assets are assessed for impairment on an annual basis and whenever events and circumstances indicate that these assets may be impaired. The Company evaluates the carrying value of long-lived assets, which include property and equipment, leasehold improvements and right-of-use assets, for impairment whenever events or changes in circumstances indicate that the carrying amounts of the asset may not be fully recoverable.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In testing for goodwill impairment, the Company has the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If the Company elects to bypass the qualitative assessment, or if a qualitative assessment indicates it is more likely than not that the carrying value exceeds its fair value, the Company performs a quantitative goodwill impairment test to compare the fair value of its reporting unit to its carrying value, including goodwill. If the carrying value, including goodwill, exceeds the reporting unit&#8217;s fair value, the Company will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value (but not in excess of the carrying value of goodwill).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing each annual impairment assessment and any interim impairment assessment for its indefinite-lived intangible assets, the Company determines if it should qualitatively assess whether it is more likely than not the fair value of its IPR&amp;D asset is less than its carrying amount (the qualitative impairment test). If the Company concludes that is the case, or elects not to use the qualitative impairment test, the Company will proceed with quantitatively determining the fair value of the IPR&amp;D asset and comparing its fair value to its carrying value to determine the amount of impairment, if any (the quantitative impairment test).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the qualitative impairment test, the Company considers the results of the most recent quantitative impairment test and identifies the most relevant drivers of the fair value for the IPR&amp;D asset. The most relevant drivers of fair value identified are consistent with the assumptions used in the quantitative estimate of the IPR&amp;D asset. Using these drivers of fair value, the Company identifies events and circumstances which may have an effect on the fair value of the IPR&amp;D asset since the last time the IPR&amp;D&#8217;s fair value was quantitatively determined. The Company then weighs these factors to determine and conclude if it is not more likely than not the IPR&amp;D asset is impaired. If it is more likely than not the IPR&amp;D asset is impaired, the Company proceeds with quantitatively determining the fair value of the IPR&amp;D asset.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing the quantitative impairment test, the Company uses the income approach to determine the fair value of its IPR&amp;D asset. This approach calculates fair value by estimating the after-tax cash flows attributable to an in-process project over its useful life and then discounting these after-tax cash flows back to a present value. This estimate includes judgmental assumptions regarding the estimates that market participants would make in evaluating the IPR&amp;D asset, including the probability of successfully completing clinical trials and obtaining regulatory approval to market the IPR&amp;D asset, the timing of and the expected costs to complete IPR&amp;D projects, future net cash flows from potential drug sales, which are based on estimates of the sales price of the drug, the size of the patient population and cure rate, its competitive position in the marketplace, and appropriate discount and tax rates. Any impairment to be recorded is calculated as the difference between the estimated fair value and the carrying value of the IPR&amp;D asset on the Company&#8217;s Condensed Consolidated Balance Sheet.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a change in circumstance occurs that indicates long-lived assets may be impaired, the Company performs a test of recoverability by comparing the carrying value of the asset or asset group to its undiscounted expected future cash flows. The long-lived asset evaluation is performed at the asset group level, i.e., the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. If this review indicates that the carrying amount of the asset group is not recoverable, an impairment loss is measured as the amount by which the carrying amount of an asset group exceeds its fair value. Any impairment loss is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets, except that the carrying amount of an individual asset shall not be reduced below its fair value.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that may indicate potential impairment and trigger an impairment test include, but are not limited to, general macroeconomic conditions, conditions specific to the industry and market, an adverse change in legal factors, impairment of goodwill or indefinite-lived intangible assets, business climate or operational performance of the business, and sustained decline in the stock price and market capitalization compared to the net book value.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Calculating the fair value of a reporting unit, an asset group and an individual asset involves significant estimates and assumptions. These estimates and assumptions include, among others, projected future cash flows, risk-adjusted discount rates, future economic and market conditions, and the determination of appropriate market comparables. Changes in these factors and assumptions used can materially affect the amount of impairment loss recognized in the period the asset was considered impaired.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo considers all highly liquid investments purchased with original maturities of three months or less at the purchase date to be cash equivalents. Cash and cash equivalents consist of cash, deposits in demand money market accounts and U.S. government-sponsored entity debt securities. Restricted cash consists of a letter of credit for $1.5&#160;million, representing a deposit for the lease of the corporate headquarters in Brisbane, California.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,514&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,444&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,570&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,872&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,014&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,944&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,070&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,372&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo classifies its marketable securities as available-for-sale and records its investments at estimated fair value based on quoted market prices or observable market inputs of almost identical assets, with the unrealized holding gains and losses included in accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;). The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as non-current marketable securities in the accompanying Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments are subject to a periodic impairment review. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time and extent to which the fair value has been less than the cost basis, the Company's financial condition and its intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value. Realized gains and losses on marketable securities are included in interest and other income, net, which are determined using the specific identification method. Credit losses related to the marketable securities are recorded in interest and other income, net in the Condensed Consolidated Statements of Operations through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company intends to sell, or if it is more likely than not that the Company will be required to sell, a security before recovery of its amortized cost basis, the allowance for credit losses is written off, and the amortized cost of the security is written down to its fair value, with an impairment charge recognized. This also results in a reversal of any unrealized gains and losses for this security that were previously included in AOCI. Impairment charges are included in interest and other income, net in the Condensed Consolidated Statements of Operations. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether it has the right to control the identified asset. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arising from the lease. Lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. Right-of-use assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the implicit rate in the Company&#8217;s leases is generally unknown, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of remaining lease payments. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease in a similar economic environment. The Company considers its credit risk, term of the lease, and total lease payments and adjusts for the impacts of collateral, as necessary, when calculating its incremental borrowing rates. The lease terms may include options to extend or terminate the lease when it is reasonably certain the Company will exercise any such options. Rent expense for the Company&#8217;s operating leases is recognized on a straight-line basis over the lease term. The Company will evaluate the lease arrangement for impairment whenever events or changes in circumstances indicate that the carrying amounts of the right-of-use asset may not be fully recoverable. To the extent an impairment of the right-of-use asset is recognized, the Company will recognize lease impairment and subsequently amortize the remaining lease asset on a straight-line basis (unless another systematic basis is more representative of the pattern in which the Company expects to consume the future economic benefits from the asset) from the date of impairment to the earlier of the end of the right-of-use asset&#8217;s useful life or the end of the lease term.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected not to separate lease and non-lease components for its real estate and copier leases and, as a result, accounts for any lease and non-lease components as a single lease component. The Company has also elected not to apply the recognition requirement to any leases with a term of 12 months or less and does not include an option to purchase the underlying asset that the Company is reasonably certain to exercise.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170252050160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents and marketable securities. Fair value is determined based on a three-tier hierarchy under the authoritative guidance for fair value measurements and disclosures that prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurements and unobservable (i.e., supported by little or no market activity).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurements of the Company&#8217;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,014&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,597&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,853&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,033&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents and Marketable Securities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally classifies its marketable securities as Level&#160;2. Instruments are classified as Level&#160;2 when observable market prices for identical securities that are traded in less active markets are used. When observable market prices for identical securities are not available, such instruments are priced using benchmark curves, benchmarking of like securities, sector groupings, matrix pricing and valuation models. These valuation models are proprietary to the pricing providers or brokers and incorporate a number of inputs, including in approximate order of priority: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications. For certain security types, additional inputs may be used, or some of the standard inputs may not be applicable. Evaluators may prioritize inputs differently on any given day for any security based on market conditions, and not all inputs listed are available for use in the evaluation process for each security evaluation on any given day.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170249625648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH EQUIVALENTS AND MARKETABLE SECURITIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">CASH EQUIVALENTS AND MARKETABLE SECURITIES</a></td>
<td class="text">CASH EQUIVALENTS AND MARKETABLE SECURITIES<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the Company&#8217;s cash equivalents and marketable securities (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,064&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,014&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(918)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,743&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(918)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,853&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of marketable securities by contractual maturity were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:74.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,597&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no realized gains and losses on the sales of investments during the three and nine months ended September&#160;30, 2023 and 2022. Total unrealized gains for securities with net gains in accumulated other comprehensive income were not material for the three and nine months ended September&#160;30, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages credit risk associated with its investment portfolio through its investment policy, which limits purchases to high-quality issuers and also limits the amount of its portfolio that can be invested in a single issuer. The Company did not record an allowance for credit losses related to its marketable securities for the three and nine months ended September&#160;30, 2023 and 2022.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had unrealized losses related to its marketable securities for the three and nine months ended September&#160;30, 2023 and 2022. The Company had no material unrealized losses, individually and in the aggregate, for marketable securities that are in a continuous unrealized loss position for greater than 12 months as of September&#160;30, 2023 and December&#160;31, 2022. These unrealized losses were not attributed to credit risk and were associated with changes in market conditions. The Company periodically reviews its marketable securities for indications of credit losses. The Company considers factors such as the duration, the magnitude and the reason for the decline in value, the potential recovery period, creditworthiness of the issuers of the securities and its intent to sell. No significant facts or circumstances have arisen to indicate that there has been any significant deterioration in the creditworthiness of the issuers of the securities held by the Company. Based on the Company&#8217;s review of these securities, the Company determined that no allowance for credit losses related to its marketable securities was required at either September 30, 2023 or December 31, 2022.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also considers whether it is more likely than not that the Company will be required to sell the debt securities before recovery of their amortized cost basis. Based on the scheduled maturities of its investments and projection of its cash flows in accordance with the current operating plan as of September 30, 2023, the Company determined that it was more likely than not that it will be required to sell various securities before recovery of their amortized cost basis. As a result, the Company reclassified its non-current marketable securities investments of $34.4&#160;million as current as of September&#160;30, 2023 and recorded an impairment charge of $0.4&#160;million related to those securities during the three and nine ended September&#160;30, 2023. No impairment charges were recorded during the three and nine ended September&#160;30, 2022, as the Company concluded at that time it had the ability and intent to hold the long-term investments until maturity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br> -Publisher SEC<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//946-320/tableOfContent<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//940-320/tableOfContent<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170249540496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIC AND DILUTED NET LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">BASIC AND DILUTED NET LOSS PER SHARE</a></td>
<td class="text">BASIC AND DILUTED NET LOSS PER SHARE<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share has been computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding during the period, without consideration of any potential dilutive securities, as their effect would be anti-dilutive.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The total number of shares subject to stock options and restricted stock units (&#8220;RSUs&#8221;) outstanding and the employee stock purchase plan (&#8220;ESPP&#8221;) shares reserved for issuance, which are all anti-dilutive, were excluded from consideration in the calculation of diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders. Stock options and RSUs outstanding and ESPP shares reserved for issuance as of September&#160;30, 2023 and 2022 totaled 22,131,291 and 18,524,016, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170248924592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES</a></td>
<td class="text">MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pfizer Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Giroctocogene Fitelparvovec Global Collaboration and License Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company entered into an exclusive global collaboration and license agreement with Pfizer Inc. (&#8220;Pfizer&#8221;), pursuant to which it established a collaboration for the research, development and commercialization of giroctocogene fitelparvovec, its gene therapy product candidate for hemophilia A, and closely related products.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under this agreement, the Company is responsible for conducting the Phase 1/2 clinical trial and for certain manufacturing activities for giroctocogene fitelparvovec, while Pfizer is responsible for subsequent worldwide development, manufacturing, marketing and commercialization of giroctocogene fitelparvovec. Sangamo may also collaborate in the research and development of additional adeno-associated viruses (&#8220;AAV&#8221;) -based gene therapy products for hemophilia A.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of the agreement, the Company granted Pfizer an exclusive worldwide royalty-bearing license, with the right to grant sublicenses, to use certain technology controlled by the Company for the purpose of developing, manufacturing and commercializing giroctocogene fitelparvovec and related products. Pfizer granted the Company a non-exclusive, worldwide, royalty-free, fully paid license, with the right to grant sublicenses, to use certain manufacturing technology developed under the agreement and controlled by Pfizer to manufacture the Company&#8217;s products that utilize the AAV delivery system. During a specified period, neither the Company nor Pfizer is permitted to clinically develop or commercialize, outside of the collaboration, certain AAV-based gene therapy products for hemophilia A.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement has a term that continues on a per product and per country basis until the later of (i) the expiration of patent claims that cover the product in a country, (ii) the expiration of regulatory exclusivity for a product in a country, and (iii) fifteen years after the first commercial sale of a product in a country. Pfizer has the right to terminate the agreement without cause in its entirety or on a per product or per country basis. The agreement may also be terminated by either party based on an uncured material breach by the other party or the bankruptcy of the other party. Upon termination for any reason, the license granted by the Company to Pfizer to develop, manufacture and commercialize giroctocogene fitelparvovec and </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related products will automatically terminate. Upon termination by the Company for cause or by Pfizer in any country or countries, Pfizer will automatically grant the Company an exclusive, royalty-bearing license under certain technology controlled by Pfizer to develop, manufacture and commercialize giroctocogene fitelparvovec in the terminated country or countries.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon execution of the agreement, the Company received an upfront fee of $70.0&#160;million and was eligible to receive up to $208.5&#160;million in payments upon the achievement of specified clinical development, intellectual property and regulatory milestones and up to $266.5&#160;million in payments upon first commercial sale milestones for giroctocogene fitelparvovec and potentially other products. To date, two milestones of $55.0&#160;million in aggregate have been achieved and paid. The Company is eligible to earn from Pfizer up to $220.0&#160;million in remaining milestone payments for giroctocogene fitelparvovec and up to $175.0&#160;million for other products that may be developed under the agreement, subject to reduction on account of payments made under certain licenses for third-party intellectual property. In addition, Pfizer agreed to pay the Company royalties for each potential licensed product developed under the agreement that are 14% - 20% of the annual worldwide net sales of such product and are subject to reduction due to patent expiration, entry of biosimilar products to the market and payment made under certain licenses for third-party intellectual property. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Pfizer in accordance with ASC Topic 606 and concluded that Pfizer was a customer. The total transaction price under this agreement was $134.0&#160;million, which represented the upfront fee and research services fees of $79.0&#160;million and fees related to two achieved milestones in an aggregate amount of $55.0&#160;million. Sangamo was responsible for internal and external research costs as part of the upfront fee and had the ability to request additional reimbursement from Pfizer if certain conditions were met. None of the constrained clinical or regulatory milestones were included in the transaction price. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at the time was uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified the performance obligations within the agreement as a license to the technology and ongoing research services. The Company concluded that the license was not discrete as it did not have stand-alone value to Pfizer apart from the research services to be performed by the Company pursuant to the agreement. As a result, the Company recognized revenue from the upfront payment based on proportional performance of the ongoing research services through 2020, the period during which the Company performed research services. The estimation of progress towards the satisfaction of its performance obligation and project cost was reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s assumptions regarding the timing of its deliverables.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company satisfied the deliverables and research services responsibilities within the arrangement. As a result, the Company recognized the remaining deferred revenue from the upfront payment in December 2020.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">C9ORF72 Research Collaboration and License Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Company entered into a separate exclusive, global collaboration and license agreement with Pfizer for the development and commercialization of potential gene therapy products that use zinc finger (&#8220;ZF&#8221;) transcriptional regulators (&#8220;ZF-TRs&#8221;) to treat amyotrophic lateral sclerosis and frontotemporal lobar degeneration linked to mutations of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene. Pursuant to this agreement, the Company agreed to work with Pfizer on a research program to identify, characterize and preclinically develop ZF-TRs that bind to and specifically reduce expression of the mutant form of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of this agreement, the Company granted Pfizer an exclusive, royalty-bearing, worldwide license under the Company&#8217;s relevant patents and know-how to develop, manufacture and commercialize gene therapy products that use resulting ZF-TRs that satisfy pre-agreed criteria. During a specified period, neither the Company nor Pfizer will be permitted to research, develop, manufacture or commercialize outside of the collaboration any zinc finger proteins (&#8220;ZFPs&#8221;) that specifically bind to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement has a term that continues on a per licensed product and per country basis until the later of (i) the expiration of patent claims that cover the licensed product in a country, (ii) the expiration of regulatory exclusivity for a licensed product in a country, and (iii) 15 years after the first commercial sale of a licensed product in a major market country. Pfizer also has the right to terminate the agreement without cause in its entirety or on a per product or per country basis. The agreement may also be terminated by either party based on an uncured material breach by the other party or the bankruptcy of the other party. The agreement will also terminate if the Company is unable to identify any lead candidates for development within a specified period of time or if Pfizer elects not to advance a lead candidate beyond a certain development milestone within a specified period of time. Upon termination for any reason, the license granted by the Company to Pfizer to develop, manufacture and commercialize licensed products under the agreement will automatically terminate. Upon termination by the Company for cause or by Pfizer without cause for any licensed product or licensed products in any country or countries, the Company will have the right to negotiate with Pfizer to obtain a non-exclusive, royalty-bearing license under certain technology </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">controlled by Pfizer to develop, manufacture and commercialize the licensed product or licensed products in the terminated country or countries.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following termination by the Company for Pfizer&#8217;s material breach, Pfizer will not be permitted to research, develop, manufacture or commercialize ZFPs that specifically bind to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene for a period of time. Following termination by Pfizer for the Company&#8217;s material breach, the Company will not be permitted to research, develop, manufacture or commercialize ZFPs that specifically bind to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene for a period of time.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a $12.0&#160;million upfront payment from Pfizer and is eligible to receive up to $60.0&#160;million in development milestone payments from Pfizer contingent on the achievement of specified preclinical development, clinical development and first commercial sale milestones, and up to $90.0&#160;million in commercial milestone payments if annual worldwide net sales of the licensed products reach specified levels. In addition, Pfizer will pay the Company royalties of 14% - 20% of the annual worldwide net sales of the licensed products. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property. Each party will be responsible for the cost of its performance of the research program. Pfizer will be operationally and financially responsible for subsequent development, manufacturing and commercialization of the licensed products. To date, a milestone of $5.0&#160;million has been achieved and paid, however no products have been approved and therefore no royalty fees have been earned under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pfizer agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Pfizer in accordance with ASC Topic 606 and concluded that Pfizer was a customer. The Company concluded the total transaction price under this agreement was $17.0&#160;million, which represented the upfront fees of $12.0&#160;million and fees related to achievement of one milestone in the amount of $5.0&#160;million. None of the constrained clinical or regulatory milestones were included in the transaction price. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at the time was uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had identified the performance obligations within this agreement as a license to the technology and ongoing research services. The Company concluded that the license is not discrete as it does not have stand-alone value to Pfizer apart from the services to be performed by the Company pursuant to the agreement. As a result, the Company recognized revenue from the upfront payment based on proportional performance of the ongoing research services through 2020, the period the Company performed research services.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company satisfied the deliverables and research services responsibilities within the arrangement in September 2020, and as a result, earned a $5.0&#160;million milestone, which the Company recognized on a cumulative basis during the year ended December 31, 2020. In addition, the Company recognized the remaining deferred revenue from the upfront payment in September 2020.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2023, Pfizer notified the Company of Pfizer&#8217;s assignment of the collaboration and license agreement to Alexion, AstraZeneca Rare Disease, pursuant to a definitive purchase and license agreement for preclinical gene therapy assets and enabling technologies that closed on September 20, 2023.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kite Pharma, Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2018, the Company entered into a global collaboration and license agreement with Kite which became effective on April 5, 2018 (&#8220;Effective Date&#8221;), and was amended and restated in September 2019, for the research, development, and commercialization of potential engineered cell therapies for cancer. The collaboration and license agreement relates to the design of zinc finger nucleases (&#8220;ZFNs&#8221;) and viral vectors to disrupt and insert certain genes in T-cells and natural killer cells (&#8220;NK-cells&#8221;) including the insertion of genes that encode chimeric antigen receptors (&#8220;CARs&#8221;), T-cell receptors (&#8220;TCRs&#8221;), and NK-cell receptors (&#8220;NKRs&#8221;) directed to mutually agreed targets. Under the agreement, Kite is responsible for all clinical development, manufacturing and commercialization of any resulting products.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of this agreement, the Company granted Kite an exclusive, royalty-bearing, worldwide sublicensable license under the Company&#8217;s relevant patents and know-how to develop, manufacture and commercialize, for the purpose of treating cancer, specific cell therapy products that may result from the research program and that are engineered </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex&#160;vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using selected ZFNs and viral vectors developed under the research program to express CARs, TCRs or NKRs directed to candidate targets.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Effective Date, the Company received a $150.0&#160;million upfront payment from Kite. In addition, Kite reimburses the Company&#8217;s direct costs to conduct the joint research program. Under the terms of the agreement, Sangamo is also eligible to receive contingent development- and sales-based milestone payments that could total up to $3.0&#160;billion if all of the specified milestones set forth in this agreement are achieved. Of this amount, approximately $1.3&#160;billion relates to the achievement of specified research, clinical development, regulatory and first commercial sale milestones, and approximately $1.8&#160;billion relates to the achievement of specified sales-based milestones if annual worldwide net sales of licensed products reach </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specified levels. Each development- and sales-based milestone payment is payable (i)&#160;only once for each licensed product, regardless of the number of times that the associated milestone event is achieved by such licensed product, and (ii)&#160;only for the first 10 times that the associated milestone event is achieved regardless of the number of licensed products that may achieve such milestone event. In addition, the Company is entitled to receive escalating, tiered royalty payments with a percentage in the single digits based on future annual worldwide net sales of licensed products. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial research term in the agreement is six years from the Effective Date and will expire in April 2024. Kite has an option to extend the research term for up to two additional one-year periods for a separate upfront fee of $10.0&#160;million per year. All contingent payments under the agreement, when earned, will be non-refundable and non-creditable. Through the amendment and restatement of the agreement in September 2019, the Company and Kite agreed to expand the scope of the collaboration program to incorporate the use of lentiviral or retroviral vectors provided by Kite. Kite has the right to terminate this agreement in its entirety or on a per licensed product or per candidate target basis for any reason after a specified notice period. Each party has the right to terminate this agreement on account of the other party&#8217;s bankruptcy or material, uncured breach.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Kite in accordance with ASC Topic 606 and concluded that Kite is a customer. The transaction price includes the upfront license fee of $150.0&#160;million and estimated reimbursable service costs for the research projects over the estimated performance period. None of the clinical or regulatory milestones have been included in the transaction price, as none of the milestones have yet been achieved, and all amounts are fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at this time is uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price also includes actual and estimated payments by Kite for the work by Company researchers and reimbursement of the Company&#8217;s costs incurred with third parties. The Company uses the expected value method to estimate payments related to the Company&#8217;s researchers&#8217; work, taking into account the impact of constraint. Variable consideration is included in the transaction price only to the extent it is probable a significant reversal of cumulative revenues recognized would not occur. The Company will re-evaluate the transaction price including the estimated variable consideration included in the transaction price and all constrained amounts in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified four performance obligations within the Kite agreement as follows: (1) a license to the technology combined with the obligation to perform research and development services to apply the Company&#8217;s technology to Kite-selected targets; (2) production of research materials; and (3-4) two material rights, each for an extension of the research period for an additional one-year term. Such extensions contain material rights because their exercise does not require payment of a fee that is commensurate with the value of the incremental research term. The license to the Company&#8217;s intellectual property is not distinct from the related research and development activities as the licensed technology is not shared with and cannot be utilized by Kite without the research services performed by the Company. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated variable consideration (payments by Kite for the work performed by the Company&#8217;s researchers and third-party costs, as well as any future milestones and royalties) to the specific performance obligations to which they relate, as such allocation would meet the allocation objective in ASC Topic 606. The Company allocated the fixed consideration of $150.0&#160;million to the performance obligations based on their relative standalone selling prices. Standalone selling prices of optional research years are similar to those of the initial year, but additionally take into account the intrinsic value of the discount upon exercise and the likelihood of exercise. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fees allocated to options with material rights are deferred until the options are exercised or expire. The exercise of options is accounted for as contract continuation, with target selection fees and estimated variable consideration included in the transaction price at that time and allocated specifically to the respective target&#8217;s performance obligation. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for the combined license and research services performance obligations is recognized over time, as Kite consumes the benefit of such services as they are being performed by the Company. For the license combined with research and development services performance obligation, the Company recognizes revenue based on proportional performance of the ongoing research services over the period during which the Company performs the services. The estimation of progress towards the satisfaction of this performance obligation and project costs are reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s assumptions regarding the estimated volume of required activities. The production of research materials performance obligation is accounted for under the right to invoice practical expedient, as the Company has the right to invoice Kite for these services in an amount that corresponds directly with the value of the services. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023 and December&#160;31, 2022, the Company had a receivable of $0.2&#160;million and $0.7&#160;million, respectively, and deferred revenue of $1.5&#160;million and $19.4&#160;million, respectively, related to this agreement. Changes in deferred revenue balances during the three and nine months ended September 30, 2023 relate to a reduction in the estimated future level of </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company's research and development services under the collaboration agreement with Kite, as well as ongoing normal progress in the delivery of the performance obligations. The amounts of transaction price (excluding the amounts recognized as invoiced for the production of research materials performance obligation) remaining to be recognized were $1.5&#160;million and $21.2&#160;million, of which $1.5&#160;million relates to fees allocated to options with material rights, as of September&#160;30, 2023 and December&#160;31, 2022, respectively. These amounts are expected to be recognized within the next 12 months. The timing of recognition will be affected by whether and when Kite exercises options for additional years of services and could be subject to significant changes.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Kite agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of license fee fixed consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services variable consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,496&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,035&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company recorded additional revenue related to a change in estimate in connection with the collaboration agreement with Kite Pharma, Inc. This adjustment was driven by a reduction in the estimated future level of the Company&#8217;s research and development services and as a result, future project costs. This resulted in an increase in proportional cumulative performance on this collaboration and an increase in revenue of $8.9&#160;million, a decrease in net loss of $8.9&#160;million, and a decrease in the Company&#8217;s basic and diluted net loss per share of $0.05 for the nine months ended September 30, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2023, the Company recorded additional revenue related to a change in estimate in connection with the collaboration agreement with Kite. This adjustment was driven by a further reduction in the estimated future level of the Company&#8217;s research and development services and as a result, future project costs. This resulted in an increase in proportional cumulative performance on this collaboration and increased revenue by $4.9 million, decreased net loss by $4.9 million, and decreased the Company's basic and diluted net loss per share by $0.03 for the three and nine months ended September 30, 2023. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Novartis Institutes for BioMedical Research, Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2020, the Company entered into a collaboration and license agreement with Novartis Institutes for BioMedical Research, Inc. (&#8220;Novartis&#8221;) for the research, development and commercialization of gene regulation therapies to treat three neurodevelopmental disorders. Under the agreement, which was effective upon execution, the Company granted Novartis an exclusive, royalty bearing and worldwide license, under its relevant patents and know-how, to develop, manufacture and commercialize certain of its ZF-TRs targeted to three undisclosed genes that are associated with certain neurodevelopmental disorders, including autism spectrum disorder and intellectual disability. The Company was performing early research activities over the collaboration period for each gene target and manufacture the ZF-TRs required for such research, costs of which are funded by Novartis. Novartis was responsible for additional research activities, studies enabling INDs, clinical development, regulatory approvals, manufacturing of preclinical, clinical and approved products, and global commercialization. Subject to certain exceptions set forth in the agreement, the Company was prohibited from developing, manufacturing or commercializing any therapeutic product targeting any of the three genes that are the subject of the collaboration. Novartis also had the option to license certain of the Company&#8217;s proprietary AAVs for the sole purpose of developing, manufacturing and commercializing licensed products arising from the collaboration.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, Novartis notified the Company of its termination for convenience, effective June 11, 2023 (the &#8220;Novartis Termination Date&#8221;), of the collaboration agreement. Novartis had indicated to the Company that the termination relates to a recent strategic review. As of the Novartis Termination Date, the collaboration agreement was terminated in its entirety and following the Novartis Termination Date the Company is not entitled to receive any further milestone payments or royalties from Novartis. As of the Novartis Termination Date, the parties have no further obligations to develop or to fund the development of any collaboration research programs under the collaboration agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon entering the agreement, Novartis paid the Company a $75.0&#160;million upfront license fee. Novartis was also obligated to pay the Company for the use of its resources and reimburse third-party costs incurred in the Company&#8217;s conduct of early research activities. The Company was also eligible to earn from Novartis development and commercial milestones and royalties on potential commercial sales of licensed products arising from the collaboration, none of which were triggered or earned. The agreement was going to continue, on a product-by-product and country-by-country basis, until the expiration of the applicable royalty term. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All payments received under the agreement were non-refundable and non-creditable. The transaction price of $95.1&#160;million included the upfront license fee of $75.0&#160;million and research costs of $20.1&#160;million. All clinical or regulatory milestone amounts were considered fully constrained throughout the term of the agreement. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Novartis in accordance with ASC Topic 606 and concluded that Novartis was a customer. The Company had identified a single performance obligation within this arrangement as a license to the technology and ongoing research services. The Company concluded that the license was not discrete as it did not have stand-alone value to Novartis apart from the research services to be performed pursuant to the agreement. As a result, the Company recognized revenue from the upfront payment based on proportional performance of the ongoing research services through the estimated research period. The estimation of progress towards the satisfaction of performance obligation and project cost was reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current assumptions regarding the timing of its performance obligation. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notice of termination was accounted for as a modification of the contract, as it changed both the scope of the Company&#8217;s remaining services and the consideration to which the Company was entitled. The effect of the modification was not material, as the Company was nearing the completion of its assigned early research activities, and consequently, of its sole performance obligation.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023 and December&#160;31, 2022, the Company had a receivable of zero and $2.2&#160;million, respectively, and deferred revenue of zero and $9.6&#160;million, respectively, related to this agreement. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands):</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Novartis agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of upfront license fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,610&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,433&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biogen MA, Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company entered into a collaboration and license agreement with Biogen MA, Inc. (&#8220;BIMA&#8221;) and Biogen International GmbH (together with BIMA, &#8220;Biogen&#8221;) for the research, development and commercialization of gene regulation therapies for the treatment of neurological diseases. The companies planned to leverage the Company&#8217;s proprietary ZF technology delivered via AAV to modulate expression of key genes involved in neurological diseases. Concurrently with the execution of the collaboration agreement, the Company entered into a stock purchase agreement with BIMA, pursuant to which BIMA agreed to purchase 24,420,157 shares of the Company&#8217;s common stock (the &#8220;Biogen Shares&#8221;), at a price per share of $9.2137, for an aggregate purchase price of approximately $225.0&#160;million. The collaboration agreement became effective in April 2020.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, Biogen notified the Company of its termination for convenience, effective June 15, 2023 (the &#8220;Biogen Termination Date&#8221;), of the collaboration agreement. Biogen had indicated to the Company that the termination relates to a recent strategic review. As of the Biogen Termination Date, the collaboration agreement was terminated in its entirety and following the Biogen Termination Date the Company is not entitled to receive any further milestone payments or royalties from Biogen. As of the Biogen Termination Date, the parties have no further obligations to develop or to fund the development of any collaboration research programs under the collaboration agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the collaboration agreement, Biogen paid the Company an upfront license fee of $125.0&#160;million in May 2020. The Company was also eligible to receive target selection, research, development, regulatory and commercial milestone payments and royalties on potential net commercial sales of licensed products arising from the collaboration, none of which were triggered or earned. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the collaboration agreement, the Company granted to Biogen an exclusive, royalty bearing and worldwide license, under its relevant patents and know-how, to develop, manufacture and commercialize ZF and/or AAV-based products directed to certain neurological disease gene targets selected by Biogen. Biogen had selected four targets over the course of the collaboration and had exclusive rights to nominate up to seven additional targets. These rights expired upon the Biogen Termination Date. For each gene target selected by Biogen, the Company performed early research activities, costs of which were shared by the companies, aimed at the development of the combination of proprietary central nervous system delivery vectors and ZF-TRs (or potential other ZF products) targeting therapeutically relevant genes. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the collaboration agreement with Biogen in accordance with ASC Topic&#160;606 and concluded that Biogen is a customer. The transaction price included the upfront license fee of $125.0&#160;million and the excess consideration from the stock purchase of $79.6&#160;million, which represented the difference between the $225.0&#160;million received for the purchase of the Biogen Shares and the $145.4&#160;million estimated fair value of the equity issued. The equity issued to Biogen was valued using an option pricing model to reflect certain holding period restrictions. None of the clinical or regulatory milestones were included in the transaction price, as all such amounts were fully constrained throughout the term of the collaboration agreement. The transaction price also included actual and estimated cost-sharing payments by Biogen for the work by Company researchers and reimbursement of the Company&#8217;s costs incurred with third parties. The amounts paid and expected to be paid to Biogen for the use of Biogen&#8217;s resources and its expenses were consideration paid to a customer. Since the Company did not acquire distinct goods or services in exchange for these payments, they reduced the transaction price and were recorded as a reduction in revenue. The Company used the expected value method to estimate cost sharing payments, taking into account the impact of the constraint. Variable consideration was included in the transaction price only to the extent it was probable a significant reversal of cumulative revenues recognized would not occur. The Company re-evaluated the transaction price as uncertain events were resolved or other changes in circumstances occurred.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company concluded that the licenses to its intellectual property for each target were not distinct from the related research and development activities, as the licensed technology was not shared with and could not be utilized by Biogen without the research services to be performed by the Company pursuant to the agreement. On the other hand, each combination of a license to the Company's intellectual property as applied to a specific target and the related research and development activities are a discrete research project that is distinct from any other target&#8217;s project. The targets Biogen could select were options that provided Biogen with material rights, as the exercise of the options did not require payment of a fee commensurate with the value of the incremental license rights. As a result, such options also represented performance obligations. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At contract inception, the Company allocated fixed consideration of $204.6&#160;million included in the initial transaction price to the existing targets&#8217; license and research services performance obligations and those performance obligations for options that include material rights, based on their relative standalone selling prices. Through June 30, 2023, all such material rights have expired.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notice of termination was accounted for as a modification of the contract, as it changed both the scope of the Company&#8217;s remaining services and the consideration to which the Company was entitled. The remaining research and development activities to be undertaken by the Company after the notice of termination were not distinct from the related activities performed prior to the modification on the same targets but were distinct from the activities on other targets. The remaining material rights were also distinct from the prior research and development activities. To account for the effects of the modification, the Company updated its estimate of the transaction price and allocated the remaining transaction consideration based on the relative standalone selling prices of the remaining distinct goods and services. Progress for each ongoing performance obligation was then remeasured using an updated estimate of the total level of effort required for each performance obligation and the total revised transaction price and a cumulative catch-up in revenue was recorded. The modification resulted in an increase in revenue of $127.1&#160;million. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023 and December&#160;31, 2022, the Company had a receivable of zero and $0.5&#160;million, respectively, and deferred revenue of zero and $132.2&#160;million, respectively, related to this agreement. Changes in deferred revenue balances during the nine months ended September 30, 2023 relate primarily to the impact of the contract modification. The amounts of transaction price remaining to be recognized were zero and $151.3&#160;million as of September&#160;30, 2023 and December&#160;31, 2022, respectively. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Biogen agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of license and other fixed consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost-sharing payments for research services, net variable consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,413&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid $7.0&#160;million for financial advisory fees during the year ended December&#160;31, 2020, equal to 2% of $225.0&#160;million received for the sale of shares and 2% of $125.0&#160;million received for the upfront fee. The fees incurred related to both the collaboration agreement with Biogen and the stock purchase agreement for the sale of shares. The Company believes that the allocation of fees on a relative fair value basis between the two agreements is reasonable. The Company recognized $4.1&#160;million, which represents 2% of the initial transaction price of $204.6&#160;million, as a contract cost asset. This balance was </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">released into general and administrative expenses on a systematic basis consistent with the transfer of the services to Biogen in accordance with Accounting Standard Codification Topic 340, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In March, as a result of the notice of termination and resulting modification of the contract, the progress for each performance obligation was remeasured and the Company recognized $2.5&#160;million as a cumulative catch-up to expense. The Company recognized as expense zero and $2.6 million during the three and nine months ended September&#160;30, 2023, respectively, and $0.1 million and $0.4 million during the three and nine months ended September&#160;30, 2022, respectively.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170342016848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentChargesTextBlock', window );">IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS</a></td>
<td class="text">IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS<div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three months ended March 31, 2023</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023, as a result of the sustained decline in the Company&#8217;s stock price and related market capitalization, termination of the collaboration agreements with Biogen and Novartis, and a general decline in equity values in the biotechnology industry, the Company performed an impairment assessment of goodwill, indefinite-lived intangible assets, and long-lived assets. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as a single reporting unit based on its business and reporting structure. For goodwill, a quantitative impairment assessment was performed using a market approach, whereby the Company&#8217;s fair value of equity was compared to its carrying value. The fair value of equity was derived using both the market capitalization of the Company and an estimate of a reasonable range of values of a control premium applied to the Company&#8217;s implied business enterprise value. The control premium was estimated based upon control premiums observed in comparable market transactions. This represents a level&#160;2 nonrecurring fair value measurement. Based on this analysis, the Company recognized a pre-tax goodwill impairment charge of $38.1 million during the three months ended March 31, 2023. As a result, the goodwill was fully impaired as of March&#160;31, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before completing the goodwill impairment assessment, the Company also tested its indefinite-lived intangible assets and then its long-lived assets for impairment. Based on the qualitative assessment, the Company determined it was more likely than not that its indefinite-lived intangible assets were not impaired. The Company determined all of its long-lived assets represent one asset group for purposes of long-lived asset impairment assessment. The Company concluded that the carrying value of the asset group was not recoverable as it exceeded the future undiscounted cash flows the assets are expected to generate from the use and eventual disposition. To allocate and recognize the impairment loss, the Company determined individual fair values of its long-lived assets. The Company applied a discounted cash flow method to estimate fair values of its leasehold improvements and right-of-use assets, including leasehold improvements in the process of construction and a cost replacement method to estimate the fair value of its furniture, fixtures and laboratory and manufacturing equipment. These represented level&#160;3 nonrecurring fair value measurements. Based on this analysis, the Company recognized pre-tax long-lived asset impairment charges of $11.2&#160;million on the right-of-use assets, $5.0&#160;million on the related leasehold improvements, and $4.2&#160;million on construction-in-progress, during the three months ended March 31, 2023. No impairment was recognized on the remaining long-lived assets as their carrying values were not in excess of their fair values.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three months ended June 30, 2023</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2023, the Company&#8217;s stock price and the related market capitalization continued to decline. In April 2023, the Company announced a restructuring of operations and a corresponding reduction in force, see Note&#160;9 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company also initiated discussions around several actions aimed at reducing costs, preserving liquidity and improving operational performance metrics. These actions include but are not limited to deferral and reprioritization of certain research and development programs, further reduction in force, and closing or downsizing its facilities. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reassessed its indefinite-lived and long-lived assets for impairment as of June 30, 2023. Given the actions contemplated above, the Company determined that it was more likely than not that its indefinite-lived intangible assets were impaired. Accordingly, the Company developed an estimate of the fair value of its indefinite-lived intangible assets using the multi-period excess earnings model (income approach) and concluded the carrying value of its indefinite-lived intangible assets were fully impaired. This represents a level 3 nonrecurring fair value measurement. As a result, an indefinite-lived intangible assets impairment charge of $51.3&#160;million, as well as the related income tax benefit of $6.3&#160;million due to the reversal of a deferred tax liability associated with the indefinite-lived intangible assets was recognized during the three months ended June 30, 2023. The impairment charge was primarily driven by a higher discount rate applied to future cash flows based on market participants&#8217; view of increased risk related to the asset. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that there were indicators of impairment in its long-lived asset group as of June 30, 2023, based on the same factors above as well as the impairment of its indefinite-lived intangible assets. As the estimated fair value of this asset group, based on a market approach, exceeded its carrying value, no impairment loss was recognized. This represented a level 3 nonrecurring fair value measurement.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three months ended September 30, 2023</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2023, the Company&#8217;s stock price and the related market capitalization continued to decline, and as such, the Company reassessed its long-lived assets for impairment as of September 30, 2023. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined all of its long-lived assets continued to represent one asset group for purposes of long-lived asset impairment assessment. The Company concluded that the carrying value of the asset group was not recoverable and the estimated fair value of this asset group was below its carrying value. The lower fair value of the asset group was mainly driven by the sustained decline in the Company's stock price and the related market capitalization. To recognize the impairment loss, the Company determined individual fair values of its long-lived assets. The Company applied a discounted cash flow method to estimate fair values of its leasehold improvements and right-of-use assets, including leasehold improvements in the process of construction, and a market approach to estimate the fair value of its furniture, fixtures and laboratory and manufacturing equipment. These represented level&#160;3 nonrecurring fair value measurements. Based on this analysis, the Company concluded the fair values of the long-lived assets were lower than their net book values due to declines in the market prices for leases, furniture, fixtures, and equipment. The Company recognized pre-tax long-lived asset impairment charges of $17.6 million on the right-of-use assets, $13.7&#160;million on the related leasehold improvements and construction-in-progress, and $13.5 million on furniture, fixtures, and laboratory and manufacturing equipment during the three months ended September 30, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to assess whether its long-lived assets are impaired in future periods. As the Company finalizes and implements its plans related to cost reductions and liquidity preservation, it is reasonably possible that additional impairment charges will be recognized if the Company changes how it uses various long-lived assets or elects to dispose of them, and the cash flows associated with these assets become separately identifiable. In this case, such assets will be tested for impairment separately from the remaining long-lived assets of the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentChargesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentChargesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170249540496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows total stock-based compensation expense recognized in the accompanying Condensed Consolidated Statements of Operations (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,656&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,189&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,256&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,402&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170252297536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITYAt-the-Market Offering AgreementIn August 2020, the Company entered into an Open Market Sale Agreement&#8480; with Jefferies LLC (&#8220;Jefferies&#8221;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of the Company&#8217;s common stock having an aggregate offering price of up to $150.0&#160;million through Jefferies as the Company&#8217;s sales agent or principal. In December 2022, the Company entered into Amendment No. 2 to the Open Market Sale Agreement&#8480; which increased the aggregate offering price under the at-the-market offering program by an additional $175.0 million. The Company is not obligated to sell any shares under the sales agreement. No shares were sold under the sales agreement during the three months ended September&#160;30, 2023. During the nine months ended September&#160;30, 2023, the Company sold 8,249,261 shares of its common stock for net proceeds of approximately $15.1 million. During the three and nine months ended September&#160;30, 2022, the Company sold 8,483,104 and 14,711,770 shares of its common stock for net proceeds of approximately $42.2 million and $66.4 million, respectively<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170253226736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING CHARGES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">RESTRUCTURING CHARGES</a></td>
<td class="text">RESTRUCTURING CHARGESOn April 26, 2023, the Company executed a restructuring of operations and a corresponding reduction in workforce (the &#8220;April Restructuring&#8221;), designed to reduce costs and increase focus on certain strategic priorities. The April Restructuring resulted in the elimination of approximately 110 roles, including 55 full-time employees and 55 contracted employees and eliminated open positions, in the United States, or approximately 23% of the total United States workforce as of April 26, 2023, and included one-time severance payments and other employee-related costs, including additional vesting of service-based stock compensation awards. No expenses related to the April Restructuring were incurred during the three months ended September&#160;30, 2023. The Company incurred approximately $5.3 million of expenses related to the April Restructuring in the nine months ended September&#160;30, 2023, of which $4.1&#160;million is included in research and development expense and $1.2 million is included in general and administrative expense in the accompanying Condensed Consolidated Statements of Operations. The Company <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expects the April Restructuring and the cash payments related to the April Restructuring to be complete by the third quarter of 2024.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of accrued April Restructuring costs included within other accrued liabilities on the Company&#8217;s Condensed Consolidated Balance Sheet as of September 30, 2023 (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//420/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170252297536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period. During the three months ended September 30, 2023 and 2022 the Company recorded an income tax expense of $1.3 million and $0.1&#160;million, respectively. During the nine months ended September&#160;30, 2023 and 2022, the Company recorded income tax benefit of $4.8 million and income tax expense of $0.2 million, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to maintain a full valuation allowance on its U.S. federal and state, Sangamo France, and Sangamo United Kingdom net deferred tax assets, as the Company believes it is not more likely than not that these benefits will be realized. The net tax benefit for the nine months ended September&#160;30, 2023 was primarily related to the impairment of the IPR&amp;D asset, which was offset by the reduction of its United Kingdom&#8217;s deferred tax asset. The tax expense for the nine months ended September&#160;30, 2022 was primarily due to foreign income tax expense.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the Inflation Reduction Act of 2022 was signed into law, and became effective in 2023, with tax provisions primarily focused on implementing a 15% minimum tax on global adjusted financial statement income and a 1% excise tax on share repurchases. The Company has evaluated the provisions of the tax law and noted that the law change would not have a material impact on the Condensed Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170252218912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">November Restructuring</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 11, 2023, the Board of Directors of the Company approved a restructuring of operations and a corresponding reduction in workforce (the &#8220;November Restructuring&#8221;), designed to reduce costs and advance its strategic transformation into a neurology-focused genomic medicine company. The Company notified employees affected by the November Restructuring on November 1, 2023.  The Company expects the November Restructuring to result in the elimination of approximately 162 roles in the United States, or approximately 40% of its United States workforce. The Company estimates that it will incur approximately $8 million to $10 million in cash-based expenses related to employee severance and notice period payments, benefits and related restructuring costs. The Company expects that the majority of the restructuring charges will be incurred in the fourth quarter of 2023 and that the execution of the November Restructuring will be substantially complete by the second quarter of 2024. The Company may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the November Restructuring.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Departure of Certain Officers</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the November Restructuring, the employment of each of D. Mark McClung, Executive Vice President, Chief Operating Officer, and Jason Fontenot, Ph.D., Senior Vice President, Chief Scientific Officer, will terminate, effective as of January 2, 2024. In connection with the termination of their employment, pursuant to the Amended Severance Plan (as defined below), Mr. McClung and Dr. Fontenot are entitled to certain severance benefits in exchange for the execution of a general settlement and release agreement. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Approval of Amended and Restated Executive Severance Plan</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2023, the Compensation Committee of the Board of Directors of the Company approved an amendment and restatement of the Company&#8217;s Amended and Restated Executive Severance Plan (as so amended and restated, the &#8220;Amended Severance Plan&#8221;).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of such amendment and restatement is to provide for the payment of certain severance benefits in the form of a lump sum (instead of in installments or monthly reimbursements) following termination. Specifically, if an Eligible Employee (as defined in the Amended Severance Plan and which includes all of the Company&#8217;s executive officers) becomes entitled to severance benefits under the Amended Severance Plan, (i) cash severance payments will be made in the form of a lump sum within 60 days following the Eligible Employee&#8217;s termination (instead of in the form of installments over the applicable severance period, which may range from 9 to 18 months following such termination depending on the Eligible Employee&#8217;s position) and (ii) cash payments intended to replace COBRA premium reimbursements may be made in the form of a lump sum within 60 days following the Eligible Employee&#8217;s termination (instead of in the form of monthly reimbursements over the applicable severance period), in the Company&#8217;s discretion, in each case to the extent that such payments (a) are exempt from Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), as determined by the Company in its discretion at the time of the Eligible Employee&#8217;s termination, or (ii) may otherwise be made in a lump sum upon such termination without causing adverse tax consequences under Section 409A of the Code.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes regarding the timing and form of payment of certain severance benefits under the Amended Severance Plan, as described above, were the only material changes made under the Amended Severance Plan. No other material changes (including changes regarding eligibility for, or the amount or type of, severance benefits) were made under the Amended Severance Plan.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change of Company Headquarters</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, the Company announced that it expects to close its Brisbane, California facility in early 2024 to conserve cash resources, and intends to transition Company headquarters to its Richmond, California facility as of January&#160;1,&#160;2024. The Company may incur charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the closure of its Brisbane, California facility and the transition of company headquarters to its Richmond, California facility.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nasdaq Deficiency Notice</span></div>On October 27, 2023, the Company received a deficiency notice (the &#8220;Notice&#8221;) from the Listing Qualifications Staff (the &#8220;Staff&#8221;) of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notifying the Company that, for the last 30 consecutive business days, the bid price of the Company&#8217;s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). The Notice has no immediate effect on the listing of the Company&#8217;s common stock on the Nasdaq Global Select Market.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170247488864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of these financial statements for the periods presented have been included. Operating results for the three and nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. The Condensed Consolidated Balance Sheet data at December&#160;31, 2022 was derived from the audited Consolidated Financial Statements included in Sangamo&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (the &#8220;2022 Annual Report&#8221;) as filed with the SEC on February&#160;23,&#160;2023.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in the Condensed Consolidated Financial Statements.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. On an ongoing basis, management evaluates its estimates including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, income taxes, fair value of assets and liabilities, including from acquisitions, useful lives and impairment of long-lived assets, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its revenues pursuant to the provisions of Accounting Standards Codification Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC Topic 606&#8221;). The Company&#8217;s contract revenues are derived from collaboration agreements including licensing arrangements and research services. Research and licensing agreements typically include nonrefundable upfront signing or license fees, payments at negotiated rates for time incurred by Company researchers, third-party cost reimbursements, additional target selection fees, sublicense fees, milestone payments tied to ongoing development and product commercialization, and royalties on future licensees&#8217; product sales. All funds received from the Company&#8217;s collaboration partners are generally not refundable. Non-refundable upfront fees are fixed at the commencement of the contract. All other fees represent variable consideration in contracts. One of the Company&#8217;s contracts also contains a provision where the Company reimburses its customer for certain costs they incur which is accounted for as a reduction to the contract transaction price as the Company does not acquire any distinct goods or services in exchange for such payments. Deferred revenue primarily represents the portion of nonrefundable upfront fees or milestone payments received but not earned.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under its agreements, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations based on estimated selling prices; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company&#8217;s performance obligations in its collaboration agreements represent distinct bundles of licenses of intellectual property and research and development services, with these components being individually non-distinct. Options to license the Company&#8217;s intellectual property and/or acquire research and development services also represent performance obligations when they grant customers a material right, e.g., a right to a discount the customer would not have received if they did not purchase the Company&#8217;s services under the existing contract. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from bundles of licenses of intellectual property and research and development services are recognized over time using a proportional performance method. Under this method, revenue is recognized by measuring progress towards satisfaction of the relevant performance obligation using a measure that best depicts the progress towards satisfaction of the relevant performance obligation. For most of the Company&#8217;s agreements the measure of progress is an input measure based on a level of effort incurred, which includes the value of actual time by Company researchers plus third-party cost reimbursements. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration allocated to options that include material rights is deferred until the options are exercised or expire. The exercise of such options is accounted for as contract continuation, with target selection fees and estimated variable consideration included in the transaction price at that time and allocated specifically to the respective target&#8217;s performance obligation. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant management judgment is required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations under the arrangement. Changes in these estimates can have a material effect on revenue recognized. If the Company cannot reasonably estimate when its performance obligations either are completed or become inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. For variable consideration, the amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint and, if necessary, adjusts its estimate of the overall transaction price. A cumulative catch-up is then recorded in the current period to reflect the updated transaction price and the updated measure of progress. The estimated period of performance and level of effort, including the value of Company researchers&#8217; time and third-party costs, are reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current expectations.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price of each performance obligation identified in the contract. The Company uses key assumptions to determine the stand-alone selling price, which may include forecasted revenues, development timelines, discount rates and probabilities of exercise of technical and regulatory success, and the expected level of effort for research and development services. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract modifications occur when the price and/or scope of an arrangement changes. If the modification consists of adding new distinct goods or services in exchange for consideration that reflects standalone selling prices of these goods and services, the modification is accounted for as a separate contract with the customer. Otherwise, if the remaining goods and services are distinct from those previously provided, the existing contract is considered terminated, and the remaining consideration is allocated to the remaining goods and services as if this was a newly signed contract. If the remaining goods and services are not distinct from those previously provided, the effects of the modification are accounted for in a manner similar to the effect of a change in the estimated measure of progress, with cumulative catch-up in revenue recorded at the time of the </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">modification. If some of the remaining goods and services are distinct from those previously provided and others are not, to account for the effects of the modification the Company applies principles consistent with the objectives of the modification accounting.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from collaboration and licensing agreements as a percentage of total revenues were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kite Pharma, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen MA, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis Institutes for BioMedical Research, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other licensing agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment of Goodwill, Indefinite-lived Intangible Assets and Long-lived Assets</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Goodwill, Indefinite-lived Intangible Assets and Long-lived Assets</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of consideration transferred over the fair values of assets acquired and liabilities assumed in a business combination. Intangible assets with indefinite useful lives are related to acquired in-process research and development (&#8220;IPR&amp;D&#8221;) projects and are initially measured at their respective fair values as of the acquisition date. Goodwill and indefinite-lived intangible assets are not amortized. Intangible assets related to IPR&amp;D projects are considered to be indefinite-lived until the completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs if and when regulatory approval to market a product is obtained, the associated assets would be deemed finite-lived and would then be amortized based on their respective estimated useful lives at that point in time.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite-lived intangible assets are assessed for impairment on an annual basis and whenever events and circumstances indicate that these assets may be impaired. The Company evaluates the carrying value of long-lived assets, which include property and equipment, leasehold improvements and right-of-use assets, for impairment whenever events or changes in circumstances indicate that the carrying amounts of the asset may not be fully recoverable.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In testing for goodwill impairment, the Company has the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If the Company elects to bypass the qualitative assessment, or if a qualitative assessment indicates it is more likely than not that the carrying value exceeds its fair value, the Company performs a quantitative goodwill impairment test to compare the fair value of its reporting unit to its carrying value, including goodwill. If the carrying value, including goodwill, exceeds the reporting unit&#8217;s fair value, the Company will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value (but not in excess of the carrying value of goodwill).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing each annual impairment assessment and any interim impairment assessment for its indefinite-lived intangible assets, the Company determines if it should qualitatively assess whether it is more likely than not the fair value of its IPR&amp;D asset is less than its carrying amount (the qualitative impairment test). If the Company concludes that is the case, or elects not to use the qualitative impairment test, the Company will proceed with quantitatively determining the fair value of the IPR&amp;D asset and comparing its fair value to its carrying value to determine the amount of impairment, if any (the quantitative impairment test).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the qualitative impairment test, the Company considers the results of the most recent quantitative impairment test and identifies the most relevant drivers of the fair value for the IPR&amp;D asset. The most relevant drivers of fair value identified are consistent with the assumptions used in the quantitative estimate of the IPR&amp;D asset. Using these drivers of fair value, the Company identifies events and circumstances which may have an effect on the fair value of the IPR&amp;D asset since the last time the IPR&amp;D&#8217;s fair value was quantitatively determined. The Company then weighs these factors to determine and conclude if it is not more likely than not the IPR&amp;D asset is impaired. If it is more likely than not the IPR&amp;D asset is impaired, the Company proceeds with quantitatively determining the fair value of the IPR&amp;D asset.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing the quantitative impairment test, the Company uses the income approach to determine the fair value of its IPR&amp;D asset. This approach calculates fair value by estimating the after-tax cash flows attributable to an in-process project over its useful life and then discounting these after-tax cash flows back to a present value. This estimate includes judgmental assumptions regarding the estimates that market participants would make in evaluating the IPR&amp;D asset, including the probability of successfully completing clinical trials and obtaining regulatory approval to market the IPR&amp;D asset, the timing of and the expected costs to complete IPR&amp;D projects, future net cash flows from potential drug sales, which are based on estimates of the sales price of the drug, the size of the patient population and cure rate, its competitive position in the marketplace, and appropriate discount and tax rates. Any impairment to be recorded is calculated as the difference between the estimated fair value and the carrying value of the IPR&amp;D asset on the Company&#8217;s Condensed Consolidated Balance Sheet.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a change in circumstance occurs that indicates long-lived assets may be impaired, the Company performs a test of recoverability by comparing the carrying value of the asset or asset group to its undiscounted expected future cash flows. The long-lived asset evaluation is performed at the asset group level, i.e., the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. If this review indicates that the carrying amount of the asset group is not recoverable, an impairment loss is measured as the amount by which the carrying amount of an asset group exceeds its fair value. Any impairment loss is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets, except that the carrying amount of an individual asset shall not be reduced below its fair value.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that may indicate potential impairment and trigger an impairment test include, but are not limited to, general macroeconomic conditions, conditions specific to the industry and market, an adverse change in legal factors, impairment of goodwill or indefinite-lived intangible assets, business climate or operational performance of the business, and sustained decline in the stock price and market capitalization compared to the net book value.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Calculating the fair value of a reporting unit, an asset group and an individual asset involves significant estimates and assumptions. These estimates and assumptions include, among others, projected future cash flows, risk-adjusted discount rates, future economic and market conditions, and the determination of appropriate market comparables. Changes in these factors and assumptions used can materially affect the amount of impairment loss recognized in the period the asset was considered impaired.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash, Cash Equivalents, and Restricted Cash</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo considers all highly liquid investments purchased with original maturities of three months or less at the purchase date to be cash equivalents. Cash and cash equivalents consist of cash, deposits in demand money market accounts and U.S. government-sponsored entity debt securities. Restricted cash consists of a letter of credit for $1.5&#160;million, representing a deposit for the lease of the corporate headquarters in Brisbane, California.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo classifies its marketable securities as available-for-sale and records its investments at estimated fair value based on quoted market prices or observable market inputs of almost identical assets, with the unrealized holding gains and losses included in accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;). The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as non-current marketable securities in the accompanying Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments are subject to a periodic impairment review. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time and extent to which the fair value has been less than the cost basis, the Company's financial condition and its intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value. Realized gains and losses on marketable securities are included in interest and other income, net, which are determined using the specific identification method. Credit losses related to the marketable securities are recorded in interest and other income, net in the Condensed Consolidated Statements of Operations through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. </span></div>If the Company intends to sell, or if it is more likely than not that the Company will be required to sell, a security before recovery of its amortized cost basis, the allowance for credit losses is written off, and the amortized cost of the security is written down to its fair value, with an impairment charge recognized. This also results in a reversal of any unrealized gains and losses for this security that were previously included in AOCI. Impairment charges are included in interest and other income, net in the Condensed Consolidated Statements of Operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether it has the right to control the identified asset. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arising from the lease. Lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. Right-of-use assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the implicit rate in the Company&#8217;s leases is generally unknown, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of remaining lease payments. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease in a similar economic environment. The Company considers its credit risk, term of the lease, and total lease payments and adjusts for the impacts of collateral, as necessary, when calculating its incremental borrowing rates. The lease terms may include options to extend or terminate the lease when it is reasonably certain the Company will exercise any such options. Rent expense for the Company&#8217;s operating leases is recognized on a straight-line basis over the lease term. The Company will evaluate the lease arrangement for impairment whenever events or changes in circumstances indicate that the carrying amounts of the right-of-use asset may not be fully recoverable. To the extent an impairment of the right-of-use asset is recognized, the Company will recognize lease impairment and subsequently amortize the remaining lease asset on a straight-line basis (unless another systematic basis is more representative of the pattern in which the Company expects to consume the future economic benefits from the asset) from the date of impairment to the earlier of the end of the right-of-use asset&#8217;s useful life or the end of the lease term.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected not to separate lease and non-lease components for its real estate and copier leases and, as a result, accounts for any lease and non-lease components as a single lease component. The Company has also elected not to apply the recognition requirement to any leases with a term of 12 months or less and does not include an option to purchase the underlying asset that the Company is reasonably certain to exercise.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents and marketable securities. Fair value is determined based on a three-tier hierarchy under the authoritative guidance for fair value measurements and disclosures that prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurements and unobservable (i.e., supported by little or no market activity).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170247447424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock', window );">Schedule of Revenue from Strategic Partnering Collaboration Agreements and Research Activity Grants as a Percentage of Total Revenues</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from collaboration and licensing agreements as a percentage of total revenues were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kite Pharma, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen MA, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis Institutes for BioMedical Research, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other licensing agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,514&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,444&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,570&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,872&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,014&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,944&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,070&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,372&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Restrictions on Cash and Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,514&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,444&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,570&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,872&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,014&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,944&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,070&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,372&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Revenue From Strategic Partnering Collaboration Agreements And Research Activity Grants As A Percentage Of Total Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170249521584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Summary of Fair Value Measurements of Cash Equivalents and Marketable Securities</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurements of the Company&#8217;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,014&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,597&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,853&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,033&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2C<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2C<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170252289712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the Company&#8217;s cash equivalents and marketable securities (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,064&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,014&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(918)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,743&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(918)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,853&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Fair value of investments available-for-sale</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of marketable securities by contractual maturity were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:74.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,597&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170248807888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Kite agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of license fee fixed consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services variable consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,496&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,035&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands):</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Novartis agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of upfront license fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,610&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,433&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Biogen agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of license and other fixed consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost-sharing payments for research services, net variable consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,413&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170248924592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows total stock-based compensation expense recognized in the accompanying Condensed Consolidated Statements of Operations (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,656&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,189&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,256&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,402&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170248821408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING CHARGES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Accrued Restructuring Costs</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of accrued April Restructuring costs included within other accrued liabilities on the Company&#8217;s Condensed Consolidated Balance Sheet as of September 30, 2023 (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170247410320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Change in Accounting Estimate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Capital resources</a></td>
<td class="nump">$ 132.1<span></span>
</td>
<td class="nump">$ 132.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letter of credit established as a deposit</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Change In Agreement Estimate, March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Change in Accounting Estimate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent', window );">Decrease in net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInEarningsPerShareBasic', window );">Decreased net loss per share, basic (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInEarningsPerShareDiluted', window );">Decreased net loss per share, diluted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Change In Estimate, September 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Change in Accounting Estimate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax', window );">Increase in revenue</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent', window );">Decrease in net loss</a></td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInEarningsPerShareBasic', window );">Decreased net loss per share, basic (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInEarningsPerShareDiluted', window );">Decreased net loss per share, diluted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_IncreaseDecreaseInEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Earnings Per Share, Basic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_IncreaseDecreaseInEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_IncreaseDecreaseInEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Earnings Per Share, Diluted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_IncreaseDecreaseInEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Net Income (Loss) Attributable To Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=sgmo_ChangeInAgreementEstimateMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=sgmo_ChangeInAgreementEstimateMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=sgmo_ChangeInAgreementEstimateSeptember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=sgmo_ChangeInAgreementEstimateSeptember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170250141280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration And Licensing Agreements (Details) - Revenue from contract with customer - Customer concentration risk<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenues</a></td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenues</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenues</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_OtherLicensingAgreementsMember', window );">Other licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenues</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_OtherLicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_OtherLicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170246818608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 56,514<span></span>
</td>
<td class="nump">$ 100,444<span></span>
</td>
<td class="nump">$ 94,570<span></span>
</td>
<td class="nump">$ 178,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Non-current restricted cash</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows</a></td>
<td class="nump">$ 58,014<span></span>
</td>
<td class="nump">$ 101,944<span></span>
</td>
<td class="nump">$ 96,070<span></span>
</td>
<td class="nump">$ 180,372<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170245832752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">$ 75,597<span></span>
</td>
<td class="nump">$ 207,033<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">50,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember', window );">U.S. government-sponsored entity debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">28,637<span></span>
</td>
<td class="nump">18,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">18,891<span></span>
</td>
<td class="nump">101,165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">11,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">8,429<span></span>
</td>
<td class="nump">24,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">5,581<span></span>
</td>
<td class="nump">7,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">12,680<span></span>
</td>
<td class="nump">37,461<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sgmo_USGovernmentSponsoredAgencyBondMember', window );">Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">50,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">75,597<span></span>
</td>
<td class="nump">207,033<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total cash equivalents and marketable securities</a></td>
<td class="nump">79,014<span></span>
</td>
<td class="nump">257,853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">50,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | U.S. government-sponsored entity debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">28,637<span></span>
</td>
<td class="nump">18,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Commercial paper securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">18,891<span></span>
</td>
<td class="nump">101,165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">11,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">8,429<span></span>
</td>
<td class="nump">24,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">5,581<span></span>
</td>
<td class="nump">7,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">12,680<span></span>
</td>
<td class="nump">37,461<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">50,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total cash equivalents and marketable securities</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">50,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">50,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | U.S. government-sponsored entity debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | Commercial paper securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">75,597<span></span>
</td>
<td class="nump">207,033<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total cash equivalents and marketable securities</a></td>
<td class="nump">75,597<span></span>
</td>
<td class="nump">207,033<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | U.S. government-sponsored entity debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">28,637<span></span>
</td>
<td class="nump">18,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | Commercial paper securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">18,891<span></span>
</td>
<td class="nump">101,165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">11,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">8,429<span></span>
</td>
<td class="nump">24,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">5,581<span></span>
</td>
<td class="nump">7,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">12,680<span></span>
</td>
<td class="nump">37,461<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total cash equivalents and marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | U.S. government-sponsored entity debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | Commercial paper securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sgmo_USGovernmentSponsoredAgencyBondMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sgmo_USGovernmentSponsoredAgencyBondMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170245494352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents, amortized cost</a></td>
<td class="nump">$ 56,514<span></span>
</td>
<td class="nump">$ 100,444<span></span>
</td>
<td class="nump">$ 94,570<span></span>
</td>
<td class="nump">$ 178,872<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Marketable securities, amortized cost</a></td>
<td class="nump">75,647<span></span>
</td>
<td class="nump">207,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(918)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Marketable securities, estimated fair value</a></td>
<td class="nump">75,597<span></span>
</td>
<td class="nump">207,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost', window );">Total cash equivalents and marketable securities, amortized cost</a></td>
<td class="nump">79,064<span></span>
</td>
<td class="nump">258,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax', window );">Total cash equivalents and marketable securities, gross unrealized gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax', window );">Total cash equivalents and marketable securities, gross unrealized losses</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(918)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashEquivalentsAndAvailableForSaleSecurities', window );">Total cash equivalents and marketable securities, estimated fair value</a></td>
<td class="nump">79,014<span></span>
</td>
<td class="nump">257,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents, amortized cost</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">50,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Cash equivalents, gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Cash equivalents, gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents, estimated fair value</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">50,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashEquivalentsMember', window );">Cash equivalents:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents, amortized cost</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">50,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Cash equivalents, gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Cash equivalents, gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents, estimated fair value</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">50,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember', window );">U.S. government-sponsored entity debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Marketable securities, amortized cost</a></td>
<td class="nump">28,655<span></span>
</td>
<td class="nump">18,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(293)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Marketable securities, estimated fair value</a></td>
<td class="nump">28,637<span></span>
</td>
<td class="nump">18,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Marketable securities, amortized cost</a></td>
<td class="nump">18,901<span></span>
</td>
<td class="nump">101,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(193)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Marketable securities, estimated fair value</a></td>
<td class="nump">18,891<span></span>
</td>
<td class="nump">101,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Marketable securities, amortized cost</a></td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">11,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Marketable securities, estimated fair value</a></td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">11,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Marketable securities, amortized cost</a></td>
<td class="nump">8,429<span></span>
</td>
<td class="nump">24,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Marketable securities, estimated fair value</a></td>
<td class="nump">8,429<span></span>
</td>
<td class="nump">24,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Marketable securities, amortized cost</a></td>
<td class="nump">5,599<span></span>
</td>
<td class="nump">7,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Marketable securities, estimated fair value</a></td>
<td class="nump">5,581<span></span>
</td>
<td class="nump">7,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Marketable securities, amortized cost</a></td>
<td class="nump">12,684<span></span>
</td>
<td class="nump">37,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Marketable securities, estimated fair value</a></td>
<td class="nump">$ 12,680<span></span>
</td>
<td class="nump">37,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sgmo_USGovernmentSponsoredAgencyBondMember', window );">Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Marketable securities, amortized cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, gross unrealized gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, gross unrealized losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Marketable securities, estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents accumulated gross unrealized gain before tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents accumulated gross unrealized loss before tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CashEquivalentsAndAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and available for sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CashEquivalentsAndAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and available for Sale Securities Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and available for sale securities, gross unrealized gain, before tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and available for sale securities, gross unrealized loss, before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sgmo_USGovernmentSponsoredAgencyBondMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sgmo_USGovernmentSponsoredAgencyBondMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170252256096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Available-for-Sale Securities by Contractual Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Maturing in one year or less</a></td>
<td class="nump">$ 41,173<span></span>
</td>
<td class="nump">$ 177,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Maturing after one year through five years</a></td>
<td class="nump">34,424<span></span>
</td>
<td class="nump">29,845<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total</a></td>
<td class="nump">$ 75,597<span></span>
</td>
<td class="nump">$ 207,033<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170249911760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH EQUIVALENTS AND MARKETABLE SECURITIES - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Realized investment gains (losses)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded', window );">Allowance for credit loss related to marketable securities, not previously recorded</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest', window );">Allowance for credit loss related to marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease', window );">Non-current marketable securities investments reclassified to current</a></td>
<td class="nump">34,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Impairment charges</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Excluding Accrued Interest, Current, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding accrued interest, of credit loss expense on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) with no credit loss previously recorded.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-8A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170248757824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIC AND DILUTED NET LOSS PER SHARE (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">22,131,291<span></span>
</td>
<td class="nump">18,524,016<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170246524816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">70 Months Ended</th>
<th class="th" colspan="1">77 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($) </div>
<div>milestone</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>milestone </div>
<div>product</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>milestone</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_AgreementTerminationTerm', window );">Agreement termination, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc. | S B Five Two Five And Other Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Revenues under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive', window );">Potential amount to be funded for achievement of specified commercialized and sales milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc. | S B Five Two Five And Other Products | Achievement of specified clinical development intellectual property and regulatory milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc. | S B Five Two Five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_MilestoneRevenueReceivable', window );">Milestone revenue receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc. | Other products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_MilestoneRevenueReceivable', window );">Milestone revenue receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc. | License | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty', window );">Percentage of net sales per developed licensed product which will trigger royalties by counterparty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc. | License | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty', window );">Percentage of net sales per developed licensed product which will trigger royalties by counterparty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc. | C9ORF72</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Revenues under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementTransactionPrice', window );">Collaborative arrangement transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerSB525Member', window );">Pfizer SB-525</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Revenues under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementTransactionPrice', window );">Collaborative arrangement transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementResearchServiceFees', window );">Research service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerSB525Member', window );">Pfizer SB-525 | S B Five Two Five And Other Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved', window );">Collaborative arrangement, number of milestones achieved | milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_MilestonePaymentsReceived', window );">Milestone payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerC9ORF72Member', window );">Pfizer C9ORF72</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_AgreementTerminationTerm', window );">Agreement termination, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerC9ORF72Member', window );">Pfizer C9ORF72 | C9ORF72</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Revenues under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_MilestonePaymentsReceived', window );">Milestone payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement', window );">Number of products approved | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice', window );">Number of milestones included in transaction price | milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerC9ORF72Member', window );">Pfizer C9ORF72 | C9ORF72 | Achievement Of Specified Preclinical Development Clinical Development And First Commercial Sale Milestones | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerC9ORF72Member', window );">Pfizer C9ORF72 | C9ORF72 | Achievement Of Commercial Milestones | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate additional revenue recognition milestone method revenue eligible to receive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_AgreementTerminationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreement Termination, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_AgreementTerminationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration and license agreements number of products approved under agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Number Of Milestones Achieved</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementNumberOfMilestonesAchieved</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementResearchServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Research Service Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementResearchServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative arrangement transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Eligible Royalties, Triggered By Percentage Of Net Sales Per Developed Licensed Product By Counterparty</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Customer contract liability milestone payment eligible to receive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_MilestonePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone payments received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_MilestonePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_MilestoneRevenueReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone&#8203; revenue receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_MilestoneRevenueReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of clinical or regulatory milestones included in transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_PfizerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_PfizerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgmo_SBFiveTwoFiveAndOtherProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgmo_SBFiveTwoFiveAndOtherProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgmo_SBFiveTwoFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgmo_SBFiveTwoFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ManufacturedProductOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ManufacturedProductOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgmo_CNineORFSevenTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgmo_CNineORFSevenTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_PfizerSB525Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_PfizerSB525Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_PfizerC9ORF72Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_PfizerC9ORF72Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfCommercialMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfCommercialMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170250184864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>performance_obligation </div>
<div>material_right</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($) </div>
<div>option </div>
<div>milestone</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,148<span></span>
</td>
<td class="nump">$ 1,148<span></span>
</td>
<td class="nump">$ 3,678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Change In Agreement Estimate, March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent', window );">Decrease in net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInEarningsPerShareBasic', window );">Increased earnings per share, basic (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInEarningsPerShareDiluted', window );">Increased earnings per share, diluted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Change In Estimate, September 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent', window );">Decrease in net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInEarningsPerShareBasic', window );">Increased earnings per share, basic (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_IncreaseDecreaseInEarningsPerShareDiluted', window );">Increased earnings per share, diluted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | License and Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount', window );">Remaining performance obligation amount, related to material rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | License and Service | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, expected timing of satisfaction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | License and Service | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, expected timing of satisfaction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | License</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_RevenueNumberOfRemainingPerformanceObligations', window );">Number of remaining performance obligations | performance_obligation</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod', window );">Number of material rights for renewal of research period | material_right</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod', window );">Renewal period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount', window );">Fixed consideration</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Collaboration And License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_MilestonePaymentsReceived', window );">Milestone payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_InitialResearchTermOfAgreement', window );">Initial research term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_NumberOfOptionsToExtendInitialResearchTerm', window );">Number of options to extend initial research term | option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ExtendedResearchTermOfAgreement', window );">Extended research term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_SeparateUpfrontFee', window );">Separate fee for additional term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 19,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Collaboration And License Agreement | Achievement of specified research, clinical development, regulatory and first commercial sale milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived', window );">Contingent development and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Collaboration And License Agreement | Achievement of specified sales-based milestones if annual worldwide net sales of licensed products reach specified levels</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived', window );">Contingent development and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment', window );">Maximum amount of achieved milestones to receive payment | milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Collaboration And License Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Development And Sales Based Milestone Payments, Maximum Amount Of Achieved Milestones To Be Eligible For Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent development and sales based milestone payments to be received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Customer contract liability milestone payment eligible to receive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ExtendedResearchTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extended Research Term Of Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ExtendedResearchTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_IncreaseDecreaseInEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Earnings Per Share, Basic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_IncreaseDecreaseInEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_IncreaseDecreaseInEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Earnings Per Share, Diluted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_IncreaseDecreaseInEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Net Income (Loss) Attributable To Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_InitialResearchTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial research term of agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_InitialResearchTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_MilestonePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone payments received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_MilestonePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_NumberOfOptionsToExtendInitialResearchTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Options To Extend Initial Research Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_NumberOfOptionsToExtendInitialResearchTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_RevenueNumberOfRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Number Of Remaining Performance Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_RevenueNumberOfRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Fixed Consideration Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Number Of Material Rights For Renewal Of Research Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Related To Material Rights, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_RevenueRemainingPerformanceObligationRenewalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Renewal Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_RevenueRemainingPerformanceObligationRenewalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_SeparateUpfrontFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Separate upfront fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_SeparateUpfrontFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=sgmo_ChangeInAgreementEstimateMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=sgmo_ChangeInAgreementEstimateMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=sgmo_ChangeInAgreementEstimateSeptember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=sgmo_ChangeInAgreementEstimateSeptember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-10-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-10-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170245483248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue related to Sanofi agreement:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 9,398<span></span>
</td>
<td class="nump">$ 26,460<span></span>
</td>
<td class="nump">$ 174,190<span></span>
</td>
<td class="nump">$ 84,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue related to Sanofi agreement:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,496<span></span>
</td>
<td class="nump">6,915<span></span>
</td>
<td class="nump">19,035<span></span>
</td>
<td class="nump">19,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | License</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue related to Sanofi agreement:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,388<span></span>
</td>
<td class="nump">6,296<span></span>
</td>
<td class="nump">17,938<span></span>
</td>
<td class="nump">18,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue related to Sanofi agreement:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="nump">1,097<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue related to Sanofi agreement:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,610<span></span>
</td>
<td class="nump">12,179<span></span>
</td>
<td class="nump">29,433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc. | License</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue related to Sanofi agreement:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,582<span></span>
</td>
<td class="nump">9,568<span></span>
</td>
<td class="nump">23,222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc. | Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue related to Sanofi agreement:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,028<span></span>
</td>
<td class="nump">2,611<span></span>
</td>
<td class="nump">6,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue related to Sanofi agreement:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,413<span></span>
</td>
<td class="nump">134,849<span></span>
</td>
<td class="nump">30,658<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc. | License</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue related to Sanofi agreement:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,306<span></span>
</td>
<td class="nump">132,165<span></span>
</td>
<td class="nump">21,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc. | Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue related to Sanofi agreement:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,107<span></span>
</td>
<td class="nump">$ 2,684<span></span>
</td>
<td class="nump">$ 8,740<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170246614144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 27, 2020</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,148,000<span></span>
</td>
<td class="nump">$ 3,678,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc. | Collaboration And License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Proceeds from collaborators</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementTransactionPrice', window );">Collaborative arrangement transaction price</a></td>
<td class="nump">95,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementLicenseFee', window );">Collaborative arrangement, license fee</a></td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts', window );">Collaborative arrangement estimated reimbursable service costs</a></td>
<td class="nump">$ 20,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative arrangement estimated reimbursable service costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementLicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, License Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementLicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative arrangement transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from collaborators during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170245733552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 15, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($) </div>
<div>product_target </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets', window );">Number of additional neurological disease gene targets (in product targets) | product_target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,148,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,148,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,678,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,918,000<span></span>
</td>
<td class="nump">$ 16,238,000<span></span>
</td>
<td class="nump">48,068,000<span></span>
</td>
<td class="nump">$ 46,239,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Change in estimate of transaction price, increase in revenue</a></td>
<td class="nump">$ 127,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc. | License and Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount', window );">Fixed consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 204,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Cumulative catch-up to expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc. | Stock Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,420,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.2137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction', window );">Sale of stock, excess consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationAgreementEquityIssued', window );">Collaboration agreement, equity issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc. | Collaboration And License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Proceeds from collaborators</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty', window );">Number of neurological disease gene targets selected by counterparty (in product targets) | product_target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue', window );">Financial advisory fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeAgreementPercentOfInitialRecognition', window );">Percent of initial recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract with customer, asset, after allowance for credit Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationAgreementEquityIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreement, Equity Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationAgreementEquityIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreement, Number Of Additional Product Targets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationAgreementNumberOfAdditionalProductTargets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreement, Number Of Selected Product Targets By Counterparty</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Arrangement, Commission Fee, Portion Of Gross Proceeds, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeAgreementPercentOfInitialRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Agreement, Percent Of Initial Recognition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeAgreementPercentOfInitialRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Fixed Consideration Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Excess Consideration Received on Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which increases (decreases) right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in measure of progress which increases (decreases) right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from collaborators during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sgmo_StockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sgmo_StockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170246530192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment on right-of-use assets</a></td>
<td class="nump">$ 17,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">44,799,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 65,232,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets, indefinite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount', window );">Reduction in deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sgmo_LeaseholdImprovementsAndConstructionInProgressMember', window );">Leasehold Improvements and Construction-in-Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">13,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember', window );">Furniture, Fixtures and Laboratory and Manufacturing Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">$ 13,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Reduction In Deferred Tax Liabilities, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479365/842-20-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sgmo_LeaseholdImprovementsAndConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sgmo_LeaseholdImprovementsAndConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170251610016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 6,189<span></span>
</td>
<td class="nump">$ 7,793<span></span>
</td>
<td class="nump">$ 21,256<span></span>
</td>
<td class="nump">$ 23,402<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">3,236<span></span>
</td>
<td class="nump">4,395<span></span>
</td>
<td class="nump">11,996<span></span>
</td>
<td class="nump">13,656<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 2,953<span></span>
</td>
<td class="nump">$ 3,398<span></span>
</td>
<td class="nump">$ 9,260<span></span>
</td>
<td class="nump">$ 9,746<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170247404032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Details) - Jefferies LLC - At-The-Market Offering Agreement - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_StockOfferingProgramMaximumValue', window );">Stock offering program, maximum value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice', window );">Stock offering program, increase to aggregate offering price</a></td>
<td class="nump">$ 175.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in at-the-market offering, net of offering expenses (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,483,104<span></span>
</td>
<td class="nump">8,249,261<span></span>
</td>
<td class="nump">14,711,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.2<span></span>
</td>
<td class="nump">$ 15.1<span></span>
</td>
<td class="nump">$ 66.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_SaleOfStockIncreaseToAggregateOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Increase To Aggregate Offering Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_SaleOfStockIncreaseToAggregateOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_StockOfferingProgramMaximumValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Offering Program, Maximum Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_StockOfferingProgramMaximumValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_JefferiesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_JefferiesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=sgmo_AtTheMarketOfferingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=sgmo_AtTheMarketOfferingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170245693280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING CHARGES - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 26, 2023 </div>
<div>employee</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,337,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=sgmo_April2023RestructuringPlanMember', window );">April 2023 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Number of employees eliminated in restructuring | employee</a></td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent', window );">Percentage of positions eliminated in restructuring</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">5,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development | April 2023 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative | April 2023 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=sgmo_FullTimeEmployeesMember', window );">Full-Time Employees | April 2023 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Number of employees eliminated in restructuring | employee</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=sgmo_ContractedEmployeesMember', window );">Contracted Employees | April 2023 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Number of employees eliminated in restructuring | employee</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=sgmo_April2023RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=sgmo_April2023RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=sgmo_FullTimeEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=sgmo_FullTimeEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=sgmo_ContractedEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=sgmo_ContractedEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170246902304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING CHARGES - Accrued Restructuring Costs (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at December 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">5,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(3,033)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Non-cash adjustments</a></td>
<td class="num">(305)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at September 30, 2023</a></td>
<td class="nump">$ 1,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170252125152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">$ 1,270<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="num">$ (4,800)<span></span>
</td>
<td class="nump">$ 170<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140170246692960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - Subsequent Event<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2023</div></th>
<th class="th">
<div>Oct. 11, 2023 </div>
<div>USD ($) </div>
<div>employee</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Approval Of Amended And Restated Executive Severance Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod', window );">Executive severance plan, severance benefits, lump sum, payment period</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Minimum | Approval Of Amended And Restated Executive Severance Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod', window );">Executive severance plan, severance benefits, termination period</a></td>
<td class="text">9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Maximum | Approval Of Amended And Restated Executive Severance Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod', window );">Executive severance plan, severance benefits, termination period</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">November 2023 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Number of employees eliminated in restructuring | employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent', window );">Percentage of positions eliminated in restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">November 2023 Restructuring Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring expected cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">November 2023 Restructuring Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring expected cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Executive Severance Plan, Severance Benefits, Lump Sum, Payment Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Executive Severance Plan, Severance Benefits, Termination Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=sgmo_November2023RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=sgmo_November2023RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>sgmo-20230930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sgmo="http://www.sangamo.com/20230930"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="sgmo-20230930.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2023-10-30</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">sgmo:ChangeInAgreementEstimateMarch2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">sgmo:ChangeInAgreementEstimateSeptember2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">sgmo:ChangeInAgreementEstimateSeptember2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:OtherLicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:OtherLicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:OtherLicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:OtherLicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sgmo:USGovernmentSponsoredAgencyBondMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sgmo:USGovernmentSponsoredAgencyBondMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sgmo:USGovernmentSponsoredAgencyBondMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sgmo:USGovernmentSponsoredAgencyBondMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sgmo:USGovernmentSponsoredAgencyBondMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfCommercialMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-27</startDate>
            <endDate>2020-07-27</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-15</startDate>
            <endDate>2023-06-15</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sgmo:LeaseholdImprovementsAndConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sgmo:FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-26</startDate>
            <endDate>2023-04-26</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">sgmo:FullTimeEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-26</startDate>
            <endDate>2023-04-26</endDate>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">sgmo:ContractedEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-26</startDate>
            <endDate>2023-04-26</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:April2023RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:November2023RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-11</startDate>
            <endDate>2023-10-11</endDate>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:November2023RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-11</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">sgmo:November2023RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-11</instant>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sgmo:ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-28</startDate>
            <endDate>2023-10-28</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sgmo:ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-28</startDate>
            <endDate>2023-10-28</endDate>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sgmo:ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-28</startDate>
            <endDate>2023-10-28</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="milestone">
        <measure>sgmo:milestone</measure>
    </unit>
    <unit id="product">
        <measure>sgmo:product</measure>
    </unit>
    <unit id="option">
        <measure>sgmo:option</measure>
    </unit>
    <unit id="performance_obligation">
        <measure>sgmo:performance_obligation</measure>
    </unit>
    <unit id="material_right">
        <measure>sgmo:material_right</measure>
    </unit>
    <unit id="product_target">
        <measure>sgmo:product_target</measure>
    </unit>
    <unit id="employee">
        <measure>sgmo:employee</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-26">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-27">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-28">0001001233</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-29">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-30171</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">SANGAMO THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">68-0359556</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">7000 Marina Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Brisbane</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">94005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">970-6000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">SGMO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">177346980</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-30" unitRef="usd">56514000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-31" unitRef="usd">100444000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent contextRef="c-3" decimals="-3" id="f-32" unitRef="usd">75597000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">177188000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent>
    <us-gaap:InterestReceivableCurrent contextRef="c-3" decimals="-3" id="f-34" unitRef="usd">602000</us-gaap:InterestReceivableCurrent>
    <us-gaap:InterestReceivableCurrent contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">794000</us-gaap:InterestReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-3" decimals="-3" id="f-36" unitRef="usd">1148000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">3678000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-38" unitRef="usd">13715000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-39" unitRef="usd">18223000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-40" unitRef="usd">147576000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">300327000</us-gaap:AssetsCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent contextRef="c-3" decimals="-3" id="f-42" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">29845000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-44" unitRef="usd">28436000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-45" unitRef="usd">63531000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-3" decimals="-3" id="f-46" unitRef="usd">0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-47" unitRef="usd">50729000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c-3" decimals="-3" id="f-48" unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">37552000</us-gaap:Goodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-50" unitRef="usd">27211000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-51" unitRef="usd">62002000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-52" unitRef="usd">14974000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">17023000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-3" decimals="-3" id="f-54" unitRef="usd">1500000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">1500000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-56" unitRef="usd">219697000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">562509000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-58" unitRef="usd">15457000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">22418000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-3" decimals="-3" id="f-60" unitRef="usd">17306000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-4" decimals="-3" id="f-61" unitRef="usd">21506000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-62" unitRef="usd">14234000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">16007000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-3" id="f-64" unitRef="usd">1485000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">51780000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-66" unitRef="usd">48482000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">111711000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-68" unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">109377000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-70" unitRef="usd">34975000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">38986000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-3" decimals="-3" id="f-72" unitRef="usd">0</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-3" id="f-73" unitRef="usd">6270000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-74" unitRef="usd">1318000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">1207000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-76" unitRef="usd">84775000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-77" unitRef="usd">267551000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-78" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-79" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockValue contextRef="c-3" decimals="-3" id="f-80" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-3" id="f-81" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-82" unitRef="usd">1773000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-83" unitRef="usd">1668000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-3" decimals="-3" id="f-84" unitRef="usd">1485811000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-3" id="f-85" unitRef="usd">1450239000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-86" unitRef="usd">-1346081000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-87" unitRef="usd">-1148545000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-88" unitRef="usd">-6581000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-89" unitRef="usd">-8404000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-90" unitRef="usd">134922000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-91" unitRef="usd">294958000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-92" unitRef="usd">219697000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-93" unitRef="usd">562509000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-94" unitRef="usd">9398000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-95" unitRef="usd">26460000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-96" unitRef="usd">174190000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-3" id="f-97" unitRef="usd">84069000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-3" id="f-98" unitRef="usd">57089000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-3" id="f-99" unitRef="usd">65116000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-100" unitRef="usd">183351000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-3" id="f-101" unitRef="usd">183719000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-102" unitRef="usd">13918000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-103" unitRef="usd">16238000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-104" unitRef="usd">48068000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-7" decimals="-3" id="f-105" unitRef="usd">46239000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-5" decimals="-3" id="f-106" unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-6" decimals="-3" id="f-107" unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-1" decimals="-3" id="f-108" unitRef="usd">89485000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-7" decimals="-3" id="f-109" unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-5" decimals="-3" id="f-110" unitRef="usd">44799000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-6" decimals="-3" id="f-111" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="-3" id="f-112" unitRef="usd">65232000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-7" decimals="-3" id="f-113" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:OperatingExpenses contextRef="c-5" decimals="-3" id="f-114" unitRef="usd">115806000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-6" decimals="-3" id="f-115" unitRef="usd">81354000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-116" unitRef="usd">386136000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-7" decimals="-3" id="f-117" unitRef="usd">229958000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-118" unitRef="usd">-106408000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-119" unitRef="usd">-54894000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-120" unitRef="usd">-211946000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-3" id="f-121" unitRef="usd">-145889000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndOtherIncome contextRef="c-5" decimals="-3" id="f-122" unitRef="usd">3515000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="c-6" decimals="-3" id="f-123" unitRef="usd">1769000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="c-1" decimals="-3" id="f-124" unitRef="usd">9610000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="c-7" decimals="-3" id="f-125" unitRef="usd">5754000</us-gaap:InterestAndOtherIncome>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-126" unitRef="usd">-102893000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-127" unitRef="usd">-53125000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-128" unitRef="usd">-202336000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-129" unitRef="usd">-140135000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-130" unitRef="usd">1270000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-131" unitRef="usd">30000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-132" unitRef="usd">-4800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-3" id="f-133" unitRef="usd">170000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-134" unitRef="usd">-104163000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-135" unitRef="usd">-53155000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-136" unitRef="usd">-197536000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-137" unitRef="usd">-140305000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-138"
      unitRef="usdPerShare">-0.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-139"
      unitRef="usdPerShare">-0.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-140"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-141"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-142"
      unitRef="usdPerShare">-1.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-143"
      unitRef="usdPerShare">-1.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-144"
      unitRef="usdPerShare">-0.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-145"
      unitRef="usdPerShare">-0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-3" id="f-146" unitRef="shares">177171000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-3" id="f-147" unitRef="shares">177171000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-3" id="f-148" unitRef="shares">158042000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-3" id="f-149" unitRef="shares">158042000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-150" unitRef="shares">173375000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-151" unitRef="shares">173375000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-3" id="f-152" unitRef="shares">150850000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-3" id="f-153" unitRef="shares">150850000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-154" unitRef="usd">-104163000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-155" unitRef="usd">-53155000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-156" unitRef="usd">-197536000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-157" unitRef="usd">-140305000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-3" id="f-158" unitRef="usd">-1144000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-3" id="f-159" unitRef="usd">-6028000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-160" unitRef="usd">981000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-3" id="f-161" unitRef="usd">-14040000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-3" id="f-162" unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-3" id="f-163" unitRef="usd">-55000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-164" unitRef="usd">-2000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-3" id="f-165" unitRef="usd">-130000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-5" decimals="-3" id="f-166" unitRef="usd">494000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-6" decimals="-3" id="f-167" unitRef="usd">135000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-168" unitRef="usd">840000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-7" decimals="-3" id="f-169" unitRef="usd">-1101000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-170" unitRef="usd">-104808000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-171" unitRef="usd">-58993000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-172" unitRef="usd">-195713000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-3" id="f-173" unitRef="usd">-155316000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesIssued contextRef="c-8" decimals="INF" id="f-174" unitRef="shares">177074546</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-175" unitRef="usd">1771000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-176" unitRef="usd">1479725000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-177" unitRef="usd">-1241918000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-178" unitRef="usd">-5936000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-3" id="f-179" unitRef="usd">233642000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-13"
      decimals="INF"
      id="f-180"
      unitRef="shares">205129</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-13" decimals="-3" id="f-181" unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-14" decimals="-3" id="f-182" unitRef="usd">-103000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-5" decimals="-3" id="f-183" unitRef="usd">-101000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-14" decimals="-3" id="f-184" unitRef="usd">6189000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-185" unitRef="usd">6189000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="c-15" decimals="-3" id="f-186" unitRef="usd">1144000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="c-5" decimals="-3" id="f-187" unitRef="usd">1144000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-15" decimals="-3" id="f-188" unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-5" decimals="-3" id="f-189" unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-15" decimals="-3" id="f-190" unitRef="usd">494000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-5" decimals="-3" id="f-191" unitRef="usd">494000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-16" decimals="-3" id="f-192" unitRef="usd">-104163000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-193" unitRef="usd">-104163000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-17"
      decimals="INF"
      id="f-194"
      unitRef="shares">177279675</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-195" unitRef="usd">1773000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-196" unitRef="usd">1485811000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-197" unitRef="usd">-1346081000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-198" unitRef="usd">-6581000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-199" unitRef="usd">134922000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-21"
      decimals="INF"
      id="f-200"
      unitRef="shares">166793320</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-201" unitRef="usd">1668000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-3" id="f-202" unitRef="usd">1450239000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-3" id="f-203" unitRef="usd">-1148545000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-3" id="f-204" unitRef="usd">-8404000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-205" unitRef="usd">294958000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-25"
      decimals="INF"
      id="f-206"
      unitRef="shares">8249261</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-25" decimals="-3" id="f-207" unitRef="usd">83000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-26" decimals="-3" id="f-208" unitRef="usd">15023000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-3" id="f-209" unitRef="usd">15106000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-25"
      decimals="INF"
      id="f-210"
      unitRef="shares">1481508</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-25" decimals="-3" id="f-211" unitRef="usd">15000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-26" decimals="-3" id="f-212" unitRef="usd">-1419000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-3" id="f-213" unitRef="usd">-1404000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="c-25"
      decimals="INF"
      id="f-214"
      unitRef="shares">755586</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-25" decimals="-3" id="f-215" unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-26" decimals="-3" id="f-216" unitRef="usd">712000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-1" decimals="-3" id="f-217" unitRef="usd">719000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-26" decimals="-3" id="f-218" unitRef="usd">21256000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-219" unitRef="usd">21256000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="c-27" decimals="-3" id="f-220" unitRef="usd">-981000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="c-1" decimals="-3" id="f-221" unitRef="usd">-981000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-27" decimals="-3" id="f-222" unitRef="usd">-2000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-223" unitRef="usd">-2000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-27" decimals="-3" id="f-224" unitRef="usd">840000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-225" unitRef="usd">840000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-28" decimals="-3" id="f-226" unitRef="usd">-197536000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-227" unitRef="usd">-197536000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-17"
      decimals="INF"
      id="f-228"
      unitRef="shares">177279675</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-229" unitRef="usd">1773000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-230" unitRef="usd">1485811000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-231" unitRef="usd">-1346081000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-232" unitRef="usd">-6581000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-233" unitRef="usd">134922000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-29"
      decimals="INF"
      id="f-234"
      unitRef="shares">153352502</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-235" unitRef="usd">1534000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-236" unitRef="usd">1373324000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-237" unitRef="usd">-1043417000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-3" id="f-238" unitRef="usd">-13160000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-3" id="f-239" unitRef="usd">318281000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-34"
      decimals="INF"
      id="f-240"
      unitRef="shares">8483104</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-34" decimals="-3" id="f-241" unitRef="usd">85000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-35" decimals="-3" id="f-242" unitRef="usd">42089000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-6" decimals="-3" id="f-243" unitRef="usd">42174000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-34"
      decimals="INF"
      id="f-244"
      unitRef="shares">82617</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-34" decimals="-3" id="f-245" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-35" decimals="-3" id="f-246" unitRef="usd">-101000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-6" decimals="-3" id="f-247" unitRef="usd">-101000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-35" decimals="-3" id="f-248" unitRef="usd">7793000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-3" id="f-249" unitRef="usd">7793000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="c-36" decimals="-3" id="f-250" unitRef="usd">6028000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="c-6" decimals="-3" id="f-251" unitRef="usd">6028000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-36" decimals="-3" id="f-252" unitRef="usd">-55000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-6" decimals="-3" id="f-253" unitRef="usd">-55000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-36" decimals="-3" id="f-254" unitRef="usd">135000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-6" decimals="-3" id="f-255" unitRef="usd">135000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-37" decimals="-3" id="f-256" unitRef="usd">-53155000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-257" unitRef="usd">-53155000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-38"
      decimals="INF"
      id="f-258"
      unitRef="shares">161918223</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-259" unitRef="usd">1619000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-260" unitRef="usd">1423105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-261" unitRef="usd">-1096572000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-262" unitRef="usd">-18998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-3" id="f-263" unitRef="usd">309154000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-43"
      decimals="INF"
      id="f-264"
      unitRef="shares">145921530</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-3" id="f-265" unitRef="usd">1459000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-44" decimals="-3" id="f-266" unitRef="usd">1334138000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-3" id="f-267" unitRef="usd">-956267000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-46" decimals="-3" id="f-268" unitRef="usd">-3987000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-47" decimals="-3" id="f-269" unitRef="usd">375343000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-48"
      decimals="INF"
      id="f-270"
      unitRef="shares">14711770</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-48" decimals="-3" id="f-271" unitRef="usd">147000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-49" decimals="-3" id="f-272" unitRef="usd">66301000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-7" decimals="-3" id="f-273" unitRef="usd">66448000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-48"
      decimals="INF"
      id="f-274"
      unitRef="shares">925455</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-48" decimals="-3" id="f-275" unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-49" decimals="-3" id="f-276" unitRef="usd">-1847000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-7" decimals="-3" id="f-277" unitRef="usd">-1838000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="c-48"
      decimals="INF"
      id="f-278"
      unitRef="shares">359468</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-48" decimals="-3" id="f-279" unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-49" decimals="-3" id="f-280" unitRef="usd">1111000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-7" decimals="-3" id="f-281" unitRef="usd">1115000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-49" decimals="-3" id="f-282" unitRef="usd">23402000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-7" decimals="-3" id="f-283" unitRef="usd">23402000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="c-50" decimals="-3" id="f-284" unitRef="usd">14040000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="c-7" decimals="-3" id="f-285" unitRef="usd">14040000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-50" decimals="-3" id="f-286" unitRef="usd">-130000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-7" decimals="-3" id="f-287" unitRef="usd">-130000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-50" decimals="-3" id="f-288" unitRef="usd">-1101000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-7" decimals="-3" id="f-289" unitRef="usd">-1101000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-51" decimals="-3" id="f-290" unitRef="usd">-140305000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-291" unitRef="usd">-140305000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-38"
      decimals="INF"
      id="f-292"
      unitRef="shares">161918223</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-293" unitRef="usd">1619000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-294" unitRef="usd">1423105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-295" unitRef="usd">-1096572000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-296" unitRef="usd">-18998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-3" id="f-297" unitRef="usd">309154000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-298" unitRef="usd">-197536000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-299" unitRef="usd">-140305000</us-gaap:NetIncomeLoss>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-1" decimals="-3" id="f-300" unitRef="usd">89485000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-7" decimals="-3" id="f-301" unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="-3" id="f-302" unitRef="usd">65232000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-7" decimals="-3" id="f-303" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-304" unitRef="usd">13238000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-7" decimals="-3" id="f-305" unitRef="usd">8765000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-1" decimals="-3" id="f-306" unitRef="usd">2031000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-7" decimals="-3" id="f-307" unitRef="usd">324000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-308" unitRef="usd">5945000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-7" decimals="-3" id="f-309" unitRef="usd">6357000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-310" unitRef="usd">-6195000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-7" decimals="-3" id="f-311" unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-312" unitRef="usd">21256000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-3" id="f-313" unitRef="usd">23402000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-3" id="f-314" unitRef="usd">-1119000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-7" decimals="-3" id="f-315" unitRef="usd">0</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c-1" decimals="-3" id="f-316" unitRef="usd">-192000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c-7" decimals="-3" id="f-317" unitRef="usd">175000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-318" unitRef="usd">-2530000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-7" decimals="-3" id="f-319" unitRef="usd">-1491000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-320" unitRef="usd">-5159000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-7" decimals="-3" id="f-321" unitRef="usd">5848000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-3" id="f-322" unitRef="usd">-5220000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-7" decimals="-3" id="f-323" unitRef="usd">9443000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-1" decimals="-3" id="f-324" unitRef="usd">-4182000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-7" decimals="-3" id="f-325" unitRef="usd">-1225000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-3" id="f-326" unitRef="usd">-159671000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-7" decimals="-3" id="f-327" unitRef="usd">-64956000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-328" unitRef="usd">-3737000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-7" decimals="-3" id="f-329" unitRef="usd">-3298000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-1" decimals="-3" id="f-330" unitRef="usd">112000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="c-7" decimals="-3" id="f-331" unitRef="usd">95000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-332" unitRef="usd">-174304000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-3" id="f-333" unitRef="usd">-166578000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-1" decimals="-3" id="f-334" unitRef="usd">59551000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-7" decimals="-3" id="f-335" unitRef="usd">225621000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities contextRef="c-1" decimals="-3" id="f-336" unitRef="usd">193858000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities contextRef="c-7" decimals="-3" id="f-337" unitRef="usd">254990000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-338" unitRef="usd">18484000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-3" id="f-339" unitRef="usd">12697000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-340" unitRef="usd">115823000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-3" id="f-341" unitRef="usd">16672000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-52" decimals="-3" id="f-342" unitRef="usd">15106000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-53" decimals="-3" id="f-343" unitRef="usd">65848000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-344" unitRef="usd">1404000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-7" decimals="-3" id="f-345" unitRef="usd">1962000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-1" decimals="-3" id="f-346" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-7" decimals="-3" id="f-347" unitRef="usd">124000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-54" decimals="-3" id="f-348" unitRef="usd">719000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-55" decimals="-3" id="f-349" unitRef="usd">1115000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-350" unitRef="usd">14421000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-3" id="f-351" unitRef="usd">65125000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-352" unitRef="usd">130000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-3" id="f-353" unitRef="usd">479000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-354" unitRef="usd">-43930000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-3" id="f-355" unitRef="usd">-84302000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-356" unitRef="usd">101944000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-47" decimals="-3" id="f-357" unitRef="usd">180372000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-358" unitRef="usd">58014000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-42" decimals="-3" id="f-359" unitRef="usd">96070000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-360" unitRef="usd">2757000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-7" decimals="-3" id="f-361" unitRef="usd">3927000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <sgmo:TenantImprovementAllowanceWithinContraLeaseLiability contextRef="c-1" decimals="-3" id="f-362" unitRef="usd">0</sgmo:TenantImprovementAllowanceWithinContraLeaseLiability>
    <sgmo:TenantImprovementAllowanceWithinContraLeaseLiability contextRef="c-7" decimals="-3" id="f-363" unitRef="usd">1531000</sgmo:TenantImprovementAllowanceWithinContraLeaseLiability>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-364">ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Organization and Description of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sangamo Therapeutics, Inc. (&#x201c;Sangamo&#x201d; or &#x201c;the Company&#x201d;) was incorporated in the State of Delaware in June 1995 and changed its name from Sangamo Biosciences, Inc. in January 2017. Sangamo is a clinical-stage genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients with serious diseases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of these financial statements for the periods presented have been included. Operating results for the three and nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. The Condensed Consolidated Balance Sheet data at December&#160;31, 2022 was derived from the audited Consolidated Financial Statements included in Sangamo&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (the &#x201c;2022 Annual Report&#x201d;) as filed with the SEC on February&#160;23,&#160;2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in the Condensed Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements and related financial information should be read together with the audited Consolidated Financial Statements and footnotes for the year ended December&#160;31, 2022, included in the 2022 Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity, Going Concern, and Capital Resources&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sangamo is currently working on a number of long-term development projects that involve experimental technologies. The projects will require several years and substantial expenditures to complete and ultimately may be unsuccessful. In recent years, the Company&#x2019;s operations have been funded primarily through collaborations and strategic partnerships, research grants and from the issuance of equity securities. As of September&#160;30, 2023, the Company had capital resources of $132.1&#160;million consisting of cash, cash equivalents, and marketable securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under Accounting Standard Codification Topic 205-40, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Presentation of Financial Statements&#x2014;Going Concern&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC Topic 205-40&#x201d;), the Company has the responsibility to evaluate whether conditions and/or events raise substantial doubt about its ability to meet its future financial obligations as they become due within one year after the date that the Condensed Consolidated Financial Statements are issued. As required under ASC Topic 205-40, management&#x2019;s evaluation should initially not take into consideration the potential mitigating effects of management&#x2019;s plans that have not been fully implemented as of the date the Condensed Consolidated Financial Statements are issued. When substantial doubt exists, management evaluates whether the mitigating effects of its plans sufficiently alleviates the substantial doubt about the Company&#x2019;s ability to continue as a going concern. The mitigating effects of management&#x2019;s plans, however, are only considered if both (i) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (ii) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity&#x2019;s ability to continue as a going concern within one year after the date that the financial statements are issued. Generally, to be considered probable of being effectively implemented, the plans must have been approved by the Company&#x2019;s board of directors before the date that the financial statements are issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s history of significant losses, its negative cash flows from operations, its limited liquidity resources currently on hand, and its dependence on additional financing to fund its operations after the current resources are exhausted raise substantial doubt about its ability to continue to operate as a going concern within one year after the date that the Condensed Consolidated Financial Statements are issued. The Company&#x2019;s current operating plan, its cash, cash equivalents, and marketable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;securities as of September 30, 2023 are expected to allow the Company to meet its liquidity requirements only into the third quarter of 2024, which is less than one year following the date these Condensed Consolidated Financial Statements are issued. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Successful completion of the Company&#x2019;s development programs and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to support the Company&#x2019;s cost structure and operating plan. Management&#x2019;s plans include, among other things, pursuing one or more of the following steps to raise additional capital and reduce costs, none of which can be guaranteed or are entirely within the Company&#x2019;s control:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;raise funding through the sale of the Company&#x2019;s common stock;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;raise funding through debt or royalty financing; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;establish collaborations with potential partners to advance the Company&#x2019;s product pipeline.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company is unable to raise capital on acceptable terms, or at all, or if it is unable to procure collaboration arrangements or external direct investments to advance its programs, the Company would be required to discontinue some or all of its operations or develop and implement a plan to further extend payables, reduce overhead or scale back its current operating plan until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan would be successful. Additional capital may not be available to the Company on a timely basis, on terms that are acceptable or at all. In particular, the perception of the Company&#x2019;s ability to continue to operate as a going concern may make it more difficult to obtain financing for the continuation of its operations, particularly in light of currently challenging macroeconomic and market conditions. Further, the Company may be unable to attract new investments as a result of the speculative nature of its newly reprioritized core neurology preclinical programs. If adequate funds are not available to the Company on a timely basis, or at all, the Company will be required to take additional actions to address its liquidity needs, including additional cost reduction measures such as further reducing operating expenses and delaying, reducing the scope of, discontinuing or altering its research and development activities, which would have a material adverse effect on its business and prospects, or the Company may be required to cease operations entirely, liquidate all or a portion of its assets, and/or or seek protection under applicable bankruptcy laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Condensed Consolidated Financial Statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts of liabilities that may result from uncertainty related to the Company&#x2019;s ability to continue as a going concern.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. On an ongoing basis, management evaluates its estimates including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, income taxes, fair value of assets and liabilities, including from acquisitions, useful lives and impairment of long-lived assets, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2023, the Company recorded additional revenue related to a change in estimate in connection with the collaboration agreement with Kite Pharma, Inc., a Gilead Sciences, Inc. subsidiary (&#x201c;Kite&#x201d;). This adjustment was driven by a reduction in the estimated future level of the Company&#x2019;s research and development services and as a result, future project costs. This resulted in an increase in proportional cumulative performance on this collaboration and an increase in revenue of $8.9&#160;million, a decrease in net loss of $8.9&#160;million, and a decrease in the Company&#x2019;s basic and diluted net loss per share of $0.05 for the nine months ended September 30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2023, the Company recorded additional revenue related to a change in estimate in connection with the collaboration agreement with Kite. This adjustment was driven by a further reduction in the estimated future level of the Company&#x2019;s research and development services and as a result, future project costs. This resulted in an increase in proportional cumulative performance on this collaboration and increased revenue by $4.9 million, decreased net loss by $4.9 million, and decreased the Company's basic and diluted net loss per share by $0.03 for the three and nine months ended September 30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:18pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its revenues pursuant to the provisions of Accounting Standards Codification Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC Topic 606&#x201d;). The Company&#x2019;s contract revenues are derived from collaboration agreements including licensing arrangements and research services. Research and licensing agreements typically include nonrefundable upfront signing or license fees, payments at negotiated rates for time incurred by Company researchers, third-party cost reimbursements, additional target selection fees, sublicense fees, milestone payments tied to ongoing development and product commercialization, and royalties on future licensees&#x2019; product sales. All funds received from the Company&#x2019;s collaboration partners are generally not refundable. Non-refundable upfront fees are fixed at the commencement of the contract. All other fees represent variable consideration in contracts. One of the Company&#x2019;s contracts also contains a provision where the Company reimburses its customer for certain costs they incur which is accounted for as a reduction to the contract transaction price as the Company does not acquire any distinct goods or services in exchange for such payments. Deferred revenue primarily represents the portion of nonrefundable upfront fees or milestone payments received but not earned.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under its agreements, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations based on estimated selling prices; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Most of the Company&#x2019;s performance obligations in its collaboration agreements represent distinct bundles of licenses of intellectual property and research and development services, with these components being individually non-distinct. Options to license the Company&#x2019;s intellectual property and/or acquire research and development services also represent performance obligations when they grant customers a material right, e.g., a right to a discount the customer would not have received if they did not purchase the Company&#x2019;s services under the existing contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from bundles of licenses of intellectual property and research and development services are recognized over time using a proportional performance method. Under this method, revenue is recognized by measuring progress towards satisfaction of the relevant performance obligation using a measure that best depicts the progress towards satisfaction of the relevant performance obligation. For most of the Company&#x2019;s agreements the measure of progress is an input measure based on a level of effort incurred, which includes the value of actual time by Company researchers plus third-party cost reimbursements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consideration allocated to options that include material rights is deferred until the options are exercised or expire. The exercise of such options is accounted for as contract continuation, with target selection fees and estimated variable consideration included in the transaction price at that time and allocated specifically to the respective target&#x2019;s performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant management judgment is required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations under the arrangement. Changes in these estimates can have a material effect on revenue recognized. If the Company cannot reasonably estimate when its performance obligations either are completed or become inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. For variable consideration, the amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint and, if necessary, adjusts its estimate of the overall transaction price. A cumulative catch-up is then recorded in the current period to reflect the updated transaction price and the updated measure of progress. The estimated period of performance and level of effort, including the value of Company researchers&#x2019; time and third-party costs, are reviewed quarterly and adjusted, as needed, to reflect the Company&#x2019;s current expectations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price of each performance obligation identified in the contract. The Company uses key assumptions to determine the stand-alone selling price, which may include forecasted revenues, development timelines, discount rates and probabilities of exercise of technical and regulatory success, and the expected level of effort for research and development services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract modifications occur when the price and/or scope of an arrangement changes. If the modification consists of adding new distinct goods or services in exchange for consideration that reflects standalone selling prices of these goods and services, the modification is accounted for as a separate contract with the customer. Otherwise, if the remaining goods and services are distinct from those previously provided, the existing contract is considered terminated, and the remaining consideration is allocated to the remaining goods and services as if this was a newly signed contract. If the remaining goods and services are not distinct from those previously provided, the effects of the modification are accounted for in a manner similar to the effect of a change in the estimated measure of progress, with cumulative catch-up in revenue recorded at the time of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;modification. If some of the remaining goods and services are distinct from those previously provided and others are not, to account for the effects of the modification the Company applies principles consistent with the objectives of the modification accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from collaboration and licensing agreements as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Kite Pharma, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biogen MA, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Novartis Institutes for BioMedical Research, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other licensing agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Goodwill, Indefinite-lived Intangible Assets and Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of consideration transferred over the fair values of assets acquired and liabilities assumed in a business combination. Intangible assets with indefinite useful lives are related to acquired in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) projects and are initially measured at their respective fair values as of the acquisition date. Goodwill and indefinite-lived intangible assets are not amortized. Intangible assets related to IPR&amp;amp;D projects are considered to be indefinite-lived until the completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs if and when regulatory approval to market a product is obtained, the associated assets would be deemed finite-lived and would then be amortized based on their respective estimated useful lives at that point in time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and indefinite-lived intangible assets are assessed for impairment on an annual basis and whenever events and circumstances indicate that these assets may be impaired. The Company evaluates the carrying value of long-lived assets, which include property and equipment, leasehold improvements and right-of-use assets, for impairment whenever events or changes in circumstances indicate that the carrying amounts of the asset may not be fully recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In testing for goodwill impairment, the Company has the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If the Company elects to bypass the qualitative assessment, or if a qualitative assessment indicates it is more likely than not that the carrying value exceeds its fair value, the Company performs a quantitative goodwill impairment test to compare the fair value of its reporting unit to its carrying value, including goodwill. If the carrying value, including goodwill, exceeds the reporting unit&#x2019;s fair value, the Company will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value (but not in excess of the carrying value of goodwill).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing each annual impairment assessment and any interim impairment assessment for its indefinite-lived intangible assets, the Company determines if it should qualitatively assess whether it is more likely than not the fair value of its IPR&amp;amp;D asset is less than its carrying amount (the qualitative impairment test). If the Company concludes that is the case, or elects not to use the qualitative impairment test, the Company will proceed with quantitatively determining the fair value of the IPR&amp;amp;D asset and comparing its fair value to its carrying value to determine the amount of impairment, if any (the quantitative impairment test).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the qualitative impairment test, the Company considers the results of the most recent quantitative impairment test and identifies the most relevant drivers of the fair value for the IPR&amp;amp;D asset. The most relevant drivers of fair value identified are consistent with the assumptions used in the quantitative estimate of the IPR&amp;amp;D asset. Using these drivers of fair value, the Company identifies events and circumstances which may have an effect on the fair value of the IPR&amp;amp;D asset since the last time the IPR&amp;amp;D&#x2019;s fair value was quantitatively determined. The Company then weighs these factors to determine and conclude if it is not more likely than not the IPR&amp;amp;D asset is impaired. If it is more likely than not the IPR&amp;amp;D asset is impaired, the Company proceeds with quantitatively determining the fair value of the IPR&amp;amp;D asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When performing the quantitative impairment test, the Company uses the income approach to determine the fair value of its IPR&amp;amp;D asset. This approach calculates fair value by estimating the after-tax cash flows attributable to an in-process project over its useful life and then discounting these after-tax cash flows back to a present value. This estimate includes judgmental assumptions regarding the estimates that market participants would make in evaluating the IPR&amp;amp;D asset, including the probability of successfully completing clinical trials and obtaining regulatory approval to market the IPR&amp;amp;D asset, the timing of and the expected costs to complete IPR&amp;amp;D projects, future net cash flows from potential drug sales, which are based on estimates of the sales price of the drug, the size of the patient population and cure rate, its competitive position in the marketplace, and appropriate discount and tax rates. Any impairment to be recorded is calculated as the difference between the estimated fair value and the carrying value of the IPR&amp;amp;D asset on the Company&#x2019;s Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a change in circumstance occurs that indicates long-lived assets may be impaired, the Company performs a test of recoverability by comparing the carrying value of the asset or asset group to its undiscounted expected future cash flows. The long-lived asset evaluation is performed at the asset group level, i.e., the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. If this review indicates that the carrying amount of the asset group is not recoverable, an impairment loss is measured as the amount by which the carrying amount of an asset group exceeds its fair value. Any impairment loss is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets, except that the carrying amount of an individual asset shall not be reduced below its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Factors that may indicate potential impairment and trigger an impairment test include, but are not limited to, general macroeconomic conditions, conditions specific to the industry and market, an adverse change in legal factors, impairment of goodwill or indefinite-lived intangible assets, business climate or operational performance of the business, and sustained decline in the stock price and market capitalization compared to the net book value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Calculating the fair value of a reporting unit, an asset group and an individual asset involves significant estimates and assumptions. These estimates and assumptions include, among others, projected future cash flows, risk-adjusted discount rates, future economic and market conditions, and the determination of appropriate market comparables. Changes in these factors and assumptions used can materially affect the amount of impairment loss recognized in the period the asset was considered impaired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sangamo considers all highly liquid investments purchased with original maturities of three months or less at the purchase date to be cash equivalents. Cash and cash equivalents consist of cash, deposits in demand money market accounts and U.S. government-sponsored entity debt securities. Restricted cash consists of a letter of credit for $1.5&#160;million, representing a deposit for the lease of the corporate headquarters in Brisbane, California.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sangamo classifies its marketable securities as available-for-sale and records its investments at estimated fair value based on quoted market prices or observable market inputs of almost identical assets, with the unrealized holding gains and losses included in accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;). The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as non-current marketable securities in the accompanying Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments are subject to a periodic impairment review. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time and extent to which the fair value has been less than the cost basis, the Company's financial condition and its intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value. Realized gains and losses on marketable securities are included in interest and other income, net, which are determined using the specific identification method. Credit losses related to the marketable securities are recorded in interest and other income, net in the Condensed Consolidated Statements of Operations through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company intends to sell, or if it is more likely than not that the Company will be required to sell, a security before recovery of its amortized cost basis, the allowance for credit losses is written off, and the amortized cost of the security is written down to its fair value, with an impairment charge recognized. This also results in a reversal of any unrealized gains and losses for this security that were previously included in AOCI. Impairment charges are included in interest and other income, net in the Condensed Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether it has the right to control the identified asset. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;arising from the lease. Lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. Right-of-use assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the implicit rate in the Company&#x2019;s leases is generally unknown, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of remaining lease payments. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease in a similar economic environment. The Company considers its credit risk, term of the lease, and total lease payments and adjusts for the impacts of collateral, as necessary, when calculating its incremental borrowing rates. The lease terms may include options to extend or terminate the lease when it is reasonably certain the Company will exercise any such options. Rent expense for the Company&#x2019;s operating leases is recognized on a straight-line basis over the lease term. The Company will evaluate the lease arrangement for impairment whenever events or changes in circumstances indicate that the carrying amounts of the right-of-use asset may not be fully recoverable. To the extent an impairment of the right-of-use asset is recognized, the Company will recognize lease impairment and subsequently amortize the remaining lease asset on a straight-line basis (unless another systematic basis is more representative of the pattern in which the Company expects to consume the future economic benefits from the asset) from the date of impairment to the earlier of the end of the right-of-use asset&#x2019;s useful life or the end of the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected not to separate lease and non-lease components for its real estate and copier leases and, as a result, accounts for any lease and non-lease components as a single lease component. The Company has also elected not to apply the recognition requirement to any leases with a term of 12 months or less and does not include an option to purchase the underlying asset that the Company is reasonably certain to exercise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-365">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of these financial statements for the periods presented have been included. Operating results for the three and nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. The Condensed Consolidated Balance Sheet data at December&#160;31, 2022 was derived from the audited Consolidated Financial Statements included in Sangamo&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (the &#x201c;2022 Annual Report&#x201d;) as filed with the SEC on February&#160;23,&#160;2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-366">The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in the Condensed Consolidated Financial Statements.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="c-3" decimals="-5" id="f-367" unitRef="usd">132100000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-368">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. On an ongoing basis, management evaluates its estimates including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, income taxes, fair value of assets and liabilities, including from acquisitions, useful lives and impairment of long-lived assets, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-56" decimals="-5" id="f-369" unitRef="usd">8900000</sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent contextRef="c-56" decimals="-5" id="f-370" unitRef="usd">-8900000</sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent>
    <sgmo:IncreaseDecreaseInEarningsPerShareDiluted
      contextRef="c-56"
      decimals="2"
      id="f-371"
      unitRef="usdPerShare">-0.05</sgmo:IncreaseDecreaseInEarningsPerShareDiluted>
    <sgmo:IncreaseDecreaseInEarningsPerShareBasic
      contextRef="c-56"
      decimals="2"
      id="f-372"
      unitRef="usdPerShare">-0.05</sgmo:IncreaseDecreaseInEarningsPerShareBasic>
    <sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-57" decimals="-5" id="f-373" unitRef="usd">4900000</sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-58" decimals="-5" id="f-374" unitRef="usd">4900000</sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent contextRef="c-58" decimals="-5" id="f-375" unitRef="usd">-4900000</sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent>
    <sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent contextRef="c-57" decimals="-5" id="f-376" unitRef="usd">-4900000</sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent>
    <sgmo:IncreaseDecreaseInEarningsPerShareBasic
      contextRef="c-57"
      decimals="2"
      id="f-377"
      unitRef="usdPerShare">-0.03</sgmo:IncreaseDecreaseInEarningsPerShareBasic>
    <sgmo:IncreaseDecreaseInEarningsPerShareDiluted
      contextRef="c-58"
      decimals="2"
      id="f-378"
      unitRef="usdPerShare">-0.03</sgmo:IncreaseDecreaseInEarningsPerShareDiluted>
    <sgmo:IncreaseDecreaseInEarningsPerShareDiluted
      contextRef="c-57"
      decimals="2"
      id="f-379"
      unitRef="usdPerShare">-0.03</sgmo:IncreaseDecreaseInEarningsPerShareDiluted>
    <sgmo:IncreaseDecreaseInEarningsPerShareBasic
      contextRef="c-58"
      decimals="2"
      id="f-380"
      unitRef="usdPerShare">-0.03</sgmo:IncreaseDecreaseInEarningsPerShareBasic>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-381">&lt;div style="margin-top:9pt;padding-left:18pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its revenues pursuant to the provisions of Accounting Standards Codification Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC Topic 606&#x201d;). The Company&#x2019;s contract revenues are derived from collaboration agreements including licensing arrangements and research services. Research and licensing agreements typically include nonrefundable upfront signing or license fees, payments at negotiated rates for time incurred by Company researchers, third-party cost reimbursements, additional target selection fees, sublicense fees, milestone payments tied to ongoing development and product commercialization, and royalties on future licensees&#x2019; product sales. All funds received from the Company&#x2019;s collaboration partners are generally not refundable. Non-refundable upfront fees are fixed at the commencement of the contract. All other fees represent variable consideration in contracts. One of the Company&#x2019;s contracts also contains a provision where the Company reimburses its customer for certain costs they incur which is accounted for as a reduction to the contract transaction price as the Company does not acquire any distinct goods or services in exchange for such payments. Deferred revenue primarily represents the portion of nonrefundable upfront fees or milestone payments received but not earned.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under its agreements, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations based on estimated selling prices; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Most of the Company&#x2019;s performance obligations in its collaboration agreements represent distinct bundles of licenses of intellectual property and research and development services, with these components being individually non-distinct. Options to license the Company&#x2019;s intellectual property and/or acquire research and development services also represent performance obligations when they grant customers a material right, e.g., a right to a discount the customer would not have received if they did not purchase the Company&#x2019;s services under the existing contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from bundles of licenses of intellectual property and research and development services are recognized over time using a proportional performance method. Under this method, revenue is recognized by measuring progress towards satisfaction of the relevant performance obligation using a measure that best depicts the progress towards satisfaction of the relevant performance obligation. For most of the Company&#x2019;s agreements the measure of progress is an input measure based on a level of effort incurred, which includes the value of actual time by Company researchers plus third-party cost reimbursements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consideration allocated to options that include material rights is deferred until the options are exercised or expire. The exercise of such options is accounted for as contract continuation, with target selection fees and estimated variable consideration included in the transaction price at that time and allocated specifically to the respective target&#x2019;s performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant management judgment is required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations under the arrangement. Changes in these estimates can have a material effect on revenue recognized. If the Company cannot reasonably estimate when its performance obligations either are completed or become inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. For variable consideration, the amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint and, if necessary, adjusts its estimate of the overall transaction price. A cumulative catch-up is then recorded in the current period to reflect the updated transaction price and the updated measure of progress. The estimated period of performance and level of effort, including the value of Company researchers&#x2019; time and third-party costs, are reviewed quarterly and adjusted, as needed, to reflect the Company&#x2019;s current expectations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price of each performance obligation identified in the contract. The Company uses key assumptions to determine the stand-alone selling price, which may include forecasted revenues, development timelines, discount rates and probabilities of exercise of technical and regulatory success, and the expected level of effort for research and development services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract modifications occur when the price and/or scope of an arrangement changes. If the modification consists of adding new distinct goods or services in exchange for consideration that reflects standalone selling prices of these goods and services, the modification is accounted for as a separate contract with the customer. Otherwise, if the remaining goods and services are distinct from those previously provided, the existing contract is considered terminated, and the remaining consideration is allocated to the remaining goods and services as if this was a newly signed contract. If the remaining goods and services are not distinct from those previously provided, the effects of the modification are accounted for in a manner similar to the effect of a change in the estimated measure of progress, with cumulative catch-up in revenue recorded at the time of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;modification. If some of the remaining goods and services are distinct from those previously provided and others are not, to account for the effects of the modification the Company applies principles consistent with the objectives of the modification accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from collaboration and licensing agreements as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Kite Pharma, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biogen MA, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Novartis Institutes for BioMedical Research, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other licensing agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock contextRef="c-1" id="f-382">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from collaboration and licensing agreements as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Kite Pharma, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biogen MA, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Novartis Institutes for BioMedical Research, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other licensing agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-59" decimals="2" id="f-383" unitRef="number">0.58</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-60" decimals="2" id="f-384" unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-61" decimals="2" id="f-385" unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-62" decimals="2" id="f-386" unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-63" decimals="2" id="f-387" unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-64" decimals="2" id="f-388" unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-65" decimals="2" id="f-389" unitRef="number">0.77</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-66" decimals="2" id="f-390" unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-67" decimals="2" id="f-391" unitRef="number">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-68" decimals="2" id="f-392" unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-69" decimals="2" id="f-393" unitRef="number">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-70" decimals="2" id="f-394" unitRef="number">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-71" decimals="2" id="f-395" unitRef="number">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-72" decimals="2" id="f-396" unitRef="number">0.02</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-73" decimals="2" id="f-397" unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-74" decimals="2" id="f-398" unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="c-1" id="f-399">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Goodwill, Indefinite-lived Intangible Assets and Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of consideration transferred over the fair values of assets acquired and liabilities assumed in a business combination. Intangible assets with indefinite useful lives are related to acquired in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) projects and are initially measured at their respective fair values as of the acquisition date. Goodwill and indefinite-lived intangible assets are not amortized. Intangible assets related to IPR&amp;amp;D projects are considered to be indefinite-lived until the completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs if and when regulatory approval to market a product is obtained, the associated assets would be deemed finite-lived and would then be amortized based on their respective estimated useful lives at that point in time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and indefinite-lived intangible assets are assessed for impairment on an annual basis and whenever events and circumstances indicate that these assets may be impaired. The Company evaluates the carrying value of long-lived assets, which include property and equipment, leasehold improvements and right-of-use assets, for impairment whenever events or changes in circumstances indicate that the carrying amounts of the asset may not be fully recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In testing for goodwill impairment, the Company has the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If the Company elects to bypass the qualitative assessment, or if a qualitative assessment indicates it is more likely than not that the carrying value exceeds its fair value, the Company performs a quantitative goodwill impairment test to compare the fair value of its reporting unit to its carrying value, including goodwill. If the carrying value, including goodwill, exceeds the reporting unit&#x2019;s fair value, the Company will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value (but not in excess of the carrying value of goodwill).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing each annual impairment assessment and any interim impairment assessment for its indefinite-lived intangible assets, the Company determines if it should qualitatively assess whether it is more likely than not the fair value of its IPR&amp;amp;D asset is less than its carrying amount (the qualitative impairment test). If the Company concludes that is the case, or elects not to use the qualitative impairment test, the Company will proceed with quantitatively determining the fair value of the IPR&amp;amp;D asset and comparing its fair value to its carrying value to determine the amount of impairment, if any (the quantitative impairment test).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the qualitative impairment test, the Company considers the results of the most recent quantitative impairment test and identifies the most relevant drivers of the fair value for the IPR&amp;amp;D asset. The most relevant drivers of fair value identified are consistent with the assumptions used in the quantitative estimate of the IPR&amp;amp;D asset. Using these drivers of fair value, the Company identifies events and circumstances which may have an effect on the fair value of the IPR&amp;amp;D asset since the last time the IPR&amp;amp;D&#x2019;s fair value was quantitatively determined. The Company then weighs these factors to determine and conclude if it is not more likely than not the IPR&amp;amp;D asset is impaired. If it is more likely than not the IPR&amp;amp;D asset is impaired, the Company proceeds with quantitatively determining the fair value of the IPR&amp;amp;D asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When performing the quantitative impairment test, the Company uses the income approach to determine the fair value of its IPR&amp;amp;D asset. This approach calculates fair value by estimating the after-tax cash flows attributable to an in-process project over its useful life and then discounting these after-tax cash flows back to a present value. This estimate includes judgmental assumptions regarding the estimates that market participants would make in evaluating the IPR&amp;amp;D asset, including the probability of successfully completing clinical trials and obtaining regulatory approval to market the IPR&amp;amp;D asset, the timing of and the expected costs to complete IPR&amp;amp;D projects, future net cash flows from potential drug sales, which are based on estimates of the sales price of the drug, the size of the patient population and cure rate, its competitive position in the marketplace, and appropriate discount and tax rates. Any impairment to be recorded is calculated as the difference between the estimated fair value and the carrying value of the IPR&amp;amp;D asset on the Company&#x2019;s Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a change in circumstance occurs that indicates long-lived assets may be impaired, the Company performs a test of recoverability by comparing the carrying value of the asset or asset group to its undiscounted expected future cash flows. The long-lived asset evaluation is performed at the asset group level, i.e., the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. If this review indicates that the carrying amount of the asset group is not recoverable, an impairment loss is measured as the amount by which the carrying amount of an asset group exceeds its fair value. Any impairment loss is allocated to the long-lived assets of the group on a pro rata basis using the relative carrying amounts of those assets, except that the carrying amount of an individual asset shall not be reduced below its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Factors that may indicate potential impairment and trigger an impairment test include, but are not limited to, general macroeconomic conditions, conditions specific to the industry and market, an adverse change in legal factors, impairment of goodwill or indefinite-lived intangible assets, business climate or operational performance of the business, and sustained decline in the stock price and market capitalization compared to the net book value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Calculating the fair value of a reporting unit, an asset group and an individual asset involves significant estimates and assumptions. These estimates and assumptions include, among others, projected future cash flows, risk-adjusted discount rates, future economic and market conditions, and the determination of appropriate market comparables. Changes in these factors and assumptions used can materially affect the amount of impairment loss recognized in the period the asset was considered impaired.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-400">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sangamo considers all highly liquid investments purchased with original maturities of three months or less at the purchase date to be cash equivalents. Cash and cash equivalents consist of cash, deposits in demand money market accounts and U.S. government-sponsored entity debt securities. Restricted cash consists of a letter of credit for $1.5&#160;million, representing a deposit for the lease of the corporate headquarters in Brisbane, California.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:LettersOfCreditOutstandingAmount contextRef="c-3" decimals="-5" id="f-401" unitRef="usd">1500000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock contextRef="c-1" id="f-402">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-403">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-404" unitRef="usd">56514000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-405" unitRef="usd">100444000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-42" decimals="-3" id="f-406" unitRef="usd">94570000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-47" decimals="-3" id="f-407" unitRef="usd">178872000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="c-3" decimals="-3" id="f-408" unitRef="usd">1500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="c-4" decimals="-3" id="f-409" unitRef="usd">1500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="c-42" decimals="-3" id="f-410" unitRef="usd">1500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="c-47" decimals="-3" id="f-411" unitRef="usd">1500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-412" unitRef="usd">58014000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-413" unitRef="usd">101944000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-42" decimals="-3" id="f-414" unitRef="usd">96070000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-47" decimals="-3" id="f-415" unitRef="usd">180372000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:MarketableSecuritiesPolicy contextRef="c-1" id="f-416">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sangamo classifies its marketable securities as available-for-sale and records its investments at estimated fair value based on quoted market prices or observable market inputs of almost identical assets, with the unrealized holding gains and losses included in accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;). The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as non-current marketable securities in the accompanying Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments are subject to a periodic impairment review. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time and extent to which the fair value has been less than the cost basis, the Company's financial condition and its intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value. Realized gains and losses on marketable securities are included in interest and other income, net, which are determined using the specific identification method. Credit losses related to the marketable securities are recorded in interest and other income, net in the Condensed Consolidated Statements of Operations through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. &lt;/span&gt;&lt;/div&gt;If the Company intends to sell, or if it is more likely than not that the Company will be required to sell, a security before recovery of its amortized cost basis, the allowance for credit losses is written off, and the amortized cost of the security is written down to its fair value, with an impairment charge recognized. This also results in a reversal of any unrealized gains and losses for this security that were previously included in AOCI. Impairment charges are included in interest and other income, net in the Condensed Consolidated Statements of Operations.</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-417">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether it has the right to control the identified asset. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;arising from the lease. Lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. Right-of-use assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the implicit rate in the Company&#x2019;s leases is generally unknown, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of remaining lease payments. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease in a similar economic environment. The Company considers its credit risk, term of the lease, and total lease payments and adjusts for the impacts of collateral, as necessary, when calculating its incremental borrowing rates. The lease terms may include options to extend or terminate the lease when it is reasonably certain the Company will exercise any such options. Rent expense for the Company&#x2019;s operating leases is recognized on a straight-line basis over the lease term. The Company will evaluate the lease arrangement for impairment whenever events or changes in circumstances indicate that the carrying amounts of the right-of-use asset may not be fully recoverable. To the extent an impairment of the right-of-use asset is recognized, the Company will recognize lease impairment and subsequently amortize the remaining lease asset on a straight-line basis (unless another systematic basis is more representative of the pattern in which the Company expects to consume the future economic benefits from the asset) from the date of impairment to the earlier of the end of the right-of-use asset&#x2019;s useful life or the end of the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected not to separate lease and non-lease components for its real estate and copier leases and, as a result, accounts for any lease and non-lease components as a single lease component. The Company has also elected not to apply the recognition requirement to any leases with a term of 12 months or less and does not include an option to purchase the underlying asset that the Company is reasonably certain to exercise.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-418">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-419">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents and marketable securities. Fair value is determined based on a three-tier hierarchy under the authoritative guidance for fair value measurements and disclosures that prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurements and unobservable (i.e., supported by little or no market activity).&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-420">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents and marketable securities. Fair value is determined based on a three-tier hierarchy under the authoritative guidance for fair value measurements and disclosures that prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurements and unobservable (i.e., supported by little or no market activity).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value measurements of the Company&#x2019;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash Equivalents and Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally classifies its marketable securities as Level&#160;2. Instruments are classified as Level&#160;2 when observable market prices for identical securities that are traded in less active markets are used. When observable market prices for identical securities are not available, such instruments are priced using benchmark curves, benchmarking of like securities, sector groupings, matrix pricing and valuation models. These valuation models are proprietary to the pricing providers or brokers and incorporate a number of inputs, including in approximate order of priority: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications. For certain security types, additional inputs may be used, or some of the standard inputs may not be applicable. Evaluators may prioritize inputs differently on any given day for any security based on market conditions, and not all inputs listed are available for use in the evaluation process for each security evaluation on any given day.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="c-1" id="f-421">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value measurements of the Company&#x2019;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-75" decimals="-3" id="f-422" unitRef="usd">3417000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-76" decimals="-3" id="f-423" unitRef="usd">3417000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-77" decimals="-3" id="f-424" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-78" decimals="-3" id="f-425" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-79" decimals="-3" id="f-426" unitRef="usd">3417000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-80" decimals="-3" id="f-427" unitRef="usd">3417000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-81" decimals="-3" id="f-428" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-82" decimals="-3" id="f-429" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-83" decimals="-3" id="f-430" unitRef="usd">28637000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-84" decimals="-3" id="f-431" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-85" decimals="-3" id="f-432" unitRef="usd">28637000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-86" decimals="-3" id="f-433" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-87" decimals="-3" id="f-434" unitRef="usd">18891000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-88" decimals="-3" id="f-435" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-89" decimals="-3" id="f-436" unitRef="usd">18891000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-90" decimals="-3" id="f-437" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-91" decimals="-3" id="f-438" unitRef="usd">1379000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-92" decimals="-3" id="f-439" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-93" decimals="-3" id="f-440" unitRef="usd">1379000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-94" decimals="-3" id="f-441" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-95" decimals="-3" id="f-442" unitRef="usd">8429000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-96" decimals="-3" id="f-443" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-97" decimals="-3" id="f-444" unitRef="usd">8429000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-98" decimals="-3" id="f-445" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-99" decimals="-3" id="f-446" unitRef="usd">5581000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-100" decimals="-3" id="f-447" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-101" decimals="-3" id="f-448" unitRef="usd">5581000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-102" decimals="-3" id="f-449" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-103" decimals="-3" id="f-450" unitRef="usd">12680000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-104" decimals="-3" id="f-451" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-105" decimals="-3" id="f-452" unitRef="usd">12680000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-106" decimals="-3" id="f-453" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-79" decimals="-3" id="f-454" unitRef="usd">75597000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-80" decimals="-3" id="f-455" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-81" decimals="-3" id="f-456" unitRef="usd">75597000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-82" decimals="-3" id="f-457" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-79" decimals="-3" id="f-458" unitRef="usd">79014000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-80" decimals="-3" id="f-459" unitRef="usd">3417000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-81" decimals="-3" id="f-460" unitRef="usd">75597000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-82" decimals="-3" id="f-461" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-107" decimals="-3" id="f-462" unitRef="usd">50820000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-108" decimals="-3" id="f-463" unitRef="usd">50820000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-109" decimals="-3" id="f-464" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-110" decimals="-3" id="f-465" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-111" decimals="-3" id="f-466" unitRef="usd">50820000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-112" decimals="-3" id="f-467" unitRef="usd">50820000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-113" decimals="-3" id="f-468" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-114" decimals="-3" id="f-469" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-115" decimals="-3" id="f-470" unitRef="usd">18417000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-116" decimals="-3" id="f-471" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-117" decimals="-3" id="f-472" unitRef="usd">18417000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-118" decimals="-3" id="f-473" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-119" decimals="-3" id="f-474" unitRef="usd">101165000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-120" decimals="-3" id="f-475" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-121" decimals="-3" id="f-476" unitRef="usd">101165000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-122" decimals="-3" id="f-477" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-123" decimals="-3" id="f-478" unitRef="usd">11670000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-124" decimals="-3" id="f-479" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-125" decimals="-3" id="f-480" unitRef="usd">11670000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-126" decimals="-3" id="f-481" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-127" decimals="-3" id="f-482" unitRef="usd">24792000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-128" decimals="-3" id="f-483" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-129" decimals="-3" id="f-484" unitRef="usd">24792000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-130" decimals="-3" id="f-485" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-131" decimals="-3" id="f-486" unitRef="usd">7938000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-132" decimals="-3" id="f-487" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-133" decimals="-3" id="f-488" unitRef="usd">7938000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-134" decimals="-3" id="f-489" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-135" decimals="-3" id="f-490" unitRef="usd">37461000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-136" decimals="-3" id="f-491" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-137" decimals="-3" id="f-492" unitRef="usd">37461000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-138" decimals="-3" id="f-493" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-139" decimals="-3" id="f-494" unitRef="usd">5590000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-140" decimals="-3" id="f-495" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-141" decimals="-3" id="f-496" unitRef="usd">5590000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-142" decimals="-3" id="f-497" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-111" decimals="-3" id="f-498" unitRef="usd">207033000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-112" decimals="-3" id="f-499" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-113" decimals="-3" id="f-500" unitRef="usd">207033000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-114" decimals="-3" id="f-501" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-111" decimals="-3" id="f-502" unitRef="usd">257853000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-112" decimals="-3" id="f-503" unitRef="usd">50820000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-113" decimals="-3" id="f-504" unitRef="usd">207033000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-114" decimals="-3" id="f-505" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="c-1" id="f-506">CASH EQUIVALENTS AND MARKETABLE SECURITIES&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the Company&#x2019;s cash equivalents and marketable securities (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of marketable securities by contractual maturity were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.986%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturing in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturing after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no realized gains and losses on the sales of investments during the three and nine months ended September&#160;30, 2023 and 2022. Total unrealized gains for securities with net gains in accumulated other comprehensive income were not material for the three and nine months ended September&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages credit risk associated with its investment portfolio through its investment policy, which limits purchases to high-quality issuers and also limits the amount of its portfolio that can be invested in a single issuer. The Company did not record an allowance for credit losses related to its marketable securities for the three and nine months ended September&#160;30, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had unrealized losses related to its marketable securities for the three and nine months ended September&#160;30, 2023 and 2022. The Company had no material unrealized losses, individually and in the aggregate, for marketable securities that are in a continuous unrealized loss position for greater than 12 months as of September&#160;30, 2023 and December&#160;31, 2022. These unrealized losses were not attributed to credit risk and were associated with changes in market conditions. The Company periodically reviews its marketable securities for indications of credit losses. The Company considers factors such as the duration, the magnitude and the reason for the decline in value, the potential recovery period, creditworthiness of the issuers of the securities and its intent to sell. No significant facts or circumstances have arisen to indicate that there has been any significant deterioration in the creditworthiness of the issuers of the securities held by the Company. Based on the Company&#x2019;s review of these securities, the Company determined that no allowance for credit losses related to its marketable securities was required at either September 30, 2023 or December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also considers whether it is more likely than not that the Company will be required to sell the debt securities before recovery of their amortized cost basis. Based on the scheduled maturities of its investments and projection of its cash flows in accordance with the current operating plan as of September 30, 2023, the Company determined that it was more likely than not that it will be required to sell various securities before recovery of their amortized cost basis. As a result, the Company reclassified its non-current marketable securities investments of $34.4&#160;million as current as of September&#160;30, 2023 and recorded an impairment charge of $0.4&#160;million related to those securities during the three and nine ended September&#160;30, 2023. No impairment charges were recorded during the three and nine ended September&#160;30, 2022, as the Company concluded at that time it had the ability and intent to hold the long-term investments until maturity.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="c-1" id="f-507">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the Company&#x2019;s cash equivalents and marketable securities (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-143" decimals="-3" id="f-508" unitRef="usd">3417000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-143" decimals="-3" id="f-509" unitRef="usd">0</sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-143" decimals="-3" id="f-510" unitRef="usd">0</sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-143" decimals="-3" id="f-511" unitRef="usd">3417000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-144" decimals="-3" id="f-512" unitRef="usd">3417000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-144" decimals="-3" id="f-513" unitRef="usd">0</sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-144" decimals="-3" id="f-514" unitRef="usd">0</sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-144" decimals="-3" id="f-515" unitRef="usd">3417000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-145" decimals="-3" id="f-516" unitRef="usd">28655000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-145" decimals="-3" id="f-517" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-145" decimals="-3" id="f-518" unitRef="usd">18000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-145" decimals="-3" id="f-519" unitRef="usd">28637000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-146" decimals="-3" id="f-520" unitRef="usd">18901000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-146" decimals="-3" id="f-521" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-146" decimals="-3" id="f-522" unitRef="usd">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-146" decimals="-3" id="f-523" unitRef="usd">18891000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-147" decimals="-3" id="f-524" unitRef="usd">1379000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-147" decimals="-3" id="f-525" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-147" decimals="-3" id="f-526" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-147" decimals="-3" id="f-527" unitRef="usd">1379000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-148" decimals="-3" id="f-528" unitRef="usd">8429000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-148" decimals="-3" id="f-529" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-148" decimals="-3" id="f-530" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-148" decimals="-3" id="f-531" unitRef="usd">8429000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-149" decimals="-3" id="f-532" unitRef="usd">5599000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-149" decimals="-3" id="f-533" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-149" decimals="-3" id="f-534" unitRef="usd">18000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-149" decimals="-3" id="f-535" unitRef="usd">5581000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-150" decimals="-3" id="f-536" unitRef="usd">12684000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-150" decimals="-3" id="f-537" unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-150" decimals="-3" id="f-538" unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-150" decimals="-3" id="f-539" unitRef="usd">12680000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-3" decimals="-3" id="f-540" unitRef="usd">75647000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-3" decimals="-3" id="f-541" unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-3" decimals="-3" id="f-542" unitRef="usd">51000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-3" decimals="-3" id="f-543" unitRef="usd">75597000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <sgmo:CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost contextRef="c-3" decimals="-3" id="f-544" unitRef="usd">79064000</sgmo:CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost>
    <sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax contextRef="c-3" decimals="-3" id="f-545" unitRef="usd">1000</sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax>
    <sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax contextRef="c-3" decimals="-3" id="f-546" unitRef="usd">51000</sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax>
    <sgmo:CashEquivalentsAndAvailableForSaleSecurities contextRef="c-3" decimals="-3" id="f-547" unitRef="usd">79014000</sgmo:CashEquivalentsAndAvailableForSaleSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-151" decimals="-3" id="f-548" unitRef="usd">50820000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-151" decimals="-3" id="f-549" unitRef="usd">0</sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-151" decimals="-3" id="f-550" unitRef="usd">0</sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-151" decimals="-3" id="f-551" unitRef="usd">50820000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-152" decimals="-3" id="f-552" unitRef="usd">50820000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-152" decimals="-3" id="f-553" unitRef="usd">0</sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-152" decimals="-3" id="f-554" unitRef="usd">0</sgmo:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-152" decimals="-3" id="f-555" unitRef="usd">50820000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-153" decimals="-3" id="f-556" unitRef="usd">18710000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-153" decimals="-3" id="f-557" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-153" decimals="-3" id="f-558" unitRef="usd">293000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-153" decimals="-3" id="f-559" unitRef="usd">18417000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-154" decimals="-3" id="f-560" unitRef="usd">101336000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-154" decimals="-3" id="f-561" unitRef="usd">22000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-154" decimals="-3" id="f-562" unitRef="usd">193000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-154" decimals="-3" id="f-563" unitRef="usd">101165000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-155" decimals="-3" id="f-564" unitRef="usd">11760000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-155" decimals="-3" id="f-565" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-155" decimals="-3" id="f-566" unitRef="usd">90000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-155" decimals="-3" id="f-567" unitRef="usd">11670000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-156" decimals="-3" id="f-568" unitRef="usd">24970000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-156" decimals="-3" id="f-569" unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-156" decimals="-3" id="f-570" unitRef="usd">180000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-156" decimals="-3" id="f-571" unitRef="usd">24792000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-157" decimals="-3" id="f-572" unitRef="usd">7950000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-157" decimals="-3" id="f-573" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-157" decimals="-3" id="f-574" unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-157" decimals="-3" id="f-575" unitRef="usd">7938000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-158" decimals="-3" id="f-576" unitRef="usd">37599000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-158" decimals="-3" id="f-577" unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-158" decimals="-3" id="f-578" unitRef="usd">142000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-158" decimals="-3" id="f-579" unitRef="usd">37461000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-159" decimals="-3" id="f-580" unitRef="usd">5598000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-159" decimals="-3" id="f-581" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-159" decimals="-3" id="f-582" unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-159" decimals="-3" id="f-583" unitRef="usd">5590000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-4" decimals="-3" id="f-584" unitRef="usd">207923000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-4" decimals="-3" id="f-585" unitRef="usd">28000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-4" decimals="-3" id="f-586" unitRef="usd">918000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-4" decimals="-3" id="f-587" unitRef="usd">207033000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <sgmo:CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost contextRef="c-4" decimals="-3" id="f-588" unitRef="usd">258743000</sgmo:CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost>
    <sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax contextRef="c-4" decimals="-3" id="f-589" unitRef="usd">28000</sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax>
    <sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax contextRef="c-4" decimals="-3" id="f-590" unitRef="usd">918000</sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax>
    <sgmo:CashEquivalentsAndAvailableForSaleSecurities contextRef="c-4" decimals="-3" id="f-591" unitRef="usd">257853000</sgmo:CashEquivalentsAndAvailableForSaleSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="c-1" id="f-592">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of marketable securities by contractual maturity were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.986%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturing in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturing after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="c-3" decimals="-3" id="f-593" unitRef="usd">41173000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="c-4" decimals="-3" id="f-594" unitRef="usd">177188000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue contextRef="c-3" decimals="-3" id="f-595" unitRef="usd">34424000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue contextRef="c-4" decimals="-3" id="f-596" unitRef="usd">29845000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-3" decimals="-3" id="f-597" unitRef="usd">75597000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest contextRef="c-4" decimals="-3" id="f-598" unitRef="usd">207033000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:RealizedInvestmentGainsLosses contextRef="c-5" decimals="0" id="f-599" unitRef="usd">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses contextRef="c-6" decimals="0" id="f-600" unitRef="usd">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses contextRef="c-7" decimals="0" id="f-601" unitRef="usd">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses contextRef="c-1" decimals="0" id="f-602" unitRef="usd">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded contextRef="c-7" decimals="INF" id="f-603" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded contextRef="c-5" decimals="INF" id="f-604" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded contextRef="c-6" decimals="INF" id="f-605" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded contextRef="c-1" decimals="INF" id="f-606" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest contextRef="c-4" decimals="0" id="f-607" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest contextRef="c-3" decimals="0" id="f-608" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest>
    <sgmo:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease contextRef="c-5" decimals="-5" id="f-609" unitRef="usd">34400000</sgmo:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease>
    <sgmo:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease contextRef="c-1" decimals="-5" id="f-610" unitRef="usd">34400000</sgmo:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings contextRef="c-1" decimals="-5" id="f-611" unitRef="usd">400000</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings contextRef="c-5" decimals="-5" id="f-612" unitRef="usd">400000</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings contextRef="c-6" decimals="INF" id="f-613" unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings contextRef="c-7" decimals="INF" id="f-614" unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-615">BASIC AND DILUTED NET LOSS PER SHARE&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share has been computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding during the period, without consideration of any potential dilutive securities, as their effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The total number of shares subject to stock options and restricted stock units (&#x201c;RSUs&#x201d;) outstanding and the employee stock purchase plan (&#x201c;ESPP&#x201d;) shares reserved for issuance, which are all anti-dilutive, were excluded from consideration in the calculation of diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders. Stock options and RSUs outstanding and ESPP shares reserved for issuance as of September&#160;30, 2023 and 2022 totaled 22,131,291 and 18,524,016, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-616" unitRef="shares">22131291</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-7" decimals="0" id="f-617" unitRef="shares">18524016</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-618">MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pfizer Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Giroctocogene Fitelparvovec Global Collaboration and License Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the Company entered into an exclusive global collaboration and license agreement with Pfizer Inc. (&#x201c;Pfizer&#x201d;), pursuant to which it established a collaboration for the research, development and commercialization of giroctocogene fitelparvovec, its gene therapy product candidate for hemophilia A, and closely related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under this agreement, the Company is responsible for conducting the Phase 1/2 clinical trial and for certain manufacturing activities for giroctocogene fitelparvovec, while Pfizer is responsible for subsequent worldwide development, manufacturing, marketing and commercialization of giroctocogene fitelparvovec. Sangamo may also collaborate in the research and development of additional adeno-associated viruses (&#x201c;AAV&#x201d;) -based gene therapy products for hemophilia A.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to the terms of the agreement, the Company granted Pfizer an exclusive worldwide royalty-bearing license, with the right to grant sublicenses, to use certain technology controlled by the Company for the purpose of developing, manufacturing and commercializing giroctocogene fitelparvovec and related products. Pfizer granted the Company a non-exclusive, worldwide, royalty-free, fully paid license, with the right to grant sublicenses, to use certain manufacturing technology developed under the agreement and controlled by Pfizer to manufacture the Company&#x2019;s products that utilize the AAV delivery system. During a specified period, neither the Company nor Pfizer is permitted to clinically develop or commercialize, outside of the collaboration, certain AAV-based gene therapy products for hemophilia A.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier terminated, the agreement has a term that continues on a per product and per country basis until the later of (i) the expiration of patent claims that cover the product in a country, (ii) the expiration of regulatory exclusivity for a product in a country, and (iii) fifteen years after the first commercial sale of a product in a country. Pfizer has the right to terminate the agreement without cause in its entirety or on a per product or per country basis. The agreement may also be terminated by either party based on an uncured material breach by the other party or the bankruptcy of the other party. Upon termination for any reason, the license granted by the Company to Pfizer to develop, manufacture and commercialize giroctocogene fitelparvovec and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;related products will automatically terminate. Upon termination by the Company for cause or by Pfizer in any country or countries, Pfizer will automatically grant the Company an exclusive, royalty-bearing license under certain technology controlled by Pfizer to develop, manufacture and commercialize giroctocogene fitelparvovec in the terminated country or countries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon execution of the agreement, the Company received an upfront fee of $70.0&#160;million and was eligible to receive up to $208.5&#160;million in payments upon the achievement of specified clinical development, intellectual property and regulatory milestones and up to $266.5&#160;million in payments upon first commercial sale milestones for giroctocogene fitelparvovec and potentially other products. To date, two milestones of $55.0&#160;million in aggregate have been achieved and paid. The Company is eligible to earn from Pfizer up to $220.0&#160;million in remaining milestone payments for giroctocogene fitelparvovec and up to $175.0&#160;million for other products that may be developed under the agreement, subject to reduction on account of payments made under certain licenses for third-party intellectual property. In addition, Pfizer agreed to pay the Company royalties for each potential licensed product developed under the agreement that are 14% - 20% of the annual worldwide net sales of such product and are subject to reduction due to patent expiration, entry of biosimilar products to the market and payment made under certain licenses for third-party intellectual property. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the agreement with Pfizer in accordance with ASC Topic 606 and concluded that Pfizer was a customer. The total transaction price under this agreement was $134.0&#160;million, which represented the upfront fee and research services fees of $79.0&#160;million and fees related to two achieved milestones in an aggregate amount of $55.0&#160;million. Sangamo was responsible for internal and external research costs as part of the upfront fee and had the ability to request additional reimbursement from Pfizer if certain conditions were met. None of the constrained clinical or regulatory milestones were included in the transaction price. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at the time was uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has identified the performance obligations within the agreement as a license to the technology and ongoing research services. The Company concluded that the license was not discrete as it did not have stand-alone value to Pfizer apart from the research services to be performed by the Company pursuant to the agreement. As a result, the Company recognized revenue from the upfront payment based on proportional performance of the ongoing research services through 2020, the period during which the Company performed research services. The estimation of progress towards the satisfaction of its performance obligation and project cost was reviewed quarterly and adjusted, as needed, to reflect the Company&#x2019;s assumptions regarding the timing of its deliverables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, the Company satisfied the deliverables and research services responsibilities within the arrangement. As a result, the Company recognized the remaining deferred revenue from the upfront payment in December 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;C9ORF72 Research Collaboration and License Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the Company entered into a separate exclusive, global collaboration and license agreement with Pfizer for the development and commercialization of potential gene therapy products that use zinc finger (&#x201c;ZF&#x201d;) transcriptional regulators (&#x201c;ZF-TRs&#x201d;) to treat amyotrophic lateral sclerosis and frontotemporal lobar degeneration linked to mutations of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;C9ORF72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; gene. Pursuant to this agreement, the Company agreed to work with Pfizer on a research program to identify, characterize and preclinically develop ZF-TRs that bind to and specifically reduce expression of the mutant form of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;C9ORF72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; gene.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to the terms of this agreement, the Company granted Pfizer an exclusive, royalty-bearing, worldwide license under the Company&#x2019;s relevant patents and know-how to develop, manufacture and commercialize gene therapy products that use resulting ZF-TRs that satisfy pre-agreed criteria. During a specified period, neither the Company nor Pfizer will be permitted to research, develop, manufacture or commercialize outside of the collaboration any zinc finger proteins (&#x201c;ZFPs&#x201d;) that specifically bind to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;C9ORF72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; gene.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier terminated, the agreement has a term that continues on a per licensed product and per country basis until the later of (i) the expiration of patent claims that cover the licensed product in a country, (ii) the expiration of regulatory exclusivity for a licensed product in a country, and (iii) 15 years after the first commercial sale of a licensed product in a major market country. Pfizer also has the right to terminate the agreement without cause in its entirety or on a per product or per country basis. The agreement may also be terminated by either party based on an uncured material breach by the other party or the bankruptcy of the other party. The agreement will also terminate if the Company is unable to identify any lead candidates for development within a specified period of time or if Pfizer elects not to advance a lead candidate beyond a certain development milestone within a specified period of time. Upon termination for any reason, the license granted by the Company to Pfizer to develop, manufacture and commercialize licensed products under the agreement will automatically terminate. Upon termination by the Company for cause or by Pfizer without cause for any licensed product or licensed products in any country or countries, the Company will have the right to negotiate with Pfizer to obtain a non-exclusive, royalty-bearing license under certain technology &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;controlled by Pfizer to develop, manufacture and commercialize the licensed product or licensed products in the terminated country or countries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following termination by the Company for Pfizer&#x2019;s material breach, Pfizer will not be permitted to research, develop, manufacture or commercialize ZFPs that specifically bind to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;C9ORF72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; gene for a period of time. Following termination by Pfizer for the Company&#x2019;s material breach, the Company will not be permitted to research, develop, manufacture or commercialize ZFPs that specifically bind to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;C9ORF72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; gene for a period of time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company received a $12.0&#160;million upfront payment from Pfizer and is eligible to receive up to $60.0&#160;million in development milestone payments from Pfizer contingent on the achievement of specified preclinical development, clinical development and first commercial sale milestones, and up to $90.0&#160;million in commercial milestone payments if annual worldwide net sales of the licensed products reach specified levels. In addition, Pfizer will pay the Company royalties of 14% - 20% of the annual worldwide net sales of the licensed products. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property. Each party will be responsible for the cost of its performance of the research program. Pfizer will be operationally and financially responsible for subsequent development, manufacturing and commercialization of the licensed products. To date, a milestone of $5.0&#160;million has been achieved and paid, however no products have been approved and therefore no royalty fees have been earned under the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;C9ORF72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Pfizer agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the agreement with Pfizer in accordance with ASC Topic 606 and concluded that Pfizer was a customer. The Company concluded the total transaction price under this agreement was $17.0&#160;million, which represented the upfront fees of $12.0&#160;million and fees related to achievement of one milestone in the amount of $5.0&#160;million. None of the constrained clinical or regulatory milestones were included in the transaction price. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at the time was uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had identified the performance obligations within this agreement as a license to the technology and ongoing research services. The Company concluded that the license is not discrete as it does not have stand-alone value to Pfizer apart from the services to be performed by the Company pursuant to the agreement. As a result, the Company recognized revenue from the upfront payment based on proportional performance of the ongoing research services through 2020, the period the Company performed research services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company satisfied the deliverables and research services responsibilities within the arrangement in September 2020, and as a result, earned a $5.0&#160;million milestone, which the Company recognized on a cumulative basis during the year ended December 31, 2020. In addition, the Company recognized the remaining deferred revenue from the upfront payment in September 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2023, Pfizer notified the Company of Pfizer&#x2019;s assignment of the collaboration and license agreement to Alexion, AstraZeneca Rare Disease, pursuant to a definitive purchase and license agreement for preclinical gene therapy assets and enabling technologies that closed on September 20, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Kite Pharma, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2018, the Company entered into a global collaboration and license agreement with Kite which became effective on April 5, 2018 (&#x201c;Effective Date&#x201d;), and was amended and restated in September 2019, for the research, development, and commercialization of potential engineered cell therapies for cancer. The collaboration and license agreement relates to the design of zinc finger nucleases (&#x201c;ZFNs&#x201d;) and viral vectors to disrupt and insert certain genes in T-cells and natural killer cells (&#x201c;NK-cells&#x201d;) including the insertion of genes that encode chimeric antigen receptors (&#x201c;CARs&#x201d;), T-cell receptors (&#x201c;TCRs&#x201d;), and NK-cell receptors (&#x201c;NKRs&#x201d;) directed to mutually agreed targets. Under the agreement, Kite is responsible for all clinical development, manufacturing and commercialization of any resulting products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to the terms of this agreement, the Company granted Kite an exclusive, royalty-bearing, worldwide sublicensable license under the Company&#x2019;s relevant patents and know-how to develop, manufacture and commercialize, for the purpose of treating cancer, specific cell therapy products that may result from the research program and that are engineered &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ex&#160;vivo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; using selected ZFNs and viral vectors developed under the research program to express CARs, TCRs or NKRs directed to candidate targets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the Effective Date, the Company received a $150.0&#160;million upfront payment from Kite. In addition, Kite reimburses the Company&#x2019;s direct costs to conduct the joint research program. Under the terms of the agreement, Sangamo is also eligible to receive contingent development- and sales-based milestone payments that could total up to $3.0&#160;billion if all of the specified milestones set forth in this agreement are achieved. Of this amount, approximately $1.3&#160;billion relates to the achievement of specified research, clinical development, regulatory and first commercial sale milestones, and approximately $1.8&#160;billion relates to the achievement of specified sales-based milestones if annual worldwide net sales of licensed products reach &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;specified levels. Each development- and sales-based milestone payment is payable (i)&#160;only once for each licensed product, regardless of the number of times that the associated milestone event is achieved by such licensed product, and (ii)&#160;only for the first 10 times that the associated milestone event is achieved regardless of the number of licensed products that may achieve such milestone event. In addition, the Company is entitled to receive escalating, tiered royalty payments with a percentage in the single digits based on future annual worldwide net sales of licensed products. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The initial research term in the agreement is six years from the Effective Date and will expire in April 2024. Kite has an option to extend the research term for up to two additional one-year periods for a separate upfront fee of $10.0&#160;million per year. All contingent payments under the agreement, when earned, will be non-refundable and non-creditable. Through the amendment and restatement of the agreement in September 2019, the Company and Kite agreed to expand the scope of the collaboration program to incorporate the use of lentiviral or retroviral vectors provided by Kite. Kite has the right to terminate this agreement in its entirety or on a per licensed product or per candidate target basis for any reason after a specified notice period. Each party has the right to terminate this agreement on account of the other party&#x2019;s bankruptcy or material, uncured breach.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the agreement with Kite in accordance with ASC Topic 606 and concluded that Kite is a customer. The transaction price includes the upfront license fee of $150.0&#160;million and estimated reimbursable service costs for the research projects over the estimated performance period. None of the clinical or regulatory milestones have been included in the transaction price, as none of the milestones have yet been achieved, and all amounts are fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at this time is uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price also includes actual and estimated payments by Kite for the work by Company researchers and reimbursement of the Company&#x2019;s costs incurred with third parties. The Company uses the expected value method to estimate payments related to the Company&#x2019;s researchers&#x2019; work, taking into account the impact of constraint. Variable consideration is included in the transaction price only to the extent it is probable a significant reversal of cumulative revenues recognized would not occur. The Company will re-evaluate the transaction price including the estimated variable consideration included in the transaction price and all constrained amounts in each reporting period and as uncertain events are resolved or other changes in circumstances occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has identified four performance obligations within the Kite agreement as follows: (1) a license to the technology combined with the obligation to perform research and development services to apply the Company&#x2019;s technology to Kite-selected targets; (2) production of research materials; and (3-4) two material rights, each for an extension of the research period for an additional one-year term. Such extensions contain material rights because their exercise does not require payment of a fee that is commensurate with the value of the incremental research term. The license to the Company&#x2019;s intellectual property is not distinct from the related research and development activities as the licensed technology is not shared with and cannot be utilized by Kite without the research services performed by the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company allocated variable consideration (payments by Kite for the work performed by the Company&#x2019;s researchers and third-party costs, as well as any future milestones and royalties) to the specific performance obligations to which they relate, as such allocation would meet the allocation objective in ASC Topic 606. The Company allocated the fixed consideration of $150.0&#160;million to the performance obligations based on their relative standalone selling prices. Standalone selling prices of optional research years are similar to those of the initial year, but additionally take into account the intrinsic value of the discount upon exercise and the likelihood of exercise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fees allocated to options with material rights are deferred until the options are exercised or expire. The exercise of options is accounted for as contract continuation, with target selection fees and estimated variable consideration included in the transaction price at that time and allocated specifically to the respective target&#x2019;s performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue for the combined license and research services performance obligations is recognized over time, as Kite consumes the benefit of such services as they are being performed by the Company. For the license combined with research and development services performance obligation, the Company recognizes revenue based on proportional performance of the ongoing research services over the period during which the Company performs the services. The estimation of progress towards the satisfaction of this performance obligation and project costs are reviewed quarterly and adjusted, as needed, to reflect the Company&#x2019;s assumptions regarding the estimated volume of required activities. The production of research materials performance obligation is accounted for under the right to invoice practical expedient, as the Company has the right to invoice Kite for these services in an amount that corresponds directly with the value of the services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2023 and December&#160;31, 2022, the Company had a receivable of $0.2&#160;million and $0.7&#160;million, respectively, and deferred revenue of $1.5&#160;million and $19.4&#160;million, respectively, related to this agreement. Changes in deferred revenue balances during the three and nine months ended September 30, 2023 relate to a reduction in the estimated future level of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company's research and development services under the collaboration agreement with Kite, as well as ongoing normal progress in the delivery of the performance obligations. The amounts of transaction price (excluding the amounts recognized as invoiced for the production of research materials performance obligation) remaining to be recognized were $1.5&#160;million and $21.2&#160;million, of which $1.5&#160;million relates to fees allocated to options with material rights, as of September&#160;30, 2023 and December&#160;31, 2022, respectively. These amounts are expected to be recognized within the next 12 months. The timing of recognition will be affected by whether and when Kite exercises options for additional years of services and could be subject to significant changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the agreement were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Kite agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of license fee fixed consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research services variable consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2023, the Company recorded additional revenue related to a change in estimate in connection with the collaboration agreement with Kite Pharma, Inc. This adjustment was driven by a reduction in the estimated future level of the Company&#x2019;s research and development services and as a result, future project costs. This resulted in an increase in proportional cumulative performance on this collaboration and an increase in revenue of $8.9&#160;million, a decrease in net loss of $8.9&#160;million, and a decrease in the Company&#x2019;s basic and diluted net loss per share of $0.05 for the nine months ended September 30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2023, the Company recorded additional revenue related to a change in estimate in connection with the collaboration agreement with Kite. This adjustment was driven by a further reduction in the estimated future level of the Company&#x2019;s research and development services and as a result, future project costs. This resulted in an increase in proportional cumulative performance on this collaboration and increased revenue by $4.9 million, decreased net loss by $4.9 million, and decreased the Company's basic and diluted net loss per share by $0.03 for the three and nine months ended September 30, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Novartis Institutes for BioMedical Research, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 27, 2020, the Company entered into a collaboration and license agreement with Novartis Institutes for BioMedical Research, Inc. (&#x201c;Novartis&#x201d;) for the research, development and commercialization of gene regulation therapies to treat three neurodevelopmental disorders. Under the agreement, which was effective upon execution, the Company granted Novartis an exclusive, royalty bearing and worldwide license, under its relevant patents and know-how, to develop, manufacture and commercialize certain of its ZF-TRs targeted to three undisclosed genes that are associated with certain neurodevelopmental disorders, including autism spectrum disorder and intellectual disability. The Company was performing early research activities over the collaboration period for each gene target and manufacture the ZF-TRs required for such research, costs of which are funded by Novartis. Novartis was responsible for additional research activities, studies enabling INDs, clinical development, regulatory approvals, manufacturing of preclinical, clinical and approved products, and global commercialization. Subject to certain exceptions set forth in the agreement, the Company was prohibited from developing, manufacturing or commercializing any therapeutic product targeting any of the three genes that are the subject of the collaboration. Novartis also had the option to license certain of the Company&#x2019;s proprietary AAVs for the sole purpose of developing, manufacturing and commercializing licensed products arising from the collaboration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2023, Novartis notified the Company of its termination for convenience, effective June 11, 2023 (the &#x201c;Novartis Termination Date&#x201d;), of the collaboration agreement. Novartis had indicated to the Company that the termination relates to a recent strategic review. As of the Novartis Termination Date, the collaboration agreement was terminated in its entirety and following the Novartis Termination Date the Company is not entitled to receive any further milestone payments or royalties from Novartis. As of the Novartis Termination Date, the parties have no further obligations to develop or to fund the development of any collaboration research programs under the collaboration agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon entering the agreement, Novartis paid the Company a $75.0&#160;million upfront license fee. Novartis was also obligated to pay the Company for the use of its resources and reimburse third-party costs incurred in the Company&#x2019;s conduct of early research activities. The Company was also eligible to earn from Novartis development and commercial milestones and royalties on potential commercial sales of licensed products arising from the collaboration, none of which were triggered or earned. The agreement was going to continue, on a product-by-product and country-by-country basis, until the expiration of the applicable royalty term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All payments received under the agreement were non-refundable and non-creditable. The transaction price of $95.1&#160;million included the upfront license fee of $75.0&#160;million and research costs of $20.1&#160;million. All clinical or regulatory milestone amounts were considered fully constrained throughout the term of the agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the agreement with Novartis in accordance with ASC Topic 606 and concluded that Novartis was a customer. The Company had identified a single performance obligation within this arrangement as a license to the technology and ongoing research services. The Company concluded that the license was not discrete as it did not have stand-alone value to Novartis apart from the research services to be performed pursuant to the agreement. As a result, the Company recognized revenue from the upfront payment based on proportional performance of the ongoing research services through the estimated research period. The estimation of progress towards the satisfaction of performance obligation and project cost was reviewed quarterly and adjusted, as needed, to reflect the Company&#x2019;s current assumptions regarding the timing of its performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notice of termination was accounted for as a modification of the contract, as it changed both the scope of the Company&#x2019;s remaining services and the consideration to which the Company was entitled. The effect of the modification was not material, as the Company was nearing the completion of its assigned early research activities, and consequently, of its sole performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2023 and December&#160;31, 2022, the Company had a receivable of zero and $2.2&#160;million, respectively, and deferred revenue of zero and $9.6&#160;million, respectively, related to this agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the agreement were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Novartis agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of upfront license fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Biogen MA, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, the Company entered into a collaboration and license agreement with Biogen MA, Inc. (&#x201c;BIMA&#x201d;) and Biogen International GmbH (together with BIMA, &#x201c;Biogen&#x201d;) for the research, development and commercialization of gene regulation therapies for the treatment of neurological diseases. The companies planned to leverage the Company&#x2019;s proprietary ZF technology delivered via AAV to modulate expression of key genes involved in neurological diseases. Concurrently with the execution of the collaboration agreement, the Company entered into a stock purchase agreement with BIMA, pursuant to which BIMA agreed to purchase 24,420,157 shares of the Company&#x2019;s common stock (the &#x201c;Biogen Shares&#x201d;), at a price per share of $9.2137, for an aggregate purchase price of approximately $225.0&#160;million. The collaboration agreement became effective in April 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2023, Biogen notified the Company of its termination for convenience, effective June 15, 2023 (the &#x201c;Biogen Termination Date&#x201d;), of the collaboration agreement. Biogen had indicated to the Company that the termination relates to a recent strategic review. As of the Biogen Termination Date, the collaboration agreement was terminated in its entirety and following the Biogen Termination Date the Company is not entitled to receive any further milestone payments or royalties from Biogen. As of the Biogen Termination Date, the parties have no further obligations to develop or to fund the development of any collaboration research programs under the collaboration agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the collaboration agreement, Biogen paid the Company an upfront license fee of $125.0&#160;million in May 2020. The Company was also eligible to receive target selection, research, development, regulatory and commercial milestone payments and royalties on potential net commercial sales of licensed products arising from the collaboration, none of which were triggered or earned. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the collaboration agreement, the Company granted to Biogen an exclusive, royalty bearing and worldwide license, under its relevant patents and know-how, to develop, manufacture and commercialize ZF and/or AAV-based products directed to certain neurological disease gene targets selected by Biogen. Biogen had selected four targets over the course of the collaboration and had exclusive rights to nominate up to seven additional targets. These rights expired upon the Biogen Termination Date. For each gene target selected by Biogen, the Company performed early research activities, costs of which were shared by the companies, aimed at the development of the combination of proprietary central nervous system delivery vectors and ZF-TRs (or potential other ZF products) targeting therapeutically relevant genes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the collaboration agreement with Biogen in accordance with ASC Topic&#160;606 and concluded that Biogen is a customer. The transaction price included the upfront license fee of $125.0&#160;million and the excess consideration from the stock purchase of $79.6&#160;million, which represented the difference between the $225.0&#160;million received for the purchase of the Biogen Shares and the $145.4&#160;million estimated fair value of the equity issued. The equity issued to Biogen was valued using an option pricing model to reflect certain holding period restrictions. None of the clinical or regulatory milestones were included in the transaction price, as all such amounts were fully constrained throughout the term of the collaboration agreement. The transaction price also included actual and estimated cost-sharing payments by Biogen for the work by Company researchers and reimbursement of the Company&#x2019;s costs incurred with third parties. The amounts paid and expected to be paid to Biogen for the use of Biogen&#x2019;s resources and its expenses were consideration paid to a customer. Since the Company did not acquire distinct goods or services in exchange for these payments, they reduced the transaction price and were recorded as a reduction in revenue. The Company used the expected value method to estimate cost sharing payments, taking into account the impact of the constraint. Variable consideration was included in the transaction price only to the extent it was probable a significant reversal of cumulative revenues recognized would not occur. The Company re-evaluated the transaction price as uncertain events were resolved or other changes in circumstances occurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company concluded that the licenses to its intellectual property for each target were not distinct from the related research and development activities, as the licensed technology was not shared with and could not be utilized by Biogen without the research services to be performed by the Company pursuant to the agreement. On the other hand, each combination of a license to the Company's intellectual property as applied to a specific target and the related research and development activities are a discrete research project that is distinct from any other target&#x2019;s project. The targets Biogen could select were options that provided Biogen with material rights, as the exercise of the options did not require payment of a fee commensurate with the value of the incremental license rights. As a result, such options also represented performance obligations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At contract inception, the Company allocated fixed consideration of $204.6&#160;million included in the initial transaction price to the existing targets&#x2019; license and research services performance obligations and those performance obligations for options that include material rights, based on their relative standalone selling prices. Through June 30, 2023, all such material rights have expired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notice of termination was accounted for as a modification of the contract, as it changed both the scope of the Company&#x2019;s remaining services and the consideration to which the Company was entitled. The remaining research and development activities to be undertaken by the Company after the notice of termination were not distinct from the related activities performed prior to the modification on the same targets but were distinct from the activities on other targets. The remaining material rights were also distinct from the prior research and development activities. To account for the effects of the modification, the Company updated its estimate of the transaction price and allocated the remaining transaction consideration based on the relative standalone selling prices of the remaining distinct goods and services. Progress for each ongoing performance obligation was then remeasured using an updated estimate of the total level of effort required for each performance obligation and the total revised transaction price and a cumulative catch-up in revenue was recorded. The modification resulted in an increase in revenue of $127.1&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2023 and December&#160;31, 2022, the Company had a receivable of zero and $0.5&#160;million, respectively, and deferred revenue of zero and $132.2&#160;million, respectively, related to this agreement. Changes in deferred revenue balances during the nine months ended September 30, 2023 relate primarily to the impact of the contract modification. The amounts of transaction price remaining to be recognized were zero and $151.3&#160;million as of September&#160;30, 2023 and December&#160;31, 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the agreement were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Biogen agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of license and other fixed consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost-sharing payments for research services, net variable consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company paid $7.0&#160;million for financial advisory fees during the year ended December&#160;31, 2020, equal to 2% of $225.0&#160;million received for the sale of shares and 2% of $125.0&#160;million received for the upfront fee. The fees incurred related to both the collaboration agreement with Biogen and the stock purchase agreement for the sale of shares. The Company believes that the allocation of fees on a relative fair value basis between the two agreements is reasonable. The Company recognized $4.1&#160;million, which represents 2% of the initial transaction price of $204.6&#160;million, as a contract cost asset. This balance was &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;released into general and administrative expenses on a systematic basis consistent with the transfer of the services to Biogen in accordance with Accounting Standard Codification Topic 340, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets and Deferred Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In March, as a result of the notice of termination and resulting modification of the contract, the progress for each performance obligation was remeasured and the Company recognized $2.5&#160;million as a cumulative catch-up to expense. The Company recognized as expense zero and $2.6 million during the three and nine months ended September&#160;30, 2023, respectively, and $0.1 million and $0.4 million during the three and nine months ended September&#160;30, 2022, respectively.&lt;/span&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <sgmo:AgreementTerminationTerm contextRef="c-160" id="f-619">P15Y</sgmo:AgreementTerminationTerm>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned contextRef="c-161" decimals="-5" id="f-620" unitRef="usd">70000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive contextRef="c-162" decimals="-5" id="f-621" unitRef="usd">208500000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <sgmo:AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive contextRef="c-161" decimals="-5" id="f-622" unitRef="usd">266500000</sgmo:AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive>
    <sgmo:CollaborativeArrangementNumberOfMilestonesAchieved
      contextRef="c-163"
      decimals="INF"
      id="f-623"
      unitRef="milestone">2</sgmo:CollaborativeArrangementNumberOfMilestonesAchieved>
    <sgmo:MilestonePaymentsReceived contextRef="c-163" decimals="-5" id="f-624" unitRef="usd">55000000</sgmo:MilestonePaymentsReceived>
    <sgmo:MilestoneRevenueReceivable contextRef="c-164" decimals="-5" id="f-625" unitRef="usd">220000000</sgmo:MilestoneRevenueReceivable>
    <sgmo:MilestoneRevenueReceivable contextRef="c-165" decimals="-5" id="f-626" unitRef="usd">175000000</sgmo:MilestoneRevenueReceivable>
    <sgmo:ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty contextRef="c-166" decimals="2" id="f-627" unitRef="number">0.14</sgmo:ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty>
    <sgmo:ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty contextRef="c-167" decimals="2" id="f-628" unitRef="number">0.20</sgmo:ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty>
    <sgmo:CollaborativeArrangementTransactionPrice contextRef="c-168" decimals="-5" id="f-629" unitRef="usd">134000000</sgmo:CollaborativeArrangementTransactionPrice>
    <sgmo:CollaborativeArrangementResearchServiceFees contextRef="c-168" decimals="-5" id="f-630" unitRef="usd">79000000</sgmo:CollaborativeArrangementResearchServiceFees>
    <sgmo:CollaborativeArrangementNumberOfMilestonesAchieved
      contextRef="c-169"
      decimals="0"
      id="f-631"
      unitRef="milestone">2</sgmo:CollaborativeArrangementNumberOfMilestonesAchieved>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned contextRef="c-168" decimals="-5" id="f-632" unitRef="usd">55000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <sgmo:AgreementTerminationTerm contextRef="c-170" id="f-633">P15Y</sgmo:AgreementTerminationTerm>
    <sgmo:MilestonePaymentsReceived contextRef="c-171" decimals="-5" id="f-634" unitRef="usd">12000000</sgmo:MilestonePaymentsReceived>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive contextRef="c-172" decimals="-5" id="f-635" unitRef="usd">60000000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive contextRef="c-173" decimals="-5" id="f-636" unitRef="usd">90000000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <sgmo:ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty contextRef="c-174" decimals="2" id="f-637" unitRef="number">0.14</sgmo:ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty>
    <sgmo:ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty contextRef="c-175" decimals="2" id="f-638" unitRef="number">0.20</sgmo:ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty>
    <sgmo:MilestonePaymentsReceived contextRef="c-176" decimals="-5" id="f-639" unitRef="usd">5000000</sgmo:MilestonePaymentsReceived>
    <sgmo:CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement
      contextRef="c-176"
      decimals="INF"
      id="f-640"
      unitRef="product">0</sgmo:CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement>
    <sgmo:NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice
      contextRef="c-176"
      decimals="INF"
      id="f-641"
      unitRef="milestone">0</sgmo:NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice>
    <sgmo:CollaborativeArrangementTransactionPrice contextRef="c-177" decimals="-5" id="f-642" unitRef="usd">17000000</sgmo:CollaborativeArrangementTransactionPrice>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned contextRef="c-171" decimals="-5" id="f-643" unitRef="usd">12000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned contextRef="c-177" decimals="-5" id="f-644" unitRef="usd">5000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned contextRef="c-178" decimals="-5" id="f-645" unitRef="usd">5000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive contextRef="c-179" decimals="-5" id="f-646" unitRef="usd">5000000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <sgmo:MilestonePaymentsReceived contextRef="c-180" decimals="-5" id="f-647" unitRef="usd">150000000</sgmo:MilestonePaymentsReceived>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive contextRef="c-181" decimals="-8" id="f-648" unitRef="usd">3000000000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived contextRef="c-182" decimals="-8" id="f-649" unitRef="usd">1300000000</sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived>
    <sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived contextRef="c-183" decimals="-8" id="f-650" unitRef="usd">1800000000</sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived>
    <sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment
      contextRef="c-183"
      decimals="INF"
      id="f-651"
      unitRef="milestone">10</sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment>
    <sgmo:InitialResearchTermOfAgreement contextRef="c-180" id="f-652">P6Y</sgmo:InitialResearchTermOfAgreement>
    <sgmo:NumberOfOptionsToExtendInitialResearchTerm
      contextRef="c-180"
      decimals="INF"
      id="f-653"
      unitRef="option">2</sgmo:NumberOfOptionsToExtendInitialResearchTerm>
    <sgmo:ExtendedResearchTermOfAgreement contextRef="c-180" id="f-654">P1Y</sgmo:ExtendedResearchTermOfAgreement>
    <sgmo:SeparateUpfrontFee contextRef="c-180" decimals="-5" id="f-655" unitRef="usd">10000000</sgmo:SeparateUpfrontFee>
    <us-gaap:ContractWithCustomerLiability contextRef="c-184" decimals="-5" id="f-656" unitRef="usd">150000000</us-gaap:ContractWithCustomerLiability>
    <sgmo:RevenueNumberOfRemainingPerformanceObligations
      contextRef="c-185"
      decimals="0"
      id="f-657"
      unitRef="performance_obligation">4</sgmo:RevenueNumberOfRemainingPerformanceObligations>
    <sgmo:RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod
      contextRef="c-185"
      decimals="0"
      id="f-658"
      unitRef="material_right">2</sgmo:RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod>
    <sgmo:RevenueRemainingPerformanceObligationRenewalPeriod contextRef="c-186" id="f-659">P1Y</sgmo:RevenueRemainingPerformanceObligationRenewalPeriod>
    <sgmo:RevenueRemainingPerformanceObligationFixedConsiderationAmount contextRef="c-185" decimals="-5" id="f-660" unitRef="usd">150000000</sgmo:RevenueRemainingPerformanceObligationFixedConsiderationAmount>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-187" decimals="-5" id="f-661" unitRef="usd">200000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-188" decimals="-5" id="f-662" unitRef="usd">700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerLiability contextRef="c-187" decimals="-5" id="f-663" unitRef="usd">1500000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-188" decimals="-5" id="f-664" unitRef="usd">19400000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-189" decimals="-5" id="f-665" unitRef="usd">1500000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-190" decimals="-5" id="f-666" unitRef="usd">21200000</us-gaap:RevenueRemainingPerformanceObligation>
    <sgmo:RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount contextRef="c-191" decimals="-5" id="f-667" unitRef="usd">1500000</sgmo:RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount>
    <sgmo:RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount contextRef="c-192" decimals="-5" id="f-668" unitRef="usd">1500000</sgmo:RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-190" id="f-669">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-189" id="f-670">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-671">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the agreement were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Kite agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of license fee fixed consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research services variable consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the agreement were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Novartis agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of upfront license fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the agreement were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Biogen agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of license and other fixed consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost-sharing payments for research services, net variable consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-193" decimals="-3" id="f-672" unitRef="usd">5388000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-194" decimals="-3" id="f-673" unitRef="usd">6296000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-195" decimals="-3" id="f-674" unitRef="usd">17938000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-196" decimals="-3" id="f-675" unitRef="usd">18682000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-197" decimals="-3" id="f-676" unitRef="usd">108000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-198" decimals="-3" id="f-677" unitRef="usd">619000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-199" decimals="-3" id="f-678" unitRef="usd">1097000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-200" decimals="-3" id="f-679" unitRef="usd">875000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-201" decimals="-3" id="f-680" unitRef="usd">5496000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-202" decimals="-3" id="f-681" unitRef="usd">6915000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-203" decimals="-3" id="f-682" unitRef="usd">19035000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-204" decimals="-3" id="f-683" unitRef="usd">19557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-56" decimals="-5" id="f-684" unitRef="usd">8900000</sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent contextRef="c-56" decimals="-5" id="f-685" unitRef="usd">-8900000</sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent>
    <sgmo:IncreaseDecreaseInEarningsPerShareDiluted
      contextRef="c-56"
      decimals="2"
      id="f-686"
      unitRef="usdPerShare">-0.05</sgmo:IncreaseDecreaseInEarningsPerShareDiluted>
    <sgmo:IncreaseDecreaseInEarningsPerShareBasic
      contextRef="c-56"
      decimals="2"
      id="f-687"
      unitRef="usdPerShare">-0.05</sgmo:IncreaseDecreaseInEarningsPerShareBasic>
    <sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-57" decimals="-5" id="f-688" unitRef="usd">4900000</sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-58" decimals="-5" id="f-689" unitRef="usd">4900000</sgmo:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent contextRef="c-58" decimals="-5" id="f-690" unitRef="usd">-4900000</sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent>
    <sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent contextRef="c-57" decimals="-5" id="f-691" unitRef="usd">-4900000</sgmo:IncreaseDecreaseInNetIncomeLossAttributableToParent>
    <sgmo:IncreaseDecreaseInEarningsPerShareBasic
      contextRef="c-57"
      decimals="2"
      id="f-692"
      unitRef="usdPerShare">-0.03</sgmo:IncreaseDecreaseInEarningsPerShareBasic>
    <sgmo:IncreaseDecreaseInEarningsPerShareDiluted
      contextRef="c-58"
      decimals="2"
      id="f-693"
      unitRef="usdPerShare">-0.03</sgmo:IncreaseDecreaseInEarningsPerShareDiluted>
    <sgmo:IncreaseDecreaseInEarningsPerShareDiluted
      contextRef="c-57"
      decimals="2"
      id="f-694"
      unitRef="usdPerShare">-0.03</sgmo:IncreaseDecreaseInEarningsPerShareDiluted>
    <sgmo:IncreaseDecreaseInEarningsPerShareBasic
      contextRef="c-58"
      decimals="2"
      id="f-695"
      unitRef="usdPerShare">-0.03</sgmo:IncreaseDecreaseInEarningsPerShareBasic>
    <us-gaap:ProceedsFromCollaborators contextRef="c-205" decimals="-5" id="f-696" unitRef="usd">75000000</us-gaap:ProceedsFromCollaborators>
    <sgmo:CollaborativeArrangementTransactionPrice contextRef="c-205" decimals="-5" id="f-697" unitRef="usd">95100000</sgmo:CollaborativeArrangementTransactionPrice>
    <sgmo:CollaborativeArrangementLicenseFee contextRef="c-205" decimals="-5" id="f-698" unitRef="usd">75000000</sgmo:CollaborativeArrangementLicenseFee>
    <sgmo:CollaborativeArrangementEstimatedReimbursableServiceCosts contextRef="c-205" decimals="-5" id="f-699" unitRef="usd">20100000</sgmo:CollaborativeArrangementEstimatedReimbursableServiceCosts>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-206" decimals="INF" id="f-700" unitRef="usd">0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-207" decimals="-5" id="f-701" unitRef="usd">2200000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerLiability contextRef="c-206" decimals="INF" id="f-702" unitRef="usd">0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-207" decimals="-5" id="f-703" unitRef="usd">9600000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-208" decimals="-3" id="f-704" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-209" decimals="-3" id="f-705" unitRef="usd">7582000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-210" decimals="-3" id="f-706" unitRef="usd">9568000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-211" decimals="-3" id="f-707" unitRef="usd">23222000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-212" decimals="-3" id="f-708" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-213" decimals="-3" id="f-709" unitRef="usd">2028000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-214" decimals="-3" id="f-710" unitRef="usd">2611000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-215" decimals="-3" id="f-711" unitRef="usd">6211000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-216" decimals="-3" id="f-712" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-217" decimals="-3" id="f-713" unitRef="usd">9610000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-218" decimals="-3" id="f-714" unitRef="usd">12179000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-219" decimals="-3" id="f-715" unitRef="usd">29433000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-220"
      decimals="INF"
      id="f-716"
      unitRef="shares">24420157</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-221"
      decimals="INF"
      id="f-717"
      unitRef="usdPerShare">9.2137</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-220" decimals="-5" id="f-718" unitRef="usd">225000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromCollaborators contextRef="c-222" decimals="-5" id="f-719" unitRef="usd">125000000</us-gaap:ProceedsFromCollaborators>
    <sgmo:CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty
      contextRef="c-223"
      decimals="0"
      id="f-720"
      unitRef="product_target">4</sgmo:CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty>
    <sgmo:CollaborationAgreementNumberOfAdditionalProductTargets
      contextRef="c-224"
      decimals="0"
      id="f-721"
      unitRef="product_target">7</sgmo:CollaborationAgreementNumberOfAdditionalProductTargets>
    <us-gaap:ProceedsFromCollaborators contextRef="c-223" decimals="-5" id="f-722" unitRef="usd">125000000</us-gaap:ProceedsFromCollaborators>
    <sgmo:SaleOfStockExcessConsiderationReceivedOnTransaction contextRef="c-220" decimals="-5" id="f-723" unitRef="usd">79600000</sgmo:SaleOfStockExcessConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-220" decimals="-5" id="f-724" unitRef="usd">225000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <sgmo:CollaborationAgreementEquityIssued contextRef="c-220" decimals="-5" id="f-725" unitRef="usd">145400000</sgmo:CollaborationAgreementEquityIssued>
    <sgmo:RevenueRemainingPerformanceObligationFixedConsiderationAmount contextRef="c-225" decimals="-5" id="f-726" unitRef="usd">204600000</sgmo:RevenueRemainingPerformanceObligationFixedConsiderationAmount>
    <us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice contextRef="c-226" decimals="-5" id="f-727" unitRef="usd">127100000</us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-227" decimals="INF" id="f-728" unitRef="usd">0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-228" decimals="-5" id="f-729" unitRef="usd">500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerLiability contextRef="c-227" decimals="INF" id="f-730" unitRef="usd">0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-228" decimals="-5" id="f-731" unitRef="usd">132200000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-229" decimals="INF" id="f-732" unitRef="usd">0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-230" decimals="-5" id="f-733" unitRef="usd">151300000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-231" decimals="-3" id="f-734" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-232" decimals="-3" id="f-735" unitRef="usd">7306000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-233" decimals="-3" id="f-736" unitRef="usd">132165000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-234" decimals="-3" id="f-737" unitRef="usd">21918000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-235" decimals="-3" id="f-738" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-236" decimals="-3" id="f-739" unitRef="usd">2107000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-237" decimals="-3" id="f-740" unitRef="usd">2684000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-238" decimals="-3" id="f-741" unitRef="usd">8740000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-239" decimals="-3" id="f-742" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-240" decimals="-3" id="f-743" unitRef="usd">9413000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-241" decimals="-3" id="f-744" unitRef="usd">134849000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-242" decimals="-3" id="f-745" unitRef="usd">30658000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:CollaborationArrangementCommissionFeePortionOfGrossProceedsValue contextRef="c-243" decimals="-5" id="f-746" unitRef="usd">7000000</sgmo:CollaborationArrangementCommissionFeePortionOfGrossProceedsValue>
    <sgmo:CollaborativeAgreementPercentOfInitialRecognition
      contextRef="c-223"
      decimals="INF"
      id="f-747"
      unitRef="number">0.02</sgmo:CollaborativeAgreementPercentOfInitialRecognition>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-220" decimals="-5" id="f-748" unitRef="usd">225000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <sgmo:CollaborativeAgreementPercentOfInitialRecognition
      contextRef="c-223"
      decimals="INF"
      id="f-749"
      unitRef="number">0.02</sgmo:CollaborativeAgreementPercentOfInitialRecognition>
    <us-gaap:ProceedsFromCollaborators contextRef="c-223" decimals="-5" id="f-750" unitRef="usd">125000000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-244" decimals="-5" id="f-751" unitRef="usd">4100000</us-gaap:ContractWithCustomerAssetNet>
    <sgmo:CollaborativeAgreementPercentOfInitialRecognition
      contextRef="c-223"
      decimals="INF"
      id="f-752"
      unitRef="number">0.02</sgmo:CollaborativeAgreementPercentOfInitialRecognition>
    <sgmo:RevenueRemainingPerformanceObligationFixedConsiderationAmount contextRef="c-225" decimals="-5" id="f-753" unitRef="usd">204600000</sgmo:RevenueRemainingPerformanceObligationFixedConsiderationAmount>
    <us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress contextRef="c-245" decimals="-5" id="f-754" unitRef="usd">2500000</us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-246" decimals="INF" id="f-755" unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-247" decimals="-5" id="f-756" unitRef="usd">2600000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-248" decimals="-5" id="f-757" unitRef="usd">100000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-249" decimals="-5" id="f-758" unitRef="usd">400000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AssetImpairmentChargesTextBlock contextRef="c-1" id="f-759">IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March 31, 2023, as a result of the sustained decline in the Company&#x2019;s stock price and related market capitalization, termination of the collaboration agreements with Biogen and Novartis, and a general decline in equity values in the biotechnology industry, the Company performed an impairment assessment of goodwill, indefinite-lived intangible assets, and long-lived assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates as a single reporting unit based on its business and reporting structure. For goodwill, a quantitative impairment assessment was performed using a market approach, whereby the Company&#x2019;s fair value of equity was compared to its carrying value. The fair value of equity was derived using both the market capitalization of the Company and an estimate of a reasonable range of values of a control premium applied to the Company&#x2019;s implied business enterprise value. The control premium was estimated based upon control premiums observed in comparable market transactions. This represents a level&#160;2 nonrecurring fair value measurement. Based on this analysis, the Company recognized a pre-tax goodwill impairment charge of $38.1 million during the three months ended March 31, 2023. As a result, the goodwill was fully impaired as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Before completing the goodwill impairment assessment, the Company also tested its indefinite-lived intangible assets and then its long-lived assets for impairment. Based on the qualitative assessment, the Company determined it was more likely than not that its indefinite-lived intangible assets were not impaired. The Company determined all of its long-lived assets represent one asset group for purposes of long-lived asset impairment assessment. The Company concluded that the carrying value of the asset group was not recoverable as it exceeded the future undiscounted cash flows the assets are expected to generate from the use and eventual disposition. To allocate and recognize the impairment loss, the Company determined individual fair values of its long-lived assets. The Company applied a discounted cash flow method to estimate fair values of its leasehold improvements and right-of-use assets, including leasehold improvements in the process of construction and a cost replacement method to estimate the fair value of its furniture, fixtures and laboratory and manufacturing equipment. These represented level&#160;3 nonrecurring fair value measurements. Based on this analysis, the Company recognized pre-tax long-lived asset impairment charges of $11.2&#160;million on the right-of-use assets, $5.0&#160;million on the related leasehold improvements, and $4.2&#160;million on construction-in-progress, during the three months ended March 31, 2023. No impairment was recognized on the remaining long-lived assets as their carrying values were not in excess of their fair values.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Three months ended June 30, 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June 30, 2023, the Company&#x2019;s stock price and the related market capitalization continued to decline. In April 2023, the Company announced a restructuring of operations and a corresponding reduction in force, see Note&#160;9 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company also initiated discussions around several actions aimed at reducing costs, preserving liquidity and improving operational performance metrics. These actions include but are not limited to deferral and reprioritization of certain research and development programs, further reduction in force, and closing or downsizing its facilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reassessed its indefinite-lived and long-lived assets for impairment as of June 30, 2023. Given the actions contemplated above, the Company determined that it was more likely than not that its indefinite-lived intangible assets were impaired. Accordingly, the Company developed an estimate of the fair value of its indefinite-lived intangible assets using the multi-period excess earnings model (income approach) and concluded the carrying value of its indefinite-lived intangible assets were fully impaired. This represents a level 3 nonrecurring fair value measurement. As a result, an indefinite-lived intangible assets impairment charge of $51.3&#160;million, as well as the related income tax benefit of $6.3&#160;million due to the reversal of a deferred tax liability associated with the indefinite-lived intangible assets was recognized during the three months ended June 30, 2023. The impairment charge was primarily driven by a higher discount rate applied to future cash flows based on market participants&#x2019; view of increased risk related to the asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that there were indicators of impairment in its long-lived asset group as of June 30, 2023, based on the same factors above as well as the impairment of its indefinite-lived intangible assets. As the estimated fair value of this asset group, based on a market approach, exceeded its carrying value, no impairment loss was recognized. This represented a level 3 nonrecurring fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Three months ended September 30, 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September 30, 2023, the Company&#x2019;s stock price and the related market capitalization continued to decline, and as such, the Company reassessed its long-lived assets for impairment as of September 30, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined all of its long-lived assets continued to represent one asset group for purposes of long-lived asset impairment assessment. The Company concluded that the carrying value of the asset group was not recoverable and the estimated fair value of this asset group was below its carrying value. The lower fair value of the asset group was mainly driven by the sustained decline in the Company's stock price and the related market capitalization. To recognize the impairment loss, the Company determined individual fair values of its long-lived assets. The Company applied a discounted cash flow method to estimate fair values of its leasehold improvements and right-of-use assets, including leasehold improvements in the process of construction, and a market approach to estimate the fair value of its furniture, fixtures and laboratory and manufacturing equipment. These represented level&#160;3 nonrecurring fair value measurements. Based on this analysis, the Company concluded the fair values of the long-lived assets were lower than their net book values due to declines in the market prices for leases, furniture, fixtures, and equipment. The Company recognized pre-tax long-lived asset impairment charges of $17.6 million on the right-of-use assets, $13.7&#160;million on the related leasehold improvements and construction-in-progress, and $13.5 million on furniture, fixtures, and laboratory and manufacturing equipment during the three months ended September 30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will continue to assess whether its long-lived assets are impaired in future periods. As the Company finalizes and implements its plans related to cost reductions and liquidity preservation, it is reasonably possible that additional impairment charges will be recognized if the Company changes how it uses various long-lived assets or elects to dispose of them, and the cash flows associated with these assets become separately identifiable. In this case, such assets will be tested for impairment separately from the remaining long-lived assets of the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:AssetImpairmentChargesTextBlock>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-250" decimals="-5" id="f-760" unitRef="usd">38100000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-250" decimals="-5" id="f-761" unitRef="usd">11200000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-251" decimals="-5" id="f-762" unitRef="usd">5000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-252" decimals="-5" id="f-763" unitRef="usd">4200000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-253" decimals="-5" id="f-764" unitRef="usd">51300000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <sgmo:EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount contextRef="c-253" decimals="-5" id="f-765" unitRef="usd">6300000</sgmo:EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-253" decimals="INF" id="f-766" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-5" decimals="-5" id="f-767" unitRef="usd">17600000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-254" decimals="-5" id="f-768" unitRef="usd">13700000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-255" decimals="-5" id="f-769" unitRef="usd">13500000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-770">STOCK-BASED COMPENSATION&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows total stock-based compensation expense recognized in the accompanying Condensed Consolidated Statements of Operations (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-771">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows total stock-based compensation expense recognized in the accompanying Condensed Consolidated Statements of Operations (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.394%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-256" decimals="-3" id="f-772" unitRef="usd">3236000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-257" decimals="-3" id="f-773" unitRef="usd">4395000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-258" decimals="-3" id="f-774" unitRef="usd">11996000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-259" decimals="-3" id="f-775" unitRef="usd">13656000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-260" decimals="-3" id="f-776" unitRef="usd">2953000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-261" decimals="-3" id="f-777" unitRef="usd">3398000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-262" decimals="-3" id="f-778" unitRef="usd">9260000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-263" decimals="-3" id="f-779" unitRef="usd">9746000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-3" id="f-780" unitRef="usd">6189000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-3" id="f-781" unitRef="usd">7793000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-782" unitRef="usd">21256000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-3" id="f-783" unitRef="usd">23402000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-784">STOCKHOLDERS&#x2019; EQUITYAt-the-Market Offering AgreementIn August 2020, the Company entered into an Open Market Sale Agreement&#x2120; with Jefferies LLC (&#x201c;Jefferies&#x201d;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of the Company&#x2019;s common stock having an aggregate offering price of up to $150.0&#160;million through Jefferies as the Company&#x2019;s sales agent or principal. In December 2022, the Company entered into Amendment No. 2 to the Open Market Sale Agreement&#x2120; which increased the aggregate offering price under the at-the-market offering program by an additional $175.0 million. The Company is not obligated to sell any shares under the sales agreement. No shares were sold under the sales agreement during the three months ended September&#160;30, 2023. During the nine months ended September&#160;30, 2023, the Company sold 8,249,261 shares of its common stock for net proceeds of approximately $15.1 million. During the three and nine months ended September&#160;30, 2022, the Company sold 8,483,104 and 14,711,770 shares of its common stock for net proceeds of approximately $42.2 million and $66.4 million, respectively</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <sgmo:StockOfferingProgramMaximumValue contextRef="c-264" decimals="-5" id="f-785" unitRef="usd">150000000</sgmo:StockOfferingProgramMaximumValue>
    <sgmo:SaleOfStockIncreaseToAggregateOfferingPrice contextRef="c-265" decimals="-5" id="f-786" unitRef="usd">175000000</sgmo:SaleOfStockIncreaseToAggregateOfferingPrice>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-266"
      decimals="INF"
      id="f-787"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-267" decimals="0" id="f-788" unitRef="shares">8249261</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-267" decimals="-5" id="f-789" unitRef="usd">15100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-268" decimals="0" id="f-790" unitRef="shares">8483104</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-269" decimals="0" id="f-791" unitRef="shares">14711770</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-268" decimals="-5" id="f-792" unitRef="usd">42200000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-269" decimals="-5" id="f-793" unitRef="usd">66400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="c-1" id="f-794">RESTRUCTURING CHARGESOn April 26, 2023, the Company executed a restructuring of operations and a corresponding reduction in workforce (the &#x201c;April Restructuring&#x201d;), designed to reduce costs and increase focus on certain strategic priorities. The April Restructuring resulted in the elimination of approximately 110 roles, including 55 full-time employees and 55 contracted employees and eliminated open positions, in the United States, or approximately 23% of the total United States workforce as of April 26, 2023, and included one-time severance payments and other employee-related costs, including additional vesting of service-based stock compensation awards. No expenses related to the April Restructuring were incurred during the three months ended September&#160;30, 2023. The Company incurred approximately $5.3 million of expenses related to the April Restructuring in the nine months ended September&#160;30, 2023, of which $4.1&#160;million is included in research and development expense and $1.2 million is included in general and administrative expense in the accompanying Condensed Consolidated Statements of Operations. The Company &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;expects the April Restructuring and the cash payments related to the April Restructuring to be complete by the third quarter of 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of accrued April Restructuring costs included within other accrued liabilities on the Company&#x2019;s Condensed Consolidated Balance Sheet as of September 30, 2023 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.405%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.395%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="c-270"
      decimals="-1"
      id="f-795"
      unitRef="employee">110</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="c-271"
      decimals="0"
      id="f-796"
      unitRef="employee">55</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="c-272"
      decimals="0"
      id="f-797"
      unitRef="employee">55</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent contextRef="c-270" decimals="2" id="f-798" unitRef="number">0.23</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent>
    <us-gaap:RestructuringCharges contextRef="c-273" decimals="INF" id="f-799" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-274" decimals="-5" id="f-800" unitRef="usd">5300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-275" decimals="-5" id="f-801" unitRef="usd">4100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-276" decimals="-5" id="f-802" unitRef="usd">1200000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="c-1" id="f-803">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of accrued April Restructuring costs included within other accrued liabilities on the Company&#x2019;s Condensed Consolidated Balance Sheet as of September 30, 2023 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.405%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.395%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve contextRef="c-4" decimals="-3" id="f-804" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges contextRef="c-1" decimals="-3" id="f-805" unitRef="usd">5337000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring contextRef="c-1" decimals="-3" id="f-806" unitRef="usd">3033000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment contextRef="c-1" decimals="-3" id="f-807" unitRef="usd">305000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve contextRef="c-3" decimals="-3" id="f-808" unitRef="usd">1999000</us-gaap:RestructuringReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-809">INCOME TAXES&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period. During the three months ended September 30, 2023 and 2022 the Company recorded an income tax expense of $1.3 million and $0.1&#160;million, respectively. During the nine months ended September&#160;30, 2023 and 2022, the Company recorded income tax benefit of $4.8 million and income tax expense of $0.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to maintain a full valuation allowance on its U.S. federal and state, Sangamo France, and Sangamo United Kingdom net deferred tax assets, as the Company believes it is not more likely than not that these benefits will be realized. The net tax benefit for the nine months ended September&#160;30, 2023 was primarily related to the impairment of the IPR&amp;amp;D asset, which was offset by the reduction of its United Kingdom&#x2019;s deferred tax asset. The tax expense for the nine months ended September&#160;30, 2022 was primarily due to foreign income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 16, 2022, the Inflation Reduction Act of 2022 was signed into law, and became effective in 2023, with tax provisions primarily focused on implementing a 15% minimum tax on global adjusted financial statement income and a 1% excise tax on share repurchases. The Company has evaluated the provisions of the tax law and noted that the law change would not have a material impact on the Condensed Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-810" unitRef="usd">1300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-811" unitRef="usd">-4800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-812" unitRef="usd">200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-813">SUBSEQUENT EVENTS&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;November Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 11, 2023, the Board of Directors of the Company approved a restructuring of operations and a corresponding reduction in workforce (the &#x201c;November Restructuring&#x201d;), designed to reduce costs and advance its strategic transformation into a neurology-focused genomic medicine company. The Company notified employees affected by the November Restructuring on November 1, 2023.  The Company expects the November Restructuring to result in the elimination of approximately 162 roles in the United States, or approximately 40% of its United States workforce. The Company estimates that it will incur approximately $8 million to $10 million in cash-based expenses related to employee severance and notice period payments, benefits and related restructuring costs. The Company expects that the majority of the restructuring charges will be incurred in the fourth quarter of 2023 and that the execution of the November Restructuring will be substantially complete by the second quarter of 2024. The Company may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the November Restructuring.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Departure of Certain Officers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the November Restructuring, the employment of each of D. Mark McClung, Executive Vice President, Chief Operating Officer, and Jason Fontenot, Ph.D., Senior Vice President, Chief Scientific Officer, will terminate, effective as of January 2, 2024. In connection with the termination of their employment, pursuant to the Amended Severance Plan (as defined below), Mr. McClung and Dr. Fontenot are entitled to certain severance benefits in exchange for the execution of a general settlement and release agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Approval of Amended and Restated Executive Severance Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2023, the Compensation Committee of the Board of Directors of the Company approved an amendment and restatement of the Company&#x2019;s Amended and Restated Executive Severance Plan (as so amended and restated, the &#x201c;Amended Severance Plan&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purpose of such amendment and restatement is to provide for the payment of certain severance benefits in the form of a lump sum (instead of in installments or monthly reimbursements) following termination. Specifically, if an Eligible Employee (as defined in the Amended Severance Plan and which includes all of the Company&#x2019;s executive officers) becomes entitled to severance benefits under the Amended Severance Plan, (i) cash severance payments will be made in the form of a lump sum within 60 days following the Eligible Employee&#x2019;s termination (instead of in the form of installments over the applicable severance period, which may range from 9 to 18 months following such termination depending on the Eligible Employee&#x2019;s position) and (ii) cash payments intended to replace COBRA premium reimbursements may be made in the form of a lump sum within 60 days following the Eligible Employee&#x2019;s termination (instead of in the form of monthly reimbursements over the applicable severance period), in the Company&#x2019;s discretion, in each case to the extent that such payments (a) are exempt from Section 409A of the Internal Revenue Code of 1986, as amended (the &#x201c;Code&#x201d;), as determined by the Company in its discretion at the time of the Eligible Employee&#x2019;s termination, or (ii) may otherwise be made in a lump sum upon such termination without causing adverse tax consequences under Section 409A of the Code.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes regarding the timing and form of payment of certain severance benefits under the Amended Severance Plan, as described above, were the only material changes made under the Amended Severance Plan. No other material changes (including changes regarding eligibility for, or the amount or type of, severance benefits) were made under the Amended Severance Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Change of Company Headquarters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2023, the Company announced that it expects to close its Brisbane, California facility in early 2024 to conserve cash resources, and intends to transition Company headquarters to its Richmond, California facility as of January&#160;1,&#160;2024. The Company may incur charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the closure of its Brisbane, California facility and the transition of company headquarters to its Richmond, California facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nasdaq Deficiency Notice&lt;/span&gt;&lt;/div&gt;On October 27, 2023, the Company received a deficiency notice (the &#x201c;Notice&#x201d;) from the Listing Qualifications Staff (the &#x201c;Staff&#x201d;) of The Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;) notifying the Company that, for the last 30 consecutive business days, the bid price of the Company&#x2019;s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). The Notice has no immediate effect on the listing of the Company&#x2019;s common stock on the Nasdaq Global Select Market.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="c-277"
      decimals="0"
      id="f-814"
      unitRef="employee">162</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent contextRef="c-277" decimals="2" id="f-815" unitRef="number">0.40</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1 contextRef="c-278" decimals="-6" id="f-816" unitRef="usd">8000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1 contextRef="c-279" decimals="-6" id="f-817" unitRef="usd">10000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <sgmo:ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod contextRef="c-280" id="f-818">P60D</sgmo:ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod>
    <sgmo:ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod contextRef="c-281" id="f-819">P9M</sgmo:ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod>
    <sgmo:ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod contextRef="c-282" id="f-820">P18M</sgmo:ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod>
    <sgmo:ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod contextRef="c-280" id="f-821">P60D</sgmo:ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>79
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M8.M<?9>/G_DVH$C[RV1>-W_18VL;TP'*UK62Q78P*"A$V?YG3]N)V!N 0\<
MLAU 7CN ;@?0)M!661/6!5-L<EK)1U1I:_"F/S1STXR&:$2I'^-,5?"K@'%J
M,KW^=G'Y;79Y@>#3[/K+U<7Y+5Q\.O]R_FUZB6:?+R]O9VB(?LPNT!]O_T1O
MD2C1[5*N:U;.Z].1 @W:TRC;WN]3>S_BN-^,KSX@&KQ')"#4,GSJ'W[!,QB.
MF^'D</@((M^%3W;AD\8?=86_KBI>*L3JFJOZQ!9/ZR"T.]"[[*1>L8R?#6 ;
MU;S:\,'DW1L<!Q]MT?TF9P>QTEVLU.=],F7U$L%30YG^P'^NQ8;E$+SU*;:N
MXL:53@6;211'.#P=;?;#,:UP$(1A9W8@--P)#;U";Z5B.2SRZH$K=I=S5/-L
M70DEN%5JZRS:$Y%$T3CI236M<)+@-+5+C792(Z_4JU)Q>%(*,EK&83Y!K4UB
M9-P\#DA/H&F3C!T3&>_4Q5YUYUDFU_" CZB+S:G!8=J39QK1.'',7K+3EWCU
MW51\Q<0<\2>@4LWK9G5*M>05I+[]C6E3G9BJ:8*CGFR+54ITYK'I3G>ZTU<L
MT.,24_/F81(E<4^C:4:#@)+$+G*\$SGVBOQJVS_O42G+X5:Y3?+8T!+TU)H6
M9)R&D5TL#CH.!4?6 I0FE7INUH!.3BLH%A3HY5:=6V\',M*0]J?68A;3B&*'
MVCUJXF/[GI7W0D^N^_%O??@FTV(2!0D9._1U6,->DDS^EG+^*/+<*HL<EV6:
M4$BJQ"&K(Q#V(^@:'C%3HKQ'.8?:"U6ZR!K*Q7!=>R>2F@\[(1CW59MF,92S
M+M4=CK"?1]=-1MK;.#ZI%LZ$XZ0/3IM9$KCR$NYPA/T\^@XLJD2F>$MYJT(3
M-#@*C!5PQ.I07P<D["=2FSD]TV=BAN!Q;-#<8A?%) I<&Z<C$DY>51#F@MV)
MO,F9UJH0>\GVJV7A[_)V&'2',^SGV:Y.6+%G5Y& +3"+PLAX,*89(2%V% JX
M@QGVTPPD5FN]JF6A:P76]H :%<4JE\^<HSM>\H5P+"L36CBA@4$+"]M@U<=V
M\:1C&_&SK4T@;!O"WM*R]ALFLG!(:#^#V,SB(' 4#:0C&_&3[8(O.&R!.=2,
M&UZN'1I-;$'%V*^]+%813E)'$B%[/9L?;H?EU['I-%$6IF':K[XM9ACC!#LJ
M!=(AC_B19\SGT1*,F!CK9V>+"0[&-'$]_0YUQ(^Z+[*\'T)+4Z"5K)H])A=;
M5A^;9Y-H%,!GK F+63I.75NL Q_Q@V\WS:*$%,&18D]6E2;6C+FU-&LD<2W:
MCGS$3SZSB#@VH9:VC.)^6V:S(LXLT&&0^#NS=HL=4V@V5VF8F(_<-",Q5).N
MK=5AB_BQ-95%(91N$]K.,9.EKBUYF;D$>_W9,8NLQSC_W]%AS!T'R=A;G\R4
MS!Z6,I_SJG[W)B4X^=AT2^K9?GCEI>HOGU[])F^'QU<=1NFQ%O%ED]=Z%JS'
M5B85^_O;:W*HK(,F]4-3KT3(E6Y9%EXF">TKLUC%L:-THATNJ1^7Y_.YT*D<
M-K0^;1F*$GJ#E8 -;I5J 2&@/36Z+:MA!#V,HP:G>^>4?F1"K;<NUCG37<P<
M:KI,6#E)30@.,0WC(#6DVBQU5*YC"]H!D_J!N:]U>W(%%6K%E_I-QP:H*6O[
M^:K)P6$<F<HM9FD8.,X%:8=+ZL=EF]]K9S*Q2K:TA(!XTB^E+'9D'(XCUT+N
M$$I?TSSN0:G)^K\81&P<65L;3(N=M<$<[;UZT>^]OK+J7I0UU$P+&!A\2& :
MJO954GNAY*IY&W,GE9)%\W')&8C7!O#[0DKU<J%?\.Q>Z$W^ U!+ P04
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M%#P610F W^=2ZK>7<H+F7G_X+U!+ P04    "  B@F%7 &?6PIT#  #)"P
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M^XNF7*Y_&N-3V33E8OUR+M*9J-H"\O/KLFR^7;2_MK']P9?S_P%02P,$%
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M,Z@&F*B\JO^2YT8VBB<DV59&%;O%@*#(RN93O.P<L;< ]. +V&X!^WF!/[*
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M?0!UTN?BNC02]!K; LCLR=8EU.9@N&DQ0@2(W)1&X^65=D1,W4P,!;8IJ0>
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MMG5/8_6F_1J(OFKMDL0>4#22UHF-:20F !\G!:&$&DTQ3MP-S;.W37TT<6/
M ;^Y*K] 0*LQA(.1/'%6I(L>@3(%5K%P^&U$7+C8@NU 7CW-U8L(%Q:!F7Y-
MM-DQ$MG*XBN1?P7)Z5D5^=;6#+2+TH#5R*2PGU19BHLF(E9J(IC(0K9%Q856
M ZJ8=@I!!85GRJB&#.4YA=%*"P_+LB$H.')42($1?\CE+_3ZND%]) <35#5
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M:Y-%)9)#V+!9<Y:A:Z[8S!6^4B;WE?,:K)F^7@^C"B0)BRR(YY'=+PNGE_Z
MK>8H:2?'X#!3QZ8J:M,4)*E!D/VAZF&*[$C'N;][294'%\^L5LA'.E/4UV6(
MW2OKAXB=7#O?V;3-FNVJWMYDM\XY\AD,)A7":H3&<3)G?J?LPZ=;.EM!<K"
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M.-TO7;/C[UI>-%W7;/E'A(U-BP?H[_B>.O<+-O!?OOWC_P!02P,$%     @
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MVF&OJ0T%?6H*9=PX/DYFCBI D^]$D%TBX$X8F8M.O=';PVR0O?RLA3@T6$A
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MB,!A1Y;#[N=H84KJ!M,#%3 =G%/=F&[=[W7Q%CQJ]*T_VE(:TCKO\^BO#3C
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M561?<%MXM_8-M S5]]KT2FL_+2_9;F^H7P151_MV!7!+P)!JE6,U@].2?VU
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MG>RQGV9^J8LU#HE(-.@"^G&I$F!J? "^GQ?@J\@O. $J25K>B_\%4$L#!!0
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M-SF_G"N9*DL+\/G4&%^_H0.:'Y:<_A-02P,$%     @ (H)A5W])O%/S @
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MIKEDU8Q^!"B- ^TOA= [PQRP_[4,_@!02P,$%     @ (H)A5TY\OV+K P
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MSI+GXGAP,GU_>B#KTX)?-&_"SC-))BOG;N3E,C\>3(00&\ZB("C\N^4S-D:
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MM_,Y$ <G?3!LBJG[.VO;H2P=E)*(4X0UDLR6D>8&XJ-T7\3'[$I7O/4F8?)
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M84JG/_4&^;G:%W&YM$S<M%IW.ENGCSNR+"Z9A[8UC<C]3C4 ZOCS@N96U1\
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MGS6>0SP^9'4L+IRE0G*1U,Z[GI8.I*,RJTU/@^I%Z'YM8))L&RB-U]J.2[N
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M<3;7:S]LGPHD]/%X=WR>XQU-#PY"?E I@":?\HRKH9-J7=PT&BI.(:?J2A3
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MX5TX">9K$DPFBX?Y.IS?D^7BIW 23B/R9DTW&:BW@X9&@&:;1ER!&9=@_,^
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M Z0QP/6M$/HX,1O4/V%&?P%02P,$%     @ (H)A5U]O?N0'!   *@L  !D
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MD+V5GL:RF06F'.3^EE)Q,M0!=7L\^QM02P,$%     @ (H)A5S9?LW+(!
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M!F)\Y_7[6&+B\,K6*QM8,\& 2ICS%)^/][?^X:U^<#"?#$:^P$ !3R%L&!7
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M2F. W[="Z,/$!#A>D\;_ U!+ P04    "  B@F%7%HHS9_\"  !>!@  &0
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M2R,YIH$U#>K61*QY_H?.<PZ:X%AB'!E_,8AC097!ZR2X$D6>,DW&7),P+Z!
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M+E/Z Z!V#F1?*F6W&Y>@_J<,_P%02P,$%     @ (H)A5XA[OO@X!   T!$
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M5D:L6J^0B<KJ48MRJ([.BR*S5X=M;;L!ZTU*@D(')*KHI,^:ANZ7J \G2F7
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MOJPGBLB;.G+ ,Q:ZM<I)48_*FQH\@#V&(I'U*H_TY1LD67^1&ZQ8G!QA%P:
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M5 I+Y<JZN%2;CQ?]4S&0;)-_[R^85-U#?KM6+2=P;:">+QF3CP/MH&IBW?\
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M?A013^18J;*:L6Q1/FW4"&H%06D42@N@-(:BF8IKW\@Y?@5)*]1V@M(HE!9
M:0Q%,V-#>U2.W:2ZY6H9C1S+U[]!)VO?H(<S];U<5V:T<:B&=QD=RR_52?FE
M>O-H#G6HH#1:TXQOX0;;6=4AI5A=:K"KE+G"09M*KMU4.G",EJ_>5A<:7:*%
MO%D3\O-*R"X)7N8\4A+>B9DJESZ0L7PK?PBCJL"X"+."4*DN^6WT(O+?/Y3V
MQ;N^(_\UJ6S_%&U5AM(HE!9 :0Q%,Z-+NUBN\_/G Q=J<$%I%$H+H#2&HIFQ
MH0TNUVJ2'#H?-"H.M:V@- JE!5 :JVGK,XWKN#LG$>U'N78_:I^47<*7,T*Q
MFA'RM1E!U1-ITYJ_"WO3K;6&FEA06@"EL3V2.2Z9E:LE;>>RML!<NP7VNK((
MI[\KBX Z<% :A=("*(VA:&9T:4?/';R"+ +J[4%I%$H+H#2&HIFQH9U"U^X4
M?D\6 ?4!H31:T_9<.1Y4BJ%Z9BJD74#7[@+^T.0 :A-":73/8=DQ =?"?GM=
MAOH4IMS: G3M:\<LJ4"C@E S#TJC4%H I3$4S519FWGNR2N8DJ'6'I1&H;0
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M"]3[2R'DRXO\ M7VZ-%_4$L#!!0    ( "."85?9D<M1W0,  "@0   9
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MML\,M[251Z$GT/4UY^KU0._]\A\'QO\"4$L#!!0    ( "."85>:HU0 % H
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M01IGQ?_DN=I7Z9%@D^7IJ@KF+5A%2?G3?ZF^B)T 37LG0*L"M&,#!E7 8#]
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MJ=!7F,:QS[N_[58AM?K"NE:Y(9?+9U":#J49%4U5=_0V.=74P7A2_]L7'M2
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M0!.ZVJ'%11UH6FN=_R\L#%IM8=#D%H;#M=[FJ&F:A-O++J3+OO(\G<4 =35
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M<\\N4_VC06$<]/F*<[4S#$'SZPK_ %!+ P04    "  C@F%7.H>DJ)@"  #
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M#HG4#%B]5C"&/-=$ZAJ_&DZKE=3 W?66_:.)7<4RQP+&+/]&4ID-K!L+I;#
M52[OV?H3-/%<:KZ$Y<(\T;KV]95S4@G)B@:L;E 06K_QILG##D#Q= /<!N#N
M _P# *\!>"]5\!N _U*%RP9@0K?KV$WB(BQQ&'"V1EQ[*S:],-DW:)4O0O5W
M,I5<G1*%D^'MY_&7NQC-AM_C*3J-0&*2BS-TCAZF$3H].4,GB% TRU@E,$U%
M8$LEJJ%VT@B,:@'W@("'[AB5F4 Q32'MP$?'\>^/X&T5;!NQNXUXY!XEG$)Y
M@3SG'7(=U^NXS_CE<+<KG/]3C_]9_4DRO+;\GN'S#I6?)JP -,,;%!&1Y$Q4
M'-"/X5Q(KO[AGUWUKAG];D;=U_JBQ D,+-6X!/ 56.';-[TKYT-7LE^3+'I-
MLOB5R)Z4Q6_+XA]CWY9%JK+ 1HT$ >AT#A061)YUE:1FNS)L>C*LPIY[[03V
M:C?5SYV\/9?HN<NY?^/L><4=:CMB=<#V3DLJ@"_-+! H8165]>?96MMQ,S1=
M=L\^ZO7'O0Y[I,93/4W^TM>S[0[S):$"Y;!04L[%M>J8O)X7]4:RTC3$.9.J
MO9IEID8L<.V@SA>,R>U&"[1#._P#4$L#!!0    ( "."85<_*6N/%00  'D6
M   9    >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;+U886^;.!C^*Q8WG3:I
M*YBD:=HED=HTIYMT[;+FNGV8[H,#;Q)K@)EMDE3:CS\;*(0>>$OEW1>"">_S
M^GG\OO#@T8[QKV(#(-$^CA(Q=C92II>N*X(-Q$2<LA02]<^*\9A(->1K5Z0<
M2)@'Q9'K>][ C0E-G,DHOS;GDQ'+9$03F',DLC@F_/$:(K8;.]AYNG!/UQNI
M+[B344K6L #YD,ZY&KD52DAC2 1E">*P&CM7^'+J>SH@O^,3A9TX.$>:RI*Q
MKWKP/AP[GIX11!!(#4'4SQ:F$$4:2<WC6PGJ5#EUX.'Y$_H?.7E%9DD$3%GT
MF89R,W:&#@IA1;)(WK/=GU 2.M-X 8M$?D2[XMYSE3'(A&1Q&:S&,4V*7[(O
MA3@(P/V. +\,\)\%]+HR],J 7DZTF%E.ZX9(,AEQMD-<WZW0]$FN31ZMV-!$
M+^-"<O4O57%RLGBX7LP^/LSN_D:S3^JX0*]O0!(:B3?H+5ID2P'?,D@DFFWU
M\16B";JE4:260(Q<J6:@<=R@S'9=9/,[LGT(Y"GRAR?(]_Q>2_CT)\(Q+L+1
MP^(&O7[U!D&<1NP1H(GG*B$J-?Q*#3]/T.](<)6FG&U)A#ZLT)4JUA!"=)6$
MZ!Z$)%(-9GL(,EUX: %;X"0) ,TCDK1)84REV_-2I"2 L:/Z3P#?@C/Y_3<\
M\-ZU"6,)K*%*KU*EEZ/WNFKD>15\^4O=@=Y+B,4_;<Q[-IE; FLP[U?,^\9Z
MJ)=;5,N=JN4^.1@O(8$5E>($15F<ZN?A"4K)8ZR%2H%3%K9)9,X[\%!('ML:
M;&H,?*$<9Y4<9\9IW=*$QEF,OB.KC6),>FRY6 )KZ#.H]!G8;92!3>:6P!K,
MSROFYQ8;10)7KS*2O\>[6\2<\0+%+)&;UAXQ1KY0B6&EQ-#<(V3_*WK$F/38
M2K$$UM#GHM+GPFZ/7-AD;@FLP1Q[M=?R_O<N^4%*/#3TB3GVI7(<6$]LG-L=
MVT*\!%[8.=T6/ MDQFFR[NP#,^2QY6 +K2E [3:Q;[<7L%5/:0NMR;YVE=AH
MW29W6;[X;%4Y>($@HGG-JZ<CU9^)AR7QO</IE])8-9TEVEF.IC^%MQ,\\$?N
MMHUQ[2:QV=;-@0=JF=7GL6:=,D%U<QM9MU*UY %+J@6:?A947+W3?@?7VBIB
MLU?\47.KY2SM9"M%JY[0%EI3BMH58LNV$%OUA;;0FNQK9XC-1JVY]+!/(="%
M'C A6[E;,F\E]P)M<%#;PX[*K@T>-CN\GZGLP@2V\K/JY&RA-:6HO1RV;.:P
M53=G"ZVY5U3;.=_LK8ZL;#/:T1M"WG\J&WO/2ML]V!?4F[*WA*^I>M]$L%)!
MWNFY>B[R8I^S&$B6YEN%2R8EB_/3#9 0N+Y!_;]B3#X-].YCM=L\^1=02P,$
M%     @ (X)A5]-R>XPP P  1A,   T   !X;"]S='EL97,N>&ULW5AM3]LP
M$/XKD1D32!-IFQ&:T5;:*B%-VB8D^+!OR&V<U))C9X[+6G[]?'&:ON#K.CYL
M=*EH['MRSSV^NV##H#)+P>YFC)E@40A9#<G,F/)#&%;3&2MH=:%*)BV2*5U0
M8Z<Z#ZM2,YI6X%2(L-?IQ&%!N22C@9P7-X6I@JF:2S,D<6L*W.US.B3=^#T)
M'-U8I6Q('L[>_I@K<_TF</>3=R<GG8?SZUW[60V<D]!+>GD Z44'Y[481AT?
M1+V'&2.^VB9>$_W.L>]Q/&W]3C&WY+ <[<]2DZ>PJ?5HD"FY+GE$G,'&IP4+
M'JD8DC$5?*(Y>&6TX&+IS#TP3)50.C"VUZR@+EBJ)P=WW0S:L.$IN%2ZCNTB
MN.])\_@.L)J!0"Y$*[!'G&$T**DQ3,L;.ZD?KHW/H* 9WR]+JS#7=-GM79*U
M0WVS029*ITRW8;ID91H-!,M CN;Y#.Y&E2& QJC"#E).<R5IK6'ET0PL[90)
M<0?OZ/=LBWN1;52V W65[= *:H:.QDV ?Y/-<6_2]E[$&Y3\49E/<[L<6<^A
M7=BM9AE?U/-%U@K V+LX.RU+L?PH>"X+YA9_<,#1@*[\@IG2_,E&@U:96@/3
M)'ADVO#IIN6GIN4]6YA5.RTR7'/O"#7_W3SG3#)-Q:9HV_NO.<LO5AQ=_2O)
M]6^57<%>C<W&^]I%7AZ#R/@81!Y%3_:/063R*D6&S0:^<4K8.B.TU@#.8D/R
M#<Y^8ATTF,RY,%PVLQE/4R:?'14LO:$3^T?"%K]]/F49G0MSWX)#LAY_92F?
M%TG[U"TDHGEJ/?X"R^O&[4'0QN(R90N6CINISB?U,+ #&[6YP&$7N:DO/X+Y
M.,R/ (;%P11@/LX+B_,_K:>/KL=AF+:^%^FC/GW4QWGYD'']P>+X?1)[^5>:
M)%$4QUA&QV.O@C&6MSB&'S\;I@T\L#@0Z<]RC5<;[Y#]?8#5=%^'8"O%.Q%;
M*9YK0/QY X\D\5<;BP,>6!6PWH'X_CC04WZ?*(*J8MJP-QA'D@1#H!?]/1K'
M2'9B^/CK@[TE490D?@0POX(HPA!X&W$$4P :,"2*ZGUP9S\*5_M4N/[/V>@7
M4$L#!!0    ( "."85>7BKL<P    !,"   +    7W)E;',O+G)E;'.=DKEN
MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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M$I3<H54:D"#.L 9Y#4!>FX6\PV&*'G"T#M RP&2=MN&2$0WN'0#WSO P8[)
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MD&=80OK)R_FQAMSCF3Y0^_T,YCPB^.&F\\[H]/%P0[>LIIM8-=^H^B(OBY5
M[>5XNNE=M:<1VT-9SE1=4D<\WYR^19Z^HW[\"5!+ P04    "  C@F%71QQ@
MN:0!  ";&@  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=F[;L)
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M<',O87!P+GAM;%!+ 0(4 Q0    ( "*"85=3HGD6[@   "L"   1
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M965T,BYX;6Q02P$"% ,4    "  B@F%7K7V@"(4%  #C%P  &
M    @(&V%   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
M(H)A5P!GUL*= P  R0L  !@              ("!<1H  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( "*"85=,=T>4@@L  /QE   8
M          " @40>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    "  B@F%75<PB D,(  "^)@  &               @('\*0  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ (H)A5Z*/<6G5)   B'L
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( "*"85<_0P;_10H  &0B   9
M      " @>:+  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ (H)A5W])O%/S @  9@8  !D              ("!8I8  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  B@F%73GR_8NL#  !N"0
M&0              @(&,F0  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( "*"85=]K@(3N00  $T+   9              " @:Z=  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ (H)A5_;L=L//
M!   4 L  !D              ("!GJ(  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    "  B@F%7WM/KM!X(   Q%@  &0
M@(&DIP  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( "*"
M85=%J!1S;AT   %@   9              " @?FO  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ (H)A5^(H>-)+!   S@P  !D
M         ("!GLT  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    "  B@F%77V]^Y <$   J"P  &0              @($@T@  >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( "*"85<V7[-RR 0  -P+
M   9              " @5[6  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ (H)A5TUQOTFZ P  ,@D  !D              ("!7=L
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  B@F%7%HHS
M9_\"  !>!@  &0              @(%.WP  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( "*"85<!@.<8ZP(  %\&   9
M  " @83B  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
M(H)A5XA[OO@X!   T!$  !D              ("!IN4  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    "  B@F%7Y4T,64L$  "#%@  &0
M            @($5Z@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( "*"85<;LCA$60,  +H)   9              " @9?N  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ (X)A5VO[K]JV#
M\H\  !D              ("!)_(  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    "  C@F%7.2=BN< )  "'7@  &0              @($4
M_P  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( "."85<;
M \ZGS@(  ,8&   9              " @0L) 0!X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ (X)A5W8>/P^H P  T X  !D
M     ("!$ P! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "."85?9D<M1W0,  "@0   9              "
M@<$N 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ (X)A
M5YJC5  4"@  [F@  !D              ("!U3(! 'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    "  C@F%7W)CAZ)X%  ";+   &0
M        @($@/0$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( "."85<F"(A*L0,  !$1   9              " @?5" 0!X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ (X)A5P[;S;<&!   U1
M !D              ("!W48! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    "  C@F%7L8D(260$  #2'   &0              @($:2P$
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( "."85<PBW,C
MN (  ,8&   9              " @;5/ 0!X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ (X)A5SJ'I*B8 @  P <  !D
M ("!I%(! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    "  C
M@F%7/REKCQ4$  !Y%@  &0              @(%S50$ >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( "."85?3<GN,, ,  $83   -
M          "  ;]9 0!X;"]S='EL97,N>&UL4$L! A0#%     @ (X)A5Y>*
MNQS     $P(   L              ( !&ET! %]R96QS+RYR96QS4$L! A0#
M%     @ (X)A5ZAGR/KR P  RQT   \              ( ! UX! 'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( "."85=''&"YI $  )L:   :
M      "  2)B 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( "."85<NTOC K@$  ,H:   3              "  ?YC 0!;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     T #0 (PX  -UE 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>282</ContextCount>
  <ElementCount>233</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>61</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES</Role>
      <ShortName>CASH EQUIVALENTS AND MARKETABLE SECURITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE</Role>
      <ShortName>BASIC AND DILUTED NET LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETS</Role>
      <ShortName>IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - RESTRUCTURING CHARGES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/RESTRUCTURINGCHARGES</Role>
      <ShortName>RESTRUCTURING CHARGES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables</Role>
      <ShortName>CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - RESTRUCTURING CHARGES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/RESTRUCTURINGCHARGESTables</Role>
      <ShortName>RESTRUCTURING CHARGES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/RESTRUCTURINGCHARGES</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails</Role>
      <ShortName>ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration And Licensing Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails</Role>
      <ShortName>ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration And Licensing Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails</Role>
      <ShortName>ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails</Role>
      <ShortName>CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Available-for-Sale Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Available-for-Sale Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESNarrativeDetails</Role>
      <ShortName>CASH EQUIVALENTS AND MARKETABLE SECURITIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails</Role>
      <ShortName>BASIC AND DILUTED NET LOSS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails</Role>
      <ShortName>IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETS</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - STOCKHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - RESTRUCTURING CHARGES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails</Role>
      <ShortName>RESTRUCTURING CHARGES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - RESTRUCTURING CHARGES - Accrued Restructuring Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/RESTRUCTURINGCHARGESAccruedRestructuringCostsDetails</Role>
      <ShortName>RESTRUCTURING CHARGES - Accrued Restructuring Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/INCOMETAXES</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="sgmo-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>44</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="sgmo-20230930.htm">sgmo-20230930.htm</File>
    <File>sgmo-20230930.xsd</File>
    <File>sgmo-20230930_cal.xml</File>
    <File>sgmo-20230930_def.xml</File>
    <File>sgmo-20230930_lab.xml</File>
    <File>sgmo-20230930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="689">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>84
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "sgmo-20230930.htm": {
   "nsprefix": "sgmo",
   "nsuri": "http://www.sangamo.com/20230930",
   "dts": {
    "inline": {
     "local": [
      "sgmo-20230930.htm"
     ]
    },
    "schema": {
     "local": [
      "sgmo-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "sgmo-20230930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sgmo-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "sgmo-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sgmo-20230930_pre.xml"
     ]
    }
   },
   "keyStandard": 185,
   "keyCustom": 48,
   "axisStandard": 20,
   "axisCustom": 0,
   "memberStandard": 30,
   "memberCustom": 31,
   "hidden": {
    "total": 5,
    "http://xbrl.sec.gov/dei/2023": 5
   },
   "contextCount": 282,
   "entityCount": 1,
   "segmentCount": 61,
   "elementCount": 385,
   "unitCount": 11,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 689,
    "http://xbrl.sec.gov/dei/2023": 29
   },
   "report": {
    "R1": {
     "role": "http://www.sangamo.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-43",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-43",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "longName": "0000007 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS",
     "longName": "0000008 - Disclosure - FAIR VALUE MEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES",
     "longName": "0000009 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES",
     "shortName": "CASH EQUIVALENTS AND MARKETABLE SECURITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE",
     "longName": "0000010 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE",
     "shortName": "BASIC AND DILUTED NET LOSS PER SHARE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES",
     "longName": "0000011 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETS",
     "longName": "0000012 - Disclosure - IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS",
     "shortName": "IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetImpairmentChargesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetImpairmentChargesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.sangamo.com/role/STOCKBASEDCOMPENSATION",
     "longName": "0000013 - Disclosure - STOCK-BASED COMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.sangamo.com/role/STOCKHOLDERSEQUITY",
     "longName": "0000014 - Disclosure - STOCKHOLDERS' EQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.sangamo.com/role/RESTRUCTURINGCHARGES",
     "longName": "0000015 - Disclosure - RESTRUCTURING CHARGES",
     "shortName": "RESTRUCTURING CHARGES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.sangamo.com/role/INCOMETAXES",
     "longName": "0000016 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.sangamo.com/role/SUBSEQUENTEVENTS",
     "longName": "0000017 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "longName": "9954471 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "longName": "9954472 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables",
     "longName": "9954473 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables",
     "longName": "9954474 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables)",
     "shortName": "CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables",
     "longName": "9954475 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES (Tables)",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables",
     "longName": "9954476 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.sangamo.com/role/RESTRUCTURINGCHARGESTables",
     "longName": "9954477 - Disclosure - RESTRUCTURING CHARGES (Tables)",
     "shortName": "RESTRUCTURING CHARGES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
     "longName": "9954478 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "shortName": "ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R26": {
     "role": "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails",
     "longName": "9954479 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration And Licensing Agreements (Details)",
     "shortName": "ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration And Licensing Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-59",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-59",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails",
     "longName": "9954480 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Details)",
     "shortName": "ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails",
     "longName": "9954481 - Disclosure - FAIR VALUE MEASUREMENTS (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-79",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
     "longName": "9954482 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Details)",
     "shortName": "CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails",
     "longName": "9954483 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Available-for-Sale Securities by Contractual Maturity (Details)",
     "shortName": "CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Available-for-Sale Securities by Contractual Maturity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESNarrativeDetails",
     "longName": "9954484 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Narrative (Details)",
     "shortName": "CASH EQUIVALENTS AND MARKETABLE SECURITIES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RealizedInvestmentGainsLosses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RealizedInvestmentGainsLosses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails",
     "longName": "9954485 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Details)",
     "shortName": "BASIC AND DILUTED NET LOSS PER SHARE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails",
     "longName": "9954486 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Details)",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-160",
      "name": "sgmo:AgreementTerminationTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-160",
      "name": "sgmo:AgreementTerminationTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
     "longName": "9954487 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Details)",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-192",
      "name": "sgmo:RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "sgmo:RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails",
     "longName": "9954488 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Details)",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-201",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails",
     "longName": "9954489 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Details)",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-205",
      "name": "us-gaap:ProceedsFromCollaborators",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
     "longName": "9954490 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Details)",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-224",
      "name": "sgmo:CollaborationAgreementNumberOfAdditionalProductTargets",
      "unitRef": "product_target",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-224",
      "name": "sgmo:CollaborationAgreementNumberOfAdditionalProductTargets",
      "unitRef": "product_target",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails",
     "longName": "9954491 - Disclosure - IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS (Details)",
     "shortName": "IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-250",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-250",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails",
     "longName": "9954492 - Disclosure - STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details)",
     "shortName": "STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails",
     "longName": "9954493 - Disclosure - STOCKHOLDERS' EQUITY (Details)",
     "shortName": "STOCKHOLDERS' EQUITY (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-264",
      "name": "sgmo:StockOfferingProgramMaximumValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-264",
      "name": "sgmo:StockOfferingProgramMaximumValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails",
     "longName": "9954494 - Disclosure - RESTRUCTURING CHARGES - Narrative (Details)",
     "shortName": "RESTRUCTURING CHARGES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-270",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated",
      "unitRef": "employee",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-1",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.sangamo.com/role/RESTRUCTURINGCHARGESAccruedRestructuringCostsDetails",
     "longName": "9954495 - Disclosure - RESTRUCTURING CHARGES - Accrued Restructuring Costs (Details)",
     "shortName": "RESTRUCTURING CHARGES - Accrued Restructuring Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.sangamo.com/role/INCOMETAXESDetails",
     "longName": "9954496 - Disclosure - INCOME TAXES (Details)",
     "shortName": "INCOME TAXES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R44": {
     "role": "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails",
     "longName": "9954497 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-280",
      "name": "sgmo:ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-280",
      "name": "sgmo:ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgmo-20230930.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r58",
      "r59",
      "r187",
      "r545"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r548"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, Cash Equivalents, and Restricted Cash",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash equivalents, amortized cost",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r121",
      "r550"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44"
     ]
    },
    "sgmo_JefferiesLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "JefferiesLLCMember",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Jefferies LLC",
        "label": "Jefferies LLC [Member]",
        "documentation": "Jefferies LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of long-lived assets",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r45",
      "r84"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r383",
      "r412",
      "r413",
      "r414",
      "r562",
      "r563",
      "r567",
      "r568",
      "r569"
     ]
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital resources",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "parentTag": "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total cash equivalents and marketable securities, gross unrealized losses",
        "label": "Cash Equivalents And Available For Sale Securities Gross Unrealized Loss Before Tax",
        "documentation": "Cash equivalents and available for sale securities, gross unrealized loss, before Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares used in computing diluted net loss per share (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r166"
     ]
    },
    "sgmo_AchievementOfCommercialMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "AchievementOfCommercialMilestonesMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Achievement Of Commercial Milestones",
        "label": "Achievement Of Commercial Milestones [Member]",
        "documentation": "Achievement of Commercial Milestones."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_CollaborationAgreementNumberOfAdditionalProductTargets": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CollaborationAgreementNumberOfAdditionalProductTargets",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of additional neurological disease gene targets (in product targets)",
        "label": "Collaboration Agreement, Number Of Additional Product Targets",
        "documentation": "Collaboration Agreement, Number Of Additional Product Targets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r237",
      "r238",
      "r239",
      "r561"
     ]
    },
    "sgmo_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in revenue",
        "label": "Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax",
        "documentation": "Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r236",
      "r442",
      "r561",
      "r572",
      "r629",
      "r630"
     ]
    },
    "sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenue from Strategic Partnering Collaboration Agreements and Research Activity Grants as a Percentage of Total Revenues",
        "label": "Schedule Of Revenue From Strategic Partnering Collaboration Agreements And Research Activity Grants As A Percentage Of Total Revenues [Table Text Block]",
        "documentation": "Schedule Of Revenue From Strategic Partnering Collaboration Agreements And Research Activity Grants As A Percentage Of Total Revenues"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares used in computing basic net loss per share (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r166"
     ]
    },
    "sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CollaborativeArrangementEstimatedReimbursableServiceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement estimated reimbursable service costs",
        "label": "Collaborative Arrangement Estimated Reimbursable Service Costs",
        "documentation": "Collaborative arrangement estimated reimbursable service costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedEmployeeBenefitsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation and employee benefits",
        "label": "Accrued Employee Benefits, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r12",
      "r90"
     ]
    },
    "sgmo_AgreementTerminationTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "AgreementTerminationTerm",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agreement termination, term",
        "label": "Agreement Termination, Term",
        "documentation": "Agreement Termination, Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r383",
      "r384",
      "r385",
      "r387"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "us-gaap_InterestReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestReceivableCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest receivable",
        "label": "Interest Receivable, Current",
        "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net pension gain",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r12",
      "r71",
      "r90"
     ]
    },
    "sgmo_InitialResearchTermOfAgreement": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "InitialResearchTermOfAgreement",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial research term of agreement",
        "label": "Initial Research Term Of Agreement",
        "documentation": "Initial research term of agreement."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_IncreaseDecreaseInEarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "IncreaseDecreaseInEarningsPerShareBasic",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decreased net loss per share, basic (in dollars per share)",
        "verboseLabel": "Increased earnings per share, basic (in dollars per share)",
        "label": "Increase (Decrease) In Earnings Per Share, Basic",
        "documentation": "Increase (Decrease) In Earnings Per Share, Basic"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FAIR VALUE MEASUREMENTS",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "sgmo_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentIncreaseDecrease",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current marketable securities investments reclassified to current",
        "label": "Debt Securities, Available-For-Sale, Excluding Accrued Interest, Current, Increase (Decrease)",
        "documentation": "Debt Securities, Available-For-Sale, Excluding Accrued Interest, Current, Increase (Decrease)"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_ContractedEmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "ContractedEmployeesMember",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contracted Employees",
        "label": "Contracted Employees [Member]",
        "documentation": "Contracted Employees"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CollaborationAgreementNumberOfSelectedProductTargetsByCounterparty",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of neurological disease gene targets selected by counterparty (in product targets)",
        "label": "Collaboration Agreement, Number Of Selected Product Targets By Counterparty",
        "documentation": "Collaboration Agreement, Number Of Selected Product Targets By Counterparty"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_RevenueRemainingPerformanceObligationRenewalPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "RevenueRemainingPerformanceObligationRenewalPeriod",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Renewal period",
        "label": "Revenue, Remaining Performance Obligation, Renewal Period",
        "documentation": "Revenue, Remaining Performance Obligation, Renewal Period"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents, gross unrealized gains",
        "label": "Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax",
        "documentation": "Cash and cash equivalents accumulated gross unrealized gain before tax."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CustomerContractLiabilityMilestonePaymentEligibleToReceive",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development and sales-based milestone payments to be received",
        "label": "Customer Contract Liability Milestone Payment Eligible To Receive",
        "documentation": "Customer contract liability milestone payment eligible to receive."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/INCOMETAXES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INCOME TAXES",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r349",
      "r353",
      "r354",
      "r355",
      "r358",
      "r362",
      "r363",
      "r364",
      "r482"
     ]
    },
    "sgmo_BiogenMAIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "BiogenMAIncMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Biogen MA, Inc.",
        "label": "Biogen MA, Inc. [Member]",
        "documentation": "Biogen MA, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "verboseLabel": "General and administrative expense",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r517"
     ]
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial paper securities",
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r579",
      "r580",
      "r581",
      "r582"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued liabilities",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Restructuring Costs",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r50"
     ]
    },
    "sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToBeEligibleForPayment",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum amount of achieved milestones to receive payment",
        "label": "Contingent Development And Sales Based Milestone Payments, Maximum Amount Of Achieved Milestones To Be Eligible For Payment",
        "documentation": "Contingent Development And Sales Based Milestone Payments, Maximum Amount Of Achieved Milestones To Be Eligible For Payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STOCKHOLDERS' EQUITY",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r141",
      "r270",
      "r271",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r377",
      "r536",
      "r537",
      "r544"
     ]
    },
    "us-gaap_CashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashEquivalentsMember",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents:",
        "label": "Cash Equivalents [Member]",
        "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "sgmo_CashEquivalentsAndAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CashEquivalentsAndAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "parentTag": "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cash equivalents and marketable securities, estimated fair value",
        "label": "Cash Equivalents And Available For Sale Securities",
        "documentation": "Cash equivalents and available for sale securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r345"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r124",
      "r142",
      "r172",
      "r179",
      "r183",
      "r223",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r366",
      "r368",
      "r390",
      "r449",
      "r507",
      "r572",
      "r585",
      "r637",
      "r638",
      "r674"
     ]
    },
    "sgmo_PfizerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "PfizerMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pfizer Inc.",
        "label": "Pfizer [Member]",
        "documentation": "Pfizer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r452",
      "r572"
     ]
    },
    "sgmo_AtTheMarketOfferingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "AtTheMarketOfferingAgreementMember",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Offering Agreement",
        "label": "At The Market Offering Agreement [Member]",
        "documentation": "At the market offering agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_MilestonePaymentsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "MilestonePaymentsReceived",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone payments received",
        "label": "Milestone Payments Received",
        "documentation": "Milestone payments received."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_CollaborativeArrangementTransactionPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CollaborativeArrangementTransactionPrice",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement transaction price",
        "label": "Collaborative Arrangement Transaction Price",
        "documentation": "Collaborative arrangement transaction price."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_CNineORFSevenTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CNineORFSevenTwoMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "C9ORF72",
        "label": "C Nine O R F Seven Two [Member]",
        "documentation": "C nine ORF seven two."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_CertificatesOfDepositMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CertificatesOfDepositMember",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Certificates of deposit",
        "label": "Certificates of Deposit [Member]",
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r579",
      "r580",
      "r581",
      "r582"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Achievement of specified sales-based milestones if annual worldwide net sales of licensed products reach specified levels",
        "label": "Achievement Of Specified Sales Based Milestones If Annual Worldwide Net Sales Of Licensed Products Reach Specified Levels [Member]",
        "documentation": "Achievement of specified sales based milestones if annual worldwide net sales of licensed products reach specified levels."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "ExecutiveSeverancePlanSeveranceBenefitsTerminationPeriod",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive severance plan, severance benefits, termination period",
        "label": "Executive Severance Plan, Severance Benefits, Termination Period",
        "documentation": "Executive Severance Plan, Severance Benefits, Termination Period"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_TenantImprovementAllowanceWithinContraLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "TenantImprovementAllowanceWithinContraLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tenant improvement allowance included in contra-lease liability",
        "label": "Tenant Improvement, Allowance Within Contra Lease Liability",
        "documentation": "Tenant Improvement, Allowance Within Contra Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and other accrued liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails",
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of employees eliminated in restructuring",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated",
        "documentation": "The number of positions eliminated during the period as a result of restructuring activities."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CollaborationArrangementCommissionFeePortionOfGrossProceedsValue",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial advisory fees",
        "label": "Collaboration Arrangement, Commission Fee, Portion Of Gross Proceeds, Value",
        "documentation": "Collaboration Arrangement, Commission Fee, Portion Of Gross Proceeds, Value"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_CollaborativeAgreementPercentOfInitialRecognition": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CollaborativeAgreementPercentOfInitialRecognition",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of initial recognition",
        "label": "Collaborative Agreement, Percent Of Initial Recognition",
        "documentation": "Collaborative Agreement, Percent Of Initial Recognition"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r68",
      "r69",
      "r82",
      "r497",
      "r513",
      "r534",
      "r535",
      "r572",
      "r585",
      "r613",
      "r627",
      "r671",
      "r688"
     ]
    },
    "sgmo_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash equivalents, gross unrealized losses",
        "label": "Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax",
        "documentation": "Cash and cash equivalents accumulated gross unrealized loss before tax."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r250",
      "r251",
      "r252"
     ]
    },
    "sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of products approved",
        "label": "Collaboration And License Agreements Number Of Products Approved Under Agreement",
        "documentation": "Collaboration and license agreements number of products approved under agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r576",
      "r577",
      "r579",
      "r580",
      "r581",
      "r582",
      "r615",
      "r616",
      "r670",
      "r687",
      "r688"
     ]
    },
    "sgmo_RevenueRemainingPerformanceObligationFixedConsiderationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "RevenueRemainingPerformanceObligationFixedConsiderationAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed consideration",
        "label": "Revenue, Remaining Performance Obligation, Fixed Consideration Amount",
        "documentation": "Revenue, Remaining Performance Obligation, Fixed Consideration Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r572"
     ]
    },
    "sgmo_IncreaseDecreaseInNetIncomeLossAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "IncreaseDecreaseInNetIncomeLossAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease in net loss",
        "label": "Increase (Decrease) In Net Income (Loss) Attributable To Parent",
        "documentation": "Increase (Decrease) In Net Income (Loss) Attributable To Parent"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "SaleOfStockExcessConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, excess consideration received on transaction",
        "label": "Sale of Stock, Excess Consideration Received on Transaction",
        "documentation": "Sale of Stock, Excess Consideration Received on Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current restricted cash",
        "label": "Restricted Cash and Cash Equivalents, Noncurrent",
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r103",
      "r140"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails",
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r175"
     ]
    },
    "sgmo_EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "EffectiveIncomeTaxRateReconciliationReductionInDeferredTaxLiabilitiesAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Reduction in deferred tax liabilities",
        "label": "Effective Income Tax Rate Reconciliation, Reduction In Deferred Tax Liabilities, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Reduction In Deferred Tax Liabilities, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r383",
      "r386"
     ]
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r554"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_PfizerC9ORF72Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "PfizerC9ORF72Member",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pfizer C9ORF72",
        "label": "Pfizer C9ORF72 [Member]",
        "documentation": "Pfizer C9ORF72"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-Sale [Table Text Block]",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203"
     ]
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]",
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromCollaborators": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromCollaborators",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from collaborators",
        "label": "Proceeds from Collaborators",
        "documentation": "Cash received from collaborators during the current period."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization in operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "sgmo_ExtendedResearchTermOfAgreement": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "ExtendedResearchTermOfAgreement",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extended research term of agreement",
        "label": "Extended Research Term Of Agreement",
        "documentation": "Extended Research Term Of Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_PaymentsForRestructuring": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRestructuring",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESAccruedRestructuringCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash payments",
        "label": "Payments for Restructuring",
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r609"
     ]
    },
    "sgmo_ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "ContractWithCustomerEligibleRoyaltiesTriggeredByPercentageOfNetSalesPerDevelopedLicensedProductByCounterparty",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of net sales per developed licensed product which will trigger royalties by counterparty",
        "label": "Contract With Customer, Eligible Royalties, Triggered By Percentage Of Net Sales Per Developed Licensed Product By Counterparty",
        "documentation": "Contract With Customer, Eligible Royalties, Triggered By Percentage Of Net Sales Per Developed Licensed Product By Counterparty"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Achievement Of Specified Preclinical Development Clinical Development And First Commercial Sale Milestones",
        "label": "Achievement Of Specified Preclinical Development Clinical Development And First Commercial Sale Milestones [Member]",
        "documentation": "Achievement of specified preclinical development clinical development and first commercial sale milestones."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment included in unpaid liabilities",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r34"
     ]
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r189"
     ]
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accretion of discounts and impairment on marketable securities",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Diluted net loss per share (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r162",
      "r164",
      "r165",
      "r166",
      "r170",
      "r379",
      "r380",
      "r444",
      "r462",
      "r556"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "parentTag": "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cash equivalents and marketable securities, gross unrealized gains",
        "label": "Cash Equivalents And Available For Sale Securities Gross Unrealized Gain Before Tax",
        "documentation": "Cash equivalents and available for sale securities, gross unrealized gain, before tax."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing Activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78",
      "r79"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r300",
      "r305",
      "r383",
      "r413",
      "r562",
      "r563",
      "r567",
      "r568",
      "r569"
     ]
    },
    "us-gaap_LicenseAndServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LicenseAndServiceMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License and Service",
        "verboseLabel": "License and Service",
        "label": "License and Service [Member]",
        "documentation": "Right to use intangible asset and performance of related service. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r300",
      "r305",
      "r383",
      "r412",
      "r567",
      "r568",
      "r569"
     ]
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r178",
      "r182",
      "r184",
      "r558"
     ]
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment charges",
        "label": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-Sale, Recognized in Earnings",
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r383",
      "r414",
      "r562",
      "r563",
      "r567",
      "r568",
      "r569"
     ]
    },
    "sgmo_StockPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "StockPurchaseAgreementMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Purchase Agreement",
        "label": "Stock Purchase Agreement [Member]",
        "documentation": "Stock Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LicenseMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License",
        "label": "License [Member]",
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover page.",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_November2023RestructuringPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "November2023RestructuringPlanMember",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "November 2023 Restructuring Plan",
        "label": "November 2023 Restructuring Plan [Member]",
        "documentation": "November 2023 Restructuring Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r105",
      "r107",
      "r108",
      "r109"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues:",
        "verboseLabel": "Revenue related to Sanofi agreement:",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "sgmo_CollaborativeArrangementLicenseFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CollaborativeArrangementLicenseFee",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement, license fee",
        "label": "Collaborative Arrangement, License Fee",
        "documentation": "Collaborative Arrangement, License Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54",
      "r309"
     ]
    },
    "us-gaap_RestructuringPlanDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringPlanDomain",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails",
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Plan [Domain]",
        "label": "Restructuring Plan [Domain]",
        "documentation": "Identification of the individual restructuring plans."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic net loss per share (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r160",
      "r162",
      "r164",
      "r165",
      "r166",
      "r170",
      "r379",
      "r380",
      "r444",
      "r462",
      "r556"
     ]
    },
    "sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent development and sales-based milestone payments to be received",
        "label": "Contingent Development And Sales Based Milestone Payments To Be Received",
        "documentation": "Contingent development and sales based milestone payments to be received."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total cash equivalents and marketable securities",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r351",
      "r450"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration received on transaction",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r453",
      "r572"
     ]
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUBSEQUENT EVENTS",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r408"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, price per share (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails",
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r144",
      "r145",
      "r267",
      "r272",
      "r405",
      "r551",
      "r553"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails",
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r144",
      "r145",
      "r267",
      "r272",
      "r405",
      "r552",
      "r553"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r71",
      "r125",
      "r454",
      "r476",
      "r477"
     ]
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetBackedSecuritiesMember",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset-backed securities",
        "label": "Asset-Backed Securities [Member]",
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans."
       }
      }
     },
     "auth_ref": [
      "r567",
      "r620",
      "r621",
      "r622"
     ]
    },
    "sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer concentration risk",
        "label": "Revenue From Collaboration Agreements, Grants And Licensing Concentration Risk [Member]",
        "documentation": "Revenue From Collaboration Agreements, Grants And Licensing Concentration Risk"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r58",
      "r59",
      "r187",
      "r545",
      "r593"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of revenues",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r58",
      "r59",
      "r187"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r483",
      "r615",
      "r616",
      "r617",
      "r670",
      "r688"
     ]
    },
    "sgmo_MilestoneRevenueReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "MilestoneRevenueReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone revenue receivable",
        "label": "Milestone Revenue Receivable",
        "documentation": "Milestone\u200b revenue receivable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r39",
      "r58",
      "r92",
      "r545"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r64",
      "r65",
      "r87"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity:",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Achievement of specified clinical development intellectual property and regulatory milestones",
        "label": "Achievement Of Specified Clinical Development Intellectual Property And Regulatory Milestones [Member]",
        "documentation": "Achievement of specified clinical development intellectual property and regulatory milestones."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Marketable securities, amortized cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss",
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USGovernmentSponsoredEnterprisesDebtSecuritiesMember",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. government-sponsored entity debt securities",
        "label": "US Government-sponsored Enterprises Debt Securities [Member]",
        "documentation": "Debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae)."
       }
      }
     },
     "auth_ref": [
      "r642",
      "r683"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails",
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total marketable securities",
        "verboseLabel": "Marketable securities, estimated fair value",
        "totalLabel": "Total",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest",
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in at-the-market offering, net of offering expenses",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r64",
      "r65",
      "r87",
      "r483",
      "r533",
      "r543",
      "r584"
     ]
    },
    "sgmo_RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "RevenueRemainingPerformanceObligationRelatedToMaterialRightsAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining performance obligation amount, related to material rights",
        "label": "Revenue, Remaining Performance Obligation, Related To Material Rights, Amount",
        "documentation": "Revenue, Remaining Performance Obligation, Related To Material Rights, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r126",
      "r142",
      "r223",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r366",
      "r368",
      "r390",
      "r572",
      "r637",
      "r638",
      "r674"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining performance obligation, expected timing of satisfaction period",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock under employee stock purchase plan",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r64",
      "r65",
      "r87"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total marketable securities",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Current",
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current."
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities, non-current",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Noncurrent",
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestAndOtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestAndOtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and other income, net",
        "label": "Interest and Other Income",
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_NovartisInstitutesForBioMedicalResearchIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "NovartisInstitutesForBioMedicalResearchIncMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Novartis Institutes for BioMedical Research, Inc.",
        "label": "Novartis Institutes For BioMedical Research Inc. [Member]",
        "documentation": "Novartis Institutes For BioMedical Research Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturities of marketable securities",
        "label": "Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities",
        "documentation": "The cash inflow associated with the maturity, prepayments and calls (requests for early payments) of debt securities designated as held-to-maturity."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r619"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate debt securities",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r567",
      "r569",
      "r686"
     ]
    },
    "sgmo_FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "FurnitureFixturesAndLaboratoryAndManufacturingEquipmentMember",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture, Fixtures and Laboratory and Manufacturing Equipment",
        "label": "Furniture, Fixtures And Laboratory And Manufacturing Equipment [Member]",
        "documentation": "Furniture, Fixtures And Laboratory And Manufacturing Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in at-the-market offering, net of offering expenses (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r64",
      "r65",
      "r87",
      "r480",
      "r533",
      "r543"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r594",
      "r610"
     ]
    },
    "sgmo_CollaborationAndLicenseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CollaborationAndLicenseAgreementMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration And License Agreement",
        "label": "Collaboration And License Agreement [Member]",
        "documentation": "Collaboration and license agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r64",
      "r65",
      "r87"
     ]
    },
    "us-gaap_AssetImpairmentChargesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentChargesTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IMPAIRMENT OF GOODWILL, INDEFINITE-LIVED INTANGIBLE ASSETS AND OTHER LONG-LIVED ASSETS",
        "label": "Asset Impairment Charges [Text Block]",
        "documentation": "The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_CollaborativeArrangementNumberOfMilestonesAchieved": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CollaborativeArrangementNumberOfMilestonesAchieved",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative arrangement, number of milestones achieved",
        "label": "Collaborative Arrangement, Number Of Milestones Achieved",
        "documentation": "Collaborative Arrangement, Number Of Milestones Achieved"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from at-the-market offering/ issuance of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r24",
      "r117",
      "r133",
      "r134",
      "r135",
      "r146",
      "r147",
      "r148",
      "r150",
      "r156",
      "r158",
      "r171",
      "r224",
      "r225",
      "r284",
      "r342",
      "r343",
      "r344",
      "r356",
      "r357",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r399",
      "r404",
      "r472",
      "r473",
      "r474",
      "r483",
      "r533"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r146",
      "r147",
      "r148",
      "r150",
      "r156",
      "r158",
      "r224",
      "r225",
      "r342",
      "r343",
      "r344",
      "r356",
      "r357",
      "r370",
      "r372",
      "r373",
      "r375",
      "r378",
      "r472",
      "r474",
      "r483",
      "r688"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r117",
      "r133",
      "r134",
      "r135",
      "r146",
      "r147",
      "r148",
      "r150",
      "r156",
      "r158",
      "r171",
      "r224",
      "r225",
      "r284",
      "r342",
      "r343",
      "r344",
      "r356",
      "r357",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r399",
      "r404",
      "r472",
      "r473",
      "r474",
      "r483",
      "r533"
     ]
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of marketable securities",
        "label": "Payments to Acquire Marketable Securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r58",
      "r59",
      "r187",
      "r545"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock under employee stock purchase plan (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r64",
      "r65",
      "r87"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring expected cost",
        "label": "Restructuring and Related Cost, Expected Cost",
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r246",
      "r250",
      "r252"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r618",
      "r673"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r58",
      "r59",
      "r187",
      "r478",
      "r545"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r13",
      "r26",
      "r371",
      "r374",
      "r404",
      "r472",
      "r473",
      "r606",
      "r607",
      "r608",
      "r615",
      "r616",
      "r617"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r603",
      "r612"
     ]
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment on right-of-use assets",
        "label": "Operating Lease, Impairment Loss",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r392"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "verboseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of milestones included in transaction price",
        "label": "Number Of Clinical Or Regulatory Milestones Included In Transaction Price",
        "documentation": "Number of clinical or regulatory milestones included in transaction price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net decrease in cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r77"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r120",
      "r142",
      "r223",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r367",
      "r368",
      "r369",
      "r390",
      "r572",
      "r637",
      "r674",
      "r675"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents, and restricted cash, beginning of period",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash, end of period",
        "totalLabel": "Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r77",
      "r140"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r171",
      "r441",
      "r479",
      "r484",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r495",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r514",
      "r516",
      "r517",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r533",
      "r578"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r441",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r549",
      "r566",
      "r573",
      "r595",
      "r635",
      "r636",
      "r640",
      "r685"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails",
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r257",
      "r299",
      "r306",
      "r334",
      "r335",
      "r336",
      "r415",
      "r439",
      "r471",
      "r485",
      "r486",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r546",
      "r547",
      "r559",
      "r564",
      "r570",
      "r574",
      "r577",
      "r632",
      "r639",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r142",
      "r223",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r367",
      "r368",
      "r369",
      "r390",
      "r493",
      "r557",
      "r585",
      "r637",
      "r674",
      "r675"
     ]
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LettersOfCreditOutstandingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of credit established as a deposit",
        "label": "Letters of Credit Outstanding, Amount",
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r441",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r549",
      "r566",
      "r573",
      "r595",
      "r635",
      "r636",
      "r640",
      "r685"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of intangible assets, indefinite-lived",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value."
       }
      }
     },
     "auth_ref": [
      "r611",
      "r631"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails",
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r257",
      "r306",
      "r439",
      "r471",
      "r485",
      "r486",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r546",
      "r547",
      "r559",
      "r564",
      "r570",
      "r574",
      "r639",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails",
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r257",
      "r299",
      "r306",
      "r334",
      "r335",
      "r336",
      "r415",
      "r439",
      "r471",
      "r485",
      "r486",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r546",
      "r547",
      "r559",
      "r564",
      "r570",
      "r574",
      "r577",
      "r632",
      "r639",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Long-term portion of lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails",
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r257",
      "r306",
      "r439",
      "r471",
      "r485",
      "r486",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r546",
      "r547",
      "r559",
      "r564",
      "r570",
      "r574",
      "r639",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Taxes paid related to net share settlement of equity awards",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r96",
      "r456",
      "r572",
      "r613",
      "r627",
      "r671"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r15"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Achievement of specified research, clinical development, regulatory and first commercial sale milestones",
        "label": "Achievement Of Specified Research Clinical Development Regulatory And First Commercial Sale Milestones [Member]",
        "documentation": "Achievement of specified research, clinical development, regulatory and first commercial sale milestones."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668"
     ]
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Fair Value Measurements of Cash Equivalents and Marketable Securities",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r56",
      "r57",
      "r91"
     ]
    },
    "sgmo_NumberOfOptionsToExtendInitialResearchTerm": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "NumberOfOptionsToExtendInitialResearchTerm",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options to extend initial research term",
        "label": "Number Of Options To Extend Initial Research Term",
        "documentation": "Number Of Options To Extend Initial Research Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]",
        "label": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]",
        "documentation": "A schedule reflecting the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r669"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenues",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r285",
      "r286",
      "r298"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenues, non-current",
        "label": "Contract with Customer, Liability, Noncurrent",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r285",
      "r286",
      "r298"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with customer liability",
        "verboseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r285",
      "r286",
      "r298"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation and employee benefits",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "documentation": "Information by form of arrangement related to research and development."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r669"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenues",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r440",
      "r610"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of goodwill and indefinite-lived intangible assets",
        "label": "Goodwill and Intangible Asset Impairment",
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r669"
     ]
    },
    "us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Impaired Long-Lived Assets Held and Used [Table]",
        "label": "Schedule of Impaired Long-Lived Assets Held and Used [Table]",
        "documentation": "For a long-lived asset to be held and used by an entity, the table may include a description of the impaired long-lived asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired long-lived asset is reported."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r669"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Marketable securities, gross unrealized losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH EQUIVALENTS AND MARKETABLE SECURITIES",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r99",
      "r100",
      "r116",
      "r190",
      "r191",
      "r388",
      "r389"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BASIC AND DILUTED NET LOSS PER SHARE",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r167",
      "r168",
      "r169"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_ManufacturedProductOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ManufacturedProductOtherMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other products",
        "label": "Manufactured Product, Other [Member]",
        "documentation": "Article or substance produced by labor or machinery, classified as other."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r269",
      "r282",
      "r376",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r460",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r623",
      "r624",
      "r625",
      "r626"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities, gross unrealized gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues under agreement",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Compensation Earned",
        "documentation": "The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_ChangeInAccountingEstimateByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangeInAccountingEstimateByTypeAxis",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Accounting Estimate by Type [Axis]",
        "label": "Change in Accounting Estimate by Type [Axis]",
        "documentation": "Information by type of change in accounting estimate."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r154"
     ]
    },
    "us-gaap_ChangeInAccountingEstimateTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangeInAccountingEstimateTypeDomain",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Accounting Estimate, Type [Domain]",
        "label": "Change in Accounting Estimate, Type [Domain]",
        "documentation": "Identification of the accounting estimate that was changed that had the effect of adjusting the carrying amount of an existing asset or liability, or that will alter the subsequent accounting for existing or future assets or liabilities."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r154"
     ]
    },
    "us-gaap_ChangeInAccountingEstimateLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangeInAccountingEstimateLineItems",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Accounting Estimate [Line Items]",
        "label": "Change in Accounting Estimate [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_ScheduleOfChangeInAccountingEstimateTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfChangeInAccountingEstimateTable",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Change in Accounting Estimate [Table]",
        "label": "Schedule of Change in Accounting Estimate [Table]",
        "documentation": "A summarization of the nature of changes in accounting estimates, including changes that occur in interim periods. Changes in accounting estimate have the effect of adjusting the carrying amounts of existing assets or liabilities or altering the subsequent accounting for existing or future assets or liabilities. Changes in accounting estimates are a necessary consequence of assessments, in conjunction with the periodic presentation of financial statements, of the present status and expected future benefits and obligations associated with assets and liabilities. Changes in accounting estimates result from new or better information. Examples of items for which estimates are necessary are uncollectible receivables, inventory obsolescence, service lives and salvage values of depreciable assets, warranty obligations, and regulatory reviews."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r154"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of investments available-for-sale",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r383",
      "r386"
     ]
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealizedInvestmentGainsLosses",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Realized investment gains (losses)",
        "label": "Realized Investment Gains (Losses)",
        "documentation": "Amount of realized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails",
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r245",
      "r518"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails",
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r250",
      "r251",
      "r252"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails",
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of positions eliminated in restructuring",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated, Period Percent",
        "documentation": "The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r407"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedInterestReceivableNet",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest receivable",
        "label": "Increase (Decrease) in Accrued Interest Receivable, Net",
        "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental cash flow disclosures:",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net pension gain",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r71"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails",
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r518"
     ]
    },
    "sgmo_SBFiveTwoFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "SBFiveTwoFiveMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "S B Five Two Five",
        "label": "S B Five Two Five [Member]",
        "documentation": "S B Five Two Five"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Measurement Frequency",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in Progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.sangamo.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense (benefit)",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r113",
      "r157",
      "r158",
      "r176",
      "r352",
      "r359",
      "r464"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturing in one year or less",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r446"
     ]
    },
    "sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential amount to be funded for achievement of specified commercialized and sales milestones",
        "label": "Aggregate Additional Revenue Recognition Milestone Method Revenue Eligible To Receive",
        "documentation": "Aggregate additional revenue recognition milestone method revenue eligible to receive."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_KitePharmaIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "KitePharmaIncMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kite Pharma, Inc.",
        "label": "Kite Pharma Inc [Member]",
        "documentation": "Kite Pharma Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r412",
      "r413",
      "r414",
      "r562",
      "r563",
      "r567",
      "r568",
      "r569"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Domain]",
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturing after one year through five years",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r447"
     ]
    },
    "sgmo_ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "ExecutiveSeverancePlanSeveranceBenefitsLumpSumPaymentPeriod",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive severance plan, severance benefits, lump sum, payment period",
        "label": "Executive Severance Plan, Severance Benefits, Lump Sum, Payment Period",
        "documentation": "Executive Severance Plan, Severance Benefits, Lump Sum, Payment Period"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_ChangeInAgreementEstimateMarch2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "ChangeInAgreementEstimateMarch2023Member",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change In Agreement Estimate, March 2023",
        "label": "Change In Agreement Estimate, March 2023 [Member]",
        "documentation": "Change In Agreement Estimate, March 2023"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restrictions on Cash and Cash Equivalents",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r94",
      "r684"
     ]
    },
    "sgmo_PfizerSB525Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "PfizerSB525Member",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pfizer SB-525",
        "label": "Pfizer SB-525 [Member]",
        "documentation": "Pfizer SB-525 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit loss related to marketable securities",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest",
        "documentation": "Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "sgmo_ChangeInAgreementEstimateSeptember2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "ChangeInAgreementEstimateSeptember2023Member",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change In Estimate, September 2023",
        "label": "Change In Agreement Estimate, September 2023 [Member]",
        "documentation": "Change In Agreement Estimate, September 2023"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_StockOfferingProgramMaximumValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "StockOfferingProgramMaximumValue",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock offering program, maximum value",
        "label": "Stock Offering Program, Maximum Value",
        "documentation": "Stock Offering Program, Maximum Value"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_AtTheMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "AtTheMarketOfferingMember",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At the Market Offering",
        "label": "At The Market Offering [Member]",
        "documentation": "At The Market Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairedLongLivedAssetsHeldAndUsedLineItems",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impaired Long-Lived Assets Held and Used [Line Items]",
        "label": "Impaired Long-Lived Assets Held and Used [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "sgmo_April2023RestructuringPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "April2023RestructuringPlanMember",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "April 2023 Restructuring Plan",
        "label": "April 2023 Restructuring Plan [Member]",
        "documentation": "April 2023 Restructuring Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r174",
      "r177",
      "r180",
      "r181",
      "r185",
      "r186",
      "r187",
      "r296",
      "r297",
      "r441"
     ]
    },
    "sgmo_FullTimeEmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "FullTimeEmployeesMember",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Full-Time Employees",
        "label": "Full-Time Employees [Member]",
        "documentation": "Full-Time Employees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      },
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r79",
      "r98",
      "r118",
      "r129",
      "r131",
      "r135",
      "r142",
      "r149",
      "r151",
      "r152",
      "r153",
      "r154",
      "r157",
      "r158",
      "r163",
      "r172",
      "r178",
      "r182",
      "r184",
      "r223",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r380",
      "r390",
      "r459",
      "r515",
      "r531",
      "r532",
      "r558",
      "r583",
      "r637"
     ]
    },
    "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total cash equivalents and marketable securities, amortized cost",
        "label": "Cash Equivalents And Available For Sale Securities Amortized Cost",
        "documentation": "Cash equivalents and available for Sale Securities Amortized Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r106",
      "r115"
     ]
    },
    "sgmo_SBFiveTwoFiveAndOtherProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "SBFiveTwoFiveAndOtherProductsMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "S B Five Two Five And Other Products",
        "label": "S B Five Two Five And Other Products [Member]",
        "documentation": "S B Five Two Five And Other Products"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_CollaborativeArrangementResearchServiceFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CollaborativeArrangementResearchServiceFees",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research service fees",
        "label": "Collaborative Arrangement, Research Service Fees",
        "documentation": "Collaborative Arrangement, Research Service Fees"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_SaleOfStockIncreaseToAggregateOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "SaleOfStockIncreaseToAggregateOfferingPrice",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock offering program, increase to aggregate offering price",
        "label": "Sale Of Stock, Increase To Aggregate Offering Price",
        "documentation": "Sale Of Stock, Increase To Aggregate Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_RevenueNumberOfRemainingPerformanceObligations": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "RevenueNumberOfRemainingPerformanceObligations",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of remaining performance obligations",
        "label": "Revenue, Number Of Remaining Performance Obligations",
        "documentation": "Revenue, Number Of Remaining Performance Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_LeaseholdImprovementsAndConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "LeaseholdImprovementsAndConstructionInProgressMember",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold Improvements and Construction-in-Progress",
        "label": "Leasehold Improvements And Construction In Progress [Member]",
        "documentation": "Leasehold Improvements And Construction In Progress"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RESTRUCTURING CHARGES",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r242",
      "r244",
      "r247",
      "r253"
     ]
    },
    "sgmo_CollaborationAgreementEquityIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "CollaborationAgreementEquityIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration agreement, equity issued",
        "label": "Collaboration Agreement, Equity Issued",
        "documentation": "Collaboration Agreement, Equity Issued"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESAccruedRestructuringCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-cash adjustments",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases)."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r634"
     ]
    },
    "sgmo_RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "RevenueRemainingPerformanceObligationNumberOfMaterialRightsForRenewalOfResearchPeriod",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of material rights for renewal of research period",
        "label": "Revenue, Remaining Performance Obligation, Number Of Material Rights For Renewal Of Research Period",
        "documentation": "Revenue, Remaining Performance Obligation, Number Of Material Rights For Renewal Of Research Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESAccruedRestructuringCostsDetails",
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restructuring charges",
        "terseLabel": "Restructuring charges",
        "label": "Restructuring Charges",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r248",
      "r250",
      "r633"
     ]
    },
    "sgmo_IncreaseDecreaseInEarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "IncreaseDecreaseInEarningsPerShareDiluted",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decreased net loss per share, diluted (in dollars per share)",
        "terseLabel": "Increased earnings per share, diluted (in dollars per share)",
        "label": "Increase (Decrease) In Earnings Per Share, Diluted",
        "documentation": "Increase (Decrease) In Earnings Per Share, Diluted"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "ApprovalOfAmendedAndRestatedExecutiveSeverancePlanMember",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Approval Of Amended And Restated Executive Severance Plan",
        "label": "Approval Of Amended And Restated Executive Severance Plan [Member]",
        "documentation": "Approval Of Amended And Restated Executive Severance Plan"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_OtherLicensingAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "OtherLicensingAgreementsMember",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other licensing agreements",
        "label": "Other Licensing Agreements [Member]",
        "documentation": "Other Licensing Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_SeparateUpfrontFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "SeparateUpfrontFee",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Separate fee for additional term",
        "label": "Separate Upfront Fee",
        "documentation": "Separate upfront fee."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerMember",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAndLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from contract with customer",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r592"
     ]
    },
    "us-gaap_RestructuringReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserve",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESAccruedRestructuringCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at December 31, 2022",
        "periodEndLabel": "Balance at September 30, 2023",
        "label": "Restructuring Reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r249"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r346",
      "r682"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r448",
      "r457",
      "r572"
     ]
    },
    "us-gaap_RestructuringPlanAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringPlanAxis",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESNarrativeDetails",
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Plan [Axis]",
        "label": "Restructuring Plan [Axis]",
        "documentation": "Information by individual restructuring plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetNet",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with customer, asset, after allowance for credit Loss",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r285",
      "r287",
      "r298"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value on recurring basis",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r381",
      "r387"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Goodwill, Indefinite-lived Intangible Assets and Long-lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r5",
      "r391",
      "r398"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other non-cash adjustments",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r234",
      "r269",
      "r282",
      "r376",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r460",
      "r560",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r623",
      "r624",
      "r625",
      "r626"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Adopted Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in estimate of transaction price, increase in revenue",
        "label": "Contract with Customer, Asset, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price",
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which increases (decreases) right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r87",
      "r455",
      "r475",
      "r477",
      "r481",
      "r496",
      "r572"
     ]
    },
    "us-gaap_ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative catch-up to expense",
        "label": "Contract with Customer, Asset, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress",
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in measure of progress which increases (decreases) right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "sgmo_USGovernmentSponsoredAgencyBondMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sangamo.com/20230930",
     "localname": "USGovernmentSponsoredAgencyBondMember",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agency bonds",
        "label": "US Government-Sponsored Agency Bond [Member]",
        "documentation": "US Government-Sponsored Agency Bond"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails": {
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cash equivalents",
        "verboseLabel": "Cash equivalents, estimated fair value",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.sangamo.com/role/IMPAIRMENTOFGOODWILLINDEFINITELIVEDINTANGIBLEASSETSANDOTHERLONGLIVEDASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold Improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STOCK-BASED COMPENSATION",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r311",
      "r339",
      "r340",
      "r341",
      "r571"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetails",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. treasury bills",
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r567",
      "r569",
      "r683"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r80",
      "r81",
      "r89"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r72",
      "r97",
      "r172",
      "r178",
      "r182",
      "r184",
      "r445",
      "r458",
      "r558"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r171",
      "r441",
      "r479",
      "r484",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r495",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r514",
      "r516",
      "r517",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r533",
      "r578"
     ]
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesTextBlock",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities",
        "label": "Marketable Securities [Table Text Block]",
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r407"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r60",
      "r451",
      "r494"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r407"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded",
     "crdr": "debit",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit loss related to marketable securities, not previously recorded",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Not Previously Recorded",
        "documentation": "Amount, excluding accrued interest, of credit loss expense on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) with no credit loss previously recorded."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r407"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r130",
      "r132",
      "r136",
      "r443",
      "r461"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetails",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining performance obligation amount",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_ServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ServiceMember",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service",
        "label": "Service [Member]",
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "us-gaap_RestructuringReserveRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserveRollForward",
     "presentation": [
      "http://www.sangamo.com/role/RESTRUCTURINGCHARGESAccruedRestructuringCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Reserve [Roll Forward]",
        "label": "Restructuring Reserve [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain (loss) on marketable securities, net of tax",
        "verboseLabel": "Net unrealized (loss) gain on marketable securities, net of tax",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r128",
      "r222"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.sangamo.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r407"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax benefit",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r88",
      "r112",
      "r360",
      "r361",
      "r614"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i-k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481047/942-405-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2C",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "270",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-14"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-12A"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//940-320/tableOfContent"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//942-320/tableOfContent"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//946-320/tableOfContent"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-8A"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//808/tableOfContent"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "(b)",
   "Publisher": "SEC"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//420/tableOfContent"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r592": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r593": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r594": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r595": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r596": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r597": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r598": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r599": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r600": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r601": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r602": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r603": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r607": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r608": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3"
  },
  "r634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479365/842-20-25-6"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r686": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r688": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>85
<FILENAME>0001628280-23-035989-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-035989-xbrl.zip
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MG@<N#M/5+^T-L=S7+C:DA?C2H-90P]1A?_;QJ@"[S/EW9G^PKZSH3=J@<E"
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M@!16:Z3SZ=T6U_IZMA72NF.>[GT[L!+8"A24Q&/(66.Y&H\"DX91LU 5$$V
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M88E[FEEU_KHF+KSQ_8NL+](I)N@>RY9B.B&C!K6JV.!!V[?L/WM^"+HVZ 9
MX0?RNL-=$C$2-B!^J8>M5K='1599\4E.W?;J[)35>*M@>EK>U.@9$4J':189
M>FN>[:G@"KG).#/K!BD7?0%92F(B?O9EZUDRQY9%.LG$'X2.+WTU[$F6U@TK
MR_"[1K=&-.C6IJ'M!*N9[#ZQ[JO.@]BZA76*[EW4(_5B9@V?$^K_G9<P'L_?
MVDG_UG[UWC[>UOI[^W6;QQSPE4[ <V_%QFF7L\WWF#D3DUAC6\AZOU W7Y\3
M3WW=J&K 'KRV9JI:_M,<SG?]];Y U!A2,'57;4>HF:3-C1E7Y;HY4E^->R&H
M,=4D]96IKA>"7E[B1X6<%/Q4J2YA;IU&([7T2% ?0;G,BZR1@-H470Y3-Q/2
M2?'^*(F*H^>K=V>Z7I''!95&V.=\G!=B-8.]L88#PL":AE=E'-PD)_])R+=D
MO% Y>R<S?UZBK,.Z,,2 $24R,$G+JS.RDU'G(I41B1/]']9)3-JJ6H3;_$!6
M.]SB ^KSWW0X<$Z1:J8<EX&7:KQ4SL\;G8\+?^7=HJ3UBL4:[K>-ORFEEQ6&
M)JSGO:V^R)Z39IJ53%O^)4.'G@8%IC9RFXZK6R?&NJB @H(K#@7A98X78*R4
M4],W5?65@C?P( H_\EOD-1+P(1#P%%2*;1?E<UG=@4B;6UJBB 8<9; ^ICA=
M&/  %A0EO!(]=,@$U5X&9H_Q_9U7T<M[Q[7#HAO_K7./1:?%Y\3? ,WR,84:
MFF7J-E!E=PA)$ Z;>7IK?Z9@F2 SY&@='@!<]$TX.TZ7\&?$KT-9E:-R#\_9
M(%[?;@<L$#?1QM9D"O1*L#)UWK31T3Z1!P!/?$+FJ#S)G(B>HETI-5 $%H8U
M#F74!X2$>'%FDI'"T"9;N/,;<2]04L>JX*@C^=O:@4EW$8A_25SSR%X_F/,-
M6-&WJ,*13M#UNJHL.M\I2DSKI;E$^>]9JI=XH9Z/NXI4PPV)\J^X&#3U>8JY
M"V#4Z'Z$PCFXU -SVG&Z=+!,VQT4)Y%:$4?(P_&%_7H#SD*7V+L?WH:0-;J_
M9_.1PE_[ANBF(ZR-SM2;E$A]@;LTI5 ##1#(062L@6M0 ZL' S,LO0!U?,_2
M2 <*1@1-(B_$ET$QM :]3BO<]A7)3N\MN$H;L[W"M <Y(O1N7*$I/>FS[#OO
M-N@65AK9[;A:I:NU1MZ5/[FCJR9PUGA3@RF37@GT;)VYH REH)90VA+-JVE=
M$,YNPAN. 11<:CP']+/1YI'?J%BE;,2S[0S[G2W1&0$?DOJ=HA]J%\=;I"5\
MBO[W[VC@/GU, _=IV\!]^@T-W&DV084_D]P>/EFV4$F0>:HG*$.E'WDY\%R8
M*4Y_[E&&I846,=1XDN*KC,G DS1AN )DE\I7$(^PI"\@(I_OHF9<KFZ8?IC5
M@D9*-@]+$V1I+M$E9MK$G.Q\A%73O'?QHF\D(45-11&-M%4]=](3%?9&+8 "
MNWPR[)4$<S:?D!^9W)&@OC9;[5AT=,)D(WM^[]70-SD'H*S4IM?>5;]JO"?(
M&T$C7]<UZ2>]:VPQ?XP?A\S#LL2\C!QG>MC*OLA4J4Q1L7.PI6R#PH.Y!LI*
M61;$BFWDM Y]=!0]_MUS>:L-3ZR/30O/9LOT89+C&SGP<25'=E?5GT6-%X8F
M":7D/ <[,:N9I2Y@DUF]D]_AT0_05$#.P#*YDL!KG<TK.)FD?]=YCT6^Q@*6
M6#4>&M!ZT1*D>)61<($]3#ZCGGF;.>;JV+=\@8[E<4-*A&AW3D^EZ\"_FU89
M,PA1[.E*/M_5"RFQ,SS5KMO8-46K&:L-C%R.5=XX'VC+T4=GC_9>EG,4 <EN
ME=E@.4B1HUX=3ZF-3(B8WJU<M5MF=PQY6*:Y2,C!)A3\M"P$+_KR9M/@Y[0$
M&!_]"CF8"7G-.A^^?P(,%U/>OBPY?,^F%TA&G-DT2W$3**Y#Z51L=<J=JX"1
MNB/#(R*/-S/QZ)B8;NE]ZZ9#<C.=KTO-^%(1WJNJL;^ 9+F+!21HC?71=:_F
MX0F#65ZC/<P2Z F:<2!^7CEB\RG3JJUN#_B8F%";> M0=,C IC5R0 ;(13'F
MARX08@NH"$XH<$4F]&ZG,2)RU%+W=O(66@6J[2!7,9[B-[2Y+W.%?EXBD23>
M5LS%\Z7M++!S@0+S.@SCX0;B#DJ<RNV?W;X@@L7>PWV; W?-OK4WZ$1[2 YB
M'ZV)CXZ<<70#\(=H%I&?V$G]WDU *FN^-IUPVU1:[D+G+31>@N'6_,(_DF!H
M#0<C1@]3*-HJ;2.([EMBULO*EA(XV?=.TK(OLX*LZQTO\WZ< 5GL.N]7_%NR
M?MT.YN)3RC!K"FQU#I^WM""KP@R>&GY%8NWHCA3D'AN>5D.2ORM R:RI7[#R
M^5,B)5)S[-Q*F]!.<U/>QY\_':#!YIV1IBVS@Z+?Q+23!IHM@&L2Y6APM).[
M]BT!9VRGK^L)'(P44>T;=Y;F!3IVD'-0 L[&::CQ*7N%#QQFQ8&9='TR[4P?
M[SJX4(^U.\I*YK3#+4!:J@PYY91\RF]I#\YA;*M@>Q?ET+2\IU0#<"T>.^L'
M.Y;$2NM0Z4C.Y<-&P\$:R.Q!"'RSXJ-K^VSSQCG7)9L$A[ %$N$42;/\CK;N
ML\>T=9^U;=UGW]#6]0M59L[31WO*A\AB$_Z@M!E6CT2C*3-RHH U!A0]6Q<S
M%+I(P:W0B)=S#:P,+B*I8#G0$0EGH>R\ <-;C0#TK]=@Y7)N*(4XH_GAU;0A
M?IKB/]; ,<@DY% (RNM*[AWS?R2EKHH-JW'9UTKF4,R;J>2'LHF$Y^>UJP^2
M]"L8^;W3G#LI7/RUM+G;ULZ:#CR%GK3%.)^C*HL9&W!ETYJ2?4%-!DXY-3NX
MKQ7G/._*'&D%(+)G('2)U:Y((](0F<N8SK3BKZD*?S:)+?E*/V<\5$X)0J1A
MSC C&\@@FZJG.(LOIT]5?-]O4R!J/ N),TF!BZQ84HEET1/^%[ID\H;^1%G$
M,[ 3"-RLH+%D: W OV^1S=[FV1T:;1/\40:6UY13*M?UBA)+35J/<YDL;V?I
MI:@ N:P7B7<;4/-?4D*4),W0.6":%P]3<Z% "ILZP>I,C\$^-5Z=Y!ME]H88
M?,<7GU 2GF)2%^A/..ZU<[B0/I^V)$!;N;724"VP( P7Q?U:0O_>RHZ6YI50
M;0OKZQSQ7-G,3,]VZ4L!:P?]W+;[$01?\W&JN9-QKJY*8Q.QR,;M&F,@TV"9
MTRTYNSH6Z#N\?:V,E#*.]C1;=+NM=@.'&FXUIJT1).?\(D\(S#^>.^L'17J7
ML.+I>7+<')]WY/%V;Q>Y_32E CTX:<[Y4J98+Y;H[UL,.(_@&%5W2ZH#JQJX
M8-Z2AF(='[DT*_^@'L'TQ;$S= LT'\!XSY<%Z]2!/HEYTK(6C-&+GKW%\O&*
MN ;F*HPPX;2\*%FP1I=P*<GN>(X\8=P3^+W4L]YF=1"?%&N8?]JQ.%T;;Q.;
ME1S4BR=#SE OB1=L20QW/M_;?8)VJ :-;4*K3>?4K,>^/>E1C?L]/.@J1FM,
M3=J.:33+U 7<5ND76BL%WCQ+?-MJ>;D>,Y T?UX(AE8ZWTM?B7FJ^Y1A%"Z8
MA!3)LW^4,G'],WR0^SE.:>5BVAH7@NEDIIG<@/W+E[MFD8E4E_LUO0/)@[G,
M\L489LP*%O[^?986\*+CBH,#UC$3>4>"LDZ2P/D"_1"4F-P$L6OU*D]!+Z2Q
M)S*V\(FN-<DOEQR"PU\=7[RY'&)@*W7Q"C=22HH(,[T^8K./V:=:98[WT>M6
M[[HZ \HU^C9;-[#_ H9P#;KS8=+Q;E=F0JVGUPZ4X)NIA*7%XMCE+=_SKH):
ML\C7"V8Z;2&3&)M]J[\$9:6>9S;FI ]VGF7*HL>K)]>XCSN^YO'.HI]Y\.2"
MW64W'&8TL#E?Z]OI]0GJ9;"4!#_MCD@Q(]&R"%H0"VJGHOFU)CYA>S@)83J#
ME9&O7NZ]V9GO(B,+XD3(0H1M6;>%1,?;;+K%J!Z-37M&Q/][?#G:WW\)3[8)
M:9X&6?L<NC%>9G+KSE/ZV7=T,SQ_3#?#\[:;X?DW=#-HUA[\+T8I9Y;\U+/M
MV+;PP,;5:D4_"([,Z79XRP1-ALD\I'";55EN'/&I8TEC<5TW]FNNK NF,KOP
M)M;6E9UX:=&:2NZ\\=V E)Y>%ALW;?^&MIFOW.4>UJIZ0_.5"D,[L8[30Q6M
M9['$W!/,]YNUTDK[.& T Q2K!=7BD&B3EXNZ@F:Q=:M[$H&XFO^8FRR+856/
MTMHJ3>+BM*\7.H@<L"@G@NH&.;\UY5E3E)GR;3QV)>/)20S,>;7";VUU513A
M]K<)ZWOK6XD[>@$Q=H>02_J&&1T_'2D9X>WP\#K4L2'A>.>[0ZW*\P.1F^"V
M HUC)O ?60D;)_G-93;GW07NSEGF_U@CI3=1$;TM%O?I9,=S JJS@9R XGVQ
M;^:"4WPMAN$P7X,#Y;=Y503V,]!92<ZJW#HU A0B1]$?X5O<A8]UM9*#1;UZ
M.)NAM$&^<HR$@?60.UKDR@J&QWK YFX$9<MFG^SJ4A$R)>6 -Z6CK*PPV4VB
M:B11 NUF^;XW\G:.J; W=,1YJ!4@4E8VB3028>AN%\GK3'S/18 ;CW5Y\/Q
M:H1[K=8N;;J;-SDYGC;B8\ J>8S<]&2[OS;[+PW'8/I*VN GSXR$4SJ+VN '
M!X;+VN(O7J%C[:#7L=91)?A_BTOM#_G1G)KWC?QHSHWV#?QHH1OM&_C1(C?:
M _QHO=&Z _24<< .!7:O<XV]:X_L7(/A_("I.3X][C:)M_G;IE_I;T/)C/FJ
M&D[]=B\U?IY$D,(6YB58NIVQ0Q_'.RTQ11.I*XAF,J#CS$L-Q GP.0=)>B1#
M+9!)F&BLRJ6-=.QJLI=#T."4!])AQ*NST<^0)CJ@HYBRV%HC)#K2-TK9,>(3
M]&6;"W"M0LJU<ICB7602VL#(NQKA0;((4Y.X3HG$ K"PR%BSUIHH,@L66\PC
MT%?5GQY UV.K,Q6V @G8+_^V*F]?Z115A=Y'@,&4@BNKU&??PZ+?3V! 8?D=
MK;\7CVG]O6A;?R^^,7S3_W>%_JM=H3VW( E5SW_"U=GV=#Z>JW.+I_/179V]
M_C=FAJ%%=:^_*E(EV!U@2PS[6! 9]Q3!5P[TAP[7-S*Z-?4#A" ,T'+N&::5
MC839=60U@&0K!"K[EXQ@/_J*[FXID:MD##?W%$BHO&D!L)C]O;U_T_-:E_AL
M1N'W.FMBD5\M-64"A#>04I/I#WL 2J1BG>%)5$@SLT>[$7-8[S";:0Z,<I5U
MBF7%B/E"]9\^9@H>O9VP+PW_$/5=!^\)<FW\A+3>@H=$7"*ZX?@;/@[.)?X7
M1APE@:+3AVV^QHF]?47=SNO'\%[[KN,YA5ML1BQQ4RD&KA0T3GTSI(ARXDI,
MYC;U): [+U\B52)=2A),G'A-3_?*B3)R.<'[\+SG0<$'TI/XA7R+2::46Y69
MQ&.$7B.7Q]6&9ZASEQ/KF)!1>&5)4(!,<2'R\KAS:F\&5X7/,LH20[9HRR*I
M/EU"2HZ3X1GG&6PS'//JAHJ%(]-1Z7?;U@W,"(OBM[E__8-IMC$$Y$-L7:+M
M4QGA#6U-/NDO?>V[4]WL'3FSRO2%0*,'L%RI\?1N7\46,=-_Z7M)#<66?[IP
M<)M*,J+;MOHB_9(OT$X5W@V'.A!H@AZI)L9PC\CK$7.^0^J_CT?JT)Q7YF1-
MJ]!->6/S$6,W<=^=3631)28G^QCSLNK0CS7N3ANW5AV/1<5<#MMGL$]DRXG<
MZ*I1K\FE\Z\^?,)!&3FQ LM.[7P8$:ME<WH)F_Y1\T"=03H._[#9PZ)'O5.1
MDSIQ!>14JU%1J<:^H SL<-H[?#[#Z>T\?29?Y%I:PX5<>ITH:9GV1I6FT'.\
MZT'!,0"#YZEQOJ\_:AE(YOFNN[+QYLA&-YV./+^JX7O:N2\?T\Y]V;9S7WY#
M.Q<=_GF)WGZ;J@[Z/KR;8S$4-^#==D*S$P&5/2JK58IQ;1H6%0:"PKS)Q_G*
M#(.F%-%9!MT:B%+CPZ9KHA4E@=?UOM(4E_Z\+;61] (_8FN]LV&(;2;=!RJN
M1*1KLK7^T(H8=*M&<6$M6+.WN.,"!\I?57?XC1UJ"\GSJ<HRIS\:Y@+=BL57
M:_FGL^XC4M 086-<3NN<[%&TS=/EVSO2MR'M'7&+1]P_K6:UJ'_=)!-13#_)
MB X/9W@/FR?MT.^-$"MBL2 (O.7)P\)I2$&+:JI1:KYS/25?D<D5\G4O.]Q5
M(]A;K&ID-.2 $K^?68WEX.7>.PD$G,[\) 5O8R*QSH5S*CU;&)]^V((VBEW=
M6N1,YZE-7C[RNRSCX*%1-GEU>1;6%REY<H,?+8/G^EJ4^&L,#53KM76.CQQ]
M)"4!MF#16^Q*R;Y,"*DE_6(#PY@8YV+UKUX%H?J@KQ(_>YU^";+^Q*K\&"=$
M!?Z62XPMH&@<BI^<*$X&UB_YNQ9FG03O=K[LBNROY^@/B;(W]/V<B*N'J^7-
M<&EZ?C_.V. *MLDME=2"3?AF8Y&UUTLV1:=13P2"WTVB5PFD64;.>UIJHBI-
M^IF3;5&?P_N/?D)21-U-$5Z?"*?'=R*>6Q% ^Z1?I%8(V8S\2VLK94VTJ!U)
MRELR:V1/"[;9P>5Y+^4^:@A#!^_<361#K:W?#<T'%VJYHJ1$<ECA"I\@P9&[
MRF[*'(/P*";@BE2+?&)O:6QX,V:BP'_CNJ*#M"?)$$W]1RDAZJ#\-K5/^^JG
M?_?5VRIH(7JY[+:&Q,N-J:SSSQ]H4E 0&\E89]X>-I%PK$[1=\\H:^ $%/]F
M7MK??R" ",N(^#)$I\8[CRI^O/7J._7.E3;- ;:@+'0@%&Z>+'/<?2-W O4O
MB][!"P2M;T$&?2V[I_7F^F^07DAS:;#,C_"AN<1/^Q8\X&!)AUGE7$D!LN;@
M&8J,EGDH*!7Q:XS7PZ%[(BW&$SEIMG(>OK'=P?[(.6F\VN]8QPAN0#CBMB&]
M/-?6JJ1]U-:E8S4-VT:49L&WT<>L064!4TJ;2O!/.%F)Z&'A8_WW;T-['_QT
MF9WA+B,^20(C)D 2E"1'6O#U$]_KN91<,3U_>S'4%X6XZVCV)U]_;Z*,)7'>
M6U[(S/#([+R1*8O;U,WYHVIV%C.6PW-S4FI #5Y3,ANI\V!L9X/Y(!&2<HZ^
MJ<V@(3".7>\X]*:A4IL5N?P>X[AH@W:\'LELVQR.6!TYE@4AK-+V]?SY'^MJ
M=01&<T8X,P%:('_7HQ'U7HI[%[=]=78J 6[AP^<@^>_?T_Q_]9CF_ZNV^?_J
M6X:Y)[L8*' ^^IS$*66Y8);DR@.]<4F +=1YFTM,80M4&&(&'(GL]"$B6RC
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M#/9DRZ:,?8H-#WC+GF@N5931_S7;\^#=^?KR3@YYR3)<Z28Z"<.R>J5/+)+
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M!BN7 MO%/\%T@N.2ST',;/I][7B3+,UF,].]%%NP$01]KDDFAP?9YDE(R3P
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M4@V88Z#D,->W0!E.E4*\FB# FX0!7MY%&^9MWTIWP.'$(N6G@R$XV V7A"C
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MCMYA@B)MJ@DW4%]A4"FJW[O+Q@TV[;PO2'QW=S>8%VG33*NJ1E&[ZV\)_5S
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M]#]O+DY^P_]]?_WA[.?_ U!+ P04    "  C@F%7[W6U6K:Q 0!P-1, $0
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M\> 0$@>PM@0^I_');^8CY_Y]N]$\SQ;#>G&C^E=FV+_Y(W9>31<U0'%(SF_
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M%@>^ZYI=W,H"/P&_-S%TVR\!H;?N>3UHE!5]S?6 WIH7+HH6"B\:+KAR4KA
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M=D%,#S>]\^"GX,:&I\JRO0>6MB#$NCN+Z'Z'O-0NMX&7M;!+U\:%J@9^<2Q
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MCS4JJI&_AU)M5)IK/G9[#X4)!S^6]:::$DO=@V%B<-"*=[IU.AA=@<,TY:W
MB*Q+6OF )1'XG(FO7R^UKHEKOID!V<%MF4I]'>/6$^3OL_E^EQ3[L$T,TU90
MH]2J-<I*U6@:1NU#UN4M(DQ_YDW%]7(MGRC0)?"R?'"S NG?<>"$MD-[<</B
M^:4;7+2<K&#06X,7TW/^I'__<I*H/BI+[BI/E4Y%2O;:!I0'T\B5[OW*+WO%
MY![$>KW9S_AFIP0JGFBZ$"^9(HT-XV=C>3FHW;R?=:)MVWC^0/*?;_ \-5TC
MFJ46O$.1OIN!XYG25_?5GO.6Y(T]\N1-5_#Q(7CVW\:VA*J46E]!'W=-;\Z8
MV/HU5.$_!(]@N8!B7]^P4=52ZPK8";=[CIG;<!Y]>)_[/\Z065G)N[12JZDK
MBO&Q*[HKDCD3TT\)2=!I'0+ +&=HNA)):VOA:]#_)/Q%^@3DDI!>"]:  @5X
MV:37QPT*2#L@YA12JJ66H2JS./EE SCBGE;WL>][,V$Q50<0UI5R#0C ;UAL
M36A-PD#_^9>&IM8_AU)$7#+$:2>11%D"R+DQ"HL$WHLI65,(.WA8I+965'33
MJ,BV492/&%U+&>UX:*9=:O4#E-@L*BG&/+,%%GSDP!-9W(L$Q):&<1#&& "+
M? GN0!.2V02J]JG["^H;S+&TK>CR2$$CO5+7M*V"1HU*K;I=&.;C:\8>RGW4
M>J6AZ@49+%"VWEAOL,5PB-?,;--&2"@2Q+3ZDN6:8;@?;Z0@Y A,NB)T1H.N
M[WX*]^3O%X,8]TE*@4*#O%M]W(0E@3_^UG?@FXG&W<0W3[0K+<,=1E+HNXX]
M5PO/53QNUY*09)$:J5J72MO8XC)8EA,(2MM&RM+0#*17TXV)]+^5BJ)B[E\*
M^WN/K9X?2Q(Q9U(^Y@>F"7_[_B"(O1_\WR0:A&5F9_UPU"\S+G@=55!HFW](
MO[E^%YS##MCP5B2Q?JJK@];K.(<<&;/8C-#"\'1W)%E]8OV4!EA _M8G-%:-
M-FLFN?M)36JC^F9(*R1LR71=N .KS= <_B-VT!@&&[A+DAO@P2&SA['$R@]8
MB55J$&>,Z915:"3C9:RNDFS:RH+>.@R(1>A"J6H2+08-I4_P/&"J%,:P-H1]
M']/,:?52U#>CV0F\F=.CI%4>],?)''Z1)=.SI4]:9J)=P ?<U/TWX@!^1.^'
M7^)0DH=A]5U(1T)':H:1U%0DVQR%E:6U,1L&<Z[B(("WL,H^U".1&<7A&+>-
M4NN?))S%Y_1K:<7VLO'<^W,WZVL5\&A%13/R%M@Z<*((T$#%// ]5'3N2,)=
MUB/I#O6?:='8T+49F1*6]LSB?/*,K!/X%,.=NF(@E)_(2^RRM$*G_"Q]0AK7
M/TM:5:LD=T1]A]9)#+%.8M^H9P,>XYB$O^2&T@S!D%X):,<H;0J4;HI2P(4I
MN3 1(IF6!2@-L!T Y5N RFKAMQ)0M[SP0C@ >,-;@E2/ $\'0(21C+H9'@>Z
M#(GV(KT$_EO43R]70%43R28]QZ,UHC2$BH$N#::X9'3TLOHYO6WE#4O'EMZ'
MJCFY=\DPTSL=CPD@V+]E+5ULLBM,90?0%"5RHZF5>GT/,1:C4M76*\;?Y+%Z
MI:EN%YWYD 9&1:\V\W]LO:(8ZY4\Y;LAX:C.^3:%L,$5"/R+'XP6F-_T)JH*
MK.2FB26N*:76M\6*9?^;%18E6Q<9\%-NTO;+R[H;1V:K&!=S:;PU;RZ1M\]8
M$G=@;4]@PZR%!#MG@I7UB+30@CHUM76_R!@20%@3"&>E-#K,!&4*8VR'LC\3
M$U, 9R>;@%+X:QS"@\)PY0Y%35V]17%CG<5C/1MWDG"SV,$2Z-\)_2E5?Z-$
MO6(T72T%VL92L%&1$@<QD=X'L0<LFUD8,G%ZBV)Z-)('R[SGTT!<'!)Z%TR4
MM298L-'5#^B[W!&^_,V!5\-K)0_FYF,XXM4)J=G@F9Z%Z %C O<MX,W8(=@V
M SN4L)[/L1>7@DAJ]9/YR\(XQ%G&L\(^<=V4O=(G8!J-++$M8Q\';I;'*O])
MPD67*$D_WJ<Z'57<N,ZR@[-96Y:KJYNG<,]WYF#1&."#%?G=U&)*.V^,:U5O
M:3 8!  /<:,4I+EE6/BGJ:J5  &6 [9!^&OI[OYV0?Z#9JUITKI#'_$01U3X
M0 JGB>[%@[+MT[W-^$!8EV"Q@6<I8Q;HI99:K\M5O28W&^/*PW2L+9;_#E/T
M.6$8XP23HCZ+I<_#%>ES67HC 9'\R2@K1ZK\$@T@B_U83AI +JM&;='=,TMU
M5[;[[M!GZ^YE0%QZ?,W2?KS)R)7)3\QNZ+MQ-/^3Y:.8;=&Z7A]A/'2&_:8?
M3$S:%U+N!L3\639[,/5+TWTS1V'I8EFS8=T0S89%L^%]-QOF8(<!LP#OKV_^
M>ZTFF)SLBV"%W!^T9SC*0EVO-!N-K1;J:D7=0T:NWJQ4F_EOE=<K:F.CE6]Z
MF:OE$6C8M\9=LD]NCRIIT1OG5!)8N9MH(ZQ.?&P_/4MW%>GV[KY]?W77_@82
M@NUCV\^T/?&<CMHP4+;8N%'U.>OF*&&\?323.P#Z%OEKW*SW'X]E W V8>&)
MR"#99E/9"HL[Q"AGK;@IM[Q\%+/N5-E\.XZ\C8_)7&0>Y<;N 0S+):5EME:
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MU:=JAC51,WRZ;/YN>N8+5;KCG;O73FC%['A?-,_:GNF.0H>Z-A-=C<J<-0?
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M 9ZV.VXYB):!"7?98[T>3+1YLNSV_.#-A#7#]?V?N ),?IZNQF\._-2CVG]
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MT]2=B=E; D\%K>>PJE!<UET7AD?&(\QF92+S)\EBP$SR@' )O@WHEGX8O>O
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MN[9SCWU%T(J@%4&O).AUFF#N1M!8>:0WZPV]EJ/_*J)61*V(NFBSMKEN6+X
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M0(F=<"4"E!$W?!EC@,<V!J[\!FTW0$OS!9@_J,H!Z,3^V)K"RU#M,;PA*,K
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MG=J 30-BC<Y/+YP&PYEF&V]+BB[+*31WRJ+*R5Y&9CV12)0BAO68G$06RID
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M[&XE6E$O\0$.KV&(DRDXT OI >H;.6 QZ.-.S'/7'[>I2N.H:+ [=2V'#R8
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M3^L3-LK0F%)^R-]R\A7%'R)200MCX+H_3Q/A;H5!D.^Y,#)1!3W+9[CW?)Y
M+>?5M3&.G1Q+&9M3]+78K"5YD9HMFGD@QF3@"V@6TD@179I[>3)(USS+!UU7
MC"O,3)B+[,,(Z9,7GL!_:?)(-X4A@X-)<RSZ'F(&,G<_9W"J='AECT:>1)PS
M*H>H8D" N^\6^: YWTZ,\10(+$=21L+GS4C-%(L<8_/FU0[)9+< \[YCXC]W
M?X46( _J?@O2PP +UTP$ZY4Y#PP/JVOX7RUQ9HXNWP&- 6R(=/C B3&$)T!;
MP+F$1Q]%[1B> +RT+3@LHAN0=L#3%J:A!XS>EW$;%Z21Y9!( ?J*9C<&-#8!
M:!<' P##IO"4D/ER!<IS$CX+HF,60[;"84T^E,Q'TE5/V6=T+:#NH1%/M&>R
M"5&VZ[!9E/+#Y_]P4OQ1>:J # *119E*U_X4O1)(+2AN _3M#G >Y%"<II*\
M7]I+:A0BG"P ,J;-P"(6#QW^^\)\\- WL\G@J>(%M(C2Y/:%7N _CFYI_<<P
MH&F)P*+[Q"K2_1R<<')MNF34X8I1MG@[)DBPGVJ51?4-@&$V33*.,OYX(H2
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M\++"L8)QK!1-1#MMQ<S.'=&.W1*T4UQ+T#+FRIR JNE-7<\(F/)HKDLR*^+
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MPH$":\U@/X1E.L+3=R<,(8$ ]P/8AN&9R6<1F^!Y@!Z^$C"JHMWQ"W0]_H2
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MHTV$GEHB&][,.G'NG5?F!SACQ+^U#=^W1A8S/\YNX5L(TM"POQH!WM/LDQ$
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MW#ERW^(/FDPNTEYP)Y3C;M-V-!?CPDSSX=W4",^*@^B:R=TD^'DP]ABC[SE
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M*:X58X+GS@P[F%T/X#[PS@7;TN,P$)5AX(MI0<0G\0R&DUT-[B/"XH -QPY
MY$6T%(.+9]G@=<2L@,M-T8=*H],) P3ZI2@A@X+XMR78)ZR[#..1() 02>[&
MH(!/!!D]!HT>P68$\-6U48CY%%/#,G<#4OJ "9 )*##,U^&L)RD]."220!6G
M"MS$DBPW(R B W(;@DV 62GT)! 0O->V*(;FSWRPQRK:)P%[#95U'AF33@A'
MA(*3('3@0F/^,\6P7R S6P37LZ/348Y%XD(!B&@^(BH*=$Z)-CT"&^STK"G\
MAX,]I#0@0]M" %/T%/%8SR ".L<,^EQDO0O-F@HQ##+SI:BFR"^5/( Q!Q=,
MP5#A\26/,*4] =Q_LW[GCHU?4RMV+$T-\B$/;<.:^/)EK^+VY3M$IA6]0(>%
M<E?RV NZ)ES8@R0U=%3CG1D+5L*]PVJPW'*CJ5U-Q1XCU?-9 !!V@#^F3%FX
MH^%[,_2 UDV?.;'QU+NZ&5FC %V/HGM'VN 1_3[P@"/+\X,$*E/]"\FOW -%
M3&@LW/H1QXAN.G//D;_/0.X!:Z%&ADX^CP'H7&_^NN%O<[?-L[?B52.I/& )
M'$-V(B@;6&E W^6)!@;Z(8:AQ[,,>-8>)NF"[!9\W4U\3;#V@>'\],)I,)1Q
M^>1#%>W'%#,8XOOA>$#!>$P/XP@O]6?)M#-2!  7\S_!6_04(\R*#K92<*@<
M[L7LJ5Y5.=PJA[M,A]@NAYL[GO+<48UE(;,C45U6E>4I4D8(7,0(A&(5<?$<
MQIJC>G-Q C_$&J3%DU>EW'"E"*'0D7@FY\5<U4TITPD;0U]D6@CM=J7-4"A[
M%W9G0N+EG?;D=$:\;_:+#4.I:"VQ!STV9-8KSUD*IR//Q;1GMD6V4GM%OM)W
M8=SW'?-3;-HG_->RG?:S^XUYJ)9]=CU*]O!QKX CA+P8DLB6EZW.[*E7KVXZ
MU<JB2<%1MA>FV8,F!J;/BR7"8 )  !S\;4.8U)?DP]V&/M -\^2YOU@B4^.K
M!3I_X#KLFS%#P-R)W3R[W_E>-CX]]H*O=BN+6D?)XP,Y3/DKP1R8BGQ2T.DL
MN"_IAXF-O\AWE7(;888)T"KO&@X,"E1/D7N2T/8G\H0\7+@5:)>E&O9E54@_
M\AI]ATT"9Q?Y/_BW",Q?&:C4IGA@=V#7 =CM]N; SC<=$J!:X?3C=IV,^ ,G
M%MIUY.]X!IY)E3(+ 1V];![<C05I61R5%X2D'BC^_CB*0.WW.3:9\X870#8R
MO.9"B'40P\';?.)5$CR;<ZS&$A3*$J$OT&%SUM.\NFFU5K(>E+82:WF!"2\?
M$?#BEVM89KKNQDKS*F"P#L\%$&)R*\IJK@.6F)X *J@X;@P7'.=;7\V3+4RP
MG(!.@,I"=-TQ[:Q#%5N!85E2=H%@:&-/U]7X@<=,$S1WO:#E/F#+O81Z,N\%
M;/90I/SS!'_1.2$"Z 2TZ8PV)KV6PDMK>>8UM^QSN7U%NW<B?WVD*M)NR/T'
M;TJK(*01RK &.1'BQ"7QZDC97>$/C4K]%MXUSPF:O^Y4$FT]P]ZXA,8NOE)J
M2SGQ76[^V;->7C <^'$&^@M:Y6#U/HX>6(!YIYA"\4GN7 1$S6_\2#A))$0C
MGF :X0@:)!)),(-B/B_Y?VC7FY^S4^9S=KE+8>Z<4H=U'$2T.$Z!:4Q1AQDJ
M.4PZ.1$/<C'?#!E'1/)DQDY)'3UIO&QD8+F^!<1G) G.%06,5&C).?),^,]V
MIID3,S)2Y5%80^:+$$I^9#NGF*C_= LJR=0::NUJ6P8R1#X;D;&T,<FS/13X
M6$FD]P&R@E7 KW3J ;PCEI",SM("&_+^[C*]?8&R\QSOYAMN9F-)T ,B;S17
M20*9%^BQ*<9+H]!5TG@3V8P\F(J9=A:6K<(GVVA)V\!"&GM/_-V?V;H#K&)P
M--!DZZUELM'!$E48V^BWO=R\N<-HMXW: NTVTOX2:BZY91*Z8MS[J)A[+86]
MWJBOHS3'606\-#6=XH!\UG-$5@4<G/\2D076 5(U/W)E*6"R1)2MH2 I\E<(
M=Y%,2/"8-1F$GL_935+_MD:1/(CK\GGN[H0%6&_N)"*<C@\ I>+(R+:&<^3;
MS;2&)?FE=&1E&2*5.,H#4J0(*^JC %SJM1G'D,PFQF1AC'-AI:4H[M?%BV4^
M"_Y9:%YI9P%)RX2MS_V"5*""-Q8Z$C@RC TKXE>Y/1R21X_'F*GHEA\R^E8P
M2Y=>,:H()2=V)A6:D,.U@9).6LYBD-#"#7$'C"@#(,I"J>H.0%<3[1K>:.!$
M-ED !:GTMT8Y(Y&C%2_!=5Y<O-8YZ3'7[R$IJ9.1.;Q8+-\U+7_HL8"RNJV
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M@%^&J=FN!+7[C?W,.^\N>-$L-8@-[$)$E?*P2F@62\QA&;Y:60>E-#E::(W
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M04%0C?YGK[>7"ZI_;EL=LE/J>?JKQX6O=A??\,OO"KF(O$*Q+FW:\ QR=J<
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MX=[)L=T_;"A^&GW9?GUY<<CEH_;1WDFW9W>[6W/ _-@4/PV73Y6N/#=H\?+
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M&2,9")G6BF04"BM2@451#HQ51P.YM&O]:5?DS<AK,9)FIS2*S:?.8-E/CM:
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ME<DIR%X)6'!-VI$(0!,1O6%Q (("RPT&\W0(>8:<DF*O-+*W+,,,K$;UQL-
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MGDP9O/&=W8T\5*/CC8[7T/$7N5$==/9.CNRCXR<'WXV.-SK>Z/@J'7^1',@
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M;SX"KX:3QV_-EL#4&6I95Q!4H<^%$8O<]5L0W]]X:%9/55QG^CTRL@H/"==
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M9ZJ\7KXX6^+QNOZM0[E@PG#6N<6@PL/]AYDL-BQLYMUR,O*MG7MOYYRN-!Z
M!^%8]&NU&R[Y*RFZ4-UB=,7!LC<.@RA2-1RC61#@E9"#+(Q.&'INV+*LS+E$
M1Q \E/P5=4>K?J].\K&VZ/-D%GL+>!6O76;!OMW"+V.558)C&S807+DQE99$
M\)_HTI"?I]>6!LB'BB4#5*%T)ID5"-)DWNO(G: Z$VSP9$_Q;C_*QO:[[4ID
MPE'9/MRMM/1SHT,\Q,3+&MF:PGF-:[C?:Y7P?F+FE&U]?/MR"::]$^69GV*
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M__MA[BH F#E#B9!=H4S[Z>4U&@_D2,'$-_\;#0X,'Y:M>Y""UH29N:2OD2&
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MC4;JL^R8HN&1/7/]&Y!0/ +@T2 0?R2>'*AHYF9NS+,UA2.S??D/V;2S[0I
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M;RSNOBTW[8^[#E:7V&I_EEQBU]+7K534XU8O>Z5\W-PHGRR]\%UK:3-7OO,
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MV+SY#+5 _^E!"(>TE7_3*23G$%) N5*HJ@?;!_[M4/%QO6<>S*4X DLO<!A
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MU !/: V%;PRY4VP.TR2AWQ$[C2JW*6ZR]%:8XI#- 0@TT/$#API4%T"8C$
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MT)NVZJ%PIZQJVS)2ZC^D#XT'>6!R/8(>#9&71W2)V9$8:VRMQG#: I^X7&7
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M==5KUX#@F])5XY9YL= >=[6W>IRJPJ+^!FV$)0&P:<EVH =QZ<(]*\@/:P.
MI!X$8^T)_E4]W)-3CY' T2A8>YSQ&_P5A+OPBT('J.U\U?$G@+" -:56 &:
MO CFG-4U584JLJ,8*$PD1G7\[>G';E%[IND>UM./P"Z4>1P]WS][KDC%/Y^(
M]76/EB\D72HV^64$ZU!1CFQ];L\EQ(0V3E/(G3GH2G2I*F2W["C]YK7M4@4%
MM45N.\\#:W<[*D@K"/.;=8%">')%+/)JA0I,HCU07 >ZY-8O7TGRN[0L<F(8
MTI5-WO>-3(+/LWH:W<$'/$(G6T>3--MBR_CPM-IR:P:'Z60ZX@_'66R;*F,$
MB8)*O8A[Z_BTY<HYLS-WC8T7 1RBA_@%6U4L0%I=I.0Z4NMR; <<@$5C1$8#
M2>%CR"E]$B)'&',@^)#5ZJXL=AI1L/1XJ0R'J!_7GGCX=,$8KUV,!25.N#4R
M1J^PG:$\G140MB8,^#N!12=S#,5<>N'!/BU;6Y,L[RN7_PMV0^&=-7@';@N@
M@=+U9NXK]A!;2/4ZQWR-RCG&#..P*&UH:YAZ+1VC]'P=\L\+]S;!:JM7:W_)
M"LNJI<2R>D2-Y6/+)M<HDMS5X>WJ\'9U>!WTJ9\5=0OHV17@ME\&+GOA"--:
M[TINV H&,(6Q\P58A> '[&5%@1K3=B?T3;1Q 60SYJ<=5.I+I5K95C#6'H?,
M7"U<S1%$J5&!^G'C%L6W2;,0FPI?FB+WTV[CON#&<=M2\M!METQSDXJAP^6Z
MK)U#EF')2K< \WTK:9U]_=,AE8X/=DBE'5)IDR:Q0RK]H5JXF-?48<]3O%3<
MV58/M;L3O^1N<!7X ["MW29\L4U 'UC5JT)!4(P8I9L%A3'AD*B#H;V%W;9\
MR;.1SS%C17FHT.23:BTLJTUV&_$E-P*N!VPS463<;&^<9C8Z61: ?2!J@[C&
M^ _%2ER]8P+]QX?R#0#84:$>?WZ8Q>ET=YB^Z!ZJV]YR*' <Q"RMXA[ 4'FM
M?J/KU'=[]*7/&>T0;1;DH2N(5*?5Q-)[]#ASA7';9K)@!&T^ $X.!L0PGEG0
MXV[KOOC6,6*"-L,G:7+]A(!T-TN3)8'/W4Y]R9T"H@-*"]H<9SQ$DPY"]A2E
MARM.TA#80(WV"#-7/EV*'P&FBS+,I5-:!MY1*0X 18BTO)ANM^F?RX*!\VFC
MA$91SN82/,RX*44KMF>U1I$OCS>V421$6*!2:&ZF?>%ZPVQ9&DIE;LSMF$[G
M4UL"-6\VO>ELK4=%$R4RM@N9.S'D18,\GV,'3?C;?G3ZB.Y)/2:T=_TI<B8'
M<VE/ L= +JV&1AC$FU$:P84LVA")UN1RL+E0BY3HFO*L3.[28EYER%@VA#3D
M2,B'6R;W6"GO'QP\(.;]PU!)/3\,E13\YBN=A?/KL[?1T3[M6O.?__EA\.[Z
M_'IP??[K631X=QJ97[R1GT_/KT[>7%Q]N#R[B@:O+CY<1V\'EW\_NXXNSZ_^
MOH6G*?DT*P YX!J5 V#K(^,C+6G8VHTQ"?%V6ZCT;K,'(< KO&:#KK$EL)!E
MQL7,!(W9RN 9S\3LM8.GOG+"/'BCVY\T!P"D35-HLZP;G7BTT;_!I+*0T9M#
M19^,C?ZOQ$';A#Z@B)258=:WPM)];J=#M(.W9C+(A@HK55@R5A@F+AJ3G4'E
M/])!PHD=FT$7M$8M75H"=D6_&&%BMEW8A/YI=( @S= XN3-*AWBT:]?6%'XB
MHK=_$% +7XIKOVW@A>N)5YN1MDB#+*X ?C*$>]XRV!!^.\R,34<\<P#G$D#0
MWK@H]\ IX\Y6\3^ Z6OA^"6;G_2:Z #J>&)>OP<>.0R-.<6).-&2W.%MAS2=
M"D6))Y7@#'KS/9+A*B6GY#/W/_W<O4XOVHYGSVOL!'OV2AHYG4HC)^ZB0YR?
M\10J "VOK+7CD5@/^%P7"&K2;\+V+"5?V3<+AX+BPX+*$$%[>6V!:(,L\VGB
M$4E2EB@<M:@1X%],!/VD6C16:(JB:AD5*&USK.A$'!TPISJ JFIFNTQLN56P
M4]\5#*/#/''4M&2$C*Q58B2&;0P ,($),:_8A#@W3Z+'/!^(/E_)I'@8%+]9
MA4K,WG>"9\C<$&>?N#C^TBSKENF]W]@&5;"X=LXXQWEK_GXVAR(T4F?C>3X4
MP*&L"$2D@&Y<B X!.VHN9C!<4SJ&63%47T!!YYY<:)$"[)6_:Q\*0JLKMP5F
MJH;.4F=?QZJ<AFL1W#D&4JS-[)[('Z4KO82,]2BZ-7<K.W^$_9>.=_ >Q6O+
MG:L$XLI\<AA2A<!HYN%P]0#EBZU-Y;#-&.IE1JDQ,BU<FT1$$'71TH-=/7"N
MX_HS'>M5/86C[?<4:'V..]V%DXMWUY<7;Z[057A_>7%R=@K>P8JJ\"M-[,QU
M3L7;%+U%L#LP3E!P0_?W +T< :YX^S2?M9U';G)#/;F9G9S#A8\2J!XA'264
M_$ P4%"G&&/:S$MDX<=OI)#2FM(J:C#R3=+TO^T],AC6''G QNVDB8 JFW&N
M\)_5? I:ZU]L?MI A?,@J"4XE6M4B@*9_WIU=F*[[97SC*TO&&W%--IF^!B3
MU'-(D<YR/IU3:9P$K><Y&FPC\05=1S\=^Z0XMODYG2'S,>8#[[#'=SI,2EYR
M^;MJ5$Q_1V)?-)+,AV*@E;&=&QEG/S)SK/ FH&H&RLGSJKM-WC;GY(-K0@XL
MY'<X1Y<8^!T+"I4[W!%XI.K'@&Q=P4U6.!X_Q-"%<(S=TU.@<06!ZA_%>_VG
M/R1/\-/]IR/^B8O;M+P_>:B?NFU2BG+INCKWEG^Q]WO7B,PCL.ZIJR.^?L5%
MP1"B7=&(N\>V*@MP)K-NN?SSX4_[._SI#G^Z29-X'/[TZYEOYSF$*_(Z>@/!
M#W&0\F_$>KOH-#*HL<OON!-'14(^$M>TKJ/QI3(78W!4@X<?Q+XBZF5DKL%P
ML9!HAAQB6!H8)67)C9W@IW$9ST?[T< ^J%I4YI[K0;[(F&10G3LQ]@_ZYM8R
MQ5%07>FHASV1L&?U,FNULFV6HP(CBF;)7!6Z]VZT@J=)3>X_O11;K82?8VJU
MRC:,QF!C#>7HD,R&)^M>8G9-L7.[WP%>KCKVJ5/J*&:\X5<)PC YG8;-E$7N
M,R7W$.#+LF" %:YBXKDY=A#<20H73&[-T+C7C\0@H439H5!V2.N'&VCD$UO1
M]!1G(K:?5PE J%N4UCA)C?%TL^_28*EU5C#=CWEQGT?C).8.(LPP[$35;PS@
M!$]\"4 G0(S3)2',&O.NVB[G]L-1%8^3VSG276!)_6@^!$-\@J$8/#4PPIS,
M<QPZ!AN%E*YC=ZC5#EM'3&N'2_R/^>C6QC;%O-^S/51R:AHSSSA7@=]!@V!D
MEJ7B]G@W+"38B!UJA_B0F?^;IA74W.X[M0@/Q:Y]((%I:7P=.)H47Z;R)*,<
MT]&<JG-QQ;'1F#EO%5:* R"XR+*Y&.GU?8%O@NJR65*8UV.1ZLU"*3#4#R7(
MFG_D&F?,B R?+BVL9O<HBR4=&K -N'0L *F=<FL$:I:.$;CTH]FJ25&,%,:/
MV@M*\[4OIO36\J-AVICZ8NT.Q M614DBW36:#\]HOI#UP^.%2'I:*?=4T$ 8
M=1MQ.I*+>3/+9:'S?1<P+? X>TIG(28<4WMFOE(AK@1/LOG(?&"[?& E?(V-
MI=B_SKG4'S#]3'0SH^Y/CB4!4Q^8M2O5/CAER#+4J0E1>>XYQR2\6\RA4#%(
MZ?PB1P8UFFX^"40G5%9O%==F1[9.W%Z<B\R>:)E];67V4F1VR^RCZR:\1$G@
M>J>5#* A!INA$:F%NP@_R%*H"WT=1Z*"S<1KDE#3S+A41W]!FFG!^67_"[WU
MAKYSJ)U#?=CM4*\3K7_VW<X-WU(/]D_LAO=MQN@//8KMU\_[P>5U='YN#(GK
M7\XNH_-WKR\NWPZNSR_>/3Z)]O);2:)%_<XLVINSGP=O*'UV=GK^[N>5\F<;
M="=SCAML)3#2B3,L7SC$YXSKG;+DEO@)P%)-L4/W:TS.IHP<0]O3L=SHDJO&
M=\T[A5VM"T*ZI.GCBO+7/_QVY&_0*8" WXQ>#TZN+RZW3?9>)1F&B1A/">X6
M5@8!"A J3=#6AWA841H'0$Q%SN8AJ$ :/BKX3Q>8^#VXH.<]A Z8]11_I T\
M?1$^_G$/<J$:U6Z54 Q8(2U>+]*SJ>DR$(IHW)(<C@0PP0!+$T8W8DYQFE4;
MSS.!RTDV[G,,'*DD*3C O"8)>9\00QIQ>9>\C(;J2!"ICS%K#]ZL#>[@NB;[
MJ&"3)FEE5AB*I!"CPWZ(YG!L$'2:)1B"7@0*-]N3P)%\>CT<B>-3./E&FN.3
MZ)H ?9Q0XU8,!FS@RJZ$\8IY)1<$?I8.Q=+RPJ]3HOYRCBO7_'SH>DPP4_GS
M%^I7:] *'S$9&A*ETF>D"B.R!1CP"?,??:"=0W(WY".TI(L$6ZNEGSIUB*T=
M:V,H#/?@"=_&>0!UZ[]\^92I5PF+S3EOCOOP(VQ?<5MQ:13.V$BRM&XK$W<L
M[1 E@2 \L@]+5O2;=MJ3_!;QQ1CZ1-X\05'\S^M(]<H-I%WPI(#U(@ WQZD=
M$2H5LNDCU,G2IQM4(PY]A+%=V0&U[KAJI+/PDH"0N$3P&OW7>ZYO"L):A>:S
MB]I"&@LZZD>PH;CU/.XD]"Y1M')^>3GOJENT7C1.1DC7ZQ#/;A&P7SFW'N;_
M!&HWB@+;3XT+,UT!_/ZF]UNO-NV]NIA:Z82[6(215$\_CO>&<0V.V,QG+T.F
M2@L"TL@CV3!O]Z6ZU.X)*DPN./!%/:VP/21>@>8TW2<*3*Y4+!1)CL7@F.="
MC&G?[FHU!,?)(J(:Z ;\GQ2GSLEP<=8O,L R4RH16IH!F7.(W(K5O +QQ3"3
M\#T2$R2%DIPRV$"MON9]23&_M/*H6D?%_*9F ^B1G,&_,<-M!P.LG'GL#@[9
MUD2O+&2:@'R=R6Q7?>>.9W7'L_I'\:P**3;R)E &EV^NJO7JXN7#)*'B%->'
M+LV(68%M<@T4WT ]LY+UN)KA3:SW1%^N_HJ%86-H$MYJFMMR$[YR1OZ=0Y>K
MM!VT> RG"=I+#[LK#T/,H+)+MXV9G* =-E'?2MS.10,V/R+9"R(L_^SWQ<5C
MO@;W%O'IPIPQ?QV\?E5V=;M8:I&H5&Z&'O=270GOC^^*<D.(T5MXT1]!BZY$
M;X1%<6$A*!., -WMHSG46R_B55G5";:0#N=97-HV Z(AY&I86Z1@L%.XZ=.:
M(BRC%$X5*&SXX@VB(]S"BAG.3_<J=G0K #=4JAG*0%MBKMY557++#"J9U;T[
M.FJ(7Y.-H.U:9S1#ZU?HX)H;C>[5%/H-P]%8,(IISE@I+A/E&9@O8QN?&8 -
MS&O_A5T< \9CYTXX<=B98CM3[ \SQ;;,. KO"*,-!N: 96Q,P)61YP5$AD9T
M5)V1$+F6IJ*B8R6Z:4Z.+>XNR!X]]]*W,^A;?AQ'/<$#2S1)P*!V!AQRHY94
M3*.H 1Y+%\.)<3W-,/(TMGUJWA5W9#.U3M$=L.5373)1^X)@KNK JYL.JRM=
M?1(6CD(' L&<5G)X= \"J_+V\,-0X3Y+825J7 HD\4RI;P$J01SR8/ K7(-5
MBNK!*%CS(!6$0\5>W)&(8\FFOC/\(JA)$H_81JMZXB1<&G4P+2!6X58=L@MB
M B,DST45;PJV3$DPX/7M*U=QO9E-+S"0L=54M)'."FXL]^<=D,8":8YVE2D[
M2,PF3>+1S.A?Z039=F)^7H=-& RK<-\]BN9.S* )[.I:DW-"@FK9-9E)#2T@
M,1\AN-4[3<=C0:N>Z4QVJL_'UR,* \F^>AH5/18Q.^W(50"#R7TX2J"K'"@)
MW66G.D<M^ 0X_A65/^IVA2,RM\T2>Z:V,P@1#AS$2MB3 ]O?V(##C\BE0*%\
M&K+?[,[EV,!YR\C;:C')N1@8OD*ACWGU^X/RT5LSS.*./2/\H&#<^5[W$T:2
M%-*H<IN4XKH:-:'1'26H@EP*SJ3I"5G'V SA;_,\X0ZI2QC9*7YT%>?%.$57
M&"LC1M:8DJ<<+:5UIZ>\2L%8DXL>?-!*/5(9"$AL Y9Q.EZ@S]BQ1/>30LI<
ML,D*U3&PP%O3AW/E9<(%R,0WI"39CS0XGA"8T>OXID1P"#HB8&%QYR?77D>J
M!TX&EWO7QO8R@F"^'WRJ<@E'.&4+Z-6:)+F0B\$T 0)\D_2$*G\\SS!OB@$!
MU"C.-YU"$*W$\(2*1S#?L=^8D9?3B0STL]31*!NF:PF6@ 5>(EBD<(M,RV:7
M%T%8V1TEW^7<X4FP3;$*4 3#!$N(\X70EC4(RX2Y13V=])3Y#BK!GNU5^$ F
MIVO<7T0HL*.L[+W;;LX7N86WN24^]MQYU$\S[4=;YT%BDI2DJ2V>^6#(D%LI
M>SX&93*0\SZF"#+> :U-F>U!1"7SMP1_;;[]YLT)1>**>\ZR.V8Q:9XEG3YU
M?L-5L4$21'0=!F!L6H1#%5H,;X%SP-M9;N%<ID,H+!G2)6>!&$).#M(-.JZ9
MI8&7<%S%Z/8QE,* JJ?()JI?JCHK83<JHE9(P0<M1*6[%M,8!5MEGY:UL?1/
M14\YL4;=I)QO@FO5DJR7)>#PU!U /AL&()/*&1[2?Q0L > /GMC:+RQN!.W&
MLV11:&NCYS,6,_Z% 0$PUB0F]6A#!4Z'E822X*&3SZT"ORIH/(;@.@QHY14-
M ^(NTJ6X[QR[B<MR#,U6YXC= ,O1_H#%4!RT0ZLN'=;BEZL0,X8E^;%#"4JZ
M4#MEPX+H(PP5R-:Y.)'FX9FK<'[A5.('>(LT<7Z/>.C&G@$FHVQ&P5V;UZ1C
M6U'Z=(1\@^&!#T7:G,$=?^96DVT-C;J)UUW6#UI4JN,]!:Y01',Q/Y=^[KR>
M%);_\ MTK/R-S@6(FYD_J#J;[6 :-.I/;4G(;48'&UQ;=^D3APL%U\I=H0O&
M2)9%YDZ!:[\MZ')6P_)0,+F-_BHQ$7*3%BI>1A70POI(N* L6IXGH:!7.T$=
MQ#-ORB(>-=))K7E$MEN6Y1+%6M+FD$TNVE@\*R..V(-_8N8UY()A;B=N9Z6F
MPET8N/<XY3N\CN8R3V:9].NX98$[U^*^*+/1O7$#W&X!'I!PA59&1FA9HN\,
M^R^N%5R!L;G\;EFT@5+JEFIM>7JVTOSDXM?ST[W^2_-%HR/,'-EHR&TJ#CO.
MFQ?7]_#N2X!DQSC$U3O3AVMEA1E#F]!FGEE"F:F/ZRA 0::U5\6J>]+CF1E"
M])KH!D0?:W P["PGN!KY0GO):2>"VTF[W":FWNF%ZBDVH\9]/$!PQ/S&%SMY
M4BW@UT^!BG>EOJD!A$'\VC8P4 W"-^^>6!,6]R&W1L>R\SC4B3@+82%I%Z?#
M:PBO;FA=IPIZZ#/NG?5_UDL1]CQ#*)>+4S7%]3+:DDO4:I<L;]MQ3AG#FR<2
MRPE;/:Y<"]G&U)G<.^Q@X/W;(AR=:E:N_KFY&>$N<TWAH$B_Q@!2^%;1=2%K
MS>?7F78JA8;_"#C!&ZYX7;'7(Y>] *TU*R:OD)6;),;A >)PAA+17=-Q-: 0
M9V1YL9@IO>ZYL"JGZ=^)*(H8=D0)!:9I=T.&5HU:>_WTWW>9]*B("&$>:4YN
ML9N#+;=3--QLY)#V2<VVX<D#&Q6X[2O&UF/LQ(>+B!7VA^B91L!W79VC=8H+
MS(C2\2T8>[IT>(C)FSKT3O0:S,E/\10Y5"@L/Z3.<$4E]#=79OKFV=&O(.2+
MZ)794+R/KWY]U3-_O&54#/P>1_0Z+<TF728<8<'?X[QIV&3_H6'I<0R 8!FG
M#B?@ N%$OTMG$]86B<"9' =,"B0I$E0/"1TB(LB6(G0-!CJYZ /ED(/(,'X^
MC[(/"EK" 0).J2B?>-@^Z$K2[<VI0:\%.%A =3,WKN>"X!M0#&>/[1Z8EFKB
M2% ?WTI3!S%X.$"#I\J&-^\3.S.I&1$!)SXA2G(04;NT,I#PKTMD")62QD*6
MA-P)#P(O-2HG?)W9%F#2P9]YJ$0'/RPQ*$DL*\"'1,] >JO*+$:,#)<^9PN4
M)02&N5L9E#WPW62EP-\S:TF8!IR:H@%BK(WQ:VNCXCQ^,KUW#$YDOAZW-IJ0
MGW+PYL,0N4/9B&D?F(^CPID#EK0$[*4[]-@:CEEF[YM.)35"M5XO\UZED,1*
M;"!%T:JYYC,8\J%OP4!"A> )YYA31993IX(*Y[R6J\[V)$2)-]_ (]6B72K6
MC7+)PIOQ?F$NLS:OJN$RLOQ(EQ.^:1YHL,&.83TQ(F7N4^%E:W-&VYS/";"V
M&/<SD:2:'S!E1Q.07KXMNC$Z>P<9L9"1XQUD9 <9V:1);!MD1)(P?F!/A54P
M[Y-P-@B4-=C6+E33S/Z2,LY=0H)C.6*'4(4L01C8I@#%;;X%S'J"#=#87H9H
M:"SNYRI-].$FF"(HE>&(:6GM)[![0Y>-#=Y*]JEPW2JT'U,M\2F6/<-W.#!6
M+IXLWAY,H"=+5L.MM"2ZOHD8X/6)"[#6H37BO1!CS(?B:_@))3:H=+N>(*FA
M-#G2+4;#HEV*-3+^@8MIJL!FT,*+.V%O>N.A$SLK973C<0+&:P(IA'A(_N9H
M7L;.(.Y(CG A4F6>4XTIK45\ VVI$#-DC(=B'AKO];M05#Q3I#51DU8,WC=?
M[H&_?EM/%CVO!H-H,V80)QA2H-8'CA HC !"BS:AW#R97(5JZ(^70 M"@N^^
M'YL',X.^#6X%>D#H=PF(T! F\%4$PP:X/D!Z>YEJ4.T3([HS\^(TC@:]9? 2
M#2URB"*@E1V1FH:>\V6CSH:1])\-S&1$L4XS6U#&\0 '7,H6]CYKQV[AE2&)
M.ET^\7/!0+=[*5ESG 2TI[XZX#LDR*&2JJ?&BW:_=)F00L4;QQ]N'&37"+!7
MX-L$&7+R]=T-_1EKQKD4P1(0F&&;2=9M,N?[D+8^P"M^:MQ*<J2$4*/ACKGJ
M189IJF [PZ+\<5@T"U7MFT,&Q,KF>0D7N8+]DNG'A!/A^]:UKVPY0GEQ3QVK
M]9QQ!D[C<SH4=3X%CD7M<P!GR6WMF28YM-#KOAL@ZD )L*15EV_F=;!L\HAA
M$4P@Y_8>/7*):+6A<\@,<[A?R]2!8(2.]19UY/([8]+:BL_C7H(+H>7G @OT
M$:9EM7SK#^:)4*FY,#[UYX&[:@-OT\=9>(F4@"ZO*6;-ZKC?'U:MMF 6$0"<
MFV' RWBEU_5$N7-S22 XJ(GORGNY^JH#D>28T<)ZX0!#@HCICML:1;$)#T,4
M:0>X6K]]\Z1B%1OK6Y0!#VBMKHE&^-*S63#X##%B4)HM_EZ[:>T4V IK@J.#
MS!I9!AJ_WZAE)HML#3$5J&W[PH@U8B[]:4JUV.?O3JN>SS,%^QNH?='O=+':
M@+&YW3/$AX+H8&S@'_,RK>!&PB=Y1I(XUH1H6V)#=UU4UQBD30"@9LDH<":5
MM"GPIJ%>&;[,#XW(I\KTMC#+5UD\RQXP)<ZGI"G<@M8)(8;Q_?5\)/@O&AMT
MNQUB+UOIF)?1M)8!DNKBD[D5P5D5I]6K=(6;/X$V#^6B4==A;JEB>2RBB:J;
MY\S;EOO*42'Y;+S()56DP\N<Q8_[TF!2(K7,#0OO0 7YSOM0-YOQ&M-E:NU9
MO\ 74U:-*5E#1VP6;01R+VCL*"KVHO&WYJYY:<L3*>H0[C&E/^C#B6*$ 4.4
MFJF!>28FD1@:-L\H<;<A M@@IN;_W9I/E>:SFU,QK<BD\CM:1%",-P: A;:;
M&&N!IN0OV]V@(:(NXMA@ZZ)G=7&;@# $]G(3T4LENO9X<@O&50\G#0G\$'%"
M+.O)V(_>.20]146-?&,5-?/UU=QGPR;ON-C?G$BC;2#EWE&K1$F^,%;H*"/8
MV>77T>ST:X@WSKP>HI)%07F]"LAKH:.+R_#6$R_]W2&<7FW>C?:U<6WQ8FUH
M:\4:&!)::& ?4W9 '5U/X*2/T*=,WEQYB!?$ B/Z!);0*T6"F>#]K&J/7+$[
MZE+L1),GF2=2>)KQRL'191G?HY"75$/51U&7\57#& D>P*P'JL(Y%IJ'\RRH
M-_%MH3!$_D(PN/(FR;!.DNF(IQ@IH*P\[F^/P^.TFJ6JA S"%2!+@*A_H(A/
MBXI5MCIAFJ_"N;&>[_,M>#O]I](JU]62NGPPK F9)$X"W8;$*EG3L+=T^-"_
MG>1FXDPXUC:(B:1+3KK"A9Q[H7Y+[.H2W=#87B0VZ!)'MYB>+X-^2'P/;^#>
MK436AD4N&"70BH'/-!Q/JT>I'(7N!P9 MQ;X=*UV%K,I0LW9B!.6EU2A4:PZ
M8,IOZ0@'%"2D&U3S7A@G'34N(6Z5B+N4ZIG52_S0M.R\%+SA13C/J3I,*G$:
MQ8KFWQ,A-RT37)"JR!+!F0@B:(PKJ-RF"U6ZIO)>G2Z:75QT&59V7N0*6*0)
M<!#F"[4 YI;B19&58&9CK\4=45PU=P8!85!J7\N*$3>Y.L3- YM6$FW>RXKB
MHYCVU(T,6=QT]S&ZZ]!^&CO3%K\!<Q*I!6N?AY#<%50SV!-GK]H!2QRPY.D.
M6+(#EFS2)+8-6 (H6T[H8<,%H\@(<EIB=[_I+*E3&S IDW1Z _7ZI/&OB?F+
MN_,%JFZ:Q&SN8O-/)E2S?[87)K9OB2'?(*S9N9CLUGD1 ]>[P*@/.B0R9G#K
M$B^6,\ME[.@B2R 1;2+6HR.ZXCKS#1;'HJJ*6ZJ)V]Q=B:1U\%'V5(FSQ9%*
MX;17\PQH_QC*"N[)7JLU71Z6LKD9 ?H8 E!PL<PY+.!N[S"0IVMG.=9DIX0^
M:4N<8P.!*:LQ]TZYX0DP/S"[O-L:9W91QQ,RR!)M.E+@S0C*75Q"OY?(\[&Z
MXJ6.R\'574R)U89+#BFG1>1Q4P;W#L%S'?K<N^V\9M:7_-:2^+IBH)5QMH//
M!:TU)GAM>3"633NRQI['[K$R+T>]O-TJGAWQS5V>7,,"FC0LCG+E2U"@#"I+
M-[E$F"0<AN8B'!1[0!1*)K9\3RQSQ+_#$+_/C:^ 6*',+(Q#6BDT5]#$G'F0
M#D?]BEN=PO4 8$.?X'D^&Y<%A)C:^ DP[JC9)*&>Q?;1=:Y"4^?C/K4%E6VE
M*\=5N,0A]KAW&'J 3AMP0[RWG:5P*GK_6G@PU]^\D0M^48<.*OO Z 8EV'*=
M+JG$%;(+\'X"GS\*HX=FC&EEOI1!XY8<&DC?Q>8A=T;FAA3M]30.8.7 5_:/
M'D43Z0W]'P^CJ^NSP>GKP=4U9DP6.MUS_5^'!P>])=K*OF%FOH GA,X1K5KT
MRYO!WN 0&OY.XWHX,<OQ,1WER8*2%+&YJ/&3HR*'*.3-O'Y0*:^S%0^>%8H:
MWSLF-3*8A+03;G;"-*YQHIBT"W0K,,U-8VX\WKP1*9Z1U1:\:VLJ6NZ55^>_
M_GIP<!1=G9S:BX2I$]B>4^ZWV]OWEV<GY__S;J]/>XL#?(OQ J)7;2/],MJ0
MN$[FE0O5.RX]2PKF$I*%&6].Z:LBC,ZW48V91TXM1UE :/O @LTP;B,K%D3H
M'\\A%=";V8.8;2C56<?MZ6<CMI6J#._4@'F\:A,(FC'7KJ;FB=:!"'R9,+9'
M]7<V,$4RZSBWN98*#B<A4ATXP%)(6D/6$B![,>HVOX467K>0,JK3V20KN1^
M:,3L++9D"$T_K+DTFS8JF+O2#YPV0YK>.E%^1%4]K!:13V3C,Y?R**?-[,:W
MU OIHI&!E%[A$N6.&1$7)/];433.@9%OBQH-$9T!;Q/WAIGG&KK')92N[+J
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M G4Z-B(%-\Y<T8G/G!7/:_"@H"*.Z CY>E7^1-I@CY=@JQVB"[JZ4+2FJ_"
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MBVVC 9M5Z[&6>GA)](/H'H5%AS*6U,A$7+8NXZV1>"DD1A2@I;XDVX\97O$
M@$*#5"%>IA1O)46%^F$&Y*$6$LG[+W=@\BFE+C;N@6/?FNP9:V3X,;[E*+AT
MO7%F2.7Z+ GKM4>VT%#)TFVWQ4"H/+4I=P$-;#]Z[>B"FGOF;1=5_TMD?PQ9
M MJH],XH=:,7R OV6S.,O=O8_:6'9*&6]8CTIKN[;?J_9W]3)>F_N.K ""9Z
MG 3A&I7Q/5&7A%^6DB7A#PP2"VSKC\#!A+ECGPG /')RMFN-%<-2/)KP5:@N
MJ2R^EU87PEYKU+R$$%J*'!X WA=EU&RDU88+]RISS/,G"?;EDS.$DT]SZ",%
M1I_1:]1I414AT5W8T3::,[5R53;Z37KX#=?MA'I@<0]#SUI> <Q!%)7(88DU
M*Q6Y[Y!0307^/V,X];;=-%Y+@" ":36K ).DJH"]EP0[@BO#!&WQ<NX:[ZD^
MYU2+%_AV0?\U$E>DYB ?IK%-MDY(*WY&>^'P!==']'-"TI2ZZCXI!93)/#!F
MSVCR84 R<3\<$!PK[5FUF^D$5(F5":[1D_KP@XY@L&;J8JUT+O JZ6H[U!.J
M )%7OY_3-U?@<>UU_]$Q'Y07Z[6ZK?8]Q=CO?NJ[H]J0JN1FM'%":]S;_JYD
MV2 VT+=HD7P&!PA7/*AOXA7GL^)D@$(0>K=7ZP>TC^LY#;W:UKRVZ[&J@UDD
MDXM.'ZC5A1,.$GI$HSR4,MJ-)WK%!V9XL.0+NL;X2$\38X&B-Q'X]6W'2K?I
M];?:NP?H:N2C)PV@UIJMV60:1E[D1O3'\-_6"M.BUSY!7HX0L^"+BN<.8N<?
M5#RDCNB+Y%?13/T])[J.N.QRI^@^<[Q4-Q"DKAB60OC=79+?)OE?[)+\NR3_
M)DWBT4G^C4X4>5ZGXD/T-7]W?%;WK>^$ZK;4 V#T(59![C!!H&Y_RF2JP'E'
M<*RR1.[;9D?]:=(W7IU5&S;:!YFWB@2._]<XNX$5ZT6O6=#\-[.[KYIL!^#U
M1AW[A<"(P4 7:T9>X]YM\RASKL"TH$)_L*[*&[;K8U[<[TT T]R=6976UV@Z
M<T@",)_N).Q'U_"ZL;%1L('**B],)3S[B4M/N<,HX5GX=T8WSBPM]3@R=L/$
M!@$9C6&TION%>Y<%0*,B2?#A(PI;@;4=0K?U\%5&!BM&C&E-7<W=R:<H%(>R
MC?>F8@A@?16E^IH:$P,Z,!@D>!O/GL0&L;<I %5D8S5!FV4+L+%#,;(]ME^L
M<R"&&(LO'7/')2X-7K9%DA=+IY@IY.CF;[:HZL:Q@!*9,6(P&/EB]Q?CM7$=
M(P4N\I"K?+K;620G%ON^;5#L'C>S&9HYP34/=+J62DU<CP]Y H1S;>+,UJ?/
M;#,/WG\*I&MWT4Q5JG,L^%>? 5OC5BFJP<0,N5@D"=.GJINLJR'VDIPC'D4"
MZ-)S"0-5AV0JH,:HDP[_;M&S4&[^NC>.SE>&7$T<3@'UR 55HB#;E1+C<X*<
MCTMBL (((\-!"GV2EHQ5HF99;O"CJ$*G$D[2RDF&0,PDW1FHA%O0%3DML'48
MXU*YQZZ)ERS"4DL!.;_]IO,NZDKC(M.#*\H]%VZI7+A&(6VL45Z?&_4:RH6X
M4/V&)'6\CM4)9+FSM)HTKQ557>-)6>SZ@TE4EZ/?7,[;4\U",PJ68?P%]ZA&
MW)B+!E=)GE+6)+[EJN4SAA$&E65VJ/9^],<[C&>D=_A\LN/NDM?#B1EV(H41
M/#V^[CL%JP6-0>@+%;&P40XOH*'S]!1V8 YSAYV3VB'8X,I\ 4Z<5SBN<P5#
MP2>J*!5Z--![*HPY<H?J*M%S$8NHN7888/4;2^AT30L"Q$^;A.LO(5-;Q^9*
MHU8K_-E .WY-%^L*[ ^L<K=;2'T-Q'06AKS+MX-K,*1G "O%.+G^'(;LXZH&
M(V/X4?^IYP7#[\RVV0Q0AZ')!,G89#>)&>\,#P]Y(4H_'H?V8E$VB(RVKH9-
MW%X!Q.+:ZS5=MGJV!!Z[)R:*B^C?_ZW_[. G(B3RRFM#[E]MM[2EP=S!?Z *
M/^@41L%JN)_0#KS%DOQ1=$$R=0HR=:HFZ? +9'#@L()GR**XQ[PEL#^T/1-S
MB1]T]G:P;SS5-B!#A*TWS>,A'5F9!S2X,> !'W*,0ES5EG<0'_NAQV3@/!0\
M':3&) (*+NL4[&/N;&:4Z\Q9.I4^5B%:?9TECN[-LV19 8+P&H[D-1Y)O;(I
M].U"[_J(ZM \L@( O7*;4:/X2YE^Q<[*4F61)!$DI@\/?GK%N8>]GYT!=6GM
M._Q0_R>I]@96"J/6<XB(7R;@L6R@9EV!N "N4^"21J7IZ4=[J9&%SHE63')B
M/*#MG'5&K=BMM:<#Q7 .F03S6>!HI%QW!_2R'<M#UA,*C^#G.C1,8W(-_=&8
M/>>- QH.JE_W$3'L*T#_L(R,Z18=/\:(#I@J4_(C&<P**U&T4F_VS/M+ZF25
M<N]V"E$Y%[!]-$#%@&O2G!3ECANWUSCTPGBSB H+\1]3\+9&-LW$];,M#R,G
MC6,M+7]WK4)<_8G#FUPUACQ$6A]4GK"8Q4< '#9N%Y8X_@#8N.@S&SD!'QE%
M.<G2VY37;BC<=3>8FD.4J$7@@^=OS,OR%D-8RGI(/AG56IG!(P!_$;PPW R6
MTX5K8ZK.@)PZHLAP\P!MJ"@+@&^"ZJV(,"3 76-6W6'&\+!Y"4OCU0!;5P-H
MJ\,Y:*$B^D=:6-I@:0E>@BAJJKZE0]-"'P"Z&Q9%$$5:D>L9FEFD8%AE4%&C
M5L3[3*7XQC@>1($+W!P;UEO6%WF_:P!QAD3_TB'.'7 ODVJ!(AH=S@TV[:E&
M:VT$G5TW4/<_HID(5^CYY W6LE497A4EK[ WNL\: 4!7EL$A^HR-LO:BMME;
MH0K-;>P3I.X6=(]4.]K^I"YK;*02DLH^9F#S-N&A%(4CG!,Z/,I.6 HZZ=\]
M"G>%1)KB)%Q Z-;3(J-MM2FLT\=DH:HOI5MLXAH[4OU/$ZY,)X4M@(RB)A#%
M(X9#BG1AE5X3@$W*3H+2*9XKH$ 1$%3IIV% V;DXM;"B2;]Y :J!/9=6'VFN
MX!??LO%G?RD#MU.#"1#Z#V(L !<*TSVV'Q4:[BS5J&J0F\H?*$]Z#I:G,3/!
MK%>8_9Z()YF8KC'7/+>BC)L5X*#:")9::$0#[6NK^4@8,')1!WQ>T'$$5]YM
M!M$T=BV_QU2];0?+"\0UI,RBK663[BQ<M9,4*ETGFQBD_R"/F*R;0J1X9\&U
MH1_VK_8]<EG?G]UA7"S&Y>4.X[+#N&S2)+:-R&*2Q"-C"1N#NR3P 2B82W-)
M30NHE&I17/:.59FYAWI1$NAS[M($/ING;=6H>:VXF:_2@NW=@#564-W#,A>O
M)[-K3@I_:B&_#]CM,>$JK6?;XEZM%RV-$"LC@U[%?GI" M=Q79?,JD1<F4"K
M";9>51O+0#W9U<"-&DN,$XH71ISV1E!NH-;-7$CH\:5Y9;S#.=L(D/_.DM%M
M8BTH!QQVKQ%.!.+N8XY!J4.E-4TK@<ZX^M2+Y6N#'KYMFZT9WFK"RJ@<:DN]
M)S:@![<!/'[:J<:%OGDVS/K0,F>"<W@*O/B>XZ5 +^TV;J;6R$?/&G55TC,G
MKD;Q/Z,K:-H1O:6N'F_>G&#,BOY&+_':[03-/JQ5E<!K($ISFL@+.^Q;&M,_
MY^F(8Q2-9[HD+([)^"RZL9'ZH-^&T/D72I0X7ZW"(QI)S(7:V-6#OZORM"VI
M_27<DQ:/[O-%4!'#]D'I+L+%!@"4E43:;6'G8TGZ&?HW9-$5-0 DB1)]#:B:
MR!A7Z70^]5/VY/T+\(,J1S%.!>JL'"7,^ X9^4B$K#OS;^$"Z-K8-X)N(@#F
MR,G3]_W]@P/0)U%EM)!K;MGX+ .)QC&B%8!2,_@J54"H\F'78/+H@/3]<$X^
M1QE38;VY@7H1AYM>F3>]QS==NBD9]9E'%\.ZP-# \YX+#]A\&U25<<1EH7E&
MR4NA']F93:(W?"S_TZ\=N(+;Q7X+?X()\);"0XEH?4X[U7.M62#2%LS.7K,T
M/?B8M^*-$SR)"7*)KGC+PG)RX882Z8Q!J<S0J_&B>^FB*L$HJW'84B&$HC,\
MLNHPQ+'QA&65+N?&"GUZ_/3@A_C)#_TG5"U+:\I-TLW)!L(NT :NFD4KW+;Y
M/GQ@R+Q 8B&'D6@=W(O^P0_#)S\</?EA\,2UA>F_,%L29PGH>B=E!$KCP--Q
MCP&K>+#:;HXE2WN#$$6\4&"#JM9I6LS. R<PQM2YD:/V\R3?-9_L=Q\CVSJ!
MVI,[IO.UYV;3&/@T:+UG03D6ST</HI,.W/(9B#OO3_()"M.P\4>-#3[,Q22X
M3*!FQGLMK>RWNVY3U1@@YJM5(C64;Z;W;=N5,D"F,RC_HME69C5KQH:ZCG4V
M1]&Z1T#26BO&?$Y_+(JY7"1M[["H>2&383@D?F929"/F+E+IOL9#D W-UKYC
M.:,ER[;&!=)[H ?+DY&# &]C*>'M#+.1R/36-OBT\E_[0)% PW*:,7LYG:RV
MXTHLJ>*5=2X@7\+SG$K[1U1+GF4N\DRUZ)"Y8:EO1()KK]*Q@(9SW6JDF-=H
MM:+>2,8%%XRU#)#TLV=68@ISF8K"HR:,X,I.O5ETB0!#G>VDS-?<7):\BXHW
M6%KTI-S"HQ?8.C$OKNF^T"FE-#H!R#UH0XL+(3Z7X[G'U@3*R=#7+GVB[1ZE
MS+9]PK;I*.\JP7UKK%A:67>'^QS1N0[:DA+<VI(>K'L9]<+G.8N,,OULE&&F
MK!;F"#+-S+HE6?.3JM^-[6@$J6C'W##6O!;.Z]$8:,1<,$+5W9Q,TQS86.;Y
MXDC*A=WMQGDE :PI )*S9_YC3T"G+,X08LIQZF YE46>#LV]D '8WFC%PGBY
M#M]JB1-YR["+ N4[=%?=]VG^,;J:F,NGDF6\N#Z)7LE37\%3Z?9Y0 $WYB<G
MG\ (#"JT"\)-A73]=/*)R5,L8>>V':/&U;;J*9*8Q;+X@/6TFXT=>H\+'&QJ
MT(">IALEI'G7;##A)-QE,R#&<.77R ^D!!^JU(.;A87:!>9NL$,6<X-Z=S@-
MP"P]D(7=+/2#8[-""TE(<W%WA<3&,?[JIBP^FB,]2HR'4KJ<'(!E2A&$:?R1
MG7?:1HP#*#HT:"O-'$#2*!*1X.89@*YI62$_:$R,+(2,Z1(0K$. "+!M];8?
MO37K1 T%G$FN"IMLWPJ5Q_7Z%#"BI!>9NV6D?[;TF<*5@Z%8*<1Q)$7Y&,@T
MJ 1F7GF?@H"#6=(-5!./+*75-3-BA.@SI=,.00Q\DE(^%B3BEJ7#19+A)Q=,
MKCX:W9RHU=[ %7R0.<11*V(YG*V'X'Y.+-^ZU!2#>4'47.D_CSA)>)#)7Q(@
M28$>:GH7H"U49?($&]?+)G@%4;%6K<Z"=MOBJM"LD82NVZS$>$L&*9N*6,.L
M&""" [:3^B(.R=+B^A99"C?J[=OG4J<"H'NF9<1$'<^2#(#-NW0TA_(O8KY4
M+-?>J:E0A^-148R)S8JSD)[>YN"03>8CJ#QUX7G]17MH.AK[2:/KJL0;9,HE
MD)6KOH)645CZ6E*#0S2T@,W*$;PI_=![0$'TG(98K* <FK('=PX)%G;.&28S
MZC%)E$W.)P3(%J8P$2PHD/1U; MIHK:>$:%H3R5,)4M.97#FB"4EM U8UBP<
M4SW#>)3 7JLD(6'"&V*EUX4C< B8ND4SN<47HN"C!WB[#!I&'3X_W,%:[)%_
M>K"#M>Q@+9LTB6V#M90%]*YP+CDF&)&&.8'2"NF'K;LX2!J%& "X#-H5MW+W
M8WWQNKZ[.EBF#"'*#I%O('3+@=-HV0O#7@-AD-'9J4T4BM&_5#^KPM086E30
MF#8T1@_1\;?.U'(6Y-@5_K1_,VC9U]XCE*T^;!I)0<8:$E2U9W='RK^";;+%
MO#Z"ENX4ZP=CQQ;&Z>B."HZ@D8N(W4W6K$!A+QS;X4)" N+,4MW,*<>PI'^9
M!\&,CYR$6NF^E\ XL)Z!51%5A67\ ?-G54. S :[?X'UWC"">U(?<ELFE0U=
M"_ZJ%WEM9I<S#NK^H=AT<@1ET6:YS3H"Y49=W"8U]OO1#7<>:-3I0;=Z;:CH
MGA4(&+P?A3'S0MKH:KV^L%M8A8L5.\AFGE!G$H'2 ?A_BK:6W=WDD\VA)L*C
MS9\6#@%%4=%:;+.$E(+#=PPUN\=<@)G773ID=+_13,DH65WN.@2MB=2FAN$8
MQ"Y*8^Y&5T2%\"N$>-Z;9R,1:2_Z!4JUS1M/_1;*7%>! :BK.+\UAC-39#9!
MX"M:LYA'<+0GH+VA/9:D!FB49W8[PH%>8_<'6/L+A>+K_OR).>AC^:S9DPM0
M.*1-1UV+0=^YLAONOH1%::Y/%O'I$ .$\R%+K[)>"@JMA/DAJJ"\8//\)O)"
M5?:PX;OBK273,+Z4;6H-./[1W&S_(F#KX,\:B2)^+7"ZHU?F' R,Q6YTC>)*
M*@.:@B7 20=[Q;NJ"_M*[C345%D<[/)0D=GE26J,%C&"T/L1QB/-X!/P+FNY
M=OJE(%FJ>JK/Q52"U4G,EY)/#"0$\N1!4H,LGY8(=!V7;G-256JTU0W\F[U^
M<1[\>="&I*E<6;=D;HI<5Q-O<CCPD0%5"N;9Q +: T4QHBIFU'. )0/F@+T,
MP64 7,@I7P7LJG"-"ML#P/)&/N$K/E>3D(!)R4^2KXM]'%S!],! .W1QOT[B
M$AEG.EYBGCT$?@3)6VPK^O(WZGMCMZBWPOY085QC1<:6^9WO4V OH!YAJ#W&
M6)9,0<6Q[G4\3,OA? KNR#"Q.=%B2#%(RIMP_5\UO[W%U(M[#;9S8 X<K[<8
M)3:1T@VS.X[M7!<XQ8II7Q(Q;/)3@@93-STRDKE&G;B45)YJ&)<E8A>!;8VL
MOUMLI)U2';@:;NKU?[$X&AXM"56%8/D\,#U&CM,9="UY"3F,=VIV>0)]3N"P
M7"6SFLR$HP,?REF8Q8%FBFHT(N6 43T^WG\![?BRE/MF?-]_>KS_7'Z%MLM,
M_$L7'S4C_0Q'7D[-YST"ARL=@>C+O'RU\P?+0T3@7J=[;RT;1VTMCI+F=GNT
M)._,U4Q$.,_H7Y@&[/]$/WSAI>F\8CHP,Y[R_]FJK/-0OLZ=? V<RKI 3?W&
MK>;@"\K>:MNO:%_>&W,N.C>3,<<WZC-'>@4H:JB6,C)!/#!@0+R&+HS] _CR
MP<N?_G/;[ISSEJ:A7=<!A@,6Y..!.X]1LGD-?H7+IS/+'F8/!/A'>0AL8W.3
MM31LQ50?-$U5-BP@S:;((S*O"!L$YZVJ1._JU* EUEQBAY )ZML;[95D^BPW
MU3/;U"UO>+# NS5JT48 EH[^X[N'8[/]_M/OELL9*ETONO_\,!"]/?C-%Y>]
M=BOU_/KL+:FVZ'!?%%[XSP_O+L]^/K^Z/KL\.XVN!F_.KJ*+U]'9?WXXO_[O
MZ.KLY,/E^?7YV54O^G!U!G]Y?WEQ<G9V:GXQ>'<:G5]=?3B[C-Y_N#SY97#5
M\=TM.[+OBKP-\[&JT+SX9H3FJ%-H3L]>#SZ\N;Z*/KR_>&=V^MWYQ>4V;WBM
M:#$?O_6'_6]FZX\[M_[M^;LSHR=>GYDC?GI^=?+FXNK#Y9]WRX^_F2U_VKGE
M%]>_&!U__N[U!;"%G5^\>\QF'S[?H/A->WAYRV1853+V^^+^8G('L=K0;]6X
M5=0VS];HQ %133/# U6C)?B_1<[\OLK[M_%351+93MRRE%6)>S,'\#?BJ+?.
M'09(XRA/YB6&@_>0@LD\,<1.218:'74LKO3A;K8<A;E .SI7 +!>_L+KB4\4
M_IGN;^(4+2/7Q&7"V63&U?\D?(7]9X<1)='YTQZU:,^RV-HO'!_\+S&\?192
MNQLT3K;H(Z^M"3-1>0_\W@4_S-"_[Q_8'S' 4TWV;I"AP))6(2*(]M*"8Y%B
MUO)[4Z&LQ'IF\8)9I3TN*'F,+X(H%OY*<Z1H!UNRL*7^#K:T@RUMTB2V#;8T
MC?]!C).<APQT$$<?I*H(M6;I:J;&!>0^(J;S@6=8ID&KK3A)YTJ;.VX+5^&J
M84G2IEPNJ2J!('[PQF.+"Z>FT:C;F7%6PMLE:G#2W:,4XC!KD [:CCF8D@@0
MIW0U^;&EWI*9/BI6MU%VXFD"B6=N777"B Y.YU=;9BZNU<9K&=#B=!]9%:*W
MPY-L#A]])'SB;]").GJ->J0P'WX_V3_=[ZV/JL#S9%$5/0<-1&[EL7E//H>6
MGX<]/D(=*R&/<"<XU9GT7C2;EQ70 $L-]F J:2BQA-YG9E]_B"ND$,F%?^-)
M+WH+I4ZT7CCWTW+?SASCO#"K.A/X% F:L["L%86-;SB!9ALP:[T3<_E6!G0=
M-;>49]L+45D69O"XS@@;=3P'@C4T$Y?-@+F"**.&<I+I[]&6'5W-6?-"/#T+
MILDK9NX&[O<:^)?965CJ!T(9@UDQ)1^X9AIML-:2\N4 (,M8?8\?RS6D[2=F
MVW(Z4!YF=,$,R4C'7&G<N9BID,5[7=/90](4?>W'G:R/<DJ'.YM/9^:%T^@'
M*"9AU%V:8VF),2.8,*"D-#F"G=/IC5%;!"QZHDDIG+;;CZZX$9TCS<BC,RFL
M/A./3RLV'EF'"D1H*)4S$8.4CSMJH)F>6#2 UH,M"T)-F;O?W#,+\X0,(/=M
M\4:MY34U=NR2M84;P?SUV0$RX01$'HUEL9SF^OX(MD>_R-^J.YZ.:LND!LZ4
M-JXM,[<&!T#E2UBB_@M!1 2L%WHPA&+E$,?R.8AG_ 2W\(=4%M,NH6ZL5R;&
MAC3#/+EX=3D U/@T11XR+7*"3?JJ2]Y^&E9:_"<]RP!IF8=Z1# ,R4AN?D#7
M<&WI+7 +[)K]$#^A._X3E(\S'):MC^.#EP/Q%\Z%!/(2K'%CEY\4E/GMOWSQ
MC,![)/0V^ 8?P#_8S@@8Y)I7S4%'[*5@FS-^X4H+BR]#24"_P%:,JTU5&SF?
M"?>"WAO8WF)>8Y4X(I&X8WT=?_*(._E\MRT.3'4;+PI)]GM0%=@%@=:*D*YV
M(SRL %$:S*ZG-W %WV!G%"S/0:19GBU<OTL9&^[C0T_>-ZX"^YJ-!_S@0&;-
M^>IV(6:R5GCC*?"/X$^+68+^97/"3VCLJXUP"\4#^)<(0$V;-M,!A+7VQS7B
M0-NDK&U+6 XL(#JM4CQHY(:YJANP(VJZ@HW.0,ZF,L$&MMC"N,?0#O2V/M4R
MR([1F#>-TRPAIE/P6B9&!MAU6@[UV7L<R&>C/!/F%3IU3))$<[AE$OJUR#)[
M(%S7*]+I;@2=YA)*1@O+YLC>CC:SC3;36C26RNL4HSG+6;YDU1NKO:&TFIIQ
M+Y@JEC@V1F>5NM0<JE5@>6HLF2O*\\BQXEQ#[\S>()NYH+-;EMD(6L'7 Q7Q
M6F(E76G@.HL#;(^E@FUBEI439G?B XPE"T)(N?0TJ-I2QIN#H32_,4K8W!R3
MQ#$=8E897,PZ:'(+4%DP59J,W:(D6@?9<S*6? )R"G4MMPH;5V( T;+X^O<E
MA&-RR8V:->%7L1BB+R6DCL,YBX52J H&S^F %K;4FX5$/!'BWT6RF2? /A.7
MB_WHE^(^P9)@ZB!F%BN)RTKVC-B*O1QR4'O=,M0>MU7C?LC.2X"O^A1M$Z^=
M3LN$N*ZTDV^V2^S=X''0;;M@>Y)A^^$.9CG/1G*T5/O10%+36$O%IPQ7+^/E
M$"$3=\R^+#;"&E/+'.(1#&/)K@%:DV=92;//=AJ51OE6:D/KI21Z/=XAOKT]
M&ER643Q&.*-JZ90L7:X=?XR%JA0+HR51-&S"?+1M%OIO7,!(?8B%;\"(2EJS
M*+=>%0V1NDGJ^P1E\-[R\03R"[\G']\!KSFWD1#^6G=0+EPG#J!*R.X:NH-+
M?!]U<79OTY\/>''8#;Q8!R?X_+LO#=<P,QSNF54#+HB_5/.I.5&+G[8(P^&-
MG]W%G[[Z #\'L.,;F-D::(]6.=Q*1.RS3D3LV7_]<O[J_'HEU/,:\R4&-*LT
MH4_''K)=SJKD+_(?/XU28]7%B[^D.8X>OR0+S)H6],0=-!TRWA=K47P?_9E5
MR,N7^\>'3T&+U*7Y_Y&\F!7,/BJ8'^M1R]_,'X]>=/[Y8+_?_=4ECSW<?W'0
M_<UE3UW^MZ>'AY]]K"\.]_M'+U=Z[(^XO+3$9A-!8O[CNZ/O IC=7PYGGZ*^
M"(:^^<*=I$W\W,?CQ4.GXV"Y(C_C !_1*MF#P8NS9-X',.OO/O='MWPU3_U@
M\&DQG(-AYBWKYY8KHZS^>",+S9BC_?XF"@PHZ_9%0G7_!QM2#TC,US<WE@^0
MS8U)7<^JO_SXX_W]_;X9Y_YM<??CH!Q.@-GFQV1T&Y<_0F?R'\W3^H='1S^:
M\?:?';XX?'%P>'1P>/#LY>&/U>VTV(-0],&S@\-/R:>CH_U);4ZPA:@ 4(]<
M?33&SG,SG!F/"%-5_".%9'6*(Q(M=K1_))[M"147V-3H">$HP[S%B[V_<\+C
M;_,\8;#9T9/]%HM)'=[ KSHB,^ KB/]C/_J $A);)2]01I<\_8_ZY+<VX*U2
M\X<[-;]3\P^H^<.#(_/_+ZV:/^P?]E]^ CW?'Z?C>D+*_C7\9SM"\=4".C&L
MK.C[CU;TI\F0J\5>HK8__+-K^RW217WCH?W;_]FIHX<6J_]TP]71\@&R.JJ(
M?-*1*#)6A71)JQ8)X"S&CF0&2\B^E_$,N=XKX.,9_LE/_=:93+L![P:\&_!N
MP+L![P:\&_!&#7B+/(BC_GY_YT#\2>(9+N;\\N@ 8Q%]#CH#_+5_%"/%:/_P
MIZA_#.4^+@3-&9SW99H/TUF<J0)*KF#^D[L/VW7D#W='_D][Y \?>^1?VQXK
MNR._;4?^<+U;?JW#^34F]+^_C/[:*:6OHY0.V0[QM$\5O5?P\OZ+Z,/^U?[)
MOJVK[1\]/=BIH&U10?V#_O[YNZOMLCN^QD+]UZO+-]%Y3FSJ%C,5[7$C(O[]
M2'[O2JNP $:J+; *G[#^ ,R/S>V=8;<*[' .!;+XGCJ^I;XYD (<C9@.RSX#
MFVO@!^5]^VW@K=TQVQCI@6-V=?++[I@]M%!:N*_C3T5>3!?&J\4^7^9RN1I.
MDFF\%+*XD_J-V4R0^I/!FYW4_TZI/XDS:$^'YM6;-/\(!+J[,[ ]9^#T[/7N
M#/S.,W!*C8EV1V [C\";P:O=$?B=1^!-?)-D.^G?0NE_?WFVD_[?*?U UVNV
M=F<%;><A.-ZN [ LBOQ%5PII_9 \$BKXO?;F%CR^E-_,$J%0<]/VGJ94:2R-
M39%/#5NCU,34IH\B,KLATRRPZ<1"T"H8=Z/>N@*]/V+U\%]= ?/785GX?\O^
MUUED[155/ST.BZKA-W_\6<+Y_.^HJW(<9<>/U9LMC8<38LKC+>.]/]SO(_T6
MUB4LY\VC;Z!PS9;%_OES1T\/B&QD5,Q H/1WO$^^/'@FM$=7<7D3YTFU=_$I
M2Q;18%A35X*#0^+LJ2:QXPH: <GX2!JO8KV$]/]D_I[+Y#:%WC_,\L2$RLC1
MY8_UA1U ,IR7QK](8)V8!)U'T7]Y=*P94KL93!I"PR+RU_][4_[XU\;7_G@-
M<V3DY]^ZQ*>M?^M-//QX6Q;S?+3'XQOC_W[ZHT9[SJVB@:@R-QJ1^GF:KT$8
M'1M2"$UY42ZB&<+IRR@ND<RXG6]FC3WYZM/_/UV;]1JKA("2"5(#:TXRL(R^
M/.-.*V_'QM#P''T6&IZC@^_^^H5I>+:(<>>KCV77-6FUKDG]PS;7X8L?Q7:"
MG*OSG]\-KE?M^=D/N6Z^HE7V/N#<"VE75[(QZ(O6= '^U=$<FBK%V)L0C;0R
M4?S+W :Q('+EF\1826.Q@5"*I$\B7!1SZ'F(SXOG]:0HS>R6V#+!.G^E907V
MNM%?;",AMMK8;9&Q_['41D8M[Q^0:EZ7V^CI\_V#%ZL1^ZSSV..#_>?]U0B,
M5@PI; \9SHIN]=7@W<^#MQ<1=)L=O#_[<'U^<M6+SM^=K(*<Z#_]@J&C/^N.
M_%C]& W>G/W7X-WIV27V_1J<7 [.VK;C,ZP-:P749K,Z,N9J.HI@DC]MR*H]
M2.K4!S:U099\BI&K'QNE#<LX^4(+MBW+@K)D6[EAK("ZN35*(78+]=U??UA2
M*O)D%4UXN-.$7T03OK\<7/_RWQ^N?AE$IQ\N!^>O!J\^[%3A\C,?UY/%O)K$
MT>F\C-.;^&:^.^+&TFEK<:GT8J->9+=HGEYTZP-K-A@.H9%0ZOJ+MJC)1J)C
MN0_U0%"NM:/QI@3R-B9F=]P=L_OQIA@MS+\F]33[Z_\'4$L#!!0    ( "."
M85=L6<>?LQ$   FS   1    <V=M;RTR,#(S,#DS,"YX<V3M75MSVSBR?I]?
M@=7+V:V*8LMQG-@USA9U<[BCVQ'IR>QYF8)(2$*%%RU(VM;^^FV I"B)=TJR
M>5:>2HTE$NANX&LTNAM-ZM>_OY@&>B+,H;9UWVA]O&P@8FFV3JW%?>-1[3>_
M-O[^[9=??OU+L_E'>SI 75OS3&*YJ,,(=HF.GJF[1.Z2H!\V^TF?,)H8V)W;
MS&PVOXEN'7NU9G2Q=-'5Y=6GL%EXE]W=W)#KJZ_ZO-G2]*OF-;[^W+S]3+XV
MOWQIM<C-%WQS_57[L+C3+LEEZW;6:MY>Z7KS^LMGW)SAKZWF-9E=MVXN;ZYN
M;G5!],6Y<[0E,3&"H5G.W8MSWUBZ[NKNXN+Y^?GC\Z>/-EM<7%U>MB[^& X4
MT;01M#6H]7.G]<N,&6'[3Q?\]@P[)&SN+$Q[I[F#K04V[8^:;5[PT5[>?KH,
M&W-2-(,XM1P76]J&N.ZRIKM>$:>5W GN7_#[G-%E\[+5O&K%NN;WO&I>?FI^
M@I[8=1F=>2[I W9=,L>>X=XW/.M?'C;HG!(=%,,@'/J=!ENW7<P6Q!UADS@K
MK)'\B?GV"T(<+FJN;.8B*]9SCIV9D-AAKNC60#ZT UO#KM!8WM*!IF)PL?87
MQ' =_JW)OWU\<?3&17&NGM-<8+PJQ7F[C\\]N%)&@BT];=W>WEZ\<,5+EB!1
ME43[)O_8;%T!NB78INED<=[PK1GV.X8,T:(K)T/8[T 9$I=9FB[D]13?G4/%
MV*S9TF($/4N)(0@Y1/NXL)\N=$*++(?]YOQ#P@+ EF6[HC^_$EQ;K:@UM_T+
M<(G#>!=B.27ST)K&3'7"@A%_[C#3F&WDK*Z+%;-7A+F4.-MF7A!8,C*_;W!C
MWPQMUY\&GGT$2<(F,0:["LEO7T 78@RBD81].1A '@ PB#\W=1[XBI&R X<N
M#NP; NC_]^/7L%%V_-!%\XS_CN'K9%YV^-"%6K3"Z'EO%>XCJM\W.C9XJ0W$
MKSU.Y53G0G#TVX;$0G*1'-\NQ7\MU(S\V282O7Z]V&^[1\5SB#ZVOHG/^XH=
M= Z:9'3<TXC"_7:G,K%;<#&<NZP9'8^ZO9'2Z\('93R0NY+:Z[:E@33J])3O
MO9ZJ%)WN?$*Y6%P!  K,) G!"&FB;:(HH(I\LN<.EJ+"_X>]D:J,^^-);RJI
M,MP]!+44BKGP?2H&7T0>C?LH8O .9#3MG?%P,NU]AS;R[[W!6#D:GG'"N;!>
M5X%UAP_BC-[AC5!0U''GM^_C0;<W57K_^RBK_SP6O@F4<P'^7 7@;4;_@WQ6
M[Q!O+31)^=X?C'\<;^5N".8">E-IQ0)])!B<$8SCZ8,TDO]/;$!M29%AGL%L
M*3 GXI(TZBJ/PZ$T_2>L+/EA)/?EC@3W.IWQXTB51P\3F,R.W"L*\M'8Y:K
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MGH53/T@[WTYAA$'A*%V+%Q; <N39&[ $>8E!8@ ,%IRB)-(DHZ2>^^J;6DO
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M*HOK&0 )(222G#5*>:9TK+UP/.9NKKZ!]]&?7]],C+PLUCD3HV21,89$EHE
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M#(>L%,YKKXT SH2KW<_DNX"ZY(?6)4<]/53O\(B0;K6AW#TY]8.F .P#L\X
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MRVD9@W8U,J(,>H#)>06A=O^Z:IUVV(^6&*^NL?9NZ[W5P5RIB*!\)"+9DEO
MD,$YA=X> V5-",KSVDO?(Y"6(M /EO*NJ:6Z/1=*1@H%, >VV+NF6D!4@$-%
MYB*3'2,^!T%B2-&"P.BS_@W@#X%9BBX_6J:ZCFJ>XY2:-9QB< D$K5TF4J1
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MJ"52XV)$<W TMQU)K@S^Y3C;STK<NB18TBNY>+U\"7X"O_WT_U!+ P04
M"  C@F%7P3OV56I1   _YP, %0   '-G;6\M,C R,S Y,S!?9&5F+GAM;.R]
MV79;29(E^MY?$3?NZ_4*GX=:E=6+DJA(=DFDBF1D=MT7+!_,)72"@ H %5)^
M?9N# $> / #\ !"!6ED*<1#.=K-]W,W,;?BW__G]JO?+-QB.NH/^7WYE_T)_
M_07Z<9"Z_<]_^?6/R_?$_OH___U__(]_^W\(^=]OSC_\\FX0KZ^@/_[E[1#\
M&-(O?W;'7WX9?X%?_CX8_J/[S?_RJ>?'>3"\(N3?)__L[>#KCV'W\Y?Q+YQR
M,?NUV4^'_ZHU2&Y3)BPF3J27BC@%EAC#&&CCM;3Q__O\KY$"92XPXGA*1!KE
M2?"6$0E!,DTUURY-/K37[?_C7\L?P8_@%UQ>?S3Y\B^_?AF/O_[K;[_]^>>?
M__(]#'O_,AA^_HU3*GZ;_?:OTU___N3W_Q23WV;.N=\F/[W]U5%WWB_BQ[+?
M_O?'#Q?Q"UQYTNV/QKX?[QZ CT_CVW]X'XWZ[>:'^*NC[K^.)O_^PR#Z\41!
M+R[AEX6_4;XBLU\CY5N$<2+8OWP?I5___7_\\LN-Y/PP#@<].(?\R_2O?YR?
M/$7:[8]_2]VKWZ:_\YOO]1#QY!/&/[["7WX==:^^]F#VO2]#R O1SY9<0*D"
MY_\MG_;;VIB^()!AO Y \+O0+Q2OB''>IZ^/^?:S2(+LKWOCBHB??G95O(,K
MWZTIX"<?70'MY(/(%5P%&-:$^N!S[^&<@7R,L'SDR/<_^ZO!O\3!U6\3=&_/
M3M\=GUX<O\._7)Q].'EW='G\[N(2__QX?'IY<?;^XO+L[7_\]>S#N^/SB^/_
M_./D\K]>7L/H\]6 E)V7.D$G8%=YS+TE(7>Z_6[9CC[@E]-G%?PM+PZ^CZ&?
MX&:OFH'I#>*#7^J5G7)PJ]J>#]";?+=S/2*?O?_:N1CCL55.,$0/)_C742<(
MET1PAJ@@))&!1^+P.T1$8QT3W#J;GA)C-"-:]J,PH<;T$;\5:?\&O?%H]IV)
M_">R7XSB1L2KK^ND'_%$'L$[N/GO2?]B/(C_^#+H)3S=C__[NCO^<3[H]=X/
MAG_Z8>HH+KD &TBR/A/IHB<V&$\\UUI9)9/WHO*BEX3X4")WM#L:SF0S?:U7
M?._S<'!5E1OCP>94<D,+7-^OOPR&^'%_^96NRZ"W@ZNKP0W$BR]^"*.3T>@:
M$)8R:**Y3+2*@4B.?WC#'.%)A^2IHXG59LH"*)MG1*LJ'-27_U-:L'5I\73!
M'>6HXHXZDASSB,A*XL$!$2%2)RT%2>MOF(]1O&XRK"GUISS@57AP0\EWUT/T
M#S_!L#M(-U0]A3\G/QIU4K8Z\HPHK4"4D5IB?62$@;&:2^-YLFUPXT5D>\"7
MNMIYRB'1$H?^YGO7< ?2I)RS"88PR@214B3<\'@B:, *A*^IT&XS%'H(;"\9
MM(9NGA)(MKH)3?Y\@V)*>)1^1=]Q$C3I*)VTU480JAURGII  HU . 0K-?/"
ML+#)'6D^S+TD5S6]/:6::G.O6H"84A6\XY(8XTN,,@&^',(0(Z.B(HKH5-[@
MQG4@6G6M/>69;G5+.[[ZVAO\ )C\TJ?K8?R"\#_U?!\]4^XI9!4)>,[*4:YQ
M$]9 -*.&@G/H+,1-;FN+H>XEXZKJ[RGM3)O;VT+4'6^<3LD9X@-#00D325")
M$LZ$CQ(M2'R9-KC#+02ZEY2KJ+NGA+/K$NXH_9_KT;A$UT:7@Z.4)OKPO4^^
MFT[Z;_W7[MCW)B]->+Q#GP-*;]0=PP4,OW4CW*SV'.+@\XU6)POO4!^%UR:3
M*&E B4J-_G'4^'Y%'H7AW@=?F9MMK^EUTWBG&/&4\6Y=QI^-O\"PP!["EW*3
M]0VE&0=7\&$P&J'\H/NY__9Z.(1^_'$YQ".A-UG;G50N_?>.]M0GISC1OAC!
M1@EB:98D1L6M=R"MJQUJJP#[=?-VTWJ=$]1=.]C_W!H^W5R['O73Y+<^#4;C
M(8R[P\G5R!OHHSK'$QOF;DFG,#[+95U,V.@XS<09;M&JR6C5F!2(M\(#9*J-
MJAV[:6DI^\OA3>E_#J_7OJU8M*X_^BC27O>?D/Z*XD23Z7?42%GL6?\"(AI1
MXRZ,CH9XJ/0_W[>I;A?F$IC,J2,EUDYD8A)?V,1(-)RR&".^M'Q#Q%YW+?O)
M[(TR8 ZUU[Z 02!W[V@'SPFC P *ACLB/1HX3BA+K,L*47$JK*S,QP< 7C>)
M5I?U',VO?6VRZ&;8NRQH,(#V SIS4EB$A#B)<<YG9IT3J79DN]'-?)5+9A>4
M-Y2CT@2^:9(Q3UQ("MU52R/WR@M7VYU[Z9)YC6RC2Q]ZT)$1J!)"$Q&")E(S
M=,:CUT2)X%,2UDE6/V9W'T'%M_9>QF?KF31KB'%>1L0O-_E[_QI[ W0L__+K
M>'@-=]\<],?P?7S<FSSP+[^.X'/Y2S4FW!"K'%"#?G%]C[YW1QV5@2>># DF
M"B*Y!N(E<I\&:TQPG@.M3_9G %7DR3-9N,_P9@5%+^+,V@)O(:GF$:9WDQ.P
M$:C.H[S@2FR8"ZCF&;\HK_D9#JRON$%;4M\8)3C5H)'JB"8R(JU"?RHE37CD
M3FMM652UD^\V2(4'*>/;9\(RPFZ! ?=LJX\36[@C&64\H3>M2Z*79)FBRV$<
MX58(#E)F!2VF7GZ\E\Z^24._@G(6IU:N(-D6<FT71+NGX+B66:/92P*4FQIN
M;.%X)HE*+ZFG/N;:0=]G ;T&"M23> MO_CF,<7V0COVPW^U_'DU199E4$BP2
MX9DB,I;,A. 248;SK%-$+W9.Q<I:/)B/Y#40H(*,6\BJ/8KQ^NJZ5THI%P6N
M9CM6#M'BID6"BF@+X\E'K%*&9)H"9V@F,\%J;PI-P;T&?K2CB85)M/_VVR-9
MH:?\C[8*Q]X>7?SU_8>SOU^T4B]V]^D;*!-;L)3VJL-0I^"-5P2/@$BDBHHX
MAF:FSYX:)%M@4>]\==@IC-_ZT9=/P\&W+DKIS8\_1H"'X!FZYGZ,N^%1''>_
MW43 PV@\]''<\3EG[P%9SKS$=>/?G,87BF4.0N$/>:J][N51[D2-V#(,F1-H
M;E,Q+9BN#T/C*0KE.1K.608\/JV,Q#L+1%%F@DC2&U<[HKGE:XBV-?;L3<0R
MXF[!3GV0L5/2;?JQVX,'$"\'RTI'*:94")0PZ0R1D#7QB4;"66:)1\6TJVWE
MMK&.5\_$K2N_!?/[]\$@_=GM]8[ZB'.,QD@W].!H-,)%77WUW6%9;4<K1QFX
M0 3DTJ$$2JP [4O0BMH<I%?<5"9H$UR;)]SV&3!H67TM[)EW2,[RAT'_\P=T
M)]($X^BOT$OO!T.444<[Z1(%05PNG@LH2D(0@=C$$H",2IO:5[F-@!U(UH("
M6]C(W@$ZJ[$[R33$O_=@?)/!=70U&(Z[_[RI=,$]/WMF*:$&G6*ILB!!:[16
M?4B21F&=J)W#U 37@6/UU=="\>Y1C,,;7/= G>5WW5$<7)=+F7[Z-(2K[O75
MZ*3_#:;R[0C%>3+>$:MSJ7-AAMA,$Z$N"*ZC\8S53E1:#>F!AIM0<0M%P;?2
M^%#2PLY+K[FSC(*:[-'W5W+\O5000,=P96/$UR=26U)1F"0A*44LOETR*R]2
M=4HNB_% QG;5VD+!\#O(,!P6B11Y7?KO4US3C.E.B!8,C6@7*&>)E,4.95P1
MHUW(@@HEJK/N!4@'DE556AO%P?-+EIT,W$4$9%QVI05F)EY231"K"C0XJE7U
M,LP=*2;?.0954%$+Y;V3*ZQ3% Y*XD8RLUTR<66 .SRGF4Y$4H' N,6U&B:,
M09=8Z=HY)0O!'.A325$MU.L^3;>_%<$T=^)V_50S'EAT)'NT^J3,G#C#,@E4
MTEQB+!!K%WTU1_?JX[(M*:H%#_(ITN)P7!?AC&&([@2^D-#]5E)_488=IBQD
M$0.A40E20BC$48-"T3F"5U[15#ONNAS"7:B!J:/K%RE535%M1%CGH9WXJW<P
M.REDY@,/1&97HL#!$.=]+&Z"@*2%@K@1,CW"M5\46D<I+01-GV+\-(2OOIMF
M7L'T*)Y5PMX$?3LA4XA9<8)04RF[D@0ISDAT5"6IJ76B]IWW:DCWB%S5%;>I
MXV_R2GSR/\K[4 *^-_OLAZX/W=[$1NBX:&+.5)*,-B:B1D%98R@!2Q,%ZK0T
MM1-Q5D.Z1W2KKK@6PJ)/4<]Z YW#),WQ/M8 )75$ %$"\ A7&H]PB^]',-8#
M6.6EK7TUM R^/:)6)26U$.!\BO7MH#\1P=^[XR]OT:]&[W4X _RC0[FDW$0@
MB-OB$1\0:2FT )\]XUPERFL7-2X)<8]H54]5+80YGY'*)/A_#ZCQAFLA2)**
MH5!0,HY:(-IH13/C%F3[^]0"<'O$IAKJ:2'J.0?H++PV:<@TOK^;R@Q<@A=$
M,8W',Y1^'BG@*V!!<TIS,KQZRLT2^/:)3764U$(0M'DHK\.D]PE*$%AP51Q:
MBLZ%X(1%'S3:?896+^%OCN[5!T%;4E0+9OD"I#?Y%/,%@_Y"CDYH!%OL/HM_
M"ZQ<+<DL.?71)5$[OKX\RM=:BE%+,2T$/M'[G'7/C/]]W1W"1S_\!XR+1WK7
MTJKC'<-_*CQAEGIT0SG:=L(HDKR.7.?(0JB==] (V,[L2=4T/&A;/6UP:#B(
M &GT'J7UT8^GJ";AM!OT1_WTUO=ZH[-<LETO!]-?^G%O"2;;P"Q$8@*>U!)X
M(%XZ1Y0&JB1NZES73D>H /OU\V_#JFTA0O_D%<(UX9$^_E'Z3XX1?ZD#_CI)
M\T\QVL2#(LP+=&$U&J<^,/S2A2 09I:T=GUT<W2OGVOM**J%*'QSP72T=@@T
M2.*M14NQ^#LN&DZX,9(%ZU*LWH*N.;I73ZF6%+4YD_Y]M^_[<;Y@LG+ (N/$
M)'!XZD==DJ<324QI89AG5&VHNOH9E*_5I*^EF#8.O'MG=FFM6::&G^5[_8LZ
M4MID2\<KX2S*0T96>BUK8D!;IH-GWM 6C:VYH'9F+ZJFV6=,J?75TJ(K.+TU
MNAQ<^N\EU/_EIM?Q^\%P09ZJ166G")E S.A^N,Q(P+40R$9&[:3D4#L*NBK6
MU\^R32AQ8YO637_@/_KXC!/\1A]%52[*YR]ATD\>?ZUW758Z>:7.OI8?C#H9
M10?9 6$4$AH2B>(QKP0ZR-*'K(Q@U;NAM;J@UT_CG:'#YMR'.;+L&"ZURJ$4
MBW \$IP6)#A1PCLV@XIH -O:*8?-T;UZ%K:DJ!;<A^.<(8[/\O'W^,7W/\,Y
M;OYG_0*^_']QG+_YWLVY@'+I1CP:R@_PY7GXC7N_V<F9NY!L)L:4^3(ZES[J
M(I,4@P1E8F*AMG_1PC)^>@=DVZIM80-<"_S-2(VG-\#3C?Z^F&Y$5XK>72AO
MI#*F)-'%0&SP@:!'KSE0:[FM'8/9[ I_>H[O,"%:V*S7>W=Y2,J&E-%X*3-)
M$A7$TS)ZEAHN3&#>R9UB\WZ3<REUM9!PN1YXX6P.D24"2I1><9F2P%@@3(!-
MW#JGM-U=KJU@F<^**&?QX7ZZ-?8F1+HU*\O@O:"I(\PD3B1%V]*6-)#HK(1(
M;8Z^>M/"IN!^^C>N'36TD"PXS6F;E(JD[OBZ##.Z24%+;Z['IX/Q?\&X] KO
MZ Q>4NJ)4(P2:3B0P%V9!F5TB+:XG+6OMYMBVX(7UXYZGVS;+>BF8MBU=$GN
M7 *NNW2:0Q=S\@(=]7J#/TNTHP3MNM.4Z\<9LLY[)P0GU#F!4DF2>.E1*N",
M!@_"/;Y3?-J1>>6GOS:Z;$8-+41,'\TY@BQ="M&0,(EI^3)JCBM>"CMB<IEI
M5;W[W\[,!5OGK%E#C#LS%^PZC+JIZX<_+M ,.LN36.=DOHTNU^716\(<,TC1
MJ$D0G!'&M?:^-#2JWJAC(9@=F0>VE((?<Z6*H%NXNKL'Y]1?X5\G0Z-Q2RR]
M &_F&C1!V-)@L)?1;6E*6!UU/B9).[K8#FNH8\%EX,3$@&]+1"\P.!-PHU7,
M6=QRK:J=*; MMKPT2&Q;9%E&!;7-TZ/QY9=IRO%9SE F&D\'F#@K#,M,D.CQ
M#^F")X%12W+.5C!O,V6TD0VZ\!%;\&(K*V-079(MS&*8U0K?GVQFN&/.<T5L
MS.@1I1B(-Z4.3X+B$?]0U9.QY\!X-02H)>J%;W?-04!GY[\?G9[\_T>7)V>G
M;XXN3B[.WG\Z/[XX/KV<?.OH]-W%'Q\_'IW_U]G[BY/?3T_>G[P]PI^]?7OV
MQ^GER>GOG\X^G+P].;XX]<-2-O4-WI6A6;W1PT4T&QO4&I;UAPQM1DR51A*]
MG5R W+:<*)<BZ$E?H5U\YT.9[+E3P1'/HR6242".&Z1X,*&,,6,\5+]6>!E6
M"^'O2<+(8#B^A.'5_0[$#HP 9R7)I3^VY 9=!,Y0 $ZP$*RV2N?V8]T+T&U^
M+ZS-F0:W*C4T4_&$G)S;3Z\5S^$;]*^A9";-:XAP_'UZ[U@:!N'_TJ7_WN&*
M,BX\$.T3*[T1-/'1" ))4I5T=,RG1M92%3BOATQ;4E%M,_OI"AYT$ST:CX?=
M<#VI^KL<?/*EP+V3I38R.T>2R*4151%7CI[PD*ERQC"=\XJ4>O'AKYY =<5?
M,?B[ .]L(.DGN$WO[<9.0.YR*ED9[>6(-$X1E_!O6BH!4.:2VK@B1>8^\-73
M8GTQ5TRF:HCQ7;=W/8;44<X']%DB 499Z9/(B%,T$B^!!B^#I:K9I5'C1^X=
M'581=0OI11]@/(;AZ"R_'4+JCL^NQZ.Q[T_.NZLBEHX H;Q0F5#))TWE#"GM
M+ A7R88RJSI5K]=X"=/KX4HK6F@A,>@B?H%T7>(=BR5Q<V.B0PXY.4LTCQ+-
M;RV)-V )];+T0%$NANHWBTW!;>K2L6VVM*.-;5]0CH;CSMNR"AA^]</QCQ)4
MFX3,&?-H:ZO2^ZGD'[M$B>6,$XZ[HS3*Y88MV/ !]^B$7]U1:=&SMW8-V8Z&
M!Q4E7=.M03SG\/5Z&+_@47GT>0@31CV&. VJ-@&YS-WD"[1H#&RSUY)U=#C8
ME *VQI9LF(K,2J(1&Y'XNA +992Q9&AJ,VV<;]3*:K=9LN Z<HLD64;NM2,D
M_]$=PR>TL:\\FN'3JQ,:T<TRTI5>;QKWR3B9C),)Y.!LA.0B<XT\FCD?OCE[
MM$4=#"H*L(6;Q\7GX)L?E_@9$UH#Y4DX*PA QL-04T,<!4\\%499':6QM1,0
MFN!ZG59$:YII(?WQF?7C)TQ?ER886TIZ:H)O.VE/];7;F#YKJJ:%'*A&6+7)
MRE 12>09/3ME2JO:% AS44%T0B96VP/>'GU>R(/:#?8LHY':ML@MP-E9/</W
M$9_QI6AR>KXF*3P [KXB1U&VX$ "32@4+YWVADH0K)&!TO2)NQ1%6U59@[8E
M7?N&>"'("_@ZGL"[!S06_H?$"(4R"U0 D.!X.9\C-R8)YFRSB^!EGKHWM%A7
MXC]5@M7TDGM4I'\Q'N+R/W?C)_07^I/LPK>#'C)U,/33,? ?NK'L\/W/MU(;
M[4!F5KU%[$Y*5TN*J94+-IATSKEY_'EW](][ 6P=.8_&$6Y<)#(F30(Z@80R
MF:C-RH58/05L(9JU#;O'G_P)O2S\AO\,K -6& &,E:,"5YH]^L#4!")$$IQ%
M )5J5^\^AV<+&W0=%CRQW6H)O8UPPV-L-WXRCT[ZK!4:J$P3Z:Q#*U4:8JS,
M$?WG(.JG_<U%LK&KK VI?GGQ[NQUE:9,<<1+D*D9Y>(EL39[ C9KS02:&+I1
M%ZZ?Z+JJACI?NIM:1JQ;NVUH G*/[Z:6TN%*UPZK*&!K;#'X;F2IT9.1D1-I
MJ"%!(>P<;?3*">-=HTC1;K-DV;NI]DFRC-PW<3<5.<W<&TFHLF6?5(($HSRQ
MD!*56<LLFF7;_41W4TOIX*6[J64$6#NB\Z8[^ S]CT=W:(RE+B(DHKTLEZL2
MB"WQ)6TX,!5!1ZH;J?/)1[\Z9:XGO-KOYNG@&RZL.SKIC\;=\?481N\'0X3X
M$5(W^MXYC*"$$N_ HJ&KC"TVKV% I-"66(X,%!J40#M8.]FLKG79)[\Z(K0J
M^MHI]9/Q@7,B,;/=R.#CK:/$Y&+V:LY(H32!I'G@^#WQ.&-V 2N>?\ZKXT!%
ML;;1AO2QC_/FQQOHQR]7?GA3V9] )L\%H")EZ=UG<.="S/@WKBU+3 .OWK7K
M!4ROP!]L1?QM9!@\P3=#-WTMFN!K*[O@!6Q;RBRHJM$7Z5)!'6UD%+R$T^A
M;6",,%>ZE$6IB-5&$<-B0I-7*WAL8ORD='DIDV"K;%E&"RVPY(42U5EO$(/[
MJ@/<5$4QB7@(Q'.O"7>6H96DC8NU^Z\V K8#%Q9KZ7/0MC(V<7]Q+]]&<28<
M0^]*@ROY-KGT$^%HKX$6GANOH7Z'\\5P7K>-LI+0-V&]WDNM: )M4Y;)UM,=
M:ZGPQ0NO]>2_"5/D'D3TKSPU9=03*WW))202\%PE3'&+/W))0^M;QK93&;?
MC&7$7CL8]N"8NY^$<NN7_S[T-WU8;GWV)VN9N>Y1<J$E"B13/&[++;'S$8A3
M.6<CN$^\62);15 [8)6LJNG!#JAIH<U2,_OM_=')^=^./OQQ_/'XZ.*/<_S/
MZ>7%&HEHSW[>^CEAS>%62L]Z[[O#O_G>-93>-%,=WS2<[L+H(_C1]1#26?^\
MC-<>WC3#/AWTA[,O2T>*T8?;A([,8U+1">*M2&BR9H'J]XE T!D2,M"PV@.M
MJRZ@1ONOR83R!WVF;B&^ZXY*7@DBZNA<NC#F0""BPRD#]_C*"$%T8BI(4_J'
M5\\(:PIN\_O:]E@XKTU8?0VVX)Z]@S"^&WI_] UWB.)]E(&;B/FNY52,P^LR
M1&X,0QB-.U9$GIVVQ&= Y\3B5FV-<WAH2)F9@*0R5.;=:DCWF80;T&T+UO^-
MV.:]*I:)H$3,A'L1B*14DV H*W6@X()&X]8U:K^P!.D6@MEG7M714 M7'S5$
M=!-\84)JF=$*#I/FV" R<=$#\<E2D80.CM8^5ZN!WU1&[NX0<CMZWW;>[Y/5
MO_DQ76OYU/=#^.]KZ,<?D[@ !<C@**Z&Q]+;RS%B&8I8!":\SCR(5#LBWP#6
MMB*N6^++(M96TEL+9_$MQ'D 9ZW%&T!L*6C; -YV@K?55;N(.I7ULB4*:4@\
M<J>(Y5J5MTB18&,D%B)Z1X(R [6+6;9&G1>"N[O G&74L2'&C&[WXFF$$+T0
M'Z5$/SD;0:2:S!X(FCBE*!62L\#D!BCS&-<6W8):"FU F+6TT4(0X]Y+<_O7
MOW9A6!(U?WR ;]";O#?1.0HL,Y*#+?T-\<2VG'J2N)<IXT$>?&O;S+/(#G90
M9>VUZ5O>?P^>XIV^<4W ;M H6@ATZ^91-8TWV;:JJFM3)]]"T-3+++CQ1&2G
MB92(/,2H"07.K6(QNE0[S7<'N-7<?MH-:BVCI38I==+_>CT>323 IJ<V%[A,
M)1UA63F$9B1QX#6Q63)C&*<TZ+8(]!3.;IA.E12YB#)K:J%-V^D>-#Z%)KPT
M/$D\QKTJ36@$)2X%]#9L8CHKS32OG?+[#)Q](\@J6MC0#C+K4F0A"^L$8I$F
M$!D90BN%<EEZP"^T\JQV-M8S</:-(*MHH0W+^&:JN>^5DKGA]60.>3ECI:5:
M4$I)9+R,MTZ9^-(M*XIH$C4^"U]]]Y@/9<_]JPKZ:2$1>#*D,L-P,C\-AM^Z
M$9=\EN>@'97TM-'\'TU?K29K:<G?JKF.+;EC-0@RV#'MMG 25EU3T%D*&H%8
M7]I*,5N"N)P2<$ZD%*+SL7:.V^XS]27G;M>)NHQ26R#HQT$??MQ,:WY_W4^S
M>F46!!H8U!(#)8T' B4V.$6BBV@Z1"NB:]0':@FJS4>R>0-M>]H=5%=-"\[?
M'Q>_#[[!L%]6>?%UT!\-T" YGM32#[LC&#W,()MB]MIS V7NDPBR#(X/!*W7
M1)+V01I/6;:UZ;0*SCTF6^MJ;:7HY^H*+6N4Q2?_];9XD<60A!&.*"'5S=QR
M*\N@4V,%32 IH_7+?>8 V6,RK:^85IH<#+^6^A*82^4$"C(/L;A'GLAL#'&!
M1?2VI6:2Q11H[4319P'M-7MJ*:H%%W3BEK_Q\1^0GD#+D:;HRC1,718M0*+'
MG11Q,@>3\6@&5]L^?P;.'C.HEI*>\F?MD:5_7%P.)U&<'T^0<1,U2.&)8;H8
M=@Z9[5@@AD*Y8+(LA=H'UV(T>\R>2BIZ2IZU)YF^A>&XF[OX:V7Y[^#K8-0=
MSWJ*A<S!<;3 N$]EJGLF3@M+G $NN*&X^NH=G!;#V6/ZU%+24_[HM6JBYUKX
M1Y]+SM>;03_-)J5)A8O3C)@ @<C@\*"EKLQWC=$Q%FQ\W !Z0;5SH\?M(4U:
MTL53MICZ)<UOCR[^>OR??YS\[>A#J0X^.GWW\>C\/XXOC]Y\.+XX?HO__O+D
M^.+B^NK*#W\,\J-21M]/MP5E^::@[&Z#7:,P>@.HUB^OWK3H*A5IWTWA>UP+
M>/?\#[<%.<D%E8W0)"6-A%4N$>\\;F]@!7#-A3>UK^^6 EBGSO HC":-DSH\
MXI'O(9'L2O,#3WDI7;,D"0$^.X$;?>UDF(<(-K]]ML>'^16#*\FZC994<XNS
MC\9O_7#X T^0R95M)QD+X !(4HR6_DL&SP./UF+.-'(A30S5@PA-@&V>)^MH
MKU%=_#JBK]UM9@'"&*^OKGMH!J;?AX/1Z(\^>A6][C_Q2Y3@F[*/PZ7_WN')
M*CS*);$ZHT\1 643HB91":,XFHN!-[.XUH+Q4U)DP]*OW8IY6>0?\*L[Y)!D
M@B@C 9I+20\(XK5-1&7+8HPF4M&L?_=:,/:'-ZM+OXV6>(V;A3">-1/H-20:
M$*C6BG@E@90F(M%1:H6N'A?8W78OK9]+ZZJ@A9#C\ST]CJX&PW'A]]O!:+RH
MP<=1QO\>]7J#/]$5+O_R+?JKW7%Y)3HJV2"ILT088X@TQI$@!'[)N,^0.0-3
MNTZ\W17]U*S<(66W$ !]O)Y'JVUXYB<%5-F<"<NTS-!UCCC#'.$00]!!@E.U
M.Q%5 ?Y3$W/SJJL80%UW$0]M!ZNLH]I0PBVZ*5(;3:Q$+UE!@H!># -5.QNF
M"O"]Y-_JJEL8DMUXZS4A*<U<E1L'$<L\:"">A4!$=)Y2[X!1M]$C>G=:KVWL
MZ*VBG*>4LFM[H/>=GWMAYB=AO0>V0X=YT&B_6J)CZ1HLA"(NE0GG3O,4H\O&
MY,;>YTH07F/P<X-*:2,(UA3U\Q&9J*A4WA&9(BY"&4$LCX'$F)UCW (\SL2J
MP*S=,KMVD&C55-9&$&W%13PZVLM^&Q4GN70ED3GS,K3;$=R=&14\,BY8V[S;
MLKFU^[Q;7645@W!++Z(C:1!>"$062QFG#QZE%!%W0 \:'1HT-.ISZ\"?946_
M\>#;3:6FTA;_CW-B-**3$BU/2SDZM3:;+%.B#C9KGF^T)^CFKI1KZV)GNGDN
MJ'%3F0G%F";<&_0L;/*X/5H@>#Z#D8FEQ&I?1^]8-75UC3>LDUY&\KM>==ID
M+8<ZZ04$K$*0-LM/5]'NKC,6;;]@DZ#$^I!P3?ANV^PIH5*$H'Q0.M4^3W>?
MJ2O62>\,49=1ZN;JI&T *ZG5:%V"(9*#),'X3)1V@4/B68O:_2%?99WT4MIM
M5B>]C&I:RAB\YZ3,NIX*"" ")RZ5MJK2>>(!'(F,@48/)<7J[;'F MECNJRO
MF!:VEY7*KP.%)"Q#UY9+BU) AGMI,DF&I1B-CYJFRF3:PZKZ=;C6NEI;J9.>
M6[RM\;QG+A*1LB#2&U4&1"8B*$"(QO+(:^=,O,:J^K4VKK45TT8BXK/%VEI;
MIAQ7Q'B.X(2/Q$F=28[1R42%$ZJV>?2:J^K78T\M1;40)7VN8)MQ(6A0E B#
MQIQD2A-GE2(\@XT1+3S!11M5-J^RJGX=!M524@MY@<^4;(-W#+@O>;>.$AE"
M)D'F3+31P@:C@Q:U@Z"OMJI^/5.HBHI:2.I[KF [>AYTE)(P0#9+*QCQ609"
M&223> K4AMH'V*NMJE_K^*JDI(I)>4M4<D?EK#8FD%"&9$K# O%L4C+B%%KY
M6F3=[/YW'ZKJ5Z%)2[I8F&]7LZK^X]'_.CM_B_OCV<?C\XM/1^>7I_C?OYY\
M*E7B%Y?G1Y?'OY^\/?KPX>3H].WQQ:?<_2<,3_IQC9+Y=1^Y?CU\U457*G8_
MAQ&@KDM5S[O2+'OP=1(&'R*Y/T]N;-\.^I,TT<O!)QCFP?#J_6!X-OZ"O+^[
MH/8*-' \QUS ?4@*=.&=-(XP2Y/2S!E3O4EK#=QK;8)'GX<P>= E#*_PQ2YL
M*'_MQ*2]B+AZG43I02T-\8 >*EJ$*C/&E7S<SWO!OK?H"9O?ZC9.D@=;7!5)
MMQ#M7D,J;P=77Z$_FBSEV _[D#I9F "1!I)R-J68&S?K9#QAGF6N?,F6KGV!
M5W4!>\3*[1.@>B+S]6@\N(+A#/"L__Z/C]T>X(_Z\,G_*"LZ[G4_=T,/+@?G
M$*'[#3H^Z:QXR@1\F;(HJ2,NRTB"I8(QEB4^JEF:W\H8]HAZF]16[:SEH\^X
MD7]&9^8HI8E^?.\<A=>_1K,Q#C[?Z.QV"1]A_&60IK_P="&9"@TI*6)BC"4$
MK(F/7!)ELW0I9DA"-CQEZZ':-R)N3:/5$YL'/?Q6"14CDGO2.[TNXC_+MVL8
M'<4O75Q!Z@3O:"RI(2@A%!J%0*P.KOCCADDEDA4-6Y@L_>Q]HUG+VJD8VY_
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M0$**@6C MUL$"3;73N6:CV3S[D];W'B2];*^Y%L(Y9]]G91?XM(!W?-'V'(
M$SQ8PF\Z@"E&0NG>Z&T,QM%@<O7).L_A>;W<J*:%%BRA.S1G>8X<T-U#.73
M*XD>':(2QI?$+4=L^9M'=UWFJ!CX1I>Z2^^:+P![O9RIKY<6[GWN@SSIC]%Z
MZ(8>W* \Z4_5 ;T"_?A[[%TG? =F&V5'XHZ88\"]4!170I8RV( ^!N!6*;/@
MAE9O^;<.WOV@6JM:K-V!ZSAGB"6U]*2/%BM<^N_G?@REK*,?N[WNM"-*<6SP
M+R?]=Y!AB/+$WYN51'9A-&U,P 5P! PD25TJB"B^25$G$J*Q%%3T-C2K JL(
MZO51;JMJ:V%TX5TD]67)W01,;4@R4#!$Q2!15L$26[KRI)S0P78.Q=C>C+F&
M(#>5&;RI#:Y=+6T[S_=>ET2T,\<_/O5\?XRK*5U^)N'\-S_*_>\DD,=L\"9F
M110NC$@>. DH/<*5E59$JEBJ/9BE :SMWX.TPHNG72RKZJ<%9V AQ )P&A!L
M K&EW)T&\+:3KU-=M4VILZ9>MD2A"#0EB(8( XI(\)GX("VAH"E3GHK :P<>
MMD:=%S)S=H$YRZBCC;N8$A3Y,N@EW(2'@V\WF0JSZ6;"B\0X$*VM*-X%0E,9
M_5L0UJ,DLO.B,E.>@;-Y>[RZ^A[?T%22?0NAR](]#LVFJ1,P*T&=94@S:A2C
MN?3:1:\S246<T)SHS"2"PW/9U2Z\>P[/ZR-&->G73N:;RU@4P/. I<F@*">4
ME?Q&2BE*@F>B+/J'GH?(XR.G:X%SO\K37P\Y-J. BG'*">#WUT,4^/40WG>_
ME_\4L!]F+>1_X!<???\Z^X@_Z_8_W\IJBCQJ8<%R@T:@*8>O<<3YI(E.H"*7
M*4EG&E%G+1BOC$.;4\G"D&/-](&+R[.W__'FZ.+XW=NSCY^.3R^.+D_.3B>9
ML6_P9<%7XZJ4OD\"6],J^#7R!-9XVOH) ;666NGF_Q@%-O@!,,TOF0RM>8+C
MJ#?YH$D7J6G/GW]"^@3#[@!_;S2^5V9ND,TQ@2 Q!]RG@*.Y(Z(DQILDO)>,
MQ]J==BHO8>V*BYLG09H/9-;$@8(+VB8@W"D@,@=)[*1/O??X!I;1PZEV-5@S
M9)O?*;?)P2=E&?6UU\84L-NX6QW9W<3F=!) E6/$.30OI(- O/&2T* "G@Q:
M!:A]1]W*0C85?=\EWFZ?$;L2Q;^Y$[L8XTM\DR)RL\Y)((B#, JB)6CFE-M^
M_"/8Y(F+:(=)X;00C4H5EKDQ7PQG^U'[K7'E\05Z)9VUD=XS']K4@&\"KJ58
M_K/ MA/%KZ;&9O180P<;)PH3+FI#R["&,MXY3V;TX58/Z-@G0967LG;$?@L$
M>2%6OQU^+"/Z%G@QOT)L:DA.'7+-4O!1:B)TF2^40B:AB"'J8%UDRM#' WQ:
MFIO\ -86LF?J*?))'^ZZ6FC!J'^A[=_L4L%8"$$ZPABZ'U*G3%Q(D63%$;9C
MPN0-=VA\?62IKXF%^TKU*-I?SSZ\.SZ_./[//TXN_VO=(-G<#ZL4 WL9:*40
MUP*K]JY$]\V/NU_YY'],"GC_],-[N5-,YI1=MF7T&R>2:TIL0LUSSQ+SELO,
M:T>UUD>]?LN'LYRAQ(\G=Q'^ZJ/_WKVZOKII'<^,"9"T)IYE%(GV$=^OK$FF
M"9BGU$O7<&3A"T_:_,:R8<(\[0912^ZU.T+<&YV(F^^PW&-=#HX^?Q["Y\F@
MIAGJ,J,I!A>M=8I8)P*15$L2C!3H$VJ=0](YV68WADL\=,^HTI(V6K"!;T!.
MQB6^F]Q(W40/)J(9G<*?DQ^-.A&BSDYS8J5! \RA*68I!)(28UQ[\!RJ=P-N
MA&QOB-6BPEJHGKGW!C08XLK1L^31HE&/="?26$.\2X;H<A4:J*3Y\>CF]=FU
M#,#](UEKZJM8)_,T:/JBU$:+Q'83**6:Y:"=) )*GTLF<5>FMEP@V:B]M4'K
MVBGDU<!OZFIEV\S<BK*W?8.RL/>NRD 9Q5</+3/<YA7ZTM8[2K342M$HBH2;
M,/:G['>^40:\U.Y\&4ULK8%U$Y![W.Y\*1VNU,EZ%05LKSE^-IP+]& M "52
M*G1H)4M$, D\*#0Q6:/C<+=9LFR[\_9)LHS<:^<@_R^8>*<P^O#A[32:ZJ0O
M91B..%$&\P:!3H4.C%!<J($HJ!3-TD2??O:N-CQ?2@.#>N)K(R'I.J#]WO7#
M'_>,^@F1)7@)$HTOY@LP9@Q!VRL2[K33S"I/7>V4BX5@]M.8J*NC=MWX\G8\
M&/@^?56:(&PIS^)E=-M)MJBDSL4^>4U=M!%3?!FIS<J:S"PQL;PM!@3Q&?=(
M!4%*HYB64'WOV1);7LB\V!I9EE%!;2OC:'SY!3[ZX3]@/(N&/^ZES!)8'6T@
M4=*RGWI!@L)-5<>0\2MPXG$Y_P*KX^5G;2&\5UD]@_9DNY$FE>?'%Y?G?[R]
MQ%\\_?WM7X_.?S^^."V]O,O=_AI7Y8T^=_U;\^7A5[I /X>;NK3)14#)^#SJ
MIY)/,_P&=^$V'SR$@/RA OF#[@F:M<$ X2"YY#EID+7WVB:X*F1OW3UC\OF]
M4AU0GG9Z76A^EC\-1A-ECHY[W:MNO_RX8Y3244M/A&"92"\3"6E2'Y"4R((&
MGEN51F.D6QFO6I=-<U*]VE99"Q[4:JAOKN6F<]D[S#EKN-8HL#(M0B=/ J5E
MQF<P+$6K'*O=&JD"[ ,%UU9F.VFK]V2$+NEG&'6HTIYZA6^&*,U8#5CBHT+!
M<&'!^1BXJ=UQ<!Z.U\Z85<3=AE]^?\K%(C[/JC\HE)(/3R2WZ$9P)8C5^(>0
M,:<,F8?<WJ7FB_ V.*FY79JTI9)=N'J\[(XGG<3ZJ?NMFZY];^*?AB@YAV!)
MM%"&G2/]0YFFDR)5P1L1J&J4M?'"]<#<AV\_7EA9RX.:TJY\8_0$T-^[XR^3
M]993\DOWZ^7@N#_NCG],7=<F4"O>,BX);_-WC144^AP]6M#&E@DDLI8YHVWE
M\)PM<[H2<<ER0KV@21H?@FQ4@?\S$.>9Z\?M\F89)=2.#[Z_[O4N44:S*MA9
MKYWHH@1J.!%4HN4-91H7CY%DP4/B4E A::.@X((';/8^LE6-#"J+L_X,PYOI
M:Y >H[)@L\FJS.%)I3D;^OR!H96=;%;"1X<+;7;?O/ 1KU3-=42ZN0+<R7;F
MT%W2FB,T#KA:JPT)V@@28@[1).I U79/=KKPOQV[LK8FVABX\&S18!-PAW+^
MI=6X5+GV*CK8>#F_5P$<:$XX'@<(TB@2+,32U=I:$:+SO/H0K)^JG+\]?BPC
M^BV5\]-<1OM161+.,T*TH=RJ)A)X2C)%)K.O72[Z$Y;S+Z7(%<KYE]'"ULKY
MM68T6,$)I&31#$-S";\L8ZPB95X"GK6T,E5^RG+^=<A27Q-MW[>4GJ&3;51(
M$QCNHR2XC,N.%.UUG@-:Z58%!T)04[M+X%P@K]UB75_Z+92</0$U<]T:P&K)
M2ET :3OV:06EO42#-22^B3UB5N\!VD>.1YODQ?'VR1-KI2616N=<S#KRVDW^
M-TJ$%^S0S?%@&4%7SV;\.NSVBAZ>@)L>8+C-L4AY*+WWH!0\6N*-@%(1("3B
MXY ?69V+<AE?>-*6K]]7U<>@+6%N)'GQXH\WI5?.\>GE\=_PCW7F9"_ZJ J-
M?9J K-76YSJ,X+^OB]G_K=B+M_?K23@C%*?$4AF)#$H1ZZ4G.3I->40%TMHV
MTR(L6\H^5#ZQK$TD#FU9(DL#+&1Q(M%2I9D+T<;0YGFPP]F'55A3*>-P&37M
M:,:AS3DEAONBH &7$(I;EB,GPFB1@W%6L-K=Z'[*C,,=HMWJ"FS;HGVXA.*=
MQ^G?62=F(Y*@C$0N36E[Q="Y2YPP$"QJB98=JQUP;8KM];-I=574'D5S_!WB
M=8G=7, W&/I^A&*SW7[Q!OHH_O'HP_75UXOKJVG]Y WC.][D#":A=6@4*R9=
M&86*VZWC5OOLA7:&-;*/UP#QDW-EHSJH&%%9!O<E#"<[)6IE"AH2\]QDW!D#
MXT0J$4G@,A&:J;2EYM:;9D5BJR+8(]:L)_VGE%E_0/5#2=R$&AF7'E+P) G(
M-PV&7$2AL$!#H,(KV:QGQ>HNQF:[,;5QWJPMV&WG+"]:R&SJ*,^!Y2 !=SA1
M^@.7^L>D.4G4:$V!:>>JCU.9#V5KT?NU5?P"9U81=1NEZ$]AS683- #65M^"
M1:"VUZY@;=6]3(<UY+Y18E#@(#PB$AG_D#X8XF2@Q!L6A HV0_6._QLF1(..
M!)OCPS+B;I\'TQBS88X;#9R L+8,$<-%6R;1-K:0+*"=+&M?V\P%LG7S<E5%
M/:_^%:3<=I3M]G(J&,ZBE8&46VDB(_/$:URK-<J(G*.4J=5PQM;O]6M;!NN+
MN85DTT775DU@[>\%_E)*:WAQNXK$-WB!#U1(!F!)=@']*.5QPV/@2%;1*::X
MMRG^S$18Z0*_#1XL(^C:%_BG9=8WGDC/73MKG53,EI,<3)F"90-Q)>QA6'(1
MUYWY8R(L"#4U>-CN7.,OI95!BR*M67Y46D&6KGXWZ=!),98,(Y*%DDY0,J&3
MLL1338-.:-6:1FF>+S4YG3WPIS_75Q=?S;#Q#,2LR68#&#4;&]\]>O/EQ"L*
M_['ZUI!<[8[$]^ PX:0)4A+-I4)&TD2L!DURPNV :QW-XPK/W53@,V6]=?6W
MC, JZ^TC2NKJ^FJ6U*\,_D^6H4<1@5A'B4,SH>SK C>3'$5LU('F!<T]>.B&
M^P>O*O9!#9E5/@&GHZNF0(26[/]6=RTY"(0P=.]=2/B$,FQ,/(%G*+^59HPF
MGM\RHAD3C?-CC!L6;'AYKS.TA1;(?0 ;;\@2 _EV3G"R1*F,H'G#Y2+B]1?]
M0_$F<U8A8LF.U+,IN>&-C1')$]#=VV.*-G*PB?D4'$@E4"S>Y*>__M\[-;-)
MK7"^^<!27/$A:"JE)EZ1_"8C,5V9#Q+/H+7BUUQ0)6VLT$&S2'\1LN%$<9<"
MR#3QZ&VPZ):N4UQ#Y"_9AEH:CV%S^>* T[F]XF&?=L?N<O6]\5@NI@OO;UZ4
M[45K)R@&]DPB-/G-8\,L1XJ. ^<H "#980F'J0C6ST+,D:U=F_.QM05E.@\.
M+W&[N0%02P,$%     @ (X)A5XE-3<S_NP  K: ' !4   !S9VUO+3(P,C,P
M.3,P7VQA8BYX;6SDO>MRY#AV+OK?3X'3CK"[(X1N7D""''N\0Z52]6B[JB1+
M*MNS.TYDX"IQ=RHI,U/JTCS] 7C)>S(!)DAQXCC&U2H5":SU@?BP *S+O_ZO
M[T]3\"J*>9;/_OR#_[/W Q SEO-L]O#G'[[=?X+)#__KW_[A'_[U_X'POS_<
M?@8?<_;R)&8+<%$(LA <_)$M'L'B48#_RHO?LU<";J9D(?/B"<)_*U^[R)_?
MBNSA<0$"+PB;QYI_+?X4QP(%"9?09SR B* (II%((,:^+V),8I2PLX<_,4]X
M?DI]F :<0X0C BE)?(@$17[LQ4&<\K+1:3;[_4_Z#TKF BCU9O/RKW_^X7&Q
M>/[3+[_\\<<?/W^GQ?3GO'CX)?"\\)?FZ1_JQ[_O//]'6#[MIVGZ2_FORT?G
MV;X'5;/^+__]Y?,=>Q1/!&:S^8+,F.Y@GOUI7O[R<\[(HD3]J%S@X!/Z;[!Y
M#.I?03^ H?_S]SG_X=_^ 8 *CB*?BELA@?[OM]NK@UVFO^@G?IF)!SVV-Z+(
M<GZW(,7B,Z%BJJ0O6UN\/8L__S#/GIZGHOG=8R'D_F:G1;'1JI8RU5+ZL9;R
M'P]U]LL)XCN2=[$KJP/A2G6_NI*Q#=.OSL2]5PPA^A=XK9N31:X^J,L9'^K;
M779ULNC]2^SJL\@79#K 9['J9DWDJ?[%9_53W8UNJ(5,RWYJZEX357Q?B!D7
M%5MN- TR_N<?U$^3ESE\(.1Y<E/D3 @^_U3D3Q?Y5/U37I!%7LPG$<,(TY#
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M;K/Y[S>BT+\@#\*?<,$$\?3VRZ,(HC!*8!HQ3_T1X$!MS?R$!3:SOZVSL7'
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M=@)J:\SP:3T,%U[L!(F-2&0W+9Y05?4#8;\+OG/#FJ(4X3 14'K::SDE')(
M"QCC). I1SSUC-(M&/0UM@6K%!724M;.]]=MV)K9^8X0ZWDMJ<"JQ.SWYMH
M#Y?U6@_T-'SUUG:5]]9R/?)*!^/8J*9.'6!QGW]1_RDR,KW-'AX7\_,G[6X]
M25BD,) 8IB(*(8IC'U*=+I(('(<>%IXD1C&HCN09&^L<*UL&2"GV&2CJ&*9%
M#IYJO4!1*F9AD#D83P.#>=A1ZIGI+.J3-6%F]SEHE *55F>@TFO8H;(PH(<=
MLH&LZ&&&SLZH=@=TJV7MH)OAS&MWF&S8V Z;[;YT?E*J[B^C,_^U(-4-PN>,
M:7_6V<-.U$&3!(TE8>)3#$,J8K6&^B%,O22!Q-<.IC1)@S2R74-="#:VQ?3B
M9;[(GT0!V$8\3:$$MF=>)R-GOEH./1[#+)M JP4.%!%3W%JI5IUM-,J!W6BH
M+H=/+H?1?B4=>CB'75(=#:O;-=4EY":+JY/^!E]E7:*T;[EUVG[7@@7;Q6.^
MY@OQ,9NS:3Y_*<2]^+[XH'#Y?8*U,V*B0W(]S"'",84I9QQBE,0APQA'GE$&
M8>N>Q[9RWMU?7_S[7ZX_?[R\O?MG</D?WZ[N_VI;Z< 4=+-SL%Z@['G1:^I+
M:=E *9S3"@F6@#@KGF#:[\!U%2SAV"VY8-M -S;Z*A8ZZ]M-D;]F7/ /;]J[
M\&I6YQN</9RS1?9:!1MPXB>2<P9Y(#V(1( 5'24Q%'[B1>IO3-G[DT6^(%,S
M.C+OVHJ/E@+T-Y.4Y%6RSI=YE2TI;V0&9"FT'4%9C(,90_6#;L\4I8$M\V V
M8NOBV#]^JU#^"2R%!^?'8;:F,'O$''&81<>#DI@](-LLUJ&%;C2F>F!"\+FV
M[Z[F\Y?R&$5J5\A\5E+I1(:,1BA4[,5QF:H]A@E-"?1D$$CD<8P"J[O#HSV.
MS8AJ! 9ZH %9P,6C@$^D^%UH9S>=>7KV\ O(:E6T_QLKE0%SK8T=FQT?#C,2
M<PIRS]RUB>_5&HZ5O%6U3W=T98R-(Y8ZWM^@Y&2L_C8GF;_8C8KNU6O7\KPH
M=!9>O;,\_Y[-)[['$2))!$,<,XBX^HD(M9=#H1^$.$P#S^R0M+67L5'.VD[[
M58 U84OGNO6_5T&=BT<R YLO_:;UL@PEVS\"9HQS,JX]LTS_D%H342MDCLAG
M?Q^#$DZKFMLDT_YPY^C\*J_NOF,+P6@<Z7A5&2/MR)"&,/7]! I)_%A*SBC%
MEM'X!SL;&\U<?;VX_G()[L__^_+..MC^,*1FA.$*J)YY8RUG]DK0GLZ"3"!Q
M%RM_N*NA8^./*KTG%O[X.ZY2>>A(,%WK[K^RQ6-S%=G$VK]-N!_2. T"B(FO
M^"/U!*1Q+"%-N9>(%"&!K2+?+?L?&Z4L<\UWRPUIB[XQU?2%:?_LLR^51R,^
M^$/)#QH%SI89/=[ZS.=AA%UO*3W:>W_GK!Y&T!Q/[&'63'?OE29A=KL/S7P2
M^3CE.J&'WF3I9-<4)EQR&/,TD3%)4AJ:AT'9]3TV7EMEER^.N'9V<-PT'8]V
MMNL9Y9Z9;NG55R-]+8_Z]_6(M+UG2 ^(#^U/Z0+Y3BX>EMB9>'&8-CFXHX:E
MKOM\,6R;.*%NS'JYJZTB5ZO$4Y. ,$(\M6GV0^E#)*1:)SRJPV5)@&C$" JL
MSNC,NQ[=,K&6R>ZD^H,6Z)O9P/U@VONBL%GEK\R1LE/N;R6ZXRHO5G"YK.QB
MUO'PU5RL -E;P<6NA:[U\YX+P;*2!=7/4U'ZJ\WX^5->++*_56LZ375$/\<P
MCBC11?0(I(&N-T^3(,:*Q]+$LRNB=[S3L;'5NLSEW")KPMK6U#/ W(RI7"/9
M,T>MBWL&E@)7UPHF>':HL&<.D+,R>P9=#EQKSQR$W8)[%N\ZJB#S.9N)JX5X
M4KMJX6$>L!A270X:!2F!*?,1Q!Z/0ZGVU#R4)]6/678U-K[9%P&@A06EM):7
ME2T(F_&,&]QZO[;L!MGI-61VT.BK@LRJH_>M'[.C\-'J,;MO=".+SV(^%^*S
M/OR;W^33C+VM+M-H2AG#)(1)JMVO, L@H81 S#CU&2-)0*S<KUKZ&AM=5$+:
ML4(;E&:TX B@GGFADO(,5'*"WRI)02_7D@:(..*&MIX&)0<#E;?9P>25CO2P
M2NQ=E[<[I_/R@F"28IQ$J4 P0EX 410J6X*(!"(_]3E!$0N9'3L<[&ILY'"Q
M6R_@3Y94<1A60Z9P E;?1+%>Z+L![;=&4)<L<10-5R1QN*-A.>*HPCL4<?R-
M#I=Z=Q\^9:_B_H]<_T?M8DK_M9LBYR]LT20I$HA2+@(*61K%BB<\ DF8(A@S
MQ1)JXR'"V"@BSK3#L;'%'?@ M+1 25W]H(-8*T^_1G*+VR03R TNZQP#V3.3
MF&#8):+;!$R+^SC'H YT"7?2!VIWZ68!4.M-FTD[PUVO66BU<:=F\YXKC[++
MI^=I_B9$G:5DHSA40"/AA1%,(P_IPV@!4TQ2[5U&L"]D&"5VV;XM.A\;:9\S
M5KSHV[/\Z5G,YJMC:E&K *B8"9F94G>G 3$S!?N"N6=*/^!>ULB^S)\T4*6H
MXYCUYE;6TO4[^Y0=!^6X0YE!&UUS,JCVJNS>G[(9F;&,3&_R>58>J#>[*65S
M>A3Y%"9QY*FM:9C"U&<)#$B8)%X<>YQ3NW0,QSL=&Y<M9=8N9$NI02.VR8ZL
M^P"8<9AK6/LV1T]'M$.R!G.(G.5I,.ARX!0-YB#L9F>P>-=5FIA)2!GB841@
MZ&$)48P(3$CLP21(U-XW# /J$YL$#+M=6-'- (D6[G4?50!R+><__6,2^/A?
M@"CE/34)S(3&.&0!HS 0(5&0"@RIAR)(0Q+CU$<2163R+(HLYVK,B\40P&YW
MUQ^\'\1#-BO](RF9:K>[D_'DGA0R%@1BG*@U,DZDLOL##I%,<!30@$><U7A>
MECG%!T*SZ:P_+%4/+H$T7>M.@:;GE:T2Z R<+Q9%1E\6NF2=3A!\0]SZN!T&
MH;<<0^^=3.CPNG3PR:YY->I J++E_R33%S%)$LQI$@F($$[U'%=[^T D,)8R
MC6B:! 19V<%[^AB;V;L4L5LRC%T,S:;WB<CT/+]7H)3BG8%2P+,R]45+B;(.
MB2X.HN LM<5N#P,GLSBHXF[ZBL./=K0T7^A<F5.*DR]?U1\Z=/UCKEWR)XD?
M^C@(E4U$6:"F>^!#$K$(<E_&$::!6NFM3O$.]C2V^;X2%)22 BTJ^*T2UG9K
M>Q!>PS7>!6A];V*[X66_U!_#PM6*?["?81?^8^KNK/]'7^A>*E@4Y2Z7*(.Z
MOLW",4\BJ?:C:824(9 P;>S[ZB=)N)0DI"+DMD6"=WH9&S6LA 3/6LK.Q7CV
M8VK&"2<CU3,?K(%4"MA#Y9U6"!R6 =[M8_ "P ?5W%?Z]_##W:;^)Y(5I951
M%;LL\R,OC]V_"**35O#KV:V>!3J%G'K@:SXKFK]^(/-L7E8KG^ TY@$3 10X
MP!#Y7@A3&ODP]07'$<,I]JSHPIED8Z,8K5AE3(-:C3IQ^5*5\OIP71GP6ZF)
MI6GB;FS-:.M=1JQGJEL-UDGC8\U_SK%TQ)GNY!J49YW#N<W-[COHQN=-5>)5
M1>//^7P^(5',HS ,(95(EV<7"4P)9U"D(4W"6# ND0TY[^]F;$S;2 FRI9AV
M#'H 33,Z/!VCGKFM$? ,K!5&US*ZH[%V#!QQTH%.!B68=D6WV>+(TUT=\'5A
M"^T==B>*5_67>L\1IR0B'(=0)*GVJDW5W$>1+.\5F0C#. FLCGD.]#.VR5^+
M6:[5M:"VGO?[\10QQ51G4/-X6;=#>)"$40JY%ZK?!!&+")F\BH+F R*ZWM_?
M(:9FC.H IYXI=0] /6R.C^#@+()A?R\#AR^TJKH;N]#^>#=FO22%OD:?WXCB
M[I$4XF,V?5D(/O']E*) 'XDE7&=]I@*25 H8^_KXG&,L(FS'! =Z&A\3U(*!
MF5B J5J[0'E6ID4&/V8SP'5*XF+MMS_9\<0AQ,UXP@&*/?-$(Z'.7 5*&<]
M+:4[FC@"@R.:.-3+H#1Q1-5MFCCV>$<7^J4U=RT_Y[.'S]FKX-5^\"]BRC_E
MQ;>YF""41!@C"F/)%&D$H8"I'ROS 3&$8NQQR8QJ4EOU.C;C;&W#D4M%(+,'
M.-5R U(*;NDI;X2[&74X1[-G(EG)>P:TO+ 4&)02GP$M,I1Y 970#EWB;3!R
MY0MOU.>P3O V,.QXOUN]W/'FGST*_C(5U[(DN0]D+OC%6I3*6O[Z^8>WU3,W
MY*W,:?\'*7AU_JNVBSZ*)88QC9%.'RTA#9" -"%10JE,<2BL/ 5<238V7FL4
MTZQ6B@VIEANL*[=>QF&N*V"M/UAK"$H5NQW[NQMV,\I\E\'LF59WQ_&#Z3A^
MZ#".]IX2KC%WY5GA3*YA/3%<P[GCN>&\@PXA^-_N?LW5[G"F6[Q[SF?SO%!K
MSH.8L;</^8S71S&I%WHAEPD,PD2GTPXE3+V 00]%J0B"6(K8*%F'>9=C(_%*
M/D"5@#;A]F;PMG-J/Z#U3);?[L!*8+B4&-0X:IF[1-R;X6D1<^\<UX&B[@WP
M=11T;X50:]B]64O#!=Y;:;81>F_W9C=+_9RQ_$51_ZU@(GO5/*]+:]:9DV,<
M!0'S/4A0HKWO4@_2.-%QJKIV2R1X0*QJM[1U-CHJKF4%Q5)8.V.X%5DS^]85
M7CVS\!*JE9QG@$@U2N!\.LW_*)/CR[P %^K[S:J+WF6N)7>6J0E:CHS-UJX&
MM1]-E-XV"8W>Z6#E;50#7+,K[]5/<UV_.I_=%!D3DSC$7A@E(:2AKS;UB4]@
M@C&%OOH]BX4(%><8&WJFO8Z-8#9K)Y*U HN+E>3@N3"^Z;0; P-KL ]D>Z:B
MPU4LUX0&-WV!:F$2]@'N0%:AQ9?[LR/ST!:M5@O1N+'AC$1;_3;L1.N7':7L
M_O"FXT#*&KA!&H7$BQ2%2U]OW3F':40"R#CQ99QZ,O&LO/Q:^AH?C^]DH-:B
MGIBL>PU;,UO1$6*]\_->L)R7#C9 HZ]TW6L]O6^^[EV5CR;LWO-*!SOPW[.%
MN'DDQ1.YFK'&=2UA HL80TST/8XNE4=#]5/(F!?% 4E]+S$V^?9T,#96T"*"
M2L8SH*0\O!":X6=@KIV(2L\S?PT0C4>78[E]N%A87"?B,Y!QM863*P.J1?E6
M6VG?>\.912U2;UA ;<^=&)UV-7M^6<P_BU<Q#>MO+L*>E#B1T.-Z^^KQ$!(<
MIY#Z?AS'NN9 :N76W-+7V&BME V$':/!]F!I9MPX0JAGBEN/V*H$U?4'2L!Z
M<,4UP,1UY-6>GMXGENJPR@>CHUI><9+=8K[,)L@#ZJ$@$I K)H#:L0Y2BH7Z
M28;,4_NAA!M5!3[6T=BX83M7P[Q[TL9#T)JQA0O >J:*3EB=FM5B!XA^DEK,
MWRGMXA%ECZ2TV'V^<S;K_$GH*XY/2D1=J3R;O62SA^MG4>VSYA^$S M1/7=/
MOHOYY7?5L>HCFY'BK:R7I$L]ZAKG^53U]' U4]-7S!<3CY!(8!K A*D_4(HD
M3&,:04Z#* QH),,0V^1I[%%6*W(:(.&C5A+04AN0E>J A=;'.C-V;X-KQFTC
M&;*>Z;&2'ORH]?P)Z+D.5JJ"E:[-B-;/E^I6]6Y7ZH%&/Z>9N?L>!'>)O'N3
M=.B\WWU#OB=->.]==CA=.W]X*,0#68ASSLN\P&1:USV_%2Q_F)6_^Y)-53?Y
M3'P1B\><UP]<3K.'C$[%?5Y=_8H)%](721!"X6.]HNB4;!@GT/?]*$FP^D5H
MY.'A7+*Q&;<W^4(9"3KO$'G2E^<ZWR@50+[,N."E<P-ACYE2IHDLF3\+ELFL
M*L]0)\_)_J;C3&8<S(D" 3PU4-CX^CD=?H-3Q?<:U)Y7F*5:8*47J.4&:YJ!
MI6J@TFWY4*,=N,]KQQ>;*V6WL]C\$/2]AG.@T]/5L)+5L!;UB!5KP[J<>^"I
M&M;F(=$,JYK@E>N7LTOL/K!O/;QUVN%PI[Y]X+1Q7-Q+!]VVBV4YI?M',KL7
M3\]YH<V&C<P<'P5=W"T3 9Z_DFRJ';8^Y<6=6D-J<=6R<C5K(DLG:>1+7ZJ]
M84A9#%$<1SJY:@PEIVG(:1CRQ*B677\BCFUQ7XL)98^D>+#=%O8PB&:[P?<=
MFIZ7Z%(YN%#:P46CWG:^H#.@500K'<_ 4LLR_%3K>096FI;EFVI=W6T(^QL'
M1_O '@0<=/O7'\#;N[X>>^KLH:^KO#4EJC[4)=V6/OJQ[Z?"0Q!'/H8H2 2D
M01A!CQ*. AQR(:P\K]J[&QMS]U4"[PCH9NSL#LJ^-T,UBLNZ=HVH_7CI&X#B
MSD^_K;.A/?4-%-_CJV_REJO*FW5WS3G51H3 )(EEFGJ!A#$F1%&-$#!!VN<S
M8E'"" \(2B>STK#F]Z>4X&R3PFC:I-6TV9&ESQ/K2M;.X4*68V%\6^ :VG<M
MO-D0U1+M]8@CI4&?Q3=-D.NM_&9KY^]<@-,$F.,E.(U:Z49S[2;;Y7<V?=$E
MMK8DF. H0FDD4AA&0001Y2%,$B^"4<Q]&G$2Q](H'/TT,<9F<565\YY(\;NH
M"F]U+5/0<50"FJIEQHO5JD.H6H0B!M.$^M +?$Z9E^"4"+O,=_V/RS")\;[L
M&Y,SH&3-GLHJQ5+[I[UJ9ZA!1@JE4LV9%$/,.=$Y"@DDH>10)&$81MQ#*$EL
MO!4&F#]#59X<!'\S$Z%_5'LV%8P.@)9Z[)@0[DR&TY!T9#IT%&)0$^(TH+9-
MB1-;.]$]?*V.QDT^S=A;]>>]^+[XH'3^?>*'0<*\((4!#YFR(K /DT M7\3W
M_509%5@&42=G\6,]C\UP.%!\I*,K^5'<S=BO%S1[)KS]0)Z!2F+P6_U?+3HH
M9>_#Z=P4+]<NZ$?[?1^'=%,X#KJG&S=@QU=<9)/[@F@"O'M[HOET@D,FXM0G
M,.))"!'Q,2024Q@D:K?#8B8),\J]L-/RV/BF%@Y4TIG1S"Y<[31R$@@]TX2A
M_L84<%#7/5-<[3]^?LA??U'O5+-;_;":U+LM#3)I#RK03,K##W0LBR$6^D._
MEE7>F^N7Q7Q!RFK>YZ4/V21(>2ABWX.8<4_-Q5!"2A,.:4S2A$L2(M_J[N98
MAV.;HI6\VEN.59F!E&&F;+=L_ECF8P8$</&<SS/+VCE'<3>S#5RBV?-<KT75
M2-8YEM:D53NB4EZ'52 ,D7%5#N)8=\/6A3!4?J= A.E[W<CF5LV=XH4M7G11
MKQOU==2U@"FF/(@%@C&/,$0)03#U)(%Z5X*3E'N16:ZE(_V,C5HVQ 1:SHY5
ME@_A:L8A#M#JF3JZ &5-&$=@<,03AWH9E!Z.J+K-"L<>=T &YS-^*Z;Z!/B<
M+;+7\ICD8S9GTUSO.%8[YH@+%J;$AZ%$:F>0B*#*^QA*FL8B\ DB5B<57808
M'8U<WMW??KNX_W9[]?57</&7\]M?+^].(!#3L>C +CT@/"CU:*^=6@&PT@"L
M5 "_]7*D<0J(?1"7J0COQVJ6(+52GFU;'0*F]#'PM;Q;J&:::^?[?.D"?BVE
M*+FW3."'$8[UY2YDD?H#D5@7*Q0,1MP/94H"3,QB]VT['AOOE4*K[40E(G@N
M\H>"/)WIT-G*+V.1 [*,M5A[SBZQHLW0M%-BGX#W3(-::G M02EWF2RJ@O@^
M!ZMPED9XZ]R5-A!;Q!'U!/5 84(N(;>+ >J 6VN(CTU[PT7P=-!R(T"GR_O=
M+.6;(G\6Q>)-F]X+M1A=_L]+]JR_P+4$C(*$(?=]91@3)"'R4: 6!:)^4O\@
M$X:D'U@Y AGT.;;UH!'YK-PA+DIC;2GV68>$ER:XFQG!CM'L^Z1N52GM7OV^
MC#0LBV\Y3X%I@8LC,]:DQT&M5@L(MHU4FU?=99@+ZJQH+%6\DO((4L93Q3C,
M@^HW,8PC/T!!1'"0R%,SS 5CSC 7G)YA+C@YPUP'A'IFC\,9YH*!,LP%@V68
M"\:282ZPSS"W_4J'7>NNAW0=@=PD(]&YJOXK6SQ>O,P7^9,H5IY.:CE1_^/W
MY/LD5B1"_""$/I(8(AH+F 9I! 6C6&+)I!\:G>FY$VEL?+.T_;-9DP/ 8G?E
M9I0,MK:#8]\SD^T+\+B:+9-K?&I2/FFU@-8+-(IM.'/6NNG,3X./FL5N>?#1
M&V@?/> HVFVSG0+>N@%WT]-P6W.GR&QLVMVVW,VH_BH6J[1=$R_D28 Q@GZ0
M,+5=3R1,_5! '+" !C$1H4=M(A V6K=:R 8(+%#"@:F2R\YRW@0LX"*001Q"
MA*6O $,4$DHQ# C#$?:CB$16)QW= 1M@Y7<!F-GFHC,,/2_"&H&-5(ON]@Y[
M57:T6]AL>]#]P5ZUMG<$^Q_JL ?XFK^6^PB-P(ZC0+V]C2GQA9<&,/%0I*.L
ME(5/$@0I]1*?1A)A3(PM?(,.1S>+:Y&!EAGL>K-8F(4F<!N8ZHY![)L#CN#7
MI5"'"9 6UK-C0 >RC3M_F':6K@4XK7:L23O#6:D66FW8H#;O=<R9L<P&=%U\
MS.;/^9Q,KZ4^UB]/]<NS_+FB_\JRO5*?677*7_W#_E@EY$DDF QAP+C.V)9&
MD/"00QFD,O!\SX\]*\^K'F0<&^VOY0'+)?@US_D?V72J3T6YD-DL6P@X+6]9
M5MI5]RSS\NZJO(:I'JA^:YFLHX>/P,R4?.>A[?M4:&U4"]#HIT=X[=ZL4J6\
MM:\/$';&>)A@N!['PE4BD1XD'#;;2'\0[Z0DZ;&KCO%#&:'9M'2):Q*/28RI
M[RM#7R*F4S!Q":E>+D1,, X"+^2"VYQH['8QMF.-*M\(JX0#TY6\EC%!NUB:
M$>YI"/7M3; 2KH=4;8=5=Q78L]O!L*$\!Q7<"=XY_&270NED_G@^X_H_VJ_@
ME4S+ C1,[4M>2E_87XM\/O\V*T25,UZ?(U2U!O2] Y(RBC%#T&-<Z/)S#"8I
M36'D>Q%F(:.,!A9IV$Z7R&A"#)^232L#Q$J;,_"@E0 O2RW*XS^K[/NGC9S!
MX4'_ S%0H5\-OE($E#^LJ0+6= &E,F"E39G3%U3Z6-[IG38R-H7;AQJAH:JY
MZP'2>R*V-5\ 61NIO5.G*;^S(-^=%7IW@6Y[]?>3>ABP)+P+)#;KQ#MIL4O)
MFE5IE&MYUQ1&N2D$4V]DC$P_:J>9O/2ON]C]E9+Y4U;,%Q?+0BK:/WB9GW]>
MGRBF<90*C @,8I)"E*:A6A<E@81'THLC&26IN:_+("*/[5!E3>G2.WY9PF9-
M;["F);C8]TO-^J7R8*4]*#WNOW0J>#/(QV.P-(_ND^AY"1_N:^ARQS#,9V%3
M66=LG\=0)7<.U;UZ7OM,^-H7L?>7V@"1Y6>R*I=5ELE:JY+EK [/D"/57J!G
M$$D&K-PS)+*;)7T&[?E$C_]5@.NJM+%'I<<#%D"UJ?<@"J0^V4L$Y#A1'TV$
M$YHFG5S^]W0V-KMC+:/=FK2=RT>WXFQVZN<*O9Z7Z.[ =0\&:$'$=33 OJ[>
M)QR@1>F#\0!M[]AG\;N<+;+%VZ5BIX=L]J!V:G\L'A5;/9/9VX3Y1%*LN",D
MF$/$&(4IE@BR1"2!(A".4Z,\8D?Z&1MM5**"1E90"0MJ:<TS_K5!VTX7#@'K
MF2DZ8F65'=  B4ZY MO:'2QSH(%RZWD$31[O9D7L\Z0N[R OJF.<[%5<D 5[
M_/9\SO^O^G=MWNAJA:4K]L6C^BC$U>RR3@I_+>\+,INKYM0>H4H"0 4..:<1
M]''@ZZ2$,20\YA"C($B)CU+.K6(/>Y9W;*142:RCB9K$^WI7M%A)727)6$NE
M81MX--2'8&8IC6AX^[[2: )9_M@,9"FUU=>OC;Z@5!B^/(.5RCIA2JVT>G3Y
MC5RN?2-KJKM*.3'P(#FR__J6=E 3<B#HMZW0H;KMMH;=L4?!7W2.C_UW$O<Z
M@__*-4YP)F6,?,@#JI:D (>0Z!R6^D0_CI*(D9#:+$EVW8]MA6FD+[.]-I=W
MV]>L=DN)Y7B8K0S]H=PST1L!#'XKY>_'L[ ;=([HU[+S0=FT&S#;Y-BQE2X1
M/"_ZW%#U4Q\Y7A>WXD'S;UZ\K4X7*Z]"79QDQPCS6!K$#.G$X+J\JZ=S#V&D
M3'*UXT=>$N*88_/PGA.E&1L35OKH:;JZ)-!V=2F^-J]VS&Z;()93A\[@2G'(
M >F9-.NQN):K:\#K JS46;_N:Q32L>+F5F\/0V03A#3@4 T5H;2</LLKN;Q0
M>]'ED)G.*E<7<ZXP;@]T.K63 :.@'.&Q&2+EJM&N-8<W'>>_BL4R#T 3QC,)
M9>*Q1(20LH!"Q#T/TB3PH)^$04B9'WO$Z@S*I-.Q+6YK02VD2XB2"<YFAKQK
M]'I>B?9$ ^E ]Q]7"4<:H1W&N]M@Y*Q*L$&7 ]<&-@=AMR*PQ;M=?!#52C5M
M#:1':IT03)$,TF[U42P@3;D'<112$:$@]+'1(8-1;V,CFU)>!R'T1U$V,(I=
M8M<SU;3"ULFK[1A^-@YI#G$<RI>LTV=HZ?UE"$N[X]:Q1@;TN3+49]-=RO2E
MDR,7SV>\S./\F$_5^W-]RK)X6WKC2.;YGD I3)B70"1U-6_,$LB)'T:*B)GO
M&1UOV'8\-O[]?'7^X>KSU?W5Y1TX__H1W-U?7_S[7ZX_?[R\O?NG?TP"'_\+
MN/R/;U?W?^T<]M@^$&:68!_P]DS1:R(OLU8OWGIQD;)%QWT497NW[Q5;:01&
M2\2EV?O=F.KRZ7F:OPE1=E"OL6$:)C@D*<0B5J2$20")"!4I28Y)E,0\-"L"
MTM+'V/BG$;&JB&#',?L@-*.3$X'IF3DV,>DAOW*+^HZH85\/@[) BXK;$[[M
MT:Y'3=L)*7=IY#:?3C_EQ1^DX)-$) Q'?@C])/4A0IBI': (H)KU"?6IX-1+
M[4Z=K/H?&R?L2^Z:S<"Z#O^\7$ZU'J!6Q-)=VW:83 ^M>@._]_,KY[AW.,[J
MA)ZSDRV[W@<^Y.H$S>YY5[=FNE+AJZB<?.97LX^"ZH"7+Z3X7>AZRZ+J[4XP
MM0NL#:X+42Q(-JO+85='<OL*%2*&.,*)#VGH<8A"BF'B)QYD+"61[_L$(2O7
MG+X$'1NY7IS?_:7<T?WG^>?+K_?5KN_+^>V_7]Z??_A\">XN+[[=EOM!6S+M
M::!-6??]AZ]W>EZJJ&E9*UEN+%=J-N2\4A3\6+H05;J"6MGZ=N*G_DM<]CTJ
MSFB_)S$'7A_Z!7MW(>FYOVXKSODKR:9: K6 Z5A*+=F:&(9Y69* T%#B"))
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MVN!@M9_.N;-=_>GLYP9?'WY=2Z$G"<X3G>W"@B2 *,<"YED:0)HQ(C,6A%%
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M>FLS8A#QD,!<\ SB *>Q^I^0.7$DQV/]C(W]ZJQ?+4=8[UN"W^KZ:8ZBA*>
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M>6Z]M[3><EJ[ 0X. $#C"7B:-V<!PPR'RY6\089EJ!MZS?"P9GBFZ^$Y>%.
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MKH0&@'5+M]#*40QAB8+LROTUAAV\. +2R2"25-K[RN!Y$T"V[(A7 <A:PFP
M!"=H)WTIQSH"/X&STB_])'^:S&'>BRF8B#(A&#H4%U,)$J3,A++$4M"VE/!7
M1L:K!+7@AE>!2SVQMX"ANV#SGI^&CEE.'@Q1E)8&E@#$E5KP8*P)*D-R\%H-
M]5K8>8Z0;GK];0,S&XNY :R<H3,_[L<IS&Z/[O&A(\]4<E;Z@\B2;"D1\UX2
M8YG)+-I2\E,9+B_1TDW+ORT@IHJP&P#-7"2];$%Q*!V074;'W<C2T5(*0C6/
M6M&0Z9;22;II\[>U7( W";*!\YZCO@_]P?R\8)AFI1N?1P,4^J3$==.;6]$8
M+FV68(D(5I3"+T6<C(Q 3HXZ;FD6KPTI6 <@J]+6[?G-UC.1MJ*B!BS//;X>
M'[_JS(RD,9,8A"N-"X"$6,8XH$T%Z:,RNG:BTLO4=)MALAWMOPRQ3531 *B6
M=X"G_N;^+;*U+$@6@%@M2N]$HXF#* AZ^TIG4"Z)VF'X\Y0T Z:-]/S"Q>L&
M0F\#.N58_.#JRV!T _ .AI#[=Q<YG)O($I4$J"OM]CQN[#E%@IL[\!A!1_E:
MBX$U(?0*1=UN>]N#4BTEM .II[+J 61KI<E$%U] :I=)R*4(#H++,3MKY&N=
M^C= TU-BNKV:V"Z0-A1] QC:'PUGTOA[?_IY_WHR'5W!>,G5LO%33TL7HY>T
M-.M GI0%X@3&'];['*,+:(=K>^>KT-7M'<66D%5=(0V [)EE8C-P+J@@SEA*
MI/">N*2!F 0J2>.R]K63U=8T35N[P]@2@#84=@.G!J\N@7MG8=PGKT2()%F.
M,8GU0#PO,QI!.X.V5JA7^ZU4-TNMY'SL)*C;AI(:,%4/KW>>8TB7EF4^ 4FI
M;/ ^.!*\5X1'H10$2<%N]V9M7;SMPL?:'M[J*J;35B!W"57S!Y=I4%=PX;_=
M$V1)=\F:"28!@]M<NB=FA1%N,@%9\QBDY.3UJX,9UTMV>Y6D9CRN[>&LIE):
ML&?EZO$^"W?KA1E0 81'*4'&:#=(XJW-1!D!N%:"9K1VD/@R-<VX8ENT8'54
MT0"H[C'1<\PP-+.:&%52IXS.Q*+%)124H^!M"7JWY\AWFU:RZ]/S-PF["4?^
MZJH_O9J5F Y3\1AQ_X9A+*P$SA32[HD6QI=DX$"\D(FH'(SRC$<J:B?0OD).
MMZDF.W+8ZRBC ?OS5$*X6\]3.D]+BW+4VG0Z[H?K:;DPN!@52UO"E=$ /_%R
MF9E^*U4E@6E!;:D<Q2V=8HCB(M=$1!Y8B()&6KNHH"X'W::][ 2]':J\ <"?
M+I\[$\.\2#^;X&+(FH L@;51CN#VX(GA7IL$5C"HO?$^0T;7?5JZ0\730KZ-
M5-0 RNXU6)W3+Z,WW%E)A"X9BC9IXG/V)('CU'-C<,_8PAY]GX:NLV^:P==&
MRFD 7'LIS9*6_.#4]S&ZWO=?^NAGWF.KYPWZ&^ SH=;0TL?-$!^C)2FI[!67
M4JKJ=^#?I:K;H[6& %A9@0U \@RFOC^$=.#'0Y369"_&ZZOK@9]">@^Y'_O3
MGHA4H94.) N%BRRY<@<C!-%.6ZI#@*3KYS9_CZIN3^$:@F1E!38 R7L<S(Z+
M2D_\,7R&X:3_%>9'DD>C23F(/,D7_AL&;D%IQQ4I]=Y$.F 8N&E'>%*<><H<
MY5M(&WH+B=T>[#4$UFVJM@'D/I5TSUJ=DU>*<'11R@PY(-:6JVPEO<DY,69J
M&\^G5'1[0M@0_C944 /'B=\[:.@YISPNCX0,E,DA5B1BA0_$9N%51HX4;#&I
MY%F:NBU V?4!]>9JJ0:S';13/K_ KQ\/CB_.3SZ<G!Z<[5T<XF\?<K)!7^47
M/GYK#9978:=2I^7Y=G=;VW(+0\>49Q0X[GFRG$,K-$@1C1PW47JKN(^Y]IG6
M"Z1L'EM\A>$UW!5_)2I-%!'C<Y,RD2H5TTTC<=[2H'6FX&K?=SRFH=NSNAHZ
M?QH ;"#E!IRF!?T?4%C/Y5/=]=293 #_2\4O!!JB]@X%!(#65$F!=A5--4>/
M4#M;IG/7=OG7(+-;K&V&B^=!MC4E-8##V^2J11^Z.\%IP86CP9/ M$%&'"4A
MN(C?A0P<?[2B>B^ EXCI]BQX&_:KCMP; - 9Z@()*+VEW^-R&8QF/9L67/7
M1:%* &MI&= !6:+O9Q/A(0!E5DC0M2]87R6H6^-42>E/.P94TD #</H-ABBC
M ?*REZ[ZPWZ13YDMO60G9Z.91WLJ71%4 (GFE27B#&-4,N=,=6?J.R1U:YNV
M ZF:6F@!5(M&3\C/HZ9@AU=??']\-6O* ABKE@&"B6F4DD%'P0;G".79*FW!
M>U:[4\4J='5["[4E>-761P,8NZ/\)!^-AI='N%S2O'?'[S!('T;C3[APG#=
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MN3VD/?Q0?PG'UU<!QB=YQM3DY'HZF?IAN?>>KPW#/5AO*.&Y=+[G$4VK,8H
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M 9]\*;^8]#(*&[(#PF8=RG*BZ,PH09*7/F1E!,NU)UEME:$F8Z?=FNDNH-&
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M$Q>I)?C_X)V,H&1M3^)E:KKM-=D]^"KIJ0'$'0$:=)CU]GJR>+37VAOOB?"
M@1Z5GGAO2XU>U"K+9.H7.;U"3K>]);O'7"U--0"Z8_CCWN'6>#3$;^-<5,][
M%I)&15W&5212R>6"1&Q@B:@<!<TF,JYJ&[^WTK@2/-W/"\^MZK0!S-ZVD/F(
M*_!Z/./LA7-9FI)EQI*42V?$%".QE >2HJ2X$FGPH7:*Q\K$K7:T3G]>F&Y'
MC3_Y)>A%\70ZO0)=4-#2!>AS0FGJ^K/D_@CE-3&6ZW(_5,ZJE"&1>5PA)BJ?
M:A_4='K].>ME>QX_0[H>P$F^=[)WCI\[A<M^//7CZ1!*]N6]\F>D[G(,L!PR
M?H9DXDK^O,C*O/EM[,LO)GNG,"[3R?PE?OA%&:FQ>,)DAH1[[<04#5P*2H3.
M4+*N&/%. <D>F  G1*+J>^NF$5Y^AIO8MRR#!VV1NQ?_FZ#4@(]T)['G3V<>
M<5?&15FK,6IQ"4K;<DE"+#.IG;$.5.GV5_O2]VT4_@S7P.O ?P?Z; JM3T:+
M/.;S[CS14\LL!BTTE'D2J<38+GD,6B!REW/INKXUR*Y,YL]PQ5P'M]O1;*/N
M_K,-?-?WW5_[N*WU&]ZB5_UJ=UD=$S?1J)*#C]&>"8IXX(YX[Z4"EQGPVJ,J
M=])U>'Y?A\!?3F[HPV01^J:3X5DYO5X4(QV/AN/EC[,,M$?67;$DN,F"8.0M
M<4$*08(2FOBL&+>*2<=KAQ/UN6BXO_%;$/CBJ48WZF[4'J[63WA] _FFS]]=
M@^0MFM W-)_5L4S@UH @9A[A[!BQ @0I,V%-"DZF7/O>?'=MDI^[_[OO!RN?
MLT[H^"I<R1F@#'U6Q"9AO )#O:T]:^15@KJN?-L*9E:YDEU/)0V$)O=DMC_P
MDTD_]\NP\66&VK4??/2EBGAZ\QX=Y\>'!@*\%PQEY\KT0\T"L=%SDCFW$7AD
M3M:ONUR?WFZ#[!VA<V<*;70K?F/GU_7WY/4>U$%SV^:O#Q05UJ('2')$:REM
MZ2/O,I L ?U4L-+$5-F,-%$]A;ZYO[P<P^7B48NCV4=KDJ8R9I$)DAPO Y$A
MHW0"?N'&:4[!:5&[ '<EPGZ&$_NW(.^9+F25M=>H17V^Z>'ZAO/5S]M>E\8M
MFL$->^$E0[E7-A#0X(@,TI*0</=W*FG*.'<BU,Y^Z[97X]VIZ0$"9G0#Z$F/
MO_8CW'7MNT]4&1(:;U=9'%WBPD>B9E.Q9Y3>JQBCN'Q%]B3P:-#[+FT%;>3$
M!J5X%"IR7;V0?UO,_-#]'=^"Z9</U;N$1Z/6^+E&:.O;XE<^;5M=V[9HAU?O
MK:4L#8EE2XSU#(' +;'&1@+,B!0Y<Z*ZG=A9[[9'=U)/'_EH4<08E&$^D915
M*O.5#7&"Z]*=VLD0G?35J_/?2.*/TK'M+:CZSDUB5:TU:LIJY<<=^_%\N,1[
MF/K^H-/TP2>TM)1(^+J@FCH3""S$;)@A1I0Q([9TRS?<D^P$J.AC&9OY,YX)
MW$N$^5P&I1P.[W+=EZ7LLQVTIT,..3E+-(^22*XE2@@LH1ZCS$"5BV%[9OL[
MQ/T,9P-O0> KZ4P5M=CA=<%D/.WM%P9@C#J8WAS[*]C[UI_T&"LCLY4CV3M/
MI$N46,XXX1Y]?J/0W98KG4[A ^XA$'^Z0]]+S^ZX4=IV5#RJ*.^.\7(&7Z['
M\3.&:[>IJH]9>C^Z\OUA#Y>9BLQ*HI$'(G4Y'X.@2BMM92W3QOF5C/UW0+0R
M0=T@JX[.1]M60)>H*LG2?^U/X?2S'U_YPV'\"%<!QCT:76)&SJ;>Z'DIK 63
M">3@;(3D(G/?\P!?^O#NP+ E_8TJ"K.!&^R7S>^[FPO\C-D2 LJ3<%80@%QR
MC"A&2Q0\\5089769%%S[B'45NKJ]D=[N%K8U_32-N<+18E%JDY6A(I+(LR52
M&4Z<28$P%Q5$)V2J?JZR"EW=NDWUT; RW-943=?[W2U#RSU@R<_'4O!3(+"P
MVTD*#X#K4^18VO?K0 )-*$0OG?:&2A!LI4UPU2>VBJ1U%3W:MM2;A=(Y?)G.
MV+G'6"QK+21&**#AEZ(DLCE>K'_DQB3!G$V;P>F9IW:[(78$J4VEW_2&>-0?
MPB&R-^F9[+E3P1'/([+$*!#'32(RF,!YUHR'ZOVMOD]6MQ5,7;M@ZVFG!<#Y
MR>='%59[PW3^>32>7L#XZEX69,^!$;B(),G,4I2<,21PAIPYP4*PVJKJ=WVK
M4]?J'KHF,)YIG;8%+76]CV*L/"[=D=[#_-_#X7>:>QY\6[0W+%4S^%^Z\-]*
MR37CZ#P0[5.Y+0QE]H%!SR%)JI*.COG5-M@JY+2Z\VX&Q([4U1Y CV$Z'^!S
M-)I,]J;3<3]<SVH8+D:G,PWULM1&9N?*"%84JBCBS=$3'C+N+L8PG?.:</SN
MP[O=A'<,OKJJ>#O4W!QJPY*YNGAO9; =^/$0I3@YA?$R9:L?>P%7"J>2$5Q(
MKE0U*.(2?J>E0O<V165M7!-@SSZPVX;3.P;5YB+_$8#TOC^XQD?UE//!Q% R
M:RC:8A\8<8I&XB70X&6P5/E*4%H\LMLNSAV#:1VQ;PJGBXJ-1Z=E6\40"TGH
M3T^NIY.I'\ZV]ZLBS9X H;Q0F5#) YK;;(CW"0A7R2);%+^O?5#[/9JZ[;F\
M[;"@JD9^\N2V9;^FO$I+J%*-'V$X*9*\;0_50%9</29:2J?;DFJ:RL.S447M
M#"X])S$LEQ$]".HT >ZL4MXPKV-EV]A$'AX^N/1-FROOK#_YY_P4CI?$VJR+
M$)@FTEFT?U0:8JS,,3D;ZN>-/T_)SY!A]Q9L/3,W:E/]M)A.IRE3'$DE D,_
M(J.7Q-KL"=BL-1-1&+U2ZYL?+IVNACZ_ESOW%N'^,+ES)I>^ZYH3)R/'$(^:
MTCVG5+3:Z)43QKN5G->?-'?N33I?*W?N+0KH^ESPN72OR&GFWDA"E2U+3 D2
MC/+$0DI49BVS6"V6_D%SY]ZDO^_ESKU%F%V#X5U_= G#CWMWU!M+7406B/:R
M))I*(+;D,NA2PJXBZ$CU2E!X\M'=W"[L" B;";)K&!R/OJ(@^I/#(<;XT^LI
M3#Z,QLC21PS-8^D7/.\L?,><3%09ZR*AA@$&Y]H2RQ'M0H,2E$F-WMQ**'GK
MD[NY)=@1B+:JAJXQ=C+]#.-GXM^EU31(KG64F%R\/,T9*<N'0-(\<'Q-/#Z
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MW8NX6$..#>1-?/3#ZUR*'?'12[-:1+043914.1=QM5A*)--  O<4+2O&:"E
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M,0TLH">+IG,61D=TRV-DZ \E6CH+6T>2LKRT7W LT,KHW[N^G1WO0U$U6S6
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M-U4^\H56_3=\+W;$WZG]'U!+ P04    "  C@F%7"2E&X= '   A)P  %P
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MDBZG'B16(#\21]*SD"Y5QE78CYC3&A6Q4EJ3@L#7CNTA- 0@UF+\W]RG.:9
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M-4,B6'U'^.+:DB72][,!<+I- (Y,_&;"517HBL(+689%HIQ@8-R:8F]>4&Q
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M97)A;F,N:'1M4$L! A0#%     @ (X)A5^]UM5JVL0$ <#43 !$
M     ( !8E,  '-G;6\M,C R,S Y,S N:'1M4$L! A0#%     @ (X)A5VQ9
MQY^S$0  ";,  !$              ( !1P4" '-G;6\M,C R,S Y,S N>'-D
M4$L! A0#%     @ (X)A5Y3<%_;3&   8^L  !4              ( !*1<"
M '-G;6\M,C R,S Y,S!?8V%L+GAM;%!+ 0(4 Q0    ( "."85?!._95:E$
M #_G P 5              "  2\P @!S9VUO+3(P,C,P.3,P7V1E9BYX;6Q0
M2P$"% ,4    "  C@F%7B4U-S/^[  "MH < %0              @ ',@0(
M<V=M;RTR,#(S,#DS,%]L86(N>&UL4$L! A0#%     @ (X)A5UOM>QT7=0
M,R4% !4              ( !_CT# '-G;6\M,C R,S Y,S!?<')E+GAM;%!+
M 0(4 Q0    ( "."85<?U8^)Q0<  *XF   7              "  4BS P!S
M9VUO+3(P,C,P.3,P>&5X,S$Q+FAT;5!+ 0(4 Q0    ( "."85<)*4;AT <
M "$G   7              "  4*[ P!S9VUO+3(P,C,P.3,P>&5X,S$R+FAT
M;5!+ 0(4 Q0    ( "."85?@%;>@# 8  &P;   7              "  4?#
M P!S9VUO+3(P,C,P.3,P>&5X,S(Q+FAT;5!+!08     "@ * *,"  "(R0,
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
